<SEC-DOCUMENT>0001628280-22-028168.txt : 20221103
<SEC-HEADER>0001628280-22-028168.hdr.sgml : 20221103
<ACCEPTANCE-DATETIME>20221103160233
ACCESSION NUMBER:		0001628280-22-028168
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		61
CONFORMED PERIOD OF REPORT:	20220930
FILED AS OF DATE:		20221103
DATE AS OF CHANGE:		20221103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SANGAMO THERAPEUTICS, INC
		CENTRAL INDEX KEY:			0001001233
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				680359556
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30171
		FILM NUMBER:		221357828

	BUSINESS ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005
		BUSINESS PHONE:		5109706000

	MAIL ADDRESS:	
		STREET 1:		7000 MARINA BLVD
		CITY:			BRISBANE
		STATE:			CA
		ZIP:			94005

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANGAMO BIOSCIENCES INC
		DATE OF NAME CHANGE:	20000208
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>sgmo-20220930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:9b84b066-0d3d-4626-933d-a605fa769a06,g:f2240c07-5619-4846-82aa-63792348e10c,d:55c688caac2b44c98200d144e37b2144--><html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sgmo="http://www.sangamo.com/20220930" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>sgmo-20220930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80L2ZyYWc6ZDg4NDYyYTQ5YTgzNDE5M2IwYzdmNjJjMWNkZjZmMDMvdGFibGU6ZTk1MmIyZGY5ODA3NGI0NmFhM2RmMjUxYmQ0ZTUzZWIvdGFibGVyYW5nZTplOTUyYjJkZjk4MDc0YjQ2YWEzZGYyNTFiZDRlNTNlYl8yLTEtMS0xLTQ5ODE2_a2ba43eb-c79d-4e10-9613-0aef880b1c2a">false</ix:nonNumeric><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80L2ZyYWc6ZDg4NDYyYTQ5YTgzNDE5M2IwYzdmNjJjMWNkZjZmMDMvdGFibGU6ZTk1MmIyZGY5ODA3NGI0NmFhM2RmMjUxYmQ0ZTUzZWIvdGFibGVyYW5nZTplOTUyYjJkZjk4MDc0YjQ2YWEzZGYyNTFiZDRlNTNlYl8zLTEtMS0xLTQ5ODE2_306b417c-cf7f-4aa4-9510-f90bf33501cf">2022</ix:nonNumeric><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80L2ZyYWc6ZDg4NDYyYTQ5YTgzNDE5M2IwYzdmNjJjMWNkZjZmMDMvdGFibGU6ZTk1MmIyZGY5ODA3NGI0NmFhM2RmMjUxYmQ0ZTUzZWIvdGFibGVyYW5nZTplOTUyYjJkZjk4MDc0YjQ2YWEzZGYyNTFiZDRlNTNlYl80LTEtMS0xLTQ5ODE2_a133d534-4812-4710-9899-fbf2cf218aeb">Q3</ix:nonNumeric><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80L2ZyYWc6ZDg4NDYyYTQ5YTgzNDE5M2IwYzdmNjJjMWNkZjZmMDMvdGFibGU6ZTk1MmIyZGY5ODA3NGI0NmFhM2RmMjUxYmQ0ZTUzZWIvdGFibGVyYW5nZTplOTUyYjJkZjk4MDc0YjQ2YWEzZGYyNTFiZDRlNTNlYl81LTEtMS0xLTQ5ODE2_39c019a3-e5a1-4d5c-9c03-9008d58c5a76">0001001233</ix:nonNumeric><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80L2ZyYWc6ZDg4NDYyYTQ5YTgzNDE5M2IwYzdmNjJjMWNkZjZmMDMvdGFibGU6ZTk1MmIyZGY5ODA3NGI0NmFhM2RmMjUxYmQ0ZTUzZWIvdGFibGVyYW5nZTplOTUyYjJkZjk4MDc0YjQ2YWEzZGYyNTFiZDRlNTNlYl82LTEtMS0xLTQ5ODE2_82d98d79-9c5a-487f-bc39-d234d377d391">--12-31</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="0" name="us-gaap:RealizedInvestmentGainsLosses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80OS9mcmFnOjQ3NDVmODQwNTRlNzRjYzlhNzRkMGZlZDIxYTA5NTg5L3RleHRyZWdpb246NDc0NWY4NDA1NGU3NGNjOWE3NGQwZmVkMjFhMDk1ODlfMTA5_376aceb8-a05f-41d7-8aea-d3ba497d30a5">0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="0" name="us-gaap:RealizedInvestmentGainsLosses" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80OS9mcmFnOjQ3NDVmODQwNTRlNzRjYzlhNzRkMGZlZDIxYTA5NTg5L3RleHRyZWdpb246NDc0NWY4NDA1NGU3NGNjOWE3NGQwZmVkMjFhMDk1ODlfMTA5_66703c93-cab1-4b8a-a5eb-e71bc60ef0ba">0</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xMzMyL2ZyYWc6MzQwMTBjOTg5MTA0NDg2OThlNjgyN2I2OTVkYzY1NWQvdGV4dHJlZ2lvbjozNDAxMGM5ODkxMDQ0ODY5OGU2ODI3YjY5NWRjNjU1ZF8xMDk5NTExNjI3OTk3_2cf88b52-4fac-4525-a48f-b581392da2d8">30,000</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="sgmo-20220930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c49b51e78f84124bb9eb7003ea63dd7_I20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i65c4b9f6e28c49ccb8e9f49894741665_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieaf636eab7a446278c2c60b3497f65dd_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifdb651fdae9f4daba649e657742b10fb_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0901c3888400484d82bc9d499ba27882_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4358e68463414d2f81e6d07be34f96f4_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f86a00ffb9a44c09b92cbd140f04b6a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f36b8087e874e84bb6cfbb657e30dd3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i477f878f2fc449a7b9b882f03d328aea_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia174d038fef54c1988b0d1f7bb55851a_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10185405784946f6866fa6235275377e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5629c83660045e689bee72501b7f3b5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1842e89b1004e10ab03df6383c15efe_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie475194a8bc5487bb425f884b64c7cb4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id44dcc12390c46679a8547aa1acebc45_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a696035ebd0409f842a3d85f1f17177_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7eb5094c50c94679a226568ebb7c0cdc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5f88f052bc74b0897f087b88dcf0e44_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id28e3d378e8e41c2b2f192f93c7e7a2d_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie86b8354fd9c48fa8f7effcc8fab0655_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b80b0627d224b51a736282e5de2e649_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe3dce0a01ae4da686148893e81e9cbf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ab6b60ff90948328c6518dfee567d60_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4437087e8514ebf9125f5ef80b34f7d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd6155b736044781a9509dd909a16744_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1f86ea542ca45139f8b891e2b341360_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b2b14725998443da0214724315022e3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67e431fd603948ddb3a910386fcf7720_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b20689a47fa4626b06dd28beb352cfc_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i888b3ba590bd4c97a8718de47daae199_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b65f408605048399b735ab6734947a4_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia153a8e0f69e430e9b0dc937bd3916b8_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9241e8a504e3490192f71c9decdcd3cf_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8bc460fcd2b4144afd1e6595036df06_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacd4ba876f2a4fb7b83c09ef9bd71e56_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bb367b30b03403c98021e1aba94eea9_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53a9405cbbd74d8e87ce89d2e69fd569_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcd86bcf9af64a3a815fcc501ba0ad77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i920d94b246904434a9c24327eda62fc2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12cb742f69d84eafb765fed1f2925d84_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib759e7d27c734ebc91eb8d8e7257be3b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56f6f40bbe064e2eae76f5a1f8c67c65_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i451b037bb41149e78da8c2582ef147c9_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d5c5e06d683406faa61d58c55c666a6_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1053b2abcb2a42f6826b1ffc69e93fbd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdbe3cb5b46d4f3881583fc8ba6c0f17_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d9943e3bd46453b9a5ad5d1f8b22844_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb067ffcdfcd40edb211090a036dab65_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9f15dab01ef4999822c32ed4f2574a1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sgmo:ChangeInCollaborationAgreementScopeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sgmo:ChangeInCollaborationAgreementScopeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0f3233d7b70474da06a55adac0cca4d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ib4943cb2b48343ef92ef1589edef40c7_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if38002de5fe848d088ca4840e3b302a0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia79b57d1d6da4b0d9ef31df01511d42d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fef75604563438abe9538958474da7d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8f43928847f42c1a83bf8800d5fa943_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88ddbc38aa6445598de986913238d214_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4327ef899954f25af6c0c80522b2c7d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fa286ca65b64056995eb4ab2664cdd0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e54c4c6f853445c95d080879c43b2b2_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ebc3bc839ea482380db614d89d89bb5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45f1ab603cb94ccc868b785c550c0609_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacda68cbeb604746812d5bd97bf218a3_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf66e1bb8ddd4393b9d770b1885a7a64_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib124d69483284e9693d405b60f7383e0_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1634f7d6a7a14dd38290439da8287bbd_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id122cadbcd79415cb294942cf9401910_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa6d0f240a92487abfb8f0f38f3112e9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f8158142c524b369324fc1ebf0f9f1e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a6fb7e7492a4f939428513d8fcff441_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96d87151f3dd48979c96441aaec7b540_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffdbeeb166274031b5cec94b4a93c065_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i681433de93e34299a5bb54fef49f27c4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfbd33edee0941eebf5eb1beb36d33b5_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie11a6708a3494e018d5eea96804cc1f8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29f19ecdd60e4cf4881d032f9b06e15e_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf1ed758ad3142609eaf08869c43df41_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idbd920e533444e47a3756a9b4a8eb6b6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32ad7e19c06a465f8f07b405b0f7cfd4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if27bae2120224abea6224708e6f3de8f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca8592334b04957a537a0d4cf813494_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc09550b59114bae9b748047cd9d24a8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ab0f243dd424f92b69b063a217eae48_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i411394c5d10d486cbce2b24abae3a661_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09186c27c86747a68746b52de10d7d1c_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5b732d846284342a16bea6ef1968757_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i769639b449a24295852cb05e72c00a17_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9606a8a617b841e885ebefda50badef9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i122ce6ac71ea4602bfd1231782ca60d8_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic67eaaf5137b4b6f9b62df6016a69f07_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd4fdedfda294dfab406c29000abe2e6_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fa8a902c3774cde978198ce09be1bb9_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i639b4eda38c648ffb15ee7b60a5bdfd4_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6065eabb66dc4690a7523d48b52983fc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a4226459e39406dbf0ef1ecac2f7183_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33868ebce0ac437282e6ca0c2cd516ea_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51cf12c7232b41e7a436caf0336ac5c1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cb99b1da6c54c77bee0c45127be6f3f_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21bb501c85b34076a54c9225ae07ee8e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73036590c4ef457f87ba13c7f72633ea_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c608a75f06a443dae43f3295a547e25_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9df22ac2f004b0fbb4e5f907ec70d9b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if90f6a0673d64365a8cac1c06453bb58_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9430e03891404dea839fb2cff64af738_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if003bbe1b3bd45aca76e20e836c5a3a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia43cd647cad04bb9a7cadc11f325af6a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcef3b61008c46d0992163cd7bffe1cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cf4147ceb5942299b88c10a4f9be27a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b800a8209c64902a695cd1dcd597172_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaeaa77913ce413b93a7c9dab1d36cab_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0de8afe4f7c2493b8c43a2e0f29a7399_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c91803551d641a8963ac07c42cfe596_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic47a895f418d48cf8f9d9eff69edeeda_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3be3d7d00461404e980d8a74a0ae2c25_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c98918b8f5542dca9d804a934e84995_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ee5a63a339b4d8991f36eaf5ff1be1c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i983119dcdc834acda4676ea99a8c08da_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa714eaea0f1411e85e65049e450b3eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86315bd8be5a4ce4b190ddec3e753c05_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6016ec92d0c640e1aed56b72f34057e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69ab4258b6f14b29bd7da873df0ba0f7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i764fb984c25d4da5b64a0b48e5199b99_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia28128c5fca64935bcf980ed70b30b2a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i386e3b89d03f479ca5825c2bebba2e54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie86bb74f566944b9839da6ff3a70d767_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i359bee546a724e5d8222c768c5722bef_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab983723fa734404b015fc014b16e4f2_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1f5af8c8327472da2ae3d160d57b379_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48e0ebe4c00048caa8ca855361cd3dec_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9e93e6a67164aee80389e38c2ed7ddc_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic708e40109d743859a0cbe3fd8575521_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9fe47fa2ac24546b0189e24f5f31056_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeb29a716f8547e093a0767d93caf9a1_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aa1ecbd5903489ea2ee1f51365efa36_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09e4f486e25d4837bc2bd16e7e92edf4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb83f685b39f49fc8b06dfce81650e59_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0d6f23a6e1e4fdd89526d7156771dde_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa0a0121a11a4f5a9c8f92c62eb8b617_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if51181fc5273431abe839125ae5e5dc9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f81a5cb7fee4760866d108a18198b21_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6be12bead5e34d9d9730b4f9983fdc54_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id24858a277a44f918d47646294044411_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3fcad2bda744a41b13d72cd6a61005d_D20200727-20200727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-27</xbrli:startDate><xbrli:endDate>2020-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7052887b1af4eb59f472680a598c7ca_D20200727-20200727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfCommercialMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-27</xbrli:startDate><xbrli:endDate>2020-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ba866a4b6af4a9491a93eb6f0ff14eb_D20200727-20200727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-27</xbrli:startDate><xbrli:endDate>2020-07-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2734364915f440429f325226570e6f66_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaae4a2b1c97a4a699c93a09a3af3d231_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d5f1ae0ab8b4decbba471d9add02a71_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6ea8c76ac97403d9fe80699600d434e_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1417415012944e48964b4778067acf9_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i916103514d9445a2b559cda726e4ef32_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2096aeabf3b946a5875461aa88d4cb20_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7556e9945944bb4963819871e859b10_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaea4ef3b62d94312a30b3961e15b1c2d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a807fb830ff454bb7a40d98e23ead88_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i813d7c4c38564599a7261dd61b7d10e1_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41aa40e6f7734a11a5ad5d91444e8c71_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i640dece72c8d481a9e06ebab15977c75_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901b43193e044942b699fb8fadfb9534_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9972fe6d5f2b42c89d347449caf70272_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba431dc7b3114e9492531e7e49f27982_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i714565e5ccc14fd6ad101d485a5a8de6_I20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i449866dd2b4e4cbca1f5dbb0c02df99b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ace65935fd74827a8e79d81a8c99883_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae8fae1af4ab4d9a8c4829058c9e5f83_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f1b352df962492a825bd38db79c1fa8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68d24c5b8cee46749f97407c43bed757_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica4b8016d6044abd95e91f31762196db_D20200501-20200531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebf44488500c4b588b4bdf5563a4334a_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie47b011a38824aa1aaad584fadb9ebba_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="sgmo:CollaborativeAgreementMilestoneAxis">sgmo:PreApprovalMilestoneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cf72a2afc0847f7a0aa31702eac099e_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sgmo:CollaborativeAgreementMilestoneAxis">sgmo:SalesBasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product_target"><xbrli:measure>sgmo:product_target</xbrli:measure></xbrli:unit><xbrli:context id="if44d955f3cee4094a3a0cecf75e1cd02_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70a681d5c2fc43359fac6166d3c7b02b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0601be924aa4f1fad543351bdf06b1f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58dad48ada774420bb627b6373806b63_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3567ee8e981a4805b1614fbb6249f324_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12d66cce985941ffa95915f401661188_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd568c62528c418d98ba3506620059b3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib95c66db249d457f8c5145b0b4180e59_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia893d1f21e7e4bfc9e693b7773c6ebb3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i582600df1f494eeba31d6db660f24309_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i107234bf3c2c4164845bafb59e087b2b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84f278d0f27941ff887205574efe505f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i640710eb43bb446395030cf119393d5e_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbafd7f9191749e7a6078d50d26cff6d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeedce2ee3f2443aa731e0a0727b79bb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e70aff9076046b0a8a267498a58548b_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ffaaa021478445aadfabd4cf2b1cd40_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i656cc305a9864393800b99c4084fc3be_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26b2aa0ee0524b8e9864406fc3e47991_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if93a6d1fdbb248ec8aa3ad0a3d16700d_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33a718c16a224765bbf657e25d2f612a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ff2b470a6b840b1b600226ae0cb70ef_D20180401-20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65b35c689bc646deaec17d1a4a06e1ae_D20180401-20180430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-04-01</xbrli:startDate><xbrli:endDate>2018-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="milestone"><xbrli:measure>sgmo:milestone</xbrli:measure></xbrli:unit><xbrli:unit id="option"><xbrli:measure>sgmo:option</xbrli:measure></xbrli:unit><xbrli:context id="i93c77ad66a244121b7e7c0650a102466_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2565b2e5ab3411d909ba058b98e784d_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f9193d162614c82aefef0bd29f76cb0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08b40673b5374b688d69a9f30889e26b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i283bbba7da5c491abef1b46ddd866d80_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb5cc7c162fc4f9f8aae9712c9c2186c_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf1383bfc9fb4e4da9138b24f4483085_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32258af563e84d3eaeffce96590ce4a3_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e36b699832646d09fb049651228fc3d_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd52871c65e74074b943d036e228c407_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc52a7e61b9445fd932586d407d4b4b5_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f401a18597344db8bea22b5b529e1fb_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd41724bd2c43c49a877cd10c22b362_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if156dd60b13643d49e1714fc2aef31f3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5ee9fe84d52410e95ad3919dcf23692_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i965c38aa9a1b4725903d0bea5a63f9e5_D20140101-20140131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2014-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="program"><xbrli:measure>sgmo:program</xbrli:measure></xbrli:unit><xbrli:context id="ib5f997ce9152448ebb21b42facd1eb60_D20140101-20220628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2022-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i710e17ccda8d423c80784fc598352f2f_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="product"><xbrli:measure>sgmo:product</xbrli:measure></xbrli:unit><xbrli:context id="i06746c47a09e4d0ebce6f17c639cd75b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c1eafcb24464080b10cb25f38311835_D20220906-20220906"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-06</xbrli:startDate><xbrli:endDate>2022-09-06</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f1f8318a747463abe0b0a5f9f6fbc8a_D20140101-20220628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2014-01-01</xbrli:startDate><xbrli:endDate>2022-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6da6fc44c004de5a49215fc13d59250_I20220628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="sgmo:CollaborativeAgreementMilestoneAxis">sgmo:MilestoneThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i905f6dd1d97f41d5aefe0d9f9ce7d481_I20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i933fae16aba14368bec01366d74236a7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c81a778afcc46f38bd393eb5ffba599_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i202d58a6a58d4af08b477d923ae048f3_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66cdb12a800d4879bf0c3f1766fa88fd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i892bdf3ab2944fb4b7a953ffd1c2f6d7_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17f9d36d461f448483df1b1e4e3a01f0_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i140d27fd2160489db7ee0eb0978a4d9a_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i724bc4b7322a4e759c114bb5082bfdac_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i364d22703c4f4fb590d565ce2c24609b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6a265c8ac4e49de84028acd0fb40413_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:MilestoneAchievementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id79ab6aa736f4dcb9f4f3a8b1435949d_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:MilestoneAchievementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09c51fb74c4c492ab74e416789db7c1c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:MilestoneAchievementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5e292264aa1455f8199ac9bf6f10164_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:MilestoneAchievementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a5d588119f04333847cb581fb37eb61_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf6145619fea4fa78fa9c0bab78ebb20_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id45979bc9fd7456cb09006afb528134e_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifda78d9bb9e34007aba808bc57d3ccc7_D20170501-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia67b43e22836459ca0c85db6bf587fa9_D20170501-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie097ba41160242b7b938ec9f67d75616_D20170501-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie76c5aed7b74477aa60d84886d741c43_D20170501-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfFirstCommercialSaleMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic34e88035a5f4bb08ff13aeb0beabca8_I20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9451d2ff95384408bb974670f4956acd_I20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:OtherProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacfe2b36ef12408dba96a7eca579c6e3_D20170501-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a0335905c59449b887401672756abb9_D20171201-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a587603a6dc495fb68564a49c608c3b_D20170501-20170531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2017-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6cc5e9855b44daa88a4b942b38da8a3_D20170501-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-05-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c3303f9b2c441e4a8661c7063d97b4f_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35335210865a4d9fb1acf14e87a58341_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f5fbe525ac74562ac7d8942cd031794_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67383e30f21c4630a881224c8ec6917b_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied5371b887eb4e1ba5e63238f1af294c_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i807e40274d2e4fa68fb97fd8f56732c0_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49341b6dd59f4dcb8dc3e02283b1a9a0_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfCommercialMilestonesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95d5384d7d794ed1b248fe403cff0f12_D20171201-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i309018fee1874efc81946dbe7c82f131_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c18ff8ca01c40e78481b76d8fe6dda0_D20171201-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92faa1298286405e93c727411f0747bf_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7de837b09974499ab74e3907f4da3664_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9394094054442f383751ceedfd5a981_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfffef1418344eb7a8831ffe392e5e22_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd20bbfeb147419cb5f8dc6db4ca9849_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56dd64461cdc41a29f9de3b35af516dd_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4198818716d4a5982ff62c84d98fc2b_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i398e9284c1254e7fa5e4faf15172c220_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ee803986f614d5eb89d119dfc27ff5c_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcb87a6bcfe548619d4c435b6326cad8_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf9d9769367043dcbd6120a50e2504a5_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida843af1fb12494eabfc5378c6f08828_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cffbe21ee8340aab6d270389c188838_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4685841a6f74d2e879fd6085f56e095_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6787fd385b854be098bb92baa474ae00_D20200801-20200831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-01</xbrli:startDate><xbrli:endDate>2020-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcc3055e11a04301bd4380530c45310f_D20220701-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99aed81b84ae4da8ac317dfc988149a4_D20220101-20220930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06ce069112274b73a381a623267ad36b_D20221001-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3f90dae3d5d49c094e3925ff3e04933_D20210701-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b3959b3e8964e39a6463ae8b22b489b_D20210101-20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001001233</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-09-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i55c688caac2b44c98200d144e37b2144_1"></div><div style="min-height:36pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:2pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.527%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">UNITED STATES</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Washington, D.C. 20549</span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________________________________</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY2_05d24faa-b42b-4b28-9731-8a022ac7555d">10-Q</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________________________________</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Mark One)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6MTFkNmYxYzg5YWMwNDcxZWE3YmVhMWYwN2IzNWU2YTAvdGFibGVyYW5nZToxMWQ2ZjFjODlhYzA0NzFlYTdiZWExZjA3YjM1ZTZhMF8wLTAtMS0xLTQ5ODE2_67794f31-69ae-4ff7-95b9-513e3e11308c">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the quarterly period ended <ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMzE_d8927d1d-26df-4460-a1ce-ae6e981b46f7">September 30, 2022</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OR</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NWM0YzNjMmY2ZTAxNGQwN2FiMzgwZjdjOGI0MDBhOTUvdGFibGVyYW5nZTo1YzRjM2MyZjZlMDE0ZDA3YWIzODBmN2M4YjQwMGE5NV8wLTAtMS0xLTQ5ODE2_4ea2faf0-bb83-4a90-b0a3-3485e43f6863">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjcw_2a7318c4-5791-4cb3-8507-41fc27cf15db">000-30171</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________________________________</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY3_4c76fbeb-10d5-456a-a2d5-43d06840297e">SANGAMO THERAPEUTICS, INC.</ix:nonNumeric></span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">________________________________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:30.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.165%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.026%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.958%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8wLTAtMS0xLTQ5ODE2_cea163d3-5b2f-4150-bbf9-505ae774315e">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8wLTQtMS0xLTQ5ODE2_d82987e2-48fb-4307-a4fb-eea0debc8a87">68-0359556</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8zLTAtMS0xLTQ5ODE2L3RleHRyZWdpb246OTNiMDJjMzBjNzBlNGM5MDkxM2FiYzRjOWZlYzBmMzZfNA_884fdea8-cf85-4a5c-866b-b8ff77c6dd90">7000 Marina Blvd.</ix:nonNumeric>, <ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8zLTAtMS0xLTQ5ODE2L3RleHRyZWdpb246OTNiMDJjMzBjNzBlNGM5MDkxM2FiYzRjOWZlYzBmMzZfOA_f4cda879-df1b-45d2-a9b1-799b396dd0af">Brisbane</ix:nonNumeric>, <ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8zLTAtMS0xLTQ5ODE2L3RleHRyZWdpb246OTNiMDJjMzBjNzBlNGM5MDkxM2FiYzRjOWZlYzBmMzZfMTI_a8c9be59-6fb7-4d2e-a9ed-8ae65b8fc870">California</ix:nonNumeric>, <ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8zLTAtMS0xLTQ5ODE2L3RleHRyZWdpb246OTNiMDJjMzBjNzBlNGM5MDkxM2FiYzRjOWZlYzBmMzZfMTY_7ab9feb9-3a96-43cd-9f02-b2c019db1892">94005</ix:nonNumeric></span></div></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices) (Zip Code)</span></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjYz_c5aebf2a-2f2c-404d-aaf9-48cb612b52f6">510</ix:nonNumeric>) <ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY0_5ce47451-95ce-4da5-982a-08d4668fc04f">970-6000</ix:nonNumeric> </span></div><div style="margin-top:2pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________________________________________________________________________________________</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.722%"><tr><td style="width:1.0%"></td><td style="width:38.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.784%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NjMyMGU1ODkxYTE5NGZmYzllYTU1ZjI2MzEwYTk4NWQvdGFibGVyYW5nZTo2MzIwZTU4OTFhMTk0ZmZjOWVhNTVmMjYzMTBhOTg1ZF8xLTAtMS0xLTQ5ODE2_ab50e3c4-650f-48cd-afae-13e267857ff6">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NjMyMGU1ODkxYTE5NGZmYzllYTU1ZjI2MzEwYTk4NWQvdGFibGVyYW5nZTo2MzIwZTU4OTFhMTk0ZmZjOWVhNTVmMjYzMTBhOTg1ZF8xLTItMS0xLTQ5ODE2_3e087f24-25b8-48ed-9fd5-ee810e45d709">SGMO</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NjMyMGU1ODkxYTE5NGZmYzllYTU1ZjI2MzEwYTk4NWQvdGFibGVyYW5nZTo2MzIwZTU4OTFhMTk0ZmZjOWVhNTVmMjYzMTBhOTg1ZF8xLTQtMS0xLTQ5ODE2_cc8c7cf3-bd6a-4dd3-9ca6-e0f9b8c8b80a">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY4_a7fe6aea-abbc-460f-936c-419cb4ff3982">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY5_553393cc-e699-46c1-bfd4-e1ce1812778a">Yes</ix:nonNumeric>&#160;&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#160;&#9744;</span></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:2pt;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.722%"><tr><td style="width:1.0%"></td><td style="width:21.773%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.055%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6N2RiMzg3YTRkYWIwNDFkMjgxNWIyOTM3MGUzYzBhNjUvdGFibGVyYW5nZTo3ZGIzODdhNGRhYjA0MWQyODE1YjI5MzcwZTNjMGE2NV8wLTAtMS0xLTQ5ODE2_3ec8c7d0-c748-41d6-857a-93276739c7b3">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6N2RiMzg3YTRkYWIwNDFkMjgxNWIyOTM3MGUzYzBhNjUvdGFibGVyYW5nZTo3ZGIzODdhNGRhYjA0MWQyODE1YjI5MzcwZTNjMGE2NV8xLTQtMS0xLTQ5ODE2_6ced6dec-98d2-4b88-a1c9-669a4ec509d0">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;text-align:center;text-indent:27pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6N2RiMzg3YTRkYWIwNDFkMjgxNWIyOTM3MGUzYzBhNjUvdGFibGVyYW5nZTo3ZGIzODdhNGRhYjA0MWQyODE1YjI5MzcwZTNjMGE2NV8yLTQtMS0xLTQ5ODE2_5fc49a16-9ece-44a1-9e33-e7afce27b707">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;&#9744;</span></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;&#160;&#9744;&#160;&#160;&#160;&#160;&#160;No&#160;&#160; <ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY1_e9b1f487-c92d-4310-8ee9-7515206f8905">&#9746;</ix:nonNumeric></span></div><div style="margin-top:2pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As of October&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i5c49b51e78f84124bb9eb7003ea63dd7_I20221031" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMTc4_78bec4ac-d8a7-491a-8183-f3231df3bb28">163,880,007</ix:nonFraction> shares of the issuer&#8217;s common stock, par value $0.01 per share, were outstanding.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.527%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.988%"><tr><td style="width:1.0%"></td><td style="width:13.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.180%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i55c688caac2b44c98200d144e37b2144_16">PART I. FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_19">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_19">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_19">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_22">Condensed Consolidated Balance Sheets at </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_22">September</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_22"> 30, 2022 and December 31, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_25">Condensed Consolidated Statements of Operations for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_25">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_25"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_25">Septembe</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_25">r 30</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_22">, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_28">Condensed Consolidated Statements of Comprehensive Loss for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_28">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_28"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_22">September </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_22">30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_31">Condensed Consolidated Statements of Stockholders&#8217; Equity for the Three and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_31">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_31"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_22">September </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_22">30, 2022 and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_34">Condensed Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_34">Nine</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_34"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_22">September </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_22">30, 2022</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_34"> and 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_34">11</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_37">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_37">12</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_76">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_76">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_97">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_97">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_97">37</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_100">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_100">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_100">38</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i55c688caac2b44c98200d144e37b2144_103">PART II. OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_106">Item&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_106">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_106">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_109">Item&#160;1A</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_109">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_109">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_112">Item&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_112">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_112">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_115">Item&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_115">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_115">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_118">Item&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_118">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_118">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_121">Item&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_121">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_121">41</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_124">Item&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_124">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_124">42</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i55c688caac2b44c98200d144e37b2144_127">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_127">43</a></span></div></td></tr></table></div><div style="margin-top:12pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated or the context suggests otherwise, references in this Quarterly Report on Form 10-Q, or Quarterly Report, to &#8220;Sangamo,&#8221; &#8220;the Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Sangamo Therapeutics, Inc. and our subsidiaries, including Sangamo Therapeutics France S.A.S. and Sangamo Therapeutics UK Ltd.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any third-party trade names, trademarks and service marks appearing in this Quarterly Report are the property of their respective holders.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE&#160;REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some statements contained in this report are &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, or the Securities Act, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These statements relate to our future events, including our anticipated operations, research, development, manufacturing and commercialization activities, clinical trials, operating results and financial condition. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements about:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our strategy;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated research and development of product candidates and potential commercialization of any resulting approved products;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, scope, rate of progress, enrollment, dosing, anticipated results and timing of our preclinical studies and clinical trials and those of our collaborators or strategic partners;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the therapeutic and commercial potential of our product candidates, including the durability of therapeutic effects;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the therapeutic and commercial potential of technologies used by us in our product candidates, including our gene therapy and cell therapy technologies, zinc finger protein, or ZFP, technology platform, zinc finger nucleases, or ZFNs, and zinc finger protein transcription factors, or ZFP-TFs;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to establish and maintain collaborations and strategic partnerships and realize the expected benefits of such arrangements, including our ability to find a potential new collaboration partner for the BIVV003 (formerly known as SAR445136) program;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated revenues from existing and new collaborations and the timing thereof;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates regarding the impact of the evolving COVID-19 pandemic on our business and operations and the business and operations of our collaborators, including clinical trials and manufacturing, and our ability to manage such impacts;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our research and development and other expenses;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain adequate preclinical and clinical supplies of our product candidates from current and potential new suppliers and manufacturers or from our own in-house manufacturing facilities;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability of Sangamo and our collaborators and strategic partners to obtain and maintain regulatory approvals for product candidates and the timing and costs associated with obtaining regulatory approvals;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with, and the impact of, regulatory requirements, obligations and restrictions on our business and operations;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property and operate our business without infringing upon the intellectual property rights of others, including our ability to obtain and maintain rights to the technologies required to develop and commercialize our product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competitive developments, including the impact on our competitive position of rival products and product candidates and our ability to meet competition from rival products and product candidates;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our estimates regarding the sufficiency of our cash resources and our expenses, capital requirements and need for additional financing, and our ability to obtain additional financing;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manage the growth of our business;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our projected operating and financial performance;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our operational and legal risks; and</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our plans, objectives, expectations and intentions and any other statements that are not historical facts.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by use of future dates or by terms such as: &#8220;aim,&#8221; &#8220;anticipates,&#8221; &#8220;assume,&#8221; &#8220;believes,&#8221; &#8220;continues,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;guidance,&#8221; &#8220;intends,&#8221; &#8220;likely,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221; &#8220;ongoing,&#8221; &#8220;plans,&#8221; &#8220;project,&#8221; &#8220;seeks,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; and similar expressions intended to identify forward-looking statements. These statements reflect our current views with respect to future events, are based on assumptions and involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties include, without limitation:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are a clinical-stage biotechnology company with no approved products or product revenues. Our success depends substantially on clinical trial results demonstrating safety and efficacy of our product candidates to the satisfaction of regulatory authorities. Obtaining positive clinical trial results and regulatory approvals is expensive, lengthy, challenging and unpredictable and may never occur for any product candidates.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Many of our product candidates are based on novel ZFP technologies that have yet to yield any approved commercially viable therapeutic products.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;We have incurred significant operating losses since inception and anticipate continued losses for the foreseeable future. We may never become profitable.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;We require significant additional capital to fund our operations and continue operating as a viable business. This additional capital may not be available to us on favorable terms or at all.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;We rely heavily on collaborations with larger biopharmaceutical companies to generate revenues and develop, obtain regulatory approvals for and commercialize many of our product candidates. If conflicts arise with our collaborators or if the collaborations terminate for any reason, our revenues and product development efforts would be negatively impacted.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Biotechnology and genomic medicine are highly competitive businesses. Our competitors may develop rival technologies and products that are superior to or are commercialized more quickly than our technologies and product candidates.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Manufacturing genomic medicines is complex, expensive, highly regulated and risky. We currently rely heavily on third&#8209;party manufacturers and have limited experience manufacturing products ourselves. Manufacturing challenges may result in unexpected costs, supply interruptions and harm and delay to our product development efforts.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Even if we obtain regulatory approvals for our product candidates, our approved products may not gain market acceptance among physicians and patients and adequate coverage and reimbursement from third-party payors and may not demonstrate commercial viability.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;We may not be able to obtain, maintain and enforce necessary and desirable intellectual property protections for our technologies and product candidates in all desired jurisdictions, which could adversely affect the value of our technologies and our product development efforts and could increase the risks of costly, lengthy and distracting litigation with unpredictable results.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Third parties, who may or may not be competitors, may allege that we are infringing, misappropriating, or otherwise practicing in an unauthorized manner their patents or other proprietary rights. Such allegations may result in infringement actions, other misappropriation actions or threats of such actions, all of which could increase the risks of costly, lengthy and distracting litigation with unpredictable results.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;Our success depends on hiring, integrating and retaining additional highly qualified skilled employees and retaining current key executives and employees, which may be challenging given that competition for these individuals is intense and increases in employee attrition across the United States resulting from the &#8220;great resignation.&#8221;</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;The ongoing and evolving COVID-19 pandemic could continue to adversely impact our business and operations and the business and operations of our collaborators, manufacturers and other business partners. If such impacts become material, our revenues and product development efforts could be negatively impacted.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;&#160;&#160;&#160;&#160;The market price of our common stock has been and will likely continue to be volatile, and you could lose all or part of any investment in our common stock.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional discussion of the risks, uncertainties and other factors described above, as well as other risks and uncertainties material to our business, can be found under &#8220;Risk Factors&#8221; in Part&#160;I, Item&#160;1A of our Annual Report on Form&#160;10-K for the year ended December&#160;31, 2021 as filed with the Securities and Exchange Commission on February&#160;24, 2022, as supplemented by the risks described under &#8220;Risk Factors&#8221; in Part II, Item 1A of this Quarterly Report on Form 10-Q, and we encourage you to refer to that additional discussion. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our plans, objectives, estimates, expectations and intentions only as of the date of this filing. You should read this report completely and with the understanding that our actual future results and the timing of events may be materially different from what we expect, and we cannot otherwise guarantee that any forward-looking statement will be realized. We hereby qualify all of our forward-looking statements by these cautionary statements.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as required by law, we undertake no obligation to update or supplement any forward-looking statements publicly, or to update or supplement the reasons that actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. You are advised, however, to consult any further disclosures we make on related subjects. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report includes discussion of certain clinical studies and trials relating to various product candidates. These studies typically are part of a larger body of clinical data relating to such product candidates, and the discussion herein should be considered in the context of the larger body of data. In addition, clinical data are subject to differing interpretations, and even if we view data as sufficient to support the safety and/or effectiveness of a product candidate, regulatory authorities may not share our views and may require additional data or may deny approval altogether.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div id="i55c688caac2b44c98200d144e37b2144_19"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 1.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS</span></div><div id="i55c688caac2b44c98200d144e37b2144_22"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:74.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMy0xLTEtMS00OTgxNg_60ee500b-8c25-4fa8-aabc-faeb54eca986">94,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMy0zLTEtMS00OTgxNg_2de840bd-acc9-47d2-8835-ec0c30c6ba94">178,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNC0xLTEtMS00OTgxNg_8b54e9ab-6ff7-4a15-90d3-e2a32c59483a">218,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNC0zLTEtMS00OTgxNg_519ba830-9b0c-41c8-9f29-95a3d8bdcfda">197,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:InterestReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNS0xLTEtMS00OTgxNg_11bfd33f-d07c-4e7e-b1e4-f6cb723b42ad">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:InterestReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNS0zLTEtMS00OTgxNg_eb86003c-2d6c-4507-a854-2b064c386a9d">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNi0xLTEtMS00OTgxNg_c1578bbd-9528-4355-95c4-bf3ea7c5678c">4,522</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNi0zLTEtMS00OTgxNg_8b1512bf-87a7-4fee-aecf-85f4750b5e20">6,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNy0xLTEtMS00OTgxNg_6819d208-b97f-4f02-a204-e17d7fa4e32b">18,007</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNy0zLTEtMS00OTgxNg_8ee05108-a0c3-4feb-a662-179f4c6692c2">15,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfOC0xLTEtMS00OTgxNg_e349d5dd-2ce2-4c79-a8c0-5d35ecc2cb9e">336,621</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfOC0zLTEtMS00OTgxNg_b5d53dfd-0260-4365-b062-e7d43365ebbe">398,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfOS0xLTEtMS00OTgxNg_89d85707-6e6b-4763-88b0-596a8df84ba7">36,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfOS0zLTEtMS00OTgxNg_6b0ae8f3-b59d-45ad-97a3-dbc9600211ef">88,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTAtMS0xLTEtNDk4MTY_cb753f5d-791d-4e0b-acdf-51656d7d3643">55,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTAtMy0xLTEtNDk4MTY_494e2e30-517f-48a1-9293-972a05e87391">51,523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTEtMS0xLTEtNDk4MTY_ba0fbd18-fbf0-41a1-ab6d-b6a05e3c68f2">46,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTEtMy0xLTEtNDk4MTY_7e816728-cdd3-4248-b9e1-4f5b1aa9fefb">53,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTItMS0xLTEtNDk4MTY_f4606a1e-f09a-4036-b647-91028c8e7dab">34,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTItMy0xLTEtNDk4MTY_96fd76d8-fea9-41f7-83c7-1eb96a183392">39,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTMtMS0xLTEtNDk4MTY_045b0a1e-3af0-432d-9c20-2f0639196d7f">64,956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTMtMy0xLTEtNDk4MTY_b496ef48-57b3-4e34-99fb-6a99304e1b37">73,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTQtMS0xLTEtNDk4MTY_ac42fe85-0c51-4500-b202-5c07c0da0800">17,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTQtMy0xLTEtNDk4MTY_68d5aff3-e181-43ce-8128-93e6faf215a8">15,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTUtMS0xLTEtNDk4MTY_3d64e3d6-e33e-4839-b733-2ec97b28373e">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:RestrictedCashNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTUtMy0xLTEtNDk4MTY_e90184f0-cedf-4d0d-b4b3-71021877fd6e">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTYtMS0xLTEtNDk4MTY_996ed829-5b82-422d-a898-a1e32b8f8f2f">593,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTYtMy0xLTEtNDk4MTY_8b93b945-09ce-4321-a302-1de18a0fec67">721,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTktMS0xLTEtNDk4MTY_a885ce0b-29c7-4b8a-8f9b-bcb0f5521da6">17,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTktMy0xLTEtNDk4MTY_d2b1300d-f88c-4c20-a9a8-1eeca0a5d191">9,759</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjAtMS0xLTEtNDk4MTY_ba678943-863f-48f5-baf6-5ebfac8b7b4f">19,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AccruedEmployeeBenefitsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjAtMy0xLTEtNDk4MTY_28bfa97e-bf2e-4d92-a59f-2d5050d0c88b">20,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjEtMS0xLTEtNDk4MTY_dd3cf789-2f88-4a8f-be16-3b64a6f4d8e7">14,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjEtMy0xLTEtNDk4MTY_834f417e-5a6d-4583-b4ee-b473f6901485">11,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjItMS0xLTEtNDk4MTY_e44a8419-0363-4e50-935d-ab964f61eddb">71,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjItMy0xLTEtNDk4MTY_86bf66eb-57c7-4d7a-ab4a-0c43b86a8dea">85,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjMtMS0xLTEtNDk4MTY_451a9902-5be8-4434-b99d-55007af61bb0">122,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjMtMy0xLTEtNDk4MTY_c8bb91f9-9d8a-494d-8f93-2a64714b1bca">127,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjQtMS0xLTEtNDk4MTY_5b016cc1-ee94-457a-a2f9-ea9e741e0c47">115,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjQtMy0xLTEtNDk4MTY_fb411656-f3f8-4d20-85cc-7383186aa8d7">166,776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjUtMS0xLTEtNDk4MTY_6208f11a-92d3-422c-a6e3-44b4fedd1791">39,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjUtMy0xLTEtNDk4MTY_ea27b395-2928-4038-a141-6cbf8a0e5107">44,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjYtMS0xLTEtNDk4MTY_b6bf5f9c-a2bc-4a32-af16-84332a42798c">5,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjYtMy0xLTEtNDk4MTY_3374e803-6fe8-4985-bae7-e60175dc5739">6,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjctMS0xLTEtNDk4MTY_a3a42341-9402-4f45-ba8d-1455ce05dd2a">1,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjctMy0xLTEtNDk4MTY_090a3431-c199-49c4-9fed-b022257e353f">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjgtMS0xLTEtNDk4MTY_7932a4e6-10a1-4a76-acf0-ff490df08599">284,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjgtMy0xLTEtNDk4MTY_a8b72b11-c8e3-4817-8cf7-557a765b2d3a">346,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjktMS0xLTEtNDk4MTY_66f7ca9f-53a2-41c0-b9b8-7fea7c19c1e4"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjktMy0xLTEtNDk4MTY_5af7b6d9-de85-4f1b-9491-12797401fe6b"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzEtMS0xLTEtNDk4MTY_323516d5-0131-4985-9212-9c7cf379c27b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzEtMy0xLTEtNDk4MTY_8faf5772-3ad6-46da-ad38-6b9342f717e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzItMS0xLTEtNDk4MTY_6461b048-3e54-46bb-9a4d-1762354873fd">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzItMy0xLTEtNDk4MTY_11ca77fb-607d-4e4c-b149-78fdd6514174">1,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzMtMS0xLTEtNDk4MTY_983634ec-cd14-4f03-9e77-6f0298da2b2b">1,423,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzMtMy0xLTEtNDk4MTY_42af8ebd-3ac8-422e-9e5f-a321e0cc6231">1,334,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzQtMS0xLTEtNDk4MTY_87e9a996-be41-4910-98c6-571fb72d8dde">1,096,572</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzQtMy0xLTEtNDk4MTY_189153e5-16b9-43ce-a86b-9dcf8d85f824">956,267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzUtMS0xLTEtNDk4MTY_806b545a-1c56-4caa-a1d6-1b2be3e859c2">18,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzUtMy0xLTEtNDk4MTY_5192a48f-46b6-494d-9a71-a5391c193b1e">3,987</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzYtMS0xLTEtNDk4MTY_92459500-c31f-47f3-a448-9b469ce4f19d">309,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzYtMy0xLTEtNDk4MTY_ba320eaa-8d8a-46ae-b8dc-ff6840d73f5a">375,343</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzktMS0xLTEtNDk4MTY_292ad0fe-ac3a-4484-a890-f05c4e0d3cb9">593,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzktMy0xLTEtNDk4MTY_fe6fdf45-dfad-4527-bdce-4853df8e1748">721,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands, except per share amounts)</span></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMi0xLTEtMS00OTgxNg_b685304a-510c-4f53-aef6-8f6455688c15">26,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMi0zLTEtMS00OTgxNg_f692449b-35d4-4fcd-8ef4-911203ed2702">28,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMi01LTEtMS00OTgxNg_a72ec2d7-334e-480b-989d-584cdc35de5d">84,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMi03LTEtMS00OTgxNg_01c0dae8-7b14-4204-9d1b-0a5d83947566">82,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNC0xLTEtMS00OTgxNg_1a10caf2-9063-42ef-b06d-a10d886adf05">65,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNC0zLTEtMS00OTgxNg_a69c3dc3-0796-4d08-98e3-61cea9ef2b34">62,498</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNC01LTEtMS00OTgxNg_56ccffe9-6d39-4730-94e2-d11111ac7a81">183,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNC03LTEtMS00OTgxNg_a3d0ab0c-2f86-4006-a0f0-889e78cc5947">179,018</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNS0xLTEtMS00OTgxNg_06f59103-6565-4339-8ff1-4f1be7542680">16,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNS0zLTEtMS00OTgxNg_38aa6a6b-2ae5-4bf8-9861-2bbc286dc492">14,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNS01LTEtMS00OTgxNg_ec7ce837-52c8-41dc-aeb3-479763c7d7cc">46,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNS03LTEtMS00OTgxNg_6210e1f0-3335-40da-954c-203f2f373de2">47,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNi0xLTEtMS00OTgxNg_b0667f92-51f8-48cc-9b12-2362965f20ec">81,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNi0zLTEtMS00OTgxNg_df6352f7-e395-4713-b383-3f21b8e38596">76,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNi01LTEtMS00OTgxNg_162f630d-5709-4712-8ae6-f1f655ea5ca6">229,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNi03LTEtMS00OTgxNg_2f28109e-9ee4-4c9e-a67c-32269209997c">226,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNy0xLTEtMS00OTgxNg_db684f45-de37-4046-84f5-2cfeb05a3b2c">54,894</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNy0zLTEtMS00OTgxNg_f94c7e39-094c-460d-9337-6e4f1d504e2a">48,436</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNy01LTEtMS00OTgxNg_efd765ff-9229-41ce-8c5d-d2c581819366">145,889</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNy03LTEtMS00OTgxNg_79ff084b-7301-4668-bfe0-57889933beb0">143,438</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest and other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:InterestAndOtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOC0xLTEtMS00OTgxNg_ce7e9970-31f9-4bde-896f-bc39f9f4493f">1,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:InterestAndOtherIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOC0zLTEtMS00OTgxNg_d8b664ba-ec17-4b53-ad9e-cedae305df59">834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:InterestAndOtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOC01LTEtMS00OTgxNg_73be24de-d13d-4b7e-85b8-a735a9a25f06">5,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:InterestAndOtherIncome" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOC03LTEtMS00OTgxNg_91c0095b-4c2a-41f3-9381-ca967da0fe52">3,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOS0xLTEtMS00OTgxNg_2a3c2c1c-0e7d-441a-b5a0-146d3a5e6782">53,125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOS0zLTEtMS00OTgxNg_9268943d-eaaa-4b89-bc74-191aee4c9186">47,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOS01LTEtMS00OTgxNg_e6910011-58bb-4eee-895b-770d8e1cb959">140,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOS03LTEtMS00OTgxNg_5f1d2ffe-ac4b-4c7d-ad06-67d0c9ee2096">140,428</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTAtMS0xLTEtNDk4MTY_448f0b44-727a-48da-a3a6-ef8f1d11a463">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTAtMy0xLTEtNDk4MTY_c0ae2e6e-952c-4d01-b5c2-e022463ab901">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTAtNS0xLTEtNDk4MTY_82fbbed1-897d-4ac6-82e2-2bdb2c2f5d8b">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTAtNy0xLTEtNDk4MTY_fed85073-c32b-478f-bdb5-68101b7c9817">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTEtMS0xLTEtNDk4MTY_e5abd17d-6803-4ce1-8bcd-b3763babe964">53,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTEtMy0xLTEtNDk4MTY_65362d4e-f17a-41e0-ad48-7c834c63a606">47,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTEtNS0xLTEtNDk4MTY_ecb11591-4682-4b95-a72b-29716e58ce33">140,305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTEtNy0xLTEtNDk4MTY_f5662da8-9ef8-4b91-86a8-8e3c357f6684">140,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTItMS0xLTEtNDk4MTY_09e5dd3b-fdf1-4b84-9f06-62320ecaf308">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTItMy0xLTEtNDk4MTY_466c2f59-da47-43f5-8ee8-f32a50af09ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTItNS0xLTEtNDk4MTY_b90c8b31-899e-4c72-83e2-d54cc5a0bae3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTItNy0xLTEtNDk4MTY_15e8ec7d-672b-4b53-9756-5ecc6c7e1a9d">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to Sangamo Therapeutics, Inc. stockholders</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtMS0xLTEtNDk4MTY_388f8d32-d536-4fac-9c8e-e95c0e07759a"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtMS0xLTEtNDk4MTY_53c780e0-ad99-4252-8fe5-ba842613a520">53,155</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtMy0xLTEtNDk4MTY_28ee90b9-f6c9-4519-99c6-56aa4b851fea"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtMy0xLTEtNDk4MTY_477e69e5-3a3a-4b30-a56e-fb41be1a3ed0">47,688</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtNS0xLTEtNDk4MTY_5d92e309-adea-40d1-adac-28ebee88a788"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtNS0xLTEtNDk4MTY_cd10c400-be2c-4f39-a8e1-8d97f440533d">140,305</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtNy0xLTEtNDk4MTY_74fde5cc-752b-4ff5-bb3d-bf42ee5bbc3f"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtNy0xLTEtNDk4MTY_781dac3d-4d2b-43b2-8f7d-d1d6632c35b1">140,790</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtMS0xLTEtNDk4MTY_9860e683-fc37-483c-a7fc-355dedd6a004"><ix:nonFraction unitRef="usdPerShare" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtMS0xLTEtNDk4MTY_9bdd9809-f6c3-4449-97f6-31f5fe965b08">0.34</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtMy0xLTEtNDk4MTY_20d44108-a163-4b05-879f-27ad5ef9d457"><ix:nonFraction unitRef="usdPerShare" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtMy0xLTEtNDk4MTY_8bc50731-9cb4-4060-8bf9-bc1e8e43aec7">0.33</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtNS0xLTEtNDk4MTY_1001dcbf-ee5c-4f95-b8a4-cc82871b4c43"><ix:nonFraction unitRef="usdPerShare" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtNS0xLTEtNDk4MTY_4b9ad625-28a7-47df-88bb-a6636b6ccd8a">0.93</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtNy0xLTEtNDk4MTY_49ca95d7-4401-40ed-85ae-1399d3bf64de"><ix:nonFraction unitRef="usdPerShare" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtNy0xLTEtNDk4MTY_5062eb4e-b0d6-42d4-8cd5-f677ae9b1b73">0.98</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used in computing basic and diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtMS0xLTEtNDk4MTY_2f002fa6-3a1c-4965-8d37-852eb63680be"><ix:nonFraction unitRef="shares" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtMS0xLTEtNDk4MTY_d524fa80-bd1c-47b3-9804-938152bdcd8c">158,042</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtMy0xLTEtNDk4MTY_4a6c3415-8abe-4b2f-b932-08bbfa7ded32"><ix:nonFraction unitRef="shares" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtMy0xLTEtNDk4MTY_8c94de00-5c68-48f1-b699-636638520c8e">145,399</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtNS0xLTEtNDk4MTY_6e74189b-60ea-430b-b9da-de4c7a496da6"><ix:nonFraction unitRef="shares" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtNS0xLTEtNDk4MTY_cb8f5579-a7fa-4e75-8206-27443f816d26">150,850</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtNy0xLTEtNDk4MTY_58ee5354-bea1-4489-b84b-96b0ff503f40"><ix:nonFraction unitRef="shares" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtNy0xLTEtNDk4MTY_6b96018e-c1f5-47ee-91f9-5b1b2783e271">144,173</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMi0xLTEtMS00OTgxNg_bd82140a-f73c-4a11-95ca-91c8f2248f28">53,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMi0zLTEtMS00OTgxNg_3d7e36f1-fe7b-4a26-8d2c-67f92e0b75cd">47,688</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMi01LTEtMS00OTgxNg_ecb11591-4682-4b95-a72b-29716e58ce33">140,305</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMi03LTEtMS00OTgxNg_67c485ba-061b-4f56-bfd8-6898d8ee904d">140,801</ix:nonFraction>)</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMy0xLTEtMS00OTgxNg_6df23e86-bb62-4f7c-bf83-982b0a4f0098">6,028</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMy0zLTEtMS00OTgxNg_93221e0c-25f6-4207-8e05-16e25d8e7462">2,565</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMy01LTEtMS00OTgxNg_efaff20d-4140-42c7-878c-9afeb9f420e6">14,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMy03LTEtMS00OTgxNg_b84f5856-2014-4326-a980-0108216c94fc">6,006</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net pension gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNC0xLTEtMS00OTgxNg_69c110ab-a381-4e7f-81b5-2fda020a38c8">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNC0zLTEtMS00OTgxNg_2e7272b0-eb01-4246-9b86-219dcce3751f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNC01LTEtMS00OTgxNg_7748b0d2-bab6-4cb3-ac82-e865ad5ae9f3">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNC03LTEtMS00OTgxNg_4e082c6e-0e31-44f7-b11e-bf2f4252e937">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized gain (loss) on marketable securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNS0xLTEtMS00OTgxNg_c4a28082-0c98-4957-8e1f-f7cfe2c1b196">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNS0zLTEtMS00OTgxNg_f5179a5d-0790-42df-a67f-05b30d55fffb">45</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNS01LTEtMS00OTgxNg_3c55fa30-f347-4793-8680-62f4a4c0b09e">1,101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNS03LTEtMS00OTgxNg_51ba145c-4748-4a4b-80e8-ef41c1195c08">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNy0xLTEtMS00OTgxNg_2f752d69-5bcc-4b78-8ae2-603901cd1f93">58,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNy0zLTEtMS00OTgxNg_1c7d5f6a-8313-4e27-997a-2e5dd62e1397">50,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNy01LTEtMS00OTgxNg_bb0a2a9d-22b6-4fe6-a9b5-6734019f56cd">155,316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNy03LTEtMS00OTgxNg_458a1b80-0926-45af-9dab-562a06cdcd29">146,843</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOC0xLTEtMS00OTgxNg_36c49630-239a-407c-902b-a005e0556a6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOC0zLTEtMS00OTgxNg_37db10d7-3133-4e5c-989f-85c0fe216c16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOC01LTEtMS00OTgxNg_eb0a2e32-2096-4ccc-ad47-501c0cbe1bae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOC03LTEtMS00OTgxNg_4a821b72-27c4-4ed7-9ea9-617aa2d1fa61">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to Sangamo Therapeutics, Inc.</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOS0xLTEtMS00OTgxNg_a8798354-5ca9-4297-a2de-c64d2c41d19b">58,993</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOS0zLTEtMS00OTgxNg_11bcef60-c8c2-44d8-b675-934ead332bf7">50,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOS01LTEtMS00OTgxNg_5f9571d0-f638-42d1-be63-00ccb5e16f3b">155,316</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOS03LTEtMS00OTgxNg_b76e5f48-43f8-4fa3-8566-1d5626af5e9d">146,832</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands, except share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.683%"><tr><td style="width:1.0%"></td><td style="width:27.276%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.790%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.896%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Income</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at June 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i65c4b9f6e28c49ccb8e9f49894741665_I20220630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy0xLTEtMS00OTgxNg_f6e35846-06f6-46a3-a1bf-ad9f12596a58">153,352,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65c4b9f6e28c49ccb8e9f49894741665_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy0zLTEtMS00OTgxNg_2f4ef2d4-4a7a-44ab-9d04-b44b02680387">1,534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieaf636eab7a446278c2c60b3497f65dd_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy01LTEtMS00OTgxNg_fb2fccf7-59e9-48e7-b603-692174d7882a">1,373,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdb651fdae9f4daba649e657742b10fb_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy03LTEtMS00OTgxNg_48194eb7-ab9f-471a-a338-e3be30473f7c">1,043,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0901c3888400484d82bc9d499ba27882_I20220630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy05LTEtMS00OTgxNg_d83a2d9f-b503-4e93-97d9-5ba448c0677f">13,160</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4358e68463414d2f81e6d07be34f96f4_I20220630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy0xMS0xLTEtNDk4MTY_64288048-abcd-4efc-bf7a-dd2e48e1321b">318,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in connection with at-the-market offering, net of offering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4f86a00ffb9a44c09b92cbd140f04b6a_D20220701-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNC0xLTEtMS00OTgxNg_823a4432-6942-4b97-bf25-33e9875ec0c0">8,483,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f86a00ffb9a44c09b92cbd140f04b6a_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNC0zLTEtMS00OTgxNg_851bb2d3-78af-473a-b152-d12a69a0a07f">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f36b8087e874e84bb6cfbb657e30dd3_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNC01LTEtMS00OTgxNg_41ba3b2c-3d4e-4483-95f8-19e28d3d81f0">42,089</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNC0xMS0xLTEtNDk4MTY_8975d95a-9604-4ebc-a3ac-02b5675b9350">42,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4f86a00ffb9a44c09b92cbd140f04b6a_D20220701-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNS0xLTEtMS00OTgxNg_cb843e75-650e-4112-a105-4bf649d64a87">82,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f36b8087e874e84bb6cfbb657e30dd3_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNS01LTEtMS00OTgxNg_a389fc5d-8825-42ff-b5a8-814e7866e5c6">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNS0xMS0xLTEtNDk4MTY_51e3d54b-a046-4f60-ad7d-50bec7d9db5c">101</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f36b8087e874e84bb6cfbb657e30dd3_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNy01LTEtMS00OTgxNg_4e876a1a-1e0e-4aca-8dcc-d18b510cb3b8">7,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNy0xMS0xLTEtNDk4MTY_59ed8a08-7a26-47a2-856a-eefd61128350">7,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i477f878f2fc449a7b9b882f03d328aea_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfOS05LTEtMS00OTgxNg_3e42c811-02cd-4247-9c64-27b63e72fd46">6,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfOS0xMS0xLTEtNDk4MTY_27a2f142-e705-4008-9a75-28ce223af521">6,028</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net pension gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477f878f2fc449a7b9b882f03d328aea_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTAtOS0xLTEtNDk4MTY_f29ec8c3-6fce-4a04-b72e-98f4f798d5cc">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTAtMTEtMS0xLTQ5ODE2_b9f67d24-f37f-4ce9-84d6-79006953d57e">55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net unrealized gain on marketable securities, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i477f878f2fc449a7b9b882f03d328aea_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTEtOS0xLTEtNDk4MTY_21e83e90-6981-4383-ac38-98fc64c0cdeb">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTEtMTEtMS0xLTQ5ODE2_fa8aa81d-3c9f-48bf-8704-026b54c5067c">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia174d038fef54c1988b0d1f7bb55851a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTMtNy0xLTEtNDk4MTY_2e23e8c3-169b-471e-a662-eb40d55c6ad9">53,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTMtMTEtMS0xLTQ5ODE2_927ac77c-adef-4b56-b1a7-27054f3029ca">53,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10185405784946f6866fa6235275377e_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtMS0xLTEtNDk4MTY_27e36487-e090-4e4e-a395-15d220e14a80">161,918,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10185405784946f6866fa6235275377e_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtMy0xLTEtNDk4MTY_33e7ba1b-0772-48fa-b21a-8b57acef4917">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5629c83660045e689bee72501b7f3b5_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtNS0xLTEtNDk4MTY_c9ba2eb6-196e-47a9-859f-1a52c994b851">1,423,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1842e89b1004e10ab03df6383c15efe_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtNy0xLTEtNDk4MTY_e96f422a-8f14-4b64-8076-a55688dd86a0">1,096,572</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie475194a8bc5487bb425f884b64c7cb4_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtOS0xLTEtNDk4MTY_e812d016-2248-459d-90c7-03c9f38f4ac1">18,998</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtMTEtMS0xLTQ5ODE2_7ff74b3b-2c69-4704-afc4-17e509370735">309,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.683%"><tr><td style="width:1.0%"></td><td style="width:27.276%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.790%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.896%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2022</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>(Loss) Income</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id44dcc12390c46679a8547aa1acebc45_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy0xLTEtMS00OTgxNg_4fea933b-d20a-4d99-a259-734cf1bfb550">145,921,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id44dcc12390c46679a8547aa1acebc45_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy0zLTEtMS00OTgxNg_d31c03ca-c5c8-4890-8d43-a737110924f4">1,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a696035ebd0409f842a3d85f1f17177_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy01LTEtMS00OTgxNg_e147abfb-6c5a-4416-96fe-e7e3fb4e57ca">1,334,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7eb5094c50c94679a226568ebb7c0cdc_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy03LTEtMS00OTgxNg_a2a0e701-c9e9-40fc-986c-a3ec25bc11f6">956,267</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5f88f052bc74b0897f087b88dcf0e44_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy05LTEtMS00OTgxNg_3e5c701d-6e35-44cd-8f8c-b4cd2040b28e">3,987</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy0xMS0xLTEtNDk4MTY_e5a34187-9f3a-4ea3-b9c0-127fd3ab258c">375,343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in connection with at-the-market offering, net of offering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNC0xLTEtMS00OTgxNg_3a45e174-c619-4521-9f81-30320e3a8bfb">14,711,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNC0zLTEtMS00OTgxNg_8a5c989f-a560-4b52-8ccf-ade42c722d7a">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28e3d378e8e41c2b2f192f93c7e7a2d_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNC01LTEtMS00OTgxNg_c211a3b7-916a-4ce5-8748-b7fc47aa68a3">66,301</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNC0xMS0xLTEtNDk4MTY_5398e364-35bf-4da4-980d-4c4bd68adcd2">66,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNS0xLTEtMS00OTgxNg_9132e051-5bd1-48b2-87ab-5cc66b51ec79">925,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNS0zLTEtMS00OTgxNg_84325d91-17b5-43a3-b977-f2183ccfa732">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id28e3d378e8e41c2b2f192f93c7e7a2d_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNS01LTEtMS00OTgxNg_d0f58623-bb94-498d-8792-0c783b818cf3">1,847</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNS0xMS0xLTEtNDk4MTY_08190b0c-cca9-450f-ab97-be60d61bf640">1,838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNi0xLTEtMS00OTgxNg_3cd4c440-a6d5-4c58-bdcb-278bb3adf92b">359,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNi0zLTEtMS00OTgxNg_62e91de4-f600-4c1f-843b-b53c71dd296d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28e3d378e8e41c2b2f192f93c7e7a2d_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNi01LTEtMS00OTgxNg_6ae63154-adeb-4415-82e8-fd64aa328499">1,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNi0xMS0xLTEtNDk4MTY_899c89a4-cbe3-444d-8cf7-7213e060e39d">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id28e3d378e8e41c2b2f192f93c7e7a2d_D20220101-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNy01LTEtMS00OTgxNg_def37cab-ed48-45be-932e-f02cdc6fd925">23,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNy0xMS0xLTEtNDk4MTY_a00ddde7-5a29-4ea2-9b54-9a86ab9e3ef7">23,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie86b8354fd9c48fa8f7effcc8fab0655_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfOS05LTEtMS00OTgxNg_195c774b-9282-45d3-b2c2-886909643e35">14,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfOS0xMS0xLTEtNDk4MTY_749cb5fb-8e9b-4f4c-8f81-1f3acf9d560b">14,040</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net pension gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie86b8354fd9c48fa8f7effcc8fab0655_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTAtOS0xLTEtNDk4MTY_3c57056f-d2dd-484f-acbd-421c5e4bafa0">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTAtMTEtMS0xLTQ5ODE2_addfe28e-0d7d-48f1-9599-16d078c7ebb5">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net unrealized loss on marketable securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie86b8354fd9c48fa8f7effcc8fab0655_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTEtOS0xLTEtNDk4MTY_a6e1429b-0fd9-4abf-8f8f-e4096f94d0de">1,101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTEtMTEtMS0xLTQ5ODE2_75518ab6-7f89-4aca-bf58-f664818764e6">1,101</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b80b0627d224b51a736282e5de2e649_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTMtNy0xLTEtNDk4MTY_181cb161-5db0-43ec-9d64-28419e978e04">140,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTMtMTEtMS0xLTQ5ODE2_8e5530b9-7357-4084-b360-ca2d057fbf81">140,305</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10185405784946f6866fa6235275377e_I20220930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtMS0xLTEtNDk4MTY_137c4f3a-1681-46a7-9255-6b6e6767e5e2">161,918,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10185405784946f6866fa6235275377e_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtMy0xLTEtNDk4MTY_8c2fe31d-6688-4c08-b6d5-430cd702fd49">1,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5629c83660045e689bee72501b7f3b5_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtNS0xLTEtNDk4MTY_b9200c3e-0f56-43e8-b92a-96f57cadee4a">1,423,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id1842e89b1004e10ab03df6383c15efe_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtNy0xLTEtNDk4MTY_9abf8710-0c81-4708-b59c-2037a4c9e49b">1,096,572</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie475194a8bc5487bb425f884b64c7cb4_I20220930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtOS0xLTEtNDk4MTY_d4b43df5-d211-4538-aff5-219d3c4670a3">18,998</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtMTEtMS0xLTQ5ODE2_2cb91c92-0b99-4174-afe4-5c5a063f7614">309,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands, except share amounts)</span></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:26.001%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.189%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.189%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.198%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>Controlling<br/>Interest</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at June 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe3dce0a01ae4da686148893e81e9cbf_I20210630" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy0xLTEtMS00OTgxNg_1d89af5b-d2e6-45e4-8caa-b5959a4f2469">145,106,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe3dce0a01ae4da686148893e81e9cbf_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy0zLTEtMS00OTgxNg_0527df1b-0e8a-4c1e-8635-57c10825c8a0">1,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab6b60ff90948328c6518dfee567d60_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy01LTEtMS00OTgxNg_a788fe8a-37aa-468a-8ecd-426b692310cf">1,313,102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4437087e8514ebf9125f5ef80b34f7d_I20210630" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy03LTEtMS00OTgxNg_f4018d1e-d86f-433a-9902-86aa5ea4fd9f">871,083</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd6155b736044781a9509dd909a16744_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy05LTEtMS00OTgxNg_b032abae-fca2-4784-8632-243764047ae6">1,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1f86ea542ca45139f8b891e2b341360_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy0xMS0xLTEtNDk4MTY_cc0148e9-520b-4f62-922f-101f19c25bed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b2b14725998443da0214724315022e3_I20210630" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy0xMy0xLTEtNDk4MTY_63420765-dc1a-43aa-8cca-9845e50e28b8">445,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in connection with at-the-market offering, net of offering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67e431fd603948ddb3a910386fcf7720_D20210701-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNC0xLTEtMS00OTgxNg_ba14817f-4c86-4a67-befb-c6e0346cd938">202,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e431fd603948ddb3a910386fcf7720_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNC0zLTEtMS00OTgxNg_968c1454-cb81-4cbe-831e-27865c4379c5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b20689a47fa4626b06dd28beb352cfc_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNC01LTEtMS00OTgxNg_09dd84f5-f7e2-455a-b32a-7b7303a95402">2,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNC0xMy0xLTEtNDk4MTY_cd3dd1e7-caf0-4eaf-a208-b22c62108278">2,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67e431fd603948ddb3a910386fcf7720_D20210701-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNS0xLTEtMS00OTgxNg_dc2eadca-3439-4dc5-8bd6-5c294ed388a5">206,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67e431fd603948ddb3a910386fcf7720_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNS0zLTEtMS00OTgxNg_2cd8a46d-5792-40d9-9831-7a39cb061986">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b20689a47fa4626b06dd28beb352cfc_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNS01LTEtMS00OTgxNg_3a105ff8-60f3-4fe8-9f7b-20d843b11b40">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNS0xMy0xLTEtNDk4MTY_46de59b7-cc35-496c-b279-14175f5a9544">617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b20689a47fa4626b06dd28beb352cfc_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNy01LTEtMS00OTgxNg_ebc107fd-2041-4b13-aa32-014ce46ccd80">7,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNy0xMy0xLTEtNDk4MTY_f854827f-3642-436a-bb33-28fc48f383eb">7,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i888b3ba590bd4c97a8718de47daae199_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfOS05LTEtMS00OTgxNg_93308b41-5879-43c9-b5c3-b6209c3542b2">2,565</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfOS0xMy0xLTEtNDk4MTY_550b77d7-0126-4dca-a855-2df50be9beca">2,565</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net unrealized loss on marketable securities, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i888b3ba590bd4c97a8718de47daae199_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTAtOS0xLTEtNDk4MTY_70322291-4817-48dc-bcff-2191c7cea130">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTAtMTMtMS0xLTQ5ODE2_dd824bc3-8f9f-4542-b87c-8984ddd92b75">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b65f408605048399b735ab6734947a4_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTItNy0xLTEtNDk4MTY_9aedc0af-3d86-470c-87ba-4d938c03135b">47,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia153a8e0f69e430e9b0dc937bd3916b8_D20210701-20210930" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTItMTEtMS0xLTQ5ODE2_cc40ff36-764f-4354-b4ab-8c0ed815dcec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTItMTMtMS0xLTQ5ODE2_49abc30f-61f0-4a6b-90da-6f8630b40947">47,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9241e8a504e3490192f71c9decdcd3cf_I20210930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtMS0xLTEtNDk4MTY_40a5f23f-9584-46c3-a9b7-6f237b1da975">145,516,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9241e8a504e3490192f71c9decdcd3cf_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtMy0xLTEtNDk4MTY_13fe711b-2762-4bb9-a74e-88c138e91c3c">1,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8bc460fcd2b4144afd1e6595036df06_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtNS0xLTEtNDk4MTY_f1b28b70-fdf5-4b40-853c-09f516403c2c">1,323,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacd4ba876f2a4fb7b83c09ef9bd71e56_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtNy0xLTEtNDk4MTY_ef2b2553-2b26-478a-98bb-44e9cf4b6fcc">918,771</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bb367b30b03403c98021e1aba94eea9_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtOS0xLTEtNDk4MTY_f6032607-653f-4637-aa12-0a55bb169a1f">623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53a9405cbbd74d8e87ce89d2e69fd569_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtMTEtMS0xLTQ5ODE2_3784c672-7942-403f-b921-196ef61932d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtMTMtMS0xLTQ5ODE2_cab8217a-6ba3-458b-85bf-e58bf2cc4570">406,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:26.001%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.711%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.189%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.189%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.349%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.740%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.198%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30, 2021</span></td></tr><tr style="height:24pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>Controlling<br/>Interest</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity</span></div></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idcd86bcf9af64a3a815fcc501ba0ad77_I20201231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy0xLTEtMS00OTgxNg_db37c4de-f8f5-4396-bccc-222c498988be">142,063,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcd86bcf9af64a3a815fcc501ba0ad77_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy0zLTEtMS00OTgxNg_cedf3a1e-959f-4689-a967-7b4a65ca25b0">1,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i920d94b246904434a9c24327eda62fc2_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy01LTEtMS00OTgxNg_cf82e385-c591-47b9-bbae-c70a166e1ba9">1,269,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i12cb742f69d84eafb765fed1f2925d84_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy03LTEtMS00OTgxNg_6deedc12-5e70-4073-930f-2dec47dbb3d3">777,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib759e7d27c734ebc91eb8d8e7257be3b_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy05LTEtMS00OTgxNg_25eb6d23-4076-409a-aa88-e7a1aefb3e50">5,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i56f6f40bbe064e2eae76f5a1f8c67c65_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy0xMS0xLTEtNDk4MTY_21de3e4f-1123-4cca-a2d3-e010999d9825">868</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy0xMy0xLTEtNDk4MTY_fc479784-5f8f-4ba3-8677-9dd9e57ea062">497,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock in connection with at-the-market offering, net of offering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNC0xLTEtMS00OTgxNg_73160e02-048c-441c-9e6c-fe95ed67d9ff">2,007,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNC0zLTEtMS00OTgxNg_8c38a57b-53db-425a-9b3d-3b25f8b94028">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNC01LTEtMS00OTgxNg_d826f859-1b50-41bc-8ff8-34c29615772e">27,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNC0xMy0xLTEtNDk4MTY_48902739-e652-4558-b042-532ab1cc86d6">27,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNS0xLTEtMS00OTgxNg_72aebb39-eccb-4e16-820d-a79963aa356f">1,200,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNS0zLTEtMS00OTgxNg_da95facf-1b20-41e2-a213-7d29f6c8fac0">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNS01LTEtMS00OTgxNg_02899b0d-52df-43d8-9503-3cef626e77d0">1,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNS0xMy0xLTEtNDk4MTY_cd9905a8-ebd9-46e4-b78b-6910025bcaf8">1,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNi0xLTEtMS00OTgxNg_3b6c85c7-418d-481a-8734-8368e19b288e">244,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNi0zLTEtMS00OTgxNg_85a650fd-145e-4a51-b78c-9b06d8a04708">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNi01LTEtMS00OTgxNg_7555b6a3-9c54-47c2-9342-43d2e1bca306">2,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNi0xMy0xLTEtNDk4MTY_b03f41ab-b85a-4cde-b107-68f16bea826d">2,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNy01LTEtMS00OTgxNg_20a8b2ae-baad-434d-9ac4-d7f5d8e11f44">24,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNy0xMy0xLTEtNDk4MTY_17e71420-3dbd-43ec-9048-105da16f509b">24,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisition of additional shares of Sangamo France</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930" decimals="-3" sign="-" name="sgmo:AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfOC01LTEtMS00OTgxNg_ffa10de6-4de5-41c5-8a68-cb82ffb40f2d">70</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i451b037bb41149e78da8c2582ef147c9_D20210101-20210930" decimals="-3" sign="-" name="sgmo:AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfOC0xMS0xLTEtNDk4MTY_fe8d1841-2543-456f-a7c0-c241b91d8930">64</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="sgmo:AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfOC0xMy0xLTEtNDk4MTY_8995eef7-361f-42ec-aae4-343ff9e31305">134</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Foreign currency translation adjustment</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d5c5e06d683406faa61d58c55c666a6_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfOS05LTEtMS00OTgxNg_8e3853fc-ba41-4866-b568-d9b8e00f72f7">6,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfOS0xMy0xLTEtNDk4MTY_9f8cd814-f91e-4a5f-84e7-8742a7228e05">6,006</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net unrealized loss on marketable securities, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d5c5e06d683406faa61d58c55c666a6_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTEtOS0xLTEtNDk4MTY_7a6d9b57-c35c-43df-b8b2-cb67e8cbb141">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTEtMTMtMS0xLTQ5ODE2_4b339e72-34aa-462b-83d2-b7b2cfb07998">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Buy-out of non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTItNS0xLTEtNDk4MTY_846166e4-ad98-4167-ab29-75194537b40d">943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i451b037bb41149e78da8c2582ef147c9_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTItMTEtMS0xLTQ5ODE2_239b19e8-b1f0-4a39-98b1-b64cf16a71b6">943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1053b2abcb2a42f6826b1ffc69e93fbd_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTMtNy0xLTEtNDk4MTY_9e40ff2b-3d4a-4334-a0d5-e428acf98b93">140,790</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i451b037bb41149e78da8c2582ef147c9_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTMtMTEtMS0xLTQ5ODE2_7b7e6736-1681-478e-ade5-55d4fc288e59">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTMtMTMtMS0xLTQ5ODE2_fda1d91f-8f42-4feb-88d1-da84ababeb44">140,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balances at September 30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9241e8a504e3490192f71c9decdcd3cf_I20210930" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtMS0xLTEtNDk4MTY_de2abdcf-b3c9-4c76-8086-6e4511b7a430">145,516,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9241e8a504e3490192f71c9decdcd3cf_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtMy0xLTEtNDk4MTY_d612bbfd-9593-48b9-a272-65e9a8092d5d">1,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8bc460fcd2b4144afd1e6595036df06_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtNS0xLTEtNDk4MTY_26c6a061-0325-4e9f-b9bd-9e5a2cbcea4e">1,323,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iacd4ba876f2a4fb7b83c09ef9bd71e56_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtNy0xLTEtNDk4MTY_5e63d019-135f-419f-8d65-90261843bf20">918,771</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bb367b30b03403c98021e1aba94eea9_I20210930" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtOS0xLTEtNDk4MTY_77be2394-2c28-4cca-914a-447acb0df680">623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53a9405cbbd74d8e87ce89d2e69fd569_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtMTEtMS0xLTQ5ODE2_c06fc792-c25b-4a5c-bccf-b29ce55f77b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtMTMtMS0xLTQ5ODE2_47b5f87e-d971-407e-9477-a58fc927cd86">406,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited; in thousands)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:74.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMy0xLTEtMS00OTgxNg_c9c1ab4f-097a-48dd-b04e-2e325b18f002">140,305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMy0zLTEtMS00OTgxNg_185eb723-6215-4354-8930-c2e9a98ead96">140,801</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNS0xLTEtMS00OTgxNg_052833ac-41a2-4f91-8245-1661414e3837">8,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNS0zLTEtMS00OTgxNg_5364766c-97f2-434b-ba85-4784ab264436">6,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of (discount) premium on marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNi0xLTEtMS00OTgxNg_86e82f7f-1703-4752-ad5f-d4d3323fb382">324</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNi0zLTEtMS00OTgxNg_2d4aa0c6-c628-4b2f-8f24-9a8ee563e878">2,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization and other changes in operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="sgmo:AmortizationAndOtherChangesInRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNy0xLTEtMS00OTgxNg_ea4b74d3-989f-447d-a9d7-8b401e919884">6,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="sgmo:AmortizationAndOtherChangesInRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNy0zLTEtMS00OTgxNg_825111cc-456d-4c76-a2b0-f0ef10ac9136">6,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on free shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="sgmo:GainLossOnFreeShares" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfOC0xLTEtMS00OTgxNg_eb89b8af-3222-480b-a64f-318fed7af291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="sgmo:GainLossOnFreeShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfOC0zLTEtMS00OTgxNg_a32d691c-492f-4e6b-b0e8-1355dd8ba220">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfOS0xLTEtMS00OTgxNg_d30771c3-0746-4049-b47b-f344bf55f19d">23,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfOS0zLTEtMS00OTgxNg_b112fb77-3926-46e9-91f8-8bafa7ba0627">24,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on disposal of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTAtMS0xLTEtNDk4MTY_5fbebc66-3480-4cbe-82fb-4c088e0b96a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTAtMy0xLTEtNDk4MTY_2aa608b2-e68e-43c0-8661-8039609967a0">30</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTItMS0xLTEtNDk4MTY_729a5064-52fe-4270-be31-ecee7567e78f">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTItMy0xLTEtNDk4MTY_1b7b292b-3973-4880-8911-3f5e1fd463ca">415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTMtMS0xLTEtNDk4MTY_a939f277-060a-475d-8eb8-1084bba2543c">1,491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTMtMy0xLTEtNDk4MTY_7d72b282-bbb9-4e4c-a24b-c3b605beee9c">2,743</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTQtMS0xLTEtNDk4MTY_4a8c14d0-4f96-4629-a1c2-0acb3bdccf7d">5,848</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTQtMy0xLTEtNDk4MTY_697ce68f-f630-4ed1-972c-3ef537b2437b">6,467</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTUtMS0xLTEtNDk4MTY_88cee4fa-e902-4580-994a-b6b41c5c976f">9,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTUtMy0xLTEtNDk4MTY_efc11a53-9072-4a0d-b9de-9f08feca8d74">4,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and employee benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTctMS0xLTEtNDk4MTY_956a2bb9-5f75-42f2-ad50-e30169d929a2">1,225</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTctMy0xLTEtNDk4MTY_243e51a0-368d-4ef7-bb65-7ea7fe9f6be2">1,932</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTktMS0xLTEtNDk4MTY_b4335a38-924f-4179-8675-9905d01509e0">64,956</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTktMy0xLTEtNDk4MTY_ae402276-0a4e-44b1-952d-6f677cc87ae4">62,292</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjAtMS0xLTEtNDk4MTY_12b89605-7726-49bf-aeb8-53e6a3cd3de3">3,298</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjAtMy0xLTEtNDk4MTY_0bfa10e2-0efe-4d66-ab72-f681aaad5622">3,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjEtMS0xLTEtNDk4MTY_6659e054-67c6-4cc0-9cce-0d4a05f1ed11">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjEtMy0xLTEtNDk4MTY_ef28770e-ff41-4bec-99d4-04f5f25e57cf">1,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjItMS0xLTEtNDk4MTY_035a0915-10a6-47c5-b671-bd3c4adcbf69">166,578</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjItMy0xLTEtNDk4MTY_af3e6c5f-1c72-4606-a799-bd27978238f8">180,537</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing Activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjQtMS0xLTEtNDk4MTY_b284a18b-b8d7-4526-b387-fdffd6f8a9ba">225,621</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjQtMy0xLTEtNDk4MTY_6eb70a08-12a6-4bd1-b936-1002d7b4cb3e">300,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjUtMS0xLTEtNDk4MTY_7a01aa08-09e8-4993-af60-18f28a4abc5a">254,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjUtMy0xLTEtNDk4MTY_93c4dfe5-06bf-41e5-84f6-cfbf64531762">509,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromSaleOfHeldToMaturitySecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjYtMS0xLTEtNDk4MTY_17c586b6-d0e5-4d26-bc72-e5ec7a69757e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromSaleOfHeldToMaturitySecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjYtMy0xLTEtNDk4MTY_bb9a4020-28c9-4108-af97-674c778e61ef">6,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjctMS0xLTEtNDk4MTY_ea562d78-1056-4f2f-abd4-56cb968c5d44">12,697</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjctMy0xLTEtNDk4MTY_eb6ed747-5fcf-429d-ac11-7fcedf4a30d5">20,420</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Purchase of additional Sangamo France shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjgtMS0xLTEtNDk4MTY_772d8a33-a691-4c6b-8e23-71ba03eb9a9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjgtMy0xLTEtNDk4MTY_d5d217e6-c9a5-4020-899a-953ed0e154cd">119</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzAtMS0xLTEtNDk4MTY_2e83191d-8196-4599-a22b-f9fb57bfdcfb">16,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzAtMy0xLTEtNDk4MTY_1b41264d-e795-4511-8a26-fa91f2f5ba5e">195,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from at-the-market offering, net of offering expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icdbe3cb5b46d4f3881583fc8ba6c0f17_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzItMS0xLTEtNDk4MTY_9a910c42-933c-4e26-a154-4868d4033d69">65,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d9943e3bd46453b9a5ad5d1f8b22844_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzItMy0xLTEtNDk4MTY_222a5cf0-e433-4cd9-a865-54e74bc54738">27,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzQtMS0xLTEtNDk4MTY_f0969ba7-2fbb-48a6-8e37-1c5bce29b90e">1,962</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzQtMy0xLTEtNDk4MTY_7f6894af-3117-45ab-acb8-1bac3dc1f842">2,988</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzUtMS0xLTEtNDk4MTY_388c663f-cbc1-401d-9c13-60ad67b5999e">124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzUtMy0xLTEtNDk4MTY_2cf2bfd7-1ac6-481b-8da5-00d5bf03ed9f">4,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb067ffcdfcd40edb211090a036dab65_D20220101-20220930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzYtMS0xLTEtNDk4MTY_e122ddde-14b8-4b9d-a483-7333fcf95ea0">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f15dab01ef4999822c32ed4f2574a1_D20210101-20210930" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzYtMy0xLTEtNDk4MTY_273461e7-cb74-4508-bd6a-518cef38ec64">2,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzctMS0xLTEtNDk4MTY_a06df171-b1fa-47b4-aa51-4c3e52ab27c1">65,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzctMy0xLTEtNDk4MTY_5ced355e-f46c-4d62-b3ed-3407e5618838">30,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzgtMS0xLTEtNDk4MTY_2e50ab29-1568-4e13-bf81-3b6b26ac23c3">479</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzgtMy0xLTEtNDk4MTY_f8fe1930-308d-468e-ad66-40b01b3af61b">148</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzktMS0xLTEtNDk4MTY_32db9586-e953-4b7f-9fb3-1d3b016bfde0">84,302</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzktMy0xLTEtNDk4MTY_b7c6f277-04c1-41a1-bb38-9b3a7e9b9f3c">45,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDAtMS0xLTEtNDk4MTY_274f08d0-14aa-474f-92ef-2a6b683bbd33">180,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDAtMy0xLTEtNDk4MTY_f3e0139c-2b92-4397-8e20-34ba748fbf1d">132,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents, and restricted cash, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDEtMS0xLTEtNDk4MTY_dda02f69-56b8-490d-ba4c-6e2603e0233a">96,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDEtMy0xLTEtNDk4MTY_a9e26bbf-ba2e-4144-b6da-af49cd85051d">178,454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment included in unpaid liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDMtMS0xLTEtNDk4MTY_1eb26a62-1644-4b00-9dea-962c826f8770">3,927</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDMtMy0xLTEtNDk4MTY_a7fc6ece-7767-4590-a338-65bb7b7d2772">650</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for lease obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDQtMS0xLTEtNDk4MTY_12e62324-809b-4520-83d5-26a534ac4314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDQtMy0xLTEtNDk4MTY_db0cdf43-3803-40d6-ba22-e1f201eeb261">1,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant improvement allowance included in contra-lease liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="sgmo:TenantAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDUtMS0xLTEtNTMxMjM_6f6e367d-2ab5-45f4-af35-567410f66510">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="sgmo:TenantAllowance" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDUtMy0xLTEtNTMxMzE_f5d3b81a-e5aa-4c60-83c6-edcd77fb4b0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buy-out of non-controlling interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDUtMS0xLTEtNDk4MTY_cb61fbb5-e8b2-4849-bae4-0ee6b871694d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDUtMy0xLTEtNDk4MTY_5b0a97d6-2b5b-49ca-aa47-d211a7ade3a5">943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div id="i55c688caac2b44c98200d144e37b2144_40"></div><div style="margin-top:12pt;padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 1&#8212;<ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDM_f5535700-d6a5-42b4-a3b8-8d7dcc55b51b" continuedAt="i45074197b8b842d598a93de52485a55d" escape="true">ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i45074197b8b842d598a93de52485a55d" continuedAt="i6ccaa72fc64e40deaa69b6a0dd2b0d59"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization and Description of Business</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo Therapeutics, Inc. (&#8220;Sangamo&#8221; or &#8220;the Company&#8221;) was incorporated in the State of Delaware in June 1995 and changed its name from Sangamo Biosciences, Inc. in January 2017. Sangamo is a clinical-stage genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients with serious diseases.</span></div><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTEzOTc_e91aae53-64e3-4a46-b67f-c94a1bed4e49" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of these financial statements for the periods presented have been included. Operating results for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The Condensed Consolidated Balance Sheet data at December&#160;31, 2021 was derived from the audited Consolidated Financial Statements included in Sangamo&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the &#8220;2021 Annual Report&#8221;) as filed with the SEC on February&#160;24,&#160;2022.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in the Condensed Consolidated Financial Statements. For consolidated entities where the Company owns or is exposed to less than 100% of the economics, the Company records net loss attributable to non-controlling interests on its Condensed Consolidated Statements of Operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements and related financial information should be read together with the audited Consolidated Financial Statements and footnotes for the year ended December&#160;31, 2021, included in the 2021 Annual Report.</span></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Management&#8217;s Plan</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo is currently working on a number of long-term development projects that involve experimental technologies. The projects may require several years and substantial expenditures to complete and ultimately may be unsuccessful. The Company plans to finance operations with available cash resources, collaborations and strategic partnerships funds, research grants and from the issuance of equity or debt securities. Sangamo believes that its available cash, cash equivalents, and marketable securities as of September&#160;30, 2022, and expected future milestones and research services revenue from collaborations, strategic partnerships and research grants, will be adequate to fund its currently planned operations through at least the next 12&#160;months from the date these Condensed Consolidated Financial Statements are issued. Sangamo will require substantial additional financial resources to complete the development and commercialization of its product candidates. Additional capital may not be available on terms acceptable to the Company, if at all. If adequate funds are not available, or if the terms of potential funding sources are unfavorable, the Company&#8217;s business and ability to develop its technology and therapeutic products would be harmed. Furthermore, any sales of additional equity securities may result in dilution to the Company&#8217;s stockholders, and any debt financing may include covenants that restrict the Company&#8217;s business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Significant Accounting Policies</span></div><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTEzOTM_4d5f9822-30cf-4111-b5c4-bba7e76df3ea" continuedAt="i6152c86d67be45e4bb66db73886e0897" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. On an ongoing basis, management evaluates its estimates including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, income taxes, fair value of assets and liabilities, including from acquisitions, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><ix:continuation id="i6ccaa72fc64e40deaa69b6a0dd2b0d59" continuedAt="ib23f9920be9f4c7e847e8c6ddc5dd510"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6152c86d67be45e4bb66db73886e0897">making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</ix:continuation></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company recorded an adjustment to revenue related to a change in estimate in connection with the collaboration agreement with Sanofi S.A. (&#8220;Sanofi&#8221;) as a result of an increase in the project costs for its beta thalassemia program and the increase in project scope and the corresponding costs for its sickle cell disease program, both of which resulted in a decrease in the measure of proportional cumulative performance.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This adjustment decreased revenue by $<ix:nonFraction unitRef="usd" contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTg4NA_6baf3a80-5aab-4658-93c5-fcd8fdbd5599"><ix:nonFraction unitRef="usd" contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTg4NA_ecc78aa8-ea54-4a9f-b48f-8188a8b7d2be">2.5</ix:nonFraction></ix:nonFraction>&#160;million, increased net loss by $<ix:nonFraction unitRef="usd" contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTg5OA_21b165ad-87fb-4ef1-90e5-b32a85c454c6"><ix:nonFraction unitRef="usd" contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTg5OA_714ed8e6-ea0f-44c1-adac-1ae8537e263a">2.5</ix:nonFraction></ix:nonFraction>&#160;million and increased the Company's basic and diluted net loss per share by $<ix:nonFraction unitRef="usdPerShare" contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTkxMg_1424a8e3-07f8-4457-ac58-f5c4eae53b41"><ix:nonFraction unitRef="usdPerShare" contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTkxMg_d51b16ae-e60d-453f-a3ef-9ce3a6d0868a"><ix:nonFraction unitRef="usdPerShare" contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTkxMg_d82481a7-bb6b-4721-95f7-909bc1205fa3"><ix:nonFraction unitRef="usdPerShare" contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTkxMg_efdbf1e7-f205-4f9b-877e-4d7c63bb3645">0.02</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> for the three and nine months ended September 30, 2021.</span></div><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDg_cdb3f7dd-58a1-4487-8b12-c7f6fbe384db" continuedAt="i97581d42160e45288a1b372e3c16e157" escape="true"><div style="margin-top:9pt;padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its revenues pursuant to the provisions of Accounting Standards Codification (&#8220;ASC&#8221;) Topic&#160;606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC&#160;Topic&#160;606&#8221;). The Company&#8217;s contract revenues are derived from collaboration agreements including licensing arrangements and research activity grants. Research and licensing agreements typically include upfront signing or license fees, cost reimbursements for research services, minimum sublicense fees, milestone payments and royalties on future licensees&#8217; product sales. The Company has agreements with both fixed and variable consideration. Non-refundable upfront fees and funding of research and development activities are considered fixed, while milestone payments are generally identified as variable consideration. Sangamo&#8217;s research grants are typically multi-year agreements and provide for the reimbursement of qualified expenses for research and development as defined under the terms of the grant agreement. Revenues under research grant agreements are generally recognized when the related qualified research expenses are incurred. Deferred revenue primarily represents the portion of research or license payments received but not earned.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations based on estimated selling prices; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC Topic&#160;606. The Company&#8217;s performance obligations include license rights, development services and services associated with regulatory submission and approval processes. Revenues from research services earned under collaboration agreements are generally recognized as revenue as the related services are provided. Revenues from non-refundable upfront fees are recognized over time either by measuring progress towards satisfaction of the relevant performance obligation, using the input method (i.e., cumulative actual costs incurred relative to total estimated costs) or on a straight-line basis when a performance obligation is expected to be satisfied evenly over a period of time (or when the entity has a stand-ready obligation). Significant management judgment is required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement, which may include total internal personnel costs and external costs to be incurred as well as, in certain cases, the estimated stand-ready obligation period. Changes in these estimates can have a material effect on revenue recognized. If the Company cannot reasonably estimate when its performance obligations either are completed or become inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. The Company includes the unconstrained amount of estimated variable consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint and, if necessary, adjusts its estimate of the overall transaction price. Revenue is then recognized over the remaining estimated period of performance using the cumulative catch-up method. The estimated period of performance and project costs, such as personnel and manufacturing cost, are reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current assumptions regarding the timing of its deliverables.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price of each performance obligation identified in the contract. The Company uses key assumptions to determine the stand-alone selling price, which may include forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical and regulatory success. Related costs and expenses under these arrangements have historically approximated the revenues recognized.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><ix:continuation id="ib23f9920be9f4c7e847e8c6ddc5dd510"><ix:continuation id="i97581d42160e45288a1b372e3c16e157"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTEzOTQ_4fb32d5c-af9d-4f8c-b01b-7c0cfb7944d6" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from major collaboration agreements and research activity grants as a percentage of total revenues were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis Institutes for BioMedical Research, Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia0f3233d7b70474da06a55adac0cca4d_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMi0xLTEtMS00OTgxNg_6f8cc16e-6be4-4048-8693-8821e4db1bf5">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib4943cb2b48343ef92ef1589edef40c7_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMi0zLTEtMS00OTgxNg_7d62dfad-f510-42ee-9e50-6c732f473bde">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if38002de5fe848d088ca4840e3b302a0_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMi01LTEtMS00OTgxNg_d61b392f-19df-4872-86ab-10635a8e415a">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia79b57d1d6da4b0d9ef31df01511d42d_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMi03LTEtMS00OTgxNg_1ea71e7f-5a2f-4be7-89bc-b6935c13ace1">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen MA, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9fef75604563438abe9538958474da7d_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMy0xLTEtMS00OTgxNg_8e592838-8af3-4d7c-8c9f-03636e69e35d">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib8f43928847f42c1a83bf8800d5fa943_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMy0zLTEtMS00OTgxNg_d252f61f-eae5-4a30-8ebe-a710e776bf7a">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88ddbc38aa6445598de986913238d214_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMy01LTEtMS00OTgxNg_110a97bc-a934-4831-845d-144d6a86d669">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie4327ef899954f25af6c0c80522b2c7d_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMy03LTEtMS00OTgxNg_81526d0e-e527-4bd1-9902-2ce33453c06e">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kite Pharma, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6fa286ca65b64056995eb4ab2664cdd0_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNC0xLTEtMS00OTgxNg_599f29b7-8641-4ae9-9eec-1e77f55dbc54">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e54c4c6f853445c95d080879c43b2b2_D20210701-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNC0zLTEtMS00OTgxNg_b83e3b05-ff63-4d4b-bed1-d7fe9b8176be">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ebc3bc839ea482380db614d89d89bb5_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNC01LTEtMS00OTgxNg_71d520d7-95d3-474e-a145-fad4b3e38353">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i45f1ab603cb94ccc868b785c550c0609_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNC03LTEtMS00OTgxNg_dec45849-7a16-447f-8cea-f8e754ae740c">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi S.A.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iacda68cbeb604746812d5bd97bf218a3_D20220701-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNS0xLTEtMS00OTgxNg_08e96ff5-0743-45a4-a0e4-dafa88900a97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="idf66e1bb8ddd4393b9d770b1885a7a64_D20210701-20210930" decimals="2" sign="-" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNS0zLTEtMS00OTgxNg_d9f0e4d5-5e5e-41d2-8bed-733a40dfae41">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib124d69483284e9693d405b60f7383e0_D20220101-20220930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNS01LTEtMS00OTgxNg_3a55e54c-b57e-49f0-b004-5d6da22af9ce">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1634f7d6a7a14dd38290439da8287bbd_D20210101-20210930" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNS03LTEtMS00OTgxNg_b2b7611c-3a43-4d0d-ab01-cee2ed678b62">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Funds received from the Company&#8217;s collaboration partners are generally not refundable and are recorded as revenue as the Company fulfills its performance obligations, which are satisfied over time (i.e., stand ready obligations) or by using the input method (i.e., cumulative actual costs incurred relative to total estimated costs). Revenue is also recognized when the Company has incurred qualified research and development costs that are reimbursable from its collaboration partners and when there is reasonable assurance that such costs will be reimbursed. Any payments received from a collaboration partner in advance of the completion of the relevant performance obligation are recorded as deferred revenue.</span></div></ix:continuation><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDA_73162dc7-870f-4d97-b6e1-09ebdee4d370" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo considers all highly liquid investments purchased with original maturities of three months or less at the purchase date to be cash equivalents. Cash and cash equivalents consist of cash, deposits in demand money market accounts and U.S. government-sponsored entity debt securities. Restricted cash consists of a letter of credit for $<ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTEwMDE_6519d9a6-2d49-415d-9c34-a75dae893764">1.5</ix:nonFraction>&#160;million, representing a deposit for the lease of the corporate headquarters in Brisbane, California.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:36pt"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDI_1643d61d-94ef-47a7-b39c-fc46f5f8ae5f" escape="true"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDI_242f90ae-6efe-44e7-833c-e0c6c854d27c" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMS0xLTEtMS00OTgxNg_244dc012-1c31-47ad-aa60-b92ff9d3eb8c">94,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMS0zLTEtMS00OTgxNg_6e446b40-27cd-4130-b2fd-70b955d9dd0d">178,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMS01LTEtMS00OTgxNg_083011bf-aeec-4cce-9eec-69af1fb50546">176,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMS03LTEtMS00OTgxNg_39e1944f-ecda-4fd7-9e3d-7ac635b9e442">131,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMi0xLTEtMS00OTgxNg_c20cf43a-3a07-4ced-8083-ea9d1a494000">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMi0zLTEtMS00OTgxNg_5d1a7b83-4f05-43fe-ac12-7f4ce47dc675">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMi01LTEtMS00OTgxNg_4289b1be-347f-40a4-a5b6-44df6948bed2">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMi03LTEtMS00OTgxNg_e280865d-5fbf-4179-a25d-6678c9867613">1,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMy0xLTEtMS00OTgxNg_f57ca302-97d8-42b0-9718-74aaafeef9ae">96,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMy0zLTEtMS00OTgxNg_5e033cef-bc97-46dc-b3bf-36cd6d9295b7">180,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMy01LTEtMS00OTgxNg_decf677e-9d5a-4b00-8b85-887348af04b3">178,454</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMy03LTEtMS00OTgxNg_284b2add-1e6f-46cb-9504-f530dbffb196">132,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:nonNumeric></div><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDc_84b787c5-ba51-4a8f-b2de-709a29bfa92c" escape="true"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div></ix:nonNumeric></ix:continuation><div id="i55c688caac2b44c98200d144e37b2144_43"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 2&#8212;<ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RleHRyZWdpb246YWQ0MTRkMzUxODEzNDViNGE0MzU5ODFiNDNkYmE5ZWZfMjI1Ng_ca4f3424-22f9-4708-b8a5-12a5075f4df1" continuedAt="idbd08623419545fabb4212905c9b6f59" escape="true"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RleHRyZWdpb246YWQ0MTRkMzUxODEzNDViNGE0MzU5ODFiNDNkYmE5ZWZfMjI1Nw_a0662061-d572-4191-87e0-c41c8cca1240" continuedAt="ica6d3996ae544b00ad62714fa8a13814" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="idbd08623419545fabb4212905c9b6f59"><ix:continuation id="ica6d3996ae544b00ad62714fa8a13814" continuedAt="i52ef6bcc56354b3bb6589a08e9bcbae1"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents, marketable securities, and the free shares asset. Fair value is determined based on a three-tier hierarchy under the authoritative guidance for fair value measurements and disclosures that prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurements and unobservable (i.e., supported by little or no market activity).</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><ix:continuation id="i52ef6bcc56354b3bb6589a08e9bcbae1"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RleHRyZWdpb246YWQ0MTRkMzUxODEzNDViNGE0MzU5ODFiNDNkYmE5ZWZfMjI1OQ_8f9fa3ee-ad09-4de6-9b4c-6e8fc6ae7fae" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurements of the Company&#8217;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id122cadbcd79415cb294942cf9401910_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfNS0xLTEtMS00OTgxNg_f30a0060-25ca-4059-8509-2fc5bbab0d89">44,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa6d0f240a92487abfb8f0f38f3112e9_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfNS0zLTEtMS00OTgxNg_12d1fd85-8cfd-495b-9841-32049591f796">44,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8158142c524b369324fc1ebf0f9f1e_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfNS01LTEtMS00OTgxNg_c65b39a6-bb46-4a45-b3cc-9a5e979e1bb7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a6fb7e7492a4f939428513d8fcff441_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfNS03LTEtMS00OTgxNg_be4fc840-2579-4ee2-83b6-86ee44941adb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d87151f3dd48979c96441aaec7b540_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfOC0xLTEtMS00OTgxNg_b4f8c5c9-7d8b-4b38-adaa-4f599a0fadb3">44,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffdbeeb166274031b5cec94b4a93c065_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfOC0zLTEtMS00OTgxNg_b6bfd095-9bd5-463f-9992-e69f48b060d2">44,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681433de93e34299a5bb54fef49f27c4_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfOC01LTEtMS00OTgxNg_58cbdfe4-4533-4e1e-8818-a9a77605b49d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbd33edee0941eebf5eb1beb36d33b5_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfOC03LTEtMS00OTgxNg_2e2fbb8a-9e63-4fc3-aaa8-0ba3afd92160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie11a6708a3494e018d5eea96804cc1f8_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTAtMS0xLTEtNDk4MTY_5b6148fb-0b99-4bea-abea-5dbea7ddcd30">23,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29f19ecdd60e4cf4881d032f9b06e15e_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTAtMy0xLTEtNDk4MTY_2f6473ad-46f9-4648-9988-b38832004e65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf1ed758ad3142609eaf08869c43df41_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTAtNS0xLTEtNDk4MTY_09db6763-189c-4fc6-aab9-429ec87b25db">23,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idbd920e533444e47a3756a9b4a8eb6b6_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTAtNy0xLTEtNDk4MTY_6878e65d-5ba3-4641-9c0b-7761a898db64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32ad7e19c06a465f8f07b405b0f7cfd4_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTEtMS0xLTEtNDk4MTY_4ce4f3f2-3b75-42af-b88f-75d8bce02e0c">120,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if27bae2120224abea6224708e6f3de8f_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTEtMy0xLTEtNDk4MTY_35058b95-3df2-4cfa-aebb-0c2f43048684">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ca8592334b04957a537a0d4cf813494_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTEtNS0xLTEtNDk4MTY_c409df31-4a21-484c-9ed2-a848867954f6">120,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc09550b59114bae9b748047cd9d24a8_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTEtNy0xLTEtNDk4MTY_9de795c6-8d6c-41c0-adb3-c93487b1ac75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab0f243dd424f92b69b063a217eae48_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTItMS0xLTEtNDk4MTY_72c96a63-805b-4da4-87d8-c66362bd1129">14,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i411394c5d10d486cbce2b24abae3a661_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTItMy0xLTEtNDk4MTY_0e0165a0-cc89-426b-adca-c6830d5af917">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09186c27c86747a68746b52de10d7d1c_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTItNS0xLTEtNDk4MTY_11524a98-d298-42f4-8d50-2d5420ff4a0a">14,888</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5b732d846284342a16bea6ef1968757_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTItNy0xLTEtNDk4MTY_70a3d740-83c0-488b-b37e-f2a1d982c9b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i769639b449a24295852cb05e72c00a17_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTMtMS0xLTEtNDk4MTY_eb77dc6b-acd5-4bbe-afe2-94fac22d8aac">37,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9606a8a617b841e885ebefda50badef9_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTMtMy0xLTEtNDk4MTY_99a00e0c-3dbe-4678-8ba5-c611350a22ac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i122ce6ac71ea4602bfd1231782ca60d8_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTMtNS0xLTEtNDk4MTY_587c28f5-b8dc-4c29-9251-f2663885abbb">37,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67eaaf5137b4b6f9b62df6016a69f07_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTMtNy0xLTEtNDk4MTY_531516a5-480e-485a-bd08-f04ce3c08e71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd4fdedfda294dfab406c29000abe2e6_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTQtMS0xLTEtNDk4MTY_51527ee6-c5d6-4942-837d-090142edc785">16,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fa8a902c3774cde978198ce09be1bb9_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTQtMy0xLTEtNDk4MTY_96538dfb-becf-4b34-ac45-ee7cac66128a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i639b4eda38c648ffb15ee7b60a5bdfd4_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTQtNS0xLTEtNDk4MTY_3c701a89-c090-444e-a81a-8d59ef0afca2">16,922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6065eabb66dc4690a7523d48b52983fc_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTQtNy0xLTEtNDk4MTY_3ed457ce-c838-4beb-943e-0e072bcf11fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a4226459e39406dbf0ef1ecac2f7183_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTUtMS0xLTEtNDk4MTY_ee6057f1-7e8d-461d-ba8a-e0d3969e3b37">42,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33868ebce0ac437282e6ca0c2cd516ea_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTUtMy0xLTEtNDk4MTY_9207104f-5d9b-4a12-b421-55dbc05742cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51cf12c7232b41e7a436caf0336ac5c1_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTUtNS0xLTEtNDk4MTY_bb4989ed-fc8d-46ec-a132-d95cc8bd18f4">42,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cb99b1da6c54c77bee0c45127be6f3f_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTUtNy0xLTEtNDk4MTY_b4e47f54-f8d7-4a5f-8fe1-c05ab432e7ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d87151f3dd48979c96441aaec7b540_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTYtMS0xLTEtNDk4MTY_f780fcdf-9657-48fe-8401-ae7868b1aeb9">255,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffdbeeb166274031b5cec94b4a93c065_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTYtMy0xLTEtNDk4MTY_907fdb62-e2b8-4b7b-93a6-754bea5fc3df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681433de93e34299a5bb54fef49f27c4_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTYtNS0xLTEtNDk4MTY_7ba8f37a-2d75-44fb-a930-1ce38d1478ef">255,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbd33edee0941eebf5eb1beb36d33b5_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTYtNy0xLTEtNDk4MTY_caa2f501-f5d2-4d15-b8c7-88fb721a4c13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i96d87151f3dd48979c96441aaec7b540_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTctMS0xLTEtNDk4MTY_9c2b0fba-7820-4fa9-a17e-c2f19d661eea">300,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffdbeeb166274031b5cec94b4a93c065_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTctMy0xLTEtNDk4MTY_479c6d18-d8d7-497e-aa12-f60c1158a81f">44,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i681433de93e34299a5bb54fef49f27c4_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTctNS0xLTEtNDk4MTY_e75004a0-5534-43c2-b372-935b2f392445">255,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbd33edee0941eebf5eb1beb36d33b5_I20220930" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTctNy0xLTEtNDk4MTY_515be143-b829-48f9-9b87-be584942f195">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21bb501c85b34076a54c9225ae07ee8e_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNS0xLTEtMS00OTgxNg_45ba50d5-5160-4358-a233-7eca883ca4f2">119,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73036590c4ef457f87ba13c7f72633ea_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNS0zLTEtMS00OTgxNg_a24d93fa-0047-48e4-ac4a-e1b067861ffa">119,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c608a75f06a443dae43f3295a547e25_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNS01LTEtMS00OTgxNg_85e85cff-1137-48b8-9d20-861fbe979b86">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9df22ac2f004b0fbb4e5f907ec70d9b_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNS03LTEtMS00OTgxNg_602e4c0c-7b4a-4500-b7b1-10002c22cfaa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90f6a0673d64365a8cac1c06453bb58_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNi0xLTEtMS00OTgxNg_8f2661ac-e246-4df3-b580-5bd2c78e674f">119,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9430e03891404dea839fb2cff64af738_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNi0zLTEtMS00OTgxNg_e825afa0-f51a-45dd-a95e-51c32c35f16f">119,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if003bbe1b3bd45aca76e20e836c5a3a5_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNi01LTEtMS00OTgxNg_de494d41-05ca-4ab1-9dbf-de2f73aebead">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia43cd647cad04bb9a7cadc11f325af6a_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNi03LTEtMS00OTgxNg_d0f866dc-7c37-4bbd-a761-07fa636de12a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibcef3b61008c46d0992163cd7bffe1cd_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOC0xLTEtMS00OTgxNg_16b4cdef-c546-4c09-bc5b-6792450707a0">30,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cf4147ceb5942299b88c10a4f9be27a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOC0zLTEtMS00OTgxNg_56b5b4b7-0344-4230-9ce8-78a688fef965">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b800a8209c64902a695cd1dcd597172_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOC01LTEtMS00OTgxNg_09623621-d3ef-4705-acfe-fca94ae4b505">30,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaeaa77913ce413b93a7c9dab1d36cab_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOC03LTEtMS00OTgxNg_9117b481-bc0a-4592-8076-1b103d039d62">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0de8afe4f7c2493b8c43a2e0f29a7399_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOS0xLTEtMS00OTgxNg_99007efb-8199-4874-b750-03fb3f171764">105,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c91803551d641a8963ac07c42cfe596_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOS0zLTEtMS00OTgxNg_609f36cd-4a1b-48b5-8abf-30cc9689b9c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic47a895f418d48cf8f9d9eff69edeeda_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOS01LTEtMS00OTgxNg_3f48d85f-a5e2-41b2-8b91-e7dff0c1efc6">105,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3be3d7d00461404e980d8a74a0ae2c25_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOS03LTEtMS00OTgxNg_3c185247-3270-457a-8a33-b7a64d9331d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c98918b8f5542dca9d804a934e84995_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTAtMS0xLTEtNDk4MTY_f9c41e68-653a-482a-9942-c6d73b74092f">33,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ee5a63a339b4d8991f36eaf5ff1be1c_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTAtMy0xLTEtNDk4MTY_1c904858-f5d0-485b-9f9d-81ec1f8f0ee5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i983119dcdc834acda4676ea99a8c08da_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTAtNS0xLTEtNDk4MTY_902888a4-6332-476d-92d4-6e2ad2a8aa44">33,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa714eaea0f1411e85e65049e450b3eb_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTAtNy0xLTEtNDk4MTY_cdb82b96-a909-4eb1-8186-f24296079386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86315bd8be5a4ce4b190ddec3e753c05_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTEtMS0xLTEtNDk4MTY_8dae0e0b-ec27-4200-85b7-393ff477082b">70,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6016ec92d0c640e1aed56b72f34057e9_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTEtMy0xLTEtNDk4MTY_92815b6d-a534-4ffd-81b8-b22eeb75405a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69ab4258b6f14b29bd7da873df0ba0f7_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTEtNS0xLTEtNDk4MTY_c9a2446f-b009-4e9a-9201-d124f30c58d9">70,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i764fb984c25d4da5b64a0b48e5199b99_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTEtNy0xLTEtNDk4MTY_16277d80-4757-4ec5-90fa-0434dba63e0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia28128c5fca64935bcf980ed70b30b2a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTItMS0xLTEtNDk4MTY_a3b0ab90-6a76-4275-8b39-8dae8b3a1f76">45,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386e3b89d03f479ca5825c2bebba2e54_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTItMy0xLTEtNDk4MTY_82e43911-1626-4872-95e6-c8635bb76ecc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie86bb74f566944b9839da6ff3a70d767_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTItNS0xLTEtNDk4MTY_a6308e62-0c1f-4746-b612-099d0d38f7b4">45,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i359bee546a724e5d8222c768c5722bef_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTItNy0xLTEtNDk4MTY_100267e1-4f7b-4fb0-a615-a8d1e847b6cf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90f6a0673d64365a8cac1c06453bb58_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTMtMS0xLTEtNDk4MTY_2df64ada-a5c0-4bb9-ae80-c8755b8fd20c">285,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9430e03891404dea839fb2cff64af738_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTMtMy0xLTEtNDk4MTY_f0a69e8f-4798-4d8d-8fdf-47d772ac2e6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if003bbe1b3bd45aca76e20e836c5a3a5_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTMtNS0xLTEtNDk4MTY_45fe3819-4c76-44fb-8740-14ed86e52908">285,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia43cd647cad04bb9a7cadc11f325af6a_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTMtNy0xLTEtNDk4MTY_0ee872b7-5a54-4696-a395-d57872ec6d19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if90f6a0673d64365a8cac1c06453bb58_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTQtMS0xLTEtNDk4MTY_da4d7607-ec00-43d6-8554-fe3183403726">405,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9430e03891404dea839fb2cff64af738_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTQtMy0xLTEtNDk4MTY_604bea92-b3af-4d62-a0cb-eb4e6f656540">119,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if003bbe1b3bd45aca76e20e836c5a3a5_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTQtNS0xLTEtNDk4MTY_e2b2dbf1-de57-4c15-b895-094ce0793331">285,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia43cd647cad04bb9a7cadc11f325af6a_I20211231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTQtNy0xLTEtNDk4MTY_4e1a4441-2878-41fe-9a5d-9333db0d4fa2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents and Marketable Securities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally classifies its marketable securities as Level&#160;2. Instruments are classified as Level&#160;2 when observable market prices for identical securities that are traded in less active markets are used. When observable market prices for identical securities are not available, such instruments are priced using benchmark curves, benchmarking of like securities, sector groupings, matrix pricing and valuation models. These valuation models are proprietary to the pricing providers or brokers and incorporate a number of inputs, including in approximate order of priority: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. For certain security types, additional inputs may be used, or some of the standard inputs may not be applicable. Evaluators may prioritize inputs differently on any given day for any security based on market conditions, and not all inputs listed are available for use in the evaluation process for each security evaluation on any given day.</span></div></ix:continuation><div style="margin-top:6pt;text-indent:27pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_46"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 3&#8212;<ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjczMw_38a70890-a66f-4f25-881e-253b9479126d" continuedAt="i0e6297e5da324a09bee14b562064a1c3" escape="true">CASH EQUIVALENTS AND MARKETABLE SECURITIES</ix:nonNumeric></span></div><ix:continuation id="i0e6297e5da324a09bee14b562064a1c3" continuedAt="i30ae8a118a644677853291407504844b"><div style="margin-top:6pt;text-indent:36pt"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjczNQ_f4b3c27c-a097-46f8-b9b3-7e219924fe60" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s cash equivalents and marketable securities (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:50.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab983723fa734404b015fc014b16e4f2_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNC0xLTEtMS00OTgxNg_85c356b1-a749-446e-9b3b-9c25280f8014">44,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab983723fa734404b015fc014b16e4f2_I20220930" decimals="-3" name="sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNC0zLTEtMS00OTgxNg_dcb237c4-723d-4d28-aabe-08864a42c7d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab983723fa734404b015fc014b16e4f2_I20220930" decimals="-3" name="sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNC01LTEtMS00OTgxNg_fc5af72f-7220-4bca-97e1-79ab8e82ac40">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab983723fa734404b015fc014b16e4f2_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNC03LTEtMS00OTgxNg_d5069027-2275-4e3d-9562-945950584ffc">44,911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1f5af8c8327472da2ae3d160d57b379_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNy0xLTEtMS00OTgxNg_0cf7cd25-f8b0-437c-be0c-1ad58f253d6a">44,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1f5af8c8327472da2ae3d160d57b379_I20220930" decimals="-3" name="sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNy0zLTEtMS00OTgxNg_d62cee8e-9975-426e-86dd-eb1d9f7481e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1f5af8c8327472da2ae3d160d57b379_I20220930" decimals="-3" name="sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNy01LTEtMS00OTgxNg_06912c29-8b68-43ad-86b9-30a72e5fc4c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1f5af8c8327472da2ae3d160d57b379_I20220930" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNy03LTEtMS00OTgxNg_98dd5b83-3876-4f97-81ea-31fae318b662">44,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48e0ebe4c00048caa8ca855361cd3dec_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfOS0xLTEtMS00OTgxNg_ead3041f-42e1-4d3d-a4a8-c72dad84eda9">23,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48e0ebe4c00048caa8ca855361cd3dec_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfOS0zLTEtMS00OTgxNg_3d4f39fd-cb93-4075-9f1b-2538026b75d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i48e0ebe4c00048caa8ca855361cd3dec_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfOS01LTEtMS00OTgxNg_4bfc4f83-3a56-4106-af91-6bf75926677d">440</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48e0ebe4c00048caa8ca855361cd3dec_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfOS03LTEtMS00OTgxNg_10b6d0e6-7fab-4510-9752-099a38ddf2fa">23,392</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e93e6a67164aee80389e38c2ed7ddc_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTAtMS0xLTEtNDk4MTY_5715af99-2bdc-4cd8-919a-0cb6ca082fb3">120,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e93e6a67164aee80389e38c2ed7ddc_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTAtMy0xLTEtNDk4MTY_8ed627bf-d114-413e-bcb7-2e99273e06b6">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9e93e6a67164aee80389e38c2ed7ddc_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTAtNS0xLTEtNDk4MTY_5acdb01d-be62-4d0c-b7c0-94a64373c74f">375</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e93e6a67164aee80389e38c2ed7ddc_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTAtNy0xLTEtNDk4MTY_82829bb8-0841-427a-8fc6-7a1edd5fb95c">120,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic708e40109d743859a0cbe3fd8575521_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTEtMS0xLTEtNDk4MTY_40fe830d-634e-4128-b512-09a13922fd0d">15,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic708e40109d743859a0cbe3fd8575521_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTEtMy0xLTEtNDk4MTY_a942e7b4-8ff9-4c20-9624-4d3bde6fe59e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic708e40109d743859a0cbe3fd8575521_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTEtNS0xLTEtNDk4MTY_6d073665-826a-44a8-9814-7185d243c984">162</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic708e40109d743859a0cbe3fd8575521_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTEtNy0xLTEtNDk4MTY_2300cbc7-4e32-4386-91c7-d4537bc0ad3b">14,888</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9fe47fa2ac24546b0189e24f5f31056_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTItMS0xLTEtNDk4MTY_1b0655af-5db1-4e2c-a632-88fdc5b4f8af">38,039</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9fe47fa2ac24546b0189e24f5f31056_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTItMy0xLTEtNDk4MTY_ef8424df-20c7-41cb-9f80-3b7c69308e6d">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib9fe47fa2ac24546b0189e24f5f31056_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTItNS0xLTEtNDk4MTY_2bddb2cd-7f08-4b48-a8ef-056688e1d2ba">268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9fe47fa2ac24546b0189e24f5f31056_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTItNy0xLTEtNDk4MTY_0a785795-bb9e-4c12-9510-b3944f2f40a5">37,773</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb29a716f8547e093a0767d93caf9a1_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTMtMS0xLTEtNDk4MTY_31a9a150-7e7b-4db2-a940-e97c94aa89dd">16,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb29a716f8547e093a0767d93caf9a1_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTMtMy0xLTEtNDk4MTY_94717392-1e22-42da-a6c8-78ded0233028">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibeb29a716f8547e093a0767d93caf9a1_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTMtNS0xLTEtNDk4MTY_7249a6d2-9642-4cc8-b8d4-be5565f94396">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb29a716f8547e093a0767d93caf9a1_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTMtNy0xLTEtNDk4MTY_815a6683-489e-4bf5-864f-97fe145f56a9">16,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa1ecbd5903489ea2ee1f51365efa36_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTQtMS0xLTEtNDk4MTY_8adb7719-dc58-403a-ac10-c1de2c267e00">42,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa1ecbd5903489ea2ee1f51365efa36_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTQtMy0xLTEtNDk4MTY_27d5de20-6b55-471d-9f36-221ea289dc5f">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8aa1ecbd5903489ea2ee1f51365efa36_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTQtNS0xLTEtNDk4MTY_3d713022-7acf-4a92-8f95-f8abcaaa1b4a">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aa1ecbd5903489ea2ee1f51365efa36_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTQtNy0xLTEtNDk4MTY_42af741e-43a4-43f1-af76-26b09efa897a">42,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTUtMS0xLTEtNDk4MTY_d600f60a-e02e-4662-8cb6-ad36289bc1cc">257,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTUtMy0xLTEtNDk4MTY_f741fbc8-9738-4d5d-a588-7cb74adf1563">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTUtNS0xLTEtNDk4MTY_c216e229-2abb-4f43-935a-bcc261971be2">1,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTUtNy0xLTEtNDk4MTY_8e177d9c-d23c-46fe-aaa7-9197c8876915">255,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTYtMS0xLTEtNDk4MTY_158f9cc6-2188-4ad1-9d63-ae5bada56732">302,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTYtMy0xLTEtNDk4MTY_1efc9830-ce07-4e85-960e-fb2de8fc4f59">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTYtNS0xLTEtNDk4MTY_b8f08b11-e39f-41e3-9b9e-9d8c5c3f0070">1,412</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTYtNy0xLTEtNDk4MTY_9ef4dcd6-040d-4589-b72a-354fa7234a2c">300,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e4f486e25d4837bc2bd16e7e92edf4_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjEtMS0xLTEtNDk4MTY_3eac10ef-5258-43e4-9614-5ce83ab25b3c">119,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e4f486e25d4837bc2bd16e7e92edf4_I20211231" decimals="-3" name="sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjEtMy0xLTEtNDk4MTY_f7b3909b-4281-422d-89dd-1ded591946ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e4f486e25d4837bc2bd16e7e92edf4_I20211231" decimals="-3" name="sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjEtNS0xLTEtNDk4MTY_62d71d53-6edd-48e4-acb0-1462caef9b1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09e4f486e25d4837bc2bd16e7e92edf4_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjEtNy0xLTEtNDk4MTY_62ed4ef9-dbc2-4b58-b45d-8146dcf5d7cf">119,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb83f685b39f49fc8b06dfce81650e59_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjItMS0xLTEtNDk4MTY_966d8bd6-5a6c-40d4-a704-2c7e361136db">119,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb83f685b39f49fc8b06dfce81650e59_I20211231" decimals="-3" name="sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjItMy0xLTEtNDk4MTY_18c411ad-9b88-43ec-a188-5c0241d1b301">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb83f685b39f49fc8b06dfce81650e59_I20211231" decimals="-3" name="sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjItNS0xLTEtNDk4MTY_6c0d21ec-e044-4d09-bd2e-84f8fd88bd3e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb83f685b39f49fc8b06dfce81650e59_I20211231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjItNy0xLTEtNDk4MTY_c5b54383-626b-477d-9c02-768bdc1e1b13">119,919</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0d6f23a6e1e4fdd89526d7156771dde_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjQtMS0xLTEtNDk4MTY_5f66d13b-c2bf-4a91-ae50-b4f9b524a012">30,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0d6f23a6e1e4fdd89526d7156771dde_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjQtMy0xLTEtNDk4MTY_7a26f7d3-8275-4837-b8db-7e8f855e9467">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id0d6f23a6e1e4fdd89526d7156771dde_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjQtNS0xLTEtNDk4MTY_12e640cc-e423-49fc-8d21-9c6c4db9d98b">87</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0d6f23a6e1e4fdd89526d7156771dde_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjQtNy0xLTEtNDk4MTY_9d381176-3c3c-4551-9385-23c917ab67f5">30,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa0a0121a11a4f5a9c8f92c62eb8b617_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjUtMS0xLTEtNDk4MTY_65b2f298-83b6-418a-8878-58a490224e72">105,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa0a0121a11a4f5a9c8f92c62eb8b617_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjUtMy0xLTEtNDk4MTY_509b73c5-424f-4b42-8028-032fdf1aebcf">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa0a0121a11a4f5a9c8f92c62eb8b617_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjUtNS0xLTEtNDk4MTY_62a185f6-46eb-4696-9c3f-2500f27b3188">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa0a0121a11a4f5a9c8f92c62eb8b617_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjUtNy0xLTEtNDk4MTY_1082d71b-2c35-4c0c-ad35-433134de28d9">105,757</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if51181fc5273431abe839125ae5e5dc9_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjYtMS0xLTEtNDk4MTY_c4cef532-0b0d-469a-b2e0-2796ec81c644">33,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if51181fc5273431abe839125ae5e5dc9_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjYtMy0xLTEtNDk4MTY_cbe9e2ad-fe04-47a1-bfb3-1886cffdee52">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if51181fc5273431abe839125ae5e5dc9_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjYtNS0xLTEtNDk4MTY_430d6b2f-b3dc-4d29-b3d3-b92339be68e8">42</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if51181fc5273431abe839125ae5e5dc9_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjYtNy0xLTEtNDk4MTY_59002100-b040-47db-a1e1-7b241e146cd0">33,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f81a5cb7fee4760866d108a18198b21_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjctMS0xLTEtNDk4MTY_d1b86cc5-8941-4763-a394-86b95c3820cc">70,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f81a5cb7fee4760866d108a18198b21_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjctMy0xLTEtNDk4MTY_d22b582f-f921-4f15-9d04-a12a45f106f4">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f81a5cb7fee4760866d108a18198b21_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjctNS0xLTEtNDk4MTY_22777088-05e4-4ea2-8f42-a95edc26c645">107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f81a5cb7fee4760866d108a18198b21_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjctNy0xLTEtNDk4MTY_27ddaacd-f31a-44f5-9a36-72b1110fac08">70,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be12bead5e34d9d9730b4f9983fdc54_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjgtMS0xLTEtNDk4MTY_0f5204ba-5519-4933-a3a2-3d8e26237ec9">45,116</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be12bead5e34d9d9730b4f9983fdc54_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjgtMy0xLTEtNDk4MTY_729b86a2-1f04-4b5e-a64d-08750028e3ef">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6be12bead5e34d9d9730b4f9983fdc54_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjgtNS0xLTEtNDk4MTY_35df8a8e-42f3-49d2-9e2c-7581c15481f2">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6be12bead5e34d9d9730b4f9983fdc54_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjgtNy0xLTEtNDk4MTY_ca131379-3ca2-41d9-a70b-e67aa88f5d4b">45,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjktMS0xLTEtNDk4MTY_5d756754-eb98-4477-a216-377cbb1fbfa6">286,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjktMy0xLTEtNDk4MTY_409b474b-a00d-459d-b81a-fe1f526f7d1d">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjktNS0xLTEtNDk4MTY_4c960a6b-4d7c-475b-90af-ebf5442b85f2">304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjktNy0xLTEtNDk4MTY_fbf0cf9d-69e3-4f5b-a43f-844d081df7e8">285,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMzAtMS0xLTEtNDk4MTY_88b85a01-4908-49ec-9aa4-d606de9ffb6d">406,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMzAtMy0xLTEtNDk4MTY_c0fe1bc0-ec6f-460f-82d7-fe1be322d142">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMzAtNS0xLTEtNDk4MTY_d5403f1b-138a-4bbd-be09-ef20059944b4">304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="sgmo:CashEquivalentsAndAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMzAtNy0xLTEtNDk4MTY_9d0805cb-9487-4871-957f-2f1e4e56ddd2">405,764</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:12pt;text-indent:36pt"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjczNg_4a7266d7-f871-4bde-9e5b-3aff37d0b351" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of marketable securities by contractual maturity were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:74.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.494%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.524%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMS0xLTEtMS00OTgxNg_d87077eb-522c-480a-aebc-9b8463c61c60">218,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMS0zLTEtMS00OTgxNg_09ac859d-d795-4460-aaba-da533b90ff8c">197,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMi0xLTEtMS00OTgxNg_03cbfe41-f7eb-4491-9381-38d525f52b22">36,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMi0zLTEtMS00OTgxNg_1126139f-bb6f-4f44-b129-05e97c1c3424">88,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="-3" name="sgmo:DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMy0xLTEtMS00OTgxNg_c38de49c-52ca-4e63-a6aa-b4bbed2c0778">255,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="-3" name="sgmo:DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMy0zLTEtMS00OTgxNg_fb1a8be1-e436-4152-ac7d-0bc92fc527d1">285,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="0" name="us-gaap:RealizedInvestmentGainsLosses" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjY0_314b73ec-3cf7-4616-8f37-04366aa8c0cf"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="0" name="us-gaap:RealizedInvestmentGainsLosses" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjY0_81292266-63dd-460f-96eb-9181d94b3ad7">no</ix:nonFraction></ix:nonFraction> realized gains and losses on the sales of investments during the three and nine months ended September&#160;30, 2022. Realized gains and losses on the sales of investments were insignificant during the three and nine months ended September&#160;30, 2021.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages credit risk associated with its investment portfolio through its investment policy, which limits purchases to high-quality issuers and also limits the amount of its portfolio that can be invested in a single issuer. The Company did <ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_0e26e49e-88ed-4aa4-8703-72e21ee326cd"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="INF" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_555e3a1f-a7a3-4aad-b66a-d35bb1fefa97"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="INF" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_608ed15a-4aef-420e-bcaa-cdf4e6321902"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_a66c8f9e-6d9e-4a5b-9040-e1944752581e"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="INF" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_a792a554-4263-46fa-9ff3-c5cee84aa104"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="INF" name="us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_d95595c2-3c38-4b5a-a865-45abfbae80b1"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_df2f6efa-cead-4794-a974-eaf650cdb70d"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_f7992cc6-7af6-4781-a522-c452aaf1b7f3">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>t record an allowance for credit losses or other impairment charges related to its marketable securities for the three and nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had unrealized losses related to its marketable securities for the three and nine months ended September&#160;30, 2022 and 2021. The Company had no material unrealized losses, individually and in the aggregate, for marketable </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i30ae8a118a644677853291407504844b">securities that are in a continuous unrealized loss position for greater than 12 months as of September&#160;30, 2022 and December&#160;31, 2021. Based on the scheduled maturities of its investments, the Company determined that it was more likely than not that it will hold these investments for a period of time sufficient for a recovery of its amortized cost basis. Total unrealized gains for securities with net gains in accumulated other comprehensive income were not material for the three and nine months ended September&#160;30, 2022. The unrealized losses were not attributed to credit risk and were associated with changes in market conditions. The Company periodically reviews its marketable securities for indications of credit losses. The Company considers factors such as the duration, the magnitude and the reason for the decline in value, the potential recovery period, creditworthiness of the issuers of the securities and its intent to sell. For marketable securities, it also considers whether (i)&#160;it is more likely than not that the Company will be required to sell the debt securities before recovery of their amortized cost basis, and (ii)&#160;the amortized cost basis cannot be recovered as a result of credit losses. No significant facts or circumstances have arisen to indicate that there has been any significant deterioration in the creditworthiness of the issuers of the securities held by the Company. Based on the Company&#8217;s review of these securities, including the assessment of the duration and severity of the unrealized losses and the Company&#8217;s ability and intent to hold the investments until maturity, the Company determined that <ix:nonFraction unitRef="usd" contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjYzMA_4ffc1c14-f252-45fe-9f7b-b6fd09074fc1"><ix:nonFraction unitRef="usd" contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjYzMA_61a5edaa-7b21-46f4-ac6a-7bae41e91b33">no</ix:nonFraction></ix:nonFraction> allowance for credit losses related to its marketable securities was required at either September&#160;30, 2022 or December&#160;31, 2021.</ix:continuation></span></div><div id="i55c688caac2b44c98200d144e37b2144_52"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 4&#8212;<ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81Mi9mcmFnOmFjZWQ0NjMwYzcwNTQyOTlhYjIzYWJjZTZhMDBhOGI4L3RleHRyZWdpb246YWNlZDQ2MzBjNzA1NDI5OWFiMjNhYmNlNmEwMGE4YjhfMTE0MQ_64c13972-e616-421f-aa57-6e490e53ce69" continuedAt="i37ef41bafb824161beaf5ff1e09ebb1f" escape="true">BASIC AND DILUTED NET LOSS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="i37ef41bafb824161beaf5ff1e09ebb1f"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share attributable to Sangamo Therapeutics, Inc. stockholders has been computed by dividing net loss attributable to Sangamo Therapeutics, Inc. stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders is calculated by dividing net loss attributable to Sangamo Therapeutics, Inc. stockholders by the weighted-average number of shares of common stock outstanding during the period, without consideration of any potential dilutive securities, as their effect would be anti-dilutive.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The total number of shares subject to stock options and restricted stock units (&#8220;RSUs&#8221;) outstanding and the employee stock purchase plan (&#8220;ESPP&#8221;) shares reserved for issuance, which are all anti-dilutive, were excluded from consideration in the calculation of diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders. Stock options and RSUs outstanding and ESPP shares reserved for issuance as of September&#160;30, 2022 and 2021 totaled <ix:nonFraction unitRef="shares" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81Mi9mcmFnOmFjZWQ0NjMwYzcwNTQyOTlhYjIzYWJjZTZhMDBhOGI4L3RleHRyZWdpb246YWNlZDQ2MzBjNzA1NDI5OWFiMjNhYmNlNmEwMGE4YjhfMTExNw_a65979e7-23f2-49ed-81ab-ba58581cc682">18,524,016</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81Mi9mcmFnOmFjZWQ0NjMwYzcwNTQyOTlhYjIzYWJjZTZhMDBhOGI4L3RleHRyZWdpb246YWNlZDQ2MzBjNzA1NDI5OWFiMjNhYmNlNmEwMGE4YjhfMTEyNA_40ba14a2-12e1-4256-8f05-6e98a9371e98">15,838,002</ix:nonFraction>, respectively.</span></div></ix:continuation><div id="i55c688caac2b44c98200d144e37b2144_55"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 5&#8212;<ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNDg_3d4ce50b-9650-4a33-9eda-c04aed34fc25" continuedAt="i04cac1c67f854e35a58ad69349ed584c" escape="true">MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</ix:nonNumeric></span></div><ix:continuation id="i04cac1c67f854e35a58ad69349ed584c" continuedAt="ia004686799d14d2ba699820da6445143"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Novartis Institutes for BioMedical Research, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2020, the Company entered into a collaboration and license agreement with Novartis Institutes for BioMedical Research, Inc. (&#8220;Novartis&#8221;) for the research, development and commercialization of gene regulation therapies to treat three neurodevelopmental disorders. Under the agreement, which was effective upon execution, the Company granted Novartis an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize certain of its zinc finger protein (&#8220;ZFP&#8221;) transcription factors (&#8220;ZFP-TFs&#8221;) targeted to three undisclosed genes that are associated with certain neurodevelopmental disorders, including autism spectrum disorder and intellectual disability. The Company is performing early research activities over the collaboration period for each gene target and manufacture the ZFP-TFs required for such research, costs of which are funded by Novartis. Novartis is responsible for additional research activities, studies enabling investigational new drug applications (&#8220;INDs&#8221;), clinical development, regulatory approvals, manufacturing of preclinical, clinical and approved products, and global commercialization. Subject to certain exceptions set forth in the agreement, the Company is prohibited from developing, manufacturing or commercializing any therapeutic product targeting any of the three genes that are the subject of the collaboration. Novartis also has the option to license certain of the Company&#8217;s proprietary adeno-associated viruses (&#8220;AAVs&#8221;) for the sole purpose of developing, manufacturing and commercializing licensed products arising from the collaboration. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement, Novartis paid the Company a $<ix:nonFraction unitRef="usd" contextRef="id24858a277a44f918d47646294044411_D20200801-20200831" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTgyNw_1d6ec99d-e5c8-4765-bf0f-058de65cc8ac">75.0</ix:nonFraction>&#160;million upfront license fee in August 2020. In addition to this fee and the cost reimbursements for early research activities, the Company is eligible to earn from Novartis up to $<ix:nonFraction unitRef="usd" contextRef="ic3fcad2bda744a41b13d72cd6a61005d_D20200727-20200727" decimals="-5" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjAwMQ_d456c2a3-5ac5-452e-9349-4d3a9e10c1ef">420.0</ix:nonFraction>&#160;million in development milestones and up to $<ix:nonFraction unitRef="usd" contextRef="id7052887b1af4eb59f472680a598c7ca_D20200727-20200727" decimals="-5" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjA0MA_fa70fe52-a6d6-48ea-83bf-5719e5980ddb">300.0</ix:nonFraction>&#160;million in commercial milestones. The Company is also eligible to earn from Novartis tiered high single-digit to sub-teen double-digit royalties on potential net commercial sales of licensed products arising from the collaboration. These royalty payments will be subject to reduction due to patent expiration, loss of market exclusivity and payments made under certain licenses for third-party intellectual property. The agreement will continue, on a product-by-product and country-by-country basis, until the expiration of the applicable royalty term. Novartis has the right to terminate the agreement, in its entirety or on a target-by-target basis, for any reason after a specified notice period. Each party also has the right to terminate the agreement on account of the other party&#8217;s bankruptcy or material, uncured breach.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All payments received under the agreement, when earned, are non-refundable and non-creditable. The transaction price of $<ix:nonFraction unitRef="usd" contextRef="i2ba866a4b6af4a9491a93eb6f0ff14eb_D20200727-20200727" decimals="-5" name="sgmo:CollaborativeArrangementTransactionPrice" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjk4NA_e3e8270c-427f-4f6e-9b3e-127aeebbfde5">95.1</ix:nonFraction>&#160;million includes the upfront license fee of $<ix:nonFraction unitRef="usd" contextRef="i2ba866a4b6af4a9491a93eb6f0ff14eb_D20200727-20200727" decimals="-5" name="sgmo:CollaborativeArrangementLicenseFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzAyMw_aedb03b5-5086-45f2-b3bf-dbbd0920dbc3">75.0</ix:nonFraction>&#160;million and estimated research costs of $<ix:nonFraction unitRef="usd" contextRef="i2ba866a4b6af4a9491a93eb6f0ff14eb_D20200727-20200727" decimals="-5" name="sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzA1OA_6f57535c-e135-4819-b8a2-e3c5ee28b368">20.1</ix:nonFraction>&#160;million to be provided over the estimated research period. All clinical or regulatory milestone amounts were considered fully constrained at inception of </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><ix:continuation id="ia004686799d14d2ba699820da6445143" continuedAt="ic75f5787cc18469f8baa9e39e5d7c884"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the agreement. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at this time is uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will re-evaluate the transaction price, including the estimated variable consideration included in the transaction price and all constrained amounts, in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Novartis in accordance with ASC Topic&#160;606 and concluded that Novartis is a customer. The Company has identified a single performance obligation within this arrangement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Novartis apart from the research services to be performed pursuant to the agreement. As a result, the Company recognizes revenue from the upfront payment based on proportional performance of the ongoing research services through the estimated research period. The estimation of progress towards the satisfaction of performance obligation and project cost is reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current assumptions regarding the timing of its performance obligation. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of $<ix:nonFraction unitRef="usd" contextRef="i2734364915f440429f325226570e6f66_I20220930" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDY3NA_4319b3c7-6c57-47fd-898e-bdd39e36cdbb">2.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaae4a2b1c97a4a699c93a09a3af3d231_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDY4MQ_ef0a0339-89ec-4d74-bc8c-40c9c9541cef">1.9</ix:nonFraction>&#160;million, respectively, and deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="i2734364915f440429f325226570e6f66_I20220930" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDcyMw_06157456-15ab-4097-99e1-ba66462b0e42">17.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iaae4a2b1c97a4a699c93a09a3af3d231_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDczMA_410c6ca3-794f-4864-89e1-6ac1372bcd2f">40.9</ix:nonFraction>&#160;million, respectively, related to this agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><ix:nonNumeric contextRef="i3d5f1ae0ab8b4decbba471d9add02a71_D20220101-20220930" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNDc_b498effc-d215-497e-bb4f-4878ff66bdf8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Novartis agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of upfront license fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6ea8c76ac97403d9fe80699600d434e_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfMy0xLTEtMS00OTgxNg_f37100b9-1e61-4108-a791-b6336d121f6a">7,582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1417415012944e48964b4778067acf9_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfMy0zLTEtMS00OTgxNg_5e7ffcd6-a2f4-4399-ac97-3dee43a0a6c7">9,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i916103514d9445a2b559cda726e4ef32_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfMy01LTEtMS00OTgxNg_0dfe3d1b-3225-42dc-bcb1-dff68b4f031b">23,222</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2096aeabf3b946a5875461aa88d4cb20_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfMy03LTEtMS00OTgxNg_6ce60adc-707c-4194-8d28-eebd47393466">22,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7556e9945944bb4963819871e859b10_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNC0xLTEtMS00OTgxNg_f8ea6688-72c7-4720-b4a4-450664b13ab0">2,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea4ef3b62d94312a30b3961e15b1c2d_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNC0zLTEtMS00OTgxNg_0601be1f-814c-4c5f-993d-1f31c340e098">2,421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a807fb830ff454bb7a40d98e23ead88_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNC01LTEtMS00OTgxNg_ee71d76f-a7b7-4bba-894a-d4a63e0ba3c3">6,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i813d7c4c38564599a7261dd61b7d10e1_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNC03LTEtMS00OTgxNg_288bb5e6-03e9-4d78-aa69-117e678d8529">6,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41aa40e6f7734a11a5ad5d91444e8c71_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNS0xLTEtMS00OTgxNg_e9a4d6c2-d5be-4f02-90cb-e65729861bd3">9,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640dece72c8d481a9e06ebab15977c75_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNS0zLTEtMS00OTgxNg_83f8a591-e9fd-4047-8d57-852c346e055c">11,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d5f1ae0ab8b4decbba471d9add02a71_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNS01LTEtMS00OTgxNg_86e3d74c-1522-4107-8b7b-f2587f067ccc">29,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i901b43193e044942b699fb8fadfb9534_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNS03LTEtMS00OTgxNg_7c466db3-129d-4927-97de-2d7b586d5e8d">28,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid $<ix:nonFraction unitRef="usd" contextRef="i9972fe6d5f2b42c89d347449caf70272_D20210101-20210630" decimals="-5" name="sgmo:CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDg2NQ_01404d89-8c3c-458e-828c-b1146bcb7cd7">1.5</ix:nonFraction>&#160;million for financial advisory fees during the year ended December&#160;31, 2020, equal to <ix:nonFraction unitRef="number" contextRef="iba431dc7b3114e9492531e7e49f27982_D20200101-20201231" decimals="INF" name="sgmo:CollaborativeAgreementPercentOfInitialRecognition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDk0Ng_0200d5ea-c38d-462e-87f0-872c87a10746">2</ix:nonFraction>% of $<ix:nonFraction unitRef="usd" contextRef="id24858a277a44f918d47646294044411_D20200801-20200831" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDk1Mg_36fa0908-2021-43ee-bb61-66c0eacf5959">75.0</ix:nonFraction>&#160;million received for the upfront license fee related to the collaboration and license agreement with Novartis. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i714565e5ccc14fd6ad101d485a5a8de6_I20200831" decimals="-5" name="us-gaap:CapitalizedContractCostGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY2NzM2OQ_fd5b5b82-30bc-45e3-813a-0df24cbb9009">1.5</ix:nonFraction>&#160;million as a contract asset as such amount represents a cost of obtaining the agreement. This balance is amortized and included in general and administrative expenses on a systematic basis consistent with the transfer of the services to Novartis in accordance with ASC Topic&#160;340, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC Topic&#160;340&#8221;). The Company amortized $<ix:nonFraction unitRef="usd" contextRef="i449866dd2b4e4cbca1f5dbb0c02df99b_D20220701-20220930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNTQzNA_6d0be332-2fe1-4460-97cf-eaa210d87ec3">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3ace65935fd74827a8e79d81a8c99883_D20220101-20220930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNTQ0MQ_9617ccc7-33e5-4d47-9a38-50c2bd509a58">0.5</ix:nonFraction>&#160;million during the three and nine months ended September&#160;30, 2022, respectively, and $<ix:nonFraction unitRef="usd" contextRef="iae8fae1af4ab4d9a8c4829058c9e5f83_D20210701-20210930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNTQ5Mw_d5481f95-5bf1-4cae-b059-73eb3223dbfa">0.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i7f1b352df962492a825bd38db79c1fa8_D20210101-20210930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNTUwMA_f5fc4624-a5ea-4455-a39a-459d5c1e72b1">0.5</ix:nonFraction>&#160;million during the three and nine months ended September&#160;30, 2021, respectively.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biogen MA, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company entered into a collaboration and license agreement with Biogen MA, Inc. (&#8220;BIMA&#8221;) and Biogen International GmbH (together with BIMA, &#8220;Biogen&#8221;) for the research, development and commercialization of gene regulation therapies for the treatment of neurological diseases. The companies plan to leverage the Company&#8217;s proprietary ZFP technology delivered via AAV to modulate expression of key genes involved in neurological diseases. Concurrently with the execution of the collaboration agreement, the Company entered into a stock purchase agreement with BIMA, pursuant to which BIMA agreed to purchase <ix:nonFraction unitRef="shares" contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjE5MQ_d90d4b2b-ad80-423a-88a2-e7d4f166dff4">24,420,157</ix:nonFraction> shares of the Company&#8217;s common stock (the &#8220;Biogen Shares&#8221;), at a price per share of $<ix:nonFraction unitRef="usdPerShare" contextRef="i68d24c5b8cee46749f97407c43bed757_I20200430" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjI3OA_94e87657-bef3-4716-b8c2-33a9a609b004">9.2137</ix:nonFraction>, for an aggregate purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjMzMQ_14ac6751-47b3-4462-a616-2b9f07160882">225.0</ix:nonFraction>&#160;million.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collaboration agreement became effective in April 2020 following the termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and satisfaction of other customary closing conditions, including the payment of $<ix:nonFraction unitRef="usd" contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjU5OQ_979d5854-d3a3-49da-974a-40687419e3fa">225.0</ix:nonFraction>&#160;million for the purchase of the Biogen Shares.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the collaboration agreement, Biogen paid the Company an upfront license fee of $<ix:nonFraction unitRef="usd" contextRef="ica4b8016d6044abd95e91f31762196db_D20200501-20200531" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjcyNg_beff9825-caca-4ebb-8fd7-f374142091c2">125.0</ix:nonFraction>&#160;million in May 2020. The Company is also eligible to receive research, development, regulatory and commercial milestone payments that could total up to approximately $<ix:nonFraction unitRef="usd" contextRef="iebf44488500c4b588b4bdf5563a4334a_I20200430" decimals="-8" name="sgmo:CollaborativeArrangementMaximumMilestonePaymentReceivable" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjg4Nw_2fdfd4d8-ca64-4a64-8d95-3920877a60e7">2.4</ix:nonFraction>&#160;billion if Biogen selects all of the targets allowed under the agreement and all the specified milestones set forth in the agreement are achieved, which includes up to $<ix:nonFraction unitRef="usd" contextRef="ie47b011a38824aa1aaad584fadb9ebba_I20200430" decimals="-5" name="sgmo:CollaborativeArrangementMaximumMilestonePaymentReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNzA1MA_9693d792-d013-4582-ae73-2bf347a51890">925.0</ix:nonFraction>&#160;million in pre-approval milestone payments and up to $<ix:nonFraction unitRef="usd" contextRef="i2cf72a2afc0847f7a0aa31702eac099e_I20200430" decimals="-8" name="sgmo:CollaborativeArrangementMaximumMilestonePaymentReceivable" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNzA5OA_efcb0786-10d4-4cf5-b129-8fa694a9366d">1.5</ix:nonFraction>&#160;billion in first commercial sale and other sales-based milestone payments. In addition, the Company is eligible to receive tiered high single-digit to sub-teen royalties on potential net commercial sales of licensed products arising from the collaboration. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the collaboration agreement, the Company granted to Biogen an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize certain ZFP and/or AAV-based products directed to certain&#160;neurological disease gene targets selected by Biogen. Biogen has already selected four of these: ST-501 to treat tauopathies, ST-502 to treat synucleinopathies including Parkinson&#8217;s disease, a third product candidate targeting DM1, a neuromuscular disease, and a fourth undisclosed neurological disease gene target. Biogen has exclusive rights to nominate up to </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><ix:continuation id="ic75f5787cc18469f8baa9e39e5d7c884" continuedAt="ie1b35ba9cc4c4442a87cc80cc0a06855"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="product_target" contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430" decimals="INF" name="sgmo:CollaborationAgreementNumberOfAdditionalProductTargets" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY5OTAzMA_cd73cb5c-e872-4db3-b5e0-5d565b928c0b">seven</ix:nonFraction> additional targets over the remaining period of <ix:nonNumeric contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430" name="sgmo:CollaborationAgreementRemainingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfODIyNQ_43b2c951-d6ae-4f82-96e9-3b37630199cc">five years</ix:nonNumeric> from the effective date of the collaboration agreement. For each gene target selected by Biogen, the Company performs early research activities, costs of which are shared by the companies, aimed at the development of the combination of proprietary central nervous system delivery vectors and ZFP-TFs (or potential other ZFP products) targeting therapeutically relevant genes. Biogen has assumed responsibility and costs for the IND-enabling studies, clinical development, related regulatory interactions, and global commercialization. The Company is responsible for manufacturing activities for the initial clinical trials for the first <ix:nonFraction unitRef="product_target" contextRef="iebf44488500c4b588b4bdf5563a4334a_I20200430" decimals="INF" name="sgmo:CollaborativeArrangementNumberOfProductTargetsSelected" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfODgxMA_313e7085-d1e5-4ca6-a852-a93a8fc9e887">three</ix:nonFraction> products of the collaboration and plans to leverage its in-house manufacturing capacity, where appropriate, which is currently in development. Biogen is responsible for manufacturing activities beyond the first clinical trial for each of the first <ix:nonFraction unitRef="product_target" contextRef="iebf44488500c4b588b4bdf5563a4334a_I20200430" decimals="INF" name="sgmo:CollaborativeArrangementNumberOfProductTargetsSelected" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfOTA2MQ_1931e15f-ee1b-4075-a694-8caaff60e84c">three</ix:nonFraction> products. The Company&#8217;s research activities for any targets will be performed over the period not to exceed <ix:nonNumeric contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430" name="sgmo:CollaborationArrangementResearchPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfOTE3Mg_41f1a42e-bd18-4086-aed3-3a827f32a5c6">seven years</ix:nonNumeric> from the effective date of the agreement (i.e., through April 2027). Subject to certain exceptions set forth in the collaboration agreement, the Company is prohibited from developing, manufacturing or commercializing any therapeutic product directed to the targets selected by Biogen.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collaboration agreement continues on a product-by-product and country-by-country basis until the expiration of all applicable royalty terms. Biogen has the right to terminate the collaboration agreement, in its entirety or on a target-by-target basis, for any reason after a specified notice period, and also has the right to replace up to <ix:nonFraction unitRef="product_target" contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430" decimals="INF" name="sgmo:CollaborativeArrangementMaximumNumberOfProductTargetsToReplace" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfOTgwNA_06edcd19-5832-442a-9be8-2ac19d0abc8b">ten</ix:nonFraction> targets. Each party has the right to terminate this agreement on account of the other party&#8217;s bankruptcy or material, uncured breach. In addition, the Company may terminate the collaboration agreement if Biogen challenges any patents licensed by the Company to Biogen.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the stock purchase agreement, Biogen has agreed not to, without the Company&#8217;s prior written consent and subject to specified conditions and exceptions, directly or indirectly acquire shares of the Company&#8217;s outstanding common stock, seek or propose a tender or exchange offer or merger between the parties, solicit proxies or consents with respect to any matter, or undertake other specified actions related to the potential acquisition of additional equity interests in the Company. Such standstill restrictions expire on the earlier of the <ix:nonNumeric contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430" name="sgmo:CollaborativeArrangementStandstillRestrictionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNTM_3250c4ef-dfac-40b2-b8c8-e1b6e70dc644">three-year</ix:nonNumeric> anniversary of the effectiveness of the collaboration agreement and the date that Biogen beneficially owns less than <ix:nonFraction unitRef="number" contextRef="i68d24c5b8cee46749f97407c43bed757_I20200430" decimals="INF" name="sgmo:CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA3Njg_f1f8438c-16f7-4bbf-8223-b65d14ceaed7">5</ix:nonFraction>% of the Company&#8217;s common stock.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the collaboration agreement with Biogen in accordance with ASC Topic&#160;606 and concluded that Biogen is a customer. The transaction price of $<ix:nonFraction unitRef="usd" contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430" decimals="-5" name="sgmo:CollaborativeArrangementTransactionPrice" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5NjI_1247673c-9561-4cac-b5bf-09c4ea7f0d9c">204.6</ix:nonFraction>&#160;million includes the upfront license fee of $<ix:nonFraction unitRef="usd" contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTEwMDE_2b6d6e33-cc91-4ec4-a8dc-163fbc09c4e1">125.0</ix:nonFraction>&#160;million and the excess consideration from the stock purchase of $<ix:nonFraction unitRef="usd" contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430" decimals="-5" name="sgmo:SaleOfStockExcessConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTEwNjA_a316392c-c771-4fc6-881d-6362d8509f45">79.6</ix:nonFraction>&#160;million, which represents the difference between the $<ix:nonFraction unitRef="usd" contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTExMDg_7fe77ca2-5069-4c6f-82d1-f72e3e4eb462">225.0</ix:nonFraction>&#160;million received for the purchase of the Biogen Shares and the $<ix:nonFraction unitRef="usd" contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430" decimals="-5" name="sgmo:CollaborationAgreementEquityIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTExNjY_5b4b8f83-8889-4a8f-99e1-53f8b597b738">145.4</ix:nonFraction>&#160;million estimated fair value of the equity issued. The equity issued to Biogen was valued using an option pricing model to reflect certain holding period restrictions. None of the target selection fees and clinical or regulatory milestones have been included in the transaction price, as all such amounts are fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that nomination of additional targets and achievement of the milestones at this time is uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will re-evaluate the transaction price as uncertain events are resolved or other changes in circumstances occur.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified a single performance obligation within the Biogen collaboration agreement, which is a stand-ready obligation consisting of a series of distinct days of research services, during which Biogen obtains access to the Company&#8217;s license and research resources. Revenue from the upfront license fee relates to access to the license and Company&#8217;s obligation to stand-ready to perform such research services corresponding to the targets selected by Biogen. As a result of this obligation to perform research services when and if requested throughout the duration of the contract, the upfront license fee and the excess consideration from the stock purchase will be recognized over time on a straight-line basis consistent with the resources expected to be dedicated to providing the research services through April 2027, the estimated period of the obligation. The estimated period of performance is reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current assumptions regarding the timing of its deliverable. Revenue from the reimbursement by Biogen of shared costs of early research activities performed by Sangamo is recognized as the research services are performed. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of $<ix:nonFraction unitRef="usd" contextRef="if44d955f3cee4094a3a0cecf75e1cd02_I20220930" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTMxODI_679ccb3d-0410-48c6-809e-ac81a3022cad">1.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i70a681d5c2fc43359fac6166d3c7b02b_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTMxODk_00219145-ddd1-4b49-a4e9-20c034cda9e3">2.8</ix:nonFraction>&#160;million, respectively, and deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="if44d955f3cee4094a3a0cecf75e1cd02_I20220930" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTMyMzE_6e4bfdd7-b0bd-449b-b44a-f6d5e99800ea">132.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i70a681d5c2fc43359fac6166d3c7b02b_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTMyMzg_34d3e3f2-e1bb-4793-95f4-db6b1391da22">154.0</ix:nonFraction>&#160;million, respectively, related to this agreement.</span></div><ix:nonNumeric contextRef="if0601be924aa4f1fad543351bdf06b1f_D20220101-20220930" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNDk_0dc6f46c-743a-4ece-ba2a-9d888e9be114" escape="true"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Biogen agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license and stand-ready fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58dad48ada774420bb627b6373806b63_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfMy0xLTEtMS00OTgxNg_e0dcfe9c-8a70-4f55-b320-148a64e1b0c2">7,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3567ee8e981a4805b1614fbb6249f324_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfMy0zLTEtMS00OTgxNg_6f9e9930-188a-47d0-9b8e-acd590ed0186">7,306</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12d66cce985941ffa95915f401661188_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfMy01LTEtMS00OTgxNg_707908ba-5fba-467d-b4ac-ef2555837ed4">21,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd568c62528c418d98ba3506620059b3_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfMy03LTEtMS00OTgxNg_d99c7b23-161f-458a-a768-291c02c76843">21,918</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib95c66db249d457f8c5145b0b4180e59_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNC0xLTEtMS00OTgxNg_28439830-2d16-4f85-8c62-c400408faec0">2,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia893d1f21e7e4bfc9e693b7773c6ebb3_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNC0zLTEtMS00OTgxNg_bda4047f-d430-4acf-a14b-9b4cf3771fbc">3,661</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i582600df1f494eeba31d6db660f24309_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNC01LTEtMS00OTgxNg_b42746ba-3266-4e93-b2a9-24a3d4e928e7">8,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i107234bf3c2c4164845bafb59e087b2b_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNC03LTEtMS00OTgxNg_a197704e-ef59-46b0-a9a9-fb62bd578e10">10,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84f278d0f27941ff887205574efe505f_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNS0xLTEtMS00OTgxNg_71cfb14c-935f-423a-aa30-b8a516a800b8">9,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i640710eb43bb446395030cf119393d5e_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNS0zLTEtMS00OTgxNg_3646d2a4-d09d-4967-a1db-1b12538ebe33">10,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0601be924aa4f1fad543351bdf06b1f_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNS01LTEtMS00OTgxNg_7f04bb0b-1396-4f7b-9afb-e71e9a530047">30,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbafd7f9191749e7a6078d50d26cff6d_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNS03LTEtMS00OTgxNg_d4f22343-5cae-4269-b040-9b73d23b7afb">32,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid $<ix:nonFraction unitRef="usd" contextRef="ieeedce2ee3f2443aa731e0a0727b79bb_D20200101-20201231" decimals="-5" name="sgmo:CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTMzNzU_b3c45a90-9811-4675-a2a9-eabe9e7eab20">7.0</ix:nonFraction>&#160;million for financial advisory fees during the year ended December&#160;31, 2020, equal to <ix:nonFraction unitRef="number" contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430" decimals="INF" name="sgmo:CollaborativeAgreementPercentOfInitialRecognition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM0NTY_f4c86d73-bbc8-4e75-853f-f19abccc01ca">2</ix:nonFraction>% of $<ix:nonFraction unitRef="usd" contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM0NjI_7fe77ca2-5069-4c6f-82d1-f72e3e4eb462">225.0</ix:nonFraction>&#160;million received for the sale of shares and <ix:nonFraction unitRef="number" contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430" decimals="INF" name="sgmo:CollaborativeAgreementPercentOfInitialRecognition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM1MDE_a6b26aae-a7fd-48e3-b7eb-88699e5199aa">2</ix:nonFraction>% of $<ix:nonFraction unitRef="usd" contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430" decimals="-5" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM1MDc_2b6d6e33-cc91-4ec4-a8dc-163fbc09c4e1">125.0</ix:nonFraction>&#160;million received for the upfront fee. The fees incurred related to </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><ix:continuation id="ie1b35ba9cc4c4442a87cc80cc0a06855" continuedAt="i382214adc0a04afcba62b827943a5526"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">both the collaboration agreement with Biogen and the stock purchase agreement for the sale of shares. The Company believes that the allocation of fees on a relative fair value basis between the two agreements is reasonable. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i3e70aff9076046b0a8a267498a58548b_I20220930" decimals="-5" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM4MTY_3075de4b-0e59-4cd2-9650-f0cdd5e2122e">4.1</ix:nonFraction>&#160;million, which represents <ix:nonFraction unitRef="number" contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430" decimals="INF" name="sgmo:CollaborativeAgreementPercentOfInitialRecognition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM4Mzc_cdcf0d94-7e6a-445d-b6d8-5505a19e7aff">2</ix:nonFraction>% of the transaction price of $<ix:nonFraction unitRef="usd" contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM4Njg_55f63adb-d9c3-4f3b-b8b5-f5c93dc5fda3">204.6</ix:nonFraction>&#160;million, as a contract asset. This balance is amortized and included in general and administrative expenses on a systematic basis consistent with the transfer of the services to Biogen in accordance with ASC Topic&#160;340. The Company amortized $<ix:nonFraction unitRef="usd" contextRef="i8ffaaa021478445aadfabd4cf2b1cd40_D20220701-20220930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQxMDQ_75869793-364c-4f5a-91ca-185c2633b95f">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i656cc305a9864393800b99c4084fc3be_D20220101-20220930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQxMTE_04a5fb53-abfb-4f92-bb9b-13277f65c075">0.4</ix:nonFraction>&#160;million during the three and nine months ended September&#160;30, 2022, respectively, and $<ix:nonFraction unitRef="usd" contextRef="i26b2aa0ee0524b8e9864406fc3e47991_D20210701-20210930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQxNjM_38aa6aca-62c1-4634-8f30-0049e8affeed">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="if93a6d1fdbb248ec8aa3ad0a3d16700d_D20210101-20210930" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSoldAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQxNzA_8579aa3f-169c-4d7a-9a27-6dff24d90cde">0.4</ix:nonFraction>&#160;million during the three and nine months ended September&#160;30, 2021, respectively. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i33a718c16a224765bbf657e25d2f612a_D20200101-20201231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQyNDE_560e83c6-e4a0-47df-978a-e07ebc196166">2.9</ix:nonFraction>&#160;million, which represented <ix:nonFraction unitRef="number" contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430" decimals="INF" name="sgmo:CollaborativeAgreementPercentOfInitialRecognition" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQyNjM_a91becd3-0a89-45b0-9f20-122bc04a697a">2</ix:nonFraction>% of the $<ix:nonFraction unitRef="usd" contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430" decimals="-5" name="sgmo:CollaborationAgreementEquityIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQyNzM_5b4b8f83-8889-4a8f-99e1-53f8b597b738">145.4</ix:nonFraction>&#160;million estimated fair value of the equity issued, as a share issuance cost and recorded this amount in equity as a reduction in net proceeds during the year ended December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kite Pharma, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2018, the Company entered into a global collaboration and license agreement with Kite Pharma, Inc. (&#8220;Kite&#8221;), a Gilead Sciences, Inc. subsidiary, which became effective on April 5, 2018 (&#8220;Effective Date&#8221;), and was amended and restated in September 2019, for the research, development, and commercialization of potential engineered cell therapies for cancer. In this collaboration, Sangamo is working together with Kite on a research program under which the companies are designing zinc finger nucleases (&#8220;ZFNs&#8221;) and viral vectors to disrupt and insert certain genes in T-cells and natural killer cells (&#8220;NK-cells&#8221;) including the insertion of genes that encode chimeric antigen receptors (&#8220;CARs&#8221;), T-cell receptors (&#8220;TCRs&#8221;), and NK-cell receptors (&#8220;NKRs&#8221;) directed to mutually agreed targets. Kite is responsible for all clinical development, manufacturing and commercialization of any resulting products.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of this agreement, the Company granted Kite an exclusive, royalty-bearing, worldwide sublicensable license under the Company&#8217;s relevant patents and know-how to develop, manufacture and commercialize, for the purpose of treating cancer, specific cell therapy products that may result from the research program and that are engineered </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex&#160;vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using selected ZFNs and viral vectors developed under the research program to express CARs, TCRs or NKRs directed to candidate targets.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the research program term and subject to certain exceptions, the Company is prohibited from researching, developing, manufacturing and commercializing, for the purpose of treating cancer, any cell therapy product that, as a result of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> genome editing, expresses a CAR, TCR or NKR that is directed to a target expressed on or in a human cancer cell. After the research program term concludes and subject to certain exceptions, the Company will be prohibited from developing, manufacturing and commercializing, for the purpose of treating cancer, any cell therapy product that, as a result of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> genome editing, expresses a CAR, TCR or NKR that is directed to a candidate target.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Effective Date, the Company received a $<ix:nonFraction unitRef="usd" contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430" decimals="-5" name="sgmo:MilestonePaymentsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTY2MzI_83459b4e-60dc-4ce1-9fbb-d19cfbdee8c8">150.0</ix:nonFraction>&#160;million upfront payment from Kite. In addition, Kite reimburses the Company&#8217;s direct costs to conduct the joint research program. Sangamo is also eligible to receive contingent development- and sales-based milestone payments that could total up to $<ix:nonFraction unitRef="usd" contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430" decimals="-8" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTY4NzU_d60daa70-7729-444a-b84f-48ce3fcf66f1">3.0</ix:nonFraction>&#160;billion if all of the specified milestones set forth in this agreement are achieved. Of this amount, approximately $<ix:nonFraction unitRef="usd" contextRef="i9ff2b470a6b840b1b600226ae0cb70ef_D20180401-20180430" decimals="-8" name="sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTY5ODU_9bf8fbec-5157-4eb1-a6bc-317854ed60d3">1.3</ix:nonFraction>&#160;billion relates to the achievement of specified research, clinical development, regulatory and first commercial sale milestones, and approximately $<ix:nonFraction unitRef="usd" contextRef="i65b35c689bc646deaec17d1a4a06e1ae_D20180401-20180430" decimals="-8" name="sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTcxMjc_9cc6df15-93c5-4f37-bf7f-3c1a2bfa5522">1.8</ix:nonFraction>&#160;billion relates to the achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach specified levels. Each development- and sales-based milestone payment is payable (i)&#160;only once for each licensed product, regardless of the number of times that the associated milestone event is achieved by such licensed product, and (ii)&#160;only for the first <ix:nonFraction unitRef="milestone" contextRef="i65b35c689bc646deaec17d1a4a06e1ae_D20180401-20180430" decimals="INF" name="sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTc1MDg_4c8e9f91-7817-4173-a9c1-2d6baa490ab1">10</ix:nonFraction> times that the associated milestone event is achieved regardless of the number of licensed products that may achieve such milestone event. In addition, the Company is entitled to receive escalating, tiered royalty payments with a percentage in the single digits based on future annual worldwide net sales of licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial research term in the agreement is <ix:nonNumeric contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430" name="sgmo:InitialResearchTermOfAgreement" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTgwODE_427d1b6a-cafd-40ca-85d0-96d0a32a8c99">six years</ix:nonNumeric> from the Effective Date. Kite has an option to extend the research term for up to <ix:nonFraction unitRef="option" contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430" decimals="INF" name="sgmo:NumberOfOptionsToExtendInitialResearchTerm" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTgxNjY_ac628a26-2dbc-4e6d-bcd3-17873cdec799">two</ix:nonFraction> additional <ix:nonNumeric contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430" name="sgmo:ExtendedResearchTermOfAgreement" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNTA_a621c4e6-31d4-40a0-82e6-68595e0b003f">one-year</ix:nonNumeric> periods for a separate upfront fee of $<ix:nonFraction unitRef="usd" contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430" decimals="-5" name="sgmo:SeparateUpfrontFee" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTgyMjY_a573e600-b6c4-4e11-9ad9-efc29d068135">10.0</ix:nonFraction>&#160;million per year. All contingent payments under the agreement, when earned, will be non-refundable and non-creditable. In connection with the amendment and restatement of the agreement in September 2019, the Company entered into a new research plan with Kite, with estimated reimbursable service cost of approximately $<ix:nonFraction unitRef="usd" contextRef="i93c77ad66a244121b7e7c0650a102466_D20190901-20190930" decimals="-5" name="sgmo:CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTg1Mzk_dcfd5a40-db2e-41a9-922e-664b00e3a083">3.4</ix:nonFraction>&#160;million, which is included in the total transaction price. The Company concluded the total transaction price under this agreement is $<ix:nonFraction unitRef="usd" contextRef="i93c77ad66a244121b7e7c0650a102466_D20190901-20190930" decimals="-5" name="sgmo:CollaborativeArrangementTransactionPrice" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTg2Njc_2b48d601-03e0-4039-bb87-1c422fb9e085">189.3</ix:nonFraction>&#160;million and includes the upfront license fee of $<ix:nonFraction unitRef="usd" contextRef="i93c77ad66a244121b7e7c0650a102466_D20190901-20190930" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTg3MTA_48f37156-77ce-459f-8e5c-bc9be4f52d7e">150.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i93c77ad66a244121b7e7c0650a102466_D20190901-20190930" decimals="-5" name="sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTg3MTc_af228502-cf10-4344-a249-1890ac021166">39.3</ix:nonFraction>&#160;million estimated reimbursable service costs for identified research projects over the estimated performance period. Further, the Company concluded the estimated fees for the presumed exercise of the research term extension options and all milestone amounts are fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at this time is uncertain and contingent upon future events which are uncertain at this time. The Company will re-evaluate the transaction price including the estimated variable consideration included in the transaction price and all constrained amounts in each reporting period and as uncertain events are resolved or other changes in circumstances occur. None of the development and sales-based milestone payments have been included in the transaction price.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><ix:continuation id="i382214adc0a04afcba62b827943a5526" continuedAt="ib95410ec32254c6e9a0abc9d8345ee6a"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Kite in accordance with ASC Topic&#160;606 and concluded that Kite is a customer. Kite has the right to terminate this agreement in its entirety or on a per licensed product or per candidate target basis for any reason after a specified notice period. Each party has the right to terminate this agreement on account of the other party&#8217;s bankruptcy or material, uncured breach.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified the primary performance obligations within the Kite agreement as: (1)&#160;a license to the technology along with the stand-ready obligation to perform research services, and (2)&#160;the ongoing research services. Revenue from the upfront license fee relates to access to the license and Company&#8217;s obligation to stand-ready to perform such research services as additional targets are selected by Kite. As a result of this obligation to perform research services when and if requested throughout the duration of the contract, the fee for the license and the stand-ready obligation will be recognized over time on a straight-line basis through April 2024, the estimated period of the stand-ready obligation. Revenue from the reimbursable costs related to the integrated service deliverable is recognized as the research services are performed. Related costs and expenses under these arrangements have historically approximated the revenues recognized. The estimated period of performance and project cost is reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current assumptions regarding the timing of its deliverables. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of $<ix:nonFraction unitRef="usd" contextRef="ib2565b2e5ab3411d909ba058b98e784d_I20220930" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjEyMTA_242382b0-c501-4ec6-9f0b-4c91a00e3c65">0.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i4f9193d162614c82aefef0bd29f76cb0_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjEyMTc_02e1871e-fea9-4c85-b37c-bdca1020dfeb">0.1</ix:nonFraction>&#160;million, respectively, and deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="ib2565b2e5ab3411d909ba058b98e784d_I20220930" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjEyNTk_5e2b0575-513e-4971-a39b-cdbe11c74c90">37.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i4f9193d162614c82aefef0bd29f76cb0_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjEyNjY_20ac7057-72e2-4bc9-85e7-e7b57ceb66cc">56.5</ix:nonFraction>&#160;million, respectively, related to this agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><ix:nonNumeric contextRef="i08b40673b5374b688d69a9f30889e26b_D20220101-20220930" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNDY_b5efebf6-8d2c-436d-a683-6818c102b8dc" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Kite agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license and stand-ready fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i283bbba7da5c491abef1b46ddd866d80_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfMy0xLTEtMS00OTgxNg_272b0959-e131-4a25-beec-2ca5a26ebec9">6,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5cc7c162fc4f9f8aae9712c9c2186c_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfMy0zLTEtMS00OTgxNg_c5ed28e2-b42f-4bd7-9a73-b04f200fd24c">6,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf1383bfc9fb4e4da9138b24f4483085_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfMy01LTEtMS00OTgxNg_982c5931-6af4-4dd6-9974-e140de6dcfec">18,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32258af563e84d3eaeffce96590ce4a3_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfMy03LTEtMS00OTgxNg_b98f141c-6856-4166-9542-a9b6801fe248">18,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e36b699832646d09fb049651228fc3d_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNC0xLTEtMS00OTgxNg_4f86401a-3469-4080-b91e-bf3e1460be04">619</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd52871c65e74074b943d036e228c407_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNC0zLTEtMS00OTgxNg_c9b7eed2-16a9-45a8-8d20-4a0d9e5466cb">113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc52a7e61b9445fd932586d407d4b4b5_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNC01LTEtMS00OTgxNg_dc6801c2-3fb7-4439-aa09-cc09c3cefcd7">875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f401a18597344db8bea22b5b529e1fb_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNC03LTEtMS00OTgxNg_9baaf7bd-9a67-43f2-87a2-9ea5409d88cf">339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6dd41724bd2c43c49a877cd10c22b362_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNS0xLTEtMS00OTgxNg_5528e514-9599-4020-9c4d-dfc0146fb156">6,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if156dd60b13643d49e1714fc2aef31f3_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNS0zLTEtMS00OTgxNg_9dfd8871-4152-4fea-a460-5a957b7b6b5e">6,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08b40673b5374b688d69a9f30889e26b_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNS01LTEtMS00OTgxNg_b3e6b843-f3a7-40da-a3c5-6f48efc572a1">19,557</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5ee9fe84d52410e95ad3919dcf23692_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNS03LTEtMS00OTgxNg_f25133e2-7a9a-483e-b89c-32ea3b977ba5">19,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sanofi S.A.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2014, the Company entered into an exclusive worldwide collaboration and license agreement (&#8220;2014 Collaboration Agreement&#8221;) to develop therapeutics for hemoglobinopathies, focused on beta thalassemia and sickle cell disease (&#8220;SCD&#8221;). The 2014 Collaboration Agreement was originally signed with BIMA, who subsequently assigned it to Bioverativ Inc., which was later acquired by Sanofi. Under the 2014 Collaboration Agreement, the Company was originally jointly conducting <ix:nonFraction unitRef="program" contextRef="i965c38aa9a1b4725903d0bea5a63f9e5_D20140101-20140131" decimals="INF" name="sgmo:NumberOfResearchProgram" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjE4MDU_39bf789a-88f2-4c58-954d-93a516099def">two</ix:nonFraction> research programs: a beta thalassemia program, which was discontinued in the third quarter of 2021, and the SCD program, which resulted in the development of SAR445136 (now known as BIVV003), a ZFN, gene-edited cell therapy product candidate for the treatment of SCD, which remains active. In December 2021, Sanofi notified the Company of its termination for convenience, effective June 28, 2022 (the &#8220;Termination Date&#8221;), of the 2014 Collaboration Agreement. A termination and transition agreement (the &#8220;Termination and Transition Agreement&#8221;) was executed by the parties on September 6, 2022.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the SCD program, the Company and Sanofi were jointly responsible for research and development activities prior to filing of an IND, but Sanofi was responsible for subsequent worldwide clinical development, manufacturing and commercialization of licensed products developed under the agreement. Subject to the terms of the agreement, the Company had granted Sanofi an exclusive, royalty-bearing license, with the right to grant sublicenses, to use certain ZFP and other technology controlled by the Company for the purpose of researching, developing, manufacturing and commercializing licensed products developed under the agreement. The Company had also granted Sanofi a non-exclusive worldwide, royalty-free fully paid license with the right to grant sublicenses, under the Company&#8217;s interest in certain other intellectual property developed pursuant to the agreement. During the term of the agreement, the Company was not permitted to research, develop, manufacture or commercialize, outside of the agreement, certain gene therapy products that target genes relevant to the licensed products.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement, the Company received an upfront license fee of $<ix:nonFraction unitRef="usd" contextRef="i965c38aa9a1b4725903d0bea5a63f9e5_D20140101-20140131" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjM0MzY_b7e7d63a-58d3-43c5-960e-8f20251e581a">20.0</ix:nonFraction>&#160;million and was eligible to receive additional payments upon the achievement of specified clinical development, regulatory and sales milestones, as well as royalty payments for each licensed product based on net sales of such product. Sanofi was also to reimburse Sangamo for agreed upon costs incurred in connection with research and development activities conducted by Sangamo. Through the Termination Date, a total of $<ix:nonFraction unitRef="usd" contextRef="ib5f997ce9152448ebb21b42facd1eb60_D20140101-20220628" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY5ODY0NA_854312f3-4830-4738-9bc9-fb036f65f243">13.5</ix:nonFraction>&#160;million has been received based upon achievement of clinical development milestones. <ix:nonFraction unitRef="product" contextRef="i710e17ccda8d423c80784fc598352f2f_D20220101-20220930" decimals="INF" name="sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjQyODM_a8cb6b69-b2d9-4132-b8e9-84f5af102e76">No</ix:nonFraction> products have been approved and therefore <ix:nonFraction unitRef="milestone" contextRef="i06746c47a09e4d0ebce6f17c639cd75b_D20220101-20220930" decimals="INF" name="sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjQzMjg_ab7ec20b-7602-4111-ab1d-4de372a26d49">no</ix:nonFraction> royalty fees have been or will be earned under the 2014 Collaboration Agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its termination notice to the Company, Sanofi indicated that its termination relates to Sanofi&#8217;s change in strategic direction to focus on allogeneic universal genomic medicine approaches rather than autologous personalized cell therapies. As of the Termination Date, the 2014 Collaboration Agreement was terminated in its entirety and following the Termination Date, the Company will not be entitled to receive any further milestone payments or royalties from Sanofi. As of the Termination Date, Sanofi has no further obligations under the 2014 Collaboration Agreement to develop or to fund the development of any </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><ix:continuation id="ib95410ec32254c6e9a0abc9d8345ee6a" continuedAt="i6d3be7197f7547ba82301702066a18cf"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">collaboration research programs under the 2014 Collaboration Agreement. The licenses granted to Sanofi under the 2014 Collaboration Agreement have been terminated, and the license rights have reverted to the Company.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Termination and Transition Agreement, Sanofi granted to the Company exclusive, worldwide, fully paid, royalty-free, perpetual, irrevocable licenses, with the right to grant sublicenses through multiple tiers, to certain of its intellectual property, to develop, manufacture, use, sell and otherwise commercialize BIVV003, the product candidate in development under the SCD program. The Company has agreed to take on responsibilities for all clinical trials related to BIVV003, including completion of the ongoing clinical trial and the related long-term follow-up study. The Company also assumed all regulatory responsibilities related to BIVV003. Sanofi has agreed to provide post-transition assistance to the Company for up to <ix:nonNumeric contextRef="i3c1eafcb24464080b10cb25f38311835_D20220906-20220906" name="sgmo:ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY5ODY1OQ_77582e72-98a5-49a5-b3cc-aedfe7445679">90</ix:nonNumeric> days after the Termination Date, and transferred or assigned to the Company all documentation, materials, contracts with third parties, and the right to use certain Sanofi-owned equipment related to BIVV003.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi has also agreed to reimburse the Company for the costs of conducting the ongoing clinical trial of BIVV003 and the costs of the long-term follow-up study through December 31, 2023, up to $<ix:nonFraction unitRef="usd" contextRef="i3c1eafcb24464080b10cb25f38311835_D20220906-20220906" decimals="-5" name="sgmo:ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY5ODY2OQ_2ea6edf4-3afa-4ef0-b467-fe335c8a2751">7.0</ix:nonFraction>&#160;million. In addition, should the Company elect not to continue the development of BIVV003 past December 31, 2023, Sanofi will become obligated to reimburse the Company for the costs of the long-term follow-up study incurred after 2023, up to $<ix:nonFraction unitRef="usd" contextRef="i3c1eafcb24464080b10cb25f38311835_D20220906-20220906" decimals="-5" name="sgmo:ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY5ODY4Mw_95cfd6fe-09f7-4b9f-889f-d739f7a015f6">5.3</ix:nonFraction>&#160;million. Sanofi&#8217;s reimbursement obligations will terminate upon certain triggering events, including the Company&#8217;s entering into a contract with a third party for collaboration, partnership, sale, licensing, or divestiture of BIVV003, or if the FDA permits early closure of the clinical trial and/or the long-term follow-up study.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the 2014 Collaboration Agreement with Sanofi in accordance with ASC Topic 606 and concluded that Sanofi was a customer, under that arrangement. The Company identified the performance obligation within this arrangement as a license to the technology combined with ongoing research services activities. The Company concluded that the license was not distinct as it did not have value to Sanofi without the research services. As a result, the Company recognized revenue from the upfront payment and the milestones based on progress of performance of the ongoing research services. The estimation of progress towards the satisfaction of the performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s then-current assumptions regarding the timing of its deliverables. Related costs and expenses under these arrangements have historically approximated the revenues recognized. Sanofi&#8217;s December 2021 notice of termination of the 2014 Collaboration Agreement represented a modification that reduced the expected scope of the Company&#8217;s services and the estimated transaction price and shortened the remaining performance timeline. Consistent with this change, all services under the 2014 Collaboration Agreement were completed by June 28, 2022, and all amounts ultimately included in the transaction price were recognized by such date. The final transaction price of $<ix:nonFraction unitRef="usd" contextRef="i5f1f8318a747463abe0b0a5f9f6fbc8a_D20140101-20220628" decimals="-5" name="sgmo:CollaborativeArrangementTransactionPrice" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzc5MA_3a652e4d-0324-4de5-9a6d-7ebbecb814f6">96.3</ix:nonFraction>&#160;million includes the upfront license fee of $<ix:nonFraction unitRef="usd" contextRef="i5f1f8318a747463abe0b0a5f9f6fbc8a_D20140101-20220628" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzgwNg_ac0c2eaf-8dff-4657-b663-b52e043725f5">20.0</ix:nonFraction>&#160;million, two milestone payments in the aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="id6da6fc44c004de5a49215fc13d59250_I20220628" decimals="-5" name="sgmo:MilestoneRevenueReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzgyMg_377a5fdb-03fc-438f-889c-3664c51eeacf">13.5</ix:nonFraction>&#160;million and reimbursement of research costs of $<ix:nonFraction unitRef="usd" contextRef="i5f1f8318a747463abe0b0a5f9f6fbc8a_D20140101-20220628" decimals="-5" name="sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzgzOA_3736ff2b-c91b-4616-a338-1018a809119c">62.8</ix:nonFraction>&#160;million. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of <ix:nonFraction unitRef="usd" contextRef="i905f6dd1d97f41d5aefe0d9f9ce7d481_I20220930" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzg2OQ_b4d99e54-fb3d-4f75-90d0-54bbb765419d">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i933fae16aba14368bec01366d74236a7_I20211231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzg2Ng_01a01020-b7c0-4cc1-bfe7-7c4aef570d37">0.6</ix:nonFraction>&#160;million, respectively, related to the 2014 Collaboration Agreement. Deferred revenue related to the 2014 Collaboration Agreement was <ix:nonFraction unitRef="usd" contextRef="i905f6dd1d97f41d5aefe0d9f9ce7d481_I20220930" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzg3Nw_93a3fa67-768f-43f9-9a22-7ad2dfa5f4fd">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i933fae16aba14368bec01366d74236a7_I20211231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzg4NQ_bd112992-6cd4-4eb9-879c-65e30ef3fa6f">1.1</ix:nonFraction>&#160;million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company concluded that Sanofi is not a customer under the Termination and Transition Agreement as Sanofi is not entitled to receive and cannot use the results of the ongoing clinical trial or the long-term follow-up study. This relationship is also not a collaboration in the scope of ASC Topic&#160;808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company concluded that the assets acquired from Sanofi do not represent a business, as substantially all of their value is concentrated in the acquired or re-acquired licenses to intellectual property. The Company has no obligation to repay Sanofi for its ongoing funding of the clinical trial or long-term follow-up study costs. Therefore, the Company will recognize Sanofi reimbursements as reductions of its research and development expense. During the three and nine months ended September&#160;30, 2022, the Company decreased its research and development expense by $<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-5" sign="-" name="sgmo:TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzODE0Ng_986d8fe5-35d5-468a-b880-b3f25a0b6723"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-5" sign="-" name="sgmo:TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzODE0Ng_f3296816-738a-49b8-9f50-242d457429d4">0.9</ix:nonFraction></ix:nonFraction>&#160;million, which is included within prepaid expenses and other current assets on the Company&#8217;s Condensed Consolidated Balance Sheet as of September&#160;30, 2022. </span></div><div style="margin-top:6pt;text-indent:36pt"><ix:nonNumeric contextRef="i710e17ccda8d423c80784fc598352f2f_D20220101-20220930" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNDI_abd0a951-32ef-4063-b5d8-e903f6cd4ec6" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the 2014 Collaboration Agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Sanofi agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of upfront fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c81a778afcc46f38bd393eb5ffba599_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfMy0xLTEtMS00OTgxNg_215ac026-bbbd-46fc-b609-8f65ec071227">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i202d58a6a58d4af08b477d923ae048f3_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfMy0zLTEtMS00OTgxNg_360b8c28-9fb2-425a-8929-93f50cd111ee">1,125</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66cdb12a800d4879bf0c3f1766fa88fd_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfMy01LTEtMS00OTgxNg_b776a239-7caa-483c-9fa6-d40952da8381">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i892bdf3ab2944fb4b7a953ffd1c2f6d7_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfMy03LTEtMS00OTgxNg_27dc6048-522c-45a8-92ab-a56075810795">692</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17f9d36d461f448483df1b1e4e3a01f0_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNC0xLTEtMS00OTgxNg_18cc43d3-18f3-4a85-9ac7-eab097517671">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i140d27fd2160489db7ee0eb0978a4d9a_D20210701-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNC0zLTEtMS00OTgxNg_f10fc074-b1c8-4df4-bd9f-ddfb792da62a">1,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i724bc4b7322a4e759c114bb5082bfdac_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNC01LTEtMS00OTgxNg_a5e27dc3-8aad-4122-9d00-18547ae03130">2,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i364d22703c4f4fb590d565ce2c24609b_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNC03LTEtMS00OTgxNg_31b79235-5abb-419b-85fd-520f07a085ee">2,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milestone achievement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6a265c8ac4e49de84028acd0fb40413_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNS0xLTEtMS00OTgxNg_334147e6-8976-441d-88bd-98ae85bb1484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id79ab6aa736f4dcb9f4f3a8b1435949d_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNS0zLTEtMS00OTgxNg_1e25b857-4c4b-4ee6-a444-65705b9c9c10">759</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09c51fb74c4c492ab74e416789db7c1c_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNS01LTEtMS00OTgxNg_e523a8f8-b854-4c7e-89fc-4bf57012d051">457</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib5e292264aa1455f8199ac9bf6f10164_D20210101-20210930" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNS03LTEtMS00OTgxNg_b36ad258-9f7f-443c-bd89-da794969d75a">467</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a5d588119f04333847cb581fb37eb61_D20220701-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNi0xLTEtMS00OTgxNg_863dfadf-ac2a-43a4-af49-3f1407f77a88">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icf6145619fea4fa78fa9c0bab78ebb20_D20210701-20210930" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNi0zLTEtMS00OTgxNg_5b6f7010-9b12-4cc9-b260-9b937144910e">759</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710e17ccda8d423c80784fc598352f2f_D20220101-20220930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNi01LTEtMS00OTgxNg_a072d0a4-2176-463e-a2b0-126a75b86712">3,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id45979bc9fd7456cb09006afb528134e_D20210101-20210930" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNi03LTEtMS00OTgxNg_74957484-a78e-477d-95bb-653478ebf693">1,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company recorded an adjustment to revenue related to a change in estimate in connection with the collaboration agreement with Sanofi. This adjustment was a result of an increase in the project costs for its beta thalassemia program and the increase in project scope and the corresponding costs for its SCD program, both of which resulted in a decrease </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><ix:continuation id="i6d3be7197f7547ba82301702066a18cf" continuedAt="id680ab2d1e18463790be14b2e32c8f4c"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the measure of proportional cumulative performance. This adjustment decreased revenue by $<ix:nonFraction unitRef="usd" contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDM5MA_0cbda428-76ca-499b-8c8a-f8985d15ce7c"><ix:nonFraction unitRef="usd" contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDM5MA_975a970b-1938-4c97-aa83-8b8469399bbe">2.5</ix:nonFraction></ix:nonFraction>&#160;million, increased net loss by $<ix:nonFraction unitRef="usd" contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQwNA_83bbbf8c-1948-45fb-ae3a-0dc3761ed039"><ix:nonFraction unitRef="usd" contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930" decimals="-5" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQwNA_a1411571-06d4-410f-a868-a45f59dd5a42">2.5</ix:nonFraction></ix:nonFraction>&#160;million and increased the Company's basic and diluted net loss per share by $<ix:nonFraction unitRef="usdPerShare" contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQxOA_20bac8dd-38ec-4032-a981-ae0a97a91dbd"><ix:nonFraction unitRef="usdPerShare" contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQxOA_2356b970-ad71-4a97-abb3-ae275d5e1f50"><ix:nonFraction unitRef="usdPerShare" contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQxOA_4bbee16f-af35-4799-b259-a0551d9f2cc4"><ix:nonFraction unitRef="usdPerShare" contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQxOA_aa2f89ab-4e0b-49e8-b47c-b53915a78679">0.02</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> for the three and nine months ended September 30, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfizer Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Giroctocogene Fitelparvovec Global Collaboration and License Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company entered into an exclusive global collaboration and license agreement with Pfizer Inc. (&#8220;Pfizer&#8221;), pursuant to which it established a collaboration for the research, development and commercialization of giroctocogene fitelparvovec, its gene therapy product candidate for hemophilia A, and closely related products.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under this agreement, the Company is responsible for conducting the Phase 1/2 clinical trial and for certain manufacturing activities for giroctocogene fitelparvovec, while Pfizer is responsible for subsequent worldwide development, manufacturing, marketing and commercialization of giroctocogene fitelparvovec. Sangamo may also collaborate in the research and development of additional AAV-based gene therapy products for hemophilia A.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of the agreement, the Company granted Pfizer an exclusive worldwide royalty-bearing license, with the right to grant sublicenses, to use certain technology controlled by the Company for the purpose of developing, manufacturing and commercializing giroctocogene fitelparvovec and related products. Pfizer granted the Company a non-exclusive, worldwide, royalty-free, fully paid license, with the right to grant sublicenses, to use certain manufacturing technology developed under the agreement and controlled by Pfizer to manufacture the Company&#8217;s products that utilize the AAV delivery system. During a specified period, neither the Company nor Pfizer is permitted to clinically develop or commercialize, outside of the collaboration, certain AAV-based gene therapy products for hemophilia A.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement has a term that continues on a per product and per country basis until the later of (i) the expiration of patent claims that cover the product in a country, (ii) the expiration of regulatory exclusivity for a product in a country, and (iii) <ix:nonNumeric contextRef="ifda78d9bb9e34007aba808bc57d3ccc7_D20170501-20170531" name="sgmo:AgreementTerminationTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjg3MDA_b56b6461-6099-45f8-898e-da813108b600">fifteen years</ix:nonNumeric> after the first commercial sale of a product in a country. Pfizer has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec and related products will automatically terminate. Upon termination by the Company for cause or by Pfizer in any country or countries, Pfizer will automatically grant the Company an exclusive, royalty-bearing license under certain technology controlled by Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec in the terminated country or countries.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon execution of the agreement, the Company received an upfront fee of $<ix:nonFraction unitRef="usd" contextRef="ia67b43e22836459ca0c85db6bf587fa9_D20170501-20170531" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjk2MjE_52e398c8-ca2c-40d8-846f-3c582256b703">70.0</ix:nonFraction>&#160;million and is eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="ie097ba41160242b7b938ec9f67d75616_D20170501-20170531" decimals="-5" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjk2NTc_4a9052da-7312-4cc9-8914-3177e26c6807">208.5</ix:nonFraction>&#160;million in payments upon the achievement of specified clinical development, intellectual property and regulatory milestones and up to $<ix:nonFraction unitRef="usd" contextRef="ia67b43e22836459ca0c85db6bf587fa9_D20170501-20170531" decimals="-5" name="sgmo:AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjk3ODY_e856cbf4-aa4c-4096-9ae0-d072dc244c28">266.5</ix:nonFraction>&#160;million in payments upon first commercial sale milestones for giroctocogene fitelparvovec and potentially other products. The total amount of potential clinical development, intellectual property, regulatory and first commercial sale milestone payments, assuming the achievement of all specified milestones in the agreement, is up to $<ix:nonFraction unitRef="usd" contextRef="ie76c5aed7b74477aa60d84886d741c43_D20170501-20170531" decimals="-5" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzAxMTU_868782b4-eb68-4a7b-b611-879fc40aa847">475.0</ix:nonFraction>&#160;million, which includes up to $<ix:nonFraction unitRef="usd" contextRef="ic34e88035a5f4bb08ff13aeb0beabca8_I20170531" decimals="-5" name="sgmo:MilestoneRevenueReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzAxNDA_c7036b63-1dfd-4bba-bfad-bbd7bcef27ff">300.0</ix:nonFraction>&#160;million for giroctocogene fitelparvovec and up to $<ix:nonFraction unitRef="usd" contextRef="i9451d2ff95384408bb974670f4956acd_I20170531" decimals="-5" name="sgmo:MilestoneRevenueReceivable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzAxODU_86cdcd4c-e3dd-4952-b62f-6a36669638a7">175.0</ix:nonFraction>&#160;million for other products that may be developed under the agreement, subject to reduction on account of payments made under certain licenses for third-party intellectual property. In addition, Pfizer agreed to pay the Company royalties for each potential licensed product developed under the agreement that are an escalating tiered, double-digit percentage of the annual net sales of such product and are subject to reduction due to patent expiration, entry of biosimilar products to the market and payment made under certain licenses for third-party intellectual property. To date, <ix:nonFraction unitRef="milestone" contextRef="iacfe2b36ef12408dba96a7eca579c6e3_D20170501-20220930" decimals="0" name="sgmo:CollaborativeArrangementNumberOfMilestonesAchieved" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzA3NjQ_e096051f-2808-46d0-8991-8c219dee4bd4">two</ix:nonFraction> milestones of $<ix:nonFraction unitRef="usd" contextRef="iacfe2b36ef12408dba96a7eca579c6e3_D20170501-20220930" decimals="-5" name="sgmo:MilestonePaymentsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzA3ODE_3bf7214e-b5f8-415c-9bc4-0089b4ae54aa">55.0</ix:nonFraction>&#160;million in aggregate have been achieved and paid, however <ix:nonFraction unitRef="product" contextRef="iacfe2b36ef12408dba96a7eca579c6e3_D20170501-20220930" decimals="0" name="sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzA4MzQ_a3b61ebb-9fe1-4298-b59f-5f37986057c0">no</ix:nonFraction> products have been approved and therefore <ix:nonFraction unitRef="milestone" contextRef="i1a0335905c59449b887401672756abb9_D20171201-20220331" decimals="0" name="sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzA4Nzk_bef39069-4783-44c3-b782-c7cf008c8b2c">no</ix:nonFraction> royalty fees have been earned under the agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer is a customer. The total transaction price under this agreement was $<ix:nonFraction unitRef="usd" contextRef="i1a587603a6dc495fb68564a49c608c3b_D20170501-20170531" decimals="-5" name="sgmo:CollaborativeArrangementTransactionPrice" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzExMDc_fe94f745-a94c-47a0-843c-d6a2ffa212a3">134.0</ix:nonFraction>&#160;million, which represented the upfront fee and research services fees of $<ix:nonFraction unitRef="usd" contextRef="i1a587603a6dc495fb68564a49c608c3b_D20170501-20170531" decimals="-5" name="sgmo:CollaborativeArrangementResearchServiceFees" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzExNzU_9a03477d-6027-44dd-a7a3-f54a3ce8e6af">79.0</ix:nonFraction>&#160;million and fees related to <ix:nonFraction unitRef="milestone" contextRef="iacfe2b36ef12408dba96a7eca579c6e3_D20170501-20220930" decimals="0" name="sgmo:CollaborativeArrangementNumberOfMilestonesAchieved" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzExOTg_054b971b-a59a-47d5-87c3-560b56496ed6">two</ix:nonFraction> achieved milestones in an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="ie6cc5e9855b44daa88a4b942b38da8a3_D20170501-20220930" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzEyNDc_34830376-7c75-45e6-81d1-47c1c2b5d160">55.0</ix:nonFraction>&#160;million. Sangamo was responsible for internal and external research costs as part of the upfront fee and had the ability to request additional reimbursement from Pfizer if certain conditions were met. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will re-evaluate the transaction price, including its estimated variable consideration included in the transaction price and all constrained amounts, in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified the performance obligations within the agreement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Pfizer apart from the research services to be performed by the Company pursuant to the agreement. As a result, the Company recognized </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><ix:continuation id="id680ab2d1e18463790be14b2e32c8f4c" continuedAt="ic80d3e9bd4d54dfe844a95b32816ca9c"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period during which the Company performed research services. The estimation of progress towards the satisfaction of its performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s assumptions regarding the timing of its deliverables.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company satisfied the deliverables and research services responsibilities within the arrangement. As a result, the Company recognized the remaining deferred revenue from the upfront payment in December 2020 and <ix:nonFraction unitRef="usd" contextRef="i7c3303f9b2c441e4a8661c7063d97b4f_D20210101-20210930" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzMwODU_08a861c2-0f7b-433b-bbeb-fef7300042e3"><ix:nonFraction unitRef="usd" contextRef="i35335210865a4d9fb1acf14e87a58341_D20210701-20210930" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzMwODU_5fbe5e4f-3dff-4ea7-a09f-492e794c8164"><ix:nonFraction unitRef="usd" contextRef="i7f5fbe525ac74562ac7d8942cd031794_D20220701-20220930" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzMwODU_61298169-9434-4b8f-ac3d-e5de62296508"><ix:nonFraction unitRef="usd" contextRef="i67383e30f21c4630a881224c8ec6917b_D20220101-20220930" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzMwODU_83a9d5a7-5e26-432e-9cde-caa80033dad9">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> revenues have been recognized during the three and nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">C9ORF72 Research Collaboration and License Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Company entered into a separate exclusive, global collaboration and license agreement with Pfizer for the development and commercialization of potential gene therapy products that use ZFP-TFs to treat amyotrophic lateral sclerosis and frontotemporal lobar degeneration linked to mutations of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene. Pursuant to this agreement, the Company agreed to work with Pfizer on a research program to identify, characterize and preclinically develop ZFP-TFs that bind to and specifically reduce expression of the mutant form of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of this agreement, the Company granted Pfizer an exclusive, royalty-bearing, worldwide license under the Company&#8217;s relevant patents and know-how to develop, manufacture and commercialize gene therapy products that use resulting ZFP-TFs that satisfy pre-agreed criteria. During a specified period, neither the Company nor Pfizer will be permitted to research, develop, manufacture or commercialize outside of the collaboration any ZFPs that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement has a term that continues on a per licensed product and per country basis until the later of (i) the expiration of patent claims that cover the licensed product in a country, (ii) the expiration of regulatory exclusivity for a licensed product in a country, and (iii) <ix:nonNumeric contextRef="ied5371b887eb4e1ba5e63238f1af294c_D20171201-20171231" name="sgmo:AgreementTerminationTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzQ1ODc_b3cf7f65-a035-4d3e-9fbe-e12174d24427">15</ix:nonNumeric> years after the first commercial sale of a licensed product in a major market country. Pfizer also has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. The agreement will also terminate if the Company is unable to identify any lead candidates for development within a specified period of time or if Pfizer elects not to advance a lead candidate beyond a certain development milestone within a specified period of time. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize licensed products under the agreement will automatically terminate. Upon termination by the Company for cause or by Pfizer without cause for any licensed product or licensed products in any country or countries, the Company will have the right to negotiate with Pfizer to obtain a non-exclusive, royalty-bearing license under certain technology controlled by Pfizer to develop, manufacture and commercialize the licensed product or licensed products in the terminated country or countries.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following termination by the Company for Pfizer&#8217;s material breach, Pfizer will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene for a period of time. Following termination by Pfizer for the Company&#8217;s material breach, the Company will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene for a period of time.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $<ix:nonFraction unitRef="usd" contextRef="ied5371b887eb4e1ba5e63238f1af294c_D20171201-20171231" decimals="-5" name="sgmo:MilestonePaymentsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzYyODE_e68381bc-1c6c-4408-a0d9-3c2eeef0c664">12.0</ix:nonFraction>&#160;million upfront payment from Pfizer and is eligible to receive up to $<ix:nonFraction unitRef="usd" contextRef="i807e40274d2e4fa68fb97fd8f56732c0_D20171201-20171231" decimals="-5" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzYzNDU_93949f01-480c-4447-8fb2-3f3b5d088e86">60.0</ix:nonFraction>&#160;million in development milestone payments from Pfizer contingent on the achievement of specified preclinical development, clinical development and first commercial sale milestones, and up to $<ix:nonFraction unitRef="usd" contextRef="i49341b6dd59f4dcb8dc3e02283b1a9a0_D20171201-20171231" decimals="-5" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzY1MzE_50e93196-c111-4462-b8fa-322a0a1c58d8">90.0</ix:nonFraction>&#160;million in commercial milestone payments if annual worldwide net sales of the licensed products reach specified levels. In addition, Pfizer will pay the Company royalties based on an escalating tiered, mid- to high-single digit percentage of the annual worldwide net sales of the licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property. Each party will be responsible for the cost of its performance of the research program. Pfizer will be operationally and financially responsible for subsequent development, manufacturing and commercialization of the licensed products. To date, a milestone of $<ix:nonFraction unitRef="usd" contextRef="i95d5384d7d794ed1b248fe403cff0f12_D20171201-20220331" decimals="-5" name="sgmo:MilestonePaymentsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzcyODE_287fe07e-605a-4ab3-94db-9ac133a75702">5.0</ix:nonFraction>&#160;million has been achieved and paid, however <ix:nonFraction unitRef="product" contextRef="i95d5384d7d794ed1b248fe403cff0f12_D20171201-20220331" decimals="0" name="sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzczMjA_1a4b7ec7-9d07-4d83-9f76-2fc547c881f9">no</ix:nonFraction> products have been approved and therefore <ix:nonFraction unitRef="milestone" contextRef="i95d5384d7d794ed1b248fe403cff0f12_D20171201-20220331" decimals="0" name="sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzczNjU_355fe55b-73d9-4abd-9d1c-588f712eeb38">no</ix:nonFraction> royalty fees have been earned under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pfizer agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer was a customer. The Company concluded the total transaction price under this agreement was $<ix:nonFraction unitRef="usd" contextRef="i309018fee1874efc81946dbe7c82f131_D20171201-20171231" decimals="-5" name="sgmo:CollaborativeArrangementTransactionPrice" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzc2MzE_b25a0564-0ee9-4861-afe1-e650b35ff239">17.0</ix:nonFraction>&#160;million, which represented the upfront fees of $<ix:nonFraction unitRef="usd" contextRef="i5c18ff8ca01c40e78481b76d8fe6dda0_D20171201-20171231" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzc2NzM_d1df3f2f-ce0d-4d6a-bd82-c4f1a89a1739">12.0</ix:nonFraction>&#160;million and fees related to achievement of one milestone in the amount of $<ix:nonFraction unitRef="usd" contextRef="i309018fee1874efc81946dbe7c82f131_D20171201-20171231" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzc3NDI_a9af79cd-edac-47d2-932e-42d350d425c7">5.0</ix:nonFraction>&#160;million. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will evaluate the transaction price, including its estimated variable consideration included in the transaction price and all constrained amounts, in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic80d3e9bd4d54dfe844a95b32816ca9c" continuedAt="i0eee15a155c7444d819f1bf89199d31e">The Company had identified the performance obligations within this agreement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Pfizer apart from the services to be performed by the Company pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period the Company performed research services.</ix:continuation></span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0eee15a155c7444d819f1bf89199d31e">The Company satisfied the deliverables and research services responsibilities within the arrangement in September 2020, and as a result, earned a $<ix:nonFraction unitRef="usd" contextRef="i92faa1298286405e93c727411f0747bf_D20200901-20200930" decimals="-5" name="sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkwNTE_a5167599-694b-4a4c-b1ea-820031de5906"><ix:nonFraction unitRef="usd" contextRef="i7de837b09974499ab74e3907f4da3664_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkwNTE_e251a10d-96d3-4a27-ae56-ac2fbc25acea">5.0</ix:nonFraction></ix:nonFraction>&#160;million milestone, which the Company recognized on a cumulative basis during the year ended December 31, 2020. In addition, the Company recognized the remaining deferred revenue from the upfront payment in September 2020 and <ix:nonFraction unitRef="usd" contextRef="ia9394094054442f383751ceedfd5a981_D20220701-20220930" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkyNzE_420b903c-0778-4adf-acb5-ab20bd856d47"><ix:nonFraction unitRef="usd" contextRef="icfffef1418344eb7a8831ffe392e5e22_D20210701-20210930" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkyNzE_be96ba25-01ad-4cfb-b8df-0ed992f70f38"><ix:nonFraction unitRef="usd" contextRef="ifd20bbfeb147419cb5f8dc6db4ca9849_D20210101-20210930" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkyNzE_d9443205-bee4-4e52-9d12-42796af30b91"><ix:nonFraction unitRef="usd" contextRef="i56dd64461cdc41a29f9de3b35af516dd_D20220101-20220930" decimals="0" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkyNzE_f4430324-5549-4915-a189-72f930bf427f">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> revenues have been recognized during the three and nine months ended September&#160;30, 2022 and 2021.</ix:continuation> </span></div><div id="i55c688caac2b44c98200d144e37b2144_58"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 6&#8212;<ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RleHRyZWdpb246ODhjNDUyOThhNjBhNDU1N2E3MDIyNjc1ZTQ5MGRiMWNfMTgy_c209746a-ea6b-4d73-96db-adf2844dbba4" continuedAt="i7b6b53325f7a425da27a7c89e4d48244" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><div style="margin-top:6pt;text-indent:36pt"><ix:continuation id="i7b6b53325f7a425da27a7c89e4d48244"><ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RleHRyZWdpb246ODhjNDUyOThhNjBhNDU1N2E3MDIyNjc1ZTQ5MGRiMWNfMTgz_ebd37058-8815-42c8-9d48-744bbef75b94" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows total stock-based compensation expense included in the Condensed Consolidated Statements of Operations (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4198818716d4a5982ff62c84d98fc2b_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMi0xLTEtMS00OTgxNg_cd66e1b9-7f4b-43a4-a63b-91a2177bed08">4,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i398e9284c1254e7fa5e4faf15172c220_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMi0zLTEtMS00OTgxNg_6992048a-e349-4158-b8d4-9fc040d71026">4,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee803986f614d5eb89d119dfc27ff5c_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMi01LTEtMS00OTgxNg_c99d68c9-a2c0-4165-b215-a0d612ac5fb7">13,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcb87a6bcfe548619d4c435b6326cad8_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMi03LTEtMS00OTgxNg_607e4d69-4966-4c85-bca3-b56136b1d47c">14,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf9d9769367043dcbd6120a50e2504a5_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMy0xLTEtMS00OTgxNg_964aea02-1ae3-4f87-8d06-4d97c229d8a2">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida843af1fb12494eabfc5378c6f08828_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMy0zLTEtMS00OTgxNg_f23bfdda-df97-4d91-b95b-ccaedabbc429">2,938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cffbe21ee8340aab6d270389c188838_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMy01LTEtMS00OTgxNg_a997431e-d8ee-4cf7-aec7-008d323a9864">9,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4685841a6f74d2e879fd6085f56e095_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMy03LTEtMS00OTgxNg_19fbe9df-fb7b-41eb-8cd2-d3b2963ea6f1">10,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfNC0xLTEtMS00OTgxNg_70f949fe-5c19-4f7f-9418-f6c721ffd90d">7,793</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfNC0zLTEtMS00OTgxNg_10760971-c83f-4dbe-a927-8f2249485c2b">7,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfNC01LTEtMS00OTgxNg_551a6a4b-b887-4fcc-90b3-4c36897a9684">23,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfNC03LTEtMS00OTgxNg_af5f99de-de01-415e-b2e2-6edc0e444333">24,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div id="i55c688caac2b44c98200d144e37b2144_61"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 7&#8212;<ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfMTE0NA_b059efd3-45a6-494a-9d32-a6200c4efe8c" continuedAt="i7cf541c13ce24ef1880b749f0c773660" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="i7cf541c13ce24ef1880b749f0c773660"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the-Market Offering Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company entered into an Open Market Sale Agreement&#8480; with Jefferies LLC (&#8220;Jefferies&#8221;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of the Company&#8217;s common stock having an aggregate offering price of up to $<ix:nonFraction unitRef="usd" contextRef="i6787fd385b854be098bb92baa474ae00_D20200801-20200831" decimals="-5" name="sgmo:StockOfferingProgramMaximumValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfMzg4_745970a3-60dc-4f3f-975a-6febbbfe0540">150.0</ix:nonFraction>&#160;million through Jefferies as the Company&#8217;s sales agent or principal. The Company is not obligated to sell any shares under the sales agreement. During the three and nine months ended September&#160;30, 2022, the Company sold <ix:nonFraction unitRef="shares" contextRef="idcc3055e11a04301bd4380530c45310f_D20220701-20220930" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfNTc1_e0ecb10f-1e8c-4f1b-aa54-d00da386d654">8,483,104</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i99aed81b84ae4da8ac317dfc988149a4_D20220101-20220930" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfMjc0ODc3OTA3MTAxNQ_65b233b3-b49a-4d1d-8867-f28e486b40c1">14,711,770</ix:nonFraction> shares of its common stock for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="idcc3055e11a04301bd4380530c45310f_D20220701-20220930" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfNjM5_7735ab33-aa07-4ff4-becd-ee9b0c92b3c5">42.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i99aed81b84ae4da8ac317dfc988149a4_D20220101-20220930" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfMjc0ODc3OTA3MTAxOQ_5417a4cc-aa82-459f-888c-445e19d92272">66.4</ix:nonFraction>&#160;million, respectively, of which approximately $<ix:nonFraction unitRef="usd" contextRef="i06ce069112274b73a381a623267ad36b_D20221001-20221031" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfNjY2_80add8ff-8751-4708-a995-9ba09769a19a">0.6</ix:nonFraction>&#160;million was received in October 2022 and recorded within prepaid expenses and other current assets on the Company&#8217;s Condensed Consolidated Balance Sheet as of September&#160;30, 2022. During the three and nine months ended September&#160;30, 2021, the Company sold <ix:nonFraction unitRef="shares" contextRef="ie3f90dae3d5d49c094e3925ff3e04933_D20210701-20210930" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfODY5_5eb311a4-68f9-4150-846a-aa7d7b69d6a1">202,705</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i9b3959b3e8964e39a6463ae8b22b489b_D20210101-20210930" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfODc2_b21f74de-8fb7-4f8c-9b24-03369b5c6fa2">2,007,932</ix:nonFraction> shares of its common stock for net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="ie3f90dae3d5d49c094e3925ff3e04933_D20210701-20210930" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfOTQw_de101ef3-15c1-43c9-9394-883e21343135">2.4</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="i9b3959b3e8964e39a6463ae8b22b489b_D20210101-20210930" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfOTQ4_606f6a0a-7302-4f9f-8473-091425279209">27.1</ix:nonFraction>&#160;million, respectively.</span></div></ix:continuation><div id="i55c688caac2b44c98200d144e37b2144_67"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTE 8&#8212;<ix:nonNumeric contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMTk2Mw_6518d5b3-bf64-4819-bb40-971890ce6fc5" continuedAt="i400d6741a0d740539c3166f62a5f843c" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i400d6741a0d740539c3166f62a5f843c" continuedAt="i6f0022a2527d4cd3b544252ba387d60f"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period. During the three and nine months ended September&#160;30, 2022, the Company recorded income tax expense of $0.1&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMjc0ODc3OTA3MTYzMg_84c258fa-57d8-46dd-8787-e5674da36a7c">0.2</ix:nonFraction>&#160;million, respectively. During the three and nine months ended September&#160;30, 2021, the Company recorded income tax expense of $<ix:nonFraction unitRef="usd" contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMjc0ODc3OTA3MTQzNw_d843f762-f161-4521-8174-9b45381d1234">0.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfNTAy_445028db-6886-44e7-983d-9b6dec6ad605">0.4</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company continues to maintain a full valuation allowance on its U.S. federal and state net deferred tax assets and on the Sangamo France net deferred tax assets, as the Company believes it is not more likely than not that these benefits will be realized. The tax expense for the three and nine months ended September&#160;30, 2022 was primarily due to foreign income tax expense.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Coronavirus Aid, Relief, and Economic Security Act, enacted on March 27, 2020, provided an Employee Retention Credit (&#8220;ERC&#8221;), which is a refundable payroll tax credit that encouraged businesses to keep employees on the payroll during the COVID-19 pandemic. Eligible employers could qualify for up to $5,000 of credit for each employee based on certain wages paid after March 12, 2020 and before January 1, 2021 and extended to September 30, 2021. Based on the Company&#8217;s evaluation of this provision and the significant pandemic-related impacts on the operations, the Company recognized <ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="-5" name="sgmo:EmployeeRetentionCreditCARESAct" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMTU0Ng_b3b4f043-272d-4727-87c7-7c8e858c4dab">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="-5" name="sgmo:EmployeeRetentionCreditCARESAct" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMTU1Mw_f63fed01-af68-401d-8b97-f653116facb8">3.0</ix:nonFraction>&#160;million of ERC for the three and nine months ended September&#160;30, 2022, respectively, within interest and other income, net in Condensed Consolidated Statement of Operations upon filing for the refund in January and April 2022. <ix:nonFraction unitRef="usd" contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930" decimals="0" name="sgmo:ProceedsFromEmployeeRetentionCreditCARESAct" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMTc1NA_6c29f16b-3c24-4495-8ce4-44526c7c2b95"><ix:nonFraction unitRef="usd" contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930" decimals="0" name="sgmo:ProceedsFromEmployeeRetentionCreditCARESAct" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMTc1NA_9688e714-732c-446e-87e9-814099adf15a">No</ix:nonFraction></ix:nonFraction> refund has been received during the three and nine months ended September&#160;30, 2022 and the amount has been recorded within prepaid expenses and other current assets on the Company&#8217;s Condensed Consolidated Balance Sheet as of September&#160;30, 2022.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6f0022a2527d4cd3b544252ba387d60f">On August 16, 2022, the Inflation Reduction Act of 2022 was signed into law, with tax provisions primarily focused on implementing a 15% minimum tax on global adjusted financial statement income and a 1% excise tax on share repurchases. The Inflation Reduction Act of 2022 will become effective beginning in 2023. Given its recent pronouncement, it is unclear at this time what, if any, impact the Inflation Reduction Act of 2022 will have on the Company's tax rate and financial results. Currently, the Company does not anticipate any material impact on its consolidated audited financial statements and will continue to evaluate its impact as further information becomes available.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 2.&#160;&#160;&#160;&#160;MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; contains trend analysis, estimates and other forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act of 1934, as amended. These forward-looking statements include, without limitation, statements containing the words &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;continues,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;seeks,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; and other words of similar import or the negative of those terms or expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties, estimates and other factors that may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Actual results could differ materially from those set forth in such forward-looking statements as a result of, but not limited to, the &#8220;Risk Factors&#8221; described in Part I, Item 1A our Annual Report on Form 10-K for the year ended December&#160;31,&#160;2021 as filed with the Securities and Exchange Commission on February&#160;24,&#160;2022, or the 2021 Annual Report, as supplemented by the risks described under &#8220;Risk Factors&#8221; in Part II, Item 1A of this Quarterly Report on Form 10-Q. You should also read the following discussion and analysis in conjunction with our Condensed Consolidated Financial Statements and accompanying notes included in this report and the Consolidated Financial Statements and accompanying notes thereto included in our 2021 Annual Report.</span></div><div id="i55c688caac2b44c98200d144e37b2144_79"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a clinical-stage genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious diseases. We plan to deliver on this mission through development of our clinical and preclinical product candidates leveraging&#160;our novel science and our in-house manufacturing capabilities.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Clinical Programs Updates:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Fabry Disease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Isaralgagene civaparvovec, also known as ST-920, is our wholly-owned gene therapy product candidate for the treatment of Fabry disease and is currently being evaluated in our Phase 1/2 STAAR clinical study. Sangamo recently presented updated preliminary data from the STAAR study at three medical conferences. Data were presented at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Meeting in August, as of the February&#160;14,&#160;2022 cutoff date. Updated preliminary data as of the July 21, 2022 cutoff date were presented at the 29th Congress of the European Society of Gene &amp; Cell Therapy, or ESGCT, and National Organization for Rare Disorders, or NORD, conference in October. The updated preliminary data showed that all nine patients from the dose escalation phase exhibited sustained elevated &#945;-Gal A activity, ranging from nearly 2-fold to 30-fold of mean normal, for up to 23 months post dosing, as of the last date of measurement. Four patients were withdrawn from enzyme replacement therapy, or ERT, and maintained significantly elevated levels of &#945;-Gal A activity up to 28 weeks post withdrawal. Since the July&#160;21,&#160;2022 cutoff date, the fifth and final patient in the dose escalation phase who started the study on ERT was withdrawn from ERT. All patients withdrawn have remained off ERT. The Phase 1/2 STAAR study has transitioned into the expansion phase, with the first five expansion patients dosed at the 5e13 vg/kg dose level, including the first two female patients. We have multiple patients in screening, including both male and female candidates. We also continue to actively plan for a potential pivotal Phase 3 trial and are engaging with health authorities, patient advocacy groups and investigators.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Sickle Cell Disease</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: BIVV003, formerly known as SAR445136, is our zinc finger nuclease, or ZFN, gene-edited autologous cell therapy product candidate for the treatment of sickle cell disease, or SCD, and is currently being evaluated in our Phase 1/2 PRECIZN-1 clinical study. In October 2022, we dosed the sixth patient in the Phase 1/2 study, who is the second patient in the study to receive a product candidate manufactured using improved methods that have been shown in internal experiments to increase the number of long-term progenitor cells in the final product. In August&#160;2022, the FDA granted Sangamo&#8217;s request for regenerative medicine advanced therapy, or RMAT, designation for BIVV003. RMAT designation is granted to regenerative medicine therapies intended to treat, modify, reverse, or cure a serious condition, for which preliminary clinical evidence indicates that the medicine has the potential to address an unmet medical need. We plan to present updated data, of which a summary of the accepted abstract is located below, from the Phase 1/2 PRECIZN-1 study in a poster presentation at the 64th American Society of Hematology, or ASH, Annual Meeting &amp; Exposition taking place December 10-13, 2022 in New Orleans, Louisiana. Phase 3 study design, enabling activities and manufacturing readiness continue.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Renal Transplant Rejection</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: TX200 is our wholly-owned Chimeric Antigen Receptor, or CAR, engineered regulatory T cell, or CAR-Treg, cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation from a living donor and is currently being evaluated in our Phase 1/2 STEADFAST clinical study. In September 2022, we dosed the second patient in the Phase 1/2 study. The product candidate continues </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to be generally well tolerated in both patients. In October&#160;2022, the second patient in the Phase 1/2 STEADFAST study experienced a serious adverse event, or SAE, of duodenal ileus. The patient was also noted to be COVID positive. The Principal Investigator and the Safety Monitoring Committee for the TX200 study assessed the SAE as unrelated to the TX200 treatment, and the patient has since fully recovered. Clinical activities continue to progress in preparation for patient three. We plan to provide guidance on timing of dosing of the third patient once the kidney transplant has been scheduled and we have confirmed a potential dosing date. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Hemophilia A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Giroctocogene fitelparvovec, also known as SB-525, is a gene therapy product candidate for the treatment of moderately severe to severe hemophilia A and is the subject of our Phase 1/2 Alta study and the registrational Phase 3 AFFINE clinical trial. We are developing giroctocogene fitelparvovec with our collaborator Pfizer Inc., or Pfizer. We and Pfizer plan to present updated data, of which a summary of the accepted abstract is located below, from the Phase 1/2 Alta study in a poster presentation at ASH on December 10-13, 2022. In September 2022, we and Pfizer jointly announced that the Phase 3 AFFINE trial had re-opened recruitment following a voluntary pause and subsequent clinical hold. Trial sites resumed enrollment in September, and dosing is expected to resume shortly. All trial sites are anticipated to be active by the end of 2022, and a pivotal readout is expected in the first half of 2024.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Preliminary Safety and Efficacy Results from the Phase 1/2 PRECIZN-1 Study of BIVV003</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">BIVV003 is a novel therapeutic product candidate comprising autologous CD34 hematopoietic stem progenitor cells, or HSPCs, modified ex vivo by ZFNs targeting specifically the BCL11A gene erythroid-specific enhancer, or ESE, to increase endogenous fetal hemoglobin, or HbF, production in erythrocytes.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">PRECIZN-1 is an ongoing first-in-human, open label, single arm, multi-site study evaluating safety and tolerability of BIVV003 in patients (n=8; aged 18-40 years) with severe SCD across six U.S. sites.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Eligible patients underwent mobilization and apheresis with plerixafor. Autologous HSPC, were transfected ex vivo with ZFN messenger ribonucleic acid to manufacture BIVV003. A single IV infusion was administered at least 72 hours after pre-conditioning with busulfan.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Patients were monitored for stem cell engraftment and hematopoietic recovery, adverse events, or AEs, clinical and laboratory hemolysis markers, total hemoglobin and HbF, percentage of red blood cells containing HbF, and SCD related events.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As of the cutoff date of May 3, 2022, four patients had received BIVV003 infusions up to 125 weeks of follow-up for the longest treated patient. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A fifth patient was dosed with BIVV003 on May 4, 2022 and has engrafted. This patient received BIVV003 manufactured using an improved process that has been shown in internal experiments to increase the number of ZFN-modified long-term progenitors in the product candidate.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Of the four patients dosed prior to the cutoff date, three have improved clinically since BIVV003 infusion through the cutoff date. For these three patients, the percent HbF levels stabilized at 30% or greater by 26 weeks after BIVV003 infusion and persisted for up to 104 weeks for the longest treated patient (2 years) (see Figure 1 below). The percentage of F cells (red blood cells that contained HbF) were sustained at 90% or greater for up to 104 weeks. Total hemoglobin levels were maintained in the range of 9.4-12.7 g/dL. The one patient whose percent HbF level stabilized at less than 20% and who did not sustain HbF levels above 10 pg per cell experienced two severe VOCs at 9- and 16-months post-infusion.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Figure 1: Total Hb and Hb fractionation over time</span></div><div style="margin-top:6pt"><img src="sgmo-20220930_g1.jpg" alt="sgmo-20220930_g1.jpg" style="height:394px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div><img src="sgmo-20220930_g2.jpg" alt="sgmo-20220930_g2.jpg" style="height:417px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div><img src="sgmo-20220930_g3.jpg" alt="sgmo-20220930_g3.jpg" style="height:417px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div><img src="sgmo-20220930_g4.jpg" alt="sgmo-20220930_g4.jpg" style="height:417px;margin-bottom:5pt;vertical-align:text-bottom;width:696px"/></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the May 3, 2022 cutoff date, BIVV003 was generally well tolerated with no infusion related reactions. AEs reported were consistent with plerixafor mobilization and busulfan myeloablative conditioning. No AEs or SAEs were reported that were assessed as related to BIVV003.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Updated Preliminary Results from the Phase 1/2 Alta Study of Giroctocogene Fitelparvovec </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eleven male patients participated in the study overall, with five patients in the 3e13-vg/kg highest dose cohort. As of the May 20, 2022 cutoff date, patients had been followed for 147 to 247 weeks, with two not having completed three years (156 weeks).</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As of the May 20, 2022 cutoff date, the most commonly reported treatment-related AEs in the highest dose cohort (3e13-vg/kg) included elevated liver enzymes and infusion-related reactions: increased alanine aminotransferase, or ALT 3/5 (60.0%), increased aspartate aminotransferase, or AST 2/5 (40.0%), pyrexia 3/5 (60.0%), and tachycardia 2/5 (40.0%).</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Treatment-related SAEs were reported in one patient in the highest dose cohort who experienced hypotension and fever with onset approximately six hours after giroctocogene fitelparvovec infusion; the events fully resolved with treatment and did not delay post-infusion discharge the next day. ALT elevations requiring more than seven days of corticosteroid treatment were observed in four of the five patients in the highest dose cohort as of the May 20, 2022 cutoff date; elevations in ALT were managed with a tapering course of corticosteroids (median 56 days; range: 7&#8211;135 days), with maintenance of clinically meaningful levels of factor VIII, or FVIII, activity, as evidenced by a lack of bleeding events around the time of corticosteroid treatment and minimal bleeding events afterwards.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">As of the May 20, 2022 cutoff date, no patient in the study developed an inhibitor to FVIII, and there have been no thrombotic events and no hepatic masses detected.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The three patients in the 3e13-vg/kg cohort with available data through Week 156 had mean FVIII activity maintained in the mild to normal range, as shown in the table below. Of the data available for the remaining two patients, one maintained FVIII activity levels in the mild range through Week 130 and one had FVIII activity levels below lower level of quantification (&lt;3%) as measured with a chromogenic assay and 5.4% measured with a 1-stage assay at Week 130.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the 3e13-vg/kg cohort, the annualized bleeding rate, meaning the number of all bleeding episodes starting three weeks after the product candidate infusion divided by the observation period in years, was zero for the first year post-infusion and 0.9 throughout the total duration of follow-up. In this cohort, two patients experienced a total of 12 bleeding events (six traumatic, four spontaneous, two unknown) necessitating treatment with exogenous FVIII. As of the May 20, 2022 cutoff date, no patients in this cohort have resumed prophylaxis.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Table. Factor VIII Activity Levels by 1-Stage and Chromogenic Assay for the Giroctocogene Fitelparvovec 3e13-vg/kg Cohort</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"></td><td style="width:20.784%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.059%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Factor VIII Activity, <br/>% Normal, Median (min, max)</span></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Study Week</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assay</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Week 12</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Week 24</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Week 52</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Week 78</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Week 104</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Week 130</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Week 156</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1-stage clotting</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.7<br/>(82.7, 167.7)<br/></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.8<br/>(30.5, 212.6)<br/></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1<br/>(12.0, 191.3)<br/></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.5<br/>(3.8, 144.2)<br/></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5<br/>(4.1, 99.1)<br/></span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.3<br/>(5.4, 164.5)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9<br/>(22.6, 129.0)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chromogenic</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.1<br/>(51.8, 109.5)<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.1<br/>(20.4, 123.8)<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1<br/>(7.8, 122.3)<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1<br/>(0.9, 114.7)<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3<br/>(0.9, 71.6)<br/></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3<br/>(0.9, 113.2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5<br/>(11.8, 91.1)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients, n</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">a</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">b</span></div></td></tr><tr><td colspan="18" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> There was one patient each who was unable to attend visits at Weeks 52, 78, and 130.</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> Two patients had not yet reached Week 156 at the time of the data cut.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">min, max = minimum, maximum</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preclinical Programs</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preclinical development is focused in two innovative priority areas: (i) CAR-Treg cell therapies for autoimmune disorders and (ii) genome engineering for neurological diseases. Indications for our preclinical programs include neurodevelopmental disorders, cancer, inflammatory bowel disease, tauopathies and neurodegenerative diseases such as amyotrophic lateral sclerosis, multiple sclerosis, and Huntington&#8217;s disease, some of which we are developing with our collaborators Biogen MA, Inc. and Biogen International GmbH, which we refer to together as Biogen, Novartis Institutes for BioMedical Research, Inc., or Novartis, Pfizer, and Takeda Pharmaceutical Company Limited.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Collaborations</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our multiple collaborations with biopharmaceutical companies bring us important financial and strategic benefits and reinforce the potential of our research and development efforts and our ZFP technology platform. They leverage our collaborators&#8217; therapeutic and clinical expertise and commercial resources with the goal to bring our medicines more rapidly to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patients. We believe these collaborations reflect the value of our ZFP technology platform and will potentially expand the addressable markets of our product candidates. To date, we have received approximately $815.0 million in upfront licensing fees, milestone payments and proceeds from sales of our common stock to collaborators and have the right to earn up to $6.7 billion in future milestone payments from our collaborations, in addition to potential product royalties.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">In-House Manufacturing</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our in-house manufacturing capacity provides us a competitive advantage. We currently operate an adeno-associated virus, or AAV, manufacturing facility in our Brisbane, California headquarters and cell therapy manufacturing facilities in Brisbane, California and Valbonne, France. Our manufacturing strategy is to provide greater flexibility, quality and control to our product candidate pipeline by building a balanced and necessary capacity achieved through our in-house manufacturing, contract manufacturing organizations, or CMOs, and partnerships; investing in manufacturing processes and analytics; and developing a strong supply chain.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our business, see &#8220;Business&#8221; in Part I, Item 1 of the 2021 Annual Report.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impacts of the Ongoing COVID-19 Pandemic</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced and continue to experience impacts from the ongoing and evolving COVID-19 pandemic on our business and operations and could continue to experience these or potentially more severe impacts as the pandemic evolves in the United States, France, the United Kingdom and locations of our clinical studies and trials, such as the new sites for our STAAR study in Canada, Italy and Australia. For example, we have experienced periodic short-term disruptions to our onsite operations while addressing positive cases of COVID-19 by onsite workers and clinical trial patients, and our operations could experience longer term disruptions in the future in the event of a significant outbreak of COVID-19 among our onsite workers or clinical trial patients. Moreover, from time to time, we have been required to reorganize and prioritize our resources to mitigate moderate COVID-19 impacts arising from travel restrictions, density restrictions and supply constraints. If our programs encounter longer-term disruptions, it could impact our ability to support our biopharmaceutical partners as contemplated in our collaboration agreements and could result in adjustments to our timelines.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our Phase 1/2 STAAR clinical study evaluating isaralgagene civaparvovec has experienced and continues to experience delays in its timeline due in part to COVID-19 impacts and the diversion of healthcare resources to fight the pandemic. For example, we have experienced delays in recruiting, enrolling and dosing patients for this study, due in part to the hesitation of patients to travel by plane to trial sites not within driving distance and to enter medical facilities during the pandemic and also due in part to trial sites prioritizing COVID-19 clinical care over research activities such as the STAAR study. The study has also experienced delays when certain patients have decided to take the COVID-19 vaccine or tested positive for COVID-19 prior to enrollment or dosing in the study, and when certain patient candidates decided not to take the COVID-19 vaccine, which disqualified them from study participation. Moreover, we had experienced some short-term delays in sourcing the necessary raw materials to manufacture supplies for the STAAR study and in transporting clinical trial materials due to COVID-19 impacts. We estimated that these challenges set back our initial STAAR study timelines by approximately three to six months. Clinical timelines for this study could be revised again if COVID-19 impacts to our recruitment, screening, enrollment and dosing of patients and to our sourcing of raw materials for this study intensify because of vaccination delays, new COVID-19 variants or unexpected events.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our STEADFAST study evaluating TX200, our wholly-owned CAR-Treg cell therapy product candidate for the treatment of kidney transplant rejection, has experienced delays in its timeline due to COVID-19 impacts related to manufacturing and technology transfer challenges with our CMOs and due to patients and donors testing positive for COVID-19. Our timelines for this study could be adjusted if COVID-19 impacts result in additional delays.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to our partnered programs, the timelines for the studies and trials managed by our collaborators are also subject to potential delay in the future if these studies and trials experience similar challenges that we have experienced and continue to experience in our STAAR and STEADFAST studies.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Going forward, we will continue to monitor the impact of COVID-19 on our operations, research commitments and clinical trials and those of our collaborators, clinical trial sites and CMOs. The magnitude of these impacts will depend, in part, on the length and severity of the COVID-19 pandemic and related government orders and restrictions, and how the pandemic limits the ability of us and our business partners to operate business in the ordinary course. Disruptions to these operations, and possibly more severe disruptions in the future that could arise due to restrictions applicable in the places we operate or our industry generally or to us and our facilities specifically, could impede our ability to conduct research in a timely manner, comply with our research obligations to our collaborators and advance the development of our therapeutic programs. These delays and disruptions could result in adverse material impacts to our business, operating results and financial condition.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not anticipate any material negative impact on our financial condition in 2022 as a result of the COVID-19 pandemic. We believe we are well positioned financially in the near term to execute on our wholly-owned and partnered research </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and clinical programs. As of September&#160;30, 2022, we had $350.3&#160;million in cash, cash equivalents, and marketable securities. Although we believe we are well-capitalized currently, the effects of the evolving pandemic (along with the effects of war in Ukraine, inflation, climate change, rising interest rates and other economic uncertainty and volatility) could result in further disruption of global financial markets, impairing our ability to access capital, which could negatively affect our liquidity in the future. We do not currently anticipate any material impairments to the valuation of the financial assets or goodwill on our balance sheet as a result of the COVID-19 pandemic. We do not believe that the remote workplace arrangements we have implemented for our office-based employees have affected our financial reporting or control systems.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic will impact our business, operations and financial condition, either directly or indirectly, will depend on future developments that remain highly uncertain at the present time. These developments include the ultimate duration and severity of the pandemic, the impacts of new COVID-19 variants, travel restrictions, new public health restrictions in the United States, France, the United Kingdom and other countries, business closures or business disruptions and the effectiveness and timeliness of actions taken in the United States, France, the United Kingdom and other countries to contain and treat the disease, including the effectiveness and timing of vaccination programs. The surge of new variants of the virus, including the recent Omicron variant and its subvariants, has resulted and may in the future result in the return of prior, or imposition of new, orders and restrictions. As our understanding of events evolves and additional information becomes available, we may materially change our guidance relating to our revenues, expenses and timelines for manufacturing, clinical trials and research and development.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the section titled &#8220;Risk Factors&#8221; included in Part I, Item 1A of the 2021 Annual Report for additional information on risks and uncertainties related to the evolving COVID-19 pandemic.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Components of Results of Operations</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues have consisted primarily of revenues from upfront licensing fees, reimbursements for research services, milestone achievements and research grant funding. We expect revenues to continue to fluctuate from period to period and there can be no assurance that new collaborations or partner reimbursements will continue beyond their initial terms or that we are able to meet the milestones specified in these agreements.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred net losses since inception and expect to incur losses for at least the next several years as we continue our research and development activities. To date, we have funded our operations primarily through the issuance of equity securities and revenues from collaborations and research grants.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to devote substantial resources to research and development in the future and expect research and development expenses to increase in the next several years if we are successful in advancing our product candidates from research stage through clinical trials. Pursuant to the terms of our agreements with Biogen, Kite Pharma, Inc., or Kite, and Novartis, certain expenses related to research and development activities will be reimbursed to us. The reimbursement funds to be received from Biogen, Kite, and Novartis will be recognized as revenue as the related costs are incurred and collection is reasonably assured.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of salaries and personnel related expenses for executive, finance and administrative personnel, stock-based compensation expenses, professional fees, allocated facilities expenses, patent prosecution expenses and other general corporate expenses. As we continue to advance our product candidates into and through the clinic, we expect the growth of our business to require increased general and administrative expenses.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying management&#8217;s discussion and analysis of our financial condition and results of operations are based upon our Condensed Consolidated Financial Statements and the related disclosures, which have been prepared in accordance with generally accepted accounting principles in the United States. The preparation of these Condensed Consolidated Financial Statements requires us to make estimates, assumptions and judgments that affect the reported amounts in our Condensed Consolidated Financial Statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our critical accounting policies and estimates relating to revenue recognition and valuation of long-lived assets including goodwill and intangible assets are the most significant estimates and assumptions used in the preparation of our Condensed Consolidated Financial Statements.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no significant changes in our critical accounting policies and estimates during the three and nine months ended September&#160;30, 2022, as compared to the critical accounting policies and estimates disclosed in &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; included in Part II, Item 7 of the 2021 Annual Report.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations for the Three and Nine Months Ended September&#160;30, 2022 and 2021</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.652%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentage values)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentage values)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,460&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,563&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,103)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenues primarily consisted of revenues from collaboration agreements. We anticipate revenues over the next several years will be derived primarily from our collaboration agreements with Biogen, Novartis, Kite, and Pfizer as we continue to recognize upfront and milestone payments received under such agreements over time.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease of $2.1&#160;million in revenues for the three months ended September&#160;30, 2022, compared to the same period in 2021, was primarily attributed to a decrease of $1.9&#160;million in revenue related to our collaboration agreement with Novartis, and a decrease of $1.6&#160;million in revenue related to our collaboration agreement with Biogen. These decreases were partially offset by a $1.9 million adjustment to revenue related to the collaboration agreement with Sanofi S.A., or Sanofi, during 2021, primarily due to a change in estimate regarding project costs, resulting in an adjustment to revenue under the agreement, offset by a decrease of $1.1 million in revenue due to the termination of collaboration agreement with Sanofi, and an increase of $0.5&#160;million in revenue related to our collaboration agreement with Kite.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $1.4&#160;million in revenues for the nine months ended September&#160;30, 2022, compared to the same period in 2021, was primarily attributed to a $1.9 million adjustment to revenue related to the collaboration agreement with Sanofi during 2021, primarily due to a change in estimate regarding project costs, resulting in an adjustment to revenue under the agreement, offset by a decrease of $0.1 million in revenue due to the termination of collaboration agreement with Sanofi, an increase of $0.5&#160;million in revenue related to our collaboration agreement with Kite, and an increase of $0.5&#160;million in revenue related to our collaboration agreement with Novartis. These increases were partially offset by a decrease of $1.5&#160;million in revenue related to our collaboration agreement with Biogen.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expenses</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.652%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentage values)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except percentage values)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cff0fc;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,618&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3%</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,501&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,737&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cff0fc;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,135&#160;</span></td><td style="background-color:#cff0fc;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(896)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,999&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,355&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,958&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">226,153&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,805&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2%</span></td></tr></table></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expenses</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses consisted primarily of compensation related expenses including stock-based compensation, laboratory supplies, preclinical and clinical studies costs, clinical supply manufacturing costs, contracted research, and facilities and information technology expenses.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $2.6 million in research and development expenses for the three months ended September&#160;30, 2022, compared to the same period in 2021, was primarily attributable to higher facilities and information technology costs of $2.7 million driven by overall cost increases and progress made on projects resulting in reassignment of additional space to our research and development departments, an increase of $0.8 million in compensation and other personnel costs as a result of increased headcount to support our programs, and an increase of $0.5 million in travel and entertainment expenses. These increases were partially offset by a decrease of $0.4 million in preclinical, clinical and lab supply expenses due to the timing of certain research and development activities, and $0.9 million in reimbursement of certain research and development expenses by Sanofi. Stock-based compensation expense included in research and development expenses was $4.4 million and $4.9 million for the three months ended September&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $4.7&#160;million in research and development expenses for the nine months ended September&#160;30, 2022, compared to the same period in 2021, was primarily driven by higher facilities and information technology costs of $7.8 million driven by overall cost increases and progress made on projects resulting in reassignment of additional space to our research and development departments, an increase of $0.9 million in travel and entertainment expenses, and an increase of $0.8 million in compensation and other personnel costs as a result of increased headcount to support our programs. These increases were partially offset by a decrease of $3.7 million in preclinical, clinical and lab supply expenses due to the timing of certain research and development activities, and $0.9 million in reimbursement of certain research and development expenses by Sanofi. Stock-based </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compensation expense included in research and development expenses was $13.7&#160;million and $14.6 million for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to devote substantial resources to research and development in the future and expect research and development expenses to increase in the next several years if we are successful in advancing our clinical programs and if we are able to progress our earlier stage product candidates into clinical trials.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The length of time required to complete our development programs and our development costs for those programs may be impacted by the scope and timing of enrollment in clinical trials for our product candidates, our decisions to pursue development programs in other therapeutic areas, and whether we pursue development of our product candidates with a partner or collaborator or independently. For example, our product candidates are being developed in multiple therapeutic areas, and we do not yet know how many of those therapeutic areas we will continue to pursue. Furthermore, the scope and number of clinical trials required to obtain regulatory approval for each pursued therapeutic area is subject to the input of the applicable regulatory authorities, and we have not yet sought such input for all potential therapeutic areas that we may elect to pursue, and even after having given such input, applicable regulatory authorities may subsequently require additional clinical studies prior to granting regulatory approval based on new data generated by us or other companies, or for other reasons outside of our control. As a condition to any regulatory approval, we may also be subject to post-marketing development commitments, including additional clinical trial requirements. As a result of the uncertainties discussed above, we are unable to determine the duration of or complete costs associated with our development programs.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our potential therapeutic products are subject to a lengthy and uncertain regulatory process that may not result in our receipt of any necessary regulatory approvals. Failure to receive the necessary regulatory approvals would prevent us from commercializing the product candidates affected. In addition, clinical trials of our product candidates may fail to demonstrate safety and efficacy, which could prevent or significantly delay regulatory approval. A discussion of the risks and uncertainties with respect to our research and development activities, including completing the development of our product candidates, and the consequences to our business, financial position and growth prospects can be found in &#8220;Risk Factors&#8221; in Part&#160;I, Item&#160;1A of the 2021 Annual Report, as supplemented by the risks described under &#8220;Risk Factors&#8221; in Part II, Item 1A of this Quarterly Report on Form 10-Q.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expenses</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses consist primarily of compensation related expenses including stock-based compensation for executive, legal, finance and administrative personnel, professional fees, facilities and information technology expenses, and other general corporate expenses.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase of $1.7&#160;million in general and administrative expenses for the three months ended September&#160;30, 2022, compared to the same period in 2021, was primarily driven by an increase of $2.1 million in compensation and other personnel costs, and an increase of $1.0 million in legal and professional fees. These increases were partially offset by a decrease of $1.6 million in allocated costs attributable to progress made on projects resulting in reassignment of additional space to our research and development departments. Stock-based compensation expense included in general and administrative expenses was $3.4&#160;million and $2.9&#160;million for the three months ended September&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease of $0.9&#160;million in general and administrative expenses for the nine months ended September&#160;30, 2022, compared to the same period in 2021, was primarily driven by a decrease of $4.3 million in allocated costs attributable to progress made on projects resulting in reassignment of additional space to our research and development departments. This decrease was partially offset by an increase of $3.4 million in compensation and other personnel costs, legal and professional fees, and travel and entertainment expenses. Stock-based compensation expense included in general and administrative expenses was $9.7&#160;million and $10.2&#160;million for the nine months ended September&#160;30, 2022 and 2021, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to build out our product portfolio and advance our product candidates into the clinic, we expect higher general and administrative expenses to support the growth of the business.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest and other income, net</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net, increased by $0.9&#160;million for the three months ended September&#160;30, 2022, compared to the same period in 2021, primarily driven by an increase of $1.2 million in interest income reflecting increases in market interest rates, and a decrease in interest expense of $0.2 million related to dissolution of the repayment obligation of a grant from California Institute for Regenerative Medicine associated with the discontinuation of the ST-400 program in 2021. These increases were partially offset by a decrease of $0.5 million related to fluctuations in foreign currency exchange rates.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net, increased by $2.7&#160;million for the nine months ended September&#160;30, 2022, compared to the same period in 2021, as we benefited from $3.0&#160;million of Employee Retention Credit under the Coronavirus Aid, Relief, and Economic Security Act, an increase of $1.4 million in interest income reflecting increase in market interest rates, and a decrease </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in interest expense of $0.6 million related to dissolution of the repayment obligation of a grant from California Institute for Regenerative Medicine associated with the discontinuation of the ST-400 program in 2021. These increases were partially offset by a decrease of $2.4 million related to fluctuations in foreign currency exchange rates.</span></div><div id="i55c688caac2b44c98200d144e37b2144_85"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have incurred significant net losses, and we have funded our operations primarily through the issuance of equity securities, payments from corporate collaborators and strategic partners and research grants.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2022, we had cash, cash equivalents, and marketable securities totaling $350.3&#160;million, compared to $464.7&#160;million as of December&#160;31, 2021. Our most significant use of capital was for employee compensation and external research and development expenses, including manufacturing, clinical trials and preclinical activity related to our therapeutic programs. Our cash and investment balances are held in a variety of interest-bearing instruments, including U.S. government-sponsored entity debt securities, commercial paper securities, money market funds, corporate debt securities, asset-backed securities and certificates of deposit. Cash in excess of immediate requirements is invested in accordance with our investment policy with a view toward capital preservation and liquidity.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, we entered into an Open Market Sale Agreement&#8480;, or the sales agreement, with Jefferies LLC, providing for the sale of up to $150.0&#160;million of our common stock from time to time in &#8220;at-the-market&#8221; offerings under an existing shelf registration statement. During the nine months ended September&#160;30, 2022, we sold 14,711,770 shares of our common stock under the sales agreement for net proceeds of approximately $66.4&#160;million, of which approximately $0.6&#160;million was received in October 2022 and recorded within prepaid expenses and other current assets on our Condensed Consolidated Balance Sheet as of September&#160;30, 2022. Subsequently in October, we sold 1,921,594 shares of our common stock under the sales agreement for net proceeds of approximately $8.7&#160;million.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we expect our rate of cash usage to increase in the future, in particular to support our product development endeavors, we currently believe that our available cash, cash equivalents, and marketable securities and expected revenues from collaborations and strategic partnerships will be adequate to fund our currently planned operations through at least the next 12 months from the date our Condensed Consolidated Financial Statements are issued. We expect to raise additional capital through additional collaborative agreements and/or the sale of additional equity or debt financing to fund our future needs beyond the next 12 months. During this period of uncertainty and volatility, we will continue to monitor our liquidity.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating activities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $166.6&#160;million for the nine months ended September&#160;30, 2022, primarily reflecting our net loss of $140.3&#160;million, a decrease in deferred revenues of $65.0&#160;million, an increase in prepaid expenses and other assets by $5.8&#160;million, and a decrease in lease liabilities by $3.3&#160;million. These decreases were partially offset by $38.2&#160;million of non-cash expenses related to stock-based compensation, depreciation and amortization, amortization of premium on marketable securities, and amortization of operating lease right-of-use assets and a $9.4&#160;million increase in accounts payable and other accrued liabilities.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $180.5 million for the nine months ended September&#160;30, 2021, primarily reflecting our net loss of $140.8 million, a decrease in deferred revenues of $62.3 million, an increase in prepaid expenses and other assets by $6.5 million, a decrease in accounts payable and other accrued liabilities by $4.7 million, a decrease in long term portion of lease liabilities by $3.2 million, an increase in accounts receivable by $2.7 million, and a decrease in accrued compensation and employee benefits by $1.9 million. These decreases were partially offset by $40.1 million of non-cash expenses related to stock-based compensation, depreciation and amortization, amortization of premium (discount) on marketable securities, and amortization and other changes in operating lease right-of-use assets.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing activities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities was $16.7&#160;million for the nine months ended September&#160;30, 2022, related to maturities of marketable securities of $255.0&#160;million, partially offset by purchases of marketable securities of $225.6&#160;million, and $12.7&#160;million from purchases of property and equipment.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by investing activities for the nine months ended September&#160;30, 2021 was $195.6&#160;million, mostly related to maturities of marketable securities of $509.6&#160;million and sale of marketable securities of $6.9&#160;million, partially offset by purchases of marketable securities of $300.4&#160;million, and purchases of property and equipment of $20.4&#160;million.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing activities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $65.1&#160;million for the nine months ended September&#160;30, 2022, mostly related to $67.5&#160;million of proceeds from the at-the-market offering, net of offering expenses of $1.7&#160;million, and proceeds from purchases of common stock under the employee stock purchase plan of $1.1&#160;million, partially offset by taxes paid related to net share settlement of equity awards of $2.0&#160;million.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $30.7&#160;million for the nine months ended September&#160;30, 2021, mostly related to $27.9 million of proceeds from the at-the-market offering, net of offering expenses of $0.8 million, and proceeds from the exercise of stock options and purchases under the employee stock purchase plan of $6.6&#160;million, partially offset by taxes paid related to net share settlement of equity awards of $3.0&#160;million.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Capital and Capital Expenditure Requirements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate continuing to incur operating losses for at least the next several years. Although we believe we are well capitalized currently, the effects of the ongoing COVID-19 pandemic, war in Ukraine, inflation, rising interest rates and other economic uncertainty and volatility could result in significant disruption of global financial markets, impairing our ability to access capital, which could in the future negatively affect our liquidity. Future capital requirements beyond the next 12 months will be substantial, and we will need to raise substantial additional capital to fund the development, manufacturing and potential commercialization of our product candidates through additional collaboration agreements and/or equity or debt financing. In addition, as we focus our efforts on proprietary human therapeutics, we will need to seek FDA approvals of our product candidates, a process that could cost in excess of hundreds of millions of dollars per product. We regularly consider fund-raising opportunities and may continue to decide, from time to time, to raise additional capital based on various factors, including market conditions and our plans of operation. Additional capital may not be available on terms acceptable to us, or at all. If adequate funds are not available, or if the terms of potential funding sources are unfavorable, our business and our ability to advance our product candidate pipeline would be harmed. Furthermore, any sales of additional equity securities, including additional sales pursuant to our at-the-market offering program, may result in dilution to our stockholders, and any debt financing may include covenants that restrict our business.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many forward-looking factors, including the following:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the initiation, progress, timing and completion of clinical trials for our product candidates and potential product candidates;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outcome, timing and cost of regulatory approvals;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of our collaboration agreements;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays that may be caused by changing regulatory requirements;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of product candidates that we pursue;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs involved in filing and prosecuting patent applications and enforcing and defending patent claims;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and terms of future in-licensing and out-licensing transactions;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost and timing of establishing sales, marketing, manufacturing and distribution capabilities;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of procuring clinical and commercial supplies of our product candidates;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which we acquire or invest in businesses, products or technologies, including the costs associated with such acquisitions and investments; and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs of potential disputes and litigation.</span></div><div id="i55c688caac2b44c98200d144e37b2144_91"></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future minimum contractual obligations as of December&#160;31, 2021 were reported in the 2021 Annual Report. During the nine months ended September&#160;30, 2022, there have been no other material changes outside the ordinary course of our business from the contractual obligations previously disclosed in our 2021 Annual Report.</span></div><div id="i55c688caac2b44c98200d144e37b2144_97"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3.&#160;&#160;&#160;&#160;QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our exposure to market risk relates to our cash, cash equivalents, and marketable securities. The goals of our investment policy are preservation of capital, fulfillment of liquidity needs and capturing a market rate of return based on our investment policy parameters and market conditions. We select investments that maximize interest income to the extent possible within these </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">guidelines. To achieve our goals, we maintain a portfolio of cash equivalents and investments in securities of high credit quality and with varying maturities to match projected cash needs.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The securities in our investment portfolio are not leveraged and are classified as available-for-sale. The majority of these available-for-sale securities are short-term in nature and subject to minimal interest rate risk. Our investments currently consist of U.S. government-sponsored entity debt securities, commercial paper securities, corporate debt securities, asset-backed securities and certificates of deposit. Our investment policy, approved by our Board of Directors, limits the amount we may invest in any one type of investment issuer, thereby reducing credit risk concentrations. All investments are carried at market value, which approximates cost. We do not use derivative financial instruments in our investment portfolio. Our market risks at September&#160;30, 2022 have not changed materially from those discussed in Item&#160;7A of our 2021 Annual Report.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have operations in the United States as well as in Europe. The functional currency of each foreign subsidiary is the local currency. We are exposed to foreign currency risk, primarily through operations of our subsidiaries in Europe which conduct business primarily in Euros. We record gains and losses within our stockholders&#8217; equity due to the translation of our subsidiaries&#8217; financial statements into U.S. dollars. Our foreign currency exchange risk at September&#160;30, 2022 has not changed materially from that discussed in Item&#160;7A of our 2021 Annual Report.</span></div><div id="i55c688caac2b44c98200d144e37b2144_100"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;4.&#160;&#160;&#160;&#160;CONTROLS AND PROCEDURES</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision of our principal executive officer and principal financial officer, we evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) as of September&#160;30, 2022. Based on that evaluation, as of September&#160;30, 2022, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inherent Limitations on Controls and Procedures</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including the principal executive officer and principal financial officer, does not expect that our disclosure controls and procedures and our internal control over financial reporting will prevent all error and all fraud. A control system, no matter how well designed and operated, can only provide reasonable assurances that the objectives of the control system are met. The design of a control system reflects resource constraints; the benefits of controls must be considered relative to their costs. Because there are inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, for our company have been or will be detected. As these inherent limitations are known features of the disclosure and financial reporting processes, it is possible to design into the processes safeguards to reduce, though not eliminate, these risks. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events. While our disclosure controls and procedures and our internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives, there can be no assurance that any design will succeed in achieving its stated goals under all future conditions. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with the policies or procedures. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in our internal control over financial reporting that occurred during the quarter ended September&#160;30, 2022 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="i55c688caac2b44c98200d144e37b2144_106"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 1.&#160;&#160;&#160;&#160;LEGAL PROCEEDINGS</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not party to any material pending legal proceedings. From time to time, we may be involved in legal proceedings arising in the ordinary course of business.</span></div><div id="i55c688caac2b44c98200d144e37b2144_109"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 1A.&#160;&#160;&#160;&#160;RISK FACTORS</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Below we are providing, in supplemental form, changes to our risk factors from those previously disclosed in Part I, Item 1A of the 2021 Annual Report. Our risk factors disclosed in Part I, Item 1A of the 2021 Annual Report provide additional discussion about these supplemental risks and we encourage you to read and carefully consider the risk factors disclosed in Part I, Item 1A of the 2021 Annual Report for a more complete understanding of the risks and uncertainties material to our business.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to identify, qualify and enroll sufficient patients for our clinical trials or complete our clinical trials in a timely manner, which could delay or prevent us from proceeding with the development of our product candidates.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifying, qualifying and enrolling patients in clinical trials of our product candidates, and completing these clinical trials, is critical to our success. Patient enrollment and trial completion is affected by factors including:</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">size of the patient population and process for identifying patients;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">design of the trial protocol;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">eligibility and exclusion criteria;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perceived risks and benefits of the product candidate under study;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perceived risks and benefits of genomic approaches to treatment of diseases;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of competing therapies and clinical trials;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential additional delays related to the evolving COVID-19 global pandemic and the diversion of healthcare resources to fight the pandemic, including the decision of certain patients to take COVID-19 vaccines, certain patients testing positive for COVID-19 prior to enrolling or dosing in the study, and certain patient candidates being disqualified from study participation because they would not take the COVID-19 vaccine;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or interruptions related to voluntary pauses of our clinical trials or those of our collaborators, such as the prior voluntary pause in enrolling and dosing additional patients in the Phase 3 AFFINE trial of giroctocogene fitelparvovec, which pause has since been lifted, and the activation of trial sites;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the imposition of clinical holds by regulatory authorities on our clinical trials or those of our collaborators, such as the prior clinical hold imposed by the FDA on the Phase 3 AFFINE trial of giroctocogene fitelparvovec, which hold has since been lifted, and the potential inability of Sangamo and our collaborators to lift clinical holds imposed by regulatory authorities in a timely manner or on acceptable terms, or at all;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays or difficulties we may experience in enrolling and dosing additional patients in our Phase 1/2 PRECIZN-1 study now that we have completed the transition back to Sangamo of the rights and obligations of Sanofi under our former collaboration agreement; </span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">severity of the disease under investigation;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">availability of genetic testing for potential patients;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">proximity and availability of clinical trial sites for prospective patients;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">required and desired characteristics of patients;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to obtain and maintain patient consent;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risk that enrolled patients will drop out before completion of the trial;</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">patient referral practices of physicians; and</span></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ability to monitor patients adequately during and after treatment.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of our clinical trials depends on our ability to recruit patients to participate as well as completion of required follow-up periods. There are also a number of other product candidates in development by our competitors, who compete for the same limited patient populations. If we are not able to enroll the necessary number of patients in a timely manner, we may not be </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">able to complete our clinical trials on our desired timelines or at all, which could negatively impact the competitive position and commercial viability of our product candidates or delay or reduce the product revenues, milestone payments or royalty payments we expect to earn from our product candidates. For example, we have experienced delays and challenges in recruiting, screening, enrolling and dosing patients for our Phase 1/2 STAAR clinical study evaluating isaralgagene civaparvovec, our wholly-owned gene therapy product candidate for the treatment of Fabry disease, due to challenges related to the COVID-19 pandemic, patients testing positive for COVID-19, patients reconsidering their participation in the study and the limited number of screening sites, among other reasons. Our Phase 1/2 STEADFAST clinical study evaluating TX200 has experienced similar delays and challenges. In addition, we and Pfizer also announced that some of the patients treated in the Phase 3 AFFINE trial of giroctocogene fitelparvovec have experienced FVIII activity greater than 150% following treatment, and that Pfizer decided to voluntarily pause screening and dosing of additional patients in this trial to implement a proposed protocol amendment intended to provide guidelines for the clinical management of elevated FVIII levels. Subsequent to the voluntary pause, the FDA put this trial on clinical hold and then in March 2022, the FDA lifted the clinical hold. While in September 2022 the voluntary pause initiated by Pfizer was lifted and the trial re-opened recruitment and resumed enrollment, and we expect dosing to resume shortly, we cannot assure you that the dosing of all remaining patients in the trial will resume or be completed in a timely manner, or at all, or that the presentation of data from such trial will be published in a timely manner, if at all, or that all trial sites will become active in a timely manner, or at all.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Continued delays or additional pauses to the Phase 3 AFFINE trial could negatively impact the projected timelines for conducting and completing the trial and seeking regulatory approvals for giroctocogene fitelparvovec, which could in turn materially and adversely affect giroctocogene fitelparvovec&#8217;s competitive position and commercial viability and therefore our business, prospects and market price of our common stock.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if fewer patients are willing to participate in our clinical trials because of negative publicity from adverse events related to genomic medicines, competitive clinical trials for similar patient populations or for other reasons, the timelines for conducting clinical trials of our product candidates and presenting clinical data may be delayed. These delays could result in increased costs, limitation or termination of clinical trials, and delays in product development timelines. If we are forced to expand to additional jurisdictions to address these challenges, it could impose additional costs, delays and risks. If we are not successful in conducting our clinical trials as planned, it would have an adverse effect on our business, financial condition, results of operations, prospects and market price of our common stock.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unfavorable global economic conditions, including as a result of the ongoing military action by Russia in Ukraine, could have a negative impact on our operations, which could materially and adversely affect our business, financial condition, results of operations, prospects and market price of our common stock.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2022, Russian forces launched significant military action against Ukraine, and sustained conflict and disruption in the region is possible. The impact to Ukraine as well as actions taken by other countries, including new and stricter sanctions imposed by Canada, the United Kingdom, the European Union, the United States. and other countries and companies and organizations against officials, individuals, regions, and industries in Russia and Ukraine, and actions taken by Russia in response to such sanctions, and responses of countries and political bodies to such sanctions, tensions, and military actions and the potential for more widespread conflict, have resulted in supply chain disruptions, and resulting increases in inflation, financial market volatility and capital markets disruption, potentially increasing in magnitude, and such effects on the global economy and financial markets could affect our business, operations, operating results and financial condition as well as the price of our common stock and our ability to raise additional capital when needed on acceptable terms. In addition, any or all of these effects could disrupt our and our collaborators&#8217; supply chains and adversely affect our and our collaborators&#8217; ability to conduct ongoing and future clinical trials of our product candidates. The extent and duration of the military action, sanctions and resulting economic, market and other disruptions are impossible to predict, but could be substantial. Any such disruptions may magnify the impact of the other risks described in the 2021 Annual Report.</span></div><div id="i55c688caac2b44c98200d144e37b2144_112"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 2.&#160;&#160;&#160;&#160;UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i55c688caac2b44c98200d144e37b2144_115"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 3.&#160;&#160;&#160;&#160;DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i55c688caac2b44c98200d144e37b2144_118"></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 4.&#160;&#160;&#160;&#160;MINE SAFETY DISCLOSURES</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_121"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 5.&#160;&#160;&#160;&#160;OTHER INFORMATION</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_124"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary;padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160; 6.&#160;&#160;&#160;&#160;EXHIBITS</span></div><div style="margin-top:12pt;padding-left:72pt;text-indent:-72pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.425%"><tr><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:82.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description of Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1001233/000156459017017005/sgmo-ex31_651.htm">Seventh Amended and Restated Certificate of Incorporation, as amended (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Quarterly Report on Form 10-Q filed August 9, 2017).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1001233/000119312520150198/d935677dex31.htm">Fourth Certificate of Amendment of the Seventh Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed May 22, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1001233/000119312520318091/d88073dex31.htm">Fourth Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company&#8217;s Current Report on Form 8-K filed December 15, 2020).</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sgmo-2022110322xex51opin.htm">Opinion of Cooley LLP.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1#+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sgmo-20220930xex101_employ.htm">Letter Agreement between the Company and Nathalie Dubois-Stringfellow dated as of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sgmo-20220930xex101_employ.htm">September 28</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="sgmo-20220930xex101_employ.htm">, 2022.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sgmo-2022110322xex51opin.htm">Consent of Cooley LLP is contained in Exhibit 5.1 to this Quarterly Report on Form 10-Q.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sgmo-20220930xex311.htm">Rule 13a &#8212; 14(a) Certification of Principal Executive Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sgmo-20220930xex312.htm">Rule 13a &#8212; 14(a) Certification of Principal Financial Officer.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="sgmo-20220930xex321.htm">Certifications Pursuant to 18 U.S.C. Section 1350.</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The cover page from Sangamo&#8217;s Quarterly Report on Form 10-Q for the three months ended September&#160;30, 2022 is formatted in Inline XBRL and it is contained in Exhibit 101</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________________</span></div><div style="padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* &#160;&#160;&#160;&#160;The certifications attached as Exhibit&#160;32.1 accompany this Quarterly Report on Form&#160;10-Q pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, and shall not be deemed &#8220;filed&#8221; by the Registrant for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended.</span></div><div style="padding-left:54pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">#&#160;&#160;&#160;&#160;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">Indicates management contract or compensatory plan or arrangement.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%">+&#160;&#160;&#160;&#160;Filed herewith.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i55c688caac2b44c98200d144e37b2144_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="padding-left:9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Table of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i55c688caac2b44c98200d144e37b2144_7">Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: November&#160;3, 2022 </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.089%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.711%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SANGAMO THERAPEUTICS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ ALEXANDER D. MACRAE</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:115%">Alexander D. Macrae</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ PRATHYUSHA DURAIBABU</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Prathyusha Duraibabu</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Senior Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Principal Financial and Accounting Officer)</span></td></tr></table></div><div style="margin-top:12pt"><span><br/></span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>sgmo-2022110322xex51opin.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>sgmo-2022110322xex51opin</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- sgmo-2022110322xex51opin001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sgmo-2022110322xex51opin001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">Exhibit 5.1    Chadwick L. Mills  +1 650 843 5654  cmills@cooley.com        Cooley LLP   3 Embarcadero Center   20th Floor   San Francisco, CA 94111-4004  t: (415) 693-2000  f: (415) 693-2222  cooley.com    November 3, 2022  Sangamo Therapeutics, Inc.  7000 Marina Blvd.  Brisbane, California 94005  Ladies and Gentlemen:  We have acted as counsel to Sangamo Therapeutics, Inc., a Delaware corporation (the &#8220;Company&#8221;), in  connection with the sale of shares of its common stock, par value $0.01 per share (the &#8220;Common Stock&#8221;),  having an aggregate offering price of up to $133,865,378.23 (the &#8220;Shares&#8221;) pursuant to the Registration  Statement on Form S-3 (File No. 333-255792) (the &#8220;Registration Statement&#8221;) filed with the Securities and  Exchange Commission (the &#8220;Commission&#8221;) under the Securities Act of 1933, as amended (the &#8220;Act&#8221;), and  the sales agreement prospectus included in the Registration Statement (the &#8220;Prospectus&#8221;). The Shares  are to be sold by the Company in accordance with that certain Open Market Sale Agreement, dated August  5, 2020, by and between the Company and Jefferies LLC, as amended by Amendment No. 1 to Open  Market Sale Agreement, dated May 5, 2021 (together, the &#8220;Agreement&#8221;), as described in the Prospectus.  In connection with this opinion, we have examined and relied upon the Registration Statement and the  Prospectus, the Agreement, the Company&#8217;s certificate of incorporation and the bylaws, each as currently  in effect, and originals, or copies certified to our satisfaction, of such records, documents, certificates,  memoranda and other instruments as in our judgment are necessary or appropriate to enable us to render  the opinion expressed below.  In rendering this opinion, we have assumed the genuineness of all  signatures; the authenticity of all documents submitted to us as originals; the conformity to originals of all  documents submitted to us as copies; the accuracy, completeness and authenticity of certificates of public  officials; and the due authorization, execution and delivery by all persons other than the Company of all  documents where authorization, execution and delivery are prerequisites to the effectiveness thereof.  As  to certain factual matters, we have relied upon a certificate of an officer of the Company and have not  independently verified such matters.    We have assumed (i) that each sale of Shares will be duly authorized by the Board of Directors of the  Company, a duly authorized committee thereof or a person or body pursuant to an authorization granted in  accordance with Section 152 of the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;), (ii)  that no more than 32.0 million Shares will be sold under the Agreement pursuant to the Prospectus and (iii)  that the price at which the Shares are sold will equal or exceed the par value of the Common Stock. We  express no opinion to the extent that future issuances of securities of the Company, anti-dilution  adjustments to outstanding securities of the Company and/or other matter cause the number of shares of  Common Stock issuable under the Agreement to exceed the number then available under the Company&#8217;s  certificate of incorporation.  Our opinion herein is expressed solely with respect to the DGCL.  Our opinion is based on these laws as  in effect on the date hereof.  We express no opinion to the extent that any other laws are applicable to the  subject matter hereof and express no opinion and provide no assurance as to compliance with any federal  or state securities law, rule or regulation.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- sgmo-2022110322xex51opin002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="sgmo-2022110322xex51opin002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">      November 3, 2022  Page Two        Cooley LLP   3 Embarcadero Center   20th Floor   San Francisco, CA 94111-4004  t: (415) 693-2000  f: (415) 693-2222  cooley.com    On the basis of the foregoing, and in reliance thereon, we are of the opinion that the Shares, when sold  and issued against payment therefor in accordance with the Agreement, the Registration Statement and  the Prospectus, will be validly issued, fully paid and nonassessable.  We consent to the reference to our firm under the caption &#8220;Legal Matters&#8221; in the Prospectus and to the filing  of this opinion as an exhibit to the Company&#8217;s Quarterly Report on Form 10-Q filed with the Commission  on the date hereof and incorporated by reference into the Registration Statement.  Sincerely,  Cooley LLP  By:     /s/ Chadwick L. Mills   Chadwick L. Mills  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>sgmo-20220930xex101_employ.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i04074864bb9845fdb8134aff771a9ebf_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employment Agreement (&#8220;Agreement&#8221;) made as of the 28</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day of September 2022 by and between Sangamo Therapeutics, Inc., a Delaware corporation (the &#8220;Company&#8221;), and Nathalie Dubois-Stringfellow (&#8220;Executive&#8221;) (collectively, the &#8220;Parties&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">R E C I T A L S</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, the Company desires to promote Ms. Dubois-Stringfellow to Senior Vice President, Chief Development Officer, and Executive desires to be promoted by the Company, on the terms and conditions set forth in this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NOW, THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, in consideration of the mutual promises set forth herein, the Parties agree follows&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company hereby agrees to employ Executive and Executive hereby agrees to accept such employment, on the terms and conditions set forth in this Agreement, with a start date of August 19, 2022 (the &#8220;Effective Date&#8221;).  To the extent of any inconsistency with Ms. Dubois-Stringfellow&#8217;s prior employment agreements with the Company, this Agreement shall supersede such prior agreements.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">At-Will Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Executive shall be employed on an at-will basis.  Either Executive or the Company may terminate employment at any time, with or without cause, and with or without advance notice.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Position, Duties and Obligations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">Executive shall be appointed as the Senior Vice President, Chief Development Officer and shall serve in such position, and in such other positions as the Board and the Company may from time to time reasonably determine, subject at all times to the direction, supervision and authority of the Chief Executive Officer (collectively, your &#8220;Duties&#8221;).  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">During Executive&#8217;s employment, Executive shall perform Executive&#8217;s Duties faithfully and to the best of Executive&#8217;s ability, and shall devote substantially all of Executive&#8217;s business time, attention, knowledge, skills and interests to the business of the Company (and its affiliates or subsidiaries).  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">During Executive&#8217;s employment, Executive shall not, whether directly or indirectly, render any services of a commercial or professional nature to any other person or organization, whether for compensation or otherwise, without the prior written consent of the Chief Executive Officer. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">The foregoing in this Section 3 shall not preclude Executive from serving on any corporate, civic or charitable boards or committees on which Executive is serving as of the Effective Date and discloses to the Chief Executive Officer prior to the Effective Date or on which Executive commences service following such date with the Chief Executive Officer&#8217;s prior written approval, so long as such activities do not interfere with the performance of Executive&#8217;s responsibilities hereunder.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">Executive&#8217;s principal place of business will be located in Brisbane, California.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">Executive represents that Executive may enter into this Agreement, and as of the Effective Date, 1) accept employment with the Company under the terms of this Agreement, and 2) perform the Duties and responsibilities contemplated by this Agreement without violating any other agreement or agreements with other parties including but not limited to and any prior employers.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Compensation and Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Base Compensation.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  The Company shall pay to Executive an annual base salary of $420,000 Dollars, prorated for any partial employment period and payable in equal monthly installments in accordance with the Company&#8217;s payroll schedule.  The Compensation Committee of the Board shall annually review the then-current level of Executive&#8217;s base salary (for increase only) to determine the amount, if any, of change to such salary.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Annual Performance Bonus.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Executive is eligible to earn an annual performance bonus commencing with the 2022 calendar year performance period. The target amount of Executive&#8217;s annual cash bonus shall remain at 40% percent of Executive&#8217;s annual base salary. The Executive&#8217;s new bonus will be pro-rated accordingly for the remainder of 2022. The Board shall have sole discretion to determine whether any annual cash bonus will be paid based upon achievement of both corporate objectives and Executive&#8217;s personal objectives, and the reasonable discretion to determine that actual amount of any such bonus.  Executive must be an employee in good standing on the date that the Board makes such determination in order to earn any such bonus, which determination shall be made by the Board no later than March 31 of the calendar year first following the performance period calendar year.  The actual bonus may be more or less than the target amount based upon the Company&#8217;s achievement over the year.  Any bonus to which Executive becomes entitled for a particular calendar year shall be paid in accordance with the terms of the applicable bonus plan, but in no event later than the second payroll period following such Board determination.  The Compensation Committee of the Board shall annually review Executive&#8217;s then target amount for the annual cash bonus (for increase only) to determine the amount, if any, of change to such target amount.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Executive Severance Plan.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Executive shall be deemed an Eligible Employee and an Executive Officer and entitled to receive certain severance benefits under the Sangamo Therapeutics, Inc. Executive Severance Plan dated February 6, 2019 (the &#8220;Severance Plan&#8221;) subject to the terms and conditions of the Severance Plan. A copy of the Severance Plan has been provided to Executive concurrently with this Agreement. Notwithstanding the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">foregoing, in the event that the Company withdraws this offer after it is signed by Executive or terminates this Agreement prior to the Effective Date for any reason other than Executive&#8217;s failure to successfully pass the requirements for a background check clearance, satisfactory reference check, and satisfactory proof of Executive&#8217;s legal right to work in the United States required under Section 8(a) herein, then Executive shall be entitled to severance under the Severance Plan as though his employment was terminated by the Company other than for Cause to the same extent as he would otherwise be entitled had such termination occurred after the Effective Date&#59; provided, however, that Executive shall not be entitled to such severance if he has not notified his current employer of his intent to resign his employment at the time the Company informs him of the withdrawal or termination of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Benefits.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Executive will be entitled to the employee benefits generally provided to other executive officers of the Company pursuant to the terms of the applicable benefit plans.  Executive will not be subject to a formal paid time off program.  Executive is free to take paid time off from work for vacation, medical appointments, and other short-term absences due to illnesses or other personal reasons.  If Executive desires to take time off for a duration longer than two (2) weeks manager approval is required.  Unlimited paid time off is available from the first day of employment.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding anything to the contrary in this Agreement, all compensation paid to Executive by the Company (whether payable pursuant to this Agreement or otherwise) will be subject to reduction, recovery and&#47;or recoupment to the extent required by any present or future law, government regulation or stock exchange listing requirement (or any policy adopted by the Company which ensures compliance with the requirements of any such law, government regulation or stock exchange listing requirement).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.03pt">Resignation from Positions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Notwithstanding any other provision of this Agreement to the contrary, upon any termination of employment (whether voluntary or involuntary), Executive, upon written request from the Board, shall immediately resign from any positions Executive has with the Company (or any subsidiary), whether as an executive, officer, employee, consultant, director, trustee, fiduciary or otherwise.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Confidentiality</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive agrees to continue to abide by the terms and conditions of the Employee Confidential Information and Invention Assignment Agreement between Executive and the Company, a copy of which has previously been executed and is attached as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Executive further agrees that at all times both during Executive&#8217;s employment by the Company and after Executive&#8217;s employment ends, Executive will keep in confidence and trust, and will not use or disclose, except as directed by the Company, any confidential or proprietary information of the Company.  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Tax Withholdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any and all cash compensation and other benefits (including without limitation, base salary, annual bonus and sign-on bonus) paid to Executive under this Agreement shall be subject to all applicable tax withholding requirements, and the Company shall make such other deductions as may be required and&#47;or allowed by applicable law and&#47;or as authorized in writing by Executive.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Arbitration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any dispute, controversy, or claim, whether contractual or non-contractual, between Executive and the Company shall be resolved by binding arbitration before the Judicial Arbitration and Mediation Service (the &#8220;JAMS&#8221;), in accordance with the JAMS Employment Arbitration Rules and Procedures, available at www.jamsadr.com.  Executive and the Company each agree that before proceeding to arbitration, they will mediate disputes before the JAMS by a mediator approved by the JAMS.  If mediation fails to resolve the matter, any subsequent arbitration shall be conducted by an arbitrator approved by the JAMS and mutually acceptable to Executive and the Company.  All disputes, controversies, and claims shall be conducted by a single arbitrator, who shall&#58; (i) allow discovery authorized by California Code of Civil Procedure Section 1282, et seq., or any other discovery required by applicable law&#59; and (ii) issue a written award that sets forth the essential findings of fact and conclusions of law on which the award is based.  The arbitrator shall have the authority to award any relief authorized by law in connection with the asserted claims or disputes.   Judgment upon the arbitrator&#8217;s award may be entered in any court having jurisdiction thereof.  If Executive and the Company are unable to agree on the mediator or the arbitrator, then the JAMS shall select the mediator&#47;arbitrator.  The resolution of the dispute by the arbitrator shall be final, binding, non-appealable, and fully enforceable by a court of competent jurisdiction under the Federal Arbitration Act.  The arbitration award shall be in writing and shall include a statement of the reasons for the award.  The arbitration shall be held in San Francisco, California.  The Company shall pay all JAMS, mediation, and arbitrator&#8217;s fees and costs, irrespective of who raised the claim and the outcome of arbitration.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:27pt">Miscellaneous</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-right:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Conditions to Agreement.</font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> This Agreement is contingent upon a background check clearance, satisfactory reference check, and satisfactory proof of Executive&#8217;s legal right to work in the United States.  Executive agrees to provide any documentation or information at the Company&#8217;s request to facilitate these processes. </font><font style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-right:4.5pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall be interpreted, construed, governed and enforced according to the laws of the State of California.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Attorneys&#8217; Fees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In the event of any controversy, claim or dispute between the parties, arising out of or relating to this Agreement or the breach hereof, or the interpretation hereof, each party shall bear its own legal fees and expenses.  Notwithstanding the foregoing, in the event of a finding by any court having jurisdiction over such matter that any party initiating an action under this Agreement failed to have a reasonable prospect of prevailing on its claim, the arbitrator shall have discretion to award the prevailing party attorneys&#8217; fees and costs incurred by it with respect to such claim or action.  The &#34;prevailing party&#34; means the party determined by the arbitrator to have most nearly prevailed, even if such party did not prevail in all matters, not necessarily the one in whose favor a judgment is rendered.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  No amendment or modification of the terms or conditions of this Agreement shall be valid unless in writing and signed by the Parties hereto.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.7pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any provision of this Agreement as applied to any party or to any circumstance should be adjudged by a court of competent jurisdiction (or determined </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">by the arbitrator) to be void or unenforceable for any reason, the invalidity of that provision shall in no way affect (to the maximum extent permissible by law) the application of such provision under circumstances different from those adjudicated by the court or determined by the arbitrator, the application of any other provision of this Agreement, or the enforceability or invalidity of this Agreement as a whole.  Should any provision of this Agreement become or be deemed invalid, illegal or unenforceable in any jurisdiction by reason of the scope, extent or duration of its coverage, then such provision shall be deemed amended to the extent necessary to conform to applicable law so as to be valid and enforceable or, if such provision cannot be so amended without materially altering the intention of the parties, then such provision will be stricken, and the remainder of this Agreement shall continue in full force and effect.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:24.03pt">Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The rights and obligations of the Company under this Agreement shall inure to the benefit of and shall be binding upon the successors and assigns of the Company.  Executive shall not be entitled to assign any of Executive&#8217;s rights or obligations under this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;padding-left:22.02pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement, along with any other agreements set forth herein, including without limitation, the Proprietary Information and Inventions Agreement, constitutes the entire agreement between the parties with respect to the employment of Executive.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:6pt;padding-left:216.9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.717%"><tr><td style="width:1.0%"></td><td style="width:12.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.873%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.118%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SANGAMO THERAPEUTICS, INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:25pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Whitney B. Jones</font></div><div style="margin-bottom:12pt;padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Senior Vice President, Chief People Officer</font></div></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 33.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; Whitney B. Jones</font></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 33.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58; Senior Vice President, Chief People Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">NATHALIE DUBOIS-STRINGFELLOW</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:41pt"><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i04074864bb9845fdb8134aff771a9ebf_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;padding-left:43.2pt;padding-right:43.2pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT A</font></div><div style="margin-bottom:6pt;padding-left:36pt;padding-right:50.4pt"><font><br></font></div><div><font><br></font></div><div style="height:82pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:83%"> </font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>sgmo-20220930xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i549734cb230b41ad871b242c951cd5c7_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Alexander D. Macrae, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed this quarterly report on Form 10-Q of Sangamo Therapeutics, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:144pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:49.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;3, 2022</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; ALEXANDER D. MACRAE</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Alexander D. Macrae</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>sgmo-20220930xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie98dc2d3d8c848a8ba6663a9a27cf9a3_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><font><br></font></div></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Prathyusha Duraibabu, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">I have reviewed this quarterly report on Form 10-Q of Sangamo Therapeutics, Inc.&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:46.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and </font></div><div style="margin-top:6pt;padding-left:108pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:42.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:6pt;padding-left:144pt;text-indent:-36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:75.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;3, 2022</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PRATHYUSHA DURAIBABU</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prathyusha Duraibabu</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>sgmo-20220930xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ia7abf610518b4081b0e1a3ede079be33_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><font><br></font></div></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certifications Pursuant to 18 U.S.C. &#167;1350, as Adopted</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the &#8220;Exchange Act&#8221;) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), each of the undersigned hereby certifies in his or her capacity as an officer of Sangamo Therapeutics, Inc. (the &#8220;Company&#8221;), that, to the best of his or her knowledge&#58;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)&#160;the Company&#8217;s Quarterly Report on Form 10-Q for the period ended September&#160;30, 2022, to which this Certification is attached as Exhibit 32.1 (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or Section 15(d) of the Exchange Act&#59; and</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)&#160;the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.116%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; ALEXANDER D. MACRAE</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Alexander D. Macrae</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;3, 2022</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; PRATHYUSHA DURAIBABU</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prathyusha Duraibabu</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</font></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; November&#160;3, 2022</font></div></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Sangamo Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form&#160;10-Q), irrespective of any general incorporation language contained in such filing. A signed original of this written statement required by Section&#160;906 of the Sarbanes-Oxley Act of 2002 has been provided to Sangamo Therapeutics, Inc. and will be retained by Sangamo Therapeutics, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>sgmo-20220930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9b84b066-0d3d-4626-933d-a605fa769a06,g:f2240c07-5619-4846-82aa-63792348e10c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:sgmo="http://www.sangamo.com/20220930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.sangamo.com/20220930">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20220930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20220930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20220930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="sgmo-20220930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.sangamo.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000007 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>0000008 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHEQUIVALENTSANDMARKETABLESECURITIES" roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES">
        <link:definition>0000009 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASICANDDILUTEDNETLOSSPERSHARE" roleURI="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE">
        <link:definition>0000010 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES">
        <link:definition>0000011 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>0000012 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.sangamo.com/role/STOCKHOLDERSEQUITY">
        <link:definition>0000013 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.sangamo.com/role/INCOMETAXES">
        <link:definition>0000014 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000015 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0000016 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>0000017 - Disclosure - FAIR VALUE MEASUREMENTS - (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHEQUIVALENTSANDMARKETABLESECURITIESTables" roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables">
        <link:definition>0000018 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables">
        <link:definition>0000019 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>0000020 - Disclosure - STOCK-BASED COMPENSATION - (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail">
        <link:definition>0000021 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail">
        <link:definition>0000022 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration Agreements and Research Activity Grants (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail" roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail">
        <link:definition>0000023 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSDetail" roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail">
        <link:definition>0000024 - Disclosure - FAIR VALUE MEASUREMENTS (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail" roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail">
        <link:definition>0000025 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails" roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails">
        <link:definition>0000026 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of cost and estimated fair value of short-term investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetails" roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetails">
        <link:definition>0000027 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASICANDDILUTEDNETLOSSPERSHAREAdditionalInformationDetail" roleURI="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREAdditionalInformationDetail">
        <link:definition>0000028 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail">
        <link:definition>0000029 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail">
        <link:definition>0000030 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail">
        <link:definition>0000031 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail">
        <link:definition>0000032 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail">
        <link:definition>0000033 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Sanofi S.A. (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail" roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail">
        <link:definition>0000034 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail" roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail">
        <link:definition>0000035 - Disclosure - STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDetail" roleURI="http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail">
        <link:definition>0000036 - Disclosure - STOCKHOLDERS' EQUITY (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDetails" roleURI="http://www.sangamo.com/role/INCOMETAXESDetails">
        <link:definition>0000037 - Disclosure - INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" abstract="false" name="CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_NumberOfOptionsToExtendInitialResearchTerm" abstract="false" name="NumberOfOptionsToExtendInitialResearchTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementLicenseFee" abstract="false" name="CollaborativeArrangementLicenseFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_AchievementOfFirstCommercialSaleMilestonesMember" abstract="true" name="AchievementOfFirstCommercialSaleMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace" abstract="false" name="CollaborativeArrangementMaximumNumberOfProductTargetsToReplace" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate" abstract="false" name="ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod" abstract="false" name="ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents" abstract="false" name="DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" abstract="false" name="CollaborationAgreementNumberOfAdditionalProductTargets" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" abstract="false" name="ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="sgmo_MilestoneRevenueReceivable" abstract="false" name="MilestoneRevenueReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax" abstract="false" name="CashEquivalentsGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementNumberOfProductTargetsSelected" abstract="false" name="CollaborativeArrangementNumberOfProductTargetsSelected" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_CollaborationAgreementEquityIssued" abstract="false" name="CollaborationAgreementEquityIssued" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborationAndLicenseAgreementMember" abstract="true" name="CollaborationAndLicenseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_BiogenMAIncMember" abstract="true" name="BiogenMAIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_ResearchServicesMember" abstract="true" name="ResearchServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_ProceedsFromEmployeeRetentionCreditCARESAct" abstract="false" name="ProceedsFromEmployeeRetentionCreditCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_InitialResearchTermOfAgreement" abstract="false" name="InitialResearchTermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_ChangeInCollaborationAgreementScopeMember" abstract="true" name="ChangeInCollaborationAgreementScopeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" abstract="false" name="AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" abstract="false" name="NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" abstract="false" name="CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" abstract="false" name="CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" abstract="true" name="RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_StockPurchaseAgreementMember" abstract="true" name="StockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_CollaborativeAgreementMilestoneAxis" abstract="true" name="CollaborativeAgreementMilestoneAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="sgmo_PfizerMember" abstract="true" name="PfizerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage" abstract="false" name="CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" abstract="false" name="ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_SanofiMember" abstract="true" name="SanofiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan" abstract="false" name="CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_MilestoneAchievementMember" abstract="true" name="MilestoneAchievementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_CashEquivalentsAndAvailableForSaleSecurities" abstract="false" name="CashEquivalentsAndAvailableForSaleSecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" abstract="false" name="CollaborativeArrangementEstimatedReimbursableServiceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_MilestoneThreeMember" abstract="true" name="MilestoneThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CNineORFSevenTwoMember" abstract="true" name="CNineORFSevenTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" abstract="true" name="AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_NovartisInstitutesForBioMedicalResearchIncMember" abstract="true" name="NovartisInstitutesForBioMedicalResearchIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_PfizerC9ORF72Member" abstract="true" name="PfizerC9ORF72Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" abstract="true" name="AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense" abstract="false" name="TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborationAgreementRemainingPeriod" abstract="false" name="CollaborationAgreementRemainingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementStandstillRestrictionPeriod" abstract="false" name="CollaborativeArrangementStandstillRestrictionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_OtherProductsMember" abstract="true" name="OtherProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_PfizerSB525Member" abstract="true" name="PfizerSB525Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_SBFiveTwoFiveAndOtherProductsMember" abstract="true" name="SBFiveTwoFiveAndOtherProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_TenantAllowance" abstract="false" name="TenantAllowance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax" abstract="false" name="CashEquivalentsGrossUnrealizedLossBeforeTax" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborationArrangementResearchPeriod" abstract="false" name="CollaborationArrangementResearchPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_JefferiesLLCMember" abstract="true" name="JefferiesLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" abstract="false" name="CustomerContractLiabilityMilestonePaymentEligibleToReceive" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate" abstract="false" name="ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" abstract="false" name="CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_GainLossOnFreeShares" abstract="false" name="GainLossOnFreeShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" abstract="false" name="CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_MilestonePaymentsReceived" abstract="false" name="MilestonePaymentsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborativeAgreementPercentOfInitialRecognition" abstract="false" name="CollaborativeAgreementPercentOfInitialRecognition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="sgmo_KitePharmaIncMember" abstract="true" name="KitePharmaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" abstract="false" name="CollaborativeArrangementNumberOfMilestonesAchieved" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_SalesBasedMilestoneMember" abstract="true" name="SalesBasedMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" abstract="true" name="AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" abstract="false" name="SaleOfStockExcessConsiderationReceivedOnTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_EmployeeRetentionCreditCARESAct" abstract="false" name="EmployeeRetentionCreditCARESAct" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementResearchServiceFees" abstract="false" name="CollaborativeArrangementResearchServiceFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable" abstract="false" name="CollaborativeArrangementMaximumMilestonePaymentReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment" abstract="false" name="ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_AgreementTerminationTerm" abstract="false" name="AgreementTerminationTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_CollaborativeAgreementMilestoneDomain" abstract="true" name="CollaborativeAgreementMilestoneDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_NumberOfResearchProgram" abstract="false" name="NumberOfResearchProgram" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="sgmo_AmortizationAndOtherChangesInRightOfUseAssets" abstract="false" name="AmortizationAndOtherChangesInRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_ExtendedResearchTermOfAgreement" abstract="false" name="ExtendedResearchTermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="sgmo_StockOfferingProgramMaximumValue" abstract="false" name="StockOfferingProgramMaximumValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_CollaborativeArrangementTransactionPrice" abstract="false" name="CollaborativeArrangementTransactionPrice" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" abstract="true" name="AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_AchievementOfCommercialMilestonesMember" abstract="true" name="AchievementOfCommercialMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_PreApprovalMilestoneMember" abstract="true" name="PreApprovalMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="sgmo_SeparateUpfrontFee" abstract="false" name="SeparateUpfrontFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="sgmo_AtTheMarketOfferingAgreementMember" abstract="true" name="AtTheMarketOfferingAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>sgmo-20220930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9b84b066-0d3d-4626-933d-a605fa769a06,g:f2240c07-5619-4846-82aa-63792348e10c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_589af96c-8b00-4e5e-a950-e7ec90b7a6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_632e214d-e43e-4a43-954b-39fdc9c3a4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_589af96c-8b00-4e5e-a950-e7ec90b7a6ae" xlink:to="loc_us-gaap_LiabilitiesCurrent_632e214d-e43e-4a43-954b-39fdc9c3a4ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_36d2cc9c-40de-42d0-b04d-c69517d436fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_589af96c-8b00-4e5e-a950-e7ec90b7a6ae" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_36d2cc9c-40de-42d0-b04d-c69517d436fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2779d442-ecb2-4e52-a954-1238a640c41d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_589af96c-8b00-4e5e-a950-e7ec90b7a6ae" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_2779d442-ecb2-4e52-a954-1238a640c41d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a0c5620d-44d4-46d8-a7d1-ff4ca10b28de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_589af96c-8b00-4e5e-a950-e7ec90b7a6ae" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_a0c5620d-44d4-46d8-a7d1-ff4ca10b28de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c2d11dd3-a114-4a65-bc60-f98123ebf16a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_589af96c-8b00-4e5e-a950-e7ec90b7a6ae" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c2d11dd3-a114-4a65-bc60-f98123ebf16a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f9c62740-735b-481c-8a39-a60f3fd90696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_79238e23-21ee-424a-b075-a994a3d01f73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9c62740-735b-481c-8a39-a60f3fd90696" xlink:to="loc_us-gaap_AssetsCurrent_79238e23-21ee-424a-b075-a994a3d01f73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_81ca93ef-8727-4b35-a53d-615d4de291e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9c62740-735b-481c-8a39-a60f3fd90696" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_81ca93ef-8727-4b35-a53d-615d4de291e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9fcbb1b5-c228-43fa-80a8-bab65f618bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9c62740-735b-481c-8a39-a60f3fd90696" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9fcbb1b5-c228-43fa-80a8-bab65f618bfd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_69adf7fd-12e3-4856-ab05-562d5e80c247" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9c62740-735b-481c-8a39-a60f3fd90696" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_69adf7fd-12e3-4856-ab05-562d5e80c247" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_cd195328-9a46-420e-ad97-0516295869e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9c62740-735b-481c-8a39-a60f3fd90696" xlink:to="loc_us-gaap_Goodwill_cd195328-9a46-420e-ad97-0516295869e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_62fe0e50-acdc-4c6a-9ba2-63fde5836be7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9c62740-735b-481c-8a39-a60f3fd90696" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_62fe0e50-acdc-4c6a-9ba2-63fde5836be7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2028d3a3-0c8a-4ce2-a962-45a00264a67f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9c62740-735b-481c-8a39-a60f3fd90696" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2028d3a3-0c8a-4ce2-a962-45a00264a67f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_913a7588-dae8-47a5-b2b2-ad3ea0ca6b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f9c62740-735b-481c-8a39-a60f3fd90696" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_913a7588-dae8-47a5-b2b2-ad3ea0ca6b82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_785f8d67-9cb4-4789-85e5-ab33ff38990b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_044f9375-618f-4a71-9ed0-7bc9a8cfe3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_785f8d67-9cb4-4789-85e5-ab33ff38990b" xlink:to="loc_us-gaap_AccountsPayableCurrent_044f9375-618f-4a71-9ed0-7bc9a8cfe3b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_8174f876-1678-4d0b-a240-2f2a6460bd98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_785f8d67-9cb4-4789-85e5-ab33ff38990b" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_8174f876-1678-4d0b-a240-2f2a6460bd98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1e032b7d-9469-4874-9cb0-517c9ba6a852" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_785f8d67-9cb4-4789-85e5-ab33ff38990b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_1e032b7d-9469-4874-9cb0-517c9ba6a852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_09f46f7f-2439-4b4d-bfc2-eca2f85c0a4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_785f8d67-9cb4-4789-85e5-ab33ff38990b" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_09f46f7f-2439-4b4d-bfc2-eca2f85c0a4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e20bf14f-d9cf-4544-8541-21eadabd65cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_9e554eef-4d9d-48a5-bbfc-a7cdeac666a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e20bf14f-d9cf-4544-8541-21eadabd65cd" xlink:to="loc_us-gaap_PreferredStockValue_9e554eef-4d9d-48a5-bbfc-a7cdeac666a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_8ff825fc-cb53-49b8-af2f-f7aec3889f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e20bf14f-d9cf-4544-8541-21eadabd65cd" xlink:to="loc_us-gaap_CommonStockValue_8ff825fc-cb53-49b8-af2f-f7aec3889f66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_af2de772-61b5-4cac-babc-0c62e4ccbbf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e20bf14f-d9cf-4544-8541-21eadabd65cd" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_af2de772-61b5-4cac-babc-0c62e4ccbbf1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9517dd61-834c-49b0-9ab9-c8c99e2f7edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e20bf14f-d9cf-4544-8541-21eadabd65cd" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9517dd61-834c-49b0-9ab9-c8c99e2f7edd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_af02df44-ec82-4813-8e24-28dc2ec0625e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_e20bf14f-d9cf-4544-8541-21eadabd65cd" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_af02df44-ec82-4813-8e24-28dc2ec0625e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_71aafbd9-db96-425a-af52-2ac8f75df215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_d1ef9568-f15f-477d-9a4a-907b0c1d657b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_71aafbd9-db96-425a-af52-2ac8f75df215" xlink:to="loc_us-gaap_Liabilities_d1ef9568-f15f-477d-9a4a-907b0c1d657b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f2443454-4f8a-4822-aa3d-2e98a995d723" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_71aafbd9-db96-425a-af52-2ac8f75df215" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f2443454-4f8a-4822-aa3d-2e98a995d723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9819e367-0192-4fe1-8b5f-8c968e2750b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_71aafbd9-db96-425a-af52-2ac8f75df215" xlink:to="loc_us-gaap_StockholdersEquity_9819e367-0192-4fe1-8b5f-8c968e2750b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cff2ce42-1877-4307-9b14-3898eef9e8b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_05b34be2-ee14-4b3f-82a6-4c3b0a26ce5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_cff2ce42-1877-4307-9b14-3898eef9e8b3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_05b34be2-ee14-4b3f-82a6-4c3b0a26ce5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_8b66dc23-9976-412f-a166-254a15051c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_cff2ce42-1877-4307-9b14-3898eef9e8b3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_8b66dc23-9976-412f-a166-254a15051c6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent_3f409d28-ccb7-4234-a6eb-5e5468b14b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_cff2ce42-1877-4307-9b14-3898eef9e8b3" xlink:to="loc_us-gaap_InterestReceivableCurrent_3f409d28-ccb7-4234-a6eb-5e5468b14b91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_da5fb355-f289-4b98-815f-668b0b6421c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_cff2ce42-1877-4307-9b14-3898eef9e8b3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_da5fb355-f289-4b98-815f-668b0b6421c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b32bdd6e-aa5e-4d8e-afe7-9583e0a8cc6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_cff2ce42-1877-4307-9b14-3898eef9e8b3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b32bdd6e-aa5e-4d8e-afe7-9583e0a8cc6c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5981a715-2539-4850-bd5f-9cb2a847a43b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ec93c862-595a-4bdf-a30e-33d4cc8cb4b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5981a715-2539-4850-bd5f-9cb2a847a43b" xlink:to="loc_us-gaap_ProfitLoss_ec93c862-595a-4bdf-a30e-33d4cc8cb4b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_759442ae-5cba-4b95-88c6-ba9811f45883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5981a715-2539-4850-bd5f-9cb2a847a43b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_759442ae-5cba-4b95-88c6-ba9811f45883" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_26faaec4-01d1-44a5-bbcf-48e58834307e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3f1470aa-45b7-404e-aa8b-45cca32d910b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_26faaec4-01d1-44a5-bbcf-48e58834307e" xlink:to="loc_us-gaap_ProfitLoss_3f1470aa-45b7-404e-aa8b-45cca32d910b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_dae5d48f-df0a-42a0-87bb-21572e79916d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_26faaec4-01d1-44a5-bbcf-48e58834307e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_dae5d48f-df0a-42a0-87bb-21572e79916d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_01e44cff-5cad-48a2-bf3b-3cde42dbbb03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2901dc40-148e-4f6f-9c8d-646573041964" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_01e44cff-5cad-48a2-bf3b-3cde42dbbb03" xlink:to="loc_us-gaap_OperatingIncomeLoss_2901dc40-148e-4f6f-9c8d-646573041964" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_bcc3c389-9c24-4540-b34c-62a6d22fc07f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_01e44cff-5cad-48a2-bf3b-3cde42dbbb03" xlink:to="loc_us-gaap_InterestAndOtherIncome_bcc3c389-9c24-4540-b34c-62a6d22fc07f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2470bfc7-a21c-4d60-9539-37a4b287599e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_71b9095c-9575-49fa-a03f-f0bc3f941deb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2470bfc7-a21c-4d60-9539-37a4b287599e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_71b9095c-9575-49fa-a03f-f0bc3f941deb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d11660ae-91c3-4266-956d-3b5b9d89bfd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_2470bfc7-a21c-4d60-9539-37a4b287599e" xlink:to="loc_us-gaap_OperatingExpenses_d11660ae-91c3-4266-956d-3b5b9d89bfd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8ded846c-cbe3-4f20-8a4b-a7ab2ee63b21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_e36d2dec-99cf-40fd-a3e4-89c236aba74f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8ded846c-cbe3-4f20-8a4b-a7ab2ee63b21" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_e36d2dec-99cf-40fd-a3e4-89c236aba74f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_931d3c0a-a665-43b5-b56a-0ed385f993b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8ded846c-cbe3-4f20-8a4b-a7ab2ee63b21" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_931d3c0a-a665-43b5-b56a-0ed385f993b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fdedddc7-5ebb-481b-951a-288fc5a38484" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_a382125e-1521-4ded-8f71-e1473fa39e6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_fdedddc7-5ebb-481b-951a-288fc5a38484" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_a382125e-1521-4ded-8f71-e1473fa39e6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6c9e8804-7ccf-40f2-959c-2aefd33221f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_fdedddc7-5ebb-481b-951a-288fc5a38484" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_6c9e8804-7ccf-40f2-959c-2aefd33221f7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_152f13e4-c7ac-4fb2-9c8c-d29bdeecc548" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6598c9eb-363a-492f-a65a-cda2043bbd80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_152f13e4-c7ac-4fb2-9c8c-d29bdeecc548" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_6598c9eb-363a-492f-a65a-cda2043bbd80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a00612c2-58ae-473d-8ef3-756dfb7db517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_152f13e4-c7ac-4fb2-9c8c-d29bdeecc548" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a00612c2-58ae-473d-8ef3-756dfb7db517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c83d0e7e-1ae6-41dd-a9b8-12f3d3c6bf8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a286a4fa-4e56-470e-8369-343a3d58ac77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c83d0e7e-1ae6-41dd-a9b8-12f3d3c6bf8d" xlink:to="loc_us-gaap_ProfitLoss_a286a4fa-4e56-470e-8369-343a3d58ac77" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e26db92c-0ced-4644-af3a-94de687a401a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c83d0e7e-1ae6-41dd-a9b8-12f3d3c6bf8d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_e26db92c-0ced-4644-af3a-94de687a401a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5956be29-1b97-4bc3-ab41-413b682fde04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c83d0e7e-1ae6-41dd-a9b8-12f3d3c6bf8d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5956be29-1b97-4bc3-ab41-413b682fde04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4353b885-cf38-45a1-8fa9-9c0cf5f20f11" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c83d0e7e-1ae6-41dd-a9b8-12f3d3c6bf8d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_4353b885-cf38-45a1-8fa9-9c0cf5f20f11" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1d388693-9d9a-4825-b586-a3f33e865b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_1d388693-9d9a-4825-b586-a3f33e865b4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_69aed56f-6b39-40bc-a92b-366ae4e72812" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_69aed56f-6b39-40bc-a92b-366ae4e72812" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2b7dc39c-0ec2-44e5-b66f-ac6f6d8c00f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2b7dc39c-0ec2-44e5-b66f-ac6f6d8c00f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b2719a08-dde3-4f49-98cd-1da0b402e551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_ShareBasedCompensation_b2719a08-dde3-4f49-98cd-1da0b402e551" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_GainLossOnFreeShares_4c90646e-40dd-4b96-9c90-6f7224d50846" xlink:href="sgmo-20220930.xsd#sgmo_GainLossOnFreeShares"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_sgmo_GainLossOnFreeShares_4c90646e-40dd-4b96-9c90-6f7224d50846" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_00e77bdf-2a6b-4d89-93fb-6422d3ccd1aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_00e77bdf-2a6b-4d89-93fb-6422d3ccd1aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_4a4984dd-c6a2-47b3-a54d-1f5c073185f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_4a4984dd-c6a2-47b3-a54d-1f5c073185f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f7df8549-1c37-4b48-8c26-8045c68263c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_f7df8549-1c37-4b48-8c26-8045c68263c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4c8046b4-c29d-4419-b9a5-4af802ec9aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_4c8046b4-c29d-4419-b9a5-4af802ec9aa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_bd1b147d-8926-4eee-9e1d-f21a3ecf6c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_ProfitLoss_bd1b147d-8926-4eee-9e1d-f21a3ecf6c72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AmortizationAndOtherChangesInRightOfUseAssets_f01fc48d-f4a7-46bc-9055-a8d9fe7f760c" xlink:href="sgmo-20220930.xsd#sgmo_AmortizationAndOtherChangesInRightOfUseAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_sgmo_AmortizationAndOtherChangesInRightOfUseAssets_f01fc48d-f4a7-46bc-9055-a8d9fe7f760c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_b347de36-f65a-444c-91c1-da52286f5e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_b347de36-f65a-444c-91c1-da52286f5e3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_088f03aa-c2ad-4b18-9a50-c4d85bbb63f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_088f03aa-c2ad-4b18-9a50-c4d85bbb63f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_0a606bad-a8c5-4f10-a7c6-792123368e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_0a606bad-a8c5-4f10-a7c6-792123368e5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8661622d-992f-4e14-a02c-b9204e7c3767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1fb3d4fd-2935-455d-adcc-48d10947fb3c" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_8661622d-992f-4e14-a02c-b9204e7c3767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6519a8e0-d3d8-4dc3-9031-af18c30c3912" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a196301f-613f-4ef5-855c-2c3c471b7863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6519a8e0-d3d8-4dc3-9031-af18c30c3912" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a196301f-613f-4ef5-855c-2c3c471b7863" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6832a13b-5b5b-4d76-8d12-65bb514083b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6519a8e0-d3d8-4dc3-9031-af18c30c3912" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6832a13b-5b5b-4d76-8d12-65bb514083b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_921f5bc5-973d-4375-a057-b5269f69d24c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6519a8e0-d3d8-4dc3-9031-af18c30c3912" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_921f5bc5-973d-4375-a057-b5269f69d24c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a684c8b5-b21c-4ff8-9a63-f776e0e0efc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6519a8e0-d3d8-4dc3-9031-af18c30c3912" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a684c8b5-b21c-4ff8-9a63-f776e0e0efc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aded5a3f-b336-443f-ba6a-63ac30718bd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_ccdefb70-a837-48c8-9f95-8dd8f8cf8bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aded5a3f-b336-443f-ba6a-63ac30718bd3" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_ccdefb70-a837-48c8-9f95-8dd8f8cf8bb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_c23b3432-c250-4fc2-aa20-0100376f2214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aded5a3f-b336-443f-ba6a-63ac30718bd3" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_c23b3432-c250-4fc2-aa20-0100376f2214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_30b2cf80-a53b-4692-8807-68923c22054d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aded5a3f-b336-443f-ba6a-63ac30718bd3" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_30b2cf80-a53b-4692-8807-68923c22054d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities_d350d1bf-caf3-48da-91bb-f517c22bcf65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aded5a3f-b336-443f-ba6a-63ac30718bd3" xlink:to="loc_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities_d350d1bf-caf3-48da-91bb-f517c22bcf65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_24f16d84-53ba-419b-aaaa-a02186977d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aded5a3f-b336-443f-ba6a-63ac30718bd3" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_24f16d84-53ba-419b-aaaa-a02186977d7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b9f50ab-f3cc-4574-9d23-7b126c4a0ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8cf29637-cdb5-4307-8be8-bcde332c3459" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b9f50ab-f3cc-4574-9d23-7b126c4a0ac4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_8cf29637-cdb5-4307-8be8-bcde332c3459" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a5ce6540-a860-461e-9e2e-d864f5791c55" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b9f50ab-f3cc-4574-9d23-7b126c4a0ac4" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_a5ce6540-a860-461e-9e2e-d864f5791c55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3095b286-c538-46b0-bd22-da7f1ad86090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_5b9f50ab-f3cc-4574-9d23-7b126c4a0ac4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3095b286-c538-46b0-bd22-da7f1ad86090" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_76dcc96b-2ae7-4b07-bd51-1b1170c50c03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1e5cc7b0-3437-4d20-ae3d-9c8327120c45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_76dcc96b-2ae7-4b07-bd51-1b1170c50c03" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1e5cc7b0-3437-4d20-ae3d-9c8327120c45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_f27546fd-83d9-4845-9131-29fc6ec10880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_76dcc96b-2ae7-4b07-bd51-1b1170c50c03" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_f27546fd-83d9-4845-9131-29fc6ec10880" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#FAIRVALUEMEASUREMENTSDetail"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_5c07bf11-5774-4078-afee-bb33dd92b861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4f782514-500f-4704-8a8c-9bd4bda7f64e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_5c07bf11-5774-4078-afee-bb33dd92b861" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_4f782514-500f-4704-8a8c-9bd4bda7f64e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0c74a036-27f6-43d8-a1c2-4259fb64d59c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_5c07bf11-5774-4078-afee-bb33dd92b861" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0c74a036-27f6-43d8-a1c2-4259fb64d59c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7ef2ff67-45b5-4154-bdf6-9990ffdfc0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5077e3de-896b-490b-a190-a442d9dc9a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7ef2ff67-45b5-4154-bdf6-9990ffdfc0f0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5077e3de-896b-490b-a190-a442d9dc9a4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ed332b2e-6e0b-4c17-a10f-959d1bc45b39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7ef2ff67-45b5-4154-bdf6-9990ffdfc0f0" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ed332b2e-6e0b-4c17-a10f-959d1bc45b39" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_20e382a7-2465-4b60-8f12-d2085c646c4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7ef2ff67-45b5-4154-bdf6-9990ffdfc0f0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_20e382a7-2465-4b60-8f12-d2085c646c4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_e58fd4ff-053d-4717-89e9-1695e892a3ef" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_4e407879-b02b-43dc-bee7-5752382af1a5" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_e58fd4ff-053d-4717-89e9-1695e892a3ef" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_4e407879-b02b-43dc-bee7-5752382af1a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_3473ab72-9445-4cbb-9e45-74292c4668dd" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_e58fd4ff-053d-4717-89e9-1695e892a3ef" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_3473ab72-9445-4cbb-9e45-74292c4668dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_d5f39392-9a50-40a1-b84e-c13dac85fc09" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_e58fd4ff-053d-4717-89e9-1695e892a3ef" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_d5f39392-9a50-40a1-b84e-c13dac85fc09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_cd3b8224-3723-4829-8d8c-7204c4d5752f" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax_150e014d-19e0-45e5-9b3f-fc2e1b794d10" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_cd3b8224-3723-4829-8d8c-7204c4d5752f" xlink:to="loc_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax_150e014d-19e0-45e5-9b3f-fc2e1b794d10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3f176737-05c5-481f-914b-c872879a1ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_cd3b8224-3723-4829-8d8c-7204c4d5752f" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_3f176737-05c5-481f-914b-c872879a1ee6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_2b37ca99-b847-4bcf-8f44-9364ee39bf89" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_955eae2a-f6c0-4bda-8fa3-7ae7cc0b18f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_2b37ca99-b847-4bcf-8f44-9364ee39bf89" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_955eae2a-f6c0-4bda-8fa3-7ae7cc0b18f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3a8820cf-bb84-4574-8832-8ecfbcfb8902" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_2b37ca99-b847-4bcf-8f44-9364ee39bf89" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3a8820cf-bb84-4574-8832-8ecfbcfb8902" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_324a9135-88aa-4a8f-aa02-49dc7343eb9e" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax_8faf9fbd-c836-4728-bfbd-ad69f8ae16e1" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_324a9135-88aa-4a8f-aa02-49dc7343eb9e" xlink:to="loc_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax_8faf9fbd-c836-4728-bfbd-ad69f8ae16e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_27f6474c-c776-4114-b9be-83fb8a197de6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_324a9135-88aa-4a8f-aa02-49dc7343eb9e" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_27f6474c-c776-4114-b9be-83fb8a197de6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a3b684d5-af18-411c-929a-a4ee8cadaaca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax_d2beff9a-bdbb-43e4-ae27-bd7f62d0b4b0" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a3b684d5-af18-411c-929a-a4ee8cadaaca" xlink:to="loc_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax_d2beff9a-bdbb-43e4-ae27-bd7f62d0b4b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax_fbba46dd-a455-4887-a16f-199baf609d6c" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a3b684d5-af18-411c-929a-a4ee8cadaaca" xlink:to="loc_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax_fbba46dd-a455-4887-a16f-199baf609d6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_677ad516-3b41-45f6-9974-88369de615d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_a3b684d5-af18-411c-929a-a4ee8cadaaca" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_677ad516-3b41-45f6-9974-88369de615d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents_92b6ec4b-937c-40f0-b3a4-8b1fa6ddcd65" xlink:href="sgmo-20220930.xsd#sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_dafabee7-a455-4483-b3e3-7c6089352617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents_92b6ec4b-937c-40f0-b3a4-8b1fa6ddcd65" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_dafabee7-a455-4483-b3e3-7c6089352617" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_57b14514-b6ec-474e-bbca-c8000eb1856c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents_92b6ec4b-937c-40f0-b3a4-8b1fa6ddcd65" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_57b14514-b6ec-474e-bbca-c8000eb1856c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>sgmo-20220930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9b84b066-0d3d-4626-933d-a605fa769a06,g:f2240c07-5619-4846-82aa-63792348e10c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="id68563529a834540a499edd59a034452_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e0108f60-4571-499e-a273-4e73920d290c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e0108f60-4571-499e-a273-4e73920d290c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d2d091c0-c378-400e-abc0-407242a0da1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_CommonStockSharesIssued_d2d091c0-c378-400e-abc0-407242a0da1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_23bd7ea8-f0f8-4547-8efa-50b07519ece9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_23bd7ea8-f0f8-4547-8efa-50b07519ece9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d12489cf-35ba-4721-9f0c-8deb16aa32c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d12489cf-35ba-4721-9f0c-8deb16aa32c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7e6c6290-5ca9-4404-8b14-1c0ca6f81b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7e6c6290-5ca9-4404-8b14-1c0ca6f81b6a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e56ad2f0-85c3-44fd-9906-a15fd03e2ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e56ad2f0-85c3-44fd-9906-a15fd03e2ad8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_fc32d127-827d-4d16-a55c-a883b50eccc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_fc32d127-827d-4d16-a55c-a883b50eccc8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_086e183e-08f6-44bb-978a-d81d192ef6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_086e183e-08f6-44bb-978a-d81d192ef6f0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_41499eaf-e833-4462-9f15-90ac33fb5794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_41499eaf-e833-4462-9f15-90ac33fb5794" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_612a863c-2637-47ac-bf6a-b3dedff5764a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_612a863c-2637-47ac-bf6a-b3dedff5764a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest_50858a60-df35-419b-86fb-7a6141165019" xlink:href="sgmo-20220930.xsd#sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest_50858a60-df35-419b-86fb-7a6141165019" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_5eadbadd-2f78-44eb-9627-9cf8183e1ade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_5eadbadd-2f78-44eb-9627-9cf8183e1ade" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_78a29692-2a96-4cd1-965d-5ba75656819f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_78a29692-2a96-4cd1-965d-5ba75656819f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_967da655-0d29-471f-92a9-bd2fd249522d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_967da655-0d29-471f-92a9-bd2fd249522d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_779e0c31-3ded-4d39-9ea1-b4abf6e15c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_779e0c31-3ded-4d39-9ea1-b4abf6e15c8b" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_af220446-e9d1-4219-a07c-baeec0ea827a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_ProfitLoss_af220446-e9d1-4219-a07c-baeec0ea827a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a7d93dc5-c8ba-4581-8f71-75d311de9704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f58a72bd-67d4-4e8c-ac3d-c59bced5b4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0d4779cf-ab59-47a3-a2bc-6b4f55b347ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e0108f60-4571-499e-a273-4e73920d290c" xlink:to="loc_us-gaap_StatementTable_0d4779cf-ab59-47a3-a2bc-6b4f55b347ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8af27787-9f9d-45c2-9141-584a27445ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0d4779cf-ab59-47a3-a2bc-6b4f55b347ce" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8af27787-9f9d-45c2-9141-584a27445ebd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8af27787-9f9d-45c2-9141-584a27445ebd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8af27787-9f9d-45c2-9141-584a27445ebd" xlink:to="loc_us-gaap_EquityComponentDomain_8af27787-9f9d-45c2-9141-584a27445ebd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8af27787-9f9d-45c2-9141-584a27445ebd" xlink:to="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_570d9438-d7b2-47be-93b1-26a8e35d5ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:to="loc_us-gaap_CommonStockMember_570d9438-d7b2-47be-93b1-26a8e35d5ec6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b56f52c1-c7d8-457c-81b6-1b9d9b327340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b56f52c1-c7d8-457c-81b6-1b9d9b327340" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d3241647-6ff6-4486-99a4-333fef3c1a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:to="loc_us-gaap_RetainedEarningsMember_d3241647-6ff6-4486-99a4-333fef3c1a4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2c9b91ed-d831-43c9-a62d-5bb18960c9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2c9b91ed-d831-43c9-a62d-5bb18960c9f7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b43c5a8b-6ddf-4213-bd80-325a45070620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b43c5a8b-6ddf-4213-bd80-325a45070620" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i88f6055e82c14e31a66310dc47219ff9_CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_be3542e6-dcdd-43b9-bae8-a1529bdf1bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:to="loc_us-gaap_ProfitLoss_be3542e6-dcdd-43b9-bae8-a1529bdf1bf9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5263a6ca-f8aa-4d36-8be1-8417a1a53b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5263a6ca-f8aa-4d36-8be1-8417a1a53b8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_411641f1-c4ed-4f97-ba36-758df1ef1731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_411641f1-c4ed-4f97-ba36-758df1ef1731" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AmortizationAndOtherChangesInRightOfUseAssets_1c46e952-5e2f-4bc1-bd62-4a271e892855" xlink:href="sgmo-20220930.xsd#sgmo_AmortizationAndOtherChangesInRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_sgmo_AmortizationAndOtherChangesInRightOfUseAssets_1c46e952-5e2f-4bc1-bd62-4a271e892855" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_GainLossOnFreeShares_2692632b-b6b9-460b-a60f-93a3ffc8159e" xlink:href="sgmo-20220930.xsd#sgmo_GainLossOnFreeShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_sgmo_GainLossOnFreeShares_2692632b-b6b9-460b-a60f-93a3ffc8159e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b78d980f-f24a-4a89-9585-97724a723b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_us-gaap_ShareBasedCompensation_b78d980f-f24a-4a89-9585-97724a723b2b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d3c49608-bbd6-4743-8682-25dd22aed015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d3c49608-bbd6-4743-8682-25dd22aed015" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_0d16d90d-5d06-4bc6-83dc-d5c347695474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_0d16d90d-5d06-4bc6-83dc-d5c347695474" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5bbc7336-fc7f-4f75-9410-a16b2219ff6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5bbc7336-fc7f-4f75-9410-a16b2219ff6f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_da113121-3387-4ba1-a3f4-046a9299e536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_da113121-3387-4ba1-a3f4-046a9299e536" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_85759101-32f0-46a8-8a05-bc60ab56e575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_85759101-32f0-46a8-8a05-bc60ab56e575" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a4ac088d-4a85-4643-8708-4ea4c0e4e0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a4ac088d-4a85-4643-8708-4ea4c0e4e0e7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_58374a3a-f226-4cd8-b097-8f2e2beff384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_58374a3a-f226-4cd8-b097-8f2e2beff384" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_8c3ccaf2-9ce1-4c64-a9f8-8d8d069f4100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_8c3ccaf2-9ce1-4c64-a9f8-8d8d069f4100" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_03296535-d50d-46f2-bef7-0228018eecb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_03296535-d50d-46f2-bef7-0228018eecb9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42c7162c-9a61-4b71-a8a6-84427b486f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42c7162c-9a61-4b71-a8a6-84427b486f1e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_61ce65b4-cfe6-456f-868a-693bb3a5c88a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_61ce65b4-cfe6-456f-868a-693bb3a5c88a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_03da33c7-e2a5-408e-aefc-6a6def201074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_03da33c7-e2a5-408e-aefc-6a6def201074" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities_fce639db-ce88-4664-83d2-3ab880876f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities_fce639db-ce88-4664-83d2-3ab880876f02" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ff471866-bef6-4602-879f-5b3b550e5aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ff471866-bef6-4602-879f-5b3b550e5aef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_5570e683-9458-446c-8568-11eeaf3e12f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_5570e683-9458-446c-8568-11eeaf3e12f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6d3042e-4aa7-4b1c-8dcb-64262e2ebb91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6d3042e-4aa7-4b1c-8dcb-64262e2ebb91" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e28783d2-1646-4abb-a93e-752b92c4157d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e28783d2-1646-4abb-a93e-752b92c4157d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f1ef739c-f9c8-4ed0-898f-32e8c7f9c6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f1ef739c-f9c8-4ed0-898f-32e8c7f9c6b3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ba83e4ba-7dae-4e12-b83c-f69848c5c024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ba83e4ba-7dae-4e12-b83c-f69848c5c024" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_458d7249-c509-4f12-aaae-ac60418964b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_458d7249-c509-4f12-aaae-ac60418964b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30aed208-247b-4a64-85f3-cb8efba25661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30aed208-247b-4a64-85f3-cb8efba25661" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_586ea372-3d1f-4457-a521-cad0a2ad7e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_586ea372-3d1f-4457-a521-cad0a2ad7e09" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9284727a-ef29-408f-8907-8cc1f9fdbba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9284727a-ef29-408f-8907-8cc1f9fdbba4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a2e105a8-2f9b-48c9-afd7-97d84bd29242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_2e5102ef-f4dc-4d14-b3b5-f3451856771d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_2e5102ef-f4dc-4d14-b3b5-f3451856771d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8ef5c08c-7cfe-4553-a6b4-5eecbdc6a5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8ef5c08c-7cfe-4553-a6b4-5eecbdc6a5f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_TenantAllowance_ab2b11d9-a6e5-458a-a70e-f768de7ede78" xlink:href="sgmo-20220930.xsd#sgmo_TenantAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:to="loc_sgmo_TenantAllowance_ab2b11d9-a6e5-458a-a70e-f768de7ede78" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_5c97aba5-2af9-44c5-aaf3-a864f121127a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_5c97aba5-2af9-44c5-aaf3-a864f121127a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c87cb072-1285-452b-9b19-c8cb63888d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_StatementTable_c87cb072-1285-452b-9b19-c8cb63888d7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_89c81d29-9cd2-44c0-a2e4-b90c2d499e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c87cb072-1285-452b-9b19-c8cb63888d7f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_89c81d29-9cd2-44c0-a2e4-b90c2d499e09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89c81d29-9cd2-44c0-a2e4-b90c2d499e09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_89c81d29-9cd2-44c0-a2e4-b90c2d499e09" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_89c81d29-9cd2-44c0-a2e4-b90c2d499e09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1d542017-cc5f-497d-ab41-c26f48db81aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_89c81d29-9cd2-44c0-a2e4-b90c2d499e09" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1d542017-cc5f-497d-ab41-c26f48db81aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingMember_ab2842f6-07ae-486a-8f4c-833e79cd89e0" xlink:href="sgmo-20220930.xsd#sgmo_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1d542017-cc5f-497d-ab41-c26f48db81aa" xlink:to="loc_sgmo_AtTheMarketOfferingMember_ab2842f6-07ae-486a-8f4c-833e79cd89e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_f40d2609-88de-4a8f-820a-aefda6d18a34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1d542017-cc5f-497d-ab41-c26f48db81aa" xlink:to="loc_us-gaap_EmployeeStockMember_f40d2609-88de-4a8f-820a-aefda6d18a34" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables" xlink:type="extended" id="i259b5e87d86640c6aac7a2079d71106f_MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_4f14092f-2a03-42d1-8253-2b1933efa467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_93b6cf66-fe88-4044-b10d-11cb64db78ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_4f14092f-2a03-42d1-8253-2b1933efa467" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_93b6cf66-fe88-4044-b10d-11cb64db78ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b26e6e24-cdc0-41d7-afd7-8d003cc91155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_4f14092f-2a03-42d1-8253-2b1933efa467" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b26e6e24-cdc0-41d7-afd7-8d003cc91155" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_954b1a10-0f9e-47a4-8afe-ac9e90d469e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b26e6e24-cdc0-41d7-afd7-8d003cc91155" xlink:to="loc_srt_CounterpartyNameAxis_954b1a10-0f9e-47a4-8afe-ac9e90d469e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_954b1a10-0f9e-47a4-8afe-ac9e90d469e7_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_954b1a10-0f9e-47a4-8afe-ac9e90d469e7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_954b1a10-0f9e-47a4-8afe-ac9e90d469e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_954b1a10-0f9e-47a4-8afe-ac9e90d469e7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_ff33c4a5-f80d-4d20-8740-95e8203bb21a" xlink:href="sgmo-20220930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_ff33c4a5-f80d-4d20-8740-95e8203bb21a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_11293922-cc20-4036-b8b7-7a39ec6b1c0d" xlink:href="sgmo-20220930.xsd#sgmo_BiogenMAIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:to="loc_sgmo_BiogenMAIncMember_11293922-cc20-4036-b8b7-7a39ec6b1c0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_787de772-1f7e-43de-9486-8a85194f4eb3" xlink:href="sgmo-20220930.xsd#sgmo_KitePharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:to="loc_sgmo_KitePharmaIncMember_787de772-1f7e-43de-9486-8a85194f4eb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SanofiMember_1cbca751-dba2-43ce-a290-41f298374317" xlink:href="sgmo-20220930.xsd#sgmo_SanofiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:to="loc_sgmo_SanofiMember_1cbca751-dba2-43ce-a290-41f298374317" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail" xlink:type="extended" id="if7cfaff634734cf789207c4ff1c10d8e_ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9d244eb-ddbc-4c44-a3b0-1fca72f68f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9d244eb-ddbc-4c44-a3b0-1fca72f68f95" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_57b18a86-efde-4eab-87c1-dad667e987c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:to="loc_us-gaap_ProfitLoss_57b18a86-efde-4eab-87c1-dad667e987c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6539c5e9-b299-4ce3-bf6c-623d53046afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:to="loc_us-gaap_EarningsPerShareBasic_6539c5e9-b299-4ce3-bf6c-623d53046afe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a00d9687-2016-4577-b974-58e3a3defb4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a00d9687-2016-4577-b974-58e3a3defb4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4a116fbb-8349-4ae3-8030-42b63c18b75b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4a116fbb-8349-4ae3-8030-42b63c18b75b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_5386350a-5a89-49b0-9b3f-94ce6d02e70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangeInAccountingEstimateTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:to="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_5386350a-5a89-49b0-9b3f-94ce6d02e70e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9e44f59b-6c81-485c-8dd9-2540c8c46b0c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_5386350a-5a89-49b0-9b3f-94ce6d02e70e" xlink:to="loc_srt_CounterpartyNameAxis_9e44f59b-6c81-485c-8dd9-2540c8c46b0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9e44f59b-6c81-485c-8dd9-2540c8c46b0c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_9e44f59b-6c81-485c-8dd9-2540c8c46b0c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9e44f59b-6c81-485c-8dd9-2540c8c46b0c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9bc8c31e-8f5b-4944-a6bc-0616f7602e5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_9e44f59b-6c81-485c-8dd9-2540c8c46b0c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9bc8c31e-8f5b-4944-a6bc-0616f7602e5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SanofiMember_a5a15769-07f1-4773-aca0-45a1fd95642c" xlink:href="sgmo-20220930.xsd#sgmo_SanofiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9bc8c31e-8f5b-4944-a6bc-0616f7602e5c" xlink:to="loc_sgmo_SanofiMember_a5a15769-07f1-4773-aca0-45a1fd95642c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e76356b2-bead-4aa6-a1fd-a94552048690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_5386350a-5a89-49b0-9b3f-94ce6d02e70e" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e76356b2-bead-4aa6-a1fd-a94552048690" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_e76356b2-bead-4aa6-a1fd-a94552048690_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e76356b2-bead-4aa6-a1fd-a94552048690" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_e76356b2-bead-4aa6-a1fd-a94552048690_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_2a7caafe-98d9-4530-94b7-204e42acf0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e76356b2-bead-4aa6-a1fd-a94552048690" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_2a7caafe-98d9-4530-94b7-204e42acf0b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInCollaborationAgreementScopeMember_cb613757-5bbe-4d30-8aa5-1f4281962481" xlink:href="sgmo-20220930.xsd#sgmo_ChangeInCollaborationAgreementScopeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_2a7caafe-98d9-4530-94b7-204e42acf0b0" xlink:to="loc_sgmo_ChangeInCollaborationAgreementScopeMember_cb613757-5bbe-4d30-8aa5-1f4281962481" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7b5ee8a0-937d-46cf-8694-63900167d449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_5386350a-5a89-49b0-9b3f-94ce6d02e70e" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7b5ee8a0-937d-46cf-8694-63900167d449" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7b5ee8a0-937d-46cf-8694-63900167d449_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7b5ee8a0-937d-46cf-8694-63900167d449" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7b5ee8a0-937d-46cf-8694-63900167d449_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09f359d8-f049-4016-afef-62a454cfd488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7b5ee8a0-937d-46cf-8694-63900167d449" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09f359d8-f049-4016-afef-62a454cfd488" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_17875a2f-dc43-417f-b246-ef1c52fb4275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09f359d8-f049-4016-afef-62a454cfd488" xlink:to="loc_us-gaap_CollaborativeArrangementMember_17875a2f-dc43-417f-b246-ef1c52fb4275" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail" xlink:type="extended" id="i9e5ae1515e1846cda91678c20eb151c2_ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_48b2b1c2-bad1-4203-b1ed-0559360086fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_52e8a4a4-d9df-4aa5-b858-bc0127d47c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48b2b1c2-bad1-4203-b1ed-0559360086fe" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_52e8a4a4-d9df-4aa5-b858-bc0127d47c52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_a8da231c-fe51-4adc-acd6-674b320daeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48b2b1c2-bad1-4203-b1ed-0559360086fe" xlink:to="loc_us-gaap_ConcentrationRiskTable_a8da231c-fe51-4adc-acd6-674b320daeb1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ae50edd2-2c5b-41b8-b9ba-d5d261e43eac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_a8da231c-fe51-4adc-acd6-674b320daeb1" xlink:to="loc_srt_CounterpartyNameAxis_ae50edd2-2c5b-41b8-b9ba-d5d261e43eac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ae50edd2-2c5b-41b8-b9ba-d5d261e43eac_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ae50edd2-2c5b-41b8-b9ba-d5d261e43eac" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ae50edd2-2c5b-41b8-b9ba-d5d261e43eac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ae50edd2-2c5b-41b8-b9ba-d5d261e43eac" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_5388cd54-826f-4640-85f8-66073c5d1dad" xlink:href="sgmo-20220930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_5388cd54-826f-4640-85f8-66073c5d1dad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_52fcd807-82f1-4c35-9386-72bbb0c98965" xlink:href="sgmo-20220930.xsd#sgmo_BiogenMAIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:to="loc_sgmo_BiogenMAIncMember_52fcd807-82f1-4c35-9386-72bbb0c98965" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_b46ecb58-fe7e-4c95-9c96-cea8856d03aa" xlink:href="sgmo-20220930.xsd#sgmo_KitePharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:to="loc_sgmo_KitePharmaIncMember_b46ecb58-fe7e-4c95-9c96-cea8856d03aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SanofiMember_895ff8a3-8171-4ef3-a2fe-f21f468a86aa" xlink:href="sgmo-20220930.xsd#sgmo_SanofiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:to="loc_sgmo_SanofiMember_895ff8a3-8171-4ef3-a2fe-f21f468a86aa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_17fb0a8a-8791-438e-bab3-97fb9b87eeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_a8da231c-fe51-4adc-acd6-674b320daeb1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_17fb0a8a-8791-438e-bab3-97fb9b87eeeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_17fb0a8a-8791-438e-bab3-97fb9b87eeeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_17fb0a8a-8791-438e-bab3-97fb9b87eeeb" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_17fb0a8a-8791-438e-bab3-97fb9b87eeeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c1eba313-9625-420f-b38a-cbf635802fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_17fb0a8a-8791-438e-bab3-97fb9b87eeeb" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c1eba313-9625-420f-b38a-cbf635802fe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_d1acb0ff-4227-4e23-bec5-558c48fed5db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c1eba313-9625-420f-b38a-cbf635802fe5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_d1acb0ff-4227-4e23-bec5-558c48fed5db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_2db42d85-2cfa-4898-99e3-c1945d95cc69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_a8da231c-fe51-4adc-acd6-674b320daeb1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_2db42d85-2cfa-4898-99e3-c1945d95cc69" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2db42d85-2cfa-4898-99e3-c1945d95cc69_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2db42d85-2cfa-4898-99e3-c1945d95cc69" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2db42d85-2cfa-4898-99e3-c1945d95cc69_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e4789a35-78b7-4426-8203-69a074fdc6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2db42d85-2cfa-4898-99e3-c1945d95cc69" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e4789a35-78b7-4426-8203-69a074fdc6df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_a025d297-e375-4cc2-9666-2c33f90693d9" xlink:href="sgmo-20220930.xsd#sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_e4789a35-78b7-4426-8203-69a074fdc6df" xlink:to="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_a025d297-e375-4cc2-9666-2c33f90693d9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#FAIRVALUEMEASUREMENTSDetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail" xlink:type="extended" id="icbe9999fa46e4a73bf453e95bb086231_FAIRVALUEMEASUREMENTSDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6a94942e-54f9-4546-907f-b211513a0ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f9fa7dd5-5ed7-4711-8de5-2a1d51bee10d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6a94942e-54f9-4546-907f-b211513a0ed1" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f9fa7dd5-5ed7-4711-8de5-2a1d51bee10d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_49ffdeb9-eb2d-470e-8f4d-7710e0e096a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6a94942e-54f9-4546-907f-b211513a0ed1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_49ffdeb9-eb2d-470e-8f4d-7710e0e096a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7ae64afa-4106-4fb5-89e9-a615e429db4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6a94942e-54f9-4546-907f-b211513a0ed1" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_7ae64afa-4106-4fb5-89e9-a615e429db4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f7aa807-a2ed-47c2-ad64-582322e4ad15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6a94942e-54f9-4546-907f-b211513a0ed1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f7aa807-a2ed-47c2-ad64-582322e4ad15" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73259926-673d-436c-9ad7-cc868a69a868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f7aa807-a2ed-47c2-ad64-582322e4ad15" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73259926-673d-436c-9ad7-cc868a69a868" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_73259926-673d-436c-9ad7-cc868a69a868_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73259926-673d-436c-9ad7-cc868a69a868" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_73259926-673d-436c-9ad7-cc868a69a868_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_887b4320-9ee4-43d2-b7f3-7d2d425d0157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73259926-673d-436c-9ad7-cc868a69a868" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_887b4320-9ee4-43d2-b7f3-7d2d425d0157" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7db0b285-b314-49c6-9706-c059c866ba07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_887b4320-9ee4-43d2-b7f3-7d2d425d0157" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7db0b285-b314-49c6-9706-c059c866ba07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0c2dea82-09df-4bab-8561-ca72eeafc45d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f7aa807-a2ed-47c2-ad64-582322e4ad15" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0c2dea82-09df-4bab-8561-ca72eeafc45d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0c2dea82-09df-4bab-8561-ca72eeafc45d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0c2dea82-09df-4bab-8561-ca72eeafc45d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0c2dea82-09df-4bab-8561-ca72eeafc45d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4153308-79f7-4ffa-8c59-c282ba4c8e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0c2dea82-09df-4bab-8561-ca72eeafc45d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4153308-79f7-4ffa-8c59-c282ba4c8e32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_39a2b31d-4eda-47d7-a256-e9d4ca916e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4153308-79f7-4ffa-8c59-c282ba4c8e32" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_39a2b31d-4eda-47d7-a256-e9d4ca916e63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_06c95684-75f0-4e54-b4b2-bcb5bf45822b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4153308-79f7-4ffa-8c59-c282ba4c8e32" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_06c95684-75f0-4e54-b4b2-bcb5bf45822b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e1b8de4e-5861-4872-9618-465f142ee910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4153308-79f7-4ffa-8c59-c282ba4c8e32" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e1b8de4e-5861-4872-9618-465f142ee910" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_81259eec-9618-4ca0-b81d-bd38827c6632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f7aa807-a2ed-47c2-ad64-582322e4ad15" xlink:to="loc_us-gaap_FinancialInstrumentAxis_81259eec-9618-4ca0-b81d-bd38827c6632" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_81259eec-9618-4ca0-b81d-bd38827c6632_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_81259eec-9618-4ca0-b81d-bd38827c6632" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_81259eec-9618-4ca0-b81d-bd38827c6632_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_81259eec-9618-4ca0-b81d-bd38827c6632" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_5db33f31-8e46-4e93-8c47-4d0c20bf16af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_MoneyMarketFundsMember_5db33f31-8e46-4e93-8c47-4d0c20bf16af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_b2381fef-4215-4932-bc50-57661a13c993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_b2381fef-4215-4932-bc50-57661a13c993" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6e102093-937b-43f5-a349-b622512fea08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_CommercialPaperMember_6e102093-937b-43f5-a349-b622512fea08" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a64b767a-c439-4b79-8e05-171ec026164a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a64b767a-c439-4b79-8e05-171ec026164a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_90f84c77-962d-4cd3-aa66-712a12822754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_90f84c77-962d-4cd3-aa66-712a12822754" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_30477f82-8dd8-4b99-ae9b-c9e1ccb4136b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_30477f82-8dd8-4b99-ae9b-c9e1ccb4136b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_df59ddb1-2ca1-42b0-a2f4-4a3765a2b11f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_CertificatesOfDepositMember_df59ddb1-2ca1-42b0-a2f4-4a3765a2b11f" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail" xlink:type="extended" id="ic91942a5f32548c6b9aeb726137a1e27_CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:to="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f3b21747-ac5c-4fcc-88c1-37ca362de53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f3b21747-ac5c-4fcc-88c1-37ca362de53c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax_722cce62-ce09-4dbb-afc8-be18ec0c5545" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax_722cce62-ce09-4dbb-afc8-be18ec0c5545" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax_acde41e4-d2cc-4073-8cbd-a9071dbeca26" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax_acde41e4-d2cc-4073-8cbd-a9071dbeca26" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1360a85f-cd7f-4dbf-bbd9-07e3e70a9504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1360a85f-cd7f-4dbf-bbd9-07e3e70a9504" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7e12c97c-c5a8-49c9-aac7-652567bea54a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7e12c97c-c5a8-49c9-aac7-652567bea54a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6dab650a-f31f-44a9-81c0-48a3f54e585c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6dab650a-f31f-44a9-81c0-48a3f54e585c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_464bbbda-8114-470b-b000-7468d1c47efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_464bbbda-8114-470b-b000-7468d1c47efb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c8f40ebe-0753-4d27-b954-0b134bd57e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c8f40ebe-0753-4d27-b954-0b134bd57e6d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_fe61f014-7da6-436a-8b25-f7104e8ca7e0" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_fe61f014-7da6-436a-8b25-f7104e8ca7e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_813999af-9a46-4c8f-8461-08f96e065031" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_813999af-9a46-4c8f-8461-08f96e065031" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_71338c78-84eb-42ea-85eb-50cd5715da18" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_71338c78-84eb-42ea-85eb-50cd5715da18" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_b3bb9ccf-c1cd-4cdf-acff-60801d11ead3" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_b3bb9ccf-c1cd-4cdf-acff-60801d11ead3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_36fd7b78-282f-43ce-9cef-165ee5789d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_36fd7b78-282f-43ce-9cef-165ee5789d5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4cd92c43-6c6a-44f7-8d8f-b88a7357db54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_36fd7b78-282f-43ce-9cef-165ee5789d5a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4cd92c43-6c6a-44f7-8d8f-b88a7357db54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4cd92c43-6c6a-44f7-8d8f-b88a7357db54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4cd92c43-6c6a-44f7-8d8f-b88a7357db54" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4cd92c43-6c6a-44f7-8d8f-b88a7357db54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4cd92c43-6c6a-44f7-8d8f-b88a7357db54" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_62ce4b94-aad9-408d-a465-d3a901fc6bec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_MoneyMarketFundsMember_62ce4b94-aad9-408d-a465-d3a901fc6bec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_070b0b08-db9b-4480-8e9a-433fc048834d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_CashEquivalentsMember_070b0b08-db9b-4480-8e9a-433fc048834d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_7c61f5f3-14ae-43e6-881e-e3dc9c19fc53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_7c61f5f3-14ae-43e6-881e-e3dc9c19fc53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d4caba1e-40e4-4c9e-a7a9-fac730e14d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_CommercialPaperMember_d4caba1e-40e4-4c9e-a7a9-fac730e14d1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_c7018487-c8bf-4d4f-9b3d-2899a89d5dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_c7018487-c8bf-4d4f-9b3d-2899a89d5dec" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_0fcacabd-9c49-48bd-bf44-97bfd1e9254c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_0fcacabd-9c49-48bd-bf44-97bfd1e9254c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_ec61bbd9-7b6b-458f-a5a0-80dc547b804f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_ec61bbd9-7b6b-458f-a5a0-80dc547b804f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_0140e134-667d-4900-9a63-59be3a17e1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_CertificatesOfDepositMember_0140e134-667d-4900-9a63-59be3a17e1b7" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail" xlink:type="extended" id="ia8f5e1511c4d41c8be121b3bc115c743_MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_6e0b2d78-4df1-423d-912e-6ff88ce1cec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_us-gaap_ProceedsFromCollaborators_6e0b2d78-4df1-423d-912e-6ff88ce1cec9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_8712d999-73d5-4580-89c9-28bee6dee82c" xlink:href="sgmo-20220930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_8712d999-73d5-4580-89c9-28bee6dee82c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_cd72e457-de78-4825-bacf-43ffa884437e" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_cd72e457-de78-4825-bacf-43ffa884437e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementLicenseFee_3089a5a9-3035-4003-8cdd-a162a0361574" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementLicenseFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CollaborativeArrangementLicenseFee_3089a5a9-3035-4003-8cdd-a162a0361574" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_52a9d774-a2f7-4fb0-8021-83bcce85f9ca" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_52a9d774-a2f7-4fb0-8021-83bcce85f9ca" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_455d90d9-cbd1-4fa8-9120-f2eb7a5ef431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_455d90d9-cbd1-4fa8-9120-f2eb7a5ef431" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_d7b4b9a7-0c0f-435e-9064-f323da47bea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_us-gaap_ContractWithCustomerLiability_d7b4b9a7-0c0f-435e-9064-f323da47bea7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_7e72eb66-ac9e-4a8e-aa76-5e49bfb6999f" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_7e72eb66-ac9e-4a8e-aa76-5e49bfb6999f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_9da1f3ad-89bf-4b01-911d-3a2455475a1f" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementPercentOfInitialRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_9da1f3ad-89bf-4b01-911d-3a2455475a1f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostGross_ddb4441d-2838-48f0-a048-837d2d5acb79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_us-gaap_CapitalizedContractCostGross_ddb4441d-2838-48f0-a048-837d2d5acb79" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_2d63944b-f3cc-4caf-b79f-c309e401a9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_2d63944b-f3cc-4caf-b79f-c309e401a9a1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_972e5e3d-cce5-4aa5-bb3c-e5f82a70180d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_972e5e3d-cce5-4aa5-bb3c-e5f82a70180d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_840e65ba-9961-432b-9c6d-749c6de7257b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_972e5e3d-cce5-4aa5-bb3c-e5f82a70180d" xlink:to="loc_srt_CounterpartyNameAxis_840e65ba-9961-432b-9c6d-749c6de7257b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_840e65ba-9961-432b-9c6d-749c6de7257b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_840e65ba-9961-432b-9c6d-749c6de7257b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_840e65ba-9961-432b-9c6d-749c6de7257b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_24649189-e3d7-48d1-8f75-2f094ca6b75b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_840e65ba-9961-432b-9c6d-749c6de7257b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_24649189-e3d7-48d1-8f75-2f094ca6b75b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_bc768082-4874-4040-bf9e-06854f26bbcb" xlink:href="sgmo-20220930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_24649189-e3d7-48d1-8f75-2f094ca6b75b" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_bc768082-4874-4040-bf9e-06854f26bbcb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_9edf9e10-8695-4c5c-81ae-0bf6e83736cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_972e5e3d-cce5-4aa5-bb3c-e5f82a70180d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_9edf9e10-8695-4c5c-81ae-0bf6e83736cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9edf9e10-8695-4c5c-81ae-0bf6e83736cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9edf9e10-8695-4c5c-81ae-0bf6e83736cd" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_9edf9e10-8695-4c5c-81ae-0bf6e83736cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ce7aabc2-c4c4-40af-b718-c95ba694f18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9edf9e10-8695-4c5c-81ae-0bf6e83736cd" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ce7aabc2-c4c4-40af-b718-c95ba694f18d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_1a457085-04c2-48dc-bcb3-65b10dfe68bb" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ce7aabc2-c4c4-40af-b718-c95ba694f18d" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_1a457085-04c2-48dc-bcb3-65b10dfe68bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_f4e4c655-0f3a-4f7b-b573-5a1dabffc0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_972e5e3d-cce5-4aa5-bb3c-e5f82a70180d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_f4e4c655-0f3a-4f7b-b573-5a1dabffc0fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_f4e4c655-0f3a-4f7b-b573-5a1dabffc0fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_f4e4c655-0f3a-4f7b-b573-5a1dabffc0fd" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_f4e4c655-0f3a-4f7b-b573-5a1dabffc0fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_218d9e11-3454-4d6e-8c63-80a99ea8ce28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_f4e4c655-0f3a-4f7b-b573-5a1dabffc0fd" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_218d9e11-3454-4d6e-8c63-80a99ea8ce28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_e35a56fb-0ec1-495f-afe3-2bd532a2dd83" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_218d9e11-3454-4d6e-8c63-80a99ea8ce28" xlink:to="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_e35a56fb-0ec1-495f-afe3-2bd532a2dd83" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfCommercialMilestonesMember_664f6194-c6e1-4c61-9880-e2f9a458f48a" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfCommercialMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_218d9e11-3454-4d6e-8c63-80a99ea8ce28" xlink:to="loc_sgmo_AchievementOfCommercialMilestonesMember_664f6194-c6e1-4c61-9880-e2f9a458f48a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail" xlink:type="extended" id="ic3875f7a2c364f658455a87a26afd432_MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_14127a8c-681a-40c2-a08d-7bab684cf292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ea00675-f435-48d5-8104-7949a8bdaf78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_14127a8c-681a-40c2-a08d-7bab684cf292" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ea00675-f435-48d5-8104-7949a8bdaf78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8f4a02b2-b1d5-4e66-bb33-2c0e6bb48bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_14127a8c-681a-40c2-a08d-7bab684cf292" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8f4a02b2-b1d5-4e66-bb33-2c0e6bb48bd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ef516252-f0ff-4ad9-ab40-fe89f81808b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8f4a02b2-b1d5-4e66-bb33-2c0e6bb48bd0" xlink:to="loc_srt_CounterpartyNameAxis_ef516252-f0ff-4ad9-ab40-fe89f81808b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef516252-f0ff-4ad9-ab40-fe89f81808b6_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ef516252-f0ff-4ad9-ab40-fe89f81808b6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ef516252-f0ff-4ad9-ab40-fe89f81808b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ef516252-f0ff-4ad9-ab40-fe89f81808b6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_9b7bf532-cf04-4187-9d23-1b527cd5c166" xlink:href="sgmo-20220930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_9b7bf532-cf04-4187-9d23-1b527cd5c166" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_74859d78-5576-4357-8c9c-4a2fe8358a02" xlink:href="sgmo-20220930.xsd#sgmo_BiogenMAIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:to="loc_sgmo_BiogenMAIncMember_74859d78-5576-4357-8c9c-4a2fe8358a02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_74767b4b-26b1-4f74-babe-ce1f10fa3aae" xlink:href="sgmo-20220930.xsd#sgmo_KitePharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:to="loc_sgmo_KitePharmaIncMember_74767b4b-26b1-4f74-babe-ce1f10fa3aae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SanofiMember_bf5a5ec6-722f-497e-8fba-5c56c97e4504" xlink:href="sgmo-20220930.xsd#sgmo_SanofiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:to="loc_sgmo_SanofiMember_bf5a5ec6-722f-497e-8fba-5c56c97e4504" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b119a6ab-1246-4ab1-b4a8-34a7e4214dbb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8f4a02b2-b1d5-4e66-bb33-2c0e6bb48bd0" xlink:to="loc_srt_ProductOrServiceAxis_b119a6ab-1246-4ab1-b4a8-34a7e4214dbb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b119a6ab-1246-4ab1-b4a8-34a7e4214dbb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b119a6ab-1246-4ab1-b4a8-34a7e4214dbb" xlink:to="loc_srt_ProductsAndServicesDomain_b119a6ab-1246-4ab1-b4a8-34a7e4214dbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_31ca373a-32f8-414f-9e1c-8c55562e6e5a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b119a6ab-1246-4ab1-b4a8-34a7e4214dbb" xlink:to="loc_srt_ProductsAndServicesDomain_31ca373a-32f8-414f-9e1c-8c55562e6e5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_1b7e63c1-8c34-4974-962f-6f70e7ef0bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_31ca373a-32f8-414f-9e1c-8c55562e6e5a" xlink:to="loc_us-gaap_LicenseAndServiceMember_1b7e63c1-8c34-4974-962f-6f70e7ef0bdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchServicesMember_7a5dfb19-6f09-4866-8caf-f5dcfafae2af" xlink:href="sgmo-20220930.xsd#sgmo_ResearchServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_31ca373a-32f8-414f-9e1c-8c55562e6e5a" xlink:to="loc_sgmo_ResearchServicesMember_7a5dfb19-6f09-4866-8caf-f5dcfafae2af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneAchievementMember_1dbaea9c-cdea-4289-b6e4-df86743539ec" xlink:href="sgmo-20220930.xsd#sgmo_MilestoneAchievementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_31ca373a-32f8-414f-9e1c-8c55562e6e5a" xlink:to="loc_sgmo_MilestoneAchievementMember_1dbaea9c-cdea-4289-b6e4-df86743539ec" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail" xlink:type="extended" id="i6cfefd2512ad4c44b29ad7a6a14b88cf_MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_079c5a6a-a7c9-4e60-b649-29b5fe80ff68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_079c5a6a-a7c9-4e60-b649-29b5fe80ff68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_a5ecb94f-4837-4e9c-af35-49caacd67485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_a5ecb94f-4837-4e9c-af35-49caacd67485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_961f5be7-b732-43bf-a307-6aa753a2a951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_961f5be7-b732-43bf-a307-6aa753a2a951" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_b31720d2-4f13-47a1-b5ce-078dbe934101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_ProceedsFromCollaborators_b31720d2-4f13-47a1-b5ce-078dbe934101" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable_4a81c131-a41e-4327-b636-7811d2258ad2" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable_4a81c131-a41e-4327-b636-7811d2258ad2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_2ea32efa-1d8e-43ff-9902-5fc2d327f0d0" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAgreementNumberOfAdditionalProductTargets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_2ea32efa-1d8e-43ff-9902-5fc2d327f0d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementRemainingPeriod_5917813b-4d71-4d93-8e16-b7c1e7444ea3" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAgreementRemainingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborationAgreementRemainingPeriod_5917813b-4d71-4d93-8e16-b7c1e7444ea3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected_6fa2802b-a85a-46cf-8b07-6b5f57a82fe4" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementNumberOfProductTargetsSelected"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected_6fa2802b-a85a-46cf-8b07-6b5f57a82fe4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationArrangementResearchPeriod_f2d4002d-8b8f-4f1a-8ce8-0c4e724dafa3" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationArrangementResearchPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborationArrangementResearchPeriod_f2d4002d-8b8f-4f1a-8ce8-0c4e724dafa3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace_41a8c4bf-b5e8-4cfd-8945-d966b13284f0" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace_41a8c4bf-b5e8-4cfd-8945-d966b13284f0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementStandstillRestrictionPeriod_c7e26434-43b5-4698-83d9-d2bab523534c" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementStandstillRestrictionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementStandstillRestrictionPeriod_c7e26434-43b5-4698-83d9-d2bab523534c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage_3014d5e2-6e5a-4a11-9ee2-afba65220f9e" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage_3014d5e2-6e5a-4a11-9ee2-afba65220f9e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_be33c3f6-213d-4357-90ba-f3c4296a1827" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_be33c3f6-213d-4357-90ba-f3c4296a1827" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_e710551e-2c4e-4154-a83a-ca90bdbf6947" xlink:href="sgmo-20220930.xsd#sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_e710551e-2c4e-4154-a83a-ca90bdbf6947" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementEquityIssued_f86ced7b-801a-4b6a-a14b-a9ac482f64e3" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAgreementEquityIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborationAgreementEquityIssued_f86ced7b-801a-4b6a-a14b-a9ac482f64e3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3a47c7b6-21c5-4823-9ad0-b0c454b6d655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3a47c7b6-21c5-4823-9ad0-b0c454b6d655" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_952ab2d8-c508-43b0-b532-f2de18919800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_ContractWithCustomerLiability_952ab2d8-c508-43b0-b532-f2de18919800" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_4dbe10eb-dab4-4931-befe-3ef2f20ea49c" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_4dbe10eb-dab4-4931-befe-3ef2f20ea49c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_80e8bbd4-5a5e-46a5-a2f5-6c4665ebaca1" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementPercentOfInitialRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_80e8bbd4-5a5e-46a5-a2f5-6c4665ebaca1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_4ff1fc6d-f3d1-4c68-9c0f-517b3a5a14c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_4ff1fc6d-f3d1-4c68-9c0f-517b3a5a14c7" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_c2f829f1-53b7-496c-9814-ebc5346c52e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_c2f829f1-53b7-496c-9814-ebc5346c52e1" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_ad0a378e-cb39-4104-a4d7-4c8749826f74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_ad0a378e-cb39-4104-a4d7-4c8749826f74" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_e115b23b-fa7d-4114-91e9-8099b1f6a516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_e115b23b-fa7d-4114-91e9-8099b1f6a516" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_433f02d7-3160-42c2-ba62-166cf78df33e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_e115b23b-fa7d-4114-91e9-8099b1f6a516" xlink:to="loc_srt_CounterpartyNameAxis_433f02d7-3160-42c2-ba62-166cf78df33e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_433f02d7-3160-42c2-ba62-166cf78df33e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_433f02d7-3160-42c2-ba62-166cf78df33e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_433f02d7-3160-42c2-ba62-166cf78df33e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bce98b18-b463-4e54-9a4e-c8a1b9212113" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_433f02d7-3160-42c2-ba62-166cf78df33e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bce98b18-b463-4e54-9a4e-c8a1b9212113" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_e70306dc-4091-45af-a8b3-74eaf2a8ee94" xlink:href="sgmo-20220930.xsd#sgmo_BiogenMAIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bce98b18-b463-4e54-9a4e-c8a1b9212113" xlink:to="loc_sgmo_BiogenMAIncMember_e70306dc-4091-45af-a8b3-74eaf2a8ee94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f6c78805-a6c0-478b-a0d4-1cd7040c5e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_e115b23b-fa7d-4114-91e9-8099b1f6a516" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f6c78805-a6c0-478b-a0d4-1cd7040c5e6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f6c78805-a6c0-478b-a0d4-1cd7040c5e6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f6c78805-a6c0-478b-a0d4-1cd7040c5e6b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f6c78805-a6c0-478b-a0d4-1cd7040c5e6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ca75b5e7-858c-4a7b-882c-15bea991d2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f6c78805-a6c0-478b-a0d4-1cd7040c5e6b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ca75b5e7-858c-4a7b-882c-15bea991d2e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockPurchaseAgreementMember_ea9a6a50-0856-4c6d-8734-c8be1d6029e5" xlink:href="sgmo-20220930.xsd#sgmo_StockPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ca75b5e7-858c-4a7b-882c-15bea991d2e9" xlink:to="loc_sgmo_StockPurchaseAgreementMember_ea9a6a50-0856-4c6d-8734-c8be1d6029e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_dad90101-8885-4513-a5a8-b18f6d81d43b" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ca75b5e7-858c-4a7b-882c-15bea991d2e9" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_dad90101-8885-4513-a5a8-b18f6d81d43b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneAxis_90a09493-c95d-4f7b-8599-eb5dfc3115ea" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_e115b23b-fa7d-4114-91e9-8099b1f6a516" xlink:to="loc_sgmo_CollaborativeAgreementMilestoneAxis_90a09493-c95d-4f7b-8599-eb5dfc3115ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneDomain_90a09493-c95d-4f7b-8599-eb5dfc3115ea_default" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneAxis_90a09493-c95d-4f7b-8599-eb5dfc3115ea" xlink:to="loc_sgmo_CollaborativeAgreementMilestoneDomain_90a09493-c95d-4f7b-8599-eb5dfc3115ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneDomain_b1f4f9be-a286-4434-b83f-0738beba2af3" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneAxis_90a09493-c95d-4f7b-8599-eb5dfc3115ea" xlink:to="loc_sgmo_CollaborativeAgreementMilestoneDomain_b1f4f9be-a286-4434-b83f-0738beba2af3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PreApprovalMilestoneMember_0ffe576a-9104-411c-8268-acb904081152" xlink:href="sgmo-20220930.xsd#sgmo_PreApprovalMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneDomain_b1f4f9be-a286-4434-b83f-0738beba2af3" xlink:to="loc_sgmo_PreApprovalMilestoneMember_0ffe576a-9104-411c-8268-acb904081152" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SalesBasedMilestoneMember_52d871ba-0893-46ed-9351-5635d18a136f" xlink:href="sgmo-20220930.xsd#sgmo_SalesBasedMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneDomain_b1f4f9be-a286-4434-b83f-0738beba2af3" xlink:to="loc_sgmo_SalesBasedMilestoneMember_52d871ba-0893-46ed-9351-5635d18a136f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail" xlink:type="extended" id="iaf1470a560004cdf8e8919a4c41eef77_MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestonePaymentsReceived_d4e47d9d-d847-4677-9654-1b36de4ef342" xlink:href="sgmo-20220930.xsd#sgmo_MilestonePaymentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_MilestonePaymentsReceived_d4e47d9d-d847-4677-9654-1b36de4ef342" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_0241263d-0d77-48fa-97bc-0592bb796e30" xlink:href="sgmo-20220930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_0241263d-0d77-48fa-97bc-0592bb796e30" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_2becf266-2d28-4269-b81a-46125fc080d1" xlink:href="sgmo-20220930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_2becf266-2d28-4269-b81a-46125fc080d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment_b424e176-2485-4f00-938d-7130475fb223" xlink:href="sgmo-20220930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment_b424e176-2485-4f00-938d-7130475fb223" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_InitialResearchTermOfAgreement_138343f7-234c-40d6-994f-83db2f01326d" xlink:href="sgmo-20220930.xsd#sgmo_InitialResearchTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_InitialResearchTermOfAgreement_138343f7-234c-40d6-994f-83db2f01326d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm_7476fa4d-f745-4871-9cdf-99b7aa1c2b9a" xlink:href="sgmo-20220930.xsd#sgmo_NumberOfOptionsToExtendInitialResearchTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm_7476fa4d-f745-4871-9cdf-99b7aa1c2b9a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExtendedResearchTermOfAgreement_b55e3c71-baf3-4b26-8f0c-a455bfed09b4" xlink:href="sgmo-20220930.xsd#sgmo_ExtendedResearchTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_ExtendedResearchTermOfAgreement_b55e3c71-baf3-4b26-8f0c-a455bfed09b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SeparateUpfrontFee_9a87ea71-9181-4559-8786-f018616aabff" xlink:href="sgmo-20220930.xsd#sgmo_SeparateUpfrontFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_SeparateUpfrontFee_9a87ea71-9181-4559-8786-f018616aabff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan_88d1d385-3079-4bee-acb3-a66ec9b7a6fc" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan_88d1d385-3079-4bee-acb3-a66ec9b7a6fc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_63dd8b48-50af-40bb-8bd6-f5c1f7e18ed7" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_63dd8b48-50af-40bb-8bd6-f5c1f7e18ed7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_63948fe4-3cd6-4d79-9d25-0d4cb5869fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_63948fe4-3cd6-4d79-9d25-0d4cb5869fd6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_b6947874-1ee9-4524-8b4f-2c9729f9613b" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_b6947874-1ee9-4524-8b4f-2c9729f9613b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_82a25fd0-d3cd-46d3-a50e-10b4964ad913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_82a25fd0-d3cd-46d3-a50e-10b4964ad913" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_62cf4acc-3177-4a6c-b77a-7dd480f74911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_us-gaap_ContractWithCustomerLiability_62cf4acc-3177-4a6c-b77a-7dd480f74911" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_968a847a-2adb-45c9-8970-3284accd85f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_968a847a-2adb-45c9-8970-3284accd85f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e2664143-af43-4910-ab09-84ac262ce0b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_968a847a-2adb-45c9-8970-3284accd85f8" xlink:to="loc_srt_CounterpartyNameAxis_e2664143-af43-4910-ab09-84ac262ce0b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e2664143-af43-4910-ab09-84ac262ce0b0_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e2664143-af43-4910-ab09-84ac262ce0b0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e2664143-af43-4910-ab09-84ac262ce0b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f94fa7bc-57db-447c-82ca-47f08f94d024" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e2664143-af43-4910-ab09-84ac262ce0b0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f94fa7bc-57db-447c-82ca-47f08f94d024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_b526f9f4-63f5-48bc-b14f-8e6bb529231e" xlink:href="sgmo-20220930.xsd#sgmo_KitePharmaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f94fa7bc-57db-447c-82ca-47f08f94d024" xlink:to="loc_sgmo_KitePharmaIncMember_b526f9f4-63f5-48bc-b14f-8e6bb529231e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_09c5f437-4066-4114-97c7-9b2c95a7e378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_968a847a-2adb-45c9-8970-3284accd85f8" xlink:to="loc_us-gaap_TypeOfArrangementAxis_09c5f437-4066-4114-97c7-9b2c95a7e378" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09c5f437-4066-4114-97c7-9b2c95a7e378_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_09c5f437-4066-4114-97c7-9b2c95a7e378" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09c5f437-4066-4114-97c7-9b2c95a7e378_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a3939d9f-942f-4cdd-9849-027f517ab448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_09c5f437-4066-4114-97c7-9b2c95a7e378" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a3939d9f-942f-4cdd-9849-027f517ab448" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_df460ccf-0b60-4002-a4c4-d584c3bec03a" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a3939d9f-942f-4cdd-9849-027f517ab448" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_df460ccf-0b60-4002-a4c4-d584c3bec03a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_56cffe0d-984b-4eae-9895-823c129d2c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_968a847a-2adb-45c9-8970-3284accd85f8" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_56cffe0d-984b-4eae-9895-823c129d2c54" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_56cffe0d-984b-4eae-9895-823c129d2c54_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_56cffe0d-984b-4eae-9895-823c129d2c54" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_56cffe0d-984b-4eae-9895-823c129d2c54_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_faa60219-accc-4f3a-8b67-f2c8aa164005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_56cffe0d-984b-4eae-9895-823c129d2c54" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_faa60219-accc-4f3a-8b67-f2c8aa164005" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_c64c62b1-053d-4133-b826-2d2f4719a59e" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_faa60219-accc-4f3a-8b67-f2c8aa164005" xlink:to="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_c64c62b1-053d-4133-b826-2d2f4719a59e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_603507aa-c5c5-49b3-9865-fac0ab3a207b" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_faa60219-accc-4f3a-8b67-f2c8aa164005" xlink:to="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_603507aa-c5c5-49b3-9865-fac0ab3a207b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail" xlink:type="extended" id="i3cd12debed9b4d88859d77f5af31b9e7_MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfResearchProgram_cc43df58-5892-4ac0-9bbc-dccda2607bec" xlink:href="sgmo-20220930.xsd#sgmo_NumberOfResearchProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_NumberOfResearchProgram_cc43df58-5892-4ac0-9bbc-dccda2607bec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_89add2ba-df4b-44e7-939e-23bcbdaaeefe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_89add2ba-df4b-44e7-939e-23bcbdaaeefe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0b8f92d-d42c-4c92-8740-6d407cba7e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0b8f92d-d42c-4c92-8740-6d407cba7e76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_ce365aa2-730b-4f53-9830-20a3efd7b25d" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_ce365aa2-730b-4f53-9830-20a3efd7b25d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_8b5a57d0-5d43-4a5e-907d-3949a70ecdbf" xlink:href="sgmo-20220930.xsd#sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_8b5a57d0-5d43-4a5e-907d-3949a70ecdbf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod_b34a2fa4-8b8d-44cb-a8f0-d91e8ea73aaf" xlink:href="sgmo-20220930.xsd#sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod_b34a2fa4-8b8d-44cb-a8f0-d91e8ea73aaf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate_52b9f744-a67a-4db5-97c2-a07469a16739" xlink:href="sgmo-20220930.xsd#sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate_52b9f744-a67a-4db5-97c2-a07469a16739" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate_593da2d3-c456-416a-8ff2-1b5174456d4c" xlink:href="sgmo-20220930.xsd#sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate_593da2d3-c456-416a-8ff2-1b5174456d4c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_858fe7b8-2546-4870-a2d4-62e849cc6a93" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_858fe7b8-2546-4870-a2d4-62e849cc6a93" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneRevenueReceivable_f76688d0-2d90-4621-9ecd-323682ca1f56" xlink:href="sgmo-20220930.xsd#sgmo_MilestoneRevenueReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_MilestoneRevenueReceivable_f76688d0-2d90-4621-9ecd-323682ca1f56" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_0b094707-555c-4a8d-bf1b-b813337786da" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_0b094707-555c-4a8d-bf1b-b813337786da" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_c06c801b-bd47-4ce6-9f04-5afa039d9ee6" xlink:href="sgmo-20220930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_c06c801b-bd47-4ce6-9f04-5afa039d9ee6" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a016e2fd-39f4-493f-bd73-6ab6a4e2879f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a016e2fd-39f4-493f-bd73-6ab6a4e2879f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_4062d3ad-14da-4c75-883d-4412a0d9dd26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_ContractWithCustomerLiability_4062d3ad-14da-4c75-883d-4412a0d9dd26" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense_6f65b6b6-16b4-4539-8296-c9a5f6812f5f" xlink:href="sgmo-20220930.xsd#sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense_6f65b6b6-16b4-4539-8296-c9a5f6812f5f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8a0c0c28-1a72-49ac-984d-5e7123c4969d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_ProfitLoss_8a0c0c28-1a72-49ac-984d-5e7123c4969d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_75d1c421-8b36-448e-98a1-1d51fdcfb80c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_EarningsPerShareDiluted_75d1c421-8b36-448e-98a1-1d51fdcfb80c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_bad0fdce-3443-4e3e-ba18-6e5c84ccecb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_EarningsPerShareBasic_bad0fdce-3443-4e3e-ba18-6e5c84ccecb6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f4a60952-64e9-40ee-8453-7142d74249f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:to="loc_srt_CounterpartyNameAxis_f4a60952-64e9-40ee-8453-7142d74249f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f4a60952-64e9-40ee-8453-7142d74249f1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_f4a60952-64e9-40ee-8453-7142d74249f1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f4a60952-64e9-40ee-8453-7142d74249f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0789e15b-ba3f-443a-8cec-1207f38113f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_f4a60952-64e9-40ee-8453-7142d74249f1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0789e15b-ba3f-443a-8cec-1207f38113f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SanofiMember_c47c9b1e-1844-448d-bf39-40c46da3c34a" xlink:href="sgmo-20220930.xsd#sgmo_SanofiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0789e15b-ba3f-443a-8cec-1207f38113f3" xlink:to="loc_sgmo_SanofiMember_c47c9b1e-1844-448d-bf39-40c46da3c34a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_c974b8a6-f294-4ffb-ab25-cd85f329a618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:to="loc_us-gaap_TypeOfArrangementAxis_c974b8a6-f294-4ffb-ab25-cd85f329a618" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c974b8a6-f294-4ffb-ab25-cd85f329a618_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_c974b8a6-f294-4ffb-ab25-cd85f329a618" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c974b8a6-f294-4ffb-ab25-cd85f329a618_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8e6ea53e-a20d-4aa8-bbe2-4284f2f2b768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_c974b8a6-f294-4ffb-ab25-cd85f329a618" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8e6ea53e-a20d-4aa8-bbe2-4284f2f2b768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_d2415f6a-cfc6-48a9-97ee-30e5e4ab066e" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8e6ea53e-a20d-4aa8-bbe2-4284f2f2b768" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_d2415f6a-cfc6-48a9-97ee-30e5e4ab066e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_0e0801a3-d753-4d1d-803e-c99486e7dff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8e6ea53e-a20d-4aa8-bbe2-4284f2f2b768" xlink:to="loc_us-gaap_CollaborativeArrangementMember_0e0801a3-d753-4d1d-803e-c99486e7dff2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneAxis_5fdb2db3-5da0-4283-9bd9-5ae299a25dcb" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:to="loc_sgmo_CollaborativeAgreementMilestoneAxis_5fdb2db3-5da0-4283-9bd9-5ae299a25dcb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneDomain_5fdb2db3-5da0-4283-9bd9-5ae299a25dcb_default" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneAxis_5fdb2db3-5da0-4283-9bd9-5ae299a25dcb" xlink:to="loc_sgmo_CollaborativeAgreementMilestoneDomain_5fdb2db3-5da0-4283-9bd9-5ae299a25dcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneDomain_e89d983f-5ec0-4264-afbc-a20d99f4f6b5" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneAxis_5fdb2db3-5da0-4283-9bd9-5ae299a25dcb" xlink:to="loc_sgmo_CollaborativeAgreementMilestoneDomain_e89d983f-5ec0-4264-afbc-a20d99f4f6b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneThreeMember_6f104e8c-b4cf-4f6a-bee5-8d5f60fcdd00" xlink:href="sgmo-20220930.xsd#sgmo_MilestoneThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneDomain_e89d983f-5ec0-4264-afbc-a20d99f4f6b5" xlink:to="loc_sgmo_MilestoneThreeMember_6f104e8c-b4cf-4f6a-bee5-8d5f60fcdd00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_d5d1d1d4-1149-4bff-91fa-d8dc2ae9fda2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_d5d1d1d4-1149-4bff-91fa-d8dc2ae9fda2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_d5d1d1d4-1149-4bff-91fa-d8dc2ae9fda2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_d5d1d1d4-1149-4bff-91fa-d8dc2ae9fda2" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_d5d1d1d4-1149-4bff-91fa-d8dc2ae9fda2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_c4aa45b6-cf78-42f8-ba6d-80096736019f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_d5d1d1d4-1149-4bff-91fa-d8dc2ae9fda2" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_c4aa45b6-cf78-42f8-ba6d-80096736019f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInCollaborationAgreementScopeMember_41eda22b-ce13-469c-a274-4c4a757d3213" xlink:href="sgmo-20220930.xsd#sgmo_ChangeInCollaborationAgreementScopeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_c4aa45b6-cf78-42f8-ba6d-80096736019f" xlink:to="loc_sgmo_ChangeInCollaborationAgreementScopeMember_41eda22b-ce13-469c-a274-4c4a757d3213" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail" xlink:type="extended" id="ia4afd3a2b41c4e33955d3f091a384bed_MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AgreementTerminationTerm_4ce36bf4-fd5a-45b5-8ac2-75d162ac48f7" xlink:href="sgmo-20220930.xsd#sgmo_AgreementTerminationTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_AgreementTerminationTerm_4ce36bf4-fd5a-45b5-8ac2-75d162ac48f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_870a8351-3f45-4abc-ae0d-87737445acf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_870a8351-3f45-4abc-ae0d-87737445acf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_0a50c687-c421-4d44-89ff-1e3e8ee52989" xlink:href="sgmo-20220930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_0a50c687-c421-4d44-89ff-1e3e8ee52989" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_b096a0ad-ffc1-4f49-98e1-641d0b04acba" xlink:href="sgmo-20220930.xsd#sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_b096a0ad-ffc1-4f49-98e1-641d0b04acba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneRevenueReceivable_ac42b84a-8d4f-4e9c-b5c4-9c2d7ccc62a9" xlink:href="sgmo-20220930.xsd#sgmo_MilestoneRevenueReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_MilestoneRevenueReceivable_ac42b84a-8d4f-4e9c-b5c4-9c2d7ccc62a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_dc24a744-9462-4885-a259-3bbb3ecbc8e0" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementNumberOfMilestonesAchieved"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_dc24a744-9462-4885-a259-3bbb3ecbc8e0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestonePaymentsReceived_4459eea5-83c8-46a6-a7c1-46dbf02b938e" xlink:href="sgmo-20220930.xsd#sgmo_MilestonePaymentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_MilestonePaymentsReceived_4459eea5-83c8-46a6-a7c1-46dbf02b938e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_76d45bc6-91a8-47cc-b072-9b60eb99896e" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_76d45bc6-91a8-47cc-b072-9b60eb99896e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_b70640c0-7511-4536-bf3c-8cbda95cc79e" xlink:href="sgmo-20220930.xsd#sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_b70640c0-7511-4536-bf3c-8cbda95cc79e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_fa0ba655-b35c-4fdb-a40c-ac0acc1ab1fb" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_fa0ba655-b35c-4fdb-a40c-ac0acc1ab1fb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementResearchServiceFees_316e0271-94ff-4d1a-a9a1-14ee789cb733" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementResearchServiceFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_CollaborativeArrangementResearchServiceFees_316e0271-94ff-4d1a-a9a1-14ee789cb733" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c003a89c-240c-493c-8677-7a5e102a5323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c003a89c-240c-493c-8677-7a5e102a5323" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ca368e47-36dc-497f-b713-81b2fd0a6a5e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:to="loc_srt_CounterpartyNameAxis_ca368e47-36dc-497f-b713-81b2fd0a6a5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ca368e47-36dc-497f-b713-81b2fd0a6a5e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_ca368e47-36dc-497f-b713-81b2fd0a6a5e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ca368e47-36dc-497f-b713-81b2fd0a6a5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ac047ef6-6ab2-4e8e-a9e4-00868b2690c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_ca368e47-36dc-497f-b713-81b2fd0a6a5e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ac047ef6-6ab2-4e8e-a9e4-00868b2690c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerMember_b8314efd-d13f-4fbd-812c-d9f5052cfa96" xlink:href="sgmo-20220930.xsd#sgmo_PfizerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ac047ef6-6ab2-4e8e-a9e4-00868b2690c3" xlink:to="loc_sgmo_PfizerMember_b8314efd-d13f-4fbd-812c-d9f5052cfa96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerSB525Member_4e883d66-c12b-483d-8d05-f591d77c3b8c" xlink:href="sgmo-20220930.xsd#sgmo_PfizerSB525Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ac047ef6-6ab2-4e8e-a9e4-00868b2690c3" xlink:to="loc_sgmo_PfizerSB525Member_4e883d66-c12b-483d-8d05-f591d77c3b8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerC9ORF72Member_b0974214-a790-4afd-b757-5863d9f590ca" xlink:href="sgmo-20220930.xsd#sgmo_PfizerC9ORF72Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ac047ef6-6ab2-4e8e-a9e4-00868b2690c3" xlink:to="loc_sgmo_PfizerC9ORF72Member_b0974214-a790-4afd-b757-5863d9f590ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_84d9a758-e09b-4ead-86eb-8f3144e6acd2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:to="loc_srt_ProductOrServiceAxis_84d9a758-e09b-4ead-86eb-8f3144e6acd2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_84d9a758-e09b-4ead-86eb-8f3144e6acd2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_84d9a758-e09b-4ead-86eb-8f3144e6acd2" xlink:to="loc_srt_ProductsAndServicesDomain_84d9a758-e09b-4ead-86eb-8f3144e6acd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0b03b967-d367-40ec-a65d-6bad59af7c02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_84d9a758-e09b-4ead-86eb-8f3144e6acd2" xlink:to="loc_srt_ProductsAndServicesDomain_0b03b967-d367-40ec-a65d-6bad59af7c02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_8a5a86c1-885d-4dd5-be63-56a0a1328058" xlink:href="sgmo-20220930.xsd#sgmo_SBFiveTwoFiveAndOtherProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0b03b967-d367-40ec-a65d-6bad59af7c02" xlink:to="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_8a5a86c1-885d-4dd5-be63-56a0a1328058" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_OtherProductsMember_935893b9-8784-454d-a5fc-0e73a34b5e6a" xlink:href="sgmo-20220930.xsd#sgmo_OtherProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0b03b967-d367-40ec-a65d-6bad59af7c02" xlink:to="loc_sgmo_OtherProductsMember_935893b9-8784-454d-a5fc-0e73a34b5e6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CNineORFSevenTwoMember_16a40d04-fd36-4bee-88c1-62ea5af12b75" xlink:href="sgmo-20220930.xsd#sgmo_CNineORFSevenTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0b03b967-d367-40ec-a65d-6bad59af7c02" xlink:to="loc_sgmo_CNineORFSevenTwoMember_16a40d04-fd36-4bee-88c1-62ea5af12b75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e8d97bd9-63cb-4704-b2d3-9ab4598df2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e8d97bd9-63cb-4704-b2d3-9ab4598df2fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e8d97bd9-63cb-4704-b2d3-9ab4598df2fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e8d97bd9-63cb-4704-b2d3-9ab4598df2fa" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e8d97bd9-63cb-4704-b2d3-9ab4598df2fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e8d97bd9-63cb-4704-b2d3-9ab4598df2fa" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_620cfd12-5879-479f-9444-d2007d0dc2be" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:to="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_620cfd12-5879-479f-9444-d2007d0dc2be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_8daed006-73c6-4dd0-8ec3-9fc2b8b7afe0" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:to="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_8daed006-73c6-4dd0-8ec3-9fc2b8b7afe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfCommercialMilestonesMember_2254db73-b5a3-4ccb-bbf2-2ddafdcfc41e" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfCommercialMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:to="loc_sgmo_AchievementOfCommercialMilestonesMember_2254db73-b5a3-4ccb-bbf2-2ddafdcfc41e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfFirstCommercialSaleMilestonesMember_d49891f8-3f5c-4841-a4d2-1e0cd4da5166" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfFirstCommercialSaleMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:to="loc_sgmo_AchievementOfFirstCommercialSaleMilestonesMember_d49891f8-3f5c-4841-a4d2-1e0cd4da5166" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_709a2830-2400-45e5-b933-ccd0fac9f74a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:to="loc_srt_RangeAxis_709a2830-2400-45e5-b933-ccd0fac9f74a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_709a2830-2400-45e5-b933-ccd0fac9f74a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_709a2830-2400-45e5-b933-ccd0fac9f74a" xlink:to="loc_srt_RangeMember_709a2830-2400-45e5-b933-ccd0fac9f74a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f88be492-8599-4dee-a352-fc95bb9c0967" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_709a2830-2400-45e5-b933-ccd0fac9f74a" xlink:to="loc_srt_RangeMember_f88be492-8599-4dee-a352-fc95bb9c0967" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_89e51c6e-8153-489e-b4cd-f7109cf5610c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f88be492-8599-4dee-a352-fc95bb9c0967" xlink:to="loc_srt_MaximumMember_89e51c6e-8153-489e-b4cd-f7109cf5610c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail" xlink:type="extended" id="i7e7db04484c74ae5980564d967add0b4_STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_905b781e-3e0f-414f-9904-7041b5e69e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0d0929c1-6c7c-4f07-9ee0-9f92f8c2ec12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_905b781e-3e0f-414f-9904-7041b5e69e84" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0d0929c1-6c7c-4f07-9ee0-9f92f8c2ec12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8d6f3bed-01b1-4587-8a29-c01addbefacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_905b781e-3e0f-414f-9904-7041b5e69e84" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8d6f3bed-01b1-4587-8a29-c01addbefacc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_598cfd72-e16b-477b-a5e0-5c3213224b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8d6f3bed-01b1-4587-8a29-c01addbefacc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_598cfd72-e16b-477b-a5e0-5c3213224b1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_598cfd72-e16b-477b-a5e0-5c3213224b1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_598cfd72-e16b-477b-a5e0-5c3213224b1e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_598cfd72-e16b-477b-a5e0-5c3213224b1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d6d87714-ed6d-43f8-b986-c35ea50b9631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_598cfd72-e16b-477b-a5e0-5c3213224b1e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d6d87714-ed6d-43f8-b986-c35ea50b9631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5626ad8c-4990-4ec3-9a2e-9fafecc9d462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d6d87714-ed6d-43f8-b986-c35ea50b9631" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5626ad8c-4990-4ec3-9a2e-9fafecc9d462" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2dee04af-0fa3-4a94-bd5e-570a72a2a31a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d6d87714-ed6d-43f8-b986-c35ea50b9631" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2dee04af-0fa3-4a94-bd5e-570a72a2a31a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#STOCKHOLDERSEQUITYDetail"/>
  <link:definitionLink xlink:role="http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail" xlink:type="extended" id="i474f24fce66d44ffaf4dc32d1529423f_STOCKHOLDERSEQUITYDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997282bc-5f07-4850-bf51-631464997a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockOfferingProgramMaximumValue_4a226488-a60b-475b-a060-8c274665d89b" xlink:href="sgmo-20220930.xsd#sgmo_StockOfferingProgramMaximumValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997282bc-5f07-4850-bf51-631464997a56" xlink:to="loc_sgmo_StockOfferingProgramMaximumValue_4a226488-a60b-475b-a060-8c274665d89b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7ed5eeef-d47c-4eef-a9a2-f5108c407dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997282bc-5f07-4850-bf51-631464997a56" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7ed5eeef-d47c-4eef-a9a2-f5108c407dff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_298cf26b-b6e2-433d-9b8f-c57aeda2e011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997282bc-5f07-4850-bf51-631464997a56" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_298cf26b-b6e2-433d-9b8f-c57aeda2e011" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_78318bcb-8ab1-4f1b-a949-7a3adeb6c592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997282bc-5f07-4850-bf51-631464997a56" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_78318bcb-8ab1-4f1b-a949-7a3adeb6c592" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_2359450c-8863-4b12-9a96-8d28fb4b714c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_78318bcb-8ab1-4f1b-a949-7a3adeb6c592" xlink:to="loc_srt_CounterpartyNameAxis_2359450c-8863-4b12-9a96-8d28fb4b714c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2359450c-8863-4b12-9a96-8d28fb4b714c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_2359450c-8863-4b12-9a96-8d28fb4b714c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2359450c-8863-4b12-9a96-8d28fb4b714c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f4d3ddd7-7cd9-40a2-bbe7-87f15b4b0f7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_2359450c-8863-4b12-9a96-8d28fb4b714c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f4d3ddd7-7cd9-40a2-bbe7-87f15b4b0f7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_JefferiesLLCMember_5411a38e-8cef-4102-b151-95aa74a0dcd0" xlink:href="sgmo-20220930.xsd#sgmo_JefferiesLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f4d3ddd7-7cd9-40a2-bbe7-87f15b4b0f7e" xlink:to="loc_sgmo_JefferiesLLCMember_5411a38e-8cef-4102-b151-95aa74a0dcd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_3e5688fa-bc4c-41f9-bb9f-81030618c2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_78318bcb-8ab1-4f1b-a949-7a3adeb6c592" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_3e5688fa-bc4c-41f9-bb9f-81030618c2e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e5688fa-bc4c-41f9-bb9f-81030618c2e5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3e5688fa-bc4c-41f9-bb9f-81030618c2e5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_3e5688fa-bc4c-41f9-bb9f-81030618c2e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243b5dda-9103-4871-9202-9af789fbc00e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3e5688fa-bc4c-41f9-bb9f-81030618c2e5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243b5dda-9103-4871-9202-9af789fbc00e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingAgreementMember_ee44c756-c65b-4049-abcd-b9d04ea26aae" xlink:href="sgmo-20220930.xsd#sgmo_AtTheMarketOfferingAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243b5dda-9103-4871-9202-9af789fbc00e" xlink:to="loc_sgmo_AtTheMarketOfferingAgreementMember_ee44c756-c65b-4049-abcd-b9d04ea26aae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ccb820ef-ea20-4625-916d-c36ee4095a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_78318bcb-8ab1-4f1b-a949-7a3adeb6c592" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ccb820ef-ea20-4625-916d-c36ee4095a74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ccb820ef-ea20-4625-916d-c36ee4095a74_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccb820ef-ea20-4625-916d-c36ee4095a74" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ccb820ef-ea20-4625-916d-c36ee4095a74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8ea41ad5-5227-4c62-8c42-546ef2efc305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccb820ef-ea20-4625-916d-c36ee4095a74" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8ea41ad5-5227-4c62-8c42-546ef2efc305" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1bd17ad0-788b-4356-88c6-94e62bed243c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8ea41ad5-5227-4c62-8c42-546ef2efc305" xlink:to="loc_us-gaap_SubsequentEventMember_1bd17ad0-788b-4356-88c6-94e62bed243c" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>sgmo-20220930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9b84b066-0d3d-4626-933d-a605fa769a06,g:f2240c07-5619-4846-82aa-63792348e10c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_afe512cc-51b0-4572-af87-ae86b471bad0_terseLabel_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach specified levels</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_label_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Specified Sales Based Milestones If Annual Worldwide Net Sales Of Licensed Products Reach Specified Levels [Member]</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_documentation_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified sales based milestones if annual worldwide net sales of licensed products reach specified levels.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:to="lab_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5786bd56-612b-471e-b6a6-f77527f9ee92_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ddfc2a35-3509-40ec-a16b-25adce04dc85_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_806b5376-05ef-4917-99fe-ab81fe705f65_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_b4c2fe8d-cf6e-4113-9131-45ae3fb2ed43_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_97ef252c-31c8-49f2-9104-f5121ba4616b_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_cdd086b0-5d5c-4180-91aa-7462f87afee1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased net loss</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_61a16c23-977d-4682-9ade-1ea6701771d2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1deb56c5-8b64-45cc-b9b4-31dfae3f78a4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_19723c0d-43a7-45c0-9107-b627c4d11fda_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_3c9a3f1f-2c4d-463d-b503-f39a5a2a8ba1_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues under agreement</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Compensation Earned</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_1852749d-d62a-4325-9bec-c2ab8e02ec94_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_c8c57f56-c41c-41c0-bc7c-5e060a61b2bd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_fba188c8-9bc7-4741-b18c-357bd8a352f5_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_241383ba-088d-4744-8395-238c3b99b054_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_f4ba69fb-a325-433d-931b-dd3db6f61b45_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashNoncurrent" xlink:to="lab_us-gaap_RestrictedCashNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4c53193a-4b96-4f52-a5b9-607be6291615_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_StockPurchaseAgreementMember_2a6f1816-1d7f-46dc-9772-2fd28f136953_terseLabel_en-US" xlink:label="lab_sgmo_StockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock purchase agreement</link:label>
    <link:label id="lab_sgmo_StockPurchaseAgreementMember_label_en-US" xlink:label="lab_sgmo_StockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchase Agreement [Member]</link:label>
    <link:label id="lab_sgmo_StockPurchaseAgreementMember_documentation_en-US" xlink:label="lab_sgmo_StockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockPurchaseAgreementMember" xlink:href="sgmo-20220930.xsd#sgmo_StockPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_StockPurchaseAgreementMember" xlink:to="lab_sgmo_StockPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_OtherProductsMember_b9288589-99b2-4034-a8c5-59ef6450f026_terseLabel_en-US" xlink:label="lab_sgmo_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other products</link:label>
    <link:label id="lab_sgmo_OtherProductsMember_label_en-US" xlink:label="lab_sgmo_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products [Member]</link:label>
    <link:label id="lab_sgmo_OtherProductsMember_documentation_en-US" xlink:label="lab_sgmo_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other products.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_OtherProductsMember" xlink:href="sgmo-20220930.xsd#sgmo_OtherProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_OtherProductsMember" xlink:to="lab_sgmo_OtherProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_JefferiesLLCMember_438c924f-67bf-456c-bb55-bd954a704c93_terseLabel_en-US" xlink:label="lab_sgmo_JefferiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jefferies LLC</link:label>
    <link:label id="lab_sgmo_JefferiesLLCMember_label_en-US" xlink:label="lab_sgmo_JefferiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jefferies LLC [Member]</link:label>
    <link:label id="lab_sgmo_JefferiesLLCMember_documentation_en-US" xlink:label="lab_sgmo_JefferiesLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jefferies LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_JefferiesLLCMember" xlink:href="sgmo-20220930.xsd#sgmo_JefferiesLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_JefferiesLLCMember" xlink:to="lab_sgmo_JefferiesLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeAgreementMilestoneDomain_422d0f29-069f-450f-b3fb-f8b3782e19c5_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeAgreementMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement Milestone [Domain]</link:label>
    <link:label id="lab_sgmo_CollaborativeAgreementMilestoneDomain_label_en-US" xlink:label="lab_sgmo_CollaborativeAgreementMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement Milestone [Domain]</link:label>
    <link:label id="lab_sgmo_CollaborativeAgreementMilestoneDomain_documentation_en-US" xlink:label="lab_sgmo_CollaborativeAgreementMilestoneDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneDomain" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneDomain" xlink:to="lab_sgmo_CollaborativeAgreementMilestoneDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_df4427d1-0323-4686-811b-4b2e5b3c0e48_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_07a5b03c-a569-4290-b114-293a263d4b83_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementStandstillRestrictionPeriod_aeaf762c-6258-451d-8c3b-1b973454380e_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementStandstillRestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standstill restriction period</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementStandstillRestrictionPeriod_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementStandstillRestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Standstill Restriction Period</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementStandstillRestrictionPeriod_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementStandstillRestrictionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Standstill Restriction Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementStandstillRestrictionPeriod" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementStandstillRestrictionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementStandstillRestrictionPeriod" xlink:to="lab_sgmo_CollaborativeArrangementStandstillRestrictionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_4c1a47d6-00dc-4608-9464-36a546eeccb3_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_82211a96-d349-4166-b6e8-162d64fcb536_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_520faeb3-6c7d-4f6c-b9c9-8276351c5883_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and employee benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_0a7c9137-81eb-4607-8570-ccc61383be70_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss related to marketable securities, not previously recorded</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss, Not Previously Recorded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_cfaa7158-617e-4575-b726-0df00f1f5841_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_874ebc4a-4abe-4be8-b70c-1c95a60ea6e6_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_SanofiMember_9335332c-f66e-4f66-84dc-c99f0b775874_terseLabel_en-US" xlink:label="lab_sgmo_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi S.A.</link:label>
    <link:label id="lab_sgmo_SanofiMember_37d8c1cc-a2c1-4e14-93f0-e426c5b8ebf5_verboseLabel_en-US" xlink:label="lab_sgmo_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi</link:label>
    <link:label id="lab_sgmo_SanofiMember_label_en-US" xlink:label="lab_sgmo_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi [Member]</link:label>
    <link:label id="lab_sgmo_SanofiMember_documentation_en-US" xlink:label="lab_sgmo_SanofiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sanofi.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SanofiMember" xlink:href="sgmo-20220930.xsd#sgmo_SanofiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_SanofiMember" xlink:to="lab_sgmo_SanofiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_9fc230b0-32cd-4157-8cc1-310da9f10412_terseLabel_en-US" xlink:label="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_label_en-US" xlink:label="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Collaboration Agreements, Grants And Licensing Concentration Risk [Member]</link:label>
    <link:label id="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_documentation_en-US" xlink:label="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Collaboration Agreements, Grants And Licensing Concentration Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:href="sgmo-20220930.xsd#sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:to="lab_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0dd58ce4-9e0e-41a3-aca9-b13063a0f086_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_56f476c1-5578-4f73-9c5f-6ffb85fb36bd_terseLabel_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized investment gains (losses)</link:label>
    <link:label id="lab_us-gaap_RealizedInvestmentGainsLosses_label_en-US" xlink:label="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized Investment Gains (Losses)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealizedInvestmentGainsLosses" xlink:to="lab_us-gaap_RealizedInvestmentGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage_03da50ee-b3ff-44dc-b9da-c49e0dfb3cfc_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standstill restriction, ownership threshold percentage ownership percentage</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Standstill Restriction, Ownership Threshold Percentage Ownership Percentage</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Standstill Restriction, Ownership Threshold Percentage Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage" xlink:to="lab_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_65e5f4c1-922d-4a0f-b8c1-4bf852d56673_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Compensation Related Costs, Share-based Payments [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_80055e05-69c3-4c11-bc8a-a07a0a358e90_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a8583899-1925-4b58-9a3d-55e87f739072_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_367a5670-db00-49bd-a243-8cc5f1dc0fac_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_37cc4d21-8284-4830-88cd-a619710188a7_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1672688b-1f7b-491e-bb22-1d5a411fce5e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9d616f09-a408-4265-9cf1-c859311124ea_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember_de41f612-333b-4518-83c4-88538323ea0c_terseLabel_en-US" xlink:label="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">S B Five Two Five And Other Products</link:label>
    <link:label id="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember_label_en-US" xlink:label="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">S B Five Two Five And Other Products [Member]</link:label>
    <link:label id="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember_documentation_en-US" xlink:label="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">S B Five Two Five And Other Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:href="sgmo-20220930.xsd#sgmo_SBFiveTwoFiveAndOtherProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:to="lab_sgmo_SBFiveTwoFiveAndOtherProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_c85ce534-f993-4c83-91f5-243cc8c3da41_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_cc7c15c7-141d-4c73-a3aa-296b2e1cacee_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Sangamo Therapeutics, Inc. stockholders, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_28ec81b5-5eea-46e7-9767-f0417dc42e87_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_4cff1dce-d27d-4728-b291-0e847580b8bd_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_e6a7b480-99f5-4141-a133-a3f3afac43fa_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_d8d2b5b7-14dd-4a74-9321-37cdaba66092_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenues</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable_62a327d9-4ff5-4baf-a23f-79c7b729ee2f_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum milestone payment receivable</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Maximum Milestone Payment Receivable</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Maximum Milestone Payment Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable" xlink:to="lab_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c7e57e70-3b60-4436-b61b-c559efeb5325_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and RSUs outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsMember_2929968f-4be1-44fe-9c78-7b834f19e4e0_verboseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsMember" xlink:to="lab_us-gaap_CashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_948ab422-9b80-42be-92e1-4b9b3a0653bb_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment included in unpaid liabilities</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_ad16e94f-b158-4089-8cfc-850ee06236dc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_7dca8c19-9cbe-48b0-956f-a6d154152fc6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_1155ac3b-267e-498b-99c6-772f7ad74ced_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementTransactionPrice_c1ff4f2a-c7d7-4f22-9f97-e631de4ad08d_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement transaction price</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementTransactionPrice_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Transaction Price</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementTransactionPrice_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement transaction price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementTransactionPrice" xlink:to="lab_sgmo_CollaborativeArrangementTransactionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_2ba7cc7d-1dd7-41a9-b4ce-471b02e34c1e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ce674276-f42a-468a-9937-bca0717023f1_verboseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_c450dec9-f861-4d80-be21-ac0673e5e37f_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_ae7e56af-8e84-477f-b9b6-e2058b99f645_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_KitePharmaIncMember_972a1993-debe-41f7-b5cb-274994730360_terseLabel_en-US" xlink:label="lab_sgmo_KitePharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kite Pharma, Inc.</link:label>
    <link:label id="lab_sgmo_KitePharmaIncMember_label_en-US" xlink:label="lab_sgmo_KitePharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kite Pharma Inc [Member]</link:label>
    <link:label id="lab_sgmo_KitePharmaIncMember_documentation_en-US" xlink:label="lab_sgmo_KitePharmaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kite Pharma Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember" xlink:href="sgmo-20220930.xsd#sgmo_KitePharmaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_KitePharmaIncMember" xlink:to="lab_sgmo_KitePharmaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_1ca9503e-03a3-48ac-b5d6-ed7f7f4a5288_terseLabel_en-US" xlink:label="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential amount to be funded for achievement of specified commercialized and sales milestones</link:label>
    <link:label id="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_label_en-US" xlink:label="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Additional Revenue Recognition Milestone Method Revenue Eligible To Receive</link:label>
    <link:label id="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_documentation_en-US" xlink:label="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate additional revenue recognition milestone method revenue eligible to receive.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:href="sgmo-20220930.xsd#sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:to="lab_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_4b3f54d5-70be-45bf-917e-88ac4904ddeb_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents and marketable securities and free shares asset</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_57d96a90-e66a-4afb-b054-0ab6b26b6a83_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_5d815728-4753-4720-9f98-7225c5527847_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to Sangamo Therapeutics, Inc.</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest_d00c3617-2e69-47b6-b2ef-3abad7c01ec1_terseLabel_en-US" xlink:label="lab_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of additional shares of Sangamo France</link:label>
    <link:label id="lab_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest_label_en-US" xlink:label="lab_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital Acquisition Of Noncontrolling Interest</link:label>
    <link:label id="lab_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest_documentation_en-US" xlink:label="lab_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital Acquisition Of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest" xlink:href="sgmo-20220930.xsd#sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest" xlink:to="lab_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_b7ebe564-7028-4193-93a4-d8b77e8dc77b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_d9400ead-8a44-4f0d-a530-bd559b39daa5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_99bd35e8-b775-4215-9cec-14a7999d6eb4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_6c3aaba8-8602-4d8f-baf1-3fa57dd59530_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_055cc7d9-c6cc-4069-a2ee-14b05c8b9aa8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of contract asset recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_1e635fec-cb39-418f-85d2-55946495daab_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_c114ec52-b459-45c1-bdb8-4f4b39fd6604_terseLabel_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Specified Preclinical Development Clinical Development And First Commercial Sale Milestones</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_label_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Specified Preclinical Development Clinical Development And First Commercial Sale Milestones [Member]</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_documentation_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified preclinical development clinical development and first commercial sale milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:to="lab_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c9d3861e-f16f-4781-8de2-119201fcbf30_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5839c490-0e75-4aa5-adbd-58f680ca43d9_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_cc889106-42c5-4751-86c4-5d9576475953_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_MilestoneThreeMember_e81e94aa-84f5-4fd4-a9a8-68242cd286df_terseLabel_en-US" xlink:label="lab_sgmo_MilestoneThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone three</link:label>
    <link:label id="lab_sgmo_MilestoneThreeMember_label_en-US" xlink:label="lab_sgmo_MilestoneThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Three [Member]</link:label>
    <link:label id="lab_sgmo_MilestoneThreeMember_documentation_en-US" xlink:label="lab_sgmo_MilestoneThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneThreeMember" xlink:href="sgmo-20220930.xsd#sgmo_MilestoneThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_MilestoneThreeMember" xlink:to="lab_sgmo_MilestoneThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_c4548088-e6ab-4817-81a3-49816c72c2ba_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and employee benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_944b0ee6-b5a1-4287-8d5b-22bfe001b362_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_c65c6fee-b8db-4667-bc9a-b4a239226b10_terseLabel_en-US" xlink:label="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of milestones included in transaction price</link:label>
    <link:label id="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_label_en-US" xlink:label="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Clinical Or Regulatory Milestones Included In Transaction Price</link:label>
    <link:label id="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_documentation_en-US" xlink:label="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of clinical or regulatory milestones included in transaction price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:href="sgmo-20220930.xsd#sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:to="lab_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_19d22b26-862e-4b6a-b6ad-f1dcb4592004_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_5852062f-82f0-4036-ace3-269dd50ebff5_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_3703b9eb-6fa5-4e60-9856-bda65a636f7a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_d39ae2c5-ec3a-46a3-9f7e-68e975e64f3a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6fe4dc43-89b4-4cfe-a014-7a7368759433_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_230ee866-f356-4919-ba67-73fe6d8b6c0d_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_a47f48e0-1de1-4739-9e03-4b415e7280df_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_132cbee7-1eb2-44a6-8e9b-1be648ac002d_negatedTotalLabel_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents and available-for-sale securities, Gross Unrealized (Losses)</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents And Available For Sale Securities Gross Unrealized Loss Before Tax</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents and available for sale securities, gross unrealized loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:to="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_45d585df-f929-48a9-9d31-c7ae19f7d738_totalLabel_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents and available-for-sale securities, Amortized Cost</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_label_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents And Available For Sale Securities Amortized Cost</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_documentation_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents and available for Sale Securities Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:to="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_f4f3abf3-5a6a-426c-b7c4-2121782f39ab_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e130e3a9-4b91-4062-86eb-4a725d7b6b52_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3aa7d0f7-dc8b-4636-a23b-ef432f7c5885_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a48aabab-0907-4624-9e62-84f10561cfeb_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_dcb047e1-d866-4902-98f5-aa85435322fe_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_b437e9a9-3138-4a6e-b979-83f0e43819c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_NumberOfResearchProgram_27b2dc39-2480-45f2-97f0-5de9ac5cd93c_terseLabel_en-US" xlink:label="lab_sgmo_NumberOfResearchProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of research programs</link:label>
    <link:label id="lab_sgmo_NumberOfResearchProgram_label_en-US" xlink:label="lab_sgmo_NumberOfResearchProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Research Program</link:label>
    <link:label id="lab_sgmo_NumberOfResearchProgram_documentation_en-US" xlink:label="lab_sgmo_NumberOfResearchProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of research program.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfResearchProgram" xlink:href="sgmo-20220930.xsd#sgmo_NumberOfResearchProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_NumberOfResearchProgram" xlink:to="lab_sgmo_NumberOfResearchProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_ac74cf1d-dd9d-499f-9331-81b1897d9f56_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net pension gains</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities_79814476-d8bf-4c2c-8230-a2a705963517_totalLabel_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents and available-for-sale securities, Estimated Fair Value</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities_label_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents And Available For Sale Securities</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities_documentation_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents and available for sale securities.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:to="lab_sgmo_CashEquivalentsAndAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_4abcc7ee-d5ba-4dea-b042-4384934f93bc_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:to="lab_us-gaap_ChangeInAccountingEstimateByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_f1940e0a-1199-4a4c-a702-97204c280c4b_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateTypeDomain_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:to="lab_us-gaap_ChangeInAccountingEstimateTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_b2f2ae6d-76cb-4bec-a927-a47f34eb6f84_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_e8bc7956-898b-4ba5-a317-b5d9f2dba34d_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_256eb95e-794a-46f1-9dd6-4dacd94c0fec_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_InitialResearchTermOfAgreement_b7a75b55-2fc0-4f89-bcd7-ebe8b4ffe8ba_terseLabel_en-US" xlink:label="lab_sgmo_InitialResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial research term of agreement</link:label>
    <link:label id="lab_sgmo_InitialResearchTermOfAgreement_label_en-US" xlink:label="lab_sgmo_InitialResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Research Term Of Agreement</link:label>
    <link:label id="lab_sgmo_InitialResearchTermOfAgreement_documentation_en-US" xlink:label="lab_sgmo_InitialResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial research term of agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_InitialResearchTermOfAgreement" xlink:href="sgmo-20220930.xsd#sgmo_InitialResearchTermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_InitialResearchTermOfAgreement" xlink:to="lab_sgmo_InitialResearchTermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_b44a1263-e3f0-40dd-b3d2-fb2c22778b2f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_7d8ad508-845c-4ac9-ad57-c7cc8eddb9dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_c95211d2-ec2a-438f-bb59-53cd1170f989_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_167f39fc-985c-4a15-84b8-22b87c177fc2_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_35210572-96db-44fb-b7a4-734dfbb3a919_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_33c40218-473f-4b9f-88c9-dce61cf5bd5f_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_4514b5df-cc06-4fa2-9134-16b0c27f50da_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with at-the-market offering, net of offering expenses</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_1b3f884b-11cf-4ca1-afd0-1cc9497e77da_verboseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e0c9f9ad-7d6c-4462-8467-60839da23d33_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_f727c0a1-83e1-4a85-adc5-f38897922c1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues Recognized under Agreement</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_ecdb6116-a41f-46f2-ab10-4b6443384c8a_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_d3562da7-f1b9-4432-ad58-7db60727c16e_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_41996f7e-d7d9-49d3-84c4-e267cbaa2bb7_totalLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_c14704f5-2cee-45e2-bd91-e9825c243a88_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenues</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_037b475d-de59-4186-b179-da6a3b2ca445_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_e4668f70-b2c0-4808-a649-a1878a143b25_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_5eb7568a-4e31-406a-b621-fff3a8139c05_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_7a7674ab-4a0e-4799-b1c8-a08b4f92e4ee_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, number of milestones achieved</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Number Of Milestones Achieved</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Number Of Milestones Achieved</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementNumberOfMilestonesAchieved"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:to="lab_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_PfizerSB525Member_cf9e26fa-7c73-4d78-898f-1944bf0160a3_terseLabel_en-US" xlink:label="lab_sgmo_PfizerSB525Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer SB-525</link:label>
    <link:label id="lab_sgmo_PfizerSB525Member_label_en-US" xlink:label="lab_sgmo_PfizerSB525Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer SB-525 [Member]</link:label>
    <link:label id="lab_sgmo_PfizerSB525Member_documentation_en-US" xlink:label="lab_sgmo_PfizerSB525Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer SB-525 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerSB525Member" xlink:href="sgmo-20220930.xsd#sgmo_PfizerSB525Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_PfizerSB525Member" xlink:to="lab_sgmo_PfizerSB525Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_0c0aaa4d-9d2d-445a-8790-e82cb5d49a50_verboseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_EmployeeRetentionCreditCARESAct_c975c07c-030b-4ada-a216-c00cddc168e5_terseLabel_en-US" xlink:label="lab_sgmo_EmployeeRetentionCreditCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee retention credit, CARES Act</link:label>
    <link:label id="lab_sgmo_EmployeeRetentionCreditCARESAct_label_en-US" xlink:label="lab_sgmo_EmployeeRetentionCreditCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Credit, CARES Act</link:label>
    <link:label id="lab_sgmo_EmployeeRetentionCreditCARESAct_documentation_en-US" xlink:label="lab_sgmo_EmployeeRetentionCreditCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Retention Credit, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_EmployeeRetentionCreditCARESAct" xlink:href="sgmo-20220930.xsd#sgmo_EmployeeRetentionCreditCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_EmployeeRetentionCreditCARESAct" xlink:to="lab_sgmo_EmployeeRetentionCreditCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_98b7183c-f152-446a-a611-f60931d268af_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_0d44436c-dd46-4023-85fe-545b9477ad26_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_3638b399-98dd-4e0d-8da4-b52b87e35175_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable_45aa0e50-a762-43c3-aab3-754e28390412_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Accounting Estimate [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Change in Accounting Estimate [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangeInAccountingEstimateTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:to="lab_us-gaap_ScheduleOfChangeInAccountingEstimateTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_2a2393f5-48d1-4c25-9779-c4e5c82b1e4a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7dc36166-668c-43ed-bcf0-48a0f414ca0e_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan_6d943290-13c5-4064-80be-351aad5eba21_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement estimated reimbursable service costs for new research plan</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Estimated Reimbursable Service Costs For New Research Plan</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Estimated Reimbursable Service Costs For New Research Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan" xlink:to="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_467e7a93-77b8-4a04-8e33-1a7fc7a2e8dd_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected_b1f01926-5dd2-4433-988e-4f252c91089d_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of product targets selected</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Number Of Product Targets Selected</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Number Of Product Targets Selected</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementNumberOfProductTargetsSelected"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected" xlink:to="lab_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_eb3d89d6-0784-441e-98bb-6fc6f60a98d3_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_PfizerC9ORF72Member_4a6c14de-7499-4c64-93a9-a12f56eb3f6f_terseLabel_en-US" xlink:label="lab_sgmo_PfizerC9ORF72Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer C9ORF72</link:label>
    <link:label id="lab_sgmo_PfizerC9ORF72Member_label_en-US" xlink:label="lab_sgmo_PfizerC9ORF72Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer C9ORF72 [Member]</link:label>
    <link:label id="lab_sgmo_PfizerC9ORF72Member_documentation_en-US" xlink:label="lab_sgmo_PfizerC9ORF72Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer C9ORF72</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerC9ORF72Member" xlink:href="sgmo-20220930.xsd#sgmo_PfizerC9ORF72Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_PfizerC9ORF72Member" xlink:to="lab_sgmo_PfizerC9ORF72Member" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AchievementOfCommercialMilestonesMember_86de903f-c3c0-429e-92cd-ad5743fa3bc1_terseLabel_en-US" xlink:label="lab_sgmo_AchievementOfCommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Commercial Milestones</link:label>
    <link:label id="lab_sgmo_AchievementOfCommercialMilestonesMember_label_en-US" xlink:label="lab_sgmo_AchievementOfCommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Commercial Milestones [Member]</link:label>
    <link:label id="lab_sgmo_AchievementOfCommercialMilestonesMember_documentation_en-US" xlink:label="lab_sgmo_AchievementOfCommercialMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of Commercial Milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfCommercialMilestonesMember" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfCommercialMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AchievementOfCommercialMilestonesMember" xlink:to="lab_sgmo_AchievementOfCommercialMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_857cce71-d988-4a47-85e4-5c172925453e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationAgreementRemainingPeriod_c4985c48-295d-4870-bab1-81021d35d8ae_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationAgreementRemainingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining period</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementRemainingPeriod_label_en-US" xlink:label="lab_sgmo_CollaborationAgreementRemainingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Remaining Period</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementRemainingPeriod_documentation_en-US" xlink:label="lab_sgmo_CollaborationAgreementRemainingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Remaining Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementRemainingPeriod" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAgreementRemainingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationAgreementRemainingPeriod" xlink:to="lab_sgmo_CollaborationAgreementRemainingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_d3766179-81ac-486e-aff9-64da8191def3_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_2c1979a0-e9d4-490d-a350-6ac77a630787_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_17accba7-31ac-456e-abf2-d631e680fc67_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_5c76fc9f-a17b-4e97-b06b-bb28c6d911b0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_20d254c8-3f1d-4c3e-a4e7-2bfc0f091d85_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_PfizerMember_aa0c5279-a76b-4a4e-ba28-90823b1852eb_terseLabel_en-US" xlink:label="lab_sgmo_PfizerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer Inc.</link:label>
    <link:label id="lab_sgmo_PfizerMember_label_en-US" xlink:label="lab_sgmo_PfizerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer [Member]</link:label>
    <link:label id="lab_sgmo_PfizerMember_documentation_en-US" xlink:label="lab_sgmo_PfizerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pfizer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerMember" xlink:href="sgmo-20220930.xsd#sgmo_PfizerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_PfizerMember" xlink:to="lab_sgmo_PfizerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestReceivableCurrent_64e56681-4d5a-4a53-a583-7ee84c0dcefa_terseLabel_en-US" xlink:label="lab_us-gaap_InterestReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_us-gaap_InterestReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestReceivableCurrent" xlink:to="lab_us-gaap_InterestReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_c9dc373a-fbe8-4c7c-880e-f3b63f8c6b8c_terseLabel_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified research, clinical development, regulatory and first commercial sale milestones</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_label_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Specified Research Clinical Development Regulatory And First Commercial Sale Milestones [Member]</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_documentation_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified research, clinical development, regulatory and first commercial sale milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:to="lab_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c5e66021-7dbd-41cd-af90-a2e9158c41d1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized portion of equity issued</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate_5018308b-e0c1-448d-8c20-b74fad73c59c_terseLabel_en-US" xlink:label="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses reimbursable after December 31, 2023 (up to)</link:label>
    <link:label id="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate_label_en-US" xlink:label="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Expenses Reimbursable, After Specified Date</link:label>
    <link:label id="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate_documentation_en-US" xlink:label="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Expenses Reimbursable, After Specified Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate" xlink:href="sgmo-20220930.xsd#sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate" xlink:to="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_8d8f50a3-d891-452f-b0e8-2b07c6bcc39a_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement estimated reimbursable service costs</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Estimated Reimbursable Service Costs</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement estimated reimbursable service costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:to="lab_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_9a1c8140-bdcd-48f5-8001-9b1eb83f9fad_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AtTheMarketOfferingMember_7b654504-0d15-4886-a297-f70eef44d3d7_terseLabel_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At the Market Offering</link:label>
    <link:label id="lab_sgmo_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering [Member]</link:label>
    <link:label id="lab_sgmo_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingMember" xlink:href="sgmo-20220930.xsd#sgmo_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AtTheMarketOfferingMember" xlink:to="lab_sgmo_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_de5a78b8-ab76-40a8-a2a4-604ca4f392e9_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_2ff0fef1-cedc-4fdd-b627-885b774b673f_negatedLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of (discount) premium on marketable securities</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_4ea0807a-a229-4e64-b84f-dbaac89b1194_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_7afd2629-228f-46a4-ba74-99d71983f014_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_99026602-d48f-4769-a5b0-01d5d97bfeac_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_36b2f1a9-0517-4ada-9a06-1529fe512e61_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Fair Value Measurements of Cash Equivalents and Marketable Securities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CNineORFSevenTwoMember_df0751c6-3861-4aa3-8f0e-91f28fa1f345_terseLabel_en-US" xlink:label="lab_sgmo_CNineORFSevenTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C9ORF72</link:label>
    <link:label id="lab_sgmo_CNineORFSevenTwoMember_label_en-US" xlink:label="lab_sgmo_CNineORFSevenTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C Nine O R F Seven Two [Member]</link:label>
    <link:label id="lab_sgmo_CNineORFSevenTwoMember_documentation_en-US" xlink:label="lab_sgmo_CNineORFSevenTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">C nine ORF seven two.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CNineORFSevenTwoMember" xlink:href="sgmo-20220930.xsd#sgmo_CNineORFSevenTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CNineORFSevenTwoMember" xlink:to="lab_sgmo_CNineORFSevenTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c1902726-7850-414f-a571-6a8e9b723e34_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_7050979e-0caa-44a5-a0b7-d451a282d6ec_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_0890f6a1-90ba-4c4f-af46-42dcf0e23366_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. treasury bills</link:label>
    <link:label id="lab_us-gaap_USTreasurySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USTreasurySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasurySecuritiesMember" xlink:to="lab_us-gaap_USTreasurySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndOtherIncome_b8831d78-bce6-4641-97c4-874fcd3ddc01_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income, net</link:label>
    <link:label id="lab_us-gaap_InterestAndOtherIncome_label_en-US" xlink:label="lab_us-gaap_InterestAndOtherIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Other Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndOtherIncome" xlink:to="lab_us-gaap_InterestAndOtherIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_aa6e4a2f-be7f-402c-804b-fce298bb32c0_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_9136c013-6d37-45ac-a804-6976dd4532a5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_261738aa-f207-4e28-a499-c735222f7e86_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateLineItems_7c2d0687-ade5-4c62-8015-06a73f331c71_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate [Line Items]</link:label>
    <link:label id="lab_us-gaap_ChangeInAccountingEstimateLineItems_label_en-US" xlink:label="lab_us-gaap_ChangeInAccountingEstimateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Accounting Estimate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems" xlink:to="lab_us-gaap_ChangeInAccountingEstimateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_95e3ca80-ad9d-422d-9c45-9cb681930bde_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ChangeInCollaborationAgreementScopeMember_2d6d9c8c-5e78-4f4d-a774-d5117e80ba0a_terseLabel_en-US" xlink:label="lab_sgmo_ChangeInCollaborationAgreementScopeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Collaboration Agreement Scope</link:label>
    <link:label id="lab_sgmo_ChangeInCollaborationAgreementScopeMember_label_en-US" xlink:label="lab_sgmo_ChangeInCollaborationAgreementScopeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Collaboration Agreement Scope [Member]</link:label>
    <link:label id="lab_sgmo_ChangeInCollaborationAgreementScopeMember_documentation_en-US" xlink:label="lab_sgmo_ChangeInCollaborationAgreementScopeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change In Collaboration Agreement Scope</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInCollaborationAgreementScopeMember" xlink:href="sgmo-20220930.xsd#sgmo_ChangeInCollaborationAgreementScopeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ChangeInCollaborationAgreementScopeMember" xlink:to="lab_sgmo_ChangeInCollaborationAgreementScopeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c5b14494-7742-4070-9dd7-14c043daa791_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration received on transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_ca8da40f-289d-4210-88bf-c7e776f51146_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_ddd0eed6-376d-4d79-83b3-6b0b189dc788_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_7921371d-949d-4e30-b050-40a8bf328a3d_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_6a2aa07e-0ed8-456a-bc56-1b5a129dde36_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of products approved</link:label>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_label_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration And License Agreements Number Of Products Approved Under Agreement</link:label>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_documentation_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and license agreements number of products approved under agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:to="lab_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities_244ffbc5-70bb-4f29-8b5d-4481d39b7a90_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Held-to-Maturity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities" xlink:to="lab_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_5b560b07-1109-4bf3-9e88-b50b3b0c2e03_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIC AND DILUTED NET LOSS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_2ce166b3-cdc9-4bcb-8101-83db418eadf2_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturing after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_8a5f66d0-e0d9-4072-97fe-a145bb20fd53_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of investments available-for-sale</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_1f5db6e0-5669-4484-ad50-24540acf327e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buy-out of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_10468370-f7a7-4b7d-bb96-b9657049b55b_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buy-out of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0b74c494-0ead-4eb9-b77a-4664f34eb376_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_56e04247-0530-4a99-b5ea-e79e1b493e6f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_8c2afc05-95df-43f8-bf0d-c16137d64d03_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_2f8c4d27-cd38-41a0-adc7-7fc92d4870e9_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_e28cd4b0-c1b1-4f80-9a6e-584e20e77a14_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from at-the market offering/ issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2d1cb92d-9c75-4bb0-99bb-fcdd110acbce_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used in computing basic net loss per share attributable to Sangamo Therapeutics, Inc. stockholders (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_a43d91a0-25b3-4b06-a655-dd853b69db95_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationArrangementResearchPeriod_0ebab49c-a47a-4666-8df7-472f43eba6a9_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationArrangementResearchPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research period</link:label>
    <link:label id="lab_sgmo_CollaborationArrangementResearchPeriod_label_en-US" xlink:label="lab_sgmo_CollaborationArrangementResearchPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement, Research Period</link:label>
    <link:label id="lab_sgmo_CollaborationArrangementResearchPeriod_documentation_en-US" xlink:label="lab_sgmo_CollaborationArrangementResearchPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement, Research Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationArrangementResearchPeriod" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationArrangementResearchPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationArrangementResearchPeriod" xlink:to="lab_sgmo_CollaborationArrangementResearchPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_15f0480b-27e8-4590-a628-0587dd7937fd_terseLabel_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified clinical development intellectual property and regulatory milestones</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_label_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of Specified Clinical Development Intellectual Property And Regulatory Milestones [Member]</link:label>
    <link:label id="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_documentation_en-US" xlink:label="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of specified clinical development intellectual property and regulatory milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:to="lab_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_33829d24-d703-4861-b187-d5cdf7a0715a_terseLabel_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent development - and sales-based milestone payments to be received</link:label>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_label_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Development And Sales Based Milestone Payments To Be Received</link:label>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_documentation_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent development and sales based milestone payments to be received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:href="sgmo-20220930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:to="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_fea7c692-1316-4688-a968-3082b6ae07a6_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_bba67bb3-ff28-47d9-9c03-f038b0f596a5_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow disclosures:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_d915b3f6-f009-4039-b17e-29708e156e33_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b9765cc6-e242-4ea9-8702-1395f3929df3_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_14821594-baf7-41a7-83e5-e001f35624fd_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_99c39a38-d591-48ec-946d-0d75fcf2dc5a_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with at-the-market offering, net of offering expenses (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5851a50c-4279-474d-b9e0-8b92f65f5203_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under public offering, net of issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_01beac16-ccd2-4f76-ab33-52f4308e2dab_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesTextBlock_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesTextBlock" xlink:to="lab_us-gaap_MarketableSecuritiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AchievementOfFirstCommercialSaleMilestonesMember_2c00863f-e268-4fa1-b6a6-8158ce567ed8_terseLabel_en-US" xlink:label="lab_sgmo_AchievementOfFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of first commercial sale milestones</link:label>
    <link:label id="lab_sgmo_AchievementOfFirstCommercialSaleMilestonesMember_label_en-US" xlink:label="lab_sgmo_AchievementOfFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement Of First Commercial Sale Milestones [Member]</link:label>
    <link:label id="lab_sgmo_AchievementOfFirstCommercialSaleMilestonesMember_documentation_en-US" xlink:label="lab_sgmo_AchievementOfFirstCommercialSaleMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Achievement of first commercial sale milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfFirstCommercialSaleMilestonesMember" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfFirstCommercialSaleMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AchievementOfFirstCommercialSaleMilestonesMember" xlink:to="lab_sgmo_AchievementOfFirstCommercialSaleMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_a9cfda02-d8fd-4f87-8a8f-fd81465fe8f6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_44be158b-46b7-4e5f-8c37-9afa201971fa_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_52ce7340-17c6-4dab-b9c2-fd08f5d67316_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of credit established as a deposit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_072365b1-761d-4925-a3ea-821574c1a0cc_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2930cf51-9577-43d9-8655-146553493166_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_92c6a8a2-d3d6-44ba-aa73-ecb990883a09_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decreased revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_c844f86f-654f-4957-98b2-4602097322f3_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Contract to Perform for Others, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:to="lab_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_397f4bb1-fe50-4e0f-9928-5f8e00dba236_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_cf78bb74-0752-484c-858d-f50d0b08a1b1_terseLabel_en-US" xlink:label="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novartis Institutes for BioMedical Research, Inc.</link:label>
    <link:label id="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_label_en-US" xlink:label="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novartis Institutes For BioMedical Research Inc. [Member]</link:label>
    <link:label id="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_documentation_en-US" xlink:label="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novartis Institutes For BioMedical Research Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:href="sgmo-20220930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:to="lab_sgmo_NovartisInstitutesForBioMedicalResearchIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_21f42cf5-023d-4002-a6c5-3fabd4d8bc04_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_b3a1811c-960a-4952-8b20-72cfd8d7ccfd_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_692ed15a-e0cf-4b82-8109-3aa24b03ce4a_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_78ea24ab-160f-47e6-abe9-993c01612fc0_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_3cd0a6da-eef8-420b-81c1-b4dd4366c5d0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_38577f9c-350d-4665-993b-65c8a7856b0e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities, non-current</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_69cc2dd6-050c-42a1-a06b-43e740ed0dc3_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_31ddda49-f25b-4b30-abe0-27239fd80a87_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional product targets</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_label_en-US" xlink:label="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Number Of Additional Product Targets</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_documentation_en-US" xlink:label="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Number Of Additional Product Targets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAgreementNumberOfAdditionalProductTargets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:to="lab_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_37863d7c-1715-4fd6-871e-c6bc160d6317_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturing in one year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_572aba1c-264f-46af-927e-31e43f03abed_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_87b55fff-5417-48fb-8689-107062e965da_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_29173e0b-004a-4070-b06e-aba41749da0f_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non- Controlling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_adfd11fb-543f-49b8-9b1e-62452ceb2498_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b3873a16-0f97-47d9-a5c4-8e40688a0a74_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_ce1b75aa-6c76-4e7b-94f8-2742d51c1a03_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_fe1db39c-213f-4d49-ad48-ef4c5d86a31b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_fbb9062b-548c-4b13-823e-6597b0c0a711_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_f291d057-1831-4481-b188-dadd9f2ea6fa_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AmortizationAndOtherChangesInRightOfUseAssets_153884b1-523f-47a2-a3cb-ef3ff8b37a78_negatedLabel_en-US" xlink:label="lab_sgmo_AmortizationAndOtherChangesInRightOfUseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization and other changes in operating lease right-of-use assets</link:label>
    <link:label id="lab_sgmo_AmortizationAndOtherChangesInRightOfUseAssets_label_en-US" xlink:label="lab_sgmo_AmortizationAndOtherChangesInRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization And Other Changes In Right-of-Use Assets</link:label>
    <link:label id="lab_sgmo_AmortizationAndOtherChangesInRightOfUseAssets_documentation_en-US" xlink:label="lab_sgmo_AmortizationAndOtherChangesInRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization And Other Changes In Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AmortizationAndOtherChangesInRightOfUseAssets" xlink:href="sgmo-20220930.xsd#sgmo_AmortizationAndOtherChangesInRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AmortizationAndOtherChangesInRightOfUseAssets" xlink:to="lab_sgmo_AmortizationAndOtherChangesInRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_d26d1da9-9bd3-43c1-8b47-088fd06e2676_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenues, non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_06b5970a-fd0a-4eba-89d9-d7b13648ef92_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f6960ab7-40a6-43ae-a990-f38fecd43d21_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6bec253b-934d-49c6-892b-004069c5f2a4_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_8d7b05d1-8d1c-487b-96b8-ba72ed853a74_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_1abd0c96-e5e5-4697-b071-ba69886ffa50_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_0200a90d-2d81-492a-8dbd-6460734d4c35_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_06e32fc8-b56a-4076-9289-a1f8a6dc641c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_MilestoneRevenueReceivable_3565dfdf-937b-4ea0-b533-52a8f397ee4a_terseLabel_en-US" xlink:label="lab_sgmo_MilestoneRevenueReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone revenue receivable</link:label>
    <link:label id="lab_sgmo_MilestoneRevenueReceivable_label_en-US" xlink:label="lab_sgmo_MilestoneRevenueReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Revenue Receivable</link:label>
    <link:label id="lab_sgmo_MilestoneRevenueReceivable_documentation_en-US" xlink:label="lab_sgmo_MilestoneRevenueReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone&#8203; revenue receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneRevenueReceivable" xlink:href="sgmo-20220930.xsd#sgmo_MilestoneRevenueReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_MilestoneRevenueReceivable" xlink:to="lab_sgmo_MilestoneRevenueReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_d1e37237-5333-4291-8a1e-2130b930c864_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial advisory fees</link:label>
    <link:label id="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_label_en-US" xlink:label="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement, Commission Fee, Portion Of Gross Proceeds, Value</link:label>
    <link:label id="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_documentation_en-US" xlink:label="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Arrangement, Commission Fee, Portion Of Gross Proceeds, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:to="lab_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AgreementTerminationTerm_849fb57d-9085-4e11-bf47-8039181a544e_terseLabel_en-US" xlink:label="lab_sgmo_AgreementTerminationTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement termination, term</link:label>
    <link:label id="lab_sgmo_AgreementTerminationTerm_label_en-US" xlink:label="lab_sgmo_AgreementTerminationTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement Termination, Term</link:label>
    <link:label id="lab_sgmo_AgreementTerminationTerm_documentation_en-US" xlink:label="lab_sgmo_AgreementTerminationTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agreement Termination, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AgreementTerminationTerm" xlink:href="sgmo-20220930.xsd#sgmo_AgreementTerminationTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AgreementTerminationTerm" xlink:to="lab_sgmo_AgreementTerminationTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_43180f59-be13-472b-be04-379b7c5ea75a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_08223444-5ea3-44d8-ae57-624e4f28e7b5_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased earnings per share, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_197468bf-f6d2-47e2-8607-d94aa91a583c_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to Sangamo Therapeutics, Inc. stockholders, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_28c3d523-c091-4b48-9fed-72ef006e407c_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_6b652132-ee4c-42d8-8a13-97b49730d80f_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_60f72503-05dd-46bd-8936-f14635abe276_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicenseAndServiceMember_c7b6fc9b-764d-4003-a825-66b1a4ba55c7_terseLabel_en-US" xlink:label="lab_us-gaap_LicenseAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of upfront fee</link:label>
    <link:label id="lab_us-gaap_LicenseAndServiceMember_label_en-US" xlink:label="lab_us-gaap_LicenseAndServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License and Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicenseAndServiceMember" xlink:to="lab_us-gaap_LicenseAndServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ad6f5f6d-321e-4dc4-96bd-d69e3d6024c7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1f363171-79cf-40b4-ae20-56f57b06e5bd_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_0a03dd87-fcb5-4b34-939f-2f25e0291b93_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_f016c48b-ec14-48c4-8465-134f25bf730b_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4ca3cc76-c382-46ed-9b94-a71059cee88a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_3ceab7a2-584e-4e25-813e-ab3c50277e81_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_eb23bec1-db67-4715-b98c-3f50277c1f75_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_0f90766e-b26c-4ee7-9419-bb0bda3c27c4_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_PreApprovalMilestoneMember_e9ac6c58-ddf6-42a0-b446-1bd101b39ea2_terseLabel_en-US" xlink:label="lab_sgmo_PreApprovalMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-approval milestone</link:label>
    <link:label id="lab_sgmo_PreApprovalMilestoneMember_label_en-US" xlink:label="lab_sgmo_PreApprovalMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-approval Milestone [Member]</link:label>
    <link:label id="lab_sgmo_PreApprovalMilestoneMember_documentation_en-US" xlink:label="lab_sgmo_PreApprovalMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-approval Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PreApprovalMilestoneMember" xlink:href="sgmo-20220930.xsd#sgmo_PreApprovalMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_PreApprovalMilestoneMember" xlink:to="lab_sgmo_PreApprovalMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeAgreementMilestoneAxis_a966b8bd-8644-42c3-95ac-557847c86a24_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeAgreementMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement Milestone [Axis]</link:label>
    <link:label id="lab_sgmo_CollaborativeAgreementMilestoneAxis_label_en-US" xlink:label="lab_sgmo_CollaborativeAgreementMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement Milestone [Axis]</link:label>
    <link:label id="lab_sgmo_CollaborativeAgreementMilestoneAxis_documentation_en-US" xlink:label="lab_sgmo_CollaborativeAgreementMilestoneAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneAxis" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneAxis" xlink:to="lab_sgmo_CollaborativeAgreementMilestoneAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_43a289e3-26a8-49d8-a22a-0e292c71bf2a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSoldAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementLicenseFee_b59652d0-6993-4334-be87-060a025e40c3_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementLicenseFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License fee</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementLicenseFee_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementLicenseFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, License Fee</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementLicenseFee_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementLicenseFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, License Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementLicenseFee" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementLicenseFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementLicenseFee" xlink:to="lab_sgmo_CollaborativeArrangementLicenseFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_1794004c-f796-4061-9c8c-81a27d785823_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH EQUIVALENTS AND MARKETABLE SECURITIES</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_29936400-e59a-412a-a040-b2bf90801d89_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ResearchServicesMember_8b68ad35-c92f-42bb-adce-325e1096b272_terseLabel_en-US" xlink:label="lab_sgmo_ResearchServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research services</link:label>
    <link:label id="lab_sgmo_ResearchServicesMember_label_en-US" xlink:label="lab_sgmo_ResearchServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research Services [Member]</link:label>
    <link:label id="lab_sgmo_ResearchServicesMember_documentation_en-US" xlink:label="lab_sgmo_ResearchServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research services.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchServicesMember" xlink:href="sgmo-20220930.xsd#sgmo_ResearchServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ResearchServicesMember" xlink:to="lab_sgmo_ResearchServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_4cf95749-5a17-494e-a376-ecb5bf69ffe1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_73860939-8d05-434e-99e9-0176c0e71490_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_AtTheMarketOfferingAgreementMember_52605701-550b-4c66-89e6-2431cb42bceb_terseLabel_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At-The-Market Offering Agreement</link:label>
    <link:label id="lab_sgmo_AtTheMarketOfferingAgreementMember_label_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At The Market Offering Agreement [Member]</link:label>
    <link:label id="lab_sgmo_AtTheMarketOfferingAgreementMember_documentation_en-US" xlink:label="lab_sgmo_AtTheMarketOfferingAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">At the market offering agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingAgreementMember" xlink:href="sgmo-20220930.xsd#sgmo_AtTheMarketOfferingAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_AtTheMarketOfferingAgreementMember" xlink:to="lab_sgmo_AtTheMarketOfferingAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_TenantAllowance_f728aac4-534e-47e0-be03-48aeaabaac0a_terseLabel_en-US" xlink:label="lab_sgmo_TenantAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant improvement allowance included in contra-lease liability</link:label>
    <link:label id="lab_sgmo_TenantAllowance_label_en-US" xlink:label="lab_sgmo_TenantAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant Allowance</link:label>
    <link:label id="lab_sgmo_TenantAllowance_documentation_en-US" xlink:label="lab_sgmo_TenantAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_TenantAllowance" xlink:href="sgmo-20220930.xsd#sgmo_TenantAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_TenantAllowance" xlink:to="lab_sgmo_TenantAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementMember_8c9d53d5-fdc3-48b7-b38b-c098594175fa_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration And License Agreement</link:label>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementMember_label_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration And License Agreement [Member]</link:label>
    <link:label id="lab_sgmo_CollaborationAndLicenseAgreementMember_documentation_en-US" xlink:label="lab_sgmo_CollaborationAndLicenseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration and license agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationAndLicenseAgreementMember" xlink:to="lab_sgmo_CollaborationAndLicenseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3c73f3cc-414f-4058-be8d-0aca2239be18_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_7537265c-c41a-4f01-abee-6e6da3777de0_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increased earnings per share, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_cac26725-7e73-458c-afb4-932fba601a52_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_a4871125-9366-427a-9368-7d09dad6c6d2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from contract with customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostGross_2d8a2976-48ee-4157-b8e3-63f6c94020e6_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostGross" xlink:to="lab_us-gaap_CapitalizedContractCostGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ae715d91-c7a8-47c0-b0d0-ab58dd10d6ef_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_a1a66fdd-f1f6-4bed-8d44-79a60d35a00d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restrictions on Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_25ef2e5e-e433-4db2-95fe-4e0c415c10a6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_d2e3bb8a-df16-4db4-9975-365a171f9fae_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_6ee1c628-698a-4652-838f-485a898ff1f3_verboseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_5de49b9d-ce9c-4d57-8ae4-eb13db507979_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_a5554765-2659-4863-86e5-34158094b522_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of additional Sangamo France shares</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Additional Interest in Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:to="lab_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod_dfa980cd-6e3b-42f3-a16a-84786b42d4f8_terseLabel_en-US" xlink:label="lab_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Post transition assistance period</link:label>
    <link:label id="lab_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod_label_en-US" xlink:label="lab_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Post Transition Assistance Period</link:label>
    <link:label id="lab_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod_documentation_en-US" xlink:label="lab_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Post Transition Assistance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod" xlink:href="sgmo-20220930.xsd#sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod" xlink:to="lab_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_d48c2cf6-9807-411d-8472-1da30119de2a_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_65c27b00-9b9a-4de2-a8e1-df298f80497f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss related to marketable securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace_4c0dd179-ddfb-4c57-aa91-87f93e7d6209_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum number of product targets replaced</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Maximum Number Of Product Targets To Replace</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Maximum Number Of Product Targets To Replace</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace" xlink:to="lab_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_bf4c07e8-cebc-42f4-95b6-36e26ec7303a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax_b93b6af6-a1f1-48fa-a70e-5831a3d6493b_terseLabel_en-US" xlink:label="lab_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, Gross Unrealized Gains</link:label>
    <link:label id="lab_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents Gross Unrealized Gain Before Tax</link:label>
    <link:label id="lab_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents Gross Unrealized Gain Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax" xlink:to="lab_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_73e613a4-2816-489c-994d-12426984d10c_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b5d12867-e9a7-4ca6-8b72-b16b6ab0fb76_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_2cb08d72-2d44-4c14-98f6-2c923ff93642_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:to="lab_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeArrangementResearchServiceFees_2b1d7c24-03b1-4288-b0d1-b2d19922c3ae_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeArrangementResearchServiceFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research service fees</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementResearchServiceFees_label_en-US" xlink:label="lab_sgmo_CollaborativeArrangementResearchServiceFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Research Service Fees</link:label>
    <link:label id="lab_sgmo_CollaborativeArrangementResearchServiceFees_documentation_en-US" xlink:label="lab_sgmo_CollaborativeArrangementResearchServiceFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Research Service Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementResearchServiceFees" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementResearchServiceFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeArrangementResearchServiceFees" xlink:to="lab_sgmo_CollaborativeArrangementResearchServiceFees" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment_2982b300-7d0e-461f-b846-58e73c2f5ab5_terseLabel_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum amount of achieved milestones to receive payment</link:label>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment_label_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Development And Sales Based Milestone Payments, Maximum Amount Of Achieved Milestones To Receive Payment</link:label>
    <link:label id="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment_documentation_en-US" xlink:label="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Development And Sales Based Milestone Payments, Maximum Amount Of Achieved Milestones To Be Eligible For Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment" xlink:href="sgmo-20220930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment" xlink:to="lab_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_7554a1ad-f73e-43f3-958a-8a7e23c7173f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) on marketable securities, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_SalesBasedMilestoneMember_48ae866d-273e-4d37-a979-d81a9be89066_terseLabel_en-US" xlink:label="lab_sgmo_SalesBasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-based milestone</link:label>
    <link:label id="lab_sgmo_SalesBasedMilestoneMember_label_en-US" xlink:label="lab_sgmo_SalesBasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-based Milestone [Member]</link:label>
    <link:label id="lab_sgmo_SalesBasedMilestoneMember_documentation_en-US" xlink:label="lab_sgmo_SalesBasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-based Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SalesBasedMilestoneMember" xlink:href="sgmo-20220930.xsd#sgmo_SalesBasedMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_SalesBasedMilestoneMember" xlink:to="lab_sgmo_SalesBasedMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_e07a16dc-c17b-4342-8489-10a706b6e279_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government-sponsored entity debt securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government-sponsored Enterprises Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3f0d9a1b-7df3-45cb-9644-2d822dd0bf3d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_StockOfferingProgramMaximumValue_31ef2c33-fa6b-4157-b5b6-19b4f1964db1_terseLabel_en-US" xlink:label="lab_sgmo_StockOfferingProgramMaximumValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock offering program, maximum value</link:label>
    <link:label id="lab_sgmo_StockOfferingProgramMaximumValue_label_en-US" xlink:label="lab_sgmo_StockOfferingProgramMaximumValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Offering Program, Maximum Value</link:label>
    <link:label id="lab_sgmo_StockOfferingProgramMaximumValue_documentation_en-US" xlink:label="lab_sgmo_StockOfferingProgramMaximumValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Offering Program, Maximum Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockOfferingProgramMaximumValue" xlink:href="sgmo-20220930.xsd#sgmo_StockOfferingProgramMaximumValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_StockOfferingProgramMaximumValue" xlink:to="lab_sgmo_StockOfferingProgramMaximumValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_36d0f63e-827c-4a1b-a809-06fa70b4e66d_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_0d16955c-98a7-4100-a5b0-229460e4db15_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_MilestonePaymentsReceived_b317a2c9-dba6-452e-88b5-50a06f8ac40d_terseLabel_en-US" xlink:label="lab_sgmo_MilestonePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments received</link:label>
    <link:label id="lab_sgmo_MilestonePaymentsReceived_label_en-US" xlink:label="lab_sgmo_MilestonePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Payments Received</link:label>
    <link:label id="lab_sgmo_MilestonePaymentsReceived_documentation_en-US" xlink:label="lab_sgmo_MilestonePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone payments received.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestonePaymentsReceived" xlink:href="sgmo-20220930.xsd#sgmo_MilestonePaymentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_MilestonePaymentsReceived" xlink:to="lab_sgmo_MilestonePaymentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_af6cd32f-ccdb-48a3-987b-5c75263e2b78_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_5d507c8b-69c7-4b60-8763-f29de56d0341_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_c5cc3fa4-e205-4a70-88f6-d17aff3f7037_terseLabel_en-US" xlink:label="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development and sales-based milestone payments to be received</link:label>
    <link:label id="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_label_en-US" xlink:label="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contract Liability Milestone Payment Eligible To Receive</link:label>
    <link:label id="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_documentation_en-US" xlink:label="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contract liability milestone payment eligible to receive.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:href="sgmo-20220930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:to="lab_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_b550c286-6a1a-4932-95aa-2b05486db590_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_9bd9ed7b-451b-46b3-adce-8f8307ad2172_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f9ef5027-afca-4f94-8180-9e913fc60c76_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborationAgreementEquityIssued_6f7d5e0a-4121-4d55-95a5-2cb9117c6dbb_terseLabel_en-US" xlink:label="lab_sgmo_CollaborationAgreementEquityIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, equity issued</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementEquityIssued_label_en-US" xlink:label="lab_sgmo_CollaborationAgreementEquityIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Equity Issued</link:label>
    <link:label id="lab_sgmo_CollaborationAgreementEquityIssued_documentation_en-US" xlink:label="lab_sgmo_CollaborationAgreementEquityIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration Agreement, Equity Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementEquityIssued" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAgreementEquityIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborationAgreementEquityIssued" xlink:to="lab_sgmo_CollaborationAgreementEquityIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_535c0e1a-7948-450d-99f4-55547980600c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_620a8d7c-13be-4b82-b946-386f9fc613c5_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b70c4045-4101-41d1-bcd3-1476bb251775_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_f527a4a1-612a-43e6-b3c7-71cfb2d654ef_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Interest Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d40378c7-9d94-4308-b13e-5447cda2abe9_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_74250e25-b8e2-4fb4-bc0f-c4129578ed80_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_db3cc4d8-55df-4200-9c38-b4b12dd7cff2_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease) increase in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_55e240b3-3cef-4032-8d63-10409ffb3d27_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other impairment charges related to marketable securities</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale, Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_1447f35d-ea92-44e1-b899-05a3dbebc866_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_cfc02d67-99ae-42e7-9045-a25843914e93_totalLabel_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash equivalents and available-for-sale securities, Gross Unrealized Gains</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents And Available For Sale Securities Gross Unrealized Gain Before Tax</link:label>
    <link:label id="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_documentation_en-US" xlink:label="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents and available for sale securities, gross unrealized gain, before tax.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:to="lab_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_3feefd70-b6ac-4f87-b673-a19fcbe2de78_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper securities</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_febbab3e-bf69-43bc-b60d-16eedc6c6257_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper securities</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_17201f3a-22f5-4bde-ba07-1f08db64d5a7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_bebae6fa-6bf9-4996-80fe-45e346cfe7b0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_6e0f9a8c-0e04-4fcf-ac4d-82a17d79f1f5_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_8ea9cbc8-f32a-4809-b778-cbdd9c95ac52_terseLabel_en-US" xlink:label="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess consideration received on transaction</link:label>
    <link:label id="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Excess Consideration Received on Transaction</link:label>
    <link:label id="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_documentation_en-US" xlink:label="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Excess Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:href="sgmo-20220930.xsd#sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:to="lab_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3734c765-156f-4b4a-9462-5b35d2d4d96f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_a3f66ed3-d624-47c0-b514-6dbd8bc751ff_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_3236c2f7-67bd-4224-9194-ff06e3c48e13_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value on recurring basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_eee2338f-73f1-4902-b4e4-8e6c4e01e9da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_b38d7b71-c6b7-409b-9f93-9c160e8b38bb_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax_24ebe4fb-2862-40e2-bf21-7090f7c2fd97_negatedTerseLabel_en-US" xlink:label="lab_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents, Gross Unrealized (Losses)</link:label>
    <link:label id="lab_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, Gross Unrealized Loss, Before Tax</link:label>
    <link:label id="lab_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax_documentation_en-US" xlink:label="lab_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, Gross Unrealized Loss, Before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax" xlink:to="lab_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_4713198c-5275-4085-839d-e9f91d16d5b2_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_BiogenMAIncMember_6a71a7b3-4652-4afe-a37f-7c4d6e864dae_terseLabel_en-US" xlink:label="lab_sgmo_BiogenMAIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biogen MA, Inc.</link:label>
    <link:label id="lab_sgmo_BiogenMAIncMember_label_en-US" xlink:label="lab_sgmo_BiogenMAIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biogen MA, Inc. [Member]</link:label>
    <link:label id="lab_sgmo_BiogenMAIncMember_documentation_en-US" xlink:label="lab_sgmo_BiogenMAIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biogen MA, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember" xlink:href="sgmo-20220930.xsd#sgmo_BiogenMAIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_BiogenMAIncMember" xlink:to="lab_sgmo_BiogenMAIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad7169ea-e9b6-4922-8ece-c8da3286d633_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_f5816b4c-5507-4ea3-8d7a-2bb06a62d058_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_055ab9c5-516a-4c69-92df-5fe7ea406544_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_9e2df90e-26d0-4ec9-be71-447e62d1fb2a_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_e8f1f181-14ba-4aef-9c8f-e5adb20a32c2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate_6b6a5860-5f02-4e0f-a16a-4090f4bc53d8_terseLabel_en-US" xlink:label="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses reimbursable through December 31, 2023 (up to)</link:label>
    <link:label id="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate_label_en-US" xlink:label="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Expenses Reimbursable, Through Specified Date</link:label>
    <link:label id="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate_documentation_en-US" xlink:label="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Arrangement, Expenses Reimbursable, Through Specified Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate" xlink:href="sgmo-20220930.xsd#sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate" xlink:to="lab_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_SeparateUpfrontFee_24f855d2-fd26-4400-afbe-805ed0f16b47_terseLabel_en-US" xlink:label="lab_sgmo_SeparateUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate upfront fee</link:label>
    <link:label id="lab_sgmo_SeparateUpfrontFee_label_en-US" xlink:label="lab_sgmo_SeparateUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate Upfront Fee</link:label>
    <link:label id="lab_sgmo_SeparateUpfrontFee_documentation_en-US" xlink:label="lab_sgmo_SeparateUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Separate upfront fee.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SeparateUpfrontFee" xlink:href="sgmo-20220930.xsd#sgmo_SeparateUpfrontFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_SeparateUpfrontFee" xlink:to="lab_sgmo_SeparateUpfrontFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_a20244be-d2eb-471a-bebc-d63813dfb222_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_d7ad3451-a81b-43c8-9490-b36873613872_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_cc4e65e4-845a-4ce6-b5c1-bbcb2732c073_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock_201dd966-81c8-4a97-97d2-61b7457761ff_terseLabel_en-US" xlink:label="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from Strategic Partnering Collaboration Agreements and Research Activity Grants as a Percentage of Total Revenues</link:label>
    <link:label id="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock_label_en-US" xlink:label="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Revenue From Strategic Partnering Collaboration Agreements And Research Activity Grants As A Percentage Of Total Revenues [Table Text Block]</link:label>
    <link:label id="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock_documentation_en-US" xlink:label="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Revenue From Strategic Partnering Collaboration Agreements And Research Activity Grants As A Percentage Of Total Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:href="sgmo-20220930.xsd#sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:to="lab_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_ad674bee-e3cc-4def-b25d-38f3d76ba33d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_baf62f94-a69f-4227-bac4-e1dbe932f43a_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities, Gross Unrealized (Losses)</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9533f1d9-aad1-4228-bf99-00d8330c17a8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense_de57dd74-2db9-4a4c-8b1e-38960e78cdd7_negatedTerseLabel_en-US" xlink:label="lab_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in research and development expense</link:label>
    <link:label id="lab_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination And Transition Agreement, Increase (Decrease) In Research And Development Expense</link:label>
    <link:label id="lab_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense_documentation_en-US" xlink:label="lab_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination And Transition Agreement, Increase (Decrease) In Research And Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense" xlink:href="sgmo-20220930.xsd#sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense" xlink:to="lab_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b0d8c5f8-10e7-46ac-aa3a-09230aaac1cf_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Loss) Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f0c144b3-5a9b-4e29-8aa1-49a935892092_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_MilestoneAchievementMember_8be0981d-529e-4014-8765-109a8d6ce50d_terseLabel_en-US" xlink:label="lab_sgmo_MilestoneAchievementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone achievement</link:label>
    <link:label id="lab_sgmo_MilestoneAchievementMember_label_en-US" xlink:label="lab_sgmo_MilestoneAchievementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Achievement [Member]</link:label>
    <link:label id="lab_sgmo_MilestoneAchievementMember_documentation_en-US" xlink:label="lab_sgmo_MilestoneAchievementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Milestone Achievement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneAchievementMember" xlink:href="sgmo-20220930.xsd#sgmo_MilestoneAchievementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_MilestoneAchievementMember" xlink:to="lab_sgmo_MilestoneAchievementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_GainLossOnFreeShares_4d898afe-6ab8-40b2-ab4f-8b72d78c89e3_negatedLabel_en-US" xlink:label="lab_sgmo_GainLossOnFreeShares" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on free shares</link:label>
    <link:label id="lab_sgmo_GainLossOnFreeShares_label_en-US" xlink:label="lab_sgmo_GainLossOnFreeShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) On Free Shares</link:label>
    <link:label id="lab_sgmo_GainLossOnFreeShares_documentation_en-US" xlink:label="lab_sgmo_GainLossOnFreeShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on free shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_GainLossOnFreeShares" xlink:href="sgmo-20220930.xsd#sgmo_GainLossOnFreeShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_GainLossOnFreeShares" xlink:to="lab_sgmo_GainLossOnFreeShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_fadfb3f6-19bf-4ffd-a91d-eb6734999ba6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents_a49d04c8-2a28-4746-8116-0a373c4e7a59_totalLabel_en-US" xlink:label="lab_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents_label_en-US" xlink:label="lab_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Including US Government-Sponsored Enterprises Classified as Cash and Cash Equivalents</link:label>
    <link:label id="lab_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents_documentation_en-US" xlink:label="lab_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Including US Government-Sponsored Enterprises Classified as Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents" xlink:href="sgmo-20220930.xsd#sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents" xlink:to="lab_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_e992c4b9-50ae-472c-af87-e498a2f63674_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7a63fa4a-d38b-4408-b7ce-63c0757ea875_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0bb5dc64-e4fe-4dee-b956-f897baef1c5e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_bc86fa3c-9b0e-4efa-a39a-2426ca5526ef_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_3d6e7e65-0449-4d9e-8ba0-a6e9ed7eb222_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ExtendedResearchTermOfAgreement_e1f2603b-2891-4621-88a0-7e4c868ec416_terseLabel_en-US" xlink:label="lab_sgmo_ExtendedResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended research term of agreement</link:label>
    <link:label id="lab_sgmo_ExtendedResearchTermOfAgreement_label_en-US" xlink:label="lab_sgmo_ExtendedResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Research Term Of Agreement</link:label>
    <link:label id="lab_sgmo_ExtendedResearchTermOfAgreement_documentation_en-US" xlink:label="lab_sgmo_ExtendedResearchTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extended Research Term Of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExtendedResearchTermOfAgreement" xlink:href="sgmo-20220930.xsd#sgmo_ExtendedResearchTermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ExtendedResearchTermOfAgreement" xlink:to="lab_sgmo_ExtendedResearchTermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_4c0a0e80-1937-4891-9191-5427c6c5544b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from collaborators</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collaborators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollaborators" xlink:to="lab_us-gaap_ProceedsFromCollaborators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bb37adb6-e197-41fc-933e-f6fff74cbfb8_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct_bcccf16a-7563-4415-b242-6233e5af931c_terseLabel_en-US" xlink:label="lab_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from employee retention credit, CARES Act</link:label>
    <link:label id="lab_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct_label_en-US" xlink:label="lab_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Employee Retention Credit, CARES Act</link:label>
    <link:label id="lab_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct_documentation_en-US" xlink:label="lab_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Employee Retention Credit, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct" xlink:href="sgmo-20220930.xsd#sgmo_ProceedsFromEmployeeRetentionCreditCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct" xlink:to="lab_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_8c20e0dc-e3c8-48a3-ae99-22ed82aac33d_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a4bc54c6-98f1-47ec-912e-0cc9675d2be9_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ca94e3d4-de9f-4b95-860e-cd97442d7a1f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm_edd53ec9-ac4d-4848-a623-7c4466f5ed7c_terseLabel_en-US" xlink:label="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options to extend initial research term</link:label>
    <link:label id="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm_label_en-US" xlink:label="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Options To Extend Initial Research Term</link:label>
    <link:label id="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm_documentation_en-US" xlink:label="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Options To Extend Initial Research Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:href="sgmo-20220930.xsd#sgmo_NumberOfOptionsToExtendInitialResearchTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:to="lab_sgmo_NumberOfOptionsToExtendInitialResearchTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_3f21506d-b2f7-4aff-bce5-e627f0ead90b_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition_1fd8e57d-6892-4f1c-a820-c16b8b482416_terseLabel_en-US" xlink:label="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of initial recognition</link:label>
    <link:label id="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition_label_en-US" xlink:label="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement, Percent Of Initial Recognition</link:label>
    <link:label id="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition_documentation_en-US" xlink:label="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Agreement, Percent Of Initial Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementPercentOfInitialRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:to="lab_sgmo_CollaborativeAgreementPercentOfInitialRecognition" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>sgmo-20220930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:9b84b066-0d3d-4626-933d-a605fa769a06,g:f2240c07-5619-4846-82aa-63792348e10c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.sangamo.com/role/Cover" xlink:type="simple" xlink:href="sgmo-20220930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_45d49a4c-572e-4368-aaa0-62d9218784f1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_DocumentType_45d49a4c-572e-4368-aaa0-62d9218784f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_fadec669-6a4a-4a7c-a44b-0d7e597938c2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_DocumentQuarterlyReport_fadec669-6a4a-4a7c-a44b-0d7e597938c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_7c54e653-a0e6-4b5f-b2e8-87e65c8e8df2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_DocumentPeriodEndDate_7c54e653-a0e6-4b5f-b2e8-87e65c8e8df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_44825850-7a23-4ba5-b4ad-9f8ed4d5f47b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_DocumentTransitionReport_44825850-7a23-4ba5-b4ad-9f8ed4d5f47b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_155dfff4-c591-4362-b5f0-92e8102be359" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityFileNumber_155dfff4-c591-4362-b5f0-92e8102be359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_cb3de1cf-7e97-4ebd-a47b-dccee9292fdc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityRegistrantName_cb3de1cf-7e97-4ebd-a47b-dccee9292fdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_5489cca5-6632-46af-b9cf-e9ea8a3fc446" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityIncorporationStateCountryCode_5489cca5-6632-46af-b9cf-e9ea8a3fc446" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_97667e14-a8cc-478c-a78a-0791b5d7692f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityTaxIdentificationNumber_97667e14-a8cc-478c-a78a-0791b5d7692f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5f29b219-328e-4b72-8035-acc9359f2b1a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityAddressAddressLine1_5f29b219-328e-4b72-8035-acc9359f2b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_27b506f2-159b-4939-bcd0-441bec3f3203" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityAddressCityOrTown_27b506f2-159b-4939-bcd0-441bec3f3203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_09833acd-2ee4-4f3d-94d9-383e8115d3ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityAddressStateOrProvince_09833acd-2ee4-4f3d-94d9-383e8115d3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f932fb32-8011-419e-bb38-ed27f6f9ec7c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityAddressPostalZipCode_f932fb32-8011-419e-bb38-ed27f6f9ec7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2494864e-43de-45fc-876c-26d1dcef3369" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_CityAreaCode_2494864e-43de-45fc-876c-26d1dcef3369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_2fec7a6f-67d6-4d0b-967f-4dfd2679f58f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_LocalPhoneNumber_2fec7a6f-67d6-4d0b-967f-4dfd2679f58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_743c5b41-9ee6-4c36-8c20-ad40baf2580d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_Security12bTitle_743c5b41-9ee6-4c36-8c20-ad40baf2580d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_d69b5900-58f9-42fc-a5b6-ab0b629d7237" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_TradingSymbol_d69b5900-58f9-42fc-a5b6-ab0b629d7237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b021c9fd-d1e3-4d70-a413-1cca013080f1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_SecurityExchangeName_b021c9fd-d1e3-4d70-a413-1cca013080f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_8b42465f-b8cc-4211-a966-72efab365203" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityCurrentReportingStatus_8b42465f-b8cc-4211-a966-72efab365203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_04116ec5-0949-4e99-927f-495651f748af" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityInteractiveDataCurrent_04116ec5-0949-4e99-927f-495651f748af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a1c06c37-883f-425e-9664-1ea5d9aa143a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityFilerCategory_a1c06c37-883f-425e-9664-1ea5d9aa143a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_981fdce0-4ff3-4bc4-a4df-5fb674f77dfa" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntitySmallBusiness_981fdce0-4ff3-4bc4-a4df-5fb674f77dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cfb5c313-9977-4d85-8769-4e659f4b9519" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityEmergingGrowthCompany_cfb5c313-9977-4d85-8769-4e659f4b9519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_1ed880cb-37ef-4c43-9e03-a43fc0cd7066" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityShellCompany_1ed880cb-37ef-4c43-9e03-a43fc0cd7066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e999a5cd-ede0-4be4-8f27-e5bde3c78d6f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e999a5cd-ede0-4be4-8f27-e5bde3c78d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4d361a52-19dd-4835-a6d4-3c2d0f5105db" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_AmendmentFlag_4d361a52-19dd-4835-a6d4-3c2d0f5105db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_96606634-2390-44ad-a339-9bd03f0a094d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_DocumentFiscalYearFocus_96606634-2390-44ad-a339-9bd03f0a094d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6e337252-acde-4553-88a6-004e5d0ef63b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6e337252-acde-4553-88a6-004e5d0ef63b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_24aae0a5-cc04-4ecc-87f3-6deace491237" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_EntityCentralIndexKey_24aae0a5-cc04-4ecc-87f3-6deace491237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_03b37406-ca28-4316-981b-fe9b139eaaea" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0ffa3c60-6d50-4f81-93fd-6bfbdda867a1" xlink:to="loc_dei_CurrentFiscalYearEndDate_03b37406-ca28-4316-981b-fe9b139eaaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_301dac73-c930-462c-832d-fcd67e27555e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0024bcd2-fb48-4641-a114-7e2ade4c9299" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_301dac73-c930-462c-832d-fcd67e27555e" xlink:to="loc_us-gaap_AssetsAbstract_0024bcd2-fb48-4641-a114-7e2ade4c9299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_a5e0417c-e034-41a1-8d0b-0c1b60b66b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0024bcd2-fb48-4641-a114-7e2ade4c9299" xlink:to="loc_us-gaap_AssetsCurrentAbstract_a5e0417c-e034-41a1-8d0b-0c1b60b66b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c5cda7cc-c30d-4eb7-a900-eac8c2b17b71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a5e0417c-e034-41a1-8d0b-0c1b60b66b3c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c5cda7cc-c30d-4eb7-a900-eac8c2b17b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fcae05e4-8fb8-4ae2-b789-419bc82c27d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a5e0417c-e034-41a1-8d0b-0c1b60b66b3c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_fcae05e4-8fb8-4ae2-b789-419bc82c27d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestReceivableCurrent_780d31e5-011b-4074-a099-b2bea79ac581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a5e0417c-e034-41a1-8d0b-0c1b60b66b3c" xlink:to="loc_us-gaap_InterestReceivableCurrent_780d31e5-011b-4074-a099-b2bea79ac581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_d0efad1b-76e2-40b6-b932-d3d84669b2df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a5e0417c-e034-41a1-8d0b-0c1b60b66b3c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_d0efad1b-76e2-40b6-b932-d3d84669b2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_30a052a7-4e66-4d63-91dd-04a1f9601e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a5e0417c-e034-41a1-8d0b-0c1b60b66b3c" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_30a052a7-4e66-4d63-91dd-04a1f9601e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_67f38c07-4f4a-4df2-9892-a1e8d52a90df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_a5e0417c-e034-41a1-8d0b-0c1b60b66b3c" xlink:to="loc_us-gaap_AssetsCurrent_67f38c07-4f4a-4df2-9892-a1e8d52a90df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_8fffe9a6-9b84-41d9-bf83-636e802da49d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0024bcd2-fb48-4641-a114-7e2ade4c9299" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_8fffe9a6-9b84-41d9-bf83-636e802da49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_e3ad7b44-72da-4089-9d40-98fa19f8d823" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0024bcd2-fb48-4641-a114-7e2ade4c9299" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_e3ad7b44-72da-4089-9d40-98fa19f8d823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6b16d131-1556-4c7c-bf71-28fc030573d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0024bcd2-fb48-4641-a114-7e2ade4c9299" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_6b16d131-1556-4c7c-bf71-28fc030573d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e5f1595a-c554-400e-9aa6-1bff4b627638" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0024bcd2-fb48-4641-a114-7e2ade4c9299" xlink:to="loc_us-gaap_Goodwill_e5f1595a-c554-400e-9aa6-1bff4b627638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_1122cea0-eb88-403c-92c2-8998b96b379e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0024bcd2-fb48-4641-a114-7e2ade4c9299" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_1122cea0-eb88-403c-92c2-8998b96b379e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4a1cf489-9671-4415-aa4c-dc681f3a9441" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0024bcd2-fb48-4641-a114-7e2ade4c9299" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4a1cf489-9671-4415-aa4c-dc681f3a9441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashNoncurrent_6b0edd45-8230-4709-896c-beef727a27c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0024bcd2-fb48-4641-a114-7e2ade4c9299" xlink:to="loc_us-gaap_RestrictedCashNoncurrent_6b0edd45-8230-4709-896c-beef727a27c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_b556e51e-f9f2-496f-95ff-12012617d33e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0024bcd2-fb48-4641-a114-7e2ade4c9299" xlink:to="loc_us-gaap_Assets_b556e51e-f9f2-496f-95ff-12012617d33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b5390d0c-bd7e-4e33-acc0-037cc0f2c890" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_301dac73-c930-462c-832d-fcd67e27555e" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b5390d0c-bd7e-4e33-acc0-037cc0f2c890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_595a635b-b354-45fd-aba5-fafd39271a83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b5390d0c-bd7e-4e33-acc0-037cc0f2c890" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_595a635b-b354-45fd-aba5-fafd39271a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_17152bbf-4841-4e6f-8f12-b0f001f6101f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_595a635b-b354-45fd-aba5-fafd39271a83" xlink:to="loc_us-gaap_AccountsPayableCurrent_17152bbf-4841-4e6f-8f12-b0f001f6101f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_93106326-49cc-4768-9c54-04177d1e0384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_595a635b-b354-45fd-aba5-fafd39271a83" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_93106326-49cc-4768-9c54-04177d1e0384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_f2a32ab8-84f9-4921-ba46-2342c07c7eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_595a635b-b354-45fd-aba5-fafd39271a83" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_f2a32ab8-84f9-4921-ba46-2342c07c7eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f9a5ffdb-d5cf-43b8-905c-46206d63b70b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_595a635b-b354-45fd-aba5-fafd39271a83" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f9a5ffdb-d5cf-43b8-905c-46206d63b70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d1c9cf92-d407-4975-b04f-3af7abc00959" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_595a635b-b354-45fd-aba5-fafd39271a83" xlink:to="loc_us-gaap_LiabilitiesCurrent_d1c9cf92-d407-4975-b04f-3af7abc00959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_43fff4ca-2d22-48ec-97ba-5f4a43361bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b5390d0c-bd7e-4e33-acc0-037cc0f2c890" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_43fff4ca-2d22-48ec-97ba-5f4a43361bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ee6ca318-0c05-4aaf-a771-fa60aff29fea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b5390d0c-bd7e-4e33-acc0-037cc0f2c890" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ee6ca318-0c05-4aaf-a771-fa60aff29fea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ccecf047-2a14-4f15-b953-156065da1e99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b5390d0c-bd7e-4e33-acc0-037cc0f2c890" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ccecf047-2a14-4f15-b953-156065da1e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_59ab44d4-1ac5-4883-8ab2-9619f3613ed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b5390d0c-bd7e-4e33-acc0-037cc0f2c890" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_59ab44d4-1ac5-4883-8ab2-9619f3613ed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e4570d1d-69aa-4741-b00d-92ac477b2707" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b5390d0c-bd7e-4e33-acc0-037cc0f2c890" xlink:to="loc_us-gaap_Liabilities_e4570d1d-69aa-4741-b00d-92ac477b2707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e09210ef-71fb-4210-9bd6-a5ba11222754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b5390d0c-bd7e-4e33-acc0-037cc0f2c890" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e09210ef-71fb-4210-9bd6-a5ba11222754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5bf1e5fc-7386-479f-8e8b-72c1723d5f25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b5390d0c-bd7e-4e33-acc0-037cc0f2c890" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5bf1e5fc-7386-479f-8e8b-72c1723d5f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_4b714760-8be9-4b10-a741-4f37fe98f8a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5bf1e5fc-7386-479f-8e8b-72c1723d5f25" xlink:to="loc_us-gaap_PreferredStockValue_4b714760-8be9-4b10-a741-4f37fe98f8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7cef6eb0-8b3f-4936-aefe-ff26f824f4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5bf1e5fc-7386-479f-8e8b-72c1723d5f25" xlink:to="loc_us-gaap_CommonStockValue_7cef6eb0-8b3f-4936-aefe-ff26f824f4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ae24347f-b065-4f68-96f8-f9e9d33c08f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5bf1e5fc-7386-479f-8e8b-72c1723d5f25" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ae24347f-b065-4f68-96f8-f9e9d33c08f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_440921bd-7bc3-437c-8185-1c7f8fce6c50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5bf1e5fc-7386-479f-8e8b-72c1723d5f25" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_440921bd-7bc3-437c-8185-1c7f8fce6c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dfee6e38-942c-48bd-b49c-b762d43caab4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5bf1e5fc-7386-479f-8e8b-72c1723d5f25" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dfee6e38-942c-48bd-b49c-b762d43caab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_64b617d2-e5ae-40ef-a660-10e02eff5ec7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_5bf1e5fc-7386-479f-8e8b-72c1723d5f25" xlink:to="loc_us-gaap_StockholdersEquity_64b617d2-e5ae-40ef-a660-10e02eff5ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_828d9046-32cd-40e3-880d-4ec500d7632a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b5390d0c-bd7e-4e33-acc0-037cc0f2c890" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_828d9046-32cd-40e3-880d-4ec500d7632a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_73b71515-f4ff-4c83-8615-529d8a9a0425" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_73b71515-f4ff-4c83-8615-529d8a9a0425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_8d359858-8563-424f-8e2d-ade6fa12035c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_OperatingExpensesAbstract_8d359858-8563-424f-8e2d-ade6fa12035c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_895344b8-cc8e-46d0-b1bf-2e9cbdcc96a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8d359858-8563-424f-8e2d-ade6fa12035c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_895344b8-cc8e-46d0-b1bf-2e9cbdcc96a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1f21adc8-6abd-423e-a406-79d1528f3629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8d359858-8563-424f-8e2d-ade6fa12035c" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1f21adc8-6abd-423e-a406-79d1528f3629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_5e6315f5-7f10-41a9-abfe-88014e2a1414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_8d359858-8563-424f-8e2d-ade6fa12035c" xlink:to="loc_us-gaap_OperatingExpenses_5e6315f5-7f10-41a9-abfe-88014e2a1414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4760e375-ea29-40bb-be66-dc5201bd4e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_OperatingIncomeLoss_4760e375-ea29-40bb-be66-dc5201bd4e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndOtherIncome_b542d150-119f-45f8-b76f-3661d2be21de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestAndOtherIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_InterestAndOtherIncome_b542d150-119f-45f8-b76f-3661d2be21de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_5f18f6c7-f21c-4588-8981-f3bb4ef128ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest_5f18f6c7-f21c-4588-8981-f3bb4ef128ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_664c3444-3019-448e-b5d1-a1058ef35faf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_664c3444-3019-448e-b5d1-a1058ef35faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c070e134-635f-4bc9-99c2-65cb89e05068" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_ProfitLoss_c070e134-635f-4bc9-99c2-65cb89e05068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f1edf74c-3862-4fcf-9114-503fce2ef1c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_f1edf74c-3862-4fcf-9114-503fce2ef1c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c904c6aa-1652-41dd-b779-512a35224db2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_c904c6aa-1652-41dd-b779-512a35224db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_384ace8b-740d-4b52-bfc5-72354e50d8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_384ace8b-740d-4b52-bfc5-72354e50d8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_d160d398-9469-4db6-9308-8f551985b90b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_EarningsPerShareBasic_d160d398-9469-4db6-9308-8f551985b90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_26f3650a-eac9-4b64-bc34-a5352ff12204" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_EarningsPerShareDiluted_26f3650a-eac9-4b64-bc34-a5352ff12204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f4bd0b92-23a7-4d07-91ed-05cbf74879ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_f4bd0b92-23a7-4d07-91ed-05cbf74879ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1b95f2cb-3b95-4f61-a223-030ccd513116" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a3a4407b-0ac9-439d-a784-499710690c1b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1b95f2cb-3b95-4f61-a223-030ccd513116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a9f2a603-2b1a-4870-9883-4ac77ff2c716" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c1ca7ce7-ca3b-4d90-9eb7-506c871eacb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a9f2a603-2b1a-4870-9883-4ac77ff2c716" xlink:to="loc_us-gaap_ProfitLoss_c1ca7ce7-ca3b-4d90-9eb7-506c871eacb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4c21cbf9-ce74-4aa9-b63f-4de25394771c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a9f2a603-2b1a-4870-9883-4ac77ff2c716" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_4c21cbf9-ce74-4aa9-b63f-4de25394771c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_292634dc-d37d-472e-9e5c-0c8c37c4fd3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a9f2a603-2b1a-4870-9883-4ac77ff2c716" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_292634dc-d37d-472e-9e5c-0c8c37c4fd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e825202d-3e9d-4423-b48e-1cceee4640a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a9f2a603-2b1a-4870-9883-4ac77ff2c716" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e825202d-3e9d-4423-b48e-1cceee4640a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b6391045-956f-4516-931d-08d859ed554e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a9f2a603-2b1a-4870-9883-4ac77ff2c716" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_b6391045-956f-4516-931d-08d859ed554e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6a22e9c6-d743-4ad3-bd36-8878a0878fac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a9f2a603-2b1a-4870-9883-4ac77ff2c716" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6a22e9c6-d743-4ad3-bd36-8878a0878fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8844f44c-fcbb-4556-b00a-e170c125c7b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_a9f2a603-2b1a-4870-9883-4ac77ff2c716" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_8844f44c-fcbb-4556-b00a-e170c125c7b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6869acc4-58bc-454b-b4de-4e9267cea2ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0d4779cf-ab59-47a3-a2bc-6b4f55b347ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6869acc4-58bc-454b-b4de-4e9267cea2ad" xlink:to="loc_us-gaap_StatementTable_0d4779cf-ab59-47a3-a2bc-6b4f55b347ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_8af27787-9f9d-45c2-9141-584a27445ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0d4779cf-ab59-47a3-a2bc-6b4f55b347ce" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_8af27787-9f9d-45c2-9141-584a27445ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_8af27787-9f9d-45c2-9141-584a27445ebd" xlink:to="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_570d9438-d7b2-47be-93b1-26a8e35d5ec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:to="loc_us-gaap_CommonStockMember_570d9438-d7b2-47be-93b1-26a8e35d5ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b56f52c1-c7d8-457c-81b6-1b9d9b327340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b56f52c1-c7d8-457c-81b6-1b9d9b327340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_d3241647-6ff6-4486-99a4-333fef3c1a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:to="loc_us-gaap_RetainedEarningsMember_d3241647-6ff6-4486-99a4-333fef3c1a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2c9b91ed-d831-43c9-a62d-5bb18960c9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2c9b91ed-d831-43c9-a62d-5bb18960c9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_b43c5a8b-6ddf-4213-bd80-325a45070620" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8532a566-ec90-41a1-bdfd-01a487710963" xlink:to="loc_us-gaap_NoncontrollingInterestMember_b43c5a8b-6ddf-4213-bd80-325a45070620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e0108f60-4571-499e-a273-4e73920d290c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0d4779cf-ab59-47a3-a2bc-6b4f55b347ce" xlink:to="loc_us-gaap_StatementLineItems_e0108f60-4571-499e-a273-4e73920d290c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e0108f60-4571-499e-a273-4e73920d290c" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_d2d091c0-c378-400e-abc0-407242a0da1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_CommonStockSharesIssued_d2d091c0-c378-400e-abc0-407242a0da1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_23bd7ea8-f0f8-4547-8efa-50b07519ece9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_23bd7ea8-f0f8-4547-8efa-50b07519ece9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d12489cf-35ba-4721-9f0c-8deb16aa32c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d12489cf-35ba-4721-9f0c-8deb16aa32c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7e6c6290-5ca9-4404-8b14-1c0ca6f81b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_7e6c6290-5ca9-4404-8b14-1c0ca6f81b6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e56ad2f0-85c3-44fd-9906-a15fd03e2ad8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_e56ad2f0-85c3-44fd-9906-a15fd03e2ad8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_fc32d127-827d-4d16-a55c-a883b50eccc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_fc32d127-827d-4d16-a55c-a883b50eccc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_086e183e-08f6-44bb-978a-d81d192ef6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_086e183e-08f6-44bb-978a-d81d192ef6f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_41499eaf-e833-4462-9f15-90ac33fb5794" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_41499eaf-e833-4462-9f15-90ac33fb5794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_612a863c-2637-47ac-bf6a-b3dedff5764a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_612a863c-2637-47ac-bf6a-b3dedff5764a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest_50858a60-df35-419b-86fb-7a6141165019" xlink:href="sgmo-20220930.xsd#sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest_50858a60-df35-419b-86fb-7a6141165019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_5eadbadd-2f78-44eb-9627-9cf8183e1ade" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_5eadbadd-2f78-44eb-9627-9cf8183e1ade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_78a29692-2a96-4cd1-965d-5ba75656819f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_78a29692-2a96-4cd1-965d-5ba75656819f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_967da655-0d29-471f-92a9-bd2fd249522d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_967da655-0d29-471f-92a9-bd2fd249522d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_779e0c31-3ded-4d39-9ea1-b4abf6e15c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_779e0c31-3ded-4d39-9ea1-b4abf6e15c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_af220446-e9d1-4219-a07c-baeec0ea827a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_ProfitLoss_af220446-e9d1-4219-a07c-baeec0ea827a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a7d93dc5-c8ba-4581-8f71-75d311de9704" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_CommonStockSharesIssued_a7d93dc5-c8ba-4581-8f71-75d311de9704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f58a72bd-67d4-4e8c-ac3d-c59bced5b4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_49ac5de2-784d-453d-9415-0d2da645a367" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f58a72bd-67d4-4e8c-ac3d-c59bced5b4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b36a059e-8027-472f-a33a-f875396933de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c87cb072-1285-452b-9b19-c8cb63888d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b36a059e-8027-472f-a33a-f875396933de" xlink:to="loc_us-gaap_StatementTable_c87cb072-1285-452b-9b19-c8cb63888d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_89c81d29-9cd2-44c0-a2e4-b90c2d499e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c87cb072-1285-452b-9b19-c8cb63888d7f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_89c81d29-9cd2-44c0-a2e4-b90c2d499e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1d542017-cc5f-497d-ab41-c26f48db81aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_89c81d29-9cd2-44c0-a2e4-b90c2d499e09" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1d542017-cc5f-497d-ab41-c26f48db81aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingMember_ab2842f6-07ae-486a-8f4c-833e79cd89e0" xlink:href="sgmo-20220930.xsd#sgmo_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1d542017-cc5f-497d-ab41-c26f48db81aa" xlink:to="loc_sgmo_AtTheMarketOfferingMember_ab2842f6-07ae-486a-8f4c-833e79cd89e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_f40d2609-88de-4a8f-820a-aefda6d18a34" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_1d542017-cc5f-497d-ab41-c26f48db81aa" xlink:to="loc_us-gaap_EmployeeStockMember_f40d2609-88de-4a8f-820a-aefda6d18a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c87cb072-1285-452b-9b19-c8cb63888d7f" xlink:to="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_be3542e6-dcdd-43b9-bae8-a1529bdf1bf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:to="loc_us-gaap_ProfitLoss_be3542e6-dcdd-43b9-bae8-a1529bdf1bf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_5263a6ca-f8aa-4d36-8be1-8417a1a53b8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_5263a6ca-f8aa-4d36-8be1-8417a1a53b8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_411641f1-c4ed-4f97-ba36-758df1ef1731" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_411641f1-c4ed-4f97-ba36-758df1ef1731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AmortizationAndOtherChangesInRightOfUseAssets_1c46e952-5e2f-4bc1-bd62-4a271e892855" xlink:href="sgmo-20220930.xsd#sgmo_AmortizationAndOtherChangesInRightOfUseAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_sgmo_AmortizationAndOtherChangesInRightOfUseAssets_1c46e952-5e2f-4bc1-bd62-4a271e892855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_GainLossOnFreeShares_2692632b-b6b9-460b-a60f-93a3ffc8159e" xlink:href="sgmo-20220930.xsd#sgmo_GainLossOnFreeShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_sgmo_GainLossOnFreeShares_2692632b-b6b9-460b-a60f-93a3ffc8159e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_b78d980f-f24a-4a89-9585-97724a723b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_us-gaap_ShareBasedCompensation_b78d980f-f24a-4a89-9585-97724a723b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d3c49608-bbd6-4743-8682-25dd22aed015" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f1abf184-13be-41d6-9304-ae7ad6274139" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d3c49608-bbd6-4743-8682-25dd22aed015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_0d16d90d-5d06-4bc6-83dc-d5c347695474" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet_0d16d90d-5d06-4bc6-83dc-d5c347695474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5bbc7336-fc7f-4f75-9410-a16b2219ff6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5bbc7336-fc7f-4f75-9410-a16b2219ff6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_da113121-3387-4ba1-a3f4-046a9299e536" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_da113121-3387-4ba1-a3f4-046a9299e536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_85759101-32f0-46a8-8a05-bc60ab56e575" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_85759101-32f0-46a8-8a05-bc60ab56e575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a4ac088d-4a85-4643-8708-4ea4c0e4e0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_a4ac088d-4a85-4643-8708-4ea4c0e4e0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_58374a3a-f226-4cd8-b097-8f2e2beff384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_58374a3a-f226-4cd8-b097-8f2e2beff384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_8c3ccaf2-9ce1-4c64-a9f8-8d8d069f4100" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_8c3ccaf2-9ce1-4c64-a9f8-8d8d069f4100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_03296535-d50d-46f2-bef7-0228018eecb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_42fe9a08-7be3-4f91-93da-2e71b5f34ab1" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_03296535-d50d-46f2-bef7-0228018eecb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42c7162c-9a61-4b71-a8a6-84427b486f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9b77c0fd-e8bb-46de-920f-e724b0906a23" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_42c7162c-9a61-4b71-a8a6-84427b486f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_61ce65b4-cfe6-456f-868a-693bb3a5c88a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_61ce65b4-cfe6-456f-868a-693bb3a5c88a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_03da33c7-e2a5-408e-aefc-6a6def201074" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_03da33c7-e2a5-408e-aefc-6a6def201074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities_fce639db-ce88-4664-83d2-3ab880876f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities_fce639db-ce88-4664-83d2-3ab880876f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ff471866-bef6-4602-879f-5b3b550e5aef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ff471866-bef6-4602-879f-5b3b550e5aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_5570e683-9458-446c-8568-11eeaf3e12f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries_5570e683-9458-446c-8568-11eeaf3e12f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6d3042e-4aa7-4b1c-8dcb-64262e2ebb91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_424c32dd-5fda-4cef-915e-071b2b3bcb3a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b6d3042e-4aa7-4b1c-8dcb-64262e2ebb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e28783d2-1646-4abb-a93e-752b92c4157d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_e28783d2-1646-4abb-a93e-752b92c4157d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f1ef739c-f9c8-4ed0-898f-32e8c7f9c6b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f1ef739c-f9c8-4ed0-898f-32e8c7f9c6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ba83e4ba-7dae-4e12-b83c-f69848c5c024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ba83e4ba-7dae-4e12-b83c-f69848c5c024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_458d7249-c509-4f12-aaae-ac60418964b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_92dd09b8-0fb1-4eb1-acc9-64963c7fd696" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_458d7249-c509-4f12-aaae-ac60418964b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30aed208-247b-4a64-85f3-cb8efba25661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30aed208-247b-4a64-85f3-cb8efba25661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_586ea372-3d1f-4457-a521-cad0a2ad7e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_586ea372-3d1f-4457-a521-cad0a2ad7e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9284727a-ef29-408f-8907-8cc1f9fdbba4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9284727a-ef29-408f-8907-8cc1f9fdbba4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a2e105a8-2f9b-48c9-afd7-97d84bd29242" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a2e105a8-2f9b-48c9-afd7-97d84bd29242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_17152949-1278-4bd7-a835-ef31f40ed490" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_2e5102ef-f4dc-4d14-b3b5-f3451856771d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_2e5102ef-f4dc-4d14-b3b5-f3451856771d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8ef5c08c-7cfe-4553-a6b4-5eecbdc6a5f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8ef5c08c-7cfe-4553-a6b4-5eecbdc6a5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_TenantAllowance_ab2b11d9-a6e5-458a-a70e-f768de7ede78" xlink:href="sgmo-20220930.xsd#sgmo_TenantAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:to="loc_sgmo_TenantAllowance_ab2b11d9-a6e5-458a-a70e-f768de7ede78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_5c97aba5-2af9-44c5-aaf3-a864f121127a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_9469aefc-d1d7-43e5-9a56-ec1843150963" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_5c97aba5-2af9-44c5-aaf3-a864f121127a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="sgmo-20220930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_318780f7-31a9-4356-ac27-9ddb3285bbf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_e516dd13-6345-4a6a-993d-dac45a3e0cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_318780f7-31a9-4356-ac27-9ddb3285bbf2" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_e516dd13-6345-4a6a-993d-dac45a3e0cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="sgmo-20220930.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9ec70307-37b6-40ef-853f-0e72dbdafab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_7b5c65c8-9459-4ecc-b0cd-e8cf683ecb9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9ec70307-37b6-40ef-853f-0e72dbdafab2" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_7b5c65c8-9459-4ecc-b0cd-e8cf683ecb9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIES"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4e386736-2275-4a68-827b-55de3c778639" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_f7bc1ff9-2529-4732-8dee-00d618a643d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_4e386736-2275-4a68-827b-55de3c778639" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_f7bc1ff9-2529-4732-8dee-00d618a643d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE" xlink:type="simple" xlink:href="sgmo-20220930.xsd#BASICANDDILUTEDNETLOSSPERSHARE"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a14c5cb1-6147-4025-8969-b622dc55422c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_d18816bd-0ead-4335-9829-6b0d5b74e3f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a14c5cb1-6147-4025-8969-b622dc55422c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_d18816bd-0ead-4335-9829-6b0d5b74e3f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7bc1790b-d013-439c-ae80-b1ebd3df3d02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_76ca821f-b7bc-48bc-ba22-cf0d8cd5458a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7bc1790b-d013-439c-ae80-b1ebd3df3d02" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_76ca821f-b7bc-48bc-ba22-cf0d8cd5458a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="sgmo-20220930.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb86ffb5-41e3-4bb2-8c82-f209949332a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f6c643e0-179f-49ae-9692-7e2179ae5bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bb86ffb5-41e3-4bb2-8c82-f209949332a2" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f6c643e0-179f-49ae-9692-7e2179ae5bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="sgmo-20220930.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2f86e944-b872-47d3-a3a3-92d9133a9bde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_64b09c8f-142f-4a48-8e4c-3cbd2b02c1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2f86e944-b872-47d3-a3a3-92d9133a9bde" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_64b09c8f-142f-4a48-8e4c-3cbd2b02c1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/INCOMETAXES" xlink:type="simple" xlink:href="sgmo-20220930.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2736fb21-a60c-4991-a4cd-ad6ab4eb530b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_d9cb4b1f-96f2-4fdd-8b61-9a8e332ea379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2736fb21-a60c-4991-a4cd-ad6ab4eb530b" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_d9cb4b1f-96f2-4fdd-8b61-9a8e332ea379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="sgmo-20220930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7dd6602e-74e4-414a-a8ed-2d7ca85a5b3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_92c55ac2-5d88-4d4c-8ade-6d17ad67ec71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dd6602e-74e4-414a-a8ed-2d7ca85a5b3c" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_92c55ac2-5d88-4d4c-8ade-6d17ad67ec71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a8bcb0b7-7b5d-439d-95f2-50664df90c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dd6602e-74e4-414a-a8ed-2d7ca85a5b3c" xlink:to="loc_us-gaap_UseOfEstimates_a8bcb0b7-7b5d-439d-95f2-50664df90c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_22100bbc-d633-4df0-bca0-8f7cc7c91897" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dd6602e-74e4-414a-a8ed-2d7ca85a5b3c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_22100bbc-d633-4df0-bca0-8f7cc7c91897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0d407f2c-d170-4e8f-80b8-078e6611ea6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dd6602e-74e4-414a-a8ed-2d7ca85a5b3c" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_0d407f2c-d170-4e8f-80b8-078e6611ea6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c0c39973-7ab9-4d55-a05b-15998a789881" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dd6602e-74e4-414a-a8ed-2d7ca85a5b3c" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c0c39973-7ab9-4d55-a05b-15998a789881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_b55c5cfe-8e28-4836-9856-dd783e43b2db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7dd6602e-74e4-414a-a8ed-2d7ca85a5b3c" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_b55c5cfe-8e28-4836-9856-dd783e43b2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="sgmo-20220930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_581e2a3c-9fc3-4911-8d68-336be016f0ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock_ba28513e-3f36-4a04-87b4-48009f66e507" xlink:href="sgmo-20220930.xsd#sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_581e2a3c-9fc3-4911-8d68-336be016f0ce" xlink:to="loc_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock_ba28513e-3f36-4a04-87b4-48009f66e507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4684b22d-e120-4df5-92d7-341a32a7e73f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_581e2a3c-9fc3-4911-8d68-336be016f0ce" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_4684b22d-e120-4df5-92d7-341a32a7e73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_71094585-c292-47ce-8a98-3814e3a64d84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_581e2a3c-9fc3-4911-8d68-336be016f0ce" xlink:to="loc_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock_71094585-c292-47ce-8a98-3814e3a64d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="sgmo-20220930.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_91fe0906-8ebd-45df-a779-f0ff65dab3af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_55b4a6d4-c558-47a0-ae31-dd1b8bc68bef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_91fe0906-8ebd-45df-a779-f0ff65dab3af" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_55b4a6d4-c558-47a0-ae31-dd1b8bc68bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESTables"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c231db3b-efb0-4bca-ae12-c31de7946788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_a3470621-a25e-48f5-9fe5-25d300d24b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c231db3b-efb0-4bca-ae12-c31de7946788" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_a3470621-a25e-48f5-9fe5-25d300d24b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_05ca9831-eab9-4da9-9fdf-2b39f73460e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_c231db3b-efb0-4bca-ae12-c31de7946788" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_05ca9831-eab9-4da9-9fdf-2b39f73460e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6913bf4e-0888-494c-808c-f921407d054f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b26e6e24-cdc0-41d7-afd7-8d003cc91155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6913bf4e-0888-494c-808c-f921407d054f" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b26e6e24-cdc0-41d7-afd7-8d003cc91155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_954b1a10-0f9e-47a4-8afe-ac9e90d469e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b26e6e24-cdc0-41d7-afd7-8d003cc91155" xlink:to="loc_srt_CounterpartyNameAxis_954b1a10-0f9e-47a4-8afe-ac9e90d469e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_954b1a10-0f9e-47a4-8afe-ac9e90d469e7" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_ff33c4a5-f80d-4d20-8740-95e8203bb21a" xlink:href="sgmo-20220930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_ff33c4a5-f80d-4d20-8740-95e8203bb21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_11293922-cc20-4036-b8b7-7a39ec6b1c0d" xlink:href="sgmo-20220930.xsd#sgmo_BiogenMAIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:to="loc_sgmo_BiogenMAIncMember_11293922-cc20-4036-b8b7-7a39ec6b1c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_787de772-1f7e-43de-9486-8a85194f4eb3" xlink:href="sgmo-20220930.xsd#sgmo_KitePharmaIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:to="loc_sgmo_KitePharmaIncMember_787de772-1f7e-43de-9486-8a85194f4eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SanofiMember_1cbca751-dba2-43ce-a290-41f298374317" xlink:href="sgmo-20220930.xsd#sgmo_SanofiMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ccf4cc20-7a31-407c-bad7-9e701d573486" xlink:to="loc_sgmo_SanofiMember_1cbca751-dba2-43ce-a290-41f298374317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_4f14092f-2a03-42d1-8253-2b1933efa467" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b26e6e24-cdc0-41d7-afd7-8d003cc91155" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_4f14092f-2a03-42d1-8253-2b1933efa467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_93b6cf66-fe88-4044-b10d-11cb64db78ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_4f14092f-2a03-42d1-8253-2b1933efa467" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_93b6cf66-fe88-4044-b10d-11cb64db78ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="sgmo-20220930.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_46a0d516-5d8e-427f-bf30-a9227ced7c87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e7c16fb8-6306-46d0-a28e-d0c3cf4ed40a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_46a0d516-5d8e-427f-bf30-a9227ced7c87" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e7c16fb8-6306-46d0-a28e-d0c3cf4ed40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_9f5f8506-9695-4ac2-942e-4f8a74d6871c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_5386350a-5a89-49b0-9b3f-94ce6d02e70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfChangeInAccountingEstimateTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_9f5f8506-9695-4ac2-942e-4f8a74d6871c" xlink:to="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_5386350a-5a89-49b0-9b3f-94ce6d02e70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_9e44f59b-6c81-485c-8dd9-2540c8c46b0c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_5386350a-5a89-49b0-9b3f-94ce6d02e70e" xlink:to="loc_srt_CounterpartyNameAxis_9e44f59b-6c81-485c-8dd9-2540c8c46b0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9bc8c31e-8f5b-4944-a6bc-0616f7602e5c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_9e44f59b-6c81-485c-8dd9-2540c8c46b0c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9bc8c31e-8f5b-4944-a6bc-0616f7602e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SanofiMember_a5a15769-07f1-4773-aca0-45a1fd95642c" xlink:href="sgmo-20220930.xsd#sgmo_SanofiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9bc8c31e-8f5b-4944-a6bc-0616f7602e5c" xlink:to="loc_sgmo_SanofiMember_a5a15769-07f1-4773-aca0-45a1fd95642c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e76356b2-bead-4aa6-a1fd-a94552048690" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_5386350a-5a89-49b0-9b3f-94ce6d02e70e" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e76356b2-bead-4aa6-a1fd-a94552048690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_2a7caafe-98d9-4530-94b7-204e42acf0b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_e76356b2-bead-4aa6-a1fd-a94552048690" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_2a7caafe-98d9-4530-94b7-204e42acf0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInCollaborationAgreementScopeMember_cb613757-5bbe-4d30-8aa5-1f4281962481" xlink:href="sgmo-20220930.xsd#sgmo_ChangeInCollaborationAgreementScopeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_2a7caafe-98d9-4530-94b7-204e42acf0b0" xlink:to="loc_sgmo_ChangeInCollaborationAgreementScopeMember_cb613757-5bbe-4d30-8aa5-1f4281962481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_7b5ee8a0-937d-46cf-8694-63900167d449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_5386350a-5a89-49b0-9b3f-94ce6d02e70e" xlink:to="loc_us-gaap_TypeOfArrangementAxis_7b5ee8a0-937d-46cf-8694-63900167d449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09f359d8-f049-4016-afef-62a454cfd488" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_7b5ee8a0-937d-46cf-8694-63900167d449" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09f359d8-f049-4016-afef-62a454cfd488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_17875a2f-dc43-417f-b246-ef1c52fb4275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_09f359d8-f049-4016-afef-62a454cfd488" xlink:to="loc_us-gaap_CollaborativeArrangementMember_17875a2f-dc43-417f-b246-ef1c52fb4275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfChangeInAccountingEstimateTable_5386350a-5a89-49b0-9b3f-94ce6d02e70e" xlink:to="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9d244eb-ddbc-4c44-a3b0-1fca72f68f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9d244eb-ddbc-4c44-a3b0-1fca72f68f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_57b18a86-efde-4eab-87c1-dad667e987c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:to="loc_us-gaap_ProfitLoss_57b18a86-efde-4eab-87c1-dad667e987c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_6539c5e9-b299-4ce3-bf6c-623d53046afe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:to="loc_us-gaap_EarningsPerShareBasic_6539c5e9-b299-4ce3-bf6c-623d53046afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_a00d9687-2016-4577-b974-58e3a3defb4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_a00d9687-2016-4577-b974-58e3a3defb4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_4a116fbb-8349-4ae3-8030-42b63c18b75b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateLineItems_c480652c-05da-4334-93fd-7652b26bd7f4" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_4a116fbb-8349-4ae3-8030-42b63c18b75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d784d13-7d58-47e3-bc00-2e70b97ef623" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_a8da231c-fe51-4adc-acd6-674b320daeb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_7d784d13-7d58-47e3-bc00-2e70b97ef623" xlink:to="loc_us-gaap_ConcentrationRiskTable_a8da231c-fe51-4adc-acd6-674b320daeb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ae50edd2-2c5b-41b8-b9ba-d5d261e43eac" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_a8da231c-fe51-4adc-acd6-674b320daeb1" xlink:to="loc_srt_CounterpartyNameAxis_ae50edd2-2c5b-41b8-b9ba-d5d261e43eac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ae50edd2-2c5b-41b8-b9ba-d5d261e43eac" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_5388cd54-826f-4640-85f8-66073c5d1dad" xlink:href="sgmo-20220930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_5388cd54-826f-4640-85f8-66073c5d1dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_52fcd807-82f1-4c35-9386-72bbb0c98965" xlink:href="sgmo-20220930.xsd#sgmo_BiogenMAIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:to="loc_sgmo_BiogenMAIncMember_52fcd807-82f1-4c35-9386-72bbb0c98965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_b46ecb58-fe7e-4c95-9c96-cea8856d03aa" xlink:href="sgmo-20220930.xsd#sgmo_KitePharmaIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:to="loc_sgmo_KitePharmaIncMember_b46ecb58-fe7e-4c95-9c96-cea8856d03aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SanofiMember_895ff8a3-8171-4ef3-a2fe-f21f468a86aa" xlink:href="sgmo-20220930.xsd#sgmo_SanofiMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d6d09d28-a3c9-4e25-9c22-0d348284d2bf" xlink:to="loc_sgmo_SanofiMember_895ff8a3-8171-4ef3-a2fe-f21f468a86aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_17fb0a8a-8791-438e-bab3-97fb9b87eeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_a8da231c-fe51-4adc-acd6-674b320daeb1" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_17fb0a8a-8791-438e-bab3-97fb9b87eeeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c1eba313-9625-420f-b38a-cbf635802fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_17fb0a8a-8791-438e-bab3-97fb9b87eeeb" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c1eba313-9625-420f-b38a-cbf635802fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_d1acb0ff-4227-4e23-bec5-558c48fed5db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c1eba313-9625-420f-b38a-cbf635802fe5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_d1acb0ff-4227-4e23-bec5-558c48fed5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_2db42d85-2cfa-4898-99e3-c1945d95cc69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_a8da231c-fe51-4adc-acd6-674b320daeb1" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_2db42d85-2cfa-4898-99e3-c1945d95cc69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e4789a35-78b7-4426-8203-69a074fdc6df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2db42d85-2cfa-4898-99e3-c1945d95cc69" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e4789a35-78b7-4426-8203-69a074fdc6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_a025d297-e375-4cc2-9666-2c33f90693d9" xlink:href="sgmo-20220930.xsd#sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_e4789a35-78b7-4426-8203-69a074fdc6df" xlink:to="loc_sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember_a025d297-e375-4cc2-9666-2c33f90693d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_48b2b1c2-bad1-4203-b1ed-0559360086fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_a8da231c-fe51-4adc-acd6-674b320daeb1" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_48b2b1c2-bad1-4203-b1ed-0559360086fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_52e8a4a4-d9df-4aa5-b858-bc0127d47c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_48b2b1c2-bad1-4203-b1ed-0559360086fe" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_52e8a4a4-d9df-4aa5-b858-bc0127d47c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f446ac9e-4b3a-49db-a15c-80d879e6d692" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0587c14f-a01d-4b3d-91d6-5485e6ab183d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f446ac9e-4b3a-49db-a15c-80d879e6d692" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_0587c14f-a01d-4b3d-91d6-5485e6ab183d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_6e56311b-bbd3-4ddd-a27b-6d15b1f6e3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f446ac9e-4b3a-49db-a15c-80d879e6d692" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent_6e56311b-bbd3-4ddd-a27b-6d15b1f6e3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cfc11dae-3d23-4ecb-8b47-0157e5702455" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f446ac9e-4b3a-49db-a15c-80d879e6d692" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cfc11dae-3d23-4ecb-8b47-0157e5702455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#FAIRVALUEMEASUREMENTSDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b1754d50-37fd-4de6-8f7c-02cd4338558c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f7aa807-a2ed-47c2-ad64-582322e4ad15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b1754d50-37fd-4de6-8f7c-02cd4338558c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f7aa807-a2ed-47c2-ad64-582322e4ad15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73259926-673d-436c-9ad7-cc868a69a868" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f7aa807-a2ed-47c2-ad64-582322e4ad15" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73259926-673d-436c-9ad7-cc868a69a868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_887b4320-9ee4-43d2-b7f3-7d2d425d0157" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_73259926-673d-436c-9ad7-cc868a69a868" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_887b4320-9ee4-43d2-b7f3-7d2d425d0157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_7db0b285-b314-49c6-9706-c059c866ba07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_887b4320-9ee4-43d2-b7f3-7d2d425d0157" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_7db0b285-b314-49c6-9706-c059c866ba07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0c2dea82-09df-4bab-8561-ca72eeafc45d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f7aa807-a2ed-47c2-ad64-582322e4ad15" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0c2dea82-09df-4bab-8561-ca72eeafc45d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4153308-79f7-4ffa-8c59-c282ba4c8e32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0c2dea82-09df-4bab-8561-ca72eeafc45d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4153308-79f7-4ffa-8c59-c282ba4c8e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_39a2b31d-4eda-47d7-a256-e9d4ca916e63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4153308-79f7-4ffa-8c59-c282ba4c8e32" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_39a2b31d-4eda-47d7-a256-e9d4ca916e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_06c95684-75f0-4e54-b4b2-bcb5bf45822b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4153308-79f7-4ffa-8c59-c282ba4c8e32" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_06c95684-75f0-4e54-b4b2-bcb5bf45822b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_e1b8de4e-5861-4872-9618-465f142ee910" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_b4153308-79f7-4ffa-8c59-c282ba4c8e32" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_e1b8de4e-5861-4872-9618-465f142ee910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_81259eec-9618-4ca0-b81d-bd38827c6632" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f7aa807-a2ed-47c2-ad64-582322e4ad15" xlink:to="loc_us-gaap_FinancialInstrumentAxis_81259eec-9618-4ca0-b81d-bd38827c6632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_81259eec-9618-4ca0-b81d-bd38827c6632" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_5db33f31-8e46-4e93-8c47-4d0c20bf16af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_MoneyMarketFundsMember_5db33f31-8e46-4e93-8c47-4d0c20bf16af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_b2381fef-4215-4932-bc50-57661a13c993" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_b2381fef-4215-4932-bc50-57661a13c993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6e102093-937b-43f5-a349-b622512fea08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_CommercialPaperMember_6e102093-937b-43f5-a349-b622512fea08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_a64b767a-c439-4b79-8e05-171ec026164a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_a64b767a-c439-4b79-8e05-171ec026164a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_90f84c77-962d-4cd3-aa66-712a12822754" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_90f84c77-962d-4cd3-aa66-712a12822754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_30477f82-8dd8-4b99-ae9b-c9e1ccb4136b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_30477f82-8dd8-4b99-ae9b-c9e1ccb4136b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_df59ddb1-2ca1-42b0-a2f4-4a3765a2b11f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1c5ac86b-876a-4c0c-ac98-9c2f1dcdbe43" xlink:to="loc_us-gaap_CertificatesOfDepositMember_df59ddb1-2ca1-42b0-a2f4-4a3765a2b11f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6a94942e-54f9-4546-907f-b211513a0ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1f7aa807-a2ed-47c2-ad64-582322e4ad15" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6a94942e-54f9-4546-907f-b211513a0ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f9fa7dd5-5ed7-4711-8de5-2a1d51bee10d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6a94942e-54f9-4546-907f-b211513a0ed1" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f9fa7dd5-5ed7-4711-8de5-2a1d51bee10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_49ffdeb9-eb2d-470e-8f4d-7710e0e096a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6a94942e-54f9-4546-907f-b211513a0ed1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_49ffdeb9-eb2d-470e-8f4d-7710e0e096a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_7ae64afa-4106-4fb5-89e9-a615e429db4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_6a94942e-54f9-4546-907f-b211513a0ed1" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_7ae64afa-4106-4fb5-89e9-a615e429db4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_27238c27-5d2f-4bf9-85eb-e15609d0f49c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_36fd7b78-282f-43ce-9cef-165ee5789d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_27238c27-5d2f-4bf9-85eb-e15609d0f49c" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_36fd7b78-282f-43ce-9cef-165ee5789d5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4cd92c43-6c6a-44f7-8d8f-b88a7357db54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_36fd7b78-282f-43ce-9cef-165ee5789d5a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4cd92c43-6c6a-44f7-8d8f-b88a7357db54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4cd92c43-6c6a-44f7-8d8f-b88a7357db54" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_62ce4b94-aad9-408d-a465-d3a901fc6bec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_MoneyMarketFundsMember_62ce4b94-aad9-408d-a465-d3a901fc6bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_070b0b08-db9b-4480-8e9a-433fc048834d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashEquivalentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_CashEquivalentsMember_070b0b08-db9b-4480-8e9a-433fc048834d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_7c61f5f3-14ae-43e6-881e-e3dc9c19fc53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember_7c61f5f3-14ae-43e6-881e-e3dc9c19fc53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_d4caba1e-40e4-4c9e-a7a9-fac730e14d1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_CommercialPaperMember_d4caba1e-40e4-4c9e-a7a9-fac730e14d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_c7018487-c8bf-4d4f-9b3d-2899a89d5dec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_c7018487-c8bf-4d4f-9b3d-2899a89d5dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_0fcacabd-9c49-48bd-bf44-97bfd1e9254c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_0fcacabd-9c49-48bd-bf44-97bfd1e9254c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasurySecuritiesMember_ec61bbd9-7b6b-458f-a5a0-80dc547b804f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasurySecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_USTreasurySecuritiesMember_ec61bbd9-7b6b-458f-a5a0-80dc547b804f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_0140e134-667d-4900-9a63-59be3a17e1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_8b8dd3a8-cc98-44a0-bd49-521e9e4ff3b5" xlink:to="loc_us-gaap_CertificatesOfDepositMember_0140e134-667d-4900-9a63-59be3a17e1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_36fd7b78-282f-43ce-9cef-165ee5789d5a" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:to="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f3b21747-ac5c-4fcc-88c1-37ca362de53c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f3b21747-ac5c-4fcc-88c1-37ca362de53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax_722cce62-ce09-4dbb-afc8-be18ec0c5545" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax_722cce62-ce09-4dbb-afc8-be18ec0c5545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax_acde41e4-d2cc-4073-8cbd-a9071dbeca26" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax_acde41e4-d2cc-4073-8cbd-a9071dbeca26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1360a85f-cd7f-4dbf-bbd9-07e3e70a9504" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_1360a85f-cd7f-4dbf-bbd9-07e3e70a9504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7e12c97c-c5a8-49c9-aac7-652567bea54a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7e12c97c-c5a8-49c9-aac7-652567bea54a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6dab650a-f31f-44a9-81c0-48a3f54e585c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6dab650a-f31f-44a9-81c0-48a3f54e585c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_464bbbda-8114-470b-b000-7468d1c47efb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_464bbbda-8114-470b-b000-7468d1c47efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c8f40ebe-0753-4d27-b954-0b134bd57e6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_44d9050d-2fd6-4382-b37e-95524e38196d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_c8f40ebe-0753-4d27-b954-0b134bd57e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_fe61f014-7da6-436a-8b25-f7104e8ca7e0" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost_fe61f014-7da6-436a-8b25-f7104e8ca7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_813999af-9a46-4c8f-8461-08f96e065031" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax_813999af-9a46-4c8f-8461-08f96e065031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_71338c78-84eb-42ea-85eb-50cd5715da18" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax_71338c78-84eb-42ea-85eb-50cd5715da18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_b3bb9ccf-c1cd-4cdf-acff-60801d11ead3" xlink:href="sgmo-20220930.xsd#sgmo_CashEquivalentsAndAvailableForSaleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_5b042bb1-57c4-433f-9722-7fadc047cfb9" xlink:to="loc_sgmo_CashEquivalentsAndAvailableForSaleSecurities_b3bb9ccf-c1cd-4cdf-acff-60801d11ead3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_dd1b1323-24f5-4493-bdf0-0899d8bfa0a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_54730e7b-c9ce-41ab-a9ed-d9ffcb9a7af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_dd1b1323-24f5-4493-bdf0-0899d8bfa0a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_54730e7b-c9ce-41ab-a9ed-d9ffcb9a7af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_08f4f8e5-d171-4cfd-baae-19bc92c20f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_dd1b1323-24f5-4493-bdf0-0899d8bfa0a3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_08f4f8e5-d171-4cfd-baae-19bc92c20f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents_54f598eb-e957-416f-908a-049ada5e5c7d" xlink:href="sgmo-20220930.xsd#sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_dd1b1323-24f5-4493-bdf0-0899d8bfa0a3" xlink:to="loc_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents_54f598eb-e957-416f-908a-049ada5e5c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetails" xlink:type="simple" xlink:href="sgmo-20220930.xsd#CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc655166-fa79-4ca1-a608-5469fc40aaae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealizedInvestmentGainsLosses_661364a8-dba4-422e-91ca-cb12cc56b32b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RealizedInvestmentGainsLosses"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc655166-fa79-4ca1-a608-5469fc40aaae" xlink:to="loc_us-gaap_RealizedInvestmentGainsLosses_661364a8-dba4-422e-91ca-cb12cc56b32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_bb970284-ba94-4f60-9933-401fce28ec31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc655166-fa79-4ca1-a608-5469fc40aaae" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded_bb970284-ba94-4f60-9933-401fce28ec31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_d0e652de-1c64-4269-86e7-0cfc26bcb81f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc655166-fa79-4ca1-a608-5469fc40aaae" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_d0e652de-1c64-4269-86e7-0cfc26bcb81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a2fe4d83-e1ea-407e-92f8-93a061e4ab8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_bc655166-fa79-4ca1-a608-5469fc40aaae" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_a2fe4d83-e1ea-407e-92f8-93a061e4ab8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREAdditionalInformationDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#BASICANDDILUTEDNETLOSSPERSHAREAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_51d6f3b0-b8e0-407e-af43-c22ae2bb2f86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_42188617-4e42-48c9-9550-3ac4e2568728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_51d6f3b0-b8e0-407e-af43-c22ae2bb2f86" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_42188617-4e42-48c9-9550-3ac4e2568728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2c8736f4-e028-4920-9f2b-de1caaca8419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_972e5e3d-cce5-4aa5-bb3c-e5f82a70180d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2c8736f4-e028-4920-9f2b-de1caaca8419" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_972e5e3d-cce5-4aa5-bb3c-e5f82a70180d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_840e65ba-9961-432b-9c6d-749c6de7257b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_972e5e3d-cce5-4aa5-bb3c-e5f82a70180d" xlink:to="loc_srt_CounterpartyNameAxis_840e65ba-9961-432b-9c6d-749c6de7257b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_24649189-e3d7-48d1-8f75-2f094ca6b75b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_840e65ba-9961-432b-9c6d-749c6de7257b" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_24649189-e3d7-48d1-8f75-2f094ca6b75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_bc768082-4874-4040-bf9e-06854f26bbcb" xlink:href="sgmo-20220930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_24649189-e3d7-48d1-8f75-2f094ca6b75b" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_bc768082-4874-4040-bf9e-06854f26bbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_9edf9e10-8695-4c5c-81ae-0bf6e83736cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_972e5e3d-cce5-4aa5-bb3c-e5f82a70180d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_9edf9e10-8695-4c5c-81ae-0bf6e83736cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ce7aabc2-c4c4-40af-b718-c95ba694f18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_9edf9e10-8695-4c5c-81ae-0bf6e83736cd" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ce7aabc2-c4c4-40af-b718-c95ba694f18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_1a457085-04c2-48dc-bcb3-65b10dfe68bb" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ce7aabc2-c4c4-40af-b718-c95ba694f18d" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_1a457085-04c2-48dc-bcb3-65b10dfe68bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_f4e4c655-0f3a-4f7b-b573-5a1dabffc0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_972e5e3d-cce5-4aa5-bb3c-e5f82a70180d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_f4e4c655-0f3a-4f7b-b573-5a1dabffc0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_218d9e11-3454-4d6e-8c63-80a99ea8ce28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_f4e4c655-0f3a-4f7b-b573-5a1dabffc0fd" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_218d9e11-3454-4d6e-8c63-80a99ea8ce28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_e35a56fb-0ec1-495f-afe3-2bd532a2dd83" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_218d9e11-3454-4d6e-8c63-80a99ea8ce28" xlink:to="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_e35a56fb-0ec1-495f-afe3-2bd532a2dd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfCommercialMilestonesMember_664f6194-c6e1-4c61-9880-e2f9a458f48a" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfCommercialMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_218d9e11-3454-4d6e-8c63-80a99ea8ce28" xlink:to="loc_sgmo_AchievementOfCommercialMilestonesMember_664f6194-c6e1-4c61-9880-e2f9a458f48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_972e5e3d-cce5-4aa5-bb3c-e5f82a70180d" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_6e0b2d78-4df1-423d-912e-6ff88ce1cec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_us-gaap_ProceedsFromCollaborators_6e0b2d78-4df1-423d-912e-6ff88ce1cec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_8712d999-73d5-4580-89c9-28bee6dee82c" xlink:href="sgmo-20220930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_8712d999-73d5-4580-89c9-28bee6dee82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_cd72e457-de78-4825-bacf-43ffa884437e" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_cd72e457-de78-4825-bacf-43ffa884437e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementLicenseFee_3089a5a9-3035-4003-8cdd-a162a0361574" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementLicenseFee"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CollaborativeArrangementLicenseFee_3089a5a9-3035-4003-8cdd-a162a0361574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_52a9d774-a2f7-4fb0-8021-83bcce85f9ca" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_52a9d774-a2f7-4fb0-8021-83bcce85f9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_455d90d9-cbd1-4fa8-9120-f2eb7a5ef431" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_455d90d9-cbd1-4fa8-9120-f2eb7a5ef431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_d7b4b9a7-0c0f-435e-9064-f323da47bea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_us-gaap_ContractWithCustomerLiability_d7b4b9a7-0c0f-435e-9064-f323da47bea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_7e72eb66-ac9e-4a8e-aa76-5e49bfb6999f" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_7e72eb66-ac9e-4a8e-aa76-5e49bfb6999f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_9da1f3ad-89bf-4b01-911d-3a2455475a1f" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementPercentOfInitialRecognition"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_9da1f3ad-89bf-4b01-911d-3a2455475a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostGross_ddb4441d-2838-48f0-a048-837d2d5acb79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedContractCostGross"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_us-gaap_CapitalizedContractCostGross_ddb4441d-2838-48f0-a048-837d2d5acb79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_2d63944b-f3cc-4caf-b79f-c309e401a9a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ae628e28-df76-4ec8-869f-d77401552fa7" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_2d63944b-f3cc-4caf-b79f-c309e401a9a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_407924b4-2637-4aae-b0f7-108545a8c7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8f4a02b2-b1d5-4e66-bb33-2c0e6bb48bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_407924b4-2637-4aae-b0f7-108545a8c7c5" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8f4a02b2-b1d5-4e66-bb33-2c0e6bb48bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ef516252-f0ff-4ad9-ab40-fe89f81808b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8f4a02b2-b1d5-4e66-bb33-2c0e6bb48bd0" xlink:to="loc_srt_CounterpartyNameAxis_ef516252-f0ff-4ad9-ab40-fe89f81808b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ef516252-f0ff-4ad9-ab40-fe89f81808b6" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_9b7bf532-cf04-4187-9d23-1b527cd5c166" xlink:href="sgmo-20220930.xsd#sgmo_NovartisInstitutesForBioMedicalResearchIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:to="loc_sgmo_NovartisInstitutesForBioMedicalResearchIncMember_9b7bf532-cf04-4187-9d23-1b527cd5c166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_74859d78-5576-4357-8c9c-4a2fe8358a02" xlink:href="sgmo-20220930.xsd#sgmo_BiogenMAIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:to="loc_sgmo_BiogenMAIncMember_74859d78-5576-4357-8c9c-4a2fe8358a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_74767b4b-26b1-4f74-babe-ce1f10fa3aae" xlink:href="sgmo-20220930.xsd#sgmo_KitePharmaIncMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:to="loc_sgmo_KitePharmaIncMember_74767b4b-26b1-4f74-babe-ce1f10fa3aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SanofiMember_bf5a5ec6-722f-497e-8fba-5c56c97e4504" xlink:href="sgmo-20220930.xsd#sgmo_SanofiMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9fcc58b1-7cce-4a8d-a5b5-a420b48e97ee" xlink:to="loc_sgmo_SanofiMember_bf5a5ec6-722f-497e-8fba-5c56c97e4504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b119a6ab-1246-4ab1-b4a8-34a7e4214dbb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8f4a02b2-b1d5-4e66-bb33-2c0e6bb48bd0" xlink:to="loc_srt_ProductOrServiceAxis_b119a6ab-1246-4ab1-b4a8-34a7e4214dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_31ca373a-32f8-414f-9e1c-8c55562e6e5a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b119a6ab-1246-4ab1-b4a8-34a7e4214dbb" xlink:to="loc_srt_ProductsAndServicesDomain_31ca373a-32f8-414f-9e1c-8c55562e6e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseAndServiceMember_1b7e63c1-8c34-4974-962f-6f70e7ef0bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicenseAndServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_31ca373a-32f8-414f-9e1c-8c55562e6e5a" xlink:to="loc_us-gaap_LicenseAndServiceMember_1b7e63c1-8c34-4974-962f-6f70e7ef0bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchServicesMember_7a5dfb19-6f09-4866-8caf-f5dcfafae2af" xlink:href="sgmo-20220930.xsd#sgmo_ResearchServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_31ca373a-32f8-414f-9e1c-8c55562e6e5a" xlink:to="loc_sgmo_ResearchServicesMember_7a5dfb19-6f09-4866-8caf-f5dcfafae2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneAchievementMember_1dbaea9c-cdea-4289-b6e4-df86743539ec" xlink:href="sgmo-20220930.xsd#sgmo_MilestoneAchievementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_31ca373a-32f8-414f-9e1c-8c55562e6e5a" xlink:to="loc_sgmo_MilestoneAchievementMember_1dbaea9c-cdea-4289-b6e4-df86743539ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_14127a8c-681a-40c2-a08d-7bab684cf292" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_8f4a02b2-b1d5-4e66-bb33-2c0e6bb48bd0" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_14127a8c-681a-40c2-a08d-7bab684cf292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ea00675-f435-48d5-8104-7949a8bdaf78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_14127a8c-681a-40c2-a08d-7bab684cf292" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4ea00675-f435-48d5-8104-7949a8bdaf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fef36e7d-2cc5-40ad-92b6-cae3eef65203" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_e115b23b-fa7d-4114-91e9-8099b1f6a516" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fef36e7d-2cc5-40ad-92b6-cae3eef65203" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_e115b23b-fa7d-4114-91e9-8099b1f6a516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_433f02d7-3160-42c2-ba62-166cf78df33e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_e115b23b-fa7d-4114-91e9-8099b1f6a516" xlink:to="loc_srt_CounterpartyNameAxis_433f02d7-3160-42c2-ba62-166cf78df33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bce98b18-b463-4e54-9a4e-c8a1b9212113" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_433f02d7-3160-42c2-ba62-166cf78df33e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bce98b18-b463-4e54-9a4e-c8a1b9212113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_BiogenMAIncMember_e70306dc-4091-45af-a8b3-74eaf2a8ee94" xlink:href="sgmo-20220930.xsd#sgmo_BiogenMAIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_bce98b18-b463-4e54-9a4e-c8a1b9212113" xlink:to="loc_sgmo_BiogenMAIncMember_e70306dc-4091-45af-a8b3-74eaf2a8ee94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f6c78805-a6c0-478b-a0d4-1cd7040c5e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_e115b23b-fa7d-4114-91e9-8099b1f6a516" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f6c78805-a6c0-478b-a0d4-1cd7040c5e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ca75b5e7-858c-4a7b-882c-15bea991d2e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f6c78805-a6c0-478b-a0d4-1cd7040c5e6b" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ca75b5e7-858c-4a7b-882c-15bea991d2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockPurchaseAgreementMember_ea9a6a50-0856-4c6d-8734-c8be1d6029e5" xlink:href="sgmo-20220930.xsd#sgmo_StockPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ca75b5e7-858c-4a7b-882c-15bea991d2e9" xlink:to="loc_sgmo_StockPurchaseAgreementMember_ea9a6a50-0856-4c6d-8734-c8be1d6029e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_dad90101-8885-4513-a5a8-b18f6d81d43b" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ca75b5e7-858c-4a7b-882c-15bea991d2e9" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_dad90101-8885-4513-a5a8-b18f6d81d43b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneAxis_90a09493-c95d-4f7b-8599-eb5dfc3115ea" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_e115b23b-fa7d-4114-91e9-8099b1f6a516" xlink:to="loc_sgmo_CollaborativeAgreementMilestoneAxis_90a09493-c95d-4f7b-8599-eb5dfc3115ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneDomain_b1f4f9be-a286-4434-b83f-0738beba2af3" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneAxis_90a09493-c95d-4f7b-8599-eb5dfc3115ea" xlink:to="loc_sgmo_CollaborativeAgreementMilestoneDomain_b1f4f9be-a286-4434-b83f-0738beba2af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PreApprovalMilestoneMember_0ffe576a-9104-411c-8268-acb904081152" xlink:href="sgmo-20220930.xsd#sgmo_PreApprovalMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneDomain_b1f4f9be-a286-4434-b83f-0738beba2af3" xlink:to="loc_sgmo_PreApprovalMilestoneMember_0ffe576a-9104-411c-8268-acb904081152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SalesBasedMilestoneMember_52d871ba-0893-46ed-9351-5635d18a136f" xlink:href="sgmo-20220930.xsd#sgmo_SalesBasedMilestoneMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneDomain_b1f4f9be-a286-4434-b83f-0738beba2af3" xlink:to="loc_sgmo_SalesBasedMilestoneMember_52d871ba-0893-46ed-9351-5635d18a136f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_e115b23b-fa7d-4114-91e9-8099b1f6a516" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_079c5a6a-a7c9-4e60-b649-29b5fe80ff68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_079c5a6a-a7c9-4e60-b649-29b5fe80ff68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_a5ecb94f-4837-4e9c-af35-49caacd67485" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_a5ecb94f-4837-4e9c-af35-49caacd67485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_961f5be7-b732-43bf-a307-6aa753a2a951" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_961f5be7-b732-43bf-a307-6aa753a2a951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_b31720d2-4f13-47a1-b5ce-078dbe934101" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_ProceedsFromCollaborators_b31720d2-4f13-47a1-b5ce-078dbe934101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable_4a81c131-a41e-4327-b636-7811d2258ad2" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable_4a81c131-a41e-4327-b636-7811d2258ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_2ea32efa-1d8e-43ff-9902-5fc2d327f0d0" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAgreementNumberOfAdditionalProductTargets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets_2ea32efa-1d8e-43ff-9902-5fc2d327f0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementRemainingPeriod_5917813b-4d71-4d93-8e16-b7c1e7444ea3" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAgreementRemainingPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborationAgreementRemainingPeriod_5917813b-4d71-4d93-8e16-b7c1e7444ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected_6fa2802b-a85a-46cf-8b07-6b5f57a82fe4" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementNumberOfProductTargetsSelected"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected_6fa2802b-a85a-46cf-8b07-6b5f57a82fe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationArrangementResearchPeriod_f2d4002d-8b8f-4f1a-8ce8-0c4e724dafa3" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationArrangementResearchPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborationArrangementResearchPeriod_f2d4002d-8b8f-4f1a-8ce8-0c4e724dafa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace_41a8c4bf-b5e8-4cfd-8945-d966b13284f0" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace_41a8c4bf-b5e8-4cfd-8945-d966b13284f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementStandstillRestrictionPeriod_c7e26434-43b5-4698-83d9-d2bab523534c" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementStandstillRestrictionPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementStandstillRestrictionPeriod_c7e26434-43b5-4698-83d9-d2bab523534c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage_3014d5e2-6e5a-4a11-9ee2-afba65220f9e" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage_3014d5e2-6e5a-4a11-9ee2-afba65220f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_be33c3f6-213d-4357-90ba-f3c4296a1827" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_be33c3f6-213d-4357-90ba-f3c4296a1827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_e710551e-2c4e-4154-a83a-ca90bdbf6947" xlink:href="sgmo-20220930.xsd#sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction_e710551e-2c4e-4154-a83a-ca90bdbf6947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAgreementEquityIssued_f86ced7b-801a-4b6a-a14b-a9ac482f64e3" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAgreementEquityIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborationAgreementEquityIssued_f86ced7b-801a-4b6a-a14b-a9ac482f64e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_3a47c7b6-21c5-4823-9ad0-b0c454b6d655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_3a47c7b6-21c5-4823-9ad0-b0c454b6d655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_952ab2d8-c508-43b0-b532-f2de18919800" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_ContractWithCustomerLiability_952ab2d8-c508-43b0-b532-f2de18919800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_4dbe10eb-dab4-4931-befe-3ef2f20ea49c" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue_4dbe10eb-dab4-4931-befe-3ef2f20ea49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_80e8bbd4-5a5e-46a5-a2f5-6c4665ebaca1" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementPercentOfInitialRecognition"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_sgmo_CollaborativeAgreementPercentOfInitialRecognition_80e8bbd4-5a5e-46a5-a2f5-6c4665ebaca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_4ff1fc6d-f3d1-4c68-9c0f-517b3a5a14c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_4ff1fc6d-f3d1-4c68-9c0f-517b3a5a14c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_c2f829f1-53b7-496c-9814-ebc5346c52e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSoldAmortization"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSoldAmortization_c2f829f1-53b7-496c-9814-ebc5346c52e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_ad0a378e-cb39-4104-a4d7-4c8749826f74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ecbbbc0c-e651-42a6-aab4-d552998b2483" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_ad0a378e-cb39-4104-a4d7-4c8749826f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb856058-f08a-4fb0-976b-64306e23068e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_968a847a-2adb-45c9-8970-3284accd85f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb856058-f08a-4fb0-976b-64306e23068e" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_968a847a-2adb-45c9-8970-3284accd85f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e2664143-af43-4910-ab09-84ac262ce0b0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_968a847a-2adb-45c9-8970-3284accd85f8" xlink:to="loc_srt_CounterpartyNameAxis_e2664143-af43-4910-ab09-84ac262ce0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f94fa7bc-57db-447c-82ca-47f08f94d024" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e2664143-af43-4910-ab09-84ac262ce0b0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f94fa7bc-57db-447c-82ca-47f08f94d024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_KitePharmaIncMember_b526f9f4-63f5-48bc-b14f-8e6bb529231e" xlink:href="sgmo-20220930.xsd#sgmo_KitePharmaIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f94fa7bc-57db-447c-82ca-47f08f94d024" xlink:to="loc_sgmo_KitePharmaIncMember_b526f9f4-63f5-48bc-b14f-8e6bb529231e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_09c5f437-4066-4114-97c7-9b2c95a7e378" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_968a847a-2adb-45c9-8970-3284accd85f8" xlink:to="loc_us-gaap_TypeOfArrangementAxis_09c5f437-4066-4114-97c7-9b2c95a7e378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a3939d9f-942f-4cdd-9849-027f517ab448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_09c5f437-4066-4114-97c7-9b2c95a7e378" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a3939d9f-942f-4cdd-9849-027f517ab448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_df460ccf-0b60-4002-a4c4-d584c3bec03a" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a3939d9f-942f-4cdd-9849-027f517ab448" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_df460ccf-0b60-4002-a4c4-d584c3bec03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_56cffe0d-984b-4eae-9895-823c129d2c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_968a847a-2adb-45c9-8970-3284accd85f8" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_56cffe0d-984b-4eae-9895-823c129d2c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_faa60219-accc-4f3a-8b67-f2c8aa164005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_56cffe0d-984b-4eae-9895-823c129d2c54" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_faa60219-accc-4f3a-8b67-f2c8aa164005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_c64c62b1-053d-4133-b826-2d2f4719a59e" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_faa60219-accc-4f3a-8b67-f2c8aa164005" xlink:to="loc_sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember_c64c62b1-053d-4133-b826-2d2f4719a59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_603507aa-c5c5-49b3-9865-fac0ab3a207b" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_faa60219-accc-4f3a-8b67-f2c8aa164005" xlink:to="loc_sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember_603507aa-c5c5-49b3-9865-fac0ab3a207b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_968a847a-2adb-45c9-8970-3284accd85f8" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestonePaymentsReceived_d4e47d9d-d847-4677-9654-1b36de4ef342" xlink:href="sgmo-20220930.xsd#sgmo_MilestonePaymentsReceived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_MilestonePaymentsReceived_d4e47d9d-d847-4677-9654-1b36de4ef342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_0241263d-0d77-48fa-97bc-0592bb796e30" xlink:href="sgmo-20220930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_0241263d-0d77-48fa-97bc-0592bb796e30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_2becf266-2d28-4269-b81a-46125fc080d1" xlink:href="sgmo-20220930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived_2becf266-2d28-4269-b81a-46125fc080d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment_b424e176-2485-4f00-938d-7130475fb223" xlink:href="sgmo-20220930.xsd#sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment_b424e176-2485-4f00-938d-7130475fb223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_InitialResearchTermOfAgreement_138343f7-234c-40d6-994f-83db2f01326d" xlink:href="sgmo-20220930.xsd#sgmo_InitialResearchTermOfAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_InitialResearchTermOfAgreement_138343f7-234c-40d6-994f-83db2f01326d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm_7476fa4d-f745-4871-9cdf-99b7aa1c2b9a" xlink:href="sgmo-20220930.xsd#sgmo_NumberOfOptionsToExtendInitialResearchTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_NumberOfOptionsToExtendInitialResearchTerm_7476fa4d-f745-4871-9cdf-99b7aa1c2b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ExtendedResearchTermOfAgreement_b55e3c71-baf3-4b26-8f0c-a455bfed09b4" xlink:href="sgmo-20220930.xsd#sgmo_ExtendedResearchTermOfAgreement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_ExtendedResearchTermOfAgreement_b55e3c71-baf3-4b26-8f0c-a455bfed09b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SeparateUpfrontFee_9a87ea71-9181-4559-8786-f018616aabff" xlink:href="sgmo-20220930.xsd#sgmo_SeparateUpfrontFee"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_SeparateUpfrontFee_9a87ea71-9181-4559-8786-f018616aabff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan_88d1d385-3079-4bee-acb3-a66ec9b7a6fc" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan_88d1d385-3079-4bee-acb3-a66ec9b7a6fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_63dd8b48-50af-40bb-8bd6-f5c1f7e18ed7" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_63dd8b48-50af-40bb-8bd6-f5c1f7e18ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_63948fe4-3cd6-4d79-9d25-0d4cb5869fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_63948fe4-3cd6-4d79-9d25-0d4cb5869fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_b6947874-1ee9-4524-8b4f-2c9729f9613b" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_b6947874-1ee9-4524-8b4f-2c9729f9613b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_82a25fd0-d3cd-46d3-a50e-10b4964ad913" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_82a25fd0-d3cd-46d3-a50e-10b4964ad913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_62cf4acc-3177-4a6c-b77a-7dd480f74911" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_ee1a331a-f452-47bf-a00f-61a16d80bdfe" xlink:to="loc_us-gaap_ContractWithCustomerLiability_62cf4acc-3177-4a6c-b77a-7dd480f74911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b744ba9d-ce71-45ef-ba66-c7c3c80f202b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b744ba9d-ce71-45ef-ba66-c7c3c80f202b" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f4a60952-64e9-40ee-8453-7142d74249f1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:to="loc_srt_CounterpartyNameAxis_f4a60952-64e9-40ee-8453-7142d74249f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0789e15b-ba3f-443a-8cec-1207f38113f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_f4a60952-64e9-40ee-8453-7142d74249f1" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0789e15b-ba3f-443a-8cec-1207f38113f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SanofiMember_c47c9b1e-1844-448d-bf39-40c46da3c34a" xlink:href="sgmo-20220930.xsd#sgmo_SanofiMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_0789e15b-ba3f-443a-8cec-1207f38113f3" xlink:to="loc_sgmo_SanofiMember_c47c9b1e-1844-448d-bf39-40c46da3c34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_c974b8a6-f294-4ffb-ab25-cd85f329a618" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:to="loc_us-gaap_TypeOfArrangementAxis_c974b8a6-f294-4ffb-ab25-cd85f329a618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8e6ea53e-a20d-4aa8-bbe2-4284f2f2b768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_c974b8a6-f294-4ffb-ab25-cd85f329a618" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8e6ea53e-a20d-4aa8-bbe2-4284f2f2b768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementMember_d2415f6a-cfc6-48a9-97ee-30e5e4ab066e" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8e6ea53e-a20d-4aa8-bbe2-4284f2f2b768" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementMember_d2415f6a-cfc6-48a9-97ee-30e5e4ab066e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_0e0801a3-d753-4d1d-803e-c99486e7dff2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_8e6ea53e-a20d-4aa8-bbe2-4284f2f2b768" xlink:to="loc_us-gaap_CollaborativeArrangementMember_0e0801a3-d753-4d1d-803e-c99486e7dff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneAxis_5fdb2db3-5da0-4283-9bd9-5ae299a25dcb" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:to="loc_sgmo_CollaborativeAgreementMilestoneAxis_5fdb2db3-5da0-4283-9bd9-5ae299a25dcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeAgreementMilestoneDomain_e89d983f-5ec0-4264-afbc-a20d99f4f6b5" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeAgreementMilestoneDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneAxis_5fdb2db3-5da0-4283-9bd9-5ae299a25dcb" xlink:to="loc_sgmo_CollaborativeAgreementMilestoneDomain_e89d983f-5ec0-4264-afbc-a20d99f4f6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneThreeMember_6f104e8c-b4cf-4f6a-bee5-8d5f60fcdd00" xlink:href="sgmo-20220930.xsd#sgmo_MilestoneThreeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sgmo_CollaborativeAgreementMilestoneDomain_e89d983f-5ec0-4264-afbc-a20d99f4f6b5" xlink:to="loc_sgmo_MilestoneThreeMember_6f104e8c-b4cf-4f6a-bee5-8d5f60fcdd00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_d5d1d1d4-1149-4bff-91fa-d8dc2ae9fda2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:to="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_d5d1d1d4-1149-4bff-91fa-d8dc2ae9fda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_c4aa45b6-cf78-42f8-ba6d-80096736019f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ChangeInAccountingEstimateTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateByTypeAxis_d5d1d1d4-1149-4bff-91fa-d8dc2ae9fda2" xlink:to="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_c4aa45b6-cf78-42f8-ba6d-80096736019f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ChangeInCollaborationAgreementScopeMember_41eda22b-ce13-469c-a274-4c4a757d3213" xlink:href="sgmo-20220930.xsd#sgmo_ChangeInCollaborationAgreementScopeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInAccountingEstimateTypeDomain_c4aa45b6-cf78-42f8-ba6d-80096736019f" xlink:to="loc_sgmo_ChangeInCollaborationAgreementScopeMember_41eda22b-ce13-469c-a274-4c4a757d3213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_b6962ac9-4e4d-41c0-8202-60ab0064c2ec" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfResearchProgram_cc43df58-5892-4ac0-9bbc-dccda2607bec" xlink:href="sgmo-20220930.xsd#sgmo_NumberOfResearchProgram"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_NumberOfResearchProgram_cc43df58-5892-4ac0-9bbc-dccda2607bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_89add2ba-df4b-44e7-939e-23bcbdaaeefe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_89add2ba-df4b-44e7-939e-23bcbdaaeefe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0b8f92d-d42c-4c92-8740-6d407cba7e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a0b8f92d-d42c-4c92-8740-6d407cba7e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_ce365aa2-730b-4f53-9830-20a3efd7b25d" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_ce365aa2-730b-4f53-9830-20a3efd7b25d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_8b5a57d0-5d43-4a5e-907d-3949a70ecdbf" xlink:href="sgmo-20220930.xsd#sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_8b5a57d0-5d43-4a5e-907d-3949a70ecdbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod_b34a2fa4-8b8d-44cb-a8f0-d91e8ea73aaf" xlink:href="sgmo-20220930.xsd#sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod_b34a2fa4-8b8d-44cb-a8f0-d91e8ea73aaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate_52b9f744-a67a-4db5-97c2-a07469a16739" xlink:href="sgmo-20220930.xsd#sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate_52b9f744-a67a-4db5-97c2-a07469a16739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate_593da2d3-c456-416a-8ff2-1b5174456d4c" xlink:href="sgmo-20220930.xsd#sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate_593da2d3-c456-416a-8ff2-1b5174456d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_858fe7b8-2546-4870-a2d4-62e849cc6a93" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_858fe7b8-2546-4870-a2d4-62e849cc6a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneRevenueReceivable_f76688d0-2d90-4621-9ecd-323682ca1f56" xlink:href="sgmo-20220930.xsd#sgmo_MilestoneRevenueReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_MilestoneRevenueReceivable_f76688d0-2d90-4621-9ecd-323682ca1f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_0b094707-555c-4a8d-bf1b-b813337786da" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts_0b094707-555c-4a8d-bf1b-b813337786da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_c06c801b-bd47-4ce6-9f04-5afa039d9ee6" xlink:href="sgmo-20220930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_c06c801b-bd47-4ce6-9f04-5afa039d9ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_a016e2fd-39f4-493f-bd73-6ab6a4e2879f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_a016e2fd-39f4-493f-bd73-6ab6a4e2879f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_4062d3ad-14da-4c75-883d-4412a0d9dd26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_ContractWithCustomerLiability_4062d3ad-14da-4c75-883d-4412a0d9dd26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense_6f65b6b6-16b4-4539-8296-c9a5f6812f5f" xlink:href="sgmo-20220930.xsd#sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense_6f65b6b6-16b4-4539-8296-c9a5f6812f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8a0c0c28-1a72-49ac-984d-5e7123c4969d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_ProfitLoss_8a0c0c28-1a72-49ac-984d-5e7123c4969d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_75d1c421-8b36-448e-98a1-1d51fdcfb80c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_EarningsPerShareDiluted_75d1c421-8b36-448e-98a1-1d51fdcfb80c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_bad0fdce-3443-4e3e-ba18-6e5c84ccecb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_6aafbd1d-5a07-4617-ba3e-d7eb10daf489" xlink:to="loc_us-gaap_EarningsPerShareBasic_bad0fdce-3443-4e3e-ba18-6e5c84ccecb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_372a36c6-e5a5-4f70-9bfe-f58fbf4508dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_372a36c6-e5a5-4f70-9bfe-f58fbf4508dc" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_ca368e47-36dc-497f-b713-81b2fd0a6a5e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:to="loc_srt_CounterpartyNameAxis_ca368e47-36dc-497f-b713-81b2fd0a6a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ac047ef6-6ab2-4e8e-a9e4-00868b2690c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_ca368e47-36dc-497f-b713-81b2fd0a6a5e" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ac047ef6-6ab2-4e8e-a9e4-00868b2690c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerMember_b8314efd-d13f-4fbd-812c-d9f5052cfa96" xlink:href="sgmo-20220930.xsd#sgmo_PfizerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ac047ef6-6ab2-4e8e-a9e4-00868b2690c3" xlink:to="loc_sgmo_PfizerMember_b8314efd-d13f-4fbd-812c-d9f5052cfa96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerSB525Member_4e883d66-c12b-483d-8d05-f591d77c3b8c" xlink:href="sgmo-20220930.xsd#sgmo_PfizerSB525Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ac047ef6-6ab2-4e8e-a9e4-00868b2690c3" xlink:to="loc_sgmo_PfizerSB525Member_4e883d66-c12b-483d-8d05-f591d77c3b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_PfizerC9ORF72Member_b0974214-a790-4afd-b757-5863d9f590ca" xlink:href="sgmo-20220930.xsd#sgmo_PfizerC9ORF72Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_ac047ef6-6ab2-4e8e-a9e4-00868b2690c3" xlink:to="loc_sgmo_PfizerC9ORF72Member_b0974214-a790-4afd-b757-5863d9f590ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_84d9a758-e09b-4ead-86eb-8f3144e6acd2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:to="loc_srt_ProductOrServiceAxis_84d9a758-e09b-4ead-86eb-8f3144e6acd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0b03b967-d367-40ec-a65d-6bad59af7c02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_84d9a758-e09b-4ead-86eb-8f3144e6acd2" xlink:to="loc_srt_ProductsAndServicesDomain_0b03b967-d367-40ec-a65d-6bad59af7c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_8a5a86c1-885d-4dd5-be63-56a0a1328058" xlink:href="sgmo-20220930.xsd#sgmo_SBFiveTwoFiveAndOtherProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0b03b967-d367-40ec-a65d-6bad59af7c02" xlink:to="loc_sgmo_SBFiveTwoFiveAndOtherProductsMember_8a5a86c1-885d-4dd5-be63-56a0a1328058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_OtherProductsMember_935893b9-8784-454d-a5fc-0e73a34b5e6a" xlink:href="sgmo-20220930.xsd#sgmo_OtherProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0b03b967-d367-40ec-a65d-6bad59af7c02" xlink:to="loc_sgmo_OtherProductsMember_935893b9-8784-454d-a5fc-0e73a34b5e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CNineORFSevenTwoMember_16a40d04-fd36-4bee-88c1-62ea5af12b75" xlink:href="sgmo-20220930.xsd#sgmo_CNineORFSevenTwoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0b03b967-d367-40ec-a65d-6bad59af7c02" xlink:to="loc_sgmo_CNineORFSevenTwoMember_16a40d04-fd36-4bee-88c1-62ea5af12b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e8d97bd9-63cb-4704-b2d3-9ab4598df2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e8d97bd9-63cb-4704-b2d3-9ab4598df2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_e8d97bd9-63cb-4704-b2d3-9ab4598df2fa" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_620cfd12-5879-479f-9444-d2007d0dc2be" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:to="loc_sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember_620cfd12-5879-479f-9444-d2007d0dc2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_8daed006-73c6-4dd0-8ec3-9fc2b8b7afe0" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:to="loc_sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember_8daed006-73c6-4dd0-8ec3-9fc2b8b7afe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfCommercialMilestonesMember_2254db73-b5a3-4ccb-bbf2-2ddafdcfc41e" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfCommercialMilestonesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:to="loc_sgmo_AchievementOfCommercialMilestonesMember_2254db73-b5a3-4ccb-bbf2-2ddafdcfc41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AchievementOfFirstCommercialSaleMilestonesMember_d49891f8-3f5c-4841-a4d2-1e0cd4da5166" xlink:href="sgmo-20220930.xsd#sgmo_AchievementOfFirstCommercialSaleMilestonesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_e1eaeefc-9ccb-4f1a-9271-757544d37edd" xlink:to="loc_sgmo_AchievementOfFirstCommercialSaleMilestonesMember_d49891f8-3f5c-4841-a4d2-1e0cd4da5166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_709a2830-2400-45e5-b933-ccd0fac9f74a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:to="loc_srt_RangeAxis_709a2830-2400-45e5-b933-ccd0fac9f74a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f88be492-8599-4dee-a352-fc95bb9c0967" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_709a2830-2400-45e5-b933-ccd0fac9f74a" xlink:to="loc_srt_RangeMember_f88be492-8599-4dee-a352-fc95bb9c0967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_89e51c6e-8153-489e-b4cd-f7109cf5610c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f88be492-8599-4dee-a352-fc95bb9c0967" xlink:to="loc_srt_MaximumMember_89e51c6e-8153-489e-b4cd-f7109cf5610c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_d3da5bd4-ae7f-44f7-814e-ad8b5a996399" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AgreementTerminationTerm_4ce36bf4-fd5a-45b5-8ac2-75d162ac48f7" xlink:href="sgmo-20220930.xsd#sgmo_AgreementTerminationTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_AgreementTerminationTerm_4ce36bf4-fd5a-45b5-8ac2-75d162ac48f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_870a8351-3f45-4abc-ae0d-87737445acf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned_870a8351-3f45-4abc-ae0d-87737445acf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_0a50c687-c421-4d44-89ff-1e3e8ee52989" xlink:href="sgmo-20220930.xsd#sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive_0a50c687-c421-4d44-89ff-1e3e8ee52989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_b096a0ad-ffc1-4f49-98e1-641d0b04acba" xlink:href="sgmo-20220930.xsd#sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive_b096a0ad-ffc1-4f49-98e1-641d0b04acba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestoneRevenueReceivable_ac42b84a-8d4f-4e9c-b5c4-9c2d7ccc62a9" xlink:href="sgmo-20220930.xsd#sgmo_MilestoneRevenueReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_MilestoneRevenueReceivable_ac42b84a-8d4f-4e9c-b5c4-9c2d7ccc62a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_dc24a744-9462-4885-a259-3bbb3ecbc8e0" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementNumberOfMilestonesAchieved"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved_dc24a744-9462-4885-a259-3bbb3ecbc8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_MilestonePaymentsReceived_4459eea5-83c8-46a6-a7c1-46dbf02b938e" xlink:href="sgmo-20220930.xsd#sgmo_MilestonePaymentsReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_MilestonePaymentsReceived_4459eea5-83c8-46a6-a7c1-46dbf02b938e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_76d45bc6-91a8-47cc-b072-9b60eb99896e" xlink:href="sgmo-20220930.xsd#sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement_76d45bc6-91a8-47cc-b072-9b60eb99896e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_b70640c0-7511-4536-bf3c-8cbda95cc79e" xlink:href="sgmo-20220930.xsd#sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice_b70640c0-7511-4536-bf3c-8cbda95cc79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementTransactionPrice_fa0ba655-b35c-4fdb-a40c-ac0acc1ab1fb" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementTransactionPrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_CollaborativeArrangementTransactionPrice_fa0ba655-b35c-4fdb-a40c-ac0acc1ab1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_CollaborativeArrangementResearchServiceFees_316e0271-94ff-4d1a-a9a1-14ee789cb733" xlink:href="sgmo-20220930.xsd#sgmo_CollaborativeArrangementResearchServiceFees"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_sgmo_CollaborativeArrangementResearchServiceFees_316e0271-94ff-4d1a-a9a1-14ee789cb733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c003a89c-240c-493c-8677-7a5e102a5323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_e0600caf-d1d6-46cc-a819-f66b8f2184f2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c003a89c-240c-493c-8677-7a5e102a5323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_867fed86-9f94-48dd-89c5-7c0c41d4825f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8d6f3bed-01b1-4587-8a29-c01addbefacc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_867fed86-9f94-48dd-89c5-7c0c41d4825f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8d6f3bed-01b1-4587-8a29-c01addbefacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_598cfd72-e16b-477b-a5e0-5c3213224b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8d6f3bed-01b1-4587-8a29-c01addbefacc" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_598cfd72-e16b-477b-a5e0-5c3213224b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d6d87714-ed6d-43f8-b986-c35ea50b9631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_598cfd72-e16b-477b-a5e0-5c3213224b1e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d6d87714-ed6d-43f8-b986-c35ea50b9631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5626ad8c-4990-4ec3-9a2e-9fafecc9d462" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d6d87714-ed6d-43f8-b986-c35ea50b9631" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5626ad8c-4990-4ec3-9a2e-9fafecc9d462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2dee04af-0fa3-4a94-bd5e-570a72a2a31a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_d6d87714-ed6d-43f8-b986-c35ea50b9631" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2dee04af-0fa3-4a94-bd5e-570a72a2a31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_905b781e-3e0f-414f-9904-7041b5e69e84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_8d6f3bed-01b1-4587-8a29-c01addbefacc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_905b781e-3e0f-414f-9904-7041b5e69e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_0d0929c1-6c7c-4f07-9ee0-9f92f8c2ec12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_905b781e-3e0f-414f-9904-7041b5e69e84" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_0d0929c1-6c7c-4f07-9ee0-9f92f8c2ec12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail" xlink:type="simple" xlink:href="sgmo-20220930.xsd#STOCKHOLDERSEQUITYDetail"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d47ac4bd-4895-4572-ac9e-e5b32d90b8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_78318bcb-8ab1-4f1b-a949-7a3adeb6c592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d47ac4bd-4895-4572-ac9e-e5b32d90b8ad" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_78318bcb-8ab1-4f1b-a949-7a3adeb6c592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_2359450c-8863-4b12-9a96-8d28fb4b714c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_78318bcb-8ab1-4f1b-a949-7a3adeb6c592" xlink:to="loc_srt_CounterpartyNameAxis_2359450c-8863-4b12-9a96-8d28fb4b714c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f4d3ddd7-7cd9-40a2-bbe7-87f15b4b0f7e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_2359450c-8863-4b12-9a96-8d28fb4b714c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f4d3ddd7-7cd9-40a2-bbe7-87f15b4b0f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_JefferiesLLCMember_5411a38e-8cef-4102-b151-95aa74a0dcd0" xlink:href="sgmo-20220930.xsd#sgmo_JefferiesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f4d3ddd7-7cd9-40a2-bbe7-87f15b4b0f7e" xlink:to="loc_sgmo_JefferiesLLCMember_5411a38e-8cef-4102-b151-95aa74a0dcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_3e5688fa-bc4c-41f9-bb9f-81030618c2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_78318bcb-8ab1-4f1b-a949-7a3adeb6c592" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_3e5688fa-bc4c-41f9-bb9f-81030618c2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243b5dda-9103-4871-9202-9af789fbc00e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_3e5688fa-bc4c-41f9-bb9f-81030618c2e5" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243b5dda-9103-4871-9202-9af789fbc00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_AtTheMarketOfferingAgreementMember_ee44c756-c65b-4049-abcd-b9d04ea26aae" xlink:href="sgmo-20220930.xsd#sgmo_AtTheMarketOfferingAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_243b5dda-9103-4871-9202-9af789fbc00e" xlink:to="loc_sgmo_AtTheMarketOfferingAgreementMember_ee44c756-c65b-4049-abcd-b9d04ea26aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ccb820ef-ea20-4625-916d-c36ee4095a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_78318bcb-8ab1-4f1b-a949-7a3adeb6c592" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ccb820ef-ea20-4625-916d-c36ee4095a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8ea41ad5-5227-4c62-8c42-546ef2efc305" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ccb820ef-ea20-4625-916d-c36ee4095a74" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8ea41ad5-5227-4c62-8c42-546ef2efc305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_1bd17ad0-788b-4356-88c6-94e62bed243c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8ea41ad5-5227-4c62-8c42-546ef2efc305" xlink:to="loc_us-gaap_SubsequentEventMember_1bd17ad0-788b-4356-88c6-94e62bed243c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997282bc-5f07-4850-bf51-631464997a56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_78318bcb-8ab1-4f1b-a949-7a3adeb6c592" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997282bc-5f07-4850-bf51-631464997a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_StockOfferingProgramMaximumValue_4a226488-a60b-475b-a060-8c274665d89b" xlink:href="sgmo-20220930.xsd#sgmo_StockOfferingProgramMaximumValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997282bc-5f07-4850-bf51-631464997a56" xlink:to="loc_sgmo_StockOfferingProgramMaximumValue_4a226488-a60b-475b-a060-8c274665d89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7ed5eeef-d47c-4eef-a9a2-f5108c407dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997282bc-5f07-4850-bf51-631464997a56" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_7ed5eeef-d47c-4eef-a9a2-f5108c407dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_298cf26b-b6e2-433d-9b8f-c57aeda2e011" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_997282bc-5f07-4850-bf51-631464997a56" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_298cf26b-b6e2-433d-9b8f-c57aeda2e011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.sangamo.com/role/INCOMETAXESDetails" xlink:type="simple" xlink:href="sgmo-20220930.xsd#INCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://www.sangamo.com/role/INCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3851a610-5c13-47ae-82d4-6cf8f51b749b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c075a2ae-4ffb-4dd4-a0a7-db1cb1a53974" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3851a610-5c13-47ae-82d4-6cf8f51b749b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c075a2ae-4ffb-4dd4-a0a7-db1cb1a53974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_EmployeeRetentionCreditCARESAct_93e6e2c8-d466-4cb9-9244-1f4610fa8f06" xlink:href="sgmo-20220930.xsd#sgmo_EmployeeRetentionCreditCARESAct"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3851a610-5c13-47ae-82d4-6cf8f51b749b" xlink:to="loc_sgmo_EmployeeRetentionCreditCARESAct_93e6e2c8-d466-4cb9-9244-1f4610fa8f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct_aa5b83f4-8798-4e75-87f2-529e76adf942" xlink:href="sgmo-20220930.xsd#sgmo_ProceedsFromEmployeeRetentionCreditCARESAct"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3851a610-5c13-47ae-82d4-6cf8f51b749b" xlink:to="loc_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct_aa5b83f4-8798-4e75-87f2-529e76adf942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>sgmo-20220930_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sgmo-20220930_g1.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  E@    $  0"6     0 !_^%EN6AT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI
M2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN
M<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0($-O<F4@-RXR+6,P,# @-SDN
M,6(V-6$W.2P@,C R,B\P-B\Q,RTQ-SHT-CHQ-" @(" @(" @(CX*(" @/')D
M9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R
M+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(@H@(" @(" @(" @
M("!X;6QN<SII;&QU<W1R871O<CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]I;&QU
M<W1R871O<B\Q+C O(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U
M<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B"B @(" @(" @(" @('AM;&YS.GAM
M<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @
M(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP
M+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V
M96YT(R(*(" @(" @(" @(" @>&UL;G,Z<W1-9G,](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]S5'EP92]-86YI9F5S=$ET96TC(@H@(" @(" @(" @
M("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO<&1F+S$N,R\B/@H@
M(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E($EL;'5S=')A=&]R(#(V
M+C4@*$UA8VEN=&]S:"D\+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @(" @/'AM
M<#I#<F5A=&5$871E/C(P,C(M,3$M,#-4,#DZ,30Z-38M,#0Z,# \+WAM<#I#
M<F5A=&5$871E/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R,BTQ,2TP
M,U0Q,SHQ-#HU.5H\+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE
M=&%D871A1&%T93XR,#(R+3$Q+3 S5# Y.C$T.C4V+3 T.C P/"]X;7 Z365T
M861A=&%$871E/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @
M(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z
M=VED=&@^,C4V/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \
M>&UP1TEM9SIH96EG:'0^,3,R/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @
M(" @(" @(" @/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T
M/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K
M6DI29T%"06=%06QG0U=!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML
M3D$K,$%!04%!04)!06QG04%!045!)B-X03M!44-704%!04%104(O*S1!1&M&
M:V(R2FQ!1U1!04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='
M0F=G3$1!;TM#=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%4
M17AW8D=X<V-(>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(
M>#AF)B-X03M(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&8O.$%!15%G06A!14%!=T52)B-X03M!
M04E205%-4D%F+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%1
M04A#06M+0W=%04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G
M8TE#46],14%!0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%
M1T4R16EC645537!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I2
M5&MQ2WE9,U!#3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P
M5G1.5DM"<GDT+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7
M-799,U(Q9&YD-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E
M66U:)B-X03MQ8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"
M455%0E%914-!341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO
M8DAW1DU(4C133D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X
M9%5K=V=*0VAG6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-
M5%4U4%)L9%E75G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F
M2#$K9C-/16A984AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K
M<4]K<&%A;G%+;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X03E5-'$W1EA9
M<3=&6%EQ-T9867$W)B-X03M&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9
M<3=&6%EQ-T9867$W1EA9<7AB>CEE5T0V6$IP16MK6G9B=4UZ4E%U-W@O=6\U
M15-3)B-X03M136I2;7%'5F%!3E4Y9V-)45='=S9:-5=U.5AT;U1:,S934U13
M>&IH<6UP249D2&ML-6-436YQ0G9G;VIR>%5656)B1FHV:%DS<'%Y)B-X03LU
M.&-*4FI+431P.'9.4C!R>EIE>%=E;E-Z,G1T9'E.<&5O6# Y:DQ%23=Q5C=3
M5F=G57=I5TYF:%1J,4YA*T]#,U!W=WA:;V-73UA&)B-X03M%>4%"<T5E9C)P
M.35A,6QT5S$U635T3W1R87AU3DQG=E9T,T-M5T=D;DEK:DY!<FM5659*5VTS
M8D-U6%1I14QV9FER>510>F108F%8)B-X03MP4WI7,6A&4$I.4$1B;%DT;61L
M5U8K3$]!3U R5C-R:3%98UA'875T;$MY.&M15S$Q87I'*SE63%9V:&AA255D
M95).2&%N2FIV,4HX)B-X03M-5'IT<&E+04AC;FUQ96%T4# S5G)B5$QI3U5Z
M6%54>E)Y3#99:D%1,&]3>G%E4C=!1&9':VLW<'IG4S=&6%EQ-T9867$W1EA9
M<3=&)B-X03M867$W1E5K,$A8<'13,69Z1EEY0TU,;S$W2&%21DLX:7-L;D)C
M,6MQ5#A82V,Y0E-L3SEC5E1V1EA9<3=&6%EQ-T9867$W1EA9<3=&)B-X03M8
M67$W1EA9<3=&6%EQ>%AZ=F]T<$M).6%E57!C,F-,,C!33W%Y4D9,:5=*,RM"
M:UDK<"LU2$9G4C<K>$-#.'DX:U)80RM:22]3=4E')B-X03MG8E=T4TUV<%(O
M1W9W<T5!<494:W4S2W%N-35M-5)13F9Z43AZ;&I'3V]W.2]I6E!U43=,9G!O
M=')#='I02DMF3"MS<W-H:6=71&Q7)B-X03MA9V55:&5'-5AU3VU-.%%K5%HV
M9V5B:CEH;6-966-S04%)=VXQ4%!I3F9G<' K5C931'IH6E,S1G=P;DAL83!3
M5T%%=65F<D1K.4MM)B-X03M-:6\K,$182W-M15)J67,K<6YQ638S2FQL56E+
M231Q.#)49FTW.5EF>3%A9E985EI"<61K5S4K;D=#=G%I;W%Z3#DR5C1S66MA
M4&-Z)B-X03ML<5HT9E9'<C5B*V).=S961R\X07=I+S%Y<&LV-S!44S=Y.&EV
M8FE!4&1123!C57170E9(*S!U>$=X>%-J<U9D:7)S5F1I<G-69&ER)B-X03MS
M5F1I<G-69&EQ539,-61H,')53F%V63=I4UIT879&=EI%:TE):4LR,%9V=U$Y
M95 W:FQ4=%AB1E4R>%8R2W5X5C)+=7A6,DMU>%8R)B-X03M+=7A6,DMU>%8R
M2W5X5C)+;U16-V%7-3 R-&AH2$M:,%E23#9H:4)A;3%855!4+V=4.'-695$V
M3F]'<V%*97EY>7E25VMW=35R>5-8)B-X03MH9%1P2$Q-5#9Z-W=1.&PV,$AH
M,SA-:5=9>2M63T-D1&I--'I0,5%*23DU-7(Y5SAL4VTS="]Q3BM:-U=+>G5.
M3&U35S-U64-)8C1Y)B-X03MT37E"67ER<U9D5EA98V0R2E!40TY19G1"*U1-
M85-!1D1L4DAZ42]L>E-.9#!A.2MV,D1W:6$S<UET2W0S<&1Y9U=T=DUP<$EV
M,650)B-X03LT>4$R-&(T4U)S84=O;FU-:%(W-UI9.$%I8DAD5$EV359J3#5K
M,#(S=&)Z5V95=&\W:4LX2FIS3&]6.4EL;RM,56(Y;W)5.2]$9F%')B-X03M/
M6F=B1%!*:D5X4EI.67<K6C=Y,6AU<F9724I96D9Q<$YT2DAY24E&44=F:V\R
M8G0T8C57,G-M=TID:7)S5F1I<G-69&ER<U9D:7)S)B-X03M69&ER<U9D:7)'
M4$\K<F5:3DM3>'9.3&5-5TMY16%N2"MJ<FY5<FAK24)4,$5T<FDS64Y51F9S
M=E=O;TYQ37%X93,X.2MB0DYB4C-6)B-X03LS44UF575*5SAQ-G)B>$Q%-D)K
M5U-A5RM-9'4V,%ET-G)D,2M&9C)L538P*S@O34]8;5@Q4%1,<%=I1'AF5CE+
M9&%'459I:V%U<GDX)B-X03MK24(R1D]8631Q>4\P,5=:-"M$5SAK.7A$4T\U
M84E22V]K0V=K8U!78W!S=U!%<U11-'%R9G!#8B]L9W50*U-8+U941E8P9#E+
M-W%P)B-X03MS-3!"3D,W96Y1935O-4]+;W)&6%EQ:$Y7,4I.37-*8C$T2G)H
M25)6;W)D3V-H2'-T4FER1V@K6BMJ1S)E-"]23W5H27I2,&)2=%%%)B-X03MG
M,DHU96M99E4T-T@T=4Y+-U9R:7%C,C-M87AU4D%B9$=L*W1+>E=W5C1#6D%M
M>D92-FQ4>#<K1TMQ;S%Y23-2=$)B>4<W0V5O8F9L)B-X03M$-F=3=$]81#%/
M6$=V9D968CE)5&8X<T9X+WE3+W=#<6U+=2]313,O04-W6$@O2DPO<7!I<4UX
M5C)+=7A6,DMU>%8R2W5X5FDR;2ME)B-X03M,56%(9C9R<D1,0F(R1C-D=U-3
M,CA5,'%I3S-V2G)A4#155U)Y,4E2>6]+8VI164I3049L24)*;TXS=C5M*U(W
M2%1)9%9V3E17,S R)B-X03LT36=H=35)<&QJ4'!0-F-L5TMF1'AC55!,17E!
M3DM!5F4U+TU$>6QB83<K9TIR-')R4$I55W@Y1V-Y3WI$:T]!0TAN.%!X17)7
M9S-/)B-X03LR1E1%9U@S<4U(-6TK43=J5#=Q+V<Q;4-71WA5>5AK83AZ8U)2
M:5@P9E5E,T,K=44Y5%E.=V]E;TY..%=8:'DT=4=V5C-)9EA0>EDX)B-X03MK
M84YA5TXO8S,S<F%D9E!*1W0W86HV=VMB>$ES:%-227DP=DUH>%)64718=&EM
M3TM20E X,VUJ1C@K-D-D6%A3<5A0,6@Q=#-J2S(X)B-X03MR9VDW2T-)<W-9
M95-,950T:DMQ:&%%=%%#=4M$:FM):59B1FME3$(R2W5X5DMT0SAY869R5%A3
M,FUZ5VI)<W%'4T(S2'%,>E5S:TUK)B-X03MR4C$X2D%P.7%96E)P:$-9;4Q(
M27!R9UIS6C@K4RMH<#EV8SA763(X=G%F0DEK6C)1-S!9<5@K4W-..3A)0E!*
M:DM107,Y2&TQ;G)S)B-X03MU<6%,8S-:=EI5=')N4TIM8WIY2WEC;VES46-Q
M>E-2<U1X*S!A:SDX<T=#5F5R858Q,VHY1' X+V)H>#5F,V-,:C12;4%F<7-'
M<38O)B-X03MP44=P6'=G,#-6-S8R=E4P.31D1S!H27(K>&U,,T9'94ML63%-
M87)695%O=EDK,E9Y0FIZ-60W=F5Z=3 T87%536-O:U-)-'E$>3E1)B-X03MU
M=4QY6G@U16YT6F9.=FY22599>5)8<TMZ:5(O9S5C1W V62M(86YU8U<O551I
M65%!23)(-'1&*V-R<W=E65!+:V%Z3$,X,2MY<D5T)B-X03M'.5%E:U9:4U,Q
M5BM&:C!W5VI4>&E9>G9U4F5H6$AM3G9-9#E&97$U<T9U0TQ-<VEO;VDT=#EK
M:&%T.%9.>3,P1W5X8U%!<W=W36Y9)B-X03MQ=R\X>F1B5W<P;3(P.#)Z>FY7
M<$HW4EA357=E;5DW4V$U-48K3$PO04QO<%)Q1#,W16A"66YP2&U#-'5D9FY7
M2S=M:FIT.6%N<W Q)B-X03MK;%9G0D=R16]36&Q(0F52;T-D=71!85I/3TM6
M17DR-FHS9DPX9#=R3E0R;G<U36-)4C)L37=.*UA58B]!23=M3V%D3D)"6C9$
M34QM)B-X03M!:&)$5VUJ,4%43$101U92>GEI4T5X25-#=3E+64IW365:<T1R
M>6-V<S-T-&%Q35EZ9UE3>6YL,'%*-FUH5G-G.&<V;6PW-7<P<C$U)B-X03MP
M<G4O8GEW2D=U6FE64U--6'A53S%F.$%D:F)F=%I!14572&,V:W=J07=&9EAY
M-C%8,TUH+TY7-FAT9DM%<W,P>5=Q9E=,665S3TUH)B-X03M(-S54.6QM02MF
M=&IB4G!)>$TV;%9B;WDK;CAX<C5Q=#1R8TXK:5-6139Q:4=-5D<Y6D-#,UAW
M3S)&>$M+9CA!;5A58C-49$5U<C)Y)B-X03MH.64V:%AL1D9W85%-97=92U99
M1'A)-F5">$-3>&4X.#,K9$Q05EET36YS=$I3-G5%95=#23-6,U9K4U=H25 Q
M6&I8,%%724I(>#!3)B-X03MP0C5!2D%*5')2+TUX,6$R=#4W86%%3F-O.&M5
M1$M$2U5I8WAU,T9*6'%!=W!52$9L3T5O;6E%>3E85F8K2R\K4E0O.#$T<T9K
M.3%Q)B-X03MK54UK<#E-:4Y3>$AP3U!S:78X05!I<5%76&YE.'5B<3%T+W$S
M0C=L=4QC;W!"-EHU1F5,;FQX<G0R2C9J0U)V4TEM=T0S<WAW36YL)B-X03MF
M;6Y43F4X=6529%)S47-.+U!Q5C%+5G5P<FTS=&]K33DY2F-R-FXQ:#=62W5S
M;$]+12]&,G!L=4=116=3-%AA3VPO35E:63=R:7(W)B-X03LW4W532DIT3SAR
M-E9O,6IP8FQ0<DTX3VUA5'%C3VQX96\W0GI&1TQE4S1K2$)I6&XY3#%&241F
M84(T;&EA:5(S<TY2<%1K>C1S9T\R)B-X03M0:2\R56%45U1Y>#4T:S@U2%9O
M8E-3,S O5&YH849*3'E2-7(Q3%-,,'EV2TLV:5%T3GE013-+341V>D,Y>$M1
M35%/-6QG,&Y";GE:)B-X03MB+W9/2"]9:6U.5R\U6&5C13AR-G-N-DAJ:#%N
M5W)D9%!U9E)M5F%+3&HV>D9--FTT83,T46@S43A&-3AI84%R=5II8T)K=794
M,TYM)B-X03M,2&QH:31E3U)N+T]*3C@K+VXU2T=U-E!O:VUN958Y04XQ<'%A
M8G!"=6)N5FU.,W!+2D]:5V8Q65=G2D5B3UAJ9FM4158R3E<U031))B-X03MM
M3D=X-W9*;$]*2FEB-6,P=S!F5#=J569Z3V)8-'15:'9R,G=T;U)A45)83VM4
M,V0V24QF:$Q-1E50-DLS4U Q:D586&9I=4$X4$-.)B-X03MT*W!:>#1U23)F
M5#!$,4EA-35H34-Y;GDU8T(R:U)$06)I,#5H6%AK,&A);#1C55!W=%)U5F9S
M9VIF2S9B3%9*9%DQ-4HT;S$P1V%2)B-X03M*07!E9$QI,C12;&Y#1EA$3W(Q
M54AM94MK8V5L5S)X5F1$<75U4UA*:&922EE9>$LP6758;G1Z1U9#:VE50D=A
M5&=X1D(X4$MV5E%.)B-X03LX5E5V3"]L<4A3<G4Y=2M+4&,S=D0Q<FIH8D-6
M=E1&04=E0S-T;69X*TUT-U5Y35EG04%C9WEK8DI096YM1D1&=GI%849D1E9P
M0D53)B-X03M'66]S=D]P4'!S2TQX-VM(=BMV2C0O<41$2CE*95$K5$DW0658
M23=W5W-D<3<V3F,R-51C,$)L<4DK56A*<65U-7I/>40Q;BMS2&LY)B-X03M6
M:7DU2CA-46%/0UAU-'5,=E5V3TYX6GDV1'(Q=$LW>E=X,%129CA!4EE),%9Q
M:65(-T4Q2#5&86)I;E-U5'A$,40K=$IY.$]L1U!()B-X03M:=FHX3$A%+T-M
M9&9L.60R;S@U*V5J>&AT-C,P0D5X3%5M*T(O:4A+<3=F-4]9=68V264U,T=N
M*W5F=E8O4#A!8V%E+VUB>55Z<TI7)B-X03MJ,4XR4C1I;U=-*VE2>6LK0G%R
M.3)$0CE-=F-N4#E54&5Z<4<W=&UL4E9U25=9:T%+=$MN-6)::D]5;4]+6%EQ
M:UAN83$P=5AY.61Z)B-X03M8,%9U-U<P57(R<W1Y;UE24W9%.%A*1V]75FEK
M:DQ69#9%:G9H0T,X:3AS43968V5A.5%U2DQ31THW9GI694]S<E9A=31P34,Y
M94E:)B-X03MG3VTS:&UD:T=W+W%"-3-5.&9J62M%1W9';&9Y-G%#,VQU3%13
M3&8Q3TU(-DXQ=U-7-E)O,TMS3&)E<CA806UU,GAQ8VU2=69F1G@K)B-X03MZ
M9$-C95!(-&XQ>$=4-U5:*U9K.6Y&-7$P3E9I5T9&.'!C575*:65A:CE)<U)#
M*W=J-54K22]$6#9-:G%F;U Y9CE$=4Y,.5DO<69P)B-X03M:5BMC:RMN>F52
M<#0U6$9W:'5B46U+,TMI43!N4VQ+<3)W4%AB<&Q';"MV-752<E W=C1H;2\Q
M,C O-6%94#A!:&8V6FI/57AJ>B]Q)B-X03M..$Y:<V1*57$Q:&,R9'AC>E)C
M;&I0<3(X.7-),DQS4'-G4T5C45)7=GEW:%-W2'EV<3@Y.7)1=#=X:$I);7$V
M<&)7;TU:35EJ:E9Z)B-X03M2:5!H,TI,1W)#<$]:2G=#07)N64(S.#-N=&9N
M;E!0:$DY4$1+63(R-5(R.39#:G5,;E1.1W-O;S5B6EAI.'8V,6-*84-/5&=F
M5&5A)B-X03M3=$,W4C$U0F9T3#E"-T$V5S5B1VA91F)6=CA!:G9:9&HY<354
M:'@X44TT1TUP1U5J8W9423=8.$\U1'IE8V19:#!M-W905F-31'ET)B-X03MP
M.3A5:&Q-03E:<FQ)=U$X4$-5541T='EP43E-4#5/5C%X9&$U9G1D=V4P;S@K
M05981GHW*VI0+T%-=DY7=4PS>G U>G1:66\O=T12)B-X03M',#5L:T1T5G97
M9V1J549U3E)4=&QC.$IJ14<K9C9'>4]P1U%M3E9W+V)B,$5$8V9!;B]"9C@S
M6E-Z4C)+6&XQ,2M93V\V4C5+,7IZ)B-X03M$8U%*<4UM;%AD>$=S1%-#1&Q'
M=7!3,G%G=DA&2G@T4G%T4&=*3DYZ53%Y55E'4F]C,$=566DU1V@S+S)7=#AW
M*V(O4&M%5VI45V-')B-X03MM85),9DYC<&0R1W-C,C0K:G9'4F124WA);DYF
M:6]9,C9G8EE/16YC8V<T*UA646AK:&I..%=3-C=V4TQ.-S=E5WA24C@K-G5N
M;FAT)B-X03M*4WAJ=G1"=59T>%IA;&$K;S-P3E!!,&EV8T]O:U%X>7EC15%Q
M4&A&5TI)-D-J,V)--&%N2$]C<V-394]&8U<S9GDS-G!4<"\U>39H)B-X03M0
M<&5R,SDS-6-A>6HP=3)A-&IL935:<F4T651#2E538U%"9'513'148F]/5D<T
M:WA)3E5B*V8S33A/8DAL06Q#431$+T%"1W=0=$%+)B-X03M/,5 X,C1T2S O
M4G11=CA!4W!$839X3DUK671M:VQM155-6$QM<TQW=W4W1U0T949".%!X06YP
M:4EN=5HS2'9(;#4K-4=2+VU9:BMC)B-X03LT=DQ+85!D4W901&)3*W9#56-W
M9E=)>DEX=6Q*5DDP4E%">6IK:S5(641B1VI6<G0S:2LW<78X04I(;G96=DTR
M;U@P8C9)3%!43%(U)B-X03LT63E54S979$I*65I&5# K2'!X=7)&1S5'=E1C
M8C1.*S<Y0U1846<K-6U72TA9<7@W>70U<V97<G958D]E0S-T<FUW85 T24PR
M1S=,)B-X03M,26Y,:WE*>&QI;S%24U)"6'%-8D)&>$YG.5=-4U-.>%(W;5$T
M<VU-*V9L<VXP<4=/+W-H9C9C.&\K=5<X;U8T1VI64WA%>4U#<DME)B-X03M.
M040S>%8U=F$S1VIZ43-E;RM89$QS3%<S;3!O>C)C34U535%J93%O<V9P5'=Q
M<V=#;FQW,T9+.4%E:V]W;$E73RMT-T@V2%@V;G14)B-X03M&<#@S0DUC55)$
M:G5*=EED4&5N;'8K6FQV64IC5SDK8EEN4SE0<UHW=WE34W$V>50X168T+W="
M-C!U.&<S0T0S-C=22F\P9C)F3C)/)B-X03M!=WI20F=D-6(P95E(4&104"M6
M9V%1;#=D,FMK0D0R;"](<'IK34%/8V]Q<B]V1VIQ2V<O635F=T$T:#-T;F=Y
M;V5A8658.6-H,6TS)B-X03MU6F]5:$,R,7I,86XP-6A)0UEQ8FMG<E$W+UHW
M65%7=6-/1DYO:"LX6#151R]:<6XO:5=,1D=9<&1I<5%E96)U,V<X=#-A4T]O
M;75))B-X03LS:G1O9E<Y0C585TYP0VMF574S0D=B:%1C03ES25%8;55';&52
M.5$Q6#E(85HU93!A1%19.5)K,#-59$]J<S=:;TI*;U%A<S-+1E-J)B-X03LP
M;T14<#0T4D%K2'DW,T4Q5W1J:&Y#2#%E26$R4$DK85EE5E!03C-9,FUH,D=R
M3D-(=31D46YL1&5R2R]P,FY/46-:0SE107$Y,6)W)B-X03M'0UE-5%(O6C@R
M-U(V,T)Q-$1*:5!#2F-O>35N;U4K9R]-;E-:1'I-2VU$.49J5G964C(K2U Q
M9E)+<5I20V@K3&]3-%!S36AX:G9C)B-X03MW-$I$-3!M*VME6DQ853E5=G)#
M2T],;%IR1$E'5UAK5U-:030U3#A*46IL,$]%149H4$=9:F0Q>C5J9W0Y9&DP
M:')A<GIC944S3#1#)B-X03M32VMD93)3,F%R,W!.4$UT;DQD-DYC4E))<VIG
M0G=R0FHY9SAT;%=P63=B0VTK25-8:G9L>$Y8:74W=5153&$X<D9Q1B].17(R
M;# U)B-X03LK<E1":$-60WA.4E1864A-,F,T.4\T3VAZ85!,4$YJ;E<P2GI*
M.7A&0DIT3W-T8G1D1C!Y16%$9#)M;WAA1')&=6Y'0S=D-&)I-6UN)B-X03M%
M15E*1&=M4G%.53$T.7E";&MS<U1)-S=C55A*:&AK26=#3F5M4S(U:#@V9F]7
M.%=+,3%$,78X041D;&)R4S)N0DXK3'5)>7%$=S-9)B-X03M+,WA.,' S>$=4
M2&8K8V9L4U1I>6-*,B]G2'IT;6YK9E5R,G<X,2M:-VY5-')Y3%1B,#)#-E4W
M,E8P>4XV545G;31H66TT04U/<D%!)B-X03LW57)M4&UL17AJ6%!E,TMW4FM*
M>4HU8E5Z;V5:=$TR2BMS0456<6)#.$9"=#%R0G0Y;V1C>'%C<3%F6'9.34=J
M,VQR87E14$MB<EI:)B-X03M!4495:S!!4&9F9D)S<$\W1'90=FM65CAO,TAL
M+U-*8G!,6%9:,F$W:&ET579(<$IC;3101FUL=$DT9W-J+W1/9F@V0W4K5UEP
M;4UR)B-X03M$6&UX:6-E13E63W@X<#9N4&$V0F%A4$)C95AR1WI3-$)-3FIP
M:5%1>7EN.3E)<T)U2F=I>2]'63%%8W9X34=9,#9G4V]%9#=6:S!S)B-X03M:
M-4E:1#E73S8O>FA25&U$.'9.5FDX=S9P<EDX=U1*3F9'27=7,$UB=W=2+U96
M0S(T:VI364Q+;T9F549&-3EU27)633=!2&,R47=I)B-X03M-<%-(3U98.$]3
M55%F:W!(1#50:SAU2G%K66$T-5)85V]#>E53=F)3>6EE5TUF=F1M85E65G%K
M0F%!<5-/4G,X8SAF2#%2*UA(0G=D)B-X03M%<#%,.'-J375M5VME:%A(-DLP
M=WIZ+U5%=&1+.4\T=7!G,&)Y>D)R-59:6D524U9+5DIA<&)Q0D=/4V=2,W!L
M:7-G+WI5>3!B>41E)B-X03M.-71U=%AN<V)I,6UK9VAJ,#9A-'1T4$YT84QA
M;W!T:S11,VLP<E!'=T%9<7%Q,4YU3WAX3U,T:5!C;4]/<$=857!R-58O3$LK
M.'-X)B-X03M4=' K<3(U,4,U=5AU3&DY:W-15TUC+T9P-&A364U/56E":TI9
M.%)S43-80FMY8U)S<FIX8T%O36ML,"]Z4UHT;6DQ:499049%.&(R)B-X03M9
M6C)93T,U4GA+;U5'3W%G1E=O,CE34&AY1%EU:# O>DE,:W1.<3A4,G9Q<WEX
M2F%"2D)#5E!&1$E:2$A-3E%L*T9#3G5)-C1Q:4Y,)B-X03LP4%0Y36%:<E-.
M56%F:5HS0U)Q>FQ24E=D:U978V=B5EEN06MM>F%0>%9I6#5H4S)K;6UM,UHT
M:DQ&5U-:4S%:23!D2%9815E:5U!))B-X03MQ44YV2'=Y95 V9W=Y9E-8:C-L
M5TM+3'EF-FMC=C%Y>EA18F]*8E-Q:TMS,W$Q-49J6&EE,WA.5'9M9FM&>DXO
M>F@Y>GE794A(;45))B-X03LW4T]#6'$O>FUV3W%H.4<X=U%88DIA86%D0C!5
M>$Q%<51.1W=U3&9K;T-L4U(P1S5P,T=3=V=81W5F1DPY3'-0>31G0U0Y6&AW
M0E!U)B-X03MR;W)A>D)P4CAW*UE#8G!V52]X6'!,;%!23D))0DQX44AN,&)U
M,4YV1$=..$UF-FAC;5E(1DQF*T],,$0X;V\W3DY+,3,P2D))1S$R)B-X03LO
M85%S:DI2>7DX;$9#,5%02$U45F-X+U9$;6%4;$PK<U=E>&-055=N0W1E,T]V
M-#5J3U5J355U>%9I4#5K95=X<3)M5S$V6FQ4.4-T)B-X03MC6&AH8TYX;D0R
M53EV-EI:6DDK23540C8W+UIP5'9H0T,X>CAR,F-5;FUR579Q.30O;R\T='9J
M8W=M2D%J369T4FYL-FI&84-L45(Q)B-X03LV6FY:8F]F,4$X,7%I0FYX8E@K
M*VPX3FMT,'5A85A3=$-6631R2W<O4FUV:39I4C1P:719;DMS<%4O1C-0=T@O
M049S=$U10V9F1D=I)B-X03LP6$)#2$=E2U524&8S*U9P671V<$HP86I88D%F
M-$=+1#EY5"LV1W%B4V9B*S!F-5!X>61M*U@K52]1-6Q#=68K5"\S>C!(.'0T
M<D)0)B-X03MZ13AZ=$1.-FMJ5T=J*W%R4G-G54-Y44I29WIC=5$S4&@W-6DV
M:BLW:C<U9F4U;6UR>$IE-E S4%)*9$DP;5<K4R]K=#1M=DDV8TIJ)B-X03LV
M;DE5,DAF34YZ:S!V8E=/-G1*<F%223-36D=2:VQ4,4EY0TMF16Q6-40R<F=3
M>$MX+TQ44W)A6EAJ4T\P0VQN07-F5F<T=E@T1VI5)B-X03MU>7!X04<Q1"M'
M4W1J4V(S,VLS4G(K2DER,#-&>4EN.5=*<%HU2%I(-&Q+;U=*-#%6>4140F%A
M4S9$.')02C!$3S!D<39Y3U=:<$9K)B-X03M:5TID*UIQ5C0Q,SAF,30X4EAH
M0V)P-6-G5D%P=G(Y>E%$:V)Q5W1F2%EG63)T2FA:5V]T8E=/,T5S:S-P:6YQ
M>DU8:V%P<E9M4%A!)B-X03ML1#,K:6%6<45S53$U8DQ.3$(O9$\Q87)V6%EG
M:G9I<GI7-CAY,V5M9FQP-6HQ8E1R>6$P;71,>39E1S1263-:4RMR>F<P4V5/
M5DM-)B-X03MR04=Q5D$Y>&MO46Q),4AM=WE:630T.%5G4T(S5F8R=#9L<C,U
M:V%P;VUI=G Q+RMI3EIV,C%+,FYI=').8FE-=$$O1T-:63E14S)K)B-X03MQ
M<5(X=7%Q,TEM:D1J:$5,0E!C-#)F5T1(;7@T<79X3TQE*UA#3#56=F9V0TYJ
M;C@Q>69M3DQ*6GHV:$1P1&EX82MS3TUC-GA",$QE)B-X03MM+W)Z=7-(>%-.
M-FAG4W!557(X2S1$0V=$,W-S5W1'5$Q014DP8UA$=F8Q8U%V;%<Q93@R=R]2
M+WI$.'DR*V@K64QT=&)-,&UN5U%U)B-X03LW3F98<S=U3VXQ<W=U-WA'4#8U
M1T)S;S5Y3T=O9G-505DK2$QI-&$Y6#0W-F-J0G%S3U5$2E5O66HS+U5/;FXQ
M*WA-9%(O3D171S!()B-X03MY:G$P5GA(8U@Y,60S='9E=U<W4D)893-9.%E8
M:FIV9E$Y5&=&3DAN1S4S0U8T0D5#8CAM,%I-44)%=5HK;#=&651.3EE7,'I3
M>%A$)B-X03M3>$DW5#(O.7DU6E%E8V4W+T$S5F9I3S-F24U%:B]-9E9,-U-F
M23)T86Q96$Q79#5A,GI345A33$<W4G-#4&E#>7)):' W<6-L1TIK)B-X03MA
M0UEY9T1C>E5E<4@O3$AZ2'%0;41Y<D9F-FQC,CEX9D-2;S5L=&QJ4F]W07))
M<S925#-33$DP8DQ*<W=Q<DME0U8T9T55:7=E6$IL)B-X03ME0E=*95(Y4C$R
M-79.5F<Q1G(V93)G844R5GAE5V-D;VA6;R]I5TM26$QZ:6]Q5V%.84AB9D<W
M1C%8:WA%5$A9;7E/<DQC5U1Z-WIN)B-X03LU5S%7-#%U.79R939H=&PQ5S-S
M.5!T,V5%,T%34TXU>3=3<5=I0W)3654T=4-D>'0Q36]M:F)'47-5>$LU.&@S
M=6EE5W(S5#(Q:7IN)B-X03MS9%!T4D)D,E,R:DQ.3&%S:&4U16-G=4IP22]5
M36<T3GAF:%$Q1"]S,FY54W9I-C-B:2]K8TXR9'%J=S)E-S-P>B]G=GE$<75H
M=E!F)B-X03LS8C(P5V\V6G P1C=&2F1W4G1(8G@X2F)65S52;WE(:V=&4T%7
M=W@Q36A22&9F>EIY,'-*03%U0T%09T]4<FYY+W=$;'A.<2MO3$QF)B-X03LS
M0G9P3EAS-3<T0FAX6%5%1$<R56M1.%9"<64O2'AW1%5307)Y<'-/:'9E:G8V
M=FMY2'EZ6657=$MT<FE,4W122W@S,3EC>E-,3$QB)B-X03LX;75I87IQ;VMJ
M1&)C2S!(8F9P:THU1$QM>6AG-$YQ-3=O=3$X>C9,2G)E;F%B1'%*=7!D4FIK
M=4Q/4T@V=DQ"27-$56-E<D9(4W98)B-X03MV,E!F24XT=WDT5$MT9WEN03%U
M>%9*9D]:;"]W>'%(<%-.1S-P3E5R0TIY4E1D94)"1S0W;G!H0T,X-C W.'90
M33)L6&PT,&9M4%1L)B-X03LQ3S=V5S%9=61/8C S;6XU96]&:6$Y9'$Q5#EL
M=6TS2$Q:6G!(-54T<#!736M327-I6$50970X:RM54$DK;V58=$UM47HR2G1R
M9E5))B-X03MB93%M=5EW-&=U5V%/-65K<TU5:%AF-U1,.$]33W%K8E!F6#)-
M;S982%$T5'A!6'5$9DY8=5!+2#5944-3>6LQ0V%K5V=I,EE,36IG)B-X03LV
M4V)N,4))<G)%43,W-SEP4U1J*UIN.70O1FM.0T-/4G%U2#E+2RMQ-DIO5W)A
M:F9E6')K4S9Z8T=W=$Y34S9L4EDO4U=$,#=B9V92)B-X03M916Q65VY'=&9P
M>4US<&M+4%)K3E!W2&E!4'$R*U-0:C@T>E<Q>D9(<6MN=UA';TIP54)T4%)K
M2S-%<')'2F<P4V5N>5AC:F-J=C)R)B-X03M5-45C57!8435#+V<Y0G=-2%EQ
M-T9867$W1EA9<3=&5TEA-35:.'5E8CE(;7,W3F]H0CE99$QQ4"]3-#1*2&EN
M8U1#5T<R;G-V55!R)B-X03M++WA-4T]7*RM3:$EX3FAJ3T%K2TMN8V9L-$Y3
M;# T83%C=S9H8C))6DI9:4Y11$]#0GAO>C,X;W(X2SAZ27)L:'1T6$AI,G!H
M3$1')B-X03M5:$EG1U5E4C=R-VQ995-0249Z<C$O2T9-*W5J,#5B-R]4-VPW
M;4QM87=/5CE9=D8O9&9U:4M5<#A/2FM32S=M47AX0DI!,U!.55@X)B-X03MS
M4$I384UD1E=Y;$=L<S-*<E589#-W87 U1E<O93%+1G9I2T@T4S-X158S=RM*
M2RM+.3!E1DAH-&$R4W4Y+TQ'935N=$IJ9#)F2W=$)B-X03M#>#5W-FEW:$HU
M04UI:E5L6&U%-$M7<'DR-F=50V]M4F9M<'AG,35*<'!V;$A664QQ43-M<4-A
M>&U1:5,S9V)5;UI!-TE&2FEK9E5*)B-X03LQ:5=T4W%O9S0Y:C-Y3G,V4F0U
M-4@X=C,R;E-A9&4O6$QM>6Q+;5='8E5,-7<T5F5)5FDP-4Q+4C%5-T4W;F9#
M2D5'=VE505)25DEV)B-X03M+1VEW:4991&1W2F)Q:5)243,Q-TA'1FI)2V=X
M<DU%8C=)6&-F6BM(<'1G=$E#>3)S=DQF-EEN<V]D4FUK,5=#;#-C5T@V5'5P
M2DDQ)B-X03ML0E9783---V-9,B]:2$AJ6'!V:F$P;DU6=DA%4U9,;78X-W4O
M=T1X26Y!;%5X5FDO=T-91'1$<&-.,&<O93(P<&MI67E#34)G:E5R)B-X03LX
M3'-F8FE.:G5D<TE&-T)H:VQ12C4P.',P9E<Q,64R;3%(:4HY4FTP3S5:6D@Y
M5#0P:F-2<E=C>'!Y4'<Y>%AX.&-Y65EJ1%DW>45N)B-X03ML3S!D5&MY:VLS
M1$A,0DLT,V4Y.#9V8S!H9DY&,60R=FQR6&(R8W-F4S!F4G=K1GA(2%!B<GIL
M9T1#2E%9*UAX9%,O,%I%-%I4;'17)B-X03LU4#1V.6IU97E/,E)I:$1'4F-C
M94M%<D@Q8GA!-69(=E9.6#%M5F9-3W52:&)9>'@K6CE,9TE.<T]2.5%3-S@K
M934X1TEQ3W=Y23 X)B-X03MY3#(S1C@K;GED=T\Q67@Y3D@P*VXU+TAK<F%6
M<F)Y86YO<UET;T]-;FUN54E'9FE&2W9%05%24F$O1C-F-UAI369!;4QU=58X
M*VYY)B-X03M:2'142$Q90U<T-%!I4#!/+TLS5G14=3E3.&A/='8V5FIC5V5P
M;3171E-S2WE*8WIH3UA"46TY4&)F2E0P-6E$6D=Z1V9A:V-P<4UF)B-X03M4
M:S-S.'A8.6HS=DUD9S=&5T9F;6IC835(<#%H8C9C:G1:6&-T>D9R0FI3;U<R
M5W=U6D%8:TM30TYF5E)">4I8-'%#=3E#46=S2# O)B-X03MZ0F(S=FUT63=K
M=$Q.6F593&EY="M2=4HQ57A!<G@Y47AJ9W18-F1",7DT665%2&DS<U=(4F%N
M5EI:-6-9:F-!37!I9E8Y44$Y+S)))B-X03M'1V)55C!R4THV=D%6,#-7;6UG
M54Q.8D5R1DE6.5=V0C(Y9W9F<FMS,D]5<&)E6#1V.6IJ97IV85%W64UE26)X
M;'A3=FMF4V(R2#=1)B-X03MK<38V>391>D)B97 X;"]7;$@Q5E11;E5U2D<W
M+UHX22]S*RM2+TQ:3#9C-C5N;CAU6#1P-G8X06QI1C-2+VXO04\Y-RMF-'1%
M83<U)B-X03MG-%0K87$R,$)%0V58<2]U:TY23DA%83=J-&EV9V5N8D5A8DEA
M-6(S,3=V9WE(82M/3E=*96IN+T%*,TPY<5IN5DY6:S%38C9R8F]N)B-X03MP
M*V9B93)U:$%R1W1V>&)L23565C)P.6]S2RLK16%C.50O1&)#6&%584%J1R]W
M1$IM+W9$,DQZ9&,V:F)E6#=Q8E1P6&AV5D%%16MC)B-X03M3>FM-5%%64GE"
M5'AY9TY:63-E4V9M0D9F1WE8>D)A<&-3>',Y='DP:5=22RMQ5U5-575!0E-&
M4W!Q,WA-47=P5&=63D9&84@U=VDQ)B-X03M(4G)F55HW:31T;6UH;75$17%R
M24)(8GE'3C)"*W)+5#EM=$].9C$T055G6'9%.%$W>'5&,3,U-#!#,&%28FI6
M-31Z1&%X,S!T66A2)B-X03MB95IW:5-%:3-P47-A94]&:TU5>C!+;G)0;5<W
M06MG,&)5:TXY83-%14XR=#,V4U)Q3&A735E6:6M16C-)2$AI>"M727!H2T5X
M5WE!)B-X03MS=D]U<'=88TU7<E13<TQV551P5G-L=$1'<%=A=%8Y57E#=$].
M83!8-59R:3)2=WE.,$YG3"M$,%!!,79*3E(Q:E503% U9"M:3"M*)B-X03LW
M:E)T4VIU<FTT9T1*16)G0S0Q4V-H;%,T.65/449:86<O6G Y;F%M5'@T>D]8
M0T144G%C<V]136]I>4\Y3&1:3%@R;"M6-W)Z;F5X)B-X03M1-C=B4V%N-BMO
M;39J,%=72DYW<G)087DS06=":59/:VAQ3W1#4T%9>$)I5#-/3'%C*U-/;WA1
M:CE%*U!I,DA33FIF<'8S8S!:3%!O)B-X03M-,S5U>&%J8WDR.$=T5W!T2D%I
M>#-D,&E35%<S,6551V4S2U%**S9N9$5A9&4O269:8D)+045193EN9S%'85=F
M2D-:4&A1-&5$-&HQ)B-X03ME+V1H=&QR<4HU0S@P>'AZ0S5T2DQ+831T,6(V
M,G-B3DQF0DHQ84=:4'%43S5"+W5J>4<U2VYK5WEW641X.$),9F@Q>&Q!6G T
M=T0O)B-X03M!1$PR-W5F,F]V6#<O5S5D23AJ3DE*;#AW3F8S2FEL;F-U54IG
M5EDU63!7*VMC4FU%,%E#-5%K.&I283AC:DA&64IV-E<W.'E)-V-))B-X03M0
M2#EI8S)L,4DO-3(K<&)P3TQ31W@P.4PR8C%&3GE)=4%+4C-%=W59-FA*<4Y,
M55,X:'E&3BM70U=/;T-8978U9U-0:#A.8U!8=G8Y)B-X03M3439.9B\X04]H
M9657;&AK1FY$*VM9<DM%>40V:7=K=49E6F9Q>&UA375Z9D5R9E9X4W(O04)(
M:V-M8TAR16(U+VIV4BMD:5(T;D)T)B-X03M(*TAV<C1D5F98-WDO2&LW>6Q"
M1W0Q*VMR:3@U4G$Y=U=F,4<P-55H97I0,3-L04]$8T%&;F@O96-Y3TA+<$5C
M5CA7+S!P+TY#4#A!)B-X03M$9D@O04Q(-U Q2CED87IQ5V\O;3EA=F).4&%W
M2F(V9&0S;'%::7)2>'9Y16MC=V=U-%EJ=TPO2'9-;BM19&U!3T]O0U8Y52]M
M<B]D)B-X03M6>3-T;2]K3%0W-GIV9%=-<V=&<$\P3#(Y<UE,2T]24W-F1C)A
M93!M;&%B;T%42W%N=S)Y<7E2=GI9:4%J<T192%@X5CEZ36-75$8O)B-X03MZ
M1%IK,% Q16EL:VQ6<5)T1$).8TUH649E6$-!4U-(<E0T63)09TLU2T)O<UII
M>%1Z3'DS<#)S43921%E4:35N,48W6#E(=$LR;C9Q)B-X03MQ8S=U<VMB4$DY
M;"LW5E97:FU25C1B8W%65W563%!%>7-C<G0P;5AS9S5*.%5J+VMZ06HS;2MF
M-T5D-6TO3"]Z461.,4]63&UW,'EA)B-X03LV,#-4-T)B-E<T;5%,3&%Y>$TU
M6FI#1D%):DE5<4MM=31W=S%%45)D,5I0>F-M3VA-66--8492:D5F-71)1U!4
M=DU/<"M:+TUD;&(S)B-X03LY=F(K;'(Y:&-,2%!+>4LP86E2<$QE365M951V
M6'!404TX04)T+T-1-5=44EI9*V\X<$5%931C,"]S=DE8;FE'-7-(;75B9#1B
M6%<W)B-X03MN5355.5-5.')7540P;VA72#=3161/;G9G3V5&2&(K1VU%8T5W
M4G8O04)%+T)4.&XO;'8U>C!Z5W9+9#EQ;'IB6$@V170W,C-V;E-3)B-X03M6
M;6M.,4Q)-D9/55,Q-'$V9SAI3VU3>39I2D5G0GIP:F@P,#1M2DHK:T8V,6U%
M-3=S5E-F>F9)13AT86I71U,T1'=/;G!X25I'*TI3)B-X03M+.%%63D(S,W=H
M0F5495@U<BLS,4LO,4LV:G9P:V)7-612=#1J<%=S:5)B930U8TDO5&5X1&II
M060K4$-U,TMU6DUS,%-+2#@P0C%/)B-X03MB<RMC.&M*:R]2:TUV9V5I87(K
M6&9M<%ER0GE,35,R5FYQ3G5*>DQ/1U)R,DUQ:DQ31D9)0E!X1FQQ3S)33V]J
M=GHS22MX9$PR64U%)B-X03M)=VIY:GAF87AT9DPS;7-8,RM(4G%6=71Y9DM0
M15A9;6LK<FU2.5$U+U=224DV,$E.3U9+-4PX>$,W<BM++VA4;&9K8W9H.%9I
M<31F)B-X03LX-VXY>69A;BM82#5G,U5U<W9&93)Y9E@P,'AB3W-K=TU:<VMJ
M5S1R4TAB,4-H<%0V8T5D4D%6='EV-V540U=M>4<Y*V9$.6Y.13-F)B-X03LU
M92MD3&DX.61R:3)+3#5O9S$Q05I*86EY:$1!=V)1+V%Q,S)F<RLK05HT9V-V
M-$LK3$DV95I04"M0:2M$2E!0;&AQ8S)P5VQY:TEF)B-X03M3;V)39&)I471!
M:%=D<#=D;VPU4%-4:5)',TE+9#9D:E$U:4)Z4W=N>2]R9S%4>EI99E=32C=Q
M,3%++W1,85)J230T>$MX2W1+55-L)B-X03M#>#)0,&1S=D](:$)V;E%)969Y
M-G).4%!I+VA(2$U%6'I!1S(Q;3!S3CEQ15=H5S!R>%!'53AV-GDW>%9J;71#
M5DUZ075#561J4DM5)B-X03MP5&9V,7E75$=:5"M)1%@R0C)N-$=$1FEJ56]6
M3V954SE->GE35S<Q-CA84G)Q5# W4EEX-51S3&QQ,C9U879D>')X04QQ3U!7
M:61")B-X03MG3VQN>4989%!4:G1K03)19'98>C<Y:WHQ6%=H1F9E6C!%8TQ.
M0G%E9V\S2T)$.$UQ<U(X4F-L>G0Y;R]:-UI!869)835B,S%05&XP)B-X03M:
M9GET06)63#!B9C9:16%:<3)Q>F592%<S='=S865D-7)7-T5!;T1';V(T;DMJ
M8U8V<S-8>'E8-6,Q6DE(<'1%*S%);6]X:50O06(K)B-X03LX4&9C>#)#42MB
M=DMS6&U/,6=T<&IB:$E:0DIY;G1,93=994E4-GES<V%C:'-4=THK5T5&0D-'
M<V9),71'9$YE*W5F<F@P,41(1D,Q)B-X03MP<#9X96U'1%)2:FAB2S9,1595
M<4EM5&114T\R3G)38G U8SAV23EY-F%884LY-S9G=D=%15%-,W)5.5@Q4T8K
M4&YX2$QL,3<T3%=L)B-X03MG.')E5T)B2F%$4TQ)5W-C:51X=T,S:3E.6EDQ
M0TI)1C0P1'%I:%$S541B1&$P;$9X*U@Q<%!/3&AT4FY76EEM=#!K1G!P4EI9
M5UIM)B-X03LY3E=A>5IG9TPO6G)4658S<E9T859T3SAJ869:,VQX8U!C=F1X
M,VEU3'DQ;71D3U=/9#5%0U-34VU#,6AK9&XO04=Q=E$Q-E4R>'1A)B-X03M4
M06564$MY=TQB<F\Y:4QD2D5M4T57,%!!4U),=VIC3'AP>5)2>%4Y44UB5VPX
M=FQV>3=.4$9C4S9885-4=T)69VUA0TUU:6\T;%%))B-X03MX5W%H6D%'04AF
M9D<P,'5H.'8V1$)C;39H,#(Q:75M;&$T861)63%K37IQ5F%1<T9R>DMK9W0Q
M<&=T85(K2W5X5FDO-6=$+V-80S1J)B-X03ME47!)5'AJ;%=*:CA$1&%P5FU0
M:'A914AF2E)&=$]E4FI!:V-W0SAN,&$P9RMO5%AS:VQX8G8X06]'83)K3C%-
M6"]D=W-G475S:E-2)B-X03ML<4E.+T1,:FA(5&)D-6Y",C%Q04EK.$TO=T)Z
M2V9,;5))9V-Q5RMA=%=G=$Y&,7-G=S-D=D9O,FHQ:FEU94Q3051W<GIA2DA2
M130X)B-X03LY:6XX,E9#17)O0S-R9$(R<FA01'@K;5E(1DPP-T1I2&8W>GED
M<75S4VI8=&-G;FI3-FEH.#%A6D1#<G5Y0T53:5%H:S1S,TDX<3%R)B-X03M1
M6F%D4$MG4G99=$],=%5!;4UH6$0V8DA7,W5L4#AH4"M#+S5U>DA93&]H*SA8
M-%5'+UIQ;B]I5TMO>D9,<U99<BM9=71A6EDV375N)B-X03LS:&M%*W,K=F$R
M26IB,'=:;S=A5S5O.&A)5E8T44XQ*U=%24QZ;E%T3VAJ.#!Y3W)85G5S3W8S
M9$5M=4A:0W-K8F]W;S!J;S!D0V50)B-X03M,<#E/6$A%2W9Y=#5Q2&%E8GA2
M2&EI46,X-&-U55%"435C+TY,<D\W5S,P,U)*27I"97=$5'1C9%=%-&EK25=/
M43!J:6I-8V)D2T4W)B-X03M5,U!825-X:T=H=3=N<W)T<4]B2$4U63A'4U(U
M04A94D\O5&)B,U=L:F$U3"MJ6$)66DQ!*U-Z9$IP-T9W;THQ14HX56]K6FE1
M3G1H)B-X03LP>7=A95)&.6)Q;EIZ-U9H2$QS3&@Y9D8Q-W%P-WIO:%8Y1G-(
M5TY&5G)A16AE6%%'36)B=&Q"1DY-<$-2<V15;W9T23%Q5'I68E@P)B-X03M)
M46%E;D@Q4C9O-T0K4W1E=G9J8D=T-U0O=T%Z5S1N,%,V56EP4D1);S102G5N
M>$-I4C%9-VIW4'E/25-8:U!L2F1F9S%%6%4Y:F18)B-X03M$:E5B;39T-%=H
M;&IB,')G;FA&*R]33&E6-6(Q*T@S>DMY6EEK8F1W9%)0<RM5.'5/6E Y,TM2
M.2]%2U5T5#AT*V).3W1B1T]B4S-E)B-X03LV6%-D43 R2R]2;6Q:2C<U<&EL
M9E)25599,4%:;5I"=%%,>6)B2BM01WHW=V9K>3 O6B]G-'A#2$M-6D1N,VML
M2TAS+T]R-EID,C!-)B-X03M6,&MX,&$Q,'A(84<T44YD>%A56FUN5FYI04LX
M95<O,FE!84$W5DEZ=W4V+VEV-$YP,"M3<78X06A!*TME86@U4B]-96%85GI(
M6G5T)B-X03MV<60U<#!L=$@V:69U;V).2D)0>D$V0U4P;T9R,49A8C!J2%!!
M5C5!+V%Y;' U;3DK6D@R8S$V95104#=A=$9F6$YK>E)*-6MB6$95)B-X03MY
M25=3,$YE3G919G1J,4]G*TAR=FHT.$MR*VI8>%@X=D\W+W S.$AT,EE4;G5X
M5C)+=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%9J2&XK)B-X03M33TQ3;W!7.5!N
M2$E8:CE4;%=O4G1K-&=I=%!(.654:'IA9%)(:6A)9#1,>6)2-VTS9E(U.59K
M:&A36G1)=6]78S%)245G05AN=S5%)B-X03M%3'E(=S%P,GI.:T)X9C5W95%J
M;TUK94A#0V5(=TI$:6\Q9D5F=%%N;E<Y9V92+TU.94XT:#!84FE,05)L54I.
M>$)8:$UN0U)I2V1+)B-X03M#;$UN:#5J<#9P3S%';&I#2E!/6&AW2%AE<5AA
M=F5Q*W8V*W-L=$1)9S@P858V3'%N06M5:R]F1FM#."M(*U9T:D=U16(O=T9Y
M<#-X)B-X03M3,B]J:3DQ*W4R;B]!0S!W9CA,+T%%>E=/,5AW,V1S,'%+='A#
M>D5G0E9P52],8D95>'A3-T974&5E=$@P=2\P3U<V=F]L9513,&YU)B-X03MR
M2U-2<$933U8W85<S6C)%6DA,.3%/-C!)4%=V6$-%1C5N<')A9&9E8EI:-VAB
M6FYS+TU%+W!3-W1X04HT=%9K4VYX53)&4E=M*UIC)B-X03MW2R]Z43AR*U9N
M:7I2-%-32F%I8VI1-4%G8R\Q<$Q:-FQ(2G R:D%324EV,&)R9TYR1VAE3U$K
M:3E!6E-S8G Q,F]..'9)1FXS>&).)B-X03M",F5-54EC4C1P4D4Y.2MQ57)D
M<4Y*.4TR8U17+W=$9V]N,$-R8RM2,5!A1#%2*S@R6&5N3#-Y9EAN+T@K:'ID
M-C5F-5 O9E!E.41V)B-X03MB5#E#868X078T22\Y1V@O9#=F1"LW1S(T<G1M
M<VXY4F1V1#91:G9R=' O>3!W9CA,+U1)36MY:U)N:EI68WAS=TE%:3 U2U0S
M2$E-)B-X03M0=D=+56E8>6)P8GEM4S9!=5,S4#%+>'AX;'DU2C5&;S%1,4AB
M:E1$84M2;SAT84%),FE&:D-%66=S;U=L4T]L8V)7;$Y02V9L>%%1)B-X03M.
M4&EO83%Q2VYC,39K;D<Q<'EE52],:4E&1VYX14%!8FIK840S2DIX=&%40WES
M<E=Y=%DW5S%J155%46]I0W!P53%/-7%E<'=*5G-6)B-X03MD:7)S5F1I<G-6
M9&ER<U9D:7)S5EEJ<5=N-C0S;B]3<GDR9W9M,'E0,79R<S!D.&M&:TMW0E4Y
M83!)6C=J-'9S8U-/3&)N144X:E1()B-X03MG;S-F4#='6%ES;EEQ;'9M3%,W
M5%4Y2FUT3'$S;'59;F]F4W0U1$9*54A9<31E16EN<S1W:$)99'!N:U=73U94
M2%IW8U8T>6-,-5HU)B-X03M%3$=L86AP-5-Z24YX6&)P=G1S8E)34#%$.'99
M<C)E3S9A2WEJ=6QQ1V%*2C1L8C1%:E5S<51!1FQJ:C1H:G5"<TUB5VM(82]L
M971T)B-X03M$1U57,6573C%M5TM6-WEA4#%65FAY3%-436%N,4="4$AC36-E
M2F5&3DIF2C!J>%)P.5(P9&A%0VMA1S%K0W%K;D53055K-D52<G13)B-X03MH
M;TU&<'!/3%1Y-6\P1%)4+U5,6F)X07!A84M-3#AA,4Y6<E4P1$UA0W4R3G)3
M85E%=7A6478T16YS<#185U(P:VI:5U-&+U1K24EP)B-X03M26$1*>%!V>4=+
M<T-S=DEA5W5O<F1A6F%00U%Y;4I,*U,T;#0K;'E:4%59,TUG235F>6<Q<4LU
M2S).238W+TQQ1S1T631"8C9D06E+)B-X03M9=E1T-%HT5DU44G1%63,T5$%/
M;D9Y3T1#;4YR4T1I+TMQ14Y+-T,S5C573'0X9#=)0W=)-&UJ>C!86E8V1&)(
M:5AH5%=,>6)+26PY)B-X03M3,#!O>3!4:S5T-5A9=$A'<U-K>4=137A%83AE
M4C-P9W1.2FQA*U9.2&$P55@K;3)2=6UL835M345613ED>2]*,35F1E5I5G%N
M=E4K)B-X03M/3G)3<C5Q=3<R,#!/-'5,2C)J=55P-F)P1W-T0U149%A+<G@X
M5%AB14M8;D9N-2\Q,BLQ6G1+:3AZ45=D.4I,4&)78U8U;W-Q0U-7)B-X03LS
M9FTQ0V)L131R04].5V1E5$AK2U5+1T%M1#%6:TDO35!46# U8G5'-VY:<&)+
M-C%#1E=A,C1T2%I-5FQ"84]/86@K13!P6#<Y<VTS)B-X03MX,#AY95A51#5P
M5VYN+U5J97DS-'4U6G1,1VIW86A(<&M3>$YC*W).2W%6-65H=79X5396-S!X
M8B]W06UA02]I-'$X;6)R4&1Z-F5,)B-X03MQ,G5P4UI9=E9H5G9Q+S=3.&Q"
M06HO:FDT56=185-A>7903WHS5G%T>%!%25,S*VQC66E#5DQB0D,P64%)2#)U
M6#!E1THU*U1'2C)")B-X03M03FM7<38O<$]L4&)P9GI'2C=T:6QU;U-2>7I+
M05-09U9V2'9I06ML34U#6%EQ-T9867$W1EA9<3=&6%EQ-T973C9J<BMR5W9M
M+U0Y)B-X03M-4S-L:S!Y-E)Z3E!$6E,S0WAS1E!(,6)L2FQ704TQ3TY95W)V
M=798145(8G%'4'%V;'-Y5$9K-T9867$W1EA9<3=&6%EQ-T9867$W)B-X03M&
M6%EQ-T9867$W1EA9<7=V>C50<7@Q0S%S,&ED.4AE,6YM=6Y!0U)I-&IN9SE!
M3DU145!H6B]G<4]1<E1F;U%G<TDP=&)I3'I:6F\V)B-X03MT9&,Y5G5M:FQB
M,#%74&1Q25-P5G%E0C1N375822\Q43A.9V\U8V1B9C12:S<Y+W!3=&)R5FPP
M93!#9U%V*V=.6EE7,$YY1$E81%1-)B-X03MR2D=9>GEA<6=$-2LR46QP-T\S
M<$9G95<W=4]X93%C<V-73TYN241'56E31%I-6DAB:7,Q,V15:3%+,#%38E1.
M47904VME-6LX<5=!)B-X03ME35--2C)M1C='5S5*1WE38W%D9FA!>7=A84]W
M2C,T<78X5TAB>3=1>6E:>5(O;3-W.4PY>C,O44MT;U=M<U53<'194V9I+S1R
M6"]+)B-X03MZ16M+3D]32D=7-39O.$1C9D%N+T%!6"]!1&1K56]F6"],1VTV
M-3E7*W5M4VQQ>DY'14E!2EE!2&M#1T)&0FEM:S)X5C)+=7A6,DMU)B-X03MX
M5C)+=7A6,DMU>%9#>396<&-T-FPY3%IW4UAS83A9-W!O,$UQ<E5.4EA)-4%6
M54AR,GA61EEQ-T9867$W1EA9<3=&6%EQ-T9867$W)B-X03M&6%EQ-T9867$W
M1EA9<6Q0;7%#4V)1-VM*1W-J24$O1FA),S)45V]734]Z16113TIR:$-#.&LX
M='!R:39N.6)K,"LV95%A:DID,CEU)B-X03LP539&;S5444I7-59/3$1C:T@T
M461Q:G1K>GEG:C15-E-F6DXU251J565#8W!6,SA626)5+TQV;F%Z<TQ+,G9.
M2U%34'!';S996C=D)B-X03M44'AN=FUN-%5L0W1):4EL1V-T5'%!=%1T:R](
M:F0W.'=F:S5/3%$K2$%1:4%!27E(>G1)<'9,+T%*;&TP,CAT-#=/-%<T8E%R
M5%)L)B-X03MK84,U5&Q08C-C8GE3<3=23%9!3U)R6&MA1V=/,5IJ57AV.$%Z
M:55N4WER;B]#0CER,F948B]8-TQ43$<Q:S!+-%IO;S!G9&Q-0D$Y)B-X03M.
M0T]:*TMV16Q.=2LT<4]T34M2<VMU9D550459=7(V-3A*8E%R:%%25G0W8VQE
M;3)Z1W S-UI';51*34-867$W1EA9<3=&6%EQ-T98)B-X03M9<3=&6%EQ-T98
M67$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&5TPS+W=$
M>7(O,4HO<E@Q6#%A=#8S1W90;%4X)B-X03MV<V(X<2M'*TAD1WDX9C1#*W)0
M>"MQ96AY6#%/3DM6<#A02VU/-C=+15@O2W5/1&-F<6Q+;79/=&9T8C U8CEE
M;$\S5&)(9&1N42\X)B-X03MQ-#E)8U!Q;DAI2V,V.'%B9GHO1E@X8V0Q,E0O
M045B.4=F;WE$.48P*V]54&]C83!P53$K,3A6959A,7=&2TYX5B\O6CPO>&UP
M1TEM9SII;6%G93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @
M(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]X;7 Z5&AU;6)N86EL<SX*(" @
M(" @(" @/&EL;'5S=')A=&]R.D-R96%T;W)3=6)4;V]L/D%D;V)E($EL;'5S
M=')A=&]R/"]I;&QU<W1R871O<CI#<F5A=&]R4W5B5&]O;#X*(" @(" @(" @
M/&1C.F9O<FUA=#YI;6%G92]J<&5G/"]D8SIF;W)M870^"B @(" @(" @(#QD
M8SIT:71L93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^,# V-S<T7S P,5]S86YG
M86UO7V%S:%]G<F%P:&EC=7!D871E7VQO/"]R9&8Z;&D^"B @(" @(" @(" @
M(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SIT:71L93X*(" @(" @(" @/'AM
M<$U-.E)E;F1I=&EO;D-L87-S/F1E9F%U;'0\+WAM<$U-.E)E;F1I=&EO;D-L
M87-S/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YX;7 N9&ED.C@Q960R
M,# X+31D,&0M-&)A.2TY.#4V+3,Q-F8T.6%E-V5A.#PO>&UP34TZ1&]C=6UE
M;G1)1#X*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HX,65D
M,C P."TT9#!D+31B83DM.3@U-BTS,39F-#EA93=E83@\+WAM<$U-.DEN<W1A
M;F-E240^"B @(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^=75I
M9#IE-C@S-68Q8BTP83=A+31A-#(M8C-C8BTS-3AD,V9F.6,R.#8\+WAM<$U-
M.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.D1E<FEV961&
M<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T
M4F5F.FEN<W1A;F-E240^>&UP+FEI9#IF-S4P.#AC.2TR-&9F+31A-S4M83(Y
M,RTU,V-F,&$T-V0W83D\+W-T4F5F.FEN<W1A;F-E240^"B @(" @(" @(" @
M(#QS=%)E9CID;V-U;65N=$E$/GAM<"YD:60Z9C<U,#@X8SDM,C1F9BTT83<U
M+6$R.3,M-3-C9C!A-#=D-V$Y/"]S=%)E9CID;V-U;65N=$E$/@H@(" @(" @
M(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z938X,S5F,6(M
M,&$W82TT830R+6(S8V(M,S4X9#-F9CEC,C@V/"]S=%)E9CIO<FEG:6YA;$1O
M8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIR96YD:71I;VY#;&%S<SYD
M969A=6QT/"]S=%)E9CIR96YD:71I;VY#;&%S<SX*(" @(" @(" @/"]X;7!-
M33I$97)I=F5D1G)O;3X*(" @(" @(" @/'AM<$U-.DAI<W1O<GD^"B @(" @
M(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.C9B.#!F-3 R+3,W9#<M-#(X
M-RTY-S<Q+6(U,V-C9F(S-&4X-CPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @
M(" @(" @(" @(" @/'-T179T.G=H96X^,C R,BTQ,2TP,E0Q.#HS.3HQ-2TP
M-#HP,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O
M9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@,C8N-2 H36%C:6YT;W-H
M*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#II;G-T86YC94E$/GAM<"YI:60Z.#%E9#(P,#@M-&0P9"TT8F$Y+3DX-38M
M,S$V9C0Y864W96$X/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z=VAE;CXR,#(R+3$Q+3 S5# Y.C$T.C4V+3 T.C P/"]S
M=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!
M9V5N=#Y!9&]B92!);&QU<W1R871O<B R-BXU("A-86-I;G1O<V@I/"]S=$5V
M=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA
M;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI
M<W1O<GD^"B @(" @(" @(#QX;7!-33I-86YI9F5S=#X*(" @(" @(" @(" @
M/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1-9G,Z;&EN:T9O
M<FT^16UB961">5)E9F5R96YC93PO<W1-9G,Z;&EN:T9O<FT^"B @(" @(" @
M(" @(" @(" @(#QS=$UF<SIR969E<F5N8V4@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" @(" \<W12968Z9FEL95!A=&@^
M+U5S97)S+V$P,S<R-#$O1&]W;FQO861S+TUI8W)O<V]F=%1E86US+6EM86=E
M("@Q*2YP;F<\+W-T4F5F.F9I;&50871H/@H@(" @(" @(" @(" @(" @(" @
M(" \<W12968Z9&]C=6UE;G1)1#XP/"]S=%)E9CID;V-U;65N=$E$/@H@(" @
M(" @(" @(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#XP/"]S=%)E9CII
M;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \+W-T369S.G)E9F5R96YC
M93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F
M.E-E<3X*(" @(" @(" @/"]X;7!-33I-86YI9F5S=#X*(" @(" @(" @/'!D
M9CI0<F]D=6-E<CY!9&]B92!01$8@;&EB<F%R>2 Q-BXP-SPO<&1F.E!R;V1U
M8V5R/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\
M+W@Z>&UP;65T83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@
M96YD/2)W(C\^_^X #D%D;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,#
M P,# P$! 0$! 0$" 0$" @(! @(# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P,# P,# P,#_\  $0@$^PC* P$1  (1 0,1 ?_$
M 1T  0 #  ,! 0$! 0         ("0H&!PL%! ," 0$!  $$ P$!
M      0#!0<( @8) 0H0   % P$!!PL+#@H'! <!$0 #! 4& 0('" D1$A,4
MUA<*TQ55E=465I97.!DAE-2V=Z=8>)BX.3$BDZ6UY6>'E[<8:1HJ([1U-G8W
MUTB(64$R)(0UR-A1QWDZ84(S-"4FYJB14Z9Q4M*&)VA)0V/G*$;HF1$  0,!
M P0)"PL-"PD&!@(#  $" P01$@4A41,&,4%AD:'14A0'<8&Q,K(C4[-T-@CP
MP2)RDC-CM"4U-^%"8M,TA!55=788. GQTG.#DY3$1;46%X+"XR14U(56&:)#
MHV25U>)$I.2E9E<FY64Y_]H # ,!  (1 Q$ /P#?P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M/@W^Y7B'.:;PC/=)QCTAV@'X<NCSY3.%N6P<VJ?!O]RO$.<TWA&>Z3C'I#M
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M/@W^Y7B'.:;PC/=)QCTAV@'X<NCSY3.%N6P<VJ?!O]RO$.<TWA&>Z3C'I#M
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MO]RO$.<TWA&>Z3C)AB@5P
M       *F]L;BO'F4M,^,D>08FU2M,W:N=)J-"2ZEFF6)DLTSO"('*B2Z%&E
M5I8^0^2+F\_ZNZG4WTIN5K2M)E$]S)5NK9[!W BKV2'7,:^)+R6^S;PJB=@[
M ]#_ +,SX&N'NUKMW7''GM5RW'+F5)X-H]#_ +,SX&N'NUKMW7#GM5RW#F5)
MX-H]#_LS/@:X>[6NW=<.>U7+<.94G@VCT/\ LS/@:X>[6NW=<.>U7+<.94G@
MVCT/^S,^!KA[M:[=UPY[5<MPYE2>#:/0_P"S,^!KA[M:[=UPY[5<MPYE2>#:
M/0_[,SX&N'NUKMW7#GM5RW#F5)X-H]#_ +,SX&N'NUKMW7#GM5RW#F5)X-H]
M#_LS/@:X>[6NW=<.>U7+<.94G@VCT/\ LS/@:X>[6NW=<.>U7+<.94G@VCT/
M^S,^!KA[M:[=UPY[5<MPYE2>#:/0_P"S,^!KA[M:[=UPY[5<MPYE2>#:/0_[
M,SX&N'NUKMW7#GM5RW#F5)X-H]#_ +,SX&N'NUKMW7#GM5RW#F5)X-H]#_LS
M/@:X>[6NW=<.>U7+<.94G@VCT/\ LS/@:X>[6NW=<.>U7+<.94G@VCT/^S,^
M!KA[M:[=UPY[5<MPYE2>#:/0_P"S,^!KA[M:[=UPY[5<MPYE2>#:/0_[,SX&
MN'NUKMW7#GM5RW#F5)X-H]#_ +,SX&N'NUKMW7#GM5RW#F5)X-H]#_LS/@:X
M>[6NW=<.>U7+<.94G@VCT/\ LS/@:X>[6NW=<.>U7+<.94G@VCT/^S,^!KA[
MM:[=UPY[5<MPYE2>#:/0_P"S,^!KA[M:[=UPY[5<MPYE2>#:9DNE;:/-,>BS
M9X8:REI7PQ#<(9"?]9^/( \2N%)E:5U<(:ZX/U%2)PCR@Q8L6E5;U;W%6Y3?
M2EM+N$2%UW=RE:5<]JN6X<RI/!M+:ME%LS=!>:MFIH:RWE72]C*<9)R-IDQ)
M+YQ,'M"XFN\EDSY$V]<[/+D82Y$E7K%RLVXR^MMEM*W5]2E Y[5<MPYE2>#:
M6!^A_P!F9\#7#W:UV[KASVJY;AS*D\&T>A_V9GP-</=K7;NN'/:KEN',J3P;
M1Z'_ &9GP-</=K7;NN'/:KEN',J3P;1Z'_9F? UP]VM=NZX<]JN6X<RI/!M'
MH?\ 9F? UP]VM=NZX<]JN6X<RI/!M'H?]F9\#7#W:UV[KASVJY;AS*D\&T>A
M_P!F9\#7#W:UV[KASVJY;AS*D\&T>A_V9GP-</=K7;NN'/:KEN',J3P;1Z'_
M &9GP-</=K7;NN'/:KEN',J3P;1Z'_9F? UP]VM=NZX<]JN6X<RI/!M'H?\
M9F? UP]VM=NZX<]JN6X<RI/!M'H?]F9\#7#W:UV[KASVJY;AS*D\&T>A_P!F
M9\#7#W:UV[KASVJY;AS*D\&T>A_V9GP-</=K7;NN'/:KEN',J3P;1Z'_ &9G
MP-</=K7;NN'/:KEN',J3P;1Z'_9F? UP]VM=NZX<]JN6X<RI/!M'H?\ 9F?
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M &9GP-</=K7;NN'/:KEN',J3P;1Z'_9F? UP]VM=NZX<]JN6X<RI/!M'H?\
M9F? UP]VM=NZX<]JN6X<RI/!M'H?]F9\#7#W:UV[KASVJY;AS*D\&T>A_P!F
M9\#7#W:UV[KASVJY;AS*D\&T>A_V9GP-</=K7;NN'/:KEN',J3P;1Z'_ &9G
MP-</=K7;NN'/:KEN',J3P;1Z'_9F? UP]VM=NZX<]JN6X<RI/!M'H?\ 9F?
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M &9GP-</=K7;NN'/:KEN',J3P;1Z'_9F? UP]VM=NZX<]JN6X<RI/!M'H?\
M9F? UP]VM=NZX<]JN6X<RI/!M'H?]F9\#7#W:UV[KASVJY;AS*D\&T>A_P!F
M9\#7#W:UV[KASVJY;AS*D\&T>A_V9GP-</=K7;NN'/:KEN',J3P;1Z'_ &9G
MP-</=K7;NN'/:KEN',J3P;1Z'_9F? UP]VM=NZX<]JN6X<RI/!M'H?\ 9F?
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MP;1Z'_9F? UP]VM=NZX<]JN6X<RI/!M+)!%)0
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MOND3PT0]I3M"%P>JM*)N;*N2HA-2XW@""2M_6N]LI3U /I((
M
M
M
M
M
M
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MGOJ^T=W*D6L]Z3V[.Z0LD$4E
M  !\*2_\$6_[M_&R!]39.+^U/NCX<@
M
M
M
M
M
M
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MU+:F;VW_ $4H.*JJK:IS1$:EB;!]L?#Z
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M<B:W6W&I[+*TN $7]-?2S]D'J&ES=#'^:YDTR.#PK)0-3MJ4QTSQR(GK5!W
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MZW)<?99A5C2V/3BX-+:XH'#)$"AS;)D"AP;#;.&:CEI=E.#NOK;8<5=>!8<
M
M
M
M
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M=[E1I:[P+?=(/TG-L;_E@X?^6I ^X(:*B\*[W*C2UW@6^Z0?I.;8W_+!P_\
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M4L>QLL:-:YR);>M+MQ )X
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M*ZMA*C*S(V07TE$WF.)3"6Y/=S$PL<?:$+:W(:K57!$)>%O,O//.OO L_
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M7-/^1UQ76XG*F)ESD>S3+%F5&IJ,L;E"FAJ-6Q2%&3=9:J1')G(BQ)54FL(
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M-8<;&URE$T*C"FY'81:K7WGK;4]B("3?0A/.;US^X1C+\X#F /1S
M
M
M
M
M !3S,_IV,+?^&UD7\_*836_-[OX5.P0G?.#?X)>R7#"$30
M                                                      IYVJ?]
M;.RB_P#$EQ%[6Y<)M)VDW\$OK$*L[>'^%3URX80B:
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MUAA9EEU:76UI6E:5W*@#R4]E6DIHUZ3; \5QM02Q,V/-=FI72_8A)47VMIK
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M6C2J) ^'%6TMN5J[CC[K:;E;]P 8N.A"><WKG]PC&7YP', >CF
M
M
M
M                                                           "
MGF9_3L86_P##:R+^?E,)K?F]W\*G8(3OG!O\$O9+AA")H
M                                                     4\[5/\
MK9V47_B2XB]K<N$VD[2;^"7UB%6=O#_"IZY<,(1-
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MVEGQ -9'S=<C #$7T(3SF]<_N$8R_. Y@#T<P
M
M
M
M                                              4\S/Z=C"W_ (;6
M1?S\IA-;\WN_A4[!"=\X-_@E[)<,(1-
M                                       "GG:I_P!;.RB_\27$7M;E
MPFTG:3?P2^L0JSMX?X5/7+AA")H
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MZHA&08XO,PU$M#0@+-4&%EWK75V7$)4Q5*[\]0=8792Z^^VVH'I]M&;\,O\
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ME]:[MP _%M8OHLMI9\0#61\W7(P Q%]"$\YO7/[A&,OS@.8 ]',
M
M
M
M
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MLFL'$3D]/KF@9VAN3.+K<H7NCFJ*1($1%+FFVVIRI6?99;2M:4WUU!PDZ/\
M7.&-TTN'5#8V-55542Q$1+579VD.<727J'/*V&+%*9TKW(UJ(JVJJK8B=KMJ
M6,#IQWD "CQYVF.<F[;71+9ND1#$]V$'Z-J759*S667W95+6DZ<Y-F*VB9ZL
MG%D1L2UD#,4FK9<R7W\3NOIO^$K0RV>E+'S%:JU=);N6=M9FMX2WK5R)7I2V
M-T=FSEM[6W/9P%X8@%P*/->VTQSEI9VB6AO2- (AB=YQSJ8D&(FF>ODP99>N
MFS4GR%F^[&3I?$7!EG# Q-YR)EMX=/5:W.%M%5=V^EQ?\&)]/2QS4TDSE6\R
MVRRRS(EN7(6^HJY(:J.%J-NO5+;;;<JV9,IR7;/[1W,FSBQ9A2<X:B&,Y>YY
M%R2Z19_2Y-;92YH$[&UQTUXOZSV166Q%0E=5*C>VT/.,4DEV4K_ 75K2MORA
MI653W->JHB)M?N*<JZJ?2L:YB(JJMF7]U"YX02<1BUB:L,9:)]/D[U$98O7G
M1N')T:="Q,]A1K]+9.\JBVZ.15C*.OL)X^[N)UM+C3*T*2IK35!M:%$WUI5@
MA?/(D3-E2E/,RGB65^PG"9]8[M8MM=FJ+$9YP!LT8,ZZ>'8I6\1RCFW3N4SB
M01U.H.*M41]6CR3!W*47'VE5H2H;HJ>6INMK<39?2M!<EHZ&-=')*NEZUG87
MLEM2LKY$TD<2:+KV]E.P6X;,#:#R3:"XOGTIF.GN8X#E^*9BGQ]+D3RJO<(J
M]2BUON6NJ2,*W%"R21&YL-G W.C:N067-W'DUEJE5=<9<7"JZ9*9Z(UR.:J6
MH3*2I6I8JN:K7-6Q2S<126          5Z:@-9\GPYE!Z@+9"V%Y1M:1F4EN
M"Y>X$*3;G-J2N!EMY2>E2K:%7J*VTW/JTH/,3TE_3TUNZ"NEZOZ-L)P##:^A
MHX*61)IIIF/<M13QS*BM8EU$:KU:EFRB93;_ *)/1KP/I'U&IM;*W$ZNFJ)Y
M)FK&R.-S4T4KHT5%=ERHVU=TZ6](_-O)O%>VKO\ _FC G_53Z0/^5,'_ )Q4
M\1DK]#+5C\=5_P#)1#TC\V\F\5[:N_\ ^:'_ %4^D#_E3!_YQ4\0_0RU8_'5
M?_)1$QM+6H=YU ()DK>(ZV1^Z,*V5,18VJE:FU5:Z$N1IEQU55*5LJ55#2E-
M[]7?5W1O3Z'GI/X]Z2^&X]78YA=)AC\(GI8V)!))(DB5#9W*KM)L*W1)99LV
MK::Y=.W0_AO1)5X;3X=63U;:Z.9SED:QMW1+&B(EW9MOK;;F)7#<TP&0NVB&
MHZ:Z1]&.=]1>.FF+/DUQA'65UC[5-4;LX196K=)C'(X9:\(V)ZCKLH3E)7DR
M^VTA:GNX2VW=NW-VE:]-$V:=L3K;JKM=0H5,KH8'2MLO(FWU3CVS)U1SW6CH
M?PCJ7R>S1"/SK)-N1^OK1 T+RVQ-+=#<MSV -]6E#(7Z3O">U2U14@TZARY1
MNJ##*VUMLK;9;]JHFP3NB9:K4LV=U$4^4DSIZ=LK[$<MNQL9%5"36>IXZXKP
M9F?)[$E;USYCC$^19XS(G8M2:U+'6(1!XD+<E<RD:I$K-;U"MNLL.M*.),N+
MK6EM]EVY=2E&U'R-8NPKD3?4JR.5D;GILHU5WD*[-C3KUR[M$=+\YS5FF-8X
MBTKB^>)1BU&@Q>TR=FCRAA9<?XPEJ1:J22N731RJ[WKINI+,OL5VDW$E%4M*
MMNI?=?)KJ=E-*D;%545MN7JJF9,Q%H:A]3"LDB(BHZS)U$7.N<X9LIMH[F37
M;E/7/!LJ1#&<8;-,F28G%H&JQ^VREO7NS')9%F1GO[[KY'+9.G7NJ-/C=+=0
M]$6@)OO/-_@*4WE+>592LIV1N8JJKT6VWK;&3=/E'5/J'R->B(C%L2SK[.7<
M+GA!)P %+VC#:ZQ#5GKYU4:0TK?&FV+XTN478#EB$QRL=LE$0!79',LU=3%R
MPQN7&WOAUKBR6HDZ6ZK*4=>;0VI=QM)T]&L-.R;+:NSN6['U=T@P5K9JE\&2
MQ-C=LV?J;A="().*(M6>WDP;@_+3OI]T\8=R/K.S9&UKHU26.XK,-0Q=F>F8
MVY,Z,%)*AC\S>7IW:EEEQ2SK<S+$B6^VZRX^IMMY5MPAP^21FDD<C(US^I.R
M6^;$8XWZ*)JOD3-ZE[!]_1)MQ,+ZJ<U)],^5,/Y&THZ@7.ZJ6/PC)9M%[4_/
M9:0Q<=%DSV>S19X:Y*8C*J:F3N32BL66TWA1EQ]Q9-_R>@?%'I6.1\>=/5ZY
M]I\0CFDT3VJR3,OJ]8N^$ G@  !3SM4_ZV=E%_XDN(O:W+A-I.TF_@E]8A5G
M;P_PJ>N7#"$30
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MSD4OP_*XRLD>#WB3.J@Y<N=8@K8E2>28K)7KS[S5"$A(]-ME;]Q&F1%VT*N
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M60VVX-LP\GBR>-/KD^*EQI]<O93-?CG(U626792B&U/:5?6M3JF6\$!HS
M
M
M
M
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ML='*^3WI4R;RHN_D0M5==DK8HX_?47+OHJ;V536T+.7D   *>=JG_6SLHO\
MQ)<1>UN7";2=I-_!+ZQ"K.WA_A4]<N&$(F@
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M:T26,OB4M:TO+:8<42;>C7)#;3+*W66UK;7U:4'PY'/
M
M
M
M
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M"+J%MY5.#3FFJ:E;5)*J0PY(&[&[]3-OE.AI5B19ILM0[9W/JY]XO6%O+@
M %/.U3_K9V47_B2XB]K<N$VD[2;^"7UB%6=O#_"IZY<,(1-
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MF4:6/.@YXL5^4")]ND?50N/S*-+'G0<\6*_*!$^W2/JH7'YE&ECSH.>+%?E
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M*%9RET4TL.-H5:6001$JZMU4Y,ED:;"<9+I*-M*U<MZ1=E>(M;$,F
M   %:VH[1QD[+^6'V=QI]@B%H<T3&G3IGQSD"9RLO;6A&@/J<2@C#FEMLO.3
MW5LWIUU:VUINTI7U*>4/I4>@KTM].'31B/2-JGB.KE/@E73TC&,JZBMCG18*
M:.%]YL.'SQHBN8JMLE55;8JHBY$W4Z&O2.U(Z.]0*757&J7%9<0@DG<YT$5.
MZ-4DE?(VQ9*F-UJ(Y$6UB9;;+4RG1GHZ\V>%&+>W<MY$#7;_ *7/3_\ CC4[
M^=XE_P"TF4OTQ>C+_8<=_D:3_?1Z.O-GA1BWMW+>1 ?]+GI__'&IW\[Q+_VD
M?IB]&7^PX[_(TG^^DVM)&GV9X$;YPDF#G&'(R2K6)0@NC2UU66%6-A#H4HHK
MJZ,K/<7??<MLWF\H92M*5W:T]3=] _0G]&;7ST;L+UAHM>:O"*N7%JBD?"M#
M+42HU*=E0U^DYQ2TJHJK*V[=1Z*B.M5N2W6/T@^EW5OI8K,+J-78*Z%E%'.U
M_.61,55E=$K;FBFFM1+BVVJW:LMRV3"&\AKJ0NVB&G&:ZN-&.=].F.G:+,<U
MR?'65JC[K-5CLWQ9(K:YC')&9<\+&)ED3LG3FI68RRVXA$HNX2ZW=MW-VM*]
M-*V&=LKK;J+M=0H5,3IH'1-LO*FWU3CVS)TN3W1=H?PCIHR>\Q"03K&UN1^O
MKO USRY1-5=,LMSV?M]&E=(6&,/"BU,U2H@HZIR%/N*"S*6TNLI;?=]JI6SS
MNE9:C5LV=Q$0^4D+H*=L3[%<ENQL955236>H&ZY4P9F?&#$J;T+YD?$^18&S
M+78Q24U(W67Q!XCS<J<S4:5:K*;TZMQLO.N*).,M+I6MME]VY;6E&Y&2->NP
MCD7>4JR-5\;F)LJU4WT*[=C5H*RWL[M+TWPKF>38YE4LE.=I1E)*NQ@Z29WC
MJ9C>H#C*)(T)ZR5Q.&.576Q9"%!IEMJ.I-I9I>],NNWU+9-=4,J94D8BHB-L
MR]55W<Y%H:=]-"L<BHJJZW)U$3,F8JMA6P[VB&"Y;EW/NF/6U <,9ZR1E3(R
M\^--9LM68OD&*)&[EOL5(E3PO@:\^LQ:W!:NN.3&QET1IZW$WI55AE#+[YCJ
M^FD1(Y8U=&B)U;=_8ZY$;05,;G20R(V17+GLLWMGK$UM#>R?SEIPF.;]8N>L
MYQ_49M!\BX^DS!!96^+I+S7PF0+X[1O;+G!_7L)DD>42E4VMZ"]44PIK&EB)
MO3)&^^E^]$>HK(Y6MAC:K:9%RYU]75V=LKT]')$YT\CKU2J9,R>KJ;&T=B['
MW9E9!T#LF>)OJ"E\&R1J+SW.2722S&#.4C?6@N)-M%+HD2T=I9%X@[7/C[+9
M YKG2MB$LD[<24K<94FE;>-;5-J%:V-%2)J;"Y^M;M'.BI'4R.=(J+*Y=E,W
M7LVRZ$02<49O^S#SC"-KO']H7ITFV)XYBJ;MY"/43CZ3KY8V2I]J[LID:F]8
MJVL\/?F!UZ\%-C6^%7J7)KNJ_$7W&4J76MQD]*J-U%S:5%5Z=JNUN;?6ZA;U
MI)&UJ5,2M1B]LF7KV9.OU2L[+^Q@VP&4M8#SK--U,Z1K<MD2TU\Q\]N4BR0[
M$X_:FPU23"VJ,QJ0:<Y)'F2R(MQEE47!V'&)EUM5EIURRZY3=+9743(-!=?<
MLR[&7/\ 7;9%?0UKY]/?9?MR;.3-]:3!Q1I Z0I'\HXW?<E[0+3Y),<,\\B+
MGD&/-ZIQ5N#]!T+^WJ98S-Z95I49TYR]S8"U!!-MZQ);4V^W^&*_]I;0?-AJ
ML5&1N1]BV=7:^N*S(<21Z*^1JMM2WJ;?UIH\%L+H   %-VUB7HFO)FRM<G)4
M0A0(=H]B92L6*3+2DZ9.3&9?>:<<;?6EI99=M-VM:^I2@FT>5LR)X)?6(-8J
M(Z%5V-*GKEI'/%BOR@1/MTCZJ(EQ^925I8\Z#GBQ7Y0(GVZ1]5"X_,HTL>=!
MSQ8K\H$3[=(^JA<?F4:6/.@YXL5^4")]ND?50N/S*-+'G0<\6*_*!$^W2/JH
M7'YE&ECSH.>+%?E B?;I'U4+C\RC2QYT'/%BOR@1/MTCZJ%Q^91I8\Z',F1_
M99(AM<V!T0O#=<:83:M;U!:E-<:36E#2Z&E5NMK>76OJT_T#XJ*F1=DYHJ.2
MU,J'UQ\/H                                  !F$Z4UYHFGCXQ]GYL
MIT+KA/O[O:>NA:<7]X;[?UE-"VH'/F+M,&'YQG3,LD)B^/8 T7.KTX7VT.6*
MC3#2TC6QLJ+?EWND@?W102C0);*TN4*CK+-VE*UNI;8XWRO2-B6N4N4LC(6+
M)(MC4,Z&B+3WE;:W:I2=IWK.C:AETYP-RJBT::?'JRJAE<6YE=5!Z&5.J*^X
MDEP8VMW2V*E:DXF^DF>J5MKO&M 0F-N=1(RCBYI O?%[9?5ZD3=4ME/$^MFY
MW.G>D[5/5ZE7<-2@M)=S\ZI(E7)CT:U,G6)%)5Y*E*J)+4)E!)E-[>4>0=;>
M4:5?;7<K;=2M*T ;)Q;F[Q_X#0[Q99?80Y7G9U.-UN9"N;:A0J&MNG?'ZENB
M490*?TOM%1/&$3"U)3^!4:H,7DGE<*0E+,X,\F^ME]N[N76UK2N[2HDTCG:1
M<J]H[N5(U6UNB3(G;M[I"SOK6V=CD'K1/U,1"58F8=:VSL<@]:)^I@+$S#K6
MV=CD'K1/U,!8F8=:VSL<@]:)^I@+$S#K6V=CD'K1/U,!8F8=:VSL<@]:)^I@
M+$S#K6V=CD'K1/U,!8F8=:VSL<@]:)^I@+$S#K6V=CD'K1/U,!8F8=:VSL<@
M]:)^I@+$S#K6V=CD'K1/U,!8F8=:VSL<@]:)^I@+$S#K6V=CD'K1/U,!8F8=
M:VSL<@]:)^I@+$S#K6V=CD'K1/U,!8F8=:VSL<@]:)^I@+$S#K6V=CD'K1/U
M,!8F8=:VSL<@]:)^I@+$S#K6V=CD'K1/U,!8F8=:VSL<@]:)^I@+$S#K6V=C
MD'K1/U,!8F8=:VSL<@]:)^I@+$S#K6V=CD'K1/U,!8F8=:VSL<@]:)^I@+$S
M&1KIG:U9&MEY@=='%:F/KC=>^+TAJQD/-:E1J4S3SJD.O3&*$%Y!UZ>\XBR^
MME:UMK=9;7<W:4 6)F+L-C 22Y[)O9W.#D44X+UFD;":A8N7%VJUBI0;"FRX
MP]2I/H8<><9=7=NNNNK=6OU:A:+$S%FO6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3
M 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y
M!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,P
MZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?
MJ8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML[
M'(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)
MF'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT
M3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUM
MG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"
MQ,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/
M6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6
MML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3
M 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y
M!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,P
MZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?
MJ8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML[
M'(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)
MF'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT
M3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUM
MG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"
MQ,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/
M6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6
MML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3
M 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y
M!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,P
MZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?
MJ8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML[
M'(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)
MF'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT
M3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUM
MG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"
MQ,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/
M6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6
MML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3
M 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y
M!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,P
MZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?
MJ8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML[
M'(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)
MF'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT
M3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUM
MG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"
MQ,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/
M6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6
MML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3
M 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y
M!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,P
MZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?
MJ8"Q,PZUMG8Y!ZT3]3 6)F'6ML['(/6B?J8"Q,Q4%+4Z=-MU\+V)R"2+;MFY
MD:ZZTDJPJVMW/PEIOJTLMMI6NY3ZHFI\WN_A4[!"5+,0;9X)>R7&"$3@
M
M    IWVJUEAF5]E(699;?9?M(\1VWV7VTNLNMK&Y=2MMUMU*TNI6G^BHFT?:
M3?P2^L0:SMX?X5/7+>>M;9V.0>M$_4Q")MB9AUK;.QR#UHGZF L3,.M;9V.0
M>M$_4P%B9AUK;.QR#UHGZF L3,.M;9V.0>M$_4P%B9AUK;.QR#UHGZF L3,.
MM;9V.0>M$_4P%B9C]11))%G!D%%$ETK6N\*+M+LW:_5KO;*4MW:@?=@_J
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ML^;KJJ %WVQ2^B/V<OQ0,'^TEK %GX
M
M
M
M
M                     IYF?T[&%O\ PVLB_GY3":WYO=_"IV"$[YP;_!+V
M2X80B:
M              %/.U3_ *V=E%_XDN(O:W+A-I.TF_@E]8A5G;P_PJ>N7#"$
M30
MK;VI_FX8_P#CAZ)?G28M$JD]]7VCNY4BUGO2>W9W2%D@BDH
M                         /A27_@BW_=OXV0/J;)Q?VI]T?#D
M
M
M
M
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MTC?1[_Y\U,_];PW_ 'D?I.Z:_A"X._*S N[X?@''/]BJ_P"1D_>C](WT>_\
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M47_B2XB]K<N$VD[2;^"7UB%6=O#_  J>N7#"$30
M                                     K;VI_FX8_\ CAZ)?G28M$JD
M]]7VCNY4BUGO2>W9W2%D@BDH
M  /A27_@BW_=OXV0/J;)Q?VI]T?#D
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MIK"3'"K%"<?QZ631T;F<M235>M);[T2"AY7&32N%+WP$T
M
M
M
M !3S,_IV,+?^&UD7\_*836_-[OX5.P0G?.#?X)>R7#"$30 (.[2+S+LS?B[_
M #K04=KU(\Z*7^,\5(::?M!/U1-;O^%_VUAQE9&P!^:  #G.,?ZRL>_TXB?W
M>;Q%K_N&;^"?W*G<NCGZ0L!_+-%\9B-IXU>/U\  8^,SY#Q_BGI0T-GV49S#
ML;01AA?_ ,=FL^DS+#HDR]=-%<P96SKM(Y$M;F=NZXO#BG2$<,=9PRD\LJS=
MOOMMK>F-<_"5:Q%5RKL)E7MBR/<UF+(YZHC4397(G:J:1/2': ?ARZ//E,X6
MY;"V<VJ?!O\ <KQ%TYS3>$9[I.,S.;3G-V%\Y[:+922#"67<89B86C(VF1F=
MGO%D^BF06AK=_P!*VQ;UJ<7*).SNB1.7$E11W &WVF\$9;?O=[=2M;I2QOCH
M9DD:K5L=LI9];NEJJY(Y*^%8W(Y+6["V_7;A(/I4OF\:6?=HEGM'O%/"/?'^
MU3LE7%_>F>V]8T5QC5-IBFTW-QE#-1N!Y=D@B\PL_'T8R]CY_FY)A-MMYQ9L
M4:I"K?B[RK;Z5NI5/2MM*TW?JBV+#*UMYS7(W/8MA<TFB<ZXUS5=FM2T[X%,
MJ&//:0L<QVP6U19M N*Y;<Q8KTJ0"=K9U,"R%K@QL^1[VE*=*GAS2IR]XHM;
M94?'XE;:9;PB=51=4J^M#:TK>J56T5)SAZ>S>J6)N?N6J62J1U;6<V8MC&(M
MJ[OJL0F7T=;4I)G##V7=!>8"U3-F+1U-WUO0,3N?;5V+@+Q)75*\,5UEYIYZ
MD['61R%Z0\REW $(W-N(+I2VRF[0Q.)$>VH9VCTX?JIZY7PR558ZF?V[%X/J
M+ZQI!%L+H          8-=NC])#E[^BN)?S:1H2(^T/1KT>/HKH?X:I\?(5"
M"H9M  UF=&G_ )DZMOZ58@^Y.0!1EVC3#TKON_!?X&I[J$T\BB:CE5VVV^BS
MU>_T+B7YT8()E!]ULZJ]A2'7_<;^HG90ASL2]96D#%.S$TS0'*.JS3;C:=L/
M/-U]A4^SGC"'2UEZZ:@LKO39UVCDBE#<\-W7%G<4ZLCAB;.&3'EFV;ME]MU:
MU?!,^K>YC'*U;,J(JIL(4*">!E(QKWL1R6Y%5$7ME)KZK=>NAB1:7-2<?C^M
M#2<^OS[@+,3,R,C-J+P^YN[R[N>.Y$B;6IJ;44Q/6N+DXK3["2"";+S3C;[;
M++:W5I04(:>H29BJQZ(CD^M7/U"1-44ZPO1)&*JM7ZY,W5*]^BY^8#E_XX<_
M_,MI^$G%ONEOM$[*D;"/N9WMU["$5]@[FS#.$<Y[69\S1ES&.(F1PS=B],@>
M,H3V*P%K7*"IUJBM-3HW"5NK2D4G%W*BJ7667W74J9;NT^NINUL1C?)'"D;5
M<MU=A+=II1P^2..299'(U+R;*V;;C6-"YU",DQQOF&.YC%9]$7:RIK5*87(6
MB4QQS+IZE3&][8UBYL6V4K7U:EFW4%F<US5NN147=+RUS7)>:J*W<,J4I_\
M-9XW_H6N^8S/1>$^:%ZO^>A9U^>$ZG^8IK7%F+R          4\[5/\ K9V4
M7_B2XB]K<N$VD[2;^"7UB%6=O#_"IZY<,(1-
M                                  "MO:G^;AC_ ..'HE^=)BT2J3WU
M?:.[E2+6>])[=G=(62"*2@
M^%)?^"+?]V_C9 ^ILG%_:GW1\.0
M             '^;[["[+C#+K;"[+;K[[[[J6V666TK======6EMMMMM-VM:
M^I2@ ZNQ+G/">?6)YE&"<PXLS5&8Y*'.#R&18ER#$LCL3%-61,WK'F(/+O#G
M=Y;VN4-"1V2FJF\\RQ6G+4E77EVVF65J!_G(.=L(8DD&/(GE7,F*L92G+TF2
MPK$\:R#D.(PR09/F2Y4C0HHECQFD;NVN,UDRQ:XIR2D#:6I5&&GEV6EUNOMI
M4#M4 ?YOOL+LN,,NML+LMNOOOONI;999;2MUUUUUU:6VVVVTW:UKZE* "*\>
MUV:(9=D*W$<4UD:59/E>];:VV8QCVH;$;UD*]QO-H18@MA;;+U,DN6WG74LH
M51-OZW5W-S= $J@                             4H;;#9QY;VDV'(+B
M]FU:RW3GIRA9.2)KJ5Q["XZG=7G4$E:6J.OF-(W>Z'KF\EI01=[CJXZ^U51:
M@O-7%J#42DY(FJ4!3/T1"-S^8[%'6I$<43BW&.4I5JUU&QO&N2KVQ*]V8]G[
MYI-TU-D.G%S,N)4HG>V)R)4F7U2G%F%**)]Y?;=;=6E0*Y-(^@9\V=G2L]!^
M'IKGV7ZF\H9 P[FS/&7LRS-!<VN4MR=DC3-J_LE"E*E4NK\Z];N$82KK35R]
M6K/-O,-OOLI?:24!Z,0 \U/I7.SCRWAQQ5;0'/.K66Y^DV=M5C]BO"F+E,=3
ML<,T_P"G*^/Y"GT.QZVG\>4W.;FPW(2$UQJ5*W$G7<.I4T6+%1BBT#TK
M
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M9V1.>X'-3K'VE08WD7GIZGT+.M) T'@
M
M                              IYF?T[&%O_  VLB_GY3":WYO=_"IV"
M$[YP;_!+V2X80B: !!W:1>9=F;\7?YUH*.UZD>=%+_&>*D--/V@GZHFMW_"_
M[:PXRLC8 _-  !SG&/\ 65CW^G$3^[S>(M?]PS?P3^Y4[ET<_2%@/Y9HOC,1
MM/&KQ^O@ #%AK"TX8QU;])$;=/>8T;NX8WR!"VGOC2,3NH8G4[O4TCOTW:.*
MNJ6VX]+P;]&TMU^]I]>7;=97U+JB^PROAPO2,[9%_P ZPL4\3)L4T3^T5/\
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M2K1K$AQ:E(K2*2[3DZI*H)NO)/3GDWTOLOLK6V^VM*TK6E1UW8.Q[.5#]
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M")H
M 5M[4_S<,?\ QP]$OSI,6B52>^K[1W<J1:SWI/;L[I"R0124
M                          &5[I>&H#/&G'9L84FNGK-F7,#S)XUOXUB;
MM+<,Y(F6+Y,Z15;@C4F]+(TXOT(>6-U6Q]6\,"%6:B--N3&*41!MUE;R2[K0
M+BMD1-YIDK9>Z",@9&E\HG\\F.EC#LAETVFS^[2J72E_<X>W*7)\D<D?5:]Y
M?'AP4WW&'J51QIQM]:W7W5K7= %BX
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M &T$
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M/)X%0XIX^9$'Q*43>90HU*_*2#J7EWVVV@;7P
M
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M>WOMNQ8O*MV=C8/BT\WX22HL[U9LVIR;-C9V30\+:7,          IYVJ?\
M6SLHO_$EQ%[6Y<)M)VDW\$OK$*L[>'^%3URX80B:
M                                      %;>U/\W#'_ ,</1+\Z3%HE
M4GOJ^T=W*D6L]Z3V[.Z0LD$4E
M   !D"Z:M]%E@/X_^+/FZZJ@!=]L4OHC]G+\4#!_M):P!9^
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MOO F,5.3M"J#0#(CBH?+'%_3WVDG)4Y%Y-#*U/MNMMLO T"
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M(C+[5;<U)23C2Z44%[H&X,
M
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M9NXSG'T>Z@PR-FAP/!V2L<BM<E'3(J*BVHJ*D=J*BY45,J*<U$4[@
M                                                   %/.U3_K9V
M47_B2XB]K<N$VD[2;^"7UB%6=O#_  J>N7#"$30
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MHE^=)BT2J3WU?:.[E2+6>])[=G=(62"*2@
M            R!=-6^BRP'\?_%GS==50 N^V*7T1^SE^*!@_VDM8 L_
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MJ[(&5I,E;4KX[I$%M;S4,?9VMH1-+40;>8=8VMY-QUUY]YM]P%G
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M'.<Q'6L<Y,KF.2RVW)L;!W>/AU\
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MM#?>LI9;8==>7999:!<"
M
M                   "GF9_3L86_P##:R+^?E,)K?F]W\*G8(3OG!O\$O9+
MAA")H
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M8>[*B]]3L$2VW$&Y%3O2[/5+JA!)X
M                                     4U[65;<W9*V5ZZQ"N<[TFT=
MQ.HM;VTLDUP65+C,ONHG1EJ#TQ%Z@W<W+:7F66UK]6M!-H\K9OX)?6(-:MCH
M5^%3URSSG0</)-ECM-&>5HBW4SIZNL2KZ\EW!QCG0</)-ECM-&>5H74SIZNL
M+Z\EW!QCG0</)-ECM-&>5H74SIZNL+Z\EW!QCG0</)-ECM-&>5H74SIZNL+Z
M\EW!QCG0</)-ECM-&>5H74SIZNL+Z\EW!QCG0</)-ECM-&>5H74SIZNL+Z\E
MW!QCG0</)-ECM-&>5H74SIZNL+Z\EW!QG/8^\FOS=:X',;W'K[CC2NML@3HT
MSC;0JM*4.N*0KG$BA)N[NV5X2M:T^K2@XJEBYSFBVI;8J'VQ\/H
M                         ! G:E_1RZU_BX91]K*T2*3[IC]NG9(]7]RR
M>T4CAL#/HF-*'X]?G*YC%7$?NQ_6[E"EAWW&SK]TI G.'_F@M'/Q<)/^9#50
M)$?S4_V_KM(TGSM'[3UG&GL6HNP   5M[4_S<,?_ !P]$OSI,6B52>^K[1W<
MJ1:SWI/;L[I"R0124                                      'PI+_
M ,$6_P"[?QL@?4V3B_M3[H^'(
M        /+DG7\]IC_2J0_=96)9Z^8?]P0?P+.Y0XJ/I+
M+T.CV>?F\>X#D+VR0$4I>UZYKSZ37T<,_*4/<3&W44#S^
M*KMMA]&1J8_$U\X'%(YQ]NAF+H"^EK"?OKXG4& L23TE
M VE]'+\R/*7QJ9O^:3!XCR]MUC0OTI/I H_R/%\9JR_H4S6P
M                                         ,,&WR^D*D?N5XQ^YBT2
M(^U/0WT;OHRB\LJ.Z0I9%0ST               =JX*_KNPY[JF/?;<T#XNP
M6?6+S?KO(YO%N/3P$0\D
M
M              IYF?T[&%O_  VLB_GY3":WYO=_"IV"$[YP;_!+V2X80B:
M
M       %/.U3_K9V47_B2XB]K<N$VD[2;^"7UB%6=O#_  J>N7#"$30
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M?]V_C9 ^ILG%_:GW1\.0
M   >7).OY[3'^E4A^ZRL2SU\P_[@@_@6=RAQ4?26               7H='L
M\_-X]P'(7MD@(I2]KUS7GTFOHX9^4H>XF-NHH'G\               57;;#
MZ,C4Q^)KYP.*1SC[=#,70%]+6$_?7Q.H,!8DGI*                !M+Z.
M7YD>4OC4S?\ -)@\1Y>VZQH7Z4GT@4?Y'B^,U9?T*9K8
M                                     &&#;Y?2%2/W*\8_<Q:)$?:G
MH;Z-WT91>65'=(4LBH9Z               .U<%?UW8<]U3'OMN:!\78+/K%
MYOUWD<WBW'IX"(>2
M
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M9M>^21UU;41539WBX80B:
M                   %;>U/\W#'_P </1+\Z3%HE4GOJ^T=W*D6L]Z3V[.Z
M0LD$4E                                      !2)M\=J#/-DWHXQ_
MJ%QYBZ(Y:>9YJ0AF$%<=F;P\LC8@:I!C;+F03GQ,J8[;U1C@G68R(3VEW?P=
M2E1EU?KK;0/BI:EA81H.U%O6KO1AI@U02..-<0?L]X3@&4W>+LBI6N:&!PF+
M D>%+4VK%]*+%*-&8IK87>;3?W6TW:^J!])9@
M                   /+DG7\]IC_2J0_=96)9Z^8?\ <$'\"SN4.*CZ2P
M            "]#H]GGYO'N Y"]LD!%*7M>N:\^DU]'#/RE#W$QMU% \_@
M            "J[;8?1D:F/Q-?.!Q2.<?;H9BZ OI:PG[Z^)U!@+$D])0
M             -I?1R_,CRE\:F;_ )I,'B/+VW6-"_2D^D"C_(\7QFK+^A3-
M;                                                      PP;?+
MZ0J1^Y7C'[F+1(C[4]#?1N^C*+RRH[I"ED5#/0              !VK@K^N[
M#GNJ8]]MS0/B[!9]8O-^N\CF\6X]/ 1#R0
M
M
M
M                                         K;VI_FX8_\ CAZ)?G28
MM$JD]]7VCNY4BUGO2>W9W2%D@BDH
M      ,@735OHLL!_'_Q9\W754 +OMBE]$?LY?B@8/\ :2U@"S\
M                                 !Y<DZ_GM,?Z52'[K*Q+/7S#_N"#
M^!9W*'%1])8              !>AT>SS\WCW <A>V2 BE+VO7->?2:^CAGY2
MA[B8VZB@>?P              !5=ML/HR-3'XFOG XI'./MT,Q= 7TM83]]?
M$Z@P%B2>DH                &TOHY?F1Y2^-3-_P TF#Q'E[;K&A?I2?2!
M1_D>+XS5E_0IFM@
M        88-OE](5(_<KQC]S%HD1]J>AOHW?1E%Y94=TA2R*AGH
M      [5P5_7=ASW5,>^VYH'Q=@L^L7F_7>1S>+<>G@(AY(
M
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M*A16P],74H[@P)H
M
M                                   K;VI_FX8_^.'HE^=)BT2J3WU?
M:.[E2+6>])[=G=(62"*2@                                      R
M!=-6^BRP'\?_ !9\W754 +OMBE]$?LY?B@8/]I+6 +/P
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M9/:$!Q_"\ 4M<H0^/B-*8=P%^\M,OMK=O+MSZE0!W,
M   ,,&WR^D*D?N5XQ^YBT2(^U/0WT;OHRB\LJ.Z0I9%0ST
M =JX*_KNPY[JF/?;<T#XNP6?6+S?KO(YO%N/3P$0\D
M
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MHSE1*&U4^2)1P)-3U)A1%++3#SC*7&W@;_@
M
M                                                      5M[4_S
M<,?_ !P]$OSI,6B52>^K[1W<J1:SWI/;L[I"R0124
M                   %%O2"MF+EK:NZ+L=Z?,-S_'6.9-!-3$*S:XO63;Y+
M8Q+&"/XQS%C]2THJQ5AD+A5X.<LF)#K*&$V$\ G.W;Z7[RVX?%6Q+2Q70!IW
MD^DC1+I7TQ35[89++<#8-Q[BV1O\7JX71QX>(?'T;0N<&2YV1-SG5M4GIJW%
M<.02;O*TWUEM?4 ^DO0
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M]MS0/B[!9]8O-^N\CF\6X]/ 1#R0
M
M     Q?:D_\ SI.S\^*)-/FVZW !^3;'.#?I^Z3;L4]3T\56M..9ICUJP,2\
MKK>+M2*0$Y(S+&%:E0X774*+);U&I5F-4W7[VQ.36AE]:6W5K0#9ZZNC:QMC
MB]/*Y(UM#.@6.CJYKSRTJ%N;6].8K7+EBDZZPI.D2)2;C##+JTMLLMK6M=R@
M QI]$?LIDO(&V:U<,A*ND"U$ZP8U9$5)I-Y2<ZC ]9UR8H)+J99:9QLAFSNV
M7'67>K9:87NTI6OJ@;.P!B^V<_\ YP#:Z?%$>/;!H) &T$
M
M
M     %;>U/\ -PQ_\</1+\Z3%HE4GOJ^T=W*D6L]Z3V[.Z0LD$4E
M                              !\*2_\$6_[M_&R!]39.+^U/NCX<@
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M[R.;Q;CT\!$/)
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MQPTS+KU<P8G* -4,;V@GF8<[*&(G]P.OXPEKP5N_-H2!H$
M
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M,?\ QP]$OSI,6B52>^K[1W<J1:SWI/;L[I"R0124
M                  'PI+_P1;_NW\;('U-DXO[4^Z/AR          ,HVWH
MU.ZMLSZU=$.Q#T79:<=/$SUF1UWR=G7-D?4.*27,^$D)F0"U#+'U[6<VN;>W
M61_$DL<W0E"M2+7?B*1OXRF2'K**0*]]<71YY]LG--,YVAFS+UVZNT&HS3<U
M79CR\CGLLC"MER=#X\1<IR<\(D$4B<9+X-J9:J'56U26Z3(G%K2J4I]]]]]M
M]0-8FRUUG4V@^@#3'J\/;$C(^9;@)UTU:$%U]6]NR+"9$^8ZR.0V6&VVG%-%
MTYB+@8BLOW;[4=Y5*W7_ .M<!Q7:@;+73[M9L(0S FHR8YHA<0@V3V[+#0XX
M2E<6C#^ID39&)3$R$;MWZP;(D=<&BYNEJF_>U;K519UEE2CR[*G6&@9!-K9T
M:W9+;,C0=FO5>KS=KF?II'&Y%$\-PY_RK@"K5,\R3-15H@[.YD-^F%M<%C"V
M*+CGAW)3*DBDQE:U="3BC=Y?0"]SHMNS_5Z)MF5#9Y-&TQ!E_6.M;M0\O3GW
M&\.RP5X9R4V%HR83?:3Q<PF!FV/*@J\NT].O?5"<RMW V4M TC
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MJEP_1[//S>/<!R%[9("*<O:]<P=Z37T<,_*4/<3&W44#S^
M *KMMA]&1J8_$U\X'%(YQ]NAF+H"^EK"?OKXG4& L23TE
M  VE]'+\R/*7QJ9O^:3!XCR]MUC0OTI/I H_R/%\9JR_H4S6P
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ML)(()LM*)))*MI8644792VPLLNRVE+;:4I2E*;E !_0
M  &&#;Y?2%2/W*\8_<Q:)$?:GH;Z-WT91>65'=(4LBH9Z
M.U<%?UW8<]U3'OMN:!\78+/K%YOUWD<WBW'IX"(>2
M
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M:P^%F
M
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MI[DB0*:G5MW=_2I>Y2OU*U'%;+<FP<TO6>RLM/MCX?0
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MC+W1;RX@ 5M[4_S<,?\ QP]$OSI,6B52>^K[1W<J1:SWI/;L[I"R0124
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MIL+E%\C1V",\A>UK>5*8L])D3K&9)/)X]O3\N(.3IC#41S92\JRI%H U$
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M5=E5555%C1RJ]KK/C]'L\_-X]P'(7MD@(2]KUROZ37T<,_*4/<3&W44#S^
M             *KMMA]&1J8_$U\X'%(YQ]NAF+H"^EK"?OKXG4& L23TE
M              VE]'+\R/*7QJ9O^:3!XCR]MUC0OTI/I H_R/%\9JR_H4S6
MP               R$=),_KNTU^Y7+/;<4*\6PINYZ*GF_BWED?BS-B*IM6
M               !Z>."OZD<.>Y7CWVHM B+LGDAK%YP5WEDWC'':@^%G
M            ,,&WR^D*D?N5XQ^YBT2(^U/0WT;OHRB\LJ.Z0I9%0ST
M          =JX*_KNPY[JF/?;<T#XNP6?6+S?KO(YO%N/3P$0\D
M
M                       ,KO28_P"Y1_B/_P"X45HMLW$]$[^O_O'^F&5P
M5C<,                #T<MG)YAFD3W <:^UM$(KNV7JGEKTI?2/C?Y2G[M
M2:8XG0@
M
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M- ^+L%GUB\WZ[R.;Q;CT\!$/)
M                                                         #*[
MTF/^Y1_B/_[A16BVS<3T3OZ_^\?Z897!6-PP                /1RV<GF&
M:1/<!QK[6T0BN[9>J>6O2E](^-_E*?NU)ICB="
M
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MIEU7U:H>C/%:NAPZAAJF0QJU[((F/;;-$BV.:Q%3(JID786PW=B.>=0
M           'ER3K^>TQ_I5(?NLK$L]?,/\ N"#^!9W*'%1])8
M    !>AT>SS\WCW <A>V2 BE+VO7->?2:^CAGY2A[B8VZB@>?P
M    !5=ML/HR-3'XFOG XI'./MT,Q= 7TM83]]?$Z@P%B2>DI;Y@C8@:[<[0
MA#/RX[!,4,KRW%NT?29@DSK'9"^-YZ>Q0C4$QV/1J6.S/QVR^G!6NA3??6FY
M=6E+*VWUIK(U%L,(ZQ^D%T=:NX@[#5EJ:VHC==>M-&U[&.1;%17ODC:ZS;T:
MO3:V<A"+5+HZU Z-IHBA.>829&U3RE/7QE_;UJ9[B4L0)C+"52F/R!!?>E4F
M(S#;**$IM"5J:AA=3B2Z&EUNY(Y';!D#4_7G5K7J@=B&KE0DK(U1)&.1621J
MN5$>Q<J6Y;KDM8ZQ;KEL6SLG1[LZ-4.M^]U6X8B;:EAK"MM;'G)$X<S8Y!43
MO=8G.N9R7 E"Z.CTZD)5-AYY#<C6&)B;[+CJ%\*3PASD;LEJUXZ4=4.CY&1X
M],]:^1MYL$3;\RMRI>5JJUK6JJ*B*]S4<J*C;;KK.P=6^R?U@:-XL9D#(D:C
M,QQRD/+3.\^Q:^+9,PQ\U2<2F17R!([,L<DK0B7*3[2BU1S?:DX:MI=QMIEY
M=M_QKVNR)LELU*Z9M1]>JQ,-PN66#%'):V&H8D;WV(JK<5KGQN5$2U6H^]9E
M1%1%5*UAS,K$Q-)F@_4OK5>'-!@N#4<F2/GDII-.I"X$QZ#1U2H*J>0C7/BJ
MTR]:Y&%;V_B: E8MM+OM,N*H77?CBYR-V3H^NG2+JGJ# R36*HN5$J*L<+&J
M^9Z)D548FPVW)>>K6VI9>MR$D]3FQKUK:6X([9-DC!"LCP6.).N,I?<1R-RD
M=\8;;;+;U#F[,;_'HI)+FQ!OJU5*4R-00E+MN--OL)MJ93XCVKD.J:I=.NH.
MN&(LPFDEJ*7$9778V5+&LTCMIK7L?)'>7ZUKG-5RV(U%<MA'K19HND^L653D
MDN=1/$>+<1Q$V>9AR_-ZWWQ^#1BRX^TF^B(M0CZY.JVU(I-*)-4HT_%T9]]Z
MBRMEEAGUSKO5.SZ^Z^TFHU'3N6GFK<8K9]#34T7;S29+<MBW6I:U%5&N=:YJ
M(U;55.::R-!AVF.%XTS1CG-<*U*:=<M+G9BB&782WGL5I4I8^'JX1R11L]T?
M;6E=?:C5<!0M>JNNN0J;#K2+R[;3/C76Y%R*0-1>D=NMM?5X#BE!485K11-:
M^6FE<C^]OLNO8]&LO)E;;:QO;L5JN155.%ZDM'+CIDPSICR!-YVE,R1J,B+S
MD0_#=(Z>B=<=P.AZ"D,?'I^->#KEJJ8HUU;^*7MZ.]&<0<36\ZXJ^MOU'6JM
MFPA/U5UYBUMQW%\-P^F5,*PN=L"55]%;/-8NE8QB-2Q(E2R\CW7D5KK&HJ6Z
M>>CE^9'E+XU,W_-)@\49>VZQJ/Z4GT@4?Y'B^,U9?T*9K8
M 9".DF?UW::_<KEGMN*%>+84W<]%3S?Q;RR/Q9FQ%4VK
M ]/'!7]2.'/<KQ[[46@1%V3R0UB\X*[RR;QCCM0?"S@              &&#
M;Y?2%2/W*\8_<Q:)$?:GH;Z-WT91>65'=(4LBH9Z               .U<%?
MUW8<]U3'OMN:!\78+/K%YOUWD<WBW'IX"(>2
M
M        &5WI,?\ <H_Q'_\ <**T6V;B>B=_7_WC_3#*X*QN&
M     !Z.6SD\PS2)[@.-?:VB$5W;+U3RUZ4OI'QO\I3]VI-,<3H0
M
M
M   %;>U/\W#'_P </1+\Z3%HE4GOJ^T=W*D6L]Z3V[.Z0LD$4E
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MH               [5P5_7=ASW5,>^VYH'Q=@L^L7F_7>1S>+<>G@(AY(
M
M                             97>DQ_W*/\ $?\ ]PHK1;9N)Z)W]?\
MWC_3#*X*QN&                !Z.6SD\PS2)[@.-?:VB$5W;+U3RUZ4OI'
MQO\ *4_=J33'$Z$
M
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MN>Q;6/:N1RV6V+8J*B=J#X6<      #X4E_X(M_W;^-D#ZFR<7]J?='PY
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M>2
M                                  &5WI,?]RC_ !'_ /<**T6V;B>B
M=_7_ -X_TPRN"L;A@                >CELY/,,TB>X#C7VMHA%=VR]4\M
M>E+Z1\;_ "E/W:DTQQ.A
M
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MAK;B#BW9UN+-)1)BS+*][3U3=LOL*MNMKN5_T5&S_H58UC%7Z4.J-/55=3)
MZLJ+6OE>YJV4-4J6HKE1;%1%2U-E+3#GI"-:WH;QQ41$7F\7QB$T*C])QY(@
M                >7).OY[3'^E4A^ZRL2SU\P_[@@_@6=RAQ4?26
M        7H='L\_-X]P'(7MD@(I2]KUS7GTFOHX9^4H>XF-NHH'G\
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M6?6+S?KO(YO%N/3P$0\D
M                                                    ,KO28_[E
M'^(__N%%:+;-Q/1._K_[Q_IAE<%8W#                 ]'+9R>89I$]P'
M&OM;1"*[MEZIY:]*7TCXW^4I^[4FF.)T(
M
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MXO\ Y5=?:V]#:KT(OUI]4/+*CXC5&&/2%^AK'?X"+XS":!!^F$\CP
M         /+DG7\]IC_2J0_=96)9Z^8?]P0?P+.Y0XJ/I+       XPEF\+6
MOZB*(I?%U<I1T,JKC25_:E#^EH32MQM5#,4KO<2*%6TK6[?%TWM*>J/EJ6V;
M9:8L?P*HQ)V#05M(_%V6WH&S1K,VS9O1(Y7I9MVMR'T7A_8H\4C/?WII8R7!
MQ2M" YX<D;:4N=EU;K438C,6G$V*7%9=9=0HBRMQAE:5WMM=P+;-DE5N(X?A
MK&28C/#3QRRMC8LCVL1\C^TC:KE2\]UBW6I:YUF1%/K#Z3    O0Z/9Y^;Q[
M@.0O;) 12E[7KFO/I-?1PS\I0]Q,;=10//X               JNVV'T9&IC
M\37S@<4CG'VZ&8N@+Z6L)^^OB=08"Q)/24                #:7T<OS(\I
M?&IF_P":3!XCR]MUC0OTI/I H_R/%\9JR_H4S6P               R$=),_
MKNTU^Y7+/;<4*\6PINYZ*GF_BWED?BS-B*IM6                !Z>."OZ
MD<.>Y7CWVHM B+LGDAK%YP5WEDWC'':@^%G               ,,&WR^D*D?
MN5XQ^YBT2(^U/0WT;OHRB\LJ.Z0I9%0ST               =JX*_KNPY[JF
M/?;<T#XNP6?6+S?KO(YO%N/3P$0\D
M
M ,KO28_[E'^(_P#[A16BVS<3T3OZ_P#O'^F&5P5C<,                #T
M<MG)YAFD3W <:^UM$(KNV7JGEKTI?2/C?Y2G[M2:8XG0@
M
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MMA<P   K;VI_FX8_^.'HE^=)BT2J3WU?:.[E2+6>])[=G=(62"*2@
M H%Z1IYD>+?C4PC\TF<!4B[;K&R?HM_2!6?D>7XS2&+02#?0
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M\CI&)=1ZO6]:C51%5-<O2BPZLI>C5DL[+K/PG FRU<NCFS*IL%&>SSQ
M          *KMMA]&1J8_$U\X'%(YQ]NAF+H"^EK"?OKXG4& L23TE
M           VE]'+\R/*7QJ9O^:3!XCR]MUC0OTI/I H_P CQ?&:LOZ%,UL
M              ,A'23/Z[M-?N5RSVW%"O%L*;N>BIYOXMY9'XLS8BJ;5@
M              >GC@K^I'#GN5X]]J+0(B[)Y(:Q><%=Y9-XQQVH/A9P
M          ##!M\OI"I'[E>,?N8M$B/M3T-]&[Z,HO+*CND*614,]
M        ':N"OZ[L.>ZICWVW- ^+L%GUB\WZ[R.;Q;CT\!$/)
M
M                     #*[TF/^Y1_B/_[A16BVS<3T3OZ_^\?Z897!6-PP
M                /1RV<GF&:1/<!QK[6T0BN[9>J>6O2E](^-_E*?NU)ICB
M="
M
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MX PRAMN\,M^OLIN[MN[2O)BHKDR(9CZ &.3I;PE5<JI_K7Q*H,)HKGI2
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M6TFMC:D0I>#)W-RW<+I7U?5K45F+:W,>B/HVHJ=&,2*MO^N5'=(4ZCF9[
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M"-&[E+P#F\E?E@G7K*'<F@O)F3A&C=REX!S>2ORP3KUE#N307DS)PC1NY2\
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M\J6HMB[:'R>>")__ 'MW]9D>RQ!_Z1/I5_[1JE_ZA4_[@<O^OSZ#'^R:^?\
MI5)_[H.>")__ 'MW]9D>RP_Z1/I5_P"T:I?^H5/^X#_K\^@Q_LFOG_I5)_[H
M=09]U3DXCP[/LBPS&<]R[+8RR\9C6-X@S*%[]*WM8L2MC:@(3M=CHXVH2E2V
MT]:<0F4&IT)1QMI=];-[6;AO[(KTDFXA NL5;JY!@6F8D\E-4U-3.R)7(CW0
MP<TC261$MNL61C57MGM;:J7O5S]NIZ%6M^,1:N8.FLE%BE2V1(IL5IJ'#\/8
M]D3Y$YU6/Q%[8&.N7$=<<JO<UC6JYR(91=-N?M6.,-3^0=9.H/9QZE=3VH*5
M'F4ATC<&3)F/X[BQN5)%#:J0Q&+WX1G=I9A#,;:W(3>,E\1;J7E667&'&G7>
M@/2EZ%>L.MO1+AO0=T:XK4ZI=&M&U.<P,PF2LFQ![7(]KZF?G=):BRHLTK=&
MNEFNO<Y&L8Q.MZF^GWZ/&":[5?2)K;K/J=C>MDZ]YD=K)AL$=,U45JMBCMGV
M&*D;%O)<CM:B*KG.71IHMV@F1M2UF2+LT:/<IZ4KH9?$;8W;-EDA=>_RDAI)
MJN]6SOEQMC"\CO8JR)N&X&U;2[K@7OJE;E*&:-:S?LA.F6-8?\/L=P[$FK?T
M_P"$:>;"='VNBT*-?B&GO]\TENBT5UG;Z3V'?-;_ -M=Z)'1WS=-;)I:]:S2
M:+^[U508ZD>BN7^=JR>DYK>TC= BZ3379NTT7LND<O%.VJK:%XM13V$S%NTJ
M:-6)'E1N4/D>4)H[F+45*DY!D5-:3E=A;9(V7&35=:?>:G/-XFYD')C[=ZIK
M:,S]&_[/'TA.C+H8UJU7U:?@:=,.LSXJ*6L6JG92TN#67YHJ>HYK?DJ*I]L<
MS6PHQL:M72)+$U%P]KY^V0]#''<5U6Z0<9J,=FU$A=4RQ89#34<V*)70R+$V
M;$*-M?=I*=MB/I5FF22?*YD3H7N<V$^J!@6036OJ>S!E'0>^[0''VHB!X_8<
M'+B&:^3&89<HU%:Q]XB#@V6MC[7'[:]/%>-7OR2A"A(646>G.XPI6VV9,PKT
M*_2.U;Z%M2>CO5;6-=4<?P/$*N7$WX2Z6HAQ%*BI66.9\C&P22R0Q(C.;U4?
M-I+ZLD58X8E*.J'[4?T*.E+7+6G77%JBGEH*BEA930:PK3X;44Z0P(UR0,EE
MFA>R5ZJJ.I)GU3%9>2-'2.MLCV6[#+M,VB;$N(\UJ':^=,]90[*6*WBCD7#&
MV229T?6N(VN)*\PI68V)EW"'4LNN+(4'F$EUN+*LNKB?TH_V;W3]TU=,^)=(
MFI46K=#@E;%3(C:BMECGEDBIXXI)I8XJ25C'.5MU$;(Y7-:U[E1[G-2#T8?M
MN?0OZ+M48M1\:EUPQ.LHIYVI/289"^E<QTKW-2!]174\SX[%M17PQK:JHUMU
M&JMA'/!$_P#[V[^LR/98U[_Z1/I5_P"T:I?^H5/^X&0O^OSZ#'^R:^?^E4G_
M +H.>")__>W?UF1[+#_I$^E7_M&J7_J%3_N _P"OSZ#'^R:^?^E4G_NA/_9M
MY 8Y-J&6-K:6X444QU)5-:J4Y11="RG..VW5K=:H,NW=\92E*4H-F_1-] GI
MP]&SI1DZ1.D2; GX _"IZ-$HZJ::72S20/9[!]+"VY=A?:M^U%LR+;DAUG[4
MST:/3&B3HDZ)*?6B/6F-WX05<0H:>G@T%.BQR=\CK:AVDO5$=UNCL5+RJY+,
MM](]*2V               %5VVP^C(U,?B:^<#BD<X^W0S%T!?2UA/WU\3J#
M 6))Z2@                ;2^CE^9'E+XU,W_-)@\1Y>VZQH7Z4GT@4?Y'B
M^,U9?T*9K8               9".DF?UW::_<KEGMN*%>+84W<]%3S?Q;RR/
MQ9FQ%4VK                 ]/'!7]2.'/<KQ[[46@1%V3R0UB\X*[RR;QC
MCM0?"S@              &&#;Y?2%2/W*\8_<Q:)$?:GH;Z-WT91>65'=(4L
MBH9Z)IZ+M!.?-=LLDT8PNDC3<BAK06ZR>:3MQ=66&,YBN^\MI9SW%F8I&XG/
MCW>2;Q9.2D-K6PDPPRI9=E;QQ<Y&[)T+7WI'U;Z.J**KQYTKI)WW8XH6M=*Z
MSMG(USV-1C+4O.5R951$M5;"'+:VN#PX(&AH0+75V=5J5M;&QM2GKG!Q<%Q]
MB9$@0(DUAJE8M6*3;2RBB[;KS+[J6VTK6M*#D=ZEEB@B=/.YK(6-5SG.5$:U
MJ):JJJY$1$RJJY$3*I<SCK8)Z^9]!R9HN;<5XW5*T)3@A@V19H[-\X4DJ"[C
M2"3F^.123L[,NO+WN_3.*Y&>1=?2PZPN^V^VVFLC;3!&*>D?T;X;B"T$;ZRJ
M8UUU9H(FNB14R+8Y\D;G)]DQCD79:JI8JU?YZT_9>TR9'=<3YMA;C")LU$DK
M*H%MZ94C=&E68>4A?6%V0'*6Q\8U]Z4VTI4F-,*J8487=6TTLRRWFBHJ6H9=
MU<UEP36W"F8SJ_4-J,/>JI>2U%:Y++6/:J(YCTM2UKD1;%1=A45>F1]+Z6^8
M(V(&NW.T(0S\N.P3%#*\MQ;M'TF8),ZQV0OC>>GL4(U!,=CT:ECLS\=LOIP5
MKH4WWUIN75I2RMM]::R-1;#".L?I!='6KN(.PU9:FMJ(W77K31M>QCD6Q45[
MY(VNLV]&KTVMG(0BU2Z.M0.C::(H3GF$F1M4\I3U\9?V]:F>XE+$"8RPE4IC
M\@07WI5)B,PVRBA*;0E:FH874XDNAI=;N2.1VP9 U/UYU:UZH'8AJY4)*R-4
M21CD5DD:KE1'L7*EN6ZY+6.L6ZY;%LL=B6Q=<G9F@T+F>K;"^.-7&48(5D+'
M^EE_0+CWE>S*VY6Z(D#_ # AX+/9'RJ5O44.(3LKB7:8E4<$:?80893CI-SV
M)BVMZ>8H9ZBOH,%KZK4JCJ=#-B#%1&HY'(U59$K;'LM5MBNE8MCFWD:KD0A-
MI&T-S74WGR:88D<@+PPSXA89W)LYY ?V6K^AQ6T8_N4('FKBV$O#*E<5]) 7
M8DX#K@GI0NAY]+[K$]]*\G.1$M._Z[=(5!JEJW3X]2Q+7SUTD,=)"Q]Q:ATU
MBMNN5KU:ESV5MQV6ZVQ%<A'O#!24C/>)R42JJY$3EZ"%)%MR>Y)<L2ES-JL3
MJKDM]YEZ:J@JE+ZEUNNK9N[E:UW-T?5V#LV/*]VK=:Z1+LBT,UJ6VV+HG6I;
MMV;%NV>G,(AY)@
M                                             97>DQ_W*/\ $?\
M]PHK1;9N)Z)W]?\ WC_3#*X*QN&                !Z.6SD\PS2)[@.-?:
MVB$5W;+U3RUZ4OI'QO\ *4_=J33'$Z$
M
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MD$U?>='GWW59E]V5(V1U;^8*/R=G<H?E3]*K]9+7C\YJ_P >\CD+T8!
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M0\D
M                                   ,KO28_P"Y1_B/_P"X45HMLW$]
M$[^O_O'^F&5P5C<,                #T<MG)YAFD3W <:^UM$(KNV7JGEK
MTI?2/C?Y2G[M2:8XG0@
M
M                              *V]J?YN&/_ (X>B7YTF+1*I/?5]H[N
M5(M9[TGMV=TA9((I*        "@7I&GF1XM^-3"/S29P%2+MNL;)^BW](%9^
M1Y?C-(8M!(-]                 -^FQ/\ HR-,_P".7YP.5A&D[=3S:Z??
MI:Q;[U^)TY:B.!AT      #X4E_X(M_W;^-D#ZFR<7]J?='PY     &035]Y
MT>??=5F7W94C9'5OY@H_)V=RA^5/TJOUDM>/SFK_ ![R.0O1@$
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M<CFJGL;5]!\1CS-
M                                               RN])C_N4?XC_^
MX45HMLW$]$[^O_O'^F&5P5C<,                #T<MG)YAFD3W <:^UM$
M(KNV7JGEKTI?2/C?Y2G[M2:8XG0@
M
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MRJ6_=B*CHG2)\P-\H9W+ST6_9@?K)3_FS6^/HS2B,'GZ%
M"J[;8?1D:F/Q-?.!Q2.<?;H9BZ OI:PG[Z^)U!@+$D])0
M -I?1R_,CRE\:F;_ )I,'B/+VW6-"_2D^D"C_(\7QFK+^A3-;
M    #(1TDS^N[37[E<L]MQ0KQ;"F[GHJ>;^+>61^+,V(JFU8
M    'IXX*_J1PY[E>/?:BT"(NR>2&L7G!7>63>,<=J#X6<
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M1%4SSU$JVR32OB=><[,F3(EJKLJJJYRJOH:B,>8P
M
M           &5WI,?]RC_$?_ -PHK1;9N)Z)W]?_ 'C_ $PRN"L;A@
M          >CELY/,,TB>X#C7VMHA%=VR]4\M>E+Z1\;_*4_=J33'$Z$
M
M
M       !6WM3_-PQ_P#'#T2_.DQ:)5)[ZOM'=RI%K/>D]NSND+)!%)0
M   4_;:W!BK4!I7@,-1R-/&#6S4!%9-<O4MICI8=8CQUE5JJCHG*6(;K+S+G
MFE^_W]:4H76FYZN[37CTEO2$H_1LU$I->:W"Y<6BJ\6BH$A9.VG5JRT]54:2
M^Z*5%1$I5;=NHJJ]%O)=L7:'T3*):_I&K84==5,$F6VRW_YJC3<SF7[T9KYY
M76KQ/6<H!H__ -5_5_\ Y*K/_4H_]S/0O^[C_"I[GZH]&:^>5UJ\3UG* /\
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M5=ML/HR-3'XFOG XI'./MT,Q= 7TM83]]?$Z@P%B2>DH
M&TOHY?F1Y2^-3-_S28/$>7MNL:%^E)](%'^1XOC-67]"F:V
M  &0CI)G]=VFOW*Y9[;BA7BV%-W/14\W\6\LC\69L15-JP
M  /3QP5_4CASW*\>^U%H$1=D\D-8O."N\LF\8X[4'PLX              !A
M@V^7TA4C]RO&/W,6B1'VIZ&^C=]&47EE1W2%+(J&>@              #M7!
M7]=V'/=4Q[[;F@?%V"SZQ>;]=Y'-XMQZ> B'D@
M
M         !E=Z3'_ '*/\1__ '"BM%MFXGHG?U_]X_TPRN"L;A@
M       >CELY/,,TB>X#C7VMHA%=VR]4\M>E+Z1\;_*4_=J33'$Z$
M
M
M    !6WM3_-PQ_\ '#T2_.DQ:)5)[ZOM'=RI%K/>D]NSND+)!%)0
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M]]MS0/B[!9]8O-^N\CF\6X]/ 1#R0
M
M RN])C_N4?XC_P#N%%:+;-Q/1._K_P"\?Z897!6-PP                /1
MRV<GF&:1/<!QK[6T0BN[9>J>6O2E](^-_E*?NU)ICB="
M
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MN'N52W[L14=$Z1/F!OE#.Y>>BW[,#]9*?\V:WQ]&:41@\_0H
M   57;;#Z,C4Q^)KYP.*1SC[=#,70%]+6$_?7Q.H,!8DGI*
M   !M+Z.7YD>4OC4S?\ -)@\1Y>VZQH7Z4GT@4?Y'B^,U9?T*9K8
M       9".DF?UW::_<KEGMN*%>+84W<]%3S?Q;RR/Q9FQ%4VK
M       ]/'!7]2.'/<KQ[[46@1%V3R0UB\X*[RR;QCCM0?"S@
M   &&#;Y?2%2/W*\8_<Q:)$?:GH;Z-WT91>65'=(4LBH9Z
M .U<%?UW8<]U3'OMN:!\78+/K%YOUWD<WBW'IX"(>2
M
M              &5WI,?]RC_ !'_ /<**T6V;B>B=_7_ -X_TPRN"L;A@ <T
M;<;Y$>85(\DL\"FCKCJ'K6YMET^;8L^+H5%G%X4)DC2@D<J2H36)D6NBM:24
MG*4GE7GF'66V4NK=;2ORU-C;($N*X7!7Q85/4T[,4G:YT<+I&)+(UJ*KE9&J
MWWHU$57*U%1$15784X;;;=?=;99;6ZZZM+;;;:5NNNNNKN4MMI3=K6M:U]2@
M^D]51$M78.:SS&>2,6.;>R9.Q_-\<O+NR(I*TM$\BC]$'-SCCD<J3MS^WH)
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M3H0
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MG1Y]]U69?=E2-D=6_F"C\G9W*'Y4_2J_62UX_.:O\>\CD+T8!
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MH9Z               .U<%?UW8<]U3'OMN:!\78+/K%YOUWD<WBW'IX"(>2
M
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M1RV<GF&:1/<!QK[6T0BN[9>J>6O2E](^-_E*?NU)ICB="
M
M                            ""NL79GZ&-?[C W;6#IZC.;G+&**0-T$
M6/S[-F0Z/(I2>TJ7Y,16'R>.T5%N![&ENKQBAW!U*^LWN^OWP$XD:-(WI$J!
M E3(4"%,0C1(D9!29(C2)BK24R5*F)ML)3IDY-EMEEEEM+;+:4I2E*4 'Z
M $9-:.I%/H]TEZB]4RJ(G3\C &'YSE6Z$)WNR-&RR^',2MX)8*2$QK?+&.UT
M.3VDW*^)+*I[;JWT(-K;P=P&;#9V:D= O2DY)F*=ZM]FG%XW--$2#%+#$5LF
MSW+LH)WF/9S7Y*>3$/!QF(X21E$M+MB.^\PA>D="S;5M=Y<7;<=88!KJ
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MT2J3WU?:.[E2+6>])[=G=(62"*2@        JLVO7FUPCW<8U[0LEC('1O\
M/DODCO&1'F?^U3_5[P;\\Z3^S<6,Y0S6> H                &J;9N^9=A
MG\8GYUIT-?\ 7?SHJOXOQ49^E_\ 9]_JB:H_\4_MK$2<0ZH;E@      5G;5
MC::8'V5.G&,Z@-0L2RY,H;.<P1K"C2V8988;(9,GE3_$IW/D;@XHYO/<=M1,
M?*9\:KBC32EIRFU2:1;:1=9<8840^.2U+"7.E[4-"]6FG7"NIK'+9*&6!YVQ
MO%<H1%IFR)I;I<W,$O:R'=M1R- Q/<D9DCP0F46VGEI5ZPFV^E:6&WT^NJ/I
MWP    #()J^\Z//ONJS+[LJ1LCJW\P4?D[.Y0_*GZ57ZR6O'YS5_CWD<A>C
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M/?;<T#XNP6?6+S?KO(YO%N/3P$0\D
M
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MWMLTC%M;>O6)L94.'[0>1;,_)N8M.:'1Q89B_'AR) QYZFC9#)NA8V!H7/C
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MA
M                                            !5'MB-JC$]D-I?B.
MI678@D6;$\TS?%L(-4/CDI;8<>0[26%9%G5'MP?'-I?"R6Y$U8V5%<&6D--,
M4'E4^MLW]]H&:/\ ;B<3?Y>&1/E$QK^R4 /VXG$W^7AD3Y1,:_LE #]N)Q-_
MEX9$^43&O[)0!%/7/TOK&FL'1UJ6TMMFAN<P5PS[AN<XL1S%=G-@?4<:42]E
M4M)3RI9D^-&P]S)0W'[^XFQ03=?2FY2^GU0!W1T&/_\ >B?X)O\ FX &_P
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M]^U*$#WG_9<_0!C'YXU?]FX2>;/IB_2;0_D*'XW6D]QZ2&IP
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MUB\WZ[R.;Q;CT\!$/)
M                                                  #*[TF/^Y1_
MB/\ ^X45HMLW$]$[^O\ [Q_IAE<%8W#                 ]'+9R>89I$]P
M'&OM;1"*[MEZIY:]*7TCXW^4I^[4FF.)T(
M
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M=QC7M"R6,@=&_P ^2^2.\9$>9_[5/]7O!OSSI/[-Q8SE#-9X"@
M      :IMF[YEV&?QB?G6G0U_P!=_.BJ_B_%1GZ7_P!GW^J)JC_Q3^VL1)Q#
MJAN6      !D"Z:M]%E@/X_^+/FZZJ@!=]L4OHC]G+\4#!_M):P!9^    #(
M)J^\Z//ONJS+[LJ1LCJW\P4?D[.Y0_*GZ57ZR6O'YS5_CWD<A>C (
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M               .U<%?UW8<]U3'OMN:!\78+/K%YOUWD<WBW'IX"(>2
M
M                            &5WI,?\ <H_Q'_\ <**T6V;B>B=_7_WC
M_3#*X*QN&                !Z.6SD\PS2)[@.-?:VB$5W;+U3RUZ4OI'QO
M\I3]VI-,<3H0
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MY<??:=(QUK7'S:JO:-[MIMCZ#/ZUNIWEM3\0JS6$->3]/(
M  &).3_SED/\N.W\?4#::#WAGM$[!^.W6/SAK_+)_&./ABJ6<
M    LWV3?G1N'N52W[L14=$Z1/F!OE#.Y>>BW[,#]9*?\V:WQ]&:41@\_0H
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MN\CF\6X]/ 1#R0
M                                              RN])C_ +E'^(__
M +A16BVS<3T3OZ_^\?Z897!6-PP                /1RV<GF&:1/<!QK[6
MT0BN[9>J>6O2E](^-_E*?NU)ICB="
M
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MR-CW(L QVC6(K;BKRT#C*HSDT^Q56R\NY84S)]_:91,74H#T?
M       %;>U/\W#'_P </1+\Z3%HE4GOJ^T=W*D6L]Z3V[.Z0LD$4E
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MSH\^^ZK,ONRI&R.K?S!1^3L[E#\J?I5?K):\?G-7^/>1R%Z, @
M    $QMG_P">#A'^7'WVG2,=:UQ\VJKVC>[:;8^@S^M;J=Y;4_$*LUA#7D_3
MR                !B3D_\ .60_RX[?Q]0-IH/>&>T3L'X[=8_.&O\ +)_&
M./ABJ6<               LWV3?G1N'N52W[L14=$Z1/F!OE#.Y>>BW[,#]9
M*?\ -FM\?1FE$8//T*               $'=I%YEV9OQ=_G6@H[7J1YT4O\
M&>*D--/V@GZHFMW_  O^VL.,K(V /S0                 :-=D+YM<W]W&
M2^T+&@PITD?/D7DC?&2GOU^RL_5[QG\\ZO\ LW"2U,8_/3
M  R$=),_KNTU^Y7+/;<4*\6PINYZ*GF_BWED?BS-B*IM6
M !Z>."OZD<.>Y7CWVHM B+LGDAK%YP5WEDWC'':@^%G               ,,
M&WR^D*D?N5XQ^YBT2(^U/0WT;OHRB\LJ.Z0I9%0ST               =JX*
M_KNPY[JF/?;<T#XNP6?6+S?KO(YO%N/3P$0\D
M
M         ,KO28_[E'^(_P#[A16BVS<3T3OZ_P#O'^F&5P5C<,
M      #T<MG)YAFD3W <:^UM$(KNV7JGEKTI?2/C?Y2G[M2:8XG0@
M
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MR!<YKKE[^M35JBO4E)4J:II:+CBL#2R                  K;VI_FX8_\
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M //!PC_+C[[3I&.M:X^;55[1O=M-L?09_6MU.\MJ?B%6:PAKR?IY
M         Q)R?^<LA_EQV_CZ@;30>\,]HG8/QVZQ^<-?Y9/XQQ\,52S@
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MV"SZQ>;]=Y'-XMQZ> B'D@
M                                                     !E=Z3'_
M '*/\1__ '"BM%MFXGHG?U_]X_TPRN"L;A@                >CELY/,,T
MB>X#C7VMHA%=VR]4\M>E+Z1\;_*4_=J33'$Z$
M
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MOKH6'B,20   K;VI_FX8_P#CAZ)?G28M$JD]]7VCNY4BUGO2>W9W2%D@BDH
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M'WVG2,=:UQ\VJKVC>[:;8^@S^M;J=Y;4_$*LUA#7D_3R
M!B3D_P#.60_RX[?Q]0-IH/>&>T3L'X[=8_.&O\LG\8X^&*I9P
M   "S?9-^=&X>Y5+?NQ%1T3I$^8&^4,[EYZ+?LP/UDI_S9K?'T9I1&#S]"@
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M^N\CF\6X]/ 1#R0
M                                               RN])C_N4?XC_^
MX45HMLW$]$[^O_O'^F&5P5C<,                #T<MG)YAFD3W <:^UM$
M(KNV7JGEKTI?2/C?Y2G[M2:8XG0@
M
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MA"<^F]K7ZN]W*_Z!68BHVQ=D]$/1M<CNC&)4V.>5'=(4ZCF9[
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M:X1[N,:]H62QD#HW^?)?)'>,B/,_]JG^KW@WYYTG]FXL9RAFL\!0
M        -4VS=\R[#/XQ/SK3H:_Z[^=%5_%^*C/TO_L^_P!435'_ (I_;6(D
MXAU0W+       R!=-6^BRP'\?_%GS==50 N^V*7T1^SE^*!@_P!I+6 +/P
M  9!-7WG1Y]]U69?=E2-D=6_F"C\G9W*'Y4_2J_62UX_.:O\>\CD+T8!
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MS:YO[N,E]H6-!A3I(^?(O)&^,E/?K]E9^KWC/YYU?]FX26IC'YZ8
M       &0CI)G]=VFOW*Y9[;BA7BV%-W/14\W\6\LC\69L15-JP
M       /3QP5_4CASW*\>^U%H$1=D\D-8O."N\LF\8X[4'PLX
M   !A@V^7TA4C]RO&/W,6B1'VIZ&^C=]&47EE1W2%+(J&>@
M #M7!7]=V'/=4Q[[;F@?%V"SZQ>;]=Y'-XMQZ> B'D@
M
M              !E=Z3'_<H_Q'_]PHK1;9N)Z)W]?_>/],,K@K&X8
M         'HY;.3S#-(GN XU]K:(17=LO5/+7I2^D?&_RE/W:DTQQ.A
M
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M:X1[N,:]H62QD#HW^?)?)'>,B/,_]JG^KW@WYYTG]FXL9RAFL\!0
M        -4VS=\R[#/XQ/SK3H:_Z[^=%5_%^*C/TO_L^_P!435'_ (I_;6(D
MXAU0W+       R!=-6^BRP'\?_%GS==50 N^V*7T1^SE^*!@_P!I+6 +/P
M  9!-7WG1Y]]U69?=E2-D=6_F"C\G9W*'Y4_2J_62UX_.:O\>\CD+T8!
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MS:YO[N,E]H6-!A3I(^?(O)&^,E/?K]E9^KWC/YYU?]FX26IC'YZ8
M       &0CI)G]=VFOW*Y9[;BA7BV%-W/14\W\6\LC\69L15-JP
M       /3QP5_4CASW*\>^U%H$1=D\D-8O."N\LF\8X[4'PLX
M   !A@V^7TA4C]RO&/W,6B1'VIZ&^C=]&47EE1W2%+(J&>@
M #M7!7]=V'/=4Q[[;F@?%V"SZQ>;]=Y'-XMQZ> B'D@
M
M              !E=Z3'_<H_Q'_]PHK1;9N)Z)W]?_>/],,K@K&X8
M         'HY;.3S#-(GN XU]K:(17=LO5/+7I2^D?&_RE/W:DTQQ.A
M
M                                          90NEL;.7+&M315C#.&
M"XNXSW(VC65S:7/,%8VZKC)7O#N1&1C3Y*<HRF)K<O<W6*KX*R.!J @N\Q2W
M$JC+*7&D%%&@5&[*SI>V(M-^DC%NF_7#@O-\QE>"80PXQ@N3\"I8+*+IM!H:
MU(&&%%SIAR-D/'I[/)FE@1%I%B],N<;7&Y/:HN)*,-,MH!1+MG-L61MG-6V$
MGN3QMWP%I2PZ=2%PEE5*.^Z;,$=GDACA^6LIR,EJ*/;E4M=VY@15L;6XHTDE
M*TI2*&*C=^<8!?YTPG5-I3R_I6V?<#T^9PQ5E,P^9RG([ U8RFS+-[4.+"8
MV1UCD#@<R.#G<TMSBJ<"TZ'CMQ1RR].IH72^J51P8$KMEMTIO9P8>V:>#,6:
MFWK(&-,]:5<&0#!Y.+8UC.93:_,K=B*(MT(B#_CF6,Z%5"6U;(XTP(C' F3N
M<=L2NAA]A5QB:TL^\"J/HZSADC:2=(;S?M%'J*=9F2(IM06?)#9:<>L;(0IS
M4U/N'L:8Z3NMA::Q>ZI8E-%A":\XNWC2-D5G;VE]M-P#TNP
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MI&:.1:+L[?'XXP,Z JTA"U,C(TITC8U-J,BREA1!!191=E*4MMI0?#D?>
M !D$U?>='GWW59E]V5(V1U;^8*/R=G<H?E3]*K]9+7C\YJ_Q[R.0O1@$
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ME]H6-!A3I(^?(O)&^,E/?K]E9^KWC/YYU?\ 9N$EJ8Q^>F
M !D(Z29_7=IK]RN6>VXH5XMA3=ST5/-_%O+(_%F;$53:L
M #T\<%?U(X<]RO'OM1:!$79/)#6+S@KO+)O&..U!\+.               88
M-OE](5(_<KQC]S%HD1]J>AOHW?1E%Y94=TA2R*AGH               [5P5
M_7=ASW5,>^VYH'Q=@L^L7F_7>1S>+<>G@(AY(
M
M         97>DQ_W*/\ $?\ ]PHK1;9N)Z)W]?\ WC_3#*X*QN&
M       !Z.6SD\PS2)[@.-?:VB$5W;+U3RUZ4OI'QO\ *4_=J33'$Z$
M
M                                      $6=1FN#1[I"5Q%!JCU,85P
M"OGI;H?#$65LA1R&*Y*F9#4!+PK:4STN2G*D38<Z)[#SK;>"*N.MI==2M0!*
M(DXE024H3FEGD'EV'$'DWVFDG$FVTO+-*,LK=88699=2MMU*UI6E=V@ _H *
MNL[;%+93:E)LY9(S'H8P5(9T]K^NK_*&1B<,?.TC=;KSS#G62GXY=8E21N:P
MQ3=<H4+J*#E-:6U-NOWEF] Z_P!3.PDV:&H_28NT@I=-\!P1!BGPF9Q"68$B
ML9@4_AN04;>XMB&:$R(EG5'2E?5 ZG)E9#W1Q3K4M]+#+=\6082!FDA_1K=D
MILU=3F*IYM$=IU!I'&E4@[\\3Z?,O-,$T_H)Y2+."6PLJ>O3EDZ6+9Q$F]Z7
M(ZJRT:-B2K+K*D'W7D7GDU MXUM]%)V:&L[.$@SZG<,U:<9?.Y$JDV2F3 [_
M  EN@TP>70RP]\?4\6FD$F*2)R)X5VW*#S6RXA"8I../-1F'&77@"X#9_P"S
METI[,W"G,9I3@AT98'!SH_S.6R%P[X<B9(DU$UJ.V0SJ4F)TESDK3I+."3)D
MY"1M0EUNM2IB*&&4N G0              "MO:G^;AC_ ..'HE^=)BT2J3WU
M?:.[E2+6>])[=G=(62"*2@        S5]*9^C[P]\<?'WYD]0@S1T%>=M1^3
MI/'4Y@?TAO,NE_*D?B*DP.C:\TV                 ]*G8!?1(:3/Q[_.8
MS*-+NEGZ0,0_B/BT)OCT,?1KAOWQ\:G+C1CDR@      !\*2_P#!%O\ NW\;
M('U-DXO[4^Z/AR     ,@FK[SH\^^ZK,ONRI&R.K?S!1^3L[E#\J?I5?K):\
M?G-7^/>1R%Z, @              $QMG_P">#A'^7'WVG2,=:UQ\VJKVC>[:
M;8^@S^M;J=Y;4_$*LUA#7D_3R                !B3D_\ .60_RX[?Q]0-
MIH/>&>T3L'X[=8_.&O\ +)_&./ABJ6<               LWV3?G1N'N52W[
ML14=$Z1/F!OE#.Y>>BW[,#]9*?\ -FM\?1FE$8//T*               $'=
MI%YEV9OQ=_G6@H[7J1YT4O\ &>*D--/V@GZHFMW_  O^VL.,K(V /S0
M            :-=D+YM<W]W&2^T+&@PITD?/D7DC?&2GOU^RL_5[QG\\ZO\
MLW"2U,8_/3                R$=),_KNTU^Y7+/;<4*\6PINYZ*GF_BWED
M?BS-B*IM6                !Z>."OZD<.>Y7CWVHM B+LGDAK%YP5WEDWC
M'':@^%G               ,,&WR^D*D?N5XQ^YBT2(^U/0WT;OHRB\LJ.Z0I
M9%0ST               =JX*_KNPY[JF/?;<T#XNP6?6+S?KO(YO%N/3P$0\
MD
M                                 ,KO28_[E'^(_P#[A16BVS<3T3OZ
M_P#O'^F&5P5C<,                #T<MG)YAFD3W <:^UM$(KNV7JGEKTI
M?2/C?Y2G[M2:8XG0@
M
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M7F79F_%W^=:"CM>I'G12_P 9XJ0TT_:"?JB:W?\ "_[:PXRLC8 _-
M          !HUV0OFUS?W<9+[0L:#"G21\^1>2-\9*>_7[*S]7O&?SSJ_P"S
M<)+4QC\],               #(1TDS^N[37[E<L]MQ0KQ;"F[GHJ>;^+>61^
M+,V(JFU8                'IXX*_J1PY[E>/?:BT"(NR>2&L7G!7>63>,<
M=J#X6<               PP;?+Z0J1^Y7C'[F+1(C[4]#?1N^C*+RRH[I"ED
M5#/0              !VK@K^N[#GNJ8]]MS0/B[!9]8O-^N\CF\6X]/ 1#R0
M
M                                RN])C_N4?XC_ /N%%:+;-Q/1._K_
M .\?Z897!6-PP                /1RV<GF&:1/<!QK[6T0BN[9>J>6O2E]
M(^-_E*?NU)ICB="
M                                                          #^
M*E,G6)ST:P@E4D5$FIE25258>G4IS[+BCR#R#;;BCB3BKJVWV74K;=;6M*TW
M !D7VAG1!-%.J&4R'*.DR?N^BN?2 Y4Y.<(9XLEGV %SJ<82?>8S0*YWB[[C
MRU<90ZAA;6ZF-*7A+*IFPNTNI1H&=W)G0Q]J+$UZGF]R?I(RLRTX2Y">CR%/
MX:_G667E6V6+V:48P(:$*DZAE;K;2G1472VR[?&4KO:7 =7-?0^=L(O4\ K;
MM,S(5P=]_'73-YIJ;?6UMI0G>,L-=UG"&;OJ5X'>>I7=NIZFZ!93IHZ$7DY6
M\M;AK%UIP./Q],I(->HCIHB$@F#R\I*&?[2B:\C92;X,BC*FXKU2U1L6=K:7
M>I5/6GJ@#:=H'V;VD+9IXFOQ%I-Q<BA;>ZF(ULWFSL?WP9.R:\(2SBTSQD&;
MJRK')[,255'U2(RZ)VIMXP;:A2)K#;[:@3J                  5M[4_S<
M,?\ QP]$OSI,6B52>^K[1W<J1:SWI/;L[I"R0124        &:OI3/T?>'OC
MCX^_,GJ$&:.@KSMJ/R=)XZG,#^D-YETOY4C\14F!T;7FFP
M  'I4[ +Z)#29^/?YS&91I=TL_2!B'\1\6A-\>ACZ-<-^^/C4Y<:,<F4
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M-KF_NXR7VA8T&%.DCY\B\D;XR4]^OV5GZO>,_GG5_P!FX26IC'YZ8
M        &0CI)G]=VFOW*Y9[;BA7BV%-W/14\W\6\LC\69L15-JP
M        /3QP5_4CASW*\>^U%H$1=D\D-8O."N\LF\8X[4'PLX
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M'IX"(>2
M                                       &5WI,?]RC_$?_ -PHK1;9
MN)Z)W]?_ 'C_ $PRN"L;A@                >CELY/,,TB>X#C7VMHA%=V
MR]4\M>E+Z1\;_*4_=J33'$Z$
M
M                                   !6WM3_-PQ_P#'#T2_.DQ:)5)[
MZOM'=RI%K/>D]NSND+)!%)0        9J^E,_1]X>^./C[\R>H09HZ"O.VH_
M)TGCJ<P/Z0WF72_E2/Q%28'1M>:;                 >E3L OHD-)GX]_G
M,9E&EW2S](&(?Q'Q:$WQZ&/HUPW[X^-3EQHQR90       R!=-6^BRP'\?\
MQ9\W754 +OMBE]$?LY?B@8/]I+6 +/P    9!-7WG1Y]]U69?=E2-D=6_F"C
M\G9W*'Y4_2J_62UX_.:O\>\CD+T8!               )C;/_P \'"/\N/OM
M.D8ZUKCYM57M&]VTVQ]!G]:W4[RVI^(59K"&O)^GD                #$G
M)_YRR'^7';^/J!M-![PSVB=@_';K'YPU_ED_C''PQ5+.               6
M;[)OSHW#W*I;]V(J.B=(GS WRAG<O/1;]F!^LE/^;-;X^C-*(P>?H4
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MM1**=>US1.^R4W7#UH/&H
M                                                    #*[TF/\
MN4?XC_\ N%%:+;-Q/1._K_[Q_IAE<%8W#                 ]'+9R>89I$
M]P'&OM;1"*[MEZIY:]*7TCXW^4I^[4FF.)T(
M
M                        .G<O:B-/^GUL(>L]YSP[A%F5%J#DKME[)L*Q
MJV*24E*7*C2%\S>V5*<6FMK2IEUM]:64KZNX ./X;U::5M19AQ.GS4QI]SL<
MG).4J"L-YFQSD\PA.G-X!0>=9"9(^7%$D'_67WW4I;;?ZE:TJ )!
M   "O77GM+]-VS\CC4;E)S<Y9DZ76?\ ZOL)0$M*[9%EMUZCB1*^]":H(31Z
M-U75X*J];>7:=?886D+5*+*D"33TLM2OL,C$V578(U15Q4R>SRO781-DYCH,
MU!:A]2^&W3)NHW3,]:6) OF[J3!H#(',Q>\N>-+VEC71Z0O*9P(:W]I>C%ZU
M:D4)US:VWW<5M.L)ML-I2G&HCBB?<B=?2S*NZ?:>265E^5EQ;<B;A-D4"0
M %;>U/\ -PQ_\</1+\Z3%HE4GOJ^T=W*D6L]Z3V[.Z0LD$4E        !FKZ
M4S]'WA[XX^/OS)ZA!FCH*\[:C\G2>.IS _I#>9=+^5(_$5)@=&UYIL
M          !Z5.P"^B0TF?CW^<QF4:7=+/T@8A_$?%H3?'H8^C7#?OCXU.7&
MC')E       #(%TU;Z++ ?Q_\6?-UU5 "[[8I?1'[.7XH&#_ &DM8 L_
M!D$U?>='GWW59E]V5(V1U;^8*/R=G<H?E3]*K]9+7C\YJ_Q[R.0O1@$
M          F-L_\ SP<(_P N/OM.D8ZUKCYM57M&]VTVQ]!G]:W4[RVI^(59
MK"&O)^GD                #$G)_P"<LA_EQV_CZ@;30>\,]HG8/QVZQ^<-
M?Y9/XQQ\,52S@              %F^R;\Z-P]RJ6_=B*CHG2)\P-\H9W+ST6
M_9@?K)3_ )LUOCZ,THC!Y^A0               @[M(O,NS-^+O\ZT%':]2/
M.BE_C/%2&FG[03]436[_ (7_ &UAQE9&P!^:                 #1KLA?-
MKF_NXR7VA8T&%.DCY\B\D;XR4]^OV5GZO>,_GG5_V;A):F,?GI@
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M22MJ*:6*-B4]<BN?(QS6-2VE1+7.5$RJB9<JFRL?H!/.@
M
M                #*[TF/\ N4?XC_\ N%%:+;-Q/1._K_[Q_IAE<%8W#
M              ]'+9R>89I$]P'&OM;1"*[MEZIY:]*7TCXW^4I^[4FF.)T(
M
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MY2N9^@M$36VHL5%^3I/'4Y@GTA7*NI=*BHJ?*D?B*DPJ#:TTY
M      ]&?8/3*0-6RDTK($.-Y8_I4_/CP3LV*HT6B5\+J0S =?P%C@^(U=.
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M+JVUK;OK:UW*[E:T&T<'O#/:)V#\>6L7G!7^63^,<?&%4LX
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MF(:Z4'0UJ(ZSHVU"HTPNF1%M2:K8C6UU2Y46Q\CI6)$Y_P!>Z)\B+WU;>W=
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MV7Q>$,=RLE!:]2Z0-,::;ERBPV].CHXO*M$CJK/L(OK87O\ ?W4LNK2E=RH
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M-7WG1Y]]U69?=E2-D=6_F"C\G9W*'Y4_2J_62UX_.:O\>\CD+T8!
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M73 _GJC\JB\8T]=(>?1Z6@
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M;BM0B;*Y$D5$RKE7JKE7;._AEXQR
M
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MQ\??F3U"#-'05YVU'Y.D\=3F!_2&\RZ7\J1^(J3 Z-KS38
M  #TJ=@%]$AI,_'O\YC,HTNZ6?I Q#^(^+0F^/0Q]&N&_?'QJ<N-&.3*
M   'PI+_ ,$6_P"[?QL@?4V3B_M3[H^'(     R":OO.CS[[JLR^[*D;(ZM_
M,%'Y.SN4/RI^E5^LEKQ^<U?X]Y'(7HP"               3&V?_ )X.$?Y<
M??:=(QUK7'S:JO:-[MIMCZ#/ZUNIWEM3\0JS6$->3]/(
M&).3_P Y9#_+CM_'U VF@]X9[1.P?CMUC\X:_P LG\8X^&*I9P
M    "S?9-^=&X>Y5+?NQ%1T3I$^8&^4,[EYZ+?LP/UDI_P V:WQ]&:41@\_0
MH               0=VD7F79F_%W^=:"CM>I'G12_P 9XJ0TT_:"?JB:W?\
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M8C5XQ31XM7N1]=5,;-(Y$1J.DD1'O6Q$1$M<Y5L1$1-A$L.U1]*X
M      !YW722_I.93[CF(_N2O&W_ $,>9#/*9>RAI%T[^?\ )Y+#W*E!PRP8
M;               .Y-.OG!8*]V/&/MV9!;<8^:*KR:7N'%TP/YZH_*HO&-/
M72'GT>EH
M                                       &<KI &M*_2#^B7O,;VY!Y
MP^?C=WTOK%>M'>ES,[FYN1B1\?X_WS?_ ,G@N _]??\ UN$.F3T$\,]-7\&_
MA'62?5[^[7.+NCHF5G./PCH+;UZII]'HN8I99?OZ1;;MWV5[P;TL:WT7])S/
M XL9_#EVV_5.IM#S*]99=@GOZ3G:VVW;MQ.VO9,Y?II#O@WE_E>N_LQ&$/\
MH4:M?_R37?\ HL7_ +F7S_JPXU_R12_^J2?[@/32'?!O+_*]=_9B'_0HU:__
M ))KO_18O_<Q_P!6'&O^2*7_ -4D_P!P*B]L-KXOU:82QA#;L560&D:RI234
M<;9O64<=_P#E*1-7$N*5B,>XO_[_ ,)PG"W_ .IO=[ZN[3+?1!^SHPGT-<:J
MM>,/UKJ,?DQ6EYBL,F'LI$C32,J-(CVU=0KEMANW;K>VMO9+%M&,>FC7^DO
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M+&M;%S=4O)))?O(MV3^S_P!KMEB 8>?83D>-R'4$U1N>OK?C/)$VR&>U3%5
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MLAV(C@
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M?."TH>XW-/;L4-G>@;YHK_*6=P:E>D9\]X;Y*_QAE'&>C7,
M   #UTM.OF^X*]QO&/M)9!Y\XQ\[U7E,O=N/2W _F2C\EB\6T[D%N+H
M          >=UTDOZ3F4^XYB/[DKQM_T,>9#/*9>RAI%T[^?\GDL/<J4'#+!
MAL               [DTZ^<%@KW8\8^W9D%MQCYHJO)I>X<73 _GJC\JB\8T
M]=(>?1Z6@
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M1_%JQ1[54 T4U[\\L3\ME[I3T/Z//,7"?((>X0GR.IG<@
M
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M79"^;7-_=QDOM"QH,*=)'SY%Y(WQDI[]?LK/U>\9_/.K_LW"2U,8_/3
M           Q ]*U\X+2A[C<T]NQ0V=Z!OFBO\I9W!J5Z1GSWAODK_&&4<9Z
M-<P                /72TZ^;[@KW&\8^TED'GSC'SO5>4R]VX]+<#^9*/R
M6+Q;3N06XN@              !YW722_I.93[CF(_N2O&W_0QYD,\IE[*&D7
M3OY_R>2P]RI0<,L&&P              #N33KYP6"O=CQC[=F06W&/FBJ\FE
M[AQ=,#^>J/RJ+QC3UTAY]'I:
M                                                       !CDZ6
MA_<"_P 5/_+@-B^@'^MOO7^D&KWI)?U+]]_T4QR#8PU?
M ]3W98_1P:(_BU8H]JJ :*:]^>6)^6R]TIZ']'GF+A/D$/<(3Y'4SN0
M
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M )X.$?Y<??:=(QUK7'S:JO:-[MIMCZ#/ZUNIWEM3\0JS6$->3]/(
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MTV.X=@>)4U1$ZR]'-#54D<C%5%5JW7-5$<U5:Y,K55%133J,*'OV
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M^<%@KW8\8^W9D%MQCYHJO)I>X<73 _GJC\JB\8T]=(>?1Z6@
M
M                   8Y.EH?W O\5/_ "X#8OH!_K;[U_I!J]Z27]2_??\
M13'(-C#5\                #U/=EC]'!HC^+5BCVJH!HIKWYY8GY;+W2GH
M?T>>8N$^00]PA/D=3.Y
M
M      9 NFK?198#^/\ XL^;KJJ $N^B>?0FZ>/=$U#_ )ZID -(0
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MO2/HL&?B%.[5VKQB.+2.PZ&O<M:B6*J)9)3QTMKK+&V52HJJB(I:>R2)ADK
MURJ/O#:\QI[:TCVT/K:L(5M3DSKDUBQ&Y(UQ-]R<]$H2F6F6&6W5MK97=W1W
M..6.:)LT3D=$YJ*BHMJ*BY45%S6&B&*8/BN"XM/@.+TTU-C5+.^&6"1CF2QS
M,<K'QO8J(YKVN16JU4M14L*P,C[9/1ACR9*H<G=)_D*B!::WN$IQW&6MVB"9
M016EA]Q#L\R6/GO*0LW=MHH;B%A!N]K<7??96VZO3JO7W *6H6!'2RV+8KF-
M16[ZN;:FZU%1=HWDU,_9O^DIKAJVS6.:#"<'TL221TN(5,L56YKLK;T4--4-
MA>J6*L=0^&1MMCVM<BM2>V#L^8GU'05)D3#\N12R-GG51J[BBST;FRNI9)1R
MAF?FA:60O:71,6?;=4LVRE+[+K3"[KRK[+[NS8=B=%BM,E50/1\2Y%VE1<SD
M7*B]7JID-4.E'HFU_P"AK6F34[I%P^7#\:8V^RU6OBFB55:V:"5BNCEB<K51
M'-<JM<BL>C7M<U.XA.,<E:F?=K!I'T_39PQX\.\QR!*6-;<VR5)C!B:WY%&W
M(HR\I6W.;P]R"--)R]N,LWJHE&<J-3F[I1EMIMEY=O4L3UUP/"ZA:61TDLS5
ML<D:(J-7;155S4M3;1%6S87+D-U>B;T!/2#Z7-6(=<,.I\.PC JJ+24S\3GE
M@?4QJB*R2*&&GJ94CD1;8GS,B;(VQ[%6-S7NDUINU9X-U7QI;(\-RVCQ>SF$
MDR.-N:0UGE<:-55.XI1X9E-:WVIUMI%]25)%YZ0VMMUMAM;[+[;;OA.-X=C4
M2RT#[RM[9JI8YN:U-W:5+47.81Z:/1_Z4N@+&HL&Z1\/YLVI1RT]3$])J6I1
MME_0S-R*YEY+\;T9*RUJN8C7-5T3,R;2A5",E9/@^(M-62<_1_ F\IGB?QAS
M(9F2!F%ISU;FG;T]S&]F2!2RD(U-%-IIC=2TQ&HWM;B2KCQ9:_6QU/5S4]#2
M3545-[\]JV(S;6S(MY4L6VV[L+M):; =&_H60:SZE8'K1TAZZX+JEBVMEOX#
MH*F)TTU<BN:R)TCDGA2G;,Y\:QJQM1:V:&U$DD2(D3,]:&)8QI(.UA-YREY@
M2N()I!&6=082T/3X_.2FC.UPHZE>N!2%Z[YJU0+;BJ*RTE23SJ<,456MUTJ,
M?H8<#_#K;74RQWFIL*KER(S;L6]D79LL5<J(8=U;]&OI QST@V^CK5M93:V1
MXBZGJ9FHZ6&""-NFEK4][5\/-N_PHY8G2WXHUT;Y+$M#V5<M?)[G?2K-Y+$C
MX$_2]NMDKK"U3E1W5198]8\>W$QC5.5$#7QQ4W<8X,RZJ8BN_MK2MEM:5I2V
MZR3R5.I\U1,Q8I9(6.5BK:K55S%LML2VSJ)U#+'HJZOX7JGZ<6!ZKX+B#,6P
MK#L=Q"FBK&QZ%M4R&EK8TG;'I);C9+MYJ:1Z6*BHYR938 ,!'Z30
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M"^;7-_=QDOM"QH,*=)'SY%Y(WQDI[]?LK/U>\9_/.K_LW"2U,8_/3
M         Q ]*U\X+2A[C<T]NQ0V=Z!OFBO\I9W!J5Z1GSWAODK_ !AE'&>C
M7,                #UTM.OF^X*]QO&/M)9!Y\XQ\[U7E,O=N/2W _F2C\E
MB\6T[D%N+H               >=UTDOZ3F4^XYB/[DKQM_T,>9#/*9>RAI%T
M[^?\GDL/<J4'#+!AL               [DTZ^<%@KW8\8^W9D%MQCYHJO)I>
MX<73 _GJC\JB\8T]=(>?1Z6@
M                                                       8Y.EH
M?W O\5/_ "X#8OH!_K;[U_I!J]Z27]2_??\ 13'(-C#5\
M #U/=EC]'!HC^+5BCVJH!HIKWYY8GY;+W2GH?T>>8N$^00]PA/D=3.Y
M
M                                      !GJZ2QHOUK:Z-!&.\1:$HT
M[R_++!JHQ_D23QQDRA$L3+'+&K1C#-$<=J5D$WF$'CK@2DE<L9E%R$U=2\RI
M5#K++[R*;@&%[]G0Z1A\&G(GRS],/_4J /BOG1K.D'R=(6@DNDN5R% 2IL6%
M(GS5WI3=DA2LLHXDM46F7ZCE!-BFPE0992^EM+J6WW4W=RM=T#^[1T;7I"\>
M0%-;!I3F+&V$7&WDMS1K TK-J F\XRXTZXI(BU($IR[C3;ZW75I;2MUU:UKZ
MH ^G^SH=(P^#3D3Y9^F'_J5 &N[HMVSKVCN@-FUM%Z_X;(($1E9ST]7XBC[]
MFN!9?O,-A"7--N0GE,5CS(&06>-VK;)<Q$77&GIU*VJ6E+K*V)R[@!K(
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M^=&X>Y5+?NQ%1T3I$^8&^4,[EYZ+?LP/UDI_S9K?'T9I1&#S]"@
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MP6"O=CQC[=F06W&/FBJ\FE[AQ=,#^>J/RJ+QC3UTAY]'I:
M
M                 !CDZ6A_<"_Q4_\ +@-B^@'^MOO7^D&KWI)?U+]]_P!%
M,<@V,-7P                /4]V6/T<&B/XM6*/:J@&BFO?GEB?ELO=*>A_
M1YYBX3Y!#W"$^1U,[D
M
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M]DWYT;A[E4M^[$5'1.D3Y@;Y0SN7GHM^S _62G_-FM\?1FE$8//T*
M        $'=I%YEV9OQ=_G6@H[7J1YT4O\9XJ0TT_:"?JB:W?\+_ +:PXRLC
M8 _-                 !HUV0OFUS?W<9+[0L:#"G21\^1>2-\9*>_7[*S]
M7O&?SSJ_[-PDM3&/STP               ,0/2M?."TH>XW-/;L4-G>@;YHK
M_*6=P:E>D9\]X;Y*_P 891QGHUS                 ]=+3KYON"O<;QC[2
M60>?.,?.]5Y3+W;CTMP/YDH_)8O%M.Y!;BZ               'G==)+^DYE
M/N.8C^Y*\;?]#'F0SRF7LH:1=._G_)Y+#W*E!PRP8;               .Y-
M.OG!8*]V/&/MV9!;<8^:*KR:7N'%TP/YZH_*HO&-/72'GT>EH
M
M                    &.3I:']P+_%3_P N V+Z ?ZV^]?Z0:O>DE_4OWW_
M $4QR#8PU?                 ]3W98_1P:(_BU8H]JJ :*:]^>6)^6R]TI
MZ']'GF+A/D$/<(3Y'4SN0
M
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MM"ZF<>/W];*75NNI96[ZE*UK7<&T<'O#/:)V#\>.L7G!7^63>,<?%%4LX
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MZ-F^@>[^":^[;]TL[@U,](J]^&L.O6?<K]C^$,MPSR:Z@
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M^M3-RM?J4H-O>AFS^Y++-CG,O90TEZ=;W]_Y+UEO-8>Y4HI&5S#@
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MXG\79ARH#O>Z.^YV[R\8XOG/LOB?Q=F'*@.][H[[G;O+QCB^<^R^)_%V8<J
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MCB^<^R^)_%V8<J [WNCON=N\O&<]C]LDL;K;94>R*'?AC:WF1](O1-U2-VG
M4M(<EJ]30ZEN[OZU,W*U^I2@XK9;DV#FEZSV5EI]L?#Z
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M=XU,BTEW   "MO:G^;AC_P".'HE^=)BT2J3WU?:.[E2+6>])[=G=(62"*2@
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MD+YM<W]W&2^T+&@PITD?/D7DC?&2GOU^RL_5[QG\\ZO^S<)+4QC\],
M         #$#TK7S@M*'N-S3V[%#9WH&^:*_REG<&I7I&?/>&^2O\891QGHU
MS                 ]=+3KYON"O<;QC[260>?.,?.]5Y3+W;CTMP/YDH_)8
MO%M.Y!;BZ               'G==)+^DYE/N.8C^Y*\;?]#'F0SRF7LH:1=.
M_G_)Y+#W*E!PRP8;               .Y-.OG!8*]V/&/MV9!;<8^:*KR:7N
M'%TP/YZH_*HO&-/72'GT>EH
M                                                      &.3I:'
M]P+_ !4_\N V+Z ?ZV^]?Z0:O>DE_4OWW_13'(-C#5\                #
MU/=EC]'!HC^+5BCVJH!HIKWYY8GY;+W2GH?T>>8N$^00]PA/D=3.Y
M
M                                                       ?X-*+
M.+,).+L-)-LO*-*-LM,+-+,MK;>699=2MM]E]M:TK2M*TK2H K$G>QBV8>1Y
MH=/Y/I&@MDC4K;G%3;%I!D2 QQ2LO/XP:<IA,"F4:A:CASJUN,MO;[K3-VN^
MI6E:[LMM=5M;=1ZV=9>%4M(CJ&D<Z\K$MZZ<"+86!8SQ=CC#,*8\<8F@\7QS
M XVGJF9(G#F5"PL;?9??4T\TI"WDD%7JUBB^XU0??2X]2??<:;?>9===6,][
MGN5SU57+G)+&,C;=8B(U-I#G@XG(   *V]J?YN&/_CAZ)?G28M$JD]]7VCNY
M4BUGO2>W9W2%D@BDH        ,U?2F?H^\/?''Q]^9/4(,T=!7G;4?DZ3QU.
M8'](;S+I?RI'XBI,#HVO--@                /2IV 7T2&DS\>_P YC,HT
MNZ6?I Q#^(^+0F^/0Q]&N&_?'QJ<N-&.3*       &0+IJWT66 _C_XL^;KJ
MJ %WVQ2^B/V<OQ0,'^TEK %GX    ,@FK[SH\^^ZK,ONRI&R.K?S!1^3L[E#
M\J?I5?K):\?G-7^/>1R%Z, @              $QMG_YX.$?Y<??:=(QUK7'
MS:JO:-[MIMCZ#/ZUNIWEM3\0JS6$->3]/(                &).3_SED/\
MN.W\?4#::#WAGM$[!^.W6/SAK_+)_&./ABJ6<               LWV3?G1N
M'N52W[L14=$Z1/F!OE#.Y>>BW[,#]9*?\V:WQ]&:41@\_0H
M  0=VD7F79F_%W^=:"CM>I'G12_QGBI#33]H)^J)K=_PO^VL.,K(V /S0
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M*]V/&/MV9!;<8^:*KR:7N'%TP/YZH_*HO&-/72'GT>EH
M
M               &.3I:']P+_%3_ ,N V+Z ?ZV^]?Z0:O>DE_4OWW_13'(-
MC#5\                #U/=EC]'!HC^+5BCVJH!HIKWYY8GY;+W2GH?T>>8
MN$^00]PA/D=3.Y
M
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M[2+S+LS?B[_.M!1VO4CSHI?XSQ4AII^T$_5$UN_X7_;6'&5D; 'YH
M          -&NR%\VN;^[C)?:%C084Z2/GR+R1OC)3WZ_96?J]XS^>=7_9N$
MEJ8Q^>F               !B!Z5KYP6E#W&YI[=BAL[T#?-%?Y2SN#4KTC/G
MO#?)7^,,HXST:Y@                >NEIU\WW!7N-XQ]I+(//G&/G>J\IE
M[MQZ6X'\R4?DL7BVG<@MQ=               #SNNDE_2<RGW',1_<E>-O\
MH8\R&>4R]E#2+IW\_P"3R6'N5*#AE@PV               =R:=?."P5[L>,
M?;LR"VXQ\T57DTO<.+I@?SU1^51>,:>ND//H]+0
M
M          ,<G2T/[@7^*G_EP&Q?0#_6WWK_ $@U>])+^I?OO^BF.0;&&KX
M               'J>[+'Z.#1'\6K%'M50#137OSRQ/RV7NE/0_H\\Q<)\@A
M[A"?(ZF=R
M
M                     K;VI_FX8_\ CAZ)?G28M$JD]]7VCNY4BUGO2>W9
MW2%D@BDH        ,U?2F?H^\/?''Q]^9/4(,T=!7G;4?DZ3QU.8'](;S+I?
MRI'XBI,#HVO--@                /2IV 7T2&DS\>_SF,RC2[I9^D#$/XC
MXM";X]#'T:X;]\?&IRXT8Y,H       ?"DO_  1;_NW\;('U-DXO[4^Z/AR
M    ,@FK[SH\^^ZK,ONRI&R.K?S!1^3L[E#\J?I5?K):\?G-7^/>1R%Z, @
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M=QDOM"QH,*=)'SY%Y(WQDI[]?LK/U>\9_/.K_LW"2U,8_/3
M   Q ]*U\X+2A[C<T]NQ0V=Z!OFBO\I9W!J5Z1GSWAODK_&&4<9Z-<P
M           /72TZ^;[@KW&\8^TED'GSC'SO5>4R]VX]+<#^9*/R6+Q;3N06
MXN@              !YW722_I.93[CF(_N2O&W_0QYD,\IE[*&D73OY_R>2P
M]RI0<,L&&P              #N33KYP6"O=CQC[=F06W&/FBJ\FE[AQ=,#^>
MJ/RJ+QC3UTAY]'I:
M                                               !CDZ6A_<"_P 5
M/_+@-B^@'^MOO7^D&KWI)?U+]]_T4QR#8PU?                 ]3W98_1
MP:(_BU8H]JJ :*:]^>6)^6R]TIZ']'GF+A/D$/<(3Y'4SN0
M
M                                                          %;
M>U/\W#'_ ,</1+\Z3%HE4GOJ^T=W*D6L]Z3V[.Z0LD$4E        !FKZ4S]
M'WA[XX^/OS)ZA!FCH*\[:C\G2>.IS _I#>9=+^5(_$5)@=&UYIL
M       !Z5.P"^B0TF?CW^<QF4:7=+/T@8A_$?%H3?'H8^C7#?OCXU.7&C')
ME       #X4E_P""+?\ =OXV0/J;)Q?VI]T?#D     9!-7WG1Y]]U69?=E2
M-D=6_F"C\G9W*'Y4_2J_62UX_.:O\>\CD+T8!               )C;/_P \
M'"/\N/OM.D8ZUKCYM57M&]VTVQ]!G]:W4[RVI^(59K"&O)^GD
M     #$G)_YRR'^7';^/J!M-![PSVB=@_';K'YPU_ED_C''PQ5+.
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MKI)?TG,I]QS$?W)7C;_H8\R&>4R]E#2+IW\_Y/)8>Y4H.&6##8
M    !W)IU\X+!7NQXQ]NS(+;C'S15>32]PXNF!_/5'Y5%XQIZZ0\^CTM
M
M                            QR=+0_N!?XJ?^7 ;%] /];?>O](-7O22
M_J7[[_HICD&QAJ^                !ZGNRQ^C@T1_%JQ1[54 T4U[\\L3\
MME[I3T/Z//,7"?((>X0GR.IG<@
M
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M+?NQ%1T3I$^8&^4,[EYZ+?LP/UDI_P V:WQ]&:41@\_0H
M0=VD7F79F_%W^=:"CM>I'G12_P 9XJ0TT_:"?JB:W?\ "_[:PXRLC8 _-
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MV/&/MV9!;<8^:*KR:7N'%TP/YZH_*HO&-/72'GT>EH
M
M             &.3I:']P+_%3_RX#8OH!_K;[U_I!J]Z27]2_??]%,<@V,-7
MP                /4]V6/T<&B/XM6*/:J@&BFO?GEB?ELO=*>A_1YYBX3Y
M!#W"$^1U,[D
M
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M/\N/OM.D8ZUKCYM57M&]VTVQ]!G]:W4[RVI^(59K"&O)^GD
M   #$G)_YRR'^7';^/J!M-![PSVB=@_';K'YPU_ED_C''PQ5+.
M     6;[)OSHW#W*I;]V(J.B=(GS WRAG<O/1;]F!^LE/^;-;X^C-*(P>?H4
M               (.[2+S+LS?B[_ #K04=KU(\Z*7^,\5(::?M!/U1-;O^%_
MVUAQE9&P!^:                 #1KLA?-KF_NXR7VA8T&%.DCY\B\D;XR4
M]^OV5GZO>,_GG5_V;A):F,?GI@               8@>E:^<%I0]QN:>W8H;
M.] WS17^4L[@U*](SY[PWR5_C#*.,]&N8                'KI:=?-]P5[
MC>,?:2R#SYQCYWJO*9>[<>EN!_,E'Y+%XMIW(+<70               \[KI
M)?TG,I]QS$?W)7C;_H8\R&>4R]E#2+IW\_Y/)8>Y4H.&6##8
M  !W)IU\X+!7NQXQ]NS(+;C'S15>32]PXNF!_/5'Y5%XQIZZ0\^CTM
M
M                          QR=+0_N!?XJ?\ EP&Q?0#_ %M]Z_T@U>])
M+^I?OO\ HICD&QAJ^                !ZGNRQ^C@T1_%JQ1[54 T4U[\\L
M3\ME[I3T/Z//,7"?((>X0GR.IG<@
M
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MG)_YRR'^7';^/J!M-![PSVB=@_';K'YPU_ED_C''PQ5+.
M6;[)OSHW#W*I;]V(J.B=(GS WRAG<O/1;]F!^LE/^;-;X^C-*(P>?H4
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MU\X+2A[C<T]NQ0V=Z!OFBO\ *6=P:E>D9\]X;Y*_QAE'&>C7,
M     #UTM.OF^X*]QO&/M)9!Y\XQ\[U7E,O=N/2W _F2C\EB\6T[D%N+H
M            >=UTDOZ3F4^XYB/[DKQM_P!#'F0SRF7LH:1=._G_ ">2P]RI
M0<,L&&P              #N33KYP6"O=CQC[=F06W&/FBJ\FE[AQ=,#^>J/R
MJ+QC3UTAY]'I:
M                                            !CDZ6A_<"_Q4_P#+
M@-B^@'^MOO7^D&KWI)?U+]]_T4QR#8PU?                 ]3W98_1P:(
M_BU8H]JJ :*:]^>6)^6R]TIZ']'GF+A/D$/<(3Y'4SN0
M
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M'!%7_5NIN5W:^J-F^@=;<)K\B)_K+.X-3/2*;=QK#LJK_JK]G^$,MPSR:Z@
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M333>/2!?UR<;N%K2O!W*N")W2B]S<LIO?4H.*K:MIS:EU++57JGVQ\/H
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M9-^=&X>Y5+?NQ%1T3I$^8&^4,[EYZ+?LP/UDI_S9K?'T9I1&#S]"@
M       !3EM_?HD-6?XB/G,8:&1NB;Z0,/\ X_XM,8OZ9_HUQ+[W^-0'FK#=
M$T.                 WQ=%F^C[S#\<?(/YD]/8U0Z=?.VG_)T?CJ@W)]'G
MS+JORI)XBF-*@PN9X               ,0/2M?."TH>XW-/;L4-G>@;YHK_*
M6=P:E>D9\]X;Y*_QAE'&>C7,                #UTM.OF^X*]QO&/M)9!Y
M\XQ\[U7E,O=N/2W _F2C\EB\6T[D%N+H               >=UTDOZ3F4^XY
MB/[DKQM_T,>9#/*9>RAI%T[^?\GDL/<J4'#+!AL               [DTZ^<
M%@KW8\8^W9D%MQCYHJO)I>X<73 _GJC\JB\8T]=(>?1Z6@
M
M                 8Y.EH?W O\ %3_RX#8OH!_K;[U_I!J]Z27]2_??]%,<
M@V,-7P                /4]V6/T<&B/XM6*/:J@&BFO?GEB?ELO=*>A_1Y
MYBX3Y!#W"$^1U,[D
M
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M'SF,-#(W1-](&'_Q_P 6F,7],_T:XE][_&H#S5ANB:'
M;XNBS?1]YA^./D'\R>GL:H=.OG;3_DZ/QU0;D^CSYEU7Y4D\13&E087,\
M            &('I6OG!:4/<;FGMV*&SO0-\T5_E+.X-2O2,^>\-\E?XPRCC
M/1KF                !ZZ6G7S?<%>XWC'VDL@\^<8^=ZKRF7NW'I;@?S)1
M^2Q>+:=R"W%T               /.ZZ27])S*?<<Q']R5XV_Z&/,AGE,O90T
MBZ=_/^3R6'N5*#AE@PV               =R:=?."P5[L>,?;LR"VXQ\T57D
MTO<.+I@?SU1^51>,:>ND//H]+0
M                                                         ,<G
M2T/[@7^*G_EP&Q?0#_6WWK_2#5[TDOZE^^_Z*8Y!L8:O@
M >I[LL?HX-$?Q:L4>U5 -%->_/+$_+9>Z4]#^CSS%PGR"'N$)\CJ9W(
M
M
M      "MO:G^;AC_ ..'HE^=)BT2J3WU?:.[E2+6>])[=G=(62"*2@
M  S5]*9^C[P]\<?'WYD]0@S1T%>=M1^3I/'4Y@?TAO,NE_*D?B*DP.C:\TV
M                ]*G8!?1(:3/Q[_.8S*-+NEGZ0,0_B/BT)OCT,?1KAOWQ
M\:G+C1CDR@      !\*2_P#!%O\ NW\;('U-DXO[4^Z/AR     ,@FK[SH\^
M^ZK,ONRI&R.K?S!1^3L[E#\J?I5?K):\?G-7^/>1R%Z, @
M$QMG_P">#A'^7'WVG2,=:UQ\VJKVC>[:;8^@S^M;J=Y;4_$*LUA#7D_3R
M             !B3D_\ .60_RX[?Q]0-IH/>&>T3L'X[=8_.&O\ +)_&./AB
MJ6<               LWV3?G1N'N52W[L14=$Z1/F!OE#.Y>>BW[,#]9*?\
M-FM\?1FE$8//T*               %.6W]^B0U9_B(^<QAH9&Z)OI P_^/\
MBTQB_IG^C7$OO?XU >:L-T30X                #?%T6;Z/O,/QQ\@_F3T
M]C5#IU\[:?\ )T?CJ@W)]'GS+JORI)XBF-*@PN9X               ,0/2M
M?."TH>XW-/;L4-G>@;YHK_*6=P:E>D9\]X;Y*_QAE'&>C7,
M   #UTM.OF^X*]QO&/M)9!Y\XQ\[U7E,O=N/2W _F2C\EB\6T[D%N+H
M          >=UTDOZ3F4^XYB/[DKQM_T,>9#/*9>RAI%T[^?\GDL/<J4'#+!
MAL               [DTZ^<%@KW8\8^W9D%MQCYHJO)I>X<73 _GJC\JB\8T
M]=(>?1Z6@
M                                        8Y.EH?W O\5/_+@-B^@'
M^MOO7^D&KWI)?U+]]_T4QR#8PU?                 ]3W98_1P:(_BU8H]
MJJ :*:]^>6)^6R]TIZ']'GF+A/D$/<(3Y'4SN0
M
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M>='GWW59E]V5(V1U;^8*/R=G<H?E3]*K]9+7C\YJ_P >\CD+T8!
M      )C;/\ \\'"/\N/OM.D8ZUKCYM57M&]VTVQ]!G]:W4[RVI^(59K"&O)
M^GD                #$G)_YRR'^7';^/J!M-![PSVB=@_';K'YPU_ED_C'
M'PQ5+.               6;[)OSHW#W*I;]V(J.B=(GS WRAG<O/1;]F!^LE
M/^;-;X^C-*(P>?H4               *<MO[]$AJS_$1\YC#0R-T3?2!A_\
M'_%IC%_3/]&N)?>_QJ \U8;HFAP                &^+HLWT?>8?CCY!_,
MGI[&J'3KYVT_Y.C\=4&Y/H\^9=5^5)/$4QI4&%S/               !B!Z5
MKYP6E#W&YI[=BAL[T#?-%?Y2SN#4KTC/GO#?)7^,,HXST:Y@
M    >NEIU\WW!7N-XQ]I+(//G&/G>J\IE[MQZ6X'\R4?DL7BVG<@MQ=
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M\FE[AQPP/YZH_*HO&-/72'GT>EH
M                                                          &.
M3I:']P+_ !4_\N V+Z ?ZV^]?Z0:O>DE_4OWW_13'(-C#5\
M   #U/=EC]'!HC^+5BCVJH!HIKWYY8GY;+W2GH?T>>8N$^00]PA/D=3.Y
M
M
M         5M[4_S<,?\ QP]$OSI,6B52>^K[1W<J1:SWI/;L[I"R0124
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M-7WG1Y]]U69?=E2-D=6_F"C\G9W*'Y4_2J_62UX_.:O\>\CD+T8!
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MXX^0?S)Z>QJATZ^=M/\ DZ/QU0;D^CSYEU7Y4D\13&E087,\
M   &('I6OG!:4/<;FGMV*&SO0-\T5_E+.X-2O2,^>\-\E?XPRCC/1KF
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M#SZ/2T
M                                     #')TM#^X%_BI_Y<!L7T _UM
M]Z_T@U>])+^I?OO^BF.0;&&KX                'J>[+'Z.#1'\6K%'M50
M#137OSRQ/RV7NE/0_H\\Q<)\@A[A"?(ZF=R
M
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M]YA^./D'\R>GL:H=.OG;3_DZ/QU0;D^CSYEU7Y4D\13&E087,\
M     &('I6OG!:4/<;FGMV*&SO0-\T5_E+.X-2O2,^>\-\E?XPRCC/1KF
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M(FO8Y+%:M]N^BI8J*EJ*BHJ*J*BGK*C04](0
M
M       ,<G2T/[@7^*G_ )<!L7T _P!;?>O](-7O22_J7[[_ **8Y!L8:O@
M               >I[LL?HX-$?Q:L4>U5 -%->_/+$_+9>Z4]#^CSS%PGR"'
MN$)\CJ9W(
M
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MYDM5KEO6V*BJCE1MB,:UB*B.<IE_I%UKQC5W4==7]8:J.HUPQ-O?&1M:UE/
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MQ]]ITC'6M<?-JJ]HWNVFV/H,_K6ZG>6U/Q"K-80UY/T\@
M 8DY/_.60_RX[?Q]0-IH/>&>T3L'X[=8_.&O\LG\8X^&*I9P
M  "S?9-^=&X>Y5+?NQ%1T3I$^8&^4,[EYZ+?LP/UDI_S9K?'T9I1&#S]"@
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ML]=+3KYON"O<;QC[260>?.,?.]5Y3+W;CTMP/YDH_)8O%M.Y!;BZ
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M2\ZRVRU;$L;:MEIZ9 TI-^
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M-$?Q:L4>U5 -3]>_/+$_+9>Z4W+Z//,7"?((>X0GR.IG<@
M
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MA&Q=MV_V0%BBU,Z#OIC'A&Q=MV_V0%BBU,Z&;7I1KTSN.@#$!#>[-J\ZW6'
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MK=9?9=3ZE:5K2HV0U;^8*/R=G<H?E4]*K]9+7C\YJ_Q[R.PO1@$
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MA(KBV5ET.6*"DQ53+G>+5MLX0Z^RS?W4MKN4W=VNX.B](?S WRAG<O/1;]F
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MM!D7HF<Y>D##T55L[_\ %IC&'3,QB=&N)*B(B_ZOM?\ FH#S@AN@:(
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MW=K_ *1M]T,JJZDLM_VF7LH:2=.R(FO\B)D3FL/<J40#*YAP
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MI4[ +Z)#29^/?YS&91I=TL_2!B'\1\6A-\>ACZ-<-^^/C4Y<:,<F4
M()[0O7]IBV<N#F;-6J^9N\'Q]+\D,.)V)U98=*)LJ53=Z8)5,V]M,:XFUNSB
MF3FQ^!.9M5!A=I%MQ-ME;J7F64N(?'):EB$DL#9NQWJ4PQC#/^(W94_8PS#"
M6#(4#>5K4XL2QSBTG0$N;.M4L[NF1NC8<H1GVW7$J"BS2ZUW+K:5 ^G;0
M ,@FK[SH\^^ZK,ONRI&R.K?S!1^3L[E#\J?I5?K):\?G-7^/>1R%Z, @
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M)?TG,I]QS$?W)7C;_H8\R&>4R]E#2+IW\_Y/)8>Y4H.&6##8
M  !W)IU\X+!7NQXQ]NS(+;C'S15>32]PXNF!_/5'Y5%XQIZZ0\^CTM
M
M                          QR=+0_N!?XJ?\ EP&Q?0#_ %M]Z_T@U>])
M+^I?OO\ HICD&QAJ^                !ZGNRQ^C@T1_%JQ1[54 T4U[\\L
M3\ME[I3T/Z//,7"?((>X0GR.IG<@
M
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M.3_SED/\N.W\?4#::#WAGM$[!^.W6/SAK_+)_&./ABJ6<
MLWV3?G1N'N52W[L14=$Z1/F!OE#.Y>>BW[,#]9*?\V:WQ]&:41@\_0H
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M3[CF(_N2O&W_ $,>9#/*9>RAI%T[^?\ )Y+#W*E!PRP8;
M.Y-.OG!8*]V/&/MV9!;<8^:*KR:7N'%TP/YZH_*HO&-/72'GT>EH
M
M                       &.3I:']P+_%3_ ,N V+Z ?ZV^]?Z0:O>DE_4O
MWW_13'(-C#5\                #U/=EC]'!HC^+5BCVJH!HIKWYY8GY;+W
M2GH?T>>8N$^00]PA/D=3.Y
M
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MOSHW#W*I;]V(J.B=(GS WRAG<O/1;]F!^LE/^;-;X^C-*(P>?H4
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M."P5[L>,?;LR"VXQ\T57DTO<.+I@?SU1^51>,:>ND//H]+0
M
M                  ,<G2T/[@7^*G_EP&Q?0#_6WWK_ $@U>])+^I?OO^BF
M.0;&&KX                'J>[+'Z.#1'\6K%'M50#137OSRQ/RV7NE/0_H
M\\Q<)\@A[A"?(ZF=R
M
M                             K;VI_FX8_\ CAZ)?G28M$JD]]7VCNY4
MBUGO2>W9W2%D@BDH        ,U?2F?H^\/?''Q]^9/4(,T=!7G;4?DZ3QU.8
M'](;S+I?RI'XBI,#HVO--@                /2IV 7T2&DS\>_SF,RC2[I
M9^D#$/XCXM";X]#'T:X;]\?&IRXT8Y,H       91^F%8@RUFK9G80B^&\79
M%RU)6W7/C.0N,=QG"9+/'U P)<!ZF6Q2^+6F+-CJO2LZ=R=TB>]3>7:38>J)
M+K=2\RREP%R^QZBTG@^RRV?\/FD<?HA+8UI2PTS2.+RAH<(_(F!W0PYM(7-3
MTR.R=(YM3DC/LK8:0>46:7?2M+K:5 %D(    ,@FK[SH\^^ZK,ONRI&R.K?S
M!1^3L[E#\J?I5?K):\?G-7^/>1R%Z, @              $QMG_YX.$?Y<??
M:=(QUK7'S:JO:-[MIMCZ#/ZUNIWEM3\0JS6$->3]/(                &)
M.3_SED/\N.W\?4#::#WAGM$[!^.W6/SAK_+)_&./ABJ6<
MLWV3?G1N'N52W[L14=$Z1/F!OE#.Y>>BW[,#]9*?\V:WQ]&:41@\_0H
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M3[CF(_N2O&W_ $,>9#/*9>RAI%T[^?\ )Y+#W*E!PRP8;
M.Y-.OG!8*]V/&/MV9!;<8^:*KR:7N'%TP/YZH_*HO&-/72'GT>EH
M
M                       &.3I:']P+_%3_ ,N V+Z ?ZV^]?Z0:O>DE_4O
MWW_13'(-C#5\                #U/=EC]'!HC^+5BCVJH!HIKWYY8GY;+W
M2GH?T>>8N$^00]PA/D=3.Y
M
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MI.93[CF(_N2O&W_0QYD,\IE[*&D73OY_R>2P]RI0<,L&&P
M#N33KYP6"O=CQC[=F06W&/FBJ\FE[AQ=,#^>J/RJ+QC3UTAY]'I:
M
M                       !CDZ6A_<"_P 5/_+@-B^@'^MOO7^D&KWI)?U+
M]]_T4QR#8PU?                 ]3W98_1P:(_BU8H]JJ :*:]^>6)^6R]
MTIZ']'GF+A/D$/<(3Y'4SN0
M
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MV6%^_19OH^\P_''R#^9/3V,3=.OG;3_DZ/QU09F]'GS+JORI)XBF-*@PN9X
M              ,0/2M?."TH>XW-/;L4-G>@;YHK_*6=P:E>D9\]X;Y*_P 8
M91QGHUS                 ]=+3KYON"O<;QC[260>?.,?.]5Y3+W;CTMP/
MYDH_)8O%M.Y!;BZ               'G==)+^DYE/N.8C^Y*\;?]#'F0SRF7
MLH:1=._G_)Y+#W*E!PRP8;               .Y-.OG!8*]V/&/MV9!;<8^:
M*KR:7N'%TP/YZH_*HO&-/72'GT>EH
M
M&.3I:']P+_%3_P N V+Z ?ZV^]?Z0:O>DE_4OWW_ $4QR#8PU?
M       ]3W98_1P:(_BU8H]JJ :*:]^>6)^6R]TIZ']'GF+A/D$/<(3Y'4SN
M0
M
M    ='S74WIMQM*DL%R+J$P? 9NMN+M1PZ:Y8@46E2NXXJAY5J6//K^@=S[C
M2;J7VTL)KOK:[M/4%1L4KDO-:Y6YT12FZ6)JW7.:CLRJAW4F4IUB=.L1J"5:
M1624I2JDQMAZ=2G/LM-(4)SRKKBCB3BKJ767VUK;=;6E:5W!3*A_8    %;>
MU/\ -PQ_\</1+\Z3%HE4GOJ^T=W*D6L]Z3V[.Z0LD$4E        !FKZ4S]'
MWA[XX^/OS)ZA!FCH*\[:C\G2>.IS _I#>9=+^5(_$5)@=&UYIL
M      !Z5.P"^B0TF?CW^<QF4:7=+/T@8A_$?%H3?'H8^C7#?OCXU.7&C')E
M       #X4E_X(M_W;^-D#ZFR<7]J?='PY     &035]YT>??=5F7W94C9'5
MOY@H_)V=RA^5/TJOUDM>/SFK_'O(Y"]& 0              "8VS_P#/!PC_
M "X^^TZ1CK6N/FU5>T;W;3;'T&?UK=3O+:GXA5FL(:\GZ>0
M   ,2<G_ )RR'^7';^/J!M-![PSVB=@_';K'YPU_ED_C''PQ5+.
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M(+;C'S15>32]PXNF!_/5'Y5%XQIZZ0\^CTM
M
M       QR=+0_N!?XJ?^7 ;%] /];?>O](-7O22_J7[[_HICD&QAJ^
M          !ZGNRQ^C@T1_%JQ1[54 T4U[\\L3\ME[I3T/Z//,7"?((>X0GR
M.IG<@
M
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MA)=:V)D*12I-K]:67==6E!]:U7.1K=E3BYR,:KG;"$"?2V:%_#W,/R/M9/\
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MJD=D:%92VE:^I=4O>W?Z*U'%45%L4YHJ.2U-@^V/A]
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MK/\ $1\YC#0R-T3?2!A_\?\ %IC%_3/]&N)?>_QJ \U8;HFAP
M     &^+HLWT?>8?CCY!_,GI[&J'3KYVT_Y.C\=4&Y/H\^9=5^5)/$4QI4&%
MS/               !B!Z5KYP6E#W&YI[=BAL[T#?-%?Y2SN#4KTC/GO#?)7
M^,,HXST:Y@                >NEIU\WW!7N-XQ]I+(//G&/G>J\IE[MQZ6
MX'\R4?DL7BVG<@MQ=               #SNNDE_2<RGW',1_<E>-O^ACS(9Y
M3+V4-(NG?S_D\EA[E2@X98,-@              '<FG7S@L%>['C'V[,@MN,
M?-%5Y-+W#BZ8'\]4?E47C&GKI#SZ/2T
M
M  #')TM#^X%_BI_Y<!L7T _UM]Z_T@U>])+^I?OO^BF.0;&&KX
M      'J>[+'Z.#1'\6K%'M50#137OSRQ/RV7NE/0_H\\Q<)\@A[A"?(ZF=R
M
M
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MB/G,8:&1NB;Z0,/_ (_XM,8OZ9_HUQ+[W^-0'FK#=$T.
M WQ=%F^C[S#\<?(/YD]/8U0Z=?.VG_)T?CJ@W)]'GS+JORI)XBF-*@PN9X
M             ,0/2M?."TH>XW-/;L4-G>@;YHK_ "EG<&I7I&?/>&^2O\89
M1QGHUS                 ]=+3KYON"O<;QC[260>?.,?.]5Y3+W;CTMP/Y
MDH_)8O%M.Y!;BZ               'G==)+^DYE/N.8C^Y*\;?\ 0QYD,\IE
M[*&D73OY_P GDL/<J4'#+!AL               [DTZ^<%@KW8\8^W9D%MQC
MYHJO)I>X<73 _GJC\JB\8T]=(>?1Z6@
M
M  8Y.EH?W O\5/\ RX#8OH!_K;[U_I!J]Z27]2_??]%,<@V,-7P
M       /4]V6/T<&B/XM6*/:J@&BFO?GEB?ELO=*>A_1YYBX3Y!#W"$^1U,[
MD
M
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M/1M_PHZ9I=:/PUS^]@M3!HN::#WR6F=>O\ZFV+EEVYEMV4LR[-!K6>N@
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M-.OG!8*]V/&/MV9!;<8^:*KR:7N'%TP/YZH_*HO&-/72'GT>EH
M
M                     &.3I:']P+_%3_RX#8OH!_K;[U_I!J]Z27]2_??]
M%,<@V,-7P                /4]V6/T<&B/XM6*/:J@&BFO?GEB?ELO=*>A
M_1YYBX3Y!#W"$^1U,[D
M
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MXB/G,8:&1NB;Z0,/_C_BTQB_IG^C7$OO?XU >:L-T30X
M#?%T6;Z/O,/QQ\@_F3T]C5#IU\[:?\G1^.J#<GT>?,NJ_*DGB*8TJ#"YG@
M             Q ]*U\X+2A[C<T]NQ0V=Z!OFBO\I9W!J5Z1GSWAODK_ !AE
M'&>C7,                #UTM.OF^X*]QO&/M)9!Y\XQ\[U7E,O=N/2W _F
M2C\EB\6T[D%N+H               >=UTDOZ3F4^XYB/[DKQM_T,>9#/*9>R
MAI%T[^?\GDL/<J4'#+!AL               [DTZ^<%@KW8\8^W9D%MQCYHJ
MO)I>X<73 _GJC\JB\8T]=(>?1Z6@
M                                                           8
MY.EH?W O\5/_ "X#8OH!_K;[U_I!J]Z27]2_??\ 13'(-C#5\
M     #U/=EC]'!HC^+5BCVJH!HIKWYY8GY;+W2GH?T>>8N$^00]PA/D=3.Y
M
M
M           5M[4_S<,?_'#T2_.DQ:)5)[ZOM'=RI%K/>D]NSND+)!%)0
M     9J^E,_1]X>^./C[\R>H09HZ"O.VH_)TGCJ<P/Z0WF72_E2/Q%28'1M>
M:;                 >E3L OHD-)GX]_G,9E&EW2S](&(?Q'Q:$WQZ&/HUP
MW[X^-3EQHQR90       ^%)?^"+?]V_C9 ^ILG%_:GW1\.0    !D$U?>='G
MWW59E]V5(V1U;^8*/R=G<H?E3]*K]9+7C\YJ_P >\CD+T8!
M  )C;/\ \\'"/\N/OM.D8ZUKCYM57M&]VTVQ]!G]:W4[RVI^(59K"&O)^GD
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M2A[C<T]NQ0V=Z!OFBO\ *6=P:E>D9\]X;Y*_QAE'&>C7,
M #UTM.OF^X*]QO&/M)9!Y\XQ\[U7E,O=N/2W _F2C\EB\6T[D%N+H
M        >=UTDOZ3F4^XYB/[DKQM_P!#'F0SRF7LH:1=._G_ ">2P]RI0<,L
M&&P              #N33KYP6"O=CQC[=F06W&/FBJ\FE[AQ=,#^>J/RJ+QC
M3UTAY]'I:
M                                        !CDZ6A_<"_Q4_P#+@-B^
M@'^MOO7^D&KWI)?U+]]_T4QR#8PU?                 ]3W98_1P:(_BU8
MH]JJ :*:]^>6)^6R]TIZ']'GF+A/D$/<(3Y'4SN0
M
M                                                   %;>U/\W#'
M_P </1+\Z3%HE4GOJ^T=W*D6L]Z3V[.Z0LD$4E        !FKZ4S]'WA[XX^
M/OS)ZA!FCH*\[:C\G2>.IS _I#>9=+^5(_$5)@=&UYIL
M!Z5.P"^B0TF?CW^<QF4:7=+/T@8A_$?%H3?'H8^C7#?OCXU.7&C')E
M #/_ -(]VD6H79>Z&\99YTV(L=+IO-M4\&PV\E9,C;I*&*V(ON*,VSM:8B0-
M,BC*@AXH]XY;Z6'7'WV6D7'6U+K6^VZP?%2U+%++]G+GZ=:J=!VD;4CDTEA(
MR%F_ 6-LES,F+MZEJCI4BED;1.KI8RMJM>Z*D+;:J47<$48I/OLLW*5ON^J!
M])H@    R":OO.CS[[JLR^[*D;(ZM_,%'Y.SN4/RI^E5^LEKQ^<U?X]Y'(7H
MP"               3&V?_G@X1_EQ]]ITC'6M<?-JJ]HWNVFV/H,_K6ZG>6U
M/Q"K-80UY/T\@                >/WD3^L"=?TQD_W;7#T.H_N2+^#;W*'
MF17?=LW\*_NE.&B210              #1'T8WZ1][^+5D[VU8V&'^FWS-;Y
M;%W,AF[H \^G^02]W$>@F-2#=,               IRV_OT2&K/\1'SF,-#(
MW1-](&'_ ,?\6F,7],_T:XE][_&H#S5ANB:'                 ;XNBS?1
M]YA^./D'\R>GL:H=.OG;3_DZ/QU0;D^CSYEU7Y4D\13&E087,\
M     &('I6OG!:4/<;FGMV*&SO0-\T5_E+.X-2O2,^>\-\E?XPRCC/1KF
M             !ZZ6G7S?<%>XWC'VDL@\^<8^=ZKRF7NW'I;@?S)1^2Q>+:=
MR"W%T               /.ZZ27])S*?<<Q']R5XV_P"ACS(9Y3+V4-(NG?S_
M )/)8>Y4H.&6##8              !W)IU\X+!7NQXQ]NS(+;C'S15>32]PX
MNF!_/5'Y5%XQIZZ0\^CTM
M                                                     QR=+0_N
M!?XJ?^7 ;%] /];?>O\ 2#5[TDOZE^^_Z*8Y!L8:O@                >I
M[LL?HX-$?Q:L4>U5 -%->_/+$_+9>Z4]#^CSS%PGR"'N$)\CJ9W(
M
M
M   "MO:G^;AC_P".'HE^=)BT2J3WU?:.[E2+6>])[=G=(62"*2@        S
M5]*9^C[P]\<?'WYD]0@S1T%>=M1^3I/'4Y@?TAO,NE_*D?B*DP.C:\TV
M             ]*G8!?1(:3/Q[_.8S*-+NEGZ0,0_B/BT)OCT,?1KAOWQ\:G
M+C1CDR@      !D"Z:M]%E@/X_\ BSYNNJH 7?;%+Z(_9R_% P?[26L 6?@
M   R":OO.CS[[JLR^[*D;(ZM_,%'Y.SN4/RI^E5^LEKQ^<U?X]Y'(7HP"
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MCCY!_,GI[&J'3KYVT_Y.C\=4&Y/H\^9=5^5)/$4QI4&%S/
M !B!Z5KYP6E#W&YI[=BAL[T#?-%?Y2SN#4KTC/GO#?)7^,,HXST:Y@
M          >NEIU\WW!7N-XQ]I+(//G&/G>J\IE[MQZ6X'\R4?DL7BVG<@MQ
M=               #SNNDE_2<RGW',1_<E>-O^ACS(9Y3+V4-(NG?S_D\EA[
ME2@X98,-@              '<FG7S@L%>['C'V[,@MN,?-%5Y-+W#BZ8'\]4
M?E47C&GKI#SZ/2T
M                                              #')TM#^X%_BI_Y
M<!L7T _UM]Z_T@U>])+^I?OO^BF.0;&&KX                'J>[+'Z.#1
M'\6K%'M50#137OSRQ/RV7NE/0_H\\Q<)\@A[A"?(ZF=R
M
M                                               "NK7CM1M*FSO2
MQ0C.3O*7Z8S2ZJABQGC%K99)/KV$LZ],IEC@VO<CBS2SQHE59<38>K6DF*S;
M#+$I9]Q)]"Y-/235-NCLNIMKL$6HJX::S26JY=I-DL5$8E     %;>U/\W#'
M_P </1+\Z3%HE4GOJ^T=W*D6L]Z3V[.Z0LD$4E        !FKZ4S]'WA[XX^
M/OS)ZA!FCH*\[:C\G2>.IS _I#>9=+^5(_$5)@=&UYIL
M!Z5.P"^B0TF?CW^<QF4:7=+/T@8A_$?%H3?'H8^C7#?OCXU.7&C')E
M #(%TU;Z++ ?Q_\ %GS==50 N^V*7T1^SE^*!@_VDM8 L_    !D$U?>='GW
MW59E]V5(V1U;^8*/R=G<H?E3]*K]9+7C\YJ_Q[R.0O1@$
MF-L__/!PC_+C[[3I&.M:X^;55[1O=M-L?09_6MU.\MJ?B%6:PAKR?IY
M            \?O(G]8$Z_IC)_NVN'H=1_<D7\&WN4/,BN^[9OX5_=*<-$DB
M@              &B/HQOTC[W\6K)WMJQL,/]-OF:WRV+N9#-W0!Y]/\@E[N
M(]!,:D&Z8              !3EM_?HD-6?XB/G,8:&1NB;Z0,/\ X_XM,8OZ
M9_HUQ+[W^-0'FK#=$T.                 WQ=%F^C[S#\<?(/YD]/8U0Z=
M?.VG_)T?CJ@W)]'GS+JORI)XBF-*@PN9X               ,0/2M?."TH>X
MW-/;L4-G>@;YHK_*6=P:E>D9\]X;Y*_QAE'&>C7,                #UTM
M.OF^X*]QO&/M)9!Y\XQ\[U7E,O=N/2W _F2C\EB\6T[D%N+H
M   >=UTDOZ3F4^XYB/[DKQM_T,>9#/*9>RAI%T[^?\GDL/<J4'#+!AL
M          [DTZ^<%@KW8\8^W9D%MQCYHJO)I>X<73 _GJC\JB\8T]=(>?1Z
M6@
M                                 8Y.EH?W O\ %3_RX#8OH!_K;[U_
MI!J]Z27]2_??]%,<@V,-7P                /4]V6/T<&B/XM6*/:J@&BF
MO?GEB?ELO=*>A_1YYBX3Y!#W"$^1U,[D
M
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M(U-;:BQ;5_!TFU\-3F"/2%5RZETMY+$_"D>W\!4F%0;6&G(
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MA!MS:38R)29XD1L-ZW@*$7J$SNN<;+:WVFW5IX/K?BF&=&CYG22SXC+5R4E
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M0=]^4?(_[X$=]C!=9RN 7I.3PH.^_*/D?]\".^Q@NLY7 +TG)X4'??E'R/\
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M)ZG^K4;%= 2-3\+6+;]R_P!(-8/205R_@:\EGW7M^2F1 ;%&L(
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MV7-G71*\;PJRM*%'<=1V6$7<-3U=[N;MO^D<5L1<BVH<VJJIE2Q3[8^'T
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M     9!-7WG1Y]]U69?=E2-D=6_F"C\G9W*'Y4_2J_62UX_.:O\ 'O(Y"]&
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MT6;Z/O,/QQ\@_F3T]C5#IU\[:?\ )T?CJ@W)]'GS+JORI)XBF-*@PN9X
M           ,0/2M?."TH>XW-/;L4-G>@;YHK_*6=P:E>D9\]X;Y*_QAE'&>
MC7,                #UTM.OF^X*]QO&/M)9!Y\XQ\[U7E,O=N/2W _F2C\
MEB\6T[D%N+H               >=UTDOZ3F4^XYB/[DKQM_T,>9#/*9>RAI%
MT[^?\GDL/<J4'#+!AL               [DTZ^<%@KW8\8^W9D%MQCYHJO)I
M>X<73 _GJC\JB\8T]=(>?1Z6@
M                                                        8Y.E
MH?W O\5/_+@-B^@'^MOO7^D&KWI)?U+]]_T4QR#8PU?
M]3W98_1P:(_BU8H]JJ :*:]^>6)^6R]TIZ']'GF+A/D$/<(3Y'4SN0
M
M                                                         5B[
M4K9P%[2W$6.\5&9COPOWA9++R%5^LQ_;D3KL7;&'^.&,U&NLU@_$+[^O=#K5
M7&#Z6\%6RI-V_P!]9*I*KFKU?=O6I9LV>LI$JZ7G3$9>NV+;L6^NA9T(I+
M   *V]J?YN&/_CAZ)?G28M$JD]]7VCNY4BUGO2>W9W2%D@BDH        ,U?
M2F?H^\/?''Q]^9/4(,T=!7G;4?DZ3QU.8'](;S+I?RI'XBI,#HVO--@
M           /2IV 7T2&DS\>_P YC,HTNZ6?I Q#^(^+0F^/0Q]&N&_?'QJ<
MN-&.3*       'PI+_P1;_NW\;('U-DXO[4^Z/AR     ,@FK[SH\^^ZK,ON
MRI&R.K?S!1^3L[E#\J?I5?K):\?G-7^/>1R%Z, @              $QMG_Y
MX.$?Y<??:=(QUK7'S:JO:-[MIMCZ#/ZUNIWEM3\0JS6$->3]/(
M      'C]Y$_K G7],9/]VUP]#J/[DB_@V]RAYD5WW;-_"O[I3_6-[K;,AP*
M^^ZVRRR:1:Z^^ZM+;;;;7Q#6ZZZZNY2VVVE-VM:_4"LRT<O\&[N5%#DK857P
MK.Z0T:=)Z*95FTAP.DD#FJ:6 [2?BU+('5N;['AP:&D_.N?*.2](T7K6ZQR6
MHF\VXXI-<H3T/NI;;4RREV^IASH065NIE4Z%J.E2OE5J*MB*N@@L15L6Q%7(
MJV+9F4SEZ0"1/UZHVSN5L*X;"CE1+RM;SBHM5&VI:J)E1+4MV+4/J2+H^4%U
M,)V#)VS&UJ82RMAIX86I6[(LRRAX032)N5J2PMRM<C,>P&0*4YRI39<;<WNS
M.QK6ZZ^I!G"ULH96G#TN56"*^AUWPRJI\2:]4186HK'I;DLTDC4R)DO,>]';
M*6;!4GZ%:/'VLQ#4#%:2IPMS$5R3O<CV+9EMT<;E2U<MU[(W-V%MLM/WZXY[
MIWV;&S"7;*[#&:8YGW4#F[("7(>I.60=2B6Q:&TL<HH[N*+AT2U=8SNSBFQ^
MP,Z1L.,-7&MI"M<JM1\82DF<=5Z3&-=->$U[Q*F?2812PK'3,>BHY^1Z(N5$
MM1%DD>KDL:CE:UMZQRISUNK,#U#Z/UZ.\*JXZW&JN=)*I\:HK&96.5,BK=54
MCC8UJJKE:CGNNWFHL&\G[+G$<$V3F-]H8UZGVI]R+,':/%+<4T2-MK&K-D$F
M[W%^/HTJ*47/IF1(&G,JXN_&+:)JI4:JTLNVEI)Q_:*'7G$*K7Z;5"2A<RCC
M:ZR6U;R76WDD<G:Z.3M669;5;:NRB=1Q#H]PVCZ-X-=H\0:^NE<VV&Q+JWGW
M5C:MM[2Q]L^W)8UUB9$590078>80UJ83Q!D+9T:UL;3*>G0IHLSCC7/3@JBK
MZP3JB8D^0*$C-"(W*I;$4258<8G*0+6Q>G-+)M/(=5)1E+A8JKI/Q/5K$ZBC
MUQPR:.D25=!) B.:YEOL457N:QZJF57-<U4ML6-JH=AH^B3"=:\)I:W4?%H)
M:Q8F\XBJ%5CFR6>R5&QM>]B(MJ(US'(J)>21R*2/D[7A/8:[/G5+@!7GB!YJ
MUY:T&'O!D46Q>XVNC'C6*VL<BB%BYRHIHF>VA%%FF9R!0D7.25$J=G96002@
MM(2JE%EF@DQ/I0UNH<6;22TVJN&OTC72I8Z1UYK[$LM:JN5D:*UJN1C$55?:
MYJ%\J(\)Z(]2L1P5U9#5ZXXJS1N9$MK8F77,M6VQS48U\BHYZ-5[W(B,L:YR
M48[,/2[&=5FK2)1C)3D@8\&8M8W[/>H=^<U'%D#5A3%5$;O++59E+;S;4[\K
M4(VDR\NVMY-CA4VE*\&,HZ[XY/@.K\D]$U78I.YL%.U,JK-+:C+/:I:_=NV;
M9B+H_P!7J?6/66*GKW-9A%.QU14N5;$2"&QS[=QRJUF38O6[1;?HEUK0C5]M
M8]0>?9ZY8X@>3)'@W)<(V<IF92$Y>+,1Y'8K6]JP,U.Z<FRB) Y)HW:L.,NL
MI98>N5KK4MM%BE)8,?ZS:M56KVH-'A-(V:6B951OQ#0^^RQNM6=4VU176(F9
MJ,O>Q:XR5JGK72:S])%;C-8Z"&ODHY8\,T_O,,K;$IT<FPBHV\JYW.?=]DYI
MSC; .64VS9X8NA6TGG&%\@;1Y/J*7.F-K\8$PDF<Q73Z;&C>N:7(ED,9V%K2
MLSB[F7&E6IDI*=5<:V74H:I3+3+8O1XR@?KA/4ZEQ5,.IJT:))I;]QU1>R+'
M?5RJJ)D6U55+'[#7-0F=)TF(QZD4])KY-23:])7*L6BT>D937<J2W&M1&J[*
MEB(BVQ[+FO4CGT8WZ1][^+5D[VU8V%YZ;?,UOEL7<R%BZ //I_D$O=Q'H)C4
M@W3               *<MO[]$AJS_$1\YC#0R-T3?2!A_P#'_%IC%_3/]&N)
M?>_QJ \U8;HFAP                &^+HLWT?>8?CCY!_,GI[&J'3KYVT_Y
M.C\=4&Y/H\^9=5^5)/$4QI4&%S/               !B!Z5KYP6E#W&YI[=B
MAL[T#?-%?Y2SN#4KTC/GO#?)7^,,HXST:Y@                >NEIU\WW!
M7N-XQ]I+(//G&/G>J\IE[MQZ6X'\R4?DL7BVG<@MQ=               #SN
MNDE_2<RGW',1_<E>-O\ H8\R&>4R]E#2+IW\_P"3R6'N5*#AE@PV
M       =R:=?."P5[L>,?;LR"VXQ\T57DTO<.+I@?SU1^51>,:>ND//H]+0
M
M                              ,<G2T/[@7^*G_EP&Q?0#_6WWK_ $@U
M>])+^I?OO^BF.0;&&KX                'J>[+'Z.#1'\6K%'M50#137OS
MRQ/RV7NE/0_H\\Q<)\@A[A"?(ZF=R
M
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M%IFR)I;I<W,$O:R'=M1R- Q/<D9DCP0F46VGEI5ZPFV^E:6&WT^NJ/IWP
M #()J^\Z//ONJS+[LJ1LCJW\P4?D[.Y0_*GZ57ZR6O'YS5_CWD<A>C (
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M/D'\R>GL:H=.OG;3_DZ/QU0;D^CSYEU7Y4D\13&E087,\
M&('I6OG!:4/<;FGMV*&SO0-\T5_E+.X-2O2,^>\-\E?XPRCC/1KF
M        !ZZ6G7S?<%>XWC'VDL@\^<8^=ZKRF7NW'I;@?S)1^2Q>+:=R"W%T
M               /.ZZ27])S*?<<Q']R5XV_Z&/,AGE,O90TBZ=_/^3R6'N5
M*#AE@PV               =R:=?."P5[L>,?;LR"VXQ\T57DTO<.+I@?SU1^
M51>,:>ND//H]+0
M                                             ,<G2T/[@7^*G_EP
M&Q?0#_6WWK_2#5[TDOZE^^_Z*8Y!L8:O@                >I[LL?HX-$?
MQ:L4>U5 -%->_/+$_+9>Z4]#^CSS%PGR"'N$)\CJ9W(
M
M                                                      "MO:G^
M;AC_ ..'HE^=)BT2J3WU?:.[E2+6>])[=G=(62"*2@        S5]*9^C[P]
M\<?'WYD]0@S1T%>=M1^3I/'4Y@?TAO,NE_*D?B*DP.C:\TV
M    ]*G8!?1(:3/Q[_.8S*-+NEGZ0,0_B/BT)OCT,?1KAOWQ\:G+C1CDR@
M    !D"Z:M]%E@/X_P#BSYNNJH 7?;%+Z(_9R_% P?[26L 6?@    R":OO.
MCS[[JLR^[*D;(ZM_,%'Y.SN4/RI^E5^LEKQ^<U?X]Y'(7HP"
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M5KYP6E#W&YI[=BAL[T#?-%?Y2SN#4KTC/GO#?)7^,,HXST:Y@
M     >NEIU\WW!7N-XQ]I+(//G&/G>J\IE[MQZ6X'\R4?DL7BVG<@MQ=
M           #SNNDE_2<RGW',1_<E>-O^ACS(9Y3+V4-(NG?S_D\EA[E2@X9
M8,-@              '<FG7S@L%>['C'V[,@MN,?-%5Y-+W#BZ8'\]4?E47C
M&GKI#SZ/2T
M                                         #')TM#^X%_BI_Y<!L7T
M _UM]Z_T@U>])+^I?OO^BF.0;&&KX                'J>[+'Z.#1'\6K%
M'M50#137OSRQ/RV7NE/0_H\\Q<)\@A[A"?(ZF=R
M
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M_*7C_P <HYW2#F-;X&7W#N(?W U\_$F+_P SJ/M8YV<5^4O'_CE'.Z0<QK?
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M/O,/QQ\@_F3T]C5#IU\[:?\ )T?CJ@W)]'GS+JORI)XBF-*@PN9X
M       ,0/2M?."TH>XW-/;L4-G>@;YHK_*6=P:E>D9\]X;Y*_QAE'&>C7,
M               #UTM.OF^X*]QO&/M)9!Y\XQ\[U7E,O=N/2W _F2C\EB\6
MT[D%N+H               >=UTDOZ3F4^XYB/[DKQM_T,>9#/*9>RAI%T[^?
M\GDL/<J4'#+!AL               [DTZ^<%@KW8\8^W9D%MQCYHJO)I>X<7
M3 _GJC\JB\8T]=(>?1Z6@
M                                                    8Y.EH?W
MO\5/_+@-B^@'^MOO7^D&KWI)?U+]]_T4QR#8PU?                 ]3W9
M8_1P:(_BU8H]JJ :*:]^>6)^6R]TIZ']'GF+A/D$/<(3Y'4SN0
M
M
M %;>U/\ -PQ_\</1+\Z3%HE4GOJ^T=W*D6L]Z3V[.Z0LD$4E        !FKZ
M4S]'WA[XX^/OS)ZA!FCH*\[:C\G2>.IS _I#>9=+^5(_$5)@=&UYIL
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M%DNP]^E4T??TRF7YJ)\.F=)_F)B/\$SQL9WOHD^D7#/X5_B9#TVAI*;]@
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M6G7S?<%>XWC'VDL@\^<8^=ZKRF7NW'I;@?S)1^2Q>+:=R"W%T
M    /.ZZ27])S*?<<Q']R5XV_P"ACS(9Y3+V4-(NG?S_ )/)8>Y4H.&6##8
M             !W)IU\X+!7NQXQ]NS(+;C'S15>32]PXNF!_/5'Y5%XQIZZ0
M\^CTM
M                                     QR=+0_N!?XJ?^7 ;%] /];?
M>O\ 2#5[TDOZE^^_Z*8Y!L8:O@                >I[LL?HX-$?Q:L4>U5
M -%->_/+$_+9>Z4]#^CSS%PGR"'N$)\CJ9W(
M
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M\1'SF,-#(W1-](&'_P ?\6F,7],_T:XE][_&H#S5ANB:'
M  ;XNBS?1]YA^./D'\R>GL:H=.OG;3_DZ/QU0;D^CSYEU7Y4D\13&E087,\
M              &('I6OG!:4/<;FGMV*&SO0-\T5_E+.X-2O2,^>\-\E?XPR
MCC/1KF                !ZZ6G7S?<%>XWC'VDL@\^<8^=ZKRF7NW'I;@?S
M)1^2Q>+:=R"W%T               /.ZZ27])S*?<<Q']R5XV_Z&/,AGE,O9
M0TBZ=_/^3R6'N5*#AE@PV               =R:=?."P5[L>,?;LR"VXQ\T5
M7DTO<.+I@?SU1^51>,:>ND//H]+0
M                                                           ,
M<G2T/[@7^*G_ )<!L7T _P!;?>O](-7O22_J7[[_ **8Y!L8:O@
M       >I[LL?HX-$?Q:L4>U5 -%->_/+$_+9>Z4]#^CSS%PGR"'N$)\CJ9W
M(
M
M            "MO:G^;AC_XX>B7YTF+1*I/?5]H[N5(M9[TGMV=TA9((I*
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M4<WFE8C7K<C?:U%M1+)&/1,NVB(I.'T_NUO^%G[Q&F?^QH=8_P )NC_\7_\
MCU/VX[;_ (S])7XR_P#IZ7[06,=(/VF\QFN3$.F[3!JAQWD?25DG3S"'#*3%
MBQ5B')# YY$*RKD)<M0K\BL[4_RED=2&:.1XXYM3.Z6TLJA5]Q-.,&5-Z=T1
MZD4U-1+C..4,T.L$-8](G2I+&Y(]%&B*D:JUKDM=(B.5BY;<N1+.\]->O]55
MUZ8%J_B$$^K4]#&LK85AE:LNFD5465J.>U4:V)5:CTL2Q;/9+; #:)Z=-F#B
M?2AI.G6C+4$;DW.\S3M-F68M29-<G7FM"R('N;_)IO%T5]RK$<F8YB2G0)68
MRPGC"98;=6AM4O&#>VZGXQKQ7X_7TNLE)H,*C5=$ZXK4M1]C6L<N25KF6N5^
M6Q438O6)TO7C ^C_  W5O#:S5:MYQC$J-TS+Z/6ZK%5SY&)EA>U]C48MEJ.7
M9NWET%Z,<3Z%='>AZ48@P;M3]$>(-6V;F-NORYJEIE/#,^>6(U5;?>=%\>QY
M7F:"JFE!$FY8:E:U1RRE]B^\YSO34/,*)38CUDK]:=8M9X\1Q3 L3J-7Z5RZ
M*ET4T:.L^ND<D+T57JB*Y$3M;&(ZQ%5V:M5<-U0U7U2DPS"-8L)I=9:MB::K
MTT$CFV_61M6>-6HQ%5&*KNVMD5MJHC:#M9&R[TB:>-/V1,W8TVN.F_5+D2,*
M(N8UX7@Q.-+II.S9--X]&WA0W*(]J2R(]WFQ]K>U#PINM:E.^3H3=_<7;6IM
MF5]7->=8<8Q>'#*W5^MH:-Z.MF?I+C+K'.2V]31M]DK48GLDRN2RW8,-:T]'
MVK."8+/BU!K+08C71JRR"/1:22_(UKE16U4KO8HY7K[!<C5MLV4ZBV34BP'@
MW(N8=:F<Y5!;G#2+C0^:8*PU(I VHI1F;4#*[7./XT21J.'KDSS(&:&+R3%[
MJI0%'WLU]Z-69O;+=VMPU_AQ;%*.GU:PN.6YB$]R>9K55L-.RQTBN=8J-5Z6
M-:CE2_[)J92V]&\^#81756M>+R0W\,I])3P.<B/GJ7VMB1K55'.:Q;7/5J+<
M6XY<B$J]EQJ\CLH2;0N!95U5)=)FK+6@EALCQYK5E"DMJ3,<C9YF]R>>Q)UF
M_&VV_'*6<V.]A5BXE0C*3D<(9898I1-Y=]AUYU>F@=A%704"XA@&&J]LE&U+
M5<U6-;&]&6+I%99;=5%55L145KGJG8NCW6:"H;C='B.(IANLF*HQT=<];$:Y
MKW/D8LEJ:))+UEY%:B):J*CF,1?E[8_4)B>6X/T1Z8V_4LT:XM0.G9HR69F3
M5<R*S'IK>;9D\H5++"&^9U4.!<^L:TJ(LFYRHL5W&$-R<\TVJI8JL+J='.$5
M]/BF)XV^B=A>$5CH]#2N2ZJ7$5'/5F31VJJK=L3*Y41+K6VT^E'&\-J<(PG5
M]E>W%\:H6RZ>L:MY'7W(K8T?ETEB(B7KRVHUJJMYSD2,&P]^E4T??TRF7YJ)
M\+YTG^8F(_P3/&QG7^B3Z1<,_A7^)D/3:&DIOV                !X_>1/
MZP)U_3&3_=M</0ZC^Y(OX-O<H>9%=]VS?PK^Z4X:))%               -$
M?1C?I'WOXM63O;5C88?Z;?,UOEL7<R&;N@#SZ?Y!+W<1Z"8U(-TP
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M"P5[L>,?;LR"VXQ\T57DTO<.+I@?SU1^51>,:>ND//H]+0
M
M                 ,<G2T/[@7^*G_EP&Q?0#_6WWK_2#5[TDOZE^^_Z*8Y!
ML8:O@                >I[LL?HX-$?Q:L4>U5 -%->_/+$_+9>Z4]#^CSS
M%PGR"'N$)\CJ9W(
M
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M_>,?U;?OIA\F?"\ ^4_@N$?O&/ZMOWTP^3/A> ?*?P7"/WC']6W[Z8?)GPO
M/E/X+A'[QC^K;]],/DSX7@'RG\%PC]XQ_5M^^F'R9\+P#Y3^"X1^\8_JV_?3
M#Y,^%X!\I_!<(_>,?U;?OIA\F?"\ ^4_@N$?O&/ZMOWTP^3/A> ?*?P7"/WC
M']6W[Z8?)GPO /E/X+A'[QC^K;]],/DSX7@'RG\%PC]XQ_5M^^F'R9\+P#Y3
M^"X1^\8_JV_?3#Y,^%X!\I_!<(_>,?U;?OIA\F?"\ ^4_@N$?O&/ZMOWTP^3
M/A> ?*?P7"/WC']6W[Z8?)GPO /E/X+A'[QC^K;]],/DSX7@'RG\%PC]XQ_5
MM^^F'R9\+P#Y3^"X1^\8_JV_?3#Y,^%X!\I_!<(_>,?U;?OIA\F?"\ ^4_@N
M$?O&/ZMOWTP^3/A> ?*?P7"/WC']6W[Z8?)GPO /E/X+A'[QC^K;]],/DSX7
M@'RG\%PC]XQ_5M^^F'R9\+P#Y3^"X1^\8_JV_?3#Y,^%X!\I_!<(_>,?U;?O
MIA\F?"\ ^4_@N$?O&/ZMOWTP^3/A> ?*?P7"/WC']6W[Z8?)GPO /E/X+A'[
MQC^K;]],/DSX7@'RG\%PC]XQ_5M^^F'R9\+P#Y3^"X1^\8_JV_?3#Y,^%X!\
MI_!<(_>,?U;?OIA\F?"\ ^4_@N$?O&/ZMOWTP^3/A> ?*?P7"/WC']6W[Z8?
M)GPO /E/X+A'[QC^K;]],/DSX7@'RG\%PC]XQ_5M^^F'R9\+P#Y3^"X1^\8_
MJV_?3#Y,^%X!\I_!<(_>,?U;?OIA\F?"\ ^4_@N$?O&/ZMOWTP^3/A> ?*?P
M7"/WC']6W[Z8?)GPO /E/X+A'[QC^K;]],/DSX7@'RG\%PC]XQ_5M^^F'R9\
M+P#Y3^"X1^\8_JV_?3#Y,^%X!\I_!<(_>,?U;?OIA\F?"\ ^4_@N$M[TZ\_?
M,O!/TG^;_GXX@X<XG-9UR[P.N/7MSZV][G7C_P")<6ZP<4X7A?5XQPFY];N"
M'+H[ZZ*W1[5NR38M)HTTMFDV[-@[K%,J
M                                                           9
M NFK?198#^/_ (L^;KJJ %WVQ2^B/V<OQ0,'^TEK %GX
M
M
M
M
M
M
M
M                              R!=-6^BRP'\?\ Q9\W754 +OMBE]$?
MLY?B@8/]I+6 +/P
M
M
M
M
M
M
M
M!D"Z:M]%E@/X_P#BSYNNJH 7?;%+Z(_9R_% P?[26L 6?@
M
M
M
M
M
M
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MER5K1&.\BD&DEO:&VQ8YKB4Y53CK*&'G6%V[M]]M*RVX= ];K)V*Y=I$1?\
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M/+*&8MQ&,8NW1;("/&KC!E6;L?X6.<9"S*\HN,K7.?75Q?C2S4[PA)NX%+_
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MJ53KZ+E7)NIM6%QH7Q+2MN*F1N7J[=I4QLT)[BWT^&OIATNN[5)=/60\6/\
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M7%"F4<(;QA$V*4MR8B_=^O))MKN4W=RD*=Z/F<]O:JY5X2; QT<+&.[9&HG
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M:+V4.6+_ ',WVZ=A3@V,.DRZ$(5C7'D-=<3:MU#G$H-$HRXGM\#PX:@/7L+
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M;4R]GJECJH)$I^=3^_O>G62Q<G8ZAZ!PZX=D
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MQNZJ=DGML\?,!T-?$\TS?F6A(CU/W3)[=W94D4WW-'[1O80F&*!7
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M1Q7#755KI="D,=C&HEBV;*E%M##IEFDM>Y5M2W83U;I;J(9-
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M4FLMN./,NM**LL*)M+)+++LARS23OOR+:XF10QP,N1)8TD.*95
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M)R;;S3+C#+MS?FFWW&7UNONNNK&<YSW*YRJKE)+6M8U&M1$:FT<O'$Y
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M:6W6WUZ>H?3/62.Q55+,O6ZF8H5%.RI8D<BJB(MN3K[BYR; H%<
M
M                   ,R'2M](FI;6CL[\-XNTKX;F.;\@L&L_'<_>8G"$J9
M8[-\-:\'ZBHZX2$\I4J264;TCW*FY-?=2ZMU#%=GJ;E:UH!;9LHL83_"NS4T
M-8DRK%G2#Y(QSIDQ)$)Q#WLLLIWC4F9(FWHG9F<BR33BK%B%65<692V^ZE+J
M?5J + P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MN[=L,*ONMK_VCBYJM56N2QR')KFN1'-5%:IR0?#Z
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M.+.#>ILN*4)C:6'IS;:V&66W4K04'L?&ZX]%1R9RNQ[)&WV*BMSH=CCB<@
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MJ:&58]+=71Y]HIZ:))-$KDTF:W*2 %,J
M
M
M
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M32K/*LKLBJ58(FP1)$W*B?NDE12*H
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MA(MNNWA9=MM_H>]4#IF]M8Y=[8[!U^O[]7MA=VMK4WUR]DTQO&QJV:3K; .
MTHX^CY^-Y!&I$PKHS<],R]Q/C"M,K3-\S5D.E3I\T.=$M"UY+U5=QNRZZM]W
M"5W]+6E=5);[-5M3U69NL75:&E6SV")8OJMS]<L[$0E@      4?2_8A8LE^
MTG;-H6KS1,DMB+(<3R^HPV1'TW!*<E0HMD-9%Y&0J/Y:Q+$[W9A)5J6JYJ.O
M.WUY%%5B>[@Z3TKWI2\VNIL66[B[A;W4#'57.;R[*+9NINEX(@%P
M
M
M
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MST_+7Y]1GI$#<DO35,XLH,,4E<&44HIT=%SJUSELC3?M.=;6I2V,:EZ12O/
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M;%MZBH<H,3>LJ15+4:JKLI:EG5135X+.7@
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M=NIPEI):5%8?4NZM;RK;M\7,7#*=Z60R+?3=1>P0DQ2H8J+-&EQ=Q4[-MIK
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MRVQKL+ZRD^CK&U352RR1-E/70MW$(F@
M
M
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MJI+4ZEUZ<BZRZ8@QDU(E398^Q%ZR[7"6K#Y'PU:TMMK%54ZZ6Y> V^BPE_
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M7[E-\<I4G77WU_TW75%FD1$D<B;%JEZ8JJQ%79L0[+' Y
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M(??7_2.6)HB5:V;:(?,,55I$ZJ]DHVVAO_F2L!?&/V?_ -V,1B?3?-;O:/\
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MN1MKDZUIMZ%A+^
M
M
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M9BV:P:/N,E6Y<PLY)&5J>9*RMK<[+U+='UJBRQ,8;OB$]]]/K:4K6^8G-%)
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MDQK=B4]+&D!A9"!:KO57)R"J;IUUI.[9<9(L,<_3N>F5;51%];9+='+B;6)
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M+(Y4V+5[)=6(J,1%V;$.S!P.0
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M#V,:YJOL;DM2W(F8LM-#*W$7O<UR,579;%LRKDRFO 68O0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M"B5:!S:75$:0=9=2ME;K-\7=>7=9?=]EB?"]8Y$L<A\BE9,Q)(UM:IWD*94
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MJDYJC%O7KR+M6666;NZ0Z2KYTKTNW;JIMVVVV[B9BV(0R8
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MW4K:==6I/#%V&7VUWTTT<39G)WMVQZV^4&5,,DKH6KWQNSZ^\34% K@
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MLHBBGFYQ"V:RRVW)L["JGK'<6H#*Y.!\#9MSBI9#9,GPSB/).5SXX0OL:CI
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MTRU*H2K4QI5WUMQ1E;-^3>85=89=;)(W1/6-_;(I<XY&RL21G:JAVR.!S
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MKWQNSZ^\34% K@
M
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M\J$5];#-[6EYHD;2TKJMZ95V.I]5>P66M5U55-I&+D39ZOU$X5.YNCJZ@9;
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MF:VI$9CFJLH:JN.,IOA5=/*^-(G.58V["%%L$+)%E:U$D=LJ2@%(K
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M';2=1/7+-C':Q]5?6-:XLQ>0 (X:QO-$U4?%PSA^;*3BK![^SVZ=DI3^\/\
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M"JZ>5\:1.<JQMV$*+8(62+*UJ)([94E *16
M
M                                                  ,V_2C/,!Q!
M\<. ?F6U BZ83]TN]HO90M>+_<S?;IV%(;:9NC7X)SKIOT^YN=]2.6V)VS'A
M'%&571D;8S#E#<SN.0H&PRY:U(#U5E5)R)O4N]Q)5YG\)<792MWJUJ*\N*21
MRNC1B*C7*FRNTMA0BPN.2)LBN=:YJ+M;:6G2.T;V F&=$VC/,>IR*9]R=-7_
M !GS>\0C,ACT50L[GWYY4@^/E7'%3;;1:5Q-%*S%!>\_UC2K:5^MK4<Z;$7S
MSMB5J(BV\"*I3JL-C@@=*URJJ69MM40MKV:?_EW2/BX:Y?SD:BQ#JOG/_+9V
M&DRE^;/\A_9<4A[('8^PC:+:6Y]DK(NH3+T 98GG6406/X\@UC1?&B9$UX^Q
MC(C9XO*?:N*12YKR)42C,L(2I3^!;R]U3=2MMI<^MK74TJ,:UJJK;;5ZJY"!
M143:J%7N<Y$1UEB=1,I9ILULJ:D]".TNEFR8SQEMZSSC&3Q5QE&!)E)#G"]S
M9[VV&+LF)#&8EQ<7Y<R,3W%FMV3.+.8L.3)'9OM-1F4LO-JJB53(JBE2LC;=
M>BY4Z]GJ4ETKY:>J6CD=>8J9%ZUO'D(Y=(]U81C).?\ 3[H),R(G@V-X<_QG
M(FHF9T2.K^WQ-YFAI;3&S7=@C:)SD;DHQSCI>M?#$25,I.6%/B>A1=QUE+15
MPR%61NJ++7JEC4ZG&N3K%+%)D=(VFML:BVN7J\29>N2^U1;1'8GYVT)S#12Q
MZFF]@BR?%#1"L35-P)J0O)A;_CUM0UQ<ZV&6X6H878T.[(CHKN*WABA)<>56
MM*&W;M&*FKXZA)U9:MMJY6Y;=G;*\U3024ZP(^Q++$R.R6;&T?GZ,]K)YT=/
M,UTBRYVN43+3VNOD\ +5GFFJW'$$S<SCE*-/4WA+S"H/-E)Q5]:WVVDI7=$2
M7;2POU&*07)$F;VKMGJIQH?,*GOQ+"[MF['47B7LD^-=.FK8WY;S.@E.O20Z
M?6C-I,%8VA"GR7JL><(R0V!I'1_4,*BD1:\Q0$E8WW.BQPM*7WHKS#JV7%<-
M=:3;99'IY:UC+*=':.W:;;EZMBDFHBH7R6U"MTEFVZS)U+4(>(M#/1HJK4E$
M<OT>*EE52>B1-Z0.4+^,*:FV4((XB;J4/*6<,;N6\%=9?:9N[VMM:5W!6YQB
MF9_N/_A*"4^%6Y%9[O\ ^(T?"V%T(_ZJ=0L1TI:=LOZAIM<5<Q8KA3M)+&XQ
M26D,D+[851)%HFB4&_P9;E+9,J2-J:MWUM#U5N[N4W:BI#$Z:5L;=E5*<TK8
M8G2NV$3U)US'#L5-<VBG F2=4NK[7%J&3L&IC.<I7-38B.Q?F&8."6-/;K9.
MY[)NN\&Q]*V)*GF\M5HTY*.BNQ0E+8KM\7:4<56Z]UU//(UD-.VV)J9T3<39
M7:3LECH*B"-[YZAUDKES*NZNPFVO8.(:T=?.DO'6U9P7M$-#66.<9L>.M?Z1
M\2:X+DJ 7G];B4\)E^^(GL-AB1VYP\9KK:$\!:KX!Z:[UBC<,,)K=R@IYG4C
MJ:H2Q?K5M1=W:5=A> XSU,+:QM33NM3ZY+%3<791-E.$U8;1C7 ETKZ I_JM
MQ:L;).Z/45B16%'2J>J]C<WK*9[8CALI,3G6EV+&AL:W:KSP)M+;5127@:[E
M3-P6BFI]-4)"_(B*MO6V>(O%54:&F69F5;$LZ^QQE$NE?8>Y$UKX8QWK1U5Z
MV,\$9]S7&T&6(.XQU86['0:/31+8]0]0H>GU;<YJ#G&/+$RSB35<R)&XH^U&
M3OK":&77":O;!(L$,;=&U;%W;-GU92WPX>Z=B3S2.TCDM3<MV/4EA^OHM#<<
MT2C:.-*E<:YJ&M_TY-Q[D?;?:<X'(G'4JF-7'6F'*+[35=Y53+J7&&5I6[U;
MKOJU^8LMJ1+[;_-&$9%E3=;_ )Q]_HJBY:KQWK1XVK5*=_/<0+KN,*#3M\M6
ML<_XZKNX2^[=5*^+E\*9_KF;RW?5KN4W/F+]M'U%]8^X/VLG53USE^3CSBNE
M*:=BRCC2[%.$WLA3869?98H)MTQYT4VDGVVUI0TJU0G+,I;=NTI?9;=]6E*T
M^-^:7>V_SD.3_G=GM?\ -4X-MC/IN=DG_333)\[<P<J+[@FZCNY.-=]WP]5O
M='2/2=-)6.(1)L<ZPFIZFZC)F;)4EQU*F-Q=&0^"M[) X$F)9U4=:R(ZE?D3
MFIM1654W'N:HB^ZMU;"BZU'/"IG.:L*V76I;NY5*>+0M:J3I;?<MFYD0O_T
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MV=.D)YHU"93RGJ'G6'-$N*9I?C_%^(\=JJUM=KZEVKFVY0V+BR8^J=[X_P
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M?\X^_P!%47+5>.]:/&U:I3OY[B!==QA0:=OEJUCG_'5=W"7W;JI7Q<OA3/\
M7,WEN^K7<IN?,7[:/J+ZQ]P?M9.JGKG+\G'G%=*4T[%E'&EV*<)O9"FPLR^R
MQ03;ICSHIM)/MMK2AI5JA.692V[=I2^RV[ZM*5I\;\TN]M_G(<G_ #NSVO\
MFJ<&VQGTW.R3_IIID^=N8.5%]P3=1W<G&N^[X>JWNCI'I.FDK'$(DV.=834]
M3=1DS-DJ2XZE3&XNC(?!6]D@<"3$LZJ.M9$=2OR)S4VHK*J;CW-41?=6ZMA1
M=:CGA4SG-6%;+K4MW<JE/%H6M5)TMON6S<R(7_Z -DGIQV<4MR%,L(37-LI<
M\E1UIC+Z1E61P1\0)$#,Y&NJ4YI*B.-X,H(5F*#JT,N.-/LK9N4I9;7U1;JF
MLEJFHV1&HB+M6^NJERIJ.*E571JY55-NSUD0M&$0EGGT[)_0%D#7[E36-""=
M2$\P3@B)2N(K\SQW':U<2^Y5=7M^RPFQXTG)*JDT>O;6!*W/YIBEP+76IS%-
MEA:,RI]YR?L=94-IV,==1TBHMENUL6^L=;HZ9U2][;RMC14MLV]FSUR><)QG
ME;8E[4_2=I^QWG6;9/TMZP'6*PU9!YBHK:6E6S68VXYL-7L* VD?*D43D[FW
M.*-Z0ID1IZ0\Y&870KAN&CN>ROI'R.:B2LRVIN);PYB0UCZ"L9&URK"^Q+%W
M5LX,Y.CI!.OO)NFJ*X/TWX>R"JPV^:B5KVKR/F9MM>*/N/,8LCBPLI]\?/CI
M"J1(E3LL>E!ZI2V%W.A*1LO*2TJ:II6V/AM.V5SI7I>1NPF=21B52^)&Q,6Z
MKME<R%!V76W9JZ?,=J,Z:"]JKJ4>M;<7-:7VIS_ \PQ5GRPXVN:'K^WHW"N%
M(P;&;E9%YZJTE_?7M LH5Q-56ZPZXZVXL6JD=HZB%F@7=3)P]A$+<]*6)NDI
MYG\X3<5+>#LJI.':C:V\IYMV:&RIUG,[JJ@F83\O2"4FO4?+L0EH<I8G+D,-
M<)4TMIQ9J,E$OE$34K4R4VPXBQ*JX"[A2ZW;^A20,CJIH%RLLLZRY215U#Y*
M2&=,C[W"F3UCL[4]L)LBXDTWY9UFN^NC-TRUAXBQQ+LWR:8GN*Y*U.9T*9E4
MTE;0P22YWNR"W+2FQM56(G"KCN&J+"[JI2;;MY9PBQ!KY6P)&U('*B6=7)U#
MG-A[F1.G61RSM15MZF5=TXAHOV?&9-M'@ C5/K+UQ9J7*+75SQ[C6%1="RDL
MD:-QX4C;"I6\-Q]"(ZK<G1RNN.46(6]$L4WV5/.7WFG5M)^SU#*&3101MSJJ
M[NT<8*9]=%IIY'9D3J>KZI,[8$9PS>SY(UNZ!,U9">LJ6Z2<B+6."2M\7+G-
M4@2QR;S#&TQ8T:MT5N#B5&#W2-(EK6CN/,L0\,ILLKO;K:6T,1CC5L=3&B)?
M3+O6H5\.DD1\E-(MZXN1>NJ*1"Q#B[.G2$\T:A,IY3U#SK#FB7%,TOQ_B_$>
M.U5:VNU]2[5S;<H;%Q9,?5.]\?X!R=WAU2KUEZMP+2)2BD9=EB:N]\>&L:QC
M4=.J6JJ^K>0H,9)B4CGO<K:=%L1$]6^ISV'-6H/8<Z^=+N!5.>Y?G+0UK$D1
M<!C\9G*@]2Z020U=8K$%3LA;[KU+='G*'ODT9E*@]IX!,\,Z@PDY'100F-*X
M.6.OIGR74;4,2W)M[?K+USFU)</J61WE=3O6S+M;"<%J;&RA,3;O:BLXL;EH
MST28)G;OB%XUL97N@DNRFTK%+4L:XT=(X) T\>(<T:A$M);'1SR/16[<74I3
MJI$%A%3.!5'6BCA\4:WYY$M2-+43?7UBOB$LB+'!&MU9'66[R>N4G[6+8\X4
MV;\*P)J)8\A9'S7"I'F1@QYF>#Y'<FE%()6O=62135>[1.2Q-L853"B=6R&N
M2<PM31>I3*5*<WC1U*7VW3Z.M?5.=&J(UR-M14WLN^6^LHHZ5K9457-5UBHN
M_M=0EGTEF'P['FF?9R0#':-4WX_@R*;0^"H%RIQ7+4,.C, Q0RQA&K6NYI[L
ML5)F1$188:J,O4&7VUN,NK?6ZHHX6YSI97.[9;%7JVJ5L5:UL436]JEJ)U+$
M+2MN3K6S9IIQ7@[!6FAPOC>>M8N05V-HC-DQMI#M%&1I51-M?CHVH-3'IVR2
M/3M.VE 2OK_#-Z=0>>FWBJT@\B)001RO=)+EC8EMGJZA,Q">2)C8XLDCUL1?
M5U4(+2+H[F685CY=FG%VNK-:W7,TL1<E+EUSRYM,<DLS0%%.BB/(I4E6W9)1
M$K%Q-Y"1S4K%%UQG!FG)+:5N+MKIB3'.T;XV\W];L$=<,>UND9([G&?=ZNR2
MQT,ZYYGKNV/&IJ9Y4/*7Y?Q;B+4)B;(C\2C3-Q4Q6-.&UC^Q33B"$DEO1*WJ
M/R%.4ML(M+*N<DJDPLHDDPHJVC/3MIZUC6=HKFJFYEV"M3U#JBA>Y_;HUR+N
MY-DHTV0.Q]A&T6TMS[)61=0F7H RQ/.LH@L?QY!K&B^-$R)KQ]C&1&SQ>4^U
M<4BES7D2HE&980E2G\"WE[JFZE;;2[A6UKJ:5&-:U55MMJ]5<A;Z*B;50J]S
MG(B.LL3J)E+--FME34GH1VETLV3&>,MO6><8R>*N,HP),I(<X7N;/>VPQ=DQ
M(8S$N+B_+F1B>XLUNR9Q9S%AR9([-]IJ,REEYM542J9%44J5D;;KT7*G7L]2
MDNE?+3U2T<CKS%3(O6MX\AP[9AKEIW2%=IP4<K5&E7PO4)ORS%!MY=_6[4-@
MU$W[ZRZ^MMW$$9EQ1.[3^"*NK;;N6UK0<JOYMBZK>Y4XTGSE+U'=TA&)5@K4
M#K/VR^T*TAX[U,S;3]B65R*F7<[F15:YU7RR,8N*AD08&1O1(5K95:ON=,E$
M$T)4+"6^U-NGG%*KT:5/=6TD<%#',YJ.>B6)U\OK%)8Y)ZZ6!KU:Q<J]:SC/
MBZM-/>0NC_:A-+N<=.FHG)DVQ%E*4OZ7(^/9JK*L+?T<55111,F63MC'1#')
M.@E,?D5UR)55"6N;%R6TZR^IMI)E$,C<1B?'*U$>B9%3@/DT3L-E9)$Y58JY
M47<LMWS<(+"7\   /.CV-^RMQWM,_P!(SO\ <IS3&G,GS0]:>]!I8W3KUSD<
MZ''NN'7FVO =;>\(G@>#_P!;A[]]]2T=FK:MU+=NHBWK>"SC.LT-&RKO7E5+
MMFQNV\1=S^RM:>/A39H\4X/_ /F"!^%Y.0W?4G_@B+ENX"(>P,Q4W8*VQVN#
M"+0ZK7UIPYBO4MBIK>W(HA.XO#=CW5+AR(HG5>0EW$Q*UP3-%IQMA?\ !VF7
MUI;ZE*"MB+UDHHY%R*Y6KOM52AAS$CKI(TV&HY-YR(?/UV:=#-6G2)K-/9>2
M95B*S(D+CY"J?PFEU9.SMT=TINTO=$39O5S=2WOD;H^:UG5N-J7:G6F5O+-M
MI4J_[3RZ'#=)8CK%V%]M8?*B+38GHK5;:FRGM;3EFK[0CF[87-<"UG:+]3V2
M95C]#D:/Q?*F*L@<6*:GI.^4/6$W2=,P*6V.RV+R-2T];U)=S:G<FX\].H3*
M:F4X5/Q@J(Z]5@G8B.LR*GJR'*>GDP]$G@>JMMRHI;KMC<F-&:=AQEG,; G-
M2,66<;:4<F,J4\RIIR9HGF;<$2EM3G&U)3U,-)1NMEMUW!V;M:;N]I]2D*B8
MK*]&+LHKDWD4FUSTDP]STV'(U=]4*3MG)LR]HQJ#T9X<R_@C:89.T^XIEW.%
MWJXACV1\Z,+/$>L&5)Q&'SB;3#9FTQM)U^DC*L<S.+)R^$-6W7F;XVZ^ZL^I
MJJ6.=S)(D<]+,MB9<B9R!2TE3+ U\<JM8MN2U<F5<RE_&S<T(ZV])V1L@RO5
M!KQGFJV*R>$IH]'8;+9;E.5I([("GU$Y72=+?D24OJ=N46MR8Y+6B4JR\ZU1
M7?W;A=M*VZJJ*>9J)#&C%1=FQ$[!<J6GGA>KI9%>U4V%M]=3@6JK2;L(LA9_
MR-,M6,GTRMNH5[7LYV2D4UUG/^+)22XIHTRH6BKQ F_.L02,"@V-)45]MMK<
MFJH+NM/NI?<;4R_E#-B#8T;"C]'M6-MX;%.$T.'.D5TRLTNW:ZS@M0X=@[1M
MT>^,YEQ9)<%2C2JY9ICL_B;]B=%'=<4BG<@.R(SO:-QA_6*&K-0,A325X+?D
MQ%Z5'>A5T./MMIP5]?4'*2?$E8J2(^XJ+;["S)MY;#Y'!AJ2(L:LTB+D]G;E
MVLEI?J+<7$IZV^?T3&J_\17SE<.";AWW8SK]RI"Q'[C?UNZ0H%V<FS+VC&H/
M1GAS+^"-IAD[3[BF7<X7>KB&/9'SHPL\1ZP94G$8?.)M,-F;3&TG7Z2,JQS,
MXLG+X0U;=>9OC;K[JW&IJJ6.=S)(D<]+,MB9<B9RVTM)4RP-?'*K6+;DM7)E
M7,I>]H T8:R=$<DS!E/5QKUG^J?'U^,%EJ*)2B593F!,87L2\F1KY6AID25/
M9")64R-RA-2Q*79>HHH^OOI0NVE;?4SP3HUD,:,=;LY$ZV0N--!/3JY\TBO;
M9L95[*F9%JU/:6]IIE7+F6-JWKGS!@*!))%8BP3ILQ%%LA/K.QQZMIYZ9S+7
M-&*,JP5ON:TUQ*50><W5>7A7PIYIQ))9%E]U6*:E8UE)&USK,KELXT7UD+2D
ML-6]7UDCFMMR-2WB5/74GML=M8B7%.T66:$<*:G)EJXT7Y5C4C787DTZ99NQ
MON/9)$8$OR$<B(:YXQ,+FPI$K=&W1J6ID24AI<3[DBXFP@VII%8];#?IN<2,
M1DZ+ELLRVK9M?NDFAGN57-XWJ^!4R6VY+$MVR(.4ME/IYKMO(!H*[\LT<S^6
MHK),BR.25DD*OR4B>U&)LI92O2LKT9CR^-DME)!$TQ-+5+0J/XG>9;4VIMUI
MUE9E7)S!:BQM]%LV[-E$S^N4'T<7/TI[77');M6["KFW,QJ!IHBTZZ+=G#EW
M3$W:C<DX1PM>U3!V<]0$UG$?:YQ U<N<D:LQ>FD<79L>MQMM[F64E3H2B"SW
M"T^J.E3;SZ6UM7.)9ZILMU'29D3(O9+MS>*"E=#>5L>7*JY4MWC'WJ8CFRZQ
MCCF3Y7T7;0G5C/-94+>(ROCSG+6B8QMKR#PLP9T#ZHC,I(Q/$'V-N4?95)KJ
M6>X/MUBCK?=872\PPJVEYB6K>Y&3QL2!<UF3)U?6++*E(QBO@E>LZ=7+EZB=
MDTQZULKR/.G1[G[,$QOL-E^1=*^!)3+%)5N\)6R=SDN,#9 XDE>KP!#B[\,?
M87NW5*M,I96Z[<WU;73L2/$KC>U1[D[)=*AZR8;?=VRL3UCO+8&?1,:4/QZ_
M.5S&*>(_=C^MW*%7#ON-G7[I3FFVV^BSU>_T+B7YT8(/E!]ULZJ]A3[7_<;^
MHG90ST[-/8NO6O71)B[*^=M6^78_BQ:;D%#@;#,$4VK([ D3#DZ9MC^^.B23
MWK&,E>_9#2NZRY(WHB#*EF6'7KKC#JDI[C55R4\ZLC8U7Y+57;R)ZQ;:6A6H
M@1\CW(S+8B;65?7M)S;$++.?,,:P]8FR[S-DUUR_']/[:^3'&4F>UCBX*&=I
MBTSB\3<$C.:YK'%:TL$J:Y\T.%&>Y0<0UK"C[2*UJ:?>90KV1R0,JV)=5V1>
MNEOK+E)% ^2.=])(MY&Y4W_7M3(5H:E]:&%MH)KFSSC_ %V:RLEZ6-$>%9!)
M8/B_&.*HU/7Y;E!=&9,KC=7QW*B<%R"QIWIQJUFNIZY\;%M49)Y*!$72G#G6
MRHH)*:G:ZG8CYW955;,G"G!U2)+.RIJ'-J'JRG:MB(EN7>1>'J'WM%.K'%&B
MS:.Z>\&:%=7V2]5&B;47)(EC&4X^R5'YZPK\<S*?22^(LJM"AET%@3+1S:7I
MP;G*YV9&M'8M07J42LFVI9)]?D\+YZ5TE0Q&3M2VU+,MG45=Y3[3S,@JFQT[
MU?3N5$L6W(JY-M$X#OS:#1//F9]N^@TS8)SY*=/;AJ,TZQ3&\TG,;5.-BHG&
ML?BLKRW*FHHEM7-J^XU8G@9E";$ZI'<<<;4DP^Q.>HI?3IG1QX?I9&HZZZU$
MW;;/7*M2V23$-%&Y6JYEBKN95]8Z1V@^@;)^Q)C^)M8.D'5UF QVDN3R,:35
M+*J,]][K(GV'RF3H'!P;4I-8Y*XZN11!Q+4H'="MJ2;5.98;=?;2ZWG35#*]
M70S,;8B6IO\ U2G4TSZ!&SP/=:JV+O<.QMG=>=]BQD5!H_F6O^1ZZ,YS75K#
M\+.>I5QD2Q8H2,?%&B)79-?XK'W7KQ6:M"M$VICBD*\E>21PY)=;6\FRM"RZ
M<=<W3I3)&U(5==];J>K9*DE Y(5J5D<LR-O<%MF?U;!8KIDVGD^:=AXX:X\E
ME63O+>'XQ(($M7/EYUJ><3QNR BQCCI[D1B*VQ6HZZ'R1F,>+[+BS51]%-]#
M"ZF4OLC2TC5K^;MR,<MO42RU?7),56Y,/YP_*]J6=5;;$]:T@/IAV.F7MI5A
MJ)ZU=;&M+-5^4<R)S<@XT:XN8WK$$%C[@;??&7&J9SM+:F:U>5914G:&!.U(
MT".\FRPW?UOL*DRUK*5ZP01MNMR+N^K.I'AH7U3$GJ)'7W94W/5F2PEYLAM0
M^IC#^KK4ELH=6N1E>9)+@:.IYOB+)[DK<'1U.AI94/66QQ:[NU3WQ>VNL3R"
MSNK82N-..:;;%:.B@TBU(650K8HGPMK(4NHY;%3=R\2E:BEE9,ZCF6\K4M1=
MS)ZRIU#HS5DUY+VJ>UWR#LYI%F7(.&-+&G#%:6:S.+P9Q):W3)KAUE@*MV<3
M$ZXM0TJW=4XY<2(D5Z],YI4C2@-/*3<(I-%2%6TE$E2C4=,Y;$MVMGB*<R/K
M*U:57*V%K;51-O8XR(&)MG/@G0QMV=-FFZ1K9/F"!2^,-.>L'O[J[JF.88_G
M$4/G$GA1LROA]&AJE?6^6895%'%T2)D2E*O3F'$VV%G%F5WU,E1A[I4L:Y%L
M7,J9+;+>J4&4L=/B#(EM<U4M3.BY;+;.H2;E/_FL\;_T+7?,9GHI)\T+U?\
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MN^;A!82_@
M
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M*I8N1.(^,H*1CD>UGLD6U,J\9:@(A,  S+](6V;62-52; F=M/&/W.<Y:8)
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MKZ5W-W[A<L<;GZ1R-M1-E;,YQQ6*25K-&U76*NPEN8TY"U%V
M
M
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M!\/H
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M:6^J([G*YRN=LJMI):U&M1K>U1+#E ^'T
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M_(N9&[G5(CXI):EKGV:!F5,ZNSKU"SX1"6
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M=VVEJK+G.7Z/M+?W>&TNU'?YJS2=O9^YP6%A0C$D
M
M
M
M #HK/NF33_JEB1$'U"XEA>6(TB5&KFM'+&JQ4K8UYY/%CW".O)%R9[CC@>F_
M@[ST*E.=>7];6ZMOJ"I'+)"MZ)RHI3DBCF;=E:CDW2)>)]CYLU<)RE)-(!I,
M@!4D;U]'1N73!UF^3R6QQLNL,)6-C9DZ53!J;5"0TNV\BX@@NJ<RE+R]Y=ZH
MK/K:IZ77/6S<L3L6%%E%2QK>:Q+=VU>S:64B*2@
M
M                    .BL^Z9-/^J6)$0?4+B6%Y8C2)4:N:T<L:K%2MC7G
MD\6/<(Z\D7)GN..!Z;^#O/0J4YUY?UM;JV^H*D<LD*WHG*BE.2*.9MV5J.3=
M(EXGV/FS5PG*4DT@&DR %21O7T=&Y=,'6;Y/);'&RZPPE8V-F3I5,&IM4)#2
M[;R+B""ZIS*4O+WEWJBL^MJGI=<];-RQ.Q84645+&MYK$MW;5[-I92(I*
M
M         A9J3V=>B?5X\%R34/IXA&0946B(;:S&TQ^B$T/;DMEY:- LF4%>
M8Q)UZ)#89=1.4>K,L(WU>#I;NU%>*IGA2R-RHF;93>4H2TT$ZVRM15S["[Z'
MZ--VSUT6Z1G&]\T\Z>('CV2WI+V_OOH6[2J;%(#2N 4HD\VFSI))8E2+"O44
M%EK++%'U3*75H$M3/,EDCE5,VUO((J:"%;8FHBY]O?4F6*!7
M
M #HK/NF33_JEB1$'U"XEA>6(TB5&KFM'+&JQ4K8UYY/%CW".O)%R9[CC@>F_
M@[ST*E.=>7];6ZMOJ"I'+)"MZ)RHI3DBCF;=E:CDW2)>)]CYLU<)RE)-(!I,
M@!4D;U]'1N73!UF^3R6QQLNL,)6-C9DZ53!J;5"0TNV\BX@@NJ<RE+R]Y=ZH
MK/K:IZ77/6S<L3L6%%E%2QK>:Q+=VU>S:64B*2@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
8                            #__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>sgmo-20220930_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sgmo-20220930_g2.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M5QJD949FIM8*)B?_V@ , P$  A$#$0 _ +_
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M[8R.3%[8F2FS&DC?$]62)8]"3'(R5B21K:Q>,RJ.!S
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MS5_DN&OGZ;]*C40=!FA!]#/A_P#92XV?,9J_R7#7S]-^E1J(.@S0@^AGP_\
MLI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?_ &4N-GS&:O\ )<-?/TWZ5&H@Z#-"
M#Z&?#_[*7&SYC-7^2X:^?IOTJ-1!T&:$'T,^'_V4N-GS&:O\EPU\_3?I4:B#
MH,T(/H9\/_LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?_92XV?,9J_R7#7S]-^E
M1J(.@S0@^AGP_P#LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?\ V4N-GS&:O\EP
MU\_3?I4:B#H,T(/H9\/_ +*7&SYC-7^2X:^?IOTJ-1!T&:$'T,^'_P!E+C9\
MQFK_ "7#7S]-^E1J(.@S0@^AGP_^REQL^8S5_DN&OGZ;]*C40=!FA!]#/A_]
ME+C9\QFK_)<-?/TWZ5&H@Z#-"#Z&?#_[*7&SYC-7^2X:^?IOTJ-1!T&:$'T,
M^'_V4N-GS&:O\EPU\_3?I4:B#H,T(/H9\/\ [*7&SYC-7^2X:^?IOTJ-1!T&
M:$'T,^'_ -E+C9\QFK_)<-?/TWZ5&H@Z#-"#Z&?#_P"REQL^8S5_DN&OGZ;]
M*C40=!FA!]#/A_\ 92XV?,9J_P EPU\_3?I4:B#H,T(/H9\/_LI<;/F,U?Y+
MAKY^F_2HU$'09H0?0SX?_92XV?,9J_R7#7S]-^E1J(.@S0@^AGP_^REQL^8S
M5_DN&OGZ;]*C40=!FA!]#/A_]E+C9\QFK_)<-?/TWZ5&H@Z#-"#Z&?#_ .RE
MQL^8S5_DN&OGZ;]*C40=!FA!]#/A_P#92XV?,9J_R7#7S]-^E1J(.@S0@^AG
MP_\ LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?_ &4N-GS&:O\ )<-?/TWZ5&H@
MZ#-"#Z&?#_[*7&SYC-7^2X:^?IOTJ-1!T&:$'T,^'_V4N-GS&:O\EPU\_3?I
M4:B#H,T(/H9\/_LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?_92XV?,9J_R7#7S
M]-^E1J(.@S0@^AGP_P#LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?\ V4N-GS&:
MO\EPU\_3?I4:B#H,T(/H9\/_ +*7&SYC-7^2X:^?IOTJ-1!T&:$'T,^'_P!E
M+C9\QFK_ "7#7S]-^E1J(.@S0@^AGP_^REQL^8S5_DN&OGZ;]*C40=!FA!]#
M/A_]E+C9\QFK_)<-?/TWZ5&H@Z#-"#Z&?#_[*7&SYC-7^2X:^?IOTJ-1!T&:
M$'T,^'_V4N-GS&:O\EPU\_3?I4:B#H,T(/H9\/\ [*7&SYC-7^2X:^?IOTJ-
M1!T&:$'T,^'_ -E+C9\QFK_)<-?/TWZ5&H@Z#-"#Z&?#_P"REQL^8S5_DN&O
MGZ;]*C40=!FA!]#/A_\ 92XV?,9J_P EPU\_3?I4:B#H,T(/H9\/_LI<;/F,
MU?Y+AKY^F_2HU$'09H0?0SX?_92XV?,9J_R7#7S]-^E1J(.@S0@^AGP_^REQ
ML^8S5_DN&OGZ;]*C40=!FA!]#/A_]E+C9\QFK_)<-?/TWZ5&H@Z#-"#Z&?#_
M .REQL^8S5_DN&OGZ;]*C40=!FA!]#/A_P#92XV?,9J_R7#7S]-^E1J(.@S0
M@^AGP_\ LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?_ &4N-GS&:O\ )<-?/TWZ
M5&H@Z#-"#Z&?#_[*7&SYC-7^2X:^?IOTJ-1!T&:$'T,^'_V4N-GS&:O\EPU\
M_3?I4:B#H,T(/H9\/_LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?_92XV?,9J_R
M7#7S]-^E1J(.@S0@^AGP_P#LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?\ V4N-
MGS&:O\EPU\_3?I4:B#H,T(/H9\/_ +*7&SYC-7^2X:^?IOTJ-1!T&:$'T,^'
M_P!E+C9\QFK_ "7#7S]-^E1J(.@S0@^AGP_^REQL^8S5_DN&OGZ;]*C40=!F
MA!]#/A_]E+C9\QFK_)<-?/TWZ5&H@Z#-"#Z&?#_[*7&SYC-7^2X:^?IOTJ-1
M!T&:$'T,^'_V4N-GS&:O\EPU\_3?I4:B#H,T(/H9\/\ [*7&SYC-7^2X:^?I
MOTJ-1!T&:$'T,^'_ -E+C9\QFK_)<-?/TWZ5&H@Z#-"#Z&?#_P"REQL^8S5_
MDN&OGZ;]*C40=!FA!]#/A_\ 92XV?,9J_P EPU\_3?I4:B#H,T(/H9\/_LI<
M;/F,U?Y+AKY^F_2HU$'09H0?0SX?_92XV?,9J_R7#7S]-^E1J(.@S0@^AGP_
M^REQL^8S5_DN&OGZ;]*C40=!FA!]#/A_]E+C9\QFK_)<-?/TWZ5&H@Z#-"#Z
M&?#_ .REQL^8S5_DN&OGZ;]*C40=!FA!]#/A_P#92XV?,9J_R7#7S]-^E1J(
M.@S0@^AGP_\ LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?_ &4N-GS&:O\ )<-?
M/TWZ5&H@Z#-"#Z&?#_[*7&SYC-7^2X:^?IOTJ-1!T&:$'T,^'_V4N-GS&:O\
MEPU\_3?I4:B#H,T(/H9\/_LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?_92XV?,
M9J_R7#7S]-^E1J(.@S0@^AGP_P#LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?\
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ME1J(.@S0@^AGP_\ LI<;/F,U?Y+AKY^F_2HU$'09H0?0SX?_ &4N-GS&:O\
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MYC-7^2X:^?IOTJ-1!T&:$'T,^'_V4N-GS&:O\EPU\_3?I4:B#H,T(/H9\/\
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MFYSG+><JJ[E*C6M:EUJ(C>0]*/A]
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MY<642K L[,XIL$TAU9IM"KOY1:+1?F;=T*@9RN9/&>QDYOX0/IM2
M
M
M
M
M
M
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M^U/NCX<@
M
M
M
M
M
M
M  "L)UI?WH71+_6/I_\ >%T*+K0_-9_<>LI::_YW3^[3OD++EKB9&>J]D@XB
M;<5J6F8"8B8NQM$C+NZ_(R,<Y9LIMJ@1RS,LXBG*Q5R$PLEDQD\8[<O_ "L6
MMJHBHJY4M+JJ*J*B9%L*EO._HT]05734IL"P=0JX\Y8#42+C9LQH'<[+8]'K
M=JC::@M-236+:16XKBTEIUU%-W")"]UB'ADE#IMWR*IR9%XIZZFOW4C2-79+
M4L7A[">N6:HH:FY>659$;EL6U.#LKZQ/#TM>85!YL<.=>[1H5(C-8DJ9U=2V
MG6<$HBI7Z%:*+%PY#0-<RD5,R=;5KLE'/8])0A5D&3Q)(_;&)DYK?5PN@G5C
MEMMRVY[2XTD[9X$>U++,BIFL-XK[57%XI5HI[2W6Z@N;+"2$,A=:$]BXZZU9
M5^W.@2<J[^;A[!$-)N/R?NC=1RQ=HE4QC)DCX^YF.U;KD=8BV<2\!7<EYJMM
M5+>-.$T)_9Z77_$IZDGSHZ _^EG$GK+?BHM#OOB/U9WQLNE/O31?J$\*K3K_
M $E19][SKYT;(06Y1\2H+%<V-L'3<G745;%R(UW"HSZ+:OZ'K4@6?K2KW#Z-
M5RYRBD^02.JDLG@R1J]-.CI%1(XT[AW B]%>4CU,"MC1=9(O=MX53I)R$VGF
MOD/2SMCWYK/DD(-Y,R>CLDZXO2=VN8>:^0]+.V/?FL^207DS)Z.R+B])W:YA
MYKY#TL[8]^:SY)!>3,GH[(N+TG=KF'FOD/2SMCWYK/DD%Y,R>CLBXO2=VN8>
M:^0]+.V/?FL^207DS)Z.R+B])W:YAYKY#TL[8]^:SY)!>3,GH[(N+TG=KF'F
MOD/2SMCWYK/DD%Y,R>CLBXO2=VN8>:^0]+.V/?FL^207DS)Z.R+B])W:YAYK
MY#TL[8]^:SY)!>3,GH[(N+TG=KF'FOD/2SMCWYK/DD%Y,R>CLBXO2=VN8>:^
M0]+.V/?FL^207DS)Z.R+B])W:YAYKY#TL[8]^:SY)!>3,GH[(N+TG=KF'FOD
M/2SMCWYK/DD%Y,R>CLBXO2=VN8>:^0]+.V/?FL^207DS)Z.R+B])W:YAYKY#
MTL[8]^:SY)!>3,GH[(N+TG=KF'FOD/2SMCWYK/DD%Y,R>CLBXO2=VN8>:^0]
M+.V/?FL^207DS)Z.R+B])W:YAYKY#TL[8]^:SY)!>3,GH[(N+TG=KF'FOD/2
MSMCWYK/DD%Y,R>CLBXO2=VN8>:^0]+.V/?FL^207DS)Z.R+B])W:YAYKY#TL
M[8]^:SY)!>3,GH[(N+TG=KF'FOD/2SMCWYK/DD%Y,R>CLBXO2=VN8>:^0]+.
MV/?FL^207DS)Z.R+B])W:YAYKY#TL[8]^:SY)!>3,GH[(N+TG=KF/D3VM'Z,
M2[5SM/:2^"]P_P TO+UPR1^V<HE^^P2JIFSVO9[..QG'W< CDMX$/CF+=]L[
MM<Q]?S7R'I9VQ[\UGR2"\F9/1V3[<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>
MD[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I
M.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3
MNUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[
MM<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[
M7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NU
MS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<
MP\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,
M/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#
MS7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\
MU\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-
M?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7
MR'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\
MAZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(
M>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'
MI9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ
M6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>E
MG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9
MVQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=
ML>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;
M'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ
M[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>
M_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'O
MS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\
MUGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-
M9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6
M?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UG
MR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\
MD@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)
M(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2
M"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@
MO)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+
MR9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\
MF9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)
MF3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9
MD]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9
M/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3
MT=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]
M'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1
MV1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=
MD7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9
M%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1
M<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7
M%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q
M>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7
MI.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z
M3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D
M[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.
M[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3N
MUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M
M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7
M,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS
M#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P
M\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/
M-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S
M7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U
M\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?
M(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R
M'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\A
MZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>
MEG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I
M9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6
M=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG
M;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9V
MQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L
M>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'
MOS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[
M\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_
M-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS
M6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\U
MGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9
M\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?
M)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR
M2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D
M@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(
M+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"
M\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O
M)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R
M9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F
M9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F
M3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D
M]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/
M1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T
M=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'
M9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V
M1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D
M7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%
MQ>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<
M7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%
MZ3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>
MD[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I
M.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3
MNUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[
MM<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[
M7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NU
MS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<
MP\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,
M/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#
MS7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\
MU\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-
M?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7
MR'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\
MAZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(
M>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'
MI9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ
M6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>E
MG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9
MVQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=
ML>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;
M'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ
M[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'OS6?)(+R9D]'9%Q>D[M<P\U\AZ6=L>
M_-9\D@O)F3T=D7%Z3NUS#S7R'I9VQ[\UGR2"\F9/1V1<7I.[7,/-?(>EG;'O
MS6?)(+R9D]'9%Q>D[M<Q[VOPRL#'%CUIR;L)RK*J^V5@<,W,B;"N<9PB95BQ
MCD,HI=CL$QW/&<8_ASD<56U<QS1+$LM53[8^'T
M             @FZG7#'DCR(YX=+?=&G]>$MNM>.FZZ_;MRV/-OHT!FFUZ,W
M#J*VN9#,/9K+#3MA_P#F%67RI4HIJ^7R9OVG:8.=,I[A23Q14\S'K8YS;$R+
MER*A;ZN"66HA>Q+6-=:N5,F5%-Y.H=I'ESO#2D5%\+^1!N/FWJA=H2\MW"Z1
MFT-L1K7^ZN4*+8)]HQDY&%AWDCA%=8F&KQA)$1RR?H*-%U,DCTTD,;[9VWF*
MEGI<I(J8YI([('77HMOI\A$?LB3]8VWWK2>XX37'WC'J)K=()_2;AR.AMA59
M%1[7)EHK#S+F+BX[:5XG:X]E(M\;"SII6LN4<D4.S3;*91P6:U,,C<DJ.>ZS
M+=L]A/5(3UQ.1BQ*UC;<BNM]E?4)<.FUP<@>GSQ9J^@8VPEN%B/,2UZV/;DF
M?M>RL.P+(A'-Y9Q%LC9,NA#QD9$,HYGE8V5U6S(BBG:G/DA8554+4S+(J6)P
M(G(3:6G2FA2-%M7A5>4WU$<D  1M]4_ZN&O_ -</A+_>DU:)5)\*ON'=ZI%K
M/@D]VSOD))!%)0   8=VSR(X_P"@VC1_O7>>G=+,'Z:ZS%[MG9M*URT>(M4E
MEG2K1S<)N&1<)MD6ZAU#$-G!"D-G/8QC/8 ^9J3E%QFW]G)=$<B=%;K,5H5_
MG&I-N4#8^<,3D*H1YG%.L$SG#0Z9RFPI_P C.,XSV>QD 9U
M                  $6_5QZG6I>E%QHJG(/<E V+L:M7O=%8TE'0NLR5H\Z
MSG[!3M@; ;2SW%IG:^PQ#HQNLW:)^T6.MW=PCV"9)VYBCXJ6I8;C<4>1%8Y;
M\:M&<G:7"3U:J6^=8U+:5<@+1B/+8H>(N$2WEV,?-8B7LC&8DFJ#G!5>X+K)
M=OC/:GSC[H'TV"
M
M
M
M
M
M
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MUUKV&K]W4X>3'#S-^C4(RTVEBBT3U2]C'NJ4RJV*Q+*XEV$NH\12>-WB9$B
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MIW5.E'SRD;.WI&Q;=R9_>MN6]A)1<BRKLE',',DK%N'[&O0T1C!I'"JJ"KL
M8HV!ZMMUV>(-.E.4E';%DKE5VB]OGT>-._YMYO\ A21^,NWDHS1B"5F7M$NS
M*<ZO<8%_*2"G:FRDFH;[F0)Y?5F_6'=K<FMC1?3XYY7<MVV?-Q#]SQOW[8#-
M6EGO;VOLEI&4U+LI\D5NVG[:I M57D',*$(\D>\UVKU5R]5:G6 O, "NOZPU
MUL2])K0M7JFG4(&P\P=^)RB6JHV?:IRT!KFGPRJ#6R;9M4-APB:2[U=.2,8)
MBMV&[^2RHHKW5NQ<MU0*-^B.EYUSNO!!2/*:SW2T; U]/2[_ ,'-J<I=P2U;
MI%G?L7TBSE6FIJ<@SG3-JW 2;99IVT/!LX)JXP=LW/VZ*Z:0'^HW??6[]6TY
M)4:G;3GKY%4>5[>=8:@NMY?;3XL[UIS!PS2LB=/72DY"&A)EEE\@FZ>1&8JQ
MQ*JS?ODA4%B)+@=/O@CS0U)U!>*>H.66EG*F*?M2NE?.Z^^<MW$[1+=&KJQ=
MRU_9L-NPF2>J%B:.&:IRE*DZ3(1RAVS==$Y@(MNM]U[-&])BAJ42L$@]O\TK
MI!IR.N]*Y=N#0U0B'RAT&^QMQ/HQ1-S!5=/N2AF$:FJE*3JR?<T.XML.'S8"
MKEZL[U*^?','K&/6')#EQOO:]/OVG=Z6Z9U=:-FVQ[IV/FTC0,K'KU/49Y3S
M=TQ.$<8[1@2*C6F&:!CI)=JFHH4X'21
M
M
M
M
M
M                                                       !&WU3
M_JX:_P#UP^$O]Z35HE4GPJ^X=WJD6L^"3W;.^0DD$4E  4A_7:^/-RN_&;AC
MR5@HN1DJKH':.U=?7EPR*59M M=_P^O',!.3"14CKMXXT[IU..*ZR<B!'<B@
MB?LJ.$< #VOJJ_6/XNV;B'J7IO;;N];U%R*TP_M\%JYE;'K: @-YU"UW2QWN
M.Q49MZHC%*["A'MF78.H4ZB;U\B@D[:%<Y.[*V NA@       *Q7K=?[FC8'
MY]]#_*AT -%_5">0N@N//28WI9-_;PT_HZNN^H#M@C6>W!LNEZSA7)T..G%/
M*Y6\I=)J$8K&1PH7)\%4SDO;8[/\( MZZ;Y(<=^1<6[G./F^M+[VA8\Q"/YC
M3>TJ/L^+8G4R8J97<A29V<:-C',3.,8.<N<YQD 9H    !A'<G)GC?QT9M9#
MD'R"TAHI@^3[LR?;DVO0]8LWB/=<H=U:N;M/0:+A/NQ<D[8ALX[;'8_A 'HM
M5[JTWO2N^%^D=M:RW'4^Z$1\*-5WRK;"KO=E$\+)I>W=2E9>-[HHCG!RE[KV
M<ESV<?< &3 !Y*\7ZBZRK4C=-DW2I:]IT05,\M;+Q8X>IUJ+(LH5%(TC.SSQ
MA%LBJJGP4N552X,;.,8^[D 83TUS4X;\C)E>N<>^6G&;>UA:IG6=0.FM\:LV
M?,MD4D3N%%5XND6J<?(IIMTS',8Q,8P0N39^YC.0!LR .;SQ$Y^\Y;;ZU-;M
M!6?F#R7G]"M^H5S:UFWT9+;LV*^TPWH-'=[YAJA5&^JE[">A(1%;8UUCWHF2
M/QW%9JFN7.%\=T '2&   5 O75OW66@_U_\ 5G]W7E4 )ONBE^Z/Z<OZH&C_
M )$Q8 T$WKZLAP*Y2=0S;O/+D7-;,V-';6>U.?=\<VTXYJNNR6V!JL#6)>6G
M[7$/L[!G(J>S )O"QK-]$(-5UE4^V5:]S;I@4Q_5!_WQU6_5WWI_)T" .IEM
MC845J/5FR]KSJ7=H36.O[EL*81[Y29]UBJ77)*R2"7?B^#(->Z-(T^.Z'QDA
M.SVV?N8 '*E]7'TLOU&.N-";>WPW:7M>CK;AYP[.;2C3O]A8;TTL; E=DG:,
M@J[-W&-W1LZ'E"%4RMDQFA4S=G!LFP!UF@!SY?7:>)E9B9OA_P V:[%LH^QV
MWPMX[;0>MFA$%;!F :)WO53]XJ@0A'4C'L%;&T466[9<[5-HD4W<VY2E LM>
MKD<CIKDWT<N'%MM+]:2MVOJE8=$6%TX7RZ<*$TG;YS7U/5<.CY[NY=NM<PT*
MNN=7'=,K*G[;)_\ Y8<"7R0U#JB6V;7]URFLM?R6XZG69:E5;:[^G5YWLBMT
M^=<D>S55@KNO'J66)KLL[3PJX9(.4VZRG9,8F<YSV0,B #EI^N.[#U/>.JK4
M*IKQ*,>7[5W&37%*W0_B4T.^#765M%YO%;K\QAKG)G<Y%:]ML0ME53&5N]7S
M=#.>U0(4H'1^X&TFYZTX-\,M<;'R]-L/7_%'CM2;X:22,A(FN=4U#3X*T9?H
MF.H9%[F<8+]U+DQLE/V<=G/\( VN   5_P#UG?D;-<<NC;R;7K#TT;9MVK4C
MCO%OB.LMCI1>S[&V1V W*0BJ*[HTIJV)G6>")F[)<N.Z&P=-,Y# 02^I*\2Z
MN:F<O><4Y#,I"UGN<#QCUU-.6:"CJLQT+78?9FU$HUV?!U4E+1FX58JV2=ID
MJ<?@O9,54V, 7V@!R1>N?K5STM>O5<-LZ%:MZNW:[-U%S:U5$11,P["+F+#)
M,;G9H9%%JEWHU@76TZ_.)$;(I9:IQJQ6_<\D*8@ ZS53LT3=:K6KE K&<0=M
MK\-9H5<^"E.O$ST<VE8Y8Q2'4(4RC-V0V<8,;&,Y^YG/\( Y0_7GMMNZAOK"
MEMX]1TJHFS0W5H/@OJ\A5<27M!W>3JU1G.YI]\8;'47V[=YU]W$O<>T[XPDI
MV5"'.8#JK:EU70]':OU]IO5]>85/76KJ=7J'2:W&()-V4-6JO%MHB(9))HII
MD,9-FU+VY^QVRJF3'-V3&SD 02^M"<3*SR<Z1&_K,ZBV2M^XP>TO(G7<XHT(
MH^BL5&1;QVQ6";LA._$XZ;UC+RN%4<&P@H[0:JJESEN3)0(7?4BN1TU,:UYN
M\3IE^LM#42VZRWO0F:J^5BMC[#C;!2-CI()J9[9HT37H5=5(1/MDSK.ECYP0
M^<Y5 F$WKZLAP*Y2=0S;O/+D7-;,V-';6>U.?=\<VTXYJNNR6V!JL#6)>6G[
M7$/L[!G(J>S )O"QK-]$(-5UE4^V5:]S;I@4Q_5!_P!\=5OU=]Z?R= @#JY
M
M
M
M
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MY_".#Z.IC:KWL5&IZ7.<F5E-(Y&,>BN7T^8D5$8E
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MV,]C[@'2@ '*-]4'_?'5;]7?>G\G0( ZN0
M
M
M
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MHF4(4WW<8SG.,9$NF55AFM7]9ZY#J41)H;$_7^L30B$3@
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MM96RPTA'U.TR!"LEE&ZL=&;6M$TE@R"G<CLVF%LF+DY\X ZQU3K,32JK6J;
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M,;.,)@7PP!RC?5!_WQU6_5WWI_)T" .KD
M
M
M
M                                            (>O_ *OY_P#6>O\
M?3$W^+O]/^U(7\9?Z#]L3"B$30
M                                  AZZDWUM.D5^N'8?T:R(FTWP,WN
M/7(55\-#[OUB840B:
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M.ESN4B'52P=(ASE Z6H
M
M
M
M                              AZ_P#J_G_UGK_?3$W^+O\ 3_M2%_&7
M^@_;$PHA$T
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M6215.S?-%2J$R8A<Y+G[N,#X<CW@
M
M
M
M
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MK4MX4M3*>1^FGQG])7_W&W_R5'2/[?7FE_\ -G_Y7C/_  X[#_9HWV_R+_\
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M/XVW_" +4SCVTC/=%A_&V_X0!:F<>VD9[HL/XVW_  @"U,X]M(SW18?QMO\
MA %J9Q[:1GNBP_C;?\( M3./;2,]T6'\;;_A %J9Q[:1GNBP_C;?\( M3./;
M2,]T6'\;;_A %J9Q[:1GNBP_C;?\( M3./;2,]T6'\;;_A %J9Q[:1GNBP_C
M;?\ " +4SCVTC/=%A_&V_P"$ 6IG'MI&>Z+#^-M_P@"U,X]M(SW18?QMO^$
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MED\YSCMTE"J$[./X<=L3.2]G 'WA/Z@
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MI=2T,4C4155$3M*OK'76TS:JOEC<JHB*JY/31/7),?\ A6N/'VIMT>*='_\
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MEP=3./NY_P H^*JKE7A.:(C4L3(A]<?#Z
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M+.+A82);M(V+CFB)<$2002323+CL%+C  VQ]:EXVZ K'2XY@\D8#3>N8S?\
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MDRSKR@623:.'T(]B+(G'1!+/3K2S9.#1[XS-DOE9HY06;IG0SDX$M8
M
M
M
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MF]QZY"JOAH?=^L3"B$30
M                  C;ZI_U<-?_ *X?"7^])JT2J3X5?<.[U2+6?!)[MG?(
M22"*2@                                      ^%9?^Q'O_1O^MH#Z
MG"<7^U/NCX<@
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MI&*HJ>V&=?:/&1EVA7S>4:IJ]LW5+@"Y&
M
M
M
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M5L6W(MBDJBW)[#4%9#7T\=2E1!*V1MLRJEYCD<VU+,J6HEJ$X0Q@9;
M                                                    "'KJ3?6T
MZ17ZX=A_1K(B;3? S>X]<A57PT/N_6)A1")H
M                                  1M]4_ZN&O_ -</A+_>DU:)5)\*
MON'=ZI%K/@D]VSOD))!%)0
M?"LO_8CW_HW_ %M ?4X3B_VI]T?#D
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M@("&;,HJ'BF#9,J:+=NDFBD0N"E+C&.P /1
M
M
M
M                          "'K_ZOY_\ 6>O]],3?XN_T_P"U(7\9?Z#]
ML3"B$30
M               AZZDWUM.D5^N'8?T:R(FTWP,WN/7(55\-#[OUB840B:
M                                                        $;?5
M/^KAK_\ 7#X2_P!Z35HE4GPJ^X=WJD6L^"3W;.^0DD$4E
M                       !\*R_]B/?^C?];0'U.$XO]J?='PY
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M#:.NH:R>I?4SNC5)&M:C4:V]:EWC)JQ3,!@
M
M
M
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MOJG_ %<-?_KA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*
M                        "HSZY[8)ZN=+O0[VO3<O O%N>^KFBKN&DGD6
MZ5:GX]<I%CME%V*R"IVYUFZ9\DSG)<F(7/8[.,=@";'HOOGLETF^G=(2+QU(
M/WG$;2;AV]>N%73MTX5I4891=RY7.HLNLH;/9,8QLFSG^'( DU
M                               &*]Z_D1W'^:O87R1EQ]3A+QL[]H*'
MQR'PC3F'"6>MX                %D[U;/\MW)3\U=3^5RHI2\"&JGG5_9_
M"?')/!EO<4#2,
M
M
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MSC5]4;AID+L'7-JI:'A%4+"@=S#R_M'PTM=DB._$4U$3G[PG8=JZ3[!L=A5
MN?\ )V!>XWOCPJ^Q;'(O#_TBQR,9)BR,>EK53@_Z)8!_9#=-#[&>E_>1[\)"
MW==JNFXN74J7XMINMJ34.L]#:]K^J-/4R%U]KFJ^VO@[4*\@=M#Q'MY-R5DE
M^\T5%%CD[_G9ATZ4[)L]E5<V?\O8$=[WR.5[UM<O&2&,9&U&,2QJ<1D<<3D
M     !#UU)OK:=(K]<.P_HUD1-IO@9O<>N0JKX:'W?K$PHA$T
M                                               (V^J?]7#7_P"N
M'PE_O2:M$JD^%7W#N]4BUGP2>[9WR$D@BDH
M             *@7KJW[K+0?Z_\ JS^[KRJ $WW12_='].7]4#1_R)BP!)^
M                                        ,5[U_(CN/\U>PODC+CZG
M"7C9W[04/CD/A&G,.$L];P                +)WJV?Y;N2GYJZG\KE12EX
M$-5/.K^S^$^.2>#+>XH&D8
M
M
M
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M   "-OJG_5PU_P#KA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*
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M                 &*]Z_D1W'^:O87R1EQ]3A+QL[]H*'QR'PC3F'"6>MX
M               %D[U;/\MW)3\U=3^5RHI2\"&JGG5_9_"?')/!EO<4#2,
M
M
M
M                                             "'K_P"K^?\ UGK_
M 'TQ-_B[_3_M2%_&7^@_;$PHA$T #1WJ1?4NW-_W=_I6HH[7L1]J*7_2>"D-
M-/T@G]T3:[_RO_WK#BJR-@#\T  &5=%?EOTW^=77ORNB!;\6\E5/B\G>*9+W
M+?GCV2_I-A?Y= 7,QK(?K?  J6=,!)0OK"_4V,9,Y2XI?(SLYR0V,8[MR,T8
MHCV<YQV,=U3QDQ?_ ,(N.SC[@O%7Y-B]-O>J6:D\I2^D[OD+:8LY>2I;9T%C
M>M8:Z4*BKDA*,^7.?"9\D(CG@_>VV%C&QCL%2RX/A/ML_<[?."_P_<%X3R0O
MI_MT+,OEA/2_:*98]9MI-LV3JGAAKZAP$E:KK=N0TM5ZI6X=#+F4G+!.50D=
M%1;%'&2X.X>/'!"%[.<%QV>R;.,8SG''"G(UTCG9&HTYXJUSV,:U+7*[UC7W
MDWUP-L\IM!7O@YK+@_O"M\Q]UTF0T_L"H2$2N_851E;FN:SL)>!KO>1+J[+(
M0;YRV;FDVD:E%]^8<+KJE;=A>I%0,AD2H?(U8&K:B^EP<A3EKWS1K3LC<D[D
ML5,V?E,.\]Z;LKC!P4Z??16H'<)3D%R FHJ[[D8Q+_+UDL^MVS).0K]3._0*
M?"U>5VG+J%R\20PEAO4L*]MDIU,FYT[FRU$E<[X-N1.PG-ZI3J6OAIXJ!OPC
MLJ]E>#3ZA,56?5UNF9%UNOQMCUG=;/88Z#B6,[9#;7V+%&L,RT8-V\I.&BXZ
MQI1\::6>IG<9;H%*BCW3M"8P7&,"$N)52JJHJ(GI(3DPRD1$1455]-31/JA=
M"#BQJ3AKLW<G$"@7&L[;T][7;&<I'O=WN&9^A0!UBWF,2CIN2EDFJT5".SS1
M'"!"+ES$]SP?!%%,9KTF(3/G2.945CLG B9>+F[)'J\.A9 KX$5'MR\*KDX^
M<FNZ57+9;FEP=TQN.:<*N+XTBE=>[1463.FHXV)1,I0TY+9R958BA;0V*VER
MY*<V"ED,$SVIRF(6#5PZBH<Q/:\*>DOHL)]'-KZ=KU]MP+Z:>BTD2$8D@
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M57PT/N_6)A1")H
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MU<J29CHIZ)@
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M7#7_ .N'PE_O2:M$JD^%7W#N]4BUGP2>[9WR$D@BDH
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MJQ0]<5"M4.DUN-)E*.KU1J$,RKU;@V"><YRFRB8:.1;I%[.>P1/& !Z\
M                 8KWK^1'<?YJ]A?)&7'U.$O&SOV@H?'(?"-.8<)9ZW@
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MY)X,M[B@:1@
M
M
M                                                         0]?
M_5_/_K/7^^F)O\7?Z?\ :D+^,O\ 0?MB840B:
M                                             $/74F^MITBOUP[#
M^C61$VF^!F]QZY"JOAH?=^L3"B$30
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M/A+_ 'I-6B52?"K[AW>J1:SX)/=L[Y"20124
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M
M
M
M            "'K_ .K^?_6>O]],3?XN_P!/^U(7\9?Z#]L3"B$30
M
M AZZDWUM.D5^N'8?T:R(FTWP,WN/7(55\-#[OUB840B:
M                                          $;?5/^KAK_ /7#X2_W
MI-6B52?"K[AW>J1:SX)/=L[Y"20124
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M6S_+=R4_-74_E<J*4O AJIYU?V?PGQR3P9;W% TC
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ME'TE5I5"2BW+<[=\D@L5=LJGDN#)GQ@"4<
M
M
M                                              !#U_\ 5_/_ *SU
M_OIB;_%W^G_:D+^,O]!^V)A1")H
M                                   0]=2;ZVG2*_7#L/Z-9$3:;X&;
MW'KD*J^&A]WZQ,*(1-
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M_BA]:7C5^?[3GZ1*X.+O:KZ1UO;/['XM]6U7@'G3&$4\G
M#%>]?R([C_-7L+Y(RX^IPEXV=^T%#XY#X1IS#A+/6\                "R
M=ZMG^6[DI^:NI_*Y44I>!#53SJ_L_A/CDG@RWN*!I&
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MMMQ[78*IN;;YZ>0M&[K 5I-=&$8>T.MMLTZLD[R3='QW4K+"ZG;?YPYLXQV
M((.LMZMUT\M1=-KDAL3I^<"+]+<NJZ741M2Q^L-B<LMW7IQB3WOJ^&OV(+5\
MMM*_,+29/6,C-'<8/$/,M&A571,)G0*LF!,ET0^F5QLX&\0M%;$UWQ[FM'<E
MN0'%7C#)<MLVFQ[9=VR5VQ'ZQBIRX1UCI6R;7,L==343?K-,=^149'Q*;1RH
M= R!"HIII@34@
M
M
M                         (2>4=0YPZIZGT/S%XT\-?I8T1[P,C^-,LS^
MD/J+1/M+;7'(2P;1?N>^+\YD9B1]KH>.8%[1*+PV6]LNR5U@[=1+,^)U.^DU
M$K[CM9>]JJY++.(@3-J&5>OBCOMU=WVR)EO6\9['Z9_5G_P6/_,:XU>2PXZB
MC^/]XXY:^L^(]^T?3/ZL_P#@L?\ F-<:O)8-11_'^\<-?6?$>_:/IG]6?_!8
M_P#,:XU>2P:BC^/]XX:^L^(]^T?3/ZL_^"Q_YC7&KR6#44?Q_O'#7UGQ'OVC
MZ9_5G_P6/_,:XU>2P:BC^/\ >.&OK/B/?M'TS^K/_@L?^8UQJ\E@U%'\?[QP
MU]9\1[]H^F?U9_\ !8_\QKC5Y+!J*/X_WCAKZSXCW[1],_JS_P""Q_YC7&KR
M6#44?Q_O'#7UGQ'OVCZ9_5G_ ,%C_P QKC5Y+!J*/X_WCAKZSXCW[1],_JS_
M ."Q_P"8UQJ\E@U%'\?[QPU]9\1[]H^F?U9_\%C_ ,QKC5Y+!J*/X_WCAKZS
MXCW[1],_JS_X+'_F-<:O)8-11_'^\<-?6?$>_:/IG]6?_!8_\QKC5Y+!J*/X
M_P!XX:^L^(]^T?3/ZL_^"Q_YC7&KR6#44?Q_O'#7UGQ'OVCZ9_5G_P %C_S&
MN-7DL&HH_C_>.&OK/B/?M'TS^K/_ (+'_F-<:O)8-11_'^\<-?6?$>_:/IG]
M6?\ P6/_ #&N-7DL&HH_C_>.&OK/B/?M'TS^K/\ X+'_ )C7&KR6#44?Q_O'
M#7UGQ'OVCZ9_5G_P6/\ S&N-7DL&HH_C_>.&OK/B/?M'TS^K/_@L?^8UQJ\E
M@U%'\?[QPU]9\1[]H^F?U9_\%C_S&N-7DL&HH_C_ 'CAKZSXCW[1],_JS_X+
M'_F-<:O)8-11_'^\<-?6?$>_:/IG]6?_  6/_,:XU>2P:BC^/]XX:^L^(]^T
M?3/ZL_\ @L?^8UQJ\E@U%'\?[QPU]9\1[]H^F?U9_P#!8_\ ,:XU>2P:BC^/
M]XX:^L^(]^T?3/ZL_P#@L?\ F-<:O)8-11_'^\<-?6?$>_:/IG]6?_!8_P#,
M:XU>2P:BC^/]XX:^L^(]^T?3/ZL_^"Q_YC7&KR6#44?Q_O'#7UGQ'OVCZ9_5
MG_P6/_,:XU>2P:BC^/\ >.&OK/B/?M'TS^K/_@L?^8UQJ\E@U%'\?[QPU]9\
M1[]H^F?U9_\ !8_\QKC5Y+!J*/X_WCAKZSXCW[1],_JS_P""Q_YC7&KR6#44
M?Q_O'#7UGQ'OVCZ9_5G_ ,%C_P QKC5Y+!J*/X_WCAKZSXCW[1],_JS_ ."Q
M_P"8UQJ\E@U%'\?[QPU]9\1[]H^F?U9_\%C_ ,QKC5Y+!J*/X_WCAKZSXCW[
M1],_JS_X+'_F-<:O)8-11_'^\<-?6?$>_:/IG]6?_!8_\QKC5Y+!J*/X_P!X
MX:^L^(]^T?3/ZL_^"Q_YC7&KR6#44?Q_O'#7UGQ'OVCZ9_5G_P %C_S&N-7D
ML&HH_C_>.&OK/B/?M'TS^K/_ (+'_F-<:O)8-11_'^\<-?6?$>_:/IG]6?\
MP6/_ #&N-7DL&HH_C_>.&OK/B/?M'TS^K/\ X+'_ )C7&KR6#44?Q_O'#7UG
MQ'OVF!;FVZDG+CE/P2M.V>G+]&C7'''?3S9=ON_TO-#;E[K$R-4?0"B7@U6C
M5J=)WJJJ0_;-4WRI^V[&$L8QDPJ)U6&&1&2WW.;8B753C*3NM331J^*XUKK5
M6\B\1/\ BW%R
M          "-OJG_ %<-?_KA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*
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MB@:1@
M
M
M
M
M
M    $;?5/^KAK_\ 7#X2_P!Z35HE4GPJ^X=WJD6L^"3W;.^0DD$4E
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M1;%L7@.K;<8!21;%8Q*CY55N%U:V*K;%L@D7+8U%L])4+B(]V#QQ
M       ,5[U_(CN/\U>PODC+CZG"7C9W[04/CD/A&G,.$L];P
M     +)WJV?Y;N2GYJZG\KE12EX$-5/.K^S^$^.2>#+>XH&D8
M   !K-S4EI6!X;\M)V"DY"%FX7C-OB6AYB)>.8Z5B96.U9:GD?)QD@S41=L)
M!@[1(JBLD<BB2A,&+G!L8R/K?;)Z9VS8*&&IVZP6GJ&-DIY,6HVN:Y$<US75
M$:.:YJVHK515145+%3(ISTOI7\I?M*[^^>/8GE&)-UN9#TW_ )F;'_R3AO\
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M]$TE-2ZSKM_4Q,CO7>J7;UQK;UV\MEMMEJV<*EF,4C4X
M
M
M
M
M
M     "-OJG_5PU_^N'PE_O2:M$JD^%7W#N]4BUGP2>[9WR$D@BDH
M                              /A67_L1[_T;_K: ^IPG%_M3[H^'(
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M#+40HFG8
M
M
M
M
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M7^])JT2J3X5?<.[U2+6?!)[MG?(22"*2@
M           ^%9?^Q'O_ $;_ *V@/J<)Q?[4^Z/AR     *VW47V3.UOE=>8
MEBUBEFR,-25"'=H.SK=E>HQ"I\9,B^;DR7!S9['WO9&O6\#]'#N/\XG:>;>K
MMKBNU=+M#7,CCDCH:F@CIT;3,; Q6,GPRIE159&BOMF<BNM5$:EB)HCOQ_3
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M+,0I2$CJ^4I<8*4I6D@4I2EQV,%+C$IC&,8QC[F!B1?T.7FRN6U<=V\55_\
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MX#2+4XOA%#%CDM?A\+6J][I(_P"<27EB8BND:Y(U5&NU&NR6R>>>:T?_ &A
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M/_AZ%&7B-//.Q_B#]_?P,M1"B:=@
M
M
M
M
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M0V"]@N,YSC ^M1MJ9>/E.Y;NW._K!P+N5\LT7&GXS$<Z\2#U9
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MAP+K>DG;%Y_172G./#;8WH7G?'.A_#@76]).V+S^BNE.<>&VQO0O.^.=#^'
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MJMSJ^I'S&_56Y"?HDMP^M]LGIG<=W?YP,"^N*+\IC.;&)9ZK
M     6H_5G/]=?\ V</_ (>A1EXC3SSL?X@_?W\#+40HFG8
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MJX<.4\(F.7">#&[; $X
M
M
M
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M   C;ZI_U<-?_KA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*
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M#H?R-AAGO83[-0^[D[]Q^;C](O\ WKL<\3PW\@@- 1W T<
M ,JZ*_+?IO\ .KKWY71 M^+>2JGQ>3O%,E[EOSQ[)?TFPO\ +H"YF-9#];X
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MB-//.Q_B#]_?P,M1"B:=@
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MX@
M
M
M
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M2ZDC=J!>Y2*:L)]K'SD4RM9M+PT)7F[U)";<O)"0=FCT63%9P +YH
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MRJMD5[5IELL;DL2Q"?3U9S_77_V</_AZ%.7B-;O.Q_B#]_?P,M1"B:=@
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M!C<M:WN9;Q1%EI->N4W:U8H]ELR,>U;G76/'M7)4FQ<K&SA+[\ 26
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MI "YV
M         #^:RR+=%5PX530003.LNNL<J2***1<G4554/DI$TTR%SDQLYQC&
M,=G( K,\@/6U.D7H?;4CJ=C9-X[WQ"2[B#G-E:%UW6K/JJ/?,S%2>G9V>V["
MHKVVQB#CMDROH%E*LG/<\G;JK)&(H<";KAGS@XP\_P#3$9OKBEM*(V?K]Z[-
M$R9VJ+V*L50LJ#5J\?U*[5>7;LYRKV2/1>)G,@Y1*59%0BZ!UFZJ2QP-L !
MWU /6/NF-T[=DS&EME7K8&X=RU9SEG==9\=:E$WJ9HS_ +5(_M5;+#9[70]?
M1L\EA7.%XTLRI),S$R5R@B;),& V;Z<?6/X(=4ME94.+.RY-6_4M@A+V_3VQ
MH!6D[2@8-RX3:(V L&JZD8JQ5\KQ5-!=[#/Y)LS7623<G1471*H!*2
M
M
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MY(F7'\!<=@#(               /A67_ +$>_P#1O^MH#ZG"<7^U/NCX<@
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M-&<NHS1/)-&JW=5NZMF[PQR$-VY^V+C&>VS_  @#ZH
M
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M(-N2'>2+E:ZZ_B) N2&.G<$<JN,E?(+'(!>)
M
M
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MF2D+C&.SG/8QC&!'?[93S6WV1LBWHXO'&U&L2:.Q$2Q$_ 1<2$CPX&+
M  /A67_L1[_T;_K: ^IPG%_M3[H^'(     JZ]3CZX5__P!!T/Y&PPSWL)]F
MH?=R=^X_-Q^D7_O78YXGAOY! : CN!HX               95T5^6_3?YU=>
M_*Z(%OQ;R54^+R=XIDO<M^>/9+^DV%_ET!<S&LA^M\               \-L
M_P#)KL/\1K;_ "!("70?/H?E6=\ATS>/^;W'OJ:M_)I2E@-H#\A
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M!]6<_P!=?_9P_P#AZ'R7B.M>=C_$'[^_@9:B%$T[
M  JJ[ZZ!G+O27+S;?,KHO<\6'".Q<AI-[/[FT?>J6TMFFY&SR4@XE)*9@XIW
M7+[5U(Q>3EG[UG%R58=^TCITN6.=MVJQ6S<"OQH3B3O?G'ZQGHNK;2YPR?4F
MD>&4Y4=U<JM_L::C6-):RF-+W9];HW1.N8Z-<2=,>5M>^-(>-=)Q[&&9.I62
MED2,\X8.7:P'2Q &K/-#F+HW@5QPV/R@Y"V=.MZ[UU%&<9;HF;J6"WV-W@R-
M<HE,C%UV^9JWVJ2[5NS;X,4A>R998Z39%99,"K5TBN(_(#J\\Q4NNWU'Z^[B
M-?04F<W3EXTR:JCJM4ZLP,T[5J.R"LG16QUH.H/"*.HEVNS;+V:R'/8,$1:(
MQQ%P+G8                      "F=ZQ'9+%#\U=7MHB?FHMLIQ<I2YV\=
M*/F*!US;8W:F98Z39=),RIDTBER;..SG!<8_@Q@5XO:]DWM\V"EI9]@:Q\T<
M;W_3$J6N:BK9U:DR6JA KX=7;XXVKQAEO98J&Q_T?0?$0_L&\P\.KM\<;5XP
MRWLL!]'T'Q$/[!O,/#J[?'&U>,,M[+ ?1]!\1#^P;S#PZNWQQM7C#+>RP'T?
M0?$0_L&\P\.KM\<;5XPRWLL!]'T'Q$/[!O,/#J[?'&U>,,M[+ ?1]!\1#^P;
MS#PZNWQQM7C#+>RP'T?0?$0_L&\P\.KM\<;5XPRWLL!]'T'Q$/[!O,/#J[?'
M&U>,,M[+ ?1]!\1#^P;S#PZNWQQM7C#+>RP'T?0?$0_L&\P\.KM\<;5XPRWL
ML!]'T'Q$/[!O,=1L1#R#                      K<\\O6-M;\;N3%BX6<
M..(F]^I-RHH7?J6S=?:!1F4H&BRL;EMF6K#F>JU!VO9YRS5PB^<2Z<?7W#&*
M<=AHN[*\(Y;M@,M],'KZZ(ZAVY;3Q.OVD]M\,>9U182,N^X[;O:+8D9F-AXY
MI*32=:G'<+5956P0<:Y[\=Q4I#1+[VO_ .=-R.$2.#-P)ZP!%MU3NKEQ9Z2V
MIZU?]_K62TW38[^5A]0Z8U\WCGVP-BR4*@T5F7C8DH^CHV$J5=/)LRR<HY5[
M1N9XBFDDX<*I(* 0BP_K7\SK6P4J8YT=)'F=PSX_;&DVS&F;ZL2%KL<7+LWR
M.'369;0-TTKIMC-L$F*A'3A.$EYAWAIVQVZ+DV")G MI:\V#2=LT*F;1UK9X
MBZZ]V)5X*ZT>WU]V1]"6>J6:,;3$#.Q3M/[UPPE(QXDLD;[F<E/CLXQGLX '
ML0                         !YVWU&K[ J=HH=W@(JUTN[5V;J-NJ\ZR0
MDH.R5>R1KF&GX"9CG)%&S^*F(IZJW<(J%,15%0Q38SC.0!3<Y6= CBMTX=>[
MNY"TWJZ\Y>GGPF=*2-@V5H_6NS9A%C9'DFQ4:15 ISN(M5:=W6:EE^RQB8Z4
MBK%*.D3%0.NIVJBX \#ZH?P!-4;%RNZE3>H7ZDZCW<:?T?Q!CMIOV<OL:?T>
MCL)"V6VXVR;BF<+#SKM_-T^ C5'[2/:M7LK$R1VZ:3?"93 75*]L&A6Z9ME<
MJEWJ%GL-"D6T/>H&O66&FIFERSQ%1PTB[9%QKUR^KDBZ;HG.F@\(BJ<A<F*7
M.,9R *^'7DZNEVXG0E0X'<%F#W:'4RY:IH5'5]1IS=.;GM-5JU&6BB;,D&.#
M8:M;>_+A?%;2>F(T;';K2S[_ )BR[D[ V5Z)72*J/2MX[/FMID&6QN7N\7#6
MZ<HMUJ.G4R[GK0J9=ZA2*W.RK="8<TBIO)!R<B[DI74M).73]Q@N5DD&P$U(
M
M
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M-_G5U[\KH@6_%O)53XO)WBF2]RWYX]DOZ387^70%S,:R'ZWP
M  #PVS_R:[#_ !&MO\@2 ET'SZ'Y5G?(=,WC_F]Q[ZFK?R:4I8#: _(0
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M4[>#10Z4Z^E7[21;8>J]S(OWNR[B!I!UX.BUU;^JWR:JLYJOD'P[J_$/3+>
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M$;&MEUE5531T7G;JC=N3.<%013*B0I4TR8 %HH
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MW\NMJP)?!&>L+6<:]U@W9LO(Q+!#(GSA9,"QR
M
M
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M9QS3NGV\2&5L(EEWA[W)\;8Y5V6V91]/!8O<RULB*V9Z6+8J,;:VU,BHV)W
MY2$\5#/H '0=Z0'[M[BY^*ML_27=1&?[=3S.WX?G4QCY:/P$1)0.!BD
M "H%ZZM^ZRT'^O\ ZL_NZ\J@!-]T4OW1_3E_5 T?\B8L 2?@    JZ]3CZX5
M_P#]!T/Y&PPSWL)]FH?=R=^X_-Q^D7_O78YXGAOY! : CN!HX
M    95T5^6_3?YU=>_*Z(%OQ;R54^+R=XIDO<M^>/9+^DV%_ET!<S&LA^M\
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M'7JQ:VDF=$^XJJV\Q;%NJJ(JI:F151/2,DCX6H
M
M
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MK5!C'1L<Q03:LF#!DU32;,V3-LD5-)),I2)D+@I<8QC& !^T
M         5AO66/_ ')XD_C5M_\ DG7XK1<9MQYJ/S_&OD:;OIBIF*QN>
M             !T<NG)]0SB)^8'6OR;9"*[VR^F>6N]+\X^-_64_?J;ICB="
M
M
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MV!GG86S^;<-G!?D[]Q^;S](M;_:MQR]P]3PW\@@-&1V\T=
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M?!#9QG)<]CL#ZU66I8B\.<[ENZ27^L' K52SZ9HN+_YF(YUXD'JT
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M$62<R<F990Q_NX-@Q<8Q]SL?Y15CLLR&[_FI(Y-GL6O*BKUR/P977%0VM
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MZ#5-Y1_97V0_E+$_^H_U0_XC#F#Z+- >\EZ\N@U3>4?V5]D/Y2Q/_J/]4/\
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M9+G30/:?<_QWHOB1*>586LS+I]@62YTT#VGW/\=Z+XD2GE6%K,RZ?8%DN=-
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MB3#1P^D%,*$QV>V-W3.#?^S XK9;DX"HV]9W7"?;'P^@
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M>9V_#\ZF,?+1^ B)*!P,4@      ?"LO_8CW_HW_ %M ?4X3B_VI]T?#D
M  5=>IQ]<*__ .@Z'\C889[V$^S4/NY._<?FX_2+_P!Z['/$\-_((#0$=P-'
M               #*NBORWZ;_.KKWY71 M^+>2JGQ>3O%,E[EOSQ[)?TFPO\
MN@+F8UD/UO@              'AMG_DUV'^(UM_D"0$N@^?0_*L[Y#IF\?\
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M3]^INF.)T(
M
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MKKU./KA7_P#T'0_D;##/>PGV:A]W)W[C\W'Z1?\ O78YXGAOY! : CN!HX
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M/6-/KN:M_56I'Z6]X"O%[7LF^OFM_F_K/KB7\FI"#*@_^_=*_&VN?RPS%1>
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MU-TQQ.A
M
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M !&MO\@2 ET'SZ'Y5G?(=,WC_F]Q[ZFK?R:4I8#: _(0
M!,7T=?RE;C_$:"_E\XQIO+^8TWRKN]/6+]$]^<+:SZFIORE2?T8?/<@
M          Q;O+\B>X?S6[!^24N,/></^8#;G^AV,_\ MM2=[W6_G-V<^O:#
M\KB*WH_*J>S@ &F?,WE%L?B[5J;8-;\6-O\ *A_:+ ]AI&NZ@C)Z3DZLT:QV
M7J<U,$@:A;UDF+M;'<"9421+E3^ V<_<&<]Q>Z39?>YB]=ANU&U^";(4])3-
ME9-B4D,<=0YS[BQ1K-4TR*]J=VMCG+9Q)PF.=XVV^,;$4--5X-@6(8[+/*K'
M1TC7N=$B-O7WW(I51JKW*6HB6\9 'K'D$OU%.JQHF1Y65]KQ(^C8FE.Z5X_7
MI&U-K_>MB(3"%@BFSZ;L=7K<:28Q.1+1]E!5".5728-VC-!TJ9PX)Z/[6;MH
M_-C\SW:&FW/5+]M/YTJL6*8Q2+3NHZ2B6)89',B@J)WK%JI)(K[7S-8Z:2:>
M2%B11NU2P3:QV][?KA<VW<3< ^AD1]'03I*D\]0CTD:CGR11MOWV,?=5L:N1
MC(XV/<KWI;('C:;YGSY:5C8&*DYR:?-8N'AH]Y*RTF^6(V91T;'-E'CY\\<*
M9*F@U:-43J*'-G!2D+G.?N8$FCHZK$:R+#Z&-\U=/(V..-B*YSWO<C6,:U,J
MN<Y41$3*JJB%&HGAI8'U52YK*>-BN<YRV-:UJ6N<JKP(B(JJO$A7 Z9D;+<^
M.H#R.ZE-S8+GU[KF3>ZDXYMWA54T&1E(H\6@JU06:IF(]@=;/\+OB'[GG$A:
M#*%+DQ<]IZB^=;547FY^;=LOYJ^!2-3:7%(FXCC2ML5762:Q4<J.6ULU<RY$
MJ6_@:!&JMB]UIWN6AJ-ZF]C&-\N(M5<)HWK2X>BVV)W-U%1%3A93NO/1;/PE
M2JHEJ9)@N3_3[XD\Q)6"L&_M3,K99JXU2C8RTQL[9:C8\0R3E=V6"?2]4EX9
MW*0Y7#I8Z:#G*I6YUE#(]S.<QLZ2[I?.3WS[D*.HPW=QC,E'A-4]7R4[XH*F
M#6JU&ZUD=1'*V.6QK45[$:KT:U'WD:B)L)MMNFV!WASQ5>U= VHK86HULK7R
M127$55N.?$]BN9:JJC76W555;8JJI&G Z?UMR(ZA&NN/&IJA$UKAOTN(Q*S3
M%7@V^<5.>Y-6YTI(PD*ME5-92:D*HLU[\>+NUG#CVP8OR+&[9V<RFU.([;;4
M[LO-JQ/>9MG6S56_'>Y*L$4\KO\ :(<"IFHR65+%1(F5".U43(VL9J9:=S$L
MA:C<,TNSV#;7;VJ/9' *>.'=WL.Q)'Q,3\$_$I5O,8MMM]T2I?>YRN=K&2HY
M;9%59^1YQ&U@ $I734__ ,T_]W/_ .G@]AOT3W_\??\ D?\ ]7-$_/5__AK_
M ,Q_@)*4/84T4               *A'K)GY;N-?YJ[9\KDA7BX%-W/-4^S^+
M>.1^#*V(JFU98GY<_N!.!/Y_(_\ DKE&*3?A%](U@V*_O)[2?5J]]AYD'B3R
M*Z95"Z>B/'*7Y3VWCOM3<D<=WR/M-&U7LR<O\JX<KR31W4$K:VU+8X%* ]H5
MB,DRLE%BHLUG!2'PLY<*F^*CU=;9:A;-M=E][6);SEVI@P>#%,'H764,<U1
MR%J(C5275K4L??OHKEO(EKD:JI=8U$VRZ1>I>FO0N2-VF.'/*C9N\=FN=(62
M-G:G=*#9ZK%Q]$6OFM74G8F\A-:JHS59^TL#.+;$1*[44,F[.;")L$,=/X]7
MJG=)D.E[[,:WK8ELK3P;=8/28?A*8@QS)(IHY'.F2&=&L5K:B94:K%D=;=1+
M6HEY+;%KQ;KXT:/NV]J+J'IMWC9_+ EIJJK^0Q*TN6KDXPLS-Y+*R3%)"=J5
M#[6&80#1!TL\6;E;(]T-@R_W,X+415LM=D-G< VLVAP_9VHQO>K3TF"K#-8E
MV5KV+&J-NK:R2;NE>JM1J+>6Q+&FO56XP[_N>\#\;:YJJV/MXHS$A!.]=+-$
MHR:CG\4D=Q(FEEI9=C&1$:R:)Y74>N5TF16^<*]U[F8IL\K4LMXCL]9M=LU0
M;/\ \ZJJLA;L\K$>DZ*KFN1RV-NHU%<YRKD1C45]N2[:BH;+:\YB]2K1^V8*
MA0>Y.3!MAU:7851AI>\3M[O#<SEB=)HUJ)]5VYQ,,E43H(E03019D4*CV.X&
M)V"FQQ5K%3BL.IXGL-NIVAP63$JBAPGZ,F8LBU43(8EL6U5EZQ&C5MM6U55R
MHJ^V1<J&_GK 6KZ#5=K<=MG1]=A*7N;<NM9J:WC5((B)6Y9R#5K*$58GJK94
MR$A)2+V5E(Y1W@O;N4X=,QCJ&[.<<8U6Q4XC&WFU8OB59@V*81)+)/@-!5L;
M22/MMN/217,1%RM:U&QO1O U951$0UDZ7=-J6KS;@ZA6WHU-[K;B)!%5H$0[
MQ@J=]Y%6Q',;KJLL,&.4SA2$4>E>KF3P8[!59HZ-CN:9\XY/R]RG"IVW>]7U
MN+I0[LL$>K<5QN2R9R?Y&BC6]/(N:_9<1%R/1'LX50R[4-'<0$M.Z[YD]2"W
M;]NU]YV["V?)4J/T<TCE6U11AK;B+LUNM[E^4ZKJ2S,R!%FK%J9T9-DJ1))@
MZ426PA\M=;=;9D+)7;0[;KCM5L+NK@PVGPW9VEIVRNJU=;(KH[T<<2)P-NML
M<]UVUR*YTC$5MZ/SGQQ1SPNY07[0S>R*6Z"@TX.=JEA=)-VTF_K-GB6TO&IS
M+5J;*"$Q&Y74:.,DPFFN=#NQ")IJE(7DUUY+3)>[?;+^?NR--M&Z)(*B17LD
M8BJK4DC<K7757*K76(Y+;51%NJJJBJO0HT5^1'3GYJ]>_)&($9>$\RMHOM!7
M>.3>$<94'PLX              !2T]8T^NYJW]5:D?I;W@*\7M>R;Z^:W^;^
ML^N)?R:D()JD_:Q5JK,H]/E-E&V"&?NU"D,H9-JSD6SAP<J9,&.IDJ2><XQC
M&<Y_@P*AL36QOFHY88\LCXG(GIJU40EXZOO,[6>_>8^K=Z<2-MV!\WHNC:G5
MVFP*NRO^M;!7[K%;!VI.N4X=S/1-1M#-TUB;0T/AVV(5//=LE*IDQ3X+P8U4
M;8XPEN0V#Q;9O86LV>VUHHFNJ,0DD6&189V/B=#3L2\C'21JBNC<EURVY+52
MQ4-#_IU<W/MC<J?_ *(3;?E<.5UN9#(O]7>[_P#D+!_]RIO]62<;4ZFDK+]+
M/C?JRG<K]UDYG5[=%@E]O2C&V;EBK\[UVO+;Y5C6\]MI3O-G:H@S"PUDI&!9
MAV9,J*!<HE[T["7%&=VJV=R8EP?=-#!O@Q7&*[!J#^8<M QM,U8Z5T*3HVC1
MRLILJQNM9/:_5-MM<MY;^7!/3XV!TU*[JKDBUYT5*6L^R[ QSG7,CB+M4W(/
MXU:)>8<Q5)DX)H\:4Z_*3Y^[YEI,R*&2&2QA8I2+)K'(^U+O =BWF89O7JL9
MPI^[N=D.$Q._#MO1L:CD<ECI6O5%EAN9-7&BK;>[E;6JW0B@<H.2VJ*\2HZM
MY#[SUK5$G;J03K% VU?J=7DW[W)3/'I(6NV".C2.W9B%RJIA+MU,XQVV<]@<
MU1%X40R1B6R.R>,U77<8PO#JNL5J-UDU-#*^Q.!+SV.=8G$EMB$@W3SZCNV-
M?<PM06[E3RYY 2.A8G-]Q?&=TV5N/9595Q(:PNL76#2=):O[0XFL(W)]'*)=
MJP<9;+E(OV"=R[<O!S45N1$M,9[SMUF"XGL/746QV"88W:1^IU*Q04L$G<U$
M3I+LJI&C+8D>B]VEY+6Y;;%U$YM\D[AR,Y";DG5]O[#V;J3&Z]NSVE6-PM%R
MDX*N4&R7>5>5I*I5:V.>VID<O62,2%9)M69D$4DT3I$[E@A>34L3E.[;O]E*
M'9;9FAIVT-+28UU"F95+%'$U[YF1-23621I^%<DE];ZN=:JJY%6VU<R[NY$:
MIK7!GCYQ X^6-S-GL+M7?'+.QEA)NOYE=N22232N:T,:9C(M>8B]:QB.$UE6
M^744\<H-'""IE$SYQ\1%O*Y2P[/[,8S5[P\3VWVFB2-(F]3PYE]C[M,VU7S]
MRYR-=.Y;41UV1K5>UR(BH2)ZUYF<!-F(\+.0>]=T;UTQNGA%K>A:_1T90*Y/
M3-1VB;6*F3PLG5).*BU:_7VMLP0J<XVD'L?W]'=I''-E) KA3BK7):B<"F,,
M5V$WDX2[']F=G:##J_ -H*J:9:N9[&R4^O\ ;MD:YU]ZQ\,+F-?<?;*B6N5J
M0><F]Q)<@^0FY=VMX%&L-=H;#L]Q9P"7<\FC&,Q)+.&3=XJC_FG,IWIDAG:Q
M<8*NZ,HIC&,&[ YHEB6&P>R6!KLSLS0;/ND69]'2QQ*_I*UJ(JI;P-MMNIQ-
ML3B.FB(IY,@              'E;W_[D7+\5;#_)#P"9AWE"#Y9G?(<N03#U
M[                 LG>K9_ENY*?FKJ?RN5%*7@0U4\ZO[/X3XY)X,M[B@:
M1@              %8;UEC_W)XD_C5M_^2=?BM%QFW'FH_/\:^1IN^F*TO&S
M=[SC=N^@[OCJ94=@26OG\C*QM4O;$\C5WTD[@I6(CWD@U2.FME>#>2)'[11,
MY%47C5)0ARG+@V*JI:EAM=M7L^S:K9^IV?EGGIHJEK6NDA6[(C4>USD:O!8]
M&JQR*BHK7*BHJ+86$NIENV\\CNC%Q#W=LE:+6NVPN249+SN86.+%1"2C>M\E
MXMFTCF!5%S-VC*-CT42=NHJJ;"?;*'.?)CYI,2R143,:S;IMG\.V6W\8WL_A
M2/3#Z7"G-9?=><MKZ!RJY<EJJYRJMB(F6Q$1+$($I[F%R2LFA*?QCE=KV8VD
MJ.O)J0M):.$XYJNWDE^^L14\]8)MY&R0D8Y.J=BS?JN&[/*QNY$+C!,$J74M
MMXS8^FV'V5I=I)]K8:*'^<%0C;TJI>5%:EEYB+:V-[DL1[F(USK$M5<MLX'3
M@E[57>DMU"K+R!?R+[CB_I\S5]-Q5E67<MO#-S5;!7YE&G$D5<E;-)"\S59;
M,3MNT;HS3=<Y,E736R6F_P!NEG":^[TX*.JWT[,4FS36MVI;.V2J=&B(NJ21
MCVK+=3*K863N>CK56)S47N5;;6H%8VM-EZGS"Y)470T_QIIVU[-6M.V>QFL\
MQ685PG'.5WB[;#:1CTI]JFE/-J_,X334>QR;DK-TJE@RB><F4[?C=2VWC.J5
MNP^RN([1Q;65U%#+CL,6K;(]+R(B+:U;B]PKVY48]6WFHMB+P639>K_2EZ@2
M<M+C?Y9VCP]J6H)!38+*QG7=4DMR37;S2SEI'O3'C5%F>NF<U[;D1)DQT';3
M#CLX.AC/"3BL]L8!\Y6'#JE<%H<-8U=N)ZYNI5EB2ZJQ6(BN3NK%G6+5JJY%
M:^[P.-!>)O+CC57]#;OX:<J:9M1UQVVKLF/VO4K5J!] XV1KBXQB49'E<%:6
MA52%DVTA"U^/;J**8<]QPFMC*"^5BG0Y*U;4<G"9(VTV*VKJ=H\/V[V.GHV[
M44=(ZGDCJ4?J)XG7G66Q]VU6O>]R(EVVUO=-NJCI)]+[BX_\B]C4/<L10;/2
M>!/2#TI+6:EL]A*L7UUV%M:P.(_-3Q-*,COXA"<G9NI-'S5HBZ6SB48(]G!4
MWG<$>"HJ)9^N<IBK'L#VEV7PNIP*>IAJ-Y&V]>V.5845(H:=B.UEVVQRL8R1
MS'.5J?@WNX5CO.KO;PW!;M_[>V+NB^.N^K7LBU2EHE>U.8[=EW\OGO&'8]OV
M#$BX*-(BR:$__IMD"%_R"JB6)8;/;/8'0[-8)2X#AR645+"V-N=;$RN7[I[K
M7.7C<JJ8J'TO!T<NG)]0SB)^8'6OR;9"*[VR^F>6N]+\X^-_64_?J;ICB="
M
M
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MD2W:S:6=:R952Q60NM6GB1%RM:C'*]&_K4>UB^T0ED&FQGH "P'Q#^KCJ_\
MT7+?*6:'Z8?,B_NL;(>)U'Y=5'D?YPWYY<<^7B_)H39$;5&&       *@7KJ
MW[K+0?Z_^K/[NO*H 3?=%+]T?TY?U0-'_(F+ $GX    *NO4X^N%?_\ 0=#^
M1L,,]["?9J'W<G?N/S<?I%_[UV.>)X;^00&@([@:.               &5=%
M?EOTW^=77ORNB!;\6\E5/B\G>*9+W+?GCV2_I-A?Y= 7,QK(?K?
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M /-/_=S_ /IX/8;]$]__ !]_Y'_]7-$_/5__ (:_\Q_@)*4/84T4
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MN\<F\(XRH/A9P              "EIZQI]=S5OZJU(_2WO 5XO:]DWU\UO\
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MGY@=:_)MD(KO;+Z9Y:[TOSCXW]93]^INF.)T(
M
M
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MJXZO_P!%RWREFA^F'S(O[K&R'B=1^751Y'^<-^>7'/EXOR:$V1&U1A@
M "H%ZZM^ZRT'^O\ ZL_NZ\J@!-]T4OW1_3E_5 T?\B8L 2?@    JZ]3CZX5
M_P#]!T/Y&PPSWL)]FH?=R=^X_-Q^D7_O78YXGAOY! : CN!HX
M    95T5^6_3?YU=>_*Z(%OQ;R54^+R=XIDO<M^>/9+^DV%_ET!<S&LA^M\
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M+.               4M/6-/KN:M_56I'Z6]X"O%[7LF^OFM_F_K/KB7\FI"
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MK;(H1S,RG1RZ<GU#.(GY@=:_)MD(KO;+Z9Y:[TOSCXW]93]^INF.)T(
M
M
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MD[]6OD+^8[;/R"GQ=<!\N47C</A&F&O.-_N][>?T,QO_ -MJ2G0-EC\G0
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M3/+7>E^<?&_K*?OU-TQQ.A
M
M
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M0OYCML_(*?%UP'RY1>-P^$:8:\XW^[WMY_0S&_\ VVI*= V6/R=
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M@%3%58>Y52^Q>!R66M<U41S'(BHJM>C7(BHJI8J'\:AL&G7TUB+4)M&;Q5+
M\J\\JW;/DF[.=8%3.[9).735NWD,(E6+GNS8RR&>S]P^0147@.&";2X'M&M4
MF"5#:A*.I=3S*UKT1LK+%<U'.:B/LM3NF*YB\3E/9#Z7P #JBB&>/
M        !Y6]_P#N1<OQ5L/\D/ )F'>4(/EF=\ARY!,/7LF:Z=_+/0.B>%_4
M<U+M2]'K&P-\:BG*OJ>!Q5KC-XM<[(:KVA6&['$K7J_+0T%_\V;"S2,K).&:
M.,+=OV^2$4R2FYJJY%3@0P1O/V+VDVBV\V6QK!Z?78;AM<R2H?K(F:MC:BGD
M5;KWM<_N6.6R-KER666JENG/!7;_ !?T]MV2DN6FBL;QU=::C+TU=!%0J\M1
M',YW-NM<H.$<O(YA+RK5AE5%(^7+5ZP,KAVR6(Y13P;DY%5,G"=ZWB8'M?CF
M",BV+Q'Z/QB&=LJ*N1LR,RI$]Z(Y6M5;%5+KFOLN2-5CELD_H$=T%=*[!A=^
M1&\>0^T'-2F65OJNA):C615-I/13I*5BF\C(OM<4Z&GVD=(LBY1;.K!ANK@R
M9'2CA/"N3</PBY,AB+$I?..Q_#)-FY\/PNC9/&L4E8V9F5CDNN5K4GE<Q7-7
M*YL-Y,JL1JW;--]P\V-6\R>HA2.07)VER33CE'3U9JKNA,';M_*1NIZZO)+Q
MZ$LM&Y3=R2CF;E5I.6;,>T,J1PNV;FSGM%,\D:K6V)PG>L#V QC87=A4;,[(
MU#%VI?')(DRHB-=4O1J.5J.R-L8U(XW/ML5&O<G"A_#E9R&XU:OYXT_D#TXH
MTE;I&O24NQ-BEA9ROU.<O<6ZD<68L%5K&RC9N$I\]7%&L>[:JMV^5%LNU$RD
M*J3L$15;8[A.6QNS&U>+[N9]FMZ;];B%5K6+W3'R,A<C=7?D8KF/E8^\]KD5
MUB7$555JDA&U=Q=$?G18VW(S?UHWGQQW.]BXH^P]?TR$F'K"^S42T33/ES*P
M.L=A0\@=9!H1B203=5UTZ;X347(DK@RA.")(W(F5#&>#8'YP&[RE79;9J'#L
M5P%KW:F:5[46%CEXFOJ(7-L55>K%;.UJVHU7)8BZ!]1_GC0>3+'4NAN.5$>Z
MQXK<>F#B-U[7Y--%&8LDH9N2,Q9Y1J1S(J,$&\:D9-HDJZ</%3.G+EVIE=QW
M-'FUMF5>%3).ZS=SB6R<E;M'M34MJ]L<3<CIGMM5K&VWM6U;&VJKLKE1J-2Z
MUC$NMM=Y.M\B-4Z3Z=EETYJ>QN9#D=RHORI.0SI*$FXP^O\ 2E"=N4JEKYK/
MO8QI'2Y[X^/[8.#1CMTGAB[<M'F"&R0@6*KK5X$)E5LQC./[T(L=QJ)&[+8/
M3)U)+[':ZJF1-9,K$<KFZE.X1)&M6^UCV6I:IM)H[D3PCW=Q)XVZ%Y4[JW+Q
MGL_#ZX7:QU:0U5"6*9AMM1-NL^;;C*'@O"32]8V-&N39;,I)V1))B8R[@BQ\
MO5$T/BHY'*K<MIU#:'9?>!L_MKBNT>QU!08M28Y!$R1M0]C74SHX]7EUCV))
M Y.Z?&U55_<M5J:M%=HUU&.4E<YC<M=D;QIM?=5VH3"=>K]8;RC=NVGY&%JD
M&R@VLW8DVJ[I DK+9:&5PF513O9ME)#)SY2R<W)B76V&0]UVQ]5L-L52[/5T
MJ2US%>^16JJL:Z1ZO5C+41;K;;+;$O.O.L2VPEK]6S_+=R4_-74_E<J.$O A
MA7SJ_L_A/CDG@RWN*!I&               5AO66/_<GB3^-6W_Y)U^*T7&;
M<>:C\_QKY&F[Z8J9BL;G@                ='+IR?4,XB?F!UK\FV0BN]L
MOIGEKO2_./C?UE/WZFZ8XG0@
M
M
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M9^04^+K@/ERB\;A\(TPUYQO]WO;S^AF-_P#MM24Z!LL?DZ
M   G$Z,W^LA_W/\ _P *0Q5O._[#_IO_ (1[*_HD/_N!_P"1?_6"<08I/94
M              J$>LF?ENXU_FKMGRN2%>+@4W<\U3[/XMXY'X,K8BJ;5@
M              =/'17Y$=.?FKU[\D8@1%X3R0VB^T%=XY-X1QE0?"S@
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M>6-]C!_6MO1_YDQ__P!0J_\ 7#Z.P_XB']@WF+6H_6:>&@
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M%5,IY/;V8G0;S,=A=8KFXG.BV<%J/6VSDT>DAM&.YF/0
M
M
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MC,^XQUNUM1D3R=)X:G,$><*U&[%TJVKY4CX5_P Q4E%0;6FG(
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MKW=;P,4?@NS=<K\4:CE;')')$Z5K<JNBOM2^B)W2MR/1MKE8B(JIOZ-<#*X
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M\T<?\>=L?.39O987US)H&K3.[2H\T<?\>=L?.39O987US)H&K3.[2H\T<?\
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M=N9!%HS4.^,5PIDHHUL\2QLIH%MC9Q\OHM*M%3S-E?4SY)'\69/186!Q;BY
M  !&WU3_ *N&O_UP^$O]Z35HE4GPJ^X=WJD6L^"3W;.^0DD$4E        !6
MK]:9_=]Z>_7'U]^A/D(,T;BOM;4?5TGAJ<P/YPWV+I?K2/P%24'1M>:;
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MY2MQ_B-!?R^<8TWE_,:;Y5W>GK%^B>_.%M9]34WY2I/Z,/GN0
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M?.W_ .;/_P KP;_AQD[Z&PWXOWS_ +X?0BXP>C+_ .[387E8']OWSM_^;/\
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M1J?^'C_$X\W#XC:7_<H/^^%],>T!IP               >5O?_N1<OQ5L/\
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M^(-;_DY$?J1\UO\ NY[$_P!&Z'P##QRWQ_G5VA^MJGPCC,XST8U
M
M
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MX^OOT)\A!FC<5]K:CZND\-3F!_.&^Q=+]:1^ J2@Z-KS38
M  #IM=#S]U5P_P#Q.N?Z6+^-)=Y_V\Q'Y1G@HS?O=)^;K#/DG^&D)7!T(R,
M     !4"]=6_=9:#_7_U9_=UY5 ";[HI?NC^G+^J!H_Y$Q8 D_    !5UZG'
MUPK_ /Z#H?R-AAGO83[-0^[D[]Q^;C](O_>NQSQ/#?R" T!'<#1P
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M_N?_ /A2&*MYW_8?]-_\(]E?T2'_ -P/_(O_ *P3B#%)[*@
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MOQ5KW\D-!^MK=W^;_ OJ>B_)HSQ&VI^T^(^/U'A7GJAW$L(
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MMH]FZ''L>J9JS&JRFCEGGE<KY)9'M1SWO>ZU7.<JJJJJVJIO&+:7\
M
M
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MXXWZ(F9<DK9K;:M/SDBKNJ*U5GVW9IP,\T;/4&$O@R+5%)<Y4VB")@+DH
M              "-OJG_ %<-?_KA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((
MI*        "M7ZTS^[[T]^N/K[]"?(09HW%?:VH^KI/#4Y@?SAOL72_6D?@*
MDH.C:\TV                 Z;70\_=5</_ ,3KG^EB_C27>?\ ;S$?E&>"
MC-^]TGYNL,^2?X:0E<'0C(P      %0+UU;]UEH/]?\ U9_=UY5 ";[HI?NC
M^G+^J!H_Y$Q8 D_    !5UZG'UPK_P#Z#H?R-AAGO83[-0^[D[]Q^;C](O\
MWKL<\3PW\@@- 1W T<               ,JZ*_+?IO\ .KKWY71 M^+>2JGQ
M>3O%,E[EOSQ[)?TFPO\ +H"YF-9#];X              !X;9_Y-=A_B-;?Y
M D!+H/GT/RK.^0Z9O'_-[CWU-6_DTI2P&T!^0@                "8OHZ_
ME*W'^(T%_+YQC3>7\QIOE7=Z>L7Z)[\X6UGU-3?E*D_HP^>Y
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MV&MQ"=DT.IIGSHK&,N.M5B]RJ.XEX4RD-G[43AU\>K%XA6WX+&G/^#YYZ?\
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MBN7*Y38#8/9&AV$V2H=E:"Q8J2%&N<B6:R5>ZED7E?(KG<B*B<"(;#C&9VX
M  )(.G!_[[;(_%6*_E<P]5?T5GYP-J_J>G_*5-,?/-^S&"^/R^")=![;'GL
M              5%?6P_R?\ "G\<=W_R)K0;![@_G>)_)P=](:T><?\ ,L)^
M5J.]B*68V4-50                .I[TL?W<'"/]6K5'R58#13;O[98GX[+
MWRGH?N\^PN$^(0]XAOR.IG<@
M
M                                                    B\ZV7[HW
MJ,_JB;J^1TB *HWJ,?\ ]5$_V)O][@ 7_                  $;?5/^KAK
M_P#7#X2_WI-6B52?"K[AW>J1:SX)/=L[Y"20124        %:OUIG]WWI[]<
M?7WZ$^0@S1N*^UM1]72>&IS _G#?8NE^M(_ 5)0=&UYIL
M !TVNAY^ZJX?_B=<_P!+%_&DN\_[>8C\HSP49OWND_-UAGR3_#2$K@Z$9&
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M(7\QVV?D%/BZX#Y<HO&X?"-,-><;_=[V\_H9C?\ [;4E.@;+'Y.@
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M5]T5^9O6/R)A!Y\XQY7JO&9>_<>EN!^1*/Q6+P;3,@MQ=
M"@]ZTS^\$T]^IQK[]-G(0;7;BOLE4?6,G@:<TV\X;[:4OU7'X>I*U0S28'
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M^K5JCY*L!HIMW]LL3\=E[Y3T/W>?87"?$(>\0WY'4SN0
M
M
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M_P#Q.N?Z6+^-)=Y_V\Q'Y1G@HS?O=)^;K#/DG^&D)7!T(R,      !\*R_\
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MU1\E6 T4V[^V6)^.R]\IZ'[O/L+A/B$/>(;\CJ9W(
M
M
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MQ3)>Y;\\>R7])L+_ "Z N9C60_6^               >&V?^378?XC6W^0)
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MS?ZR'_<__P#"D.@[SO\ L/\ IO\ X1Z3?HD/_N!_Y%_]8)Q!BD]E0
M       "D#ZUK]8+BA^9NZ?+9(;.[AO)%?XRSO#4KSC/+>&^*O\ "%4<9Z-<
MP                .NEQU^K[HK\S>L?D3"#SYQCRO5>,R]^X]+<#\B4?BL7
M@VF9!;BZ               %![UIG]X)I[]3C7WZ;.0@VNW%?9*H^L9/ TYI
MMYPWVTI?JN/P]25JAFDP.                !V-AYT'J"
M >-V+^3Z]_B;9_Y$?"31?/(OE6]\A%KOF4WR3^]4X_8]#CS(
M     M<>JE?6"Y7_ )FZ7\ME1@7?SY(H/&7]X;&>;GY;Q+Q5GA"[\-8C;4
M             J*^MA_D_P"%/XX[O_D36@V#W!_.\3^3@[Z0UH\X_P"983\K
M4=[$4LQLH:J@                =3WI8_NX.$?ZM6J/DJP&BFW?VRQ/QV7O
ME/0_=Y]A<)\0A[Q#?D=3.Y
M
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ME717Y;]-_G5U[\KH@6_%O)53XO)WBF2]RWYX]DOZ387^70%S,:R'ZWP
M         #PVS_R:[#_$:V_R!("70?/H?E6=\ATS>/\ F]Q[ZFK?R:4I8#:
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M35T4*4]%+/@SXXD6U(F.?C3F1HJY51C51J+QV6D[ Q8>PX
M!2!]:U^L%Q0_,W=/ELD-G=PWDBO\99WAJ5YQGEO#?%7^$*HXST:Y@
M         ==+CK]7W17YF]8_(F$'GSC'E>J\9E[]QZ6X'Y$H_%8O!M,R"W%T
M               *#WK3/[P33WZG&OOTV<A!M=N*^R51]8R>!IS3;SAOMI2_
M5<?AZDK5#-)@<                #L;#SH/4$               \;L7\GU
M[_$VS_R(^$FB^>1?*M[Y"+7?,IODG]ZIQ^QZ''F0                !:X]
M5*^L%RO_ #-TOY;*C N_GR10>,O[PV,\W/RWB7BK/"%WX:Q&VH
M    !45];#_)_P *?QQW?_(FM!L'N#^=XG\G!WTAK1YQ_P RPGY6H[V(I9C9
M0U5                 ZGO2Q_=P<(_U:M4?)5@-%-N_MEB?CLO?*>A^[S["
MX3XA#WB&_(ZF=R
M
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M)G#PL/&M$\K.Y"4E9%9NQCV+5(N3**K*$3(7'9SG&!]1%5;$RJ?%5$2U<B&
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MC?'2I^,</[,"Z[,HOLSII'A[1OCI4_&.']F!==F47V9TTCP]HWQTJ?C'#^S
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M8^[G/9R,];"JJ[-PJO#?D[]Q^;K](NB)YUN.(G!U/#?R" T-';S1P
M        RCH]%)QNG4""Z2:Z"^T: BLBL0JB2R2ELB2*)*IGP8BB:A#9P8N<
M9QG&>QD6_%O)53XO)WBF2]RWYX]D_P"DV%_ET!<+\ J-\2ZGXN0_L,:S7G9U
M/UNW&9DT#P"HWQ+J?BY#^PPO.SJ+C,R:!X!4;XEU/Q<A_887G9U%QF9- \ J
M-\2ZGXN0_L,+SLZBXS,F@> 5&^)=3\7(?V&%YV=1<9F30/ *C?$NI^+D/[#"
M\[.HN,S)H'@%1OB74_%R']AA>=G47&9DT#P"HWQ+J?BY#^PPO.SJ+C,R:!X!
M4;XEU/Q<A_887G9U%QF9- \ J-\2ZGXN0_L,+SLZBXS,F@\3LNC4E+7%_52I
MU6353I-J4343K\211-0D$_,0Y#E:8,4Y38[.,X^[C(E4#G=>ARK\*SOD.F;Q
MF,_J]Q[(GD:MXO\ Y:4ILC9\_(4                !+QTB(2&F]C[>2F8B
M,ETD*3!J(IR;!J_314-.G*8Z1'22I4SF+]S.<=C.<#&N\I52AIK/C7=Z>L/Z
M)]$7>%M9:EO_ (-3?E*D\G@%1OB74_%R']AC$%YV=3W'N,S)H'@%1OB74_%R
M']AA>=G47&9DT#P"HWQ+J?BY#^PPO.SJ+C,R:!X!4;XEU/Q<A_887G9U%QF9
M- \ J-\2ZGXN0_L,+SLZBXS,F@> 5&^)=3\7(?V&%YV=1<9F30/ *C?$NI^+
MD/[#"\[.HN,S)H'@%1OB74_%R']AA>=G47&9DT#P"HWQ+J?BY#^PPO.SJ+C,
MR:!X!4;XEU/Q<A_887G9U%QF9-!A3DK2J:TXY[^=-:E66SEMI3:CANX;P,4B
MNW71HL\HBLBLFT*HDJDH7!BF+G&2YQC.,]D77 G.^G*/*OSN'PC3#7G&,:GF
M][=Y$^QF-?\ MM25#ALH?D\                 FNZ/,#!3GTB?;J%B9?O7
MS2=[>VD<SD.]^[><[NW<.^T5>Y=U[B3MNU[';=KCL_P8&*]YJJG4;/\ /?\
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M"O<E,4V&>,XSC./N9$FC<[KD65?A&]\A%KF,ZE-D3X)_%]RIR)AZ&'F4
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M-@MPBJM7B=J_Y.'OI#6GSCFHE%A-B(GX6?O8BF4-DS58
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MR;844SV3GP@V332P<^<?=SV.SD<555RJ?41$R)P'[@/H
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M;$/V<XN,]1$VD930+;QNR*GJ\OJ%M@IYG5;ZFH2SB:EJ+ZG)ZJE@46XN0
M !&WU3_JX:__ %P^$O\ >DU:)5)\*ON'=ZI%K/@D]VSOD))!%)0        5
MJ_6F?W?>GOUQ]??H3Y"#-&XK[6U'U=)X:G,#^<-]BZ7ZTC\!4E!T;7FFP
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MU:^0OYCML_(*?%UP'RY1>-P^$:8:\XW^[WMY_0S&_P#VVI*= V6/R=
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M6 T4V[^V6)^.R]\IZ'[O/L+A/B$/>(;\CJ9W(
M
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M?QI+O/\ MYB/RC/!1F_>Z3\W6&?)/\-(2N#H1D8      #X5E_[$>_\ 1O\
MK: ^IPG%_M3[H^'(     JZ]3CZX5_\ ]!T/Y&PPSWL)]FH?=R=^X_-Q^D7_
M +UV.>)X;^00&@([@:.               &5=%?EOTW^=77ORNB!;\6\E5/B
M\G>*9+W+?GCV2_I-A?Y= 7,QK(?K?               /#;/_)KL/\1K;_($
M@)=!\^A^59WR'3-X_P";W'OJ:M_)I2E@-H#\A                 $Q?1U_
M*5N/\1H+^7SC&F\OYC3?*N[T]8OT3WYPMK/J:F_*5)_1A\]R
M   #!W)WZM?(7\QVV?D%/BZX#Y<HO&X?"-,-><;_ '>]O/Z&8W_[;4E.@;+'
MY.@                )Q.C-_K(?]S__ ,*0Q5O._P"P_P"F_P#A'LK^B0_^
MX'_D7_U@G$&*3V5               *0/K6OU@N*'YF[I\MDAL[N&\D5_C+.
M\-2O.,\MX;XJ_P (51QGHUS                 ZZ7'7ZONBOS-ZQ^1,(//
MG&/*]5XS+W[CTMP/R)1^*Q>#:9D%N+H               4'O6F?W@FGOU.-
M??ILY"#:[<5]DJCZQD\#3FFWG#?;2E^JX_#U)6J&:3 X
M'8V'G0>H(              !XW8OY/KW^)MG_D1\)-%\\B^5;WR$6N^93?)/
M[U3C]CT./,@                "UQZJ5]8+E?\ F;I?RV5&!=_/DB@\9?WA
ML9YN?EO$O%6>$+OPUB-M0              "HKZV'^3_ (4_CCN_^1-:#8/<
M'\[Q/Y.#OI#6CSC_ )EA/RM1WL12S&RAJJ                !U/>EC^[@X
M1_JU:H^2K :*;=_;+$_'9>^4]#]WGV%PGQ"'O$-^1U,[D
M
M
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M:^0OYCML_(*?%UP'RY1>-P^$:8:\XW^[WMY_0S&__;:DIT#98_)T
M        !.)T9O\ 60_[G_\ X4ABK>=_V'_3?_"/97]$A_\ <#_R+_ZP3B#%
M)[*@              %('UK7ZP7%#\S=T^6R0V=W#>2*_P 99WAJ5YQGEO#?
M%7^$*HXST:Y@                ==+CK]7W17YF]8_(F$'GSC'E>J\9E[]Q
MZ6X'Y$H_%8O!M,R"W%T               *#WK3/[P33WZG&OOTV<A!M=N*^
MR51]8R>!IS3;SAOMI2_5<?AZDK5#-)@<                #L;#SH/4$
M            \;L7\GU[_$VS_P B/A)HOGD7RK>^0BUWS*;Y)_>J<?L>AQYD
M                 6N/52OK!<K_ ,S=+^6RHP+OY\D4'C+^\-C/-S\MXEXJ
MSPA=^&L1MJ               5%?6P_R?\*?QQW?_(FM!L'N#^=XG\G!WTAK
M1YQ_S+"?E:CO8BEF-E#54                #J>]+']W!PC_5JU1\E6 T4V
M[^V6)^.R]\IZ'[O/L+A/B$/>(;\CJ9W(
M
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MENW@[G6H^2</LH&,BH]A6RR1/^<N%3 =$8              $;?5/^KAK_\
M7#X2_P!Z35HE4GPJ^X=WJD6L^"3W;.^0DD$4E        !6K]:9_=]Z>_7'U
M]^A/D(,T;BOM;4?5TGAJ<P/YPWV+I?K2/P%24'1M>:;
M=-KH>?NJN'_XG7/]+%_&DN\_[>8C\HSP49OWND_-UAGR3_#2$K@Z$9&
M  B@ZQ?5!H?2;XO5#D+L+5UNVU#7S>%6T@TKM,F(:$DV$K8*3L;8*,XY=3A#
MM58]NSUDNW,F7'=,JNDS8^]*8#XJ6I8;I\0^1<+R[XO:#Y05RN2E0@=]ZKIV
MTXBK3;MH^EX"/N,.VF&T5)/&."LW+QFFYP0YTL8(8V.SC[@'TV,    !5UZG
M'UPK_P#Z#H?R-AAGO83[-0^[D[]Q^;C](O\ WKL<\3PW\@@- 1W T<
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M %D/^Y__ .%(8JWG?]A_TW_PCV5_1(?_ ' _\B_^L$X@Q2>RH
M   !2!]:U^L%Q0_,W=/ELD-G=PWDBO\ &6=X:E><9Y;PWQ5_A"J.,]&N8
M             '72XZ_5]T5^9O6/R)A!Y\XQY7JO&9>_<>EN!^1*/Q6+P;3,
M@MQ=               "@]ZTS^\$T]^IQK[]-G(0;7;BOLE4?6,G@:<TV\X;
M[:4OU7'X>I*U0S28'                 [&P\Z#U!               /&[
M%_)]>_Q-L_\ (CX2:+YY%\JWOD(M=\RF^2?WJG'['H<>9
M  %KCU4KZP7*_P#,W2_ELJ,"[^?)%!XR_O#8SS<_+>)>*L\(7?AK$;:@
M          %17UL/\G_"G\<=W_R)K0;![@_G>)_)P=](:T><?\RPGY6H[V(I
M9C90U5                 ZGO2Q_=P<(_U:M4?)5@-%-N_MEB?CLO?*>A^[
MS["X3XA#WB&_(ZF=R
M
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MU=>_*Z(%OQ;R54^+R=XIDO<M^>/9+^DV%_ET!<S&LA^M\
M\-L_\FNP_P 1K;_($@)=!\^A^59WR'3-X_YO<>^IJW\FE*6 V@/R$
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MK[HK\S>L?D3"#SYQCRO5>,R]^X]+<#\B4?BL7@VF9!;BZ
M%![UIG]X)I[]3C7WZ;.0@VNW%?9*H^L9/ TYIMYPWVTI?JN/P]25JAFDP.
M              !V-AYT'J"               >-V+^3Z]_B;9_Y$?"31?/(
MOE6]\A%KOF4WR3^]4X_8]#CS(                 M<>JE?6"Y7_F;I?RV5
M&!=_/DB@\9?WAL9YN?EO$O%6>$+OPUB-M0              "HKZV'^3_A3^
M..[_ .1-:#8/<'\[Q/Y.#OI#6CSC_F6$_*U'>Q%+,;*&JH
M  '4]Z6/[N#A'^K5JCY*L!HIMW]LL3\=E[Y3T/W>?87"?$(>\0WY'4SN0
M
M
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MMAP4>]CJ=5*=$N<2##6^N6\L5.8<0QYCL/9*3=I-'$LX1;=LU;D:I$R!8'
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MR=^K7R%_,=MGY!3XNN ^7*+QN'PC3#7G&_W>]O/Z&8W_ .VU)3H&RQ^3H
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M&BFW?VRQ/QV7OE/0_=Y]A<)\0A[Q#?D=3.Y
M
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MH>?NJN'_ .)US_2Q?QI+O/\ MYB/RC/!1F_>Z3\W6&?)/\-(2N#H1D8
M "O1ZROT[^2/4NX(ZNT=Q>C*C*WRF<KZ'MZ;;W.UM*A&)TV$U)O*D/UVTD\0
M<)N) L[L&.*5#&,&,D90_9[!,]D?%6Q+5)/.FQHF_P#&'@%P]X[[5;Q;39.E
M^/FLM<7AK"224S$(6:K5IC%RR4;*HD32D&9':!L$6*7&#E^[C 'TW;    !5
MUZG'UPK_ /Z#H?R-AAGO83[-0^[D[]Q^;C](O_>NQSQ/#?R" T!'<#1P
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MO]9#_N?_ /A2&*MYW_8?]-_\(]E?T2'_ -P/_(O_ *P3B#%)[*@
M     %('UK7ZP7%#\S=T^6R0V=W#>2*_QEG>&I7G&>6\-\5?X0JCC/1KF
M             !UTN.OU?=%?F;UC\B80>?.,>5ZKQF7OW'I;@?D2C\5B\&TS
M(+<70               H/>M,_O!-/?J<:^_39R$&UVXK[)5'UC)X&G--O.&
M^VE+]5Q^'J2M4,TF!P                .QL/.@]00              #QN
MQ?R?7O\ $VS_ ,B/A)HOGD7RK>^0BUWS*;Y)_>J<?L>AQYD
M    6N/52OK!<K_S-TOY;*C N_GR10>,O[PV,\W/RWB7BK/"%WX:Q&VH
M          !45];#_)_PI_''=_\ (FM!L'N#^=XG\G!WTAK1YQ_S+"?E:CO8
MBEF-E#54                #J>]+']W!PC_ %:M4?)5@-%-N_MEB?CLO?*>
MA^[S["X3XA#WB&_(ZF=R
M
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MCL%SG&9]Q;53:VHML\G2>&IS!/G"O1VQ=*B6^5(^+_,5)14&UIIR
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M5,<H^#YW#QI\8TPWYQDK5\WO;M,OV-QKB_\ W;4E34;)GY/@
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MYH?!2%[.?NYSG&,8$BC8O7(N#X1O&G20C5TK>I3</P3^)>BIR4!Z&'F8
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M7#_\3KG^EB_C27>?]O,1^49X*,W[W2?FZPSY)_AI"5P=",C       ?"LO\
MV(]_Z-_UM ?4X3B_VI]T?#D     5=>IQ]<*_P#^@Z'\C889[V$^S4/NY._<
M?FX_2+_WKL<\3PW\@@- 1W T<               ,JZ*_+?IO\ZNO?E=$"WX
MMY*J?%Y.\4R7N6_/'LE_2;"_RZ N9C60_6^               >&V?\ DUV'
M^(UM_D"0$N@^?0_*L[Y#IF\?\WN/?4U;^32E+ ;0'Y"
M)B^CK^4K<?XC07\OG&--Y?S&F^5=WIZQ?HGOSA;6?4U-^4J3^C#Y[D
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M^K5JCY*L!HIMW]LL3\=E[Y3T/W>?87"?$(>\0WY'4SN0
M
M
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MM^F_SJZ]^5T0+?BWDJI\7D[Q3)>Y;\\>R7])L+_+H"YF-9#];X
M    !X;9_P"378?XC6W^0) 2Z#Y]#\JSOD.F;Q_S>X]]35OY-*4L!M ?D(
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M![UIG]X)I[]3C7WZ;.0@VNW%?9*H^L9/ TYIMYPWVTI?JN/P]25JAFDP.
M             !V-AYT'J"               >-V+^3Z]_B;9_Y$?"31?/(O
ME6]\A%KOF4WR3^]4X_8]#CS(                 M<>JE?6"Y7_ )FZ7\ME
M1@7?SY(H/&7]X;&>;GY;Q+Q5GA"[\-8C;4               J*^MA_D_P"%
M/XX[O_D36@V#W!_.\3^3@[Z0UH\X_P"983\K4=[$4LQLH:J@
M    =3WI8_NX.$?ZM6J/DJP&BFW?VRQ/QV7OE/0_=Y]A<)\0A[Q#?D=3.Y
M
M
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M/\1K;_($@)=!\^A^59WR'3-X_P";W'OJ:M_)I2E@-H#\A
M  $Q?1U_*5N/\1H+^7SC&F\OYC3?*N[T]8OT3WYPMK/J:F_*5)_1A\]R
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M:^_39R$&UVXK[)5'UC)X&G--O.&^VE+]5Q^'J2M4,TF!P
M .QL/.@]00              #QNQ?R?7O\3;/_(CX2:+YY%\JWOD(M=\RF^2
M?WJG'['H<>9                 %KCU4KZP7*_\S=+^6RHP+OY\D4'C+^\-
MC/-S\MXEXJSPA=^&L1MJ               5%?6P_P G_"G\<=W_ ,B:T&P>
MX/YWB?R<'?2&M'G'_,L)^5J.]B*68V4-50                .I[TL?W<'"
M/]6K5'R58#13;O[98GX[+WRGH?N\^PN$^(0]XAOR.IG<@
M
M
M         "B#Z\6O=BZNZ=;9AAWYN%K]R07M>28/WCB[-Z]IQ/7^'&<9[GAW
MF"=6;N/9QG/:85['8QV>R!93Z$NH=2Z;Z1G :)T_&1#*)N_&S5NWKJ^B\-%7
M$]MK:U1B+KM.3G)!L3"LC+L[I+.X[_/F.LS:L$66,E3:ID(!O=RJK&B;CQJW
MQ7.3[:MN>/#_ %1>3[G-;B,C5YAKMA7GTC9YI^K()+MF1H"-:'?(.NU[HT<-
MR+IY*HF4V .>;ZDI [%<<Z>7%GC,/?-+$<3$(&[&3-CVNQL6Q[AH$AJ[#HO<
M\YR]-6JM<.X9[;'8)A;[F>SV2@=*\                 !&WU3_ *N&O_UP
M^$O]Z35HE4GPJ^X=WJD6L^"3W;.^0DD$4E        !6K]:9_=]Z>_7'U]^A
M/D(,T;BOM;4?5TGAJ<P/YPWV+I?K2/P%24'1M>:;                 =-K
MH>?NJN'_ .)US_2Q?QI+O/\ MYB/RC/!1F_>Z3\W6&?)/\-(2N#H1D8
M "H%ZZM^ZRT'^O\ ZL_NZ\J@!-]T4OW1_3E_5 T?\B8L 2?@    JZ]3CZX5
M_P#]!T/Y&PPSWL)]FH?=R=^X_-Q^D7_O78YXGAOY! : CN!HX
M    95T5^6_3?YU=>_*Z(%OQ;R54^+R=XIDO<M^>/9+^DV%_ET!<S&LA^M\
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MUTN.OU?=%?F;UC\B80>?.,>5ZKQF7OW'I;@?D2C\5B\&TS(+<70
M      H/>M,_O!-/?J<:^_39R$&UVXK[)5'UC)X&G--O.&^VE+]5Q^'J2M4,
MTF!P                .QL/.@]00              #QNQ?R?7O\3;/_(CX
M2:+YY%\JWOD(M=\RF^2?WJG'['H<>9                 %KCU4KZP7*_\
M,W2_ELJ,"[^?)%!XR_O#8SS<_+>)>*L\(7?AK$;:@              %17UL
M/\G_  I_''=_\B:T&P>X/YWB?R<'?2&M'G'_ #+"?E:CO8BEF-E#54
M          #J>]+']W!PC_5JU1\E6 T4V[^V6)^.R]\IZ'[O/L+A/B$/>(;\
MCJ9W(
M
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MZOU..3GZ$[N.Q['_ &MPOZQIO#,.K[<?8O&/JNK\!(<I ;Z'G,
M      !<;]4O_P!?W_96_P!X\:Y[_OXI_?7\'-H/-M_CK]Z?PHN-C70VA
M            *0/K6OU@N*'YF[I\MDAL[N&\D5_C+.\-2O.,\MX;XJ_PA5'&
M>C7,                #KI<=?J^Z*_,WK'Y$P@\^<8\KU7C,O?N/2W _(E'
MXK%X-IF06XN@              !0>]:9_>":>_4XU]^FSD(-KMQ7V2J/K&3P
M-.:;><-]M*7ZKC\/4E:H9I,#@                =C8>=!Z@@
M    'C=B_D^O?XFV?^1'PDT7SR+Y5O?(1:[YE-\D_O5./V/0X\R
M        +7'JI7U@N5_YFZ7\ME1@7?SY(H/&7]X;&>;GY;Q+Q5GA"[\-8C;4
M               J*^MA_D_X4_CCN_\ D36@V#W!_.\3^3@[Z0UH\X_YEA/R
MM1WL12S&RAJJ                !U/>EC^[@X1_JU:H^2K :*;=_;+$_'9>
M^4]#]WGV%PGQ"'O$-^1U,[D
M
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M4F5EE.QDQNVP6Q[N%D7!94=\&E2ZS]@RWL>NJFP7Z5&'#(]_6#RTMB8G)LK
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MU_*5N/\ $:"_E\XQIO+^8TWRKN]/6+]$]^<+:SZFIORE2?T8?/<@
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M1\E6 T4V[^V6)^.R]\IZ'[O/L+A/B$/>(;\CJ9W(
M
M
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M]/?KCZ^_0GR$&:-Q7VMJ/JZ3PU.8'\X;[%TOUI'X"I*#HVO--@
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M=7ZG')S]"=W'8]C_ +6X7]8TWAF'5]N/L7C'U75^ D.4@-]#SF
M       N-^J7_P"O[_LK?[QXUSW_ '\4_OK^#FT'FV_QU^]/X47&QKH;0@
M            %('UK7ZP7%#\S=T^6R0V=W#>2*_QEG>&I7G&>6\-\5?X0JCC
M/1KF                !UTN.OU?=%?F;UC\B80>?.,>5ZKQF7OW'I;@?D2C
M\5B\&TS(+<70               H/>M,_O!-/?J<:^_39R$&UVXK[)5'UC)X
M&G--O.&^VE+]5Q^'J2M4,TF!P                .QL/.@]00
M    #QNQ?R?7O\3;/_(CX2:+YY%\JWOD(M=\RF^2?WJG'['H<>9
M        %KCU4KZP7*_\S=+^6RHP+OY\D4'C+^\-C/-S\MXEXJSPA=^&L1MJ
M               5%?6P_P G_"G\<=W_ ,B:T&P>X/YWB?R<'?2&M'G'_,L)
M^5J.]B*68V4-50                .I[TL?W<'"/]6K5'R58#13;O[98GX[
M+WRGH?N\^PN$^(0]XAOR.IG<@
M
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M=?RE;C_$:"_E\XQIO+^8TWRKN]/6+]$]^<+:SZFIORE2?T8?/<@
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M58#13;O[98GX[+WRGH?N\^PN$^(0]XAOR.IG<@
M
M
M  "H%ZZM^ZRT'^O_ *L_NZ\J@!MWZIY^Y-X\?G$Y#_IJN0 LA
M#5OG'5K'>>%/,&DTZ$DK+;KCQ;Y U:K5R&:JOI>P6.P:FML3!PD4R0*99Y)2
MLF[2002)C)E%5"EQCLY%:G5&SL<[(U'IZJ%&H170/:W*Y6+ZBE9+@=U$^<O
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ME</R,([!C*X^[DO<L=K_ .W(XK9;DX#FBJJ94L4^V/A]
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MKMLFJHF<R3CLGN=5:S#XHY?A;>UE]1%1"V4EU^(2R1?!6=O)ZJHJEJD6@NX
M  1M]4_ZN&O_ -</A+_>DU:)5)\*ON'=ZI%K/@D]VSOD))!%)0        5J
M_6F?W?>GOUQ]??H3Y"#-&XK[6U'U=)X:G,#^<-]BZ7ZTC\!4E!T;7FFP
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M<G/T)W<=CV/^UN%_6--X9AU?;C[%XQ]5U?@)#E(#?0\Y@
M +C?JE_^O[_LK?[QXUSW_?Q3^^OX.;0>;;_'7[T_A1<;&NAM"
M    4@?6M?K!<4/S-W3Y;)#9W<-Y(K_&6=X:E><9Y;PWQ5_A"J.,]&N8
M            '72XZ_5]T5^9O6/R)A!Y\XQY7JO&9>_<>EN!^1*/Q6+P;3,@
MMQ=               "@]ZTS^\$T]^IQK[]-G(0;7;BOLE4?6,G@:<TV\X;[
M:4OU7'X>I*U0S28'                 [&P\Z#U!               /&[%
M_)]>_P 3;/\ R(^$FB^>1?*M[Y"+7?,IODG]ZIQ^QZ''F0
M  !:X]5*^L%RO_,W2_ELJ,"[^?)%!XR_O#8SS<_+>)>*L\(7?AK$;:@
M         %17UL/\G_"G\<=W_P B:T&P>X/YWB?R<'?2&M'G'_,L)^5J.]B*
M68V4-50                .I[TL?W<'"/\ 5JU1\E6 T4V[^V6)^.R]\IZ'
M[O/L+A/B$/>(;\CJ9W(
M
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M8TV(%,J@  !&WU3_ *N&O_UP^$O]Z35HE4GPJ^X=WJD6L^"3W;.^0DD$4E
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MHI^[[YU?J<<G/T)W<=CV/^UN%_6--X9AU?;C[%XQ]5U?@)#E(#?0\Y@
M           +C?JE_P#K^_[*W^\>-<]_W\4_OK^#FT'FV_QU^]/X47&QKH;0
M@              %('UK7ZP7%#\S=T^6R0V=W#>2*_QEG>&I7G&>6\-\5?X0
MJCC/1KF                !UTN.OU?=%?F;UC\B80>?.,>5ZKQF7OW'I;@?
MD2C\5B\&TS(+<70               H/>M,_O!-/?J<:^_39R$&UVXK[)5'U
MC)X&G--O.&^VE+]5Q^'J2M4,TF!P                .QL/.@]00
M       #QNQ?R?7O\3;/_(CX2:+YY%\JWOD(M=\RF^2?WJG'['H<>9
M           %KCU4KZP7*_\ ,W2_ELJ,"[^?)%!XR_O#8SS<_+>)>*L\(7?A
MK$;:@              %17UL/\G_  I_''=_\B:T&P>X/YWB?R<'?2&M'G'_
M #+"?E:CO8BEF-E#54                #J>]+']W!PC_5JU1\E6 T4V[^V
M6)^.R]\IZ'[O/L+A/B$/>(;\CJ9W(
M
M
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MY-=A_B-;?Y D!+H/GT/RK.^0Z9O'_-[CWU-6_DTI2P&T!^0@
M    "8OHZ_E*W'^(T%_+YQC3>7\QIOE7=Z>L7Z)[\X6UGU-3?E*D_HP^>Y
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M6J/DJP&BFW?VRQ/QV7OE/0_=Y]A<)\0A[Q#?D=3.Y
M
M
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M_P 1H+^7SC&F\OYC3?*N[T]8OT3WYPMK/J:F_*5)_1A\]R
M #3CJ*?N^^=7ZG')S]"=W'8]C_M;A?UC3>&8=7VX^Q>,?5=7X"0Y2 WT/.8
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M13;O[98GX[+WRGH?N\^PN$^(0]XAOR.IG<@
M
M
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M7_\ T'0_D;##/>PGV:A]W)W[C\W'Z1?^]=CGB>&_D$!H".X&C@
M    !E717Y;]-_G5U[\KH@6_%O)53XO)WBF2]RWYX]DOZ387^70%S,:R'ZWP
M              #PVS_R:[#_ !&MO\@2 ET'SZ'Y5G?(=,WC_F]Q[ZFK?R:4
MI8#: _(0                !,7T=?RE;C_$:"_E\XQIO+^8TWRKN]/6+]$]
M^<+:SZFIORE2?T8?/<@               TXZBG[OOG5^IQR<_0G=QV/8_[6
MX7]8TWAF'5]N/L7C'U75^ D.4@-]#SF                 N-^J7_Z_O^RM
M_O'C7/?]_%/[Z_@YM!YMO\=?O3^%%QL:Z&T(              !2!]:U^L%Q
M0_,W=/ELD-G=PWDBO\99WAJ5YQGEO#?%7^$*HXST:Y@                =
M=+CK]7W17YF]8_(F$'GSC'E>J\9E[]QZ6X'Y$H_%8O!M,R"W%T
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M,YQC^ 7YCK[$?8J6HBV+PI;Q+RYSKKVW'JRU%L54M3@6SC3D7B.Q4/.H]/P
M             #QNQ?R?7O\ $VS_ ,B/A)HOGD7RK>^0BUWS*;Y)_>J<?L>A
MQYD                 6N/52OK!<K_S-TOY;*C N_GR10>,O[PV,\W/RWB7
MBK/"%WX:Q&VH              !45];#_)_PI_''=_\ (FM!L'N#^=XG\G!W
MTAK1YQ_S+"?E:CO8BEF-E#54                #J>]+']W!PC_ %:M4?)5
M@-%-N_MEB?CLO?*>A^[S["X3XA#WB&_(ZF=R
M
M
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MSJZ]^5T0+?BWDJI\7D[Q3)>Y;\\>R7])L+_+H"YF-9#];X
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MV(;+^;1A6%X?CN)R4%-3P2.I(T58XV,54UEMBJU$M3D+K8UI-Q
M     #3CJ*?N^^=7ZG')S]"=W'8]C_M;A?UC3>&8=7VX^Q>,?5=7X"0Y2 WT
M/.8                "XWZI?_K^_P"RM_O'C7/?]_%/[Z_@YM!YMO\ '7[T
M_A1<;&NAM"               4@?6M?K!<4/S-W3Y;)#9W<-Y(K_ !EG>&I7
MG&>6\-\5?X0K'Z@U+L#?&SZ-IS5=><6K8>QK''U:IP+91! SZ5DE>T3RN[=*
M(LV#!JE@Z[ERN<B#9NF=50Q4R&-C-N(XA2850RXC7O2.CA8KGN7B1.1,JJO
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M+>E;;[O\9V&J8V5ZQS4,Z*L4T=MQUEEJ*BY6N1%1;%M146UKG6+9&\.YG10
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M#U4KZP7*_P#,W2_ELJ,>;^?)%!XR_O#)OFY^6\2\59X0N_#6(VU
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M#23;O[98GX[+WRF_V[S["X3XA#WB&_(ZF=R
M
M
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M7LIBFQ^)_1F)ZMRNC22.2-;T<L;K41[%L1;%5%2Q4145,UBKT(.AY^ZJX?\
MXG7/]+%_&HV\_P"WF(_*,\%&;K;I/S=89\D_PTA*X.A&1@      *@7KJW[K
M+0?Z_P#JS^[KRJ $WW12_='].7]4#1_R)BP!)^    "KKU./KA7_ /T'0_D;
M##/>PGV:A]W)W[C\W'Z1?^]=CGB>&_D$!H".X&C@              !E717Y
M;]-_G5U[\KH@6_%O)53XO)WBF2]RWYX]DOZ387^70%S,:R'ZWP
M    ##?(KZON]?S-[.^1,V+C@_E>E\9B[]I:\<\B5GBLO@W'(M'H,>:0
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MS$]6Y71I)')&MZ.6-UJ(]BV(MBJBI8J(J*F:Q5ZO@T)/1P
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M1_JU:H^2K :*;=_;+$_'9>^4]#]WGV%PGQ"'O$-^1U,[D
M
M
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M3]WWSJ_4XY.?H3NX['L?]K<+^L:;PS#J^W'V+QCZKJ_ 2'*0&^AYS
M          7&_5+_ /7]_P!E;_>/&N>_[^*?WU_!S:#S;?XZ_>G\*+C8UT-H
M0              "D#ZUK]8+BA^9NZ?+9(;.[AO)%?XRSO#4KSC/+>&^*O\
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MJZ^G^CZ=:7!J*E93T\2K><D;.!7.SKD2RU;$:F55M5>HX-&CT(
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MJ*BF-*B?>!L*YF&S3XEAS51)&QI+(R-;R(MJ-:[5JO CTRJBVM>B.142=SG
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M/JI7U@N5_P"9NE_+940]_/DB@\9?WA.\W/RWB7BK/"%WX:Q&VH
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M&NFW?VRQ/QV7OE-H=WGV%PGQ"'O$-^1U,[D
M
M
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MFC<8K5VMJ+$L7Z.DX_\ /4Y@CSA4<FQ=+>6U/I2/B_S%245!M8:<@
M         =)7HJUN_O>E[Q)=1&RO:2.6J%PRUBO V%DN\REVG>R')W\Z7(NX
M[=4IC]DV,=CMNQ_!@:4;SE:FW>(VI:NL9Q_YJ,WWW2M>N[O#+'6)JG\7^>D)
M2?!#:/I@_J_KOLD="O,Z/;,C79.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(/!#:
M/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!_5_7?9(7F='MB[)TNT@\$-H^F#^K^N^
MR0O,Z/;%V3I=I#1[G[TVM5=1'2T)IKES/2.R=;T_8T)M:#@8QM(T)=O>(>OV
MJEQLJ>9H]D@I9PBW@+[)I9;**G;G,M@YB9.FF8JUB_K>V?%21$MO=I#8K17&
M1YQNTWK+0>H=C+US5^GZ7 Z^H,"ZJK*><1%5K+!*-AV"\S.2LA,2:C9F@4N5
MW*ZJRF<=DQLY^Z%YG1[9]NR=+M(97\$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1]
M,']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD*VG4992\?ROO+6
M<F_"&1)#4G*TI[6MHGNY#U*).D3O%F<Z"?<4\X)V<9[)NQV<_=R,\["V+LW#
M9D2_)W[C\W?Z19%3SK<<15M7J>&_D$!HT.WFCH              !DW2J;A;
M<FI46CGO-TKLRAIMGG<2..]7![3%%1<][J9PFOW!3.#=H;."F['8S]S(@8MY
M*J?%Y.\4R7N6_/'LG9_S-A?Y= 6X_!#:/I@_J_KOLD:S7F='MGZV[LG2[2#P
M0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_
MKOLD+S.CVQ=DZ7:0>"&T?3!_5_7?9(7F='MB[)TNT@\$-H^F#^K^N^R0O,Z/
M;%V3I=I!X(;1],']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'
M@AM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ7:0Q#R#J>S$]
M";O47VUWPB34.RCK-_ .OI=W2+3)HRB/=2.<G2[J3&2]MC[I>SV<"XX.YGTM
M2]S_ -ICX_NVEKQQLGT+6=U_V67B3XMQR?QZ!GFL                !:1]
M5QB[)*;[Y2IURU>"JR6H:<=RX]HV$YWVD:YJE(CW)^HF1#M#_?=L7LYS_ ,#
M;^%1,)H+4M_VE_>&Q7FZHY<:Q&ZMG^RL\(73?!#:/I@_J_KOLD:R7F='MFV=
MV3I=I!X(;1],']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@A
MM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!_5_7
M?9(7F='MB[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1],']7]=]DA>9T>V
M+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(:A
M]02K;';\"N;KA]M3VQ9(<0^2:SR/\!X)IW\U2TS=#N&??2+@RK;OE(N2=T+C
M)B=MV<?=P.Q['N9_.W"[&Y?I&FX_\\PZOMNU_P#,O%[79/HNJXO\Q(<MT;XG
MG4                !;O]57B+3*_3O\&KAX*=P^B_W[_P#._'3O?_=?I$=[
M?_CZJ?>O>O<U/^1V>W[I]W_DX&NN_P!5J?1-J6_.OX.;/>;>CE^F;JV?-.+Q
MHMW^"&T?3!_5_7?9(UUO,Z/;-G[LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@
MAM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!_5_
M7?9(7F='MB[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1],']7]=]DA>9T>
MV+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(/
M!#:/I@_J_KOLD+S.CVQ=DZ7:0I9>M'1=DB]]\6D[':O"I974-Q.V<>T;"#[T
M2+<TBG1[DP44(OVY_ONV-V,X_@&S>X=47":^Q+/]I9WAJ9YQ2.3&L.O+;_LK
M_"%:+7>Q;UJ2\5C96LK9.4:^TR6;S=7M=;?K1DS"R;;ML$<M':!BFP51,YDU
M4S=LDNB<Z:A3)G,7.<*RCI<0I7T5;&V6DD;=<QR6HY%SIVTXT7*F4U_H:ZLP
MVKCKZ"1\-9$Y',>U;'-5.-%[2IP*EJ+:BDZT=ZRKU#6E<:QTC6^,5CNC*--&
MM=O36H9<NQD"J%QA5PAB&O</1$%5<Y/DR9((K;.53_YKL9QC&+'[EMD'3*]C
MZYE,KK5B25-7VV*_W]N3A,OLW\[;-@1CX\/DJD;8DSH7:U.7N9&QY\FKLRKD
M(C-@<MMV;CY&Q'*/>5@9[NV7&7"K6UPTV3')R5*F&U1FFTU&TA_48A2$C66N
MUC-S-EHB.[Q;Y:KJE3[F90QQD&DV?PS#L&=@6%L6EHG1N9;&MCTOM5%>CUO*
MLG&CW7EM1+;;+#&E;M+BV*8ZW:'%WI5U[96/LE2V-R,<CDC5C;J)%DL5C;J6
M*MEBK:3>%]:7Z@)"E(33G#<A"%P4A"Z]W64I2EQV"E*7'(3&"E+C'8QC'\ Q
MC_47LDN5:G$K?E(?^[F6O[0VVB9$I<+L^3G_ .\FCW/KK.<H>HOJ*L:7W;0]
M!U:K538\7M".?ZLJNP(2P+3\16+;5&S-X]MVT+PQ/#*1UR='423;)*F731-W
M7!2&(?M&R>[? ]CL0?B6&2U<D\D*Q*DKHW-NJYCU5$9$Q;;6)E552RW(=1VS
MWI[0[<89'A6+0T4=/'.DJ+"R1KKS6/8B*KY9$NV/6U$1%M1,N2Q<7W7JI\K;
M]P6K/3WGW](/HVLXKS$LLUKL@CL6:K-1GFMFJ=-G)X\\M!N*Y7)F.:*ML(1;
M=YG#-$BKA0A.US.IMA,!I-J7[70I+]*/O+8KDU;7/:K7O:V[>O.151;7*F5;
M$12WU>\7:.LV0CV*F=#]$1W4M1JZUS&.1[&.=>NW6N1JI8Q'=RB*Y40^#L7J
M3;[V'P@U;T_LP.KJ5H75TJVFB'HM=L,3<KW(-I.=GL*W^6DK=,PLF5>RV!>4
M6PRCH["[\J:I^VRGC JT>QF$T>T\^UM^>7%9VJWNW-5C$5&M_!HC$<G<M1J7
MG.L;:B<)1KMN\9KMDJ?8NY3Q8-3N1WX-KD?(J*YWX15>YJ]VY7K=:VUUBKP$
M?8[<=+-J*ER^VE1N)FT.'-484^%USN?9=:V1LRU,XN63V5;4Z>Q8I5K7\G/8
MG?:537<1,,"RJ3/VLP[Q)'4/EUE(YD<V&HV>H:K'X-HZA9'5E- Z.-JJFK9?
M5;TB-NWM8J+<5;UEVSN;4M.Q4VTV(T>S=1LO3-B90U4[997HBZU]Q$NQJZ]=
MU37)?1MVV]:MZQ;#,?"CJ8\BN"T+=Z5KJ-U=LO5.Q'[.;MFF=ZTUS?M8O[-'
M(MT&-J0A64[6Y&/L""+)L4ZK=XF1SAHV[N17O=#N=NVFV*P?:F6*IK'3P5\*
M*UDT#TCE1J\+;RM<BMRKD5%LM6Q4M6VZ;*;?8YLA%-24+:>HPZ=R.?!4,62)
M7I98^ZCFJCLB94<EMC;46ZEF$.6W+W>?-O;[W=F_[*UL%N6B(^MQ+.)C&\'6
MJK5HE1TM&5FL0K7MDXZ(:.7[A;L&.JNLX<*JK***',?-SV?V>PO9G#DPS"6*
MRG1RN556\YSELM<YR\*JB(G$B(B(B(B%HVEVFQ?:S$UQ;&I$?4JU&HB(C6L8
MEMC&-3@:BJJ\:JJJJJJK:=.3CY4]F*:$T@HAMKO=$^H=:G1;^ =?5[@D:F0I
MDT>ZG<X.KW(F<%[;/W3=CLY&C&,.9]+57<_]IDX_NW'H5@;9/H6C[K_LL7$G
MQ;3+W@AM'TP?U?UWV2+=>9T>V72[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X
M(;1],']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U?
MUWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!_5_7?9(7F='
MMB[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1],']7]=]DA>9T>V+LG2[2#
MP0VCZ8/ZOZ[[)"\SH]L79.EVD**OK.L;/1?/74C>Q63PH>GXAT)9*0]IV4)W
M%J;<V_2$9]ZL3J)*=S53.?NF<]MGNG8_@+@;6;C%1=DJBQ+$^D9/ TYISYPJ
M*FVE+>6U?HN/P]25RQF@P0                !UWO!#:/I@_J_KOLD>==YG
M1[9Z>W9.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ
M7:0>"&T?3!_5_7?9(7F='MB[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1]
M,']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U?UWV2
M%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!_5_7?9(7F='MB[)
MTNTAY#8-2V>6A7<RFW.Z)EJ%E,=/P!KQ.Z$Q#/<F)VY7/9)V^/N=G'W<"31N
M9UN+N?\ *-X_ND(M<V3J4W=?Y)_$G14Y0FN]BWK4EXK&RM96R<HU]IDLWFZO
M:ZV_6C)F%DVW;8(Y:.T#%-@JB9S)JIF[9)=$YTU"F3.8N?0*LHZ7$*5]%6QM
MEI)&W7,<EJ.1<Z=M.-%RIE/-:AKJS#:N.OH)'PUD3D<Q[5L<U4XT7M*G J6H
MMJ*3K1WK*O4-:5QK'2-;XQ6.Z,HTT:UV]-:AER[&0*H7&%7"&(:]P]$055SD
M^3)D@BMLY5/_ )KL9QC&+'[EMD'3*]CZYE,KK5B25-7VV*_W]N3A,OLW\[;-
M@1CX\/DJD;8DSH7:U.7N9&QY\FKLRKD(8]\\CMV\F]KS6[MX[#GK[LR<7;*+
MV.0519YCF[$YE(R+KL;%HL8JLPL28^<M64>@V;-S&,8A,&,;.<D85@V&8)0-
MPS"X614347N4RVV\*N5;5<Y>-7*JKQJ8LQC'<6Q_$GXMB\[YJ]ZIW2Y+$3@1
MJ)8C&IQ-:B(G$A+)ISUASJ#ZMHT/0;<;2?(V,KZ3=&%EN0^OYJV6AIAD3*+)
M=S8:E=*(_G9)LW.=/#V2,\?*%.;*BQS9[8=!Q'=!LC753JNGZS1O?PI3R(QJ
MV\-C7L>C47HML;F1#)&%[[=M<.I&T53U2NC8B75J8W/>EG!:YCXU<J)DO.O.
M6W*JFC7-CJ0\LN?\S!/N1%^;R->J:KAQ4M>5.)0JVOZX\=I81=R32#:G6<2<
MRNEVQ._I)P^>IHG,DFJ1'.4QVC9G8S -DHWMP>)4FD]O(];TCD3@17+P)]RU
M&I;E5%7*=1VLVZVDVTE8_&YD=!&JJR)C;D;57A5&IE5WW3E<Y$R(J)D/:\NN
MJGRMYLZ*TSQZW8_I"U&TLXBI..=UFNR$38[K8H*MOJE#6F_/WD]*L9"<CH"5
M>($-'M8QN?+M4YTCJ&P;$;9[83 =F<4J<7PQ)4JJE%14<Y%:QKG(]6QHC45&
MJY$7NE<N1$1;"5M-O%VCVLP>EP3%G0K1TBHJ*QJHZ1S6JQKY%5RHKD:KD[E&
MIE5515(W1W,Z*;NT7GON/7W!?<W3[A:_KAQI?>>RXG:=NL4G#61?9;"P0[_5
MDDW9UZ:;6YG66D,JXU#%]T3<P[M?)5'&"K%[H3*76*K93#JO:FFVNE?,F)4L
M"Q,:BMU:M5)4M<U6*Y5_#.X'HG!DR+;VRCVRQ2BV0JMBHF0+A594),]RM=K4
M<U851&N1Z,1ML++45BKE=ERI9JEKRXK:[O\ 1]@-X*N6EQ1KA6;BA6;@Q=2=
M2L:U9FF4TE!6F-8OXI[(5R7.RPW?((NFRJK90Y2*IFS@^+]64R5E)+2*]\:2
MQN9>8J(]MYJMO-545$<EMK55%1%LR*=<HJI:&MAK6LCD=#*Q]QZ*K'7'(ZZ]
M$5%5KK+'(BHJHJHBIPF8MZ\L=U\A.2]FY:W2SGB]S6&ZQ-Z8SE24D8="F2M9
M-'%IC6E9<2,C*0T=26L,S0B^W=+N$$VJ9CK**8,H:W85@&&81@C-GZ9E[#61
M*Q6OL6^CK;ZOR(BJ]5579$1;5R(F0NF,;28MC>/R;2U<EW%7RMD1S+6W%99<
M2.U55J1HUJ,RJJ(B6JJY3?K=_7+YO;VTO;],SB6DZ9YSZXC4MR[3UKK!.J[=
MW)7DF7M::+OUGS-R$69NXBS*-%,1<=&9RT650QV$E#DSU/"]U^S&%8E'B476
M9=0^_#%)+>BA=;;;&VZB\.7NG.RHB\*(IW/%][NUN,85+A<R4D76&7)YHHKD
MT[;++)'WE2Q4R+<:S(JIP*J$@OJN,79)3??*5.N6KP562U#3CN7'M&PG.^TC
M7-4I$>Y/U$R(=H?[[MB]G.?X!TS?PJ)A-!:EO^TO[P[UYNJ.7&L1NK9_LK/"
M%TWP0VCZ8/ZOZ[[)&LEYG1[9MG=DZ7:0>"&T?3!_5_7?9(7F='MB[)TNT@\$
M-H^F#^K^N^R0O,Z/;%V3I=I!X(;1],']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ
M[[)"\SH]L79.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CV
MQ=DZ7:0>"&T?3!_5_7?9(7F='MB[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X
M(;1],']7]=]DA>9T>V+LG2[2%3_UIN&M<50N&IK)<_"LBUOW3AHGX.QL'WD8
MD-KC*Q^V8*J9<]WP8N.P;L=KVOW/X<C8'<*K5J\3L2S\'#WTAK5YQJ.2BPJ\
MMOX6?B^YB*C^NMJ[0T_8"6S4NR+[JZTII903LNNKA8:38"(9.53*))FM2,9(
ME2RH3!NUPIV.SC&?X<#8BLH*'$8>KXA#%/!T9&->W0Y%3M&L=#B.(89-UG#9
MYJ>HZ43W1N_9,5%[9]7:&\]V;OD6TONG<.T]O2S(G<F<IM#8-MO\BT3[0B7<
MVSVUR\LY0)W-,I>P0V,=J7&/X,8%.APO#,+8L>&TT%/&O"D4;(T7TT8B(5<0
MQ?%L7>DN*U5152)P++(^14])7N54,6">6X]A0=AW_5-MB+]JZ\7#6U[KYGIH
M&ZT&S35/ML(:2CG<1(FB+'7GL=,1IG\3(+M5LHK$[JW743-V2',7,:KHZ2OI
MW4E=%'-2OLO,D:U['6*BI:UR*BV*B*EJ9%1%X4)-'6UN'5+:W#YI8*QEMV2-
M[F/;:BM6ZYJHY+4546Q<J*J<"GR)ZQ6"TV"9MMGG9FQVJQS,C8K#9IZ4>R]@
MGK!+O5I.6G9F9D%W$E*3,I).%'#ATNH===<YE#F,8V<YJ10PP0MIX&-9 QJ-
M:UJ(C6M1+$:B)D1$3(B(EB)D0IS3SU$[ZFH>^2ID>KG/<JN<YSEM5SG+:JN5
M55555M5<JGJMB[<VMN"2C)G;6SMA;1EX6(:U^&E=BW2R7:2B8%CVW>4)&/K+
M)2;IA$,^VSW)LD8B*?9SVI<"A1X?08<QT>'P0P1N<KE2-C6(KEX7*C41%5>-
M5RDBNQ/$L3D;+B51/42L:C6K+(Z14:G U%>JJC4XD3(A^W5^[MT:0E7,[I;;
MNS]0S;U#O9Y,ZOOUKH$J[;=J<O>[F0JDM$NUT.U4-CM#GR7L&S]S[N1QKL,P
MW%(TBQ*G@J(D6U$EC9(B+R(]%0YX?BV*X1(LV%5-12S*EBNBD?&JIF56*BJ?
M#OVQ]A[6LCNY;1OESV3;WY<%?6J_6B<N%D>EPJLO@KN<L+Z1DW)<+.%#]@ZN
M?OCFS_#G/9JTE'1T$*4U#%'#3IP-C:UC4])K41.T4:RNKL1G6JQ":6>J=POD
M>Y[E]-SE55X<Y_F#V+L&KU:YT:M7JY5ZD[')!);#I\'9YN)JU\3J[U>3K*=S
MK[!\WB;02NR3I5PPP^17PT74,HEVAC9SE+1TD\\=5/%&^IAO:M[FM5T=Y+'7
M'*EK;R(B.NJEJ)8HAKJVGIY:2GFE923W=:QKW-9)<559?:BHC[JJJMO(MU55
M4L/\478%\U?9XV[:TNUNUW<X8YE8BW46R3-2L\4H<O:G4C9Z >Q\JQ.8OW,Y
M25+G. JJ2DKH'4U;%'-3.X6/:CVKZ;7(J+V4/E'6UF'U#:N@FE@JF^U?&YS'
MIZ3FJBIV%/\ M[V'?]I69_=-FWBX;&N,J8II2V7NS35NLTD8N39*9_/6![(2
MCPQ<FSV,J*F['9R%+1TE# E-0Q1PTS>!C&M8U/2:U$1- K*VMQ&H=5XA-+/5
M.X7R/<]Z^FYRJJ]E3IA],.L;$==/#A>XCMH>U;!;CEJU1I'>!,&^[R0-5V&4
MVW?B[@JSGN1?N=N;&#&_AR-(-NE;_/+$[4R]=EX_NE/0+=XU_P#,;";'9.H0
M\7W"&]?@AM'TP?U?UWV2.IWF='MG<KLG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EV
MD'@AM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!
M_5_7?9(7F='MB[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1],']7]=]DA>
M9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U?UWV2%YG1[8NR=+
MM(/!#:/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!_5_7?9(7F='MB[)TNT@\$-H^F
M#^K^N^R0O,Z/;%V3I=I!X(;1],']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"
M\SH]L79.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ
M7:0>"&T?3!_5_7?9(7F='MB[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1]
M,']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U?UWV2
M%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!_5_7?9(7F='MB[)
MTNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1],']7]=]DA>9T>V+LG2[2#P0VC
MZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_KOL
MD+S.CVQ=DZ7:0>"&T?3!_5_7?9(7F='MB[)TNT@\$-H^F#^K^N^R0O,Z/;%V
M3I=I!X(;1],']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM
M'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!_5_7?
M9(7F='MB[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1],']7]=]DA>9T>V+
MLG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(/!#
M:/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!_5_7?9(7F='MB[)TNT@\$-H^F#^K^N
M^R0O,Z/;%V3I=I!X(;1],']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L
M79.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ7:0>"
M&T?3!_5_7?9(7F='MB[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1],']7]
M=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U?UWV2%YG1[
M8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!_5_7?9(7F='MB[)TNT@\
M$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1],']7]=]DA>9T>V+LG2[2#P0VCZ8/ZO
MZ[[)"\SH]L79.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.C
MVQ=DZ7:0>"&T?3!_5_7?9(7F='MB[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!
MX(;1],']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U
M?UWV2%YG1[8NR=+M(/!#:/I@_J_KOLD+S.CVQ=DZ7:0>"&T?3!_5_7?9(7F=
M'MB[)TNT@\$-H^F#^K^N^R0O,Z/;%V3I=I!X(;1],']7]=]DA>9T>V+LG2[2
M#P0VCZ8/ZOZ[[)"\SH]L79.EVD'@AM'TP?U?UWV2%YG1[8NR=+M(/!#:/I@_
MJ_KOLD+S.CVQ=DZ7:0>"&T?3!_5_7?9(7F='MB[)TNT@\$-H^F#^K^N^R0O,
MZ/;%V3I=I!X(;1],']7]=]DA>9T>V+LG2[2#P0VCZ8/ZOZ[[)"\SH]L79.EV
MD/>U]A,QT<5M/3WA'(855.:3]JVL/VZ1\XRDCWDS.= O<<?<[;L]DW^4<5L5
M<B6(<VHJ)E6U3[8^'T                                   B\ZIG3B
MD^I5JS76K&^_'^C(ND7ES=I-1&AN-AL+6L:$<P\<T?0J>P: W15B<O%545U%
M'.294.4I"]MDV9=)5)2O5]V\JI9PV>LI$JZ5:IB,O741;>"WUT-'XOHZ=0>#
MC(Z%A>M[R AX:'8-(N)B8O3\]'QD7&1[=-HPCHY@TY*HM63!DU1(DBBD0J::
M9<%+C&,8P)"UM,JVK3MM]/\ _"1TH:E$L2H=9Z7_ .(T(]6VXU[QM])/R-K?
M+F]4/2NO^1=]K%QXHQ=<=/*3M&<+I[7BQK=-6#-X8L8]Z=.V1R>4\P3M7&(-
M'L+X[?&$9&*2QM=JE8BR*U+'<:95R<'K\9'PN*1S=:CU2-'+:WB7(F7AY<W$
M7&A9"]@  !&WU3_JX:__ %P^$O\ >DU:)5)\*ON'=ZI%K/@D]VSOD))!%)0
M       5J_6F?W?>GOUQ]??H3Y"#-&XK[6U'U=)X:G,#^<-]BZ7ZTC\!4E!T
M;7FFP                '3:Z'G[JKA_^)US_2Q?QI+O/^WF(_*,\%&;][I/
MS=89\D_PTA*X.A&1@      /A67_ +$>_P#1O^MH#ZG"<7^U/NCX<@    "K
MKU./KA7_ /T'0_D;##/>PGV:A]W)W[C\W'Z1?^]=CGB>&_D$!H".X&C@
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MXH?F;NGRV2&SNX;R17^,L[PU*\XSRWAOBK_"%4<9Z-<P
M.NEQU^K[HK\S>L?D3"#SYQCRO5>,R]^X]+<#\B4?BL7@VF9!;BZ
M      %![UIG]X)I[]3C7WZ;.0@VNW%?9*H^L9/ TYIMYPWVTI?JN/P]25JA
MFDP.                !V-AYT'J"               >-V+^3Z]_B;9_P"1
M'PDT7SR+Y5O?(1:[YE-\D_O5./V/0X\R                 +7'JI7U@N5_
MYFZ7\ME1@7?SY(H/&7]X;&>;GY;Q+Q5GA"[\-8C;4               J*^M
MA_D_X4_CCN_^1-:#8/<'\[Q/Y.#OI#6CSC_F6$_*U'>Q%+,;*&JH
M        '4]Z6/[N#A'^K5JCY*L!HIMW]LL3\=E[Y3T/W>?87"?$(>\0WY'4
MSN0
M
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MOJ^[U_,WL[Y$S8N.#^5Z7QF+OVEKQSR)6>*R^#<<BT>@QYI
M    6N/52OK!<K_S-TOY;*C N_GR10>,O[PV,\W/RWB7BK/"%WX:Q&VH
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M??ILY"#:[<5]DJCZQD\#3FFWG#?;2E^JX_#U)6J&:3 X
M'8V'G0>H(              !XW8OY/KW^)MG_D1\)-%\\B^5;WR$6N^93?)/
M[U3C]CT./,@                "UQZJ5]8+E?\ F;I?RV5&!=_/DB@\9?WA
ML9YN?EO$O%6>$+OPUB-M0              "HKZV'^3_ (4_CCN_^1-:#8/<
M'\[Q/Y.#OI#6CSC_ )EA/RM1WL12S&RAJJ                !U/>EC^[@X
M1_JU:H^2K :*;=_;+$_'9>^4]#]WGV%PGQ"'O$-^1U,[D
M
M
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MNBORWZ;_ #JZ]^5T0+?BWDJI\7D[Q3)>Y;\\>R7])L+_ "Z N9C60_6^
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MU?=%?F;UC\B80>?.,>5ZKQF7OW'I;@?D2C\5B\&TS(+<70
M H/>M,_O!-/?J<:^_39R$&UVXK[)5'UC)X&G--O.&^VE+]5Q^'J2M4,TF!P
M               .QL/.@]00              #QNQ?R?7O\3;/_ "(^$FB^
M>1?*M[Y"+7?,IODG]ZIQ^QZ''F0                !:X]5*^L%RO\ S-TO
MY;*C N_GR10>,O[PV,\W/RWB7BK/"%WX:Q&VH              !45];#_)_
MPI_''=_\B:T&P>X/YWB?R<'?2&M'G'_,L)^5J.]B*68V4-50
M    .I[TL?W<'"/]6K5'R58#13;O[98GX[+WRGH?N\^PN$^(0]XAOR.IG<@
M
M
M                                                "-OJG_5PU_\
MKA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*        "M7ZTS^[[T]^N/K[
M]"?(09HW%?:VH^KI/#4Y@?SAOL72_6D?@*DH.C:\TV                 Z
M;70\_=5</_Q.N?Z6+^-)=Y_V\Q'Y1G@HS?O=)^;K#/DG^&D)7!T(R,
M!4"]=6_=9:#_ %_]6?W=>50 F^Z*7[H_IR_J@:/^1,6 )/P    5=>IQ]<*_
M_P"@Z'\C889[V$^S4/NY._<?FX_2+_WKL<\3PW\@@- 1W T<
M   ,JZ*_+?IO\ZNO?E=$"WXMY*J?%Y.\4R7N6_/'LE_2;"_RZ N9C60_6^
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M+CK]7W17YF]8_(F$'GSC'E>J\9E[]QZ6X'Y$H_%8O!M,R"W%T
M    *#WK3/[P33WZG&OOTV<A!M=N*^R51]8R>!IS3;SAOMI2_5<?AZDK5#-)
M@<                #L;#SH/4$               \;L7\GU[_$VS_R(^$F
MB^>1?*M[Y"+7?,IODG]ZIQ^QZ''F0                !:X]5*^L%RO_,W2
M_ELJ,"[^?)%!XR_O#8SS<_+>)>*L\(7?AK$;:@              %17UL/\
M)_PI_''=_P#(FM!L'N#^=XG\G!WTAK1YQ_S+"?E:CO8BEF-E#54
M       #J>]+']W!PC_5JU1\E6 T4V[^V6)^.R]\IZ'[O/L+A/B$/>(;\CJ9
MW(
M
M                                                    C;ZI_P!7
M#7_ZX?"7^])JT2J3X5?<.[U2+6?!)[MG?(22"*2@        K5^M,_N^]/?K
MCZ^_0GR$&:-Q7VMJ/JZ3PU.8'\X;[%TOUI'X"I*#HVO--@
M  .FUT//W57#_P#$ZY_I8OXTEWG_ &\Q'Y1G@HS?O=)^;K#/DG^&D)7!T(R,
M      !4"]=6_=9:#_7_ -6?W=>50 F^Z*7[H_IR_J@:/^1,6 )/P    5=>
MIQ]<*_\ ^@Z'\C889[V$^S4/NY._<?FX_2+_ -Z['/$\-_((#0$=P-'
M          #*NBORWZ;_ #JZ]^5T0+?BWDJI\7D[Q3)>Y;\\>R7])L+_ "Z
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M6M?K!<4/S-W3Y;)#9W<-Y(K_ !EG>&I7G&>6\-\5?X0JCC/1KF
M      !UTN.OU?=%?F;UC\B80>?.,>5ZKQF7OW'I;@?D2C\5B\&TS(+<70
M             H/>M,_O!-/?J<:^_39R$&UVXK[)5'UC)X&G--O.&^VE+]5Q
M^'J2M4,TF!P                .QL/.@]00              #QNQ?R?7O\
M3;/_ "(^$FB^>1?*M[Y"+7?,IODG]ZIQ^QZ''F0                !:X]5
M*^L%RO\ S-TOY;*C N_GR10>,O[PV,\W/RWB7BK/"%WX:Q&VH
M   !45];#_)_PI_''=_\B:T&P>X/YWB?R<'?2&M'G'_,L)^5J.]B*68V4-50
M                .I[TL?W<'"/]6K5'R58#13;O[98GX[+WRGH?N\^PN$^(
M0]XAOR.IG<@
M
M
M"-OJG_5PU_\ KA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*        "M7Z
MTS^[[T]^N/K[]"?(09HW%?:VH^KI/#4Y@?SAOL72_6D?@*DH.C:\TV
M           Z;70\_=5</_Q.N?Z6+^-)=Y_V\Q'Y1G@HS?O=)^;K#/DG^&D)
M7!T(R,      !")U\>E]?.K)PXU_QZUYM&HZEF:'R0IF[W=BN</,S<8_BJ_K
M;;FOEH-LU@S$=)R#AYLU!P50W^;PDU4+G[XQ0/BK8EI(1P.XZ37$3AAQ@XOV
M.QQ=OGM":3H&K)>T0C5VQB)^0IT TAW,K&LW^<O&S-XHVR=,BN>W*7/8S]T#
MZ;9@    JZ]3CZX5_P#]!T/Y&PPSWL)]FH?=R=^X_-Q^D7_O78YXGAOY! :
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MOU2__7]_V5O]X\:Y[_OXI_?7\'-H/-M_CK]Z?PHN-C70VA
M *0/K6OU@N*'YF[I\MDAL[N&\D5_C+.\-2O.,\MX;XJ_PA5'&>C7,
M         #KI<=?J^Z*_,WK'Y$P@\^<8\KU7C,O?N/2W _(E'XK%X-IF06XN
M@              !0>]:9_>":>_4XU]^FSD(-KMQ7V2J/K&3P-.:;><-]M*7
MZKC\/4E:H9I,#@                =C8>=!Z@@              'C=B_D^
MO?XFV?\ D1\)-%\\B^5;WR$6N^93?)/[U3C]CT./,@                "U
MQZJ5]8+E?^9NE_+948%W\^2*#QE_>&QGFY^6\2\59X0N_#6(VU
M     *BOK8?Y/^%/XX[O_D36@V#W!_.\3^3@[Z0UH\X_YEA/RM1WL12S&RAJ
MJ                !U/>EC^[@X1_JU:H^2K :*;=_;+$_'9>^4]#]WGV%PG
MQ"'O$-^1U,[D
M
M
M  1M]4_ZN&O_ -</A+_>DU:)5)\*ON'=ZI%K/@D]VSOD))!%)0        5J
M_6F?W?>GOUQ]??H3Y"#-&XK[6U'U=)X:G,#^<-]BZ7ZTC\!4E!T;7FFP
M            '3:Z'G[JKA_^)US_ $L7\:2[S_MYB/RC/!1F_>Z3\W6&?)/\
M-(2N#H1D8      #X5E_[$>_]&_ZV@/J<)Q?[4^Z/AR     *NO4X^N%?_\
M0=#^1L,,]["?9J'W<G?N/S<?I%_[UV.>)X;^00&@([@:.
M&5=%?EOTW^=77ORNB!;\6\E5/B\G>*9+W+?GCV2_I-A?Y= 7,QK(?K?
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M^K[HK\S>L?D3"#SYQCRO5>,R]^X]+<#\B4?BL7@VF9!;BZ
M %![UIG]X)I[]3C7WZ;.0@VNW%?9*H^L9/ TYIMYPWVTI?JN/P]25JAFDP.
M               !V-AYT'J"               >-V+^3Z]_B;9_Y$?"31?/
M(OE6]\A%KOF4WR3^]4X_8]#CS(                 M<>JE?6"Y7_F;I?RV
M5&!=_/DB@\9?WAL9YN?EO$O%6>$+OPUB-M0              "HKZV'^3_A3
M^..[_P"1-:#8/<'\[Q/Y.#OI#6CSC_F6$_*U'>Q%+,;*&JH
M   '4]Z6/[N#A'^K5JCY*L!HIMW]LL3\=E[Y3T/W>?87"?$(>\0WY'4SN0
M
M
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MY_I8OXTEWG_;S$?E&>"C-^]TGYNL,^2?X:0E<'0C(P      'PK+_P!B/?\
MHW_6T!]3A.+_ &I]T?#D     5=>IQ]<*_\ ^@Z'\C889[V$^S4/NY._<?FX
M_2+_ -Z['/$\-_((#0$=P-'               #*NBORWZ;_ #JZ]^5T0+?B
MWDJI\7D[Q3)>Y;\\>R7])L+_ "Z N9C60_6^               8;Y%?5]WK
M^9O9WR)FQ<<'\KTOC,7?M+7CGD2L\5E\&XY%H]!CS2                 M
M<>JE?6"Y7_F;I?RV5&!=_/DB@\9?WAL9YN?EO$O%6>$+OPUB-M0
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MR58#13;O[98GX[+WRGH?N\^PN$^(0]XAOR.IG<@
M
M
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MC!L8,;&<S[C'*NUM0B_R=)X:G,$><*QK=BZ54_E2/C7XBI**@VM-.0
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M%[3OSZ1'=^Z^TDG'=\]MWJ3M>Z]OVG8SVO8[8W9UUW^N5OT39_\ -?P<V?\
M-O:COIFW_P"4_A1;O\R6N?<R=\>KYY3#76^[DT(;/:IG+I7G'F2US[F3OCU?
M/*8+[N30@U3.72O./,EKGW,G?'J^>4P7W<FA!JF<NE><>9+7/N9.^/5\\I@O
MNY-"#5,Y=*\X\R6N?<R=\>KYY3!?=R:$&J9RZ5YQYDM<^YD[X]7SRF"^[DT(
M-4SETKSCS):Y]S)WQZOGE,%]W)H0:IG+I7G'F2US[F3OCU?/*8+[N30@U3.7
M2O./,EKGW,G?'J^>4P7W<FA!JF<NE><>9+7/N9.^/5\\I@ONY-"#5,Y=*\Y2
MR]:.I\!3]]\6FT W>MT7FH;BNX*]F9J9,91.YI)ER16:D9!5$N"_PE(8I<_P
MYQV1LWN'<JX37V_C+.\-3/.*:C<:PZS\5?X0JW#/)KJ                !
MU@./FF->N=":0<K1TV99QJ'6JZIBW:\)%RHK3(50^2I)6,B29<F-GL%*7!<?
MP8QC \_,8>[Z6JN#YS)Q)TW'I3@<;/H6CX?FL7&OQ;>4R]YDM<^YD[X]7SRF
M%NONY-"%TU3.72O./,EKGW,G?'J^>4P7W<FA!JF<NE><>9+7/N9.^/5\\I@O
MNY-"#5,Y=*\X\R6N?<R=\>KYY3!?=R:$&J9RZ5YQYDM<^YD[X]7SRF"^[DT(
M-4SETKSCS):Y]S)WQZOGE,%]W)H0:IG+I7G'F2US[F3OCU?/*8+[N30@U3.7
M2O./,EKGW,G?'J^>4P7W<FA!JF<NE><>9+7/N9.^/5\\I@ONY-"#5,Y=*\X\
MR6N?<R=\>KYY3!?=R:$&J9RZ5YRBKZSK5H6H\]=21L$@[;M%^(="?*$>2TO,
M*Y<J;FWZ@<Q7,R^D'2:>4FQ,83*?">,XSG!<9,;.=K-QBJNR50J_RC)X&G-.
M?.%:C=M*5$_DN/P]25RQF@P0                !UWO,EKGW,G?'J^>4P\Z
M[[N30AZ>ZIG+I7G'F2US[F3OCU?/*8+[N30@U3.72O./,EKGW,G?'J^>4P7W
M<FA!JF<NE><>9+7/N9.^/5\\I@ONY-"#5,Y=*\X\R6N?<R=\>KYY3!?=R:$&
MJ9RZ5YQYDM<^YD[X]7SRF"^[DT(-4SETKSCS):Y]S)WQZOGE,%]W)H0:IG+I
M7G'F2US[F3OCU?/*8+[N30@U3.72O./,EKGW,G?'J^>4P7W<FA!JF<NE><>9
M+7/N9.^/5\\I@ONY-"#5,Y=*\YY#8.E==I4&[JDC9S!TZA95"9S>+T?&#$A7
MIBYR4]D,0V,9Q_!G&<9_RB31O=UR+Y1O$G20BUT3.I3</P3^->BO*<E >A9Y
MF                 6D?5<:? 7#??*5M/MWKA%GJ&G+MRLIF:AC%44N:J9L
MG5A9&/56+DO\!3F,7'\.,=D8&W\.5,)H+/QE_>&Q7FZM1V-8C;^*L\(73?,E
MKGW,G?'J^>4PUDONY-"&V>J9RZ5YQYDM<^YD[X]7SRF"^[DT(-4SETKSCS):
MY]S)WQZOGE,%]W)H0:IG+I7G'F2US[F3OCU?/*8+[N30@U3.72O./,EKGW,G
M?'J^>4P7W<FA!JF<NE><>9+7/N9.^/5\\I@ONY-"#5,Y=*\X\R6N?<R=\>KY
MY3!?=R:$&J9RZ5YQYDM<^YD[X]7SRF"^[DT(-4SETKSCS):Y]S)WQZOGE,%]
MW)H0:IG+I7G'F2US[F3OCU?/*8+[N30@U3.72O.5/_6G*+6J=0N&JD U?MSO
M[=NDCG+V?L$U@Y6\-K@R6$RS<I(E;YQE4W9RG@F3?Y>SV,=C8'<(Y5J\3M^+
MA[Z0UJ\XUK6T6%6?&S][$4X1LF:K@                =//IAZCHDOT\.%\
MH_CYA1Z_XY:M=.CHW&YLTCK+5=@=0R;5E8&[1N3)L_<(F0A"_P"3&,#1;;I[
MDVRQ-$_'9>).DIZ&;O(VKL-A*K;\PAXUZ"<IO7YDM<^YD[X]7SRF'5+[N30A
MW'5,Y=*\X\R6N?<R=\>KYY3!?=R:$&J9RZ5YQYDM<^YD[X]7SRF"^[DT(-4S
METKSCS):Y]S)WQZOGE,%]W)H0:IG+I7G'F2US[F3OCU?/*8+[N30@U3.72O.
M/,EKGW,G?'J^>4P7W<FA!JF<NE><>9+7/N9.^/5\\I@ONY-"#5,Y=*\X\R6N
M?<R=\>KYY3!?=R:$&J9RZ5YQYDM<^YD[X]7SRF"^[DT(-4SETKSCS):Y]S)W
MQZOGE,%]W)H0:IG+I7G'F2US[F3OCU?/*8+[N30@U3.72O./,EKGW,G?'J^>
M4P7W<FA!JF<NE><>9+7/N9.^/5\\I@ONY-"#5,Y=*\X\R6N?<R=\>KYY3!?=
MR:$&J9RZ5YQYDM<^YD[X]7SRF"^[DT(-4SETKSCS):Y]S)WQZOGE,%]W)H0:
MIG+I7G'F2US[F3OCU?/*8+[N30@U3.72O./,EKGW,G?'J^>4P7W<FA!JF<NE
M><>9+7/N9.^/5\\I@ONY-"#5,Y=*\X\R6N?<R=\>KYY3!?=R:$&J9RZ5YQYD
MM<^YD[X]7SRF"^[DT(-4SETKSCS):Y]S)WQZOGE,%]W)H0:IG+I7G'F2US[F
M3OCU?/*8+[N30@U3.72O./,EKGW,G?'J^>4P7W<FA!JF<NE><>9+7/N9.^/5
M\\I@ONY-"#5,Y=*\X\R6N?<R=\>KYY3!?=R:$&J9RZ5YQYDM<^YD[X]7SRF"
M^[DT(-4SETKSCS):Y]S)WQZOGE,%]W)H0:IG+I7G'F2US[F3OCU?/*8+[N30
M@U3.72O./,EKGW,G?'J^>4P7W<FA!JF<NE><>9+7/N9.^/5\\I@ONY-"#5,Y
M=*\X\R6N?<R=\>KYY3!?=R:$&J9RZ5YQYDM<^YD[X]7SRF"^[DT(-4SETKSC
MS):Y]S)WQZOGE,%]W)H0:IG+I7G'F2US[F3OCU?/*8+[N30@U3.72O./,EKG
MW,G?'J^>4P7W<FA!JF<NE><>9+7/N9.^/5\\I@ONY-"#5,Y=*\X\R6N?<R=\
M>KYY3!?=R:$&J9RZ5YQYDM<^YD[X]7SRF"^[DT(-4SETKSCS):Y]S)WQZOGE
M,%]W)H0:IG+I7G'F2US[F3OCU?/*8+[N30@U3.72O./,EKGW,G?'J^>4P7W<
MFA!JF<NE><>9+7/N9.^/5\\I@ONY-"#5,Y=*\X\R6N?<R=\>KYY3!?=R:$&J
M9RZ5YQYDM<^YD[X]7SRF"^[DT(-4SETKSCS):Y]S)WQZOGE,%]W)H0:IG+I7
MG'F2US[F3OCU?/*8+[N30@U3.72O./,EKGW,G?'J^>4P7W<FA!JF<NE><>9+
M7/N9.^/5\\I@ONY-"#5,Y=*\X\R6N?<R=\>KYY3!?=R:$&J9RZ5YQYDM<^YD
M[X]7SRF"^[DT(-4SETKSCS):Y]S)WQZOGE,%]W)H0:IG+I7G'F2US[F3OCU?
M/*8+[N30@U3.72O./,EKGW,G?'J^>4P7W<FA!JF<NE><>9+7/N9.^/5\\I@O
MNY-"#5,Y=*\X\R6N?<R=\>KYY3!?=R:$&J9RZ5YQYDM<^YD[X]7SRF"^[DT(
M-4SETKSCS):Y]S)WQZOGE,%]W)H0:IG+I7G'F2US[F3OCU?/*8+[N30@U3.7
M2O./,EKGW,G?'J^>4P7W<FA!JF<NE><>9+7/N9.^/5\\I@ONY-"#5,Y=*\X\
MR6N?<R=\>KYY3!?=R:$&J9RZ5YQYDM<^YD[X]7SRF"^[DT(-4SETKSCS):Y]
MS)WQZOGE,%]W)H0:IG+I7G'F2US[F3OCU?/*8+[N30@U3.72O./,EKGW,G?'
MJ^>4P7W<FA!JF<NE><>9+7/N9.^/5\\I@ONY-"#5,Y=*\X\R6N?<R=\>KYY3
M!?=R:$&J9RZ5YQYDM<^YD[X]7SRF"^[DT(-4SETKSCS):Y]S)WQZOGE,%]W)
MH0:IG+I7G'F2US[F3OCU?/*8+[N30@U3.72O./,EKGW,G?'J^>4P7W<FA!JF
M<NE><>9+7/N9.^/5\\I@ONY-"#5,Y=*\X\R6N?<R=\>KYY3!?=R:$&J9RZ5Y
MSWM?KL35XXL3"HN4&)%E5RINY*3E5L*+9QE3.7<L\?/,ESG'W"Y4[4O^3&!Q
M555;5.:(C4L3@/MCX?0                                  #&VXK!L
M2J:JV'9=1T9ILS9\%4)V4H6OW\\VK#.X6IG'K+0T YGWA<M8Q*0>E*3*BF2%
M^[V,G3[/;EY,1JO1'K8RW*N8X/5R,56):^S(F<K]5#UBFD:YK&*7S3XI<C-.
M\GX1#,7,:^J] 2S6K?9D,&;8S4"W>U0MGAFLG(8)@K9VD]PV(X3PF\>_=/FY
M+ACG+>@>UT6>WF+<W$VM2[.QS9<UG#Z5JGS^BYH[D+L+F%S(ZF&WM53O'^E\
MDD9Z#UMJ^P(OX>3FF5FNL!;UK2[@W[.->.T(:.JS1!*87;-B2SJ2>KMD\)&,
M%=)&V%E*Q;SF\*]@^4$<KIWU;T5K7\"=FVWV>,LO"UEU   "-OJG_5PU_P#K
MA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*        "M7ZTS^[[T]^N/K[]
M"?(09HW%?:VH^KI/#4Y@?SAOL72_6D?@*DH.C:\TV                 Z;
M70\_=5</_P 3KG^EB_C27>?]O,1^49X*,W[W2?FZPSY)_AI"5P=",C
M 5 O75OW66@_U_\ 5G]W7E4 )ONBE^Z/Z<OZH&C_ )$Q8 D_    !5UZG'UP
MK_\ Z#H?R-AAGO83[-0^[D[]Q^;C](O_ 'KL<\3PW\@@- 1W T<
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M6M?K!<4/S-W3Y;)#9W<-Y(K_ !EG>&I7G&>6\-\5?X0JCC/1KF
M      !UTN.OU?=%?F;UC\B80>?.,>5ZKQF7OW'I;@?D2C\5B\&TS(+<70
M             H/>M,_O!-/?J<:^_39R$&UVXK[)5'UC)X&G--O.&^VE+]5Q
M^'J2M4,TF!P                .QL/.@]00              #QNQ?R?7O\
M3;/_ "(^$FB^>1?*M[Y"+7?,IODG]ZIQ^QZ''F0                !:X]5
M*^L%RO\ S-TOY;*C N_GR10>,O[PV,\W/RWB7BK/"%WX:Q&VH
M   !45];#_)_PI_''=_\B:T&P>X/YWB?R<'?2&M'G'_,L)^5J.]B*68V4-50
M                .I[TL?W<'"/]6K5'R58#13;O[98GX[+WRGH?N\^PN$^(
M0]XAOR.IG<@
M
M
M"-OJG_5PU_\ KA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*        "M7Z
MTS^[[T]^N/K[]"?(09HW%?:VH^KI/#4Y@?SAOL72_6D?@*DH.C:\TV
M           Z;70\_=5</_Q.N?Z6+^-)=Y_V\Q'Y1G@HS?O=)^;K#/DG^&D)
M7!T(R,      !4"]=6_=9:#_ %_]6?W=>50 F^Z*7[H_IR_J@:/^1,6 )/P
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M'O6F?W@FGOU.-??ILY"#:[<5]DJCZQD\#3FFWG#?;2E^JX_#U)6J&:3 X
M             '8V'G0>H(              !XW8OY/KW^)MG_D1\)-%\\B^
M5;WR$6N^93?)/[U3C]CT./,@                "UQZJ5]8+E?^9NE_+948
M%W\^2*#QE_>&QGFY^6\2\59X0N_#6(VU               *BOK8?Y/^%/XX
M[O\ Y$UH-@]P?SO$_DX.^D-:/./^983\K4=[$4LQLH:J@
M =3WI8_NX.$?ZM6J/DJP&BFW?VRQ/QV7OE/0_=Y]A<)\0A[Q#?D=3.Y
M
M
M                                             $;?5/\ JX:__7#X
M2_WI-6B52?"K[AW>J1:SX)/=L[Y"20124        %:OUIG]WWI[]<?7WZ$^
M0@S1N*^UM1]72>&IS _G#?8NE^M(_ 5)0=&UYIL                !TVNA
MY^ZJX?\ XG7/]+%_&DN\_P"WF(_*,\%&;][I/S=89\D_PTA*X.A&1@
M*T?K4G"_D[SGZ>NH=4<4-32^X]@UCF/KS9$[6H67J\*ZCJ1%:6Y!U60GU'5L
MG:_'*-VU@N48VRFFL=?)G938)DA3F*'!PDL?2PU+L30O3@X1:7VY6'5+V?J_
MC5JBDWRI/74<^>5VTU^J1["8B'+R(>2,6Y68O$3$,=NNLD;..R4V<?= &_(
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MK5DA/;?4&J#DV_N(K@G9C7M<JSQL:"J;WML83<DNUN59,%V^#%54C3O%"?\
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M<4/S-W3Y;)#9W<-Y(K_&6=X:E><9Y;PWQ5_A"J.,]&N8
M'72XZ_5]T5^9O6/R)A!Y\XQY7JO&9>_<>EN!^1*/Q6+P;3,@MQ=
M      "@]ZTS^\$T]^IQK[]-G(0;7;BOLE4?6,G@:<TV\X;[:4OU7'X>I*U0
MS28'                 [&P\Z#U!               /&[%_)]>_P 3;/\
MR(^$FB^>1?*M[Y"+7?,IODG]ZIQ^QZ''F0                !:X]5*^L%R
MO_,W2_ELJ,"[^?)%!XR_O#8SS<_+>)>*L\(7?AK$;:@              %17
MUL/\G_"G\<=W_P B:T&P>X/YWB?R<'?2&M'G'_,L)^5J.]B*68V4-50
M           .I[TL?W<'"/\ 5JU1\E6 T4V[^V6)^.R]\IZ'[O/L+A/B$/>(
M;\CJ9W(
M
M                                                         C;Z
MI_U<-?\ ZX?"7^])JT2J3X5?<.[U2+6?!)[MG?(22"*2@        K5^M,_N
M^]/?KCZ^_0GR$&:-Q7VMJ/JZ3PU.8'\X;[%TOUI'X"I*#HVO--@
M       .FUT//W57#_\ $ZY_I8OXTEWG_;S$?E&>"C-^]TGYNL,^2?X:0E<'
M0C(P      'PK+_V(]_Z-_UM ?4X3B_VI]T?#D     5=>IQ]<*__P"@Z'\C
M889[V$^S4/NY._<?FX_2+_WKL<\3PW\@@- 1W T<               ,JZ*_
M+?IO\ZNO?E=$"WXMY*J?%Y.\4R7N6_/'LE_2;"_RZ N9C60_6^
M     8;Y%?5]WK^9O9WR)FQ<<'\KTOC,7?M+7CGD2L\5E\&XY%H]!CS2
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M^L%Q0_,W=/ELD-G=PWDBO\99WAJ5YQGEO#?%7^$*HXST:Y@
M   ==+CK]7W17YF]8_(F$'GSC'E>J\9E[]QZ6X'Y$H_%8O!M,R"W%T
M         *#WK3/[P33WZG&OOTV<A!M=N*^R51]8R>!IS3;SAOMI2_5<?AZD
MK5#-)@<                #L;#SH/4$               \;L7\GU[_ !-L
M_P#(CX2:+YY%\JWOD(M=\RF^2?WJG'['H<>9                 %KCU4KZ
MP7*_\S=+^6RHP+OY\D4'C+^\-C/-S\MXEXJSPA=^&L1MJ
M5%?6P_R?\*?QQW?_ ")K0;![@_G>)_)P=](:T><?\RPGY6H[V(I9C90U5
M              ZGO2Q_=P<(_P!6K5'R58#13;O[98GX[+WRGH?N\^PN$^(0
M]XAOR.IG<@
M
M                                                           "
M-OJG_5PU_P#KA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*        "M7ZT
MS^[[T]^N/K[]"?(09HW%?:VH^KI/#4Y@?SAOL72_6D?@*DH.C:\TV
M          Z;70\_=5</_P 3KG^EB_C27>?]O,1^49X*,W[W2?FZPSY)_AI"
M5P=",C       ?"LO_8CW_HW_6T!]3A.+_:GW1\.0    !5UZG'UPK__ *#H
M?R-AAGO83[-0^[D[]Q^;C](O_>NQSQ/#?R" T!'<#1P               RK
MHK\M^F_SJZ]^5T0+?BWDJI\7D[Q3)>Y;\\>R7])L+_+H"YF-9#];X
M       !AOD5]7W>OYF]G?(F;%QP?RO2^,Q=^TM>.>1*SQ67P;CD6CT&/-(
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MM:_6"XH?F;NGRV2&SNX;R17^,L[PU*\XSRWAOBK_  A5'&>C7,
M      #KI<=?J^Z*_,WK'Y$P@\^<8\KU7C,O?N/2W _(E'XK%X-IF06XN@
M            !0>]:9_>":>_4XU]^FSD(-KMQ7V2J/K&3P-.:;><-]M*7ZKC
M\/4E:H9I,#@                =C8>=!Z@@              'C=B_D^O?X
MFV?^1'PDT7SR+Y5O?(1:[YE-\D_O5./V/0X\R                 +7'JI7
MU@N5_P"9NE_+948%W\^2*#QE_>&QGFY^6\2\59X0N_#6(VU
M  *BOK8?Y/\ A3^..[_Y$UH-@]P?SO$_DX.^D-:/./\ F6$_*U'>Q%+,;*&J
MH                '4]Z6/[N#A'^K5JCY*L!HIMW]LL3\=E[Y3T/W>?87"?
M$(>\0WY'4SN0
M
M
M !&WU3_JX:__ %P^$O\ >DU:)5)\*ON'=ZI%K/@D]VSOD))!%)0        5
MJ_6F?W?>GOUQ]??H3Y"#-&XK[6U'U=)X:G,#^<-]BZ7ZTC\!4E!T;7FFP
M             '3:Z'G[JKA_^)US_2Q?QI+O/^WF(_*,\%&;][I/S=89\D_P
MTA*X.A&1@      ,#<B^0&A^..OD[KR%W9J/0]-F+!&U.)MNYMD4W5]9E+4]
M0?S3.M1T]=YF#BGM@=P\ ^=I,DE3.5&S)=4I,D14,7ZG"<7>U,HTF[TO951K
MFP-<V^KW^AW&'8V&HW:DS\3:JC:8"30*YC9RN62"=OX:<AY!L<JB#EJLJBJ3
M.#$-G&>R/AR/4     JZ]3CZX5__ -!T/Y&PPSWL)]FH?=R=^X_-Q^D7_O78
MYXGAOY! : CN!HX               95T5^6_3?YU=>_*Z(%OQ;R54^+R=XI
MDO<M^>/9+^DV%_ET!<S&LA^M\               PWR*^K[O7\S>SOD3-BXX
M/Y7I?&8N_:6O'/(E9XK+X-QR+1Z#'FD !)IP+T_TQ=F5R\/.?'*_:?'>S1ME
MAFE$A->T.RVMM9JVNQ45F)!_(PNH]EM(MTUD,%13[LHA]Z;MNYG+C.1TG:O$
M=MZ*:)NR=!!60.8JO=(]K5:ZW(B(Z6-514RY+?30[]L=AF[^O@F=MEB510U#
M9&I&V.-ST>VSNE56PRHBHN3*J>DI.'U0M<1%)Z2.JJ'TQUZIM#IXPERS9^0.
MT*]>EKIM"2NQ)IFO&.-B1)H6+3BHA.R.F;F3,GA)RS?88HFCHYBV(9?&&PU9
M)4[P)ZK;=)(-KW1W8(G,N1(RZMNK6\MJW45&\**V\M][G+9EO>#0Q4F[6FH]
M@%CJ-B&2WZF5LE^59+R6+*EU+$O*U7V6*UUQ+C&-2W&W04JUZD.+?,!MRC8Z
MV;]**SLI=3;S[:\U-UU7SCQ\-#HO9C63B(PDJ<Z+!C$MY1SW=JY*_0C,1:IW
M[=1$3-ZT]*S'<.=@2S+MZQ4U*1-:[\&JK8DEO*KU:EBI=5]]$8J*0-SE/6/V
M>Q-NT*0)NXD1VN69SF_A4:VUT2MY$8CUM1;R1ZM5>U4-^N-E!X7Q'&;ER?H%
M6VGW_EU*U(\)8)3;D]LJ(V7%4!9=YW5#6\;L"MUC";Q1RF4T*ZRV0B5)<[0T
MJ],9!!+'5,:J]I),;P]-[$<D6SS9+S4B;&L:R9/A%C<[)TTM5]R]JVY54[G@
M-%LK%@&)KN:EBFVF=%=<LSI6RI':OP22-9EM]HMB,5]W6/R(A1CD(]_$OWT5
M*L7D9*1CQS'R4;(-EF3^/?LECMGC%\S<D3<-'C1PF9-5)0I3IG+DIL8SC.!M
M$Q[)&))&J.8Y$5%1;45%RHJ*G"B\2FHCV/C>L<B*V1JJBHJ6*BID5%1<J*B\
M*&^'2M_>0<)/UD=6_*9D.J[=_8W$_$I>]4[AN[^W6$^/P]^ALEU_?WM_+/\
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M3GZ$[N.Q['_:W"_K&F\,PZOMQ]B\8^JZOP$ARD!OH><P
M%QOU2_\ U_?]E;_>/&N>_P"_BG]]?P<V@\VW^.OWI_"BXV-=#:$
M      I ^M:_6"XH?F;NGRV2&SNX;R17^,L[PU*\XSRWAOBK_"%4<9Z-<P
M              .NEQU^K[HK\S>L?D3"#SYQCRO5>,R]^X]+<#\B4?BL7@VF
M9!;BZ               %![UIG]X)I[]3C7WZ;.0@VNW%?9*H^L9/ TYIMYP
MWVTI?JN/P]25JAFDP.                !V-AYT'J"               >-
MV+^3Z]_B;9_Y$?"31?/(OE6]\A%KOF4WR3^]4X_8]#CS(
M  M<>JE?6"Y7_F;I?RV5&!=_/DB@\9?WAL9YN?EO$O%6>$+OPUB-M0
M        "HKZV'^3_A3^..[_ .1-:#8/<'\[Q/Y.#OI#6CSC_F6$_*U'>Q%+
M,;*&JH                '4]Z6/[N#A'^K5JCY*L!HIMW]LL3\=E[Y3T/W>
M?87"?$(>\0WY'4SN0
M
M
M      !&WU3_ *N&O_UP^$O]Z35HE4GPJ^X=WJD6L^"3W;.^0DD$4E
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M&FP.HWIX_+L_JUH5IX;RQV:MTMJ:Q67<BHKK;53(K[RI:BVEC<8<,Y@
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M^K5JCY*L!HIMW]LL3\=E[Y3T/W>?87"?$(>\0WY'4SN0
M
M
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MN_G;A>1?*--X9AUC;=[%V+Q=$5+?HNJX_P#,2'+#&^9YT
M  6_O52;16:U]/3PBL4% =^_1<[S]NI>/BN^^]OI%=\=[=_.$.[]P[N3M^T[
M/:]N7L]CLX&NF_U%7Z)L3\:_@YL_YM[FM^F;RHGS3^%%O[SHZS](M%\;J_\
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M=MVN>Q_!D;!;A$5*O$[4_P G#WTAK5YQSFNHL*NJB_A9^]B*:0V3-5@
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MOC=7_A +CLRC6,Z2:1YT=9^D6B^-U?\ A +CLRC6,Z2:1YT=9^D6B^-U?^$
MN.S*-8SI)I'G1UGZ1:+XW5_X0"X[,HUC.DFD>='6?I%HOC=7_A +CLRC6,Z2
M:1YT=9^D6B^-U?\ A +CLRC6,Z2:1YT=9^D6B^-U?^$ N.S*-8SI)I'G1UGZ
M1:+XW5_X0"X[,HUC.DFD>='6?I%HOC=7_A +CLRC6,Z2:1YT=9^D6B^-U?\
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M[./\H^*BID4Y(J*EJ94/I#X?0
M (@.K/U*B<)=>P.K=.,B7SF1OHZ=7TEKV/:YF7\%F:=9@TMAS,.B14SE%K*J
ME:PS%3';2\MG!"D4;MWN4YM'2Z]U]^2!O"OK<^8A5E5J&HQF6=W GK\QZ'I#
M=/\ E."'':3)LJ3\(N1F]IUOL[?$\=WB24:3Z[58T32"2^%%C31*B62=F<O,
MJ*X=2S]ZJF<R!TNQ\K:E*B7N<D3<B<_9/M%3+3Q=WEE<MJ\W8]4E>$,F'X)2
M*BYR->P\W&L)B(DVRK*2BI1FWD(V09KDRFNT>L7::S5VV6)G)3IJ%,4V,]C.
M 151;4X3XJ(J6+P&+?H\: ]!NGOFSI7P(.>LDZ3M*G'51]%NA".[J<:3TS7^
M/=!?P.I-8PCX_+CABP.]B*%58UV=C(\F]8LI!D9PSBD5C-'[-<Z*R><]HJD<
MQ38R7.<"32O>LBVJOM'<?W*D6KCC2)%1J>W;Q?=(2J^"U8^+D%[T1_L<1+5)
MEB9D'@M6/BY!>]$?['"U18F9!X+5CXN07O1'^QPM46)F0>"U8^+D%[T1_L<+
M5%B9D'@M6/BY!>]$?['"U18F9!X+5CXN07O1'^QPM46)F0K:^M&PL/'< -0+
MQ\3&L%C<PZ D99FQ:M53)&TKR".9,RB"1#Y3R<A<YQV>QV<8S_D&:-Q:K_.V
MH^KI/#4Y@?SAD1-BZ6S^5(_ 5)0P&UQIN                !TP^B)7X%YT
ML>(3EW"1#IPK3[EE5=Q&LUUE,XVM?BXRHJJB8Y\X*7&/NY_@P-)MYZK_ #\Q
M'Y1G@HS?K=(B?U=89D_R3_#2$JW@M6/BY!>]$?[''0K5,C6)F0>"U8^+D%[T
M1_L<+5%B9D'@M6/BY!>]$?['"U18F9!X+5CXN07O1'^QPM46)F0>"U8^+D%[
MT1_L<+5%B9D*F7KD$U,:UZ8^BYW7,M)T";=\[]8Q+J9I+]U595S%+\?N3[Q>
M,<2$$JP=K1ZSM@@J=$Q\IF413-G';$+G"U18F9":+HVLF=EZ4W3WL%C:-K!/
M3/$S2TC+S<V@E*R\K(.J9&*N7TE)/R+O'SQPH;)E%53F.<V>SG.<A:HL3,A)
M7X+5CXN07O1'^QPM46)F0>"U8^+D%[T1_L<+5%B9D'@M6/BY!>]$?['"U18F
M9"L5U+6C1CR[OK9DU;LVY(2BY(@U03;HER>GPYCY*DB4A"Y,;.<Y[&/NY&>]
MA/LU#[N3OW'YN?TB^3SK<<L_$\-_((#0D=O-'               #*6C4TU=
MUZ?25(11)3:6OTU$U"X.FHF>V1!3D.0V,E,0Q<]C.,_<S@6_%O)53XO)WBF2
M]RWYX]DOZ387^70%QGP6K'Q<@O>B/]CC66U3];UB9D'@M6/BY!>]$?['"U18
MF9!X+5CXN07O1'^QPM46)F0>"U8^+D%[T1_L<+5%B9D'@M6/BY!>]$?['"U1
M8F9!X+5CXN07O1'^QPM46)F0>"U8^+D%[T1_L<+5%B9D'@M6/BY!>]$?['"U
M18F9!X+5CXN07O1'^QPM46)F0>"U8^+D%[T1_L<+5%B9D,.\B*S6T^/^\SDK
M\&0Y-.[-.0Y(E@4Q#%I4WDIBFPWQDIBYQV<9Q]W&1<<'5?I:E\9C[]I:\<1/
MH6LR)\UE\&XY) ]!3S3                 M5^JKQL=)<@.59)%@R?D3T[3
M#ID>M4'14S9NJN,F(5=-3!#9Q]SLX^[V!@7?SDPF@\9?WAL9YNB(N-8C;^*L
M\(7;O!:L?%R"]Z(_V.-8[5-M+$S(/!:L?%R"]Z(_V.%JBQ,R#P6K'Q<@O>B/
M]CA:HL3,@\%JQ\7(+WHC_8X6J+$S(/!:L?%R"]Z(_P!CA:HL3,@\%JQ\7(+W
MHC_8X6J+$S(/!:L?%R"]Z(_V.%JBQ,R#P6K'Q<@O>B/]CA:HL3,@\%JQ\7(+
MWHC_ &.%JBQ,R#P6K'Q<@O>B/]CA:HL3,AIYU#JW74. '.5="!A45D>'G)E5
M%9*+8IJI*IZ5NQTU$U"(8.10A\8SC.,XSC..S@=CV/5?YVX7]8TWAF'5]N$3
M^9>,9/XKJO 2'*I&^9YS@                7#/5/(N,D_I\>V,<PD.X?19
M[CWZS;NNX]T^D;W3N7=TU.Y]T[F7MNQV.SVN.S_ -=-_RJGT3^^OX.;0>;<B
M+],V_P#RG\*+AO@M6/BY!>]$?['&NEJFT%B9D'@M6/BY!>]$?['"U18F9!X+
M5CXN07O1'^QPM46)F0>"U8^+D%[T1_L<+5%B9D'@M6/BY!>]$?['"U18F9!X
M+5CXN07O1'^QPM46)F0>"U8^+D%[T1_L<+5%B9D'@M6/BY!>]$?['"U18F9!
MX+5CXN07O1'^QPM46)F0>"U8^+D%[T1_L<+5%B9D*2/K5$;'1O(#BH2.8,F!
M%-.W,ZA&35!J50V+JEC!CE033P<V,?<[.?N]@;.;ALN$U_C+.\-2_.+1$QK#
MK/Q5_A"JH,]&N8                '6WX[UFMJ<?]&'/7X,YSZ=UD<YSQ+
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MB<!)"(I*   "-OJG_5PU_P#KA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*
M       "M7ZTS^[[T]^N/K[]"?(09HW%?:VH^KI/#4Y@?SAOL72_6D?@*DH.
MC:\TV                 Z;70\_=5</_P 3KG^EB_C27>?]O,1^49X*,W[W
M2?FZPSY)_AI"5P=",C       ?"LO_8CW_HW_6T!]3A.+_:GW1\.0    !5U
MZG'UPK__ *#H?R-AAGO83[-0^[D[]Q^;C](O_>NQSQ/#?R" T!'<#1P
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MK7ZP7%#\S=T^6R0V=W#>2*_QEG>&I7G&>6\-\5?X0JCC/1KF
M    !UTN.OU?=%?F;UC\B80>?.,>5ZKQF7OW'I;@?D2C\5B\&TS(+<70
M           H/>M,_O!-/?J<:^_39R$&UVXK[)5'UC)X&G--O.&^VE+]5Q^'
MJ2M4,TF!P                .QL/.@]00              #QNQ?R?7O\3;
M/_(CX2:+YY%\JWOD(M=\RF^2?WJG'['H<>9                 %KCU4KZP
M7*_\S=+^6RHP+OY\D4'C+^\-C/-S\MXEXJSPA=^&L1MJ               5
M%?6P_P G_"G\<=W_ ,B:T&P>X/YWB?R<'?2&M'G'_,L)^5J.]B*68V4-50
M              .I[TL?W<'"/]6K5'R58#13;O[98GX[+WRGH?N\^PN$^(0]
MXAOR.IG<@
M
M                                                          "-
MOJG_ %<-?_KA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*        "M7ZTS
M^[[T]^N/K[]"?(09HW%?:VH^KI/#4Y@?SAOL72_6D?@*DH.C:\TV
M         Z;70\_=5</_ ,3KG^EB_C27>?\ ;S$?E&>"C-^]TGYNL,^2?X:0
ME<'0C(P      'PK+_V(]_Z-_P!;0'U.$XO]J?='PY     %77J<?7"O_P#H
M.A_(V&&>]A/LU#[N3OW'YN/TB_\ >NQSQ/#?R" T!'<#1P
M RKHK\M^F_SJZ]^5T0+?BWDJI\7D[Q3)>Y;\\>R7])L+_+H"YF-9#];X
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M>M,_O!-/?J<:^_39R$&UVXK[)5'UC)X&G--O.&^VE+]5Q^'J2M4,TF!P
M            .QL/.@]00              #QNQ?R?7O\3;/_(CX2:+YY%\J
MWOD(M=\RF^2?WJG'['H<>9                 %KCU4KZP7*_\ ,W2_ELJ,
M"[^?)%!XR_O#8SS<_+>)>*L\(7?AK$;:@              %17UL/\G_  I_
M''=_\B:T&P>X/YWB?R<'?2&M'G'_ #+"?E:CO8BEF-E#54
M  #J>]+']W!PC_5JU1\E6 T4V[^V6)^.R]\IZ'[O/L+A/B$/>(;\CJ9W(
M
M
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M-0^[D[]Q^;C](O\ WKL<\3PW\@@- 1W T<               ,JZ*_+?IO\
M.KKWY71 M^+>2JGQ>3O%,E[EOSQ[)?TFPO\ +H"YF-9#];X
M !AOD5]7W>OYF]G?(F;%QP?RO2^,Q=^TM>.>1*SQ67P;CD6CT&/-(
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MT]^IQK[]-G(0;7;BOLE4?6,G@:<TV\X;[:4OU7'X>I*U0S28'
M      [&P\Z#U!               /&[%_)]>_Q-L_\ (CX2:+YY%\JWOD(M
M=\RF^2?WJG'['H<>9                 %KCU4KZP7*_P#,W2_ELJ,"[^?)
M%!XR_O#8SS<_+>)>*L\(7?AK$;:@              %17UL/\G_"G\<=W_R)
MK0;![@_G>)_)P=](:T><?\RPGY6H[V(I9C90U5                 ZGO2Q
M_=P<(_U:M4?)5@-%-N_MEB?CLO?*>A^[S["X3XA#WB&_(ZF=R
M
M
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M+%/R[ZG1J[Z5FIN6<.Y.5DGBY\G5775454/G.3&SD 20@    JZ]3CZX5_\
M]!T/Y&PPSWL)]FH?=R=^X_-Q^D7_ +UV.>)X;^00&@([@:.
M  &5=%?EOTW^=77ORNB!;\6\E5/B\G>*9+W+?GCV2_I-A?Y= 7,QK(?K?
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M7ZONBOS-ZQ^1,(//G&/*]5XS+W[CTMP/R)1^*Q>#:9D%N+H
M  4'O6F?W@FGOU.-??ILY"#:[<5]DJCZQD\#3FFWG#?;2E^JX_#U)6J&:3 X
M                '8V'G0>H(              !XW8OY/KW^)MG_D1\)-%\
M\B^5;WR$6N^93?)/[U3C]CT./,@                "UQZJ5]8+E?\ F;I?
MRV5&!=_/DB@\9?WAL9YN?EO$O%6>$+OPUB-M0              "HKZV'^3_
M (4_CCN_^1-:#8/<'\[Q/Y.#OI#6CSC_ )EA/RM1WL12S&RAJJ
M      !U/>EC^[@X1_JU:H^2K :*;=_;+$_'9>^4]#]WGV%PGQ"'O$-^1U,[
MD
M
M                                                   1M]4_ZN&O
M_P!</A+_ 'I-6B52?"K[AW>J1:SX)/=L[Y"20124        %:OUIG]WWI[]
M<?7WZ$^0@S1N*^UM1]72>&IS _G#?8NE^M(_ 5)0=&UYIL
M  !TVNAY^ZJX?_B=<_TL7\:2[S_MYB/RC/!1F_>Z3\W6&?)/\-(2N#H1D8
M    "H%ZZM^ZRT'^O_JS^[KRJ $WW12_='].7]4#1_R)BP!)^    "KKU./K
MA7__ $'0_D;##/>PGV:A]W)W[C\W'Z1?^]=CGB>&_D$!H".X&C@
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MN*'YF[I\MDAL[N&\D5_C+.\-2O.,\MX;XJ_PA5'&>C7,
M#KI<=?J^Z*_,WK'Y$P@\^<8\KU7C,O?N/2W _(E'XK%X-IF06XN@
M      !0>]:9_>":>_4XU]^FSD(-KMQ7V2J/K&3P-.:;><-]M*7ZKC\/4E:H
M9I,#@                =C8>=!Z@@              'C=B_D^O?XFV?^1'
MPDT7SR+Y5O?(1:[YE-\D_O5./V/0X\R                 +7'JI7U@N5_Y
MFZ7\ME1@7?SY(H/&7]X;&>;GY;Q+Q5GA"[\-8C;4               J*^MA
M_D_X4_CCN_\ D36@V#W!_.\3^3@[Z0UH\X_YEA/RM1WL12S&RAJJ
M        !U/>EC^[@X1_JU:H^2K :*;=_;+$_'9>^4]#]WGV%PGQ"'O$-^1U
M,[D
M
M                                                     1M]4_ZN
M&O\ ]</A+_>DU:)5)\*ON'=ZI%K/@D]VSOD))!%)0        5J_6F?W?>GO
MUQ]??H3Y"#-&XK[6U'U=)X:G,#^<-]BZ7ZTC\!4E!T;7FFP
M   '3:Z'G[JKA_\ B=<_TL7\:2[S_MYB/RC/!1F_>Z3\W6&?)/\ #2$K@Z$9
M&       J!>NK?NLM!_K_P"K/[NO*H 3?=%+]T?TY?U0-'_(F+ $GX    *N
MO4X^N%?_ /0=#^1L,,]["?9J'W<G?N/S<?I%_P"]=CGB>&_D$!H".X&C@
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MK]8+BA^9NZ?+9(;.[AO)%?XRSO#4KSC/+>&^*O\ "%4<9Z-<P
M     .NEQU^K[HK\S>L?D3"#SYQCRO5>,R]^X]+<#\B4?BL7@VF9!;BZ
M           %![UIG]X)I[]3C7WZ;.0@VNW%?9*H^L9/ TYIMYPWVTI?JN/P
M]25JAFDP.                !V-AYT'J"               >-V+^3Z]_B;
M9_Y$?"31?/(OE6]\A%KOF4WR3^]4X_8]#CS(                 M<>JE?6
M"Y7_ )FZ7\ME1@7?SY(H/&7]X;&>;GY;Q+Q5GA"[\-8C;4
M J*^MA_D_P"%/XX[O_D36@V#W!_.\3^3@[Z0UH\X_P"983\K4=[$4LQLH:J@
M                =3WI8_NX.$?ZM6J/DJP&BFW?VRQ/QV7OE/0_=Y]A<)\0
MA[Q#?D=3.Y
M
M                                                    :P<H.9_&
M'AC6X&U\F-NP6KHBT2:D/6TWL?8K%.3KU B1WF8FK4Z&L5G?LHTBZ67;I-F9
MJS[LGW91/NA.VJQ02SJJ1-553T<92EGB@1%E=8B^CB-GQ2*H    !&WU3_JX
M:_\ UP^$O]Z35HE4GPJ^X=WJD6L^"3W;.^0DD$4E        !6K]:9_=]Z>_
M7'U]^A/D(,T;BOM;4?5TGAJ<P/YPWV+I?K2/P%24'1M>:;
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M<<G/T)W<=CV/^UN%_6--X9AU?;C[%XQ]5U?@)#E(#?0\Y@
M  +C?JE_^O[_ +*W^\>-<]_W\4_OK^#FT'FV_P =?O3^%%QL:Z&T(
M       !2!]:U^L%Q0_,W=/ELD-G=PWDBO\ &6=X:E><9Y;PWQ5_A"J.,]&N
M8                '72XZ_5]T5^9O6/R)A!Y\XQY7JO&9>_<>EN!^1*/Q6+
MP;3,@MQ=               "@]ZTS^\$T]^IQK[]-G(0;7;BOLE4?6,G@:<T
MV\X;[:4OU7'X>I*U0S28'                 [&P\Z#U!
M /&[%_)]>_Q-L_\ (CX2:+YY%\JWOD(M=\RF^2?WJG'['H<>9
M      %KCU4KZP7*_P#,W2_ELJ,"[^?)%!XR_O#8SS<_+>)>*L\(7?AK$;:@
M              %17UL/\G_"G\<=W_R)K0;![@_G>)_)P=](:T><?\RPGY6H
M[V(I9C90U5                 ZGO2Q_=P<(_U:M4?)5@-%-N_MEB?CLO?*
M>A^[S["X3XA#WB&_(ZF=R
M
M
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MV+G&1GG85+-FX4^[D[]Q^;O](LMOG6XXN5/]CPW\@@-&AV\T=
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M'[/8.^M0TY+N-9BO;5=OVES5/W1TGWPAW)(_\!<]G/9S]P8&W\);A-!E1/\
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M^[U_,WL[Y$S8N.#^5Z7QF+OVEKQSR)6>*R^#<<BT>@QYI
M  6N/52OK!<K_P S=+^6RHP+OY\D4'C+^\-C/-S\MXEXJSPA=^&L1MJ
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M5JCY*L!HIMW]LL3\=E[Y3T/W>?87"?$(>\0WY'4SN0
M
M
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MQ]<*_P#^@Z'\C889[V$^S4/NY._<?FX_2+_WKL<\3PW\@@- 1W T<
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MN.OU?=%?F;UC\B80>?.,>5ZKQF7OW'I;@?D2C\5B\&TS(+<70
M    H/>M,_O!-/?J<:^_39R$&UVXK[)5'UC)X&G--O.&^VE+]5Q^'J2M4,TF
M!P                .QL/.@]00              #QNQ?R?7O\ $VS_ ,B/
MA)HOGD7RK>^0BUWS*;Y)_>J<?L>AQYD                 6N/52OK!<K_S
M-TOY;*C N_GR10>,O[PV,\W/RWB7BK/"%WX:Q&VH              !45];#
M_)_PI_''=_\ (FM!L'N#^=XG\G!WTAK1YQ_S+"?E:CO8BEF-E#54
M        #J>]+']W!PC_ %:M4?)5@-%-N_MEB?CLO?*>A^[S["X3XA#WB&_(
MZF=R
M
M                                                      (V^J?]
M7#7_ .N'PE_O2:M$JD^%7W#N]4BUGP2>[9WR$D@BDH        *U?K3/[OO3
MWZX^OOT)\A!FC<5]K:CZND\-3F!_.&^Q=+]:1^ J2@Z-KS38
M    #IM=#S]U5P__ !.N?Z6+^-)=Y_V\Q'Y1G@HS?O=)^;K#/DG^&D)7!T(R
M,      !4"]=6_=9:#_7_P!6?W=>50 F^Z*7[H_IR_J@:/\ D3%@"3\    %
M77J<?7"O_P#H.A_(V&&>]A/LU#[N3OW'YN/TB_\ >NQSQ/#?R" T!'<#1P
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M7ZP7%#\S=T^6R0V=W#>2*_QEG>&I7G&>6\-\5?X0JCC/1KF
M   !UTN.OU?=%?F;UC\B80>?.,>5ZKQF7OW'I;@?D2C\5B\&TS(+<70
M          H/>M,_O!-/?J<:^_39R$&UVXK[)5'UC)X&G--O.&^VE+]5Q^'J
M2M4,TF!P                .QL/.@]00              #QNQ?R?7O\3;/
M_(CX2:+YY%\JWOD(M=\RF^2?WJG'['H<>9                 %KCU4KZP7
M*_\ ,W2_ELJ,"[^?)%!XR_O#8SS<_+>)>*L\(7?AK$;:@              %
M17UL/\G_  I_''=_\B:T&P>X/YWB?R<'?2&M'G'_ #+"?E:CO8BEF-E#54
M              #J>]+']W!PC_5JU1\E6 T4V[^V6)^.R]\IZ'[O/L+A/B$/
M>(;\CJ9W(
M
M                                                           C
M;ZI_U<-?_KA\)?[TFK1*I/A5]P[O5(M9\$GNV=\A)((I*        "M7ZTS^
M[[T]^N/K[]"?(09HW%?:VH^KI/#4Y@?SAOL72_6D?@*DH.C:\TV
M        Z;70\_=5</\ \3KG^EB_C27>?]O,1^49X*,W[W2?FZPSY)_AI"5P
M=",C       5 O75OW66@_U_]6?W=>50 F^Z*7[H_IR_J@:/^1,6 )/P
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M\BOJ^[U_,WL[Y$S8N.#^5Z7QF+OVEKQSR)6>*R^#<<BT>@QYI
M      6N/52OK!<K_P S=+^6RHP+OY\D4'C+^\-C/-S\MXEXJSPA=^&L1MJ
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M]3C7WZ;.0@VNW%?9*H^L9/ TYIMYPWVTI?JN/P]25JAFDP.
M   !V-AYT'J"               >-V+^3Z]_B;9_Y$?"31?/(OE6]\A%KOF4
MWR3^]4X_8]#CS(                 M<>JE?6"Y7_F;I?RV5&!=_/DB@\9?
MWAL9YN?EO$O%6>$+OPUB-M0              "HKZV'^3_A3^..[_P"1-:#8
M/<'\[Q/Y.#OI#6CSC_F6$_*U'>Q%+,;*&JH                '4]Z6/[N#
MA'^K5JCY*L!HIMW]LL3\=E[Y3T/W>?87"?$(>\0WY'4SN0
M
M
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M_P"UN%_6--X9AU?;C[%XQ]5U?@)#E(#?0\Y@                +C?JE_\
MK^_[*W^\>-<]_P!_%/[Z_@YM!YMO\=?O3^%%QL:Z&T(              !2!
M]:U^L%Q0_,W=/ELD-G=PWDBO\99WAJ5YQGEO#?%7^$*HXST:Y@
M      ==+CK]7W17YF]8_(F$'GSC'E>J\9E[]QZ6X'Y$H_%8O!M,R"W%T
M            *#WK3/[P33WZG&OOTV<A!M=N*^R51]8R>!IS3;SAOMI2_5<?
MAZDK5#-)@<                #L;#SH/4$               \;L7\GU[_$
MVS_R(^$FB^>1?*M[Y"+7?,IODG]ZIQ^QZ''F0                !:X]5*^
ML%RO_,W2_ELJ,"[^?)%!XR_O#8SS<_+>)>*L\(7?AK$;:@
M%17UL/\ )_PI_''=_P#(FM!L'N#^=XG\G!WTAK1YQ_S+"?E:CO8BEF-E#54
M               #J>]+']W!PC_5JU1\E6 T4V[^V6)^.R]\IZ'[O/L+A/B$
M/>(;\CJ9W(
M
M
MC;ZI_P!7#7_ZX?"7^])JT2J3X5?<.[U2+6?!)[MG?(22"*2@        K5^M
M,_N^]/?KCZ^_0GR$&:-Q7VMJ/JZ3PU.8'\X;[%TOUI'X"I*#HVO--@
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MG')S]"=W'8]C_M;A?UC3>&8=7VX^Q>,?5=7X"0Y2 WT/.8
M  "XWZI?_K^_[*W^\>-<]_W\4_OK^#FT'FV_QU^]/X47&QKH;0@
M     %('UK7ZP7%#\S=T^6R0V=W#>2*_QEG>&I7G&>6\-\5?X0JCC/1KF
M             !UTN.OU?=%?F;UC\B80>?.,>5ZKQF7OW'I;@?D2C\5B\&TS
M(+<70               H/>M,_O!-/?J<:^_39R$&UVXK[)5'UC)X&G--O.&
M^VE+]5Q^'J2M4,TF!P                .QL/.@]00              #QN
MQ?R?7O\ $VS_ ,B/A)HOGD7RK>^0BUWS*;Y)_>J<?L>AQYD
M    6N/52OK!<K_S-TOY;*C N_GR10>,O[PV,\W/RWB7BK/"%WX:Q&VH
M          !45];#_)_PI_''=_\ (FM!L'N#^=XG\G!WTAK1YQ_S+"?E:CO8
MBEF-E#54                #J>]+']W!PC_ %:M4?)5@-%-N_MEB?CLO?*>
MA^[S["X3XA#WB&_(ZF=R
M
M
M          (V^J?]7#7_ .N'PE_O2:M$JD^%7W#N]4BUGP2>[9WR$D@BDH
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MUPN*'ZRNBOTH5867:3[.U_B4_@G%^V5^T^&^/T_A6'6A&@1Z1@
M    &&^17U?=Z_F;V=\B9L7'!_*]+XS%W[2UXYY$K/%9?!N.1:/08\T@
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M[P33WZG&OOTV<A!M=N*^R51]8R>!IS3;SAOMI2_5<?AZDK5#-)@<
M        #L;#SH/4$               \;L7\GU[_$VS_P B/A)HOGD7RK>^
M0BUWS*;Y)_>J<?L>AQYD                 6N/52OK!<K_ ,S=+^6RHP+O
MY\D4'C+^\-C/-S\MXEXJSPA=^&L1MJ               5%?6P_R?\*?QQW?
M_(FM!L'N#^=XG\G!WTAK1YQ_S+"?E:CO8BEF-E#54                #J>
M]+']W!PC_5JU1\E6 T4V[^V6)^.R]\IZ'[O/L+A/B$/>(;\CJ9W(
M
M
M                                          C;ZI_U<-?_ *X?"7^]
M)JT2J3X5?<.[U2+6?!)[MG?(22"*2@        K5^M,_N^]/?KCZ^_0GR$&:
M-Q7VMJ/JZ3PU.8'\X;[%TOUI'X"I*#HVO--@                .FUT//W5
M7#_\3KG^EB_C27>?]O,1^49X*,W[W2?FZPSY)_AI"5P=",C       0Y=;[J
MF_LC>)='Y%^8KZ07A]R J.B_ [SG>:CVI\(J!M'8GA3X0^;W97?_ 'GYK^\^
M\>\4>Z=_=U[X+W'N:H^*EJ6&]W"GDC],+B/QRY3^!GF[^D!I^C[7\!/"+PN\
M$O#.$:S/M#X3^T58]OO:WOGN??7M<R[MVO;=Q)V>UP/IL^    #G$>L2?O5=
MW_B=I7]$]3&Y&Y_[!TORDWA7FC&^_P#.+5_)0>!80@#)YB4VXX.<NK+P<Y)4
M7D;5:/3-B2-0+*L7-5N[ CAC(0\_'K1,QB)E2HKOJM8\1[A0K23;%.HW,;)5
M$UVZBS=7KVU&ST.U&"RX-/+)"R2Q4<Q<J*U;4M3@<VWA:O#Q*BHBIV79':6?
M9''8<<IX8IWQ6HK)$R*UR6.NKPL=8O<O3*G&BM56K.&MU'>@G)VC&_)7I<;+
M)R -)>$ZM79R</G2BMFROET=1:"2V_'T1RS.Z4,H;*E"RF<_8,9#.?X,8)L;
MO69!]$QX[!]$W;MY4777>#VVI5Z+9_G^R9;7;K<Y)4?3,FST_P!-7K]Q%;J+
M_#[77)&J6Y?F_8- -J]5F8Y0=1'3O,?E%JB#NVH]36:&1@N.;51O+UZ#UU&O
MGK[$4BM,-V#*W6DDH_S*N'<BBBWDWZ"2*B2+$B39'MM!L''@>Q]3LY@=0Z+$
M*ABWJA<CG2*B);DM5C;$NHC556M5515?:Y>EXCO&EV@VWI=J-H:9DN&4TC;M
M,ECFMB156SNK$>^U;ZJY$1[D1%1&(C4P_P!4WECH3FARPEMV<<],N-*T-Y3*
MQ7GD9)Q%>K]AN5DAE)4\A>K-!U.5FZY&3+U@]:QW:-7:^%&L8BJH?*RB@N.P
MN 8MLW@#<,QBI2IJTD<Y%17.:QJV6,:YZ-<J(J*[*B97*B9$0MF\/:3!MJMH
MW8M@=*M)1K$QJHK6M<]S;;9'M8KFHY45&Y%7(Q%5;54SOU0>HCIGFUHCIZZP
MU=5=G5V?XG:AGZ'L9W?HFJQL/,SDQ3M'5Y):DN*[<;.]DHE%[K)\8RK]O&K9
M260SA'MC*%3M6P^Q^);,XKB]=720/BQ"H;)&D:N54:CYW=W>8U$6R5N1JN2U
M%R\%MXW@[;X5M9@^"8?A\=0R;#:5T<JR-8C7.<RG;^#NO>JI;$[*Y&K8J9.&
MS W3\YAZ[X2MN2FUB5BW3'**PZ<=ZPXKVB+:PRE0U?/7I1[&;!V+8GSV=83,
M=9(&N8;X@LLF,@1PHJY0<]P24[?-UVMV=K-IG45!?C;@;*E):IJJZ_*UEBQQ
MM1&JBM<ZV_><VRQJMM5+"S[%[3T.R;:_$=7*[:%]*L5(]$;<B=):DDKE5R.1
MS6V:NZUUJJY'6(MIZOI]<X=/Z"I_)#CCRSU7:]R<5.6,72D]G1U"F$(G9]9M
M.N9]Q9*A<:@\D)6$CY-TSE'.%UFCMZV(JY:ME,J]S370<T-KMF,1Q:HHL9P"
M>.FQZ@<_5+(EL3FR-NO8]$1RHBHEB*B+8BN2RU45LC8K:[#,&I:_ MI*>2JV
M=Q)L>M2-R)*Q\3E<Q[%56HJHJVJBN2U4:MMB*COI=0KG;I?D!K'CEQ5XE:CM
MNGN*'%UO<W%(CMC3+*<V/<;3?)=28G[3:CL'\VQB%57CATOAJVD':>74@Y-V
M^$N]T4*>R&RN)8375F/;05$=3C]<K+ZQHK8V-C2QK6VHU5R6):K4R-;DMM5:
MFVVV&%8UA]#L[LW32TNSF'H]8TE<CI7OD=><]]BN1N556Q'.2USEMLNHD5 [
MZ8Z-E>&/UPN*'ZRNBOTH5867:3[.U_B4_@G%^V5^T^&^/T_A6'6A&@1Z1@
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MK]7W17YF]8_(F$'GSC'E>J\9E[]QZ6X'Y$H_%8O!M,R"W%T
M  *#WK3/[P33WZG&OOTV<A!M=N*^R51]8R>!IS3;SAOMI2_5<?AZDK5#-)@<
M                #L;#SH/4$               \;L7\GU[_$VS_P B/A)H
MOGD7RK>^0BUWS*;Y)_>J<?L>AQYD                 6N/52OK!<K_ ,S=
M+^6RHP+OY\D4'C+^\-C/-S\MXEXJSPA=^&L1MJ               5%?6P_R
M?\*?QQW?_(FM!L'N#^=XG\G!WTAK1YQ_S+"?E:CO8BEF-E#54
M     #J>]+']W!PC_5JU1\E6 T4V[^V6)^.R]\IZ'[O/L+A/B$/>(;\CJ9W(
M
M
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M&G#9E,]"F5
M                                     *@7KJW[K+0?Z_\ JS^[KRJ
M$WW12_='].7]4#1_R)BP!)^
M
M
M
M
M
M
M
M         *__ *Q[TW>0O5"X-ZRT-QL>ZZ8W>D\IZ-N295V99)2KP1JC!:HW
M;1'J;)_$UVS.%YC,WL:/R1$R!"&0*L;*F,D*4X^*MB6J27].70-ZXK<#N(W&
M[9JT"OL+2&@M;:TN:U7D',K75;%4ZVRBI0\+).V$6Z?1IG3<W<E5&R!SD[&<
MD+_ !]-T0
M
M
M
M
M
M
M                                                      !\*R_]
MB/?^C?\ 6T!]3A.+_:GW1\.0
M
M
M
M
M
M
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MMUN15S\Y3;A,+FHY7.RIR<Q,ITZ.FEJCIM579E5U9?MCWQMM"P05@F%]@NH
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M0*FMDJFHUZ-1$6W(3Z:BCI7*YBN552S*0!<G.%]&Y]>L-<F^/FR+;;Z=6G5
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M\UOHM[!<X%D+Z
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MDQR<V/J;DH+%:OMN&]9Z.U;8<&.DZXU<0M1R>UX+MO8]%O"72!8R^@
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MN=;%+C@LA?
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M-_DP8V<?\DN3GQCLY_RYQC_*.&$_.7>X7U4.>+?-F^[3U%,*:U]9SXGTG7-
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M&[3NM=E^ZL'12(]OWA(JH65477*?AL[I/5[*=LCTLTE++U.HX/UJ^IV%[1;
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M93M5C%<J*MN5;>8W3% K@
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MX5X#XB(G ?7'P^@
M
M                                              ?(:U^!8RTK/L82
M(9SLZ1BE.336-9MY:93BT3-XU.5DD42/)$D<@?)$,+'/A$F<X)V,9[ ^VJJ6
M6Y$/EB6V\9]<?#Z
M
M                                      'R#5^!-.)V@T)$&LJ48:$2
ML)HUGF<3ACN>_3Q"<ME'O\D8=Y_G<M\*=RRK]]VO;?='VU;++<A\L2VWC/KC
MX?0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M:D42L
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M=K.K7<EJ);QY>.S-^J3]"W%Q
M
M
M
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MG9R%*9RX(Q9(HX.?)C821(3L]J4N,4L1^>/['>H5,.^9L[/?*3&B$3@
M /$;"UGK?;E9<TK:VOJ1LZFO5D'+RI;"JD#=*R[<-3&,U<.8&R,)**76;&-G
M*9SI9,3.<]C.!R:]S%O,54=R9#BYC'I=>B*W,J6GIXF)BH"+CH."C(^%A8AD
MVC8F(B63:.BXN.9(D;LV$='LTT6C)DT03*1))(A2)D+@I<8QCL#XJJJVKPGU
M$1$L3@/H#X?0
M                            *V_K1GU =0?KAT#]"W($73"?G+O<+ZJ%
MKQ?YLWW:>HIN'T#/W3'%#_OU_O*[C%#$?GC^QWJ%?#OF;.SWRDLUIJE7O%>E
MJE=:W 7"J3[0\?.UBTP\=8*]-,%,E,HREH66;NXV1:*&)C)DUDCDSG&.S@0T
M56K:U5128K4<EUR(K5/RTNCTK6]8B:3KNGU:A4R ;Y:051I=?B:M6(5IE0ZN
M6L3 P;1C%1K?*JAC=HBD0O;&SGL=G.0<YSEO.55=RAK6M2ZU$1J<2'J1\/H
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MQE^_8E_/9ETF1QQ.8
M
M
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MT;)-4GK%XCVY2'[DY:K$.7LXQGL&^[C ZZJ*BV+PG8T5%2U. ^D/A]
M
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MU5-UN%+'IE7L<*+RIG.5---2U75)EO,5;$[/ J>GF+D8LA?"&/KR<DMV\8>
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M)UQ=P7#G_P!2C3G /3#OVQC-6V2(U8AE!15S%.-R[)=Q#C8-CD\,S=@T1KJ
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M%5\)M\GSA5=:R5<T4\B/B;=2S+RKV"]T<$L$:LE=>6W)PY$[)74W6[=_\4[
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M*JJJ<%O%9D5"VB+.7D
M
M
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M(1I3\TFN/D=#"T2_".]TOJEXC^#;Z2>H4]=U_P#JGH;\[>@?[IFN!>H_)/\
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M9RLAANT[ICMEB8Q(PN%\:.GDR,LX^VI'Q29DEV"/NGHMN30B$EO55UQ+:=Z
M=JU'/K'<3NK-'<,=<33A5=%THO+4C:_'RLR*RCIN=1!R=5Y&'-E0AC$/G/9Q
MG.,XR(M(Y'XBCTX%<Y=**2ZQJLPU6+PHUJ:%:?7]7%_=DT[\[>W/Y>;CYB?S
MI?<H?<+^:)Z:D:OK8/\ J#_[4O\ NYB5@_\ E/\ H_MB)C'^3_Z7[4M7Z!_(
M1I3\TFN/D=#"T2_".]TOJEXC^#;Z2>H9;' Y@
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M^ZRQ/25%/O>KCF*3ICU YS%(0FV=NF.<V<%*4I9U#)C&-GL8*4N,=G.<_P
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MRSU"PTGE.3TW^J7918B_
M
M
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MDQJ76HW,AZH<3Z
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MEMS<EGKD"*BU54ZIO6WE7)9G6WAM]8FJ$$G@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MY+E%6;+'2MIF/C=;.O"GJY.*Q=)"AEJG5+V2-L@3@7U,O':F@EU$(F@
M 58/5GN27(3D)]-OS\;PVQN7P6=<>'=8\Z%_M%Z\&E;1Y]O" E>\)9.2]I&L
MM[0,N[(->Y(F[U3^\QVN!=\4BCCU>K:UMM[@2S,6C"I99=9K'*ZR[PK;G+3X
MM!=RK!TM>27(38_6YZCVHM@[PVQ=]54KZ6/@9K6UW^T3]#I_@7ROH%0JO@I4
MI23=0-<]HZQ(KL4.\D$.U;*F)GLXR+O5Q1MH(GM:U'K=M6S*MK5XRT4DLKJ^
M5CG*K$O6);D2QR)D0];9.1._$/65Z!H%#=&T4=%O*0\(\TVE>K(GJYV<O$*Z
MW<KIS0B2.*NO(%MC5)_AR9KEQAPF0W;_ 'N,8XI%']%K)=366\-F7VR)P^D?
M5ED^E4CO+J[."W)[55X/3+.0M1=B*_K7[)V%J+IC\F]@ZJO%LUO?()+3Z,'=
M*-/RE6M4*2<WYJRO2^8BP0KIE*QBK^#EG+50Z"J9\HKG+V>QG(ET+6OJF->B
M*W+D7TE(=>]S*1[F*J.R94]-" 'A'P/ZJ_-KC!K+D[6>K3OZCPFS?#3O*K3N
M[>1TG*Q?@9L*V:^<]]/H_8"31?OUW5%'!.T+CM4UBES]]C(N4]11P2K$L+55
M+.)O&EN8MU/3UE1"DJ3.1%MXW<2JF?D)+^*?2UZEVEN1&J=I[>ZH^T]S:UI=
MEQ+7#5TWLG?<W%72)]KWS4\.]B[5=I*ONTC+N2*=AT@H0ID\&QCML%SB+-5T
MKXE8R)&O5,BV)D[1*AI*J.5'OF<YB+E2U<O;+#XMA<P   BOZU^R=A:BZ8_)
MO8.JKQ;-;WR"2T^C!W2C3\I5K5"DG-^:LKTOF(L$*Z92L8J_@Y9RU4.@JF?*
M*YR]GL9R)="UKZIC7HBMRY%])2'7O<RD>YBJCLF5/30@!X1\#^JOS:XP:RY.
MUGJT[^H\)LWPT[RJT[NWD=)RL7X&;"MFOG/?3Z/V DT7[]=U11P3M"X[5-8I
M<_?8R+E/44<$JQ+"U52SB;QI;F+=3T]940I*DSD1;>-W$JIGY"2_BGTM>I=I
M;D1JG:>WNJ/M/<VM:79<2UPU=-[)WW-Q5TB?:]\U/#O8NU7:2K[M(R[DBG8=
M(*$*9/!L8[;!<XBS5=*^)6,B1KU3(MB9.T2H:2JCE1[YG.8BY4M7+VRP^+87
M,      "-WJ\[ O6K.G!RGONM+A9:!>("FUX\#<*=-2%<L\&M(;!I\2[<PT[
M$N&DG%NU8Y^LEA9!5-4I5,]J;&?NB51-:^J8UZ(K57@7TE(M:YS*5[F*J.1.
M%/30\CT4-D["V[TQ^,FP=JWBV;(ODZEN!&<NEYGY2TVJ:)![\VG7HC,O8)IT
M]E9-5A!Q+9JF==50^$4"%[/8Q@?:YK653VL1$;DR)Z2'&@>Y](QSU579<J^F
MIZ[J\[ O6K.G!RGONM+A9:!>("FUX\#<*=-2%<L\&M(;!I\2[<PT[$N&DG%N
MU8Y^LEA9!5-4I5,]J;&?NCY1-:^J8UZ(K57@7TE.5:YS*5[F*J.1.%/30\CT
M4-D["V[TQ^,FP=JWBV;(ODZEN!&<NEYGY2TVJ:)![\VG7HC,O8)IT]E9-5A!
MQ+9JF==50^$4"%[/8Q@?:YK653VL1$;DR)Z2'&@>Y](QSU579<J^FI*@(A,
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MD3SR;58?*MR2)&IG1$]:Q?5.#J7$(TOQRJYV957M6VIZA8^XS/-[2&@-2/\
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MV6.E;3,?&ZV=>%/5R<5BZ2%#+5.J7LD;9 G OJ9>.U-!+J(1-
M
M
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M8C9%7TDYS2;UFNZH;*X\=//8K6OVJI-K]YP+JWJMZA_!Z[UE"U4?5DZC7[E
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MI6CCWOC%5C-W5FOU2T66!)J>8=L;I#QE=MMQ:+5"<P],5@Z4<IJ.NX'4*GW
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MRS2CZ0Q&1#6 UCJ=^ZFW*BV4&I8F.\^J4JY.^-V,I)9;E7-VV,9)@W9+B?\
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MN=)(Z;#ZB%E]UBM3AL7@]0^0XA3SON-M1R\%O'VU)D1")P
M
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M&S3A5"*9Q[YX@C!/[._(CEPG"HNSS)F)B.^]>]CD6-:TAE6/7(U=7;P^CU>
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M?/=$2KJ%*;M<XP5A3G/22-RJK+$[=MI\Q9K6+'(Q$1]JY?2LL+@@LI>P
M
M
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MEUTT<UZRXMMEG#EMSF0>H/TT>/G47I,#!;7+.52]4A5XXU[MBE'8M[?5^_\
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M[MEVS+;PV)9P6$*&C2&I?47K;]N2S@M6WAM,4\N^A=J+F;RMVMR>V7NV_P
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M90EB$,F
M
M
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MGQ(Y&6)>2Q5X[.1>(I20QRN:K\MU;43BMY4XS9P4BJ
M
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ML5>.SD7B*4D,<KFJ_+=6U$XK>5.,V<%(J@
M                            %1*LZNZD'2 YH\K]LZGXEV'G3H;D_:GM
MO6EZ*I)26P#E/;[3;X5"1>5ROW2ZUVSPQ;>_:RN%(-S&3"QT7"2ACI%(G>5?
M2UL#&/>D<C$LR\&;D3BSY"RHRJHIWO8Q9(WK;DX>&WE7CS'Y-OZ0ZC76\WSH
M'&_^)#_A1Q,TY./IJ82V$L_3OKV/LCB#<VMDCBRQ51N$]/SD17&[%B1" C8Z
M/4.HL[4.;N9,&24U!&[5OUDSLW!R9_5#XZJOD;K&:N%J\?#Z.P6^!9B]
M         !K'#<1=+P_*:X\R#Q<[-[SMU%A=;(3=DL<G.0M(I\0BW3<16NJZ
M]4/&TTE@5:)K2)FI<977RL<O<S.WG?%59GK"D&35HMOIKRYRDD,:3+/_ )14
ML]).3,;."D50
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M"V+AL3M\*]LVT%$K
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MZ-1ZHMQ>.S)I.*/8KU8BI?3BMRZ#(PXG(
M
M
M
M
M
M
M                        "H'UG,\O$^6M3SQ@+RGQ I\D>*QCYV?X'K<=
ME.5^<QJO'#/& M^,J7+O';.2V4J6,5_$GCL26.SVG9O5#J=2NMN6W'<%MMW]
M=>L[7'F++7:[7)JK]EYO#9=O?K;MO;XLY83Z;QW)^(NN"RA.41;(F]MQ+IGF
M(5]C>*E]S:I92\GF,O<]J>OXM:CLL1E#_,>UY4L%^[@PMM5\,MERSBN\%G%[
M)<J7X%+;]N6V]PV\?L$4'K1GU =0?KAT#]"W($3,)^<N]POJH0\7^;-]VGJ*
M62!:RZ       0]=?/\ =,<K_P#N*_O*Z<$W#OGC.SWJD+$?F;^QWR&X73Q^
MH#P:_4\XS?H6I(HU/SF3W;O54K4WS:/W#?40AZY,_P#J9NGC^IY=ODGSE$V+
MR5+[M/VA"E\JQ>X7U'ED@6LN@ %;?U7/Z@.W_P!<._\ Z%N/PNF+?.6^X3U5
M+7A'S9WNU]1"R0+670      #3[GORP+P>XF;8Y1GH1MG8U@6C]BCEL^*9F<
M-=-D4_7A,>$N:]:O:PL<>VX=YS[7N.ZX0[GV"]OVY:U/#UB9(K;+;<O#P(JE
M"IFZO"Z:RVRS)P<*HGKF8>/6V"[ZT%H_>9($U6)N?3^M-L$K!I/$T:N%V+2X
M6WE@33&&$5B6-$8F.]\N<-6W=^Y]OW)/MNTQPD9JY'1\-URIH6PJ1/UD;9++
M+S472EIF <#F                  %;?C-_ZF;J'?J>4GY)\&A=)?)47NU_
M;EKB\JR^X3U&$D^L^H0GL7J8<ANG5C4IX=30NGH/;&=OYO17Y+5[<Q6D9,T!
MB@^![(T'WJ7<Q"8=>W3ONF8[.>XE[MC"45]-=I6U-OMG666>GQV\F8E,J;U4
MZEN^U;;;;Z7%9RYR2$124
M
M
M
M
M
M
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MX?0
M
M
M
M
M
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MF\/"EO!E]A<A,D(1.
M
M
M
M
M
M
M                                             "#NS<.N1/)GK"UC
MDMOO7Q:OQ+XA49!'C/WU;Z1/EV3M!4S9\K<G%3A+#+V"L*L;'*KOB+/FS%4V
M*[$8[7)LJE)/2>**B6*-;9GKW61<B9O1G4MZP2RUJ2R)9"Q.YRIE7/9Z.!"<
M00"X
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
/                ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>sgmo-20220930_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sgmo-20220930_g3.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
M     !  E@    $  0"6     0 !_^%ELFAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"\ /#]X<&%C:V5T(&)E9VEN/2+ON[\B(&ED/2)7-4TP37!#96AI
M2'IR95-Z3E1C>FMC.60B/SX*/'@Z>&UP;65T82!X;6QN<SIX/2)A9&]B93IN
M<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0($-O<F4@-RXR+6,P,# @-SDN
M,6(V-6$W.2P@,C R,B\P-B\Q,RTQ-SHT-CHQ-" @(" @(" @(CX*(" @/')D
M9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R
M+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(@H@(" @(" @(" @
M("!X;6QN<SII;&QU<W1R871O<CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]I;&QU
M<W1R871O<B\Q+C O(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U
M<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B"B @(" @(" @(" @('AM;&YS.GAM
M<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @
M(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP
M+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V
M96YT(R(*(" @(" @(" @(" @>&UL;G,Z<W1-9G,](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]S5'EP92]-86YI9F5S=$ET96TC(@H@(" @(" @(" @
M("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO<&1F+S$N,R\B/@H@
M(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E($EL;'5S=')A=&]R(#(V
M+C4@*$UA8VEN=&]S:"D\+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @(" @/'AM
M<#I#<F5A=&5$871E/C(P,C(M,3$M,#)4,3DZ,38Z,#DM,#0Z,# \+WAM<#I#
M<F5A=&5$871E/@H@(" @(" @(" \>&UP.DUO9&EF>41A=&4^,C R,BTQ,2TP
M,E0R,SHQ-CHQ,5H\+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE
M=&%D871A1&%T93XR,#(R+3$Q+3 R5#$Y.C$V.C Y+3 T.C P/"]X;7 Z365T
M861A=&%$871E/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @
M(" @(#QR9&8Z06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z
M=VED=&@^,C4V/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \
M>&UP1TEM9SIH96EG:'0^,3,R/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @
M(" @(" @(" @/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T
M/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K
M6DI29T%"06=%06QG0U=!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML
M3D$K,$%!04%!04)!06QG04%!045!)B-X03M!44-704%!04%104(O*S1!1&M&
M:V(R2FQ!1U1!04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='
M0F=G3$1!;TM#=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%4
M17AW8D=X<V-(>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(
M>#AF)B-X03M(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&8O.$%!15%G06A!14%!=T52)B-X03M!
M04E205%-4D%F+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%1
M04A#06M+0W=%04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G
M8TE#46],14%!0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%
M1T4R16EC645537!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I2
M5&MQ2WE9,U!#3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P
M5G1.5DM"<GDT+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7
M-799,U(Q9&YD-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E
M66U:)B-X03MQ8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"
M455%0E%914-!341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO
M8DAW1DU(4C133D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X
M9%5K=V=*0VAG6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-
M5%4U4%)L9%E75G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F
M2#$K9C-/16A984AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K
M<4]K<&%A;G%+;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X03E5-'$W1EA9
M<3=&6%EQ-T9867$W)B-X03M&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9
M<3=&6%EQ-T9867$W1EA9<7AB>CEE5T0V6$IP16MK6G9B=4UZ4E%U-W@O=6\U
M15-3)B-X03M136I2;7%'5F%!3E4Y9V-)45='=S9:-5=U.5AT;U1:,S934U13
M>&IH<6UP249D2&ML-6-436YQ0G9G;VIR>%5656)B1FHV:%DS<'%Y)B-X03LU
M.&-*4FI+431P.'9.4C!R>EIE>%=E;E-Z,G1T9'E.<&5O6# Y:DQ%23=Q5C=3
M5F=G57=I5TYF:%1J,4YA*T]#,U!W=WA:;V-73UA&)B-X03M%>4%"<T5E9C)P
M.35A,6QT5S$U635T3W1R87AU3DQG=E9T,T-M5T=D;DEK:DY!<FM5659*5VTS
M8D-U6%1I14QV9FER>510>F108F%8)B-X03MP4WI7,6A&4$I.4$1B;%DT;61L
M5U8K3$]!3U R5C-R:3%98UA'875T;$MY.&M15S$Q87I'*SE63%9V:&AA255D
M95).2&%N2FIV,4HX)B-X03M-5'IT<&E+04AC;FUQ96%T4# S5G)B5$QI3U5Z
M6%54>E)Y3#99:D%1,&]3>G%E4C=!1&9':VLW<'IG4S=&6%EQ-T9867$W1EA9
M<3=&)B-X03M867$W1E5K,$A8<'13,69Z1EEY0TU,;S$W2&%21DLX:7-L;D)C
M,6MQ5#A82V,Y0E-L3SEC5E1V1EA9<3=&6%EQ-T9867$W1EA9<3=&)B-X03M8
M67$W1EA9<3=&6%EQ>%AZ=F]T<$M).6%E57!C,F-,,C!33W%Y4D9,:5=*,RM"
M:UDK<"LU2$9G4C<K>$-#.'DX:U)80RM:22]3=4E')B-X03MG8E=T4TUV<%(O
M1W9W<T5!<494:W4S2W%N-35M-5)13F9Z43AZ;&I'3V]W.2]I6E!U43=,9G!O
M=')#='I02DMF3"MS<W-H:6=71&Q7)B-X03MA9V55:&5'-5AU3VU-.%%K5%HV
M9V5B:CEH;6-966-S04%)=VXQ4%!I3F9G<' K5C931'IH6E,S1G=P;DAL83!3
M5T%%=65F<D1K.4MM)B-X03M-:6\K,$182W-M15)J67,K<6YQ638S2FQL56E+
M231Q.#)49FTW.5EF>3%A9E985EI"<61K5S4K;D=#=G%I;W%Z3#DR5C1S66MA
M4&-Z)B-X03ML<5HT9E9'<C5B*V).=S961R\X07=I+S%Y<&LV-S!44S=Y.&EV
M8FE!4&1123!C57170E9(*S!U>$=X>%-J<U9D:7)S5F1I<G-69&ER)B-X03MS
M5F1I<G-69&EQ539,-61H,')53F%V63=I4UIT879&=EI%:TE):4LR,%9V=U$Y
M95 W:FQ4=%AB1E4R>%8R2W5X5C)+=7A6,DMU>%8R)B-X03M+=7A6,DMU>%8R
M2W5X5C)+;U16-V%7-3 R-&AH2$M:,%E23#9H:4)A;3%855!4+V=4.'-695$V
M3F]'<V%*97EY>7E25VMW=35R>5-8)B-X03MH9%1P2$Q-5#9Z-W=1.&PV,$AH
M,SA-:5=9>2M63T-D1&I--'I0,5%*23DU-6]Y9GE*85-W>&=A>$M,4T=X;C!W
M9S)6=W Y3RME47HP)B-X03M646]*2T]!=3-W;F,Q<E1$*UEL.6]0>5IJ4U%!
M;V)#:5!M<F%"-6%T9$=U;#%$5$Y99C8Q8C)%3VQW<S%L9$]I,C%V2W!+=E%#
M<F)/)B-X03M/5S%$5%DP3EEZ>D=1;SDY<SAE0TU463=Q4F9M2WAL.'EA8F(R
M=#5R4'%7,&1X1F5%>#)&,$LK:U,P9D9Q3BLP5G%E+VAV=$A(37=.)B-X03MH
M;&MX:5EO<VUS669-.35A=S-6=G)%17--:3%5;3)K:C5%14-O1%!Y56).,CA.
M.')B5U19175X5C)+=7A6,DMU>%8R2W5X5C)+=7A6)B-X03LR2W5X5FI(;F96
M=DUM;$I9,VUL=D=,1EI#3E1J+U(Q>G%6=WE%07 V0U<Q>&)S1W%#=C)8<E55
M1S%'5EEV8BME+TYG;71O-W$W;T=0)B-X03MQ6$5R959D5G0T;&ED07E,2DY,
M9D=/,V1A35<Y5G4V+T-V-U-Q9&%F969M2$QZ3#9N<&PP<E)"-'9Q*VQ/=$1)
M2WA33EA6-65314$W)B-X03M#;DQS8U9:2&%A<DTX9D)R95-E-&AP2&-T14EL
M55-"45-/2')/53)92&E72F]C5E9V,&A.+W=!<T9X+WE3+S9Q67%U:G9P6&16
M3FY/)B-X03MG2F]88C V1#-.2$IX5D99<3=&54IQ,G!*<&QH3&5V0DYC2D-+
M=$9B<'IK23EL<4U663!0>E P63)Z,T@V2C$P2D=A3VIA3G%!:T=X)B-X03M0
M3#!J1#9N2%DO1GAP6&%T8U94;3(X>E=.>4E$8F\P=C%P5V$R0W9!5$E%,EEQ
M4%5Q95!F=WA65D=U4D<V3F],95$S650Q1&(X;V95)B-X03M#5G!Y-&5P>30Q
M-S1Q<F9P0V(O;&=U4"M36"]65$989G!#8B]!2EE,:B]K;"]W0E9-5E)M2W5X
M5C)+=7A6,DMU>%8R2W-7,#-Z>&%J)B-X03M1-R]69%E:64QE=W4W=4-35S-I
M;6Q54C(Y-4YB4B]#:7E/5W!#3U9"5&MA1$)+44%S<$%*3D)U.2]-,WE0639:
M1'%T-7%A,BMM,T)K)B-X03M%3C-*1DUS6CE*+U1K<7A4-&5,:6@U66U10G!1
M0W(S4#5G955R8EAF,$).9D9D6C5+:3)0;WIM4C)98VAW05$X+V@K26QA,$<U
M,G=Q)B-X03M9:T,K.5)G+TTS>4AC869D6#A'<W=3=S)+;5,X:EAM8FE+35,K
M:C9J,C18,7=N<6)"=49$,4)P=FEY.$]81G<Q-G4U1#8U*V)(:VI2)B-X03MR
M4WAV-VTK.6)4<C4U23%V8E5F5T5J94I&:TM32D=7;#5K3TM+<49Q.7-5>'A3
M24HO;3@P679N,U%4<38V5E,U*W-/='4X6E<S;&-%)B-X03M86E%21FQJ1'E2
M8GEF15I654Q1;'%!5GA18V-H15-R67-J>%E/>%8R2W!6;UAM5%0Y86$V5S R
M83!:1FQ1>5%/-#E296%L:VAK;&%/)B-X03MV:$E&4'141$M.34E417A9-49.
M8T1.:E!N>5@P3E!T-VYI>D<S;#E4-$I%:D]Y2&5J1E,O>59H=G9H04HU35I3
M049N;S@R<SED;#%4)B-X03M28FTW3C=+;'1C-E)->FUE4E=4;$56:41L5V%3
M3FEE4#)J56YV;&=W4W(Q8E-U=3AF;V10;C=C3U!,*S=H8V9#37=$.59G,5A8
M.4M!)B-X03LQ2RM%1VTV=F97,39M;G9$;S)K2D9F,DUX931O>GA5<D=P:E9A
M<GE&1C=(,GEU44UE9DQV9#<R9#)N1%93:&IL16E22$=195AQ1C%X)B-X03ME
M5$]026LY<DPU=#@V2D-R1U-+.6A78U-0.$A,9S%05$AW-U4Y>FDS-FEC5$-!
M0D=W+T9O=GIL9&U$>D(U56I76EE8;78R5EEL;S-Q)B-X03M$,&ER2U-7<79W
M<V5M0S!A94U41V0Y>4PP2S0X>'0U:G9O<C%83F=T=U):;&M61D581G9S:TQ6
M=FEP=5<K9S$R3&E!1FU'0FLW1E=()B-X03LO;6)R83)':S(R;FTR96,V,4I0
M84LV4VU$,'I(85184$EV>%IF.3!5;S%"-SEI46=S5#!J>D)C6$]V>G)&9'I2
M>#(K=%0R539Y4W%W)B-X03M!:E9I54I,>6IG=DDP0D\S5V=.36Y(1DMI6F)D
M4C=V;"M/.3%M<#=4-&-M3T5)-U-M64<O3'%.+W@S36,P-F%#0WHP1UE834)#
M,D=T)B-X03M.2'%!;5='94UQ:FYL16M*:5%K1F0V57=49UDX>EE(6&LU9EIV
M8G<Q55EX;D%W;&Q03'!55#%.0W):0C5",4Y,,WIH<%AR>E189"LS)B-X03ML
M9U-.8WI%<6MK679I;V1Q+W=#-T<R+V%Y04E)<T\U,4IH1T)G2RMV;#%Q=G5:
M1"MA=#%$82M52EI:<&MT52MS5W<Y66-:0U S>6XW)B-X03M,34(X+V)',FI3
M4FE:,4MQ,U)L.5 U:EAZ5F)X5S1B.45K<4HQ5D5-67%.-GE%1G5V9V1S3&E5
M52]W1$UU;S-U;39*9%AT;$0V.3%#)B-X03MV2TM,9S!G63EG=U5Q=TAI4C X
M1&E%;&DY-35V.#9797%X85I06F%3;#%C23AS15)U<G5R26MT0U%F<79'=F]G
M<U%34&IO;%-$>4%3)B-X03M!4VY7:BM::G$Q=&)Z,C P26$U4C5);T=51U5P
M135J9'5+4W950FA3;T],2V-*4DY%2FPV=7$O.%8O.$%)<"\K83A70WEE-C%3
M2T=3)B-X03M5*VU21W!9:C!N2#)26"MF1E5G<W9/.35C,U9R8B]6=40S3&-7
M-5)31#!Z>4LX6%!,:EAB<U0Q1T5J96M23F=(=EIJ9UI02R].3VUA)B-X03LY
M-6,X:39J66A98BMF57)Q57)D5%A.=F)225HW-E,U6#%0<D0R<59D6DMC54HK
M3'143&--9TI!;'=U,&1,*UEW>7@S6$98,S)L8VM3)B-X03M4860U6#!R4G)(
M4S-+9E=:-&1-,&Y5-&1,:3E2,D1M2TU7.&QX24]$1790-EAQ2U%'*S!$>$Q%
M,45J=EEA:E-N2FYX6D%D<V9&+W-O)B-X03LP;7-N;&IZ>$HU>4]R43)K;'9P
M*VY00S!+4UAK:GI8<5=K6'!L9556,45H86)K94IU55E(9FU&-VE59UEG9'I,
M0G!/1%!K>3,O96-0)B-X03LK>$9-870O>74X-$HU6#%:4#!02$1R3W17-C9F
M8RMJ37$P55A(,6U+6C%.=S%V=VA$=6@T3'HU13!"6&-Z131$2F1E;G5B35=0
M3$1&)B-X03MW.&-J4"MC4V(U.2]0>55.9#!F4DI.3SAR-D%B<E15,#-31&,S
M3W)-8G9355-C>7,O<7=T05-),F-V1R]);4ER<V%T>4)W4DUA3FHS)B-X03ME
M5$MC4U1%,WDU<&AO*VXS1V\O;6,R=GAA<$1F6'1H8E%I,&=I=61);G4W,%%7
M+T-764MO9C!6=6MF<D=)=74O1F-"-&5%8F(Y4WIJ)B-X03MX8U)S*VYO2'%1
M,7IZ0UE&;%!L>31$=$EI1T$S1G!Z0W5V2G!#4DQW-&]F:&%J8W$O6D)'*U8P
M,E=Q4S9X<GE4>%)R;TTP:5-"4S@V)B-X03M81G1W:DQ/14MU1V18<6]033A6
M230Y2W1T:7$V2%9D8VMU5$,K:5-W>&E6;WAC=E!B;4UQ1DI%;T--,&Y":4M$
M-&5697%G8C1Q<&58)B-X03LO3%5/;%AD-V0X564U=F5(<EA(0S)%<F5M2T%-
M.$9V8DTO:CA:8C)P:UEX04%!-4)L23)393E034M'3&9M23!+-DMR4T-):TUX
M4EIE)B-X03MD4V946558:C-)4&8Y951X+U5'1U0V4SAH.&U2,D$X=5(S9W19
M-U8S,&$U='EM-6]$3%52.'!#5%4Y9'IM9&M(<E X05=$>65Q>%IC)B-X03MK
M*T=)3DA"3#-C6$8S<5AN1S1S-61",38R;&0U<EDV2F]V.$%O<T5A2S%24$0Y
M:6%J.&ET3GA4<%A*-&@V:"]7:S5E2%-J2&IS,W@K)B-X03M&:FEF:%1/=GDK
M=3=596,O4%(T=S(Y8C9!:5EL<51F02]W05$U5EAB+TIZ1GHO4D0S3S0P+W="
M8R]E<BMF-VI4,SAZ95-M9&A+,&5P)B-X03MU>5!%5D-X;C!33U5N=TY69G5W
M65!P;#=K-2]Q:#<R9%$S9',P<4MT>$-Z16="5G!5+TQB35IY:WAX4S=&56DX
M-U=U;'DK6')U82MI)B-X03MT,V$R:6QE,6QU5D1#2U8T;FDU23%#>7-5:UIA
M<G91:V0X25%8:UAL:4A3<FIZ6'%&>$IA47A08BMA<G@Q;&%R5C-&2F=8<GA$
M34(P)B-X03LR.$UZ<V<R2#E14$\V;FHX8DAW9S$T,'(K6%915SAT>&%A4F(K
M<'AG+U)U=4-3,U-.1S56:&)B,69I-$4Q,C).5&MY3GHW-'50,F)O)B-X03M4
M:G@T+T4K=4EY9F%J4'ES;G,T=DY7:'%S4W=O=FQ,:6QX351Z569P1FE)6#)%
M9DMN>$@T82]2:V14.4(O<B]O9'AP9G)(.50Y3$MV)B-X03MZ:VXP*V)Y3E!(
M2S1U14YZ845X5S554T=K-E5P5E<R0C8W9$UO,'8Q+TYY3EHO9"]%33,K=3)N
M+T%#,'=F.$PO045Z1V-P:DAN+U5B)B-X03LT87I9-E-P5G)#-7,W:35M:35,
M1V96=#4W65)S6%EF6D%K231G:71F;&A#;&=0;&96-3<W5VAB,VI#4U).5C%3
M,G1167E9>$A'<FUJ)B-X03M%9D1U4U=.5T938WE49T5"6$]W1'8U=E!A+U!/
M969#4C9E1U5X='1Y:G0W,$9(8UA/;6%.6E)2>3)Y=D8U9C%Q-%,P16-N02MM
M.#!L)B-X03MA1C)J<GE#+V%8-D0R0C!T>3).0W=+,G)F.&0W3'-F=%A+8T]0
M:4)N07AL27EK8FPV6DAA+V@S265B>FIR14]K,V0U-G)I4656=%!V)B-X03MI
M:TUP9TAR3F-P1T-(:#13:6=D='562TAP:"]*>75U3')83#ER=40R;$AN=T-Q
M-'5F9C!:+W=$;#5Q,7AE*V103V1R3$9(+V]J86-Y)B-X03MY0C)Q,W)13WAQ
M0S-';W R>75E17AI1&90.41:2%5J251'<31F='0V0T)U4&=4+V=V*V)S<%IO
M-T9,>C8V+TU(561).&QA-35H=4E%)B-X03LQ1U13<G4T:E="<$)">6I857!B
M5E%8:FEK-#A),5=N=T5M;35Q835+341),$]A1$M-4F-J43<O-TQ7*UEF3B]N
M>4-,4G!R3T143DEL)B-X03MV;755=3=$5T]B8V92,VI)=6]P66M4;79X54UB
M9%%.<TA#5'5/46-F3'%O47E1>&TK3$ID9#-P1FTY.79,66]O*V9D6%1Z=S)K
M<%EX)B-X03LS,F<S2S(T<W13=&958C!M;F=A4EAU2%5325DU6D]#259(=VER
M16MD0E(W=&UC3E1J;D]73TI02$-U3&)V-6(Y57 P+S@U9%%N,'96)B-X03LW
M*S<X=4Y:4C988DYC4GEV8W,Q=F--2FA%<4I/24%U,TE&,G!T,$A+:F-366M'
M<4XO4#=M94A.:GEG4VA)8T(O:4YG9F%!561Q9C5T)B-X03MX859P*VIA:&8V
M5DEB6%=*<&MJ1G,P:W-W:6AI-6,Q:&5'1C-9>69$=V]0:"M)13E-4D4Y>D\T
M.30X=E S27E0.'I%9GIN1C5:5%(W)B-X03MQ5C4T8F%8,313:FU$-GA'6D=.
M,'!+<$=I2T%/56-K;DDW06)9,&%T9'4X6#-D5B]K:GHS<3-M8E5,-DXY149N
M<&QO.#A-97%*9$Q/)B-X03MK:W--:7 V9D0P-#-6:6IC:EAP=4XX1R]D*VA*
M<F]19F-Z3$9$<U99.357.#)0<E8S<4YN4$)B,C%Z64Y(.$5&-T1D;&QK5&QY
M6D4T)B-X03MY>%5A;W!)9W(Q1TYG:31M=V5R1TI*1S1O.7I)8U=41V90>3)4
M-E9$2&8R478Y3V559EA,955+.$12<7!9:5I'0E9L4$=G0C<T<3@S)B-X03MT
M8FI2-6]B=E5F3'5L,D9R8GIA55HW3T='2T=)4G9A,%=0,' T5E=10E1Y-&)I
M;&5G4%-565-K3$AF5SEJ.41R.50R<&DP*V)G;4]+)B-X03M):'@S13-S3VYV
M5'DS+TUY,W-%=4QE+TYS5'!E;C)-.31:2DI69%I**T-0.&8W,7!D-4)U14AV
M,3)I5%)O+W,K8G-C0FAM:41!-WDS)B-X03MO.'=/939E9CAR03!H3#(W=$I)
M0TAT3"M05&Y)64%C-5)66"]!2&I2,4919G-C=C1!8U$W,GIW6E503DY03"MU
M439Z8C--,$M1:&)A)B-X03LU;'14-F-W:T)-5DYY459O9"]S.7-)3%A/2$-M
M,%$O94PX2T1F<S%4+W=!4WA9;WI&3'-64T1Z>F0R.$AL=3=34C%%,7A'.&1T
M1#8S)B-X03MO4$LV>'1)56HV;#(T27IC2V)G2'1H0T,X>6<P<GE0<4=Q+V\W
M5%!,,FI186)(<4UM;39J<#!D;F).0DI.0T16;351<55E;$%A9%!()B-X03M#
M245G*UAE-&UQ,7-C3311*W)X1%=X-4AZ5$1Y<#4U=3=',#!/=S%:;U$Y,T1Q
M13AO8C%:6#E/,#5Y1&I)6'%!1EAU<F5!=U1":6%0)B-X03LW4&TS85!7-$Y8
M05I-4C123&Q'6$TY0VXP2#5K-E1)95IH57=F;W-A=#9Q3S-X4BMR-DI65$M)
M55!X9$-80CEH:T]-9#=M2$))9D]K)B-X03LS,&IZ2F$V;G%L.5E24GAC<DY9
M6D%Y>3AI>51)2$A*9FA+16-U:'=G9W-*-'I%8G5U9DUC1G9R<U=K3F)696)J
M=VTU9D%34E5J<C)Y)B-X03M7>E9E.4IP-6QS-6)V4G)I2TI&:V-!3T99369S
M2&QS<3%,2&)953-X0U,X9#AU2G$X5C-D>6%H8EAL6711=C5O;&4P=6Y0,6%9
M34E3)B-X03MO5TIQ2V$W035M>FY(<#-",$]B4C5:-7-C-C)H3UI0=4EO2DYP
M,6QR9')O=6U1:E%B=3 Q1TQ19%ET,#1W6&)V1&-833 T9VI"26-%)B-X03MY
M3E)Q;79(=5%-<VQL:5I(9F)I:35-34UH14%2<C!Y5S--4&Y4.4,S:7A7=6]E
M="]H=7ET,7!B5&=M+T8S15I60C1B<T9B-&TV53<T)B-X03MJ2FIV+T]0>7!*
M>%I/13=F=T0U,GI4>5!Q5C=996$O33EZ<6-6-49P=#9B0F1+9#=+-EI'.4M#
M451C47-48T%'2%9G061Q5GI(>E-I)B-X03M9>')N=F)L64EY135%.'1Q6C!0
M33)M8D4O5T%#2S%.:&5#9S(V,6<R*S!/=5DQ3U9A=G(S;6U$4C=Y,71:24AL
M3C%S<V=)0W%384%()B-X03MV=G9G,E5N9&@S;C-Y2W$K56)J>2]P170P;')Q
M<S=.9'=X5W%8:C!K=51C2&EZ4S)K8U%74B\R;E!W.4)89DQ-57I'5FAR>EEX
M3U!#)B-X03ME<6Y9*U4Y5&YT9$%T3DAG=5!,,6I:<&-!;4=X,'A)25I:5"LK
M:U=!,T5W4EIF:DUA:4]8-&U$36%D44I50T\Y<7EA5TTX:TUH*W)()B-X03MD
M9C5W;W!Z0BM8;7%X95ED53%S95E*:VUV:D593&%'3C1922]Q<6AB8U-2<$U&
M;%5#=G%#:3@K,T56<6UD9T1U8DE94D=5<$1N2W(K)B-X03M(2DM)4'E5:F@X
M;GEE6$4Q4TU.8V-O<G)50EIQ2EAT<%I24$Q'4#-U>DY-2W$Q4T%T059*2$DR
M94]E4&HV;R],:F<T3VE5-FPK5U)M)B-X03M85$Q34%%R:CE&85E:-2]Q0U=U
M;&5N8UA5=V%.-5IG,3AQ<W-I27!+;$MK=%5T,4%J2$I123<P>7A7468U<5IA
M3C5"=D<X,C-7<GHR)B-X03M.>&%Z4U%1>#9D3F-7,FYM,G1&=%55,GEC26)Y
M859N:EE!35965F%M,TA9-&Y*8U)(=51(2%5J3'%5,3AQ+VQL9F5767 R,"]6
M8F,V)B-X03MH8S-,,T9X97E724Q'3V9I,#A1<$U'2$M207E%<V5),DEB<F=Y
M6D]),E9X-'5!54=34S9F-7!-.%1287A#<T%#:65.-TU--TU(0F-O)B-X03LT
M;%5+1$A644-R56)E<$AW-4)S6%$V9C5K1GE7;3%E2C=8,5=:66MT06MG:$MN
M:6AK36IJ;4=O4R]#:$<S161C5E)';#9(<"MM3DTQ)B-X03MP1W%.4'A--VA)
M,5IY;V]R3WE+<D]13G%S5&=35%IT2#1Q>$PX=W!B4U145&)S.%)L:7)*37!A
M<VMA3VIQ<FE-37)(:U9)1S-J-%I0)B-X03M(.5%96E!P3'@W>7)&1D8U4#E3
M3U@V-5IR;TXP171P5E-&5V(Q83AI>')X4&(T;7 S>E!Y0S5M+S5W*S4U3%!$
M:GI#161P2$),,68U)B-X03MZ6&Y642MJ95E)3'1K=$Y.3V<V2UEL:59*;6I9
M6$9V>55"4W!)-D1C,#=J2EE13&I84&EL*VPR2#5C44)**W)W-$%N,U8P5G1:
M9S!O)B-X03LK669-0DXP,W%F-'(P;'EN;VUG:T%L-&]$>C9.,V%M,VAJ1RM'
M4#A!54QK>D$T<&(O=T%C6&](-5)2,F%A5G)V;U-#44YR="LP:%I')B-X03M3
M:FQL-4M+1G%G94]9;7$U:BMQ2$TP;DM8.5ES.6DT96]T3T9A.75D9GAZ1V-P
M1UEP9&ER169Z23AT:E9T371R,'I+;C9&831V1$,T)B-X03MB:D](<W W9C!Y
M>7E2.%)Y;40Q,RMZ4VYF0T5&-6XU6',T<%!.5W!F5C=X+U(O>&)F1S5H35-"
M1UDO86I03#%'2S!&2V=J<C!Z3WDS)B-X03M1+W%"-7)61410:3)V.3E,-&)*
M8G!C,#!U;&%%<7AX5U9H*VI.9D8Q16IX5$9A>$]66E-P*TQU9F=0.$%R6F%9
M9T4K*TM.1F]U0T5/)B-X03M-.%5O:64O=CAR4WAB9E-4;S%'=3)!+W=-54@W
M:VXY,$Y5,FLK,SEO+W=!;C0U3WIF3"]+9F]C>6A84"]!0V8K*V5G+VQV1EE*
M*UEN)B-X03MM9&]:=E5K87<P9C%684YK0V=74T)+34=B;'E'-3A09DU8568S
M8V9F3#<S33 Q94I,,U(K-39*3'!':WDS>5@X;'9%,35(5&A-9E4U)B-X03M#
M;7<W-6AU8VUL-V%X,U9P3F)32D<V5$EY36MQ97!'45)4-&MQ=DEE,6-#5TI7
M4#5A859B5$LX85(R9U5S-$9J-G-(1C8O03!A;#)6)B-X03M/24$R;V9W>59S
M851E*SAM-DYF>$I&96TT=5)%+W%X3DQ023=)+T5P5D-X4$=Q=5%A64Q44UA1
M9FQ:-4]G6C)J=%A74GEZ3DES:DMX)B-X03M,=GI.4W9'=2]J*W9(:4LX251D
M4$QK0V]&3CEF=6%!8VID4S%R-#=%1$<Q<$U,2S%&<F%X,C1L:VTY354Y5UII
M.&I63F%S>#8T16]E)B-X03LO=T)%,')52EEP<GDR5V%71"LV9'$Q6&5U>$)(
M9D98;70Q-6QU.4TO3%1Z2'$R;EAK,7!.85AL,#A.=VEX=7EL.5AN0F]K.&-Q
M55I7)B-X03M!3E5Q0C=J2E%H2U)Q4$YH:WEX>'@T<$%K1'5Q+W1B,4Q8=GI)
M,5123D9F5'(O.$%21W,S-V%L8E1X5S%M='A'5V=F:D)-<V5O2F)3)B-X03M6
M5DDK6%968FM44FAX=VE&9VYU8V)0<D)J>EDX5E@T;D9V9DQH1CAQ,W8S:$=X
M>BMA-5!Z1VQK<S4Y46@P:'A9=&972$=/9%EG-D9V)B-X03M49C$U,U=$-'!'
M.5%W2E5Q2U8K1F-":%%"-S)73%=J2FQN:45A3TQH,W8V=4E8>7)A=F5B669O
M+S5H*UIB9E$O348R,G1M8514<DE8)B-X03MD;79R,F0S2%0V,EE89#1J2#EC
M:D$R56,U2$154#)+04UF1&QX8TYE<CAD.4]29S%72$M":W%535(W+W%(5'HV
M+UEM3V\O;6AR1&%$)B-X03LU4C%A2S1J=4PK-G4W,C-V64QD;V=R=F)S94U,
M>'@S=F]E<'=#;6IZ:F,W:$LX06E"3BM484UM24%I6$TO4SEI<TIM;7-,85IP
M67)H)B-X03MP66MD<#=F*S5C<V]03U!D+V=B<79X2&)V:T=#4B]M4'%L.7!0
M:V)7=%-S3&QR3SAT8EIP24QP1FID;S)"2'A"6E9K43 Y,4]3:D5Y)B-X03M.
M0DU:44)U6G%05D0O;&HU:C%(>D(U5FEV.5-U8F4T=FA),&-Y,GEX;S!9059K
M5V1)<#=P1FMA3FQK,EE65FQ00DLX44-+4EE03&MY)B-X03MV07)%=DDK;S8W
M8S-M<7=A:3$Y4&)13D-B2S1V3$]/,%%Q,&9X3$9)<FPU>%563$Y'=$1T=FID
M:39R>5EI2FIS5%I(5FQU3$HU.35Z)B-X03LX<F%R8V$S93,Q=F11,GDV<F(R
M96XR-W9#8F=*2D<X-61P5DQ20E9P34MC6$)/-#(V;5544G1J25=+66QC*U$W
M,U)03%8W<#=A>%IZ)B-X03LR3VXR;V=U-TIB4FQM;'17479C:4]16$4P:V9Q
M1U%C1S1V=V]A:"\R8E1Q2EAX9&)T>&9Y3T<W3S%2-&)09#<P-2]W6#5",5A1
M,VYV)B-X03LW=#=A3%5D33 V0SEI:W4T23)J=#0K171Q<F-O,%I$>5%#<$%,
M65DV;5%O:G9V-7,U85=%9V$S0D%(=TA*,7HU9B],:6)6.5%75R]U)B-X03M$
M9E-A=EIZ,W=$1&EU;TE'3G-P26@T<415.2M0:F=';VM"6&Q4661$93E(9C%F
M2FM0;&UW.'1A5F)815=L86E6:G9R-C5M:U=75S,U)B-X03M.9$4Q;E922D='
M,C16;T\R+U1)5'E'6$YL1$)W8E9Z,U)D<C5N,%=45SE/,#)(551D4S9J2$IC
M5V-K4#%E5T-264=O-#E72T]L979F)B-X03MS92M18GAH;'=M5F)";$]"<F1I
M<5,K8WI,+VAJ55!3:V%.=E-A<%=%5&MI;38X0T-.>#-05$-%1C4Q<#,U965:
M=$MV3'AO+TUE;DQQ)B-X03MD,V5T<7AC-F,S<'9.4'DY44Q%,38W5G%N-TQD
M3G5/5WEZ4U!Y<'A4;W-:26M26D5U264Y8C5*.&]E4CE1.'9A6DUH;G-48E<K
M;U$R)B-X03LY<DYC>&AX0F-S,&1Y.4I967!#=2]W0G!L*TA*2%933FYV<C='
M561,:F]C2C1G3#-"=FUR,TAL1#AS24)*6E-A:$Y33%%28DU&;5)W)B-X03MD
M2DYZ-F=K5C%I26(Y.2LP<$IX+TUZ*S(O:7E':$)(23%81"ML1F969$4P3%9T
M4G9V3#%Y2F1:=4195VUP2F13;W-F<$Q"-F1T=U!O)B-X03MS0U-Q<E1J5W8P
M-4=757E&2&]Y1VXT1'A!2#%B9DI(>"MC6G)A-6EJ,5-4-$QJ544P<4$R;F]Y
M1F)I53%J17=A2E!4-4QU4G52,S=6)B-X03MQ8VE/2U5R;V-H9G=E9S1'1'-6
M9&ER<U9D:7)S5F1I<D5.8SAS*UA03BMJ>E=D;3!19RMS3VPQ2"]P8V-%:GA4
M=4IH3$1B5#)8<4@Q)B-X03ML9C1M2DA,9F9*46M9;7=X;D%31D94=5!Y.$=P
M4S9C3F%U6611=#=%36MS4D=O0FY"030P6C<K558K1F5::U9Y=S(R<FIX8E5W
M;&AJ)B-X03M+46M11$M023DQ.7ES4$I(:T,U,38O;$-M9EA2-F-T.2]P.7DY
M>D9Z3EE(2RMS6&DO=78S4D9+52M(17E*1F1Z25DT9VMG8FYM<4PK)B-X03M7
M2&MP3D=/:7):4VI3,F)K,7%,=3<T3E4X:7)F=F%L0S-X1D0X2F(T:4LW-&9%
M;&9&93900VIW.$YB2EAE+VQJ4&-Z,FMX=3=0;%E")B-X03MH63@T9%)946LX
M9T=24G%3<GI#8T9,535B9%%+0E54279Z531W83AK,# S>6IQ<T8Q26)Z5D).
M67I)4DIB=TYQ54UG9&M#:WA34'%%)B-X03LV>$Q7<%9546-E>#<U1S)D274X
M.&HK6#<W5'!.3W9F<FQZ6E-L5$Q$3G%&.#1C2W9%2WAA8VQL239Q9&ED>G9H
M16E$65)+04EO<6M8)B-X03ML1%)94D-S0G4T170Q4DEO;V(V.6IJ0WAK1E%9
M,6U#3CEK3'50<R]$,#)W5VM"6F)76&QV.4U4,E5/;WI387)"4S=U3$0Y2C-5
M:VMA)B-X03MY9W%R3F)M9'5-8F9S:FIX<C S>'1A5&U+,VII2DML>E@K9#-F
M+VE23T)+<&ER1B]Z061O9$QH=6M(-S(R;$UK5$=14F=-16%L9FAD)B-X03MJ
M-V-2<V1Z=&A!=EE-36MQ0E!/;FQM:C8R=7(R,#)O.%)0<4TR:#-,3$DO<69'
M:V)I3F%Z;4Y/4BM(=4LK4&IM5$1%66)(95%K.' R)B-X03MJ<6-M56MM-%DU
M64I81S<S=FY6-VUK3#5O=7)U,3AT83=E>FQJ-E=J-D]%9W5)-#4W9&5C<T%9
M4DM$2'DK3'%8*VI);D1+8W1Q,THO)B-X03M&+W-D>C)2,GE-54E9>4QJ:GA1
M;%DK<F5)2$PT.39P<2MS>7(U:#%Y34QB1T]0>E!P8T)"=&AY4'%#6&9N>C-0
M9WA&4C)'4D=N;5)E)B-X03LR-'9N,"M4=4(R<D=0<&\K;C O4#0X;&)3=&)E
M5%4Y1FI&=$)X:S@P-FA!>CA1<%8T9T-#2TQ8-'4W+V$X4FHT17AD,7EV;C K
M5$DY)B-X03MQ635B05,S2$(X4BMH,S57-G1Q9#-Q6&M*,70O4W-B:7HQ33-#
M=W%6:%=23&UC2GDT2T4S<#=B-4ME;DU18DDR67HW56IL3E)J-F-M)B-X03LY
M;FU++W-E.35J<TA9<7=R.#!B:EA).4]S3&94:V1R2S=L=5ET64UA5D,R>3)&
M>DE#.&A345)R-G%)3U)++T915C-O4T5&9RMN*UE,)B-X03ME.3@Q<DAC;'!:
M<DQZ0F-75G9Y3GA/<6U)1F50<4=-8T9Q+U1O3W581$1W9SA7.6EW-DQ5-G),
M4$QJ16)G0FQ-5#9V<4%(=BMX07=Z)B-X03MA:75L85)05C1#=6TV,# P0VA:
M<EEL67!#=G$Q-$\S<T8W.6-L;7AY;$QB>2]&+W-C8C)D-U-'1$)J>$1E375+
M5CAJ-E1E=R]A16Q8)B-X03M85UA31UE,8C%0:W8V,&\K<7%A139L>$DS9C=0
M:$@Y;C-Y4#5B2F94;EA-."]L>2]&4%8O>7A#-V\O>B]!4&4Y+U X049O:EAF
M34A#)B-X03MF>E97,F=)9U1Y.5@Y,&AQ2F\T:EAC9D56.$0P-UEJ5%I$6$QE
M*W9D.$=1-UAX>'%X3#!C+W=$3S5F=%1--G!Q<VUQ5&968F1%.5!Z)B-X03LW
M8C(Q,$E&63%T*TQC<$A+<74Q4'1&:%@S=VI4;G%F-&)94S=3:E%%63,O:WIF
M,V@W1C5U=612='9,.3%.<#!R=S-Q9T-#4T]*6GE')B-X03M*;TMO-4%P-#51
M1W-S8G9*4'I!:79J6DPU9W15=4I9,F4R-6%23$EL9E9,2T=+6$%!<$-P53%B
M-&U)655P=TMM:6ET1#@T4F%J;S%V)B-X03MQ33EX8U=Z5%%Z6$)I5E9K06IT
M-41'-T$O5FQ**WI7;D=V-CA!2U%,,VEE260T,T,V-S@X84)A3DET>'$X.%IH
M=%DW-E=S46]T=DTT)B-X03M22D-28C!O5TY02$-Y1TM:-D94,6YZ3&1G4U%A
M3G%31RMT8FE#1S=7-SE*23%&=W)'34MX4TE--VM$:GA9+TQ%57=L0UER6D%7
M6&Y8)B-X03M5-$QU1TQ6<'!71C-Q2C!Q,E,R:&I5<DY7<2MQ6D)7;D=T84PX
M<3%X8DDT6D<V1W=&+T(V2&=A,VMM;S9X<4AL;CAU+TUL+T4Y>&\R)B-X03MP
M4C-6>F-10FMI3G="8V%P3U%Y<&-E=DA)0W-T469S,"MZ=%1*-#A:;DQH0G!O
M,4]754E'55):2&5L=7-L<C=3+TLY,35Z=EEO9&1T)B-X03MP3E0Y9E549%(V
M3$Q%;316,6YT6F)G44%X2VY343%(5VA*04U99WA*-VY&,4]F2DA566]2*VEF
M2'AB1'!'>'8P,S=U84UL;C!'8C@S)B-X03M9=%)U6F)E1%=R53)K9U)9-W4V
M4DI*<F(V=DM$4&)L244O9%1U:4Y/=F9K4'-T9VQ!0TE097IW86I.3%!K:$UN
M=V]C4$(X4C9V9G5W)B-X03LR>3$Q13AH96%9-#5H8S)K;&Q.8U<V=#EB5TYM
M;'9G:S9T1$UN,4IN8V<O,U(U1&-L5'E,6EE-0C0K06QV=S8T>6=-,#A90B]M
M6'0S)B-X03MC+W12978S*W1Y-E(U1V%15$PU9V$O=51&3$\U8V]407%X>7AO
M=#E)-&I-2F]W1GEH2C5':3$T-4=/2W=49C!T,S5K4C(T4650-T4U)B-X03MT
M3'%2+W=!-V95=#!N1G!$639E;#=.-FEM-458049)-VE96$UD46LQ1VQQ2F51
M-4-M+TQ"3$A50DQV6#AW2DAW*T=U2'(S,RMP261')B-X03MV+SA!;E%V4$Q3
M=WE#>F@O4TU6;$-:0CE265-80W9-=C%9>DY'6%IV:59V<31P5B]I4$DU3310
M5TDS>B]!0C-O+T]X23A49S)J+T0S)B-X03LQ.$]Q=G(Y-69J>60U4V=J5S8O
M4U9X96-O,64T3% V:F%C<5%V6FXV-WEG2$)U04-Z=R]V3UI(1&Q5:4]+*TQF
M-E4O;6A(*T<K4#A!)B-X03LR4#)F<50V-C%N5712+TXV,64R864Q9U,S,#8W
M=DQ5>D97:FIF:TI)-6A"9'=X2&=8*U!E6E X04E/>D%(2%5"2RMQ9GI6+W5Q
M-6(R)B-X03MZ9GE&<#DY6C-U<D=744,P;F%&-V4R349L2$EP5U!I-TY08513
M=$XP04IL5E0T8EI66DDS-7-205(R0G-$<BM+*S5M3TQ*:2\U:'-Y)B-X03MA
M2#9I4E-Y4W$Q23)H9VUU1U%S0W9,:$%*2D0Q<#A-8DAW1F-L03!737A9<#5L
M-6(P-U=)9$EH<TIX8WHV:3ER*VHR;&)4.5963V0S)B-X03M74TYN:V5Y+V1Q
M<7)2>DEQ.$YU5DMR6$ML;FE:5T]6,C943#)18VLK2U(O>5IG4C=Z9E Y:4\X
M>F9L+S5O3VTV;DML>EEA6DYD86)P)B-X03LY9W0Y3&-4249L=%I9;6-S>&A#
M9T52:TM61E188UE986E)274V<VXU=51(46U-3T=.0V]X:5 X04YP07@V9#5H
M,5!Z4#5J<W)E+W0W)B-X03MF,'1F<TQH634U5U)7:E533DIB>&HP>GED-CE+
M64)N9T%.=C132$MY84Q,2#%(;$EG:C-$;6XY;#5#.#A1,TYG.#%Z8G9$838S
M8S9N)B-X03M+;G%3;FQA>6=E;$5+=R]A46IP,#DX0GIW;S=F=S!W:F=M0TXO
M=T-);C1+9FLO.$%,9GIN<&UT954W-U9,;3)U4#!*8C-T=F9/:VMR)B-X03M.
M26)Q5U(P2V-O;')X5C%"-45D36QL,4532D%$;E1(1'!P>$U35#E)3#%R34IZ
M,UEQ:R]M*U%*-6$Q1W--;'=(9V105&E1>4XX4VM6)B-X03LT9W%A1'9V:$-#
M.&TX=GI8.79Q5B]Q5C%(9E1),G1Y-FIB>$A3=%I%:3(Y>'DT4BMM.6E(2$5!
M-SAE1F1U5F-Y6EIO:U50-6]$<6,S)B-X03M:.#4U251**VI)6F9!.44Q6#AU
M+TY3>%=$:U=9;'-R4%5B8U1M5V--:EAS6E9'5VM+2U%#9FE,3%5D<VMD4DAF
M;G52.6DV6'-W64E2)B-X03MH2&Q(:2LQ:F$K6'9.679V.$]J57)D8FLK565)
M=7A.2CE836HV:'HK<VE14C%O46%C<59Y6#5I1C-8.%8O0VY++TDU9D0T<D96
M=R\U)B-X03LS4#=K*S%0.'50>D)U<&1:94LY=&LK=G!P:3)D6DIG67I:2D=T
M>%=K3S-Q1D13;C T239I07)B;&8R.&U%=$YK3C<X*T@W3V%*=2]Y)B-X03LY
M.#981C4V-UA&<U58>E)"<G%!>5,Q1FQ#1T)G,F@K,59V<R]:.3A!>GA!-69W
M5CA74C X>65F.&9&.$=3969,1%4U=%-T3&Q)42ML)B-X03M1,FLV,T5H84)#
M<S=4,C=23'EE:VY%:4YU454W,#=':'I%1&UL:%!L+UA"<6YM>7<K<VM4,U9R
M<58O85<P:D=2>'AI5FE6855O;$M&)B-X03MJ<V9O-UIE8U!#1&9/9U$X+VPQ
M5V%E9D8O0T]/64EV;4%.=').<%EB-U5)=$-T<%AI94UP-68Q;#-I<DA.845Q
M6FU"8T5O-T=I57!3)B-X03MM+V9R:W-M37EN.%%'=G-$=%!W34=,1D=P47%C
M*V]L-EIN:VMT,W(Q-'5J6%5N<#)I>&IY;EE83%9T,6,Q93=J6&E!6%5C971%
M-D1!)B-X03MD3%!K2W4V96Y(8DE"<V<W979N,S=*;G%U=$-+*SAZ;TDT5V%$
M53E"4G550T@T6E99:C1I-4QN8C=2*WHR>4$P*U$Q>3-V<65N4&]Y)B-X03LO
M;&%!,G%8;S(O,'E),'I6=%9M.'=/='9B:%DP.#=Z5W0R24)11TY1,WA/5D<T
M<C%:=79J:W9Y-7%Y45!484HY<5).4FI%;BM!,SDT)B-X03ME*S5J<T5H.#-E
M5EEV361R0F)41S-#47E#5&Q085<Y,G<X46XQ;%I9,#5$66YG5#AS24M#14Y9
M*U)R84TV83DY8R]81'!Q1T]+1G)4)B-X03M4,6DY34U':6I(0S)6,%=)<7!5
M4DUM-F=K9'-B5VLS5'DU-652-VPP,'4P5C<S,4)E34E)9UIV5W V=G%K3#AF
M4&E/6$QR,W=7=$Q")B-X03LU5SAS0S)3,$=K5U%T635%;FIG1G9&-F%Y>'%%
M4U%,>&](5D9#:'5O1S)',7!+3&HX=G)396-81&%J3W-Y>$YB<$E,5%-I>7=S
M>DXV)B-X03MA<S%K>D)!6"MZ5VUW<G97<F$P<F%D-4<P*WIV3&DT935E-VIV
M1F-8;').839C<V,W>4E%:VML349R1$DW4#A!=%9E:'(P<'1J83!M)B-X03M!
M.'%E5FQG5S-84C=%5S932DUK271O94%K:5AH1S18:E1K:6II<#9G63)T3#5F
M3&9L,F%E2S1L,'4P:VYG0W)"33!%6F1&4GA+9U)I)B-X03MT5D-Y04U!3RLK
M3G!P9$0U9C!'0S5.,41P=')&9$Y+,7<P-E%X<DE:;E5Q,&A93%AM5DI"8G)4
M0F$P:CA69&ER1B]Z04@K-'5&>$<X)B-X03MH4U%N:DA+<U1(-$=',5-R369$
M:7=)3RM3:4QA8SAJ1T))-6=&-5!O,7!".5%M=EI*3&DS9CE!>E<P:'5P:2\W
M=49K0T8Q:V%33712)B-X03M"=C1:8V-)-F)B=DTT3S)T44)%;FAN*S5L4&QZ
M26M13U9,9DY7<E%7;6DV,E%98G4S:3!B4C9X>%A01G!!2C16-71%:F]I8V5E
M>%0K)B-X03MB2VA#5C!"8C%U9S=6=VYH-"]4341I;#9D:'A$=CDU-4\Q6%=*
M4G(R=5%4>'!D4E$K871-:&A6,UI"0TI225%Y8U=B:V5683%O371/)B-X03MN
M;%%),W-7;D8R<4%41U%R:#E.:G)B,U-N*U%N+T)F.#-::G-&,%$O94PX2T1F
M<S%4+WA,1E5::6PR2W-6+TU85W1-<V1'6%0W=WE#)B-X03MF5V98=&)%4G0V
M64TP9'1,8S!E46M+<3A)1S8O3$-%1C5Z;U=N47@K85I(5G)Q,U=(6#=U:518
M1'-H5U-.,%E585(P84]H4$AL,"MN)B-X03M,:FE&6#57.#%$=%!.-&]J>%))
M3V5C3UA+24%O8W5F;6PQ;F1R8C9B;VMK6F=V64)P,G5/<D-C4E-%3$A)85)X
M4FU/3G5L0V1Q8FYR)B-X03MK2EEY1%$S9'HR5C(Q2$YJ:6-S941*23AG1'-)
M;F9P='0W<E-X=&-L+U)R9W%S;&=F2EIU:S Y:315139I12M+55-->$E',G<V
M6EE.)B-X03M026DK=#%4<S4Y<7=J;#)&=RMV:38Y,54Y-3!1<2MI,D1R1VEQ
M,71#479,;T1'3G0R>6=I;6U5:$DR3W%56#)K83%*-7%T<C9%24Y0)B-X03M4
M:C9O.55D:"]*5W98,WAT:E<Y<"]W0UIR8U0V2F1+4E5O:&M58TAK,U0T:%))
M-G-D>#1(-4A%2DQY2'EK=79W86E,<65X=7)H>'%.)B-X03MZ9%<X3%%Y>'0V
M5G=4=VDO9G!&>$LX=#8O1#<U;%I-<U-.=31/;VXR9DME6$A-;BLW;$DK+VE&
M2U=P*U<O3FUN5W1J2$YP8G9D3'!/)B-X03MO86)&9F]Z4W-K.3@P>%-V;V]Q
M2W-A9TUZ36<R;T8U3G1K+TAJ6CDT4'E:869S+W=C66A$;$=-:'HW>5-L1#)F
M;E8Y374W84=+-E-9)B-X03LV3F$V66IT1&-)1W4T<G%->E1Q>GA!1F503&8W
M4D%.061Q:UHT6&1F>%@X1S V9DI66"]#0CA5.#%$>6HK63@P=7)M3WID8F95
M-WI4)B-X03MP3&%0,44O9%$R85-#9FU",$5P<%%,6'%+,#-P1T]E07)Y0BLQ
M;$Q4>DXW.'E0<S5R,#AM968R,6%+*W5B2FUI5'I),G5+<&M1<VQO)B-X03MA
M.&)E9R]B2'%D0CA06&9(>#166#E'=FEV-65D,R]4=C108G-W;E!D:7)S5F1I
M<G-69&ER<U9D:7)S5F1I<G-69&ER1U!0.$%*2$9P)B-X03M557)E;GIJ:TQX
M*W!Y<E5),GEC45)7;FHK=DIW-71/;VIX46M/.$8U3F\Y>F)V;S@K<7E1=W!-
M,FM854Q/86M%0U%!3'HT8VE#1C5$)B-X03LT83 W6FUY031V.$%/1'E%9$)K
M:G<T451W*T))8U9'<C1J.7%%.#8S<T0V4#5H<GAV14]I-DU264--<6A*=4E+
M.$IK-%--4E1P455P)B-X03MK.%!-9%!62C)O,'-94DHU>3A/038W,5,W5C<Q
M6#$O6#%K=&]:14AM:E-V4F15-$5I:VXW-'-G6&YW+WET<UDQ=VIF*T%U5D\K
M2U<S)B-X03LX8UAU=C$R,"]W0U=M1"]H9C9:<DAA<C1B=3)A5D97-&A::5%!
M<3!Q9FQT:7%9-'!D:7)(=E!7:C989C9(3&18,%-V2G!A5#-6;$I))B-X03LP
M:7!(2SET3&)S-T--:FPK-FYD845(<EAR:$-#.'HP,71/=G9.<W,Y=W1S>C)F
M;4-F,'!D,C1G13A7<7E*5#1Q8D-O<E1F37591F8U)B-X03MO958O2WIX6F\X
M2DI%=%)/4F]C9U%/9C8P;',Y4VIK,#=29TI%15@V3C%W1S%J479(269296=-
M<%=.,#8W54<K6&M#>C<T=&UG-U!')B-X03M+14]).%5O:64K+U9+5G4Q1VLK
M;6)/2G)F+T)24&]&5S4X:G%E,$AQ:CDU<W4Y3UAV:RMV4"M0.41M-S%Y+WEF
M*RME.39(93)N-D4P)B-X03LO=T1F=U(O-DY$*S<R*T@Y,DYT>%AB3EI0-FDW
M94@P:$AF6&)4+VQP9R\T6"MM45I*;$EJ4$=Y<35J6F=12D9P>55N=4]1669E
M355P)B-X03M%=FLS4S-L36PP0F-L=69Q5FIJ:DQL>51Y3%)Q:'%/,T=M1S!5
M:E(U83!!4G1%3$=%27A"6E%T2VMD2S0R=$MA954O3&EG9V%F1E$Q)B-X03MR
M559/-7(Q2D].<E1K.' K6$512TY0:4E!03-(23!(=5-4:F$P;49L6E=T;&%X
M,G1R1TEO26A214944W!Q9'I5.51G4W)9<3=&6%EQ)B-X03LW1EA9<3=&6%EQ
M-T9867%X2%5T4#%X=E K;%AL=$)F3G!K9G)F6%IO-S5)3$E69T-P-C%O47HS
M2'AF631K8U<S3TE*-4=M4$)2=2MF)B-X03LR375X6D]X5DQF35=L,FUP-E1.
M85A6=DQC>%!1*VQB>4=+4V]/>%9W.$I&4%IX:$-#=S=44$ES<V-Q;4]Z9S1R
M>&LT6'EZ>4E73DLQ)B-X03M$5'EL;5%B:74S5&9B63)I:V9Q2#5E>%AS.&0P
M,%9L2&1,54TP4U1X2S-W2D=P6E5M04Q,2$AX1$AC1%E9,G1)3S$O2SEB84=-
M;W1Q)B-X03LX<V)R37-5<C-K,&9Q<7)$:U=K;5DQ4'%-0V5/-%DT.%,X2V%3
M*U1P2&EJ5#9J;S=#249),$YR24962D]):T%P2C!):EAA;$1164Q4)B-X03M3
M8U=N;'I2;T=I;BMO5WDS:4)3,#!565@T,7%A<E=P;T=9,$9D<V)7:S!W2F1I
M<6AF=TI06E1W=7-J<$I'>7-K3"MN25%24VEU1U1I)B-X03MF9FM-5EE&6F51
M,'1D4E<V,'DP945H;$U36#AL>$QX.4QK>65O>'5:05)Y+VQ"<E56>59S85(Q
M,RM854YX87AW0S,P-D)%57AE;F)W)B-X03MZ=W%9;6IA27AV=VU!9$],:V-'
M1DUB5VM(1BM654EA5C)&=7)Y<UAB-#<R449G4GA.2&YO=7ER,$<R4$5V0VUS
M6&LR55),-FQP<%)L)B-X03MO;DIZ8GEU>&%/3EEL2FM-9UII23$T.&IV5$)A
M851+,3AQ84\Q;V]V.4YS:F1.2S%Z35E)<4HV-VPK5')Y*TMP17)64&5P.&-B
M5VQ8)B-X03MZ5F0S='!O9'AC5U1T2&-P5# S4TY:845M;39U5EAJ-&UU,DE5
M=D],4'HO<G0Y<7IA5D8U;6=S-S935V4R<S1R>E):545K='4O3G%%)B-X03LS
M2TIX5T%C87,V.&U0255O54U"34AQ<DE2*UEE;79P>3-C3C-/>E,R5C%Q14MS
M,71X84]Y67)+0S!C8S%$.$IP4W8S-UI.=FIP-6LX)B-X03MU;TAZ4W104"MP
M1SEL=GAD>7IA5TY(9S%#4%1);&EA-3E78595<GDY1&1F:7 P<C-P:3,O04I-
M,$(O1GA6-4TS5V4W;C X6%9T9%-K)B-X03MY>&5R0W)F5B]W0G!E4V=G4B]X
M>&-+44E.2DY:6&YN6C=Q,5<T;FE%2F(O4W5-4D)+;'1G:&%-045$-UA,-E!$
M13@O2FI%-T%N;7E,)B-X03M69&8P;E-N=#!V-6I%.3)X4S-52DDU6FQ!2DAW
M2S-J,WA!4U-M1T),<U9D:7)S5F1I<G-69&ER<U9D:7)'.5(Q+U9R6'IF<"MM
M2F)Y)B-X03MY85ID235M;FAS<&)H63)#;FHV='EK>7)!1V%N1W-,5C,S6')I
M0T1T,41(,5AY,EI*:7ED:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-6)B-X03MD
M:7)S5F1I<G-665@U.&XQ639H83)A4D\K:G9A>GI85&="27AC4GIW96=';4E)
M2'=S+W=62$E6<'8P25%716%7='A&-7-S,&17=75E)B-X03MQ,U12>70V87)(
M=3%%2E5Q,5!!.%1M6$QK9C9O94=W56-U3W1V.$EY9"LO,'!7=#%Q>39084)1
M25@O44=S<TQA1S5":TQH<&U6:VI-)B-X03M:-4Y644(X+V))4S Y;F(P:7=0
M3&0S2%EV87573TQ(1WIK0FI+4DI"<VU-:G1X5V$W=7%286QA87!.<&UO6&YP
M4U!C>6563$%01TI')B-X03M%-U1#.6I,8VMJ6DI/5D]V=V=:64Y.2%E%-SA6
M6"M,1'0U9&]:4DTU22]Z8C1E;"LU-R]O1E<P3%172TI5,G-*4'AF.%9R+VQ:
M:5-&)B-X03M';DI%:DQC.55E0G509U0O04E,+T%*=7E+55!R+VQJ5&1C*W)F
M6%1*4S%:;6I#14%%<T%$>4)$06EG>%138EEQ-T9867$W1EA9<3=&)B-X03M8
M67$W1EA9<6A:9$LP=5<Y4RML<S1*3#).94UD,#!A1U96<4=O<FMC9TMQ1#$W
M67%I<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-6)B-X03MD:7)S5F1I<G-6
M4VYZ5D)*3F]D>45J5U)K069I=VMB-TIR54Q'2%II3V](13%W:$)E4V57,#%X
M9%0K='EA9F1024Y2:W4W93-A2V1#)B-X03LP8W!O17)C<6Y&:'531#A)3S%2
M,GE:-5%2.$MD2E!S;3AK2GAQ4$)/57$W*TMK3G%F;#-Z=%HR1FQB6&UL24I(
M,&I59$U-.75P;C1Z)B-X03LS>E0X2U-H5VM215-J3U=P,4%7<#)Y9FIX=3DK
M65!Y8VY&;V9$9TE204%%6D0U,FM5,VPO>DQ.<'0U8G@R9'=T=S)H5VUJ3$DP
M1GEN)B-X03M+93-U-#-K;%8R:5=Q06-J5W9),$Y!9'%Z1W!J9BMC4VLV5U9C
M+S114'1E>C9B9C8O6F%:63)S;6A81$Y&1VM$<W!G24AP;U)Z4'A6)B-X03LT
M:W!T,S-&4C%P:%-.:VQZ-&EG06I&,6984&A,849C2T-+='9B:W(P,C)9,4\O
M8DDP>5I*9U,W1EA9<3=&6%EQ-T9867$W1EA9<3=&)B-X03M867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ>&4O.$$K5F8K<% X
M05=V<79Q,6(Q=4YE9DMP-699,S56)B-X03LX3CA/-DYL-"]W04)F5FXT+U90
M435,-FY';$LP*TAL5$AD9&Q#3"]L6$A"=5 Q4VQ46&Y7=C)T-F-T*W93;F)P
M=&IU=7IO9BM68V5K)B-X03M/2#%4:GA&3V1E5DYV-2]I<BM/3S8W2B]O,S9-
M+U)K2#9,<#E1;V91-#%P4W!R.7(T<3AQ,7)G2U5B:7(O.6L]/"]X;7!'26UG
M.FEM86=E/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z06QT/@H@(" @(" @(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @(" @
M(" \:6QL=7-T<F%T;W(Z0W)E871O<E-U8E1O;VP^061O8F4@26QL=7-T<F%T
M;W(\+VEL;'5S=')A=&]R.D-R96%T;W)3=6)4;V]L/@H@(" @(" @(" \9&,Z
M9F]R;6%T/FEM86=E+VIP96<\+V1C.F9O<FUA=#X*(" @(" @(" @/&1C.G1I
M=&QE/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D
M9CIL:2!X;6PZ;&%N9STB>"UD969A=6QT(CXP,#8W-S1?,# Q7W-A;F=A;6]?
M87-H7V=R87!H:6-U<&1A=&5?;&\\+W)D9CIL:3X*(" @(" @(" @(" @/"]R
M9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @(" \>&UP34TZ
M4F5N9&ET:6]N0VQA<W,^9&5F875L=#PO>&UP34TZ4F5N9&ET:6]N0VQA<W,^
M"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z,3-D8S$R,S8M
M934T92TT,&9C+3EF-64M83 X8C1B,C-E8V$Y/"]X;7!-33I$;V-U;65N=$E$
M/@H@(" @(" @(" \>&UP34TZ26YS=&%N8V5)1#YX;7 N:6ED.C$S9&,Q,C,V
M+64U-&4M-#!F8RTY9C5E+6$P.&(T8C(S96-A.3PO>&UP34TZ26YS=&%N8V5)
M1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.F4V
M.#,U9C%B+3!A-V$M-&$T,BUB,V-B+3,U.&0S9F8Y8S(X-CPO>&UP34TZ3W)I
M9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z
M:6YS=&%N8V5)1#YU=6ED.F$U9#-B-6%C+64P,C,M,S<T82TY9#8V+3!F,V8S
M.61C-F8X8SPO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F
M.F1O8W5M96YT240^>&UP+F1I9#HV8C%E-3AC.2TX,V4R+31A,38M.3$R-BUF
M8C1E,C-C.38U-&0\+W-T4F5F.F1O8W5M96YT240^"B @(" @(" @(" @(#QS
M=%)E9CIO<FEG:6YA;$1O8W5M96YT240^=75I9#IE-C@S-68Q8BTP83=A+31A
M-#(M8C-C8BTS-3AD,V9F.6,R.#8\+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)
M1#X*(" @(" @(" @(" @/'-T4F5F.G)E;F1I=&EO;D-L87-S/F1E9F%U;'0\
M+W-T4F5F.G)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \+WAM<$U-.D1E<FEV
M961&<F]M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @(" @(" @
M/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#II;G-T86YC94E$/GAM<"YI:60Z-F(X,&8U,#(M,S=D-RTT,C@W+3DW-S$M
M8C4S8V-F8C,T93@V/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z=VAE;CXR,#(R+3$Q+3 R5#$X.C,Y.C$U+3 T.C P/"]S
M=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!
M9V5N=#Y!9&]B92!);&QU<W1R871O<B R-BXU("A-86-I;G1O<V@I/"]S=$5V
M=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA
M;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL
M:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\
M+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A
M;F-E240^>&UP+FEI9#HQ,V1C,3(S-BUE-31E+30P9F,M.68U92UA,#AB-&(R
M,V5C83D\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IW:&5N/C(P,C(M,3$M,#)4,3DZ,38Z,#DM,#0Z,# \+W-T179T.G=H
M96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D
M;V)E($EL;'5S=')A=&]R(#(V+C4@*$UA8VEN=&]S:"D\+W-T179T.G-O9G1W
M87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\
M+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*
M(" @(" @(" @/'AM<$U-.DUA;FEF97-T/@H@(" @(" @(" @(" \<F1F.E-E
M<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O
M=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$UF<SIL:6YK1F]R;3Y%;6)E
M9$)Y4F5F97)E;F-E/"]S=$UF<SIL:6YK1F]R;3X*(" @(" @(" @(" @(" @
M(" @/'-T369S.G)E9F5R96YC92!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(" @(#QS=%)E9CIF:6QE4&%T:#XO57-E<G,O
M83 S-S(T,2]$;W=N;&]A9',O36EC<F]S;V9T5&5A;7,M:6UA9V4@*#$I+G!N
M9SPO<W12968Z9FEL95!A=&@^"B @(" @(" @(" @(" @(" @(" @(#QS=%)E
M9CID;V-U;65N=$E$/C \+W-T4F5F.F1O8W5M96YT240^"B @(" @(" @(" @
M(" @(" @(" @(#QS=%)E9CII;G-T86YC94E$/C \+W-T4F5F.FEN<W1A;F-E
M240^"B @(" @(" @(" @(" @(" @(#PO<W1-9G,Z<F5F97)E;F-E/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@
M(" @(" @(" \+WAM<$U-.DUA;FEF97-T/@H@(" @(" @(" \<&1F.E!R;V1U
M8V5R/D%D;V)E(%!$1B!L:6)R87)Y(#$V+C W/"]P9&8Z4')O9'5C97(^"B @
M(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M
M971A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B
M/S[_[@ .061O8F4 9,     !_]L A  ! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! @(" @(" @(" @(# P,# P,# P,# 0$!
M 0$! 0(! 0(" @$" @,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,# P,# P,# P/_P  1" 5&",H# 1$  A$! Q$!_\0!*  !  (#
M 0$! 0$!          D*!P@+!@4$ P(! 0$  00# 0$             " ,$
M!0<"!@D!"A    8" 0$!" H-!0H)!@$=  (#! 4& 0<("1$2$Q06EM87"M05
M5E>7MSA8>#DA(E6UU7:V=X<8F+@9,94WUQHCD].4I>4V9Z>(03(DM#5U2,A9
M43.$):;'J-@Z0B;G:&%QTD,TYNB2ADEI>9%28G)35">9QD=:$0 ! P$#!@4*
M#@P("@@# @\  0(#!!$2!2%1D1,&!S%!85((<:'1(C*RLQ0T-H&QP>%RDB-3
M<W2T%74W\$+2,X-4A#6U%S@)8L1%A196=ACQ@L*3TR24U%49HD-C9*0EE=7B
MHV6E5T3D9O(FY4:F)SG#Q=8*&O_:  P# 0 "$0,1 #\ O\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M:B#F,T(/U,^'_P U+C9\!FK_ #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\
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M #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\ -<-?/SWZ5&H@YC-"#]3/A_\
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M:B#F,T(/U,^'_P U+C9\!FK_ #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\
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M #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\ -<-?/SWZ5&H@YC-"#]3/A_\
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M:B#F,T(/U,^'_P U+C9\!FK_ #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\
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M #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\ -<-?/SWZ5&H@YC-"#]3/A_\
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M:B#F,T(/U,^'_P U+C9\!FK_ #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\
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M #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\ -<-?/SWZ5&H@YC-"#]3/A_\
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M:B#F,T(/U,^'_P U+C9\!FK_ #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\
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M #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\ -<-?/SWZ5&H@YC-"#]3/A_\
M-2XV? 9J_P UPU\_/?I4:B#F,T(/U,^'_P U+C9\!FK_ #7#7S\]^E1J(.8S
M0@_4SX?_ #4N-GP&:O\ -<-?/SWZ5&H@YC-"#]3/A_\ -2XV? 9J_P UPU\_
M/?I4:B#F,T(/U,^'_P U+C9\!FK_ #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&
M:O\ -<-?/SWZ5&H@YC-"#]3/A_\ -2XV? 9J_P UPU\_/?I4:B#F,T(/U,^'
M_P U+C9\!FK_ #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\ -<-?/SWZ5&H@
MYC-"#]3/A_\ -2XV? 9J_P UPU\_/?I4:B#F,T(/U,^'_P U+C9\!FK_ #7#
M7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\ -<-?/SWZ5&H@YC-"#]3/A_\ -2XV
M? 9J_P UPU\_/?I4:B#F,T(/U,^'_P U+C9\!FK_ #7#7S\]^E1J(.8S0@_4
MSX?_ #4N-GP&:O\ -<-?/SWZ5&H@YC-"#]3/A_\ -2XV? 9J_P UPU\_/?I4
M:B#F,T(/U,^'_P U+C9\!FK_ #7#7S\]^E1J(.8S0@_4SX?_ #4N-GP&:O\
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MC%)!E'1L<R0(B@@B0B2*1"D(7!<8P*:JJK:N55*B(B)8F1$/I#X?0
M                                     "-OJV?(7OOYX>'W[Y.@1=4?
MW]/8N[U2UK?)U]DWOD))!:ET
M  $4'6+Z7U#ZLG%ZH<>MA;1MVI8:A[PJV[VEBID/#3<F_E:_2=C:^1@W+6<.
M1JE'N&>S5W!E"Y[YA5JF7'VIC ?%6Q+3=/B'QTA>(G%[0?%^N6.4M\#H35=.
MU9$6F;:-&,O/Q].AVT.VE9)FQR9FV>/$VV#G(EG)"FSV8^P!]-C
M
M
M
M
M
M
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M "-OJV?(7OOYX>'W[Y.@1=4?W]/8N[U2UK?)U]DWOD))!:ET
M                          'PK+_T(]_]&_YV@/J<)Q?W)]T?#D
M
M
M
M
M
M
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MPH3';W1N^9P;_P F!Q6RW)P%1MZSMN$^V/A]
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M?:'QG]HJQ[?>UOA/>_"O:YEW[N>Z[R3M[G ^FSX
M
M
M
M
M
M
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M.,XSV #^P
M
M
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M:MO#R+8;/"D50
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MF5) F, ;K@    K%>MU_4T; _/OH?\J'0 UW]2I^JRWY]/\ VG^[KQ5 %OT
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MI+HXR5&5K=JB&<[!2*6#?;83?1;])4N,_9[# #G+>N0]06Y;&Y2:_P"G'0[
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M4YW7NQ'=B6T]/5BW+Q[:=V TB*S'R+S.V:;&M5$X["Z7@\BS<*M,NH_NC+*
M9QX6>KL=*CAYJR'I,AQ7U)R;O1HQHG>-N\GM=U/<EAMT\5)#+^4BJW?(ZQU#
M7L8HX2[&K"%:-N\-^PJRSI;*SA8"K!ZU=T2>*W#S4NM.<W#VAQ&E(:=VG&Z>
MW'J"LKN$**X?6BNV.?I]]I-?<G6;U19LK474?*,62A&2^'319!JB=-XJL!89
M]5&Y47GD_P!(RC1VPIA[8I[C-MF]\8V4])944D7U1I\#1[]1&+IP<^2NDZK2
MMFL(5J<N"]C*-1(?NE"G4.!9/
M
M
M
M      $;?6 ^K,YE?F>DOOM$"ZHO*F>R+6M\DD]B;A\>/Z -&_F>UG^14(*$
MGWQWLE],KQ?>V^Q3TC,(X',
M                               (>N@9]4QQ0_3K^\KN,7N(^6/]#O4+
M+#O(V>CWRDPHLB]
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MN[.LYY>3UEZ':WB*;6Z-U@X+A)*PO3,5W*9>Z<%P8^ /L^MU_4T; _/OH?\
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MD/ENY<:ZOLY7VKM53!\)%69);26(GC)<F,5P?.,XQ@V,@=&T  !S:O6X>J5
M<J]T:YZ:'&^04OM;T%L0UAW/)53ODZC;^2#I@ZI]7UE6$XG+DTP]UC%V&29R
M!$<+&4GY91CW";B-/A0"X+T&. %CZ;_34TMHC8*/@NX;0XF]T[ICBG243@=B
M[)\!<K5+!T%%T%'-(JT;%PKI5-11)=Y'K*IF[VH7& )D
M
M
M
M                         !&WU@/JS.97YGI+[[1 NJ+RIGLBUK?))/8F
MX?'C^@#1OYGM9_D5""A)]\=[)?3*\7WMOL4](S".!S
M                                                  "'KH&?5,<4
M/TZ_O*[C%[B/EC_0[U"RP[R-GH]\I,*+(O0
M                                                          C;
MZMGR%[[^>'A]^^3H$75']_3V+N]4M:WR=?9-[Y"206I=   !IGS'Z>O#'G]3
M2TKEOQ\U_N%FS9.F,!8YB,-&;"IJ3LW?5\T?9, M%7NH=^<8*HJ1A(((N#$+
MWXBA<=R .=IUW?5DY[ITT2Q\O.(]QLFV>*$-)QY=A4JYE:N]JZ,;3\DC%QTR
MO,Q3-A'7_7)9IZ@T,\PU:2<7X0AX4F[2*XD" 3T^J.]6+;G+S5NU>$?(VUR=
M_P!A<9:O6[CJ'8,^\6D[78=*/Y(U8DZM;)9VNH^F'>M)]>-18/ELJKK1TJFW
M4-C#),R@%>[A'_\ '@%T_P#SH?4#_*#DF .I^ .6!T=?_CLMK]+OJ6?%#RV
M%LKUNOZFC8'Y]]#_ )4.@!J!ZE5K/7&>GKO_ &Z:@TPVUE.:NPZ(;99JQ"FO
MV:3%:'XY3,94/&\S+,_BLL)>S2+I)CAQX*1P^74P3!U3Y,!^_P!;PZ:^B;WP
M?L74+J5%K=.Y!\?KCKEM?[O QS*(D-H:NV3=H35IH6Z%9)MO&:<K]SN,,[C9
M!SWYVS:)NV^,Y26_N0&PWJ@G)*T;QZ4:FNKA*/95_P 7]]WS3E96?JKNG">N
MI* I^SZLT\,6)VF;1,E?)..:H=V?P5DR03+W*6$B8 J6<H/_ ([DK/\ ^=VX
MA?'%I0 6+?74N3=HUMPUXQ\9*Y,N8EAR9V];K/=V[3*Z9[%3=!1-6?EK[U4B
MI43Q7CMLB$D#HG(;*CF.0-C.,)FP8#0SH(=9/HJ=+/A-7*5>9'9K+EALQ[*6
MKDG=8/2,S/KRDH2>F4Z13(RT(937<5"E4X[5-!J0YFWMFX?.BXP9T?& (Y?6
M5.H5TM>I;*Z)WQPRS<2\DJZ[F:3N68L&K9.@XO>LLQ;=S2GTY(N\G0G9RCRS
M%5FT4-V.O )'*1S'1;-R( 6<]1]0_:NM_5&(+F>WLLTGMZH<69K1E5NKI59W
M88VT1G("5X6T*XE>D65<+S4*H1@_1=K'.?*Z)5E^ZSWS&0(9?4]NF5HSD?9=
M]<Z>0=)K>U#Z.N->UAI"IW!DE/5Z%V,^A,6VX['EZ^^RK&R\Y!0DK%-X0SQ%
MP@U</'3HA"O&[1= "\3SSZ:W#SJ2:I)J;E3JB,MC&.69NJE=X0K:O;0H#EFZ
M3<]U1KXV:*R\$T?%*9%XSQE1B\1/DJR!^PF2@9[UMQDX_P"I-$TOC)0M1T:(
MT+KZOQ=9JVKG, QFZHRBXAUB0:F=Q\XE)%F)-:7P9^Y>O,KO'<BH=VNJHX4.
MH8#F&\,*/2I'UM.XT&0J%7?T5/J8<]81.EO*_$NJD2&BY[D62,B25Q=H>'+&
M1Q&:6$&^$>](X2)@A<=R7L ZD-,T]J/7#YW)Z\U;KFAR3]IX ^D*92*S5WSQ
MCWY-QX&[=P<8Q<.&GA")#][.;).[+@W9VXQD 9& 'PK+_P!"/?\ T;_G: ^I
MPG%_<GW1\.0 '*-]4'^N.JWT=]Z?>Z! '2]Y]T%QM?@GS4U:S267=[)XE<CJ
M"U0;&.5PLXN.G;E74$D#)-W:I5E%9'&"9*DJ;!LX["&S]C('.]]2VV!&5SJ9
M;OHLAWM)QL?AW=4X-<RV"J+3-2VKJ*</&I(&QCOOA$"9^Y,;&>Z)AG_Q<X,8
MQ0.GN *8GKL]^C8[@%Q2U<KE'VWN',%I?F.#.4RN,QNMM+;4KTKE)IG/?5T<
M.MK,^^*%QW*1NX*;[*A0!N5ZHO0G-/Z,VN;"NW<HI;4WGOJ^LE%S9,D[;1UM
M2U@=PSQE%/N&Q7FN%DLX[I3^[)'SW6.WN2@6*]OZDUUOO5FP])[=K#2Z:NVM
M3K!0;_4WKJ18MK#4[1&N(B;BSOX=Y'3$<9TP='*1RT<-W3<_8HBJFH4I\ 0,
M7GU4WH@VRNO(2 XM6_6,DY_\S;Z-R,Y#2%BC_P"YJD_Y&VV5LO8=3/\ ;*8/
M_P HBU_MB%_^1[HI@*37.;BWRV]5UZC>J]F<9=TR]DU[>HQ_<M06^7;99,MF
MT2'EVL?L+1F]*FP4;PMA=PF)!F1\HU*1!9O(L)-CF/?]B+$#IU<9.4M=Y8</
M-2<N-6P;]U$[BTO$;4KM1<Y-[:MY:1KYG[ND.U443]]DXFQ(K1:JB1#D461R
M=/NRY+G(%#ISZTOU_"N%RI]-W1S=,JRI2-W/$7FFJX0)@YL%174+OYL519(O
MVIS833QDV,Y[DO\ )@"2'I%=>_J^<V.H#H[C1RFX0:PU9HO8K3::EVV/4>.O
M)[7\M43T[4%\O59=9M6Q=LW*GQ[28MM9819RNV7:OE^5-(Y5C)]H$S'K&U!<
M;)Z*'/JNM4EEE8[6M-OQB(&.4^&^J-Q:WVD\5-E-NY-WE!I3CG4QW."Y3*;!
MCIE[5"@5N_4<]@1F$>HMJM?O:4R=3C9L",_NV,K/HQ,NYJY._P#)\X*8B<2Z
M5COM\9-@V7O9GN>Y+W8%_@ <\7UXN_1LCM'IUZN2RC[;T^@\D+\^P5RF9QB-
MV38=.5Z*RJTQGOJ".76J7G>U#8[E4W=E+]E,P MD=!:A.=<='3IYUYVW<ME9
M'CG5KZ1-T;)U3-MJ/)39[)P7.44.QL[9W!-5''<Y[E$Y<=T?L[K('/&VP9IQ
MC]:PE9NRI&;Q+'J\5K84PH]7,EX'7MS;ZA;XYF.^K-FV.\LH6_Y>)$SC"9B$
M*3OIBY[[D#K5@",+K57Z-UMTD.HW897*.&LCP^WG04N_N4VI/;+:U%EM70V"
MJJYP4RV9>XH=[3Q]LLIW*9?MC8 %,WU(*A.9'DMSJV>1NY,SI^C-6T)=V4V<
M-$7.Q[],V%HW7)WDV#.7*6JUS)9[X7L*BI]J;M[2 =&\ 5._67NNPAT^]7NN
M'W&*T(FYH;FJZ^;!8XP_?5N..K9YJHU\;#N4UDO MIW%LLH6MHE[XI'()J2B
M^$NR.P\ CE]5FZ$KELI2NJMS)K*CN=D^YMW$'65N8.E7C7P\OA+#DO:VLEG&
M'4C)I.#+TTBZ:G>RG).DSWXT8ND!?>
M
M
M
M             1M]8#ZLSF5^9Z2^^T0+JB\J9[(M:WR23V)N'QX_H T;^9[6
M?Y%0@H2??'>R7TRO%][;[%/2,PC@<P
M                                      AZZ!GU3'%#].O[RNXQ>XCY
M8_T.]0LL.\C9Z/?*3"BR+T
M                                             (V^K9\A>^_GAX??
MODZ!%U1_?T]B[O5+6M\G7V3>^0DD%J70 %=#UB'K1[&Z0VH]!J:/UM7[UN+>
M]^ED6$AL>OVI[J^OZ_UVC#R%W2=2$#(U\CNZSZT^P9Q[0K[!V[51T\43SWE
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M]7:I:8QZT2D$%.Y<L4L*(KIJ$R8ARFR!M"
M
M
M
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M%%D7H
M                  8^V3MK56F:^G;-P;,U]JFJJR#6)2LNR;G7*+7U95[A
M3+.,3F;1)1<<>0=X2/WI'"F5%.YSW.,]F1R:Q[UL8BJO(EIQ>]C$M>J(G*MA
M[\QBD*8YS%(0A<F.<V<%*4I<=IC&-GLP4I<8[<YS_(.)R,&5KE%QGN=Q5UW3
M^1.BK7L!!;#9:BUK;E G;BBXSD^,-U:Q%V!U-IK9RF;L)E#!OM<_8^QD5%BE
M:V\YKD;GL6PII+$YUUKFJ[-:EIG44RH   $;?5L^0O??SP\/OWR= BZH_OZ>
MQ=WJEK6^3K[)O?(22"U+H #"?(7C?HCEAJJQ:1Y(:KIVX]56DJ.9BFW6*3DH
MXSIKDYF$M&KE,C(P5@BU#Y49R3!9L_9*Y[M!9,_VP J7<B_4J^$5_FY.:XW\
ME]Y\=4)!-4[:J6B%KV]ZC!O#%<82+$8D)'7EU4BDS&1SE%]./G)NX4_Y3COA
M>] ?(XY>I1</J#8XF<Y+<K-R<BHV,6\(=4ZF4V#T%6K!DIC]PRFW*%FVA<$X
MPQ#8[X6.EH]T8Q>TK@F,Y* +A&G-,:HX]:RJ&FM'Z^JFK-64&*3A:A1:7$-8
M2OPC JBCA7P=FU(7OSU^\74<O'2V5'3UVLHX<**+***& B-ZN'08XA=7+%7N
M6RY&UZ>W_1H7-:K.\];H1#F8?U7#EV^:T^_UR9;GCKK68R1?N'+(N%F,@R77
M4P@[316715 @ETIZD+H:L7AG,;^YW;*V_0VCMJY4I.M](0&D9:33;KF55CY*
MYS.SMSYPP?)X(DKEI'-'."=WE-9,YBG3 G/X_P#J\O3DXK<[-<\^^/-9V5JG
M8.JZ<YJ-/U)7+C$'T2U6?ZDEM*2EO>UZ6J<E?I"XS-*FW)WSE6RY0?2JIY%P
M@H\5664 WFZB/3^TIU,^,EBXI[^FMC5S7UBLE3M:LYJF<@*_=8Z8ITH65BU8
MZ0M-5NL!WE8^#)+IN(UP4Z2ANY[@^"G*!!7RY]43Z>&_=7ZGK&E+;L;C-M'4
M^O:]K<VW(UG![!]+,;6HLD='67==&4\2HBRW[)DL'5E85S7#KD,9%9-1%-F1
MH!B;@UZG%PWXX;0KFT^3V];;S-6I\FWFX+7#[6\5I_44E*L7174<I?*JG<]F
M3MSC&:B1#&CCS#6.>&+DCQ!RV.=L8"X4V;-V;=!FS01:M&J*39JU;)$0;MFZ
M!"I(((()%*DBBBD7!2$+C!2EQC&,=@ Y2?*#_P".Y*S_ /G=N(7QQ:4 '54M
M-6K5XK5@IESK\+;*A;(63KEHJ]CC&<U7[%7YIFM'2\)-Q$BBX82D5*,'"B+A
MNLF=)9(YBF+G&<X %._EWZF#PPW)=9ZZ\7.0^RN)2-A?GDE-?2-,C=[ZUKR[
MAXHN\:4^.D;=KFZ1<09 _<(-G<_(^#'^R0_>L%1*!]CB+ZF9P8TM;X6Y\G-W
M[1Y=&@U&SM.A^+[#2&KYI\@=)7NK+#5ZR7&\2<=WU/.<-$;&U2.7/<+]_)G)
M3 7!8>(BJ_$Q<#!1S*(A(2.91$/$QK9)G'1<5&MDF4?',&B!2(-63)HB1)),
MA<$(0N"XQC& !7CZH?JS_ _J4WN8WD@[M?&/D78E,.+;LS4K*&>US8C_ +G)
M<S&R-:RR:$1.6(V,]JDI'.X>2>'[#/%W7<D[D"+3CKZDKQHHUWBK!R7YF;-Y
M!U",D4'R] H&J(OC^UL#=OW"F(:P6-79&WY_VJ>JER5SF,4C'ID#9*BX;J=B
MV +G^LM9:^TQKZG:HU13J_K[6^OJ_'56ETNJQS>)K];K\2W*V81D8P;%*DBB
MBD7MSG/:=0^3'.8QS&-D"KWU6?53M#=1KDQ:.5NM>25BXK;)V8I&OMN1.-4,
M=Q46X6",B48;QLAX+TB:LDJE8IAFR;9DC%?O&CQ=$SCP=-PNNLH!GWI/>K3\
M5NEENB-Y+Q&Z=T;QWY#U^PUB)G)Y6'H.N8J+M,2K#SIFVNZT1\^DW;UHX4QC
M$M-R;1$V$E4D$W")%P!9  &B?4+Y_<8NG+HZ&W5RON<O1]?6_9$#J>"E86G6
MB[.G5WFH"U7./C5(NIQ<M(MFZM?H4FKEPHF5 ID2DR;!U"8,0^.2U+$-DM#;
MNUWR4TQK#?\ J.6=3VL-PTF V%0YE[%2,$\DZM9V",G#O7,/+MF<I&+.&:Y3
M&1<))JIYSV&+C('TRT ( ^G3ZN'P3Z8W)U3E9Q_V!R?LM]+3KA2(ZN;8ONM+
M#1H>(NBT>>058L:IIVD65=^Q:Q^&[4[N5<D*DH?*I%5>X5(!/X -#>H!TU>(
M74SU,CJ3EAK5.ULX91\]HE[@GGB[L[6,Q(IMTGDQ0;B@@X7BU'F&B'A3-RD[
MBI#O"6'C1P5,F"@51K-ZCSI5U;/#*;U!=HP-%\)>&\7+-H6IVVV>"'30PP0\
M=(K9%*A_"6RQ5#+*^T'<KE.4I4TLDR8X$_W2WZ"O!+I3N%KQJ*OV+:/(&1BG
M,-*<@]O.HZ9NK&+?D[B2A:'$1<?&5?7D*^*8Z:V6#7,H[;'[P\?.DL%+@":T
M 17]2?HW<&>J?78]MR6UX]9;&KD<O&4S>NMGS2I[>JK)1-[WF,)/JQTI&V:N
MM'CX[E.+FF4C'IN,Y432(<QS9 K#67U''7CJR)NJ?U'+G!5##E,RT'9>,4':
M[(HTPX[I9!.U1>\:9&).5&GVA5<PQRD4^WRF;']S $T_3+]6AZ?_ $W-@0>\
MVV;KR1Y"UA8SRH[*W(>&]I=?2)D<(>VVO==0#%I 1$XF7M,A(R*DQ),E,Y.T
M<-\YR +$0      BGZFG1IX0]5FL1;3DC296'V958X\71=\ZR?L:SMNIQIEW
M#LL'[;O8R9AK15/#72JOM7,,7[5%1955MANNH98 5HR>H[ZAQ:S/%.H9L@U'
MS_Q*Z3CW6$[67_ERJF.ZN1MJ*1!__5F2(_8@2_W<IEO^(;"!0+.O33Z0?"CI
M4TF6KW&*B2*UWMS)FRV+N[8<BWM&W+\@R4*N@PDYY%A%Q4!74G*952Q$*QC(
MPRR95U$%'&,K& D_ &+MTZ3U-R+U?<=*[SU_6=HZJV!%&A;A1K?')R<'-,,K
M).D>_(G[E5L]8/6Z3EHZ0.DZ9ND4UT%$UDR'*!3OY#>I.\2[S;):=XW<N=P<
M?8"3=G>-J1=Z%!;ZAZ_A9X@J>,@97-MU79S1#=GA5%OB2>R3TIC$.JZ7R0Q5
M0-R.G[ZIGT^>&FQ83<>V[%=>9&QJE)M9BFL=IQ,)6M15R7CUBN(^<-JR$4DB
M6F79K8[2$G)24BRFP10K(JR9%< 6F0! MU-O5V^$?59W_!<D>0FR.45*OT#K
M*!U2BRTQ?=:0=7>5RMSUHL,8Y=1FP-.[+>(2I7EN=%4,T=-FQR8)G*/?>^**
M 1U_V*GI9>_YS_\ A3XZ_P#Q*H ?V*GI9>_YS_\ A3XZ_P#Q*H G^Z;'3@T5
MTM..)N,/'JQ;1M5$6V!:-DNIO;\]6+%<G5BMC6%8R!%7U/IM"@4XYLRK[9-!
M)*.3,7!<Y.=0YLF &_X
M
M
M
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MD;/1[Y28461>@
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M/%\B;M)W5EWCO&4X&RTW53B405/V9;,W)#*%R8ABY ZS
M J!>NK?59:#^G_JS]W7E4 )ONBE]4?TY?H@:/_(F+ $GX
M
M
M
M
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MRP[R-GH]\I,*+(O0
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M*V9-2$P8YC&-W/;G.<_9&.5[W*KE5;5,@D;&HC41+$-$.J/P&KW,OAAM'4M
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M*0LW%O")NH^28.DS)JI*%P<A\9QG': )#0
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M%V*_@V:2:LE(5W,=-6BE7#VG*8V7J$1,OW31),RZJ16_8MD"8\
M
M
M
M                1M]8#ZLSF5^9Z2^^T0+JB\J9[(M:WR23V)N'QX_H T;^
M9[6?Y%0@H2??'>R7TRO%][;[%/2,PC@<P -7KCP?X6;$L\U=M@<0>+UZN=D>
M&D;%;KCH#5%GL\]('(1,[^:GYNI/I64>'33*7*JZJA\X+C';]C SE-M/M+1P
M-I:3$:Z*F8EC6,GE:UJ9FM:]$1.1$.O56R6RE=4/JZW#,/FJI%M<]]-"][ES
MN<YBJJ\JJ>9_AU]/OYBO#C]F/2?F0*_],-K?^*8C_M,WW90_H/L7_P 'PO\
MV2#_ $8_AU]/OYBO#C]F/2?F0'],-K?^*8C_ +3-]V/Z#[%_\'PO_9(/]&;!
MZQU!J;25;4INF=7Z[U'4%9-U-*U76-)K5!K:DP^2;-WLLI!U6,B8P\F[09(D
M57REWU0B1,&-G!2]F(KL1Q#$YO&<2GFJ*BZC;TKW2.L2VQ+SE5;$M6Q+;,JF
M:P_#,-PF#Q7"J>"FIE<KKD4;8VWEL15NL1$M6Q+5LM6Q#(@LR^
M                                                "'KH&?5,<4/T
MZ_O*[C%[B/EC_0[U"RP[R-GH]\I,*+(O0
M                                                        C;ZM
MGR%[[^>'A]^^3H$75']_3V+N]4M:WR=?9-[Y"206I=
M                    !\*R_P#0CW_T;_G: ^IPG%_<GW1\.0
M                                      5O?6P_J3>0_P"<3CQ\=5-
M$H?2=^JRZ:?T .&_[NNN0!6]]5F^7IZQ!]+O7/QR\[ !<2:[!H3ZZRFMF5WJ
M#S8L)#-;'-4%K989Q=8BO/EDV[&>E*JD]/.Q\,\75*1)TJ@1!0YL8*;.<XP
M/B:^W-J/;+^^Q>KMG4'8DEJRXO\ 7NRF%*ML'9GE!O<6FFK)4^X-H=\\6KMD
M8$5QWYFZPDNGGMP8N,XSC %*_KEZUU-K7K]=$RT\0Z]5:YS#O^ZJ?*;^@:$R
M8P[F=U^QW'KB-I5OV/%5S#%=;QEISF^QTO*.>Y=NZ[%8246R@T2[V!>:
M
M
M
M                      $;?6 ^K,YE?F>DOOM$"ZHO*F>R+6M\DD]B;A\>
M/Z -&_F>UG^14(*$GWQWLE],KQ?>V^Q3TC,(X',
M                                               (>N@9]4QQ0_3K
M^\KN,7N(^6/]#O4++#O(V>CWRDPHLB]
M                                                      "-OJV?
M(7OOYX>'W[Y.@1=4?W]/8N[U2UK?)U]DWOD))!:ET
M                   'PK+_ -"/?_1O^=H#ZG"<7]R?='PY
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M#-&ZC=%9WAT!/F
M
M
M                                        (V^L!]69S*_,])??:(%U
M1>5,]D6M;Y))[$W#X\?T :-_,]K/\BH04)/OCO9+Z97B^]M]BGI&81P.8
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MZ/?*3"BR+T
M                                 (V^K9\A>^_GAX??ODZ!%U1_?T]B
M[O5+6M\G7V3>^0DD%J70                                      8T
MVSL"AZXJ*LWL.[5&APSR091+27N=DAJO&.I58RCU&,;/YQZQ:KR"K-@NL5$I
M\J&204-C'<D-G'U.$XN[D]O"3D+98B-L%<F(NP0,RS0D8B;A)!I*Q$K'NB85
M;/HV28++LWS-PF;!DU4CF(<N>W&<X'PY'U
M                 %?O<WK 6G],[@VOI^3X^[*FI+5.RKUK:0F&%GJ[=C+/
MJ+:)2KNY-F@X3RN@T?KQ9E4R'^W*0^,9^SC(J)&JI;:26P'HU8YCV!T6.0XG
M21Q5M)#.UJQR*K4FC;(C55,BJB.L54R6F-?[29I'YM>U/*RH_P""'W5+G,K_
M '5-H/\ BU'_ )N0?VDS2/S:]J>5E1_P0:I<X_NJ;0?\6H_\W(/[29I'YM>U
M/*RH_P""#5+G']U3:#_BU'_FY!_:3-(_-KVIY65'_!!JESC^ZIM!_P 6H_\
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M;?H_XQL1LO5;3U6(4T\%+J[6,8]'.UDL<26*N3(LB*O(BDW8ID?P
M
M
M
M           "-OK ?5F<ROS/27WVB!=47E3/9%K6^22>Q-P^/'] &C?S/:S_
M "*A!0D^^.]DOIE>+[VWV*>D9A' Y@ 5-^;%@GFO*W>3=M-R[=!*[NBI(H23
MQ)%,O@;+[5---8I"%^S_ "8Q@2'V6AB=L]2*YK575)Q)G4_,#TPL<QNGZ3>V
M<%/654<+<9>B-;+(UJ)JX\B(CD1$ZAJWXSV7W0SG\[/_ &0,_J(.8S0A&O\
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MJ8XH?IU_>5W&+W$?+'^AWJ%EAWD;/1[Y28461>@
M
M !&WU;/D+WW\\/#[]\G0(NJ/[^GL7=ZI:UODZ^R;WR$D@M2Z
M                          "H%ZZM]5EH/Z?^K/W=>50 F^Z*7U1_3E^B
M!H_\B8L 2?@                                          .;'SJ^6
MYS&^E3R$^-NW"Z;W*=0]5MW?U?X%]#T7R:,U6'([B               2I=$
M_P"LWXS_ *9?W?MK#A)W"FG=_OU2XM^2_+*<OYBV/-H
M
M
M
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M_P!#O4++#O(V>CWRDPHLB]
M                                             "-OJV?(7OOYX>'W
M[Y.@1=4?W]/8N[U2UK?)U]DWOD))!:ET
M          %0+UU;ZK+0?T_]6?NZ\J@!-]T4OJC^G+]$#1_Y$Q8 D_
M                                     <V/G5\MSF-]*GD)\;=N%TWN
M4ZAZK;N_J_P+Z'HODT9JL.1W$               E2Z)_P!9OQG_ $R_N_;6
M'"3N%-.[_?JEQ;\E^64Y?S%L>;0
M
M
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M-<R"ZJ:.#%P?)R_:&6!E/(V9R(CELLX[%2S(G"*^*>2HC= U5<W+R6HMN5>
MU_Y(;$ZP/5EKL%PFFN"T_P 1:!)V^J/]Z[6N<5=8VFR3"M2"4@FM'S=PC86,
ME*O&SS,DJ6,A%9R2=N6;,A'.$L*&6YQ-HJ-5G21'NL6Q$LM^SJV%*5U;6(D"
MQJQMN55MLZ_J6F\?6QXH78G2LT]QKXVZNV%M=;4E\T95X6K:WI5@N]J-4:%0
MK75\3KJ!JS"7E#I8SA SMQWLQ<++]T<_:;MS0H)F^-NEE5$O(O"MF550N*^%
MWB;8HD5;JIP);D1%)<."M;L-.X1\.:A;8.7K%KJO%;CW6[-6I^.=Q$]7K#!Z
MDJ,9-0<W$OTF[Z+EXF2:JMW+=9,BR"R9B'+@Q<X%G4*CIWN;E17KZ:E[3HK:
M=C79%1C?20VI%$K          $/70,^J8XH?IU_>5W&+W$?+'^AWJ%EAWD;/
M1[Y28461>@
M                      !CO;.V=<Z+US;=M;:ML11M>4:(7F[-9IM?*+*/
M9(Y*0A"$(51R^D'SE0C=HT;D5=/'2J:**:BJA"&Y,8Z1R,8EKE.+WMC:KWK8
MU#7+@OSMTUU!]4VO<>CHF_Q-0J6SY_5#PNQ86$@9:0G*_7JG9UY6,90=ELZ1
MH![%7-GE [A5N[[O"A5&Z?<X[JK44[Z9Z,DLO*EN3[.0I4]0RI8KX[;J+9E]
M#LF.TNJ-Q4DN<U9Z?55E[3>-X3Y;:WE)FHQ<+(ZTI$]2Z98[W-U.VVEQ8V+\
MME;PE8<$.A&Q\DFU>F*V=*(+%6(ER\4F2G6I=8D>3AX5M6PX>-PK4)3):LBV
M\' EB6Y2146Q=   !&WU;/D+WW\\/#[]\G0(NJ/[^GL7=ZI:UODZ^R;WR$D@
MM2Z                                      "H%ZZM]5EH/Z?\ JS]W
M7E4 )ONBE]4?TY?H@:/_ ")BP!)^
M           YL?.KY;G,;Z5/(3XV[<+IO<IU#U6W=_5_@7T/1?)HS58<CN(
M             !*ET3_K-^,_Z9?W?MK#A)W"FG=_OU2XM^2_+*<OYBV/-H
M
M
M
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MZV(W88(NS>P&&TV%8$Z=TRPP(J,65Z-:]]CE<MYR,:BY?M4/="T.Z
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MWAG9'.R9]G6I#+<D<Y:KM9)1JHL5EDY@+UH
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M".!S
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M'NT'K;*B>>PY,+ME%$LG)G/V<=O;@<514R*?45%RIP'[@/H
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M?>V^Q3TC,(X',
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MAA>=G47&9DT#Q"HWN+J?DY#^PPO.SJ+C,R:!XA4;W%U/R<A_887G9U%QF9-
M\0J-[BZGY.0_L,+SLZBXS,F@>(5&]Q=3\G(?V&%YV=1<9F30/$*C>XNI^3D/
M[#"\[.HN,S)H'B%1O<74_)R']AA>=G47&9DT#Q"HWN+J?DY#^PPO.SJ+C,R:
M!XA4;W%U/R<A_887G9U%QF9-!]Z/C(V);89Q4>QC&A3G4*UCVB#)MA13/:<^
M$&R::6#GSC[.>SMR.*JJY5/J(B9$X#]P'T
M         ^/8H@M@K\Y G7,U)-P\G$&<E3PJ9N629+LS+E2R8F%#)86[K!<F
MQV]G9VX'U%L6T^*EJ6$>O2[Z>Y>FQQ_MNC"[<-N?-JW!8-L'M.:'C7>&1IVF
M4"H8@2P>+E>>_E:DHN''A.7A.^9=9)WHO>^Z/<U=3XU(DEV[8VSAMXU7,F<M
MJ2F\5C6.]>M=;P6<2)G7,?'O'3@3N?4_TYU(O3&>--J76DIKWT->C\KPL^I)
M4S:E.]N?2%XZM<Q1$4=F=_\ !?:-SDQF7<]^QA;M2-JKM(ZEN]TMMMO*B\%G
M)G/CJ6]5MJKW<I999R*G#;RYB3H6I=@  !&WU;/D+WW\\/#[]\G0(NJ/[^GL
M7=ZI:UODZ^R;WR$D@M2Z                                      #X
M5E_Z$>_^C?\ .T!]3A.+^Y/NCX<@
M           YL?.KY;G,;Z5/(3XV[<+IO<IU#U6W=_5_@7T/1?)HS58<CN)8
MGY<_4"<"?S^1_P!ZN48I-^^+U",&Q7[2>TGT:O?8>/5OOE1;U_,&;XPZ:$O
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MS%L>;0
M
M
M                         !&WU@/JS.97YGI+[[1 NJ+RIGLBUK?))/8F
MX?'C^@#1OYGM9_D5""A)]\=[)?3*\7WMOL4](S".!S
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M;4SO&2*N2OW;C&542&_XQ2YP!F8
M                               $;?5L^0O??SP\/OWR= BZH_OZ>Q=W
MJEK6^3K[)O?(22"U+H                                      *NOK
M:_)KD+Q4Z<6F-@<;-S;%T==YWFOKBE3-JUE:92I3LG49#1G(Z?>UQ[(Q*[=P
MXAW4W6H]T= QLD,NS1/G':0N<!P\)+[TE=AWG;73)X([-V;;)Z]["O?%[4-H
MN=SM$DYF+'9[%+U&.=RDU-RCPZCJ0DG[I0RBJJALG.?.<YSV@"0T
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M7%OR7Y93E_,6QYM
M
M
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M:CT,=;+YZ?#S]G*?_"@7Z'F/]L-77^^,]J/0QULOGI\//V<I_P#"@7Z'F/\
M;#5U_OC/:CT,=;+YZ?#S]G*?_"@7Z'F/]L-77^^,]J/0QULOGI\//V<I_P#"
M@7Z'F/\ ;#5U_OC/:CT,=;+YZ?#S]G*?_"@7Z'F/]L-77^^,]J/0QULOGI\/
M/V<I_P#"@7Z'F/\ ;#5U_OC/:CT,=;+YZ?#S]G*?_"@7Z'F/]L-77^^,]J/0
MQULOGI\//V<I_P#"@7Z'F/\ ;#5U_OC/:CT,=;+YZ?#S]G*?_"@7Z'F/]L-7
M7^^,]J/0QULOGI\//V<I_P#"@7Z'F/\ ;#5U_OC/:CT,=;+YZ?#S]G*?_"@7
MZ'F/]L-77^^,]J/0QULOGI\//V<I_P#"@7Z'F/\ ;#5U_OC/:CT,=;+YZ?#S
M]G*?_"@7Z'F/]L-77^^,]J/0QULOGI\//V<I_P#"@7Z'F/\ ;#5U_OC/:CT,
M=;+YZ?#S]G*?_"@7Z'F/]L-77^^,]J/0QULOGI\//V<I_P#"@7Z'F/\ ;#5U
M_OC/:CT,=;+YZ?#S]G*?_"@7Z'F/]L-77^^,]J/0QULOGI\//V<I_P#"@7Z'
MF/\ ;#5U_OC/:CT,=;+YZ?#S]G*?_"@7Z'F/]L-77^^,]J/0QULOGI\//V<I
M_P#"@7Z'F/\ ;#5U_OC/:CT,=;+YZ?#S]G*?_"@7Z'F/]L-77^^,]J/0QULO
MGI\//V<I_P#"@7Z'F/\ ;#5U_OC/:CT,=;+YZ?#S]G*?_"@7Z'F/]L-77^^,
M]J/0QULOGI\//V<I_P#"@7Z'F/\ ;#5U_OC/:CT,=;+YZ?#S]G*?_"@7Z'F/
M]L-77^^,]J/0QULOGI\//V<I_P#"@7Z'F/\ ;#5U_OC/:CT,=;+YZ?#S]G*?
M_"@7Z'F/]L-77^^,]J/0QULOGI\//V<I_P#"@7Z'F/\ ;#5U_OC/:CT,=;+Y
MZ?#S]G*?_"@7Z'F/]L-77^^,]J/0QULOGI\//V<I_P#"@7Z'F/\ ;#5U_OC/
M:CT,=;+YZ?#S]G*?_"@7Z'F/]L-77^^,]J/0QULOGI\//V<I_P#"@7Z'F/\
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M2\MB':-C-E:S;;:6FV8H)(HJNIUEU\EZXFKB?*MMU'.RMC5$L1<JIQ$,G]I
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M1T5ZZC7221HBWVM6];$J\%EBIEX3<T<3H8
M                              $;?5L^0O??SP\/OWR= BZH_OZ>Q=WJ
MEK6^3K[)O?(22"U+H                                      *@7KJ
MWU66@_I_ZL_=UY5 ";[HI?5'].7Z(&C_ ,B8L 2?@
M                       .;'SJ^6YS&^E3R$^-NW"Z;W*=0]5MW?U?X%]#
MT7R:,U6'([B               2I=$_ZS?C/^F7]W[:PX2=PIIW?[]4N+?DO
MRRG+^8MCS:
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M_"!\HM\+965P0W<ESV9 &50
M
M
M               $5W6P^K(Y,?H:_>!U2.<?=H;BW!?6UA/Y5\CJ"@6+D])0
M                +I?JY?R(]I?2IN_Q2:/%O+W7H$"^E)]8%']#Q?*:LGZ%
M,C8                                                        !
M&WU;/D+WW\\/#[]\G0(NJ/[^GL7=ZI:UODZ^R;WR$D@M2Z
M                        "H%ZZM]5EH/Z?^K/W=>50 F^Z*7U1_3E^B!H
M_P#(F+ $GX                                          #FQ\ZOEN
M<QOI4\A/C;MPNF]RG4/5;=W]7^!?0]%\FC-5AR.X@              $J71/
M^LWXS_IE_=^VL.$G<*:=W^_5+BWY+\LIR_F+8\V@
M
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M<1-NN$1L2XM7*#:$8;$M$)5V24PJ562>OG'VN56;-HT9E Z8
M
M
M                                         "*[K8?5D<F/T-?O ZI'
M./NT-Q;@OK:PG\J^1U!0+%R>DH                %TOU<OY$>TOI4W?XI-
M'BWE[KT"!?2D^L"C^AXOE-63]"F1L
M                          C;ZMGR%[[^>'A]^^3H$75']_3V+N]4M:WR
M=?9-[Y"206I=                                      !HGU"^ /&+
MJ-:.AM*\KZ9+WC7U0V1 [8@HJ%N-HI+IK=X6 M5,CY)24J<I$R+ENE7[[)I9
M;J*&0,98I\ER=,F2D/CEL2U#9+0VD==\:],:PT!J.)=0.L-/4F U[0X9[*R,
MZ\C*M6&",9#LG,Q+N7DI)K-V:!2F6<*J*J9QVF-G('TRT
M                            YL?.KY;G,;Z5/(3XV[<+IO<IU#U6W=_5
M_@7T/1?)HS58<CN(              !*ET3_ *S?C/\ IE_=^VL.$G<*:=W^
M_5+BWY+\LIR_F+8\V@
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M I?>NT_(+XF_2[)\36RP!=!
M
M
M                17=;#ZLCDQ^AK]X'5(YQ]VAN+<%];6$_E7R.H*!8N3TE
M                 NE^KE_(CVE]*F[_ !2:/%O+W7H$"^E)]8%']#Q?*:LG
MZ%,C8
M !&WU;/D+WW\\/#[]\G0(NJ/[^GL7=ZI:UODZ^R;WR$D@M2Z
M                          #X5E_Z$>_^C?\ .T!]3A.+^Y/NCX<@
M                                       YL?.KY;G,;Z5/(3XV[<+I
MO<IU#U6W=_5_@7T/1?)HS58<CN(              !*ET3_K-^,_Z9?W?MK#
MA)W"FG=_OU2XM^2_+*<OYBV/-H
M
M  "%#UA'B)R$YR=+C=''7B[02[-W+:;CIF7KU--:Z52LR;"J;2J]@GU26'8-
MBJE4:&CX5BLX[EP_1,KA+)$L'5R0A@-LN*'%PR/2XXR\+N3E):&<,^!>D^,^
M_=>N)*)FFB3YAQ^K&L=FU/,U O92$DBMGB#UJ5XQ<N&RF2X505.3)#Y K :3
MX*>L<]$U_L31?34KW'?G[PWLMWE[7K&M;RLU9KUAUPG,',LZ=OHFP[FX[.8*
M>?D02))(1,W*PCQX7+Y%HU6<.,8 WAZ571[YII<[KEU<.KOL6F7GE[(0+^KZ
M7U-0W;&:J&E8F7AG-:=/LOH]MBO1KF#J3YW#P\9$+/&R*,B]>NWCM^YRHF!G
MWE+J?KFS'6DXQ['XZ;,@XWI?PS2A)[<K:MCH;&MM*XBX<EW1!7?7\I)(; NV
MQK:R,IXL3$<U=,X=0[/)C-N\.LN0,8^M%]/'E]U&N)''G6/#?4Z>W;Q1^2*-
MYM,(I?=:Z^]JJD;6=[KYYO,EL^X4N(?)HR\LV1,W;.%GF>_8.5$Q"G,0"S8
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M64N4N>I0;CZGPOY%%V%GAJ;6!.F.> H)[@7J3^F[-A+8#;[+54[0?16.+?\
MZYS8L)E@<Q'_ "_VLQC_ ): +HM9?S,K6Z_*6* -5+!)0<2_G:N>3931ZW,O
M&#=Q)P!IF._]7RQH=ZH=OETA_<7&4^[)]J;  ^X
M
M                                                    BNZV'U9'
M)C]#7[P.J1SC[M#<6X+ZVL)_*OD=04"Q<GI*                !=+]7+^1
M'M+Z5-W^*31XMY>Z] @7TI/K H_H>+Y35D_0ID;
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M<P (V^K9\A>^_GAX??ODZ!%U1_?T]B[O5+6M\G7V3>^0DD%J70
M                            ?"LO_0CW_P!&_P"=H#ZG"<7]R?='PY
M                                         !20Y7=.[QVY2<E+GZ8/
M:SQNW]N.S^UOH_\ #?:_V_V)8Y7P'PSQV:>%^">%][[[WI+OG<]UW!>WLQY7
M[P_WG/\ 0';_ !S87^A'C?S+C%;0:_YYU6N\3J9*?6ZKYJDU>LU=_5ZQ]RV[
M?=9>7UYW:8!KMW.S\VNLOX)0K9=X+:6);.Z,!?PQ_P#7=_LV_P#M^'3_ /FS
M?_D!_P#;G_ZG.[?T;_[;_H?_ !$4NX.+//BX<F;CQPXS4E*NU*BQL'(2_(W<
M, G5:1,%G6F5VSFKJMW&P&<I'97PHCA%FVE)/"C=3+ENS[DQ!)K#OW@.Y^GW
M28?O+VQDBI<9Q"29C<'P^H^<JZ-8G6*V76PX>V%UVZY5F2.%4>W5336HI'G;
M"??-B^V51L9N\H8Z*@I6,<_$:QB)$^^EJ+$MDS%;;:VZV.:6UJJ]L=BH85CZ
M?RAXS\M-,<6N<$U2T8'?LBT@=?;OU_&EGH)>=D9%O 1Q?!L(T+*K,MCD&;-^
MFZ8QSAB1\DZSW:'9@_=L!Z7FRF\+<SC^]G=-A]1B]9LY Z:JPRKD;A]4R-C%
MF>JOCCKHU58&2R1:O6ME=$Z)'->BHG6<*VNWE;![>X=L+O;6DGH\6<D=/6T[
M4NZQSDC;W+(45NL<QDC711N9?;):K,BSB?PQ_P#7=_LV_P#M^$+_ /FS?_D!
M_P#;G_ZG)6?T;_[;_H?_ !$,W,30O)RL]032'"+CINZIL9K<.E%=AL)J[U&.
MA*PTE(ISNB3ETI1R6O[1GTL*5_5N2(9;I'3.X5(4R:9<G6$J=W?3:P':SH^8
MYTA=J,"K,,P' L8;02TE+415]1)?7#FLEC=-'AT:6R8BQ'1N5+K(G/1[W.2-
M(M[T\0WEQ[W\+W;[ 8G3TC\0PK7HLT,2QZQCJU[U<]T%3(EL=,C6HU%2]9D2
MU7&>-9]*+JA-=@5!QM7DUQO=ZX1G6"ET;5EK+R5@7KQ5<9D4H=@MH:FI.GYT
M>W"9#2K#&3?RK$_E&I<5_>G;EX<-FEP/ =J:G%VQJL,4\=!30R/^U;)/'753
MXF*O"]M/,K>%(W<!V'9W=[TC*?':2?:3'\&FP!L[5J(XV)K'Q(O;M99AT/;*
MG![JSV2'X.?_ !BMVG-@<0-'US?>*9&\J=JRU!L>W5*@E"$H#2(\5B-6C596
MW.^_3%G6LYL,B$78G469=[\(3(H?([?NBZ>,N]K8?;3:VEV2?35NR.%Q5K:.
M+$5J9JY)$J+R-5,/AU$<.H19I49.K6R(J1K=L==;ZIL<PJNV>V2P?$5PV+'L
M0=!-6HU$="QFK1&,<KLCY5E[145CE5EV^U'./#:)XYRM!YB\G.)5]Y3*W_6F
M@-'-MYR^[;!6/;=W3"M/%M6QU"Z=S;E5XZ1:1L^L][A5^[-AK'94*FB911(N
M0J^FUB]/N.V:WN4>QDTV-;3[0_-5+A3L1U<LBNUZ15%/4+A[O&(I'PLB\GB1
MLDJ-1[D1'/PNP,^*[-;PL=W>X]C<F*;/X7AB5OCDZ7Y*>S5K+%,^^YUMV17V
M.>ZQL=K49><TRET[>'&QN5U,V+RBMFU+!3:%LR\R<3I&F2U9<RK<NMZ8[=0K
M6W$B#6R-80CZPR!%45BH]^[\HR.KE4Y%"9&!Z0'[P;#]QFWB;OH=FV8UC=/1
M025RQXIJ(J6JF9K%I&.^;YUGU<;F.656PVWT18FN1R)V+<O2[0[:Q8GO"Q:J
MJ(\'Q*K5E!3/O*R.E@5S$D:R\C6OE7(]6IVSHU<JJCD)%_X8_P#KN_V;?_;\
M-'_\V;_\@/\ [<__ %.;Q_HW_P!M_P!#_P"(W[Z7O!7T-\Z-';(]*7C'XN>D
MO_U-XD>U'AGMOI_8$#_TCXWRG@_@_MIWW_S!^[[CN?M>Z[K&X-PG[PW]>>]G
M"=UG]$/FOYT\:_UKYU\9U7BU'45?WGYMI[]_Q?5_?67;]_MKMUVD^D5@GB>Y
MO&*C6WKOBF2[9PUU,G#>7/F+>(](#R\
M
M   UAV)S5XDZDN,QK[9W(S4%#O%?]K_;NJ6B[PD/.Q7MK%LIN-\.CGCI-PW\
M.B))NY2[HN.[16(;'V#8'U&JO BG;L+V!VUQJA9B>$8775.'RWKDD<3W,==<
MK'6.1+%L<US5S*BH>*_B-\#/G=Z!^$JM^S1]NNS*7_ZK=X__  3$O\P_L#^(
MWP,^=WH'X2JW[-"Z[,H_5;O'_P""8E_F']@?Q&^!GSN] _"56_9H779E'ZK=
MX_\ P3$O\P_L#^(WP,^=WH'X2JW[-"Z[,H_5;O'_ ."8E_F']@?Q&^!GSN]
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M?4-+)6UF#XA%1PQN>][H7HUC&(KG.<JI8C6M1555X$0VX'PZ2
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MQ[!HDL\D'SA%LW34653(8"J1(>MG6&58SVZ-6='WFSL7A#7'LNG*<LRFEXJ
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M26K3M'K&$AG;UXN1TZRUQA!-5$OA*1P!8/
M
M            17=;#ZLCDQ^AK]X'5(YQ]VAN+<%];6$_E7R.H*!8N3TE
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M.BIYSG[4V2]R;_@R.*I8MA4:Y'):A]L?#Z
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M/(.J[IG5\?)DJ+AM!G1*Y=R]\MD(5VLQ3QC+Y1L;*)S$D!-3>BFQ>R&.;O\
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MA,/H"_M:;)_SI^AL1-$])?ZDL:_(_E]*3WC])!Y/
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M54U^4N2X*MDQ@+QH
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MD-7VE1@&<?.)W%E8L0W'GCVD[<RTBNP4;=VUDC$*@IV*I8-W!@)80
M             !%=UL/JR.3'Z&OW@=4CG'W:&XMP7UM83^5?(Z@H%BY/24
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MG( "-OJV?(7OOYX>'W[Y.@1=4?W]/8N[U2UK?)U]DWOD))!:ET
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M,2E(Q!7!'*1W$#45^XR1A*V%0K8"Q7ZKC]11P9_WF?WP^00 G^
M             4[^3;ER7DER$*5PN4I=X;8QC&%5,8QC%]G\8QC&#=F,8P-^
M8-LWL[/A%+//043YGTT3G.=!$KG.5C55556VJJKE55RJN53\KO2&VQVNI=_V
MW--38KB4=-'MAC+6,;4S-:UK<1J4:UK4>B-:U$1$1$1$1+$,'^%.O_YEQ_?E
M/_JADOZ+;,?\.H/]GB^X-/\ ].-M?^,8I_M<_P#I#7Z=XK\8;1-2MDLW''0U
MBL4](.Y:<GIW4&OI>:F9607.Z?R<K*2%></I&0>N5#*+++*'44.;)C9SG.<B
MNW ,!:B-;14B-3@1(8_N3NE'T@=_.'TL=!0;;;704,+&LCCCQC$6,8QJ6-8Q
MC:E&M:U$1&M:B(B)8B6'_(3BMQ?K,S$V.M\;]"U^PP,BRF(.>A-/Z]B9F&EX
MURF\CI6)E&%=;OHZ18.T2*HKHG(JDH7!BFP;&,@N 8$Y%:ZBI%:O"FIC^Y/M
M7T@=_6(4LE#7[;[7ST4T;F21R8QB+V/8Y%:YCV.J5:YKFJJ.:Y%14545+#)]
MIH=&O#^N2MUIE3N$I3Y#,M4I*TUV'L#^K2N<IYS)UQY+,W;B$D,Y1)_=FQDE
M/M,?9^Q@4V[-;.,149A]$B+PV01);U>URG7\.WJ[T,(AGIL)VDQ^EIZIER9L
M.(5<;9F9>TE:R9J2-RKVKT5,JY#Z5HKM?N\,YKMT@H:WU][V>&05HBV4_#.^
MYQG!?"8R50=LE^YP;/9W1,]G:/C=F-FV+>9A]"CLZ01)_D%OA^\K>-A%4VNP
MK'\;I:UG<R15U5&].H]DJ.3T%/*T#46I]49=YU;K#7FM<R!.X?YH%*K=-R])
MDR9\D=YKL9'9<DR=$F>P_=8[2XS_ ,&!R?LYL]+]]H*)W5@B7TVF1QK?%O<V
MDN_TBVJVCK[G<^,XG6SW>'N=;,ZSA7@SJ>YF&+*Q1$K7[ S:SD#.1SZ'FX28
M;I2<1,1$FV59245*QKTB[.0CI!FN=%=!8ATE4CF*8N2YS@<$V7V::J.;AU"C
MD_[O%]P8BEWA;?4-3'6T6.8Q#60R-?'(RLJ6/8]BHYKV.;(CFN:Y$<US5145
M$5%14/\ ,)'1]9AXNNUQ@SK]?@V#6*A8.$:H14/$1;%$C9E&Q<8P(@RCV#-N
MF5-)%(A$TR%P4N,8QC .V7V:<JN=AU"KEXU@B^X/M7O#V_KZJ2NKL<QB:MF>
MKY))*VI>][W+:YSWND5SG.5557*JJJY54\97]3ZLJ5JE[U5=::_K-WL&3FGK
MC7Z;78:U39E>WOF9>PQL:VEY+*G=9[KORQ^WM^R.;MF]G7M1CJ"B5B<"+!%9
MHNF5K=\&]K$L.BP?$=J=HZC"8/O<$F)5CX8[."Y&Z96-L_@M0R/X4Z__ )EQ
M_?E/_JA3_HMLQ_PZ@_V>+[@P7].-M?\ C&*?[7/_ *0W@Z<#A<_,_313KK'+
MGTA]I3*',7/9JF\YQVXR;.,]F<#K>UN 8%1;/5%51T5)#4MU=CV0QM<ELK$6
MQS6HJ6HJHMBY454X"8'0(VJVGQ+I9;*46(XE7U%&_P"<[T<E1*]CK,&Q!R7F
MN>K5L<B.2U,BHBIE0M0#2I^D(                     "@_P!)?@WJ?UC;
M;O,3JA=2N7NNZ*5%[]GM#Z!XW--@W"A4W7-+A*W7;O'QZIJ-8H:VQ<'"5N^Q
M+=@WC9)@F]E4I-\_.^<N#GP!]N]<=H[U<_KA<",<3K=;X/@KU,+,EI.^:-ME
MPF;' UBQXM=(UW,/_#YF26?23*B2VTZU8(J4DE',HU(K),C.%&JAB& OB@#S
M-UNE2UQ3[5L&_62%IU&HU=F;=<;;8Y!M$U^LU>NQSB7G9^;E'BB32.BHB,:*
MKN%E#%(DDF8QLXQ@ <L#K[\X^3_5>J#SFO6*_-43I9:2Y*Q'%;B^RL"4C"2.
MY-J6>B;*N5HW&O#N&Y?;:1) ZQ617RKE!.NLI-A'(D5>GFE@!U90
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MUEW==.#FYF=9DS((-X]A*T^O7UG$NF#(N8Z-<,CM&9CM443F Z#0
M              "@9UL/K-^3'Z&OW?M4BYC[A#TEW!?5+A/Y5\LJ"*T<S<0
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M_P#A'_\ S!0U7*/[IW_U_P#\#_\ C@_M,?\ \Y1_\(__ .8*&JY1_=._^O\
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M0F]+=[^K7:"' O'/'=;1LGOZK4V7I)8[EW62VV:JV]>2V]99DM7?T<36P
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M]W%/UJS;#L4DA%-H>'BGDK4J;0X,E?KK1%;+)NE'$,FL]<J'.H=8Q@!)@
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MSW.?:E>0=(:KN,.)-UG+M54Q,D3R1,@$GH
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MSA7B]4F&4[0XE_)Q<O#HQI$,QCB.D(]&025[V!:L
M $5W6P^K(Y,?H:_>!U2.<?=H;BW!?6UA/Y5\CJ"@6+D])0
M  +I?JY?R(]I?2IN_P 4FCQ;R]UZ! OI2?6!1_0\7RFK)^A3(V
M                                               1M]6SY"]]_/#P
M^_?)T"+JC^_I[%W>J6M;Y.OLF]\A)(+4N@
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MW?EHZ9_2)\5-Z'5=M_->J_!^%C)E?N^_VN]D?YT_0N(EJ81^/TP
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MI=CG8"-LT2G$6A.+CIHT0Z9VN#@)+"WM5*MUL'*B9(Q%<=ALYQG& -L
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MKG4]-631-5RHKE;'(YC5<J(B*Y41+51$2W@1. R>/AB
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MLHD-,V%5:>22:M6T(F4"P!ZKC]11P9_WF?WP^00 G^
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M]" B2-N^*=ZL#NS[RE9E1HDHZ/'UZ(9ED#-',@@VR!>+
M     $5W6P^K(Y,?H:_>!U2.<?=H;BW!?6UA/Y5\CJ"@6+D])0
M      +I?JY?R(]I?2IN_P 4FCQ;R]UZ! OI2?6!1_0\7RFK)^A3(V
M                                                   1M]6SY"]]
M_/#P^_?)T"+JC^_I[%W>J6M;Y.OLF]\A)(+4N@
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M=^6CIG](GQ4WH=5VW\UZK\'X6,F5^[[_ &N]D?YT_0N(EJ81^/TP
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MBU:-44FS5JV2(@W;-T"%200002*5)%%%(N"D(7&"E+C&,8[ !_8
M            4#.MA]9OR8_0U^[]JD7,?<(>DNX+ZI<)_*OEE016CF;B
M           -J>"ORW.'/TJ>/?QMU$<7=RO4.G;Q/J_QWZ'K?DTATG!:GE2
M              1K]7_ZM[E'^*M3^,NE#FSNT-K;C_K4P?X:3P$ISXA<GIB
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MR\@N*'&K>MCC4TT8ZP;CT5J[9TVP11+@B*3*5NU6FW[5-(I<8*4BA<%QC[
MSG4ZA4Z#7(JGT6KUVEU*!;99P=6J<)&URN0S3*JB^6L5"0[9G&1S;*ZQS]PB
MD0O=FSGL[<Y 'H@                    !%=UL/JR.3'Z&OW@=4CG'W:&X
MMP7UM83^5?(Z@H%BY/24                "Z7ZN7\B/:7TJ;O\4FCQ;R]U
MZ! OI2?6!1_0\7RFK)^A3(V
M                    1M]6SY"]]_/#P^_?)T"+JC^_I[%W>J6M;Y.OLF]\
MA)(+4N@                                      ^%9?^A'O_HW_.T!
M]3A.+^Y/NCX<@                                           IT<G
M?E*<A?SX[9_+V?$EL!_,=%\4A\&T_)UTC?VA-O/[9XW^DJDP<,J::
M        -XNF[\M'3/Z1/BIO0ZKMOYKU7X/PL9,K]WW^UWLC_.GZ%Q$M3"/Q
M^F
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MUN9!^KO=_P#\"P?_ &*F_P!&/UZN;GSQN5/[0FV_.X+K<R#]7>[_ /X%@_\
ML5-_HQ^O5S<^>-RI_:$VWYW!=;F0?J[W?_\  L'_ -BIO]&/UZN;GSQN5/[0
MFV_.X+K<R#]7>[__ (%@_P#L5-_HQ^O5S<^>-RI_:$VWYW!=;F0?J[W?_P#
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M$5.DWL[L_@'S)\Q4-'1:WQR_J(8X;]WQ6[?U;6WKMYUVVVR\MG"I9.%(BH
M             17=;#ZLCDQ^AK]X'5(YQ]VAN+<%];6$_E7R.H*!8N3TE
M              NE^KE_(CVE]*F[_%)H\6\O=>@0+Z4GU@4?T/%\IJR?H4R-
M@                                                        $;?
M5L^0O??SP\/OWR= BZH_OZ>Q=WJEK6^3K[)O?(22"U+H
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M\^.V?R]GQ); ?S'1?%(?!M/R==(W]H3;S^V>-_I*I,'#*FF@
M  #>+IN_+1TS^D3XJ;T.J[;^:]5^#\+&3*_=]_M=[(_SI^A<1+4PC\?I@
M            -+.HW\@SEW^8'97Y-O1R;W2=4[[NM^L?!/I*#OT.<:+H]2@
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M0\7RFK)^A3(V
M         1M]6SY"]]_/#P^_?)T"+JC^_I[%W>J6M;Y.OLF]\A)(+4N@
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MSX[9_+V?$EL!_,=%\4A\&T_)UTC?VA-O/[9XW^DJDP<,J::
M  -XNF[\M'3/Z1/BIO0ZKMOYKU7X/PL9,K]WW^UWLC_.GZ%Q$M3"/Q^F
M            TLZC?R#.7?Y@=E?DV]')O=)U3ONZWZQ\$^DH._0YQHNCU*
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M]/8N[U2UK?)U]DWOD))!:ET
M %0+UU;ZK+0?T_\ 5G[NO*H 3?=%+ZH_IR_1 T?^1,6 )/P    4M.K1PZW%
MM3J";^OM5)5\P,[Z*_ ,R,X9F\_]5Z4UO#.N_-L,5L)_\LCE.Y^VSVD[,_\
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MPD9?4$T9U21JGB:[1LMC8]F31<F>0:JQYB(=A%/!DNR/R_O&.BXKKWSGB?\
MZ?4_<FZ\=W%U&-[QZ/>$ZIJ(I*58E6!+BH]T*VLNR:Y%C8O_ %D:,<C[794O
MN(_^/77 NG3'M.U>GIKOI+37+O<=639V[<][U9NF>7FMAP-L@*_8X1Q/46"X
MP;1D&-4IE?V.PA,84?+,/"5CJ=RDJ^4(:0V ;^MT^T6[O#]ZZXU18;L+BDTD
M--4XE+'A[9)8I:B%T2>-/C36*ZEG5K+;SF1N>B*U%5(K[\Z3;3:3>[6;/X33
MU];489! Z*"GCDF="Q\-/*^1&P(Y6HLDK+TG#:K&J[(Q$V4X[]6"*WSM"+UM
M/^K!T+2,9+1LX[5V'L^)B*W3XI2+BW#Y!J^E9W@166*3B352P@@7PLBAU3EP
M7&<CJNUW2RZ.^QN"28]6[7X'6P1O8U8L/K::OJ7*]R-164U--)*YK;;7N1MC
M&HKG*B(5]B-C]_FU.T46#XK5[7851O8]RU$[:](VJQJN1JK++ RUZI=2V1%M
M7(B\!%[49[;?#WJ&\6M;1G&^J\JMF^ RF]SZH6VVUUG7"5JKH65I5;!.7N1I
MUI91*,;>H'P_O:D>YP[Q%^!E)E1XF=.RPGI?;C<9W9U^]R'$:F'8/#L090RU
M$M)4-<M4]L3TABA:Q\TCKLT;G*UBM:UUYRHUKE;(C>YB>U=571;IMD*6_M5B
M]%)(][I6,;#2VN8]UZU4MD1DK+5<V[9VJ.>YJ)[7A]RRYC6OEIR4Y?71O0]:
M<FN)^U+-9>1L3:;"HYHS.%LT3;5I0B9FI7_=Z[>TV(E6*&&SI7+9@S36:+XS
MA Q+W:/I5;GMFJ'9BNJJJMJ:/;%EN$.IJ2>7QI;\,>K1MUKXY4?40L6.5K'-
M<^ZJ(J.1,/LA34.V&[W%]W.U="F&NV=C;!6M9*U6Q-C:Z2.J8]57+>A?(JVR
M-<K5<KGMD5#>^C<R=L\_.%]Q1XL\%=+<&]1\C+JN_ODG%[&=V*X;JCZ7.J=Z
MFFB9=?4EO1Z5)61LX(A$X)(%1317(BOA!RKW[KV\GIH[@MT^V%1L-MCB=4W:
M2C;&LT<%+-.V)9&-D:QTD;59K$8YKG-15NWD1;'6HF-W)[!;0;7)3;R=I:BN
MKH*5\T6&-G>RQ(4]SU[VJMJR.5'-MMRJQ'JY]C%34'^'SR"__ATKRE/^#1T?
M_F-=%W_B>)_^GU/W)*+YGQ/WE?;,^Z-C>'G!K>52Y<<6K7+IU'$56.1FD;#)
MY;6$ZSG$?"[,K$D]RW1S'DPJOX,V-W!>W'=&[,=N!G-F.GOT<=L=I,/V1P/$
M,0?C>*UT%'3M=0U#&NGJ960Q-<]S;&M61[45RY&IE7(ATS>/A6(Q[O,>D?$J
M,;@M:JK>9D1*:55X'6E]<3#/)D                "G1R=^4IR%_/CMG\O9
M\26P'\QT7Q2'P;3\G72-_:$V\_MGC?Z2J3!PRIIH               WBZ;O
MRT=,_I$^*F]#JNV_FO5?@_"QDROW??[7>R/\Z?H7$2U,(_'Z8
M    #2SJ-_(,Y=_F!V5^3;T<F]TG5.^[K?K'P3Z2@[]#G&BZ/4H
M       "V9ZM/_H3RV_&K4'WIV *,O$0PZ5WE^"_ U/?0EGD42(X
M      !6&]98_P!">)/XU;?^].OQ6BXR7'11\OQKX&F[Z8J9BL3/
M         Z.73D^09Q$_,#K7\FV0M7=TO5/+7>E]8^-_24_?J;ICB="
M          *!G6P^LWY,?H:_=^U2+F/N$/27<%]4N$_E7RRH(K1S-Q
M         &U/!7Y;G#GZ5/'OXVZB.+NY7J'3MXGU?X[]#UOR:0Z3@M3RI
M            (U^K_P#5O<H_Q5J?QETH<V=VAM;<?]:F#_#2> E.?$+D],0
M               +I?JY?R(]I?2IN_Q2:/%O+W7H$"^E)]8%']#Q?*:LGZ%,
MC8               5,_65_]-^)7XJ[>^^] %:+C)H=%'\WXU\-3=[,5AA6)
M;@                =,;B?\EGC5^8#3?Q=5P6CNZ7JGD[MIYXXM])U7AWF?
MQ\.M               %(KUA/Y></^8'7OY27X5XNY]$] >C+]7#_I*;O(2"
M\520P              !ZJB_Z;4[\:J]]]F@^%IB'D$_P+^]4ZC8M#R#
M           -5N=7R(^8WT5N0GQ26X?6]TG5.X[N_K P+Z8HOE,9S8Q=GJL
M               !:C]6<_[:_P#NX?\ OZ%&7B(>=+'^0/R[^)EJ(42'8
M           !%=UL/JR.3'Z&OW@=4CG'W:&XMP7UM83^5?(Z@H%BY/24
M            "Z7ZN7\B/:7TJ;O\4FCQ;R]UZ! OI2?6!1_0\7RFK)^A3(V
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MPF3OF,=UW)>WLQ)/ OS'1_%(?!M/R>](RW^\)MW;P_TRQK])5)AD94TV
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M^$[K^3MP/K4;>2Q>L=^W6*_]8^"6M2SYR@X_^T3D.>N+@]30
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M.S!NW_@[,\F(V\EBY>H;7W'J_P#6K@]J)9KI./\ ["7D*$PKGIH
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M7#\C".P8RN/LY+WK'<_^7(XK9;DX#FBJJ94L4^V/A]
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M75']_3V+N]4M:WR=?9-[Y"206I=
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MU#3_ #'M)#KZRM8ZFI8=;/@\4$6MGE8S6321Q,O7I'L8BN2SN/=HCV
M          !3HY._*4Y"_GQVS^7L^)+8#^8Z+XI#X-I^3KI&_M";>?VSQO\
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MR]UZ! OI2?6!1_0\7RFK)^A3(V
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MKUA/Y></^8'7OY27X5XNY]$] >C+]7#_ *2F[R$@O%4D,
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M.PO>)NH<;X7&?%"K.NU)-TT\;"O.Z.DK@ILXD)5L?MRB7LYIVS[>)#;V&?\
M\2=[<V-.[?979BV"#C9+7/\ OLB<2ZNS(J<R%Z=TI"$*A($NE^KE_(CVE]*F
M[_%)H\6\O=>@0+Z4GU@4?T/%\IJR?H4R-@
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M(OEH[F_1W\5-%$@=B/->E_">%D/S/_O!/VN]KOYK_0N'&CH[40U
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MMNVOL5JI>545$L!^K3_Z$\MOQJU!]Z=@"G+Q$:NE=Y?@OP-3WT)9Y%$B.
M            5AO66/\ 0GB3^-6W_O3K\5HN,EQT4?+\:^!IN^F*F8K$SP
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MM]6SY"]]_/#P^_?)T"+JC^_I[%W>J6M;Y.OLF]\A)(+4N@
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M2_5R_D1[2^E3=_BDT>+>7NO0(%]*3ZP*/Z'B^4U9/T*9&P
M J9^LK_Z;\2OQ5V]]]Z *T7&30Z*/YOQKX:F[V8K#"L2W
M  Z8W$_Y+/&K\P&F_BZK@M'=TO5/)W;3SQQ;Z3JO#O,_CX=:
M   *17K"?R\X?\P.O?RDOPKQ=SZ)Z ]&7ZN'_24W>0D%XJDA@
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M)G2D^L"C^AXOE-63]"F1L
M                  C;ZMGR%[[^>'A]^^3H$75']_3V+N]4M:WR=?9-[Y"2
M06I=                                      !4"]=6^JRT']/_ %9^
M[KRJ $WW12^J/Z<OT0-'_D3%@"3\    %5GJ1?+1W-^COXJ:*) [$>:]+^$\
M+(?F?_>"?M=[7?S7^A<.-'1VHAJ               9QXQ?*4X]?GQU-^7L
M,5CWYCK?BDW@W&Y>CE^T)L'_ &SP3])4Q<7$:3]8H                %.C
MD[\I3D+^?';/Y>SXDM@/YCHOBD/@VGY.ND;^T)MY_;/&_P!)5)@X94TT
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M_5R_D1[2^E3=_BDT>+>7NO0(%]*3ZP*/Z'B^4U9/T*9&P
MJ9^LK_Z;\2OQ5V]]]Z *T7&30Z*/YOQKX:F[V8K#"L2W
M Z8W$_Y+/&K\P&F_BZK@M'=TO5/)W;3SQQ;Z3JO#O,_CX=:
M  *17K"?R\X?\P.O?RDOPKQ=SZ)Z ]&7ZN'_ $E-WD)!>*I(8
M    ]51?]-J=^-5>^^S0?"TQ#R"?X%_>J=1L6AY!@              &JW.K
MY$?,;Z*W(3XI+</K>Z3JG<=W?U@8%],47RF,YL8NSU6
MM1^K.?\ ;7_W</\ W]"C+Q$/.EC_ "!^7?Q,M1"B0[               (KN
MMA]61R8_0U^\#JD<X^[0W%N"^MK"?RKY'4% L7)Z2@                72
M_5R_D1[2^E3=_BDT>+>7NO0(%]*3ZP*/Z'B^4U9/T*9&P
M                                         "-OJV?(7OOYX>'W[Y.@
M1=4?W]/8N[U2UK?)U]DWOD))!:ET
M      %3#UR/7]\V-TQ=%PNO:3;KY,L^=^L99W$TRMS-HDVL4CQ^Y/LEI-RP
M@V3YTA'I/'Z"1EC$PF559,N<]T<N,@32=&V#FJUTINGM7['$2D!/0_$S2T?+
MPDW'NXJ7BI!K3(Q)RQDHU\D@\8O&ZA<E.DJ0IR&QV9QC( DK    !59ZD7RT
M=S?H[^*FBB0.Q'FO2_A/"R'YG_W@G[7>UW\U_H7#C1T=J(:@
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MOVMM6QSD56MLEN]6G_T)Y;?C5J#[T[ '"7B-*]*[R_!?@:GOH2SR*)$<
M           K#>LL?Z$\2?QJV_\ >G7XK1<9+CHH^7XU\#3=],5,Q6)G@
M             ='+IR?(,XB?F!UK^3;(6KNZ7JGEKO2^L?&_I*?OU-TQQ.A
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MCQ;R]UZ! OI2?6!1_0\7RFK)^A3(V
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MSX[9_+V?$EL!_,=%\4A\&T_)UTC?VA-O/[9XW^DJDP<,J::
M  -XNF[\M'3/Z1/BIO0ZKMOYKU7X/PL9,K]WW^UWLC_.GZ%Q$M3"/Q^F
M            TLZC?R#.7?Y@=E?DV]')O=)U3ONZWZQ\$^DH._0YQHNCU*
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MXU4TSVR4\F"5CFN:J*US74LBM<U4R*BHJ*BID5,J'2+%J>5P
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M>JP                %J/U9S_MK_P"[A_[^A1EXB'G2Q_D#\N_B9:B%$AV
M              17=;#ZLCDQ^AK]X'5(YQ]VAN+<%];6$_E7R.H*!8N3TE
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M:2AS-G3F5(2,FY&&6=Q97KPU=D$\II+*&1<,ET5.X52.0H&Q
M   /A67_ *$>_P#HW_.T!]3A.+^Y/NCX<@    "JSU(OEH[F_1W\5-%$@=B/
M->E_">%D/S/_ +P3]KO:[^:_T+AQHZ.U$-0              #./&+Y2G'K\
M^.IOR]@!BL>_,=;\4F\&XW+T<OVA-@_[9X)^DJ8N+B-)^L4
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MHY=.3Y!G$3\P.M?R;9"U=W2]4\M=Z7UCXW])3]^INF.)T(
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M:-5:_P!W1U16*U6V-[6U)8^[N]TG+95L%8E^3F<>.=/#_<W$RH\*NHI5;TE
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M07BJ2&               /547_3:G?C57OOLT'PM,0\@G^!?WJG4;%H>08
M            !JMSJ^1'S&^BMR$^*2W#ZWNDZIW'=W]8&!?3%%\IC.;&+L]5
M@                +4?JSG_ &U_]W#_ -_0HR\1#SI8_P @?EW\3+40HD.P
M              "*[K8?5D<F/T-?O ZI'./NT-Q;@OK:PG\J^1U!0+%R>DH
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M&T??@_V?UWV2%YG-ZXNR<[K(/%#:/OP?[/Z[[)"\SF]<79.=UD'BAM'WX/\
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M&T??@_V?UWV2%YG-ZXNR<[K(/%#:/OP?[/Z[[)"\SF]<79.=UD'BAM'WX/\
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M*;/=]O=&[KLS_)@58U14R)8EIZ!]&-%3=P^\MJ_.<_@X2$T5"1
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M['==O:;_ (1Q6Q5R)8AS:BHF5;5/MCX?0
M       #$V_-9GW5HO=.G$I=6OJ;9U-L;6:<\AE3"T(>^4^9JQ)='*6<*X5C
M32O?B]S]MVD^Q]D<XWZN1K^:J+H4X2,UD;F<%YJII0J@]/GJ#XZ,FMKOPLY^
M\;]T4*6KVR[/;*3L2@5&+GZS?VU@;QR;PI)65G:W&V(A%(KNX^6C73U!=F;#
M9<C51GGON8J:;QYR3T[VJBIE1>(P]-4^(L6"I:Y%1;45$X3.G!"G;NY]]76=
MZH[W2%WX^<<J%2Y.JZZS?XQ2O67:;EUK5[K"&R[9F[@EA.>+L#N4>.V>7,9'
M':-&!'3E5+ON:=0YE-1I27D=*JY;.++:5*=LE36K5W5;$B9+>/)9]F@M1C$&
M7   "-OJV?(7OOYX>'W[Y.@1=4?W]/8N[U2UK?)U]DWOD))!:ET
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M               4#.MA]9OR8_0U^[]JD7,?<(>DNX+ZI<)_*OEE016CF;B
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M-]!4,7#Z9<Z8W$_Y+/&K\P&F_BZK@M'=TO5/)W;3SQQ;Z3JO#O,_CX=:
M           *1OK!^$\\]X3"ICD2SH/76%#ID*JH1/-FOW=F(F91(JARE[<X
M+DY<9S]CMQ_**\7<^B>@'1FM_5O)9P_.4_@X>J>GB>8O2,XKP-.H^F^%:/,=
M61@(ASL?;&_6<%&3R4G)HIK2S.*A;G2;LR1F83..\F1BVL3&X.7L0>NL9.Z4
M77KE5;"TFV&WU[8U,^(8[CZX$C9')!34:O<RZU;&JY\4L2JU_#;(Z1]G=1LR
M,3RO5&XF\98_CSQVY\\1*^[U]J[?DHVK-BUNNN<S"$LTI SLY&JQ+!=Z_/".
MV*M-F6$HU;KK1V'#=$S;"9<FRK]8Y;5:[A0O-T.VFULNT^*;M]MI6U.,8:Q9
M&3HF5\;7L8Y'*B)?14EB?&YR(^QSD?:MEV%JC4>V[+N-:U_0H"1M-SN,RPK]
M:KT2CA:0EI>27(V9M&Y3&(F3NU#]IU%#$22)C)SF*0IC8Y\&53?6(8A1830R
MXGB4K8:""-7R/<MC6M:EJJO82U57(B*JV%G7D;TY=%\0.D-O_,A#:YV)R>K,
MIIY?9&TTHR)F[)0;G8MH:=7=T:GS3QLI.5"&:T>W(DRFGX&M+,Y#PM=/";I-
M,E)'*YZ9B)&RV]+:+;??=ANJDJJ79&9E2D%/><QDT3*>J1)I6(MR5RRQJMJW
MDC<RXU;6*JU7Q6)AFW7"AMQ 5W6W><VI:\,-.0U=F)I&*H\:_>JVZUQN6KB'
MJ,\ZA3XGXJ#G&Y7"65F6$U<NLHD.Y:(F5<I\77K.UX3I.WS]MTP!8]@&4[L=
MDE:Q72N1-7&ZU'2,1_:.>Q;JV/M2[>5&/<B,6;'C]RGZ6/,3;%<XDSG3CH^G
MJUL)\K4-;[2@G-<1O2TX\;.LPQ+-+5:LURW0CZ0=$(BW5Q.SI,.U$RJX[SW1
MRTU1[4O6F@MI=C]\.PV#2[:T^U-175=*W6ST[T>L*,14O:MLDCXWHU+5<FIA
M6ZBJWMK$,1<.^&6L-(]7G<7'&\Q\'M-;3-*O5RX_U>^9B5(Z_79Q6JE=]6Q5
MD2<%Q#.I9C0;4N]54RAE)&08>$D13RD7O?USE5EIF]N=O,7V@W)4.U.'.DHV
MU]1#%620WKT,22215#H[.V1JS1HQ$MM5C[BN6U;<G<N5=W\B^FWLC;7.W0L-
MJ?DK1]_4FD\9WJ6N7FOM@76.G96&CK!0V=>>G7L<E6FD(\E'++/:=K(^UZ2B
M95%6WA"GQMB.L:N2PQ&Q*;/[+;U:7!=W6)25NRE1ALLM>FO2:&)S&N<R97I8
MQLBO2-KN!S+[D541]U-2NH,A"</^*W'3IS02<:IL?M8<E^5LJU*V7<EVC:8A
MRRJE..]22QD^*Q OE4<YQW.563>/6[.U93MY-[95=Q'==V;JC;C;'%-Z50KT
MPK+08<U;43Q>-R+)+9_VCT1>1[I6_:H1!47_ $VIWXU5[[[-!S-WXAY!/\"_
MO5.HV+0\@P              #5;G5\B/F-]%;D)\4EN'UO=)U3N.[OZP,"^F
M*+Y3&<V,79ZK  ?MC8V0F)!A$1#![*RTJ]:QL9&1K5=](2,@^7(V9,&#)L15
MR\>O'*I4TDDRF.H<V"EQG.<8 X2RQ01.GG<UD+&JYSG*B-:U$M555<B(B955
M<B)E4F9UUT$^?-^HZ-T?1NJ];NG;%*08T;8MTEH^\.47"9E4$5H^N52SP\,^
M.GW/=MI%\S70,?!%B)G*<I::R-M-$8ITC]V^&X@M!&^LJF-==6:")KHD5,BV
M.?)&YR?PF,<B\+55+%6+_?7'[;W&38\KJ?=M+D:1=HI%%YE@].V=,Y2)=J+I
M,9V!EF"SF,G(-^=JJ5)TV542RHDHF;)54U"%YHJ*EJ&W=G-I<$VMPIF,[/U#
M:C#WJJ7DM16N2RUCVJB.8]+4M:Y$6Q47@5%78'B%TZ^3_-DLQ*:=J\0QH]>=
MFCIW9E\F,UFB1LH1)LY5BBR";.3E9:1;,G1%UTF#)V9LB8IEN]]\2P?XYR-X
M3K.V^]#9'8!60XY,]V(2MO,@A;K)G-RHCKMK6M:JHJ(KW-O+:C;;%L]SROZ5
MG+/B%32;,N\/3K]JPJC9%_LK45C=6VK0JCY=NT8'FB2</7+#&LGSUR5!)VHP
MPSRXR5+*N#J)%/\ $>CLB<)C]C-\6Q>V]?\ -.'OGIL8L54@J6)'(ZQ%5;EU
MSV.5$2U6H^]9ENV(JI\7AOP,6Y.4O9>Z-C;KI7&OCKJ5]$P5OV[=H]>=*K:9
MSO&8^N5VMH2D$66?$*\:]_PH_:F*9\V(B5<ZABIG.LR)E4N-NMX[=DJ^DP'"
MZ"HQ7:BM:Y\5-$Y&>YLMO/>]6ONID=98QW</5RM1$5?)\Q^$5RXE777D2TN%
M<W5KO=59:7#2.TM>).%HK8L&\7;-BH-HDJL@LUGDE'[4YFR"[Y$Z3UN9)=0Q
MS$3^M=:F92\V%W@4&VE!53/@EH,3H)5BJZ>941T#T15M5V1%8MCDO*C%M8Y%
M:B(BK\[FKQ%6X87NA:LG]BQMUV/,:IJ=]V;7(N#-&(ZKM-HP[7]'R\GF:EB6
M1TP8()./#<)L>^HN$S8;E*8IC&NO);Q%78';9NWF'5.,4U*^GPIE9)# ]S[R
MU$<=B:Y&W6W$555MVU]BM5+RJBHFFPY'>BU'ZLY_VU_]W#_W]"C+Q$/.EC_(
M'Y=_$RU$*)#L               BNZV'U9')C]#7[P.J1SC[M#<6X+ZVL)_*
MOD=04"Q<GI*                !=+]7+^1'M+Z5-W^*31XMY>Z] @7TI/K
MH_H>+Y35D_0ID;
M           (V^K9\A>^_GAX??ODZ!%U1_?T]B[O5+6M\G7V3>^0DD%J70
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MQU-^7L ,5CWYCK?BDW@W&Y>CE^T)L'_;/!/TE3%Q<1I/UB@
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MIF"U'ZLY_P!M?_=P_P#?T*,O$0\Z6/\ ('Y=_$RU$*)#L
MBNZV'U9')C]#7[P.J1SC[M#<6X+ZVL)_*OD=04"Q<GI*
M!=+]7+^1'M+Z5-W^*31XMY>Z] @7TI/K H_H>+Y35D_0ID;
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M&5Q\,,      !4"]=6^JRT']/_5G[NO*H 3?=%+ZH_IR_1 T?^1,6 )/P
M 56>I%\M'<WZ._BIHHD#L1YKTOX3PLA^9_\ >"?M=[7?S7^A<.-'1VHAJ
M            9QXQ?*4X]?GQU-^7L ,5CWYCK?BDW@W&Y>CE^T)L'_;/!/TE
M3%Q<1I/UB@                4Z.3ORE.0OY\=L_E[/B2V _F.B^*0^#:?D
MZZ1O[0FWG]L\;_2528.&5--               &\73=^6CIG](GQ4WH=5VW\
MUZK\'X6,F5^[[_:[V1_G3]"XB6IA'X_3                :6=1OY!G+O\
M,#LK\FWHY-[I.J=]W6_6/@GTE!WZ'.-%T>I0                %LSU:?\
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M+]7+^1'M+Z5-W^*31XMY>Z] @7TI/K H_H>+Y35D_0ID;
M"IGZRO\ Z;\2OQ5V]]]Z *T7&30Z*/YOQKX:F[V8K#"L2W
M   Z8W$_Y+/&K\P&F_BZK@M'=TO5/)W;3SQQ;Z3JO#O,_CX=:
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M\B/:7TJ;O\4FCQ;R]UZ! OI2?6!1_0\7RFK)^A3(V
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M;\O8 8K'OS'6_%)O!N-R]'+]H38/^V>"?I*F+BXC2?K%
M IT<G?E*<A?SX[9_+V?$EL!_,=%\4A\&T_)UTC?VA-O/[9XW^DJDP<,J::
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MK6V10CF;E+4?JSG_ &U_]W#_ -_0HR\1#SI8_P @?EW\3+40HD.P
M      "*[K8?5D<F/T-?O ZI'./NT-Q;@OK:PG\J^1U!0+%R>DH
M       %TOU<OY$>TOI4W?XI-'BWE[KT"!?2D^L"C^AXOE-63]"F1L
M                      ##NU.._'_>BT*XW;HS3NXEZTF_1KB^U-94K82T
M C*F:'DTH52VPDN>*3DCL$,KE0RGA;**>3]O<%[ ,Q     T\Z@_(FV<1^#O
M*[DY0X:NV&[:)T1L;9U3A+<C).*M)6&J5Q[)Q#6Q-H:2AI9U"G?(D\)2;/&B
MZJ6#%(LD;.#E KT] GJ2S_7J?<IIWGKQ)X23UHXDFT,GJ:PU?2#V7?,6.YUM
MP/+&U.XW-<=OR,:9K(ZBCUT31KEB0YSYRJ0YDTS% ML@
M (V^K9\A>^_GAX??ODZ!%U1_?T]B[O5+6M\G7V3>^0DD%J70        1"==
M'ZM[;OXU:E^,JMCG'W:&[NCQ]:E#\#4^ D*&HN3T9)0^FOP5B>3-HLNYMZR:
M-%X?:%14LNY+O*NEHIE/&BT$Y/% B9%!1%V1R^:9*K(+MLY6:,S8(GG#IRTP
M;@]UF1.Z-1;UMXDVR=)%@.SK%J-N,275TL341RLO+=USFK:EB+D8CLCG95[1
MC[)(N,W.R6YF]8?BNRJC ](XY:G:;DJ6B=7LFR,3&PM<C^/&T8Y&P2,,Q/F.
M:S\NP:(IE12QWF.8HHM$>W":BBW!6W6+G-5[6;NH=@]QV,25CO&-J:UU+)5U
M"JKG.>M;3N5C7+VRL:JJMJY7O5SW<*(V$/G5\MSF-]*GD)\;=N%1O<IU"0&[
MOZO\"^AZ+Y-&?TX.\B&_%'E?I3?S]@ZDX>A6EQXR,F!4#R"M2M,'+4NW&C4G
M1#(+22-9L;M1NF;*>%%RE+WQ+.>^$.2UMA\W@[,.VRV,Q#9N-R,GJ84N*MMU
M)(WMECO694:LC&HY<MB6K8O LSG)WI=:[Y<[<N/+#BQS(XRI::W)8GNR;GZ1
M[L]@96C6&WR)I"T%*E'Q$L50[V=<NG&&4M[2.F:RF6JF,Y)WP4T>K4L5%M-$
M;([W\3V)P2#8S;' L67':")((M1$CVRLB;=C[IS>!B-;>CUK7(E].&PR5U2Z
M%K'B[TCN(O&JF7QKM=H[VG'6>G7PBC [6UQ;B)V7?+7=ZV:/R_99KBTOL9NW
MCBI.5>R-D$?^4+]R8ZIEJO53$[G\2Q;:_?7C>U=?3+1/;1NCEARVQN1T$,<3
M[UBWT; KGVM3W1CNU;D1(#M2;@Y:6UE6^*^J=Q;AQ6]E6",ID+JF$V!:V-4D
MI"T2"4<G&9A&LD6/;13]TZP9VGA,K8Y>Z.L7.,9R*BHWA4DAC>![%T4DNV.,
MT-#XW21.E?4/AC61K8VJZ]?5MY7(B=JMMY,B-4WPZFMC1A)32'3=T,C(VZD\
M/JEB.MQ:K%N'ZU[WY.-#3&R[,I&Q30ZS@\(L]73SVD,=H[=R"9L]F.T<6<;U
MXS76Z6E=40XAO4VC5L&(8Y/>CUCD1(:-BW8([SER7T1%X;'-;$J$.2R*S=95
MNX240704.BLBL0R2R*R1LD4253/@ITU$SES@Q<XQG&<=F14-YM<US4<U45JI
M:BIP*A_(#Z7=?5Z_D&3/Y_\ 87Y-4 6\O=>@>?\ TF_K&C^C(?"3$Z ID>
M     /A67_H1[_Z-_P [0'U.$XO[D^Z/AR     *K/4B^6CN;]'?Q4T42!V(
M\UZ7\)X60_,_^\$_:[VN_FO]"X<:.CM1#4               SCQB^4IQZ_/
MCJ;\O8 8K'OS'6_%)O!N-R]'+]H38/\ MG@GZ2IBXN(TGZQ0
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M6\O=>@0+Z4GU@4?T/%\IJR?H4R-@
M  !%YULOJC>HS]$3=7Y'2( JC>HQ_P#XT3_<F_[W  O^
M  (V^K9\A>^_GAX??ODZ!%U1_?T]B[O5+6M\G7V3>^0DD%J70        1"=
M='ZM[;OXU:E^,JMCG'W:&[NCQ]:E#\#4^ D*&HN3T9)3^*/5RY$<0-)):#H&
MNM V^CIV*9LQE-FU&\6"7</YMRU=N$G!X7959B%6C9=F0R)? ^[)G';DQL]F
M<<%8CEMRVFGML]RFS&W&/KM)B=5B4&(+$V/W"2)C41B*B*E^"1UJHJV]M8N9
M"5OIR=7O>_)_F9IO1EVTYQ>J59O.=@EDK!KS7MQ@;@P-7-67BVL"P\K+;+GX
M]KEY)0*+=?"C1;OC950A>Y,8IR\',1&VY336]+<CLYLCL)7[0X?78O-5T^IN
MLFFB?$M^HBC6\UL#'+8UZJECDL<B*MJ)8L:O4VY6W3ECRNG./UWAM+:VJ&E>
M3.VM8US85;K$U$2B\$XV1FDFM>SIAW9)TLWF/C(!)\Y.S;LDS*&7.5+'=E*7
MDQ+K;>0VONEV-H-C-C(]IL/DKZNNK\)IJA\+Y&.:CT@UNKIVHQER\YZL:CG/
M6RZBKD55\)U/N VO.!]OU# Z^W7C;+?9%+D+!)L'[6,:V"OK1:T4DWFU20[A
MPP\5KH24,>*^V,L7P%Q@RBI<$4-]8Y7<)D=T>\C%-XU%75.)X?XDZDG:QJHK
ME8]'(ZUG;(BZR*[9)Q=NVQ$6U$V6XL]-#4^I*!1N9_4;VE1*1H*3@X:^Z\U!
M$6!&P7+<[>1BV5@@&"Q(-57+B.D63]LJI&1)WK]9%0Q71X],ASY^.<J]JWA.
MI[8;V,9QO$JC8/=;1U-1M(R1T,U2YBLBI5:Y6/5+Z9'-5'(DDB-8BHBL2551
M#1KJ&\WYOG#NI*W-87-*U)0HKQ,TKKO"3)OXK4U Z><N9%O&F/&IV">4;IJN
MB-S&0;))(-$CJ)MB*'Y-;=3E-A[L=WU/N^P!:)\GC&-5+];53Y5UDJ\35=VU
MQEJHV]E<JN>J(KU1-@^G*V@>-NJ.0'4?N*$6]DM-M%],\:8*2PBX)/\ (_8,
M'@F)/+)0IO"&U I\KA\Y3SDF56CI8R9L*HER/CLJHTZSO2?4[58SAFZRA5[8
MJYR55>]MJ7*&%_<V\2S2MN-7B<UJ*ECE-Q>F5:-OW;BGO1/AA?=9P74:M?(1
M"V;'GMHDK;R[771S^%3?K9IRUOBIF#=]S>%G3M_WULKA+'A1E>X56CS8XOLM
M[;N;#HV]FCP/#]LL.7;RFJY-UL.&+' RGOI%%5H^Q-:D3FO3W)&M98Y+>T1+
M6ME0U)ZTL[K:<Y%:TS"3&O;-O&.T52(WE3:=3X:>($[NYOAU[>.8\[7[9:53
M3SV+95[5TF>6B"V<+(JD)]CMLY#NNX6GQ6GV7J_&(ZJ'9Y^(RNP^.IMUS*1;
M+B+;P-S69%=?<WM7(JP[BH;Q+NOJ]?R#)G\_^POR:H MY>Z] \_^DW]8T?T9
M#X28G0%,CP      !\*R_P#0CW_T;_G: ^IPG%_<GW1\.0    !59ZD7RT=S
M?H[^*FBB0.Q'FO2_A/"R'YG_ -X)^UWM=_-?Z%PXT=':B&H
M !G'C%\I3CU^?'4WY>P Q6/?F.M^*3>#<;EZ.7[0FP?]L\$_25,7%Q&D_6*
M               !3HY._*4Y"_GQVS^7L^)+8#^8Z+XI#X-I^3KI&_M";>?V
MSQO])5)@X94TT               ;Q=-WY:.F?TB?%3>AU7;?S7JOP?A8R97
M[OO]KO9'^=/T+B):F$?C],               !I9U&_D&<N_S [*_)MZ.3>Z
M3JG?=UOUCX)])0=^ASC1='J4                !;,]6G_T)Y;?C5J#[T[
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M=_BDT>+>7NO0(%]*3ZP*/Z'B^4U9/T*9&P
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MD+^?';/Y>SXDM@/YCHOBD/@VGY.ND;^T)MY_;/&_TE4F#AE330
M    !O%TW?EHZ9_2)\5-Z'5=M_->J_!^%C)E?N^_VN]D?YT_0N(EJ81^/TP
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M=P<*\)Z4?3*ELSU:?_0GEM^-6H/O3L 49>(AATKO+\%^!J>^A+/(HD1P
M          "L-ZRQ_H3Q)_&K;_WIU^*T7&2XZ*/E^-? TW?3%3,5B9X
M           '1RZ<GR#.(GY@=:_DVR%J[NEZIY:[TOK'QOZ2G[]3=,<3H0
M            !0,ZV'UF_)C]#7[OVJ1<Q]PAZ2[@OJEPG\J^65!%:.9N(
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M@2I.Y-=U#9]13GXU%VVCIM.MW:'G(8DNP;R"Z:+G".%DB+J%*;&#FQD#5?\
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M\73=^6CIG](GQ4WH=5VW\UZK\'X6,F5^[[_:[V1_G3]"XB6IA'X_3
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MU*QT;IJ:D:]D#=8^FG<V1RMD5T4MSE#0[:[\MIMO,!B5FQ;(UIV.2\C9I7+
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MCG'W:&XMP7UM83^5?(Z@H%BY/24                "Z7ZN7\B/:7TJ;O\
M%)H\6\O=>@0+Z4GU@4?T/%\IJR?H4R-@
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MI8W30OCB;)-,YL;%DD<UC+SDO/<UJ6JJ(0J>,=:]TM;\H(?V:/#;^YWTJO\
M[O=KO_3*K_1DT/[_ -T'_P#[VMWG_KN'?[P8-Y+T*+Y Z#VQI.*V[$:W?;.I
MLI3T[O'OXZ7=5]&7(5!VZ)%MK/7%I%-9GE1%1##YMA5-4Q3&[G.<9V!NJZ.7
M2@W;;QL&V]K-UNU6*4^$UT=2M*_#ZF-LRQK:UJR.IIT8J.L<UVJ?=<U%1+41
M4ZQMGTW>A+M9LK7[-0;Y-W]'+6TSHM<W',/>L:/R*MU*N-76I:BMOMM1515L
M(5M7]'OD-I.IH47476 MVMJ<W>O9)*MTS7",!$^V,BIA5\_4:1_(Y%-9ZZ,4
MN#JG[H^2D*7M[DI<8GAM;M7O)V]QEVT.VO1;Q?%<;=&UBSU2S327&)8QB.?@
M:JC6Y;&I8EJJMEJJJQNP3?;T6=FJ!,+V?Z2VQ5'AR.5R1PXE01LO.RN=8W%D
MM5>-5RV(B<"(1\ZDXD<A)KJP<EM&QG46O%5VG2=)UZSV;E<VA#JV/9\&YB./
MCE"C2$<?;37O#1BA:X] IS3;\N<5Y/M0Q@W<H;BVF@Q)_1LP"*/<=/B-9\[2
MV[((Q]_"DOXE_KZM3#7.1)+4DM\4A_.262+:BR8FBWL[J*#;*JVXKM\F!T&Q
M%9 V&GVJ?6TS:/$YFI"CJ&*H=7-ADDC6"=BL;4R*BX?(BL2XY&3V;&ZI&G=,
M<R]3<'9ZOW.TV2ZH4>#D=LQQHL]7CK+=R$:5C"S4BRJ\G'/'1DC2D@BJ1M%]
M^-DW?.\..]>:>&_N]=_N.[OL2V]GPV3"]I(I97TV 3P3MQ&HB8MKDC8K45KW
M)>2EB5JOJ+EB7+[+TQ(NG!T>I'15V#[1X5BF[R*-?&L?IZVEDPNF<Q/=%FJ6
MR+$C8LBU#U>UL".M=;8ZS0KUD25B7_%W1*<?+1,@H3?A3G3CY-B^4(3T>7(O
M=G3:N%CD)W6<8[<XQCMSV"3G[O#<7ODW5[S,<Q?>3LQC>!X74X%J8I:VDFIX
MY)?&J=^K8Z1K4<^XUSKJ9;K57B-*[^>DMT>]]NSM'@.Y_;;9C:?&Z2M\8F@P
MS$:6MEB@U4D>NDC@E>YD>L>QE]41MYS4MM5"Q5XQUKW2UOR@A_9H\_?[G?2J
M_P#N]VN_],JO]&;T_O\ W0?_ /O:W>?^NX=_O!"QH.3C^:?/#<7,Y_)0DEJ#
MB2C8>//$B(DYJ+8Q=OV$5DMG:NU&2C\Z1#,W3AX6/CY!+"B*[5PD;NL*L<X$
MQ\;Z/&_+8'HT81N@V%V2VAKMHMKJIF);2U5'0U$Z4L$3VI1X6Y\37-62)$UM
M1#>O1R,>EBMJ#4>(=+'HR0;Z:S:?>7M_LA@S,&HTAP>DQ#%:.DEG2=KEDKTB
MGE8](ILK();MV1BHJ+;$0G2_(ZPGU"[Y<.N=_(*-ZGB>[5*Q^J:W5E4*!'D+
ML@T-C6R&KU8M5$M51J&?#L9.Y/&'=]L8=J=Z8R^984^X^HI]Y#>CVN[' 7=&
ME,+NKC#V,^=75/BEJSNGOI/XXM9_JUQ($J$3_6&RMB1(DZ2N]W!*O8#]=4.W
M%6N\!TGC+862VX7XGK+R*UR(M,M'XI_K"2ZY8%;VBM5RK(7/Z[;F+ZOP3VP2
MM6B)YY#1CJ;B4;/"ND8N7<,D%9*.2<E?9*X39/#G2*IC.<'P7M_X1Y*XGT-N
MD[!B51!ANP6U\^',GD;%(N%U35DC1RHQZM6.UJN;8Y4XK;"15)^\!Z$\E+%)
M5[V-WD=4Z-JO:F/8<J->J(KFHOC&5$6U+>.RT^SXQUKW2UOR@A_9HLO[G?2J
M_P#N]VN_],JO]&7']_[H/_\ WM;O/_7<._W@F&X)T2B7K2CR:>]_EED[S.L/
M"H:X6!HSP1"-@E2I=[K\XUCS*D\(SDQNYR?[.,9S]C&,>T/0$W>[>;L-QDNS
M>\+"*_!<>=CU5,E/60/@F6)\-*UDER1J.N.<QZ-=98JM6S@(@[\=ZV[#?/MH
MW:[=/C^$[2;,,HHJ9U7AU5%5TZ3QND?)#K8'O9K&-DC<YMMK4>VWA-SO0EKG
M[F3OEU?/.83;ONY-"&G=4SETKV1Z$M<_<R=\NKYYS!?=R:$&J9RZ5[(]"6N?
MN9.^75\\Y@ONY-"#5,Y=*]D>A+7/W,G?+J^><P7W<FA!JF<NE>R/0EKG[F3O
MEU?/.8+[N30@U3.72O9*R7K6VQK9PWZ>&FMG<?W<97;E.\S]>4.3>W6M5C=4
M4K69/1_(JP/&K>K;NA]BU1A('E:NR.20;LDI!),BB*:Y45UTU5]W)H0:IG+I
M7LDM72CKD3N3IJ<&MK; 1<R-WV%QDU);;4^A)*3I40[G9JIQ[V1<1M1I#RN4
M^N,U'"ILD9QK!HS0+]JDD0N,8PONY-"#5,Y=*]DD#]"6N?N9.^75\\Y@ONY-
M"#5,Y=*]D>A+7/W,G?+J^><P7W<FA!JF<NE>R/0EKG[F3OEU?/.8+[N30@U3
M.72O9*S?4%A(VN<O-N0T2DNC'L_$+P=-R^?R2Y?"-8TMTKW;V3<O'RW:NN;.
M.[4-W.,X*7L+C&,;^V)55V8IE7_M/"R'YHOW@2(G2ZVM1.#_ ,K_ $+AQIF.
MU$-@              #,W')BVD^0NAXUX50[20W-J]BZ(DNX:JG;.[O!H+E3
M<M54'3=0R2F<843.10F?LE-C.,9&*QW)@=8O_=)O!N-R='-+>D)L(G_Y98+^
MDJ8ME>A+7/W,G?+J^><PC9?=R:$/UA:IG+I7LCT):Y^YD[Y=7SSF"^[DT(-4
MSETKV1Z$M<_<R=\NKYYS!?=R:$&J9RZ5[(]"6N?N9.^75\\Y@ONY-"#5,Y=*
M]D>A+7/W,G?+J^><P7W<FA!JF<NE>R/0EKG[F3OEU?/.8+[N30@U3.72O9'H
M2US]S)WRZOGG,%]W)H0:IG+I7LCT):Y^YD[Y=7SSF"^[DT(-4SETKV1Z$M<_
M<R=\NKYYS!?=R:$&J9RZ5[(]"6N?N9.^75\\Y@ONY-"#5,Y=*]D>A+7/W,G?
M+J^><P7W<FA!JF<NE>R5->1K%M&<A=\1K,JA&D?N;:#%J15=PZ5(V:7><00*
MHY=*KNG"A4D\8RHH<ZA\_9,;.<YR))X%EP.C7_ND/@VGY/>D8EG2$V[3_P#+
M+&OTE4F&1E338              !N9T^H2-L?+S4<-+)+K1[SQ]\(3;/G\:N
M;P?6-T=)=P]C'+-\CV+H%SGN%"]UC&2F[2YSC/5=ME5-F*E4_P"S\+&3)_=^
MHB]+K9)%X/\ S3]"XB69/0EKG[F3OEU?/.8:!ONY-"'Z7=4SETKV1Z$M<_<R
M=\NKYYS!?=R:$&J9RZ5[(]"6N?N9.^75\\Y@ONY-"#5,Y=*]D>A+7/W,G?+J
M^><P7W<FA!JF<NE>R/0EKG[F3OEU?/.8+[N30@U3.72O9'H2US]S)WRZOGG,
M%]W)H0:IG+I7LCT):Y^YD[Y=7SSF"^[DT(-4SETKV1Z$M<_<R=\NKYYS!?=R
M:$&J9RZ5[(]"6N?N9.^75\\Y@ONY-"#5,Y=*]D>A+7/W,G?+J^><P7W<FA!J
MF<NE>R8FWQJ.B1&F-GRC"/F$WK"E3[IJ=:XW-XD1=%@L=,RC5[8'#1P3!L?9
M(H0Y#?R9QG T+TI'N7HY;;)_^35=Q)[P\V7N;C:F];9Y4MM^=J;C7WQI X/R
MUGL@ !70YZ<@=H=0K?2G3'X9S"C>FQL@3];_ '<P*=>!KT'%2B*$Y3DGR"R&
M'<9"NR82?MT5DE9J6*2,P<C9-Z93T\Z.N[;9+HT[NDZ6&_.!'8Y+'_\ HWA3
M\DTTLD:K%4JQ46[)*U;T+W-<VEIU6K5KI70(V(&]/:S&][>U2[E=W,BMPYC_
M /S:L;E9&QKD1\*.14M:Q<CVHJ+-+9!:C$E5TWG&_COK/BOIRG:1U-#$B:G4
M&/>\KJ8(>5L,TYSA::M%@=E+@S^=G7V3++*9^U)C)4DBD1323) 3>CO,VKWO
M[<5VWVV4ZS8S6R6V);JX8FY(J>%OVD43+&M3A7*]ZND>]SI+[';(X+L-L[3[
M-8#'JZ"G;P_;2/7*^61?MGO=E5>!,C6HC6M1/F4OD+Q[Y!36U]1:SV[4+K;J
M$F_K6Q8&L2R+R6K*CWPR%=*=P=/O#U-F](HW47;9<-T'1>]*&*I]IF[QW=IO
M*W:T&#;:;5X+6T&"XBK)Z*:>-6QSHR[*U,BVL5S51[6/N/=&M]J*W*4<-VMV
M2VLJ:_9_!<0IZG$*5'1U#(W(KX[;6+R.1%M:KFWFM<EU51<A!EZO[9*/J!#E
M%Q&OJ$%4>3-4W5*RDM&RB+>,M5KJT+#1%1/%1JSI!!]-1U)L4$_<X;E.?#<L
MWW\I,%6.?/H)^\BPO:#;:39'?3LZZHK=U-9@,<<;XU62GIZB662I21Z-561/
MJH9H67U1+ZTNK5RK&UJ1BZ*%9AFS[,<V Q5(J?;2#$G.>UR(V66)C&176JJ(
MY[89&/==M6ZDUY$L<JGU.?<Y2]F=7_IOU+13B+F]XZWN^'N]Y"MX1DG,/KN,
MLU>L7BY9W3!-?#21AJ7&6E99!<V%6K>22R?">%29S:=''#\>V4Z$^]'&MX39
MJ?=_BE!=PED]K&R5LD$T.O@:]4O,EJI,/:U[$NR/@>C;RL<5]ZU3AN-=(+8Z
M@V75DNT]'4VUKH['*RG;)')JY%;;8YD+:E5:[*ULC;;+R$PW.?DVSXD<9MB[
MA*AB3MS=DC5M75PJ*CMS:MIVLYHFDPC5@B15>0QB35\+<HIERH9DU7R7&<X$
M(^C[NGGWT;UL,V(5VJP5TBU%?/:C6T^'TZ:RJE<]51&>YIJV.<J(DLD:+D4D
M)O/VUCV V+K-H42_B"-2*FCLM66IE[6%B-3*[MEON1,MQKK. B;K:W(/@!J3
MBGPZT;"4.P\\.<UHV9M39^SMO/W&:/7[DTAVEMV#(SSV.[AY8)J&BW*3!B5+
M#I-52.65PV75=(H+3(Q1F[7I(;9[8[[]X%1B--T>-WU)0X?04&&L3QN:F=*Z
MFHV0M?:V&*61KII5=JW-2>-FMC9"^1FAJ-VUNZC ,"W>;,14LV]+:>>IJJFI
MJW+J8YD8DL[GN;ED>QJHQEEY%6-SKCW/:UV[' CEQOG9NU>1?$[E? :]:\@N
M,RU-=3%OU(Y?N:!>:W=XO$K&/VZ+[&58R79-G#4ZQ#8;95P[[@S1LJW73&AN
MD7N7W=[)['[,;Y-SE3B;]VNU;:EL5-B+6-K*2>EDU;V*K,DD;G)(C52_=U=Y
M)I62QN-E;J]O]J<:QW&-@]O(J1NUF"K"KY:57+!-',V\UR([*UZ(K55.UMOV
M+&QS'(2BB(YN\DPX T6M7&(V:I/M7[@["1JY&V64_8(7!"N&TX97"A824CBN
M,YRD7LRI@^2_\'9VY[?9_P#=2.5-G]M;/QS#?!UA /IIM:[$]G[?>*OOZ<D,
M]"6N?N9.^75\\YAZWWW<FA"$&J9RZ5[(]"6N?N9.^75\\Y@ONY-"#5,Y=*]D
M>A+7/W,G?+J^><P7W<FA!JF<NE>R/0EKG[F3OEU?/.8+[N30@U3.72O9'H2U
MS]S)WRZOGG,%]W)H0:IG+I7LCT):Y^YD[Y=7SSF"^[DT(-4SETKV1Z$M<_<R
M=\NKYYS!?=R:$&J9RZ5[(]"6N?N9.^75\\Y@ONY-"#5,Y=*]D>A+7/W,G?+J
M^><P7W<FA!JF<NE>R/0EKG[F3OEU?/.8+[N30@U3.72O9*V'K&-%K5.IG%52
M :OVYW]GVP1SE[/V":P<K>*H9DL)EFY21*WSC*INW*>"9-_P]O9CLJ1N5;;2
M771/8UN(8W9[S3<:\Z8JPBJ31                 Z%'3VU'1)?@YQ1E'\?
M,*/7^B==.G1T;C<V:1UUJZS.H9-JRL#=HW)DV?L$3(0A?Y,8Q@6[GN1RIZB'
MEEO3C:N\?&U6VWYRGXU]\7E-Q?0EKG[F3OEU?/.8?+[N30AT'5,Y=*]D>A+7
M/W,G?+J^><P7W<FA!JF<NE>R/0EKG[F3OEU?/.8+[N30@U3.72O9'H2US]S)
MWRZOGG,%]W)H0:IG+I7LCT):Y^YD[Y=7SSF"^[DT(-4SETKV1Z$M<_<R=\NK
MYYS!?=R:$&J9RZ5[(]"6N?N9.^75\\Y@ONY-"#5,Y=*]D>A+7/W,G?+J^><P
M7W<FA!JF<NE>R/0EKG[F3OEU?/.8+[N30@U3.72O9'H2US]S)WRZOGG,%]W)
MH0:IG+I7LE$[K*0D;7.I'R.AHE)=&/9^B#P=-R^?R2Y?"-#:O=*]V]DW+Q\M
MVKKFSCNU#=SC."E["XQC%9BJK453TIW (B;I,)1.#_6OEM01ACF;B
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MXQA4W;A/),&_X>WLQV5(W*ZVTFET3VHW#\;L]^IN]F*V JDN0
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M+1W-^COXJ:*) [$>:]+^$\+(?F?_ '@G[7>UW\U_H7#C1T=J(:@
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MHL>CVAVDJI*&KAJ$AJ&T$E/,L,C9$BGC2D8KX9+MR5B.:KF*YJ.2VTLL3_\
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M&XG_ "6>-7Y@--_%U7!:.[I>J>3NVGGCBWTG5>'>9_'PZT
M 4BO6$_EYP_Y@=>_E)?A7B[GT3T!Z,OU</\ I*;O(2"\520P
M  !ZJB_Z;4[\:J]]]F@^%IB'D$_P+^]4ZC8M#R#               -5N=7R
M(^8WT5N0GQ26X?6]TG5.X[N_K P+Z8HOE,9S8Q=GJL                !:
MC]6<_P"VO_NX?^_H49>(AYTL?Y _+OXF6HA1(=@              $=W5=UO
M.;<X![[UY6W42RFK!Z+? G4XN\;1:7M3NC7,XX\*68,9)V3NVD:H4G<('[5,
MEQGLQG)L:XWM[T]G]RN[W$-YFU,-948#AFHUL=(R-]0[QBIAI&:MLTL$:V23
ML<Z]*VQB.5+SD1J[IZ/%.^KWPX/3QJB/=XWP\&2BJ5XD7-F*9W\-_>'NJU3_
M #Y;_,80I_YI?1^_X/MC_LF&_P#NQZ>?T>K>=%I=]R?%L?3(WE8*]/0);UK>
M)--PTI$%E8RQ7!O)1F9)BNRQ(1ZY*.4R+YEE;OB1\9QDJA<9_P" %_>E='Y4
ML^9]L?\ 9,-_]V+'%-D:[$L,J,.2=(5J()(]9&YR/COL5M]BW<CVVWFKQ*B*
M0B0G3[GM!=5;0/%6 L$ _L=DUM8KAXPR<W-/8QX[7UQM^2?N9)]BL-'C=PLV
MJYRE208&3P;).TV<F.?&\\)Z86[+%MQ.)=(BEH<=;L5A5:VEF@?#2)7.D?/2
MTZ.CC2M= K+]9$JJZI8ZZV1;JJC6NAIA&[BBV"Z26![*X2]\B.H)9722O5SG
MR.I:Z\YRHU$2U&)8C6HB9.%555G5_AO[P]U6J?Y\M_F,-&?\TOH_?\'VQ_V3
M#?\ W8FS_1ZMYT6EWW)#KU2*[<^-<KJSCO,[*H%7E]VIYDK;;HV0M+QE1=;X
MF4H)68GL(U=O/$C)-V1X90L:U?/7#6,<H)(J**D3/)7<MTG-D]_NR>+[7;!8
M/M"E!A,FJ6.HAHXY:N?5+-XO27*Z6)9+JQHY:B6GB:LT:OD:R^]D7.D?M36;
M.Q4.PM+5Q4D^+9:F>U_N%)?1BJMUM^Z];][5M<]S(GL:U5?8N*N,FS^%=.DH
MK4-.VU5:::2=,(]?:%_KE\A(*US#K'<)O9RQ(4I[(0K+PI3N,'D6K&/8E-VY
M,FE@Z@V-M!O Q;9S9U^/_P!%-I*UT4;GR4U+\U2U;6MRK9&N*L;*ZRU4C@DE
MD=W+6N>J-7%[M=XNY'99D6RV!U+J9SU:U]740/8D\B_;2RHU7,;:MB:QK(HT
M7[5MKB4W??2'Y)[+)KN\ZVV1I".ONLII>RU%>8F;D[KLTUDT&>7T8\6:4555
M-M)ECV_<K)X-C),&+]KW>%"0F?\ O1=P+9=5+@^V4<C76+>H\.2ZMMBWD^=5
M<EG&EBKDX+3<V\;=5M#M2N&8]LQ5T<.TF$U"S4ZRWW0R->C;\;U:Q7(U]QG;
M(BY$5,EJ.;HMR#X6<H.(-2M_)?=%PU'/;WW<XJ_'S3VN-32-I>/$)VV.T<,V
MD(WFZ]'YDY!IB(*\Q_RA;":J."Y44[_@I-M;H^G!NFWS[3UFSNRU#M!!'08=
M/75-;5T]+%14]+3HU7R2R,K996HJN1&HL-JK:JV-1534&TV ;;[O*7$MX^U5
M113;P<9CBPR@IZ/67(W2N;9<UB(Y[VZM)$RNL<VQ7.O]K(QH3I'[HU#JNK4P
MMFU1B419ED[,XS/6LZKRSRA2NIE955.E+$6PBX-X.F;!S8[PB3';GL[1J5_[
MT?H^1/=&S"=L'M:Y41S:3#['6+W27L5:ZQ>%+S6K9PHBY#?.[O=A/L1LC28"
MUT*U;67YW6N[>>3MI76W<J(O:-7F-:G$9C_AO[P]U6J?Y\M_F,./_-+Z/W_!
M]L?]DPW_ -V.[_T>K>=%I=]R/X;^\/=5JG^?+?YC!_S2^C]_P?;'_9,-_P#=
MA_1ZMYT6EWW):IZ&^D[5H;B;L*H6^0K\E)27(BV61!>MNY%XQ(Q>:UU)%I)*
MJRD5#N"NRN(=7)BX2,3!#%S@V<YS@LLMQ&_S8_I%;(5.VVQ--B=+A5+B4E"]
ME='!'*LL<-/.YS6P5%2Q8U94QHBK(CKR/16(B(KO/CI84<M#O%HHI5:KEP6%
M<EMEGC-8G&B9B9D;K(P@                               1S]4WIO:F
MZIO$.Z<7MH//%F2<O6=RU1LMO%IS$IJO:D$U?MJ]<64:HZ8>V;(S.3=Q\DRP
MX;Y>Q;YPB55%0Q%DP.=&3A#ZR#T+ME7-AQ>@N1QZ-)R9WKF\<6*D\Y)\?]@)
M-DE&3"XV36CFGWB%AI--DW[R1:U5J/DFQ<X3+GO9T\J ?PN6M/6@>M O!ZLW
M74>7]KUPZE6)W*6U=:QW$CCNBNR6,B6PV1@VI>G]>6QS7,I*'[HC*5DT3]WA
MND9=3N#@7M.AAT8:+T@./EA@9"Q1VRN2NYW,)-;WV=&M%6T%CV@1?$K.NJ"B
M]11DD:14<RSM3#AR4CN5?NEG2Q$4_!6C0"<<                 !&WU;/D
M+WW\\/#[]\G0(NJ/[^GL7=ZI:UODZ^R;WR$D@M2Z        #0'J<?(^OW_7
ME#_+&''<-A/.6'V$G>.(-_O&/V4L<^.X;\O@*NHWV?FY
M LH])OY+DA^=6V?>:JC1^\3\_M^+L[YY^A/]U_\ LVS_ -IJWP%$2;CHAZ+@
M      ?"LO\ T(]_]&_YV@/J<)Q?W)]T?#D     56>I%\M'<WZ._BIHHD#L
M1YKTOX3PLA^9_P#>"?M=[7?S7^A<.-'1VHAJ               9QXQ?*4X]
M?GQU-^7L ,5CWYCK?BDW@W&Y>CE^T)L'_;/!/TE3%Q<1I/UB@
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M=+]7+^1'M+Z5-W^*31XMY>Z] @7TI/K H_H>+Y35D_0ID;
M "IGZRO_ *;\2OQ5V]]]Z *T7&30Z*/YOQKX:F[V8K#"L2W
M    Z8W$_P"2SQJ_,!IOXNJX+1W=+U3R=VT\\<6^DZKP[S/X^'6@
M      "D5ZPG\O.'_,#KW\I+\*\7<^B>@/1E^KA_TE-WD)!>*I(8
M       ]51?]-J=^-5>^^S0?"TQ#R"?X%_>J=1L6AY!@              &J
MW.KY$?,;Z*W(3XI+</K>Z3JG<=W?U@8%],47RF,YL8NSU6
M   M1^K.?]M?_=P_]_0HR\1#SI8_R!^7?Q,M1"B0[               -6N:
M?R9]E?\ X&_E_51#SI]?LE[6?S7^F<.-[=&CZ[<%_+/D%40(#\VYZP@ 5R]Q
M_P#QQSQ0_,#8_B<Y*CT^V'__ )7VV/\ :2#])X&0_P!HOVPL!^B9/DF(EA1U
M;*LQL474'MEK[.V3;1W(0M7=3,<WL4NPCRF,_>Q<*JY))/VC(I,Y6522.1/&
M,]UG'8/-.'!L7J,,FQJ"DJ7X-3O:R6=L3UAC>_N&22HU6,<ZWM6N<BNXD4EJ
M^OH8JMF'R31-KY6JYD:O:DCVM[IS6*MYR-XU1%1.,K6=0NCZW-UN>$4UR/BX
MNP:)O>M(6NHM;=G'BB>UP\IMII6X*3*\<D8.(MCL2P0#YVW6[&:Y'_<+IJ)J
M*E/ZH=&C:#:E.@-M]0;KIIJ;>%AV*RS*ZF\I2GDCPYT\L=UJO;(^BAK(HWM]
MU:L-Z-S7-8K8:;V\,P9>DMLS4[8L9+LO543(T27[UK6.JDC8ZU;JM;420/>U
M>T5'V/145R+)WU8-8:#F^ &^U]HP%2CFFOM;3LOJJ34CHQB\K&R&K3LU_'U-
MR1-%:+4L%IPTCED&V2E<M7!TCE,3.<")O0XVMWC4'20V<CV2J:V6;$L5BCQ"
M-'O>V>B<[_7'U#554D2&GUDS7R(JLD8U[51R(INO?Q@FRM3NHQ5V.14[(Z2B
M>^E<K6M6.H1/<&Q+D5JR2W(U:VR\URM5%0]#TDYJZ3_3FXK2-^.[5G\4.2C6
MRCY99PX4J4)<[/"Z_4RJX565,B>A1\9E+'==R5+)<%P4N,%QC>F;08#AO2>V
MPI=G$8F&_.+'N1B(UJ5$M+!+6)8B(EJ5CY[V2U76JJJJJJWFX.IQ*KW/X%-B
MJN6K\5<U+RJJZIDTC(,JVK9J&QV<EEF0TOL&Q*SR/YU;;Y27]TNIPXZ4=5N3
M2&?-D32,=;^1K6'S,["G(IFDOWN9D*!&LB-VZ9.T^'[6/42SV.L]N]<-V8Q;
M==T>\%W1;.,:F_#?%64SI6.6X^FP5TNJHXI'*EL3*Q[E>]RY-3)4L>GN2&N*
MO%Z+;'>A7[<8JY5W=["03(QR)>;+B",OU#VHB]NZ!K4:U$RWVPN;W9]R@=63
M>"5HTA<^0O"^;TKQ0Y16^M4W1^ZO2#"V.42>79$[JC25WK;9))Q'1EJC29?D
M,H1AE./*HNV\/22,<V/VDZ&VP#\)Q_ MVFW=/CV^/9&BGJ<5POQ.6"-6TJW:
MME+.Y51\E.]=2J-69%F5L<OBSWHU+G"=_6TS:[#,1VMV;EPW8/'*B.&BK->R
M1R+,EL+IHT1%:V5O;I:C+(T<]FM:U56<L>?A)T "9WIU_P!"=H_.E-_DE2![
MS_NN?J QC^V-7^C<)/-GIB_6;0_04/RNM-]QZ2$3@
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M7OOYX>'W[Y.@1=4?W]/8N[U2UK?)U]DWOD))!:ET        &@/4X^1]?O\
MKRA_EC#CN&PGG+#["3O'$&_WC'[*6.?'<-^7P%74;[/S<@
M  64>DW\ER0_.K;/O-51H_>)^?V_%V=\\_0G^Z__ &;9_P"TU;X"B)-QT0]%
MP      /A67_ *$>_P#HW_.T!]3A.+^Y/NCX<@    "JSU(OEH[F_1W\5-%$
M@=B/->E_">%D/S/_ +P3]KO:[^:_T+AQHZ.U$-0              #./&+Y2
MG'K\^.IOR]@!BL>_,=;\4F\&XW+T<OVA-@_[9X)^DJ8N+B-)^L4
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MU^K_ /5O<H_Q5J?QETH<V=VAM;<?]:F#_#2> E.?$+D],0
M  +I?JY?R(]I?2IN_P 4FCQ;R]UZ! OI2?6!1_0\7RFK)^A3(V
M     %3/UE?_ $WXE?BKM[[[T 5HN,FAT4?S?C7PU-WLQ6&%8EN
M       !TQN)_P EGC5^8#3?Q=5P6CNZ7JGD[MIYXXM])U7AWF?Q\.M
M          %(KUA/Y></^8'7OY27X5XNY]$] >C+]7#_ *2F[R$@O%4D,
M            >JHO^FU._&JO??9H/A:8AY!/\"_O5.HV+0\@P
M   #5;G5\B/F-]%;D)\4EN'UO=)U3N.[OZP,"^F*+Y3&<V,79ZK
M        6H_5G/\ MK_[N'_OZ%&7B(>=+'^0/R[^)EJ(42'8
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M^.1NARQ.AFROA2)<L+8W(D62ZMMJK;5?22WR.?4TF$8]B=#LY4R/<M#'4/\
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M[K-V^Z+$F;-[K\$PS , G@;4R4]# RGB?4/>^)\SF1HC5D='#$Q7*EJMC8G
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M&+Y2G'K\^.IOR]@!BL>_,=;\4F\&XW+T<OVA-@_[9X)^DJ8N+B-)^L4
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M513]H^E<NE^KE_(CVE]*F[_%)H\6\O=>@0+Z4GU@4?T/%\IJR?H4R-@
M         !4S]97_ --^)7XJ[>^^] %:+C)H=%'\WXU\-3=[,5AA6);@
M            =,;B?\EGC5^8#3?Q=5P6CNZ7JGD[MIYXXM])U7AWF?Q\.M
M             %(KUA/Y></^8'7OY27X5XNY]$] >C+]7#_I*;O(2"\520P
M             !ZJB_Z;4[\:J]]]F@^%IB'D$_P+^]4ZC8M#R#
M     -5N=7R(^8WT5N0GQ26X?6]TG5.X[N_K P+Z8HOE,9S8Q=GJL
M         !:C]6<_[:_^[A_[^A1EXB'G2Q_D#\N_B9:B%$AV
M   0Y=?WZI#EG^@C]YC30V-NF^L##_P_R:8U?OG^K7$OR?Y5 <U831('
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M+IN_+1TS^D3XJ;T.J[;^:]5^#\+&3*_=]_M=[(_SI^A<1+4PC\?I@
M        -<N7WR7-^_FJN/WG<C-[-_G^C^,,[Y#0'2J_9MVX_LS7^ >5!!)
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MS3[!NE;/B=R*GI6K0TBMFGEJI:>.%TEC6-9'??<\8?$Y4OV.-<[3[%[K]Q>
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MG;3_ $='X:H)D]'GS+JOI23P%,65!I<WP
M    !0#]><__ !7?^^S_ -T< ;@])GU5OISS'"W1FY>:5'M'(W<V^]44G;DJ
MT/M/9&NJ3K9GL>N15M@:I5&&I;31I&4?U^%DT4'[R3>R2+I_W\Z!$T.\E*!
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M]?O^O*'^6,..X;"><L/L).\<0;_>,?LI8Y\=PWY? 5=1OL_-R
M     !91Z3?R7)#\ZML^\U5&C]XGY_;\79WSS]"?[K_]FV?^TU;X"B)-QT0]
M%P      *@7KJWU66@_I_P"K/W=>50 F^Z*7U1_3E^B!H_\ (F+ $GX    *
MK/4B^6CN;]'?Q4T42!V(\UZ7\)X60_,_^\$_:[VN_FO]"X<:.CM1#4
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MP=&W_1K?7_7E _YA:QJ7>9]_H_82>FP]KOW2_F]MO\<PSP=:34#5QZ^
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MM#A<,6&53[J.;+$M0DD,2N5$=*]9X9V16HLGBMB6JB(:QZ6>!8Q6X'@^T-+
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M:/SI3?Y)4@>\_P"ZY^H#&/[8U?Z-PD\V>F+]9M#]!0_*ZTWW'I(1.
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M^+U6;ZOO</TQ]@_$GQ[$4-^OG;3_ $='X:H)D]'GS+JOI23P%,65!I<WP
M                            !7!]9DZ56Q^IIPJK,CH)A[?\BN+UKF]D
M:_I1G*+8^R*E8(1*-V/0(<ZY2HDM\DC#QC^)[XJFFX<QF6>>PSHBB0%4CI]>
MM4<M.FCHR$X4\FN(A=\+<?6!-:T0EMOD[QUVQK>MUQ)O'P>N;[&26K;_ (F$
M:.Q;^ LDU8^*?H,B(HK**Y2P8P$274LZF?(7JP\A]:\L^5NL)RK<8J/9(35E
M4I>L8F:\2ZK4S2B%GO=0K^P)M-FPL6V[9#M'#MRY<N6ZRF44<$1;-&R2:8$Z
M/K4'50X*<_./O!O6?#/;3+;LQ%6^R[/GHJN5BPPI-?0$E4(VL5NK61A-Q$.K
M%V^0>O%B$B4$U5VB; ^5RHE5:Y7 S1T__6V:!PPX,TKB5RHXG[LF>2W$V@Q6
M@:(UIQ*E6*;:8K4T<6DU&$VUFWRL-=-1VBJ0T*UB);#6#LJKARR4='3055,V
M3 P5ZKQ0-Y<_.LUR(ZH6THK_ -64AMN38ENM+:+<$K.-U<C,RE:A=>559YE?
MP5M#4.Q3BJ:2:RJS&-9-D5?M729C =)X      8[VIMS6&CJ1,;*W#?:KK6A
MP!"&E;5<9EE!P[8ZQNX:M2N7JJ>',@^5[$V[9+"CARKG!$B'/G!<\F,?(ZXQ
M%5RYCB][(VWGJB-3.89XC\T- <X:):ME<=;2_ME/J%_F-<2<C)04G6G"LY#Q
MD+-&=M(J:0:2WM/(1=@;+-5UD$3*8,8N2%.F<I:DT$E.Y&2I8Y4M*<,\=0U7
M1+:U%L-JA1*P   1M]6SY"]]_/#P^_?)T"+JC^_I[%W>J6M;Y.OLF]\A)(+4
MN@        T!ZG'R/K]_UY0_RQAQW#83SEA]A)WCB#?[QC]E+'/CN&_+X"EO
MRUYKZ>X>P$.\ORDM8+?;%%D*7KFI((/K58U4<D2.Z[TX7;MHR&1=*II'=+&[
M3'/W"*:ZF,DQM_&]H*# HFNJ;SIW]Q&W*YW+R);QKZ"*N0\0>C]T9MXO2*Q:
MIIMDTIZ/9W#T:ZLQ&K<YE+3HMJHVUK7.EF5J.<V)B9&I>E?$Q4<:20G5]2KE
MFKT=R5XE[MXWU"VODVE>OEH:3+^,6;+][RG*O&$S2J4Z4CD4S]\7S&FDU$TO
MMBD4_D'7H]N4BF8S%J&HI('K8U[D54ZJHK&+9GNWO1).8G^[ODQG!*RLW*[P
M-F-L]HL/B5]10TSX8Y4<VVV)DD-;6M2152ZQ*A*9KG=JYS.$F09/6<DS:2,>
MY0>L'[5!ZQ>-52+MG;-TD1=LY;K)Y,FL@NBH4Y#%SG!BYQG'V!WQKFO:CFJB
MM5+47.BGG#4TU115,E'5L?%5Q/<Q['(K7,>U5:YKFKE1S5145%RHJ6*8,Y+\
MBZ!Q:U%8]N;"<YS'Q"96D)!-ED4I:VV9VFKF(K,,5;/<F>OSHF,<_88K9LFJ
MN?'<)&&.Q?%:;!J%]=5+VK<B)QN<O U.5>LEJ\"&TMR>YS:W?MO"HMWNR#/]
M;J%OS3N:JQ4E,Q4UM3-9P,C141J6HLDCF1-6\]I\[B5R +REX^:_WN6IYHV+
MUBT__*MF=Q9<Q1JS=;'3C8]N\0\!X=AX:O9<8SX(CWO"O<=ANY[LW#!,3^><
M+BQ*YJ]9>[6V]9=>YO#8VVV[;P)PEYT@=T:[BM[N+[JEQ#YT7"O%?]:U'BVM
M\9HJ>L3W'73W+GC&K^^OO7+V2]=389TJ=NV<+I-U7:J*"RJ;5#*>%G)TTS'(
MW1RJ=-+"JQB]R7)C%+VY^SG&/LC**JHBJB6K9P&H((VRSLB>]L;'/1%<ZVQJ
M*MBN6Q%6Q.%;$5;$R(JD+Y^IYRY*<Y<=*7D<;!3&+@WA.R_LXQG.,9^TXZ*$
M^S_] QL?^3.1T#^F&.?\%J__ )G^@/2EO0>Z/;FHY=_FQB*J<W#?5VA1=*(O
M(?7T5U3-H;@Y)5/C3/<++7JZVS3GOMF+;=C2K.:I-=1AS6!W89:JS>GZV^RA
MB'[A5NFJLVPZRND4A^U4G;4PW;*LK\69A$N'OAG<O;7I%16-LO*Y6K$U>#*E
MJI;:EG"8[>GT$MAMW6Y?$-]>$[RZ#'=GZ9EE-XIAT3X:VH6;Q=E/%50XO4LO
M:Z\V1S62ZJY(KF]HZSR<IU)>4TY7+]R7U5QUH=CX:ZUN+^N24M,V=\SVK:X6
M(DF<;(6Z!RA)EC(Z-QX>BJ<F8B0*V[LQ<JK8074)1?M9C,D4N+T5+$_ (9%:
MJJY4D<B*B*YN6Q$RI]JZS.MBJF?H>A=N)PO&<)W)[>[8XM1=)#&L.941Q0TS
M'X72S31ODCI)[T6LDD]S>U'>-TZR76NU<:RQ,=M]RDYGNM:Z6TM:=$PL3>MJ
M\GI:B1>@ZI9F[\\?+-KBVB)I:>G6$/)1SXT7%PLLV36[R]2[TZ?(&,?*6#C.
M8SCZTF'T\V&M;)6UCF)"UUMBWK%O*B*BV(BI;8N153B(\;BNC9!MKO+VEP'>
MI4U&%;!;#4]=+CM53.C22)U&Z6%(())HY&)++-%(YE^%U^*"5$:CU:;[-/"_
M!&OA^6^7W@Z/AN6F%"M,N^]E\(RU*L8RQ6^5NWN,'SDV"]G;GM'96WKJ7K+U
MF6S@M(GU'B_C#_%+_BM]UR_9?N6K=O66)>LLO6)9;;9D++/2;^2Y(?G5MGWF
MJHTAO$_/[?B[.^>?H._=?_LVS_VFK? 41)N.B'HN      !")U\>E]?.K)PX
MU_QZUYM&HZEF:'R0IF[W=BN</,S<8_BJ_K;;FOEH-LU@S$=)R#AYLU!P50W]
MSPDU4+G[8Q0/BK8EI(1P.XZ37$3AAQ@XOV.QQ=OGM":3H&K)>T0C5VQB)^0I
MT TAW,K&LW^<O&S-XHVR=,BN>[*7/9G[('TVS    !59ZD7RT=S?H[^*FBB0
M.Q'FO2_A/"R'YG_W@G[7>UW\U_H7#C1T=J(:@              &<>,7RE./
M7Y\=3?E[ #%8]^8ZWXI-X-QN7HY?M";!_P!L\$_25,7%Q&D_6*
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MMM5;R97;?5L$=-5XPY:M\3'*YD;INW5C7.RN1MMB*MBJ;;C.E,
M     H!=;3FYR?U#U.N3.N]=[//7:=7O0S[3P^*?093#/VVX^ZHG)#_E\W59
M*37\(E)-=7^ZK'[GN^Y+V$P4N.P4/0:Z*>^*E;O'WD['TF*;:XC;XS5/JL0C
M=+XNJTL-K(*N*)MR"&*-+K&VHQ%=:Y55=*;7=*WI [M=H:C8K8C:.>@V7HM7
MJ8&T]&]L>NB9/)8Z6FDD6]++(_MGK8KK$L:B(D5?\27FI[]2GP?ZL\QQ=_\
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M>.<-Q?XU1=K\),9,YG'C$RU*A+]_,=(N<G[]W6<EQGM^Q@;$KNA;T=,3P?\
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MD\V>F+]9M#]!0_*ZTWW'I(1.               (H.I+_P!-ZF_ZJMW_ #N
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M7JLWU?>X?IC[!^)/CV(H;]?.VG^CH_#5!,GH\^9=5]*2> IBRH-+F^
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MYBGU*LD/F17RV>QJC=8A5U4\Y,DLJ0X%3'8?3H]6LZ#O++2^QN3VPM^S^T[
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MRHC+51KK?4+8S%]ENAAC&QG1UV/?35^_':S:3!$VEKFHCVTE+/74[5HHE<G
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M_P#A +CLRC6,YR:1Z4=9^^+1?*ZO_A +CLRC6,YR:2IAZU3:ZO9*#PQ)7;)
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M%\KJ_P#A +CLRC6,YR:1Z4=9^^+1?*ZO_A +CLRC6,YR:1Z4=9^^+1?*ZO\
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MO$Y3V0^F<+0WJVUHK-:_7-\8K%!0'AOZNW@?MU+Q\5X7X-Z=/"/!O#G"'?\
MO'?R=WW';W/=E[>SMP*4B*MEB$.NEDYK?F"\J)Y=_$RT+Z4=9^^+1?*ZO_A
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MJ'R;/9C[.<YS_*) ;$>;%+^$\+(?F@_>!_M=[7?S7^A<.-)!VHAJ
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M#WLA%7I'(B5N$V>]3]]$5)!((C2                !UAN&=:KBO#_BDJK
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M,4;5?)++(]6LCCC8U7O>]4:QJ*YRHB*IW+=RR]O"P%K4M<N,T2(B)E5?&8N
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M[Y+F_?S57'[SN1F]F_S_ $?QAG?(: Z57[-NW']F:_P#RH()('Y5
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M)P5^F/QC^.RD#KFV'FEBGT=4^!>=HV'\],'^E*3P\9U;Q L]&0
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M6N_Z0*+^.-8^_;$6U9Y)+\&[O5+JA\MA^%9WR'8$'GB>FX
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M='X:H)D]'GS+JOI23P%,65!I<WP
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MG&,8QC[&,8P.6V_FO5?@_"QEI^[]57=+S9)SEM5?G7]"XB6IQ'\_2^
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MV_EG^@C]V?30FCNF^K_#_P /\IF(';Y_K*Q+\G^2P$.(V,:O
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M9R^L?A/HU:Q_*K9(EON2\S7?'9>]C(6;_P#SZ9\0B[^4KN#<!I$
M      ]EKO\ I HOXXUC[]L1;5GDDOP;N]4NJ'RV'X5G?(=@0>>)Z;@
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MM/\ 1T?AJ@F3T>?,NJ^E)/ 4Q94&ES?
M     1O<K.KYTT.$D^\J')GF-J'7MWC4SJRNOV#^8V+L6&*5/"I<3>OM7P]T
MND,HX3SVH$=,43N/_K>#]F0!C_CAUSNDKRQM$92=(\X]0RUPG'.&4#5[TG<=
M*S\_(&7\'2C(")W95]>/9R5<J_\ F6K0BSA<OVR9#%^R )80
M       1M]6SY"]]_/#P^_?)T"+JC^_I[%W>J6M;Y.OLF]\A)(+4N@
M  T!ZG'R/K]_UY0_RQAQW#83SEA]A)WCB#?[QC]E+'/CN&_+X"KJ-]GYN0
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M2YOW\U5Q^\[D9O9O\_T?QAG?(: Z57[-NW']F:_P#RH()('Y5
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MG!7Z8_&/X[*0.N;8>:6*?1U3X%YVC8?STP?Z4I/#QG5O$"ST9
M    (H^N']55S _$ZF?&Q0!WW=AY^8=\(_P4AKG>W]76)_!,\-&<R43:("
M               7XO59OJ^]P_3'V#\2?'L10WZ^=M/]'1^&J"9/1Y\RZKZ4
MD\!3%E0:7-\               %++UL+^D'A3^)N[OOWK424W!^1XG\+#WLA
M%3I'^6X3\%/WT146$@R-(                '6@X8?(\XG_ $:=$_%=5A +
M:3SBK_CL_A7'I'LKYKX;\0I_!,-EAA3/               '/L]9R^L?A/HU
M:Q_*K9(EON2\S7?'9>]C(6;_ /SZ9\0B[^4KN#<!I$               ]EK
MO^D"B_CC6/OVQ%M6>22_!N[U2ZH?+8?A6=\AV!!YXGIN               :
M<=13ZOOG5]#CDY\2=W'8]C_.W"_I&F\,PZOMQYEXQ]%U?@)#E(">AYS
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MKB7NSK3YYZ.I]NH]@DWISOYJ,UY9)Z%-$NG"B[E-K,F9F4*V:,DR 780
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ME*<A?SX[9_+V?$EL!_,=%\4A\&T_)UTC?VA-O/[9XW^DJDP<,J::
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MA(JAL$R;!LXP.&'8UA6+6_-\[)'(EJIE1R)GNN1'6<MA=[S]P>^+<RL;MY>
M5V%TTSU9',[5S4SWHBK<;54[YJ=7V(KD8DMY6HKD1415,3\E>?NB>,%MB]?V
MMKL"]7^0A_&1U2]559*USD!6LF6*6?L/ADK!QL<Q,5LH?O?A!W6$2=]RCA(Z
M9SV6+;38;@\Z4LR2R52MO*R-MY6MYSK51$3T;;,MEEAW_<KT2MZF_+9^?:[
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MK8?]'_"G\<=W_>36@D'N#\KQ/X.#OI"-'2/\BPGX6H[V(I9B2A%4
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MTQ]@_$GQ[$4-^OG;3_1T?AJ@F3T>?,NJ^E)/ 4Q94&ES?
M!2R];"_I!X4_B;N[[]ZU$E-P?D>)_"P][(14Z1_EN$_!3]]$5%A(,C2
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MG^@C]YC30V-NF^L##_P_R:8U?OG^K7$OR?Y5 <U831('
M 7XO59OJ^]P_3'V#\2?'L10WZ^=M/]'1^&J"9/1Y\RZKZ4D\!3%E0:7-\
M                         !KSR8Y8\;^&^OF.U>46XZ5I#7<G:(ZDQULO
M<B:-BGUMEHZ8EXVOM#IHN%7$F[BZ^^<%3(3.>\M53Y["DSD :'_Q[NCC_P"(
M7QW\HY'\$ "H-ZV]S,X)<[=1<,+OQ5Y9:FW9<M&[$V]6;%1:1.+/)I"K[EKE
M'DSVM1HZ9M,J1T1+Z=:M%#$R;)%))/MQV9SG $]O29Z[/2VK'31X.T+;G+G4
M.F-F:HXU:JTQ=M=766D8^Q0T_IJK,-7NW[MN2(REEM:,5,LLV,0QRF;/D\]U
MG/: ,V\QO67NEGQ\X];%V-J'DWKWD7MUC7Y-IJS4.M#S,U*6R_.H]UBLMYU[
MB+;L*Q3F\F4BLK).52]X9D/A!-PZ,@V6 @G]2[Z?VT*C*;\ZC=^@).KT:_ZY
M7XXZ+S)I.F2NP(IU=JM>-I7./9.6Z.'57B9S7\)&,)%,RB+I\220+G!FBG:!
M?M                  1M]6SY"]]_/#P^_?)T"+JC^_I[%W>J6M;Y.OLF]\
MA)(+4N@        T!ZG'R/K]_P!>4/\ +&''<-A/.6'V$G>.(-_O&/V4L<^.
MX;\O@*NHWV?FY                 LH])OY+DA^=6V?>:JC1^\3\_M^+L[Y
MY^A/]U_^S;/_ &FK? 41)N.B'HN      !\*R_\ 0CW_ -&_YV@/J<)Q?W)]
MT?#D     56>I%\M'<WZ._BIHHD#L1YKTOX3PLA^9_\ >"?M=[7?S7^A<.-'
M1VHAJ               9QXQ?*4X]?GQU-^7L ,5CWYCK?BDW@W&Y>CE^T)L
M'_;/!/TE3%Q<1I/UB@                4Z.3ORE.0OY\=L_E[/B2V _F.B
M^*0^#:?DZZ1O[0FWG]L\;_2528.&5--               &\73=^6CIG](GQ
M4WH=5VW\UZK\'X6,F5^[[_:[V1_G3]"XB6IA'X_3                :Y<O
MODN;]_-5<?O.Y&;V;_/]'\89WR&@.E5^S;MQ_9FO\ \IP7*J1-[J-HI,]E^6
M$M]?F*U,9BI)[#R6(R<8.(U]X!*QRS=]'N_!G)NX62.4Y#=F<9$BZB%E3 ^G
MDMU<C5:MBJBV*EBV*F5%Y4/RW;-X_7[*[0T.T^%:E<3PZKAJ8=;&R:/6P2-D
M9?BD1S)&7FI>8]JM<F14-(ZOTYN#&I]3R51G-142;K[6*=K6;9&T4(:0N>&R
M955WDT[V"Y;1CFJ>#)9SG*D8>,;HD)C."E[,Y'7H=E=G**B6"2"-T2-6]))8
MK^55?DN_XMU$).8YTR.E+M_M_#M#A>T.*TN+R5#$IL.PQTT='>6QK(64#72M
MJKRY$;4I4R/5;%<[(::]$MM-QU>Y4Q,*_DI71<;N!BVU%*ON_=ZDW")+&VLC
M]MDW8W[X\KK:N*+=ZQC'?#_9^R,!N]21D5:R-5=AJ3IJE7C[J\OHMN6DD/WF
M\V&5F,;!XAB44-/O3GV=>[%HF66QM5:=U-&[[:QE0[$6LO+W*9,AKIR&WW0>
M;'*"X4+<^](G3/"3CO8,1LI&8G\L)C=ESB7D@V<'BHQKA:6G,N'48[*DY;MG
M245&))')A-W(IF-BL4Q.FVAQB2FKZEM/L]2NL5+UBRO15X$X5X%RHBW6V<#G
MH;DW/[I]K.C+N-P[:O=MLM4;2])S;&DUD4NHOPX+1RLC<U)9761076R1*Z.2
M2)U54N>UROIZ-[6S8<4[=Q(FJ+XO\2)?6*U/KA6J;^#H'@S.0CSKIY\&>V>+
M<)M[+E](8(?.7DDF9=TH53)E#GP?LV#@L^!R4VJP-T.H99:C,BIRN3NK5SNR
MKERGF7O[V>Z06&;5?._2#I\<;M%6*Y8YZ^\^.1&KVS*:5JNIKD=J>XT[D9$U
M6(C&M5IM*,R:)-'9KI[<<+CR%M_(S95>D-JV6T,H=LUJ>R'V+90JTM%M<,EE
MX>MR:*R#AN\023[EF]RZ9-#=WENDGW>,$Z[)LOA,^*28K5L6:9Z)VLBWF-L2
MS(U<^9;43B1"4.&]+W?-LYN@P[<WL560X#@M#+,YU5AS/%*^I25U]&S5$2HY
MKF.5ULT*132I=2:1]U5=&%R^U7KKCUU$>#3SBQ6H:A;%N]L98OU$HK)M"0"E
M2<6R#@B22M>CN\1L0PLM==6!J^[PD@AX/'Y5[,*%,H.GX[14N%[4X<[!F-BJ
MY'I?8Q+&W;R);=3(B.:KT6RQ+&V\.4G%T=]O-L=[_0\WI4^_>MJ<6V-PO#W^
M(5U<]TTZ5;:2>=8TJ)+TDLE-4-H)8+[GOUE1J[58YK#;?;FM.4F@^96R.5.@
MM*0O(V"W?K:M4F<K"]YAZ-9*)8JTSA(M@\:O9["B3BJ/$JZV7<H-L=JZZA^^
M&;]Z(LIG*ZDQG#,?EQG#*=M7'40M8K;Z,<QS41$5%=]JMU%5$X5X;++5CYN^
MVUW%;V.C?@NX?>SM-4[&XKLQC536P5+:&:MIJZGJ7SRR,<R"Q6U3%J)(XWR+
M[FQK;B3:QT;-,934.WM7Z+U=T\?;&.C]Y\V]T6C;&X6M2/AU :CU"92&/:(Z
M,5;E,V(Q4:50ILE04.V4\&?M"F5(JFHI@'T-=1X=#LM:B8CB-0Z26[W,462\
MB<EC>+)D<W+:BK).AWA[O-N=Z>.],#4S3;K=V.S5+A6$.JTNSXMBR),E-)(C
MNV5Z/JE2U[4D;K*6H5K',>QE@ZD4VNZ[IU7H51CTHJKTV BJU 1R.,=PTB89
MDBP9)9-C!>^*X00QDY\_;*'SDQNW.<Y&SZ>GBI8&4T"788VHUJ9D1+$/(C:?
M:3&-L=HZ[:O:&9U1CF)5<M3/(O"^69ZR/7D2\Y;K4R-2QJ9$0L$=&W_1K?7_
M %Y0/^86L:KWF??Z/V$GIL/9+]TOYO;;_',,\'6DU U<>O@
M !45];#_ */^%/XX[O\ O)K02#W!^5XG\'!WTA&CI'^183\+4=[$4LQ)0BJ
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MK-]7WN'Z8^P?B3X]B*&_7SMI_HZ/PU03)Z//F75?2DG@*8LJ#2YO@
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M>Q_G;A?TC3>&8=7VX\R\8^BZOP$ARD!/0\Y@                +C?JE_\
MV_?]U;_O'B.>_P"_DG\J_BY*#HV_RU^2?QHN-B.A*$               ARZ
M_OU2'+/]!'[S&FAL;=-]8&'_ (?Y-,:OWS_5KB7Y/\J@.:L)HD#@
M        +\7JLWU?>X?IC[!^)/CV(H;]?.VG^CH_#5!,GH\^9=5]*2> IBRH
M-+F^                             B)ZTG2G:=8'BI3>,[G>;GCXM2M[
MU/>+"\H:X2VFDZ=UFB[+HAZZ\JREYUV;+9^PV4NOAR22(9%9J3'>U"F-@ 5>
M?[#'_P#E1/\ X$W_ -UP ']AC_\ RHG_ ,";_P"ZX #^PQ__ )43_P"!-_\
M=< !_88__P J)_\  F_^ZX %AKH==$MQT9:[R+KZG*Z<Y,-M^2^L95NR<ZL/
MJ6NT$^N6E[;+KQ%?-M+:*;V7MV;L7#]V5=IDZ,6T3RF;O># ">(
M        !&WU;/D+WW\\/#[]\G0(NJ/[^GL7=ZI:UODZ^R;WR$D@M2Z
M   #0'J<?(^OW_7E#_+&''<-A/.6'V$G>.(-_O&/V4L<^.X;\O@*NHWV?FY
M                LH])OY+DA^=6V?>:JC1^\3\_M^+L[YY^A/\ =?\ [-L_
M]IJWP%$2;CHAZ+@      ?"LO_0CW_T;_G: ^IPG%_<GW1\.0    !59ZD7R
MT=S?H[^*FBB0.Q'FO2_A/"R'YG_W@G[7>UW\U_H7#C1T=J(:@
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MM_+/]!'[L^FA-'=-]7^'_A_E,Q [?/\ 65B7Y/\ )8"'$;&-7@
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M>LY?6/PGT:M8_E5LD2WW)>9KOCLO>QD+-_\ Y],^(1=_*5W!N TB
M       >RUW_ $@47\<:Q]^V(MJSR27X-W>J75#Y;#\*SOD.P(//$]-P
M          #3CJ*?5]\ZOH<<G/B3NX['L?YVX7](TWAF'5]N/,O&/HNK\!(<
MI 3T/.8                "XWZI?_V_?]U;_O'B.>_[^2?RK^+DH.C;_+7Y
M)_&BXV(Z$H0              "'+K^_5(<L_T$?O,::&QMTWU@8?^'^33&K]
M\_U:XE^3_*H#FK":) X                "_%ZK-]7WN'Z8^P?B3X]B*&_7
MSMI_HZ/PU03)Z//F75?2DG@*8LJ#2YO@
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MCMG\O9\26P'\QT7Q2'P;3\G72-_:$V\_MGC?Z2J3!PRIIH
M WBZ;ORT=,_I$^*F]#JNV_FO5?@_"QDROW??[7>R/\Z?H7$2U,(_'Z8
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MHV_Z-;Z_Z\H'_,+6.H;S/O\ 1^PD]-A.#]TOYO;;_',,\'6DU U<>O@
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MJN8'XG4SXV* .^[L//S#OA'^"D-<[V_JZQ/X)GAHSF2B;1 0
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MR<^).[CL>Q_G;A?TC3>&8=7VX\R\8^BZOP$ARD!/0\Y@
M+C?JE_\ V_?]U;_O'B.>_P"_DG\J_BY*#HV_RU^2?QHN-B.A*$
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M6_U;;8\CO\XA<Y6Z1K/X+M ]*W^K;;'D=_G$+G*W2-9_!=H'I6_U;;8\CO\
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M^SDN?L?8$M=R:6;&N3(O^NR][&0OW^NO;<L6Q4_U"+A]G*5^QM\TD
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M-B[IVV;P*!;4_P"O^33&K]\S[=VV))8Y/)^+_O4!SF!,\@D
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MO>LXQWPS7OJW8DIV]I,]U]G XJEBV'-JWDML5.J?;'P^@
M    %0+UU;ZK+0?T_P#5G[NO*H ;=^J>?4F\>/SB<A_CJN0 LA
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MI$^*F]#JNV_FO5?@_"QDROW??[7>R/\ .GZ%Q$M3"/Q^F
M URY??)<W[^:JX_>=R,WLW^?Z/XPSOD- =*K]FW;C^S-?X!Y4$$D#\J@
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MZP3@K],?C'\=E('7-L/-+%/HZI\"\[1L/YZ8/]*4GAXSJWB!9Z,@
M      $4?7#^JJY@?B=3/C8H [[NP\_,.^$?X*0USO;^KK$_@F>&C.9*)M$!
M                 +\7JLWU?>X?IC[!^)/CV(H;]?.VG^CH_#5!,GH\^9=5
M]*2> IBRH-+F^               "EEZV%_2#PI_$W=WW[UJ)*;@_(\3^%A[
MV0BITC_+<)^"G[Z(J+"09&D                #K0<,/D><3_HTZ)^*ZK"
M6TGG%7_'9_"N/2/97S7PWXA3^"8;+#"F>               .?9ZSE]8_"?1
MJUC^56R1+?<EYFN^.R][&0LW_P#GTSXA%W\I7<&X#2(              ![+
M7?\ 2!1?QQK'W[8BVK/))?@W=ZI=4/EL/PK.^0[ @\\3TW
M -..HI]7WSJ^AQR<^).[CL>Q_G;A?TC3>&8=7VX\R\8^BZOP$ARD!/0\Y@
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MM_'+2OQKU0;/W/\ GW3?!3>"<:EWW_5U5_"P>&8<X@3((,
M   =!/U8SZN&=^DML[\E-:B)&^[SR9\2B[^0FEN \Q7_ !^7O(BQ&-/F[P
M    *@7KJWU66@_I_P"K/W=>50 F^Z*7U1_3E^B!H_\ (F+ $GX    *K/4B
M^6CN;]'?Q4T42!V(\UZ7\)X60_,_^\$_:[VN_FO]"X<:.CM1#4
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M?EHZ9_2)\5-Z'5=M_->J_!^%C)E?N^_VN]D?YT_0N(EJ81^/TP
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MMOY9_H(_=GTT)H[IOJ_P_P##_*9B!V^?ZRL2_)_DL!#B-C&KP
M   #<?IU_6"<%?IC\8_CLI ZYMAYI8I]'5/@7G:-A_/3!_I2D\/&=6\0+/1D
M               BCZX?U57,#\3J9\;% '?=V'GYAWPC_!2&N=[?U=8G\$SP
MT9S)1-H@(                !?B]5F^K[W#],?8/Q)\>Q%#?KYVT_T='X:H
M)D]'GS+JOI23P%,65!I<WP               4LO6POZ0>%/XF[N^_>M1)3<
M'Y'B?PL/>R$5.D?Y;A/P4_?1%182#(T@                =:#AA\CSB?\
M1IT3\5U6$ MI/.*O^.S^%<>D>ROFOAOQ"G\$PV6&%,\               <^
MSUG+ZQ^$^C5K'\JMDB6^Y+S-=\=E[V,A9O\ _/IGQ"+OY2NX-P&D0
M       #V6N_Z0*+^.-8^_;$6U9Y)+\&[O5+JA\MA^%9WR'8$'GB>FX
M         !IQU%/J^^=7T..3GQ)W<=CV/\[<+^D:;PS#J^W'F7C'T75^ D.4
M@)Z'G,                !<;]4O_P"W[_NK?]X\1SW_ '\D_E7\7)0=&W^6
MOR3^-%QL1T)0@              $.77]^J0Y9_H(_>8TT-C;IOK P_\ #_)I
MC5^^?ZM<2_)_E4!S5A-$@<                !?B]5F^K[W#],?8/Q)\>Q%
M#?KYVT_T='X:H)D]'GS+JOI23P%,65!I<WP
M   $%/K!_2\WEU9^%6O>.O'RZZHHU\I')>D[M5D=R2MOA*C(P%=UIN"A2,2G
M)TFEWZ9;2YW&RD'*/;''1.1LH4QR9,7( IM?V*GJF^_YP ^%/D5_\2J ']BI
MZIOO^< /A3Y%?_$J@!_8J>J;[_G #X4^17_Q*H ?V*GJF^_YP ^%/D5_\2J
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M]&M]?]>4#_F%K&I=YGW^C]A)Z;#VN_=+^;VV_P <PSP=:34#5QZ^
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M^)U,^-B@#ON[#S\P[X1_@I#7.]OZNL3^"9X:,YDHFT0$
M OQ>JS?5][A^F/L'XD^/8BAOU\[:?Z.C\-4$R>CSYEU7TI)X"F+*@TN;X
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MC?JE_P#V_?\ =6_[QXCGO^_DG\J_BY*#HV_RU^2?QHN-B.A*$
M    ARZ_OU2'+/\ 01^\QIH;&W3?6!A_X?Y-,:OWS_5KB7Y/\J@.:L)HD#@
M               +\7JLWU?>X?IC[!^)/CV(H;]?.VG^CH_#5!,GH\^9=5]*
M2> IBRH-+F^
M        (V^K9\A>^_GAX??ODZ!%U1_?T]B[O5+6M\G7V3>^0DD%J70
M   0@>L2_55[M_'+2OQKU0;/W/\ GW3?!3>"<:EWW_5U5_"P>&8<X@3((,
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MES?OYJKC]YW(S>S?Y_H_C#.^0T!TJOV;=N/[,U_@'E0020/RJ
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M],?C'\=E('7-L/-+%/HZI\"\[1L/YZ8/]*4GAXSJWB!9Z,@
M $4?7#^JJY@?B=3/C8H [[NP\_,.^$?X*0USO;^KK$_@F>&C.9*)M$!
M            +\7JLWU?>X?IC[!^)/CV(H;]?.VG^CH_#5!,GH\^9=5]*2>
MIBRH-+F^               "EEZV%_2#PI_$W=WW[UJ)*;@_(\3^%A[V0BIT
MC_+<)^"G[Z(J+"09&D                #K0<,/D><3_HTZ)^*ZK" 6TGG%
M7_'9_"N/2/97S7PWXA3^"8;+#"F>               .?9ZSE]8_"?1JUC^5
M6R1+?<EYFN^.R][&0LW_ /GTSXA%W\I7<&X#2(              ![+7?](%
M%_'&L??MB+:L\DE^#=WJEU0^6P_"L[Y#L"#SQ/3<               TXZBG
MU??.KZ'')SXD[N.Q['^=N%_2--X9AU?;CS+QCZ+J_ 2'*0$]#SF
M        N-^J7_\ ;]_W5O\ O'B.>_[^2?RK^+DH.C;_ "U^2?QHN-B.A*$
M              ARZ_OU2'+/]!'[S&FAL;=-]8&'_A_DTQJ_?/\ 5KB7Y/\
M*H#FK":) X                "_%ZK-]7WN'Z8^P?B3X]B*&_7SMI_HZ/PU
M03)Z//F75?2DG@*8LJ#2YO@
M                   "-OJV?(7OOYX>'W[Y.@1=4?W]/8N[U2UK?)U]DWOD
M))!:ET        $('K$OU5>[?QRTK\:]4&S]S_GW3?!3>"<:EWW_ %=5?PL'
MAF'.($R"#                 '03]6,^KAG?I+;._)36HB1ON\\F?$HN_D)
MI;@/,5_Q^7O(BQ&-/F[P      /A67_H1[_Z-_SM ?4X3B_N3[H^'(     J
M3=6BD1>S.1W*'7$VHLE"[ ID'2)=5OV>$)Q=KT;4X%^HAVYQCOQ&C\^2]O\
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M._*4Y"_GQVS^7L^)+8#^8Z+XI#X-I^3KI&_M";>?VSQO])5)@X94TT
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M[TL?JX.$?T:M4?DJP$%-N_/+$_CLO?*>A^[SS%PGXA#WB&_(ZF=R
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M3^)N[OOWK424W!^1XG\+#WLA%3I'^6X3\%/WT146$@R-(
M '6@X8?(\XG_ $:=$_%=5A +:3SBK_CL_A7'I'LKYKX;\0I_!,-EAA3/
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M]P_3'V#\2?'L10WZ^=M/]'1^&J"9/1Y\RZKZ4D\!3%E0:7-\
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M4WY>P Q6/?F.M^*3>#<;EZ.7[0FP?]L\$_25,7%Q&D_6*
M !3HY._*4Y"_GQVS^7L^)+8#^8Z+XI#X-I^3KI&_M";>?VSQO])5)@X94TT
M              ;Q=-WY:.F?TB?%3>AU7;?S7JOP?A8R97[OO]KO9'^=/T+B
M):F$?C],               !KER^^2YOW\U5Q^\[D9O9O\_T?QAG?(: Z57[
M-NW']F:_P#RH()('Y5                 )X.C;_HUOK_KR@?\ ,+6-2[S/
MO]'["3TV'M=^Z7\WMM_CF&>#K2:@:N/7P               J*^MA_T?\*?Q
MQW?]Y-:"0>X/RO$_@X.^D(T=(_R+"?A:CO8BEF)*$50                .
MI[TL?JX.$?T:M4?DJP$%-N_/+$_CLO?*>A^[SS%PGXA#WB&_(ZF=R
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MA3^)N[OOWK424W!^1XG\+#WLA%3I'^6X3\%/WT146$@R-(
M  '6@X8?(\XG_1IT3\5U6$ MI/.*O^.S^%<>D>ROFOAOQ"G\$PV6&%,\
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MW#],?8/Q)\>Q%#?KYVT_T='X:H)D]'GS+JOI23P%,65!I<WP
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M\=3?E[ #%8]^8ZWXI-X-QN7HY?M";!_VSP3])4Q<7$:3]8H
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M*?QQW?\ >36@D'N#\KQ/X.#OI"-'2/\ (L)^%J.]B*68DH15
M     ZGO2Q^K@X1_1JU1^2K 04V[\\L3^.R]\IZ'[O/,7"?B$/>(;\CJ9W(
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M6POZ0>%/XF[N^_>M1)3<'Y'B?PL/>R$5.D?Y;A/P4_?1%182#(T@
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MB]5F^K[W#],?8/Q)\>Q%#?KYVT_T='X:H)D]'GS+JOI23P%,65!I<WP
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MY._*4Y"_GQVS^7L^)+8#^8Z+XI#X-I^3KI&_M";>?VSQO])5)@X94TT
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M?JX.$?T:M4?DJP$%-N_/+$_CLO?*>A^[SS%PGXA#WB&_(ZF=R
M    .:OU_?K;^6?Z"/W9]-":.Z;ZO\/_  _RF8@=OG^LK$OR?Y+ 0XC8QJ\
M              W'Z=?U@G!7Z8_&/X[*0.N;8>:6*?1U3X%YVC8?STP?Z4I/
M#QG5O$"ST9               (H^N']55S _$ZF?&Q0!WW=AY^8=\(_P4AKG
M>W]76)_!,\-&<R43:("                 7XO59OJ^]P_3'V#\2?'L10WZ
M^=M/]'1^&J"9/1Y\RZKZ4D\!3%E0:7-\               %++UL+^D'A3^)
MN[OOWK424W!^1XG\+#WLA%3I'^6X3\%/WT146$@R-(                '6
M@X8?(\XG_1IT3\5U6$ MI/.*O^.S^%<>D>ROFOAOQ"G\$PV6&%,\
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M?8/Q)\>Q%#?KYVT_T='X:H)D]'GS+JOI23P%,65!I<WP
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M?)E,9P7MSCMS]@;-W07?Z=TUEMNKF\$XU-OMUGZNZN]99K8/#,Y#GCB8Y!L
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MM+C&<[^V)L_HQ36<'NGA9#\T7[P*W^]UM;>X?_*_T+AQIF.U$-@
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M13#&S>#X9XBHJ2*J0Q>[[O)\DSC.,=G;VY[-3;R[NOI+UO<2>FP]K/W3%_\
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MY[<]DM=R5G]#76<'CLO>QD+]_M[^G++UEOB$7?RE?L;?-)
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MQ;'W/Z6X79;;\XTWAF'6-M]9_0O%[4;9\UU7&OO$G(<MP3R/.D
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M.<K9+V]WC*?9C/\ )G(XK9;DX#FEZSMK+3[8^'T
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MO%TW?EHZ9_2)\5-Z'5=M_->J_!^%C)E?N^_VN]D?YT_0N(EJ81^/TP
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M_7]^MOY9_H(_=GTT)H[IOJ_P_P##_*9B!V^?ZRL2_)_DL!#B-C&KP
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MB?\ 1IT3\5U6$ MI/.*O^.S^%<>D>ROFOAOQ"G\$PV6&%,\
M  <^SUG+ZQ^$^C5K'\JMDB6^Y+S-=\=E[V,A9O\ _/IGQ"+OY2NX-P&D0
M           #V6N_Z0*+^.-8^_;$6U9Y)+\&[O5+JA\MA^%9WR'8$'GB>FX
M             !IQU%/J^^=7T..3GQ)W<=CV/\[<+^D:;PS#J^W'F7C'T75^
M D.4@)Z'G,                !<;]4O_P"W[_NK?]X\1SW_ '\D_E7\7)0=
M&W^6OR3^-%QL1T)0@              $.77]^J0Y9_H(_>8TT-C;IOK P_\
M#_)IC5^^?ZM<2_)_E4!S5A-$@<                !?B]5F^K[W#],?8/Q)
M\>Q%#?KYVT_T='X:H)D]'GS+JOI23P%,65!I<WP
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M2VSOR4UJ(D;[O/)GQ*+OY":6X#S%?\?E[R(L1C3YN\      #X5E_P"A'O\
MZ-_SM ?4X3B_N3[H^'(     JL]2+Y:.YOT=_%311('8CS7I?PGA9#\S_P"\
M$_:[VN_FO]"X<:.CM1#4               SCQB^4IQZ_/CJ;\O8 8K'OS'6
M_%)O!N-R]'+]H38/^V>"?I*F+BXC2?K%                 IT<G?E*<A?S
MX[9_+V?$EL!_,=%\4A\&T_)UTC?VA-O/[9XW^DJDP<,J::
M -XNF[\M'3/Z1/BIO0ZKMOYKU7X/PL9,K]WW^UWLC_.GZ%Q$M3"/Q^F
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M?K^_6W\L_P!!'[L^FA-'=-]7^'_A_E,Q [?/]96)?D_R6 AQ&QC5X
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MQ/\ HTZ)^*ZK" 6TGG%7_'9_"N/2/97S7PWXA3^"8;+#"F>
M  .?9ZSE]8_"?1JUC^56R1+?<EYFN^.R][&0LW_^?3/B$7?RE=P;@-(@
M          'LM=_T@47\<:Q]^V(MJSR27X-W>J75#Y;#\*SOD.P(//$]-P
M            #3CJ*?5]\ZOH<<G/B3NX['L?YVX7](TWAF'5]N/,O&/HNK\!
M(<I 3T/.8                "XWZI?_ -OW_=6_[QXCGO\ OY)_*OXN2@Z-
MO\M?DG\:+C8CH2A               (<NO[]4ARS_01^\QIH;&W3?6!A_P"'
M^33&K]\_U:XE^3_*H#FK":) X                "_%ZK-]7WN'Z8^P?B3X
M]B*&_7SMI_HZ/PU03)Z//F75?2DG@*8LJ#2YO@
M                                  "-OJV?(7OOYX>'W[Y.@1=4?W]/
M8N[U2UK?)U]DWOD))!:ET        $('K$OU5>[?QRTK\:]4&S]S_GW3?!3>
M"<:EWW_5U5_"P>&8<X@3((,                 =!/U8SZN&=^DML[\E-:B
M)&^[SR9\2B[^0FEN \Q7_'Y>\B+$8T^;O       KH^LX<_N3W3FX$:IW5Q0
MN<11MA6_EO0=3SLK,TZK79JZI$UI_?%SD(U.+ML7+1S9PK8*%&*X<)IE7*5$
MQ,&P10^##XJ6I8I*3TR]W;$Y*=/?AIO_ &Y+-9[9^X>.VK]A7R:914;!-)2T
MV:L,9.8>MH:';,XN,1</%S&*BW2323QGL*7&/L ?3>4    %5GJ1?+1W-^CO
MXJ:*) [$>:]+^$\+(?F?_>"?M=[7?S7^A<.-'1VHAJ               9QX
MQ?*4X]?GQU-^7L ,5CWYCK?BDW@W&Y>CE^T)L'_;/!/TE3%Q<1I/UB@
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MK8?]'_"G\<=W_>36@D'N#\KQ/X.#OI"-'2/\BPGX6H[V(I9B2A%4
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MTQ]@_$GQ[$4-^OG;3_1T?AJ@F3T>?,NJ^E)/ 4Q94&ES?
M!2R];"_I!X4_B;N[[]ZU$E-P?D>)_"P][(14Z1_EN$_!3]]$5%A(,C2
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MG^@C]YC30V-NF^L##_P_R:8U?OG^K7$OR?Y5 <U831('
M 7XO59OJ^]P_3'V#\2?'L10WZ^=M/]'1^&J"9/1Y\RZKZ4D\!3%E0:7-\
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M'C%\I3CU^?'4WY>P Q6/?F.M^*3>#<;EZ.7[0FP?]L\$_25,7%Q&D_6*
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M*^MA_P!'_"G\<=W_ 'DUH)![@_*\3^#@[Z0C1TC_ "+"?A:CO8BEF)*$50
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MOJ^]P_3'V#\2?'L10WZ^=M/]'1^&J"9/1Y\RZKZ4D\!3%E0:7-\
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M]C_.W"_I&F\,PZOMQYEXQ]%U?@)#E(">AYS                 7&_5+_\
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M 7XO59OJ^]P_3'V#\2?'L10WZ^=M/]'1^&J"9/1Y\RZKZ4D\!3%E0:7-\
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M'C%\I3CU^?'4WY>P Q6/?F.M^*3>#<;EZ.7[0FP?]L\$_25,7%Q&D_6*
M            !3HY._*4Y"_GQVS^7L^)+8#^8Z+XI#X-I^3KI&_M";>?VSQO
M])5)@X94TT               ;Q=-WY:.F?TB?%3>AU7;?S7JOP?A8R97[OO
M]KO9'^=/T+B):F$?C],               !I5U'K3*4?@5RZN$)X-F6K.@MC
MS<<5XCE=H=U'5UXY23=(E42.HW4,GW)\%.0V2YSV&+GLSCLVQD#*G:S#J>2V
MX^KC1;.'*Y. UKOCP.@VFW5;0;/XJCG8;683412HURM<K'QJCD1R9454XTRH
M<XW^(COK[GZ\\GI?SD$ROZ*8;SIO;-^Y/'/^Z=N<_%JW_:I!_$1WU]S]>>3T
MOYR!_13#>=-[9OW(_NG;G/Q:M_VJ0?Q$=]?<_7GD]+^<@?T4PWG3>V;]R/[I
MVYS\6K?]JD'\1'?7W/UYY/2_G(']%,-YTWMF_<C^Z=N<_%JW_:I!_$1WU]S]
M>>3TOYR!_13#>=-[9OW(_NG;G/Q:M_VJ0?Q$=]?<_7GD]+^<@?T4PWG3>V;]
MR/[IVYS\6K?]JD'\1'?7W/UYY/2_G(']%,-YTWMF_<C^Z=N<_%JW_:I!_$1W
MU]S]>>3TOYR!_13#>=-[9OW(_NG;G/Q:M_VJ0?Q$=]?<_7GD]+^<@?T4PWG3
M>V;]R/[IVYS\6K?]JD'\1'?7W/UYY/2_G(']%,-YTWMF_<C^Z=N<_%JW_:I!
M_$1WU]S]>>3TOYR!_13#>=-[9OW(_NG;G/Q:M_VJ0MF>K3;_ +UOFE\MWMV2
M@4%*W:-/M8Y.!CW#!+N)*)V$JZ.XPY?OU%5#&:)XQV&+C&,?R=N<Y&@-]>%T
MV&5.'MIU>J/CF5;RHO L>9$SD^>A=NLV1W88;M!!LG'-''63TCI-9*Z2U8V5
M"-LO<&1ZVY\A9[&CB;H              !45];#_ */^%/XX[O\ O)K02#W!
M^5XG\'!WTA&CI'^183\+4=[$4LQ)0BJ                !U/>EC]7!PC^C
M5JC\E6 @IMWYY8G\=E[Y3T/W>>8N$_$(>\0WY'4SN0              !S5^
MO[];?RS_ $$?NSZ:$T=TWU?X?^'^4S$#M\_UE8E^3_)8"'$;&-7G^BE,<Q2$
M*8YSFP4A"XR8QC&SV%*4N.W)C&SGLQC'\H^<&51PY$X3ZDY SE8E7<'9(:6K
MTVP,D5]#SD<\B95D9=!)RB5W'OT6[ML99LL10N#D+W1#E-C[&<9'"*6*>-)8
M7-?$O K5147BR*F3A*DT,U/(L,[',E;PM<BHJ<>5%L5,F4^2*A3     /=:Z
MU?LS<%F0I>I==WK:-Q=-UWC:IZZJ,_=K,X:->]X<ND(&M1\G*+-V^52]\.5+
M)2=UCMSCMP+2LKJ+#H%J<0FB@ID6Q7R/:QMJ\"7G*B=<NZ'#Z_$ZA*3#8)JB
MJ5+49$QTCU1.%;K$5;$ZA\>V5&UT.Q2U/O-8L-,ML ZRQG:O;(62KMBA7N"$
M5RSEH28;,Y..=824*;O:R1#]R;&>SLS@5:>HIZN%M12O9)3O2UKF.1S7)G1R
M*J*G44I5--4T<[J6KC?%4L6QS'M5KFKF5KD147D5#Z5MUQL.@M*E(7JAW.E,
M+_665UHCVVU><KC2ZTV2.HG'6VI.9ABS1L=9?J(G*B_9F6:JY)G!3YSC(X4]
M91U;I&4LL<KXGJQZ,<URL>G"QZ(JW7)QM6Q4S%2IH:VC;$^LAEB9-&DD:O8Y
MJ2,7@>Q7(EYB\3FVHN<V3Z=?U@G!7Z8_&/X[*0,+MAYI8I]'5/@7F>V'\],'
M^E*3P\9U;Q L]&0              "*/KA_55<P/Q.IGQL4 =]W8>?F'?"/\
M%(:YWM_5UB?P3/#1G,E$VB @                %^+U6;ZOO</TQ]@_$GQ[
M$4-^OG;3_1T?AJ@F3T>?,NJ^E)/ 4Q94&ES?               !2R];"_I!
MX4_B;N[[]ZU$E-P?D>)_"P][(14Z1_EN$_!3]]$5%A(,C29LLG&_?=-T_6=_
MV[45]J^F+I8TZG4-CV&NOX:LVB>6C)"909P#R02;FEDG$;$NU4W"!3ME/!5B
ME4R9,Y2XR'&<)J<1?A-/4128E$R^^-KD5S6VHEKD3@RJB*BY<J9,J&5GP+&:
M7#(\:J:::/"I9+C)7-5K'NL5UC56RVU$545,BV+ER*8SJ]3M-XG8^KTNM3]O
MLTLKE"*KM7AI&P3LFL4AE#(Q\1$MG<@\5*F3)LE33-G!<9S_ "8%[/404L2S
MU+V1P-X7.5&M3JJJHB>B6%/35%7,VGI(WRU#ER-8U7.7J-1%5?00]UL_0>]=
M(JL4-T:6VSJ):3[/:U'9^N;A059#M1PXQX"G:X:).[[4#8/CO>#?:9[?Y/LB
MUH<6PO$T5<-J:>H1O#JI&26=6XJV%YB&#8QA*HF*TE33*[@UL3X[>/)?:EN0
MQ*,@8T_=&QLC,R#*)AX][*RLDZ08QT9&M5WTA(/7*A46S-DR:IJN73IPJ?!2
M)IE,<YLXQC&<C@][(V+)(J-C:EJJJV(B)PJJKD1#E'')*](XFJZ1RV(B):JJ
MO B(F557,9>V)QJY&Z@A6-DVSH#=FKZ[*%0-&3^Q-57JDPLB5T;)&QF,K98&
M,8NRN#%S@F4U#=WG'V.T8^CQK!L1E6'#ZNFGF;PMCE8]R6<-J-<JH9.NP'',
M,B2?$J*KIX'<#I89(VK;P6*YJ(MO(?RT)QXW;RAV-':FT!K:R;1V#)M7,@E7
MZVV1-EG%,U&Z+R:FY1\NSA:Y M%W:*2K^0<MF::JZ1#*8.H0ION*XQAF!T:X
MABTS(*1JHEYR\*KP-:B6N<Y;%5&M155$5;,BGS!L$Q;:"N;AN"P25%:Y%6ZU
M.!$X7.5;&M:EJ(KG*C4542VU4/9<GN'')OAG;(JE<F=06354[/,G$C7SRBT-
M-0%C:,CMTY!2N6^JRD]4; >+4=HE=ILWRZC3*Z7?BD[ZGW5M@>T>";24[JG!
M*AD\3%L=9:US57@O,<C7MML6RUJ6V+9;8I=;0;+X_LM4MI,?I9*:9Z*K;;KF
MN1.&Z]BN8ZRU+;KE5+4MLM0\U>>-.\-::<U!OZ]T%[6M3;[7M:&H[3(2M?[[
M<_$EXW861RTKB$NM:HZ.9N7:6$G3UBV;/"'P=LHL3/="M2XUA=;B-1A-+*C\
M0I$9K6HCNTOI:U%=9=551%M1KE5.!R(I0K,!Q>@PNEQFLA6/#:Q7ZEZJWM]6
MJ(Y4;>OHB*J6*YJ([A:JH8+&5,0=:#AA\CSB?]&G1/Q7580"VD\XJ_X[/X5Q
MZ1[*^:^&_$*?P3#9884SP              !S[/6<OK'X3Z-6L?RJV2);[DO
M,UWQV7O8R%F__P ^F?$(N_E*[@W :1               /9:[_I HOXXUC[]
ML1;5GDDOP;N]4NJ'RV'X5G?(=@0>>)Z;@              &G'44^K[YU?0X
MY.?$G=QV/8_SMPOZ1IO#,.K[<>9>,?1=7X"0Y2 GH><P
M%QOU2_\ [?O^ZM_WCQ'/?]_)/Y5_%R4'1M_EK\D_C1<;$="4(
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MQ]@_$GQ[$4-^OG;3_1T?AJ@F3T>?,NJ^E)/ 4Q94&ES?
M                                         $;?5L^0O??SP\/OWR=
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M7Y\=3?E[ #%8]^8ZWXI-X-QN7HY?M";!_P!L\$_25,7%Q&D_6*
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M^C_A3^..[_O)K02#W!^5XG\'!WTA&CI'^183\+4=[$4LQ)0BJ
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MN'Z8^P?B3X]B.F_7SMI_HZ/PU02@Z//F75?2DG@*8LJ#2YO@
M   I9>MA?T@\*?Q-W=]^]:B2FX/R/$_A8>]D(J=(_P MPGX*?OHC5_I>\.-
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MO7U6;ZOO</TQ]@_$GQ[$>M^OG;3_ $='X:H),]'GS+JOI23P%,65!I<WP
M                                                     !&WU;/D
M+WW\\/#[]\G0(NJ/[^GL7=ZI:UODZ^R;WR$D@M2Z        "$#UB7ZJO=OX
MY:5^->J#9^Y_S[IO@IO!.-2[[_JZJ_A8/#,.<0)D$&                 .
M@GZL9]7#._26V=^2FM1$C?=YY,^)1=_(32W >8K_ (_+WD18C&GS=X
M'PK+_P!"/?\ T;_G: ^IPG%_<GW1\.0    !59ZD7RT=S?H[^*FBB0.Q'FO2
M_A/"R'YG_P!X)^UWM=_-?Z%PXT=':B&H              !G'C%\I3CU^?'4
MWY>P Q6/?F.M^*3>#<;EZ.7[0FP?]L\$_25,7%Q&D_6*
M!3HY._*4Y"_GQVS^7L^)+8#^8Z+XI#X-I^3KI&_M";>?VSQO])5)@X94TT
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MI8_5P<(_HU:H_)5@(*;=^>6)_'9>^4]#]WGF+A/Q"'O$-^1U,[D
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MT16KPHN5"+#'OC<CV*K7IP*BV*GHD_>M&\UP$Z4\]=V",H?EYU890^LM71;
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M?IC[!^)/CV(H;]?.VG^CH_#5!,GH\^9=5]*2> IBRH-+F^
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MZOO</TQ]@_$GQ[$8-^OG;3_1T?AJ@EOT>?,NJ^E)/ 4Q94&ES?
M                                     'C=BV.>I] NULJU+E=CV6LU
M.P3U?U_!/8V,F;O-1,4Z?1E4BY&760BV#^?>H$:I++FPDF=7!C8SC'9GDU$<
MY$5;$5>',<7*K6JY$M5$X,_(5Q"6+UD;D) O.05 QH7BY5<F>2U3XL72O5]/
M95@A4ESE81<SF_:WMLG&S:Z#?^Z>V<[5%5#J9/ALV*9-,F3LPR-=4Z\]><G!
MUE]13&6XI*FL;=8G-7AZZ+Z:&_72&ZC]CZ@>IMCL]K4R-H'(/C_;(ZE;<K\(
MF\:PSW,PA*8@+*SB9-P[DZZXD9"MRS-U'JK.,(.HXYR*Y(KA)&WK:5*9Z7%M
MC<EJ?9H+BBJEJ6+?2R5JV*2YBR+T   (V^K9\A>^_GAX??ODZ!%U1_?T]B[O
M5+6M\G7V3>^0DD%J70        0@>L2_55[M_'+2OQKU0;/W/^?=-\%-X)QJ
M7??]757\+!X9ASB!,@@P                !T$_5C/JX9WZ2VSOR4UJ(D;[
MO/)GQ*+OY":6X#S%?\?E[R(L1C3YN\      #X5E_P"A'O\ Z-_SM ?4X3B_
MN3[H^'(     JL]2+Y:.YOT=_%311('8CS7I?PGA9#\S_P"\$_:[VN_FO]"X
M<:.CM1#4               SCQB^4IQZ_/CJ;\O8 8K'OS'6_%)O!N-R]'+]
MH38/^V>"?I*F+BXC2?K%                 IT<G?E*<A?SX[9_+V?$EL!_
M,=%\4A\&T_)UTC?VA-O/[9XW^DJDP<,J::               -XNF[\M'3/Z
M1/BIO0ZKMOYKU7X/PL9,K]WW^UWLC_.GZ%Q$M3"/Q^F                T
M&ZIWU<'-SZ-6U_R5?CMFPGGEAGQV+OD.F[P_,7%OB$W>*<L(3K//
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MAM9ME)L:R&9*F.\B2*G:J]C;[DLX6ML1;KUR.5$1$RM5:5=NTQ2AV%BVZ?/
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M^ZX6JUS2'S7?](%%_'&L??MB-B5GDDOP;N]4UC0^6P_"L[Y#L"#SQ/3<
M           TXZBGU??.KZ'')SXD[N.Q['^=N%_2--X9AU?;CS+QCZ+J_ 2'
M*D@XES/S4/!,SH).YJ4CXEJHY,H1LFYDG:+- [@Z2:RI$"*K8R?)2'-@O;V8
MSG[ GA+(V*)TKK;K6JJV<-B):>=44;II6PMLO/<B);P6JMF4O6]6_DIT]."5
M;XG\6MN<69'EC/:BU3%RNIM,2UK?475%5I3?)*!&7BZ*)1TU7K+:YQU0'C1H
M5>&F%FJ2;\V<M"OS^&Q:W?X+M?M5-7X[A]<E!%45"I+,C$?*Y_WQ6,RM<UC4
MD15L>Q%56=U<2[+[>5CVQ.Q\&&[/8GASL2FIJ9%A@5ZQPLC3W-)'Y'->]RQN
M1MK'JB(_N;ZWXJMU\=^!'4@X![NYJ\']('XH;^XG($L&\]'1DFYEZ9-4O+1S
M-R+Q@FT22B$D&U>823Z+E&4=$&6/%.VCUI@G@[E#OF&8QM7L9M92[-;3U7C^
M$UZW8)U1$>C[4:B+;E[I6M<USGV7FN:ZVUJZZQ;!-C=NMC*O:O9*D^;<9PU+
MU13HJJQT=BN54L[7(U'.8]K66W'->VRZY/M;+[B,]5QX]>+1NY-8>2LUZ0L-
M5,G[X=#=N\? BR1<&[$>Q.#@S%+G[&>Y2-V=IL9%*B[??G6:_P"THFZNWX&"
MVSVS^N5:_P!SZ/=#XO\ ;U[M99\/466^UCZQ7&TJ\EH[<FI9" .NG.L=F4-Y
M"G;=UX226;6F*6CCM^YS@W?RO"$R3L^SW78-R8DV-^'5#);-4L#T=;P6*U;>
ML:,PI\K,4IGPVZY*B-6V<-Y'I99Z)/7ZT&UA6_43HJL5A+#Y]Q5UNZLG>S&R
M?,T38^XV2&5\9^P57Q=9L.S&/L=QW.?Y<Y&J=QSI5V/E23N4KY$;['5PKWRN
M-R=()L3=N(5C[M<.B5WLM;.G>HT@9TKIC9'(;:E(TOJ*LO+=L384XV@*S!,\
MD3RN[7P=1=T\=+9(VCHF,9I*.7CI8Q$&K5%150Q2$-G&U<3Q*BPB@EQ+$'I'
M1PM5SG+FS(G"JJN1$3*JJB)E-.85A5?C>(PX5AD:RUT[T:QJ<:YU7@1$2U7*
MN1$157(A8?YM;JUOTDN+COI@\0[4PG.2FS(UC+<ZN1%;R="31=R4=E/.L:Y)
ME7\/BE31+H[4C7[7$1"NE#=SB3E'BJ.H-F<,K=X&.IMQM#&K<%@<J4-.[@L1
M?OKDX%RI;;]N]$^T8U%W=M9BM!NUV>7=_LS(C\>J&HN(5+>&U4^]-6VU,BV6
M?:1JO_62.5/A];WZOOH,_0X>_$GPY%7=CYV[5_2*>&K"CO:\R]COHM? 41 S
MIGDOR'XZN)EUH7=^U-.K6)N5K/YUO>K)4$YI%,IBH>VB$)(,T'RK7N\Y044*
M91 V>U,Q<_9&U<2P3!\81K<5I8*E&+:W6,:^[U+R+9;QV</&:=PK'\;P-SW8
M-5U-*KTL=JI',O=6ZJ6V<2KE3B)H]K6.T\%^E9$T.=F9J2YC=667:[:VY+3+
MMY)WR'XP0JART^)G91^1>==R.T'LB=?/A"ISN&TI)MSX[M+/;K:@A@VIV[=5
M1-:W9S &K%$B(B1K4KW:M1.U1(D2S(F16L5,BFU<1GJ-D-W;:.9[W;4;2.2:
M9SE59&TC>X:Y5[95E5;<JY4?(U<J$DOJJ%8LM0D^H!"VRO3E7F4DN*"ZL38H
ME_"R::+@O(\Z"RC"2;MG1$ER?9(;).PV/LX[1TO?Q/#4,PF6G>U\?^M96JCD
M_P#P?C2U#O?1TIYZ:3&HJECXY;*/(Y%:N7QKB5$4M_B/))L
M  ARZ_OU2'+/]!'[S&FAL;=-]8&'_A_DTQJ_?/\ 5KB7Y/\ *H#FK":) X
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M&S=T"HNW=-D1/<YO!.-3;[6.3=W5JKE7W6#PS#GCB8Y!P
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M?:X[.S[/;('<(J+5XG8EGN</?2$:^D:U6T6%6JJ^ZS][$4X1),BN
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M9K13_*:#63@[)!.E$E7=>M->DDG,5/0SA5!-3O2Z9C(KIIK(F37334+L;',
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M>T<8["]B?=?^7.1Q5;5S%1J*B6*MI]L?#Z
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M8@S    1M]6SY"]]_/#P^_?)T"+JC^_I[%W>J6M;Y.OLF]\A)(+4N@
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MSZ-6U_R5?CMFPGGEAGQV+OD.F[P_,7%OB$W>*<L(3K//
M "Z9ZIY_1_S6_''2'WDV6(U[_/*\,^#G[Z,E5T</(L6^%I^]E+=0CX27
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M%?IC\8_CLI ZYMAYI8I]'5/@7G:-A_/3!_I2D\/&=6\0+/1D
M   BCZX?U57,#\3J9\;% '?=V'GYAWPC_!2&N=[?U=8G\$SPT9S)1-H@(
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MU%/J^^=7T..3GQ)W<=CV/\[<+^D:;PS#J^W'F7C'T75^ D.4@)Z'G,
M          !<;]4O_P"W[_NK?]X\1SW_ '\D_E7\7)0=&W^6OR3^-%QL1T)0
M@              $.77]^J0Y9_H(_>8TT-C;IOK P_\ #_)IC5^^?ZM<2_)_
ME4!S5A-$@<                !?B]5F^K[W#],?8/Q)\>Q%#?KYVT_T='X:
MH)D]'GS+JOI23P%,65!I<WP
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ME.0OY\=L_E[/B2V _F.B^*0^#:?DZZ1O[0FWG]L\;_2528.&5--
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M?K^_6W\L_P!!'[L^FA-'=-]7^'_A_E,Q [?/]96)?D_R6 AQ&QC5X
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MQ/\ HTZ)^*ZK" 6TGG%7_'9_"N/2/97S7PWXA3^"8;+#"F>
M  .?9ZSE]8_"?1JUC^56R1+?<EYFN^.R][&0LW_^?3/B$7?RE=P;@-(@
M          'LM=_T@47\<:Q]^V(MJSR27X-W>J75#Y;#\*SOD.P(//$]-P
M            #3CJ*?5]\ZOH<<G/B3NX['L?YVX7](TWAF'5]N/,O&/HNK\!
M(<I 3T/.8                "XWZI?_ -OW_=6_[QXCGO\ OY)_*OXN2@Z-
MO\M?DG\:+C8CH2A               (<NO[]4ARS_01^\QIH;&W3?6!A_P"'
M^33&K]\_U:XE^3_*H#FK":) X                "_%ZK-]7WN'Z8^P?B3X
M]B*&_7SMI_HZ/PU03)Z//F75?2DG@*8LJ#2YO@
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M7VZ6I+V6D:C(S]0KK.(DGE<?SL)6YEW#KN6YC(*.F#-8Q,XR=(F?M<#Z;C@
M   JL]2+Y:.YOT=_%311('8CS7I?PGA9#\S_ .\$_:[VN_FO]"X<:.CM1#4
M              SCQB^4IQZ_/CJ;\O8 8K'OS'6_%)O!N-R]'+]H38/^V>"?
MI*F+BXC2?K%                 IT<G?E*<A?SX[9_+V?$EL!_,=%\4A\&T
M_)UTC?VA-O/[9XW^DJDP<,J::               -XNF[\M'3/Z1/BIO0ZKM
MOYKU7X/PL9,K]WW^UWLC_.GZ%Q$M3"/Q^F                T&ZIWU<'-S
MZ-6U_P E7X[9L)YY89\=B[Y#IN\/S%Q;XA-WBG+"$ZSSP
M  NF>J>?T?\ -;\<=(?>398C7O\ /*\,^#G[Z,E5T</(L6^%I^]E+=0CX27
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MU?>X?IC[!^)/CV(H;]?.VG^CH_#5!,GH\^9=5]*2> IBRH-+F^
M     "EEZV%_2#PI_$W=WW[UJ)*;@_(\3^%A[V0BITC_ "W"?@I^^B*BPD&1
MI                 ZT'##Y'G$_Z-.B?BNJP@%M)YQ5_P =G\*X](]E?-?#
M?B%/X)ALL,*9X               Y]GK.7UC\)]&K6/Y5;)$M]R7F:[X[+WL
M9"S?_P"?3/B$7?RE=P;@-(@              'LM=_T@47\<:Q]^V(MJSR27
MX-W>J75#Y;#\*SOD.P(//$]-P              #3CJ*?5]\ZOH<<G/B3NX[
M'L?YVX7](TWAF'5]N/,O&/HNK\!(<I 3T/.8                "XWZI?\
M]OW_ '5O^\>(Y[_OY)_*OXN2@Z-O\M?DG\:+C8CH2A               (<N
MO[]4ARS_ $$?O,::&QMTWU@8?^'^33&K]\_U:XE^3_*H#FK":) X
M        "_%ZK-]7WN'Z8^P?B3X]B*&_7SMI_HZ/PU03)Z//F75?2DG@*8LJ
M#2YO@
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MU<'-SZ-6U_R5?CMFPGGEAGQV+OD.F[P_,7%OB$W>*<L(3K//
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MQ^,?QV4@=<VP\TL4^CJGP+SM&P_GI@_TI2>'C.K>(%GHR
M11]</ZJKF!^)U,^-B@#ON[#S\P[X1_@I#7.]OZNL3^"9X:,YDHFT0$
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M]\ZOH<<G/B3NX['L?YVX7](TWAF'5]N/,O&/HNK\!(<I 3T/.8
M      "XWZI?_P!OW_=6_P"\>(Y[_OY)_*OXN2@Z-O\ +7Y)_&BXV(Z$H0
M            "'+K^_5(<L_T$?O,::&QMTWU@8?^'^33&K]\_P!6N)?D_P J
M@.:L)HD#@                +\7JLWU?>X?IC[!^)/CV(H;]?.VG^CH_#5!
M,GH\^9=5]*2> IBRH-+F^
M                  (V^K9\A>^_GAX??ODZ!%U1_?T]B[O5+6M\G7V3>^0D
MD%J70        0@>L2_55[M_'+2OQKU0;/W/^?=-\%-X)QJ7??\ 5U5_"P>&
M8<X@3((,                 =!/U8SZN&=^DML[\E-:B)&^[SR9\2B[^0FE
MN \Q7_'Y>\B+$8T^;O       ^%9?^A'O_HW_.T!]3A.+^Y/NCX<@    "JS
MU(OEH[F_1W\5-%$@=B/->E_">%D/S/\ [P3]KO:[^:_T+AQHZ.U$-0
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MIY_1_P UOQQTA]Y-EB->_P \KPSX.?OHR571P\BQ;X6G[V4MU"/A)<
M         J*^MA_T?\*?QQW?]Y-:"0>X/RO$_@X.^D(T=(_R+"?A:CO8BEF)
M*$50                .I[TL?JX.$?T:M4?DJP$%-N_/+$_CLO?*>A^[SS%
MPGXA#WB&_(ZF=R               .:OU_?K;^6?Z"/W9]-":.Z;ZO\ #_P_
MRF8@=OG^LK$OR?Y+ 0XC8QJ\               W'Z=?U@G!7Z8_&/X[*0.N
M;8>:6*?1U3X%YVC8?STP?Z4I/#QG5O$"ST9               (H^N']55S
M_$ZF?&Q0!WW=AY^8=\(_P4AKG>W]76)_!,\-&<R43:("
M 7XO59OJ^]P_3'V#\2?'L10WZ^=M/]'1^&J"9/1Y\RZKZ4D\!3%E0:7-\
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M_5+_ /M^_P"ZM_WCQ'/?]_)/Y5_%R4'1M_EK\D_C1<;$="4(
M  !#EU_?JD.6?Z"/WF--#8VZ;ZP,/_#_ ":8U?OG^K7$OR?Y5 <U831('
M              7XO59OJ^]P_3'V#\2?'L10WZ^=M/\ 1T?AJ@F3T>?,NJ^E
M)/ 4Q94&ES?
M        $;?5L^0O??SP\/OWR= BZH_OZ>Q=WJEK6^3K[)O?(22"U+H
M   (0/6)?JJ]V_CEI7XUZH-G[G_/NF^"F\$XU+OO^KJK^%@\,PYQ F008
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M/Z1/BIO0ZKMOYKU7X/PL9,K]WW^UWLC_ #I^A<1+4PC\?I@
M  -!NJ=]7!S<^C5M?\E7X[9L)YY89\=B[Y#IN\/S%Q;XA-WBG+"$ZSSP
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M<%?IC\8_CLI ZYMAYI8I]'5/@7G:-A_/3!_I2D\/&=6\0+/1D
M    BCZX?U57,#\3J9\;% '?=V'GYAWPC_!2&N=[?U=8G\$SPT9S)1-H@(
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MQU%/J^^=7T..3GQ)W<=CV/\ .W"_I&F\,PZOMQYEXQ]%U?@)#E(">AYS
M             7&_5+_^W[_NK?\ >/$<]_W\D_E7\7)0=&W^6OR3^-%QL1T)
M0@              $.77]^J0Y9_H(_>8TT-C;IOK P_\/\FF-7[Y_JUQ+\G^
M50'-6$T2!P                %^+U6;ZOO</TQ]@_$GQ[$4-^OG;3_1T?AJ
M@F3T>?,NJ^E)/ 4Q94&ES?
M                   $;?5L^0O??SP\/OWR= BZH_OZ>Q=WJEK6^3K[)O?(
M22"U+H        (0/6)?JJ]V_CEI7XUZH-G[G_/NF^"F\$XU+OO^KJK^%@\,
MPYQ F008                 Z"?JQGU<,[]);9WY*:U$2-]WGDSXE%W\A-+
M<!YBO^/R]Y$6(QI\W>      !4"]=6^JRT']/_5G[NO*H 3?=%+ZH_IR_1 T
M?^1,6 )/P    56>I%\M'<WZ._BIHHD#L1YKTOX3PLA^9_\ >"?M=[7?S7^A
M<.-'1VHAJ               9QXQ?*4X]?GQU-^7L ,5CWYCK?BDW@W&Y>CE
M^T)L'_;/!/TE3%Q<1I/UB@                4Z.3ORE.0OY\=L_E[/B2V
M_F.B^*0^#:?DZZ1O[0FWG]L\;_2528.&5--               &\73=^6CIG
M](GQ4WH=5VW\UZK\'X6,F5^[[_:[V1_G3]"XB6IA'X_3
M:#=4[ZN#FY]&K:_Y*OQVS83SRPSX[%WR'3=X?F+BWQ";O%.6$)UGG@
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M3@K],?C'\=E('7-L/-+%/HZI\"\[1L/YZ8/]*4GAXSJWB!9Z,@
M    $4?7#^JJY@?B=3/C8H [[NP\_,.^$?X*0USO;^KK$_@F>&C.9*)M$!
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MZBGU??.KZ'')SXD[N.Q['^=N%_2--X9AU?;CS+QCZ+J_ 2'*0$]#SF
M           N-^J7_P#;]_W5O^\>(Y[_ +^2?RK^+DH.C;_+7Y)_&BXV(Z$H
M0              "'+K^_5(<L_T$?O,::&QMTWU@8?\ A_DTQJ_?/]6N)?D_
MRJ YJPFB0.                 OQ>JS?5][A^F/L'XD^/8BAOU\[:?Z.C\-
M4$R>CSYEU7TI)X"F+*@TN;X
M          QMN.8V97M5;#G-,U&$OVUXFH3K_7E+LDX:MP=FMK5@LK"P\E-%
M15PR;O'A2E^V,@10W80R[8ILKI\V(Q7HCUL9;E4XO5Z,56):^S(G*5V:]T]N
MM=R+K1=Z[HZFEMXU;?ED5)VM<?->LYUOK^N%<(F-&UNZJZ]NM8JL>LV)W!%B
MDB;49/'VRB[A?!QDEJ:&)=7'$CV9UX?0M2WTC&)35\J:Q\JL?S4X/1L7U%-J
M>B]SNWQR7C>1W&WEEX$^Y)\/+\G0[C;&+%A'^-[ \S;*POF50AT&L.I9*O9J
M2]:.G#9NU1=ME6JG>S+>$*&HUU/'$K)8?O3TM3K=DJT-1)*CHIOOK%L7E^RP
MG&%@9    (V^K9\A>^_GAX??ODZ!%U1_?T]B[O5+6M\G7V3>^0DD%J70
M    0@>L2_55[M_'+2OQKU0;/W/^?=-\%-X)QJ7??]757\+!X9ASB!,@@P
M              !T$_5C/JX9WZ2VSOR4UJ(D;[O/)GQ*+OY":6X#S%?\?E[R
M(L1C3YN\      "H%ZZM]5EH/Z?^K/W=>50 F^Z*7U1_3E^B!H_\B8L 2?@
M   JL]2+Y:.YOT=_%311('8CS7I?PGA9#\S_ .\$_:[VN_FO]"X<:.CM1#4
M              SCQB^4IQZ_/CJ;\O8 8K'OS'6_%)O!N-R]'+]H38/^V>"?
MI*F+BXC2?K%                 IT<G?E*<A?SX[9_+V?$EL!_,=%\4A\&T
M_)UTC?VA-O/[9XW^DJDP<,J::               -XNF[\M'3/Z1/BIO0ZKM
MOYKU7X/PL9,K]WW^UWLC_.GZ%Q$M3"/Q^F                T&ZIWU<'-S
MZ-6U_P E7X[9L)YY89\=B[Y#IN\/S%Q;XA-WBG+"$ZSSP
M  NF>J>?T?\ -;\<=(?>398C7O\ /*\,^#G[Z,E5T</(L6^%I^]E+=0CX27
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M_55<P/Q.IGQL4 =]W8>?F'?"/\%(:YWM_5UB?P3/#1G,E$VB @
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M?0XY.?$G=QV/8_SMPOZ1IO#,.K[<>9>,?1=7X"0Y2 GH><P
M   %QOU2_P#[?O\ NK?]X\1SW_?R3^5?Q<E!T;?Y:_)/XT7&Q'0E"
M        0Y=?WZI#EG^@C]YC30V-NF^L##_P_P FF-7[Y_JUQ+\G^50'-6$T
M2!P                %^+U6;ZOO</TQ]@_$GQ[$4-^OG;3_ $='X:H)D]'G
MS+JOI23P%,65!I<WP
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M'V1L[= ]SMNZ9%7)JYO!.-3;[8V-W=U:HF76P>&8<\<3&(-@
M    7VO5K]:TJV]/&;E+!"^V#\O(W930J_MC+->QNE5M<G33[TR?MD<]R94V
M>WN>ZSV_9S_((E;[7N;MDU$X/$HN_D)H;@HV.V&>KDR^/R]Y$6!/0=J[W+_Y
M:L7X6&H-8_.;MU,>;TQZ#M7>Y?\ RU8OPL&L?G&ICS>F/0=J[W+_ .6K%^%@
MUC\XU,>;TQZ#M7>Y?_+5B_"P:Q^<:F/-Z8]!VKO<O_EJQ?A8-8_.-3'F],@%
M]8VU9RXKG"#6$ATU]9;%M.\<\IZ.WMS'65&QMV=;:E4U-NXTX^>UNSQ-QCV$
M.2YIP"9WQ&J:R:ZJ*6%2E6,0[6/SGS51IPIZ9)3TY=,3[W@=Q&=\F*-/1'()
MSH+6RVY(NT-I.GV-AL12N,C6AK-U:,4AH^OR2,IE3"K1%HW31/VE*F7&.P-8
M_.?=5'F],W1]!VKO<O\ Y:L7X6#6/SC4QYO3'H.U=[E_\M6+\+!K'YQJ8\WI
MCT':N]R_^6K%^%@UC\XU,>;TRLWU!8.+K?+S;D+"M? HQEXA>#-N_N''>_"-
M8TMVM_=G:R[@_=N%SF^V/GL[>S'9C&,#?VQ*JNS%,J\/NGA9#\T7[P)$;TNM
MK43@_P#*_P!"X<:9CM1#8               S-QR8M93D+H>-?)=_92.YM7L
M7B/=J)=^:N[O!MW"7?$3IJI]\24SCNBF*;';VXSC/V1BL=6S!*Q4X?%)O!N-
MR='-+>D)L(B\'],L%_25,6RO0=J[W+_Y:L7X6$;-8_.?K"U,>;TQZ#M7>Y?_
M "U8OPL&L?G&ICS>F/0=J[W+_P"6K%^%@UC\XU,>;TQZ#M7>Y?\ RU8OPL&L
M?G&ICS>F/0=J[W+_ .6K%^%@UC\XU,>;TQZ#M7>Y?_+5B_"P:Q^<:F/-Z8]!
MVKO<O_EJQ?A8-8_.-3'F],>@[5WN7_RU8OPL&L?G&ICS>F/0=J[W+_Y:L7X6
M#6/SC4QYO3'H.U=[E_\ +5B_"P:Q^<:F/-Z8]!VKO<O_ ):L7X6#6/SC4QYO
M3*FO(UBUB^0N^(UBEWAE';FV@Q9H]VHKWEJTN\XW;I=\6.HJIWM)/&.Z,8QL
M]G;G.<_9$D\"6W!*-5X?%(?!M/R>](Q+.D)MVB<'],L:_25289&5--@
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MV_9[?L"0.X5SG5>)V^]P]](1JZ1K&MHL*NI_UL_>Q%.$23(K@
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MGL[>S'9C&,"9^Z=57=_0*O#[O\IF(([YD1N\G$D3@_U?Y+ 1#C8IK
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M],>@[5WN7_RU8OPL&L?G&ICS>F/0=J[W+_Y:L7X6#6/SC4QYO3'H.U=[E_\
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M8^1Z[6X6BKD^<:;PS#J^V\3$V+Q=43+\UU7@)#ENB>)YU
M  6[_55Z/5KG^O?XRQ?ME[6_JO\ @7_+9%GWGPS]8CPG_P"P';7OG?/!4_\
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MO;CLSC&1L7=.]R[P*!%7)[O\FF-7[YHV-W;8DJ)E_P!7^50'.8$SR"0
M           %ZOU8K7-,M_ K;<E8H;VQ>H<O+ZQ26]L95IW+5+3.@G!$N]L7
MS9(W<JN3Y[K)<FSW79V]F,8Q%/?F]S=K:=$X/FZ/PU03&Z/3&NV+JE<F7YTD
M\!3%C/T':N]R_P#EJQ?A8:7UC\YO?4QYO3'H.U=[E_\ +5B_"P:Q^<:F/-Z8
M]!VKO<O_ ):L7X6#6/SC4QYO3'H.U=[E_P#+5B_"P:Q^<:F/-Z8]!VKO<O\
MY:L7X6#6/SC4QYO3'H.U=[E_\M6+\+!K'YQJ8\WIGO:_7(:JQQ8F!9^ 1Y%5
M5RM_"'3KL57S@RIN^O%W"^>ZSC^3NNS'_ .*JJK:O"<VM1J6)P'VQ\/H
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M9O"O%L:IO&]7)XS627=90U,3^TEJ'QK;&]S>V:MEMJ6*B*G0H$0CU-
M         -!NJ=]7!S<^C5M?\E7X[9L)YY89\=B[Y#IN\/S%Q;XA-WBG++9O
M'<>[:OV#IPQ?,7"#QD]9KJ-G;1VV4*LV=-7*)B+-W#=8F#D.3.#$-C&<9QG
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M+/\ 01^[/IH31W3?5_A_X?Y3,0.WS_65B7Y/\E@(<1L8U>
M ;C].OZP3@K],?C'\=E('7-L/-+%/HZI\"\[1L/YZ8/]*4GAXSJWB!9Z,@
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MY?6/PGT:M8_E5LD2WW)>9KOCLO>QD+-__GTSXA%W\I7<&X#2(
M   ![+7?](%%_'&L??MB+:L\DE^#=WJEU0^6P_"L[Y#L"#SQ/3<
M      TXZBGU??.KZ'')SXD[N.Q['^=N%_2--X9AU?;CS+QCZ+J_ 2'*0$]#
MSF                 N-^J7_P#;]_W5O^\>(Y[_ +^2?RK^+DH.C;_+7Y)_
M&BXV(Z$H0              "'+K^_5(<L_T$?O,::&QMTWU@8?\ A_DTQJ_?
M/]6N)?D_RJ YJPFB0.                 OQ>JS?5][A^F/L'XD^/8BAOU\
M[:?Z.C\-4$R>CSYEU7TI)X"F+*@TN;X
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M#4               SCQB^4IQZ_/CJ;\O8 8K'OS'6_%)O!N-R]'+]H38/\
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M(_HU:H_)5@(*;=^>6)_'9>^4]#]WGF+A/Q"'O$-^1U,[D
M<U?K^_6W\L_T$?NSZ:$T=TWU?X?^'^4S$#M\_P!96)?D_P E@(<1L8U>
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M/D><3_HTZ)^*ZK" 6TGG%7_'9_"N/2/97S7PWXA3^"8;+#"F>
M    .?9ZSE]8_"?1JUC^56R1+?<EYFN^.R][&0LW_P#GTSXA%W\I7<&X#2(
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MCV(H;]?.VG^CH_#5!,GH\^9=5]*2> IBRH-+F^
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MZ 7UM_$S]._[L^Y1KG>S]7^(?@/E,)M#<Q]96&_E'R6<Z5 A<3Q
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M].OZP3@K],?C'\=E('7-L/-+%/HZI\"\[1L/YZ8/]*4GAXSJWB!9Z,@
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M"?1JUC^56R1+?<EYFN^.R][&0LW_ /GTSXA%W\I7<&X#2(
M![+7?](%%_'&L??MB+:L\DE^#=WJEU0^6P_"L[Y#L"#SQ/3<
M   TXZBGU??.KZ'')SXD[N.Q['^=N%_2--X9AU?;CS+QCZ+J_ 2'*0$]#SF
M                N-^J7_\ ;]_W5O\ O'B.>_[^2?RK^+DH.C;_ "U^2?QH
MN-B.A*$               ARZ_OU2'+/]!'[S&FAL;=-]8&'_A_DTQJ_?/\
M5KB7Y/\ *H#FK":) X                "_%ZK-]7WN'Z8^P?B3X]B*&_7S
MMI_HZ/PU03)Z//F75?2DG@*8LJ#2YO@
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M?DY\=EW$]-C_ #2POZ.IO L/.;;CSTQCZ4J_#R&G [&=7
M)CN@%];?Q,_3O^[/N4:YWL_5_B'X#Y3";0W,?65AOY1\EG.E0(7$\0
M        #0;JG?5P<W/HU;7_ "5?CMFPGGEAGQV+OD.F[P_,7%OB$W>*<L(3
MK//                 "Z9ZIY_1_P UOQQTA]Y-EB->_P \KPSX.?OHR571
MP\BQ;X6G[V4MU"/A)<               J*^MA_T?\*?QQW?]Y-:"0>X/RO$
M_@X.^D(T=(_R+"?A:CO8BEF)*$50                .I[TL?JX.$?T:M4?
MDJP$%-N_/+$_CLO?*>A^[SS%PGXA#WB&_(ZF=R               .:OU_?K
M;^6?Z"/W9]-":.Z;ZO\ #_P_RF8@=OG^LK$OR?Y+ 0XC8QJ\
M   W'Z=?U@G!7Z8_&/X[*0.N;8>:6*?1U3X%YVC8?STP?Z4I/#QG5O$"ST9
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M]9R^L?A/HU:Q_*K9(EON2\S7?'9>]C(6;_\ SZ9\0B[^4KN#<!I$
M       ]EKO^D"B_CC6/OVQ%M6>22_!N[U2ZH?+8?A6=\AV!!YXGIN
M         :<=13ZOOG5]#CDY\2=W'8]C_.W"_I&F\,PZOMQYEXQ]%U?@)#E(
M">AYS                 7&_5+_ /M^_P"ZM_WCQ'/?]_)/Y5_%R4'1M_EK
M\D_C1<;$="4(              !#EU_?JD.6?Z"/WF--#8VZ;ZP,/_#_ ":8
MU?OG^K7$OR?Y5 <U831('                 7XO59OJ^]P_3'V#\2?'L10
MWZ^=M/\ 1T?AJ@F3T>?,NJ^E)/ 4Q94&ES?
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M8)SJ^F/R<^.R[B>FQ_FEA?T=3>!8><VW'GIC'TI5^'D-.!V,ZN
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M?K^_6W\L_P!!'[L^FA-'=-]7^'_A_E,Q [?/]96)?D_R6 AQ&QC5X
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MQ/\ HTZ)^*ZK" 6TGG%7_'9_"N/2/97S7PWXA3^"8;+#"F>
M  .?9ZSE]8_"?1JUC^56R1+?<EYFN^.R][&0LW_^?3/B$7?RE=P;@-(@
M          'LM=_T@47\<:Q]^V(MJSR27X-W>J75#Y;#\*SOD.P(//$]-P
M            #3CJ*?5]\ZOH<<G/B3NX['L?YVX7](TWAF'5]N/,O&/HNK\!
M(<I 3T/.8                "XWZI?_ -OW_=6_[QXCGO\ OY)_*OXN2@Z-
MO\M?DG\:+C8CH2A               (<NO[]4ARS_01^\QIH;&W3?6!A_P"'
M^33&K]\_U:XE^3_*H#FK":) X                "_%ZK-]7WN'Z8^P?B3X
M]B*&_7SMI_HZ/PU03)Z//F75?2DG@*8LJ#2YO@
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M!.=7TQ^3GQV7<3TV/\TL+^CJ;P+#SFVX\],8^E*OP\AIP.QG5P
M    "8[H!?6W\3/T[_NS[E&N=[/U?XA^ ^4PFT-S'UE8;^4?)9SI4"%Q/$
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MV_EG^@C]V?30FCNF^K_#_P /\IF(';Y_K*Q+\G^2P$.(V,:O
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M9R^L?A/HU:Q_*K9(EON2\S7?'9>]C(6;_P#SZ9\0B[^4KN#<!I$
M      ]EKO\ I HOXXUC[]L1;5GDDOP;N]4NJ'RV'X5G?(=@0>>)Z;@
M         &G'44^K[YU?0XY.?$G=QV/8_P [<+^D:;PS#J^W'F7C'T75^ D.
M4@)Z'G,                !<;]4O_[?O^ZM_P!X\1SW_?R3^5?Q<E!T;?Y:
M_)/XT7&Q'0E"               0Y=?WZI#EG^@C]YC30V-NF^L##_P_R:8U
M?OG^K7$OR?Y5 <U831('                 7XO59OJ^]P_3'V#\2?'L10W
MZ^=M/]'1^&J"9/1Y\RZKZ4D\!3%E0:7-\
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M^)GZ=_W9]RC7.]GZO\0_ ?*83:&YCZRL-_*/DLYTJ!"XGB
M :#=4[ZN#FY]&K:_Y*OQVS83SRPSX[%WR'3=X?F+BWQ";O%.6$)UGG@
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M*_3'XQ_'92!US;#S2Q3Z.J? O.T;#^>F#_2E)X>,ZMX@6>C(
M  !%'UP_JJN8'XG4SXV* .^[L//S#OA'^"D-<[V_JZQ/X)GAHSF2B;1 0
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MI]7WSJ^AQR<^).[CL>Q_G;A?TC3>&8=7VX\R\8^BZOP$ARD!/0\Y@
M         +C?JE__ &_?]U;_ +QXCGO^_DG\J_BY*#HV_P M?DG\:+C8CH2A
M               (<NO[]4ARS_01^\QIH;&W3?6!A_X?Y-,:OWS_ %:XE^3_
M "J YJPFB0.                 OQ>JS?5][A^F/L'XD^/8BAOU\[:?Z.C\
M-4$R>CSYEU7TI)X"F+*@TN;X
M            "C=ZP;<>H3<I=Y.;CJR6G.&U2WG-ZFT=48NW-7+O;TM$M[!+
M1VZ;)%1RYWKPLI!0>%&19 C9**POA%HDJH9X[5S^&I3-2QBWIU;:N3@Y#K^)
M.J7+:]+L".L1+>'E+R(P!V  #S=SN%9UY3[7?[K,LZY3:/6YVX6VPR)CDCX&
MLUF+=34],OCID44(SBXIDJNKDI39P0F>S&?Y!]:U7.1K<KE6P^.<C6JYV1J)
M:I'_ /Q@.F9\\K3W\Y2WX(%SXE5<QQ;>.TGOC31;J1=3/@5N'B/;=?ZQY0ZR
MN=SE=I\7Y..KL,^DE9%VPJ?*;2]OL;I$BL:B3*<16H%X\5^VQG"+<V<=N>S&
M:]+2U#)D<]BHVQW>JA;U573OA5K'HKK6]9R*3:^G/4?N\@O[ZO\ X 6.K?F4
MOM;'G0>G/4?N\@O[ZO\ X -6_,HUL>=!Z<]1^[R"_OJ_^ #5OS*-;'G0>G/4
M?N\@O[ZO_@ U;\RC6QYT'ISU'[O(+^^K_P" #5OS*-;'G0>G/4?N\@O[ZO\
MX -6_,HUL>="%GU@;:>O;1TOMT0U?M<5*RCBWZ;419-5%3+*$;[2JZRQBX,D
M7'8FD3)L_9_DP-F[H&N3;NF54R:N;P3C4V^V1CMW=6B*ENM@\,PYXXF.0;
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M?N\@O[ZO_@ U;\RC6QYT'ISU'[O(+^^K_P" #5OS*-;'G0>G/4?N\@O[ZO\
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M?N\@O[ZO_@ U;\RC6QYT'ISU'[O(+^^K_P" #5OS*-;'G0>G/4?N\@O[ZO\
MX -6_,HUL>=!Z<]1^[R"_OJ_^ #5OS*-;'G0T4ZGFX=8S'3PYH149<X=[(R'
M'+:31DT146RJX<K5=^1)%/!D2XR<YL]F/LCM>PK')MEABJF3QV+OD.G;PY&+
ML-BR(J6^(3=XIS#!.D\\P                +CWJL=]IU,H7,I*TV!A"*2%
MNTLHS*].H7+@C>&V.58R?<)G[<)F5+C/_P!,1LW]M5U7AEGO<W?1DJ.CD]K:
M+%;RV>ZP=[*6P/3GJ/W>07]]7_P C]JWYE)*ZV/.@].>H_=Y!?WU?_ !JWYE
M&MCSH/3GJ/W>07]]7_P :M^91K8\Z#TYZC]WD%_?5_\  !JWYE&MCSH/3GJ/
MW>07]]7_ , &K?F4:V/.@].>H_=Y!?WU?_ !JWYE&MCSH/3GJ/W>07]]7_P
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M^[R"_OJ_^ #5OS*-;'G0>G/4?N\@O[ZO_@ U;\RC6QYT'ISU'[O(+^^K_P"
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MH_=Y!?WU?_ !JWYE&MCSH/3GJ/W>07]]7_P :M^91K8\Z#TYZC]WD%_?5_\
M !JWYE&MCSH1;=:O;6M[#TO>6T-"V^)D91]4:>FT9-U%<K+G3VG1%CE)@R)<
M9R5)(QOY?Y,#OF[%CDV[PY53)K'^"D-=;VI&+N[Q-$5+=4SPT9S:A-@@.
M             !>K]6*V11:?P*VW&6>S1L,_7Y>7U\BU>'4*JHS5TSH)NFX+
M@B9\=[,LU4+C[/\ *3(BEOS:Y=K:=43^3H_#5!,;H]/8W8NJ1RV+\Z2> IBQ
MGZ<]1^[R"_OJ_P#@!IC5OS*;WUL>=!Z<]1^[R"_OJ_\ @ U;\RC6QYT'ISU'
M[O(+^^K_ . #5OS*-;'G0>G/4?N\@O[ZO_@ U;\RC6QYT'ISU'[O(+^^K_X
M-6_,HUL>=!Z<]1^[R"_OJ_\ @ U;\RC6QYT'ISU'[O(+^^K_ . #5OS*-;'G
M0>G/4?N\@O[ZO_@ U;\RC6QYT'ISU'[O(+^^K_X -6_,HUL>=!Z<]1^[R"_O
MJ_\ @ U;\RC6QYT*</K3=VJESOW#56K3C*;385#=";P[(QS8;G<36N3(E4[L
MA.S*A4C9Q_\ 2$DMPB*VCQ*WWR'O9"*_2-<UU;A5U;?<I^^B*GXD$1J
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M54N<_8_X1+7<DBIL:Y%X?'9>]C(7[_7([;EBMRIXA%W\I7[&WS20
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MBZI'+8OSI)X"F+&?ISU'[O(+^^K_ . &F-6_,IO?6QYT'ISU'[O(+^^K_P"
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MMOXF?IW_ '9]RC7V]GZO\0_ ?*839>YCZRL-_*/DLYTJ!"XGB
M    :#=4[ZN#FY]&K:_Y*OQVS83SRPSX[%WR'3=X?F+BWQ";O%.6$)UGG@
M              !=,]4\_H_YK?CCI#[R;+$:]_GE>&?!S]]&2JZ.'D6+?"T_
M>RENH1\)+@              %17UL/\ H_X4_CCN_P"\FM!(/<'Y7B?P<'?2
M$:.D?Y%A/PM1WL12S$E"*H                '4]Z6/U<'"/Z-6J/R58""F
MW?GEB?QV7OE/0_=YYBX3\0A[Q#?D=3.Y               '-7Z_OUM_+/\
M01^[/IH31W3?5_A_X?Y3,0.WS_65B7Y/\E@(<1L8U>               ;C]
M.OZP3@K],?C'\=E('7-L/-+%/HZI\"\[1L/YZ8/]*4GAXSJWB!9Z,@
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M[+7?](%%_'&L??MB+:L\DE^#=WJEU0^6P_"L[Y#L"#SQ/3<
M  TXZBGU??.KZ'')SXD[N.Q['^=N%_2--X9AU?;CS+QCZ+J_ 2'*0$]#SF
M               N-^J7_P#;]_W5O^\>(Y[_ +^2?RK^+DH.C;_+7Y)_&BXV
M(Z$H0              "'+K^_5(<L_T$?O,::&QMTWU@8?\ A_DTQJ_?/]6N
M)?D_RJ YJPFB0.                 OQ>JS?5][A^F/L'XD^/8BAOU\[:?Z
M.C\-4$R>CSYEU7TI)X"F+*@TN;X
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MSXZF_+V &*Q[\QUOQ2;P;C<O1R_:$V#_ +9X)^DJ8N+B-)^L4
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M/U<'"/Z-6J/R58""FW?GEB?QV7OE/0_=YYBX3\0A[Q#?D=3.Y
M    '-7Z_OUM_+/]!'[L^FA-'=-]7^'_ (?Y3,0.WS_65B7Y/\E@(<1L8U>
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M0<,/D><3_HTZ)^*ZK" 6TGG%7_'9_"N/2/97S7PWXA3^"8;+#"F>
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M'Z8^P?B3X]B*&_7SMI_HZ/PU03)Z//F75?2DG@*8LJ#2YO@
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M^.IOR]@!BL>_,=;\4F\&XW+T<OVA-@_[9X)^DJ8N+B-)^L4
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MQQW?]Y-:"0>X/RO$_@X.^D(T=(_R+"?A:CO8BEF)*$50
M.I[TL?JX.$?T:M4?DJP$%-N_/+$_CLO?*>A^[SS%PGXA#WB&_(ZF=R
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M'A3^)N[OOWK424W!^1XG\+#WLA%3I'^6X3\%/WT146$@R-(
M   '6@X8?(\XG_1IT3\5U6$ MI/.*O\ CL_A7'I'LKYKX;\0I_!,-EAA3/
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MJ^]P_3'V#\2?'L10WZ^=M/\ 1T?AJ@F3T>?,NJ^E)/ 4Q94&ES?
M                                                $;?5L^0O??SP
M\/OWR= BZH_OZ>Q=WJEK6^3K[)O?(22"U+H        (0/6)?JJ]V_CEI7XU
MZH-G[G_/NF^"F\$XU+OO^KJK^%@\,PYQ F008                 Z"?JQG
MU<,[]);9WY*:U$2-]WGDSXE%W\A-+<!YBO\ C\O>1%B,:?-W@      5 O75
MOJLM!_3_ -6?NZ\J@!-]T4OJC^G+]$#1_P"1,6 )/P    56>I%\M'<WZ._B
MIHHD#L1YKTOX3PLA^9_]X)^UWM=_-?Z%PXT=':B&H              !G'C%
M\I3CU^?'4WY>P Q6/?F.M^*3>#<;EZ.7[0FP?]L\$_25,7%Q&D_6*
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M_A3^..[_ +R:T$@]P?E>)_!P=](1HZ1_D6$_"U'>Q%+,24(J@
M     =3WI8_5P<(_HU:H_)5@(*;=^>6)_'9>^4]#]WGF+A/Q"'O$-^1U,[D
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MK87](/"G\3=W??O6HDIN#\CQ/X6'O9"*G2/\MPGX*?OHBHL)!D:0
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MZK-]7WN'Z8^P?B3X]B*&_7SMI_HZ/PU03)Z//F75?2DG@*8LJ#2YO@
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M@YN?1JVO^2K\=LV$\\L,^.Q=\ATW>'YBXM\0F[Q3EA"=9YX
M    73/5//Z/^:WXXZ0^\FRQ&O?YY7AGP<_?1DJNCAY%BWPM/WLI;J$?"2X
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MUP_JJN8'XG4SXV* .^[L//S#OA'^"D-<[V_JZQ/X)GAHSF2B;1 0
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MJ^AQR<^).[CL>Q_G;A?TC3>&8=7VX\R\8^BZOP$ARD!/0\Y@
M    +C?JE_\ V_?]U;_O'B.>_P"_DG\J_BY*#HV_RU^2?QHN-B.A*$
M         ARZ_OU2'+/]!'[S&FAL;=-]8&'_ (?Y-,:OWS_5KB7Y/\J@.:L)
MHD#@                +\7JLWU?>X?IC[!^)/CV(H;]?.VG^CH_#5!,GH\^
M9=5]*2> IBRH-+F^
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M$X*_3'XQ_'92!US;#S2Q3Z.J? O.T;#^>F#_ $I2>'C.K>(%GHR
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MX4_CCN_[R:T$@]P?E>)_!P=](1HZ1_D6$_"U'>Q%+,24(J@
M   =3WI8_5P<(_HU:H_)5@(*;=^>6)_'9>^4]#]WGF+A/Q"'O$-^1U,[D
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MV%_2#PI_$W=WW[UJ)*;@_(\3^%A[V0BITC_+<)^"G[Z(J+"09&D
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MU?>X?IC[!^)/CV(H;]?.VG^CH_#5!,GH\^9=5]*2> IBRH-+F^
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M3'XQ_'92!US;#S2Q3Z.J? O.T;#^>F#_ $I2>'C.K>(%GHR
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M3WI8_5P<(_HU:H_)5@(*;=^>6)_'9>^4]#]WGF+A/Q"'O$-^1U,[D
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M#PI_$W=WW[UJ)*;@_(\3^%A[V0BITC_+<)^"G[Z(J+"09&D
M   #K0<,/D><3_HTZ)^*ZK" 6TGG%7_'9_"N/2/97S7PWXA3^"8;+#"F>
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M?IC[!^)/CV(H;]?.VG^CH_#5!,GH\^9=5]*2> IBRH-+F^
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M/T[_ +L^Y1KG>S]7^(?@/E,)M#<Q]96&_E'R6<Z5 A<3Q
M-!NJ=]7!S<^C5M?\E7X[9L)YY89\=B[Y#IN\/S%Q;XA-WBG+"$ZSSP
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M!7Z8_&/X[*0.N;8>:6*?1U3X%YVC8?STP?Z4I/#QG5O$"ST9
M   (H^N']55S _$ZF?&Q0!WW=AY^8=\(_P %(:YWM_5UB?P3/#1G,E$VB @
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MG'44^K[YU?0XY.?$G=QV/8_SMPOZ1IO#,.K[<>9>,?1=7X"0Y2 GH><P
M            %QOU2_\ [?O^ZM_WCQ'/?]_)/Y5_%R4'1M_EK\D_C1<;$="4
M(              !#EU_?JD.6?Z"/WF--#8VZ;ZP,/\ P_R:8U?OG^K7$OR?
MY5 <U831('                 7XO59OJ^]P_3'V#\2?'L10WZ^=M/]'1^&
MJ"9/1Y\RZKZ4D\!3%E0:7-\
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M@/XO4:8_NQ^HC:/\:I=$OW _5=V)[VO([]GJ<\YP_7-@/XO4:8_NQ^HC:/\
M&J71+]P?=JW'*_05FKLVXUCR36;PT[$2JZ2/'J:[\JC'R#=VJFEW=I(3OIR(
MYP7MSC';G[.<"E/OBP*6!\24]0BN8J<,?&EG/*U/N,VBAJ&3.JJ56M>U>"7B
M5%YA>4_M N@/F7=23]G.E?USB+WS=)[Y%[9>P2Y^<H_>Y?:IV1_:!= ?,NZD
MG[.=*_KG#YND]\B]LO8'SE'[W+[5.R/[0+H#YEW4D_9SI7]<X?-TGOD7ME[
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MI%C5454XTRIP6E[%(DT:2(BHB\2Y%X;#/0IE0
M
M   "H%ZZM]5EH/Z?^K/W=>50 F^Z*7U1_3E^B!H_\B8L 2?@
M
M
M
M
M
M
M
M                                 "('K5]*3^,'Q8H/&CT]?J[^(_("
MK;T\=?1=Z6_;3Q9UUM6@>*WBYZ1=9>!>&^DWPOP[P];O?@7>O!S=^[XD!N_P
MIXW?J>\1^.7%CQS](GZO^GZ/JCQ[\7?%'QM\3(1K#>WWBQ[>V?VA]LO!N^>"
M^V+WO/==SWX_9W60-GP
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MCBTC8ZW-8&18(V2*:M;(_3PT>E6;&(\5P8F<'R&'1QR1RJ]J*J-2RU+;,CN
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M>%,FHJG=I3T=6QRTMYLK4X%_PKP]4LUJ*RDD:E7==$Y>%.+K)UT+4XQ!F
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MM>C)!&-3<Y3;9<HM"*&02,8Q193.8^171MNL7@0OH6R,C1LKKS^-38T4BJ
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MD+%2+^T4YC(H5^PNW$?7V*6%'C=8R>&B629+DA<XYT\<;L/D>YJ*]%6Q;,O
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M:H(MT>[[A,A"8*7%A.U&3/8WN4<J)Z"F0@<Y\#'N[I6HJ]54-D!2*H
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M4S%>>$X:Y:AH&RMULZ=HO G!;R]@Q%?7NB=JH%[=.%>&SD[):7&),N
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M_H K\W_K&,@./DL_NC2 @L(D=-2M;#W]>FDPH=3./:@N.[3QCOYZLDZ4U1#
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MRU:YR\,"4D#YH%ULBI9DLL3KJ8>:=:N=D,[=5&BVY;;5ZR?9QEV48(SP
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MCURR<E>-7C%4S=QE%M85=,V%&RQ+; _@+ZDJGS*Z*9+L[.$F'%D7P
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M4C76<NXC*6&"W8HV,7&'JG2/J'.E2Q]O!FS=8S-*R-E.UL2VLLX<YO&+<N
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MUG^YJ?\ !E8FPNPUB3JK8[5RI[)>13$RNG9B;UIVHZ2Q,B^Q3E0E%T7RX]8
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ME<%5<Y33R-)4K45BJF2)&*C4S):TQU93)34:6Y95D17+RV.+N@P)GP
M                                           " 2/Z_NB=;\A=Q:!Y
MFZAVMQ2<4>ZST91K=8*Q8;?'6BE1SU1A#6*PP-=@U[9#.[+AL=VS-&,9F+6:
MGQW+S[7!E,C\W2.C;) Y'VIEXLOV=0QR8C&R5T<[598N1>&U/3],B.Y^;MU)
MU:^HGPGK73Q@9VZ737DFB\V5OQK1K%4VA*VVN]0FH>8F4[-$1-@:5O3S6(D7
MGAL@R;X5<3)6C?"RIDTS7E/&^CII%J51&KP);R>KZA95,C*VIC2FM5R<*V6<
M:>EZI*-UO^GMN[;4[J/GKPX))'Y.<9THX[ROUY,J]IME5JM@5MU4EJ='&;K(
M3ELHTX]>J'C5"*&F(]V9 A55$$6KBTH*F-B.IY_O3^M;DR]7K%W7TTCU;4P?
M?6>IE2SE3KGB^/\ ZRQQDD:@2&Y;Z[V?HW=E;-[47.'K]0=6JH/YEEV-9!>&
M(9^WMM=<9>(J96BY-GW;'M*EAVZ-@Q\<I,+EO6PJCHUX,IQCQ6%6V3(K9$X<
MF3LF9^*/6NG^<W,FO:;XR<3]B6#C6TC)DNSMXVQ5M!S-.?E157A;"ZCV3N3J
M436U5&?>$X]S)*3<KX9A1!% [11LXX34*4\%^5Z)+Q)G^S05(:]:B=&1,58N
M-5XO4]4U/Z@G_P <:=-C\R^M_C+Y.BM3?FR7V2^DTHU/YTB]BGIN-SNOAPPE
MN1W$YOO#6#)^7?/$J2<;2ISZ (N2R/Z2EEFXO\-%KLB9?^'Q;>+:SS/O><JE
M7B,IHXP=?/;0PZ=(IM6_[V_(O5XNQZ)7Q&!98=8S[XS*G4X^SZ!MGTI^;[#G
MEP[U_M9^Z:>E*LI%UWNN*041PHTV+6F;5-[-E:)]R9I&W>-6;S+4G<]PB5X9
MO@YS-SF%&L@\7G5B=PN5.IZW 5J.H2H@1_VZ9%ZOK\)6\X2\[N-G!/JI]6.T
M\D;=+U*&OO(+=]?K*\14K);5'DG%\C-@2+U%9O6XZ169D3:JE-@ZN"E-G/9C
M.<C)ST\M11PMB2U4:G'9]JABZ>HBIZR995L17+Q6_;*3@P7K ?2_L4W#5]AN
MFV%?SDK'0[(SO3^SFK0KN3=HLFQG3E2L][;M\++E[M0WV"%[<Y^Q@6"X=5HE
MJM32AD$Q*D5;$<MO44U;]:,^0#J#Z8= ^);D"*V$^4N]@OIH4<7\F;[-/24R
M=J7K^=,>IZJUG5IO<5P;S-:U]3*_+H):>V:X30DX:N1L<_13<(UHZ*Y$W38Y
M<')G)38QVXSG&1P?AU6YZN1J6*J\:=DYLQ*D1B(KEM1$XE),^'O/7C)SNA+M
M8.-EUDK>PUY*Q,/;"RM3LU2=QKN=:.WL28K:R1D<H[;O46"_<J)=WC!D38-V
M9[.VUFIY:=425++?1+J"HBJ$58EM1.')80E]%KZT+K:?2/N'[PN^A?5WDL'L
M/40L*#RNH]FO?*2B]47IN4#J*Z,5J[C,;5]XT1)_,Z0V<NDH0\!.K$2.ZK-@
M<-$%WSBC6LS5))\FF511LL1%VD0ZJ&$U+2DJG4TEO#&O"GV<9=U=*VJCLX)$
MX%^SB(*_5T:EN"B\X.H#5^0#&R1^[(VMPJFT4[<X,]L;JZ26P925FY>5DS+.
M2S*TZ[>Y>E?$562?IN"N$U%$U"G-D,3<QU/&Z.S5VY.I88_#&O;/*DENLLRV
MY[3,^KO_ (Z7Y(?F7@OW7="C@[\TM]E_E*5&?G=_L?\ ):>HZ_?RN^B_](^Z
M_&;Q+''#OO$_L$])Q]Q'[_![-?3:64KO2:ELFGV;7]]KL5;:5<X.2K=IK,XT
M3?1$Y!2[51E(QK]JKC)56[ILJ8N?Y#8[>TN<9QC.,6USFN1S5L<AE7-:]JM<
MEK5*"'._IR[.Z?/,SC=6(64L]HX>6WDE7+?H62?OG4A'4VS6RVT5"Y4:?(?L
M;LKTG#TR**9Y@A<3D5'-5L&,JW=(M>Q4]4RIA<JV).C<O+PV+U/2.N5%*^FG
M8B6K K[4Y+52U.KD]$M\]5#@>TZA/$ZR:;CY"-@=E5^8C]A:@L<L4^(N/O<$
MV?,BQDVLW07>HP%H@I5Y'.3I%/EL=PDZ[VMEL5(^%I*CQ:9'\+>!>H9JLI_&
M858G=IE3JD'?"[K:VK@M7XOA9U0=.[>I=VTW'HU*J[-80GMY*2=2A\&CX%O<
M(>1D62\\RCV;++=A9(1S*-Y9L5'M1[2*/%\A/0-J%U](Y%:[+9V.PI805ZTZ
M:BK:Y'-R6]GLH:C=7#J'].+FKK.0I/%7CHZLW*;9-WI4H\WDGQ]I-<O$@V@S
MI,5:^XN2>%=K627EHULW9I-TT54#-TB)Y4["%3%:CIJF!UZ9UD2(N2U;-' 4
M*VII9V786VS*J9;J6Z>$_/ZS=6K!2_5V.E]3K;#25<M53VQPIK5FKTRT682\
M#8(+@WOR+F8:58N"D<,I*+D6JB"Z)RX.FJ0Q38QG&1AJA4=.]R945Z^FIFJ=
M%;3L:[(J,;Z2%F7HI?5'].7Z(&C_ ,B8L42L2?@    HQ]!KJ8\0^"NGM[U#
MDA>YVI3MZV7 62N-HBBVZVINXEA5R1CE=9S7(F10:'(\QW."*&*?./LXQV?9
M&?Q"EFJ'M6)+41,Z(=?PZK@IXW-E6Q57,JF^'-KKKQ')>E2O$SICT#:^W]U[
MOC'E'/>4:3*0R=8KEC:N8JP.*?#+J)V=6SDCW!B^V;QM'QT*DKE[E<YD>PEO
M!AZQ.UU6J-8W+9;Z?V92XJ,025NII$5TCLEMGI?9D-D-0ZWC^A'TB-FWBU.(
M=WR&FV"]KGLH+MI!D_WY?FC&IZ[I,697*J4S :^+AL=YA'NTG"3*2>)XP17/
M92>]<0K4:GWKU$X5]'L%5C4P^B5R_?>'T5R(GH=DC=Z=_14Y@;*T%6^4M>ZC
M>Y.']MY,1Y+_ &*JZVKUYS-V2ONY28D*78KM:JMOC61YY[8(^65EVR*[1;P1
M&4_\YWQ14N+JIKH6R+"L37M;DRV>C9D4M::@G?&DR2N8Y^7);Z%N5.J?VZAW
M1/Y@T'CW:^2UCZCF[N8MJXVQBVP:S2MAUN^*3$%"MI2%>7BQ4RT6;?NRE:X]
MK\'%8F')6S(AG243C'=X.1+L^4U= Z1(DB:QKLEJ6>A;D3J"IH)VQ+*LKGJS
M+8MOHV95ZOH%E+IN\M6/-CAMIG?'A+52V2M?3K.SV3;."XC-H5+!(:Y)&;X1
M0PS1E7Z&)-JEC&<$8OT.PQL9[K.,JH=1.Z/BMR=1> RM+-KX&R?;69>JG"0A
M:N_^.E^2'YEX+]UW0HOW?FEOLO\ *4L&?G=_L?\ ):6HQB#+FL',/EKJ;A+H
M2X[_ -PR1V]?K:'@4'!,\ES.WFY/FSM2N4:M(FQDBLU/KM#XP<_8@U;IJN5S
M$;H*J%JPPOGD2-G"O63.49YF4\:R/X$ZZYBH/PIYP<)MR\O[AU&NI_R-BHW<
M$1,>UG'7CVUUAO2ZU73T)$+Y<5ZP8D:IKFP5MR:O$=*DAVI7*Q\/U7,J[+A\
MH@9+-3P3LA2FI&]I]LZU$MZ^G1P&%@J())EJJM_;_:ML543K:-)<'XN\N>//
M,_7\KM+C3L(NRJ)!V^0H<K.8JMVJ&6ELBH>!GW\2:+OM;JTRH9"(L[%;OQ&Y
MFY\.,%*IDQ3E+A989('7)4L=9;Q+Z1FX9HIVWXEM;;9QIE]$AUZB/4RXM5B^
M.-,<5=*:[YG=0V2DW]"IS>$U7"[$1UC:F_?H1\O9+>I#N',K+UKP14JD/&NE
M.\9:'+(K,4"9R>]IJ656ZR9RLIN%<MEOH>KH+&IJX4=<A:DE3P)DML]'U-)M
M?TE. %KX9ZKO6P=\3)+=RYY-V<VR^0%E.Y8RAXN4=.I.38TIM-L<&;2IXQ]-
MO'DDZ;FRV<RCU;")E&R+=0U&LJ$G>C8\D+$L3LE:BIG0,5TF69ZVKV"6L69>
M@            !4Q]9\X^6.8;\3>0] 92I[(O/VOC-/'A,JDD9@FQ8]:9H=?
M(HU61<>#R.&]F9*HFP=%T22[T;N<&R57,85(B7XG<&1VCA]0PV+1*MR5O#;=
MT\'JEC?AMQ_CN*_%C0W'V/(WP?5VMJ[7YM=IW/@\C;U&OMI>)I+N<=SW,[<I
M!^]^QV_97_ES_*,9-(LTKI%XU_P=8RD$20PMBS)U^/KE2SB5T^G^O/6![%IG
M,:_3TSQVM.P.6=+A<X6S Q]1M,/#.]8JPQ5U<,TW$);K378]PX23,JX4KYDC
M=G>>Z1S$U3>PU'_]8Y$:OH</6MTF&AIE;B2L^T:JN3J<775-!:GZAWR ><OT
M/.3/Q+788FF\IC]FWTT,O4^32>P=Z2E;'HS]77@UPYX05S2F^=D6.L["CM@[
M"L#N*C-<7FS-4XRP2R3J+6Q*P,(^CSG60)G.284R8G\AL8R,G74=1//?C2UM
MB<:&+H:VG@ITCD54=:O$I.WQAZOG!'F!MJ+TAHS9\_8-CS<5-S$3#2^N;U6&
M[YI76!Y26*E*3D$RCBN&\<BHMA,ZA<G(F;N>W.,8SCY:*HA9K)$L;U4,A%6T
M\[]7&MKNHI /M/E7I;AMZR#R9W3ORPR%8U\TUI2:VO*1E>FK,Z++3_&'1:48
MAB+@&3^0,18[<W='PGW!.S[;..W R+(9)\,;'&EKK5[Y3'/FC@Q1\DBV-L3O
M4)=?[0WTL_?GNGP,;1\V!9_-M7S4TIV2]^<Z/G+H4^EUP[7 WSHU\A[Q57Y9
M2KW.N\;[76Y,J*[<LC V+D%I*7AWY4'22+E KR/>)J8(H0BA>Z[#%QG&<#Y0
M(K:YK5X45WI*,0<CJ%SDX%1J_P#20U[U;T\]9]13HI\0]9VDS6M['K>EV$YI
MK9W@IW#VBVU1R\PHD\21.161J5E2;$:2S//=8.CW*Z6"NF[=0E5]2^FKWO3*
MQ794S^OF*;*9E50,8N1R-R+F/ =(SJ);.U1LUWTK>H(9W4M^ZO?DI.E[O:'9
M3(WF,8I-T*[KEU,&030EWZ\1A-Q5IC*JB=@CCIM^[RZ*W\,Y5E,U[?&Z;+&N
M54S<O93B.-%5/8_Q.IR2)D1<_)V%XRS4,494IZT#;=*Z8W6XY@;#YV1,[!U'
MDH>[3>B>0C^L3-FAH2L6NW1EFBHZ--$QTG)GA6%>RC67[B/27<1CF,1062*T
M746)FG,=5T#&T]EK;+4ZB?8IA&O;25[W5&1K[;'>C]B'D^JOR0T_U7>2/"_C
M[T^/;7;.XJ==9&;FMZ5RHV.$8Z_KTF_K/9GVQGH:(EG,!4'#',Y)/E$B1T>9
M%$B"JJ[A=-/E21/HXGR5.1BIP9_\/ ?*R5E9+''3=L]%X;.#_!PES88,S@
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M=M&S]HZ8O4$G3-ZW6:.VRY,*(N&SE,R*Z"R9NTITEDCY*;&?L9QGL%F7O"5
M.G9RSI/11W#R=X"<WR6?7>NGVT9+;>G-R(U&T6BO6.-D8R*JJ,FHPJ\#*V.0
MB[;5ZM%*-W3%HZ29R#1VU<X15)GLS53"ZO8RHI[%=98J&$I9FT#WTU1:C;;4
M6ST.N9$N.](;K(]5;A0ZXKP%GEN./ RVK;=O6^96N3%6B9J5+9:9<THIJA,1
MS:8;,IJ1UO%1T8S?HM9%R=T^6RV2;(G7'%L:T5)(DRIK9$L1.'D]4YND2NK(
M]2BZJ-;570OJ$BFX.MKICB_S$V+QEY9:HVCH>C0+*)=ZXWQ)04M;:YL9NLT1
M5E9E&N5.'DYI&L&=+Y18.XWVX.=1!5-XDR7*9$MJR@?+ DL*HYR\*<%FDN7U
M\<,ZQ3-5K>)<_P!GHD4_4HY<T?K4WOCAP#X&L+/L^#1VW%[9VGNMS3K%5:W2
MH6+@YBGGE"LK?%P<^C!5Z$NTF[D5WS9B5P[29-&17:[@I<7E+"ZA:ZHJ+$6R
MQ$MMMX^+J%G53-KW-IJ>U4O6JMG!Q<?5+>\3&-82*C(9C@Y643'LHQF54^5%
M"M6#9-JWPHIG&,J'PBECMS_PY^R,,JVK:9M$L2P^@/@       U8YOZ))R:X
MA\C-$X;%=26QM36^'K*9BIG*E=VL8K+T-X8BITB*%C[I&L%\ER=/NN]]G=DS
MGNL5J>353-DXD<FCCZQ1J(];"Z/C5JZ>+KE>CU7_ (Y2S"C<@.6]T0?KS-PD
MH#05 ?3!UU)%M4-=,6#^V(ME'1CN/:=61-"QJ*?:4C?-?RB4N"IXP7(XK*EY
ML+>!,J]5?L728W"8E1KIG<*Y$ZB</J:#^7K0''"2>4SC_P NZ6VD$)VJR$WQ
M\V!(0V719!U3M@,9:4J"#Q1H8JI(5"2S.QJQ,]J;DUA*@?&<*=R9A4J7G0NX
M%RIU4^Q-!\Q:);K9F\*9%ZB\'JZ2PYP@T23C+Q#XYZ)RV*UDM<ZFJ$/9DRE3
M(56[NHQ*7OCPI$CJD3+(722?KX+@ZG<]\[.[/G'=9QU1)K9G2<2N71Q=8R=/
M'JH6Q\:-33Q]<J\;3Y5Z6X;>L@\F=T[\L,A6-?--:4FMKRD97IJS.BRT_P 8
M=%I1B&(N 9/Y Q%CMS=T?"?<$[/MLX[<#*LADGPQL<:6NM7OE,2^:.#%'R2+
M8VQ.]0EU_M#?2S]^>Z? QM'S8%G\VU?-32G9+WYSH^<NA34[UERUP-\Z:G'B
M\55^64J]SY0:EM=;DRHKMRR,#8M![XEX=^5!TDBY0*\CWB:F"*$(H7NNPQ<9
MQG K86BMJG-7A1B^FA1Q5R.I6N3@5Z+UE,X:EZ_G3'J>JM9U:;W%<&\S6M?4
MRORZ"6GMFN$T).&KD;'/T4W"-:.BN1-TV.7!R9R4V,=N,YQD4WX=5N>KD:EB
MJO&G9*C,2I$8B*Y;41.)23/A[SUXR<[H2[6#C9=9*WL->2L3#VPLK4[-4G<:
M[G6CM[$F*VLD9'*.V[U%@OW*B7=XP9$V#=F>SMM9J>6G5$E2RWT2Z@J(JA%6
M);43AR6$!/2(KD#<.JIUL:G:8B/L%9LVT=WP-@@I9JD]BYF%E^2&R6$G%R+-
M<IT73)\S7.DJF;&2F(;.,C(UBJVC@<F141.]0QU$B.JZAJY45R]\IB#8-3W%
MZO)S!QMK6S&R[&Z;?(ZRE96JF(+G>.**_P G=KM:ZJ^?^%9;76D,W2R]>?.%
M4O&.)259.ELKHJN4>;59B4%QUB534X<_K+QYE*;FOPR>^RU:5R\&;UTXLY;;
MU3M77N\-<T_;6J;3&777E]A6T_5;-#J'.RDXYQDZ>>TBI$G+-ZS<I*-W35<B
M;EHZ2416(15,Y"X9['1N5CTL<AFF/;(U'L6UJF#N<O*>N<+^*VXN1=A*U=*T
M.L*^*<(Y5[WBSWZ<71@Z-7"E)GP@Z,G99!OAT9(ISMV)5U\X[A(V<5*>%9YF
MQ)QKEZG&4ZB9((72KQ)U^(BI]7PXNS]"XX7;F'MC"LIN[FK;Y+8S^>E"'/.9
MUZG+RCF"7>+*G4QAQ>+'(25@542[C#IJ]8Y4QDR)>YO,2F1TJ0,^]QI9Z/K<
M!9X;"K8EG?\ ?)%M]#U^$Q9ZRAJ#9UKU#Q?W=7JE+[&U!QZVC9)_>="C2.EF
MCN!L*%04B+-84VB3A1G7XMM6)**<OLIF*RQ.X,;L(8V<<L+>UKWQJMCW)D73
M]GH'#%&/<QDB):QJY4T?9Z)[#DUUO^EY=^$&S8& M7CW+;!TU/TB XX.-;6J
M)F$)B>K+B&BZS/F=5U.D5R,K#U5,R[YM(+MD$FW?(\SE3#<BGR*@JVU"*J6(
MCK;UOV+E_P )REKZ1U.J(MJJVR[8O^#[,AG#U??1.X-#=/&!C=R1DY79/8>S
M[IM*G5&QM7$?,U:@V*+JL3"M'<8Z*FYC2STA7GDVDDH4I\HRI#F+C)\XQ3Q&
M1DE2JLRHB(B]7[,A4PV-\=,B29%555$S)]F4F[%@7X        5,?6?./ECF
M&_$WD/0&4J>R+S]KXS3QX3*I)&8)L6/6F:'7R*-5D7'@\CAO9F2J)L'1=$DN
M]&[G!LE5S&%2(E^)W!D=HX?4,-BT2K<E;PVW=/!ZI8WX;<?X[BOQ8T-Q]CR-
M\'U=K:NU^;7:=SX/(V]1K[:7B:2[G'<]S.W*0?O?L=OV5_Y<_P HQDTBS2ND
M7C7_  =8RD$20PMBS)U^/KE2SB5T^G^O/6![%IG,:_3TSQVM.P.6=+A<X6S
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MU4],WVZ>/R >#7T/.,WQ+4D6]3Y3)[-WIJ7%-Y-'[!OI(;AB@5P
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M8N$B]F3&P]1+'*Y'1L1B6<"?X$,S3Q21-5LCU>MO"O\ A4W3% K@
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MOM54?GX])55C'-N.1%9FLR:#[-4J55H=;A:;1JS7Z94*U'MXFNU2J0T;7:W
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MM<7+1K>7:L91RBFY(EA8B+A4A38*H?&?K'OC6\Q5:O(MA\>QDB79$1R<J6F
M_P"'CP!^8UP\_9FTMYDBKXS4^^/]LO9*7BU-[VSVJ=@S;JK1&C]$L):*TAIK
M5.FXR?=H2$[':JUW4->,)I^U1,V:O99G48>(;R+MLW-E--18ISD)G)<9QC[
MIODDD6V1RN7E55],J,CCCR1M:U%S(B>D8LLG!7A'<;#.6VW\.>*UJM=GEY&?
MLMFLG'O4DY8;#/2[M5_+3<Y-2=1=24M+RCYPHLX<N%5%EUCF.<QC9SD<TJ)V
MI=:]Z(G*O9."T].Y;SF,55_@IV#\,?P!X(1+]E*Q7"CB1&2<8[;2$=(Q_&_3
MC-_'OV:Q'+-ZR>-J:FX:.VCA,JB:B9BG3.7!BYQG&,@M14*EBR/L]DO9"4U.
MF5(V6^Q3L&:]@:5TWME_497:FI=9[,D]?RIIVAR.P*'5KF_I,X=9@Y/,U%Y8
MXJ2<5N5.XBFJF7#(R*V3MDC=UVIDSC@V1[$5&.5$7AL6RWJG-T;'V*]J*J<%
MJ6V=0R8.!S,-4_CIQ\UY?+#M.@:)TU1MG6[VU\:]C4_6%)K-\L_M[(HS$YXP
MV^%@V5@FO;F7;ING?A+A7PAR0JJG='Q@V.;I9'-1CG.5B<2JMF@X-BC:Y7M:
MU'KPJB);I,RC@<S&.S])Z9W;%MH/<^H]8[<A&2WA+.'V?0JK?HMHX[2&\(;1
M]KBI9H@MW29<]V0F#=I<?9^P.;))(UM8Y6KR+8<'QQR)9(U')RI:?<H>N=>Z
MKKC2G:PHE-UQ46!LF8U:AU>$I]<9FRDDADS2#KS&.C&YLHMTR=I$L?:D+C^3
M&!\<YSUO/55=RY3ZUK6)=8B(WDR'S]D:CU1N.$+6MO:QU[M2N$5,N2O[(I=;
MO$(18V"E,L6*L\;*,"JF*7&,FPGVYQC ->]BVL547D6P/8QZ6/1%3E2T_AK/
M36H-+1#B TYJG6VIH)VJFNZA=9T:L4.(<K)96RDLXC:M%Q3-95/+A3N3&)G.
M.[-V?RY[3WO>MKU55Y5M/C(V1I8Q$:G(EADD<3F          >6IU'I6NX-.
ML:_I]6HM:1?R\HE7J=7XFL0:4G/RKR<GI%.)A&C%@1_-S<@X>.UL)X4<NEU%
M5,F4.8V?KG.<MKE55Y3XUK6I8U$1.07&CTK8D&I6-@4^K7JM+/XB45KUQK\3
M9X-63@)5G.0,BI$S;1\P._A)N/;O&BV4\J-G2":J>2J$*;!KG-6UJJB\@<UK
MDL<B*G*>I'P^FM^P.&_$/;%LE+[M/BKQOV7>ILK$LU=-@:.UC<K9+EBX]K$1
MA92QV*KR4P_+'13!!JAA58_>6Z)$R=A"%+BJV>9B76/<C<R*J%)T$#W7GL:K
MLZHBJ>,_AX\ ?F-<//V9M+>9(Y>,U/OC_;+V3CXM3>]L]JG8,WW[16D=K4V&
MUUM'3FJ]DZ^KKJ,>U^BW[7M1N--@GL+&NX:'=PU8L41(PD8ZB8=^NT;*(($.
M@V642)DI#F+FFV21CKS'*CEXT6Q2HZ.-[;KVHK4XE1%0PA_#QX _,:X>?LS:
M6\R14\9J??'^V7LE/Q:F][9[5.P9MU5HC1^B6$M%:0TUJG3<9/NT)"=CM5:[
MJ&O&$T_:HF;-7LLSJ,/$-Y%VV;FRFFHL4YR$SDN,XQ]@4WR22+;(Y7+RJJ^F
M5&1QQY(VM:BYD1/2/U5'2NF]?VVZ7ZA:EUG2+WLAWF0V)=:C0ZM6K;?7YG;F
M0,]NECAHIE,6EWE^]67RH^67/WY4Y^WNC&SDZ1[D1KG*K4X$5>#J!L;&N5S6
MHCEX51,J]4^U?]<Z]VO59*B;2HE-V52)DS0TO3;_ %B$N-5E31[Q"18&DJ]8
MF,C$/C,I!JDNCE5$W>UDRG+V&+C./C7.8MYBJCLZ9#ZYK7I=>B*W,N44#7.O
M=456-HFK:)3=:TB&,[-$4V@5B$IU5BC2#Q>1?FC:]76,=$,3/9!TJNME)$O?
M%E#'-VF-G.3G.>MYZJKLZY0UK6)=8B(W,F0_'LG56K]RUE2E;?UO0=JTU5ZT
MDE:ELFGUZ\UE618&.9B_4@;/'2D4=ZR,H;**N4LJ)Y-GN<X[<@U[V+>8JH[.
MBV![&2)=>B*W,J6GKHF)BH"*C(*"C(^%@X6/91,-#1+)M&Q43%1K9-G'1D9'
M,TT6C"/8-$2)(HI$(FDF3!2XP7&,#XJJJVKPGU$1$L3@/VJI)K)J(K)D515(
M=)5)4A5$U4U"Y*=-0AL9*<ARYSC.,XSC.,CX?37B#X@<2ZQ<?2'6N+O'6O7_
M ,(,[\>8/2>M(FX^%G.FH9UXS,*RWFO"#*)$-D_?^ZSDN,]OV,"JL\RMNJ]U
MW-:MA22"%'7D8U'9[$M-BA2*H         !Y:UT>E7QK%,;S3ZM<V,%8H.WP
MC.UU^)L36&ME9>DDJW:(IO+M'B,?8J_(IE<,7J.".6BY<'2.0V,9'U'.;E:J
MHMA\5K7=TB+8MOHGJ1\/IY9&CTIO<GNQD*?5D-A2==8U"2O:-?B4[E(5.+D'
MDM&5=[:"-"S;NNQTK(N'*#)1<S9%PNHH0F#G-G/V\Z[=M6[;P<1\NMO7K$O6
M66\=A_&^:^H6U*G+4+9](J&QZ+/E9EG:7?*U#6^IS18Z0:2\>66KEA92,/)%
M82K!!TCA9$_>G"":A>PY"FQ]:YS%O,54<G&F0^.:U[;KT16KQ+E0UK_AX\ ?
MF-<//V9M+>9(J^,U/OC_ &R]DI>+4WO;/:IV#*NJN,W&_14C*R^D>/ND=.2T
MZR2C9N4U5JBAZ]D9B.;K^%(,)5[48&(<R#)%SCOA$EC'3*I]MC&,_9'!\LLB
M62.<Y$SJJ^F<V111K;&UK5Y$1/2/.[ X;\0]L6R4ONT^*O&_9=ZFRL2S5TV!
MH[6-RMDN6+CVL1&%E+'8JO)3#\L=%,$&J&%5C]Y;HD3)V$(4N/K9YF)=8]R-
MS(JH?'00/=>>QJNSJB*IXS^'CP!^8UP\_9FTMYDCEXS4^^/]LO9./BU-[VSV
MJ=@V*L^L-:W:B.-6W/7E&MNLG<;&PSK7-GJ4!/41S$0RK->'BG%0E8]W7UHV
M*7CFYVR!F^4D#H)Y(4N2%[*2/<UU]JJC\_'I*JL8YMQR(K,UF30?9JE2JM#K
M<+3:-6:_3*A6H]O$UVJ52&C:[6X"*:$[VUC(6#B&S.+BH]L3[5-%!)-,F/L8
MQ@?%<KEO.55<I]1J-2ZU$1J&.KAQTX^;#OE>VG?]$Z:O.SJC[5>*FQKAK"DV
M:^5CVBD5IB#\7K?-0;VP0OM-+N%'33P9PEX.Y.95/N3YR;/)LLC6JQKG(Q>)
M%6S0<711N<CW-:KTX%5$MTF91P.9A*S\;=!77;U7WY<=04"U[EI$ C6*;L6Q
MUN.F[+589O)R$PV;UYY)(N2P[AK)2[M1)RW*FZ2\*6*53!5#E-4261K%C:Y4
M8JY4*:Q1N>DCFHKT3(IFT4RH>*V%K77.W*J_HFUJ!2MG4B559+RE-V%58*Z5
M626C7B$C'+/Z]9&$E$/%8^0;)KH&41-E)9,IR]ABXSCDUSF+>8JH[.F0XN8U
MZ77HBMS+E/O0$! U.!A*M5H2(K58K41&P%<KD!&LX:!@(&&9HQT1"0D1'(MH
M^*B(J/;)H-FR"::*"*92$*4I<8Q\555;5RJI]1$1+$R(A]<?#Z
M   'FKC2Z=L2L3-)V!4ZU>J98VF8^PU&XP479JQ.L#*$5RRF8&;:O8J4:952
M*;*:Z1R=T7&>SMQ@?6N<U;S55')QH?'-:Y+KD16KQ*>B223133113(DBD0B2
M221"III)IEP4B:9"XP4A"%QC&,8QC&,8'P^GF9"CTJ6M=<ODK3ZM)WBGL)R+
MJ5SD*_$O;75HRSE8DLL=7+$Y:*2\(PL)(QMA\BV623=X;I85P?O9.S[><B*U
M%6ZO$?%:U51RHEY.!3U(^'TT^-T\^ 9S&.?@YP^.<YLF.<W&?2YC&,;/:8QC
M9I6<F,;.>W.<_P HK>,U'OC_ &R]DH>+4WO;/:IV#T50X1\+]?6:&NM!XB<8
M*1<JX]))5ZVU#06J:U9H&12*8J;^&GH:ILI6+>IE/G!54%4U,8SGLS]D?'3S
MN2ZY[U:O$JJ?6T\#5O-8Q')QHB=@]/M+BSQBWE/,K3NOCEH?<%GC8A& CK'M
M+4.OM@3S"!;O'TBWA&4O;*]+R#6(0D)-RN1LFH5$JSA4^"X,H?.?C)I8TLC<
MYJ<BJAR?#%(MLC6N7E1%],QI_#QX _,:X>?LS:6\R1S\9J??'^V7LG#Q:F][
M9[5.P;%1.L-:P.ORZF@M>4:%U62 ?50FLXFI0$=K\E7E$'+:2K9::SCT:X6
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M1AQ.0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MV,<)&.B>L;TL<ASCD9*Q)&+:Q3*(X',
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MU&CE RJ"N4%4\F*LBLF2K/3RT[D;*EEO 4H*B*H15B6VSA-QQ0*X
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M)9<*D:F5P[.5#-RE).L/C")[GZF>PMEJX$F\75WNGJYK<Y( +8N0
M
M
M
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M<INIY1;PU0F<8,F=?),_9+D86H:UL[VM[E'+Z9FZ=SGP,<[NE:GI%-OG+_\
M',U)^F'T\?R3XS#-T_YJ7V#_ /*,'4?G5/9L])I9ZZR7#,O-+@ULRIP,062V
MMK%NKN#4/>&N'$J[M5.CWJ\E4X_N<IJJ*WNKJO8M)')\(F?+M55,9[P7LQ-#
M/J*A%7N%R+Z/8,M70:^G5J=VF5.JG%Z)$_ZL3S&-;]6;-X66V5(I-:H=.-I:
MG0<*IX<K:^M4H1&\0K,AG&%%6M8O#])]]A+.<&GSXR?N2D*6\Q6"Z])V\"Y%
MZO%UO2+/"9[S%@=PMRIU./K^F6LQB#,%#+J>WNU=5SJ^T3B'JF2=.Z'K6VDX
M_P!>>-,^$L(YW%/E9KD7M##?!5D\D@L0[Q(ZB9E$W<;66RA,=TIW.>PTC6T=
M$LS^Z5+?N4^S.==JW.K*U(&=RBV?=+]F8LD=4WIZU3?O3;EM":IJJ"%CXW4N
M$M7':*9-"+R*+G4]:/&I4B.REA!19:Z4E!U$D3R8J2D@LV74QG*)<XQ=)4K'
M5:QZY'+E]'C]!3*UE,DM+JV)E8G:^AQ>BF0C1]6)YC&M^K-F\++;*D4FM4.G
M&TM3H.%4\.5M?6J4(C>(5F0SC"BK6L7A^D^^PEG.#3Y\9/W)2%+=8K!=>D[>
M!<B]7BZWI%IA,]YBP.X6Y4ZG'U_3+68Q!F"AEU/;W:NJYU?:)Q#U3).G=#UK
M;2<?Z\\:9\)81SN*?*S7(O:&&^"K)Y)!8AWB1U$S*)NXVLME"8[I3N<]AI&M
MHZ)9G]TJ6_<I]F<Z[5N=65J0,[E%L^Z7[,Q=3G9#6W#[C+,RK*-+"ZFXSZ3D
M9!I#M,D(=G1]24E9RA&M<E2[%'>8>"PD3L)DRBV<?:Y,;LS@DOS2V<+W.ZZJ
M9Y5;!%;]HQO61"DCTQ>(DUUI.9N^N2_,*8G[!KFKOV-FOL=$2LA"YM%GMKA^
ME1=6PDHW5Q(0%&K-?A%\*$8K).FS)JU;IJ)&7[^3/54R4,#8H;+R\'JKU3 4
MD*UT[I9[5:G#Z/ G4+#_ "VZ"'!3=&E;+6M)Z@K^AMPQL$[4UK?JA(V)LT)8
M&C;*L;%W6)>2TA&6*OS+I%-!ZNLW4DD$CF5;KD/W6%,9#B-0R1%D<KF<:+ZA
MDYL.IY(U2-J-?9D5/5(O_5G>6=YA[MNC@%LY[)%:UR-F-E:QAIG*QG5.G:_8
M&M?VM2&^5EE,M6[YW+-I))F0I$D'+605^R=P;MN\4A:K6U#./(O+F7[.0M,*
MF<CG4S^+*G)G3[.4F?ZUW,.Q<,N!U]N-!EE8+:6SIN'TOK:;;&,5[ 35P:2L
MC/6)B9/^Z-Y*$HU?E5F+C&<8;R7@Q\YSG&"FL:&%)ZA&N[A,J^AZY?U\ZP4Z
MN;D>N1/1]:TA7Z'G1KT1O#13'F'R]J#C:+K8\Y.GU1K^=E9=I5VU9A))[!/;
MK:64<[8/++,6*?9O,-4':JC%-FB1QE)51<AD;ZOKI(Y-3"MEG"OJ%AA]#')'
MKYTMM7(GJGH^MST7^/&KN.=@Y:\2*,75,[J9Q$R&SM?UY_-/:K::7*2K"#<V
M6&BI1])9K4_4';YNY6*R.V8+1A'*ATN_D*<_R@KI'RZF9;4=P+RGVOH8F1+-
M"EU6\*<GK$K'0JYDV/F#P6K;G8<RXGMJ:1L3W3=VFGYU59.QLX2.C):E6>17
M6577>OY"I2[9J[=*'RJ[D&#E8^,9/]FTQ"!(*A;N1CDM3U2\P^=9Z=+V5[5L
M7U.L>2Y/=#71_+GG,3EGN?9VPK+0)&M1#.TZ)7D'J;.2GJVV:Q<*S@KJWDT)
M>I:Y<1Z1UWL.Q13<GD5%5D'J)7!TR_8J^2&GU+$1'6\/K9^4XRX?'-4:YZJK
M;,J>OQ)R'M.471 X#;GT=;:-KW0M#TGL)"NR*FN]DT!B> EH&U-&"YH-Q8CI
M.BHVR 6>X(G(-Y#OIU6QCY3507PFNGQAKZADB.<Y7-MRHIRFH*9\:M:U&NLR
M*GV92%[U6#<]]/=^3/'YU(R#[6B=.KVV8F-7P=6-K=P1GFU4EE8]3.>Y9KVR
M*D6^5T_LX6]J2'+@N2'R>^Q9C;K)/M[;/0+'")'7GQ?:V6_9U?4+F(PAG  *
M&7JN?R_MO_0\O_QT\?AV'%O)F^S3TE.NX1Y2[V"^FA?-'7CL0   0)>LAVZ;
MK/33FXN(>+M&M[W1JRHV$J*ZR/AD(DK.W'P-7"*A,+H'F*BS.8A^Z)GN.WL[
M<8SC(X8U%JK5XFJOJ>J8[%'*E+8G&Y$]7U#^70#XXZ/1Z8FI[P\UA2IRU;LF
M-MS.R)FQ5B"G7UB-7MM7O7,-%NG4E'.'"D!'5FI-BI,3F.W375<*E+@SA3NF
M(RR>-*VU;&V6:$7U1AL4?BC76):ZVW2J>H37:LU'K#1],8ZZT]0JKK2B1CV8
MD8VHTR&90%?8/)^5>3<NLSC(])%JV\,DWZJF2D+@I.ZP4N"D*4N+![WR.O/5
M5=G4OV,9&VZQ$1N9#(@XG(     TFYU< ]"]0O5\)JS>^+BP85>SIVZK6C7\
MU'P-NKTQB/=Q3K+%Y,0EDAG#*1CWIDW#=VP<I'R5,^,%43(<M>GJ)*9]^.S*
MEF7@+>HIHZEER2VQ%MR<)G'CQH'6?%O2U T%IZ'6@M=:WB%XFO,7;L[]^H9]
M)OIR9E9-\H4F7DO/3\JZ?.U<%(51RY.8I"%S@N*<DCY7K(_NE*D4;(8TC9W*
M&:!P*@
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MKL,'3>4Q^S;Z:&=J?)I/8.])2MQZI]_V^/\ =:_[Q@R>,?\ 5_XW^28O!_\
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MSDV;M*V=(/%TLN66<MF8M%HH%J/&5MOVV\EN<E!%H78
M
M
M
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MR+R(BIRY,BH7.!@S.
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M564(4V9.PN3=B94R=AL9R7)\F,:OBJ(E2BYV)Z:E'"5MIEY'KZ2$2NC,$O\
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M-.LD>22Q4ZCBBIR'_B2_Q):!Z?/K#_2/Q_\ $7^@7^D+PRH^@G_0O_\ H?\
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M='13M*ZC2FL?':L:]9?7+R@K5J45DB(DJ)I0GN&.,B
M
M
M
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MQ'][;U$,K#@<P
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M4Z>/$5A:L,C$CLR9/_A/1TKHP]4>V\^M&<V^4?(WBQ>;-0MLZ?N6P+!2E[-
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M^L<\L6$L<L<]F]P<ZD8AJ[_N*TBJZV!:+*V(U(;LRJ9> 9JO"]G\J!,GQ]C
MSM5EPQEG-9Z2&!I<F*/1>-S_ $R=WK\NVC;I.<I$7#IN@M(.-&-&"2RR:2CU
MV3D5J5^=JT(<Q3.7!&+)9;)"8,;"2)S]G<E-G&/P[RQGH]ZID,1\C?Z'?(8/
M]7MK,%=>E&PIMIC49FL6V_;SK-CB')E2MY6"GGV8J7C7!D%$5RHOH]VHD?)#
ME/@IL]F<9^R*F)*K:R\G"B(<,-1'4=U>!54B[VUTM>I7TI+W>M^]-+:EDV-I
M@_9/6&BQN&$G?"UN(7<.TH6^:HEFCFN[91A&;I1%"0ATCS.4U%U$6;+.3'S=
MLJZ6L:D=4B(_/Q>@O%Z)9OI*JC<LE*JJS-Q^BG'Z&4F7Z._5H1ZD-.NE5V#4
M8JA\@=4-(B2M<?6/#S4JYU>8449-;?5DI)R_DH-5I*H9;/XURY==XRJW51<+
M%7.FVL:VC\5<BM6V-=*%]0UGC351R62)H7E(1-U__'3T-^=O0/[IFN!?Q_FG
M_%=WRE@_\[^BG>H?4Z\1(PO6!X.'WF=$W'D];X^8G2R!B>+Y**3D):L;;*_(
M\QB/PZS"YSE[DW:7+++;"F>YQC&/F'V^)2:O[[:NFS(?<1L\=CUGWJQNB]E+
MI+0S0[1J=@9N=B=NB9F9IE,S0S0R9<MS-3(]J.6^4<XR3)/M>Y[.S[ P9G>H
M4J.%F:XX]98VRMQ\4C_186X\BU+AF"R@6%69^C*:2MOM?B/QX"K%YWF= Z.4
M_P"XF+@IB9S]KVYV>WYK36=W8WT\G6,#!9\ZNU7<6NMT9>N?A]8':-)#J]\,
M&#]JW>L7NG..K1XS=HIN6CMHYY.[G1<-73=8IT5VZZ)\D.0^,E.7.<9QG&1]
MPW)1O]DO>H,2RUL:+S6]\I=K*4I"E(0I2$(7!2$+C!2E*7'84I2X[,%*7&.S
M&,?R# F>*272Q9-:]ZPQR[@H- D3#,=C\Y(5I&,,9;,D(B.VU*E81I&Z62I^
M!-,,D>]IYQDI<I$SC':7'9GJO+AK%7AL9Z1@:/)B;T3@M?Z9=O&!,\
M
M
M
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M=0F^ZN''_:_*3IZ<A=%:/K25PVE=TM7*5:M+3D!6R2QZING7%UET,35HDX:
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M[<9SC(QSU1SU<G JJ9)B*C$1>%$0R".)R
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M:$&),L
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M0-J%5+KK,G5RH6D59'+4.IT1;S;>MD4DY%H78
M
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MD3E.2N:VQ'*B*JV)RKR&/G_*#C3%7_&J)3D/HR-VD9W[7EUJ_P!M4%G?S/\
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MC;14+!!VNM3+?#N'L5;EF$Y!2S3)SIX=1LM%N'3!\WRHF8O=I*'+W1<X[>W
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MU%13+PX',
M
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M0PF5P>.>'*IG.55>VG4.\9PY)WHFL:OJV=<J4[?%<16G8JZMR>I:7$AA3-@
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M>G;Z1\K(64,D<U/:F7@MS6>GQEX$8$SX
M
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M]1G1VKM4T]G6X5QK:2H,M0Y%[*V4\FX3F63].G;?V2LFU2B^X4+E=!L7)_\
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M6)$EMBK;E1,V<L+C&F3
M
M
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M!2$+C&/L8%!555M7A+A$1$L3@/I#X?0
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M(J,:I,H^/9-DL%2;M&31 B:9"XP4A"XQC[&!0555;5X2X1$1+$X#Z0^'T
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MJJ^N6SM93K$Q+)'+VR\G$B>J6RP.?4)-(ML;4[5.7C5?4)"A;%R
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M^BW+D
M
M
M                          #S]IJ55O$&]K-UK-?N%;DR83D:]:86-L$'
M()XSVX3>Q,LV=L'1,9^SV*)FP/J.<U;6JJ*?%1')8Y$5#%6N^+O&;4$NI8=3
M<=M%:OGUCKJK3FN]1T"DRZJCHF$W*BDE6J_&/3G<$QW*F<GSD^/L9[1S=-*]
M+'N<J<JJIP;#$Q;6-:B\B(AG44RH
M
M         !Y^TU*JWB#>UFZUFOW"MR9,)R->M,+&V"#D$\9[<)O8F6;.V#HF
M,_9[%$S8'U'.:MK55%/BHCDL<B*ABK7?%WC-J"74L.IN.VBM7SZQUU5IS7>H
MZ!29=51T3";E122K5?C'ISN"8[E3.3YR?'V,]HYNFE>ECW.5.554X-AB8MK&
MM1>1$0SJ*94
M                       QCLO2>F=T,6\7N+4>L=L1C/OG@D=LNA56]L6O
M?L=BW@[2T14JW0[[C[!NY+CNL?RCFV1[.X<J=1;#@^..1+'M1R<J6G]];Z<U
M%IR,6A=0ZKUQJN'<=Y[_ !.MZ/6*/&+^#DRFW[\PK$7%M5.\)YR4G=$SW./L
M8[!\<][UM>JJO*MI]:QC$L8B(G(EAD<<3D
M                                               'G[34JK>(-[6;
MK6:_<*W)DPG(UZTPL;8(.03QGMPF]B99L[8.B8S]GL43-@?4<YJVM544^*B.
M2QR(J&*M=\7>,VH)=2PZFX[:*U?/K'756G-=ZCH%)EU5'1,)N5%)*M5^,>G.
MX)CN5,Y/G)\?8SVCFZ:5Z6/<Y4Y553@V&)BVL:U%Y$1#.HIE0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MVF= *&^R;.<_;*',;/\ Y39SG^7(R>+>4-]@GIJ8O"?)G>S7TD+(@QAE
M   -;^7/*+7_  PX\["Y+;2BK?.436I:KF<BJ''P\K;'>;?=JW0HLL2PGYZL
M1"YDYFTMSK=^?-\$;E4,7)C8*0U6&)T\B1,LO+GY$M*4TS8(EE?;=3-PY5L,
MDZ<VA7MWZBU7NFI-9=E5-O:XH^T*RSGV[1G/-*]?ZQ%VN%:S;1@^E&+67;QL
MLD1RFBY<(D6P8I%5"XP?/![%C>K'<+55-!S8])&)(W@<B+I,CCB<@
M           K=\F%5,>LQ]/)/"A\)YX>7?M3P<V"9[JJ\X3&[2]O<Y[HR),Y
M_P#+DN/_ "8&3B_-<GLT_P DQ<OYUB]@O^62V4?GEIZ_\X]R< 8: V,WW-H_
M6T3M&VV&2AJXCK5_7YAAJV1;LZ]--K:\LSN82;[<B^^)N(=HA@R;C!53=P3*
MMFZG>VG;4+9<<MB9^/L9R];4,=4.ID1=8U+5S<7+RYC=@4"N
M
M
M
M
M
M
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M3U3('0:Y8;6Y T7E/J_9FZY#DC'<<MUEJFLM[3;=ZE.[%UQ/'LJ<#,2"\O\
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M3I3)C9.NJ;.<Y[>T8-RWG*Y$L15X#.M2ZU&JMJHG">J'P^@
M
M
M
M
M
M
M                                      0F]>7B#R%YJ<0M<:MXU4(F
MQ+U <DJ=?I:$4M=+I^&M2C-9[?K<A+>V=ZL-:B%_!9>UL4\H)KG<G*MDQ$S%
M(?);_#YHX)E?*MC5:J<:Y;4S%AB,$L\",B2UR/1>),EBY^J>HZE'!KD%M7;.
M@>;O"6W5:L\NN,[>7@HJOWK!$J?M/7<Y[99D:;)R!B]PS<$).2:!$UCMV[EM
M+.,>%,UDT5\<:6>-C'03HJPOS<*+G/M53R/>VH@5$G9GX%3-]F<U&)Q/ZH?4
M=W;H:;ZC-*TYQIXU<=+_ !.U":;UI88NX3^V[Y +'-$KOWL-=-B-V,4LW.LT
M755E6AFT>Y5319JN%S.4*^NI*6-R4RN=*Y++5XDT)Z11U-752-6J1K(FK;8F
M6U=*F:.<?!;E]5.9M?ZD?3JE*'+;L<4EKK?<^D]E+-8NN;4JT<V:-&BC:;=/
M8AME5Y'PT:U<-UI"*41/%M7#=Y@V%$LTZ>HA6!:6IMU=MJ*G$5*BGG;/XU2V
M:RRQ47C^ST. ]+I76_5OY/I\@U.;4[JOBWJ[9O'386D*5H?5!8*XS\-=+S"R
M,(WW ]N\78;@K&2=<2>F4131G7:3K!BDRS:F2[\K\D=1Q7=0CGO1R*JKDR)Q
M69/2/L;:V6]K[K&*U41$RY5X[<OID9S#@]U:"=/>[],QEQ1XQURCUYK99,O(
M#.U*TZE=T9C[/(;,A(RG5AF]\/AM@V2?:MH=.;LZ42T19*E*MAL4AG"=TM11
M^,I5*]ZNYMG!DLR\G'8A:>+UGBRTEQB-3CMX>/)R\5JDFO*SB#R%V3T-JSPX
MI5")-<C(SC;PXH+O7WC72XXA+;J:?T<_OD26VRUA84@_M,VILB8J^)+P9UE#
M&$%%,J)]W:PS1MKUG<ON5YRVY>!;;,G#QEW-!*_#T@:GNMQJ69.%++<O!Q$D
M7#?7]LU/Q#XJZLOL66$O6M.-^CM?W2%*^CY0L1;*;K&KUVQQ99.(=/XJ1*PF
M(U9+"[5=9NMW'=IG.3)39M9W(^9[V]RKE5/14NH&N9 QCNZ1J(O51"-WJB<0
M>0O(WE[TF]I:<H1+=1>,O))U?MVS9K72Z_FF5)39G'&R$EBQEGL,-+V/NHC7
MTJIWB)0?.<&;X+E/NE4L'NJ2:.*&9CUL<]MB<.5;'=DM:N"66>%[$M:Q]J\&
M1+6]@U^7XR=17AQU!N6O(WC+QMT_RXIW+YW"S3&ZWK:%8US;M)N&1I%56MN5
M[#(LIQ:K%=R7>W+2(;O<2+&.C<Y5;K-S)"IK::>F9%*YS',XD2U%^SEY2GJJ
MJ"I?+$QKVOXU6Q4];J<AG_I$\-N4'%+8G/6R<FJ]0(R5Y!;CJ6T8&;U9*,%M
M>6!]-MKK:+NA38 SY6TU>NUBQW/,:V;R[5FN8C?M2PJC@JIJ=;/%,R-(E6QK
M53+P\5EN@J44$T+I%E1+7.1<G!QVV:>,C!X,\8.NWTW]$RE$TCH?CYL:)W!8
MI>Z2^O[OL"F*6K25_,5*DJV9S,,MCU&K62-L=3J\.^RV:2TT4A$DB=Y;+X=)
MKW51+A]5)>D<Y%:EEJ(N5.',O+Q(6E/#B%+'=C:U4<MMBJF1>#.G)G)&>)?2
M!>USA)RLTMRKO36U;YYW34Q>=]7RKE++-:W:UGKF?I9XA=^SBL6.0IUO>+3;
MA0Z2""\D[612SW@B:Y[::M19V20I9''D1/3T\!=0T5E.^.9;9),JKZ6A<IK'
M5]>>L(Z=TZTX/4.G\:K51J_6RZNH?,AW<HQC-U77#9N2$@3J0+ZUH6+,O7*Z
MF1NW7-3I%PW13+C/A:Y"N#55=AKW^,.5Z.5;5;9Q_9RE%&XE&SQ=J,5J)8CK
M>!/LY#Y?-WH\;F@>DQQUX1<4J\3=^S:!R2@]N[+DSV"G4!*==RE!W%'6^T-%
M+Y9H"+2BXV9MT;',VA7*CW+!)(YB*'*L?'V"M8M8Z>;M6*VQ./C2S@Z@J*&1
M*-M/"EYZ/M7@3B6WAZI8VWGKISN#2>X=2LK [J;S:.K-@ZZ:6J/[?#ZTYNU2
MEZTA8&7<YP;PN&5D\.4^S.,]VG@8R-UQ[7V6V*BZ#)R-OQN8BV*J*FE"K6PX
M/=6@G3WN_3,9<4>,=<H]>:V63+R SM2M.I7=&8^SR&S(2,IU89O?#X;8-DGV
MK:'3F[.E$M$62I2K8;%(9PGEEJ*/QE*I7O5W-LX,EF7DX[$,1XO6>++27&(U
M..WAX\G+Q6J2Q;TX3[AW5T5JQPD:LXRN[U8<4^,5,<P<K,QBD8VV-I)KJ>QR
MU37L,:XD80Q'LY0%HTKY%=5EW2N%<*Y2^W%G'.R.N6?ACON7T%M[)>20/DH$
MI^"2XU/12SL'@^G7KWJ4RFJ6_%GGGH/1^L^+E0XL-..4,TK%UC[#M6X>T]>A
M-=LI*;5K%RV)5%HV6U\@[3=XP>+.1V8BA$C%-E(G*I=2W];3N<LJOO<&1./,
MB\)QI6U2LU-0UJ0HR[PY5XLZ\74-3M6:)ZX'3OJ4SQ.XI4K0')_CVUFK,KI+
M;E_L4'6K5JB#M,F_EU$+!6Y>_P!)6>+,Y:46?&:),YYN1XHIWM51L8K4E9\E
M!4KKIE<R7C1.!>LOJ%%D=?3-U,*-?%;D5>*WT4]4VQT)TU-I<>>G!SAU3-65
MANCF'S'UMR*LNQY^-=M(F$LFX-H:PM%?K]3A9>>Q7F!8I.?F#F-)/DXY)1Y(
M.%CD;M^X(E1DJF2U4;T2["Q6V=1%*\=*^*ED8JWIWHZWJJAL_P!(O0.V>+W3
MRX]Z+WE5BTK:='+M7-IK!9VN67$7FS[MV3<84OMW4I>>KSTSJO6%HOGP9VMA
M/*O>SY*H4Y2TJR1DM2Z2-;6+9Z2(5:*-\-,V.1+'I;Z:KQ$9_K)=,JD#HOCU
MR9KMP=4+DQJ3=<17],2=?,NG:[.VLS=Q+3<)'98&*\P>O/*ZUE4'*A5$&YDU
M6W9@\@7!KK"W.61T2I;$K<I:XHU$C;*BV2M=DS_9]G&2=]*GAXEPBX3:DU#(
MQY&6Q)>/SL?<"G<I>$*[-NK=H^FXURJD1,CCQ18)-(-(^,?;H1A#=N<FSG-I
M5SZ^=ST[G@3J)V>$NJ.#Q>G:Q>ZX5ZJ]C@-A^9&O[9MCB'RJU90HLLW>ME\;
M]XZ_I<*9]'Q99>V7+6-HKM<BS2<NZ814<5_,22*65W2Z+='N^[4.0F#&Q3@<
MC)F/=W*.15]!2K.USX'L;W2M5$ZJH:V](O0.V>+W3RX]Z+WE5BTK:='+M7-I
MK!9VN67$7FS[MV3<84OMW4I>>KSTSJO6%HOGP9VMA/*O>SY*H4Y2U:R1DM2Z
M2-;6+9Z2(4J*-\-,V.1+'I;Z:KQ&B.T^'O/OACS;WAS%Z=M/UIOO7_*KP.5W
MAQSOEJBZ%+-[PR4</,V>O6*<F*S!G[Y.2DA((N%'_?$LRCUNHT5P9!<EPR:G
MG@;!4JK7,X')ER%N^"I@J'3TR(YK^%JY,I(3Q2E>I3/Z[WG8^6E4XX4;9$V=
M5[QTUW2YN?DHBFKIUEZT0A-KV2,\8TGL*O96S%R9U&K23W!7#[."E)AHU3MI
MDI4<U(5<K?ME7CZA<PK5*URS(U'?:HG%U2#CDCP:ZJG4'NVD:UR$XM<5=!VW
M6M_K4_:>=NKKE YO4[6J^U<,LQD5"QUHF[LY,0YB231F\8I-B2K9MWA2.0RX
MP:_BJ*2F:Y8WO<BIW"ID,?+3UE2YJ2L8UR+W:+E[/KYC?CJ=\*N75CY5<8NH
M?P2CZ1=-^\>*_)T"6U;>9..@F=RIK\]NRDDRE9J9K<,H@XC]@SS!^BM)QJY4
M7R:S5?"J>>RWI)X4A?35%J1NRVIQ+D["%S5P3+,RII[%D:EEB\:9>RIKQICA
M]U0=E]4WB7U"^8=&U-7HJNUK<% L=#U=:Z\Y0T'0VFG=C0NO8^8RZL<D^N<E
M>MA;4D53'B'E@RT-WP[A5JV,@@A4?/2-I'TT"K:JHMJ\:VI;U+$3D*4<%6^K
M94SHU$1%2Q.)+%LZMJKQ6FU>\N(/(6Y=<GAMS'KE")(<<]4<;;50;]L'-KI;
M0\%;9" Y3L&43BI/K"VN\IX0YV;#%PNSC7#8N'6<F4+A)7N*4<T;:!\"K[JK
MK43+P=KQ\'$I6D@E=B#)T3W)K+%7)P]MQ</&AK#R-XJ=3C1G56W5SFX,Z@U'
MN>'Y&:9K.L)-QLRY04)$:ZS&US4\%(+RL$]OU!L4BX1DM.L'J"C#,@DHW=JI
M'3PIC&2U8IJ62D;3U"N:K76Y$X>'D7.498:N.L=44[6N1S;,J\'!RIF-ON:T
M+UBK!5>%*G$J7U)5;RV6C7/+YNSDJNO5$[3B.J??%FSG8,4E+2^I$'Y9LKEK
M$(XG#%5;][(MDI5$Z$"T2+)KKRM^UZ^;CX.0KSI7*D>INH[[;K9^+AX,I,D+
M(O@
M
M
M
M
M
M
M                               KW;HTCN/G?UC]6M=BZHV76^%W NMI
M7B%L%YHUDA-<[JW4Z7BI@JU-EYB/:0EN:MY]:)26PEEVW,SJ[O&<X3?$[O),
MD93T2W519Y%LR+E1.7-ZYC9(WU%<EY%2"-+<J9%7DS\6@L(C&F2
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
%   __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>sgmo-20220930_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sgmo-20220930_g4.jpg
M_]C_X  02D9)1@ ! @$ E@"6  #_[0 L4&AO=&]S:&]P(#,N,  X0DE- ^T
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M  (# 0$! 0$!          D*!P@+!@4$ P(! 0$  00# 0$
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M&F2D1>66YD8G* K_V@ , P$  A$#$0 _ +_
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M3CV4M#22:*JR1'C%VD9-3!3FQ@V/V<@"0,
M
M
M
M
M
M
M                            %&#E)H[FC0.JWTS]O\XMI4N\[/WERSU
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M_)PU_P#/#X2_G2:M$JD^-7X#NU4BUGQ2?#9VR$D@BDH
M                     /A67_P1[_W;_6T!RG"=7^Y/NC@[
M
M
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M!S2]\7^S/S^Q=QE-4W':.QH2)6J^L6Z4NM&+.7J\8\LD:8CHYDCYR!>R
M
M
M
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M.P/$G8WIHG?(RA^\87F\U.477\Y="=@>).QO31.^1E#]XPO-YJ<HNOYRZ$[
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M;*ZK9D113N3GR0L*JJ%J9ED5+$X$3B)M+3I30I&BVKPJO&;ZB.2  (V^J?\
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M&L8UGE9)VH;!46ZF>W& )R0
M
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M#9]GU"Q6"'HL@8CYMA S^;V,6P7M%?!47[5I#0S9PGCZF< 7AP
M
M
M
M
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MGBS89IX]P962L$C0)J(-(N^^+9=O\++&-A10Y" 3K
M
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MKH:5B6N?)3RL8VU;$M<YB(F543*O"MAF,<%B
M
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M[5JBX643;E^H3!< #E=>J#_3'5;YN^]/X.@0!TW>9VSG>D^'O*_<K!^I%/\
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MLMLCHERD1)-W"U91VE#,G&"ERZ:QR:YL8.H8 2A@
M
M                                *!G6P^DWY,?V-?F_:I$F/W"'I+N"
M^Z7"?Z5],J"*T=S,0              !)/T@?I(>+G\JK7^36ZCI)[A3%6^_
M[J\8_0Q]_B.@\(QYF@
M
M          !#S<_IV-+?^6UL7\O+836_5[OTJ=8A.^L&_HEZY,,(1-
M
M  "'GJI_UL]*+_S)=1?>W;A-I/<3?HE]8A5GNX?TJ>N3#"$30
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M[A%%H[W/JNPJ/HR&N<RS:((LT[K5I:.Q'3:R14DWN'3%U@N5UW7<@55>$?\
MZP"Z?^:'U _O@Y)@#J?@#E@='7_U9;7YW?4L_)#RV %LKUNOZ&C8'X]]#_?0
MZ $4'JBO3BX)\E>#^[^1'(WBKI??VV(SEK>=114WNJEQ>TH6*H-?TQH>VQD1
M&T>[I3E%9.TI^^RBYWZ<:605[^4AUS)HHE(!\[UI_H;\4M,\6E>H1P^U'4M
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M*9 F<%AXG8L(Q82*<_7FSY19\WJMYK\FUDV::BB_@BJR['OZYV:BI@)@P
M
M                                                 % SK8?2;\F/
M[&OS?M4B3'[A#TEW!?=+A/\ 2OIE016CN9B               ))^D#])#Q<
M_E5:_P FMU'23W"F*M]_W5XQ^AC[_$=!X1CS-
M
M                              "'FY_3L:6_\MK8OY>6PFM^KW?I4ZQ"
M=]8-_1+UR880B:
M                      $//53_ *V>E%_YDNHOO;MPFTGN)OT2^L0JSW</
MZ5/7)AA")H
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M2_90 %T4
M
M!0,ZV'TF_)C^QK\W[5(DQ^X0])=P7W2X3_2OIE016CN9B
M))^D#])#Q<_E5:_R:W4=)/<*8JWW_=7C'Z&/O\1T'A&/,T
M
M                                       (>;G].QI;_P MK8OY>6PF
MM^KW?I4ZQ"=]8-_1+UR880B:
M                                $//53_K9Z47_ )DNHOO;MPFTGN)O
MT2^L0JSW</Z5/7)AA")H
M                  1M]4_Y.&O_ )X?"7\Z35HE4GQJ_ =VJD6L^*3X;.V0
MDD$4E  :.<]NG-Q)ZE6G_,SRQUDTND/'+/)"DW"+7Q [*UC./DVR;F=UW=&R
M*LA .W>&2'A;8Q5XR2(W23?-7*1"DP!2FY%^I$[3:3<F]XE<UM?V"N+)JK0U
M;Y%TNQT^;C5L%<=YCI.[:T:WAA-IF,1+NGB5?C\XPH?L:Y[V7OH'R..7J1V\
MGUCB77+CF7JBKU%!;OL[!<<J[;[Y8Y5N4Q\> 1-LV9 :XC*^LL7N3>%K0LF5
M//:7P8_U# "];PVX8<<^ VA:MQOXO:^9:]UG6%',BJ@5PO)S]KM$DDU3G+O=
MK$],I)6:WSV6:6'#M<W8F@BBV;D0:-V[=("##KD>K?:ZZK=VB.1^I-GQW'_E
M1&5V/J5FF9VONK!KG;]<@TU$:TE=&L2Y:S5?M5<;J^#-YQJF^.K&IIM%VBI4
M6JC8"N[I3U)7F7*7AFCR,Y;\9*/K9)VU4D)+2B>U-J7A\Q(N8SUFSA;UKW3<
M#%.W#8N").3R#PB)SY.9!7!.X4 L'\+?5>./? CJ3Z<YWZ Y#WYOK_3=.G8B
M)X]7*FL[-+S-QM.C+/I.TW*3W06WQN4VD_FUNY]6+1K!$T)-4Z399!CA%JB!
M*MU;NG(TZJ'#&U<1G6W7.CCV"YT2Z,]AMZ,EL<L:[I,SB3*S<U%2VT;,DVDD
M#J)9R24;&1.8JG[?!<IF J]\N?4L:78M7ZG5X;<EV%4W;3]>UZI;7)N2O3#/
M5>Z;?#19&SS9L3FK+7&S:>DYQZGG+N,31LC(Z9DS$,DNDNJ^ Q-P:]2NN4)M
M"N6_J$\C-8676U<DV\I)Z?XV*WR36V&1FZ*LE 3NS;Q5=;R53K[\B>"O\QT0
MO(*H'.DV=-%<D=$ OVU"HU>@52M46DP$55:;38&)J]5K,$R0CH6O5V!8H1D-
M"Q,>V(1NRCHR/;)HHI$Q@I$R8QC]@ <J_E!_ZN2L_P#F[<0ORQ:4 '4?W=I/
M5G(_4NP-%[MI<1L/5&T*V^J=XITXFJ>/FH9^4N3D[ZW50>L'[-PFFX9O&RJ+
MMD[12<-U$UDTSE HA\E?4P]WTW:$AL'IR\TZO5X?V34DJ?7-[N;]0+I0D7+I
M7"D6VV_J& N;NQ%8,3XP@[]@8Q=3'^C5QG.,KG ^SQ=]3$VG-[3C]G=0GFVP
MLR1)-G/V:!X]GN=AN]QEFZK9;)7.[=KQ,!)PQ<&0[DSLM>=O5"8QWL[<^"G*
M!?EAXQ"$B8N&:KR+IM$1S*,;N9B4D9R6<(,&R35)>4FI=R]EIB1632P9=TZ6
M5<.%<F44.8YC&R!3WZKWJD6F.8FU+?R,X9;4B.,&T[_+OK)L#6%IKKV<T?;+
M5+.5GLO9Z^K JELFL9.9?N#N'R#9K+1BRQNUNT9YR?*@$4/'7U)3E#(W>*/R
MTY<:$IVMVTB@M-M^.J&P]E7>9B4NX4<QT4\V50-40-9D7W89$CQ9"62:=N%L
MM7'9E#(%_CBWQ?TEPST-KKC9QWI;*A:EUA"^P];@FIU'+I=5PY7D)B>G9-?)
MGDW9K),.UWTB^7,99V\744-GZO9@"G5UD/5.MR\S.8VR^6O"_>.DZ<3>\XE<
MMG:QWV[OU98P%\<,$V]GL5,M= H>RW,LPM\DU+(+,'S!J=H]=.3)N3HF102
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MBZZBBRASF R,
M
M     H&=;#Z3?DQ_8U^;]JD28_<(>DNX+[I<)_I7TRH(K1W,Q
M    $D_2!^DAXN?RJM?Y-;J.DGN%,5;[_NKQC]#'W^(Z#PC'F:
M
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M/53_ *V>E%_YDNHOO;MPFTGN)OT2^L0JSW</Z5/7)AA")H
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MT<'8
M
M                                        "@9UL/I-^3']C7YOVJ1)
MC]PAZ2[@ONEPG^E?3*@BM'<S$               23]('Z2'BY_*JU_DUNHZ
M2>X4Q5OO^ZO&/T,??XCH/",>9H
M
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MO;MPFTGN)OT2^L0JSW</Z5/7)AA")H
M                  4;O6%.$VQ=9O7',3;G(JQ;@G=M<@Y?7VKJ"O"HQ-8T
M[I0T-<[?6::Q5\+7R^?Q&6B2!E&Z#))0W?EU_"7*YUL7_#9VO[@QJ-1K;57.
MN3*6#$J=S.[O<KE<ZQ$S)E6PM>\X^"NJ.?>MZEJO<5BV-"5&K["@+\XCZ#:E
MJ^A:<0_?T75;M#(Z#R.DXJ19.E"IK91*]8+9PLU62-W>%+/3U#Z=RO8B*Y4L
MREXJ*=E2U&/5;J+;D(Y.IYTY.G-K/IT\@K PX\Z<T])ZFU3,S>M=B5"J1->O
M:>PF"*;?7L-+7= B5GN1;A;EF<2NG+NW^5R/LF[,K8(<LJDJ:E]2U+SG(JY4
M7@LZ>3I=0BU=+2LI7*C6M5K<BIPV]++T[>#*;*=$6R[.M?3$XNRNUE)!S.)5
M^U0]??RYCFDY#7T#?+1#:]7==\-E3**%28M6[0YL8RLP104SW7=]V:E7HU*M
MZ,X+>6S+RE6@5[J1BOX;.2W)R$K8ADP "-OJG_)PU_\ /#X2_G2:M$JD^-7X
M#NU4BUGQ2?#9VR$D@BDH                #!'*'5][W=QQWGIW6&SW.E=@
M[1U5>:#4-LLX8MA=Z]G+97G\(SM36'S(11WCF).][X3O;INL0V,'34(H4IL
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MSGSG.<]H D-
M
M                                               % SK8?2;\F/[&
MOS?M4B3'[A#TEW!?=+A/]*^F5!%:.YF(               DGZ0/TD/%S^55
MK_)K=1TD]PIBK??]U>,?H8^_Q'0>$8\S0
M
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MXA1ZC477W+MG G9/M>K%\Q6LO6-N\(+'-K.5J6]D-PZ4S*=X:.G5-F)!K'[
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MF*1S5*NC>KD<B/GD<U5L:O"U45.)36G_ (7>07HIM7V.V^V1J;_@_P#29_\
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MF<NY9X^>9+G./J%RIW)?^C&!U555;5.Z(C4L3@/MC@Y
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M\\/A+^=)JT2J3XU?@.[52+6?%)\-G;(22"*2@
M               J!>NK?19:#^?_ *L_-UY5 ";[HI?1'].7YH&C_O)BP!)^
M
M
M                                    *!G6P^DWY,?V-?F_:I$F/W"'
MI+N"^Z7"?Z5],J"*T=S,0              !)/T@?I(>+G\JK7^36ZCI)[A3
M%6^_[J\8_0Q]_B.@\(QYF@
M
M              !#S<_IV-+?^6UL7\O+836_5[OTJ=8A.^L&_HEZY,,(1-
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MCFJB+:BHMJ+[KI*2,#XX^Y
M                    "'GJI_UL]*+_ ,R747WMVX3:3W$WZ)?6(59[N']*
MGKDPPA$T
M      (V^J?\G#7_ ,\/A+^=)JT2J3XU?@.[52+6?%)\-G;(22"*2@
M                                C\ZDO3OXW=2[0D#H[E#&6Z5H=,VA
M7]O0C>F6MU4)-.Y0E<N%(8+.9)H@X4<1Y8+8,B4R&2X*94R9^WM)CM(<.6Q+
M4-G^/.B:!Q@T9J?COJIO*--;Z7H=<UQ1VTW)*3,NA6:M'(Q<2E)2JQ$U9!X1
MH@7"BQBXR<WU>P#DS(
M
M                                                      *!G6P^
MDWY,?V-?F_:I$F/W"'I+N"^Z7"?Z5],J"*T=S,0              !)/T@?I
M(>+G\JK7^36ZCI)[A3%6^_[J\8_0Q]_B.@\(QYF@
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M9RQCYES()MDE''>,MDE5B 34@
M                                             "'FY_3L:6_\MK8O
MY>6PFM^KW?I4ZQ"=]8-_1+UR880B:
M                                     $//53_K9Z47_F2ZB^]NW";2
M>XF_1+ZQ"K/=P_I4]<F&$(F@
M                     !&WU3_DX:_^>'PE_.DU:)5)\:OP'=JI%K/BD^&S
MMD))!%)0                                      ?"LO\ X(]_[M_K
M: Y3A.K_ ')]T<'8
M
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M]Y?2J;[OKQS5WK5-4IFBS8I@+Q(
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MJ      !#SU4_P"MGI1?^9+J+[V[<)M)[B;]$OK$*L]W#^E3UR880B:
M                                                     $;?5/\
MDX:_^>'PE_.DU:)5)\:OP'=JI%K/BD^&SMD))!%)0
M                   ?"LO_ ((]_P"[?ZV@.4X3J_W)]T<'8
M
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MIF:T]6;8LA/.=<-'>&Z3=K<Y5SW@UG4:?]B;J-&\6P[&;/*KL"R$
M
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M];/2B_\ ,EU%][=N$VD]Q-^B7UB%6>[A_2IZY,,(1-
M                                        "-OJG_)PU_\ /#X2_G2:
MM$JD^-7X#NU4BUGQ2?#9VR$D@BDH
M      (+?6"NIUMKI1<+M=\@]-T#76QK->^3%*TE(PNS264\$S@+!K'<6P',
MLRQ59ZO2&)A&2UFT1)E18Z/>'"W:3)^X,4<*EJ6$BO #D19^6_"7BOR=NL)
MUJV[YT;KW:5C@*OB0+7(>8N%?9R[Z/A"RSV1D\1K9=SDJ7?UUE>XQCNCFS]4
M#DV]
M
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MJ)DD,-G1\G;+8[4S 6F0
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M_,EU%][=N$VD]Q-^B7UB%6>[A_2IZY,,(1-
M                                 "-OJG_)PU_\\/A+^=)JT2J3XU?@
M.[52+6?%)\-G;(22"*2@                                      J!
M>NK?19:#^?\ ZL_-UY5 ";[HI?1'].7YH&C_ +R8L 2?@
M
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M'0>$8\S0
M
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M<)M)[B;]$OK$*L]W#^E3UR880B:
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MD5$8E   !&WU3_DX:_\ GA\)?SI-6B52?&K\!W:J1:SXI/AL[9"20124
M                                  %0+UU;Z++0?S_]6?FZ\J@!-]T4
MOHC^G+\T#1_WDQ8 D_
M
M                      !#'QUZ0Z.@>K]R[ZK9>0*EK-RIU"OJK&AC:K+!
MEH?A+S0KU>>SM#&Q9?-I_P!+I#&"-?%V-[DLG]58V6_:N!GWJP=/HG5 X2['
MX=&VT;2!K]8-=SR>QBT3&R<0YZ%>(.XY;'I^;C0LR199.(,U[K$HWRAE7"O8
MI@G>S@:\\M.CC7^6'21TWTLIGD!9J432NJN-M @MX0-.[^E.S?'*F0%.CI^T
MZJ\=&#>7KMG3ASNU80\]V,W1T%4W9U6J:I@-JN('3XU7Q>Z?&N>G9;)1[R(U
M-4]76C5ER>;08%<DV1 WF5LDQ;HZ3@EG\LG%UEPI:G3..C".ER1<6FW:I*F*
M@0X K[R?JH]IU?8K?$\$.KWS.X6\?]@2[^1N.AJPI<K!&2C.4*FS=PZD_2-Z
M:892S0D+W;%-:;B)EV9MWO#A5QW!^^@3:]*_I$\6>DMJFR4/0B%@MEYV*_CY
M;;>[+^I'.]@[#>Q)'1(:.<*1C-E'P=2KV9!R:/BVI.]I*.EE55%W"JBQ@)3@
M                    !0,ZV'TF_)C^QK\W[5(DQ^X0])=P7W2X3_2OIE01
M6CN9B               ))^D#])#Q<_E5:_R:W4=)/<*8JWW_=7C'Z&/O\1T
M'A&/,T                #G[<S>9O,&K<P>5M9K/*WDI7:W7>2F](*OU^"W
MIM"(@X*#B-H6F/B8:&B8^TMV$9%1C!NF@W;H)D101(4A"E*7&,26M;=3(G >
MEFPFPFP]9L/@U75X-A4M5+A5(][WTE.Y[WNIXW.<YSHU5SG*JJYRJJJJJJK:
M:V?\=7-S_&-RI_YA-M_"X<W6YD/JO[N]W_\ 46#_ /)4W\V/^.KFY_C&Y4_\
MPFV_A<%UN9!_=WN__J+!_P#DJ;^;'_'5S<_QC<J?^83;?PN"ZW,@_N[W?_U%
M@_\ R5-_-C_CJYN?XQN5/_,)MOX7!=;F0?W=[O\ ^HL'_P"2IOYL?\=7-S_&
M-RI_YA-M_"X+K<R#^[O=_P#U%@__ "5-_-C_ (ZN;G^,;E3_ ,PFV_A<%UN9
M!_=WN_\ ZBP?_DJ;^;'_ !U<W/\ &-RI_P"83;?PN"ZW,@_N[W?_ -18/_R5
M-_-C_CJYN?XQN5/_ #";;^%P76YD']W>[_\ J+!_^2IOYL?\=7-S_&-RI_YA
M-M_"X+K<R#^[O=__ %%@_P#R5-_-C_CJYN?XQN5/_,)MOX7!=;F0?W=[O_ZB
MP?\ Y*F_FR9;H7<F>2.W.:LK5=K\@MW[.JZ>D+U+)UO86U[Y=($DJSL%(1:2
M9(>R3TE'ED&J+M4B:V$^^$*J?&,XP;/;3D1$;D3IF"O2'V2V5P38%E9@V&8?
M25BXA"V_#3PQ/NJR55;>8QKKJJB*J6V+8F8N#"B:/
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M5%3(;J#Y<V^
M         "'GJI_UL]*+_P R747WMVX3:3W$WZ)?6(59[N']*GKDPPA$T
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MH=(QL%4[VH4W9GZO9G F(BIA[K?E4ZQ$O-=B#5:MJ:I>N32""3P
M                                                           A
MNZL3]E%[,Z5LE).D&+!CU'M3.7CQRH5)NV;HUFWG5665/G!4TTRX[<YS]3&!
M-H\K9D3Y)?6(-8J(Z%5X-:GKDI'GBU7Z0*G[M,_KHB7'YE)6MCSH//%JOT@5
M/W:9_70N/S*-;'G0>>+5?I J?NTS^NA<?F4:V/.@\\6J_2!4_=IG]="X_,HU
ML>=!YXM5^D"I^[3/ZZ%Q^91K8\Z#SQ:K](%3]VF?UT+C\RC6QYT'GBU7Z0*G
M[M,_KH7'YE&MCSH>RA)^%LC$LG 2C&8CC*J(E>Q[A-RV,JCG&%4\*I9,7)T\
MY^KC_H'"HJ9%X3NBHY+4RH?7'!R
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MM&FS['S 4)1_ R)M90V4M?3$<Y49KH$[^FFC89J'[K)<9[E0R>?V<8[0L1.
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M1O\ 6P%B9A[%QGM<P^Q&_P!; 6)F'L7&>US#[$;_ %L!8F8>Q<9[7,/L1O\
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MVSY)>N3&"$3@
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MDU:)5)\:OP'=JI%K/BD^&SMD))!%)0
M        ?"LO_@CW_NW^MH#E.$ZO]R?='!V
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MV/WXEEW#<%#V?9\VFXR90ZT<>VR3EO'8,8^4(MNV1P;)4L "0<
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MGJFO/I-?=PS[2A[28NZB@>?P
M                                      !#S<_IV-+?^6UL7\O+836_
M5[OTJ=8A.^L&_HEZY,,(1-
M                              "'GJI_UL]*+_S)=1?>W;A-I/<3?HE]
M8A5GNX?TJ>N3#"$30
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M6]HUWKRW;-LE%O=V=VZ-E"W%K7*6Z34;0\7,),I$Q6;U5JX*N1$"6L
M                !6NN_K&5,I=TMU.5XJ6>04J=HGZTH_3VS%-R/3P4J[BS
MNR-S4-8R!')FO=X)DYLEP;L[<]G:*NJXS:S#_1<KJ^@@KDQF%J30LDL\&<ME
M]J.LMUR6V6V6V'E_UEBD_P"$FU?&_$_W?CG5<9,_PHU_]=0_\L[^>'ZRQ2?\
M)-J^-^)_N_#5<8_PHU_]=0_\L[^>'ZRQ2?\ "3:OC?B?[OPU7&/\*-?_ %U#
M_P L[^>'ZRQ2?\)-J^-^)_N_#5<8_P *-?\ UU#_ ,L[^>'ZRQ2?\)-J^-^)
M_N_#5<8_PHU_]=0_\L[^>'ZRQ2?\)-J^-^)_N_#5<8_PHU_]=0_\L[^>'ZRQ
M2?\ "3:OC?B?[OPU7&/\*-?_ %U#_P L[^>'ZRQ2?\)-J^-^)_N_#5<8_P *
M-?\ UU#_ ,L[^>'ZRQ2?\)-J^-^)_N_#5<8_PHU_]=0_\L[^>'ZRQ2?\)-J^
M-^)_N_#5<8_PHU_]=0_\L[^>) >GCU9*_P!0#9UVUK$:3F=8KTRAGO"LM)7A
ME:$I!(E@AH#V.(T:UF$.W4R>8PKWS*A\=B>2]S]7MQT<RZEIC3>?N7J=VN$4
M^+3XA'5MGJ=3=;$L:M6X]]ZU9'V^YLLL3AX27@=#"0
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M?+SF/Q ["^^2@BE+[GJFO/I-?=PS[2A[28NZB@>?P
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MFIE O?NYSE3&,9QGND])&QZ1-DO.:J9;#HL%7)(QTSH[K'(N2TG/%O+@
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MHNBN625*HL17X")9TQ&Z.:@:+8.FYD2,,,F\)B(B4U%%'8%]0
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M=O9+-*+LV,7%,?#TX9N5-JT;(HI$2QG/?%3*JJ ="\
M    !S#]Z_UW;C_&IL+[[I<2TX#UOV=\WZ'Q.'O;3%0Y+P
M 6)/5O\ Y4V\_P 0"WY1:0*4ON>J:P^E/YG8=]IIWB4N0B@:+
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M6!9HR8+3NPK],*L8Y'P:/9J2="O;T[1@W[3=X9-S+Y(D3MSW),8Q_P! [O\
M<&7]\L"4NZ+%*9KG.;'2PMM<MKENS0I:J]-5LM5<YT!A&/-0
M    #FQ\ZOEN<QOG4\A/RMVX2F^Y3U#U6W=_=_@7V/1?1HS58=C[$
M        G0]7L^7G,?B!V%]\E!%*7W/5->?2:^[AGVE#VDQ=U% \_@
M
M
M
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M;\HM(%*7W/5-8?2G\SL.^TT[Q*7(10-%@
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M:\^DU]W#/M*'M)B[J*!Y_
M
M
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MJZDXVFQND>1%:?V%RF[=LTRQ[6=MD<U,;!LF[Z[3QV=F<YP'!PDN'2BUA?\
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M+(%M*TOKS=VOO&'SK^<5EF#3;H;D\)\#\6WF3GCNX\(+AQW2 $S@
M              #F'[U_KNW'^-387WW2XEIP'K?L[YOT/B</>VF*AR7@
M           L2>K?_*FWG^(!;\HM(%*7W/5-8?2G\SL.^TT[Q*7(10-%@
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M_$#L+[Y*"*4ON>J:\^DU]W#/M*'M)B[J*!Y_
M
M
M
M    !&WU3_DX:_\ GA\)?SI-6B52?&K\!W:J1:SXI/AL[9"20124
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MQJ;"^^Z7$M. ];]G?-^A\3A[VTQ4.2\               %B3U;_ .5-O/\
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M.KY;G,;YU/(3\K=N$ION4]0]5MW?W?X%]CT7T:,U6'8^Q
M)T/5[/EYS'X@=A??)012E]SU37GTFONX9]I0]I,7=10//X
M
M
M
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M+?SA^E-Z>O\ BOU7[H2?O6%QV8?W/;S?ZFK/R6_G&_HZF-@
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M#EA\EGDK^(#<GY.K&.6^Z3U3Z78OSQPG[3I>_L.9R)9ZQ
M  6]_5L_ZD>2GXU*G]Z*HH2\*&D?I5^<&$^)R=\+)PI&J@
M!6Q]9,_J1XU_C4MGWHI"K%PJ;5^BIYP8MXG'WPJ$"N;N
M =,;B?\ )9XU?B TW^3JN"([W2^J>3NVGGCBWVG5=_>9_'!\T
M    4#.MA])OR8_L:_-^U2),?N$/27<%]TN$_P!*^F5!%:.YF(
M     DGZ0/TD/%S^55K_ ":W4=)/<*8JWW_=7C'Z&/O\1T'A&/,T
M        #FQ\ZOEN<QOG4\A/RMVX2F^Y3U#U6W=_=_@7V/1?1HS58=C[$
M            G0]7L^7G,?B!V%]\E!%*7W/5->?2:^[AGVE#VDQ=U% \_@
M
M
M
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M$[6MQ(PJEAOZ3Z!K[^I5Y9%5:2=5*%DIIR>/)DC-NV1^KW#APNNXS1D1W"O
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M8J?9/9A$I:9:&>&GL>]VK=*Q]UU]ZO>MCWWK555+,KC<^JM;<E.17/NW\_\
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M29[YG.<?LXP.JI8N<[HMJ6V*A]L<'(
M    !6$WA_ZH+AS\W"S_ )$.5 NL?U4_X?KM+3)];1_ ]9Q_;KF1-NXS\M.
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MI*Y%L930(DCF1PQ-UC7L6^Y'Q67T8V-J6 QYN&V  %I0?L+/"@
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M)012E]SU37GTFONX9]I0]I,7=10//X
M
M
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M*'M)B[J*!Y_
M
M
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M;2X1Y$BVQK5HKMV\^GH9*BS)_P#5<E*ZJMR>ZUU[ARY5MW:K%6K5*@(JJ4^
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M_P#N<["?^085_P"$(7^-[TT?_NO;T/\ ^:L=_P#'EVD?%'ZB@
M     .8?O7^N[<?XU-A??=+B6G >M^SOF_0^)P][:8J')>
M "Q)ZM_\J;>?X@%ORBT@4I?<]4UA]*?S.P[[33O$I<A% T6
M  , <L/DL\E?Q ;D_)U8QRWW2>J?2[%^>.$_:=+W]AS.1+/6(
M     "WOZMG_ %(\E/QJ5/[T510EX4-(_2K\X,)\3D[X63A2-5
M     "MCZR9_4CQK_&I;/O12%6+A4VK]%3S@Q;Q./OA4(%<W<
M      Z8W$_Y+/&K\0&F_P G5<$1WNE]4\G=M//'%OM.J[^\S^.#YH
M         H&=;#Z3?DQ_8U^;]JD28_<(>DNX+[I<)_I7TRH(K1W,Q
M        $D_2!^DAXN?RJM?Y-;J.DGN%,5;[_NKQC]#'W^(Z#PC'F:
M          !S8^=7RW.8WSJ>0GY6[<)3?<IZAZK;N_N_P+['HOHT9JL.Q]B
M              3H>KV?+SF/Q ["^^2@BE+[GJFO/I-?=PS[2A[28NZB@>?P
M
M
M
M                            1M]4_P"3AK_YX?"7\Z35HE4GQJ_ =VJD
M6L^*3X;.V0DD$4E        !%9U>ODUTC\>-:^\+98R!NW^O)?%'=\B/,_\
M%3_R]X-^^=)_TW%BN4,UG@*                !;[X@_)<T%^*JG?P.V&M^
MTGU_6>,/[93]5?HJ_P"6W8?]V:#O##8T60S^      !C3;.OZ'L>HJPFPZ34
M;Y#,Y!E+-(BYUN&M$8UE43*,D9-LPG&3YJA(),WZZ)5BDPH5)=0N,]R<V,\I
MPG5WN3V\)!PM:B(VOUR'BZ_ PS-".B(2$CVD5$14>U)A)LQC8U@B@S8LVZ9<
M%322(4A"X[,8Q@<'8^H    "!_K)?[RZ&_V'?_\ 7ZJ,M[L_B*SX<?6>>*'X
MM'G#L3XEB??:(A7&4#R$(:IWH?\ %JS3<O8YS:?)B3FIZ3?3$M(O;MKEV\?2
M4DY5>/7;ETYU*LX<+N'"QC&.H<QS9SVYSG/U1\%)N[P::1TLDU6LCE5557QJ
MJJN55^*/2#"OQ0-^V"893X-A> [$P8;20,ABC918BQC(XVHQC&M;BJ-:UK41
M$1J(B(EB(B&6..O2=XZ\9=PU+=E#NFZY:U4TL^2+C[=9*0^KR^+'69BJOO9!
MI"ZZK\BOWJ.FU3I8(Z3P5<I#&P;&,ES.PK8K"L(KV8A325#IH[UB.<Q6^V:K
M5M1&-7@5;,O"? [X_3]WQ[[MW6(;LMJ\-V9I\!Q)8%EDI*:M94-\'J8:IFK?
M-B%1&VV2%B/MB<JL5R)=54<F;JSP-T'4^4\WR]B6EG+M&;S,.C1Z\PT4IT;-
MV&*7A+!9(N)+$IRB4S,QKQPFMWU\LVQERH8B)#&[<7"'9K#(,9=CK$?X8ZU;
M+4NHKDL<Y$LMM5%6W*J95R&,,;]*W>QC^XBE]'C$)*%=A:74MUC87I620T\K
M9J>GEE658EAAD9&YEV!DG<V(Z1R)8NYXOYK8:Q;UXGZXY";%X_;-NLO<XZ?X
MW752]T9K69*%91,G+J3=,GLMK4WDZ],.WT;A]1F>,$:+L5>]G5QWSM,7)+1B
M6"4F*55+65#I$EI)+[$:J(BK:QWMK6JJI:Q.!4Z>4SANKW_;9[H=CMKMB-F:
M?#9L)VTPQ*&N=4QS/EBA2&L@O4KHJB%C)+E=-EE9.V\D:W+&JCMG1=S!Y@CC
MSQWHG&JE2=+HSNQ3.;!;K%>[5:[D^82EOMMLL[O#B2FK#)1D5"LG;O"*23=/
M)&R6,((D[>Z/W9S6W"\+IL)IUIZ97NO/<]SG*BN<YRY5<J(B*O G F1#*N]_
M?#M5OJVF@VEVHCHZ;P3#Z>AI:6C9)%24E+3,NQPT\<DLSV,M5\CKTCK7O=98
MVZUNI3GI/\3'>PU;HJSV$6L+6CQU4TBC<N\:2S:<K86/+%IZ,6213[O_ -WE
ML60*SPWSWC".$/\ 1BR+L5@CJKPA4EU-^_J;_<;V>[9;U+UEF2RS(; P>GWZ
M0%/L>W9IDF#KCC:'P),:6CO8UX+98D2U:RK&MGNM8M.LVL[JLBR^W)*RE*4N
M"EQ@I2XP4I2XQ@I2XQV8QC&/J8QC ^M-*557*KG+:JG_ $ 7B!JH?LJ
M            YA^]?Z[MQ_C4V%]]TN):<!ZW[.^;]#XG#WMIBH<EX
M        +$GJW_RIMY_B 6_*+2!2E]SU36'TI_,[#OM-.\2ER$4#18
M         P!RP^2SR5_$!N3\G5C'+?=)ZI]+L7YXX3]ITO?V',Y$L]8@
M            +>_JV?\ 4CR4_&I4_O15%"7A0TC]*OS@PGQ.3OA9.%(U4
M            *V/K)G]2/&O\:EL^]%(58N%3:OT5/.#%O$X^^%0@5S=P
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MQJJ*C50RQZO9\O.8_$#L+[Y*".)?<]4LWI-?=PS[2A[28NZB@>?P
M
M
M
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ML1[6V>T0SMZO9\O.8_$#L+[Y*".LON>J?.^DU]W#/M*'M)B[J*!Y_
M
M
M
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MPW$]I%<[$7XBQ$D=D=+&WPAL<CN#*YJ(EY<KT1'Y;UJV9!2-30
M
M
M
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M\./K//%#\6CSAV)\2Q/OM$0KC*!Y"                 7B!JH?LJ
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M"(B9$1$CFL1$S%V\4#0
M
M
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MX<?6>>*'XM'G#L3XEB??:(A7&4#R$                 O$#50_94
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MV_Y7:D_*171LY^'C_FFP7Q+$?H4QB'TH_N;Q#QBE^D1F[?!#Y#W#3YJ7'?\
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M545>E?<J-]ZB6Y2R1ZMG_4CR4_&I4_O15%*7A0U5]*OS@PGQ.3OA9.%(U4
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M3@1"]1Q/^2SQJ_$!IO\ )U7!'=[I?5/._;3SQQ;[3JN_O,_C@^:
M      *!G6P^DWY,?V-?F_:I$F/W"'I+N"^Z7"?Z5],J"*T=S,0
M     !)/T@?I(>+G\JK7^36ZCI)[A3%6^_[J\8_0Q]_B.@\(QYF@
M        <V/G5\MSF-\ZGD)^5NW"4WW*>H>JV[O[O\"^QZ+Z-&:K#L?8@
M           $Z'J]GR\YC\0.POODH(I2^YZIKSZ37W<,^TH>TF+NHH'G\
M
M
M
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M^_W<W/+<MVVWP1W?(CS0_%1UG^'O!KUEG]LJ3@^S<6( 1FD\"
M      +6/%/SP_\ #9H[V'\VOL5YLZE['^R?C1[(>">Q+?O/AG@O_9O".X[.
MZ[C]KV_L#7':/5^7JRVVWPA_;*?JH]%76_X;MA[+MG]F:#/\@PS_ /TY_@G_
M )X"R]S]]R&?N[>]Y1_3G^"?^> =S]]R#NWO>4?TY_@G_G@'<_?<@[M[WE']
M.?X)_P"> =S]]R#NWO>4?TY_@G_G@'<_?<@[M[WE*D?KF/G(_1@:(\</$CV,
M_P"/36'>/%KV>\.\._X>^47>N^^RG_9_!/!^^]UV?M^[[GL^IVCA;EGM;;3E
MNLM]M99Q$U?1E\\/Z)_IX^P_FU]BO^$C2GL?[)^-'LAX)XEQG>?#/!?^S>$=
MQV=UW'[7M_8'*:NS+;:<+K;<EVSJDF/].?X)_P"> =S]]R#NWO>4?TY_@G_G
M@'<_?<@[M[WE'].?X)_YX!W/WW(.[>]Y2$[JU^.WC#I'QS\5N^^PMY\ \6/9
M;O?>_#JSX1X9[*_MN[[KN.X[CZG9V]O_ $#+6[2[J*N[;[N/K//%+\6:_P#V
MAV)OV?,L3X/TM$1 #)QY#                 7,/Z<_P3_SP&J_<_?<A^R;
MNWO>4?TY_@G_ )X!W/WW(.[>]Y1_3G^"?^> =S]]R#NWO>4?TY_@G_G@'<_?
M<@[M[WE'].?X)_YX!W/WW(.[>]Y1_3G^"?\ G@'<_?<@[M[WE'].?X)_YX!W
M/WW(.[>]Y1_3G^"?^> =S]]R#NWO>4?TY_@G_G@'<_?<@[M[WE'].?X)_P">
M =S]]R#NWO>4?TY_@G_G@'<_?<@[M[WE*G6P-D7QO?+LW5FDBJ(6ZR(J%0CX
MTZ)3I3+TA\(G<,3+G2P8O[7)\Y/G'[.>WM&/IOPXO0QQN9^,XGL;K<1JW+-*
M_P K8XV_)*M^1UUF)M8V\YRK=:UK4ML:B)8AX;;4_C ?B*[-;38CLY@N\34X
M/A]?44T$?D'9E]R&"5\43+\F#/D?=8UK;SW.>ZRUSE<JJOD?.=>/;O\ >V(]
M[Q3_ /C/]"3_ -E?_EC'O_5"Q?\ S-?B4?\ W2/_ +7]EO\ T0BKY7],_3?,
MK<4INW<.S-[8M,E$0<$A%UJST=C5X.)@(])BV8U^*E]<SKB+;.5RJO'"97&2
M*/7*RO9C*F<#.N[[T;-TFZ?9Y-D]VV'R81LXDSY=1'-)-;)(J*][YJI:BHE<
MZQ$MEF?=:C8V78V,8VC5?BW>EOCURKV\DV<VCV@:RXZMK*!\,SV(YRL8L6&5
M6'T+&QHZZU(:2*\B7Y%DE<^1^MZ?0FXCIG(H78O([NB'*?'_ .&&M"_5+G!L
M?MB:B(<OU<?LXSC./^C(^X7=M@2I8Z6J5J]*]'_-$1?Q4_2%_BX/L:BYTI,2
MM3C3_P"EC?/EIPOTWS4O&M=@;P\97\]K%(S"/Q7WT/#,;' &DL2V:Q;&QH%Z
M>0A,2!E#XPW.T<X[^J7"W<GS@8WW:^BKN.W.X54X'NQPF?",(K9]=/&ROKYT
MDDN)'>OUE3421+<1$M@?$Y;&JJVM:J0<5_%A]-?:B26JV\V@PS'\3\&U-//5
M8/AD#Z-+RNOP-PZFH8977EMNUL57%TM78KD=FCE1K%ER_P!+V+1.U+-9V5,L
MS^OR3]U3_%J(GTG-:FV4]'^"/I&MS3--,[Q@0JN#ME.Z3,;&.Y-V&Q\7L'Z"
M/HM;KMI8=L=WNS3\+VIIV2,CJ&XEBL[F-E8L<B)%65M3 M]CG-M=$Y4MM:K7
M(BI>9OQAO3ZQEG@&W&UM#M#LXY;9*&KP7!X()7-RQN?+A=#AU:U8WW9&I'5Q
MM5S421'QJYCLG:L=3.H-8ZYU-5)^15J^KZ'4-=UM67:P;R64@*37X^M0ZDF[
M0AV:#J1/'1B>5U"(I$.IW1L$+C/<XLF/?AV>AWM3CM;M-M#LBM5C^(U<U54S
M+BN-1K-45$CI9I59#B,<3%DD>YZLBCCC;;8QC6HC4[Q_C(_B*44;:+ ]O8</
MP6%$93TL6 [.R14T#$NQ4\3ZK"JBI?'#&C8V/J*B>=S6HLTTLBN>[&/&;5T9
MQ2HLS1=:SUBD26F\6?9%RM=SS7YNYW.[6YV1S+V"S3#2OQ2#YZ9%!%NGDC=+
M!4$"8SC)^Z.:_;;^@IZ+F\FLI,0V[V;?B-;04$5%3N7$L5IV0TL%[4P1PT=;
M3T[&,O.LN1-5;;7*Y<I0B_&"]/K":NJDV-VOHL"PVLJ%J)*:EP7!9XM>]K6R
M2Z[$Z'$*U[I5;?=K:J1$<JI&C&76-TI=]*WBL]V*M=EF^PBU5Q<<[!5T4A;T
MVVALW$R_?SS1*$A$)JI8/]5++0CTK'#7/@^$,-_]$,Q1;E-WL%W5TLUYM E$
MDBSS.JO!D;=U:U[GKB"K_&UBU:R:SNM_6>V/F'?BB>EH_9U<$?B.#KB*U2U'
MAODVG276JMMO@:68,B?Q;ODN[<]I9=R$KQ=F78A2D)-8*4N,%*4L9#E*4I<=
MF"EQB/QC&,8Q]3 UJ7\-#T)7+:NQ5JK_ /7C'O\ U0^P3\9K\2=$L3>1D_=_
M9;_T0_[YSKQ[=_O;$>]XX_\ C/\ 0D_]E?\ Y8Q[_P!4.?\ YFOQ*/\ [I'_
M -K^RW_HA)ETO;=M"Q;>V VAI"N/'"&MU%U4[*U6;LRHYL\ GDZ&8!L@X,Y[
MLV,8[O.2=SG/_3V"^8#Z)7H]^C[4/VEW1[/KA&-5K/!9I/#L2JK\%J2W+E;6
M5,;>Z1L=>8UK\EEZZJHNXGH8>GGZ67I7[>8IL;O\VK\O[.8;A"UM/"N&8/0I
M'4^$00:W68;A]'*_N4LC;DCW1^VMNWD14G!_IS_!/_/ ?4]S]]R'I%W;WO*/
MZ<_P3_SP#N?ON0=V][RC^G/\$_\ / .Y^^Y!W;WO*/Z<_P $_P#/ .Y^^Y!W
M;WO*/Z<_P3_SP#N?ON0=V][RC^G/\$_\\ [G[[D'=O>\H_IS_!/_ #P#N?ON
M0=V][RC^G/\ !/\ SP#N?ON0=V][RC^G/\$_\\ [G[[D'=O>\H_IS_!/_/ .
MY^^Y!W;WO*8(Y2^>C_ADY&>'^:_P'S$;=\-\#\:_"_!/-_8?"?!>_?Z'PCO/
M==QW?[7NNSM^H.4U=N2];U#Z78O6_P!L<)MN_6=+G^78<XD2#UF,G:;T]L+?
MNSJ=J#5E?=6:]7F80AH.+;8-A,IU.Z4=R4DZ[DR4;"0[)-1T^=J]B+5HBHJI
MG!29R.%5$2U2TX[CF&;-X1/C>,2I#AU.Q7/<O(UJ?QGN6QK&IE<Y41,JDZ74
M+N^M.!_#"I]+#4-F0N6R[#)1>Q>4UTC,X29EDW+N/L1($Z1#F4:24U)1$7WE
ML8Q5FE?BVV')3G>]V*;45SKZ\!KQNRP_%MXVWDV^'&X5@PF)CH,/B=PW4167
M[>FUC726NX'32/N6)'80L<8="6CD]OW5NB:@DMF5V':F,2Z>I$,<L'7D>[D+
M59'."IK=C2MUMFZ?*_M39R1#.,8,;.,9J*MB6F>MKMI*/9'9NLVBKE34TL*N
M1.>]?:QQIP97O5K$XU)8NN)O>K9V3JW@_I_N(W3_ !&I\+ NHA@LF:.5OKN!
M8-T6BF44\$?.*=3RM6IEC'RH20>R"9RE4P?)J<:9+R\*F&/1\V<K/)59O!QS
MV^.8W.YZ.5/;:E'JJKEX$EEO.LLL5C(E2U++()!5-BC)VF]/;"W[LZG:@U97
MW5FO5YF$(:#BVV#83*=3NE'<E).NY,E&PD.R34=/G:O8BU:(J*J9P4F<CA51
M$M4M..XYAFS>$3XWC$J0X=3L5SW+R-:G\9[EL:QJ97.5$3*I.EU"[OK3@?PP
MJ?2PU#9D+ELNPR47L7E-=(S.$F99-R[C[$2!.D0YE&DE-241%]Y;&,59I7XM
MMAR4YWO=BFU%<Z^O :\;LL/Q;>-MY-OAQN%8,)B8Z##XG<-U$5E^WIM8UTEK
MN!TTC[EB1V$'NJ>0&\M%+RKG3&WMD:L5G4"MYK-"N4]5R2R1,&*C[(HQ#YJB
M\4;=WG*)U"F.CG/:3)<_5%141>$V"QG9K9[:)K&X]0TM8D:VLUT3)+N>ZKD5
M4MZ:)D7IVDLFR9ZQ\.NF_&4R9E99_P J.I?*-]F[.DY5TZD+G%<>(DYBU:,F
M9%X5:9<OMB.WQUL]_4,99O(R"!L=VGGMZ)[9_$AAC"J:EVYWIOKX&,;L=LFQ
M8*=K41L3JUWQCFM2QJ) B(F1,CF1.3(I"K.UZ?J\@>)LL',5V533264C)V,>
MQ,@FBN7NT53LWZ#=R5-8GU2FR7L-CZN!W,]T]535<6NI)&2PJMEYCD<VU.'*
MBJF0M6^KM><'S,<B_$WQ-\%\Y]5\,\9O9OO_ '_Q45[WX+[%?Z/O/>_V>[_;
M=U_]04Y+MOMK32CTK+_]H,)NV?,Y.'](6*/Z<_P3_P \!3[G[[D-4N[>]Y1_
M3G^"?^> =S]]R#NWO>4?TY_@G_G@'<_?<@[M[WE'].?X)_YX!W/WW(.[>]Y1
M_3G^"?\ G@'<_?<@[M[WE'].?X)_YX!W/WW(.[>]Y1_3G^"?^> =S]]R#NWO
M>4?TY_@G_G@'<_?<@[M[WE'].?X)_P"> =S]]R#NWO>4?TY_@G_G@'<_?<@[
MM[WE*Z_K$OG!\S''3QR\3?!?.?:O _%GV;[_ -_\5$N^>%>RO^C[SWO]CN/V
MW=?_ %!4CNV^UM-K?13O_P!H,6O6?,X^#](5.A5-WB:WB'H#HY7&LZCE>17+
MS9$%M25:M'.P-5N(6QU.A,9PK]7NH)_L3.IE(QE KM$T^_N$9U$^"J9[AVD;
M':6FY7]),A@/;?:7?G0U=;#LO@E+)@[%5(:A',DF5EB>W2#PF\KT6VQJPJF3
M*Q4/8==YAN_SW:J>V&NUF-XP1M 0KW%>6H,SFQTZ2JB+6*<RCAS*^!LL-K2^
M;> **-BD.U)'IM<-5W9$SN3\1V6<9!]'239_^S]9'2RROVN?4J_$&S-N2MD5
M7(U$;:ML:+?1'9'7U??:Q51J25;EV%Q#X1=,'A%JW?.IYC=J&P*77MC06GX.
M>DZK6[S?%*U%W6^6.]6%CAJ1U6:_8=FIG;-7B#[*KI9FKAD<S,JS3JB.<]50
MQ3@6&;;[P-[FT&,;.5L>'NIJA\#ZE[&R/BAUCHH60L6VR1[(%1SFJRQJ2-UB
M(]6OT_I6M.!_5@TYN:*X^\;V7$+EWJ*G/=@5BN5.:4F:A=H=CV-DXU8D7%0$
M9*1\C(^#,G:OL(TD(UT];+(J.DS+HJ=K7,7*MJ'V]?BN\;<SCM!-M-BKL;V)
MKITAD?(V[+$Y<MY+SGN:K6WGM36N8]K'M<C%1KDK<"J;4G^TTU%5"))$.JJJ
M<J:::93'444.;!2$(0N,F.<YLXQC&,=N<@<*J-2U<B(68]#52-Z-'#6Y\CMM
MJ)M^:7*6G&J.EM7*X(2:U] .$22C=U8F*O\ VA#,8^49R]@(J3!4'#5A%_Z)
MT=4V:*]T=8GN4-3MHZV7?MMW!LM@B*NP6#SZRJJ/XDST6ZJ,7@6\EZ.&Q<J.
MDFRL1I7DUMN7;>G;.K==4[+O6NK:X361=V*FVB9KTL^;N3]]<MI%Y&/&ZLBU
M<*_ME$E\J)G-]7.,Y^J*JHB\)L[BN!8+CE(E!C-)3U5$BHJ,EC:]J*G K4<B
MW53@14L5"8S3^PKYQAX-[PYV;/N-FLW*'FLI(\>^/]FN,S(3MU::^8JYSM'9
M:4S,G=S&$"KL_!6BF%<$0=L&)L8RFL7LZ*B*ZZG A@S',,P[:[>%A^[K"((H
M=D, 1M;61Q-:R)9E^;P*UMC;;%O.2S*U\B<+5(0YBM6.NECSV" FX(LNR3DH
MHTQ%/HPLG'*XQE)_'Y>H(8>LE,&QW*J?=$SV_4R.YL#!5TM4KDII8Y%8ZZZZ
MY'779G6*MB\2Y3HM\6O/1_PR<<_ /-?X#YB-1>!>&>-?A?@GF_KW@WA7>?\
M0^$=Y[GN^X_:]UV]GU!075VY;UO4/*#;36_VQQ:R[]9U6?Y=YG?^G/\ !/\
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M!W;WO*/Z<_P3_P \ [G[[D'=O>\H_IS_  3_ ,\ [G[[D'=O>\H_IS_!/_/
M.Y^^Y!W;WO*/Z<_P3_SP#N?ON0=V][RC^G/\$_\ / .Y^^Y!W;WO*/Z<_P $
M_P#/ .Y^^Y!W;WO*/Z<_P3_SP#N?ON0=V][RC^G/\$_\\ [G[[D'=O>\H_IS
M_!/_ #P#N?ON0=V][RC^G/\ !/\ SP#N?ON0=V][RC^G/\$_\\ [G[[D'=O>
M\H_IS_!/_/ .Y^^Y!W;WO*/Z<_P3_P \ [G[[D'=O>\H_IS_  3_ ,\ [G[[
MD'=O>\H_IS_!/_/ .Y^^Y!W;WO*/Z<_P3_SP#N?ON0=V][RC^G/\$_\ / .Y
M^^Y!W;WO*/Z<_P $_P#/ .Y^^Y!W;WO*/Z<_P3_SP#N?ON0=V][RC^G/\$_\
M\ [G[[D'=O>\H_IS_!/_ #P#N?ON0=V][RC^G/\ !/\ SP#N?ON0=V][RC^G
M/\$_\\ [G[[D'=O>\H_IS_!/_/ .Y^^Y!W;WO*/Z<_P3_P \ [G[[D'=O>\H
M_IS_  3_ ,\ [G[[D'=O>\H_IS_!/_/ .Y^^Y!W;WO*/Z<_P3_SP#N?ON0=V
M][RC^G/\$_\ / .Y^^Y!W;WO*/Z<_P $_P#/ .Y^^Y!W;WO*/Z<_P3_SP#N?
MON0=V][RC^G/\$_\\ [G[[D'=O>\H_IS_!/_ #P#N?ON0=V][RC^G/\ !/\
MSP#N?ON0=V][RC^G/\$_\\ [G[[D'=O>\H_IS_!/_/ .Y^^Y!W;WO*/Z<_P3
M_P \ [G[[D'=O>\H_IS_  3_ ,\ [G[[D'=O>\H_IS_!/_/ .Y^^Y!W;WO*/
MZ<_P3_SP#N?ON0=V][RC^G/\$_\ / .Y^^Y!W;WO*/Z<_P $_P#/ .Y^^Y!W
M;WO*/Z<_P3_SP#N?ON0=V][RC^G/\$_\\ [G[[D'=O>\H_IS_!/_ #P#N?ON
M0=V][RC^G/\ !/\ SP#N?ON0=V][RC^G/\$_\\ [G[[D'=O>\H_IS_!/_/ .
MY^^Y!W;WO*/Z<_P3_P \ [G[[D'=O>\H_IS_  3_ ,\ [G[[D'=O>\H_IS_!
M/_/ .Y^^Y!W;WO*/Z<_P3_SP#N?ON0=V][RC^G/\$_\ / .Y^^Y!W;WO*/Z<
M_P $_P#/ .Y^^Y!W;WO*/Z<_P3_SP#N?ON0=V][RC^G/\$_\\ [G[[D'=O>\
MH_IS_!/_ #P#N?ON0=V][RC^G/\ !/\ SP#N?ON0=V][RC^G/\$_\\ [G[[D
M'=O>\H_IS_!/_/ .Y^^Y!W;WO*/Z<_P3_P \ [G[[D'=O>\H_IS_  3_ ,\
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MDZ;FRV<RCU;")E&R+=0U&LJ$G>C8\D+$L3LE:BIG0,5TF69ZVKV"6L0R:
M$;?5/^3AK_YX?"7\Z35HE4GQJ_ =VJD6L^*3X;.V0DD$4E        !%9U>O
MDUTC\>-:^\+98R!NW^O)?%'=\B/,_P#%3_R]X-^^=)_TW%BN4,UG@*
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MXJE/ONK8QUO)^JH/&/Y#CU(_"E^^3:+]V5^G4A89&&3WB
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M%W44#S^
M
M
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M[^LK87\N+9_#T@-H:#YC#^B9VJ'Y!]XWWA8]]LUOTF4\,)1\:
M    2W]'W^N_9OXJE/ONK8QUO)^JH/&/Y#CU(_"E^^3:+]V5^G4A89&&3WB
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M?.KY;G,;YU/(3\K=N$ION4]0]5MW?W?X%]CT7T:,U6'8^Q
M )T/5[/EYS'X@=A??)012E]SU37GTFONX9]I0]I,7=10//X
M
M
M
M               (V^J?\G#7_P \/A+^=)JT2J3XU?@.[52+6?%)\-G;(22"
M*2@        BLZO7R:Z1^/&M?>%LL9 W;_7DOBCN^1'F?^*G_E[P;]\Z3_IN
M+%<H9K/ 4                "WWQ!^2YH+\55._@=L-;]I/K^L\8?VRGZJ_
M15_RV[#_ +LT'>&&QHLAG\      #X5E_P#!'O\ W;_6T!RG"=7^Y/NC@[
M   $#_62_P!Y=#?[#O\ _K]5&6]V?Q%9\./K//%#\6CSAV)\2Q/OM$0KC*!Y
M"                 7B!JH?LJ                 I8;._K*V%_+BV?P](
M#:&@^8P_HF=JA^0?>-]X6/?;-;])E/#"4?&@              $M_1]_KOV;
M^*I3[[JV,=;R?JJ#QC^0X]2/PI?ODVB_=E?IU(6&1AD]X@
M# '+#Y+/)7\0&Y/R=6,<M]TGJGTNQ?GCA/VG2]_8<SD2SUB
M    M[^K9_U(\E/QJ5/[T510EX4-(_2K\X,)\3D[X63A2-5
M  "MCZR9_4CQK_&I;/O12%6+A4VK]%3S@Q;Q./OA4(%<W<
M   Z8W$_Y+/&K\0&F_R=5P1'>Z7U3R=VT\\<6^TZKO[S/XX/F@
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M;[>-JJK51;$LZ9A[?_A5%3[G\;FB:NL;!%9E7]HA3.6FQ[:'E
M      !S8^=7RW.8WSJ>0GY6[<)3?<IZAZK;N_N_P+['HOHT9JL.Q]B
M          3H>KV?+SF/Q ["^^2@BE+[GJFO/I-?=PS[2A[28NZB@>?P
M
M
M
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MYC\0.POODH(I2^YZIKSZ37W<,^TH>TF+NHH'G\
M
M
M
M      $;?5/^3AK_ .>'PE_.DU:)5)\:OP'=JI%K/BD^&SMD))!%)0
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M]_KOV;^*I3[[JV,=;R?JJ#QC^0X]2/PI?ODVB_=E?IU(6&1AD]X@
M      # '+#Y+/)7\0&Y/R=6,<M]TGJGTNQ?GCA/VG2]_8<SD2SUB
M          M[^K9_U(\E/QJ5/[T510EX4-(_2K\X,)\3D[X63A2-5
M        "MCZR9_4CQK_ !J6S[T4A5BX5-J_14\X,6\3C[X5"!7-W
M          .F-Q/^2SQJ_$!IO\G5<$1WNE]4\G=M//'%OM.J[^\S^.#YH
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M5K>4KT$:Q;!A876>P9B"NTU<Y2 >S;)=>SUY-=)&&7;L4TV^6JAG)BK+*7K
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M/G5\MSF-\ZGD)^5NW"4WW*>H>JV[O[O\"^QZ+Z-&:K#L?8@
M $Z'J]GR\YC\0.POODH(I2^YZIKSZ37W<,^TH>TF+NHH'G\
M
M
M
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M[^LK87\N+9_#T@-H:#YC#^B9VJ'Y!]XWWA8]]LUOTF4\,)1\:
M    2W]'W^N_9OXJE/ONK8QUO)^JH/&/Y#CU(_"E^^3:+]V5^G4A89&&3WB
M              , <L/DL\E?Q ;D_)U8QRWW2>J?2[%^>.$_:=+W]AS.1+/6
M(                "WOZMG_ %(\E/QJ5/[T510EX4-(_2K\X,)\3D[X63A2
M-5               "MCZR9_4CQK_&I;/O12%6+A4VK]%3S@Q;Q./OA4(%<W
M<                 Z8W$_Y+/&K\0&F_P G5<$1WNE]4\G=M//'%OM.J[^\
MS^.#YH               JL]2+Y:.YO[._R4T4; [$>:]+_M.^R'YG_Q!/\
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M)K[N&?:4/:3%W44#S^
M
M
M                                              "-OJG_ "<-?_/#
MX2_G2:M$JD^-7X#NU4BUGQ2?#9VR$D@BDH        (K.KU\FND?CQK7WA;+
M&0-V_P!>2^*.[Y$>9_XJ?^7O!OWSI/\ IN+%<H9K/ 4                "
MWWQ!^2YH+\55._@=L-;]I/K^L\8?VRGZJ_15_P MNP_[LT'>&&QHLAG\
M  "$3KX]+Z^=63AQK_CUKS:-1U+,T/DA3-WN[%<X>9FXQ_%5_6VW-?+0;9K!
MF(Z3D'#S9J#@JAO]'A)JH7/[8Q0.%6Q+20C@=QTFN(G##C!Q?L=CB[?/:$TG
M0-62]HA&KMC$3\A3H!I#N96-9O\ .7C9F\4;9.F17/=E+GLS]4#DVS    !
M_P!9+_>70W^P[_\ Z_51EO=G\16?#CZSSQ0_%H\X=B?$L3[[1$*XR@>0@
M             %X@:J'[*@                *6&SOZRMA?RXMG\/2 VAH/
MF,/Z)G:H?D'WC?>%CWVS6_293PPE'QH              !+?T??Z[]F_BJ4^
M^ZMC'6\GZJ@\8_D./4C\*7[Y-HOW97Z=2%AD89/>(               P!RP
M^2SR5_$!N3\G5C'+?=)ZI]+L7YXX3]ITO?V',Y$L]8@                +
M>_JV?]2/)3\:E3^]%44)>%#2/TJ_.#"?$Y.^%DX4C50               K8
M^LF?U(\:_P :EL^]%(58N%3:OT5/.#%O$X^^%0@5S=P                #
MIC<3_DL\:OQ :;_)U7!$=[I?5/)W;3SQQ;[3JN_O,_C@^:
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MF=K,6K,'DPZCJIW/;#+4ND5'4E1&EU'TD;56UZ*MKVY+<MN0O&#5D]Z@
M            .;'SJ^6YS&^=3R$_*W;A*;[E/4/5;=W]W^!?8]%]&C-5AV/L
M0              "=#U>SY><Q^('87WR4$4I?<]4UY])K[N&?:4/:3%W44#S
M^
M
M
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M._K*V%_+BV?P](#:&@^8P_HF=JA^0?>-]X6/?;-;])E/#"4?&@
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MC\0.POODH(I2^YZIKSZ37W<,^TH>TF+NHH'G\
M
M
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MV2&*;LSGLSC/U01R6ID3E/IMBV._MCA/ME^LZ7O[#G$"2>LP
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M]3*A\?M<]WDV.S]C':*D:HJK8B(;7>BDU6[08M:JK_P<??%*G(JF[P
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M;E7<G+DY\)D(3!C9[DN,=F!7;P)ZAZM[NLF[[ D_^LU%]&B-81V/L0
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MV%[$^Z_]N<CJJVKF*C45$L5;3[8X.0
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MOY97+\E%^'P6\_S$Q']$SOL9D;=)]XN&?I7]YD.FT-)3?L
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M:3%W44#S^
M
M
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MP^_EE<OR47X?!;S_ #$Q']$SOL9D;=)]XN&?I7]YD.FT-)3?L
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MUNZJ.ZB)_P#2U/WN<G 'O@>98
M
M
M                                                     1M]4_Y.
M&O\ YX?"7\Z35HE4GQJ_ =VJD6L^*3X;.V0DD$4E        !%9U>ODUTC\>
M-:^\+98R!NW^O)?%'=\B/,_\5/\ R]X-^^=)_P!-Q8KE#-9X"@
M      6^^(/R7-!?BJIW\#MAK?M)]?UGC#^V4_57Z*O^6W8?]V:#O##8T60S
M^      !4"]=6^BRT'\__5GYNO*H 3?=%+Z(_IR_- T?]Y,6 )/P    0/\
M62_WET-_L.__ .OU49;W9_$5GPX^L\\4/Q:/.'8GQ+$^^T1"N,H'D(
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M #S*
M
M
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M_62_WET-_L.__P"OU49;W9_$5GPX^L\\4/Q:/.'8GQ+$^^T1"N,H'D(
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MO8VMPJOVCW9R,P'8NNFD=34DU4]SG-1;JZA^I<K<J*Q)56%RJU$O.:V^2?\
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M@              %;'UDS^I'C7^-2V?>BD*L7"IM7Z*GG!BWB<??"H0*YNX
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MTCFE>R^B.<B.LM1'*B+E4OF#!AL^
M
M
M                                                        $;?5
M/^3AK_YX?"7\Z35HE4GQJ_ =VJD6L^*3X;.V0DD$4E        !%9U>ODUTC
M\>-:^\+98R!NW^O)?%'=\B/,_P#%3_R]X-^^=)_TW%CGV]<+8EJ5J''_ (Z4
MYI*2KW<EXD)23@H1-=24L)ZNXKT34JPV23;K^'*3=CMF%4D284-X6Q1SDF?V
MG;]'O$JIE@I<*IT5SJB155$X77;J-;QVN=P9T0U9_"^V/P&/:':[?'M')!!3
M;-X7'%'/,K4BITJFU$M74N57-N)#3TMUSU5J:J>1$=[JS^RV.KIH#54;>:]5
M>,K+6VMZRW.GQOIT<\DI:O5&#;Y=+M>^Y2(\EG4;&(F(OEG9WCQP8ICE*LL;
M)C<K_;C#*)*F)E&E)$SXAB*JM:G2SK8G#9(JKQJ4XU_#VWM;>S;+8Q7[;R[:
M8U6N1=HJR1D<515SNNM=9:K(FR2*BLUV&0PQHJ-<Z.-$1/H\L9F1ZE_34A]H
MZ;KTF:UU"[1M[G=<-#G?3!)REQUBJ]QK,;DC/&9\S6*M9Y5B5+":SQL1+!2X
M<F\&SWQN1^UVR3:R@:NNCD1ZQIE6UB.:YJ9/;9'7DZ:I9T\A#W 8;1^A/Z:M
M3L+O'K($P'$<,DH8,1>B,A6"LDIZFCJ9+7]P1TM*E+.KE<R&1TBJY84UZ9)H
M769XD.-51DW?9.UU79\?#MVT_JEE1;'(2BUB9-TT'[2N2S2/Q4,QSE\0^&N7
MD@Q4*GV8533-CN1+IMOL#6B22I5[*Q&^VC1CE6\G"C51+MEO!:Y.-$/BMJ_P
MV_2"AV]GPO92"@K]AIJASH,5?74\<3:=[E<Q]1$^3PO6-8J:W4T\[5=:L;WH
MMI@3HPV*2V-MWG?MMC!FJU.V'L"MV)I7<J=_1BY*P6;:=F;P;5T1FV1<FK,7
M,X06,4J/;A9+/>^PV.XMFP,KZNNQ*N:VY3RRM<C<RN=(ZRVS^*BV+P<*9#+'
MXD^#T6QN[W=5N^JJI*_:/!\(J:=]19=66.GIL+IG3N:KW*U*F6&^Q%5^5DB7
M[46]/P,F'DP1+<G^HGO?2%@V=6JCP9W%;(REN'+*)V_(1UQ3U=()$9I+)V15
MU&4)9N[AFZRO8=-*32PKA,Q?"$\_5Q\3C&U.)8=+-#!AT[V1K8DJH[5KD]UD
M9E3_ $D]5#T!W'>AWNJWH81@>-;0[TMG,/KL38U\N$1R4:XG&JO5%IT;+7HY
MDSD3(YU,^[>1=2],B^?Z-U<I"VGMG[B8[#@[UMC=5]S9=P,H<CIFK2I)%>;?
M0M8D8Z1:LGY77?;!(.\N2IY9+G<G(U5631[\>EL'%3K035[96R5M1+>E1+4N
M+E5&JBHB_P 9RV\"VY%5$M+O^(]C.T\>\7 ]W-5@]5A6P&S.$^#80^96O2MC
M<V%DU3')&Y\:MLIZ>)(U<DS$C:Z=D3Y-6W9O8G3]X/RU[F^0&P-05I.989DK
MG;)!U+V!A3G;AB1:6E;)9*HUED*N^.4J:CAWE5KE)R;NCKD5-G.1>*K9C9U]
M2[$ZJ!FL2U[E57(U;,JN<U%NKG7)EZ=IA#8_TN/2?H-E:7='LCM%6KALNKHZ
M2-L-/)6,:]6Q14U-5.B=4L3*V.)&RHZ-+K8G,1$0PET_:V]W?LG=O/RW1SAM
MG;<LZUWH.,D42IJUG1M+>%BVSAHW[RDFR4LK^*3PKA/&/]*S64QDV')C&MVS
M$3L1JZC::=%37NN0HO\ %A8MF3->5.15Z9D[TN,9I=V&Q>S'HE[/3,>FS].W
M$,=EC=:E3C=8Q97->ZU5>E-'*Y6JY5]K-&Q41841)6Q]H:$%OOB#\ES07XJJ
M=_ [8:W[2?7]9XP_ME/U5^BK_EMV'_=F@[PPV-%D,_@      ?"LO_@CW_NW
M^MH#E.$ZO]R?='!V     ('^LE_O+H;_ &'?_P#7ZJ,M[L_B*SX<?6>>*'XM
M'G#L3XEB??:(A7&4#R$                 O$#50_94
M!2PV=_65L+^7%L_AZ0&T-!\QA_1,[5#\@^\;[PL>^V:WZ3*>&$H^-
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MZBGT@G.KYX_)S\MEW&^FQ_FEA?V=3=Y8><VW'GIC'VI5]_D-.!]&?+@
M         %B/U8WZ1^;^;5L[[ZM;##^^WS-;X[%VLAF[<!Y]/\0E[>(Z"8U(
M-TP
M
M
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M?UE;"_EQ;/X>D!M#0?,8?T3.U0_(/O&^\+'OMFM^DRGAA*/C0
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M</OY97+\E%^'P6\_S$Q']$SOL9D;=)]XN&?I7]YD.FT-)3?L
M    #E(=13Z03G5\\?DY^6R[C?38_P TL+^SJ;O+#SFVX\],8^U*OO\ (:<#
MZ,^7               +$?JQOTC\W\VK9WWU:V&']]OF:WQV+M9#-VX#SZ?X
MA+V\1T$QJ0;I@
M
M
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M*JJ7"^(/R7-!?BJIW\#MAKCM)]?UGC#^V4_5!Z*O^6W8?]V:#O##8T60S^
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M[-_%4I]]U;&.MY/U5!XQ_(<>I'X4OWR;1?NROTZD+#(PR>\0
M  !BK>W]2&Y/Q5;#^]&7%PPCZUI?&(^W0QGOJ^YO:W]V<4^@SE,P;-GY(0
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MYX_)S\MEW&^FQ_FEA?V=3=Y8><VW'GIC'VI5]_D-.!]&?+@
M %B/U8WZ1^;^;5L[[ZM;##^^WS-;X[%VLAF[<!Y]/\0E[>(Z"8U(-TP
M
M
M
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MLY>    C;ZI_R<-?_/#X2_G2:M$JD^-7X#NU4BUGQ2?#9VR$D@BDH
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M %W[-_%4I]]U;&.MY/U5!XQ_(<>I'X4OWR;1?NROTZD+#(PR>\0
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M*?2"<ZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;<>>F,?:E7W^0TX'T9\N
M        6(_5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT_Q"7MXCH)C4@W
M3
M
M
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M"F+G.,_LCEKG,<CFK8Y#JYK7M5KDM:IH3^A_Z9G^#73WN;+>^XD^&U7/<1_
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M[OX>/^:;!?$L1^A3&O/I1_<WB'C%+](C-V^"'R'N&GS4N._Y(J>,">D/]_\
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M^=)JT2J3XU?@.[52+6?%)\-G;(22"*2@        BLZO7R:Z1^/&M?>%LL9
MW;_7DOBCN^1'F?\ BI_Y>\&_?.D_Z;BQ7*&:SP%                 M]\0
M?DN:"_%53OX';#6_:3Z_K/&']LI^JOT5?\MNP_[LT'>&&QHLAG\      "H%
MZZM]%EH/Y_\ JS\W7E4 )ONBE]$?TY?F@:/^\F+ $GX    ('^LE_O+H;_8=
M_P#]?JHRWNS^(K/AQ]9YXH?BT><.Q/B6)]]HB%<90/(0
M"\0-5#]E0                %+#9W]96POY<6S^'I ;0T'S&']$SM4/R#[Q
MOO"Q[[9K?I,IX82CXT               EOZ/O\ 7?LW\52GWW5L8ZWD_54'
MC'\AQZD?A2_?)M%^[*_3J0L,C#)[Q               &*M[?U(;D_%5L/[T
M9<7#"/K6E\8C[=#&>^K[F]K?W9Q3Z#.4S!LV?DA                 G\Z.
MO]6NY/Y<0/\  *@P_O+^?4WZ)W;'N/\ A/?=[M;]LTWT928P8T/6,
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M^E4X??RRN7Y*+\/@MY_F)B/Z)G?8S(VZ3[Q<,_2O[S(=-H:2F_8
M       '*0ZBGT@G.KYX_)S\MEW&^FQ_FEA?V=3=Y8><VW'GIC'VI5]_D-.!
M]&?+@              %B/U8WZ1^;^;5L[[ZM;##^^WS-;X[%VLAF[<!Y]/\
M0E[>(Z"8U(-TP
M
M
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M;^*I3[[JV,=;R?JJ#QC^0X]2/PI?ODVB_=E?IU(6&1AD]X@
M #%6]OZD-R?BJV']Z,N+AA'UK2^,1]NAC/?5]S>UO[LXI]!G*9@V;/R0@
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MA]_+*Y?DHOP^"WG^8F(_HF=]C,C;I/O%PS]*_O,ATVAI*;]@
M    <I#J*?2"<ZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;<>>F,?:E7W^0TX'T9\
MN               6(_5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT_Q"7M
MXCH)C4@W3
M
M
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M;^*I3[[JV,=;R?JJ#QC^0X]2/PI?ODVB_=E?IU(6&1AD]X@
M #%6]OZD-R?BJV']Z,N+AA'UK2^,1]NAC/?5]S>UO[LXI]!G*9@V;/R0@
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MA]_+*Y?DHOP^"WG^8F(_HF=]C,C;I/O%PS]*_O,ATVAI*;]@
M    <I#J*?2"<ZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;<>>F,?:E7W^0TX'T9\
MN               6(_5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT_Q"7M
MXCH)C4@W3
M
M
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M@=L-;]I/K^L\8?VRGZJ_15_RV[#_ +LT'>&&QHLAG\      #X5E_P#!'O\
MW;_6T!RG"=7^Y/NC@[     $#_62_P!Y=#?[#O\ _K]5&6]V?Q%9\./K//%#
M\6CSAV)\2Q/OM$0KC*!Y"                 7B!JH?LJ
M   I8;._K*V%_+BV?P](#:&@^8P_HF=JA^0?>-]X6/?;-;])E/#"4?&@
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MU?K^_2W\L_["/S9]-#='=-]W^'_[?Z3,:';Y_O*Q+^C_ $6 AQ&1C%X
M         !*YT/?I5.'W\LKE^2B_#X+>?YB8C^B9WV,R-ND^\7#/TK^\R'3:
M&DIOV                !RD.HI]()SJ^>/R<_+9=QOIL?YI87]G4W>6'G-M
MQYZ8Q]J5??Y#3@?1GRX              !8C]6-^D?F_FU;.^^K6PP_OM\S6
M^.Q=K(9NW >?3_$)>WB.@F-2#=,
M
M
M                                                       (V^J?
M\G#7_P \/A+^=)JT2J3XU?@.[52+6?%)\-G;(22"*2@        BLZO7R:Z1
M^/&M?>%LL9 W;_7DOBCN^1'F?^*G_E[P;]\Z3_IN+%<H9K/ 4
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M;"_EQ;/X>D!M#0?,8?T3.U0_(/O&^\+'OMFM^DRGAA*/C0
M"6_H^_UW[-_%4I]]U;&.MY/U5!XQ_(<>I'X4OWR;1?NROTZD+#(PR>\0
M          !BK>W]2&Y/Q5;#^]&7%PPCZUI?&(^W0QGOJ^YO:W]V<4^@SE,P
M;-GY(0                )_.CK_ %:[D_EQ _P"H,/[R_GU-^B=VQ[C_A/?
M=[M;]LTWT928P8T/6,               JC^M:_)]XH?CCNGWDHC/6X;ZWK_
M !9G;FN7I&?4N&^-2=[*0(V=-2P                .M!PP^1YQ/^;3HG\E
MU6&@6TGG%7^.S]]<>D>ROFOAOB%/WIALL+*7X               YJ_7]^EO
MY9_V$?FSZ:&Z.Z;[O\/_ -O])F-#M\_WE8E_1_HL!#B,C&+P
M  "5SH>_2J</OY97+\E%^'P6\_S$Q']$SOL9D;=)]XN&?I7]YD.FT-)3?L
M              #E(=13Z03G5\\?DY^6R[C?38_S2PO[.IN\L/.;;CSTQC[4
MJ^_R&G ^C/EP              "Q'ZL;](_-_-JV=]]6MAA_?;YFM\=B[60S
M=N \^G^(2]O$=!,:D&Z8
M
M
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M^L\\4/Q:/.'8GQ+$^^T1"N,H'D(                !>(&JA^RH
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MA\CSB?\ -IT3^2ZK#0+:3SBK_'9^^N/2/97S7PWQ"G[TPV6%E+\
M      <U?K^_2W\L_P"PC\V?30W1W3?=_A_^W^DS&AV^?[RL2_H_T6 AQ&1C
M%X              !*YT/?I5.'W\LKE^2B_#X+>?YB8C^B9WV,R-ND^\7#/T
MK^\R'3:&DIOV                !RD.HI]()SJ^>/R<_+9=QOIL?YI87]G4
MW>6'G-MQYZ8Q]J5??Y#3@?1GRX              !8C]6-^D?F_FU;.^^K6P
MP_OM\S6^.Q=K(9NW >?3_$)>WB.@F-2#=,
M
M
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MUK[PMEC(&[?Z\E\4=WR(\S_Q4_\ +W@W[YTG_3<6*Y0S6> H
M    %OOB#\ES07XJJ=_ [8:W[2?7]9XP_ME/U5^BK_EMV'_=F@[PPV-%D,_@
M      5 O75OHLM!_/\ ]6?FZ\J@!-]T4OHC^G+\T#1_WDQ8 D_    ! _UD
MO]Y=#?[#O_\ K]5&6]V?Q%9\./K//%#\6CSAV)\2Q/OM$0KC*!Y"
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MU%/I!.=7SQ^3GY;+N-]-C_-+"_LZF[RP\YMN//3&/M2K[_(:<#Z,^7
M         +$?JQOTC\W\VK9WWU:V&']]OF:WQV+M9#-VX#SZ?XA+V\1T$QJ0
M;I@
M
M
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MYS%Q2KN$8)(.%DT>_JDQDN3X*8Q<Q]N,'P]F&U&+I';B#W1(KE55L1%:W(G
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ML6I]@U78$2@97NL80=O:M*RB+)V4Y#$.BMDBJ9R&(8N#%SC &9
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M::%I+N   $;?5/\ DX:_^>'PE_.DU:)5)\:OP'=JI%K/BD^&SMD))!%)0
M     16=7KY-=(_'C6OO"V6,@;M_KR7Q1W?(CS/_ !4_\O>#?OG2?]-Q8KE#
M-9X"@                6^^(/R7-!?BJIW\#MAK?M)]?UGC#^V4_57Z*O\
MEMV'_=F@[PPV-%D,_@      ?"LO_@CW_NW^MH#E.$ZO]R?='!V     ('^L
ME_O+H;_8=_\ ]?JHRWNS^(K/AQ]9YXH?BT><.Q/B6)]]HB%<90/(0
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MZ[]F_BJ4^^ZMCY/>3]50>,?R'&Z'X4OWR;1?NROTZD+#(PR>\0
M    !BK>W]2&Y/Q5;#^]&7%PPCZUI?&(^W0QGOJ^YO:W]V<4^@SE,P;-GY(2
M"GE/I/K#7"F[(B8K<.J;-KZ96L*2=%U@JVKFP9:ENEG1F\">7E=;U4QUE(?)
M4'*#>8*H[[3I9RL4^2FQSC.'[=SP2L9/ ^E=>]I'[5ZLS6K&WI9%1'9>#*>I
M^XC>;^'3L[M)@N(5^SF/T.UU,VG5:[$T=48?%6-:V].D46(U2(B36OC?)2*V
M*QLB)$K45OL^+.Q]3;$Z7F]:-H:K35$L6MM(;CJ-NITT\3>V5KL23UU9'F;
MZG$6,427-9I YE4G'@K3*2B1V_>$BH%**^#5=%5;'5--AK'1RPT\K7-5;77U
M8Y;UMB6WERVV)9P6)8?-;]MC-O\ 8[TYME=J=ZU?38K@^-;48/5TE9"Q64SL
M/CQ"F9X.V!7RK$E-&B-='K94<US9M;(LJJ91Z-#F/7X+4M)D9++EG=MC-I;"
M?9W9) UF<.TRK]GU>^YBG3;..WZO<9*)FP2M79R-&\*226^K>MZRH?#?B10U
M<7I38F^I1R0R89ASHK>!8TIFL6[Q:ULB>JBF!>N?C+O4_'>'BSX);)+=AL5[
MO9LD=]I*V]:JG;G+VJ$P22?LNW.,9[#9)_T]@MN\;VU%2QL^.6H]KG]ROKJA
ME?\ "U5*?;_;#$:Y+< AV9_XBU+69:ECD1R+D6V-DUB+TD<3F#(IY;D!/6I:
M6W8]^X3\?H!VUBVNT-A3K1L\E\J9@%+;*S5!I5<=RA"-'.?!:\G:G)U\E*L;
M*+TW^C_8P?&F\!L]74X?AD2HULTJI:ON;RJQC57)_%O+;PY%X#UE_#0J-G]C
M-D]YN]S%HWSSX'@\#W,BLUZ4D4-?6U#(E5[?;5"TL:,M5B7X4]OPW<@WOI-W
M&/J,E?\ 7_,'D?*\EXF-7EHVUSMR41@9^;9D4D2Q*#5C@EIKZ,K)%[E)4TP]
M(V,?!C)*XQG&953L3.V!:FEKZMV+M2U'.?[5RIELR>V;:O MY;,RGR.ROI_;
M.5>T,.R6UV[K8R#<I43-BDI8*-%G@A>J1ZUSGVTM0L4>5S$I(5D1MB21VHJ;
M<=-3DW9>57%Z#O%X.@YO=4LDQKBY2K9(C9*=EX!E$2K2<.T211;M'DE7[ R.
MY(CVHY==\,GA,IL))WO9+%YL:P=M146+4L>L;USJU$5%LZ2JUR6V9+;;+.!-
M?/36W(8)N&WYU6R^RZ/9LK7T4.(T<3E5RP0SOFB? CU57/9'44\S8U?[=(KC
M7J]S5D?C7J'V&2N+?5?!?5.4(N[\I;,4MR=1C5(F:AIBONRRU[M#Q%!'N$S2
MF&)DB9/V8=)-G:7;W>2B)M3*^=(=G**Q*BL?[=4_BQ-6U[E]6SJHCD/M?0^P
MBBV<FQ[TIMO;\^R^PE#_ ,&V5RKX7C%0Q8J&F8KEM5(KZ.<B?%/DIY++J*;5
MT[=7%?6<[5N+E8VOK.%M=.BHBEP&MRVF)),L\1+-&.CZ^HEW\J9K(9%$N3,S
M&P^5,;N\IYR;MS>H,0P:DD9@\,\+9HVHQL=Y+4L2Q&_"XN'B,"[1[L]_&VV%
MU^_3', QNIP'$:B:LGQ'P6587ZUZR25"+=5?!T55LF1-0U$NH]$;8EICHZ_U
M:[D_EQ _P"H,;;R_GU-^B=VQZL?A/?=[M;]LTWT928P8T/6,
M   JC^M:_)]XH?CCNGWDHC/6X;ZWK_%F=N:Y>D9]2X;XU)WLI C9TU+
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M$?JQOTC\W\VK9WWU:V&']]OF:WQV+M9#-VX#SZ?XA+V\1T$QJ0;I@
M
M
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M9U>ODUTC\>-:^\+98R!NW^O)?%'=\B/,_P#%3_R]X-^^=)_TW%BN4,UG@*
M              !;[X@_)<T%^*JG?P.V&M^TGU_6>,/[93]5?HJ_Y;=A_P!V
M:#O##8T60S^      !\*R_\ @CW_ +M_K: Y3A.K_<GW1P=@    "!_K)?[R
MZ&_V'?\ _7ZJ,M[L_B*SX<?6>>*'XM'G#L3XEB??:(A7&4#R$
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M9#;6KHH4IZ*7:")\<2+:D3'0.<R-%7*J,:J-1>G9:30#&YZJ
M   %4?UK7Y/O%#\<=T^\E$9ZW#?6]?XLSMS7+TC/J7#?&I.]E($;.FI8
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M5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT_P 0E[>(Z"8U(-TP
M
M
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MK7WA;+&0-V_UY+XH[OD1YG_BI_Y>\&_?.D_Z;BQ7*&:SP%
M   M]\0?DN:"_%53OX';#6_:3Z_K/&']LI^JOT5?\MNP_P"[-!WAAL:+(9_
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MOZRMA?RXMG\/2 VAH/F,/Z)G:H?D'WC?>%CWVS6_293PPE'QH
M   !+?T??Z[]F_BJ4^^ZMC'6\GZJ@\8_D./4C\*7[Y-HOW97Z=2%AD89/>(
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M_+/^PC\V?30W1W3?=_A_^W^DS&AV^?[RL2_H_P!%@(<1D8Q>
M   2N=#WZ53A]_+*Y?DHOP^"WG^8F(_HF=]C,C;I/O%PS]*_O,ATVAI*;]@
M               <I#J*?2"<ZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;<>>F,?:
ME7W^0TX'T9\N               6(_5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&
M;MP'GT_Q"7MXCH)C4@W3
M
M
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M/QXUK[PMEC(&[?Z\E\4=WR(\S_Q4_P#+W@W[YTG_ $W%BN4,UG@*
M        !;[X@_)<T%^*JG?P.V&M^TGU_6>,/[93]5?HJ_Y;=A_W9H.\,-C1
M9#/X      %0+UU;Z++0?S_]6?FZ\J@!-]T4OHC^G+\T#1_WDQ8 D_    !
M_P!9+_>70W^P[_\ Z_51EO=G\16?#CZSSQ0_%H\X=B?$L3[[1$*XR@>0@
M             %X@:J'[*@                *6&SOZRMA?RXMG\/2 VAH/
MF,/Z)G:H?D'WC?>%CWVS6_293PPE'QH              !+?T??Z[]F_BJ4^
M^ZMC'6\GZJ@\8_D./4C\*7[Y-HOW97Z=2%AD89/>(               Q5O;
M^I#<GXJMA_>C+BX81]:TOC$?;H8SWU?<WM;^[.*?09RF8-FS\D(
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M0ZBGT@G.KYX_)S\MEW&^FQ_FEA?V=3=Y8><VW'GIC'VI5]_D-.!]&?+@
M          %B/U8WZ1^;^;5L[[ZM;##^^WS-;X[%VLAF[<!Y]/\ $)>WB.@F
M-2#=,
M
M
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MCSAV)\2Q/OM$0KC*!Y"                 7B!JH?LJ
M I8;._K*V%_+BV?P](#:&@^8P_HF=JA^0?>-]X6/?;-;])E/#"4?&@
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M7Z_OTM_+/^PC\V?30W1W3?=_A_\ M_I,QH=OG^\K$OZ/]%@(<1D8Q>
M         2N=#WZ53A]_+*Y?DHOP^"WG^8F(_HF=]C,C;I/O%PS]*_O,ATVA
MI*;]@                <I#J*?2"<ZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;<
M>>F,?:E7W^0TX'T9\N               6(_5C?I'YOYM6SOOJUL,/[[?,UO
MCL7:R&;MP'GT_P 0E[>(Z"8U(-TP
M
M
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MB58%G9G%-@FD.K--H5=_*+1:+\S;OA4#.5S)XSV9.;]D#DVI    ! _UDO\
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M_G1U_JUW)_+B!_@%08?WE_/J;]$[MCW'_">^[W:W[9IOHRDQ@QH>L8
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MKYX_)S\MEW&^FQ_FEA?V=3=Y8><VW'GIC'VI5]_D-.!]&?+@
M  %B/U8WZ1^;^;5L[[ZM;##^^WS-;X[%VLAF[<!Y]/\ $)>WB.@F-2#=,
M
M
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M0AVZQ4'KR'USJ/>;O9++7.\]+WC-AT<FJP<RKN[3#=Y SDA7B,&22RJ6(U[
M,7R<@X)EDR5)WE7)/#<&S\)MW'2QTD&).E2+$:>2]#DM5ZVHJML3,K46\N1.
M!?='HS^'-BFV&([9;0[K:?!9<9W6[2X7X/C:I(V)E%"YD\$=0LCU1%UC)YX'
M4\:I-,UVLC1W@UA'1R4YL<FN1M!UKI;DQJ];B7I':5BJ^;[N"0UMLY1A/Q\0
M^0G6ZT$QEFYLGC4W\:D_PS;F=N%#(H'RX(WPID_RN+;0XOBM-#A^+P^ X=,]
MM^58Y+'(BWLB+TK4ML2U<B+;9:;C[E?1EW([FMK,:WE[DL<;O WG8%1U7@&$
M1XCAB/@DF8Z!R3OB<EDBQR.@6:1(HVH^5J0NF5B-L916D])VCCY5=)'@8"^Z
M/SK^IUV%CW2J$K$SM5BXN.S7)A"38'3PX<KHM4'J,@V4(KE?.'":F#YP8959
MA^'S86S#KK9<.U36HBY45J(EU;4]1%1R=/*BGC=7[S=YN![WJ_><VKJ\)WH>
M5ZJHFD:CHI8*J663PB%T4B+=:U7/A?3R-5J,MB>Q6VM(T>2>D-$<%=-RU4XH
MZW3A.17*N40T)KE_F<GK%;>]7!RU0L2L=+6)_,/(2$AHHY>[4;91P1ZJT55-
MDQ"G+\CBV'8;LY0.AP6*[BM:NI8MKG.]M9>L5RJJ(B9K,MU5SFZ^Y;>?O5]*
M?>/3X_O\QI:K<YL% ['<1CU$%/26TC7.ITDBIXX63332HMC9+]L+:AD:(CE:
MZ37C?H^N\<=):\TU6L)*,Z9 -V<A(II82/.V)T8[^RSZY<%*;OLS..EU\%-V
MY3(<J>/VI,8'U^$X=%A6'14$/N8VV*N=RY7.ZJVKR&D>^?>AC&^7>=C&\C&[
MR5&)5;GQQJMJ04[;(Z:!O%# UD=J>Z5%>N5RF;Q<#&!>(&JA^RH
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M\CSB?\VG1/Y+JL- MI/.*O\ '9^^N/2/97S7PWQ"G[TPV6%E+\
M     <U?K^_2W\L_["/S9]-#='=-]W^'_P"W^DS&AV^?[RL2_H_T6 AQ&1C%
MX              !*YT/?I5.'W\LKE^2B_#X+>?YB8C^B9WV,R-ND^\7#/TK
M^\R'3:&DIOV                !RD.HI]()SJ^>/R<_+9=QOIL?YI87]G4W
M>6'G-MQYZ8Q]J5??Y#3@?1GRX              !8C]6-^D?F_FU;.^^K6PP
M_OM\S6^.Q=K(9NW >?3_ !"7MXCH)C4@W3
M
M
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MMQS6'KM7J\1'P%=@8EDGA%G%PL)$MVD;%QS1$N")(())I)EQV%+C  ^\
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MDL9C,$[IL?N55/\ H@U$3(9+C'H]MG"G\*D^GE?-'?>Q6.MX%_@0W$% K@
M!&WU3_DX:_\ GA\)?SI-6B52?&K\!W:J1:SXI/AL[9"20124        $5G5
MZ^372/QXUK[PMEC(&[?Z\E\4=WR(\S_Q4_\ +W@W[YTG_3<6*Y0S6> H
M            %OOB#\ES07XJJ=_ [8:W[2?7]9XP_ME/U5^BK_EMV'_=F@[P
MPV-%D,_@      ?"LO\ X(]_[M_K: Y3A.K_ ')]T<'8     @?ZR7^\NAO]
MAW__ %^JC+>[/XBL^''UGGBA^+1YP[$^)8GWVB*LW-3ECQ*T#!%BM]LJOL6W
MFCO9>J:@6K<1<K-+&=J*H,G>(^59O(ZMQCQW'F+E\],@F;O!L)=^5(5(WUFT
M&-X)AD=S$T9+/9:V*ZCW+;P+8J*C454X5LX,EJY#3#T:-P/I [VL56OW3RUV
M#;.I-JJK%DJ):.FBN(CGLUD3V25$K&2(NHA1[DOM5^K8Y7IJAP;XZ;<V]O!Q
MSMY.5!GKQZA"JU[CII=O&(1C6@5!Z20*264ALH(N(?O+26=%:$<)(NW3I^[?
M*I(X.V[JR[.X575V(KM)C$:1.NW8(K++C5MRV=+(JV6V*JJYRHF0S[Z46^/=
M]N\W7L]%;<AB,F,4SJE*C:'&72NE=7U;%CMB2:\K9K7Q1+*Z-SXHHH*>E8^1
M6SV?ZZJ'4&2T1#*<>-36%"/W+=F**-MM:9WG<ZBJ$PDCW+_*D>V=.R6N=8.<
MG:E;IK.&3/NG6"85.S[MMGM0F&Q^2Z%R)7R)[9V7N35Z>3+>5."RU43+PJTZ
M^@?Z(DF]7$DWP[P*-\V[?#)56DI51EN+5<*K;'9(YK%I8)&V2K(YD<TUD"N5
MC:B[C_A1RHZ8?#K4[2D07(-"<N\\9O*[+OBFI=W(.;78^Y4P4J/A&NC&95Z%
M*X,@P;YR7!$^Z54[5UECGB[/XSL?@-$E/'57JAV61^JF]L[\C(U.!$ZJY54^
MN])K</Z</I&;?R;3XKL@^EV8I$=%AM"F*X*YM+3Y,JW<0L?43*U'SR9;761L
MLBCC:W>'EYU!];\/;]JJA7.F72SN=D]T_=R5;;HF;5RODE$H<[])%;&5K'*X
M=G,;$>U[E7O1,9R?!E$2J?18YM128%4PTU1'(]9LJJW^*VVRWWRV_P 5,NE+
M=7O1Y]$/;/TB]D\>VKV;Q+#*&'!?:,CJ'*CJBH6)9DC56Y*>*XB)X1+:V\MB
M-5&2.9H5U4(F8UKRSXC\JKO49>^<>-?*04+;XMDRQ),*[.QETD)MQ(/&RW8Q
M(]G&,JS.S3<&30?.(;"!CE[<#YK;-DE)C=#C50QTN%Q6(Y$2U&JCU6U>E:J*
MEEN15;9:;7^@?B&';:^C_O!W#;,8A3X3O@Q=)YJ25[]7)4024<<#8V.3VZL@
M?%,DSHT<^".L65K5L4^GU .H5Q W9Q:MNI]96!3<NPMGX@(NF5:-IML;/(.;
M--1KMI/.U9V CLLI*,RGDC=NW[Z]<NE"HX3[T=50G?:?:C L0P9]%1N\(JIK
MJ,:C76HMJ*CEM:EBITD3*JY+++5(7HD>B#Z1&[+?KA^W^V]&FS>R&!Z^6LJI
M*RD<R>#4R,? Q()Y+\<MJ+)))=ABB:Z17ZQL;'20\!M;7K47#[1.OME$=H72
M#J;I>7CW_P!1]")SM@F;%%5QZ3.<]Y=UJ&EF\>HG_P#HSMLD_P"@?6;,TE30
MX%34M7:E0UF5%X4M<KD:O&U%1O4-,/2QVTV6WA>D5M5M=L6L;]FJK$&MADC]
MQ,L%/#3RU#%Z;*F:*2=KOXR2([IFK>DDG'+CF%M'E<9#$SJSC2G.Z.XTL%CE
M)%66\IM5?.1L)LLLEWKO*R[K#)H[)W::K==//:51IV"S8>BXYCLV-67J*DMA
MITZ3GV=T?RV(N94Z;3.N\Z2'T?/1TP+<&UW@VW>VJP8WM)(B6RTU"KD\G8>Y
M$6VU&M6:6);'-D8]+%94$2$IO"PYUPZY'.>7^\(_J&I[=4K6>,R6)5&HL3EO
MN8?&ODM=*1BA"P*5;SX7V'7.Q,Z_^'G;&=YRMGXA^(R^"+BRUU2FU&ON^#Y;
MJ>WLN:NSW-W+PV6^TLO93T&H=U^#IME'N9@W=[+S>A^NSR5/]I%U3JMZ+0:[
MP]<121%UZU/<K48DZ1?\8V9M.B1I:]@W$F\A8=W-,4XR8=1<>XEHU);#A*/D
MUVB*K]BFX+G)5TVCHQT\'QGL-@O;_P!(S3&KW1M=(EDBM2U,RV94ZBG@7BD-
M%3XG44^&RK/AS)Y&Q2*EU9(VO5&/5O\ %5[41RITK;"\X-5S]C@
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MY'G$_P";3HG\EU6&@6TGG%7^.S]]<>D>ROFOAOB%/WIALL+*7X
M     YJ_7]^EOY9_V$?FSZ:&Z.Z;[O\ #_\ ;_29C0[?/]Y6)?T?Z+ 0XC(Q
MB\               E<Z'OTJG#[^65R_)1?A\%O/\Q,1_1,[[&9&W2?>+AGZ
M5_>9#IM#24W[                 Y2'44^D$YU?/'Y.?ELNXWTV/\TL+^SJ
M;O+#SFVX\],8^U*OO\AIP/HSY<               L1^K&_2/S?S:MG??5K8
M8?WV^9K?'8NUD,W;@//I_B$O;Q'03&I!NF
M
M
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M:U^3[Q0_''=/O)1&>MPWUO7^+,[<UR](SZEPWQJ3O92!&SIJ6
M     !UH.&'R/.)_S:=$_DNJPT"VD\XJ_P =G[ZX](]E?-?#?$*?O3#9864O
MP              !S5^O[]+?RS_L(_-GTT-T=TWW?X?_ +?Z3,:';Y_O*Q+^
MC_18"'$9&,7@              $KG0]^E4X??RRN7Y*+\/@MY_F)B/Z)G?8S
M(VZ3[Q<,_2O[S(=-H:2F_8                '*0ZBGT@G.KYX_)S\MEW&^
MFQ_FEA?V=3=Y8><VW'GIC'VI5]_D-.!]&?+@              %B/U8WZ1^;
M^;5L[[ZM;##^^WS-;X[%VLAF[<!Y]/\ $)>WB.@F-2#=,
M
M
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M8)1=W+3TT[3;D+E5=7)$42$10(D@FFD2%+-).^_(MKB;##' RY$EC38@4RJ
M  $;?5/^3AK_ .>'PE_.DU:)5)\:OP'=JI%K/BD^&SMD))!%)0        16
M=7KY-=(_'C6OO"V6,@;M_KR7Q1W?(CS/_%3_ ,O>#?OG2?\ 3<6*Y0S6> H
M               %OOB#\ES07XJJ=_ [8:W[2?7]9XP_ME/U5^BK_EMV'_=F
M@[PPV-%D,_@      5 O75OHLM!_/_U9^;KRJ $WW12^B/Z<OS0-'_>3%@"3
M\    $#_ %DO]Y=#?[#O_P#K]5&6]V?Q%9\./K//%#\6CSAV)\2Q/OM$0KC*
M!Y"                 7B!JH?LJ                 I8;._K*V%_+BV?P
M](#:&@^8P_HF=JA^0?>-]X6/?;-;])E/#"4?&@              $M_1]_KO
MV;^*I3[[JV,=;R?JJ#QC^0X]2/PI?ODVB_=E?IU(6&1AD]X@
M  #%6]OZD-R?BJV']Z,N+AA'UK2^,1]NAC/?5]S>UO[LXI]!G*9@V;/R0@
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M3A]_+*Y?DHOP^"WG^8F(_HF=]C,C;I/O%PS]*_O,ATVAI*;]@
M     <I#J*?2"<ZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;<>>F,?:E7W^0TX'T9
M\N               6(_5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT_P 0
ME[>(Z"8U(-TP
M
M
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M%GV%PMLULV)KTW*/J,]V':*I&$B8J608R66D J\RD9L[;'R!>\
M        1M]4_P"3AK_YX?"7\Z35HE4GQJ_ =VJD6L^*3X;.V0DD$4E
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M'XM'G#L3XEB??:(A7&4#R$                 O$#50_94
M   !2PV=_65L+^7%L_AZ0&T-!\QA_1,[5#\@^\;[PL>^V:WZ3*>&$H^-
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M'G$_YM.B?R758:!;2><5?X[/WUQZ1[*^:^&^(4_>F&RPLI?@
M  #FK]?WZ6_EG_81^;/IH;H[ION_P_\ V_TF8T.WS_>5B7]'^BP$.(R,8O
M             )7.A[]*IP^_EE<OR47X?!;S_,3$?T3.^QF1MTGWBX9^E?WF
M0Z;0TE-^P                .4AU%/I!.=7SQ^3GY;+N-]-C_-+"_LZF[RP
M\YMN//3&/M2K[_(:<#Z,^7               +$?JQOTC\W\VK9WWU:V&']]
MOF:WQV+M9#-VX#SZ?XA+V\1T$QJ0;I@
M
M
M                              $=/4ZZ8O'WJP<?:YQPY'V/:]4I=4VO
M7MR0DWINPU:M6YM;JU5KM3F::CRXTF_P3B(<05_D4UD5(XQ\G,F<BA#$QG($
M#'ZE3TLO3YS_ /C3XZ__ $JH ?J5/2R]/G/_ .-/CK_]*J 'ZE3TLO3YS_\
MC3XZ_P#TJH ?J5/2R]/G/_XT^.O_ -*J )B>E/T7.*?1^8[Q:<9K?O6Z..0+
MO73B]2>\;92+,^;HZN1NR5585].B:WUM&L&B9]@R:B^5F[E=8ZI,94P1,I<
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MN_9OXJE/ONK8QUO)^JH/&/Y#CU(_"E^^3:+]V5^G4A89&&3WB
M    ,5;V_J0W)^*K8?WHRXN&$?6M+XQ'VZ&,]]7W-[6_NSBGT&<IF#9L_)"
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MI5.'W\LKE^2B_#X+>?YB8C^B9WV,R-ND^\7#/TK^\R'3:&DIOV
M      !RD.HI]()SJ^>/R<_+9=QOIL?YI87]G4W>6'G-MQYZ8Q]J5??Y#3@?
M1GRX              !8C]6-^D?F_FU;.^^K6PP_OM\S6^.Q=K(9NW >?3_$
M)>WB.@F-2#=,
M
M
M            B)ZTG58:='[BI3>3#G1CGD&M==[U/1S"C(;'2U8DU=V:B[+O
M9[$\M*E&V(;#9@PUJNAAL2-.999T3/?$RE-D 5>?UYS_ .U=_P#V;/\ ^2.
M'Z\Y_P#:N_\ [-G_ /)' #]><_\ M7?_ -FS_P#DC@!^O.?_ &KO_P"S9_\
MR1P!8)Z&G7+8]:)CR:43XRN^-TEQN=Z?([:'W CM]C;6.WT=FFCW#>0+K+6#
MB&=PSC6#HJR)FKDBA'*1BJXS@Y, 3Y@                 (V^J?\G#7_SP
M^$OYTFK1*I/C5^ [M5(M9\4GPV=LA)((I*        "*SJ]?)KI'X\:U]X6R
MQD#=O]>2^*.[Y$>9_P"*G_E[P;]\Z3_IN+%<H9K/ 4                "W
MWQ!^2YH+\55._@=L-;]I/K^L\8?VRGZJ_15_RV[#_NS0=X8;&BR&?P
M/A67_P $>_\ =O\ 6T!RG"=7^Y/NC@[     $#_62_WET-_L._\ ^OU49;W9
M_$5GPX^L\\4/Q:/.'8GQ+$^^T1"N,H'D(                !>(&JA^RH
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MY/O%#\<=T^\E$9ZW#?6]?XLSMS7+TC/J7#?&I.]E($;.FI8
M   '6@X8?(\XG_-IT3^2ZK#0+:3SBK_'9^^N/2/97S7PWQ"G[TPV6%E+\
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M-;X[%VLAF[<!Y]/\0E[>(Z"8U(-TP
M
M
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M16?#CZSSQ0_%H\X=B?$L3[[1$*XR@>0@                %X@:J'[*@
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M^\4/QQW3[R41GK<-];U_BS.W-<O2,^I<-\:D[V4@1LZ:E@
M  =:#AA\CSB?\VG1/Y+JL- MI/.*O\=G[ZX](]E?-?#?$*?O3#9864OP
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M?/)YI>.L3OWP;V&TGQO\WGC![*:QV/XI]^]E9SP3O?@?A_<K=UW[P?'>M8L
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M^;^;5L[[ZM;##^^WS-;X[%VLAF[<!Y]/\0E[>(Z"8U(-TP
M
M
M                                                 J!>NK?19:#^
M?_JS\W7E4 -N_5//H3>/'XQ.0_Y:KD +(0                     C;ZI_
MR<-?_/#X2_G2:M$JD^-7X#NU4BUGQ2?#9VR$D@BDH        (K.KU\FND?C
MQK7WA;+&0-V_UY+XH[OD1YG_ (J?^7O!OWSI/^FXL5RAFL\!0
M     +??$'Y+F@OQ54[^!VPUOVD^OZSQA_;*?JK]%7_+;L/^[-!WAAL:+(9_
M       J!>NK?19:#^?_ *L_-UY5 ";[HI?1'].7YH&C_O)BP!)^    "!_K
M)?[RZ&_V'?\ _7ZJ,M[L_B*SX<?6>>*'XM'G#L3XEB??:(A7&4#R$
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M>QGX9FP>UVP>PVT]'M=12453/BU.^-KG1NO-2G5JJBQO>F1<F544G/&*CTT
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M%BD>^16.14<QZ)#):K7-546RU+4R.;:EJ):AT*1J(;K@
M<I#J*?2"<ZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;<>>F,?:E7W^0TX'T9\N
M            6(_5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT_Q"7MXCH)
MC4@W3
M
M
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MV6,@;M_KR7Q1W?(CS/\ Q4_\O>#?OG2?]-Q8KE#-9X"@
M6^^(/R7-!?BJIW\#MAK?M)]?UGC#^V4_57Z*O^6W8?\ =F@[PPV-%D,_@
M   5 O75OHLM!_/_ -6?FZ\J@!-]T4OHC^G+\T#1_P!Y,6 )/P    0/]9+_
M 'ET-_L._P#^OU49;W9_$5GPX^L\\4/Q:/.'8GQ+$^^T1"N,H'D(
M        !>(&JA^RH                "EAL[^LK87\N+9_#T@-H:#YC#^B
M9VJ'Y!]XWWA8]]LUOTF4\,)1\:               2W]'W^N_9OXJE/ONK8Q
MUO)^JH/&/Y#CU(_"E^^3:+]V5^G4A89&&3WB               -:>9_R/.6
M'S:=[?DNM(O6S?G%0>.P=]:6':KS7Q+Q"H[T\Y+XW]/-P
M "[]ZJ5\GWE?^..E_>2L-8M_/UO0>+/[<VT]'/ZEQ+QJ/O9:X&!38T
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MJO(K<^H+!O2^/K]>(K3>T[YK6 =R*N#-89F>.J,_$I/FM8@RI1S$[GORZ;1
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MC\G/RV7<;Z;'^:6%_9U-WEAYS;<>>F,?:E7W^0TX'T9\N
M6(_5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT_Q"7MXCH)C4@W3
M
M
M                                                     (B>M)TI
MVG6!XJ4WC.YWFYX^+4K>]3WBPO*&N$MII.G=9HNRZ(>NO*LI>==FRV?L-E+K
MX<DDB&16:DQWM0IC8 %7G]1C_P#MHG_V$W_Y7  ?J,?_ -M$_P#L)O\ \K@
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M<&QC&<9^_P!W%WRY+9;;X([OD1YH_BI7_P##W@UZRS^V5)P?9N+$ (S2> X
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MJ"];-W/[14%EMOAL'?6EAVJUG]F,2M5MG@%1TE^2?QG*N&_1YP
M       73?5<$]@GT+RES37M.:ML;>IN'I;-&3;]<R_B8MWO+4\5+QR::6$_
MV<'*;.<_L9[!K'OXN^5Z"];\V?VYMEZ.M_R+B5VSYU'P_HRTCX/O/VWU/Y.W
M#X4# _<^,V+[KG;H7LCP?>?MOJ?R=N'PH#N?&.ZYVZ%[(\'WG[;ZG\G;A\*
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M_)VX?"@.Y\8[KG;H7LCP?>?MOJ?R=N'PH#N?&.ZYVZ%[(\'WG[;ZG\G;A\*
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MZ&_V'?\ _7ZJ,M[L_B*SX<?6>>*'XM'G#L3XEB??:(A7&4#R$
M      O$#50_94                !2PV=_65L+^7%L_AZ0&T-!\QA_1,[5
M#\@^\;[PL>^V:WZ3*>&$H^-               );^C[_ %W[-_%4I]]U;&.M
MY/U5!XQ_(<>I'X4OWR;1?NROTZD+#(PR>\0              !K3S/\ D><L
M/FT[V_)=:1>MF_.*@\=@[ZTL.U7FOB7B%1WIYR7QOZ>;@
M %W[U4KY/O*_\<=+^\E8:Q;^?K>@\6?VYMIZ.?U+B7C4?>RUP,"FQH
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MF:WQV+M9#)6X#SZ?XA+V\1T$QJ0;I@
M
M
M                                                   :X<8.)''K
MAE09?5_&K7A-:T6>N,E?I:"3L]TMF'=MEHB!@9"6]D;U8[/+H=_B*PQ1P@FX
M(V3*WQDB93&/DU66:2=U^5;766=+@ZA2BAB@;<B2QJK;T^'JFQXI%4   (V^
MJ?\ )PU_\\/A+^=)JT2J3XU?@.[52+6?%)\-G;(22"*2@        BLZO7R:
MZ1^/&M?>%LL9 W;_ %Y+XH[OD1YG_BI_Y>\&_?.D_P"FXL5RAFL\!0
M          +??$'Y+F@OQ54[^!VPUOVD^OZSQA_;*?JK]%7_ "V[#_NS0=X8
M;&BR&?P      /A67_P1[_W;_6T!RG"=7^Y/NC@[     $#_ %DO]Y=#?[#O
M_P#K]5&6]V?Q%9\./K//%#\6CSAV)\2Q/OM$0KC*!Y"
M7B!JH?LJ                 I8;._K*V%_+BV?P](#:&@^8P_HF=JA^0?>-
M]X6/?;-;])E/#"4?&@              $M_1]_KOV;^*I3[[JV,=;R?JJ#QC
M^0X]2/PI?ODVB_=E?IU(6&1AD]X@              #6GF?\CSEA\VG>WY+K
M2+ULWYQ4'CL'?6EAVJ\U\2\0J.]/.2^-_3S<                 N_>JE?)
M]Y7_ (XZ7]Y*PUBW\_6]!XL_MS;3T<_J7$O&H^]EK@8%-C0
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M*/"J%S&N5[E17O>J(C(D1JHYS;S5<BJVQ')8JKD-2A] ?-@ =:#AA\CSB?\
M-IT3^2ZK#0+:3SBK_'9^^N/2/97S7PWQ"G[TPV6%E+\               <U
M?K^_2W\L_P"PC\V?30W1W3?=_A_^W^DS&AV^?[RL2_H_T6 AQ&1C%X
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M9K?'8NUD+WN \^G^(2]O$=!,:D&Z8
M
M
M                                                         1M]
M4_Y.&O\ YX?"7\Z35HE4GQJ_ =VJD6L^*3X;.V0DD$4E        !%9U>ODU
MTC\>-:^\+98R!NW^O)?%'=\B/,_\5/\ R]X-^^=)_P!-Q8KE#-9X"@
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M*_\ ''2_O)6&L6_GZWH/%G]N;:>CG]2XEXU'WLM<# IL:
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M5R_)1?A\%O/\Q,1_1,[[&9&W2?>+AGZ5_>9#IM#24W[
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MJ)(KD+DACLY!H?.,K$[6V*NVIVEH]AX55</C5*JM5.#5L7N<2K[]<JIQL<G
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M5NW;VN14<E!-:G^G$= \:DFZ0
M
M
M                                                     1M]4_Y.
M&O\ YX?"7\Z35HE4GQJ_ =VJD6L^*3X;.V0DD$4E        !%9U>ODUTC\>
M-:^\+98R!NW^O)?%'=\B/,_\5/\ R]X-^^=)_P!-Q8KE#-9X"@
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M+?T??Z[]F_BJ4^^ZMC'6\GZJ@\8_D./4C\*7[Y-HOW97Z=2%AD89/>(
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M-7Z_OTM_+/\ L(_-GTT-T=TWW?X?_M_I,QH=OG^\K$OZ/]%@(<1D8Q>
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MIG.7.KI(E5=*E_P:F&YP
M
M
M                                                1M]4_P"3AK_Y
MX?"7\Z35HE4GQJ_ =VJD6L^*3X;.V0DD$4E        !%9U>ODUTC\>-:^\+
M98R!NW^O)?%'=\B/,_\ %3_R]X-^^=)_TW%BN4,UG@*                !
M;[X@_)<T%^*JG?P.V&M^TGU_6>,/[93]5?HJ_P"6W8?]V:#O##8T60S^
M  !4"]=6^BRT'\__ %9^;KRJ $WW12^B/Z<OS0-'_>3%@"3\    $#_62_WE
MT-_L._\ ^OU49;W9_$5GPX^L\\4/Q:/.'8GQ+$^^T1"N,H'D(
M     !>(&JA^RH                "EAL[^LK87\N+9_#T@-H:#YC#^B9VJ
M'Y!]XWWA8]]LUOTF4\,)1\:               2W]'W^N_9OXJE/ONK8QUO)
M^JH/&/Y#CU(_"E^^3:+]V5^G4A89&&3WB               -:>9_P CSEA\
MVG>WY+K2+ULWYQ4'CL'?6EAVJ\U\2\0J.]/.2^-_3S<
MN_>JE?)]Y7_CCI?WDK#6+?S];T'BS^W-M/1S^I<2\:C[V6N!@4V-
M       *H_K6OR?>*'XX[I]Y*(SUN&^MZ_Q9G;FN7I&?4N&^-2=[*0(V=-2P
M -Z.GISSVAT\.0L7O+73%K9HUW%N*IL37LH_=1\/?:3(.6CMY$K/&I%S1<NR
M>,DG4<^[ROX(Z2QDR2R)UD%?EMK]E*':_"'876*K'HZ_'(B(JQO1%1%L7A14
M54<VU+47A1;%3Z_8G;'$-B,;;B]"B21JU62QJJHV2-5152U.!R*B*UUBV*G
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MK&_2/S?S:MG??5K88?WV^9K?'8NUD,W;@//I_B$O;Q'03&I!NF
M
M
M
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MCSAV)\2Q/OM$0KC*!Y"                 7B!JH?LJ
M I8;._K*V%_+BV?P](#:&@^8P_HF=JA^0?>-]X6/?;-;])E/#"4?&@
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M?I;^6?\ 81^;/IH;H[ION_P__;_29C0[?/\ >5B7]'^BP$.(R,8O
M       )7.A[]*IP^_EE<OR47X?!;S_,3$?T3.^QF1MTGWBX9^E?WF0Z;0TE
M-^P                .4AU%/I!.=7SQ^3GY;+N-]-C_ #2PO[.IN\L/.;;C
MSTQC[4J^_P AIP/HSY<               L1^K&_2/S?S:MG??5K88?WV^9K
M?'8NUD,W;@//I_B$O;Q'03&I!NF
M
M
M                                                       $;?5/
M^3AK_P">'PE_.DU:)5)\:OP'=JI%K/BD^&SMD))!%)0        16=7KY-=(
M_'C6OO"V6,@;M_KR7Q1W?(CS/_%3_P O>#?OG2?]-Q8KE#-9X"@
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M'I ;0T'S&']$SM4/R#[QOO"Q[[9K?I,IX82CXT               EOZ/O\
M7?LW\52GWW5L8ZWD_54'C'\AQZD?A2_?)M%^[*_3J0L,C#)[Q
M    &M/,_P"1YRP^;3O;\EUI%ZV;\XJ#QV#OK2P[5>:^)>(5'>GG)?&_IYN
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M3A]_+*Y?DHOP^"WG^8F(_HF=]C,C;I/O%PS]*_O,ATVAI*;]@
M     <I#J*?2"<ZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;<>>F,?:E7W^0TX'T9
M\N               6(_5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT_P 0
ME[>(Z"8U(-TP
M
M
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MOV;^*I3[[JV,=;R?JJ#QC^0X]2/PI?ODVB_=E?IU(6&1AD]X@
M   #6GF?\CSEA\VG>WY+K2+ULWYQ4'CL'?6EAVJ\U\2\0J.]/.2^-_3S<
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M[^65R_)1?A\%O/\ ,3$?T3.^QF1MTGWBX9^E?WF0Z;0TE-^P
M    .4AU%/I!.=7SQ^3GY;+N-]-C_-+"_LZF[RP\YMN//3&/M2K[_(:<#Z,^
M7               +$?JQOTC\W\VK9WWU:V&']]OF:WQV+M9#-VX#SZ?XA+V
M\1T$QJ0;I@
M
M
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M8B?\([OD1YH?BHLN^CW@RVJO_P!F5)PK_P#6W%B $9I/ @
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M[3&[,=ILYR-GJ#YC#^B9VJ'Y"]XWWA8[]LUOTF4\8)1\:
M2E]*.N>,NY-C-/9ZR0'>-9'<>$UF4]BG:W_X55Y/O#A;O"_?&_[?NNY[,?ML
M8SV_4&.]Y"V85 MB+_Q'\AQZC_A3MO;X]HDM5/\ [&5X/'J0GE\U/X2=L>6/
M\7##=_B;H/=_5^^=I'FI_"3MCRQ_BX+_ !-T#5^^=I'FI_"3MCRQ_BX+_$W0
M-7[YVD>:G\).V/+'^+@O\3= U?OG:1YJ?PD[8\L?XN"_Q-T#5^^=I'FI_"3M
MCRQ_BX+_ !-T#5^^=I'FI_"3MCRQ_BX+_$W0-7[YVD>:G\).V/+'^+@O\3=
MU?OG:1YJ?PD[8\L?XN"_Q-T#5^^=I'FI_"3MCRQ_BX+_ !-T#5^^=I-<N8FL
M?!.(_*9WYPMH.O!>.6[W'@SRV=^:..\ZSLZG>'2/@!>^MU>Y[DY>W'=%SG':
M+ULV^W:*@R)\]@Z7_>M+#M3'9LQB2WG?,*CI_P#=/.5<-^CS@
M      NF^JX4[QFT+RE7\:;E7_!MO4U'O-9G/8I!QW=,6/WUTGX*OWU8O[&#
M=N.POU!K)OX=9B]!D1?^&?VYMEZ.K;V"XEE5/^*CX/T9:1\U/X2=L>6/\7#
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MYSGLQVC?'8_+LEA:_P#UNIN\L/.G;=+-M,73_P"NE5W^0U#'T9\P
M       6!/5KX+QBZA\U'^S,]!=G'+93CPVNR/L9(9[W:-=%[QESWE?M;J=\
M[3%[GZN2X^K]08@WV+9L:U<B_P#&Q=K(9MW!-O;<O2U4_P" EX/AQ%]KS4_A
M)VQY8_Q<-2K_ !-T&Z&K]\[2/-3^$G;'EC_%P7^)N@:OWSM(\U/X2=L>6/\
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MCS4_A)VQY8_Q<%_B;H&K]\[2/-3^$G;'EC_%P7^)N@:OWSM(\U/X2=L>6/\
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MCS4_A)VQY8_Q<%_B;H&K]\[2/-3^$G;'EC_%P7^)N@:OWSM(\U/X2=L>6/\
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MCS4_A)VQY8_Q<%_B;H&K]\[2/-3^$G;'EC_%P7^)N@:OWSM(\U/X2=L>6/\
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MCS4_A)VQY8_Q<%_B;H&K]\[2/-3^$G;'EC_%P7^)N@:OWSM(\U/X2=L>6/\
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M#_62_P!Y=#?[#O\ _K]5&6]V?Q%9\./K//%#\6CSAV)\2Q/OM$0KC*!Y"
M              7B!JH?LJ                 I8;._K*V%_+BV?P](#:&@
M^8P_HF=JA^0?>-]X6/?;-;])E/#"4?&@              $M_1]_KOV;^*I3
M[[JV,=;R?JJ#QC^0X]2/PI?ODVB_=E?IU(6&1AD]X@              #6GF
M?\CSEA\VG>WY+K2+ULWYQ4'CL'?6EAVJ\U\2\0J.]/.2^-_3S<
M       N_>JE?)]Y7_CCI?WDK#6+?S];T'BS^W-M/1S^I<2\:C[V6N!@4V-
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M4^D$YU?/'Y.?ELNXWTV/\TL+^SJ;O+#SFVX\],8^U*OO\AIP/HSY<
M        L1^K&_2/S?S:MG??5K88?WV^9K?'8NUD,W;@//I_B$O;Q'03&I!N
MF
M
M
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M9_$5GPX^L\\4/Q:/.'8GQ+$^^T1"N,H'D(                !>(&JA^RH
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M>*'XX[I]Y*(SUN&^MZ_Q9G;FN7I&?4N&^-2=[*0(V=-2P
M .M!PP^1YQ/^;3HG\EU6&@6TGG%7^.S]]<>D>ROFOAOB%/WIALL+*7X
M          YJ_7]^EOY9_P!A'YL^FANCNF^[_#_]O])F-#M\_P!Y6)?T?Z+
M0XC(QB\               E<Z'OTJG#[^65R_)1?A\%O/\Q,1_1,[[&9&W2?
M>+AGZ5_>9#IM#24W[                 Y2'44^D$YU?/'Y.?ELNXWTV/\
M-+"_LZF[RP\YMN//3&/M2K[_ "&G ^C/EP              "Q'ZL;](_-_-
MJV=]]6MAA_?;YFM\=B[60S=N \^G^(2]O$=!,:D&Z8
M
M
M
M          1M]4_Y.&O_ )X?"7\Z35HE4GQJ_ =VJD6L^*3X;.V0DD$4E
M     !7D]99V5>-6<%-46"@SZ]=F'G+2BPSEZW:Q[LZL8XT]O=ZLURG(M'B!
M2G=1Z)^ZP7!\9)C&,]F<XSE_<K1TU;M34153;\:8>];+53+KH$MR*G2536;T
MJ]E-G-L-WE'AFT]'!74$>-0RMCE2\U)&TU6Q'HF3*C7O3U'*4?O^,;DIZ4I+
MW%JOO$-G_P"S^#_(I^4_\XT _N,W0_\ M_#?U?LC_C&Y*>E*2]Q:K[Q!_9_!
M_D4_*?\ G#^XS=#_ .W\-_5^R/\ C&Y*>E*2]Q:K[Q!_9_!_D4_*?^</[C-T
M/_M_#?U?LC_C&Y*>E*2]Q:K[Q!_9_!_D4_*?^</[C-T/_M_#?U?LC_C&Y*>E
M*2]Q:K[Q!_9_!_D4_*?^</[C-T/_ +?PW]7[(_XQN2GI2DO<6J^\0?V?P?Y%
M/RG_ )P_N,W0_P#M_#?U?LC_ (QN2GI2DO<6J^\0?V?P?Y%/RG_G#^XS=#_[
M?PW]7[(_XQN2GI2DO<6J^\0?V?P?Y%/RG_G#^XS=#_[?PW]7[(_XQN2GI2DO
M<6J^\0?V?P?Y%/RG_G#^XS=#_P"W\-_5^R/^,;DIZ4I+W%JOO$']G\'^13\I
M_P"</[C-T/\ [?PW]7[(_P",;DIZ4I+W%JOO$']G\'^13\I_YP_N,W0_^W\-
M_5^R=+KIGSLM9^GWPYL<\]5DIJ<X]:SE95^L5,BCM^^K;)PY7,1$B2*??%5,
MYP4A2D+CZA<8QC&!I3MM%'#M=B,,261MK)$1,R(Y3U8W4X;08-NUP/"L+B9!
MAU/AD#(XVY&L8V-$:UJ=)$3(B&\0^7,@       5 O75OHLM!_/_ -6?FZ\J
M@!-]T4OHC^G+\T#1_P!Y,6 )/P    0/]9+_ 'ET-_L._P#^OU49;W9_$5GP
MX^L\\4/Q:/.'8GQ+$^^T1"N,H'D(                !>(&JA^RH
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M^1YQ/^;3HG\EU6&@6TGG%7^.S]]<>D>ROFOAOB%/WIALL+*7X
M    YJ_7]^EOY9_V$?FSZ:&Z.Z;[O\/_ -O])F-#M\_WE8E_1_HL!#B,C&+P
M              "5SH>_2J</OY97+\E%^'P6\_S$Q']$SOL9D;=)]XN&?I7]
MYD.FT-)3?L                #E(=13Z03G5\\?DY^6R[C?38_S2PO[.IN\
ML/.;;CSTQC[4J^_R&G ^C/EP              "Q'ZL;](_-_-JV=]]6MAA_
M?;YFM\=B[60S=N \^G^(2]O$=!,:D&Z8
M
M
M
M1M]4_P"3AK_YX?"7\Z35HE4GQJ_ =VJD6L^*3X;.V0DD$4E        !6K]:
M9^C[T]\\?7WY$^0@S1N*\[:C[.D[]3F!_2&\RZ7[4C[Q4E!T;7FFP
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MU'\V/.SJOTEZ_P#+*N>^0> UOR,OY#NP/[ ;>?U)B_\ R=1_-CSLZK])>O\
MRRKGOD'@-;\C+^0[L#^P&WG]28O_ ,G4?S8\[.J_27K_ ,LJY[Y!X#6_(R_D
M.[ _L!MY_4F+_P#)U'\V/.SJOTEZ_P#+*N>^0> UOR,OY#NP/[ ;>?U)B_\
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M\4/QQW3[R41GK<-];U_BS.W-<O2,^I<-\:D[V4@1LZ:E@
M =:#AA\CSB?\VG1/Y+JL- MI/.*O\=G[ZX](]E?-?#?$*?O3#9864OP
M         !S5^O[]+?RS_L(_-GTT-T=TWW?X?_M_I,QH=OG^\K$OZ/\ 18"'
M$9&,7@              $KG0]^E4X??RRN7Y*+\/@MY_F)B/Z)G?8S(VZ3[Q
M<,_2O[S(=-H:2F_8                '*0ZBGT@G.KYX_)S\MEW&^FQ_FEA
M?V=3=Y8><VW'GIC'VI5]_D-.!]&?+@              %B/U8WZ1^;^;5L[[
MZM;##^^WS-;X[%VLAF[<!Y]/\0E[>(Z"8U(-TP
M
M
M
M      C;ZI_R<-?_ #P^$OYTFK1*I/C5^ [M5(M9\4GPV=LA)((I*
M "M7ZTS]'WI[YX^OOR)\A!FC<5YVU'V=)WZG,#^D-YETOVI'WBI*#HVO--@
M               .I[TL?HX.$?S:M4?>JP&BFW?GEB?CLO;*>A^[SS%PGQ"'
MM$-^1\F?9       ?"LO_@CW_NW^MH#E.$ZO]R?='!V     ('^LE_O+H;_8
M=_\ ]?JHRWNS^(K/AQ]9YXH?BT><.Q/B6)]]HB%<90/(0
M "\0-5#]E0                '(MY%?*"WK^./9WW[38]!<'^J*7Q:+M&GF
MECGUU6>-2]\<8;%R+6               6AO56/EA\A_FTK_ )4=?C!V_?S=
MH_'?]U(;!>CMYT5WB'^]C+V U9-OP              #6GF?\CSEA\VG>WY+
MK2+ULWYQ4'CL'?6EAVJ\U\2\0J.]/.2^-_3S<                 N_>JE?
M)]Y7_CCI?WDK#6+?S];T'BS^W-M/1S^I<2\:C[V6N!@4V-
M *H_K6OR?>*'XX[I]Y*(SUN&^MZ_Q9G;FN7I&?4N&^-2=[*0(V=-2P
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MQOTC\W\VK9WWU:V&']]OF:WQV+M9#-VX#SZ?XA+V\1T$QJ0;I@
M
M
M
M                 !&WU3_DX:_^>'PE_.DU:)5)\:OP'=JI%K/BD^&SMD))
M!%)0        5J_6F?H^]/?/'U]^1/D(,T;BO.VH^SI._4Y@?TAO,NE^U(^\
M5)0=&UYIL                !U/>EC]'!PC^;5JC[U6 T4V[\\L3\=E[93T
M/W>>8N$^(0]HAOR/DS[(      #X5E_\$>_]V_UM <IPG5_N3[HX.P    !
M_P!9+_>70W^P[_\ Z_51EO=G\16?#CZSSQ0_%H\X=B?$L3[[1$*XR@>0@
M             %X@:J'[*@                .1;R*^4%O7\<>SOOVFQZ"X
M/]44OBT7:-/-+'/KJL\:E[XXPV+D6L               M#>JL?+#Y#_ #:5
M_P J.OQ@[?OYNT?CO^ZD-@O1V\Z*[Q#_ 'L9>P&K)M^               :T
M\S_D><L/FT[V_)=:1>MF_.*@\=@[ZTL.U7FOB7B%1WIYR7QOZ>;@
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M*?2"<ZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;<>>F,?:E7W^0TX'T9\N
M        6(_5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT_Q"7MXCH)C4@W
M3
M
M
M                             "-OJG_)PU_\\/A+^=)JT2J3XU?@.[52
M+6?%)\-G;(22"*2@        K5^M,_1]Z>^>/K[\B?(09HW%>=M1]G2=^IS
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M[_\ Z_51EO=G\16?#CZSSQ0_%H\X=B?$L3[[1$*XR@>0@
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M$_YM.B?R758:!;2><5?X[/WUQZ1[*^:^&^(4_>F&RPLI?@
M#FK]?WZ6_EG_ &$?FSZ:&Z.Z;[O\/_V_TF8T.WS_ 'E8E_1_HL!#B,C&+P
M            "5SH>_2J</OY97+\E%^'P6\_S$Q']$SOL9D;=)]XN&?I7]YD
M.FT-)3?L                #E(=13Z03G5\\?DY^6R[C?38_P TL+^SJ;O+
M#SFVX\],8^U*OO\ (:<#Z,^7               +$?JQOTC\W\VK9WWU:V&'
M]]OF:WQV+M9#-VX#SZ?XA+V\1T$QJ0;I@
M
M
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MU,Z#QIK'W1P7NO'_ &P%BBU,Z#QIK'W1P7NO'_; 6*+4SH/&FL?='!>Z\?\
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MD+G/U.W(SSN&14Q>O\69VYKGZ1BHN"X;9^U2=[0I(C9TU+
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MZ9^X4)DN>S/U,XSC]D;H;ION_P /_P!O])F-#]\_WE8E_1_HL!#R,C&+P
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M8OU#%PJB<Y,F+G]G';]0<'-J+P'Z0
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M&^6Q_FEA?V=3=Y8>=.V^3;3%T3@\J57?Y#3\?1GRX              !8/\
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M6K]:9^C[T]\\?7WY$^0@S1N*\[:C[.D[]3F!_2&\RZ7[4C[Q4E!T;7FFP
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M^4%O7\<>SOOVFQZ"X/\ 5%+XM%VC3S2QSZZK/&I>^.,-BY%K
M   +0WJK'RP^0_S:5_RHZ_&#M^_F[1^._P"ZD-@O1V\Z*[Q#_>QE[ :LFWX
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MRS_L(_-GTT-T=TWW?X?_ +?Z3,:';Y_O*Q+^C_18"'$9&,7@
M  $KG0]^E4X??RRN7Y*+\/@MY_F)B/Z)G?8S(VZ3[Q<,_2O[S(=-H:2F_8
M              '*0ZBGT@G.KYX_)S\MEW&^FQ_FEA?V=3=Y8><VW'GIC'VI
M5]_D-.!]&?+@              %B/U8WZ1^;^;5L[[ZM;##^^WS-;X[%VLAF
M[<!Y]/\ $)>WB.@F-2#=,
M
M
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MK/AQ]9YXH?BT><.Q/B6)]]HB%<90/(0                "\0-5#]E0
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M<,/D><3_ )M.B?R758:!;2><5?X[/WUQZ1[*^:^&^(4_>F&RPLI?@
M       #FK]?WZ6_EG_81^;/IH;H[ION_P /_P!O])F-#M\_WE8E_1_HL!#B
M,C&+P              "5SH>_2J</OY97+\E%^'P6\_S$Q']$SOL9D;=)]XN
M&?I7]YD.FT-)3?L                #E(=13Z03G5\\?DY^6R[C?38_S2PO
M[.IN\L/.;;CSTQC[4J^_R&G ^C/EP              "Q'ZL;](_-_-JV=]]
M6MAA_?;YFM\=B[60S=N \^G^(2]O$=!,:D&Z8
M
M
M
M     1M]4_Y.&O\ YX?"7\Z35HE4GQJ_ =VJD6L^*3X;.V0DD$4E
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M1K^8F9A^SBHB(BF;B0DY63D'";1A&QK!HFL[?/WSM8B2**1#**J&P4N,YSC
M^JDD9$QTLKD;&U%555;$1$RJJJN1$1,JJO ?'1QR32-BB:YTKG(C6HBJJJJV
M(B(F555<B(F55)7-P]''DSQOX@3W++D?8=8Z5<H*UG%+T+;K8P3W->6\[-PL
M7(990Q%RQC*5@H^<)(+Q6'+F63;-W&'#9LHG@I_@L.WC8)C.T3, P9D]2U;U
M^=C%U++K55+5X51RMNHZQ&*JI8YR+DR-B>Z_'\"V8?M)CKZ>D<ERY3O>FOD1
MSFHMC>!%:CKRLM5Z(CKS6JEB^)X*=.!?EQ0ML;[VGOZ@<4>+FE9&%KMWW=?X
MQQ8RK7&P^#9C*M5ZJVEZZ6:D$ROVGA.%9)H8II!J1 CDZIBIRMJ=LDV?JZ?"
MJ"DFK\=J4<YD,:W?:-MM<YUCKJ9%LL:ON7*MU$RQ-C]A5VEHZG&<1K8<-V>I
M'-;)/(BN]NZRQC&(YMY<J6VN;[IJ(CE7)XOG7T^KWPJOVL(9E>:MOW5^_:DR
MO/'W<.L4'2\-M&OOG#1J1NTA2K23AG8T5)%F<S1LYD$#HR#4R3E4RATTY.RV
MUU+M+23R.BDI*ZDD5E1#+9;$Y+5RKDM;D7*J-6UKK42RU8NU^Q59LI6T\3)H
MZW#ZV))*:>*V[*U51+$;EL=E;D17)8YMCEM5$^7S[X2+<"]BZWT[9=HQ5_VI
M.::I>R-MU:'KQXA#3EPMY7KC.LW$MF?FD[6\C8YNDY\/*E']^0<I'PV(4Y#&
M[[)[3)M71S8C# Z&@94OCB<KK=<QEG=$2ZEU%6U+MKK%1?;%/;/9-=CJZ#"Y
MZALV(OI8Y9F-;9J'OM75*MYU]41$6]8VU%1;J(J6Z)#ZH^/  ZGO2Q^C@X1_
M-JU1]ZK :*;=^>6)^.R]LIZ'[O/,7"?$(>T0WY'R9]D      !\*R_\ @CW_
M +M_K: Y3A.K_<GW1P=@    "!_K)?[RZ&_V'?\ _7ZJ,M[L_B*SX<?6>>*'
MXM'G#L3XEB??:(A7&4#R$                 O$#50_94
M  !R+>17R@MZ_CCV=]^TV/07!_JBE\6B[1IYI8Y]=5GC4O?'&&Q<BU@
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M?I;^6?\ 81^;/IH;H[ION_P__;_29C0[?/\ >5B7]'^BP$.(R,8O
M       )7.A[]*IP^_EE<OR47X?!;S_,3$?T3.^QF1MTGWBX9^E?WF0Z;0TE
M-^P                .4AU%/I!.=7SQ^3GY;+N-]-C_ #2PO[.IN\L/.;;C
MSTQC[4J^_P AIP/HSY<               L1^K&_2/S?S:MG??5K88?WV^9K
M?'8NUD,W;@//I_B$O;Q'03&I!NF
M
M
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M_:LCM3A1))',8JITT1RJG3,8\BN)?)+B596%2Y':<NNIIF70<.83-ECB9A[
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M;^6?]A'YL^FANCNF^[_#_P#;_29C0[?/]Y6)?T?Z+ 0XC(QB\
M    E<Z'OTJG#[^65R_)1?A\%O/\Q,1_1,[[&9&W2?>+AGZ5_>9#IM#24W[
M                Y2'44^D$YU?/'Y.?ELNXWTV/\TL+^SJ;O+#SFVX\],8^
MU*OO\AIP/HSY<               L1^K&_2/S?S:MG??5K88?WV^9K?'8NUD
M,W;@//I_B$O;Q'03&I!NF
M
M
M                                                 $;?5/\ DX:_
M^>'PE_.DU:)5)\:OP'=JI%K/BD^&SMD))!%)0        5J_6F?H^]/?/'U]
M^1/D(,T;BO.VH^SI._4Y@?TAO,NE^U(^\5)0=&UYIL !-_TANF[5>14K9.7G
M+5XUH'!'CD=:R7^R698\5$;/G:]A*0/1&;O)<N%ZTSSE',XHU*=PN59*-:?]
MK=]\;8PWA;9SX/&S9[9]%EVJK/:QM;E6)KLE]4YRY;EN1+%>[VK;%RUNSV$I
M\<DDVFVE5(=CZ'VTCGY&RN;EU:+PJU,FL5,JVI&WVSK6X,ZJG4CLG4'W6T<5
M]DZI'&S4Z"]7T#JPB#>+;P]?3PBU5M<Y$QZRT8A:[&V9H%,DADS>.8H(,T<F
MPDHLO=-@]C(=D<,5)E27&JA;T\O#:[AN-5<MQJJN5<KG*KEX41+1O%V[GVUQ
M9'0(L. TR*RGAL1$:W@ON:F2^Y$3(F1K4:U.!569"?V?N!7U9#1\EQ>L5AJ2
MVOMISM,Y&YU^NNSFV6N5-C[>7L;1](P[=*1BF4_8K35I2351.B91@]43<*'0
M6<%5QS%0X<F^VJ9CC&2)- U]/K,K5DU<5U41<BJUK96M1;?;(BHEJ)9E&;$,
M37<#22;/R/C6"H<RJU>1R1:V97(JMRHCG/A>Y4LM:Y4<JM5UNHGJV^R=_-^?
ML?K.H2EFE](W2B[(EM]5I9R^?U!K'1]5D'%7M\C&K96C&U@/L#$5&IO,E*X4
M0D%D>Z,10Y<_0[YJ+"5V36MJ&L;B<4L:0.L1'JJN2\Q%X5;J[SK.!%:B\*'S
M.XFOQENV;:"F=(["9895J&VJK$1&*K'JG CM9<:CN%4<J<"D,?*6N5")Y6\C
M*EJ5N1W08SD)MZN:S:Q#4N4W-09;(L,93&\8R9(IER1:%3;%1223+CLR4I2X
M^I@9(P*:HDP&CJ,06RK=1Q.D55X'K&U7VJOOK;54Q7M#!2Q;1UU-AJ6T3:V9
ML2-3A8DKD8B(GO;+$1"?[8_&.Y1VO.%_0CT5)PD-OK<LBWY0\[[,[5SX#5[1
M(5?-O@*79U6R1%WC76- B\/#,"GQE\X911T<E5=]HQ-18W3/K,2WIXHUSL*I
MD\&H6IPN:CKCGMMX%ED6R]_%1TB+D:9HKMGZJ.APK<_A#F,QFJ<E7B#UX&/5
ME]L;[.%(HTO7?XRMC5,KC37D5TN^-[;C3MWDCP0YLQ?+F+XP2-9B.257<:\F
M*)*P"%GDU(2/NE-7>J*(3M7<R#9PHGE/#EDJR:.5F\DYRW.GGZ/!]N<9=C5/
M@VU6&.P]]<CEIW:Q'HZZEY6/L]RY$5$RV.1RM16-M13Y;'-WN!-P&IQW8_%F
MXG'A[F-JF+&Z-6WUNH]EONF*J*J66M5J.5LCKJH0C#)QB8 #J>]+'Z.#A'\V
MK5'WJL!HIMWYY8GX[+VRGH?N\\Q<)\0A[1#?D?)GV0      %0+UU;Z++0?S
M_P#5GYNO*H 3?=%+Z(_IR_- T?\ >3%@"3\    $#_62_P!Y=#?[#O\ _K]5
M&6]V?Q%9\./K//%#\6CSAV)\2Q/OM$0KC*!Y"                 7B!JH?
MLJ                 Y.]EVC,Z2YLW#;U=AZM8)W6W).X7.)A+O ,[14Y1_
M ;&E9!NRGH-]C*+Y@NHCC!NY,FNEGL41426(10N_$%#'B>S,>'3.D9%-1,8K
MF.5KT1T:):UR<"\B\"HJ6H><,^(2X3M9+B<#8WS05[WHV1J/8JME541S5X4T
M*G"BHJ(IM-NKK0]1W=&Y5MMLN2NR]5%2EL.JMK+4=HFZEK"O,4UBG80JU+:O
M%(N[))8+C"BL^G*+NLY-A0V29P3%BPS=ML;AN&^3W44$_M;'2RM:^5R]-;ZI
M:SB2.ZB=+.?0XKO4VZQ7%%Q)E?/36.M9%"]S(FITFZM%LDXUD1ZKT\F0E&]8
MX293%#Z:FV-DP415N7=YT0[<[Q@&C%))RAX/7]9S2D;-1RR1RI,JUL2>GVC
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MK]?WZ6_EG_81^;/IH;H[ION_P_\ V_TF8T.WS_>5B7]'^BP$.(R,8O
M         )7.A[]*IP^_EE<OR47X?!;S_,3$?T3.^QF1MTGWBX9^E?WF0Z;0
MTE-^P                .4AU%/I!.=7SQ^3GY;+N-]-C_-+"_LZF[RP\YMN
M//3&/M2K[_(:<#Z,^7               +$?JQOTC\W\VK9WWU:V&']]OF:W
MQV+M9#-VX#SZ?XA+V\1T$QJ0;I@
M
M
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MY8?(?YM*_P"5'7X^%W[^;M'X[_NI#(?H[>=%=XA_O8R]@-63;\
M     UIYG_(\Y8?-IWM^2ZTB];-^<5!X[!WUI8=JO-?$O$*CO3SDOC?T\W
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MP^_EE<OR47X?!;S_ #$Q']$SOL9D;=)]XN&?I7]YD.FT-)3?L
M     #E(=13Z03G5\\?DY^6R[C?38_S2PO[.IN\L/.;;CSTQC[4J^_R&G ^C
M/EP              "Q'ZL;](_-_-JV=]]6MAA_?;YFM\=B[60S=N \^G^(2
M]O$=!,:D&Z8
M
M
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M'G#L3XEB??:(A7&4#R$                 O$#50_94
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MV^7JK'RP^0_S:5_RHZ_'RN_?S=H_'?\ =2'V/H[>=%=XA_O8R]@-63;\
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MV$?FSZ:&Z.Z;[O\ #_\ ;_29C0[?/]Y6)?T?Z+ 0XC(QB\
M E<Z'OTJG#[^65R_)1?A\%O/\Q,1_1,[[&9&W2?>+AGZ5_>9#IM#24W[
M             Y2'44^D$YU?/'Y.?ELNXWTV/\TL+^SJ;O+#SFVX\],8^U*O
MO\AIP/HSY<               L1^K&_2/S?S:MG??5K88?WV^9K?'8NUD,W;
M@//I_B$O;Q'03&I!NF
M
M
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M29SG&/JY^H,\;AVJF+U]MGS9G;FNOI%/1V"X=9;\Z?TO^[*60V<-30
M          .JCP[VW6&7$;BRS6CKJ=5IQRT@V5,WHEM<H&40UG6$CF1<(Q)T
M5TLF)GN3DSDIL=F<9SC(T$VD:J[15ZY/GL_33Y5QZ/;+2M39C#4R_,*?I?\
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M??D3Y"#-&XKSMJ/LZ3OU.8'](;S+I?M2/O%24'1M>:;
M=3WI8_1P<(_FU:H^]5@-%-N_/+$_'9>V4]#]WGF+A/B$/:(;\CY,^R
M ^%9?_!'O_=O];0'*<)U?[D^Z.#L     0/]9+_>70W^P[__ *_51EO=G\16
M?#CZSSQ0_%H\X=B?$L3[[1$*XR@>0@                %X@:J'[*@
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M.&'R/.)_S:=$_DNJPT"VD\XJ_P =G[ZX](]E?-?#?$*?O3#9864OP
M       !S5^O[]+?RS_L(_-GTT-T=TWW?X?_ +?Z3,:';Y_O*Q+^C_18"'$9
M&,7@              $KG0]^E4X??RRN7Y*+\/@MY_F)B/Z)G?8S(VZ3[Q<,
M_2O[S(=-H:2F_8                '*0ZBGT@G.KYX_)S\MEW&^FQ_FEA?V
M=3=Y8><VW'GIC'VI5]_D-.!]&?+@              %B/U8WZ1^;^;5L[[ZM
M;##^^WS-;X[%VLAF[<!Y]/\ $)>WB.@F-2#=,
M
M
M                                                         @FZ
M^/#'DCS7XYZ9H?&?7A-CVNJ;N2M=@BCV^C4[V/KAJ+;88TKE]?++6(UT1*2D
M4$S(H+*N<]\P;">2E.8MPPZ>*"5SI5L16YE7IIF+?B,$L\36Q):J.MX43I+G
M)V1;RX     $;?5/^3AK_P">'PE_.DU:)5)\:OP'=JI%K/BD^&SMD))!%)0
M       5J_6F?H^]/?/'U]^1/D(,T;BO.VH^SI._4Y@?TAO,NE^U(^\5)0=&
MUYIL                !U/>EC]'!PC^;5JC[U6 T4V[\\L3\=E[93T/W>>8
MN$^(0]HAOR/DS[(      #X5E_\ !'O_ ';_ %M <IPG5_N3[HX.P    ! _
MUDO]Y=#?[#O_ /K]5&6]V?Q%9\./K//%#\6CSAV)\2Q/OM$0KC*!Y"
M           7B!JH?LJ                 Y%O(KY06]?QQ[.^_:;'H+@_U
M12^+1=HT\TL<^NJSQJ7OCC#8N1:P              "T-ZJQ\L/D/\VE?\J.
MOQ@[?OYNT?CO^ZD-@O1V\Z*[Q#_>QE[ :LFWX              !K3S/^1YR
MP^;3O;\EUI%ZV;\XJ#QV#OK2P[5>:^)>(5'>GG)?&_IYN
M  7?O52OD^\K_P <=+^\E8:Q;^?K>@\6?VYMIZ.?U+B7C4?>RUP,"FQH
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MZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;<>>F,?:E7W^0TX'T9\N
M   6(_5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT_Q"7MXCH)C4@W3
M
M
M
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M7Y/O%#\<=T^\E$9ZW#?6]?XLSMS7+TC/J7#?&I.]E($;.FI8
M    '6@X8?(\XG_-IT3^2ZK#0+:3SBK_ !V?OKCTCV5\U\-\0I^],-EA92_
M              '-7Z_OTM_+/^PC\V?30W1W3?=_A_\ M_I,QH=OG^\K$OZ/
M]%@(<1D8Q>               2N=#WZ53A]_+*Y?DHOP^"WG^8F(_HF=]C,C
M;I/O%PS]*_O,ATVAI*;]@                <I#J*?2"<ZOGC\G/RV7<;Z;
M'^:6%_9U-WEAYS;<>>F,?:E7W^0TX'T9\N               6(_5C?I'YOY
MM6SOOJUL,/[[?,UOCL7:R&;MP'GT_P 0E[>(Z"8U(-TP
M
M
M
M            C;ZI_P G#7_SP^$OYTFK1*I/C5^ [M5(M9\4GPV=LA)((I*
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M>JL?+#Y#_-I7_*CK\8.W[^;M'X[_ +J0V"]';SHKO$/][&7L!JR;?@
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M#WZ53A]_+*Y?DHOP^"WG^8F(_HF=]C,C;I/O%PS]*_O,ATVAI*;]@
M         <I#J*?2"<ZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;<>>F,?:E7W^0T
MX'T9\N               6(_5C?I'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT
M_P 0E[>(Z"8U(-TP
M
M
M                                            C;ZI_P G#7_SP^$O
MYTFK1*I/C5^ [M5(M9\4GPV=LA)((I*        "M7ZTS]'WI[YX^OOR)\A!
MFC<5YVU'V=)WZG,#^D-YETOVI'WBI*#HVO--@                .I[TL?H
MX.$?S:M4?>JP&BFW?GEB?CLO;*>A^[SS%PGQ"'M$-^1\F?9       5 O75O
MHLM!_/\ ]6?FZ\J@!-]T4OHC^G+\T#1_WDQ8 D_    ! _UDO]Y=#?[#O_\
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M4?UK7Y/O%#\<=T^\E$9ZW#?6]?XLSMS7+TC/J7#?&I.]E($;.FI8
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M'YOYM6SOOJUL,/[[?,UOCL7:R&;MP'GT_P 0E[>(Z"8U(-TP
M
M
M
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M.6'S:=[?DNM(O6S?G%0>.P=]:6':KS7Q+Q"H[T\Y+XW]/-P
M   "[]ZJ5\GWE?\ CCI?WDK#6+?S];T'BS^W-M/1S^I<2\:C[V6N!@4V-
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MD$YU?/'Y.?ELNXWTV/\ -+"_LZF[RP\YMN//3&/M2K[_ "&G ^C/EP
M        "Q'ZL;](_-_-JV=]]6MAA_?;YFM\=B[60S=N \^G^(2]O$=!,:D&
MZ8
M
M
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MMB83 B04S4R-;#'D:J)TKZVOLZ2.1.DA' /LSX4 #L;#SH/4$
M     #D6\BOE!;U_''L[[]IL>@N#_5%+XM%VC3S2QSZZK/&I>^.,-BY%K
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M-7Z_OTM_+/\ L(_-GTT-T=TWW?X?_M_I,QH=OG^\K$OZ/]%@(<1D8Q>
M          2N=#WZ53A]_+*Y?DHOP^"WG^8F(_HF=]C,C;I/O%PS]*_O,ATV
MAI*;]@                <I#J*?2"<ZOGC\G/RV7<;Z;'^:6%_9U-WEAYS;
M<>>F,?:E7W^0TX'T9\N               6(_5C?I'YOYM6SOOJUL,/[[?,U
MOCL7:R&;MP'GT_Q"7MXCH)C4@W3
M
M
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M3S/^1YRP^;3O;\EUI%ZV;\XJ#QV#OK2P[5>:^)>(5'>GG)?&_IYN
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M*0ZBGT@G.KYX_)S\MEW&^FQ_FEA?V=3=Y8><VW'GIC'VI5]_D-.!]&?+@
M           %B/U8WZ1^;^;5L[[ZM;##^^WS-;X[%VLAF[<!Y]/\0E[>(Z"8
MU(-TP
M
M
M                       A[ZZ?)BU\8NG;L^;H<NK7[KM:<KVCZ_.M7*K2
M1B$[TG*.K4[B'#=9NZ;3'B+ 2J;5=(Y56JQRKDSW26!-P^)):E$=[E,NCV2%
MB$JQ4RJW(Y<FGV#Q73YZ//#'6/$'5T3N'CKJ?;VU]B:[KMJVK<=E4Z(NDXWL
MMNA4):0@ZE*3[-R[IT96"R7@#52)]CUE?!L.5,^$'R;':IK9W3*K'*UB+D1%
MLX.N=::B@9 B/:USU3*JI;PYLQH?P#K#GIQ=:K>W *F2CW_AQY$4%3:>K*M*
M2CZ0/!RT76#W>)RR._74-EU"1<;9(-=7M5<R+)@R6<JF.WQ@LBH7PFA;4.^-
M:MB];L*1Z9/!:]U,WXIR6IU^RA:I%H+N>1OMCEJA2K1:(&FSVQ)J A)"5BZ+
M5EX5M8[8]9MSK-X&$<6.3A8%&2DE"X32,[=MF^#FQW:A<=N1V:B.<B*J(B],
MZN56M54155.EG-"?^.#D?_E>\P_*OBW_ ']B1J(OE6?]KL$?PB7Y%^EO9--.
M=V_>6F[-$LJ]4NF3RQ:2]1W)H;;O>Y.<T3)I23'3^WJ?L61A6[*B[2NMI5?S
M+.NG;(9:Q;PR:BF#F3R0IA6IXX8Y+72LL5JIT^FBITT0H5$DTD=C8GVHY%Z7
M25%Z2J?W_2W<VO\ )5YA^Z\C_=(.? X/EV='5'AM1\@_HZ@_2W<VO\E7F'[K
MR/\ =('@<'R[.CJCPVH^0?T=0?I;N;7^2KS#]UY'^Z0/ X/EV='5'AM1\@_H
MZ@_2W<VO\E7F'[KR/]T@>!P?+LZ.J/#:CY!_1U!^ENYM?Y*O,/W7D?[I \#@
M^79T=4>&U'R#^CJ#]+=S:_R5>8?NO(_W2!X'!\NSHZH\-J/D']'4(PNK#N7G
MEU*..M,T9"=*;EAJ5U5-TUW;"ECE8R;M[=ZW@J-L:GGA"1K2@U]1!9RI>R+X
M7RL8I2MLD[C.3X,7[?8':*CV+QB3%);M0V2F=%=1R,LO/C?>M5'<%RRRSI\.
M0Q_O'V6K-O,#BPB)74SHZMLUY6*]%1L<K+MB*WAUEMMO2LLRE?#]%5U&O\%?
M)'XIK9]H#+G]]^&?L:_KF_F&%?\ #[BG[<W]0[^<'Z*KJ-?X*^2/Q36S[0#^
M^_#/V-?US?S!_A]Q3]N;^H=_.#]%5U&O\%?)'XIK9]H!_??AG[&OZYOY@_P^
MXI^W-_4._G!^BJZC7^"ODC\4UL^T _OOPS]C7]<W\P?X?<4_;F_J'?S@_15=
M1K_!7R1^*:V?: ?WWX9^QK^N;^8/\/N*?MS?U#OYP?HJNHU_@KY(_%-;/M /
M[[\,_8U_7-_,'^'W%/VYOZAW\X/T574:_P %?)'XIK9]H!_??AG[&OZYOY@_
MP^XI^W-_4._G!^BJZC7^"ODC\4UL^T _OOPS]C7]<W\P?X?<4_;F_J'?S@_1
M5=1K_!7R1^*:V?: ?WWX9^QK^N;^8/\ #[BG[<W]0[^<'Z*KJ-?X*^2/Q36S
M[0#^^_#/V-?US?S!_A]Q3]N;^H=_.#]%5U&O\%?)'XIK9]H!_??AG[&OZYOY
M@_P^XI^W-_4._G"V1Q-Z@'.3C5QGT5H![T=^7=M>:=UA4=>N;.U5E8AM/+5B
M);QBDHA%K:PD%6"3PR'=X2,NKDF,]G=9_9& \?GIL:QNJQ9LC(VU,[Y$:JVJ
MV\MMEN2VS/8AL?LW2U6 X!1X*^-\KJ6G9&KT2ZCKC42VS+9;FM4V$_2W<VO\
ME7F'[KR/]T@M'@<'R[.CJE[\-J/D']'4'Z6[FU_DJ\P_=>1_ND#P.#Y=G1U1
MX;4?(/Z.H/TMW-K_ "5>8?NO(_W2!X'!\NSHZH\-J/D']'4'Z6[FU_DJ\P_=
M>1_ND#P.#Y=G1U1X;4?(/Z.H/TMW-K_)5YA^Z\C_ '2!X'!\NSHZH\-J/D']
M'4([NIEUW.>FAM!UFU0?!J>X2.9G:]?JR^UN6\-.W77,^U=52\31M?0<6R9:
MH5;7B5<0*<DV<9D5RECXEZ3P8^5,*HO X/EV='5.%K)U2Q8']'4-H^-G6AYS
M[$T#IZ]R/2GW[NY_;=>UF>=[>U":6A-7[(<248@Y5N-!AUZ-;%HVJSIC]_9H
MFDWYDT3XQE=3_K9>!P?+LZ.J<^&U'R#^CJ&;OTMW-K_)5YA^Z\C_ '2!X'!\
MNSHZH\-J/D']'4'Z6[FU_DJ\P_=>1_ND#P.#Y=G1U1X;4?(/Z.H/TMW-K_)5
MYA^Z\C_=('@<'R[.CJCPVH^0?T=0@^ZN[;GYU.K'HZ=@NF/RHU 34$)>XERV
MEJW/W$TZ:XOJP\37059TVO88%88KQBF*8JO?.^XSC)>Y^KD[=[MM1;$0U44K
M$J/"',6U'HR[<1R=-'6VWN+@,2[S-@*[;^>DFAD6E2E9(BHL:OO7U8O2<VRR
M[QVVD.GZ*KJ-?X*^2/Q36S[0&1?[[\,_8U_7-_,,7_X?<4_;F_J'?SA.AQ4J
M%])Q5I_#3G]T2>06V=<ZWEI^8H6T]):KGZGM>.?VEWX5-2DMCP^E.Y"S.,IH
M)K/T9YHC(M6+1!XT6PW*H;&N+[=5;]H9-H]G*N:DJ9FM1\<CVRQJC4L1$16V
M(U,JHU6JK5<Y6N2VPRK@N[JA9LS%LOM11P5E+ YSHY8XWPRHKUM<JJUUJO7(
MBN1[4<C6HYJW;3-MRN.V>-'';:/'[I1]'OF'HZ2W3&J0U\WAN2@3TEL D<NR
M?L%%&;%K.;%=2<M',IMZC$*N)M)C$&6.NFR455/W-N_M3)C&,T^+;93K6Q4S
MK60L5D;+;47I-L1%5J*^QMY]B(KD1"Z?V.BP/ JG!MAJ=M!-5-NOG>CY9+%1
M4Z;K5<B.<C%5]UEJJC5536?IAZUV]PYTIRDUUR,Z/G(S?=FW)%$:U*;)HK$P
M@_C_ &">Q:NN[H^LRT;)U:F*2"^'OAD*1T]RLJ?)D3'1;'3O.V6W\NTF(T=;
MAT\M%'3+;=;+;[:\BWTL1J7K/:V.14L]546Q;#;M8-E<,KJ#%((:^2K2Q'NA
ML]K=5-6ZUSE1EOMK6JBVKG1JI_?I_0_*#1''VU<,^9'1QW)R,XU6ZX.+V=_7
MM-RL/M"%LSM)HV6D%73II%%LCQFV:%)'/DY2'EHU(QT"/%&V4T4:>U&V[,6Q
MJ/:/ YYZ'%HX[GQJ21JU+5L1MU+J+;[9JHYCEL6ZBVJM79+=\_!<!EV7V@@I
ML1P:276?$K'(CUL155UYRN5$3VKD5CVI:EY6V(FW2MTF.'-#V PZ3/1,Y=Z;
MW!LJ!4KC[=&\->6F?FJBP7.1912'9S%XW7+SR#5TT0<-XU66CXDSY))PY;N<
M(805LE1M16[054+]LZQ]9A\+[VIC6.)KEXU8QJ);:J*ZXK[JJC7-MM2_TVR&
M'[-4<[-A*)E#B<[+NOD229S$XD>]SE1+$5&WT9>1%<UUEBUUJ?TP.>,IM"K3
MNYN&?+Z:I,C?826VLZKNJK$_O4M5G=A:O+TX@E)C,<S>6Q_$J.C-3.G:"2CP
MY<JJD+DQ\99EWUT#:1T-%2-CE2-6QVRMNM6RQEK48GM46S(G2R&&(=P6(/K&
MSU]<Z2%94=)9"Y'N:KK7V.61?;.2VQ5MRK:I(/R?J'4\VKU *'S!U-P)Y(U&
MD\=Y[5\9QCU;8]/V8L=3M5Z8>,W%0J,O&11WS5DG8%D'+J4;LWBI4%9%9)NX
MR1-)3'R.#[=X'A^RT^SE7 Z:6L;*M1,DS4=))-:CGY6+E1+$;;;[E%7A4^UQ
MS=SC^);84^U%'4LAAHG0I30+ YS(XH+%;'DD3(Y;5=99[I42RQ#?N\RMHI3'
ME-O+B1T?.>E"YK\T:!>Z/M>U;#K4I+ZIUVIM61;3>R)K7J#1_+2-E=6*Q(%E
M#)O8F*3+(((Y)A-MA1JI\U%M;5U#,/PW&JAD^ X;+&^.-J-8]^J2[&U[[%L1
MK?:Y+5NJMOMK')]5-L314TF)XK@-.ZGVBQ6&2.25ZNDCCURHZ5S&6I:KG>WL
M6Q$<B66-M:M<#]%5U&O\%?)'XIK9]H#+?]]^&?L:_KF_F&%_\/N*?MS?U#OY
MP?HJNHU_@KY(_%-;/M /[[\,_8U_7-_,'^'W%/VYOZAW\X73/TMW-K_)5YA^
MZ\C_ '2#6SP.#Y=G1U3:KPVH^0?T=0?I;N;7^2KS#]UY'^Z0/ X/EV='5'AM
M1\@_HZ@_2W<VO\E7F'[KR/\ =('@<'R[.CJCPVH^0?T=0?I;N;7^2KS#]UY'
M^Z0/ X/EV='5'AM1\@_HZ@_2W<VO\E7F'[KR/]T@>!P?+LZ.J/#:CY!_1U!^
MENYM?Y*O,/W7D?[I \#@^79T=4>&U'R#^CJ#]+=S:_R5>8?NO(_W2!X'!\NS
MHZH\-J/D']'4'Z6[FU_DJ\P_=>1_ND#P.#Y=G1U1X;4?(/Z.H/TMW-K_ "5>
M8?NO(_W2!X'!\NSHZH\-J/D']'4'Z6[FU_DJ\P_=>1_ND#P.#Y=G1U1X;4?(
M/Z.H/TMW-K_)5YA^Z\C_ '2!X'!\NSHZH\-J/D']'4*<^R>FOU%K[L6_7I'@
M]R4C$KI=;3;$HY35MJ=*1Z=CG'\P1DHY+%H%<':%>83R?!"8/DO;W..WL&Q5
M%OHPVDHXJ5:57+%$UENN:EMUJ);9<Z=AJ_7[AL4K*Z:L2M1J2RO?9J'+9><K
MK+=9ELM/%_HJNHU_@KY(_%-;/M 2?[[\,_8U_7-_,(O^'W%/VYOZAW\X/T57
M4:_P5\D?BFMGV@']]^&?L:_KF_F#_#[BG[<W]0[^<'Z*KJ-?X*^2/Q36S[0#
M^^_#/V-?US?S!_A]Q3]N;^H=_.#]%5U&O\%?)'XIK9]H!_??AG[&OZYOY@_P
M^XI^W-_4._G!^BJZC7^"ODC\4UL^T _OOPS]C7]<W\P?X?<4_;F_J'?S@_15
M=1K_  5\D?BFMGV@']]^&?L:_KF_F#_#[BG[<W]0[^<'Z*KJ-?X*^2/Q36S[
M0#^^_#/V-?US?S!_A]Q3]N;^H=_.#]%5U&O\%?)'XIK9]H!_??AG[&OZYOY@
M_P /N*?MS?U#OYP?HJNHU_@KY(_%-;/M /[[\,_8U_7-_,'^'W%/VYOZAW\X
M/T574:_P5\D?BFMGV@']]^&?L:_KF_F#_#[BG[<W]0[^<)5NDO2>H!TT=T;(
MVO-]-7E+MMO?-8*:\1A8JIV&H+1JQ[77;)[**/G=1L!'*6"0>4N]82)GM4P;
MNOVO9GX/;_;VAVUPV&@BC2G6*?67ED1]OM'-LL1K;/=6VV](R+NVW;U^P6*S
MXE--X2V:GU=U(U99[=KK;5<ZWW-EEG3)]OTMW-K_ "5>8?NO(_W2#%'@<'R[
M.CJF9?#:CY!_1U!^ENYM?Y*O,/W7D?[I \#@^79T=4>&U'R#^CJ#]+=S:_R5
M>8?NO(_W2!X'!\NSHZH\-J/D']'4'Z6[FU_DJ\P_=>1_ND#P.#Y=G1U1X;4?
M(/Z.H/TMW-K_ "5>8?NO(_W2!X'!\NSHZH\-J/D']'4'Z6[FU_DJ\P_=>1_N
MD#P.#Y=G1U1X;4?(/Z.H/TMW-K_)5YA^Z\C_ '2!X'!\NSHZH\-J/D']'4'Z
M6[FU_DJ\P_=>1_ND#P.#Y=G1U1X;4?(/Z.H/TMW-K_)5YA^Z\C_=('@<'R[.
MCJCPVH^0?T=0?I;N;7^2KS#]UY'^Z0/ X/EV='5'AM1\@_HZAB_=W4LYP;<T
MOMW5#?HT\OH-QL[6%^UXA-+/)1^C#K72J2U;2E%6)-6-3O$H\\EA4R6%4\J8
M)W.#%[>W$W#$I\/Q*GKUE8Y()XY+O!;<>CK+;5LMLLML+?BR5.)X54X:V)['
M5%/)'>X;NL8K;;+$MLMMLM2TJ!_HJNHU_@KY(_%-;/M ;#?WWX9^QK^N;^8:
MR_X?<4_;F_J'?S@_15=1K_!7R1^*:V?: ?WWX9^QK^N;^8/\/N*?MS?U#OYP
M?HJNHU_@KY(_%-;/M /[[\,_8U_7-_,'^'W%/VYOZAW\X/T574:_P5\D?BFM
MGV@']]^&?L:_KF_F#_#[BG[<W]0[^<'Z*KJ-?X*^2/Q36S[0#^^_#/V-?US?
MS!_A]Q3]N;^H=_.#]%5U&O\ !7R1^*:V?: ?WWX9^QK^N;^8/\/N*?MS?U#O
MYP?HJNHU_@KY(_%-;/M /[[\,_8U_7-_,'^'W%/VYOZAW\X/T574:_P5\D?B
MFMGV@']]^&?L:_KF_F#_  ^XI^W-_4._G!^BJZC7^"ODC\4UL^T _OOPS]C7
M]<W\P?X?<4_;F_J'?S@_15=1K_!7R1^*:V?: ?WWX9^QK^N;^8/\/N*?MS?U
M#OYP?HJNHU_@KY(_%-;/M /[[\,_8U_7-_,'^'W%/VYOZAW\X3M=(^\\]NF7
MKK;M%G.EGRMVZKLZZP=L0D8J%G:>G#IQ$&>',R5;/*+83/#KF/WS!\'3P7'U
M.YS^R,6;P-JJ/;:LIZJ)$IT@B<RQ7H^VUUMMJ(VPR_NUV-K=@:&IHYG+4K42
MM?:C%9=NMNV6*KK;>H2Y?I;N;7^2KS#]UY'^Z08_\#@^79T=4R7X;4?(/Z.H
M/TMW-K_)5YA^Z\C_ '2!X'!\NSHZH\-J/D']'4'Z6[FU_DJ\P_=>1_ND#P.#
MY=G1U1X;4?(/Z.H/TMW-K_)5YA^Z\C_=('@<'R[.CJCPVH^0?T=0?I;N;7^2
MKS#]UY'^Z0/ X/EV='5'AM1\@_HZ@_2W<VO\E7F'[KR/]T@>!P?+LZ.J/#:C
MY!_1U!^ENYM?Y*O,/W7D?[I \#@^79T=4>&U'R#^CJ#]+=S:_P E7F'[KR/]
MT@>!P?+LZ.J/#:CY!_1U!^ENYM?Y*O,/W7D?[I \#@^79T=4>&U'R#^CJ#]+
M=S:_R5>8?NO(_P!T@>!P?+LZ.J/#:CY!_1U"(WJX7GGMU--=:BHL'TL^5NHE
M=8W6<MB\C*PL[<$YA.7@R0Y6239G1:\9F= Q.^9/DZF#8^IW./V1D#=_M51[
M$UE152HE0D\366(]&66.MMM5'6F--Y6QM;M]0TU'"Y:9:>5S[58K[UYMVRQ%
M;99U2"7]%5U&O\%?)'XIK9]H#*?]]^&?L:_KF_F&(/\ #[BG[<W]0[^<'Z*K
MJ-?X*^2/Q36S[0#^^_#/V-?US?S!_A]Q3]N;^H=_.#]%5U&O\%?)'XIK9]H!
M_??AG[&OZYOY@_P^XI^W-_4._G!^BJZC7^"ODC\4UL^T _OOPS]C7]<W\P?X
M?<4_;F_J'?S@_15=1K_!7R1^*:V?: ?WWX9^QK^N;^8/\/N*?MS?U#OYP?HJ
MNHU_@KY(_%-;/M /[[\,_8U_7-_,'^'W%/VYOZAW\X/T574:_P %?)'XIK9]
MH!_??AG[&OZYOY@_P^XI^W-_4._G!^BJZC7^"ODC\4UL^T _OOPS]C7]<W\P
M?X?<4_;F_J'?S@_15=1K_!7R1^*:V?: ?WWX9^QK^N;^8/\ #[BG[<W]0[^<
M'Z*KJ-?X*^2/Q36S[0#^^_#/V-?US?S!_A]Q3]N;^H=_.#]%5U&O\%?)'XIK
M9]H!_??AG[&OZYOY@_P^XI^W-_4._G"WYI'J6<X-1Z7U%JAQT:>7TXXUCK"@
MZ\7FD7DHP1F%J75(FMJRB3$^K'1V:4@>-RJ5+*JF4\'[G)C=G;G7G$TI\0Q*
MHKTE8U)YY)+O#9?>KK+;4MLMLML-FL)2IPS"J;#71/>ZGIXX[W!>U;$;;98M
MEMEMEJV&4/TMW-K_ "5>8?NO(_W2"%X'!\NSHZI</#:CY!_1U!^ENYM?Y*O,
M/W7D?[I \#@^79T=4>&U'R#^CJ#]+=S:_P E7F'[KR/]T@>!P?+LZ.J/#:CY
M!_1U!^ENYM?Y*O,/W7D?[I \#@^79T=4>&U'R#^CJ#]+=S:_R5>8?NO(_P!T
M@>!P?+LZ.J/#:CY!_1U!^ENYM?Y*O,/W7D?[I \#@^79T=4>&U'R#^CJ#]+=
MS:_R5>8?NO(_W2!X'!\NSHZH\-J/D']'4'Z6[FU_DJ\P_=>1_ND#P.#Y=G1U
M1X;4?(/Z.H/TMW-K_)5YA^Z\C_=('@<'R[.CJCPVH^0?T=0?I;N;7^2KS#]U
MY'^Z0/ X/EV='5'AM1\@_HZA6&ZAW%OJ%<XN8>W^4<5T]N3VNF&S_$#O%.D*
M%9;([A_$K5U)UVKWZ:;5V'1>^R"U2,Z+V-D^]E7PGGNLER8V;MD-Z&'[+[.T
M^!20:Y\&L]NDJ-1;\KY/<W5LLOV</2M-?]M]T.([7;3U6T,=3J&5&K]HL3G*
MW5Q1Q>Z1[;;;EO EEMAI9^BJZC7^"ODC\4UL^T!]+_??AG[&OZYOYA\K_A]Q
M3]N;^H=_.#]%5U&O\%?)'XIK9]H!_??AG[&OZYOY@_P^XI^W-_4._G!^BJZC
M7^"ODC\4UL^T _OOPS]C7]<W\P?X?<4_;F_J'?S@_15=1K_!7R1^*:V?: ?W
MWX9^QK^N;^8/\/N*?MS?U#OYP?HJNHU_@KY(_%-;/M /[[\,_8U_7-_,'^'W
M%/VYOZAW\X/T574:_P %?)'XIK9]H!_??AG[&OZYOY@_P^XI^W-_4._G!^BJ
MZC7^"ODC\4UL^T _OOPS]C7]<W\P?X?<4_;F_J'?S@_15=1K_!7R1^*:V?:
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MS..]N\=[-V&P8HN2(L>%+;_'=DTIV"VKW3%DN_Q&Y="]DM!"TEV
M                                    *@7KJWT66@_G_P"K/S=>50 F
M^Z*7T1_3E^:!H_[R8L 2?@
M
M
M
M
M
M
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M7SM<[R6>=PHM@A444DXM55K4*C6I=B;P(2J2D2F17*MZ5W"I*V(9,
M                                      *@7KJWT66@_G_ZL_-UY5 "
M;[HI?1'].7YH&C_O)BP!)^
M
M
M
M
M
M
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MJKW"O!9QJG#;Q9@E5;5K2W>!+;;>)%X+./.>KYS]2W5O /;'$^D[EKKLNO\
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M-(JJIRDS(IZ:6I<K8[,G"J\!'J*J*F:BR6VKTDX3?,1R0
M                                   4NN.>_P!+HI=33F'5>9M$LZ>M
M.5%M>VFE<@(R$>V1T6L%O5MM,!9VN$D3/[!7YII=LIVAO'&=R,?,1R*?@[C*
M?:+Y+'X=2L6!4O,3*G4]C)Q%BBD\ JWMG1;CUM1>JO9R\9;"TKNWC1RLA83;
M^D+SK/<C.OF=MXJV5U6+EY^FN)ANHV?QSI)R@2ST>2E&262K-'23-PLAV=T3
M),X[;1)'+"JLD16V]+/V2\1R13)?C5'6<G8*TO5O7LO/GJT\2.F-XR2D#IV
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M*1"]%/JL\!N)'!:M:<Y";Y\W^R(_8FQ9UW7/-=N>U]YBIV71=13KV7I&NK)
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MR8YW:IE,F/G/;F.K$GJU9'[ESUL]2WAT$E)%IZ-'R^Z:Q+?5LX-)5DX*<XN
ME)VE.<\.HG=KCR&YI;3MSZ8@JU"ZY>V^G<=Z^A)NF<(^0;SRT76D[(DW8$5C
M$8Q:2\788[-%L1)[EV5*[5$%0YG@],B-@1,]BNZ.52T4]13->M14JKIU7-:C
M>CD0N=<9.5>A>8>LF>W>/.P(V_TQP[5BWRK=N^C)FO3K9)%9Y7[/7I=LRF8&
M8:IKD/WIPB0JR)R+(F50435/8Y89(7W)$L<7R*:.=E^);6FPPIE4
M(C>N5H/S_=-3D T9M?";#J6/C=[UPW>N_9;*:P<'D[8L4F.P_=J:W<S:)<ES
MC)<JXS]7&,ES,H)-75-MX%R:>#EL(6(1ZRE=G;ET>Q::<.>HCFM^KWUWD6E.
M%=;.DM&-.-$4Y[X7V6\[:3IYH]Q-KDPH4J4Q'1L4YM'8?N2JI(X/@ABJ$(:O
MX-;B2Q?Q+U[J</L%#PJS#4EM]O=N]7@]DCHZ:^LKITJ^HIQ!U_?I%VC2^H1Q
M.J9[ 1\JCX#7]MV%!:P1M3R0J#90TW6;C$,X@O\ [TI2V3/<J*8S^TE53VU=
M*]S?=1O71_!UB-2L=1U3&N]S*SE_AR=4W$V4W)S,]8^UE3DEO96A\#M21UNG
MFZ2>562%J@61K@T?IJ&,9(D@TV3M2MMG!\8^IF*[WC&#DR?%!O<,,5W\:1>C
MD12L_N^*(W^+&VWU^NJ'CO65;##U'<W2LM=A>>Q\!6-G;HL,X_\ !W3OP&'A
M;5Q=DI-YX*Q0<O7/@S)L<_>T4U%3]SV$*8V<8SVPM%5DR)PJB?RCC%%1LD+E
MX$5>NTDX_3Y])C_%?_\ B*Y*_P!S@B>3JSF<K>R2_*-'S^1W8)5M?7RI[4H5
M(V?0I8L_1=CU"M7RESI6<A'%FJG;X9E8:Y+%CY=HPE6!9*'D45L(ND$'"7=]
MRHF0^#%Q$<U6.5CLCD6Q>H2VN:]J/;E:J6IZBE*_H"=1OAGPFTSOVJ<G-Q^;
M.?NNSJ]8:RP\WNU+G[)P[&JEC73SPK7U'M;)GWI[CN.]N%$E3?LX+DOU1?,1
MIIYWM6)MJ(F=$ZZEBPVJ@@C<V5UBJN95Z7$A:-XN=3;@_P T;[,ZPXT;N+LF
M]5^H/KY+P7FXVW33-:G&S,#7GTMB0O\ 0JK%.2MYBSL4<HI+J.,^$8-A/)"G
M,6TRTL\#;\K;&JMG"B]92[PU=/.ZY$ZUR);P*F3JH5].K[NNC<<>NAP@WILI
MT]9T;5_&VDVRQ*1K%:2DEFD?L?DYWIC&L4,=TXD))XHFW0P;)$L*JERH=-/!
MCEN5$QTM!)&WW2N5.1I;:V1L6(1R/]RC$Z[CU?%#C[M[KD<A([GUS1A4H#A=
MKJ5FX7C=Q\2?&7BK@:&G#-'[>3,D1!66KK29B\XLDFJ5%2=DVV&"*:<>V.@C
MUFD901^#P?'K[IW1R9O5.88GXA)X3/D@3W*9^CIYRV0Q8LHQDTC8UHUCXZ/:
MMV+!@Q;I-&3)DT2(@U:-&J!$T&S5L@F4B:9"E(0A<8QC&,"S\.5>$O/!D3@/
MBW&GU?8-3LM$N\#&6FFW*"E:Q::U--4WT1/5^<9+1LO$23-;!DW+)^Q<'24)
MG]DILCEKE:J.:MCD.'-1S5:Y+6JAH)F<Z6?"?3-MT.\M7%+46JJO&O8^]ZIG
M;=39B8DRY25>NH^X56:E)Z^W^RODULY*B]2D95WDQ2D*IG)"B395SR))8]7K
MP+8O(O A&MI(&+':QK$X4M3E3A7KD7?JV^NK!"4OFGM>OQ4Y7^-.W-YQV>.4
M--D6244@Z:]V TFYIH5SV+.4E(B;@XM9Q]4IW<.JGVY.D?&)>*.171L6Q96M
M]MU;/9(F%M5&R/3)$YWM>I;[&@\KZNE7:#L.0YI[XVRPAYSFXKR-L3/8#ZQ8
M:2]RIU6F(]K)Y4AG3Q5Z^BF]AOSFPM7JS8^,.,1B*9SG*D3&.<35S=7&SXB[
MDS+T)8<88C7:R1_SB]ESHG\-IY3JCQ.N.)?6#Z:'('2JD'4MF[DO[&J[XJE0
M58QK^;I[N\4C7N+188-BNWSEW?JG>YF+(Z<)D2>G@2Y[3J-U#8[4BOFHI8Y+
M58U,BKZBKR6)I.M6C8:Z*6/(]RV+I1.5%706N!9R\        !5XUDEGAIZQ
MUM"CG7+$Z_YZ:F?W2$:KE*@Q<6R6CE+BYD%%\F(F>2=;'UA9FS;/[)S2V$NY
M,H<ILW9W=\,1W\:->CD5"TL[ABBM_BR);U>'KHNDU-ZH6M+CU2>>W+O7VOW3
MLU0Z<O$6POX<K Z6$+3N1HJQM\M5T<+).<^RME=/74-DIO!T\FK6<X.3MP=2
MM2.;24['.]U*_DX/9ZI0JVNJZA[6^YB9R\/L=0WD@NH9XP^KQ6?>SZP_TGP6
ME)3BK+N^^]\F,;076::9B);NB&QW<Z^JLZPLQS8^HGA8RF2]A<X$=::S$DC1
M/:*Z]U.'KY"0E3;ABR6^WNW>KP>R;Q]#70?F!Z:G']H\:^#6';4?);WL9N]=
MYRY4V>X))U-8Q,]I^[3UNVA$39-G.392SGZF,X+B/7R:RJ=9P)DT</+:2,/C
MU=*W.[+I]BPKY= 3J-\,^$VF=^U3DYN/S9S]UV=7K#66'F]VI<_9.'8U4L:Z
M>>%:^H]K9,^]/<=QWMPHDJ;]G!<E^J+EB--/.]JQ-M1$SHG74MN&U4$$;FRN
ML55S*O2XD+1O%SJ;<'^:-]F=8<:-W%V3>J_4'U\EX+S<;;IIFM3C9F!KSZ6Q
M(7^A56*<E;S%G8HY1274<9\(P;">2%.8MIEI9X&WY6V-5;.%%ZREWAJZ>=UR
M)UKD2W@5,G50@T]95L,/4=S=*RUV%Y['P%8V=NBPSC_P=T[\!AX6U<79*3>>
M"L4'+USX,R;'/WM%-14_<]A"F-G&,W#"T563(G"J)_*+?BBHV2%R\"*O7:2<
M?I\^DQ_BO_\ Q%<E?[G!$\G5G,Y6]DE^4:/G\CNP;)\S;Y4]J=,/E=L^A2Q9
M^B['X&[TOE+G2LY".+-5.W\?+38:Y+%CY=HPE6!9*'D45L(ND$'"7=]RHF0^
M#%Q2@:K*MC'9')(B+U%*L[FOI'O;E:L:JGJ*TJ"<,^H'NV/X-:;Z9/!B'>R7
M++D!L?:K:PW(IO8S&MZ;8'SEXHE79%\1)FWL#VLQSR0?3'=F2K\0@=9+M>'(
MHSO4]/&L[JJH^):B9,Z]'2Z99(*F3P=M)3_'.5<N9.C0A;$Z9W38U5TZM-(U
MF#386S=-Q:,7VZ-NJ-C>R-JG$RY7S!P2KHA7D90X!RL<D>T["&6SVNG&,N%3
MYQ9ZJJ?4OM7)&G G1TR\TM*RE98F61>%>CI$E(BDHJ6=5;DU2.%G76X7<HMJ
M0%WG-<Z]XAR+:69T**B).R2+BS.>6]&;-X1O8Y^JP3M:/E+LQ7=D5D$#)-#9
M/C!SY334O%)$Z?#WQ,5+ROZ?^BOK%FK)6P8A',]%NHSI?Z2>N2(<<O6#^GCR
M)OL+KGV9VCI.P663;PM<=;RJ-?KU<EI9X=%)DS/:*9=+[!07ABRO>TUI5=@W
M[X7N<J8R9/!XTN&U,3;V1R)F]E$),6)4TKKN5JKG3L*I(YO?A1Q?Y-; U)LW
M>NHJUL>W:2?23ZA.K"FX<QR&)0A,KQ]@@^_EAK9#HOD$GB#230=-T':6%"%Q
MDRF#QHYYHFJR-RHUW#T=(E2012N:^1J*YO 1%>LB%T!$]/Y&/ND%6L[?DK_1
M('CD="/CR6>*D(R<CWUW+#900]D6]30URB_:O$D\E9%=.V.#X[Z9OC,S#-8M
M3:U5N6+>];E(6*:M*;VUE^U+OK]2PE_X45W8U1X?<7JMMY1VILZO:"U/#7G$
MBHHM*(6..I$*UD6<NX6QA9S,,5DN\NU3Y,95RF<^3&R;NLPIU:LSU9[E7+9I
M)T"/2!B/]VC4MT&SHI%4      #4[G9H4O)[AWR.T21N5U)["U3:&%72,GA4
MI;Q%L\V"A.#)9SCOA6ETB&"N<8R4V>X^IG&>S.*U/)JIVR=)%Y.GR%&HCUL#
MH^FJ<O2Y2%WI!<ZXC7W16O\ LVXO$I25X2M]MU5S$O3Y3?2G@*6+UJ^!53*J
MBH1O,KW9G ,U,Y2)W3;),FP9(YQ.K:=75R-;P26=A>M:0**H1M KW<,=O93K
MV$+?%*J[.X#[:Z9O4NV+/R"T!S8V)M2&W@N_5;D9Q%>V!;U8-M-S)2MT,Y)8
MJS8<VY I%%2]W%8SGO9L=P:=*K*ADM*WAC1+.HG9R$&%KZ=\54[@D5;>JO0I
M+7U?VY.7/5-Z:7 MHM[(0$'+K;CVG$(IY607K\E,8FYQI(8R;*17K/6VH94R
M/=8_T2<K@QL'PI@HAT7<:26H7A7(G1ZJDRM[M5Q4_2X5Z/40R)ZT9\@'4'SP
MZ!^1;D".N$_.7? 7KH=\7^;-^&G64S_J#KK=*VKZFU?69WE+X#-UW7=)@IEE
MYD>1CGP.5B*U&1\@U\)9ZA<-''@[MN<G=I*'3/V=I3&+G&<TWX?5J]51F157
MIM[)49B%&C$17Y41.D[L$M.A-]ZFY.ZFJ>\M&VPMYU9>2S9JM:2PECKF)3%<
ML<Q4IK_X+;8>!L+$S&PP+MMG#EHCD^4>[)W29B'-"DC?$]8Y$L>A-CD9*Q)(
MUM8O\'3*B/ _FYQ@X2]5?JTV;D[LWS90EXW]NV"JSWQ+V%<_925C.1VP)!\U
M\&U]4[6[9=X:*E/W;A-%,W;V%-DWU!>JB"6>CA2)+51J=-$_BIG++3U$-/63
M+*MB*Y>DJ_QES(I8LT#U=.GERAVS5M&Z+Y"%O&T[J6=-6*MG56[:QF4Q6JY+
MVV;[F:N.MJ]7FIF5>@7;GL7=I94PCDB?=*&*0ULDHZF)BR2-L8G&GK*7..MI
MIGI'&ZUZ\2^KTT(9O64Y^(JFZ.E5:; \+'0-:V?N>?FY R+AP5C$0UKXNR,D
M\,@T27=+%:LVQSY(D0ZANY["ESG.,"=A:*K)D3A5$_E$'%%1LD*KP(J]=IXB
M";;A]8CY-'G9TLQK#I>\:KXNS:0B#SV/LVUK8V9(N2MW:J':OXZV.#D$%79\
M9PWJL&^PBW,=\Z,NYY6YAL5B9:MR:/8ZZG5+^)RVKDI&+I7L]9"V-1*)3=84
MVM:]U[6H>G4BG0[*OU>KU]DC'0\)#QR)4&C%BT0*4B:29"_5S]4QS9R8V<FS
MG.;0YSGN5SEM<I>&M:QJ-:EC4/6#J=BB9O+G?Q)YG=038FV^>&Q[(]X<\7[
M\J?&SC?1X2:L*NZ9"-DY)NO;9AO&F1@F\%.K0?A\JX?OX]=\B]BXU(RK1![E
M+Z".GF@ID93HFO>EKG+TN+HXU/GI*B&>I5]0JZAGN6IT^CL(6E^"'4CX0<SH
MY6@\7K2W@9FA0#-3&F)JI8UY/UZI,RMF+5Q7ZXB3->?UV*.HFV4]AW#I%@;*
M95<)%50[Y:*BFG@6],EJ*O#;;T=4N]/54\Z78EL5$X++,G1F*_\ N'G7JCIS
M^L!\X=W[QJFS[%4;IQ_UGK>$::S@JW+SBLO,:TXI6!O)G;V^WT>,/ (HZ^D&
MZJR+M54KO!$\)&QWPR=R93OJ<.CCC5$<CE7+ZKLR+G+:^H92XE))(BJU6HF3
MU&YU3,31<.^M]P1YHWZ)U32++>=9[-L:JC>J4O=-9C*J\M;Q/*N?8V!G:Y9+
MC3G,PNFG@S=BI))/'7=X*@DH?!R%@ST%1 V^Y$5B=-.A%)\%?3SNN-54>O B
M]/KH2]"$30        K!]?N*?\>]]=.KJ*5Y-=!73>Y8[7E[=MF^5E7\ A+I
M;(KT(?),X/EJ_A8NW-54_P!E0CWL(8ANW.;KARI)'+3+_&;:G6[!:<218I(J
MI/XKK%Z_9,D=<VZ.>0\SP4Z<^MY8CEYS W16+I<IB)73638ZBK#MLW:RQER]
M_27B'BLR[FB*))K&SBM9SCZAL%4ZT#=4DE2[^(VQ/5Z,G5.^(.UJQTK?X[K5
M]3HR]0\WT'[T_P".=EYY=.G:,WX.[XG;;LE]IS^771QEUK*0>N(2QS2!DRI$
M1@D3P\5-=N2$_;6/)LE+G.2%[8@W6I'4L_CI8OJ]%J=0ZX<[5+)3/_B.MZG1
MEZIYCH 0SS?^^.HMU$9U)=8^Y=T2U HCIR@9)5A!O)MQLVRPQ#*Y,IAJRB9>
MI-DD^W_1$9]R;)L]G<L15(XXJ9/XK;5ZW9.,-3622U*_QG6)U^P:P; Y/:-X
MB^LE\F-P\AKOYOM<M=8TRO+V+Q:M]L[W,3G&#1:<6S]B*1 66=-X4= ^.^%:
MY2)V?MS%[<"LV*2;"VLC2UUJYN<N<I.FCAQ1[Y5L;8F=?XJ9B<O776RZ8NV=
M@4;5M Y-%GKWLFWUNATJ#-IOD!$8FK9;IAG 5V)]E)S5,9#1QI*7D$4<+.W"
M#=/)^Z44(7&38M[J"K8U7N9[5$M7*G2ZI/;7TCW(QK[7*MB9%X5ZAH5ZT9\@
M'4'SPZ!^1;D").$_.7? 7KH1\7^;-^&G64S_ *@ZZW2MJ^IM7UF=Y2^ S==U
MW28*99>9'D8Y\#E8BM1D?(-?"6>H7#1QX.[;G)W:2ATS]G:4QBYQG--^'U:O
M549D55Z;>R5&8A1HQ$5^5$3I.[!+3H3?>IN3NIJGO+1ML+>=67DLV:K6DL)8
MZYB4Q7+',5*:_P#@MMAX&PL3,;# NVV<.6B.3Y1[LG=)F(<T*2-\3UCD2QZ$
MV.1DK$DC6UB_P=,I&ZSZB=<Z<G.OK+['S!%M^T;SOK=%.T]471'J<(_M)>1F
MQWKJ:M+]J4N6U:K#/L<N$"*I.GQ\IMD3)]\.X0OSJ9:FG@9P,1J*OY*%@95)
M2U$[N%ZN5$3_ $E)R^E7TR+W 7>8ZA_/W/C_ ,U-O/3VV A["FU=):6C)9FF
MFV7/'()%BH[8*\48C5-!N3O%<C2)LFV$U<N,%@5=6U6^#4V2!.7V.N7"CI'(
M[PFIRSNR^I[/6+ XMI<@ *U/7QW3;]O3G&WI7:+DRFVARFOE6F]D)(+]B$3K
MYG.Y;U-E8<IK8,G#O[*P7G7A>S"B;6M%/_U%<8/=,.C:Q'5<GN&)D]7I]CJE
MJQ&1SU91Q^[>N7U.EV>H?5ZX/#*Z0G2EU7IGB_"34CKSBW:M?S%MID*W7>3D
MSK*G4:W5IU:GJ;!,[V<=0L[-(2\JGDAB*=\<2*N<&:%R.*"=JUBOE]T]%L7C
M54_@Y#G$(')1I'"GM6*EJ<2(O\/*>)Y=]2[I8;-Z5]OTWK.;J\Y)W+22>OM*
M\:XJJS.;O0]GJP98ZBD7A_8--"&<:WM1DGJDGWTK=_X&?#5=R9RF5;M#2U;:
MM'NML1UJNZ2IT])UFJZ-](K&*EJML1MF5%Z6@E&Z/6F]NZ$Z='&_6F[TI2.O
MT9!6::<5J;142F*9!V^\66V5BHRF'!LO$Y"&@9IN59NO@BD>H;++N2E;%P(E
M:]DE2]T?N;=-B66DNB8^.E8R3W5FBU> DQ$4E@       !5XZ0"6>)'5(ZEO
M 9VN6/K<M,$W3JN&7*5NBA LIA&6AFL;C)BE5?OM:[;AS+%)C/?$HC*A2D*F
M? NU;W:DBJ$X4R+T>JA::+N-7+3=+A3H]14T$3_-JH;(Y\[-ZEG4BUU-2;&M
M\(=EZBH6EU(M5(F)>O:_L:M=L=BAS*HN#E) H,4[@?)U43DQ*_M2F[,HEF0*
MVG;%2NX9$55ZO180JAKJETM4W@C5$3J=%I+_ -6SG=%[+Z(VM-DUN01:V#FL
MUU'43Q\;G)UX^014Q<]MPK?"9C?]EAY>A/8)T;]L7/A'>_V5"YQ"HZ=65ZM7
M@CM7L=>TG5M0CZ!'IPR6=E>M8>RZ@^A2\8?5T[#HD[<K63U[JGC$PM"14\)%
M->)3D3INP7UP5+&<][*[NDN_5QC.3&QW?U<YSVYSUII-;B:2=)5=HNK9R'-3
M'JL,6/IHC=-Y+>4\UTY.LOTV=#<&^,VGMK\C_%78VOM8Q=>M]=\S^^ISV(F&
MSIZHLS]EZWJZ8@G_ '!%BY[XU=+I9[?J&S]4<U5#525#WL;:U5R94[)Q2UU+
M'3L8]UCD3+D7L$Y?%WESQYYGZ_E=I<:=A%V51(.WR%#E9S%5NU0RTMD5#P,^
M_B31=]K=6F5#(1%G8K=^(W,W/AQ@I5,F*<I8$L,D#KDJ6.LMZ2]8N$,T4[;\
M2VMMLZ:9>J5<=@<GM&\1?62^3&X>0UW\WVN6NL:97E[%XM6^V=[F)SC!HM.+
M9^Q%(@++.F\*.@?'?"M<I$[/VYB]N!=FQ2386UD:6NM7-SESEI=-'#BCWRK8
MVQ,Z_P 5,Q.7KKK9=,7;.P*-JV@<FBSU[V3;ZW0Z5!FTWR B,35LMTPS@*[$
M^RDYJF,AHXTE+R"*.%G;A!NGD_=**$+C)L6]U!5L:KW,]JB6KE3I=4GMKZ1[
MD8U]KE6Q,B\*]0\;U\_HF.5_]A7YRNG!VP[YXSJ]JIQB/S-_4[9"O7J_ECR"
MYW<:^)O2!X,$]@NYT=%)<L=Q2GA,:VAZFUD"8M=>14.BF]9TB#3FFB$NX;%.
M[G7SI*,:]C<ZN7MR?#%3ROK:C+[;VJ='3ZW"6QDTE1$RBI^;[9>OU.OP%M[A
M1PJTKP0TA!Z5TQ#%200*C(W2Z/T$/&O9%O,V31D+9:'B6,Y4<+Y)W#9J3/@T
M>UP1! I2%^K9IYY*B36/ZB9D+U!!'3QZN/JKTU4V[%$K%7+U=*NT'8<AS3WQ
MMEA#SG-Q7D;8F>P'UBPTE[E3JM,1[63RI#.GBKU]%-[#?G-A:O5FQ\8<8C$4
MSG.5(F,7;$U<W5QL^(NY,R]"6%IPQ&NUDC_G%[+G1/X;3RG5'B=<<2^L'TT.
M0.E5(.I;-W)?V-5WQ5*@JQC7\W3W=XI&O<6BPP;%=OG+N_5.]S,61TX3(D]/
M ESVG4;J&QVI%?-12QR6JQJ9%7U%7DL32=:M&PUT4L>1[EL72B<J*N@^CZP9
MP U@74'(3G_8+ILRT[34<:*IE"I\M9,9UOK&&Q/U&FS^*O D;^$]]LB!%W:R
M9W&&A'CUPOA#*ZG?<<8;4OOMID1$9E55Z:\*G.)4S+CJE557Y$1.DG A/)T\
M?D \&OF><9OR+4D6^I^<R?#=UU+A3?-H_@-ZR&X8H%<             *O&L
MDL\-/6.MH4<ZY8G7_/34S^Z0C5<I4&+BV2T<I<7,@HODQ$SR3K8^L+,V;9_9
M.:6PEW)E#E-F[.[OAB._C1KT<BH6EG<,45O\61+>KP]=%TFIO5"UI<>J3SVY
M=Z^U^Z=FJ'3EXBV%_#E8'2PA:=R-%6-OEJNCA9)SGV5LKIZZALE-X.GDU:SG
M!R=N#J5J1S:2G8YWNI7\G![/5*%6UU74/:WW,3.7A]CJ&\D%U#/&'U>*S[V?
M6'^D^"TI*<59=WWWODQC:"ZS33,1+=T0V.[G7U5G6%F.;'U$\+&4R7L+G CK
M368DD:)[177NIP]?(2$J;<,62WV]V[U>#V3>/H:Z#\P/34X_M'C7P:P[:CY+
M>]C-WKO.7*FSW!).IK&)GM/W:>MVT(B;)LYR;*6<_4QG!<1Z^3653K.!,FCA
MY;21A\>KI6YW9=/L6%?+H"=1OAGPFTSOVJ<G-Q^;.?NNSJ]8:RP\WNU+G[)P
M[&JEC73SPK7U'M;)GWI[CN.]N%$E3?LX+DOU1<L1IIYWM6)MJ(F=$ZZEMPVJ
M@@C<V5UBJN95Z7$A:-XN=3;@_P T;[,ZPXT;N+LF]5^H/KY+P7FXVW33-:G&
MS,#7GTMB0O\ 0JK%.2MYBSL4<HI+J.,^$8-A/)"G,6TRTL\#;\K;&JMG"B]9
M2[PU=/.ZY$ZUR);P*F3JH0"=6;<&NM ]>?@5N/;5B\4];Z_T#KF=MUC]B9V=
M]B(HFT^2S4SKV(K49,SS_L7<D+W#5JLI^V[>Y[,9SBXT;'28?(QB6N5RV:&E
MMK'MCQ&-[UL8C4MTN):B]?'I,',4F.6!<9,;!<9-HSDF0N,FSV8[HY].E(0O
MU?JYSG&,?](A^3JSF<K>R3?*-'S^1W8-P.H=\@'G+\SSDS^1:["C3?.8_AMZ
MZ%:I^;2? =UE*:O#/J![MC^#6F^F3P8AWLERRY ;'VJVL-R*;V,QK>FV!\Y>
M*)5V1?$29M[ ]K,<\D'TQW9DJ_$('62[7AR*,[W/3QK.ZJJ/B6HF3.O1TNF6
M."ID\';24_QSE7+F3HT(6Q.F=TV-5=.K32-9@TV%LW3<6C%]NC;JC8WLC:IQ
M,N5\P<$JZ(5Y&4. <K')'M.PAEL]KIQC+A4^<6>JJGU+[5R1IP)T=,O-+2LI
M66)ED7A7HZ1)2(I**2OK"O #6''ZM*<LFETV9L#</(WE/,GFY"]63$E#4RER
ME4N=D8:^IL4FW3.V@(%RS;H-,N5G!V[1LD@AA!(IB&ON&U+Y%U-B(QK.ETUM
M3*I8<2IF1IKK55[G]/I)ER(6:NJAO*P<<>GORGV[4I1:"M4'KCQ>K$XU[</(
M6Q;&L$'K6$F&!\%/A.0BY.W)+MSYQDI%DRFS]3&1:Z2-):EC'<%O6R^L76LD
M6*F>]OND3KY/7-2^@[Q'UMH7@/J#9;2KP:VU^0-=7V3>[PI%M33[Z%LD@Z7I
M]61DU2+/D*[#U-)E_P!D*IANH^4<..XP9;.,5L0F=)4.;;[1JV(G7Y2CAT+8
MZ9KK/;N2U5ZW(:!<G=?5O@#UWN$NV-*1\;KVD<T2HZPV73*['-XNO2]DMEG;
M4">5)&,$TV;5I,2\_5Y<R2*2>/9EB=T<QLJGQB1$Y:C#Y&297,RHO+V2-*U*
M;$(WQY&R9%3U<G87U2Q/RLY1:GX<:,N^_MRS!HRHTYAG+=@TPFK.VVQNB*$@
M*95V:BB17UBL;XF$4"F,1%(O=KKJ)-TEE4[;#$^>1(V>Z7HM+G-,R"-9'^Y3
MEXBBCU)-4<FM[\9F'5>Y:/I.K6;D'O\ HVKN/ND<'7+%:\X\NJ!N*W,')VC]
MLDZ9HRSVJ,58ON"-CODU'DJY*JI)I92O]*^*.7P.'*C6JJKG6U.SZW2/GZID
MLD7ADV17.1$3,VQ5Z-/3.AP/FSZ4
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M_(6>%DCJAE&_W+'JOK^MREW#J'?(!YR_,\Y,_D6NPL5-\YC^&WKH7ZI^;2?
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MZBQR+12TF9 ^,G-G!D\]N<_LBTR-N2.8F5$54T*7>-U^-KUR*K472AE@=#N
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MW+5LTRBGW"9>XS)JU5U#$^7XVWJV9?8(M(C65\K(OB;.I;D]DM "U%V
M   #X=FKL1;ZW8*E/M2OH*T0<M79MD;.2E>1$VP<1DDU,;'U<%<,W)R9S_\
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M9N]5.N;[=/'Y /!KYGG&;\BU)$>I^<R?#=UU)%-\VC^ WK(;AB@5P
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M<%L]1"R%R-8]KTLX4_A4O-/,^9JN>QS%1>!?X$-TQ0*X
M                                5^][= 76MBW%8=^\0^4.\>$>S[;(
M2LK87NO'\Q/PII&=D%)2;<PF(VY:_NT(27?K&56;%GE6)38+A%!$A<%%QCQ%
MR,U<S&R-3/\ P*G(6V3#F*]9('NC>N;^%%Y3V/%7H;Z_U#OBN<H>3W)';W-[
M>U*69/:79=M'D&T)!3$4Z.\@I]6,G;;L&RS,O6W"F58XKN;48M')LN"MLKE1
M41XFKW/C6*)J1QKPV?P)UCM#A[62)-,]TDB<%O\ "O7)A-RZ7U=R$UK:=0;F
MI</?]=7-A['V"M3:2AVSE,BA%VKMJY;J(/HN5CG:1%VCQJJBZ:.$R*HJ$4*4
MV(3'OC<CV+8Y";)&R5BLD2UJE<ZW^K1UF$M,U+\6><N[>.E<G7'?G=8<5M>\
M+)HE,HHWCT[!6=C:D>O&+ ZIL-_#DWBY$_J'54/DRF;FW%%5+)8VN71ZREL=
MA2(ZV&1S47J^NANYP0Z'7%GA1?V^[)&<M_('>[%P[>P^PMDE8H1M7DI BA'T
MW5ZBQ\(0;V)YX0IDTA(NY-VCD^3-SHFR<QX]17S3MU:6-CS)ZZE>GP^&!VL6
MUTF=>P94Y!=,XN]NHQQJY_XW4:JGX\TVNU$VI_-SB<+<"U^R[,L1'^+SX]P^
M:\9UG8^4<I>P[[N/ \&[K/?>Y3Z156KIGT]VV\O#;P<'2LXLY4DI=95,J;UE
MU+++.'AZ=O'F-]=\Z4H?([3>Q]&;-C?96C;/JLE59]L4W<.447R>#-)2/6_9
M;2\)(I(O6:V/JHNVZ9\?5*(\<CHGI(SW2*2)(VRL6-_N50TVZ8W RZ=.[2=A
MT1.<B#[]IZ]Q=6VC87UCC7"E"Q,MR^,L*V+YP;\:4BY>51*^(3NVQ6[I5P;&
M#Y7SDM>KJ&U,B2(VZZRQ<MMO(A0I*=U-&L:NO-MM3)99RJ1=[*]7NVC9.1?(
M+D%JOJ1;!T2]W]MC8FS):"H6HK#&NXYO?;O-W5.L2%DKG(JIJV5K!.9HR2:R
MK1N57).^813R;)<2VXDQ(FQOB1UU$3*N9+.:I$?AKUE=*R56WG*N1,ZV\Y#]
MM2Z#W+2M6JLV)SUD>1\JV@+!#33B,\3]BH>R2$5)-GRK#O[OE+*-4?#$T,I]
MVJV<IE[KM,DICM)GA<0A5%34-X.+\T)ATR*BZ]^1<R_G$G/5$Z>Y>I/Q_J6C
M#;<-IC-5W!7]L$M.*'C8F'IH*F7^H9@30>;E1N\%=$O67'A.'A^]Y:X)WHW?
M.Z)%I*GP619+MZUMG#9TT7,N8EU=-X5&D=Z[8ZW@MZ2IG3.1/-/5^>6$>T:L
M&'66Y#LF+)NBT9LVE#V2V:-&C9,J+=JU;H\LB(H-T$28(0A,8*0N,8QC&,"7
MY1A7_4-TI^:0_)LR9$G=H7\XEFZ='!S:_"&J[,KNT^8.Q^7#F^6""FH>3V#%
M3\1XDH1$:\8O&$0A8=E[-=*>S:CE-1P<CELG_P!G3QWK.<9/F'4U#)U16,1E
MB=+I\B$REIWTZ*CWJ^U>GTN53X7"[IP)\0>4'-ODB7<9]A&YC;'E-@XIN=?E
MJF-<^RNP+]?%8C-AQ=;)FW][4O&&Q7'@,7^U:]\RGVJ]PGS/5:Z*.*[9<2RV
MWAR(F;)P'$%+J)I);UM];;+.#*JY\O"2<&*4Y3$.4IR'+DIR&Q@Q3%-CL,4Q
M<]N#%-C/9G&?V1%)9&7Q'Z8.IN%W*;D;R"TM/&A*3R!@()@GI%"M(-(37<PP
MF'$W,NJM8D)G./%J5>.,F:Q&8U(L9@QB)+F0PDBE*FJWSPMB>GMFKPY^C.1(
M:1D$SI(_<N3@S=&8^+6.F<6M=4O8W4L+NHSS.P*4QJ!]+9USA#$49EK"B:VQ
M)%V+B]K>&E4)2,/.\Y@DNS+G*7?,][[X?E:JVD2EN\"\-O&J\%G'G"4ME6M5
M>X4LLLXD3AMXLQ];GWTX$^<NW>%^U5-QGUA_PA[+E]A9@2:_+<_.&G+V?4]C
M4AL2F;K5?%(Z/FNPB5UX/)XSX=D^4?\ 0]RKQ3U7@[)&7;;Z6<-EG#Q9>$5-
M+X0^-]ZRXMO!;;P<:9B3H1261D<^NE_J3G5:M([1?3GFQW1HZ[U.>A=DQM9;
MV-S8J57[&E9'NM[/&&F*\I(Q#E\51:/<>%X4B72ZRJ9%"+N$5I=-5OIT<WA8
MY.#CSD2HI&5#FOX)&JF7BS$F2Z"+E%9LY12<-W"2B"Z"Z9%45T529351624P
M8BB2A#9*8IL9QG&>S(B$LKR\D/5S^-.R-A/=K\:-L;"X=W20</GZC*ALB66B
MQTH_.J=P^K5>Q.U&PU=)?+A0IV;&;1CR)9*FW0;D+DN;E%B<K&W)6H]O'P^O
MUBV2X9$YU^)RL=Q<'1U3%-(]6>UO+66.L/*GF7O7D<E%=R5K&LXI*@]^;%6R
MMF,>2]EMNW9LD6OGLPJ1DX9*Y^KDBI#9QG'=V*O1+(6-;R]@Z-PIJK;-(YW)
MZZF__4RZ@''SHI<+-/W>U:KV%:=2-KUK3BQKVDZN5A'LQ6VK'6MTL%5RY<W>
MR1!7$)$5;4:K,RAG2[PZRJ.<X/C*ARVQSE<Y7N]TJVKU2YHQ&L1C<C41$3J&
M^G%'D16.6_&K1G)VEPD]6JEOG6-2VE7("T8CRV*'B+A$MY=C'S6(E[(QF))J
M@YP57O"ZR7=XSW)\X^J.IW-@@    52*'ZM?NC5321CM5]5;:>M(R5=E?2,=
M0]-VNHM)!VDGWA!U(H5SE#%MWSM)OC!,*J$R;!<=F.S'U!=W8I&_*^%%7C5%
M_DEG;A<C,C)E1.)%3^4;$Z6]74TQ';$BMH<Q.1^WN:]CA#H'915V(_JE3D",
MW9W3)I9F[ZX[!N$Y&-3FQGP,LXV9KFR?"R2J2ADA3?B3[MR!K8TXN'K(G(58
M\,8CK\[W2+Q_PJO*2=\_>%TSS,XI2'%+7^VV7'"KSDG36\])0^M4+HR<4"F*
MXD66OXFMLKEKU"!CU9F-BU,*HNC)IM&)FO@YDU\Y3B4TZ03:YS;RY>G9E7I\
M"DNI@6>'4M==1;.E;D3I<*&P'&;05-XM:!U/Q[H.#&JVJ:;%U9F]4;HM'4V^
M0*=U/6:0;M\F02E;58'3J2=X)G)?"72F<9[!3ED=-(LCN%5*D4;88TB;P(A_
M7DEH6D\H=#[5X_;#0[[4MJTZ4JS]P5$J[F'>."%<P5ECTCG33-+U6P-6LDS[
MK/<X=-$\F[<8S@(I'12)(WA11+&V:-8G>Y5.C08$Z=7#VU\$^,\+QOLN\%M\
ML:E9[+)4RSN**?7YZ]5+"NVE2TTL0I=KZ9VC&V->1=IN?#$R][?%0*B0J.#'
MJ5,Z5$NM1MVU,N6WJ\"%.E@6GBU2NO(BY,EG4X5,,5CIG%K75+V-U+"[J,\S
ML"E,:@?2V=<X0Q%&9:PHFML21=BXO:WAI5"4C#SO.8)+LRYREWS/>^^'[K56
MTB4MW@7AMXU7@LX\YT2ELJUJKW"EEEG$B<-O%F)4!$)9I)U!.*-^YJ\;Y[CU
M1.0,KQR2N4Q'%O%MAZ7F\.+304F<HE-Z\<QB=QHKEK%65XY:G>*IO_\ 3-6I
MVBJ2B#E4HKTTS8)4D<V]9P);9ES\"D>IA=/$L377;>%;+<F;A0A3UKZOIRLT
MS6BTS3_62Y!ZHIY7[N4+4]:T'8]%K19-_P!ZP^D2P57Y8Q<7A^\P@3OJW>N^
M*=P7NLY[,">[$87K>? U7<:HO\D@LPV:-+K)W(W,B*G\HFOX&\7MO<2]/3^M
M]T\L=D\QK5+[&F;HQV?M%*R(V"$@)*N5*%:45F6U;%V=)YAXN0KSI^GG$B1+
MO\FKW*!,]T=2!42LF?>C8C$LLL3K\"$^GA?"Q62/5ZVVVKU,G"IH):>C1*<E
MN4EJWKSSY07WDCJN%V#8YS1'&U BU5U[3:>]EW+V A+9F-<M&D@=E%*H,WA(
MEA%+2.61%'CUT10[?$E*Y(H4CIV(U]F5W35>(C+0K+,LE0]7L1<C>DB=&8F^
M@H*#J\+$UJLPT57:[ 1K*&@H""CFD1"PL1&MTV<=%1,5'HMV,;&L&B)$D$$4
MR)))EP4I<%QC @*JJMJY54GHB(EB9$0^J.#D             - NH1T_M?=0
MK7VJ]?WZ?/5VFL]UT[:N9%M )3KJ=K\.E(QMQU[G!Y:&-&,KS R9T#/"G6\$
M<(H+Y;N,)=Z-)IJEU,Y7-2VUMG87J$:IIFU+6M<MB(Y%[*=4WX001;(HMFR*
M3=NW2300003(DB@BD3":2**2>"D323(7!2E+C&,8QV8$8DF@-2Z>VMZ?U$=F
M=0N/FN[MNRM-Q&LW=&-7TBM(NSM%H)C,;':V+V6/DTA-5"IQD7X(2/1RE@KI
M8SA7+O)$I*U+EIDIOXJ.MM];21FTS&U*U*<*MLL]?0AM'R%U.7?6@MX:,//&
MJQ-SZ?V7J<]G+&8FC5PNQ:7-5 T\6'R_BL2QHC$QX1AMETV[_P![[COJ?==W
MBC&_5R-DX;KD70MI6E9K(W1VV7FJFE+"MQ2_5Q^0.MX)*KZ[ZMFXZ%6D'#EV
MC7:7J>[5:"1=O#]\=NDHF#Y4,6";ATICNE#X3P8YOJFSG(NCL3B>MKH6JO&J
M?FEK;A<K$L;,Y$XD7\XWKX-=)WD+Q(Y PFY]@]2G=?)&L1=?L\*\U/;JY<HJ
MO32\_&F8LW\@YG]\;%8Y]A'.2NDB8CN^973)G"I,8S@T>HK(IH[C8FM6WA2S
ML(2*>CEADUCI7/2S@6WLJ8BYB]"Z\\F.9^T^9.M^=UOXX679;2FL?8>EZIF'
MLW!-*KK:FZ[=-4KW [TH+]\TG$Z>1THEX&@4F5N]9[Y@F#F[P5[8H$@?&CD2
MWA7C5>"Q<Y3GP]TLZSLD5BK9P)Q(G#:F8P[^@$Y=_P"=!R/\BMF__3:#OY1@
M^09I3\TZ>3I_EWZ%_.)CN67"MURMX(6+A9/;?EXB2LE+U-69+=$G6L6V:?R^
MK[71+<I:9:M+62%S)O;5(TGM=$S*)F(9X<^%39+CNH4,^IJ$G1N1%7)P<-J>
MN3IH-=3K KLJHF7U+%]8S%Q&X_I\5>-.F..R5K/>2ZBI$;3\V]2$+6S6%1D9
M95:3Q EE9W$01PLN;)4/#'64R]F,JGS^VSTFDUTKI;++R\!WACU,38K;;J66
MD:\9T;V6IN?S;G!Q/Y#O>.$/.2C9_M;0,9J]*U4O83*3E</MA5MM(DV#5FM8
MK%V323639YBGY(:5+X:SR3O;=!O*6NOT^HF;>7I+;E3-TNERD5*%&5/A$+KJ
M=-+,BY^GDMY";,0">0V\T.CCKSDKO!MRKTCO+9W#KE*1!%"4VQJ?*[EK95&T
M:E#-Y.>K[.?J,KB:+#-TV2R["78)O6>,INTG&<X/B=!6NBCU,C4?%F7H7K$&
M>A;+)KHW*R;.G0G7/ :!Z(=;K.^*CR8YC<J=Q\[-NZ[<,GE 6V@DZA*777T.
M_P 2=>>YK<E;;_+O#5V0+ATU:XEDHSPS)EE6BI\X[GM)7JL:Q0L;&Q>&S^!#
MK'0(DB2SO=(]."W@ZZ]<G1%O+@           !'[;.GQKBW=1#6O4*?S)26W
M7&F9?6+6C8KJ"C23LSIQ-M(?9#BQFE2G2DH6HVJ2BO!<L%3*E.V5*X2\%[VK
M)2I<E,M-_%5UMOK:2,ZF:ZI2I7A1MEGKZ#?U=!%RBLV<HI.&[A)1!=!=,BJ*
MZ*I,IJHK)*8,11)0ALE,4V,XSC/9D1B2:"]/3I^:]Z>6O-I:\H%@5M+/96Z;
MAM,LD[@R0KV#KTNE'1E-U]DWLQ-*RS2CP,81 KTZB.7CE9=QANW[[WHLFIJ7
M5+D<Y++&HG97JD:FIFTS5:U;45RKV$ZAYSJB=/<O4GX_U+1AMN&TQFJ[@K^V
M"6G%#QL3#TT%3+_4,P)H/-RHW>"NB7K+CPG#P_>\M<$[T;OG=$YI*GP619+M
MZUMG#9TT7,N8XJZ;PJ-([UVQUO!;TE3.F<B>:>K\\L(]HU8,.LMR'9,63=%H
MS9M*'LELT:-&R946[5JW1Y9$10;H(DP0A"8P4A<8QC&,8$ORC"O^H;I3\TA^
M39DR).[0OYQ+-TZ.#FU^$-5V97=I\P=C\N'-\L$%-0\GL&*GXCQ)0B(UXQ>,
M(A"P[+V:Z4]FU'*:C@Y'+9/_ +.GCO6<XR?,.IJ&3JBL8C+$Z73Y$)E+3OIT
M5'O5]J]/I<JD6FRO5[MHV3D7R"Y!:KZD6P=$O=_;8V)LR6@J%J*PQKN.;WV[
MS=U3K$A9*YR*J:ME:P3F:,DFLJT;E5R3OF$4\FR7$QN),2)L;XD==1$RKF2S
MFJ1'X:]972LE5MYRKD3.MO.0_;4N@]RTK5JK-B<]9'D?*MH"P0TTXC/$_8J'
MLDA%239\JP[^[Y2RC5'PQ-#*?=JMG*9>Z[3)*8[29X7$(514U#>#B_-"8=,B
MHNO?D7,OYQ(EU$^F@TY^["XC7UQN5QJH_%B^6*X^Q:-!3NI;VTLDWK"9=Q'A
MA[E5,UAPAG6B::;KO4B7_M9C90SWO&#1J:J\&:]MVV^EG#99P\7&2JFE\)<Q
MUZRXMO!;;P<?$2'[.UG0]RZ^N&J]GUB,N5 OD$^K=JK4PCWYC*1,@EE-5,V2
MY(LV=('[E5NX1,FX:N$R+(G(J0ARQF/<QR/8MCD4DO8V1JL>EK50C!Z;O2[M
M_3BNVVFU1Y76'97';8KJ3E('0=CUJE%GI-B/*,LP=H0OB>P)=*0G6E6:YBY)
M1M"1B4SC"*ZJ:9FR!"2ZJK;5-2UB)(G3MX>I9Z^0B4M(M*YUUZK$O2LX.K;Z
MV4EX$(FD8MXZ<"=SZG^G.I%YXSQIM2ZTE->^9KS?E>%GU)*F;4IWLSYPO'5K
MF*(BCLSO_@OL&YR8S+N>_8PMVI2FU5VD=2W?=+;;;QHO!9Q9R(ZEO5;:J][E
M+++.)4X;>/,>9YX=)?5?-+8U6W]7ML;6XV<F:5%,X*O[IU1-O$7V8>.4?+1C
M62ARR42N1Q%*2;CP=W%OXIWW*QB+*+$PF5/M3UCX&K&J(Z)>DIQ44;)W)(CG
M,E3IH:EUSH+K;#V13K[SUYU;XYQ1E!>D>UO7]MCW]-IZA4U4G!HR;1D]A;*D
M%HA\N0V7B<:O%+.R]P117)"F*>LN(76JVGC;&J]-.'K(44PZ\Y'5$CI$3I+D
M3KJ6#&C1I'M&K!@U;LF+)NBT9LVB*;9HT:-DRHMVK5NB4B*#=!$F"$(3&"D+
MC&,8QC MO"7+@R(?H         !^"4BXZ;C)&%EV;>1B9=@[BY2/=IE6:/XY
M^W4:/6;I$^,E5;NFRIB'+GZABFS@<HJHMJ<(5$5+%X#1OIU\"Z1T[]"/M(4V
MS+W=29V)<-@SUR>0*5=?R[F?<MV4$Q<L$Y:<S_\ @U4(F.CLJ^$F*Z6;*.2I
MH=_RBG7J:AU3)K')9D1.CJD>EIVTT>K:MN55MZ.(_P ]1;@31^HEH6.TC<[,
MXHZD)L:G[#@+BQ@R6!]$.H!=TPGF"$>:7@N[+9:?,2,=A3+G!&J[A)UE)?+<
MJ)U-4.II-8U+<BIT=4XJJ9M5'JW+9E1;>CB-YHN+CH2,CH6(9MXZ)B&#2+BX
M]HF5%HPCF#=-HR9M428P5)NU;)%(0N/J%*7&!0555;5X22B(B6)P%?7F+T+K
MSR8YG[3YDZWYW6_CA9=EM*:Q]AZ7JF8>S<$TJNMJ;KMTU2O<#O2@OWS2<3IY
M'2B7@:!296[UGOF"8.:XP5[8H$@?&CD2WA7C5>"Q<Y;)\/=+.L[)%8JV<"<2
M)PVIF,._H!.7?^=!R/\ (K9O_P!-H._E&#Y!FE/S3IY.G^7?H7\XDJZ@?32?
M<\^(6F^+<SR!DZ9+ZIN.NKG(;:EZ%G84M>9.BZSN6O'R\O GO51.VD+0M<%)
M)=S[(KY363R3)5.^94+%IJKP>9TR-M145++;++51<RYB54TJU$#85=8J*BVV
M6VV(J9TSD9K3U?GEA'M&K!AUEN0[)BR;HM&;-I0]DMFC1HV3*BW:M6Z/+(B*
M#=!$F"$(3&"D+C&,8QC E>485_U#=*?FD7R;,F1)W:%_.)9NG1P<VOPAJNS*
M[M/F#L?EPYOE@@IJ'D]@Q4_$>)*$1&O&+QA$(6'9>S72GLVHY34<'(Y;)_\
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MVY,K*V2R2)6Y,+/7BJJV4TTTBY*BDDF2/++),^_(MKB3%%'"RY&EC3.HIE0
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M6V'3GO'?.X[ZIW/=YIR/UDCI."\Y5TK:58F:N-L=MMUJ)H2PS .AW
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MWA4:1WKMCK>"WI*F=,Y)"(I*
M                                                    "H%ZZM]%
MEH/Y_P#JS\W7E4 )ONBE]$?TY?F@:/\ O)BP!)^
M
M
M
M
M
M
M
M                         -;N47$'C1S5H$1JSE3IRH;NU[ W"/O\/5+H
M@\<1<?<HJ%L%=CK"W*Q>,5BR#2$M4BV+G)\E[V[4QG'U<9P!E75VL*!I775*
MU)JJK1='UMKFMQ50H]/A$U4HBM5F#:ILHF&C4UE5E2,V+1(J9,&.;."X^KG(
M ]X
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*A3-G<C]"ZYN#HQ2M:G?-P:]J%E<F-WO!2H05@L4?*+&-E8G9@J6>WNL?^W
MJ-AE>EYC7*WB15*;IHF+=>YJ.S*J(9MC9*.F8]E+1#]E*Q4DU0>QTG&ND'T>
M_9.4RK-G;)XU45;.FKA(^#$4(8Q#ESC.,YP.BHJ+8O"5$5%2U. _:.
M
M                    8IVKO?1^B6$3*[OW+JG3<9/NUX^"D=J[$J&O&$T_
M:HE<NF42\MTQ$-Y%VV;FPHHFB8YR$S@V<8Q]4=V1R2+9&U7+Q(J]8Z/DCCRR
M.:U%SJB=<PE^D.X _P".7AY_S,Z6^&PJ>#5/R;_R5[!3\)IOE&?E)V1^D.X
M_P".7AY_S,Z6^&P>#5/R;_R5[ \)IOE&?E)V3876VU=7[EK*=UU!LB@[5IJK
MUW&I6W6UPKUYK*LBP,0KY@G/5B1E(H[UD90N%DL*Y43R;'=8QVX%)S'L6Z]%
M1V94L*K'LD2\Q45N=%M/?#J=@
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MB7GM<B<:*A3;-$];K'-5W$J*9X%,J
M
M
M
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MW6:%0Z-\SG1)9&JY"13MD9"ULRVR(F53;D42L
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M)3*:!<8HULD,LZN@2QEF:RU<]A6HHYXX+LZVOMSVV)FM)/A$)8
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M\EG32SV.,L@BUET
M
M
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M2<3T%1 V^Y$5B=-.A%.8*^GJ'7&JJ/S+T^NA+J(1-
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M[D[5VGC*C=99/]N(<T$L#KDJ6*389XJAE^);4ZQM"*15
M
M
M
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M8ZU\\S*I[6O<C<F1%6S@0[T$$+Z1CW,:KLN542WW2F@WK8/_ -8/_P#-+_\
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MV[1Q/P;&57;-SJYRJ9%!5WDA,F_;9+C';]46%Z77*W,I?VK>:CLZ'M!U.P
M
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M+):)DR^ZR+I3*G1F+;A]L5:^%/<Y4T+D+NXL)?@
M
M
M
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M.X
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M%EIOG,?PV]="]U/S:3X#NLI6X]4^_P#K^/\ Y6O_ *(P7/&/]7_I?R2UX/\
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M_E<GQ?:KZL9\%G6+#2?6<GJOZY=E%B+\
M
M
M
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M1;M6K=$I$4&Z"),$(0F,%(7&,8QC&!TX3OP9$/T
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M.)$3K'RWO'3CY)[3;;SD=$Z:D-V,SM56>X7NL*2ZVFT48Q>(-DHVV"O!J6U
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M61S;CG.5B=*U;-!T2*)KK[6M1Z].Q+=)F4=#N
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MJ"#A5RT2=M5'":1';8RO=8WI&DJIW-5L1?4*:2QK(L2+W1$M5/5,S#H5
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MILEK/@E9&DSDLC=P+D_A*+*B%\BPL6V1O"F7^ VL%$K
M:I\I>;O%SA7'4F6Y-[4:ZOC]B2\C!TYPXJUYM/LO(Q*#-S)D,E1ZQ9EXUJQ1
MD$3*N794&Q.^EQE3MSV"M#!+.JI$EJIP\'KE&:HA@L65;+>#A]8VL%$K  ?
MM=H@:15[)=+5(I0]7J$!,6BR2ZZ:ZJ,7 P$<XEIB162:I+N54F,>T45,5,AU
M#8+V%+G/9@<HBN5&IPJIPY4:BN=P(AA'C!RUX]\S->R.U>->PTME4.)MDC1I
M*<3K5QJ9V5JB8N$FG\0O$7FO5B<*JA%6-DOA3P;O)R."]P<V<&QBI+#) ZY*
MECK+>DO6*<4T4[;\2VMMLZ?KFQHI%4^0UL$"^EI6 8S<0\G8(C%6<A6LDS<2
MT,G*(F<1JDK&HK'>1Q)% F3H96(3"Q,9R3MQCM'-BHEMF13BU+;.F?7'!R
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M@SETB3.<=S@W=9QC/5]#51L5[VV-3ARIV3LRNI9'HQCK7KP9%[!)R(A+
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M;'(Y:HG[M'.<8R7)3921OB>L<B6/01R,E8DD:VL4RX.AW
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MCO(XDB@3)T,K$)A8F,Y)VXQVCFQ42VS(IQ:EMG3/KC@Y
M
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MK"_UB=33^6F@OX<Y-B\XM[F+U%_DEFPGW4OJI_*+:XLQ>0 *E'6,^FYZ2?\
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M3K%HQ2)41M4SW35L7UEZB]<L#<0>1M:Y;\9],\BJKX.E'[1I,;-R$<V5[\G
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MU_S-_J)UT/%] SZ)CBA_;K^<KN,<XC\\?U.U0XP[YFSJ]LI,*(1-
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MUEIVTZM1$;9E]1+/X2'%1I%4OJ$<JWK<GJY>KQ$KPADP
M
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MAA G:<QC#M'_ ,90+'_K8^#J<&E,AUD_X+$$D_U,G#U>'0N4M <L^2M&X?\
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MBO@YBKI/!J.JB<ZEM;(U.!?9MX>(X\*K*65K:NQT;NFEGK6<'&6SA9R\@
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MM5RHO2*U-53:Y:6J1-:B9%3ID#^TM7=43]-Y0*-_Q'Z7_P".>5JMDD-5[FQ
MQ)=:UK7YM3;2DT(.:B<Z)48*R9-9-96.R92K21_#'*9O"3&QATE<&/I/ %==
M=X/;E3IVVIQY^,MSV5?AZ-OM\(LR+TK+%XLUO2+76M:IU,:%P:O4+LG9VE-U
M<\VR-O>T.W-(MJPU9(F6?-U:I#R#.-H^F6B3IM%%62[ZI'(HD=&3.L==,I\9
MM#G4KJA%:CFT_33I]=2\,;5-IU1ZM=49;%Z7%TD(0N2N[^O[PPUM8>56V>1_
M$F^:^U]+U<NPM'T^OTZ:D*NUL]LB*G%$L"#34E0LJ<8]FY=JU.=G:UG*97>#
M8SC.,F)/BCPZ=VI8UZ.7@5;<UN?UB!+)B4#%F>YBM2RU,F?U$ZY)#U*-QQW(
M;H:[4WM$LCQ;';_'K3.Q4XE4W=K0RMNMVM)IU"K*=N2JKP[MX=L<Y<F(<R6<
ME,8N<9S%I6+'7I&O"URIH1255/27#UD3^,U%TJA[3H&?1,<4/[=?SE=QCKB/
MSQ_4[5#MAWS-G5[93VG6V^BSY>_R+J7Y4:(.*#YVSU5ZRG-?\S?ZB=="O3TT
MYGKB[.X2:NI'!TNHM*: U2KL&/JFR;W$U)6Q;?F9;9USN=I;Q>+[ ;";.F$-
M/65>**Y;14:P*HS.EEX=RDX*E<:I*!DZNJ+SI'69$Z61$Z5A;:5<0? C:>ZV
M-+<J]/*J].WK$Q_2#ZD^]N4%VWUQ)YC5"*JO*KC<X<JSKZ$CF\,WM,'%V#%2
MLGLQ#,'3J&:S]8LJ[4F7<88L7),Y!!1!(F$S*+PJVECB:V:!;87$ZBJI)G.A
MG2R9O+TC".\.H-SXYD\PML<+.E876= C>/:K^+W)R2VDSCI5@TL\3+J0$FSA
MF\M7[M$M(1O86SB-0*G 34A)K-5G27>&B1CF[QTU/! D]7:JNX&IT)UT*<E3
M4SSK!1V(C>%R]"]93^W&[J <^>+7-W6G KJB%UM?5M\-&Q=,\A]9QS&)8RUA
MDWDA&0;!\G"U^FP\G%34_'^Q&$,P$/*1[YPW57(JT<$4*EIJ:6G6HI+4N\+5
MZ%]7A415-1#4)35=BWN!R=">IP(>2YY=2KJ :5ZG,KPZXI5>K;?7V;H^FQVI
M-8V2#@$&M6V9-%>V6<V:K/I$@YR62B*G!O\ OS*2F$89NB7#I0F,-U"+]J>E
MIGTFOF54L<MJ\6;H2TXJ:JICJ]1"B.M:EB<>?H6PUZW)SRZW/2\G]?;2YSHZ
M?Y":+V-/N:ZK!U5K1:\2%FLQ+B63K$?;J/1ZQ+P%BPS;+.&RD@SG&3I)FX)@
M^38[X2HRGH*M%93WFR(G'ZZKZQ2DJ*^D5'U%UT:KQ==$[)Z':?)#UB.!TY)\
M[56.C*!HR(KN-GNN/K.!H$].1>K544IU*?L"<G'2-T5:,:VH5=\FA:&DJDAW
MPYF:"A<II\,BPU9/!_;+);9;EX>MR'+Y<31GA'M4C1+;N3@Z_*32\>.I1K+:
M/3CC^H-L-F:FUN H=DFMHUN%PK*+Q%QI$J]K$[7*ZDX.FJ[-8K$R3Q#)KJER
M9&0;875+G)SX@R4KV57@S<JJN3U%Z,I.BJF/I?"79$1,OJIT9"'#7'*#K]=0
M:"<\D>*,1IGCAQ_<S$KYN*=;&%*?R.PHB(=':G0+/;!J%HF;!C#E$[566;IU
MF.<NDU<-^]X3/@DU\6'4RZJ:\Z3I\.319ZY"9-B52FMANMCZ2+9ETHOK$CG2
MGZF&Q.7,YM[C/RGULUT[S'XZ]R:^5ADV=QL9;ZZA((03ZT1\&]=2#B$D(68=
MM$9%)-RYCW&)%H[8JY0<]X;1JRE;"C98EO0.X.(E4=4Z9713)=G;P\9@KG#S
MZYK[(YP_HU^FFCKZO[5JE.:7/<N[-@,V$K'4-)[$1\SEFV:S4198%O$0\7:(
M<SMS[$33M>2D$FB3=/**_?:E/3P-I_"JJU6*MB(G3Z/50IU%3.^H\%I;$>B6
MJJ]+HR=)34#CIR#ZQT!U1=8<%^8G,>L5E5T2,VBFRA]':+GZCO\ UQ7%G5EL
M53J%IA=7T>T5SQQJ]3G6:4BH1D[8.&#C_18632(I6EBHEI%J(&*O2X5M1>/*
MO!D*$4M<E6E/.]$Z? EBIF3(G#E/YVG_ -5GK?\ D6^_,9OHY3ZH7U?Y:!?K
MA/4_D*;^=2CJ9;^UIR$UWP"X!ZUBMG\N=C1K6;GYFQM#/J[K&!DD%7L;V1[A
MS&Q+B5/"MEI5](23DD5#1I$C*).CN<X:QJ6EC?$M14+9"G*2:JKD9*E-3);,
MO)T<AI'<.;G6HZ9$K2-G=06 UMR5XSVVRM8"Y6#6L34(^=UV:341,BW92]'J
MU":1DPDEA3+(DQ'O(Z443,T\-065273KM@H:I%93*K943);;ETVD=U17TBH^
MIL?$JY;+,FBSE,=>L_W"M[#T7P$O]-E6\[4+P^V7<*K-M.Z\$F*W9J?K":@Y
M5MW92'\'D(QZDL3MQC/<GQVXP.^$M5LDC7<*6)USIBSD='&YON5M7D0R1MC:
M7K(W&&IS7*/93S06Q-7TQ@K;MA:4KD%K633I]2BL%>3CM^: @JY>7D;'L4CF
M<JQ=FEEVR'=KFQWI,ZA.C&87*[5-O(Y<B+ER^MI0[O?BD3=<^ZK$RJF3(G7T
M*I,1IGGQ$\JNF]>N96HFYJE:X72VW9A]7) B$P:@[;UQ39I^^AEC.FQ&<[&L
MY=F@[:*G2*5Y'.$#JI)G.HB2$^F6&J2!^5%<G515)S*E)J59V9'75ZBHAIST
M=.;W)?E1TZ>1N^=];!;WS:NMMF;DKM6M&:?2:N5O$5/2>MKQ MG<'3*[7:Z\
M,RG[*[/E0[3OBJ9RD4,;!<"O6T\454V.-+&*B=->FJITRA0U$LU,Z21;7HJ]
M),R+TB-7B#SUZ[/45U1'0G&;S357S7&E*]M+E/=ZS1HTMYNKYZXGXF%;0SZI
M2]*8RL)49%@BLSA:PXPEVINGBZ.'K=(2IZ?#Z9]LMY;>!J6Y$TV\.=2)!48A
M5,LBNI9PN6S*NBS@S(;T]-+J6<P)'F;?>F[U$X"M8WU 0[^7IE\K,7#0JTV\
MA:ZSM[N)F&E9PVJ4O&V*BN,S47(1S1CWM-!5)=(YE2>#QZJE@2!*JF5=7TTZ
M./(2*6JG6=:6J1-8G O+ZG!E+&8MA=  (>NOG]$QRO\ ["OSE=.";AWSQG5[
M52%B/S-_4[9" 7IR4+KXS7#/3DGPKW9K&H\9G/G"\VE>L,5H5S,1_>=J7AO<
MO#%[IJ2SV4_A=_2E5T_"7R_8DJ7"?<)8(F2XU+L.2=R3M59<EO#F2S@7,6VE
M;B*P-6!R)%ELX,ZV\*9S-W)G7'K(C'C?R">[SW]J29TFSTCM=UN&(C8;CBE(
MRNK&]#GEM@QK!6#TI%3:;U]4B.TDC,W39UA0V,I*IJ=R?'2)V%ZUNK:NLO)9
M[KAMR=/.5)68HD3M8YNKNK;[G@LR]+,;D^JY_(!V_P#/#O\ ^1;C\*&+?.6_
M 3KJ5\(^;.^&O60@[Z4$/U/+)?\ FO =-^UZPH!WMRH;G<5XV,VJ3U6)RRG-
MQYUY'P+2UUNZHJ&E^_SF')DX=U@O>4N[40[2=\GUBTB-8M4BKD6Q$MXK<W%T
MRWT:5:ND2E5$RI:J]6S/Q](G(X6=3'FKJCF; =//JE4^L,-E;%CT'>H=QU-E
M!L6UG?OTWA:\A*)4TQ*?+5^Y+PCQJR>L6<>Y8RY/!'C;'=G,S@3TL#X%J:15
MNIPHOLY<A<(*N=D_@U6B7UX%3V,F4W>ZG?21TMU(X*&G96;=ZNWQ2H=:%I.V
M(J.3F$5X0SI>1)4KQ73NH_QCK24@Z66;92<MGD>NX5414R11=!:/25CZ5;$R
MQKPIV"15T4=4EJY)$X%[) ?)[EZS/0]>0S;<JK?E-P_923"O1<[,2TE=*>UC
MCN%4XZ'B;RY10V3J2<,TR5%FSETEX0JF,(M4794L9Q<490U_N/:3Z.3@7J92
MW*^NP_W?MX-*:>%.KD+-.L=V5SJ3\%Y&_P#';95JTPYWGKBX5.$O$<GWV_:2
MORC:0K<BJ=K$S<*N:P4J>)E5$S:09'=(E2<-W")5DE<6I\:TM1=E1'75X.DJ
M>R75DB55/>B56WD5+>FB^P12?H3.?W^>YS#^PMT__3A"9X?3?L[.3\TA^ 5/
M[0_E_.)+NGSPLWWP\9;5;;RYT[AYK*[ =4Q>LK[80MB/FW3K*5G3ETH#-MVO
MM5X?QM-/-LNL)+M$\>QJ/^C.;.38BU,\<]FKC;'9;P69=")P$JF@D@1=9(Z2
MVSAZ6E5X21H12408]3SHD:TYWVTF^=97A71')MJWB$'MP28N)&IWTE?11;0*
MMLCX]TREHFRPS5J@@UFV"AETVR":2S=QA-#*$^DKWT[=6]+T6;-T9BWU= RH
M=K&+=ES])>C.1&1'4"ZM/1UO-5UOS\JCWD5Q^E9 D/ 7Y_+EL\E*1S!%$CE7
M76Z2D;2,E--F:>5\Q%Q0S)+)DSGN6A#]_$U::CK6J^G6[)F[*=@A)4UM"Y&U
M*7H\_87UE)<>K1U!-A:KZ;&M>7?"S9:%;7VQ>]4YJ]V4JM2L[CQ*NM;M$^Z9
M*P%VA;+!LI?OL2BW=D6:G7:*IJI=I%,9SB'1TS7U2PSI;=1<G&EF8FUM2YE*
MDT"V7E3+DX%MSF0=Q=3YAQ(Z77&KEWN! FPMS;IT/HR0K=5:$:0"6P-Q;"U+
M"7*;>O$XMH1G7*JP74=R#\[= J:")2MT"8560)GJRDUU6^%F2-KEZB(MAV?5
MI#2,F?ED<U,F=52W01G0^U/67+UKYERSK<9J%A1YB%2NT'Q?)2M>$M$K5':1
MY5B=K792)=[([\\B5"'2CEK<C.*$R0F&_A)N]YE*S"VNU*WKW!>M7AZW)814
M?BKFZY+MWANV)_#RVF2.N[<]G[$Z.NE[QNC6OF>VK:-O:;F+UK/V52F?%"?=
M5/8AG4;X:G^V)W9>Y6\'5R9PS[[X.L8RJ1S9Z8>UC:US6+>8C5L7/E0[8@Y[
MJ%KI$NO5R6IFR*8\?=62[U7BAP,X(=.6";[MYM7#B=QKK<I,0[:'LE6TL\2T
MM42RK5Z625/67U\@DFRBSXDH;$+74DSJRF3&35:8[I1M=-)45/M8$>[JY5Y.
M5>D=?#'-ACIZ5+U0K&]3(G+R)TR8U>B<EM?=-7D1$<N-XM=^;R?\=]Z3ELM<
M72Z71X" 4D-22Y<4>ML*16ZJQEX6NN6ZV22;IHF]?*KJ',5)+O2"4%'1.JFK
M"V['>3):J]/ARDV[*VE<DSKTEU>DB=+@R$5?JX>R*EIWI<<G-L7V1]B*3K7D
MEN.]6R2PGE91G7ZKQ_T3-2RR#<N<'=.L,F1\)(D_;K*9*0N,F-C EXFU7U;&
M-]TK43E4B86]K*1[W>Y1ZJNA#X&K^4'7 ZG3&U[_ .$]CT+Q-XV1-IG(#745
MLB,KT[:-C)0*A2.T'LG.:QVXL]E45C81<.4&]>BB.#&;HJJF;K*XY?%04ED<
MZ.?+9ELZ7*GKG#)L0J[9(%:R*W);T^1?60WWZ4_4?V]R>N>^.)O+FCP>O^7O
M&1^NC;T:RB9I7[M76,UXM24XTCROI1JRDH*:4:$=*M7!XV00DVKEE@J1SIIQ
MZRE9$ULT*VPOY"11U3Y7.AF1$G9P\9-4()/.?3TG[AU(T-J<QM5].FJ4/$]L
M:UU&5VEM_8C%DX@M3Q%,GML-:OA%Q.'=U[$E:WEQ>=[;*1<P]<)QIS(-N](N
M54_HZQM+<8^I5;$1;$3IVV=CB/FZ-U5?>RE1+55+57I66]GC)G.,740ZC'%_
MGCK/@IU04*3>4M]I1C76.WJ=#5>(4+-V!V_BJFY8/*1#U2MSM=F+-'GAWC-S
M$,I9D[51<9-WCL(Y@RTU++3K44EJ7>%%]GLDZ*IJH:A*>KL6]P*G)P6>IP&X
M_5!ZDVW>/NU-+\*>&E%@MB\RN0I&3V!\:<)K577]7DY*3B(^8?-5)"+9O)J2
M<0D@LGEXY381C./4=NR*I&33/1I*5DC'3SK9 WE*]75/C>V"!+9W<AH-MCE?
MUM>ER:C;QYPV;17+#C9:+C$5:\LM90T##V*@&F$W;I%DPE(/6.GW$=-+MV*V
M&CEXWG8A5=(K959%5PBIF0R&@J[8X$<R5$R6]/E7UB,^:OI+)*A6OB5;%LZ7
M(GKH;>]87J4;3XAZ;X4\B>-%@BI>C;6V9#66RQ#^&AG+':VI75,:W%G6LRDU
M"2TI4F]EC7I#8?QQ4)!L8Q#%-G!3)GHT5*R9\D<J>V1-"VV%>MJGPQQRQ+[5
M5TI9;U#2';>^/6.M;ZOL'-6T--(TS4E7B%]@6/C@A5]?RDK5Z&@8CYR\GV3F
M->; \"B(@_?WJ25OQ*MVZ:AE$DSD,4E=D>&/>D"7E>N2]EX>MR$=\F*-8LZW
M48F6[DX.ORGV=>\V.N!U,:<KN3@]3=*\9--5TJ<&F^M#^FVN;V/>8%DU5N$7
M#O\ 8-5LQ?8TTDXPDW-F(BFR!#82-(K+IK'3X=!04KKE0KGO7-TDZ7!T<1RV
M?$*MM^G1K&)ZBVKT^%/6ZIO]T;^H]MWF?%;WTOR?K,+5^37&&U-*Y>#0;%.(
M:V-@ZD)^ <KO(5NZ?1\=9ZQ9ZL[9RF&:A6*G?FQT$R8,<N(];2L@5KXE58GI
MD)-#5/G1T<R62L7*:=['ZC?4>Y[<D-O:#Z3==HU*U7HF25K]RY)["BX:02F9
MY!ZO&G<LU+G#6&LP\5)R+%T2)CDH:5E7K-J9^J9NF<S=O6;2TM/$V2L55>[@
M:GL=DH.JJJIE='1HB,;PN7V>Q:>\XI]2/G)H'F)1.!?51IE2Q8MR>!L])\A:
M2QCHJ$M5BD<%9PT2]Q7FS"I3\?9)HA8Q)1BQBY",EUT4G34Z#HBS;K-2P20+
M44BK8WA1>CH0[0U51'.E/6(EKN!R=%GLFX?5OZB-ZX14G3^OM!U"(OW*+D_=
M'&O].U^;34=1<:=)6&B7EB<,$WD>G(R>)^V1+*,:.'#=LNY=&55,HDV514HT
M=,VH<YTBV1,2U>CJ%>MJ74[6MC2V9ZV)T:"$3E]R!Z_7!UQIVS<E>7^MJGJK
M<EUCJ@[V!KG46A[Y ZJF98JDBK!VN.E]&5^:7=Q4$V>.R8:*R"+EM'+][=JJ
MDQ@\^&+#JB\D3%5[4X%54MY2!/)B5/=65Z(QRV6HB+9R'JO6:8JX07';IXPF
MP[BWV)?X8M_BKSL!I!L*PTO-PCZ-JMI9KBUK<7G,97F]FFD5WI&+;/>&A5\)
M)_M"8'7"E:LDJM2QN2Q,R6KD.<51R11(Y;79;5SK8F4G@ZHW40@^G9H-C>FE
M6+L+;VQI_P 1]+Z\5.]183EF,@5P_F)]>/34?>+M99JD56;MNY=/W*S=FD=#
MP@SIO;Z2F6IDNVV,1+54N-74I2QWK+7JMB(0\3NU?64]94)URQMD1I>Q46*A
M4+O8.+Z%,I3FT0M6(1&3D$W,# 1+#8WA4?%Y,9TR1MCN7;$*<N4>_D,7$U&8
M6]VI;>O<%ZU?X.0@J_%6-URW5;PW;$_AY;24O7_-FD\_NE3OGD)3XH]8?O>/
MO(*J; I"S\LHO1MA5_5\Z>=KV9,C=J619*LY!I(,7&4D5%HY\W.HDDJ8Z1(C
MH'4]8V-V7VR6+G2TEMJ&U-&Z5N1;KD5,RV%9?I U[K'6KBW?H_IXWK4.M=.Q
MF];1*62<O+.@/[+8MGGU]K%*9K;!*YTV_90C$JJWA5$U,LV*.5EU,8=9S@Y4
M[K6K1)*BU*.5]WI6\%JYE3C+51)7+"J4RM1E[IV<-B9T7B)WNF+U.N0>T.0^
MR>G_ ,_=?P^O.6VM(UW+Q$Q7VK5E%WQA&MFLM*QTDQB'\K7DIQ*O2K:5CWT4
MM[%2L5WPY2(G1+EU;ZJDC9$E33K;"O(7&DJY'RK35*63)RGFN"?/#E'NKK'\
MZN*&R-B-9[0NGJQN"1UM2$Z71HA2LO*/N+5=*A%BV>&KC"W3';!VAZ58L@_=
MD455P?&"Y(7LYJ*>*.BCF:G='*EJVKTT5?4.M/4325TD+UMC:BV)8G25$]4U
M5V7U+NJ;8^H5S X(\2*Q2=I6)I?(S&K)FU5RLL&''[7%5AV>+O,R#Y-O!QTP
MPF9.?C^U_9',CELYSAJU076>MT4ZS:6D2F943*J)9EXU7@Z$*3ZJK6I?3PHB
MK;DXDZ?0I^)?J)=5[IL<E=(TCJ;OM9[>T5O:<5BT[S2H*GQBE=8DD86-G)*L
M3-)K%!*9_05)YFZ>Q\Q%K&>L5C%17P<Q5TG@U'51.=2VMD:G OLV\/$<>%5E
M+*UM78Z-W32SUK.#C+9PLY>0
M
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MQ3H&)-4OJG9&(JKU5["%6O>L-,RE;E>J(G43)RJ*+ZK3QV6I-06V+R!WDVV
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M%C9PEDW9V=I*V![%:V!B*J*EN3)Q^Y.(Z*H9(CW3O<U%MLRY>+W2D^HMQ<0
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M_J=JA4P[YFSJ]LI,*(1-(.>5'2LYC;]W]L;;VMNKGR8X[TBZ2$4\@-,TAKM
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M*U%3R,HUC<JM>ZU>-+<B=:TQ?^A,Y_?Y[G,/["W3_P#3A#OX?3?L[.3\TZ^
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M.N,>YC]5?6+:XLQ>0
M
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M>1LD@Y9.B%4+@V,'(;&,XQD<(JM6U%L4Y5$<ECDM0PW0^*'%K5E@-;-8<:M
MZXM1UCN3V:AZ<UW4+ 9PID^5'!IFO5R.D3+'RJ;M/E3NL]UGMS]7([NFE>EC
MW.5.-54Z-AA8MYC&HO$B(9^%,J     'DKI0*)LB%4K>Q*54K[75C]\5@;I6
MX:TPJJG<'2[XI%SC)\Q.?O:AB]N4\Y[DV<?L9R.S7.:MK55%XCJYK7)8Y$5.
M,\#K'C7QSTFZ7?:9T#I34CUR11)R\UCJNBT)TX35P7"J:[BJP44LJ17!<=U@
MV<X-V8[1V?++)[MSG>JJJ=6111Y6-:U>)$0];LG56K]RUE2E;?UO0=JTU5ZT
MDE:ELFGUZ\UE618&.9B_4@;/'2D4=ZR,H;**N4LJ)Y-GN<X[<CJU[V+>8JH[
M.BV'9[&2)=>B*W,J6GJX2$AJU#1%<KD1&5^O5^,80D# PC!I%0T)#131)A%Q
M$1%L$D&,;&1K%!-%NW13(DBD0I"%P7&,#A555M7*JG*(B)8F1$,,/>*W&"2O
MGG3D>.&A7^SO"/"_..]T_KUU?/"^^G7\*\;UZZI8/"._*&/W?A'==T;.>WMR
M.^NENW+SKF:U;-!TU,2NOJUM_/8END]YLG56K]RUE2E;?UO0=JTU5ZTDE:EL
MFGUZ\UE618&.9B_4@;/'2D4=ZR,H;**N4LJ)Y-GN<X[<CJU[V+>8JH[.BV'9
M[&2)=>B*W,J6GH656K,966E*C:[!1]-CX)O5F%291$>TK+*LM(\D2UKK2!0;
MIQ3:";1296R;0B16Y&Y<)X)@F.P<6JJWE5;UO"<V(B743VN8Q=KGC-QOT]'6
MZ(U'Q]TCJR)V R:1M\B]<ZHH=(CKM',$)5JQ86YE68&,;61DS;3KY-))X59-
M--XN4N,864P;NZ65ZHKW.54X+55;/4.C8HF(J,:U$7AL1$M]4]5K'4.IM)UU
M6GZ:U?KO4E27DW,VO5]8TFM4*NK3+U!JV>2ZL)58R*C%)-VV8()JN,I954(B
M0IC9P0N,=7O?(MYZJY>-;3LQC(TNL1&MXDL/-[,XW\=]TOV$IN/0NE]LR<5W
MGV+D=F:MH][?QO@^5<H> .[3!2KAGWC*Q\D[V8O<Y.;L[.W(Y;+*Q+&.<B<2
MJAU?%%(MLC6N7C1%,H5^NU^IP[&NU:"AZU7XM(R$9!5^,90T/'(G547.BQC(
MY!LR:)&65,?)4R%QDQLY_9SD=5556U<JG=$1J6)D0^P.#DQ=KC1^E=..;2\U
M%J#5VJW=XD$9:ZNM<:_J='<W"5;J/E6\G:5ZS$Q:M@D$%9-R8BSO*RA3.%<X
MSC*A^WNZ21]B/<JV<%JVV'1L<;+;C42WAL1$M/\ -QT9I/8EPINPM@:>U9>K
M]KEVUD->WBXZ^J5GN%$?LI%"89O:;99N(?358=M)9JDZ248KH'3<IE4+G!RX
M-@V21K5:URHU>%$5;%]4.CC<Y'.:BN3@542U/4,ART3%3T8^A9R,CYJ'E&JS
M*3B99DVD8R19."937:/F#Q-9J[:KIYR4Z:A#$-C/9G&1U151;4X3LJ(J6+P&
M']><9.-NHYQW:-4<>]'ZQLK]5PN^L6O-3T*ESCU9V19-VL[EJW 1K]RJY3<*
M%4,=0V3E4-C/;@V>WNZ65Z6/<Y4XU53HV*)BVL:U%XD1#[NTM&:3WDPB(O=F
MGM6;AC(!^I*0,=M+7U2V"PA)-9'P=61B&=MB)=O&OU6_^C,LB4BAB?M<Y[/J
M#ADDD>6-RM5<RJAR^..1+)&HY$SHB]<R!-PD-98:7KECB(RP5ZP1C^$GH&;8
M-)6&FX:5:*L)2(EXM^DNQDHR28KJ(N&ZR9TEDCF(<N2YS@=4546U,BH=E1%2
MQ<J*>9UUK#6NH*LTH^I=>4;5U*8.'CMC3]=5* I-69.Y%P=W(.FE?K4?&1+=
MP_=*&56.1'!E5#9,;.<YSD<N>YZWGJJNSKE.&L8Q+K$1&YD2P^+3M&:3UW<+
MEL+7^GM646_;&=NI#85XIVOJE6+A>W[V17F'CVY66$B&,U9W;N6=*NE5'RZY
MU'*AE#9R<V39Y=)(YJ-<Y5:G BJMB>H<-CC:Y7-:B.7A5$2U?5/H[(U'JC<<
M(6M;>UCKW:E<(J9<E?V12ZW>(0BQL%*98L59XV48%5,4N,9-A/MSC&!PU[V+
M:Q51>);#E[&/2QZ(J<:6GT:+KS7^KJ\VJ.LZ-3M=U1F<RK2L46LPM1KS50Z:
M21U&T+ ,H^-0.9) A<Y*EC.2D+C]C& <YSUM>JJO'E#6M8EUB(B<60J3=5W7
M;;9O62T)I_B%LF_<9N7^XZ+%LMN[^B-G3FO:MFOXK4P:OQ;-&L$C+8_N)Z-1
MBMC$;RJ+*5SF-CRHY<Y56)>*-URA<^9$?"U<B66^Q9:N;.I9JQM^N:R!59.Y
M,JVV)V;;$ZR'TN:_"/J/]/+CY;>6E?ZS'(#:BFKW=<5=TC8TIL6$CIM*?L<3
M7$&T4SN.[]N5:R3!7<J10L>\C,$7134[%.ZQ@AN()Z6ID2%8&I;TTL]9$.9Z
M>JIHEF2=RV=);?752<GA9.T?J1<%^+N]^56B]4[$MTU 2<NM';&UC4K7%QMP
MK5FG:+)W2J1%HCIQO7"V_-7Q(H&:Y3SALZ3+CL+C!<0)T=2U#XX7*B(O254R
M<-G4)\"MJJ=DDS45UG31.'@M3U22\1268,C.+_&F%OAMIPW'C1D3LXS@KLVQ
MXS4M!87PSLJN%RNC6]K7TK!EP5<N#X/X1W6#X[>WM%1995;<5SKF:U;-!32&
M)'7T:V_GL2W29FDHV.F8Y_$2[!E*Q,JR=1LI%R35!]'24<^04:O6#]DZ35;/
M&3QLJ9-5)0IDU$S9*;&<9S@4T546U.$J*B*EB\!A&:XJ<7K'1*WJVP\;M"3V
MLJ9X1XGZZFM/:\E*)5/"W2CYUXMU%]75Z_!>$OECK*>"MTN[5/D^>TV<Y%1)
MID<KT>Y'+PK:MI36&%6HQ6MN)P)8EF@RY6*I5Z1!1]7I=;@*C6HE+*$77:Q#
MQT!!1J)CF4,C'Q,4V:,&:65#Y-DJ:9<9-G.?V<CHKE<MKE55.Z(C4L:B(AXV
MMZ/TK3K_ &G;%0U!JZJ[3O*"S:[;+K>OZG!W^X-G#EF\7;VFY1D2UL5@07>1
M[=4Y';E8IE$$S9QDQ"YQV621S48KE5B<"6Y$ZAU2.-KE>UJ(]>%;$M7JG^:]
MHS2=1V)9MOU33VK*QMFZM%X^Y;0KVOJE"[$MK!TYCGCEE9KM&Q#:RSS1P[AV
MBJB;IRJ0ZC5$V<9,D3)2R2.:C'.56)P):MB=0)'&URO1J(]>%;$M7JG^MG:/
MTKNUM!L]S:@U=MQI69!26K;79VOZG?FU>E54R)*R<&A:HF62B9!1),I3+-\)
MJ9*7&,Y[,8!DDD>5CE;;F6P/CCDLOM1UF=$4RB.AW
M
M
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M:Y5+DUK6-1K4L:B9#U@X.P
M
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MSG.;8YSGN5SEM<JER:UK&HUJ6-1,AZP<'8
M                                            @9Y.]"37VT=^6GD]
MQ>Y,;AX3;EO3V2E[A+:M\->PDC/S+SV3G9Z-:P=LU[:H)[9)8I7<@BA-99+N
M2]\(@D?)C&N$6(.9&D4K&R,3@MZ%ZQ;IL/:^1987NCD7AL_A3KG^^-'0AU?K
M/>=;Y+<H>1>X>;6YZ<]C):M3.V57*%>:SD,J9Y$3,I&S=DOUGGW4%*&\*8(N
MIL[)!?\ ;G06-C!L)<0<^-8HFMC8N;H3K"+#F,D265SI)$S]"]<GC%O+B
M
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MF,H?/:8YC&SG.;8YSGN5SEM<JER:UK&HUJ6-1,AZP<'8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
B                                          /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>sgmo-2022110322xex51opin001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sgmo-2022110322xex51opin001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHL@N@ ORLS$&/!SR,]_2N;T#XL'3[CQ.GB :G?)8ZO-$LEI9;TM+<-A3(R@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^9G=_9#=?3RCC],5PWPE_P"1INO^O)O_ $-*]/\ $$:1>$]4C10J+8RJJCH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M9A6!J7@OP_JLS37.G1B9CDO$3&2?4[2,_C6_10TGN.E6J4GS4Y-/R=CG=/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KA_'R+<:UX.M+L Z;-JX\]6^
MZ[K&[1*WJ"PZ>H%=Q6?K6B6'B#3)-.U*'S;=R&X8JR,#D,K#D,#R"* *WB"#
M0W73I];\I?(O8FLW=BI6X)P@4CG)SC'0]Z\Z@L]673_'^L6.OWE@;#4[R>""
M!(RC.D2,3)N4E@< 8R,8]Z[6Q\"6%OJ5K?WNI:MJTMH=UJNHW7FI"V,;@H !
M;'<Y-:">&-/CT[6K%?.\G6)9I;GY^=TJ!&V\<<#B@#DM7UZ?4+C28O[6U6%I
M],CNY+#0[3S)R[_QNY5@B=0!QDYY-9ND^)M>U?2=#T=]1N+:ZOM6N[*:^:.,
M3K# ';& "@D(4+D CJ>>M=C-X'L6N[>[M+_4K">*T2R9[2<*9HD^Z'RIY&3R
M,'GK3(_A]HD&B#2X#>0QQWC7MO,DY\ZWE/5D<\]SUSG)SF@#C+J#6M!UOQO-
M9ZM<7EY9:?874,LJH9'B1Y6:-\  DJ'&< X([\U:G^(5S:^+K_4FN!)X9%G-
M#;)@ -<10I.3GKRKNN/5*[/1?"%AHM[J%ZMQ>7EUJ$:1W4MY+YAD";L=@!PQ
M&!@8 XJ@OPU\.+X:L- ,,S6-C=B\BW298ODGYCCD88C'I0!S[>(M>\/.O]HW
M+75Q:^$Y=1GB=0 URK@\X X&2OTK<T73M;MO['U.Y\52W7VI0;RVNEC$4A9"
M0(0J@J0>@R<@'-;]QX?L+O67U2XC:29[)K!T8Y1HF8,01]1^59>F^!--TV\L
MI_MFI7<5AG[#;75SYD5MQMRHQDD*2 6)P.E '"?"O6[_ %*'0]$>6;2[.SLV
MN(D9!NU(^8P8ACT1#C(')R#TKK_BM_R3Z[_Z^;3_ -*8ZT(?!&D6VG:+9PFX
MC_L:7S;.99/WBYSN4G'*L"01CD5H>(=!M/$VB3Z5?-,EO,R,6A?:X*L'!![<
MJ* -2BN>TGPFNE7Z78U[7;O:"/)O+XR1G(QRN*U=+T]=*TV&R6YNKE8LXENI
M3)(V23\S'KUQ],4 >5:?_P 2GXF:EX@7Y8GUYM*NS_L300F,GZ2JH_X&:ET+
M_3_BKI?B)N3JT>H/"?\ IWC,4<7X$*7_ .!UW5WX+TB]T_6[*83F+6)Q<7.)
M,$. H!0XXQL4_45:A\,:;;WVDW<*.C:5:O:6R!OE$;!001WX1: . \-:E=ZO
MJ/PWO[^8S74UCJ+22$ %C^[';CM5'1;C6X/A[X0-FNK'2?L\QO/[&6-KH-O^
M0X<$E/O9VC/2O1=-\&Z5I7]B_9O/_P")/%-#:[GS\LN-V[CG[HQ51?A_I<%C
MIEO97>H6,VFQO#;W5M,%E\MSED8D$,"0#@CM0!8\$:F-4\.K+_:SZFT4TD33
M36WD2J0W"2)QAU! )P,]<<UT=9NAZ%9^'[%[6S,K^9*T\TTSEY)I&^\['N3_
M $K2H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ I&.U23T S2UEZYX?T_Q#;)#J$<SK&2R>5<R0\XQR48$_C0 _2-;M-:\
M/VVM6PE6TN(1.@=?G"XSR!GGZ5@^&/%]YXA\4:O8RZ7+86=K;P36PN4*S2!R
MX+,N?E!V#"D9[GK@)\/_  5!X3T*R62-QJ@MEBN6%U))&3U.U6;:.1V I^EP
M3+\4?$,[1.(7T^R59"IVL0TV0#WQD?G0!?\ %>O3:%I]L+.".>_OKE+2U25M
ML>]@26<CG:JJS''I6?IWB#6(+75KG5CIEY8V=J;F/4=-;$;%02\;(78AA@'.
M<$'L:J_$S2/[2T_1KN2SEO+/3]3CN+RWB0NSP;65_E'+ ;@2HZC-8=O;6=YK
M7B&_\-Z ;C1)-&\B>T6)K2*^N-Q(505'(3*E@/X@* -OPAX@\2:[)9S7E]X9
M:%X5FN;2S:0W,.Y<@$%B 02 <CUJG_PF^N_V'_PEWV?3_P#A&OM&WR-K_:?L
M_F>7YV_.W/\ %MV].^:HQKHVLZ_X5_X131Y+&YL9_,O9!8M;BWM_+8-"Y*C+
M,Q4 <]"?>L[=-_PK'_A7GV.\_M[=]@\O[,^SR_-SYV_&W9L^;.>O% 'JNMZG
M_8V@ZAJGDM/]CMI)_*3J^U2V!]<5RFC>*=<_MO0K35CI-Q#KEO)-"=/#AK?:
M@?YBS$.I!QN&WG''-;OC*/57\&:M'H9<:D;9A!L.&SWV_P"UC./?%>?Z79:.
MNOZ&? -A=65V@=-2DFMI418?+;Y9]X&Y_,VD8R<@]J .JUKQK+9^-='T#3[=
M)HYKH07]PV<0EHW=$7!^^0NX]<#']X5)K^K^*;275;JQM],M=,TV$2"2_P!Q
M-V0NYMI5@(P/NY(//;%<;>^&?&.CS>&+9+O2+IUU=IVN%LYBS3-%)NEF._D'
M)'&.=H' Q71>+-4T2^EO]%\6Z'=-%#A[!X899OM65ZQE%^60-D8)R.#G!H [
M+1]1&KZ)8:D(7A%W;QSB)_O)N4-@^XS7$Z;XM\0ZYJMQ'87WAB&W%[-!!;W+
M2?:98XY"A<*&[[3CBNF\&1ZM#X,TF/7&=M36W43ESEL]@Q[MC&??->;ZO'H^
MH>$[C0]-\*2:;XK>Y_<V\=JY>";S,B?[1M V8^;?GIQ[4 =;J7BG6;G6-2M=
M$ET:V@TZ06Y?4F;-W<% YC3#+MP&4$G/)Z<4GB#Q=J]@^@VD,>EZ9>W]O)<7
M8U67,=L$"94LC $[G !SS7.RZ9H.B>(?%:^*M&EOGU*7S[*7[$\XG1HP&CC*
MJ=CAP>.#]T]!Q:L$MM#L/"X\::";F:+2_*.IR1-<_9Y,C]TZA3@[<?/W((H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M!DYKEHK:[\+7]HEYJ%SI%S968TP7YTYKNVO+5&)B8%?]7*H)!W<9SP17KU%
M'C_AFPVZE9VNG7U]XDMH+Y[Q&EM&M8(7=B6FFE8'SI &.T*.O.!U'63^#=7A
M?5+71_$"V.EZI.]Q.GV8M/"S_P"L\F0. NXY/*G:3D5VE% ''/X1U?3M0OYO
M#FNQV4&H[6N([JU-PR2! AEC;>OS$*,[MP)&:BA\!2Z(=,N/#6I+:7=E9FR<
MWD!G2YC+;_G 92&WEFR#_$1C%=M10!Q</@%EBM)9]4,]^NLIJ]W<&' F=4*!
M%7/R* 0!R<8[YIH\&ZW8Q7NG:+XC6QTB[G>;9]DW7%MO;<ZQ2;P "22"5)7-
M=M10!YOXRTJT\2>+O#^B6[73W%H^=18QMM-GA7*.Y&&WND8P"3]ZNYN;.ZN=
M01C=I_9I@>.>T,()E9L8;?G( &1C'.:OT4 <5IO@W6;"'3M+/B0G0]/E1X8H
MK<QW#HARD3RA\%!P#A02!@U7?P!J2Z1/X;M]?2+PU.[DP?9,W"1.Q9H5EWXV
MG)&2I(!Q7>T4 <Y!X46WO/$<T=R FL111+&(_P#4!(O+ZY^;U[5%'X/,>G^$
MK7[=G_A'S&2WE?Z_;"T73/RYW9[],5U%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZUOY_/O(;6..>7.=\@4!FSWR<T 7Z*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@<AA\[9((4CZ5UE% ')V?A?6'U:+5=9UR&\O+.VD@L3%9>4D3. &E9=YW,<
M8! QGCFLSP]X&\2^'$,=MXMM)%EF,US))I ,MPQ.26<RY)[9[5W]% '!GP/X
MAB\4:EKUIXJM4N+QMJ&?21*T$(^[$K&484=\ 9/)KMK..XBLH([N=;BX5 )9
MECV!VQRP7)QD]LG%344 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF6UM;2-?,*+C<S;F55 R <GJ<#-.T33+VW\;^)=2GMS';7T=F('+*=Q1'##
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M>SE;RT*J9#&21EN05?:/]HCC'-7%\665C?Z]=ZA<WT$-C:6L\UK/$F+?S ^
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ K-UK6[;0K1+FZAO)4=Q&!:6KS
ML#@GE4!(''6M*JNIW\.E:5=ZC<'$%K"\\A_V54D_H* ,32O'>B:O>W=I$;RW
MFM+?[3.+RTD@$<?]XEP/?\CZ4_2/&NCZU?16=N;N*2XC,MJ;JUDA6Y0=6C+
M!A@@^N#GI7%WVFWD7P2\0:M<@MK&LVCW]XPZA6 (C'^RD?RX]CZUO>*3$^J^
M Q9%2YU,-%L_YX_9Y-V/;&/TH TV\>:$NIFS,ESL%S]D-Y]F?[,)\X\LRXV[
ML\=<9XSFJ'C'4O"4ETMCKEC/?S6:?:':VM9)6LT;C>SQC* @'OR!TKD?E'[-
MEPC?\?'E2(P_B^T?:#_X]O\ UKK?"95/%7CC[85$PO86D+?\\OLZ;?PX;]:
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MP_\ ^2=>&O\ L&6__HM:Z.@ HHHH **** $551 J*%51@ #  I:** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %<OXWU6]TJWT-K&<PM<ZU9VTI"@[HW?#+R.X_&N
MHKD?B%8ZA>Z7I4FFV$M]+9ZO:WCP1,JLR1MN;!8@9_&@#IK^^MM,T^XO[R41
M6UO&TLKD9VJ!DG ZU@:?XWM+W5;+3Y]+U73WOU8VDEY;A$GVKN(!#$@[<G#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !117.>*M7O=%N=!N('464^
MI1VEXK*#\LH*JV>V'V_G0!T=%<#>>+M2@^)D.GH8QH*2Q:?.2F6^U21/*N&]
M,!%QZM5ZU\6B'4/%%]J=TD.B:;<Q6<!V98RA 9.G+$LZJ .XH ["BL;1O%&G
M:W=36D NK>\A02/;7EL\$NP\!PK@97/&15#QSXBE\,V&EWBS+%#+JD$%RQ3?
M^Z8G=@=<X';F@#J**Y_3O&>C:@+_ #)<6;V$0FN8[ZW>W>.(@D/AP#MX//M4
M6G^.M&U&_M[-%OX9+I&>T-S8RPK<A1N/EEE ;CG'7% '2T5BCQ7H[>'[77%N
M2UC=/''"PC8L[N^Q5"XSG<<8QQ@^E4[[QYH.GWMQ;S2W+):N([JYBM9'@MV]
M)) I53R,\\=\4 =-12*P90RD%2,@@\$5R]W\0M LIYUE>\:WMYO(N+V.SE:V
MAD!P5:4+M&"0#S@=Z .IHK U?QEI&C7S64QN[BYCB$TT=G:R3F&,_P ;[ =H
MX/6LV#QU!>>.K/1K2.2?3[G3?M:74=M(RLQ9=IWXVA-I.3TW<9!XH [&BN9M
M/'V@7M[!!%-<^5<2^1;WCVLBVT\F<;4E(VDD@@<\XXS5+Q1\0--TBPUF*UDN
M'O+&WDW3QVDDD$$VPE%D<#:"3MX)[\XH [.BJ&B74M]H&G7<Y!FGM8I7(& 6
M903^IK&U#X@:#IUQ=1RM>R0V<GE7=U!92R06[]P\BJ5!&1GT[T =117/:KXT
MTC2;MK:3[9<RQPB>;[':23B&,YP[E 0H."?7 S6W9W=OJ%E!>6DJS6T\:R12
M+T92,@C\* )J*YO4_'6AZ3?7-K/)=2&TQ]KEM[226*UR,CS'52%XY]AUI=2\
M<:+IEVUJSW5U+'$LTWV*UDN!!&PR&<H"%!'/KCF@#HZ*R[?Q'I5W>6%M;7:S
M/?VS75L4!*R1+M!;/3^)>*IWGC70;"UNKFYO#'#:WPT^9C$QVS;0VW@<\,.1
M0!T%%<Y9^.-#NH]0:26XLFT^'[1<QWUM) Z1'.'VN 2IP>E2:5XPTK5KXV2"
M\M;GR3.D=[:26YDB! +KO R!D?3- &_17,V/CW0=0O;>WAEN1'=2&*UNI+61
M+>X?GY4D*[6/!QSSCC-2>$=7N]8AUAKQU8VNKW5I%M4#$:/A1[G'>@#HJ*Y6
M;Q<T/Q'C\--:S>0; W!F%M(1OW #Y\;0@7.6Z9XSGBGVGQ \/WEY!!%-<B*Y
ME\BVO'M9%MYY.FU)2NTDD''/..,T =/13)G,<,CJA=E4D(O5L=A7E^BZ]XJ\
M1Z)_;6E>)M*GU+:93X?^SH A!_U+,6#JW;<<#/M0!ZG16!J7BVQTF>"TN8+R
M7498!.UE9VSW,D:="6V @#.1GN1QFH9/'OAV+2M/U(WDC6VH.T5ML@D9WD7.
M4V ;@V5(QC.>* .EHKGK3QMH=UIFHW[W$MI'IIQ>1W<#PR09&1N1AGD=,=>U
M,T[QQHVI:I#IBF\MKZ:-I8X+NSD@9HU&2_S*./?V- '245RUO\0= NKJUBC>
M\$%W,(+:\>SE6WFD)P%60KM.2" >A[4V^^(OAW3[F[@FFNF^Q2^5>216<KQV
MQXYD8+A1SU^M '5T5S^F>--&U751IUO)<+,\330/-;211W$:XRT;, ' R.1V
M.>E5[7X@>'[R\@ABFN1#<R^1;WCVLBVTTF<;4E*[2200.<'MF@#J**@O([B:
MRGBM;@6]PZ$1S&,.(VQPVT]<>E>>QGQM)XWN/#O_  E\ 6+3X[WS_P"R4R=T
MC)MV[O\ 9SG/>@#TFBN C\=_V3XGU_2M7DNKM;!;8Q_8[!Y&53"&DD<(#M7<
M<\_0=*Z&\\8Z+9V6GW*SRW0U%-]G%:0/-).N 25103@ C).,=Z -ZBN<E\=^
M'H=#76);QTM#<?96W0N)(YO[C)C<K<="/3U%1OX\TA8;4K#J<MS<QM*EG'I\
MK7"HK%2S1A<J,C&3C/;- '3T5S4GC[P[%H]CJC7DAMKV9K>#;;R%VE&[,90#
M<&RI&,=>.]3VGC+1;JQU"[>XDM%TX WD=Y"T,D (R"RL <$=".O:@#>HK TK
MQCI.K7GV./[9;W)B,T<5Y:20-+&.K)O W#D=.1FI5\5:0^A6&M+<-]AOY(H[
M>3RVRS2,%3C&1DD=: -JBO/9?'KW'_"60-++I:Z3,B0WDFG2NJJ1'DL#@%BS
MG X^7#<CFNAU?QKH^C7TMG.;N:>",2W(M+22<6Z'HTA0$*, GGG'- '0T5S5
M[X\T*S<!9+J\7[.EU(]C:27"Q0L"5=R@(4$ D=\#-;]I=07UG!=VLJRV\\:R
M12*>&4C((_"@":BL#QOJMUH?@G6-4L65;JUMFDB9EW ,/;O4-YXVTK3+F+3[
MDW<^I-:QW/V:TM))G9&R-P" \ J<^G'J* .EHKGW\:Z"NA6>L)=O-;7K^7:K
M#"[RS/R"BQ@;BPP<C'&#FKFB:_8:_!-)9-*'MY/*G@GB:*6%\ X9& (X(/O0
M!J445FZUKMAH%K'/?22#SI!##%%$TDDKG.%1%!)/!Z#M0!I45CZ'XET[Q ]U
M%:?:(KFT95N+:ZMWAEBW#*DJP!P0#@]*RO'.IZM8OH%GI%ZEE-J.I+:O,\ E
MVJ8W;[I([J* .MHKAIM2\2^$]7TI=:U*UU?2]2NELC*EI]GEMY7SY9P&(921
M@]",BM2^\>:#I][<6\TMRR6CB.ZN8K622"V;TDD52JGD9YX[XH Z6BN4_P"$
MG^R^+];@OKN&+2+'3(+SS"!A=S2;FSW&%%26WCW1;BX,#)J%M(T#W$*W5C+%
MY\:#<QCW*-V!S@<^U '3T5B'Q;H@ET2,WHW:VI>P^4_O1M#9Z<<$=<=<5%=^
M,]$LTG+SRR/%>&Q\J&!Y)))PH8HBJ"6(!Y(X'.>E '045S4?CO06TK4-0EFG
MM8].9$O([FV>*6 L1MW(PS@Y'/2FCQ]HAL8;H"_)N)FAM[<6,OG3E0&)2/;N
M*X(.[&.>M '3T5G:-KEAK]F]S82.PCD,4L<D;1R1..JNC %2,C@CO4.M>)=.
MT&2WANC/+=7.[R+:U@>:63;]XA5!.!GD]* ->BN<;QUH TFWU!+F65;B9K>*
MWCMW:=Y5^]'Y0&X,,'((XI/^$\\/KHUUJLUW);P6DR0723P/') [$ !T(W#[
MPYQC'- '245RG_"Q-" M5*ZB+B[5VM[4Z?,)I=A .U-N>X/TR>QJV/&N@_V"
MVLF\9;9)OL[(T+B439QY7EXW;\_PXS^% '045SD'CG1);+4;B62YM6TV'S[J
MWNK62*:./!.[8PR0<'D9J)/B!H,EC]K1[UHWF$%NHLI2]RQ&X>4NW+C )R.,
M4 =117"Z]\1[2T\'ZOJFEPW#7VGE8I+6YLY4>%VY4R)@$*1SGH?6M6'Q+:_V
MQ=R7&HFWLX=-CO'M;FT:%H%+.#(S-@\[<;2,C;GO0!TM%<[I7C71]7OX;*$W
M<$]PADMA=VDD N4'),9=0&XYXYQS52'XD^&[AX#'/=FWFF%N+O['*(%E)VA&
MDV[0<^_>@#K:**\[U'QW>V7A'5/%$,9FMGOA:Z=$L#.HC63RVD8J,_,0Y&2!
M]P=3R >B45P7_"P$M?%^I65U%?26PL;6YM;:#3Y'G&_?YA90NY0,)G=C&<=3
M6]-XTT.+1[#4TNGN(=0XLTMH7DEG.,D*@&[(P<\<8YQ0!OT5FZ+KUAK]O++8
MR2;H9#%-#-$T4L+@9VNC $'!%9?B2^\1VUYLT?3Y+B#[,&+(4SYAFC4CYCU$
M9=AVR.<\"@#IJ*\^\7^+=<?Q=:>#/"26PU26 W-U>7(+):Q9P#CNQ]_4>O$_
MAR\\:Z3K=Y8^+7M+W2H[;[1'K$2+"J$=4=<C'&3G'&.O/ !W5%<9IOQ3\):K
MJL&GVU_+ON9#%;2R6\B13N.-J.1@G-.U?XH>%=$U"_L+N\G-U8;?M$<-M))L
M!&<Y Q@ C)SQG'6@#L:*Y&R^)GA74=8L=,M-0>66^'^C2"!Q%(<9*AR,;AW'
M8\'GBH-0^*_A+3;J^MIKVX>6PF,-T(K21Q$0<$L0N ,\9H [6BN:U?Q[X>T:
MVL)I[QYSJ$?FVD5K$TTDR8SN"J"<8[FHF^(WA=/"L?B5M1QI<DP@$GE-N$G]
MTKC(/']: .JHKD]/^)'AG4[N_MK:[F,ME;-=R![:1-\*\ETR/F'3IUSQ5BX\
M=^'[?PW8ZZ]ZWV'4'6*U9869Y7;( " ;L\'M0!TE%<9I\7C8Z7>_:[R,W@L8
MFMBT$:@W +EE8*3P0(P?3)P>,UT6@:Q!X@T"QU:W!6.[A60(>J$]5/N#D?A0
M!HT5E>);[^S/#6HWPO18^1 S_:6A,HBP/O;!]['I6=?>.='TV]DT^1KRZOH8
MDFDAM+*29@C#._"@X''X<4 =-1533-2L]8TRWU'3YUGM+A!)%(N1N!]CR/H:
MMT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 5@>-=*EUGP;JEG; FZ,/FVX'7SD(>/_P >5:WZ* /,
MTT'5+SX8:A>R64L6OW-Z^M+;D?O$F24/&@]]B(E5[_PMJT_PUTF06]W_ &DF
MJ+K-[;V[!+AB[L[JN>-ZAQ@'NF*]4HH \\\*Z?\ :/&/]J);>(VBM[)H1>:U
M(8SEV4F-8BH8CY<EL@9'>MGQO87-_'X?%M;//Y.MVL\H1<[$5B2Q]AZUU5%
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MEEW'<DC[69 !C'0<DYKT"B@#Q*UCO_#^F>&FOM'OVN$\474OV63]Y,R,DI#
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M,(6X\.YN(96 .8I(]I4;"< G@@]178Z#K&H06V@Z5KMI(NKW=D99I(D7RD=
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MB3&7AV[,>@^09]: .532]6_X3R?PW_PE>LG3GTQ+]G,D?GB3S&3"OL^53C.
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MC)L3QA<7[$D<0-&X63KTR1[T =1:>.=(GM-5GNENM.;2E5[R&^A,<D:L"5;
MSD'!QC//%,L/'6GWNLV6DRV&J6-Y>J[V\=Y:F/S%52Q8'..@Z=1D9 S7-^+_
M  [?7VH>+;@>5;P3V5@;:>XD"122PS.^PDGC)VKS_>I]QK&H:M\2?!PNM!NM
M,2,7C'[4\99F\G!VA&;Y1D?,<9R.* .\U?5K/0]*GU+4)3';0 %F"EB22
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M =Q^[B4J,[B/F/H,>M6_#&G7,WC74]?BTB71M-GLX[86TRJCW$JL296120N
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MDG Y\OUK/A.N^#-3\,V$^LIJFG7T@L#;FU2(P$1%E>,KR5&S!#9X/6KEVO\
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MQY?!7.<9/(S7"7=KXA\.^"6#2:/XG\)6]F&,4\9@N&M54$8(RC84#J 3CUH
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M$C.K,N[/(& /D;D\<5R4]A=Z-XI\-Z,-=U:ZAU!;YKF2>Y)=B(DQ@C&T Y(
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M4HS!AE2, YSQ4=IX\AFU?3--O-#UC3YM49OLC742!754+DDJYV\#[IYY''7
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M8T<#<,=\[1R>?SK+U'QU;6>K7.F6FDZGJ=U;V\=TZVD:%?*;.&W,P';IU.>
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ML#H3G.,#G%8OB+QK>:=I'B2]TZ/4S?6[V2FWN(HMMEYJ*>!NYX.#G.&([<T
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M;S"YTE%CM9(YV4A%QA6P?F''?U/K5;P5XDU'7KWQ!%?6-Q EGJ4D$+2+&%5
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M30:-X=DB34I4 (GF=U!C&1_".#CN3[4 >OW.DV=WJMCJ4T9:ZL1(('W$!?,
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M2, 3A5&3P.3P*YJR\<Q7&HZ=:W>B:MIT>I$K97%TD825MI;!"N60D D!@.E
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M4;@>M=910!Y-:^'/$EEIGAJQO].U2ZTNUTI8)['3-06!UN@W61A(FY-O PQ
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MU6.X\^/9+ ;CS&(&[(*J.01SVS6GXM\(7_B/7]3$8$5K=^'I+%+AF&%F,H8
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M-5DFC-L;?S,[R@82;]IQMQUYSBNXL=2L]3%P;.82BWG>WE(!&V1>&7GT-6Z
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M7$D+["<E2R,"5SV/% 'DXBEUCPOI]OJ4]Z39>,4L8U-_([QQ^8OR&12"Q7.
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MM/ 7ANRGM9XK!VFM'5[:2:YEE:$CH$+,=J_[(X/<<4 >9H+G0/#6J1Z/)?\
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MO]ND9%8;G\L.8B=X4L1SC.#G%6=>TS56\:Z#K&GVL=Q!!#/:W&90C1"0QD2
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MK&%T#( .%RW?GD<<5R=]X!\1:AX>FL[O1(;O71+YDFL76I&02XDW?ND.=A(
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M.U*K,) X10H<$=,XZ=JZ"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "LS7]<M?#FCRZG>)-)%&R((
MX$W.[.X10HR,DEA6G7+>.K*QU*QTJROM7ETL2ZG 898X]S22J2RH"00I)&03
MQD4 :&B>(3K4LR?V-J]AY:@[K^V\H/GLO)R:V:X?1);S1OB!>>'FU:ZU'3O[
M-6^+7L@>2VD\S;M+X'RL,D ]-IKMU974,I!4C((.010!SNI^,;73]4GTVWTW
M4]3NK:-9+E;" .(%;E=Q9AR0"0HR<=J2?QOI*:;I=Y9K<ZBVJ FRM[./=+*
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M- $.<QK$Y<CV"]?K7H"R(^[8ZMM.TX.<'TH S[W6K:QUK3-*E24W&H^;Y+*
M5'EKN;<<\<'C -:5<#XYT^SU3QQX,L[Z5T@D>\!5)3&9/W2G9D$'![CN..]8
M=S8W<"^,=,T*>=H="FM-0TZ,S,XCF"F22$$DDJ0OW>@WT >M45Q/A+4QXL\2
MZCXDMY7;2X;>*RLAGY6) EE?'KED7/\ L&K/Q N8(])L;*07\LE]?1P16ME,
M(6N6P6\MW.-J$*<D$'C'>@#K:*\/NFN](;QQIT5L-*B7P[]I%E!J#W BDRXW
MY(&QB,9 [8.:Z5=(A\/>)_!ES82W9N-1,T5\TER[_:O]'9P7#$C.Y01C&/I0
M!UVJRZ+X2M;_ ,1/IZ))*T8N9;>%?-E+,J+D\9P6'4UNUX;?:99:A\(8_$][
M=W#:W=7$3W$S7+_/(;@ PE,XVKC 7'&T'M7N5 &;HFM6VO64EW:)*L<=Q+;D
M2@ [HW*-T)XR#BM*O$[?2--B^'?B;Q&E[<1:O97]_);SI<NOV>19G*1JH.W#
M'&01SO\ I5V<:MXG\9ZS!?Z,FH+96]J(;:357LQ;[X@[.JJIR2Q8;NHVXH ]
M2NM6L[/4K#3YI"+F_+B! I.[8NYN>@P/YU=KQVPL!J^I_#N;69X[^Y(OHVN8
M;II%D6,,8_F&-Q'&3CD@YK-O]1U6&PBT:VNK@W'@^>XO[H[SNFBAE0Q*W<AH
M9&Z_W: /=**\8U;4]0U*S74[2226Q\0>(1:H!=M;K):Q(R(@D )02.C'(&3N
MQWI;^XUWPI9^*!I\-OI:)I G2PBU)KMH)-^WSE#*-@VEL]LH#0![-3)H8[B&
M2&:-)(I%*.CC*LI&""#U%>5Z3I]_H_B+P[-:VEMIL=U(4F=M<>Z.HQF,DG:R
MC<X.'##W[&LB/3$B^%0\5BYO3K<%\6AN3=2?NU%X8]@7.W:5SD8YR: /:X88
MK>"."&-(XHU"(B* JJ!@  = !6'-XPTJ*%)4::9&U1=))C3[LY?8<YQ\H;@D
M?AFM\C((/0UX8-"LH] G@M_.@\[QP+9I(YGWJBW#!=I)X(!/(YH ]SJG=:3I
MU[>VMY=6-O/=6A)MYI(PS1$XR5)Z=!T]*\QUP2^"M6\2P>'#/#'_ ,(V;Y83
M*\BI,LC+Y@#$X.WD^N.:9I-CJ.EZGX8O;6VMM/\ M4Z)-<OKCW)U&-D);*,H
M#-_&#VQZ&@#UTG R>E<:_P 1;-XYKJPT36M1TR$L'U"UME:$[>&*Y8,X&#RJ
MD<<9KH/$5O<W?AG5K:SS]JELYHX<==Y0A?UQ6-X%U/3/^%;:/<QSPQ6MK81I
M.68 0LB .&]""#G- '1:??VNJZ?;W]C,L]K<1B2*1>C*>AJS7F2W.F^+O$?A
MW3Q%/:^&[C2YKVVLN;=;B02*H!52,@*2X7WS6+J1FA&I^'K+4+P:9;>)-.MK
M:5+AB\(EV&6)7SG"D\<\9H ]GHKS"U\'Z3)\0M6T)OM?]D+IT%T++[9+Y?G,
M\BE_O9SA1WZ\]:Q_#RCQ%+X#M-9O[F6*;2KSS(S<,OVIDD0*KX(+8 S[[?K0
M![/17D,UY%8VVM>'UFU.YT]=>@LM.@M;G:\K-$LCVQE8Y6,'<#SD#C/:J;&Z
MTB^\9Z=':+I,7_",277V*#4&N1'(-X#Y(&QB.P] <T >U45Y;%H\&AW_ (%U
M"TFNS=ZC*(+Z26Y=_M*M;NYW@DC[R@CCCM5>UN+MYK?X=-<3&XM]68RRESO;
M3TQ.I+=>=R1_G0!ZU14%Y<1VEC<7,SF.**-I'<#)4 9)Q7BC>;:6_A?7+/3K
MNT%YJEH%U2]U8O=7D<KC(:)<KAE))&1@=J /<J*\CET.WU?3OB!J=Y/>/<V%
M]="R9;J1!;%($<,@! !W'] *NZ5"GC#Q+;VOB"6:6*'0;.ZM[<3/&LDDF[S)
MOE(RP(49[9]Z .]T76K;7K.6ZM4E6.*XEMF$H .Z-RC'@GC(.*T6.U2QZ 9K
MB?A6D<7A">.&X:YB74[Q4G9MQD G?#$]R>N:Z676M/&IW6E-<!;R"T%U(C @
M"(DC=D\$94Y]* #P_K=KXDT&SUBR25+:Z3?&LH 8#)'(!([>M&O:W:^'=$N=
M6O5E:"W )6)=SL2P554>I) _&O&])?4+KP[\/M#6T^U65S87$[VCWK6JW+J1
MM4N 20 Q;;WZ]JGUK3ICX+\3V-^L*6UC?V36EG'J+W+69>1 Z%L X(.0ISC<
M?04 >D6_C);C6;/2?[#U5+V:$7$\;+'_ *)&79%:0A\<E2<+N.*Z>O(=5TFU
M\.^+O%%]H]LZW>G^'$N;7]Z[[9,S#."3NX X.1Q46D6>I6$OA;4[:WM[)[NY
MA6:^EUQYVU!''SJ4*89B,L/0CB@#UG4KW^SM.GO/LMS=>2F[R+5-\K^RKD9-
M60<@'!&>QKQ5]+C7X:>+/$;7%V^J+-?PQ3-<R8BC$[ *JYP!P3G&>36C?Q:C
MXA\>:]:3Z4NJ0:?%;I;0R:J]H(5>,,9%55.XEB1N[;<4 >M45XY';:OK>D^&
MUGN;#Q!-#:W!DTTZFT?VE!*%299%&'90 I+#&23U-=U\/[RWNO#'E0+?QFTN
M9K:6&_F$LD+JQRF\?>5<X!R> * -9]=M4\3Q: 4E^URVC7BMM&S8KA",YSG+
M#M1K&NVNB/IRW22L=0O4LHO+4'$CAB"V2,#Y3Z_2N=N2!\:;') _XD$_7_KO
M'1\0F!F\($$8_P"$CMN_^Q+0!V-Q<0VEM+<W$JQ01(7DD<X"J!DDGTQ7'GXD
MV*6HU%]$UQ-%.#_:C6H$.P]'V[O,V=]VVIOB=;SWOPUUZ&S!>7[/N*IU9%8,
MX_%0U:5UK^A0^#GUF6:!]%^R[\C#*\>W[H!X)/3;Z\4 ;4<B2QI)&ZNC@,K*
M<@@]"*=56PN8+BQM7AC,"R0+)' ZA&1"!@%>V.F.U9/CB_@TWP;J5Q<7%[;Q
M[%C\RQ($VYV"@(3P"2P&>V<\4 =!17D6GPSZ%\1-%@33AH,5Y9W?GQ#4VNFE
M"(&5Y%/R@@YP<DGGTJ'P[#)H.H>'KO4[::7[9<+#%KVFZFTT>H-(K;1-$_.#
MUXS@C@@4 >NVUI;6:R+:V\4"R2-*XB0*&=CEF..I)Y)[U-5+6;R'3]$O[VXF
MDAAM[>25Y8@"Z*JDDJ#P2,<5Y!%'/IE_X-U&VTRXT[[;J$$1O+K5FFN;V-T)
M/F1C*G(P3SP< "@#VRBO$=1TT-X*\5^(OMEZ-6LM<N19W N7'V91= ;47.W'
M)SQSGV%;6L6[^#/$NH?V UR'D\-7=VT<D[S>9/&R;)"&)RWS'ZYH ]4HKQK2
M+34[(>%M5M[>WLY;NY@$VH2ZX\S:@D@^=6C*89F&6 _A(XJ.ZTB*?P/XR\0R
MW-Z=4L-2OWLIQ=2#[-Y<I*A #@#.<\<Y]A0![36;H.M6WB+1H-4LTE2"8N%$
MH ;Y6*G(!/=3WKB[>QMO%?C778M=FG*Z?:VALHTN'A$:O&6>9=I'S;\C=VVU
MQVDRWMSX>\"Z);Q?;]/N4OI7A>]-JMVZ2G:&=020 2VWO^% 'N]9K:U;+XE3
M02DOVM[-KP-@;-BNJ$9SG.6':O*I9=4TZSOM&FN$L-+EUFQMI(+?4FGDL89<
M^:AE(!16(3'IO-='I6BZ;H7QC6VTUG2-M D=K9IF<1GSXQD;B2,XZ>V>YH [
M+7=;MO#VD2:E>)*\$;QH1$ 6R[J@ZD=V%:5<7\6 C?#C41),8$,ML&E!P4'V
MB/+9]NM9ESH=EI'C72='TJ6Y2UUBPNX]0A^TO)N1579-\Q.&W,1N[YH ]'HK
MRSPYJ5]KVH>'O#=U-)]IT!Y9-68,07:$F*')[[R?,]]M>CZMJ5OHVD7FIW3;
M8+2%YI#[*,_G0!F6WC#2[KQA=>&(S-]NMX_,9RH\MB I95;/+ .A(QWK?KPS
M;XETCPUIOB6X\-21W5G?OK-Y>"[C)>.;/FKY?4#RRHQVV"NFDTJQ\5^-?%#7
M<]Q<6,6GV<MM''<ND8+I(?, 4C)P!@^YH ]-JKJ&FV.K6;VFHV<%W;/]Z*>,
M.I_ UY/I%H;;0OA]XC%W>2:OJ%[!#=W,MR[F:.2*3*,"<8^5<<=L]:S(UUC5
MO#NK>(9K6*/4H[JXQJTVMO";%DD*JGE;"%50 "I/S \]: /:=,TC3=%M?LNE
MV%M909W>7;Q!%)]2!W]ZN5YI9:+!XJ\=Z_%KCS310V%@PMXKF1(A(Z2;F 4C
M)^7@^]9'AV67Q)#X*TC7+NXFL);"[E96F9?M<L4@1%<@@MM3+8SSU.: /4-.
MUJVU._U2S@242:;.L$Q<  L45QMYY&&'7%:5>(W-I'8:?XJL--O[I8AXFL($
MG2=C)&#Y *A\Y^7)7D_PUT$7A#2C\1[W0O\ 3/[(;28KQK+[9+L:8RNF\_-G
M.T>O7GJ : /3J*\-L+S5M7LO!VCS1/J5K):WCM!/?M;"Z>*;8H9P"7VISM[]
M3TJU=)J<&A7NE/=_9($\06$,$%KJ+7$MFLCIOC\S (Z[@.V[':@#V2>:.VMY
M)YFVQ1*7=L9P ,DU%IU_;ZKIEKJ-HQ:VNH4FB8C!*L 0<=N#7F]_H=EI/BG6
M-%LQ.FFW?AR6YEMFN)&4RI( '&6)!P><'FNI^'-G;V?P[T!;="HEL()7RQ;+
M-&I)Y/'/;I0!9F\8:5;^-8?"DSR1ZC/:_:8BRCRW&2-H.<[OE8XQT'6KHUNU
M;Q,^@!)?M:6:WI; V;"Y0#.<YRI[?C7">(/#J>)?B3JUH)3;WD6C6L]G=+]Z
MWG6:4HX_'@^H)%<[)XMU.ZU?Q)J*0-:Z]IGA<P7407/DW"3.2R^HP0X]B* /
M;Z*\QN]+L?#+>$=2T*\N'N[^_@MYI&NGE^W0R*3(S@DAL#Y\]L5Z8LB/NV.K
M;3M.#G!]* *^HZE9:1837VH7,=M:PKN>61L #_'VJ#0=:M?$6AVFKV2R+;72
M>9&)5 ;&<<@$^E37^FV6HK#]MM(;C[/()H1*@8)( 0&&>X!/-<W\+/\ DF'A
M_P#Z]1_,T =%?ZM9Z;/8PW,A62^G^SP*%)W/M+8]N%)Y]*NUP7Q"TJRU'7?!
MOVJ)GW:J8CB1E^4PR-C@CNHYZUBPZ=9Z[H?BO7M8O;F/5;*\O(XYUNGC-@L1
M/EA " . &Z?-NYSF@#U>N<U?QC:Z;JITFTT_4-6U)4$DMO81JQA4]"[,RJN>
MP)R?2KOA:\NM1\):/>WPQ=W%E#+-QCYV0$\=N37.>#)([7QCXRT^[95U*74!
M=H&.&DMFB01E?4###CH: +MK<>&?'PEMM1T9'O+!@);+5+1?.MRPX.#D8('5
M20<5T]M;06=M';6L$<$$:[4BB0*JCT ' %>8>*[@7/C'Q/<Z=)G[!X3N8;R6
M(_<E8EHT)'\0 8^V:(K"UT.U\#ZKI-Y<2ZAJ-U;PW$C7+R?;(I(R9"P)(.W&
MX<?+CC% 'JE%>$0C6=4\+:AXDEMH8=36YF;^V)M;>(V;I*55/*V%548"[#]X
M'WKK;30K?Q3X[\2Q:VT\L4%M8E+>*YD2-'>)MS *1SQP>W/K0!Z517+?#:\N
M;_X=:)<WD[SSM;X:60Y9L,5!)[G '-=30 4444 %%%% !1110 4444 %%%%
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MDC9B?F9BH+$X_/'6JNK>)-6M+^[M]-\-SWL5G&KS7$UPMO&V1G;&6!WD#KT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N4^(.H7>FZ!:3
M65Q)!(VI6D3,AP2C3*&'T()%=77->.='O=;T2VMK&,22QZA:SL"P7Y$E5F//
ML#0!5O\ QV;?5-7T^Q\/ZEJ,FDE3=O 8U55:,.""S#<<$_*.>#[9Z32]2MM8
MTFTU*T8M;7<*S1$C!VL,C(]>:P--T2^M]:\87,L2B+4I(VMCO!W 6ZH<^GS
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M1D'?P4( .1DCG@U5T+P;JNEZGX7N;@0R/;/J%Q?M$_RQR7!#!5!Y(!R,^V:
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M5O/ DZ121/&6*L"Y"E2'((SGCO7)WVFZUH%QX>O'M;>;5]0\1W%^]FLV$7?
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M^S=O\O=QNQ[]*[.O&[/X=7MEI$>@-X4M+N6.3RQJL]\WV=X=V=S0AP^[;QM
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MC@XKQG5? _B75?#E[97FB/>Z\TC.=4NM4W0N!)N'E1;OD.W"@%5 ]: .^O\
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M"7(&#(0<?[% '9Z/JUKKNCVFJ6+%K:ZC$B;A@@'L1V(/!'J*O5XS'KVL>&=
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M;RQ7'C31)K.73[,^'OM?V :D]SLE!?#;L_(3A<J"00!G.<4 >R6=U%?64%W
MQ:&>-98R1C*L,CCZ&IJ\86"ZEO?#'AVUL)K[31H*7WV3^TWMQ-,S ,2_)8*,
M87.!N]J[;X>-J":?J=G?2HR6M\\5O&+W[4]NFU3Y3OU)4DXSS@B@#L:Q_$/B
M.V\.06KS6UW=S7<XM[>VM(P\DCX+< D# "DY)'2N9DL(?%/Q$US3M8FN6M=-
MMK8V=I'<O"I\P,7E.P@L<C:#VQ[UR45JFO'PHNHSW-ZD'B"\T^&Z-S(K3V\:
MS;&)4C)^4#=U..O)H ]?NK_[)I,E^UI=2>7%YIMXH]\QXSM"@\MVQFK2-OC5
M]K+N .&&"/K7.?$*:6V^'?B":"1XI4L)61T8AE.T\@CI7-6NCP^)?'>KVNJ7
M%[)9V^F6+I;QW4D:;W$F7.UAS\OZT >E45X_H5S=>(+3P3HVK7]V]E<PWS3G
MSV1[MH)-D:.ZD,<+EB,\XYJ]J$%K;:QI?A.TUR]?2;G5I([Q/M#[H,0>8EJ)
M<[MK'!QG/.,T >I45XUXM>;PTGBW1M&O;I+&/2(+Q$,[R&TG:8KA6))4,H!V
MY_G6QJ_AFQT_Q1X4T--0U%+.]DO);E6OI2UTXCC.&8MG!(R0,#KZF@#TVH+R
MRM=1LY;2]MX[BVE7;)%*H96'H0>M>2ZE>76D7.M^';#4;J'1QJ^G6WVCSV9[
M2.<9F19"25'"XY^7S*T-=M4\)ZZVGZ)<726U]HE_+<VS7+RB)HD7RYEW$E22
MQ7(//U% 'J-5[^^MM,TZYO[R3RK:VB::5\$[449)P.>@KRU-/L].\&>'09];
MO=3U[[,\T,%\P>\<1%V4NS 1QX)SM()"@<UDW,$J:=\0]&N+66RM8-%2[CL!
MJ+W ADVR'.[MG:I*\@\=<XH ]BAU6.XOH;:.WN2LUK]I6X\H^5C( 4MV;G./
M3-7J\CU"\N_#;XTB28"U\&SW,,;2-(!)YB'?AB<D9/7MQTJ[<Z=;^&H/">K:
M1J-Y+>W]_;6\\DEY)*+Z.4?.65F() RP( QCTH ]/HKQ6ZT\O\/_ !1XE:_U
M$ZK8:A>O9S"\D MQ'.V%50VW'7.0>N.PQ[(TZQ61N)6V(L>]VQT &2: )J*\
M,GFG@TS1/$5C::I$;C4;8IJ]_JI\VZ224 CR%)7:RD_+Q@#I6])HL>MR^/KN
M]O-09[&[D%D([R2-;=A;HVY0K 9SCKGI[G(!ZK6=I&LVNMQ74EJ) MM=RVDG
MF+CYXV*MCGID<5Y]H^[QCK>D6>NW-R]NGANTOD@CN'B$TTF1)*=A!)& !Z;O
M>MOX71)!H&J0QW+W*)K-ZJSNVYI )3\Q/<GU[T ;^HZYI4/]J65T?.:SLC=W
M4'E[OW)#>O!SL;C\Z@\,Z'X<L[2'5-#T>TLA>P)('C@5'*, P!QT'(XZ5Q.M
MZ7:+XT\;W063SE\.K(#YSXW,LZGY<XQ@#C&!U'-1V.D1^'K#X?:I975[]LOK
MBVMKMY+J1UFCDMW8J4)V@ J,  8Q0!ZS37<(C.>B@DUX9"^NZMX:U#Q(UL\6
MIK<3LNJRZV84LRDA58S"?E"   J?O9)[U[6'DDTH22A1(T&7"'(R5YP?2@"+
M1-7MM?T2SU:S$@MKN(2QB08;!]15^O$M'TZ#1/A3X;\2Z;?7;:QYEHJ'[4[+
M-OE5&@\O.W:%+# &1MSUS6QJ^HZAI-WK_@Z&ZF%YK%Y$VERER6CAN,B7:>PC
MV2D>F10!Z)9:S:WVKZGID(D^T:<T:SEEPIWIO7!SSQ6C7D^H7%OI6I>.8&N-
M0A62?3+2'["X$\C-$JJBLQX+="Q(P"3G-58-,O?^$PG\/PVEQH<>IZ'<G[/_
M &J]RWF!D"2GD[&!)Y!.>: /8J*\5@\9WESJFC>*;B[EBTS2HK>QU.+<=GG3
M)()2PZ91Q#^9JV=.UC4-+\/RR%=4N+N*XU*[T234GM9)/-=65E(ZB,,%VG &
M: /7Z*Y7P#?6]QX<>&)M11K2[EM9(=2E$DL,BMDQ[QG<JY !R3C'-7?&NHWF
MD>"=:U"P_P"/NWLY)(CC.TA3\V/;K^% &[17D6DVFJZ9J/AJ]M[;[%]JGC2Y
MN;G73<#4$="6^1N"_P#&,=,8Z5C:[=R/X5N_%6F6VJ,1=>;!KEYJAC9OW^W"
M0*2-G50I"\<T >[5G1:S:S>(+G15$GVJVMX[AR5^7:Y8#!SURAKC5TVW\5>+
MO%4>M7=VB:8\4-I%%=/"+=&A#^: I'S%B?F.?NXK,TK1=.\3^.IOM.HW>I62
MZ#9E9EG>'[22\H$C["I)X)].<^E 'JU%<G\-KFXN? ]H;JXEN)(I[F 2RMN=
MECG=%R3U.U0,UROB-8]:UCQ%+;V&HZD+ >4]Q+JAL[>Q=8PQ$84[B1D,6*GG
MC.* /5J*\>1=6\0Z3X5N7"ZZW]BI+<Z4=3:TF9B0/M ((#]"OS$<].37>^!+
MZ"^\)6Q@DU!Q \ENXU%P\Z.CD%68<-@C /.0!GF@#I**\U@TVU\3W_B^\US4
M;RWETZ]>VMFBNWB%C$D2LLJJI R<ELD'.,=*T?">H>?XR\09U%[JV73].EBE
MD. ZF.0F0#H-W!. * .YHKQ70H'\2VO@"ROK^^:TN[/4'N5CNG0SA73:&92#
MP<=^V.AK5M=/,>I^-=76>^N+C0I#_9L#74A1&6T0_=SALG&=V>GN: /5:*\6
MTB+68+#PWK<,!M[FZGMS/J5SKID6^63&]#$?ERP)VJ.5(&.E276E_:_"/CC7
MIK_43J.G:C?M8R)>2*+;RV+*%4-CKUR#QQV% 'J5UKVGV=Y=6<DK&YM;,WLL
M:J<B+)&<].2K<9[59TS4(=6TFSU*V#B"[@2>,.,-M=0PR/7!KS*\L+>X\<:S
MJ,@D-RWA1+@GSGQO;S5)VYQC '&,9YQGFDL=8_X0W3/"FO74TG]DWGAV.WGC
M+':L\4 EC('3+*)%]R!0!ZQ16#X,LKVQ\*V0U.1Y-0G!N;HNQ)$DA+LO/0+G
M:!Z"MZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "JM]IMGJ:P+>VZS+!.EQ$&S\LB'*M]0:M5S_BF
M^BL3HGFR7B>?JL$"_99=F6;=@/\ WDXY7OQ0!T%48-&TZVTV73HK.(6<ID,D
M#+N5]Y)?(/7))S]:Y&Y^(\L5OJM]#X;O9]-TFZEMKVZ$T:[?+;#,BDY? Y/3
MKWYKNHY%EC61#E' 93Z@T 8VD>$- T*Y:YTW38H9RGEB0LSLJ?W5+$[5]A@5
M'8^"/#>FZ@E]::3#%/&Q>/!8K$QZE$)VJ>3R *JWOB^Z&JW]CHV@W.J_V=M%
MY)',D81BN[8FX_.^T@XX'(&<UROB'7[SQ+X@\)QZ1%J$ND7]M/=@6E\+5IRH
M3 8@@C9N.1GDGVH V_#?PXTO3X?/U:PM+C4!>SW(D1F*'=*SH64X#,H(&2#C
M'!XK=UCPCH.O7*W.I:='-.$\OS0S(S)_=8J1N7V.17!^$_$MY965_K6J6NJ7
M6H:AJDME9VOVT2)*XD<"-$SMC"!.6.. 3S75IXZ@LTU1-?L)M*NM.M1>21&1
M91)"20&1E^]\PVX.#DCUH U;_P +:'J5A:V-SIL)M[3'V98P8S#QCY"N"O''
M!J*;P;X=GT:#2)-)@^PP2>=%$,KL?GY@0<[N3DYR<FLO_A+M8\MDN/"M]:2S
MVLD]HS2HZL57.V0CB-L'.#P<$9SQ5KX?ZIJ.L^!M)O\ 5(V%U-;HS2,RDS94
M'?\ +P,Y/':@"6^\#>&=2U">^O-'MYKBX&)BV<2<8RRYP6Q_%C(]:DU+P9X>
MU:2&2]TR-Y(8A CJ[(WECHA*D%E]CD5NUQ5SX]NK.%-1N?#5]!HKW*V_VN61
M$D7<_EAS"?F"EB/?!SB@#<?PW9?VKHUY#'% FDQ2QV\4<> H=0N!S@* .F/3
MD8YOZCIUGJVGSV%_;I<6DZ[9(G&0PKE[[QQ=Q:IK-CIOAR[U!M(*_:I%GCC7
M:T8<;=QRS8)X]NO(J63QPEU_9<6AZ9/J=UJ-D+]8O,6$10'&&=FX!). !GD'
MTH W--T'3-'=GL+187>*.%F#$DHF=@))/3<?SJM/X2T&YTB'2I=,A:R@D,D,
M?(,;DDEE8'*G)/(/>LCX=ZK=ZQ8ZY<7GVI776;B-(;ELO HVXCZD #G@''I6
MKX@\1C1);&S@LIK_ %*_=DM;6)E7=M&79F;A548R?<<4 7-(T33=!M&M=+M(
M[:)G,CA<DNQZLS'EC[DU+%IEE#J=QJ4=NHO;A$CEFY+,JYVCV R>E<M<_$2'
M3M(U>YU+2KJUOM):'[39;U=BLK!4=&'#*<GT.01BD7Q)*?$&DMK-AJ&CRO;7
MDH@:[1XO*C$9+R!,@G#<<_+\WK0!O:UH<6H"2\MT@CU=+:2"VN98]X0..0R]
M&4D#(-<=H7@*Y@\2Z7J=QHVBZ3%IQ=\:?*\K7$C(4'WD7RT&YB%&><5>7XB3
MB'3+V?PU?0Z9JMS#;V=TTL9)\U@%9T!R@(.1U]."13?^$SM]&@U&9;;4[]W\
M0MIJPM,KMYK("!'G 5.@ )X))S0!UL&BZ;;:2^E164(L'WAK=EW(V]BS9!ZY
M+$_C5/1_"&@Z#=-<Z;IT<,Y3R_,+,[*G]U2Q.U?88%9]EXSD:?5;35-$O+&^
MTZV6[-M&RW!FB;< 8]G4Y4C'K26?C"].N:;IFK>'[C33J8?[)(UQ'+ED3>5<
M+RIV@^H[4 7+;P/X:M-3748-(@2X20RIC.Q'/5E3.U6]P,U>;0-*>RU"S:RC
M-OJ+M)=Q\XE9@ Q/U  _"N'\,^,[NV\,Z%:&"?5=8U&2\,8FN5CRD4[ Y=SV
M!4 #)_ 5W6BZE+JNG"XGTZZT^8.T<EO<KAE93@X(X93U##@B@"5]+LI+RSO'
MMT-Q9HZ6\G.8U8 ,!]=H_*LJV\#^&K34UU&#2($N$D,J8SL1SU94SM5O<#-=
M!7%3_$!T@O=2M= O+K0K&5XY]021!]PXD=(R=SHI!R>.AP#B@#I1HFFK9W]H
M+1!!J#R/=)SB5G&')^HXJ)_#6COJ%C?FPC^UV$7DVTH)#1IC&W@\CV.:R'\:
M23^)SHNE:+<:ALC@GEN8YD2..&7.'^8\XQG Y(SZ5T]Q<16EK+<SN$AA0R2.
M>BJ!DG\J */A[18?#V@VNE0,&CMP0"%VC)8L<#)P,DX&3QW-07OA/0=1OKF]
MN]-BDN;JW^S3ODCS8_[K '!^O6LO3/&EU?R:?/+X<O[;2M1.+6\9T<X*EE:1
M%),:L!P3G&1G&:JCXBYL4UIM"O%\-O*$&IF1/NEMHE,6=PCSWZXYQ0!ULVF6
M4]U97,MNK3618VSG.8RR[3CZJ2*RCX'\-'5?[2.D0?:?.\_/.SS/[^S.W=WS
MC-9]QXUO#K.KZ=IGAR[U!M)91<R),B AHU<!-WWFP3\OMUY%,B\7:3=:W9:B
MEW>+9RZ%+J&XR8@6)73<6CZ^8,]>PR* .SKFK[X?>%-1OY;VZT2W>>9M\N"R
MK*WJZ@A6/U!JI9^.)I)=-EU#0+O3].U218K.[EE1B6<9C$B Y3=VZ\D XI+'
MQS/J5SYMGX?O+C2OMALS=PRH[JP<H7:(?,$R.IYQSC% &[JGAW2-9LX+2_L(
MI8;<@P 90Q$# V%<%>.."*9!X6T.VTR/3H=-A2TCG6Y6, \RJP8.3U+9 .3G
MI6O7&MX[FD-Q=V7AZ^O-&MKDVTM]"REBRML9DB^\ZJW!(]#@'% '4+IUHNJ/
MJ0@47KPK TW<Q@E@OTR2?QKE=5^']A?ZOH 2SMAH^FQW2O;EF#!I2A5D(Y!#
M*QSD$9XJ:\\;3K=:D-+T"[U*STMS'>7,<J)AU 9UC5CERH//3G@9IEQX]\W5
MK/3M#T:YU:2[L(M11XY4B00.Q7<2Y&",#CJ<^QH UO\ A$/#_P#89T;^RH/[
M/,GFF+G)?.=^[.[=G^+.?>F6W@OP[:&9H=+B5YH'MYI"S,\L;XW*S$Y;.!U)
MZ5QEAXJU.[TW49=:AO[=8O$B6D+VURBLN9E41':.57C=_>!/-9UYJU_)K'C'
M5-6&MV]MILT,$2V6IB-801%A0@."6WEBQ!XXZT >J/H^GR16$;VJ%-/=7M1S
M^Z95*@CZ*2/QK$TC0+]_&5]XEUB*RCN/LPL;-+9B^(0Y8L[$#YF)' Z =3FB
M^\770U:^L-&T*YU4Z<%^V21S)&J,R[@B[C\[[2#C@#(YS43>.X+Q=+30-/FU
M6ZU&V-XD0D6$10@@%G9NAW';CGD'TH Z#5M&T[7;+['J=I'<P;@X5\Y5AT8$
M<@CU'-,T?0=+T&&2+3+1(%E;?(V2S2-TRS,23QZFN>^'FJWFL6_B&>]%TCIK
M,T207+;F@4)'^[ZD8!)Z''I2^.=<UC1[_P -Q:7:O,EWJ(BF"R(OF#RW81_-
MTSC.?]G'>@#=UGPYI&OB'^T[))V@),4FYD=,]<,I!&>XSS4,_A'P_<Z/;Z3)
MI5O]BMFW01H"OE-_>5A@@\GD')R:R+OQU,LNI2Z=X?O-0T[2Y6BN[N.5%.Y.
M9!&C'+[>_3D$#-=38WMOJ5A;WUI()+:YB66)Q_$K#(/Y&@#.MO"FA6FG)80:
M;"ELMPMULY),JD,')SEFR!R2>E6-0T'2]4OK&]O;-);JQ?S+:4DAHSP>"#TX
M'!XXK(O_ !;<KK5YI>C:'<:K-8(C7C),D2QEAN5 6/S.1SCH,CGFG:;XVL-6
MNM#BM(9BFK03S(SC:8C"5#HP_O L1]0: -.V\.Z19KIXM[&.,:>7-IC/[K>"
M&QSWR?SJ*?PKH=SICZ;-IL+VC3M<F,YXE9BQ<'.5;))R".M8^I>/[;3;?4Y3
MIUS,;#4XM.*1$%I'D"$%1_P,#%=%I%W>WVG1SZAIKZ=<L2&MGF64K@X!W+P<
MCG\: ,[_ (0KPY_9!TO^RH?LAF%P5RV_S?[^_.[=_M9S4MCX1T#39)9+32X(
MWFA,$SG+&5"<D.23N^IR:S]4\83VVO76D:7HLVIW-E D]R%N$B(5L[0@8Y<X
M4]..G-3WGB6]!L8M,\/7]Y<75O\ :62;%NL"\?+(S='R<;1D\'M0 YO OAIM
M,MM..E1BVM69[<*[AHBW7:X.Y<^@-:NEZ38:)8)8Z;:QVULA)$<8[GJ3W)/J
M>:X+6?'>IW6CZ/=:1IT\,[:ZFGWMN\L8975\-%NY!#?WAV^M7CXQMM'.M2M#
M?W%Q_:T5BEO-<KL\YXD(5&.!&F#DY[Y]: .CUCPKHFOS1S:G8)--&I190S(X
M4]5W*02OL>*G30=*CBT^*.PACCTYM]HB+M6$[2N5 ]F(_&N-\6^+-<A\ ^(9
MX]$O-,U&TBV^9YJE%5E/[V.0</CH0.02*NZ=J6J:+96FDV/A[5;Z[$!N)FO+
M\.L8+$ &=R0S'&=HZ#TH ZZ^L;;4[">QO85FMIT,<L;=&4]0:9;Z796E[->P
M6Z)<SQQQ22#.65,[!^&X_G7,Q_$"WNM%TRZL],NI]0U*>2V@T_<JN)(RPDW-
MG:%7:<MSV]:RO$GC378M,MA;:)=V-_'J]K:W,;R(5=7=2 DAX8.#MR.5YSB@
M#K)_"6@W.D0Z5+IL1LX)#)#&"08W))+*P.Y3ECR#WH_X1#P__8AT;^RK<V!?
MS3$03E\YW[OO;O\ :SGWK";Q=::1?>))[F/4I)X+BT@%GYHD#32Q)LCA7@+D
ML,\X)R:M1^-9;:YGL]:T6?3;Q;.6]@0S)*EPD8RX5UZ,,C(/KGF@#1@\'^'[
M;2KK3(M,B%I=D&Y5BS-,1TW,3N;&.YJEXG\(IXE\0:%<W<4$UA8BX\^.1F#D
MNJA"F.A!7.<@CM5/3_'\MW)HTUSX?O+/3-8=8K2\DEC;+LI90R Y4, <'Z9
MS7:T 9-OX8T.UT6;1XM,M_[/G),T#+N$A/4L3DL>!R>>!46G^#] TJ*ZCL]-
MC3[7'Y,[,S.[QXQM+,2=O/3.*=XB\0Q:!;VV+6:\O+R<6]I:PD!I9"">I(
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MO"FIGP+XNTC;%]JU2ZOI;8;_ )2LK$ID]NO-=I9Q-!8V\+XWI&JMCU Q4]%
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M)%+RLZ/%(1P0#@CCKUXK3T&WUKP?X>MH)H%G:[U=4CM&NVE-G;2, $5R,N4
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M$4-II;W"M9KX<N-*FN!][SI75BP7T^\?R%>B16MO!---%!%'+.P:5T0 R$#
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M+^+0[/0#;LS:C+8WA,5[\A&U80 H!8ALD C'>O3:J3WCPZC:6@M+B1)PY:=
M#'%M P'.<C.>, ]#0!5T#4[G5;&:>ZM4MV2ZFA4(^X.J.5# X'7%9GB72=3;
M7='\0:1#%=7.GB:&2TEE\OSHI0N=K8(# HIYX/-=15"PU>TU*[U"VMF9I+"<
M6\^5P ^Q7P/7AA0!P<OA#Q)JQUW4;J.RL]1GO[+4+"(2F2-6MP,)(0 ><8)
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MZAX0\.ZJMLM_HME<"VC$4/F0@[$'11_L^W2M>&&*W@C@@C2**-0J(BA54#H
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M$>%K=W>'P_IR,[!B1;KP0P88XX^8 \=P*TC9+9VUZVEV]M%=W!:;++A))BN
MSXY/103UP* //O"FJW?B[7-%@NRPD\.VKG4ESP;W<T !^@25_P#@2UK^-4CO
M_%7A71M0=AH]Y)<&>+>42>5$!CC8C&1RQV]RHK7\*:!/HEM>SWSV\FIZC=/=
MW;VZE8]QP JYYVA0!SR3D]ZU-3TK3]9LFL]3LX+NV8@F.9 PR.AY[^] 'D/B
M:)=*L_&VB:-/+#I<":=(B12$BTG><!U0Y^7*A6QVS[UZSHNA:;X=L39:7;^1
M 7,C+O9R6.,DEB3DX%,M_#6B6NDMI<&E6<=@[!WMUB 1F!!!([G(!R?05J4
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M^V/[&^T;=O/G^3NZ>N[M5Z\\)^'M1U-=2O-%L9[T$'SI(%+$CH3ZX[9Z5LT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME6<OA_PG EC(AFU6*V5Y[E$Z81H_D=L#+;C@Y(J]=^#=>NM8F\4B]MT\0PW
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M#(RDON**#T/'; ZY-4M&\"ZA;76DQ3^'O"=HMA(CS:E;6RO-<A.FU#&/+8D
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M[9TC\LMM"D2 @ XRO- #8?B!>7ZZ!'IF@?:+K6=/:]C1[L(D(4KD.VT\?-U
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MTN%<J!DL7EV*6)..,8&/6NCU*WAO-+N[:X#&":%XY @R=I4@X]\4 <7_ ,+
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M: *QRNR%8SNXXY';/% &=)\0%NXM&31=/6ZO-4LOMRQW-R+=((>!EWPW.XX
M .<'M4,OQ'\O2$G&CR2:BNJ)I4UC'<*=LK#*E7QAE(*X/'7MBLA?AQ>6EGX=
MN7T[1=8NM.TP:?=65_S$X!W!XW*-M8'/5>03TK0M_ ^H+IVGC[/HUE-'KD.H
MR6]A"(HHX4R-@*J#(V/XB!G/8"@"^GCN33Y=8@\2:6--FTVR6_/D7/VA9826
M'RG:OS;EQ@C\:2P\;WAU+3;;6-'AL(=3;R[:2*^6=EDVE@DJA1M) /0L,C&:
M;XC\$2^(]9UB26>.*SO]%73U89+I()7<-C&"!E>_8U1T7P;?Q:OILUQX=\*:
M8ED=\UU86ZO+<L!A=@,2^4,\GDGC H N:!X[OO$$MM<6NAQR:7/.8?-AOEDG
M@Y(#2P[1L''/S$C/2BQ\=WVJ:A,+#0X[FP@O6LYFCOE-U'M?89&@V\+GG[V<
M<XK(_P"$&UJ[UK3[FZL=%MKVTO%GEUVR=HY[F-6R5,2H!EA@-EB.O6C6/ NM
M:O?GSK'15NQ=B:+Q#"[0W<<0?< 8U0!G"_+DOCO0!Z=7,:EXGOQX@FT30M(3
M4;NV@2>Z>:Z^SQQ!R=BYVL2QVDXQC'>NGKD;W2-=TOQ7>ZYH,-C>)J,$45U;
M7<[0E7CW!'5@C9&&(*D=AS0!ROBKQ%>^*-/\.P66G2I#<ZLUI?VC7[6[^=&L
MFZ!F0$[<KNW \X''/'JEO"MO;10H"J1H$4%BV !CJ>3]37#6?@?4;>'19);J
MVEO(M;EU?4&7<J%I$D!6,8)P"Z@9QP"?:N]H YS6=>UFTU"6VTS04N8H(EDE
MNKR[^RPDG.$1MC;FXYZ 9'-<_;^)CXCU_P ":E:^=;V]]#?M);F3(W(JC!QP
MV&!P:?K7@_4;SQC>ZH^E:-K5O<11):C5)6Q8%00V(]C!@3\W!4YXSWI/#?@;
M5-'7PDES/:/_ &,+Y9VC+#>)CE"HQ^8[=LT :WPSN)KKX;:#/<3233/; M)(
MQ9F.3U)ZUU=8/@K1;GP[X-TK2+QXGN+2$1R-$25)R>A(!_2MZ@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;41(8VBS]S.6.5ZFL/Q)%::AI/C^3$ES"NB:;- ]TN9,A)2KMD9#8Y/ .<T
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M"CW)('XUA_\ "2Z_I*2W?B31;>#3UM);II[&X,WD;%W&.0,J\D9P5R"1CWH
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M"[OM*MK.PO=8M98C!=,\L:D,565=H'(/8D C%>@ZY?W>FZ5+<V-@U]<@JL<
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M74>-DT]LCNN.F"1FM.O.[#XD3O-I4]_!I*6.J31PQ1VVH"6YMS)]SS$V@<G
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M'EL" 0V.<CC@]* -2[\,Z#?V]M;WFBZ=<0VHVV\<MJC+$/101P/85831M+C
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M;@B8/Y<B3&4$9 R"!)Z=14&K> ]:UNX6&_DT:54NUGBU@0%+^.,2!P@V@+D
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MQSGKST.,C@BK]S>6UE%YMW<0P1YQOE<*,^F33OM$.8AYT>9>8QN'S\9X]>*
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MX7,!MS<":,P@$F0.-N!UYZ4 <1<>#-9/AW3XX;O3/[5M-574PHMO)ML@,/+
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MK1R:3H5[/8-:1C2(2R-(6#"60.H#$8P!CH3S7<C4+(WALQ>6YNA_RQ\U=_\
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M].J'\ZO>)]!O-3GTO4M+GAAU/2YVE@^T*3%(K(4=&QR 0>HS@CI6P-1L3/'
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M\=[:S6ZW$=S"\#$!9%D!4DG'!Z=>*;'J-C,DKQ7ENZPG$K+*I"'_ &N>/QH
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M>3REW,5^Z2<<D=O2@#R[Q7IQT7Q'KL/ABS2RGF\*2N([.,1[G64 , O\04L
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M:OF].<;<Y]LUJ>&M DT2"\DN[L7NI7UP;B[N1%Y8=L!0%7)PJJH &3^M;3E
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M6,B6T;*I996?<-Q)QA@,>N:RD\!WUI#;W5AJ,$>JV>IW=];R21%HF2=F+1.
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M%-%(TBR*&)XW%>">QYH M0>(-?TS7=+L/$=GIPBU0O'!-8R.?*E52^QPPYR
M<,.XZ5B67CWQ)-X=TWQ/<Z5IL>CW-Q'!)$DSF<!Y?*\P<;<;C]WT[CMN6_AW
M7=0US3-0\1ZA8RQZ67>WALH&02RLI3S'+,<8!.%'<]:@3P-.GPYL?"_VV/S;
M::&0S[#M;9.)<8]P,4 ==>S2VUC<3P6[7,T<;.D"L%,C 9"@G@9Z9-<'8>/-
M07Q-I&EZC-H$YU)FC,&G79DFM&"%QO'1AP5R,<UV'B/2#K_AO4=)6Y>V-Y;O
M")D&2F1C..X]JY.T\$:Q]NT"XGGT:T@TBX$@MM/M&C6;]VR%B2>#@\#&.3DG
MC !4?Q[XD7P]=^)?[*TT:38W<D$T9F?SY428QETXVC'H<YP>G%;5UXAUZ_US
M5;'P_86,L&E;$N&NY65IY60/Y<>T87"D?,<\GIWJ*3P/._P[U+PQ]MC$MW-/
M()]AVKYDQD Q[ XJ>Y\-ZW9Z[J5]X?U*SMXM5V-=)=0,YBD50GF1X89)4#Y3
MQD9SVH /A<2?AEX?)SG[*,Y^IKF_%?B+7]=\$>*KO3;"Q.B0Q75IF25A<2A
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M/W]MK=]KVLW<%QJ5W%';JEM&4B@B0DA5R2226))/Y"@#+UVYUE/BIX:MK66
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M!Z(6#$#IC% 'L=F\TME!)<>4)FC5I/)8LFXCG:2!D9Z' JG_ ,)!HO\ :?\
M9G]KV'V_.W[+]I3S<^FW.<UH,1'$2J$A1PJCT["OGR_U6UNO!5G+;SZ#8J;^
M&9-+MH6FO86^T*6:65GW*1SEBO?&>: /=+SQ!HNGR&.]U>PMG#^65FN40[L
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MEM!'X]\;.D$:L+NV 94 (!MD)_,\TSXG&UBTS0[N]$2VUOK=H\TLH&V./?\
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M&&.7R2#ME$:AP<?Q ]:ZF@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "HY3%L"3%-KG:%?&&/ISUJ2
MN9\8WBV<GAT-:6]QYVM00CSE)\HE7^=<$888X/N: .B>WAD*%X8V,?*$J#M^
MGI4E>9W/C+Q;_8NO:];PZ.MAHU[<PM!(DADN8XG()#!L(=OL<D'H.*VI-?U_
M6/$5_IWAX:=!#IL,+SR7T;N99)5WJB[6&T!<98YY/2@#K"EO=*DA6*95.4;
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M]*S-5\>:K;^)M1TV.[T33Y+694MK'4UDC>^3"G>LVX(N22 ,-TYH ]("JN<
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MO'= \:7_ (>^'OA.UN;_ $V.ZU42-%>7@<1P0H 6,GS9=RS8&"H.X=,<Z?\
MPLZ\7P]K\MNVF:G?Z5):^7/:[E@N4FD"="258?,",GG!YZ4 >GR1I-&8Y45T
M/56&0?PH1%C0(BA5 P%48 KSS7/%7B3PY)IUGK-[HE@;KS7?4VM)GMDQMVQ8
MW@ACECN9@,#IFNO\-ZA=:IH-O=WC63SONS)8S>9#( Q 9#Z$ '';I0!JE5+
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MA5 "@8  X%!52P8@9'0XZ4M% ";%&["CYNO'6FQ0Q0)LAC2-,YVHH _2GT4
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M#A@1D9]J?<>$;^WO[+4]&UHQ:C!9"QGEOX3<BZC!W OAE.\,2<@]R,8KK:*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1O0C_=(8'V-=;X7UR3Q%I#:F8%BMY;B5;4@Y,D*L55SZ;L$_0BO/O$^BC2_
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MET7[)J-Q)<B:]M#)/:/)R^SLXSD@'&,]Q7=6=M]CL;>VWF3R8UCWE0"V!C.
M !^ Q0!XT8- G\6^+GUGPQK.L3)J1$<MC;RR!%\I/ERC#!SD_C6[X7\4WEEX
M&T&TM"-3U;4;N:VM8KF<@P*I=MLS8+9C0 $8SG ]ZUH?#WB_2=;UNZT:]T/[
M-J=W]JVWD$K.AV*N/E8#^&HH?A]>V-A:W=KJL3^((-2FU-KF6$B&6252LB%
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M:\;:QX<L+2VUF#2K/4[N]>VANYI]MF8E7<9CSN7^[L)R3WQ0!W L+-7E=;2
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MMG'6M7Q3XIL?"OAU]8N7C>+<B1+YJKYK.0!@GKQEN.P)J@OCW2(M?O[.]O\
M3[:P@MK:>"]DNE5)_-W\ DX/"9X)SF@#K*X'0/"/C#PYH]MI5CXFTLV=OD()
M-+8M@L6.3YON>U=C<ZQIEEIPU&ZU"T@L6 87,DRK&0>F&)P<U)8ZA9ZG:)=V
M%W!=6S_=E@D#H?H1Q0!Q<O@/5%GU^&RU:RAL]:FDFFF>R+W4?F+M9%?>!M],
MC@&I;OX>"\@\*))J&UM$CBAG*Q<7<:&-@I&>!OB1N_>M#QOXLF\*Z?;O96']
MH7]P[B*U#[2R(C22-G!Z*OYD5MV^K6-QHT.KK<QI8RP+.)I&"J$(R"2>!P:
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M5;;7-&M-4LR3!=1"1-W!&>H/H0<@^XJ]0 4444 %%%% !1110 4444 %%%%
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M&(9Y1*HF9.Q!RH)'!(->V%%9"A4%3U!'!ICR00F*)WC0N=L:$@;B!G '?@4
M>8>++<:/\1=,N?M^FZ'I8TUXK6XN[(26Z3F3+C[R*CLFWDGD BM[X9PQQZ3J
MD]M?&\M;C49)8I$L_LT).%#&)=[90L"<\ G-=HZ+(I5U#*>H89%.  & , 4
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M2?P&?PJAH4.DZO\ $[7+^**UNX#I5D+>4*&7RW,N=OL=H_*O02,C!Z4@55Z
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MI<^H6RO:K;O)E8I-Y&QB@4KR#C(]J]L>-),;T5L'(R,X-#HDBE74,IZAAD4
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ME;;([[\ G'WL8]JS/^$ \FSMC9:K);ZE9W]Q?6UX(0P7SF8O&R$_,I#8Z@\
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MUUM1U">QEL(9$M5ACMXY/O%4!.22!DD]L<5>F\)I+I/ANP^V,!HD\$ROY?\
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M<5V.J:;;:SI-WIMXA>VNHFAE4'!VL,'![&N9MO!>H27.EC6?$+ZC9:7*LUK
M+58F:11A&E<,=Y7.> N3R<T 9OPOT^ZBD\1WMY+9332:O=QM+%:>7(S+(=Q+
M%B2IP,+VQU-/OTU-OC)'Y=[ MJ-"D?RF@).SS4#+G?C<6P=V.@Q@]:ZGP_H2
MZ##?QK<&;[7?SWI)7;M,C;MO7G'K5;4?#<UUXKL]>M=1-L\5J]G/"81()HF8
M-@'(VG(Z\T >?^$-6\2Z#X \):A)/ITFE3R6UF;,0-YJQR/L$GF[L%LD';MQ
MCC/>KFI?$>\?4=:^Q:KI=BFF7$EM#9W-I+*]V\?WB75@$!;(& >F374)X(C3
MP;HWAW[<Q73)K:43^5S)Y+A\8SQG&.O%13^#=3@NM3_L/Q&^F6>IRM/<0_91
M*Z2,,.T3[AL)QGD-@\B@#HM%U-=9T.PU-(GA%W;I-Y;_ 'DW*#M/N,XKB_ N
MD:=XBMM5U_6;&WOM1N]0N(F-U&)/)BCD*)$H;.T #.!USS7>VEL+.S@MEDEE
M$,:QB29R[M@8RS'DD]S7+3>#]3LM3OKOPWXA.EQ7\IGN+66S6XC\T_>=,LI4
MG&3R03VH IW(7P/IMKHOAIUEGU/5##;173[X;+>I=@%7!V*%)"YSENN*@U+Q
M3K_AHZWI^I2V-[=6^C3:I8W<5NT2MY?#)(FX]"5.0>15\?#RVCT1+>+4KD:J
MM]_:7]J.JM(USC!8KT*[25V=,?G1+X%N-1CU>;6=:-YJ.H:<^FI-';"*.WA;
M.=L>XY)."26YP.E &8=<\:IJF@VCW.CYU^"1TQ:OBQ*(KG^/][\I(_AYP>G%
M12>,_$EOI3VX73Y]6A\1)HQF,3)%(K*&$A7<2I^89&3T/K772>&DDU3P_??:
MF!T>.6-4V?ZW?&$R3GC&,]ZSI/ T;W$LOV]AYFNQZSCRNA157R^O0[>OOTH
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M."1D>Q%;E4='TXZ3I-O8M>7-XT2X:XNI"\DA)R23]3T[#BKU !1110 4444
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M;W...*HZ+>?8;O0=,TBZ?4;>._1?[!U33A]ITT;CND$J]-@).3G(Z&@#T_\
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M\));0$QMAY0=Q3., XYYK T^.\TI_!^J76IRZ/8_\(W':QWC68F2*;=N96W
M["R[>>,[2* /7)?$VAP:-'K$FK6@TZ0@1W/F@HY/8'N>#P.>#4^E:QIVN6?V
MO2[V&[@W%"\39PPZ@^A]C7D\=I91: NIR:AK=O')KLEW;ZN+!$2"0Q[3*8N?
MW+\C)4<G/ .3U_P\O[J^DUMI_LEW"+A/+U>VLS;B_.P;BRGJ5P%W#@_A0!V]
M8L'B_P .W.KG2H-:LI+[<4\E9026'51V)'H.:T=2BGGTN[AM7V7$D+K$V<;6
M*D _G7D37EC>_#+1O"-A:3)XE@:UC^R?9V62VGCD4R2L<84<.V[/.?>@#L-%
M\:R:_P"/M3T>RNM,_L_3\*5RS7$S; 69>=H568*>#T-=J2%4L3@ 9)KDO"\;
MIXT\:LR,%>]MRI(X;_1H^E==0!YX/BG97>F_;;)K3RX];CTZ8O-D) TA3SB>
M,9"EAGBNNTCQ+HFOK.=*U.VN_(QYHB<$IGH2/0^O2O+6$-UI\NCRPN\\/C=9
M+BW>)O\ 527+%6.1@J5R<^E;/C33+^_\4Z_!I<3_ &FY\*/&A08\Q_.;"Y]2
M"0/K0!VNF^+?#^LWS66G:Q9W5RH)\N*4$D#J1_> ]1FMFO'M)D@U;4_"MK#K
MM]>S6,Z2K9PZ4D)LE5"&$K8&Q<?*1WR, U[#0!S&N^(M0BU^V\.Z!:V\^J2P
M&ZEENG*PVT(;:&;;RQ+9 48Z'D4[1M3\1IK;Z5K^G6Y!A\^'4-/5_(;!P8W#
M9*/SD<D$9]*R-:N!X5^(H\17T4QTB^TY;.:YCB:06TJ.64N%!(5@Q&?4<T7O
MB:Z\80:MIGA>!IK(Z9.IU)E:-?M#+B-(R0-QZDGH..: .BLO%_AW4M3.FV6M
M64]YD@11R@EB.H7^]COC-,F\:^&8+];&77+%+II3"(C,,APQ4J?0Y!'/<5P$
MNHZ=K/A?PKX?T:VE76;.[LV-M]G9'L/*93*SY'R@ ,/]K=QG-0ZCIH;X6^/E
M^R$RSZU=.1Y?S/B=<'WX'% 'I-AXL\/ZI)=QV.L6=PUHA><1R@[%'5O<>XXI
M+#Q?X=U/4$L+'6;*XNG7<D<<H)<8R<>I Z@<BN5\56PA\8(T,.R)?#-_'E%P
MH ,>U?YX%8.G:CIVM^#_  -HFB0R?VI:W%C.\8@93:H@#2R,2, ,-V#GYMXQ
MG- 'HM[XT\-:=J)T^\UNRAN@P5HWE V,>@8]%/UQ3]4\7>'M$F>'4M8M+65
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M;P_#?1HY$9&6-QM88('F-C]*ZZ@ HHHH **** "BBB@ HHHH **** "BBB@
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M#?="%^2?X@0/;&>] ';6UW;WL/G6L\4\6YEWQ.&7()!&1W!!!]Q4U>,Z/?\
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MLH4J_('<$=>:C\)>+M3O]<L+/4M<A6]G1OMFD7VGM:2Q-MSB D?. ?4G(YH
M],HKG?&.M7NCZ=91Z:(OMVHWT5C!),I9(F?.7(&,X"DXSR<5@:A>^(M,U&7P
M]>ZQ%=#4-.GN+6]%HJ20O%MWJR@[2I5N#P1[T =GINLZ9K"S-IFH6MXL+^7*
M;>59 C>AP>#5ZN/^%UI):?#C1/-F27S;2*5-L(CV*47"G'WB.?F/)S784 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5A^)/#B^($L)([V6RO+"Y%S;3QHK[7VE2"K<$$,:W*PO%GB
M%O#NE12P6WVJ^N[F.SL[<MM$DSG"@GL  23Z"@#+7X?V]Q=ZI<ZOJ=UJ3ZI9
M"SNA*JH-H)*E H&W&>.O//6HF\*SZ=?:?KVJZ_JFJG11(UO MLI9E:,H<K&N
MYWP1S[=.34AG\=:3<6EQ>?V9JUI+,D=S;V-L\4ENK'&]&9SO"]P0#BM/5/&O
MAW1K][*_U..*>,!I5".XA!Z&1E!"9_VB* .7\-^#KR[\&>'II+B[T;6-/EN9
MX'\M69%FD<E'1ACE6&1U!K5A\ +#;ZCC7=2^W7MU%>F]!4.DR* #@#:5./ND
M8QQ6OJGB_0-&ECAOM2CCEEB$T4:*TC2(3@%0H);H>GIFJL/Q \*W%Q:0PZU!
M(UV56$JK%2S?=4MC"L?[K$'VH J'P%'>0ZRVL:K<7]YJMG]ADN!&D7EQ#. B
MJ,9RQ.3GM5_2?"[:?J\&J76IS7MY'IXL&=XU3>HD+AB%& ><?A3;_P >>&-+
MNYK6\U:*.:"3RYEV.WE' /SD A1\P^8X'OP:L:?XOT#5=5;3+'4HIKL*SA K
M .%."48C:X'^R30!17P/:+X3A\/_ &N;R8KT7@EP-Q87'GX],9X^E17?@F<W
MFHOI7B"^TNVU-S+>6\,<; N0 SQLP)1F Y(SSS5VW\<^&KK4TT^#5HGN'E,*
M':PC>0=463&QF]@2:9?^/O"^F7,]M=ZM''-;R>7.HC=O*/'W\ [1R.3@>_!H
M LV7AFUL->AU2&:8F'34TY8W;=\BON#%CR6^M9=SX"ADTO[+;ZI<VTZ:N^KP
MW*HC&.5F8XVL""OSD<UUL;I+&LD;*Z, RLIR"#T(->=Z;XB\7^);"[U?1;K1
M(T@EE2/2IH7>8[&*[9'#C8[;<@;<#(ZT :FH^!)]034+,^([]-*U%R]U9F.-
M\EL;PCL"44XZ#IDXQ77""-;86ZKB()L"CL,8Q7)R>.DM_$?A[1KNS>UN-4M6
MFFCD5F:!_E"Q\#!R68$YP-O/6K__  G/AK^U/[._M:+[1YWD9VMY?F_W/,QL
MW=L9SF@#)L_AX;#3=,@M=?O$O-*+I87GE1EHX6 !A=<8=?E!R><]ZW/#_AQ-
M#>]NI;R>^U&_D62ZNY@H+[1M50J@!5 Z >IINK>,_#VAWIL]0U)(IU4/(@1W
M\I3T9RH(0>[8JI%XL1/$NNV]Y/:Q:3IUE;72W.<<2>9N);."/D&,#OWH FU;
MPO+=ZV-9TO5I]+U!H!;S/'&DJ31@DJ&1AC()."/4CD51?X?6J:19VUGJ5Y;Z
MA:7K:@FHG:\CSN"'9P1M8,&((P.U=7:W,5Y:Q7,!8Q2J'0LI4D'IP0"*YNT\
M9Z;:Z#I]YJVJ6LLUV9/+-E!*PEVL02B8+X' )QC- %9?A]!+:>(8K_5KR\FU
MZ".&ZG<(I4H& * # X;ICMWY-3-X2U5)(KFV\67T5X;<6]S(8(G2<*25;RR-
MJL V,CKW!K0E\8^'X=(MM5.IQ-9W3%('C5G:5AG*JB@L2,'(QD8.:?;>*]#O
M+*VNX-1C>&XN19QG# ^<?^69!&5;CH0* ,J'P#:V,?AY=,U&ZM&T3S C;4?S
MTD(,@?(_B(ZC&,G%9TGPQ,GAU_#G_"1WZZ*K%H+9(HP4^?> S[<N W...V<U
MV,NL:=!?3V<UW''/;VPNIE<X"1$D;R3P!E6_*L[3/&OA[6-0CL;'40]S*I>)
M'B>/S5')*%E <8Y^7/% %FQT&*RUG6=369VDU0Q&1"!A/+CV#'U'-8<'@!-.
MLM'72=7N;*_TNU-FEVL:/YT)()5T88/(!'3!JOX7^).E:E86Z:M?VT&I2W,L
M!1(W$:L)65%+'*JQ4*<%LG/ Y%:=KXI":WXIAU.:VMM/T=X-LS?+A7A5R6).
M#R<#&/QH JV?P^MK6SC@?4[RX==976'FE"[GE  (. !@XSP._%7?^$.MO^$>
MU[1_M4WE:S-<RRR8&Z,S=0/IGC-7=&\4:-K\LL.FWHEFB4.\3QO&X4]&VN 2
MI]<8J[<:E9VM]9V4\ZI<WA<6\9!S(57<V/H.: . UVTDTCQ&TMJOB.R,EE%
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MO.\3Q/&ZQKC+%64$#YASW[9H S+;X?E([&PN]>OKO1=/E26VT^1$ !0YC5W
MW.JG& ?09SBM[2=#BTF^U:ZCF=VU*Z^TNK 80[%3 ]L(#^-4;;Q[X6N[.\NX
M-9@:VLU1IY<,%7?]T D88D@C R<\=:N:7XHT768;F6ROT86HS<+*K1-$,9RR
MN 0, \D8XH BU+PZ;WQ+IFN0:A-:7%FCPNB(K+/$S*S(=PXY0<CFJ2^![1?!
M%IX7^US?9[:2.19L#<2DHE&>W48JYI/C+P_K=Z+33]126=D+QJ8W3S5'5D+
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M]K<6$5M'8[$(.]_)7(ZKM5N<UZ]10!Y##:W,?CH>.CHTHT26\:W%MY3^;&Q
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MRX!4D*< CL:]QHH \8OM*?4?#GB:\MQK6I+?7NG)Y]];+']J$<R;F2)8T.T
MX+$<A?:O9Z** /'FMYIK.XTE["[,\/C2.YE1[9]I@>YW!PV,,NW))!X'6MCQ
MGHNHZMXHUJ#3X9!)=>%9+>.3!"M(93A-W3)!/YUZ310!Y#I47]JW_AFT%_XG
MNYK&XCG>TGL(K:.QV*0=[^2N1U7:K<YKM?'VDWNJ>'HI=-A\^^TZ\@U""#./
M.,3ABF?4C./?%=310!PUW\0'O[6.T\-Z3J$^MS.J>1>V$T4=MR-S3,0  !GH
M3DXQ56TU*+PEXE\4#6;*]D.HW*7-K-!9R3BY3RE01 J#AE*D;6Q][/2O0Z*
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M0<^9C&=_;.<8[5?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MXU))V@MD+UP*=IWC;44O[JR_M :O$=/GN8[O^S)+7R)8QG8P;AE8<C'/!!H
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M;J.KZ]-J;:6KBS5K=(B"R["SL.7.W/H.^*T/%/AQ?$UA;6QO9[)[:[CNXYH
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M9%DBD4.CH<JRD9!![BL'_A.?#/\ ::Z?_;%O]H:;R!UV&3.-F_&W=GC&<YH
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MW^S>4(Q-"\>01F-C@,,<,,'''-6O#?A^#PUI L()I)BTLD\LT@ ,DCL69L
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MXV*9XPV!G;UKV.B@#COAU:>3I6I72OJ#I>ZA)<+)?0K"TN0H,BQJ!M5MN0"
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M[2-FEB]FNR1#<F$%V!W;@>>,# [GFO1O#FC/X?T.VTMK^>]2V41Q23JH98P
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MCD4$ X8$$88C!]:R1X AGO[Z^U'6=1O;J^L38S2%DCVINW H$4;"#G'U.<T
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M*T;+(X78IP!O.<=>">:J?\+!CO%\2Q0W$-B^E7*11SW-M*R%#Y8); ')9RH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% $)M8#>+=F)3<+&8UD(Y"D@D#V) _(>E3444 %%%% !1110 4444 %%
M%% '+7_@'2[^YO7-WJ4%M?N9+RSM[MDAN&( 8LHY&0 #@C/>NFBBC@A2&)%2
M.-0J*HP% X %/HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** ,+Q5J%W8V%I%8R"&XO;R&T6<J&\D.W+8/!. <9XR1G/2JEQ->>%
M(Y[BXU6XU6"18T@MK@1B8SO(L:X954;"74'(./TK<U33+76+"2RO$9HG*ME6
M*LK*0596'(8$ @CH162/!FFR)<_;)KV]GN(UC-Q<SDR1JK!U"$8VX8!L@9R
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M1$LR%<-CJ?NC@DCVSS0O@;1PX$GVF:V2.:*.TDF)ACCE!#JJ^A![DXZ# XH
MR8_B*7BD5=,BFN]UNL4=M>"1&\Z01@,^T;64D9&",'@FKW_"872&2:;2%2QM
M[J*RNYENMS1S.44[5VC<BLX!;(/!(4U=B\)62A?/NK^[99(71KBX+%/*<.@'
M;&X<GJ>Y-/F\*:=/J#W3/<B.6X2ZEM5E(ADF3&UROJ-JG&<$J"030!!K5S>W
M?B73]"M;V2QBFM9KN>>%5,C!&C4(I8$#)DR3C. ,8S5*^\03^$XH;&]OX-2N
M;BY=+:2ZE6WV1A Q\YE4C(S@87G*\=36]JVAVVKM;RR27$%S;,3!<VTFR2/(
MPP!Z$'C(((.!Z"J"^#=-C@C$4MY'=I.US]N68F=I&7:Q9CD'*@#!&, 8 P,
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MA@D\<FK$.G6\&IW6H(&\^Z2-)"3QA-VW _X$: ,#0;O7[W0-1#W-G+JD5_/
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M$<'Z=,#'2M2TM8;&SAM;= D,*!$4#H!0!-1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5D^)M8?0/#=]JL=NUP]M'O$0[G./RYK6K/UW2
MQK>A7NF&8P_:8FC\P+NV$]#CO]* )[6[^U-(OV>XB*!<^;'MSN4'@]\9P?0@
MU@R>*I%T:[U"*!)GDNI;73;<$AIF0E26/IN1V)[(,UO6D5Y'O-W=1SDA<!(?
M+"D* W<]3D^V<<]:YJS\'VES8/8:G;R$V5Q<BSG29T)BF;S/X&'3(4@]T]Z
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
-HH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>sgmo-2022110322xex51opin002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 sgmo-2022110322xex51opin002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **P/$GB_3/#,0%RQEN6&4MX_O'W/H/?\ G7FU_P#%37;B0_9([>TC[ )O
M;\2>/T%93JQCHSTL)E.*Q4>:"LN[T/:**\/M_B=XEA<-)/!./[LD( _\=Q7H
M'@_QW#XFF:SEM3;WJ(7PIW(P& 2#U'7I^M$*T).QIBLEQ6&@ZDDFEV?_  QV
M%%%%:GDA1110 4444 %%%% #)IH[>"2>9PD4:EW9NB@#))JC8:]I6J3M!8W\
M%Q*J[RL;9(&0,_J*;XC_ .17U?\ Z\IO_0#7EWPE_P"1INO^O)O_ $-*RE-J
M:CW/3PN!A6PE6NV[Q/9****U/,"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0IUJ#;A)=>_]?DQ-4U:QT6S^UZA<""#<%W$$Y)[8'-1:1KVFZZDKZ;<&=(B
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%%  0",'D5S]_X(\.:C(9)M+B60\EH28_T4@5T%%)Q3W-
M*5:I2=Z<FGY.QR]M\//#%LX<:=YC#IYLC,/RSBND@MX;6%8;>)(HEX5(U"@?
M0"I**%%+9%5<16K?Q)-^KN%86I^#= U>5IKO3H_.;DR1DH2?4[2,_C6[10TG
MN33JU*3YJ<FGY:'.6/@/PWI\HEBTU)) <@S,9,?@3C]*Z,  8 P***%%+8=6
MO5K.]23?J[A6;JOA_2=;4#4;&*<@8#D88#V88-:5%#2>Y,)RIRYH.S\CE8?A
MUX8AE$G]GE\= \SD?EFNEM[:"T@6"VACAB085(U"@?@*EHI**6R+JXFM6_B3
M;]7<9-#'<0203('BD4HZGHP(P15'3] TG2IVGL+""WE9=A:-<$C(./T%:-%.
MRW(52<8N*;LPK U+P7X?U69IKG3HQ,QR7B)C)/J=I&?QK?HH:3W'2K5*3YJ<
MFGY.QSNG^!O#FFS":'34>53D-,QDQ^!.*Z*BBA12V'5K5*KO4DV_-W(+Z\AT
M^QGO+AML4*%W/L!7B/A^TF\:>.C/=+NC:0W%P.H" \+].BUV?Q2U.X73X-(M
M8Y7:<^9,44G" \#\3S_P&KGPST$Z7H#7L\96YO3NPPP50?='X\G\16$_?J*/
M1'N8-K!8">)^W/1>G]:_)';4445T'SP4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLH;'ZT :51-;0-=)=-$AG1&C60CYE4D$@'T) _(5+10 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M78F)#T&TX.W!)+=* .PE\5:!#IMMJ,FL62V5UN\BX,PV28!)P>G 4_E3M/\
M$VB:KIT^H66J6LUI;Y\^42 "+ R=V?N\<\UY7X:LI9K3P?%<VMPWE>)+Z21;
MB#8R_+,REE  4Y(/0#/2K_BG2[N[U3QV+6REG1ETF>2&-,FX1&9I%']X[5Z=
M^!0!U<'CW3]4\6:/I6C7EI>V]W%<O.Z,2\9C"%,#T.X\D<XXK<UV_ETW3EN(
M9K.%S/%'NO&94PSJI&1SN(.![XKC%UG2O$/Q/\-W>D)),D%E=I-="W9%&0FV
M,D@<CYCCMGWK8^)$4DOA2-8T9V_M&R.%&3@7$9- &A?^-O#.EW+V]]KEE!,D
MGENCR %&P#\WH/F')XYK=5E=%=&#*PR"#D$5YW86 -O\2G>UR]Q<RH"4YD46
MJ8'N,EOS-=5X-5U\#^'UD#!QIMN&##!!\M<YH ?'XKT";6/[)CU:T;4 9 ;<
M2#<-F=^1VQ@_D:32_%OA_6KUK/3=7M+JX4%O+CD!+ <$K_> ]1FN%BT2\O/
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M"*(\\'&<]JZ/P6$O_&>I:M#JU[JJ_8H[>2\-FD$$A#E@H(P7=1GG! #8SVH
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MU I4<<DD\T =C;75O>VZW%K/%/"V=LD3AE.#@X(XZ@BI:X[X5B0?#?2A* )
M9]X7H#YSYQ78T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5A^)?#@\0PV+)>26=W872W5M.B*^UP"
M.5;@C#&MRN;\8^+8/"5G8SS(&-U>PVW(;Y59P';@'. 2<=Z ,^3X?F[FUBXO
M]<N[JYU736TZ=VC10BDG!10,+C)XYZYS6U=>'(;JYT&9IY%.CR%XP /WF8FC
MY_!LU@)\2-+L_$6N6.KWL%O;V;P&U*Q.SM&\*2,S@9P 6ZX '>NBU'Q1HFE6
M=K=7>H1+%=C-L8P9#,,9RBJ"6&"#D"@#FKOX:F?2Y=%A\07L&A--YT=BL49\
ML[]^T/C<4#<A?UQQ7>53TS5;'6;!+[3KJ.YMGR!(A[C@@]P0>H/(KDI=8\6Z
MGXSUW2-&GT:WMM,%O\UY;22.YE3=U5P."#VH GM/ L^DZ;I-OH_B"\LYM.MV
MMO,,:R),A;=\T9XR#T(P:6'P&UA9VW]F:[>VNH17$US)=;49;AYCF3?%@*1P
M,8QC''>F:/XX$":O;^*I;&RN=*NTM9;B!F\B3S$#H1G)4X/()XQUK1?QYX93
M3[2^.J*8+LL( L3EY-IPQ"!=V 1R<8H SV^'L+:5)$=5NAJ<FHKJAU$(@87"
MC:"$QMV[>-OZTZ/X?P7$VKS:SJ=SJ<FK6:6ER9$6,!5+$% H^7&[CKR,]ZUY
M?%N@0Z-!J[:I UC<-LAECR_F-S\JJH)+<'@#(P?2F+XS\.MI!U7^UK=;$3"W
M>5\KLD_NL",J?J!0!4T_PI?PZA9W&I^);[4HK)6%O Z)$I)&W=*5'[P@>O'?
M&:S)?AL7TY-'3Q#?1Z)#.D]O8B-#Y>V0.$+XW,@(X!Z<<G%=)I/B?1M;^T#3
M[Y)&MP&F1U:-D4]&*L =I]>E0Z9XS\.ZS?K96&J137#AC&NUE$H'4HQ #X_V
M2: -:\M(K^QN+.<$PSQM$X!P=K#!Y^AKC$^'=PUAI5A=>)+R:STB>":RA$$:
M >4P*!R!E^!CMUSC-;<GC7PY%JW]EOJT(NQ*(",-L$I_@+XVAO\ 9)S6=I/Q
M"TJ_N-=6YF2VATR\%N'*O\ZG8 QXX)=]N/I0!Q_B2QO /$VEZ?!XEM&U&24K
M86MJ);:Z=UP)!/LQ$K'!=2P[^M=9:^"+NSN+:]L-;FT^[.G065V$A259!$,
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M..E<QI.GZEJ_B_PU,+GQ'=6^E-))*VK60ME@4Q,@7.Q?-D)89;G@'UY]9HH
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MNC,S%B!],TV[\'S?VI)J.D:W=:7/<01P7?E1)()@@PK88':X!(R.W;BNIHH
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MQ)+"MG(P!6X#&;?MVE2,G(/.['K7M=% 'G%SX=GUR^^(=EY<D3W,MK)9S,I
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M.AI<(_9\D068$L]Q^] C^9\WPSGN> /P KL)+" ?&2PE%K&!%H$H1@@PA$R
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M9-P]LG&:XJ.-H/"FI>'-7UR>'49KJ83Z5%I2R7-Q(TI*R1L2"^<JP?.!Z\4
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MB1[B4R EXG7G:3AE/S =\5M6WB#P[HGCKQTNLA8Y;B2W4;X2_P!H3[,G[I<
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MVUK?6XF="4M9FF^1F_N@HK*#_C76?#R:SNM9\87>GPM'9SZDDD1,90/F%,N
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M/M([G!SZU7N/%/B__A'->\217FG):Z/?7,2V9M2QN(XI2IW/N^4XX&!U&>_
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M<>#Q@=L=35W4M3UK4_&$WA_1;NWT^.SM([FYNI;?SF9I&8(BKN  PA))SV%
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M26-DMDWF0B6*9!R&,9( ?W!Z<'-;/AKP_!X9T6/3H)7FP[RR2N "[NQ9C@8
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M\^ 0" =IZ,<D# R<\5<MO%6A7>BS:S#JEL=.@)66=FVK&1U#9P0>1P>>1ZT
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M!D^&M#C\-^'[;28IVG2#?B1EP3N=FZ?\"K6HHH **** "BBB@ HHHH ****
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M;5H=+6X6\A,2@*"T;'<,$;#CKTY->PT4 <_X'L&TOP3I-DR7<?E0#$=WM$J
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MN7\-QVWA+P_HNDZE<JNHWK-N)!)FN7S))R/<MU["NHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** &I&D>=B*N3DX&,T[ ]*** "FJBH"%4+DY.!CFG44 -5%4L54 MU
M('6G=*** &JB)G:H7)R<#&36+K7AUM<U"Q>XU&9=.MI$F>P2-=D\B-N0LV-V
M 0#MZ' K<HH K7-C;WDUK+.I9K63S8AN( ;:5R1WX8]?K5FBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ KA?BE]H_L?0_L9B%U_;UEY)F!*;_,^7=CG&<9Q7=5
ME:_X>L/$MA'9Z@)O+CF2=&AE:-U=>58,IR"* .'U$^(+/QQX5OO%0TR6U^TR
M6MH=,WJR7$L9 +A\EEVAAP1@\G-,77-6%H?!QOY_[<_MK[%]JW?O?LG^O\[/
MKY7RY]:ZO3? FBZ;J<.I?Z=>7D&?(EOKV6X\K(P2H=B 2.^,U3T?0KN[\?W_
M (IU/2TL'2U6PM4\Y9&D4,6:4[>!D;0!UP#F@#I;6Q>VO;VX:]N9EN75EAE8
M%(,+C"#' /4YSS5RJ=KIL%G>WMW&TQDO'5Y \I9057:-H/"\#M4M[)<0V<LE
MI;K<7"KF.%I/+#GTW8./RH GK!\:7LUCX2U!K8XNYT%K;?\ 765A&G_CS _A
M57^V/%__ $*5I_X-Q_\ &ZIZA+XGU-K0W/A&W(M;A;F,#6  74$#/[KD#.?J
M!0!A^(+75=+U-;. :[)H5G80P6PT&=!+;.H(+2Q9#/D!<=1@'BM6POX_$NJ>
M$8X;[^T(+>S?4YKDQ>7YKA?)C)3^$DO(<=BE4]5T?7=5U)]1/AB2SNY(Q%-)
M8^(F@,R#. ^V/G&3@]1GK5K2+/7-#F:33_!5I"#;Q6RH-8!"1Q[MJC,?J[$^
MI- $WQ'"LWA9+G']GMKMN+D-]T\/L#?[._;U]JW_ !(VAQV%O+KPB^SI=PF$
MNI)$^X"/;CG.3V]^V:Q-4D\1:UIL^G:CX)L;FTG7;)$^K#!'7_GGP<\@CD5A
M6/AG5K+4+:\D\+S7\EH=UJE_XD>=+<^J*R8!'8\D4 58M*N[C_A8.I6^N:E8
MM9ZA/)!':2A%\Q;>-MSC'S@_*,'C /K5R[UN?63HJ/?:[//-I$-W-IVAH(W#
MR 'S))BR@*>0%R.A/-:45MKT,&K0IX.MPFJR/+=#^VOO,Z!#C]WQ\JCI6=+X
M=UAY;66#PM)9RV]HEEOM/$31&2%/NJY5.<>O7GK0!GZ+KFMZU9>']!N=3O;8
MW6I7]O<70=1<F*WR5C+KD;CP"R]0IP>]1W%OJ7A[5/'%S9:I>74NFC3;S=*X
M:1X4WL\3D?>&S=UYZ?6M-?#-_%HZZ7!X*B@@CNFO(&BUXK)!*>K(_EY7OW[F
MK&DZ/K&CG46@\'I-)J2*EY)<Z\96FVA@"Q:/T8C\O2@#)NO'FH6'B#7=4^U-
M+H]Q;W%OI40Y4W%N(QQ_ON[C_@%/U;7=?\+IK%N=2DGNK+0+'$DQWJMQ),\;
MS8/4]_\ @(JXGAF]31](TL>!;4VFDW(NK13K>2L@);)/E_,,L20>M7[JRUJ^
MO;ZZNO!%G,]]:K9W"OK *O$I8@8\OCECSUH ;K>BSZ'I&HY\4WES'<:3=K)9
MZA*)&G<1D[X^A7'.0 1@C@=:H_#;5K_6+NWM]2DN-/\ [.TRW^QZ9D 3PM&!
M]H8@_/D@@+T7OR:+7PWJUOYQD\*/=L]L]HC7GB)IC#"XPRQ[D^7(QSUX'-7E
ML-;2YTBY3P;;I/I41@M9%UK!$94*4;]W\PP!P>XS0!<\=?\ (=\%?]AH?^B9
M:[2O/_$-CK_B:"VBO_":K]EF\^%[?7C"Z/@KD,L8/0FJEIH>OV=K>VZ^'[V6
M.[B,,GG^*99"H]5+(=I]QS0!Z4_W&^E>&^ =67P1X:BNV7-OJFB?;8$_OW<)
M\LH/=E:+\C7I$6I>+88$A7PE;%44(-VL G &.3Y?-<__ ,(]J!TS1M/;P/;-
M;Z-,LUF&UO)1EY&3Y?(]CZ"@#F;>WO/"&D^.(K:Z>*_MQI1EGC.&:5PIE;/N
MS-^=:'B+_D(>,?\ L/:/_*"MV]TC6-0.K&X\&0-_:IA-UC6\;O*QLQ^[XQ@=
M.M%UI.L7DM])-X,@+7US!=3XUO&9(=NPC]WQC8O'>@#*\07VLZ?J^KWNI7FO
M6]G%<;K34=+9)[2VB4+E9H <Y'S;B0>O&*]6BD2:%)8V#HZAE8="#T->9WWA
MG5;^[NYI/";QPWK^9=VD/B)HX+AN 2Z!,'.!G&,]\UTR:KXMC143PA9JJC
MU8  ?]^Z .IHKE_[8\7_ /0I6G_@W'_QNC^V/%__ $*5I_X-Q_\ &Z .HHKE
M_P"V/%__ $*5I_X-Q_\ &Z/[8\7_ /0I6G_@W'_QN@#J**R=(O=:NY)1JNC0
MV"J!L:.\$^\]QC:N*UJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<^2PSNRAX!Q@C'I6;JT>NZ7\2I-;L/#UQJEG+I$=IN@N(8RKB5V.0[#L1^=
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-0\2R23 O)OM85M&Z_Q"/=MX]:[72M'M])6X,4DTT]S)YL\\[[GD; 49/
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>1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708050839616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-30171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANGAMO THERAPEUTICS, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">68-0359556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7000 Marina Blvd.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Brisbane<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">970-6000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SGMO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163,880,007<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001001233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708049698704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 94,570<span></span>
</td>
<td class="nump">$ 178,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">218,998<span></span>
</td>
<td class="nump">197,676<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestReceivableCurrent', window );">Interest receivable</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">4,522<span></span>
</td>
<td class="nump">6,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">18,007<span></span>
</td>
<td class="nump">15,859<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">336,621<span></span>
</td>
<td class="nump">398,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Marketable securities, non-current</a></td>
<td class="nump">36,700<span></span>
</td>
<td class="nump">88,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">55,986<span></span>
</td>
<td class="nump">51,523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">46,439<span></span>
</td>
<td class="nump">53,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">34,511<span></span>
</td>
<td class="nump">39,702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">64,956<span></span>
</td>
<td class="nump">73,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">17,200<span></span>
</td>
<td class="nump">15,319<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashNoncurrent', window );">Restricted cash</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">593,913<span></span>
</td>
<td class="nump">721,923<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">17,380<span></span>
</td>
<td class="nump">9,759<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Accrued compensation and employee benefits</a></td>
<td class="nump">19,045<span></span>
</td>
<td class="nump">20,840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">14,046<span></span>
</td>
<td class="nump">11,577<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenues</a></td>
<td class="nump">71,890<span></span>
</td>
<td class="nump">85,711<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">122,361<span></span>
</td>
<td class="nump">127,887<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenues, non-current</a></td>
<td class="nump">115,641<span></span>
</td>
<td class="nump">166,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion of lease liabilities</a></td>
<td class="nump">39,705<span></span>
</td>
<td class="nump">44,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income tax</a></td>
<td class="nump">5,740<span></span>
</td>
<td class="nump">6,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">1,312<span></span>
</td>
<td class="nump">1,217<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">284,759<span></span>
</td>
<td class="nump">346,580<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock</a></td>
<td class="nump">1,619<span></span>
</td>
<td class="nump">1,459<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">1,423,105<span></span>
</td>
<td class="nump">1,334,138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(1,096,572)<span></span>
</td>
<td class="num">(956,267)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(18,998)<span></span>
</td>
<td class="num">(3,987)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">309,154<span></span>
</td>
<td class="nump">375,343<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 593,913<span></span>
</td>
<td class="nump">$ 721,923<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708050922832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 26,460,000<span></span>
</td>
<td class="nump">$ 28,563,000<span></span>
</td>
<td class="nump">$ 84,069,000<span></span>
</td>
<td class="nump">$ 82,715,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">65,116,000<span></span>
</td>
<td class="nump">62,498,000<span></span>
</td>
<td class="nump">183,719,000<span></span>
</td>
<td class="nump">179,018,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">16,238,000<span></span>
</td>
<td class="nump">14,501,000<span></span>
</td>
<td class="nump">46,239,000<span></span>
</td>
<td class="nump">47,135,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">81,354,000<span></span>
</td>
<td class="nump">76,999,000<span></span>
</td>
<td class="nump">229,958,000<span></span>
</td>
<td class="nump">226,153,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(54,894,000)<span></span>
</td>
<td class="num">(48,436,000)<span></span>
</td>
<td class="num">(145,889,000)<span></span>
</td>
<td class="num">(143,438,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Interest and other income, net</a></td>
<td class="nump">1,769,000<span></span>
</td>
<td class="nump">834,000<span></span>
</td>
<td class="nump">5,754,000<span></span>
</td>
<td class="nump">3,010,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(53,125,000)<span></span>
</td>
<td class="num">(47,602,000)<span></span>
</td>
<td class="num">(140,135,000)<span></span>
</td>
<td class="num">(140,428,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">30,000<span></span>
</td>
<td class="nump">86,000<span></span>
</td>
<td class="nump">170,000<span></span>
</td>
<td class="nump">373,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(53,155,000)<span></span>
</td>
<td class="num">(47,688,000)<span></span>
</td>
<td class="num">(140,305,000)<span></span>
</td>
<td class="num">(140,801,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to Sangamo Therapeutics, Inc. stockholders, basic</a></td>
<td class="num">(53,155,000)<span></span>
</td>
<td class="num">(47,688,000)<span></span>
</td>
<td class="num">(140,305,000)<span></span>
</td>
<td class="num">(140,790,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss attributable to Sangamo Therapeutics, Inc. stockholders, diluted</a></td>
<td class="num">$ (53,155,000)<span></span>
</td>
<td class="num">$ (47,688,000)<span></span>
</td>
<td class="num">$ (140,305,000)<span></span>
</td>
<td class="num">$ (140,790,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Earnings per share, basic (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.93)<span></span>
</td>
<td class="num">$ (0.98)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Earnings per share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.93)<span></span>
</td>
<td class="num">$ (0.98)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used in computing basic net loss per share attributable to Sangamo Therapeutics, Inc. stockholders (in shares)</a></td>
<td class="nump">158,042<span></span>
</td>
<td class="nump">145,399<span></span>
</td>
<td class="nump">150,850<span></span>
</td>
<td class="nump">144,173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used in computing diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders (in shares)</a></td>
<td class="nump">158,042<span></span>
</td>
<td class="nump">145,399<span></span>
</td>
<td class="nump">150,850<span></span>
</td>
<td class="nump">144,173<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.18)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708050560848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (53,155)<span></span>
</td>
<td class="num">$ (47,688)<span></span>
</td>
<td class="num">$ (140,305)<span></span>
</td>
<td class="num">$ (140,801)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(6,028)<span></span>
</td>
<td class="num">(2,565)<span></span>
</td>
<td class="num">(14,040)<span></span>
</td>
<td class="num">(6,006)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net pension gains</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable securities, net of tax</a></td>
<td class="nump">135<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="num">(1,101)<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive loss</a></td>
<td class="num">(58,993)<span></span>
</td>
<td class="num">(50,298)<span></span>
</td>
<td class="num">(155,316)<span></span>
</td>
<td class="num">(146,843)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Comprehensive loss attributable to non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss attributable to Sangamo Therapeutics, Inc.</a></td>
<td class="num">$ (58,993)<span></span>
</td>
<td class="num">$ (50,298)<span></span>
</td>
<td class="num">$ (155,316)<span></span>
</td>
<td class="num">$ (146,832)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708046353072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive (Loss) Income</div></th>
<th class="th"><div>Non- Controlling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,063,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 497,366<span></span>
</td>
<td class="nump">$ 1,421<span></span>
</td>
<td class="nump">$ 1,269,375<span></span>
</td>
<td class="num">$ (777,981)<span></span>
</td>
<td class="nump">$ 5,419<span></span>
</td>
<td class="num">$ (868)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with at-the-market offering, net of offering expenses (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,007,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with at-the-market offering, net of offering expenses</a></td>
<td class="nump">27,099<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">27,079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax</a></td>
<td class="nump">1,594<span></span>
</td>
<td class="nump">$ 12<span></span>
</td>
<td class="nump">1,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">244,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">2,054<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,052<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">24,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,880<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest', window );">Acquisition of additional shares of Sangamo France</a></td>
<td class="num">(134)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(6,006)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,006)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net pension gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable securities, net of tax</a></td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Buy-out of non-controlling interest</a></td>
<td class="num">(943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">943<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(140,801)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140,790)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,516,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">406,016<span></span>
</td>
<td class="nump">$ 1,455<span></span>
</td>
<td class="nump">1,323,955<span></span>
</td>
<td class="num">(918,771)<span></span>
</td>
<td class="num">(623)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,106,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2021</a></td>
<td class="nump">445,457<span></span>
</td>
<td class="nump">$ 1,451<span></span>
</td>
<td class="nump">1,313,102<span></span>
</td>
<td class="num">(871,083)<span></span>
</td>
<td class="nump">1,987<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with at-the-market offering, net of offering expenses (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with at-the-market offering, net of offering expenses</a></td>
<td class="nump">2,367<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax</a></td>
<td class="nump">617<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">7,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(2,565)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,565)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net pension gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable securities, net of tax</a></td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(47,688)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(47,688)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,516,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2021</a></td>
<td class="nump">406,016<span></span>
</td>
<td class="nump">$ 1,455<span></span>
</td>
<td class="nump">1,323,955<span></span>
</td>
<td class="num">(918,771)<span></span>
</td>
<td class="num">(623)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,921,530<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">375,343<span></span>
</td>
<td class="nump">$ 1,459<span></span>
</td>
<td class="nump">1,334,138<span></span>
</td>
<td class="num">(956,267)<span></span>
</td>
<td class="num">(3,987)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with at-the-market offering, net of offering expenses (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,711,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with at-the-market offering, net of offering expenses</a></td>
<td class="nump">66,448<span></span>
</td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">66,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax</a></td>
<td class="num">(1,838)<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="num">(1,847)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock under employee stock purchase plan</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">1,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">23,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(14,040)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,040)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net pension gains</a></td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable securities, net of tax</a></td>
<td class="num">(1,101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Buy-out of non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(140,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(140,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,918,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">309,154<span></span>
</td>
<td class="nump">$ 1,619<span></span>
</td>
<td class="nump">1,423,105<span></span>
</td>
<td class="num">(1,096,572)<span></span>
</td>
<td class="num">(18,998)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Beginning balance (in shares) at Jun. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">153,352,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="nump">318,281<span></span>
</td>
<td class="nump">$ 1,534<span></span>
</td>
<td class="nump">1,373,324<span></span>
</td>
<td class="num">(1,043,417)<span></span>
</td>
<td class="num">(13,160)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with at-the-market offering, net of offering expenses (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,483,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with at-the-market offering, net of offering expenses</a></td>
<td class="nump">42,174<span></span>
</td>
<td class="nump">$ 85<span></span>
</td>
<td class="nump">42,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax</a></td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">7,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(6,028)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,028)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net pension gains</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable securities, net of tax</a></td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">(53,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(53,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Ending balance (in shares) at Sep. 30, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,918,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">$ 309,154<span></span>
</td>
<td class="nump">$ 1,619<span></span>
</td>
<td class="nump">$ 1,423,105<span></span>
</td>
<td class="num">$ (1,096,572)<span></span>
</td>
<td class="num">$ (18,998)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital Acquisition Of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32262-110900<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=125521441&amp;loc=d3e30755-110894<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708049259936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (140,305)<span></span>
</td>
<td class="num">$ (140,801)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">8,765<span></span>
</td>
<td class="nump">6,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of (discount) premium on marketable securities</a></td>
<td class="num">(324)<span></span>
</td>
<td class="nump">2,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_AmortizationAndOtherChangesInRightOfUseAssets', window );">Amortization and other changes in operating lease right-of-use assets</a></td>
<td class="nump">6,357<span></span>
</td>
<td class="nump">6,104<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_GainLossOnFreeShares', window );">Gain on free shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">23,402<span></span>
</td>
<td class="nump">24,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Gain on disposal of property and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(30)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Net changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet', window );">Interest receivable</a></td>
<td class="num">(175)<span></span>
</td>
<td class="nump">415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">1,491<span></span>
</td>
<td class="num">(2,743)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(5,848)<span></span>
</td>
<td class="num">(6,467)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and other accrued liabilities</a></td>
<td class="nump">9,443<span></span>
</td>
<td class="num">(4,699)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and employee benefits</a></td>
<td class="num">(1,225)<span></span>
</td>
<td class="num">(1,932)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenues</a></td>
<td class="num">(64,956)<span></span>
</td>
<td class="num">(62,292)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="num">(3,298)<span></span>
</td>
<td class="num">(3,227)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="nump">95<span></span>
</td>
<td class="nump">1,204<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(166,578)<span></span>
</td>
<td class="num">(180,537)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of marketable securities</a></td>
<td class="num">(225,621)<span></span>
</td>
<td class="num">(300,387)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities', window );">Maturities of marketable securities</a></td>
<td class="nump">254,990<span></span>
</td>
<td class="nump">509,620<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities', window );">Sales of marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(12,697)<span></span>
</td>
<td class="num">(20,420)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries', window );">Purchase of additional Sangamo France shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(119)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">16,672<span></span>
</td>
<td class="nump">195,564<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(1,962)<span></span>
</td>
<td class="num">(2,988)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">4,582<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">65,125<span></span>
</td>
<td class="nump">30,746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">479<span></span>
</td>
<td class="num">(148)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease) increase in cash, cash equivalents, and restricted cash</a></td>
<td class="num">(84,302)<span></span>
</td>
<td class="nump">45,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, beginning of period</a></td>
<td class="nump">180,372<span></span>
</td>
<td class="nump">132,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash, end of period</a></td>
<td class="nump">96,070<span></span>
</td>
<td class="nump">178,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental cash flow disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Property and equipment included in unpaid liabilities</a></td>
<td class="nump">3,927<span></span>
</td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,349<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_TenantAllowance', window );">Tenant improvement allowance included in contra-lease liability</a></td>
<td class="nump">1,531<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Buy-out of non-controlling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">943<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=sgmo_AtTheMarketOfferingMember', window );">At the Market Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from at-the market offering/ issuance of common stock</a></td>
<td class="nump">65,848<span></span>
</td>
<td class="nump">27,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from at-the market offering/ issuance of common stock</a></td>
<td class="nump">$ 1,115<span></span>
</td>
<td class="nump">$ 2,053<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_AmortizationAndOtherChangesInRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization And Other Changes In Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_AmortizationAndOtherChangesInRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_GainLossOnFreeShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on free shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_GainLossOnFreeShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_TenantAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tenant Allowance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_TenantAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of noncontrolling interest during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale of securities that had been designated as held-to-maturity. Excludes proceeds from maturities, prepayments and calls by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sgmo_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sgmo_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708052167744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Organization and Description of Business</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo Therapeutics, Inc. (&#8220;Sangamo&#8221; or &#8220;the Company&#8221;) was incorporated in the State of Delaware in June 1995 and changed its name from Sangamo Biosciences, Inc. in January 2017. Sangamo is a clinical-stage genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients with serious diseases.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of these financial statements for the periods presented have been included. Operating results for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The Condensed Consolidated Balance Sheet data at December&#160;31, 2021 was derived from the audited Consolidated Financial Statements included in Sangamo&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the &#8220;2021 Annual Report&#8221;) as filed with the SEC on February&#160;24,&#160;2022.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in the Condensed Consolidated Financial Statements. For consolidated entities where the Company owns or is exposed to less than 100% of the economics, the Company records net loss attributable to non-controlling interests on its Condensed Consolidated Statements of Operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements and related financial information should be read together with the audited Consolidated Financial Statements and footnotes for the year ended December&#160;31, 2021, included in the 2021 Annual Report.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity and Management&#8217;s Plan</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo is currently working on a number of long-term development projects that involve experimental technologies. The projects may require several years and substantial expenditures to complete and ultimately may be unsuccessful. The Company plans to finance operations with available cash resources, collaborations and strategic partnerships funds, research grants and from the issuance of equity or debt securities. Sangamo believes that its available cash, cash equivalents, and marketable securities as of September&#160;30, 2022, and expected future milestones and research services revenue from collaborations, strategic partnerships and research grants, will be adequate to fund its currently planned operations through at least the next 12&#160;months from the date these Condensed Consolidated Financial Statements are issued. Sangamo will require substantial additional financial resources to complete the development and commercialization of its product candidates. Additional capital may not be available on terms acceptable to the Company, if at all. If adequate funds are not available, or if the terms of potential funding sources are unfavorable, the Company&#8217;s business and ability to develop its technology and therapeutic products would be harmed. Furthermore, any sales of additional equity securities may result in dilution to the Company&#8217;s stockholders, and any debt financing may include covenants that restrict the Company&#8217;s business.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Significant Accounting Policies</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. On an ongoing basis, management evaluates its estimates including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, income taxes, fair value of assets and liabilities, including from acquisitions, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company recorded an adjustment to revenue related to a change in estimate in connection with the collaboration agreement with Sanofi S.A. (&#8220;Sanofi&#8221;) as a result of an increase in the project costs for its beta thalassemia program and the increase in project scope and the corresponding costs for its sickle cell disease program, both of which resulted in a decrease in the measure of proportional cumulative performance.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This adjustment decreased revenue by $2.5&#160;million, increased net loss by $2.5&#160;million and increased the Company's basic and diluted net loss per share by $0.02 for the three and nine months ended September 30, 2021.</span></div><div style="margin-top:9pt;padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its revenues pursuant to the provisions of Accounting Standards Codification (&#8220;ASC&#8221;) Topic&#160;606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC&#160;Topic&#160;606&#8221;). The Company&#8217;s contract revenues are derived from collaboration agreements including licensing arrangements and research activity grants. Research and licensing agreements typically include upfront signing or license fees, cost reimbursements for research services, minimum sublicense fees, milestone payments and royalties on future licensees&#8217; product sales. The Company has agreements with both fixed and variable consideration. Non-refundable upfront fees and funding of research and development activities are considered fixed, while milestone payments are generally identified as variable consideration. Sangamo&#8217;s research grants are typically multi-year agreements and provide for the reimbursement of qualified expenses for research and development as defined under the terms of the grant agreement. Revenues under research grant agreements are generally recognized when the related qualified research expenses are incurred. Deferred revenue primarily represents the portion of research or license payments received but not earned.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations based on estimated selling prices; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC Topic&#160;606. The Company&#8217;s performance obligations include license rights, development services and services associated with regulatory submission and approval processes. Revenues from research services earned under collaboration agreements are generally recognized as revenue as the related services are provided. Revenues from non-refundable upfront fees are recognized over time either by measuring progress towards satisfaction of the relevant performance obligation, using the input method (i.e., cumulative actual costs incurred relative to total estimated costs) or on a straight-line basis when a performance obligation is expected to be satisfied evenly over a period of time (or when the entity has a stand-ready obligation). Significant management judgment is required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement, which may include total internal personnel costs and external costs to be incurred as well as, in certain cases, the estimated stand-ready obligation period. Changes in these estimates can have a material effect on revenue recognized. If the Company cannot reasonably estimate when its performance obligations either are completed or become inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. The Company includes the unconstrained amount of estimated variable consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint and, if necessary, adjusts its estimate of the overall transaction price. Revenue is then recognized over the remaining estimated period of performance using the cumulative catch-up method. The estimated period of performance and project costs, such as personnel and manufacturing cost, are reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current assumptions regarding the timing of its deliverables.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price of each performance obligation identified in the contract. The Company uses key assumptions to determine the stand-alone selling price, which may include forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical and regulatory success. Related costs and expenses under these arrangements have historically approximated the revenues recognized.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from major collaboration agreements and research activity grants as a percentage of total revenues were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis Institutes for BioMedical Research, Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen MA, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kite Pharma, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi S.A.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Funds received from the Company&#8217;s collaboration partners are generally not refundable and are recorded as revenue as the Company fulfills its performance obligations, which are satisfied over time (i.e., stand ready obligations) or by using the input method (i.e., cumulative actual costs incurred relative to total estimated costs). Revenue is also recognized when the Company has incurred qualified research and development costs that are reimbursable from its collaboration partners and when there is reasonable assurance that such costs will be reimbursed. Any payments received from a collaboration partner in advance of the completion of the relevant performance obligation are recorded as deferred revenue.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo considers all highly liquid investments purchased with original maturities of three months or less at the purchase date to be cash equivalents. Cash and cash equivalents consist of cash, deposits in demand money market accounts and U.S. government-sponsored entity debt securities. Restricted cash consists of a letter of credit for $1.5&#160;million, representing a deposit for the lease of the corporate headquarters in Brisbane, California.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,570&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,872&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,954&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,329&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,070&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,372&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,454&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,829&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708050495200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents, marketable securities, and the free shares asset. Fair value is determined based on a three-tier hierarchy under the authoritative guidance for fair value measurements and disclosures that prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurements and unobservable (i.e., supported by little or no market activity).</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurements of the Company&#8217;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,609&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,764&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Equivalents and Marketable Securities</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generally classifies its marketable securities as Level&#160;2. Instruments are classified as Level&#160;2 when observable market prices for identical securities that are traded in less active markets are used. When observable market prices for identical securities are not available, such instruments are priced using benchmark curves, benchmarking of like securities, sector groupings, matrix pricing and valuation models. These valuation models are proprietary to the pricing providers or brokers and incorporate a number of inputs, including in approximate order of priority: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. For certain security types, additional inputs may be used, or some of the standard inputs may not be applicable. Evaluators may prioritize inputs differently on any given day for any security based on market conditions, and not all inputs listed are available for use in the evaluation process for each security evaluation on any given day.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708050563312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH EQUIVALENTS AND MARKETABLE SECURITIES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">CASH EQUIVALENTS AND MARKETABLE SECURITIES</a></td>
<td class="text">CASH EQUIVALENTS AND MARKETABLE SECURITIES<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s cash equivalents and marketable securities (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302,003&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,609&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,057&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,764&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:12pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of marketable securities by contractual maturity were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:74.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,676&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,845&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no realized gains and losses on the sales of investments during the three and nine months ended September&#160;30, 2022. Realized gains and losses on the sales of investments were insignificant during the three and nine months ended September&#160;30, 2021.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages credit risk associated with its investment portfolio through its investment policy, which limits purchases to high-quality issuers and also limits the amount of its portfolio that can be invested in a single issuer. The Company did not record an allowance for credit losses or other impairment charges related to its marketable securities for the three and nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had unrealized losses related to its marketable securities for the three and nine months ended September&#160;30, 2022 and 2021. The Company had no material unrealized losses, individually and in the aggregate, for marketable </span></div>securities that are in a continuous unrealized loss position for greater than 12 months as of September&#160;30, 2022 and December&#160;31, 2021. Based on the scheduled maturities of its investments, the Company determined that it was more likely than not that it will hold these investments for a period of time sufficient for a recovery of its amortized cost basis. Total unrealized gains for securities with net gains in accumulated other comprehensive income were not material for the three and nine months ended September&#160;30, 2022. The unrealized losses were not attributed to credit risk and were associated with changes in market conditions. The Company periodically reviews its marketable securities for indications of credit losses. The Company considers factors such as the duration, the magnitude and the reason for the decline in value, the potential recovery period, creditworthiness of the issuers of the securities and its intent to sell. For marketable securities, it also considers whether (i)&#160;it is more likely than not that the Company will be required to sell the debt securities before recovery of their amortized cost basis, and (ii)&#160;the amortized cost basis cannot be recovered as a result of credit losses. No significant facts or circumstances have arisen to indicate that there has been any significant deterioration in the creditworthiness of the issuers of the securities held by the Company. Based on the Company&#8217;s review of these securities, including the assessment of the duration and severity of the unrealized losses and the Company&#8217;s ability and intent to hold the investments until maturity, the Company determined that no allowance for credit losses related to its marketable securities was required at either September&#160;30, 2022 or December&#160;31, 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708050563312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIC AND DILUTED NET LOSS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">BASIC AND DILUTED NET LOSS PER SHARE</a></td>
<td class="text">BASIC AND DILUTED NET LOSS PER SHARE<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share attributable to Sangamo Therapeutics, Inc. stockholders has been computed by dividing net loss attributable to Sangamo Therapeutics, Inc. stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders is calculated by dividing net loss attributable to Sangamo Therapeutics, Inc. stockholders by the weighted-average number of shares of common stock outstanding during the period, without consideration of any potential dilutive securities, as their effect would be anti-dilutive.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The total number of shares subject to stock options and restricted stock units (&#8220;RSUs&#8221;) outstanding and the employee stock purchase plan (&#8220;ESPP&#8221;) shares reserved for issuance, which are all anti-dilutive, were excluded from consideration in the calculation of diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders. Stock options and RSUs outstanding and ESPP shares reserved for issuance as of September&#160;30, 2022 and 2021 totaled 18,524,016 and 15,838,002, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708052264832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</a></td>
<td class="text">MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Novartis Institutes for BioMedical Research, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2020, the Company entered into a collaboration and license agreement with Novartis Institutes for BioMedical Research, Inc. (&#8220;Novartis&#8221;) for the research, development and commercialization of gene regulation therapies to treat three neurodevelopmental disorders. Under the agreement, which was effective upon execution, the Company granted Novartis an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize certain of its zinc finger protein (&#8220;ZFP&#8221;) transcription factors (&#8220;ZFP-TFs&#8221;) targeted to three undisclosed genes that are associated with certain neurodevelopmental disorders, including autism spectrum disorder and intellectual disability. The Company is performing early research activities over the collaboration period for each gene target and manufacture the ZFP-TFs required for such research, costs of which are funded by Novartis. Novartis is responsible for additional research activities, studies enabling investigational new drug applications (&#8220;INDs&#8221;), clinical development, regulatory approvals, manufacturing of preclinical, clinical and approved products, and global commercialization. Subject to certain exceptions set forth in the agreement, the Company is prohibited from developing, manufacturing or commercializing any therapeutic product targeting any of the three genes that are the subject of the collaboration. Novartis also has the option to license certain of the Company&#8217;s proprietary adeno-associated viruses (&#8220;AAVs&#8221;) for the sole purpose of developing, manufacturing and commercializing licensed products arising from the collaboration. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement, Novartis paid the Company a $75.0&#160;million upfront license fee in August 2020. In addition to this fee and the cost reimbursements for early research activities, the Company is eligible to earn from Novartis up to $420.0&#160;million in development milestones and up to $300.0&#160;million in commercial milestones. The Company is also eligible to earn from Novartis tiered high single-digit to sub-teen double-digit royalties on potential net commercial sales of licensed products arising from the collaboration. These royalty payments will be subject to reduction due to patent expiration, loss of market exclusivity and payments made under certain licenses for third-party intellectual property. The agreement will continue, on a product-by-product and country-by-country basis, until the expiration of the applicable royalty term. Novartis has the right to terminate the agreement, in its entirety or on a target-by-target basis, for any reason after a specified notice period. Each party also has the right to terminate the agreement on account of the other party&#8217;s bankruptcy or material, uncured breach.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All payments received under the agreement, when earned, are non-refundable and non-creditable. The transaction price of $95.1&#160;million includes the upfront license fee of $75.0&#160;million and estimated research costs of $20.1&#160;million to be provided over the estimated research period. All clinical or regulatory milestone amounts were considered fully constrained at inception of </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the agreement. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at this time is uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will re-evaluate the transaction price, including the estimated variable consideration included in the transaction price and all constrained amounts, in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Novartis in accordance with ASC Topic&#160;606 and concluded that Novartis is a customer. The Company has identified a single performance obligation within this arrangement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Novartis apart from the research services to be performed pursuant to the agreement. As a result, the Company recognizes revenue from the upfront payment based on proportional performance of the ongoing research services through the estimated research period. The estimation of progress towards the satisfaction of performance obligation and project cost is reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current assumptions regarding the timing of its performance obligation. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of $2.0&#160;million and $1.9&#160;million, respectively, and deferred revenue of $17.7&#160;million and $40.9&#160;million, respectively, related to this agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Novartis agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of upfront license fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,514&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,433&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,956&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid $1.5&#160;million for financial advisory fees during the year ended December&#160;31, 2020, equal to 2% of $75.0&#160;million received for the upfront license fee related to the collaboration and license agreement with Novartis. The Company recognized $1.5&#160;million as a contract asset as such amount represents a cost of obtaining the agreement. This balance is amortized and included in general and administrative expenses on a systematic basis consistent with the transfer of the services to Novartis in accordance with ASC Topic&#160;340, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC Topic&#160;340&#8221;). The Company amortized $0.2&#160;million and $0.5&#160;million during the three and nine months ended September&#160;30, 2022, respectively, and $0.2&#160;million and $0.5&#160;million during the three and nine months ended September&#160;30, 2021, respectively.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Biogen MA, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2020, the Company entered into a collaboration and license agreement with Biogen MA, Inc. (&#8220;BIMA&#8221;) and Biogen International GmbH (together with BIMA, &#8220;Biogen&#8221;) for the research, development and commercialization of gene regulation therapies for the treatment of neurological diseases. The companies plan to leverage the Company&#8217;s proprietary ZFP technology delivered via AAV to modulate expression of key genes involved in neurological diseases. Concurrently with the execution of the collaboration agreement, the Company entered into a stock purchase agreement with BIMA, pursuant to which BIMA agreed to purchase 24,420,157 shares of the Company&#8217;s common stock (the &#8220;Biogen Shares&#8221;), at a price per share of $9.2137, for an aggregate purchase price of approximately $225.0&#160;million.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collaboration agreement became effective in April 2020 following the termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and satisfaction of other customary closing conditions, including the payment of $225.0&#160;million for the purchase of the Biogen Shares.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the collaboration agreement, Biogen paid the Company an upfront license fee of $125.0&#160;million in May 2020. The Company is also eligible to receive research, development, regulatory and commercial milestone payments that could total up to approximately $2.4&#160;billion if Biogen selects all of the targets allowed under the agreement and all the specified milestones set forth in the agreement are achieved, which includes up to $925.0&#160;million in pre-approval milestone payments and up to $1.5&#160;billion in first commercial sale and other sales-based milestone payments. In addition, the Company is eligible to receive tiered high single-digit to sub-teen royalties on potential net commercial sales of licensed products arising from the collaboration. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the collaboration agreement, the Company granted to Biogen an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize certain ZFP and/or AAV-based products directed to certain&#160;neurological disease gene targets selected by Biogen. Biogen has already selected four of these: ST-501 to treat tauopathies, ST-502 to treat synucleinopathies including Parkinson&#8217;s disease, a third product candidate targeting DM1, a neuromuscular disease, and a fourth undisclosed neurological disease gene target. Biogen has exclusive rights to nominate up to </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">seven additional targets over the remaining period of five years from the effective date of the collaboration agreement. For each gene target selected by Biogen, the Company performs early research activities, costs of which are shared by the companies, aimed at the development of the combination of proprietary central nervous system delivery vectors and ZFP-TFs (or potential other ZFP products) targeting therapeutically relevant genes. Biogen has assumed responsibility and costs for the IND-enabling studies, clinical development, related regulatory interactions, and global commercialization. The Company is responsible for manufacturing activities for the initial clinical trials for the first three products of the collaboration and plans to leverage its in-house manufacturing capacity, where appropriate, which is currently in development. Biogen is responsible for manufacturing activities beyond the first clinical trial for each of the first three products. The Company&#8217;s research activities for any targets will be performed over the period not to exceed seven years from the effective date of the agreement (i.e., through April 2027). Subject to certain exceptions set forth in the collaboration agreement, the Company is prohibited from developing, manufacturing or commercializing any therapeutic product directed to the targets selected by Biogen.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The collaboration agreement continues on a product-by-product and country-by-country basis until the expiration of all applicable royalty terms. Biogen has the right to terminate the collaboration agreement, in its entirety or on a target-by-target basis, for any reason after a specified notice period, and also has the right to replace up to ten targets. Each party has the right to terminate this agreement on account of the other party&#8217;s bankruptcy or material, uncured breach. In addition, the Company may terminate the collaboration agreement if Biogen challenges any patents licensed by the Company to Biogen.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of the stock purchase agreement, Biogen has agreed not to, without the Company&#8217;s prior written consent and subject to specified conditions and exceptions, directly or indirectly acquire shares of the Company&#8217;s outstanding common stock, seek or propose a tender or exchange offer or merger between the parties, solicit proxies or consents with respect to any matter, or undertake other specified actions related to the potential acquisition of additional equity interests in the Company. Such standstill restrictions expire on the earlier of the three-year anniversary of the effectiveness of the collaboration agreement and the date that Biogen beneficially owns less than 5% of the Company&#8217;s common stock.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the collaboration agreement with Biogen in accordance with ASC Topic&#160;606 and concluded that Biogen is a customer. The transaction price of $204.6&#160;million includes the upfront license fee of $125.0&#160;million and the excess consideration from the stock purchase of $79.6&#160;million, which represents the difference between the $225.0&#160;million received for the purchase of the Biogen Shares and the $145.4&#160;million estimated fair value of the equity issued. The equity issued to Biogen was valued using an option pricing model to reflect certain holding period restrictions. None of the target selection fees and clinical or regulatory milestones have been included in the transaction price, as all such amounts are fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that nomination of additional targets and achievement of the milestones at this time is uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will re-evaluate the transaction price as uncertain events are resolved or other changes in circumstances occur.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified a single performance obligation within the Biogen collaboration agreement, which is a stand-ready obligation consisting of a series of distinct days of research services, during which Biogen obtains access to the Company&#8217;s license and research resources. Revenue from the upfront license fee relates to access to the license and Company&#8217;s obligation to stand-ready to perform such research services corresponding to the targets selected by Biogen. As a result of this obligation to perform research services when and if requested throughout the duration of the contract, the upfront license fee and the excess consideration from the stock purchase will be recognized over time on a straight-line basis consistent with the resources expected to be dedicated to providing the research services through April 2027, the estimated period of the obligation. The estimated period of performance is reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current assumptions regarding the timing of its deliverable. Revenue from the reimbursement by Biogen of shared costs of early research activities performed by Sangamo is recognized as the research services are performed. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of $1.7&#160;million and $2.8&#160;million, respectively, and deferred revenue of $132.1&#160;million and $154.0&#160;million, respectively, related to this agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Biogen agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license and stand-ready fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,967&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,184&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company paid $7.0&#160;million for financial advisory fees during the year ended December&#160;31, 2020, equal to 2% of $225.0&#160;million received for the sale of shares and 2% of $125.0&#160;million received for the upfront fee. The fees incurred related to </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">both the collaboration agreement with Biogen and the stock purchase agreement for the sale of shares. The Company believes that the allocation of fees on a relative fair value basis between the two agreements is reasonable. The Company recognized $4.1&#160;million, which represents 2% of the transaction price of $204.6&#160;million, as a contract asset. This balance is amortized and included in general and administrative expenses on a systematic basis consistent with the transfer of the services to Biogen in accordance with ASC Topic&#160;340. The Company amortized $0.1&#160;million and $0.4&#160;million during the three and nine months ended September&#160;30, 2022, respectively, and $0.1&#160;million and $0.4&#160;million during the three and nine months ended September&#160;30, 2021, respectively. The Company recognized $2.9&#160;million, which represented 2% of the $145.4&#160;million estimated fair value of the equity issued, as a share issuance cost and recorded this amount in equity as a reduction in net proceeds during the year ended December&#160;31, 2020.</span></div><div style="margin-top:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kite Pharma, Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2018, the Company entered into a global collaboration and license agreement with Kite Pharma, Inc. (&#8220;Kite&#8221;), a Gilead Sciences, Inc. subsidiary, which became effective on April 5, 2018 (&#8220;Effective Date&#8221;), and was amended and restated in September 2019, for the research, development, and commercialization of potential engineered cell therapies for cancer. In this collaboration, Sangamo is working together with Kite on a research program under which the companies are designing zinc finger nucleases (&#8220;ZFNs&#8221;) and viral vectors to disrupt and insert certain genes in T-cells and natural killer cells (&#8220;NK-cells&#8221;) including the insertion of genes that encode chimeric antigen receptors (&#8220;CARs&#8221;), T-cell receptors (&#8220;TCRs&#8221;), and NK-cell receptors (&#8220;NKRs&#8221;) directed to mutually agreed targets. Kite is responsible for all clinical development, manufacturing and commercialization of any resulting products.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of this agreement, the Company granted Kite an exclusive, royalty-bearing, worldwide sublicensable license under the Company&#8217;s relevant patents and know-how to develop, manufacture and commercialize, for the purpose of treating cancer, specific cell therapy products that may result from the research program and that are engineered </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex&#160;vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> using selected ZFNs and viral vectors developed under the research program to express CARs, TCRs or NKRs directed to candidate targets.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the research program term and subject to certain exceptions, the Company is prohibited from researching, developing, manufacturing and commercializing, for the purpose of treating cancer, any cell therapy product that, as a result of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> genome editing, expresses a CAR, TCR or NKR that is directed to a target expressed on or in a human cancer cell. After the research program term concludes and subject to certain exceptions, the Company will be prohibited from developing, manufacturing and commercializing, for the purpose of treating cancer, any cell therapy product that, as a result of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ex vivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> genome editing, expresses a CAR, TCR or NKR that is directed to a candidate target.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Effective Date, the Company received a $150.0&#160;million upfront payment from Kite. In addition, Kite reimburses the Company&#8217;s direct costs to conduct the joint research program. Sangamo is also eligible to receive contingent development- and sales-based milestone payments that could total up to $3.0&#160;billion if all of the specified milestones set forth in this agreement are achieved. Of this amount, approximately $1.3&#160;billion relates to the achievement of specified research, clinical development, regulatory and first commercial sale milestones, and approximately $1.8&#160;billion relates to the achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach specified levels. Each development- and sales-based milestone payment is payable (i)&#160;only once for each licensed product, regardless of the number of times that the associated milestone event is achieved by such licensed product, and (ii)&#160;only for the first 10 times that the associated milestone event is achieved regardless of the number of licensed products that may achieve such milestone event. In addition, the Company is entitled to receive escalating, tiered royalty payments with a percentage in the single digits based on future annual worldwide net sales of licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial research term in the agreement is six years from the Effective Date. Kite has an option to extend the research term for up to two additional one-year periods for a separate upfront fee of $10.0&#160;million per year. All contingent payments under the agreement, when earned, will be non-refundable and non-creditable. In connection with the amendment and restatement of the agreement in September 2019, the Company entered into a new research plan with Kite, with estimated reimbursable service cost of approximately $3.4&#160;million, which is included in the total transaction price. The Company concluded the total transaction price under this agreement is $189.3&#160;million and includes the upfront license fee of $150.0&#160;million and $39.3&#160;million estimated reimbursable service costs for identified research projects over the estimated performance period. Further, the Company concluded the estimated fees for the presumed exercise of the research term extension options and all milestone amounts are fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at this time is uncertain and contingent upon future events which are uncertain at this time. The Company will re-evaluate the transaction price including the estimated variable consideration included in the transaction price and all constrained amounts in each reporting period and as uncertain events are resolved or other changes in circumstances occur. None of the development and sales-based milestone payments have been included in the transaction price.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Kite in accordance with ASC Topic&#160;606 and concluded that Kite is a customer. Kite has the right to terminate this agreement in its entirety or on a per licensed product or per candidate target basis for any reason after a specified notice period. Each party has the right to terminate this agreement on account of the other party&#8217;s bankruptcy or material, uncured breach.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified the primary performance obligations within the Kite agreement as: (1)&#160;a license to the technology along with the stand-ready obligation to perform research services, and (2)&#160;the ongoing research services. Revenue from the upfront license fee relates to access to the license and Company&#8217;s obligation to stand-ready to perform such research services as additional targets are selected by Kite. As a result of this obligation to perform research services when and if requested throughout the duration of the contract, the fee for the license and the stand-ready obligation will be recognized over time on a straight-line basis through April 2024, the estimated period of the stand-ready obligation. Revenue from the reimbursable costs related to the integrated service deliverable is recognized as the research services are performed. Related costs and expenses under these arrangements have historically approximated the revenues recognized. The estimated period of performance and project cost is reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current assumptions regarding the timing of its deliverables. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of $0.6&#160;million and $0.1&#160;million, respectively, and deferred revenue of $37.8&#160;million and $56.5&#160;million, respectively, related to this agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Kite agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license and stand-ready fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sanofi S.A.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2014, the Company entered into an exclusive worldwide collaboration and license agreement (&#8220;2014 Collaboration Agreement&#8221;) to develop therapeutics for hemoglobinopathies, focused on beta thalassemia and sickle cell disease (&#8220;SCD&#8221;). The 2014 Collaboration Agreement was originally signed with BIMA, who subsequently assigned it to Bioverativ Inc., which was later acquired by Sanofi. Under the 2014 Collaboration Agreement, the Company was originally jointly conducting two research programs: a beta thalassemia program, which was discontinued in the third quarter of 2021, and the SCD program, which resulted in the development of SAR445136 (now known as BIVV003), a ZFN, gene-edited cell therapy product candidate for the treatment of SCD, which remains active. In December 2021, Sanofi notified the Company of its termination for convenience, effective June 28, 2022 (the &#8220;Termination Date&#8221;), of the 2014 Collaboration Agreement. A termination and transition agreement (the &#8220;Termination and Transition Agreement&#8221;) was executed by the parties on September 6, 2022.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the SCD program, the Company and Sanofi were jointly responsible for research and development activities prior to filing of an IND, but Sanofi was responsible for subsequent worldwide clinical development, manufacturing and commercialization of licensed products developed under the agreement. Subject to the terms of the agreement, the Company had granted Sanofi an exclusive, royalty-bearing license, with the right to grant sublicenses, to use certain ZFP and other technology controlled by the Company for the purpose of researching, developing, manufacturing and commercializing licensed products developed under the agreement. The Company had also granted Sanofi a non-exclusive worldwide, royalty-free fully paid license with the right to grant sublicenses, under the Company&#8217;s interest in certain other intellectual property developed pursuant to the agreement. During the term of the agreement, the Company was not permitted to research, develop, manufacture or commercialize, outside of the agreement, certain gene therapy products that target genes relevant to the licensed products.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the agreement, the Company received an upfront license fee of $20.0&#160;million and was eligible to receive additional payments upon the achievement of specified clinical development, regulatory and sales milestones, as well as royalty payments for each licensed product based on net sales of such product. Sanofi was also to reimburse Sangamo for agreed upon costs incurred in connection with research and development activities conducted by Sangamo. Through the Termination Date, a total of $13.5&#160;million has been received based upon achievement of clinical development milestones. No products have been approved and therefore no royalty fees have been or will be earned under the 2014 Collaboration Agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In its termination notice to the Company, Sanofi indicated that its termination relates to Sanofi&#8217;s change in strategic direction to focus on allogeneic universal genomic medicine approaches rather than autologous personalized cell therapies. As of the Termination Date, the 2014 Collaboration Agreement was terminated in its entirety and following the Termination Date, the Company will not be entitled to receive any further milestone payments or royalties from Sanofi. As of the Termination Date, Sanofi has no further obligations under the 2014 Collaboration Agreement to develop or to fund the development of any </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">collaboration research programs under the 2014 Collaboration Agreement. The licenses granted to Sanofi under the 2014 Collaboration Agreement have been terminated, and the license rights have reverted to the Company.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Termination and Transition Agreement, Sanofi granted to the Company exclusive, worldwide, fully paid, royalty-free, perpetual, irrevocable licenses, with the right to grant sublicenses through multiple tiers, to certain of its intellectual property, to develop, manufacture, use, sell and otherwise commercialize BIVV003, the product candidate in development under the SCD program. The Company has agreed to take on responsibilities for all clinical trials related to BIVV003, including completion of the ongoing clinical trial and the related long-term follow-up study. The Company also assumed all regulatory responsibilities related to BIVV003. Sanofi has agreed to provide post-transition assistance to the Company for up to 90 days after the Termination Date, and transferred or assigned to the Company all documentation, materials, contracts with third parties, and the right to use certain Sanofi-owned equipment related to BIVV003.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi has also agreed to reimburse the Company for the costs of conducting the ongoing clinical trial of BIVV003 and the costs of the long-term follow-up study through December 31, 2023, up to $7.0&#160;million. In addition, should the Company elect not to continue the development of BIVV003 past December 31, 2023, Sanofi will become obligated to reimburse the Company for the costs of the long-term follow-up study incurred after 2023, up to $5.3&#160;million. Sanofi&#8217;s reimbursement obligations will terminate upon certain triggering events, including the Company&#8217;s entering into a contract with a third party for collaboration, partnership, sale, licensing, or divestiture of BIVV003, or if the FDA permits early closure of the clinical trial and/or the long-term follow-up study.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the 2014 Collaboration Agreement with Sanofi in accordance with ASC Topic 606 and concluded that Sanofi was a customer, under that arrangement. The Company identified the performance obligation within this arrangement as a license to the technology combined with ongoing research services activities. The Company concluded that the license was not distinct as it did not have value to Sanofi without the research services. As a result, the Company recognized revenue from the upfront payment and the milestones based on progress of performance of the ongoing research services. The estimation of progress towards the satisfaction of the performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s then-current assumptions regarding the timing of its deliverables. Related costs and expenses under these arrangements have historically approximated the revenues recognized. Sanofi&#8217;s December 2021 notice of termination of the 2014 Collaboration Agreement represented a modification that reduced the expected scope of the Company&#8217;s services and the estimated transaction price and shortened the remaining performance timeline. Consistent with this change, all services under the 2014 Collaboration Agreement were completed by June 28, 2022, and all amounts ultimately included in the transaction price were recognized by such date. The final transaction price of $96.3&#160;million includes the upfront license fee of $20.0&#160;million, two milestone payments in the aggregate amount of $13.5&#160;million and reimbursement of research costs of $62.8&#160;million. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of zero and $0.6&#160;million, respectively, related to the 2014 Collaboration Agreement. Deferred revenue related to the 2014 Collaboration Agreement was zero and $1.1&#160;million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company concluded that Sanofi is not a customer under the Termination and Transition Agreement as Sanofi is not entitled to receive and cannot use the results of the ongoing clinical trial or the long-term follow-up study. This relationship is also not a collaboration in the scope of ASC Topic&#160;808, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Collaborative Arrangements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company concluded that the assets acquired from Sanofi do not represent a business, as substantially all of their value is concentrated in the acquired or re-acquired licenses to intellectual property. The Company has no obligation to repay Sanofi for its ongoing funding of the clinical trial or long-term follow-up study costs. Therefore, the Company will recognize Sanofi reimbursements as reductions of its research and development expense. During the three and nine months ended September&#160;30, 2022, the Company decreased its research and development expense by $0.9&#160;million, which is included within prepaid expenses and other current assets on the Company&#8217;s Condensed Consolidated Balance Sheet as of September&#160;30, 2022. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the 2014 Collaboration Agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Sanofi agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of upfront fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milestone achievement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(467)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2021, the Company recorded an adjustment to revenue related to a change in estimate in connection with the collaboration agreement with Sanofi. This adjustment was a result of an increase in the project costs for its beta thalassemia program and the increase in project scope and the corresponding costs for its SCD program, both of which resulted in a decrease </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the measure of proportional cumulative performance. This adjustment decreased revenue by $2.5&#160;million, increased net loss by $2.5&#160;million and increased the Company's basic and diluted net loss per share by $0.02 for the three and nine months ended September 30, 2021.</span></div><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pfizer Inc.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Giroctocogene Fitelparvovec Global Collaboration and License Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2017, the Company entered into an exclusive global collaboration and license agreement with Pfizer Inc. (&#8220;Pfizer&#8221;), pursuant to which it established a collaboration for the research, development and commercialization of giroctocogene fitelparvovec, its gene therapy product candidate for hemophilia A, and closely related products.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under this agreement, the Company is responsible for conducting the Phase 1/2 clinical trial and for certain manufacturing activities for giroctocogene fitelparvovec, while Pfizer is responsible for subsequent worldwide development, manufacturing, marketing and commercialization of giroctocogene fitelparvovec. Sangamo may also collaborate in the research and development of additional AAV-based gene therapy products for hemophilia A.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of the agreement, the Company granted Pfizer an exclusive worldwide royalty-bearing license, with the right to grant sublicenses, to use certain technology controlled by the Company for the purpose of developing, manufacturing and commercializing giroctocogene fitelparvovec and related products. Pfizer granted the Company a non-exclusive, worldwide, royalty-free, fully paid license, with the right to grant sublicenses, to use certain manufacturing technology developed under the agreement and controlled by Pfizer to manufacture the Company&#8217;s products that utilize the AAV delivery system. During a specified period, neither the Company nor Pfizer is permitted to clinically develop or commercialize, outside of the collaboration, certain AAV-based gene therapy products for hemophilia A.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement has a term that continues on a per product and per country basis until the later of (i) the expiration of patent claims that cover the product in a country, (ii) the expiration of regulatory exclusivity for a product in a country, and (iii) fifteen years after the first commercial sale of a product in a country. Pfizer has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec and related products will automatically terminate. Upon termination by the Company for cause or by Pfizer in any country or countries, Pfizer will automatically grant the Company an exclusive, royalty-bearing license under certain technology controlled by Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec in the terminated country or countries.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon execution of the agreement, the Company received an upfront fee of $70.0&#160;million and is eligible to receive up to $208.5&#160;million in payments upon the achievement of specified clinical development, intellectual property and regulatory milestones and up to $266.5&#160;million in payments upon first commercial sale milestones for giroctocogene fitelparvovec and potentially other products. The total amount of potential clinical development, intellectual property, regulatory and first commercial sale milestone payments, assuming the achievement of all specified milestones in the agreement, is up to $475.0&#160;million, which includes up to $300.0&#160;million for giroctocogene fitelparvovec and up to $175.0&#160;million for other products that may be developed under the agreement, subject to reduction on account of payments made under certain licenses for third-party intellectual property. In addition, Pfizer agreed to pay the Company royalties for each potential licensed product developed under the agreement that are an escalating tiered, double-digit percentage of the annual net sales of such product and are subject to reduction due to patent expiration, entry of biosimilar products to the market and payment made under certain licenses for third-party intellectual property. To date, two milestones of $55.0&#160;million in aggregate have been achieved and paid, however no products have been approved and therefore no royalty fees have been earned under the agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer is a customer. The total transaction price under this agreement was $134.0&#160;million, which represented the upfront fee and research services fees of $79.0&#160;million and fees related to two achieved milestones in an aggregate amount of $55.0&#160;million. Sangamo was responsible for internal and external research costs as part of the upfront fee and had the ability to request additional reimbursement from Pfizer if certain conditions were met. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will re-evaluate the transaction price, including its estimated variable consideration included in the transaction price and all constrained amounts, in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has identified the performance obligations within the agreement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Pfizer apart from the research services to be performed by the Company pursuant to the agreement. As a result, the Company recognized </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period during which the Company performed research services. The estimation of progress towards the satisfaction of its performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s assumptions regarding the timing of its deliverables.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, the Company satisfied the deliverables and research services responsibilities within the arrangement. As a result, the Company recognized the remaining deferred revenue from the upfront payment in December 2020 and no revenues have been recognized during the three and nine months ended September&#160;30, 2022 and 2021.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">C9ORF72 Research Collaboration and License Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2017, the Company entered into a separate exclusive, global collaboration and license agreement with Pfizer for the development and commercialization of potential gene therapy products that use ZFP-TFs to treat amyotrophic lateral sclerosis and frontotemporal lobar degeneration linked to mutations of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene. Pursuant to this agreement, the Company agreed to work with Pfizer on a research program to identify, characterize and preclinically develop ZFP-TFs that bind to and specifically reduce expression of the mutant form of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of this agreement, the Company granted Pfizer an exclusive, royalty-bearing, worldwide license under the Company&#8217;s relevant patents and know-how to develop, manufacture and commercialize gene therapy products that use resulting ZFP-TFs that satisfy pre-agreed criteria. During a specified period, neither the Company nor Pfizer will be permitted to research, develop, manufacture or commercialize outside of the collaboration any ZFPs that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless earlier terminated, the agreement has a term that continues on a per licensed product and per country basis until the later of (i) the expiration of patent claims that cover the licensed product in a country, (ii) the expiration of regulatory exclusivity for a licensed product in a country, and (iii) 15 years after the first commercial sale of a licensed product in a major market country. Pfizer also has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. The agreement will also terminate if the Company is unable to identify any lead candidates for development within a specified period of time or if Pfizer elects not to advance a lead candidate beyond a certain development milestone within a specified period of time. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize licensed products under the agreement will automatically terminate. Upon termination by the Company for cause or by Pfizer without cause for any licensed product or licensed products in any country or countries, the Company will have the right to negotiate with Pfizer to obtain a non-exclusive, royalty-bearing license under certain technology controlled by Pfizer to develop, manufacture and commercialize the licensed product or licensed products in the terminated country or countries.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following termination by the Company for Pfizer&#8217;s material breach, Pfizer will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene for a period of time. Following termination by Pfizer for the Company&#8217;s material breach, the Company will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> gene for a period of time.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company received a $12.0&#160;million upfront payment from Pfizer and is eligible to receive up to $60.0&#160;million in development milestone payments from Pfizer contingent on the achievement of specified preclinical development, clinical development and first commercial sale milestones, and up to $90.0&#160;million in commercial milestone payments if annual worldwide net sales of the licensed products reach specified levels. In addition, Pfizer will pay the Company royalties based on an escalating tiered, mid- to high-single digit percentage of the annual worldwide net sales of the licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property. Each party will be responsible for the cost of its performance of the research program. Pfizer will be operationally and financially responsible for subsequent development, manufacturing and commercialization of the licensed products. To date, a milestone of $5.0&#160;million has been achieved and paid, however no products have been approved and therefore no royalty fees have been earned under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C9ORF72</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Pfizer agreement.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer was a customer. The Company concluded the total transaction price under this agreement was $17.0&#160;million, which represented the upfront fees of $12.0&#160;million and fees related to achievement of one milestone in the amount of $5.0&#160;million. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will evaluate the transaction price, including its estimated variable consideration included in the transaction price and all constrained amounts, in each reporting period and as uncertain events are resolved or other changes in circumstances occur.</span></div>The Company had identified the performance obligations within this agreement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Pfizer apart from the services to be performed by the Company pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period the Company performed research services.The Company satisfied the deliverables and research services responsibilities within the arrangement in September 2020, and as a result, earned a $5.0&#160;million milestone, which the Company recognized on a cumulative basis during the year ended December 31, 2020. In addition, the Company recognized the remaining deferred revenue from the upfront payment in September 2020 and no revenues have been recognized during the three and nine months ended September&#160;30, 2022 and 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -URI https://asc.fasb.org/topic&amp;trid=5833765<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708052206608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows total stock-based compensation expense included in the Condensed Consolidated Statements of Operations (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,873&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,880&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708052241952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">At-the-Market Offering Agreement</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the Company entered into an Open Market Sale Agreement&#8480; with Jefferies LLC (&#8220;Jefferies&#8221;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of the Company&#8217;s common stock having an aggregate offering price of up to $150.0&#160;million through Jefferies as the Company&#8217;s sales agent or principal. The Company is not obligated to sell any shares under the sales agreement. During the three and nine months ended September&#160;30, 2022, the Company sold 8,483,104 and 14,711,770 shares of its common stock for net proceeds of approximately $42.2&#160;million and $66.4&#160;million, respectively, of which approximately $0.6&#160;million was received in October 2022 and recorded within prepaid expenses and other current assets on the Company&#8217;s Condensed Consolidated Balance Sheet as of September&#160;30, 2022. During the three and nine months ended September&#160;30, 2021, the Company sold 202,705 and 2,007,932 shares of its common stock for net proceeds of approximately $2.4&#160;million, and $27.1&#160;million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708052137952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period. During the three and nine months ended September&#160;30, 2022, the Company recorded income tax expense of $0.1&#160;million and $0.2&#160;million, respectively. During the three and nine months ended September&#160;30, 2021, the Company recorded income tax expense of $0.1&#160;million and $0.4&#160;million, respectively.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company continues to maintain a full valuation allowance on its U.S. federal and state net deferred tax assets and on the Sangamo France net deferred tax assets, as the Company believes it is not more likely than not that these benefits will be realized. The tax expense for the three and nine months ended September&#160;30, 2022 was primarily due to foreign income tax expense.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Coronavirus Aid, Relief, and Economic Security Act, enacted on March 27, 2020, provided an Employee Retention Credit (&#8220;ERC&#8221;), which is a refundable payroll tax credit that encouraged businesses to keep employees on the payroll during the COVID-19 pandemic. Eligible employers could qualify for up to $5,000 of credit for each employee based on certain wages paid after March 12, 2020 and before January 1, 2021 and extended to September 30, 2021. Based on the Company&#8217;s evaluation of this provision and the significant pandemic-related impacts on the operations, the Company recognized zero and $3.0&#160;million of ERC for the three and nine months ended September&#160;30, 2022, respectively, within interest and other income, net in Condensed Consolidated Statement of Operations upon filing for the refund in January and April 2022. No refund has been received during the three and nine months ended September&#160;30, 2022 and the amount has been recorded within prepaid expenses and other current assets on the Company&#8217;s Condensed Consolidated Balance Sheet as of September&#160;30, 2022.</span></div>On August 16, 2022, the Inflation Reduction Act of 2022 was signed into law, with tax provisions primarily focused on implementing a 15% minimum tax on global adjusted financial statement income and a 1% excise tax on share repurchases. The Inflation Reduction Act of 2022 will become effective beginning in 2023. Given its recent pronouncement, it is unclear at this time what, if any, impact the Inflation Reduction Act of 2022 will have on the Company's tax rate and financial results. Currently, the Company does not anticipate any material impact on its consolidated audited financial statements and will continue to evaluate its impact as further information becomes available.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708050924880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#8220;U.S. GAAP&#8221;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of these financial statements for the periods presented have been included. Operating results for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The Condensed Consolidated Balance Sheet data at December&#160;31, 2021 was derived from the audited Consolidated Financial Statements included in Sangamo&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the &#8220;2021 Annual Report&#8221;) as filed with the SEC on February&#160;24,&#160;2022.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in the Condensed Consolidated Financial Statements. For consolidated entities where the Company owns or is exposed to less than 100% of the economics, the Company records net loss attributable to non-controlling interests on its Condensed Consolidated Statements of Operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties. </span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements and related financial information should be read together with the audited Consolidated Financial Statements and footnotes for the year ended December&#160;31, 2021, included in the 2021 Annual Report.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. On an ongoing basis, management evaluates its estimates including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, income taxes, fair value of assets and liabilities, including from acquisitions, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for </span></div>making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-top:9pt;padding-left:18pt;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for its revenues pursuant to the provisions of Accounting Standards Codification (&#8220;ASC&#8221;) Topic&#160;606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC&#160;Topic&#160;606&#8221;). The Company&#8217;s contract revenues are derived from collaboration agreements including licensing arrangements and research activity grants. Research and licensing agreements typically include upfront signing or license fees, cost reimbursements for research services, minimum sublicense fees, milestone payments and royalties on future licensees&#8217; product sales. The Company has agreements with both fixed and variable consideration. Non-refundable upfront fees and funding of research and development activities are considered fixed, while milestone payments are generally identified as variable consideration. Sangamo&#8217;s research grants are typically multi-year agreements and provide for the reimbursement of qualified expenses for research and development as defined under the terms of the grant agreement. Revenues under research grant agreements are generally recognized when the related qualified research expenses are incurred. Deferred revenue primarily represents the portion of research or license payments received but not earned.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations based on estimated selling prices; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC Topic&#160;606. The Company&#8217;s performance obligations include license rights, development services and services associated with regulatory submission and approval processes. Revenues from research services earned under collaboration agreements are generally recognized as revenue as the related services are provided. Revenues from non-refundable upfront fees are recognized over time either by measuring progress towards satisfaction of the relevant performance obligation, using the input method (i.e., cumulative actual costs incurred relative to total estimated costs) or on a straight-line basis when a performance obligation is expected to be satisfied evenly over a period of time (or when the entity has a stand-ready obligation). Significant management judgment is required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement, which may include total internal personnel costs and external costs to be incurred as well as, in certain cases, the estimated stand-ready obligation period. Changes in these estimates can have a material effect on revenue recognized. If the Company cannot reasonably estimate when its performance obligations either are completed or become inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. The Company includes the unconstrained amount of estimated variable consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint and, if necessary, adjusts its estimate of the overall transaction price. Revenue is then recognized over the remaining estimated period of performance using the cumulative catch-up method. The estimated period of performance and project costs, such as personnel and manufacturing cost, are reviewed quarterly and adjusted, as needed, to reflect the Company&#8217;s current assumptions regarding the timing of its deliverables.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price of each performance obligation identified in the contract. The Company uses key assumptions to determine the stand-alone selling price, which may include forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical and regulatory success. Related costs and expenses under these arrangements have historically approximated the revenues recognized.</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from major collaboration agreements and research activity grants as a percentage of total revenues were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis Institutes for BioMedical Research, Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen MA, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kite Pharma, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi S.A.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Funds received from the Company&#8217;s collaboration partners are generally not refundable and are recorded as revenue as the Company fulfills its performance obligations, which are satisfied over time (i.e., stand ready obligations) or by using the input method (i.e., cumulative actual costs incurred relative to total estimated costs). Revenue is also recognized when the Company has incurred qualified research and development costs that are reimbursable from its collaboration partners and when there is reasonable assurance that such costs will be reimbursed. Any payments received from a collaboration partner in advance of the completion of the relevant performance obligation are recorded as deferred revenue.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sangamo considers all highly liquid investments purchased with original maturities of three months or less at the purchase date to be cash equivalents. Cash and cash equivalents consist of cash, deposits in demand money market accounts and U.S. government-sponsored entity debt securities. Restricted cash consists of a letter of credit for $1.5&#160;million, representing a deposit for the lease of the corporate headquarters in Brisbane, California.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents, marketable securities, and the free shares asset. Fair value is determined based on a three-tier hierarchy under the authoritative guidance for fair value measurements and disclosures that prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and</span></div><div style="margin-top:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurements and unobservable (i.e., supported by little or no market activity).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708054353776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock', window );">Schedule of Revenue from Strategic Partnering Collaboration Agreements and Research Activity Grants as a Percentage of Total Revenues</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from major collaboration agreements and research activity grants as a percentage of total revenues were as follows:</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Novartis Institutes for BioMedical Research, Inc.</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biogen MA, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kite Pharma, Inc.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi S.A.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash and Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,570&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,872&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,954&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,329&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,070&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,372&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,454&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,829&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock', window );">Restrictions on Cash and Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,570&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,872&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176,954&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,329&#160;</span></td><td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,070&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180,372&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,454&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,829&#160;</span></td><td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Revenue From Strategic Partnering Collaboration Agreements And Research Activity Grants As A Percentage Of Total Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708052236096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS - (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock', window );">Summary of Fair Value Measurements of Cash Equivalents and Marketable Securities</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurements of the Company&#8217;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,888&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,773&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,698&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,609&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,764&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,845&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2C<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=SL7498348-110258<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708052140592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesTextBlock', window );">Marketable Securities</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below summarizes the Company&#8217;s cash equivalents and marketable securities (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:50.349%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,832&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,392&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(375)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(162)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,888&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,039&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(268)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,773&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. treasury bills</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,922&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,478&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,698&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302,003&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,412)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300,609&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr style="height:11pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,919&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. government-sponsored entity debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,792&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,757&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,701&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,116&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,845&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">406,057&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(304)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">405,764&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Fair value of investments available-for-sale</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of marketable securities by contractual maturity were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"><tr><td style="width:1.0%"/><td style="width:74.986%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.524%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 30,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing in one year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218,998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,676&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturing after one year through five years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255,698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285,845&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708049242880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock', window );">Revenues Recognized under Agreement</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Novartis agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of upfront license fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,093&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,222&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,028&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,421&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,610&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,514&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,433&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,956&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock', window );">Revenues Recognized under Agreement</a></td>
<td class="text"><div style="margin-top:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands): </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Biogen agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license and stand-ready fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,306&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,918&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,266&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,413&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,967&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,184&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock', window );">Revenues Recognized under Agreement</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Kite agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of license and stand-ready fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,296&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,915&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,409&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,557&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock', window );">Revenues Recognized under Agreement</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues recognized under the 2014 Collaboration Agreement were as follows (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue related to Sanofi agreement:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognition of upfront fee</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(692)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Milestone achievement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(467)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(759)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,260&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,258&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 808<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6931272&amp;loc=SL5834143-161434<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_SanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_SanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708052264832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows total stock-based compensation expense included in the Condensed Consolidated Statements of Operations (in thousands):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,935&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,938&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,793&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,873&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,402&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,880&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708049684032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">102 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Change in Accounting Estimate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Decreased revenue</a></td>
<td class="num">$ (26,460)<span></span>
</td>
<td class="num">$ (28,563)<span></span>
</td>
<td class="num">$ (84,069)<span></span>
</td>
<td class="num">$ (82,715)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Increased net loss</a></td>
<td class="nump">$ 53,155<span></span>
</td>
<td class="nump">$ 47,688<span></span>
</td>
<td class="nump">$ 140,305<span></span>
</td>
<td class="nump">$ 140,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Increased earnings per share, basic (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.93)<span></span>
</td>
<td class="num">$ (0.98)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Increased earnings per share, diluted (in dollars per share)</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.93)<span></span>
</td>
<td class="num">$ (0.98)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letter of credit established as a deposit</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Change in Accounting Estimate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Decreased revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 759<span></span>
</td>
<td class="num">$ (3,260)<span></span>
</td>
<td class="num">$ (1,258)<span></span>
</td>
<td class="num">$ (13,500)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi S.A. | Change In Collaboration Agreement Scope | Collaboration agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ChangeInAccountingEstimateLineItems', window );"><strong>Change in Accounting Estimate [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Decreased revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Increased net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Increased earnings per share, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Increased earnings per share, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_SanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_SanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInCollaborationAgreementScopeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInCollaborationAgreementScopeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708049691504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration Agreements and Research Activity Grants (Detail) - Revenue from contract with customer - Customer concentration risk<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenues</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenues</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">36.00%<span></span>
</td>
<td class="nump">39.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenues</a></td>
<td class="nump">26.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Percentage of revenues</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(3.00%)<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_SanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_SanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708050952672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 94,570<span></span>
</td>
<td class="nump">$ 178,872<span></span>
</td>
<td class="nump">$ 176,954<span></span>
</td>
<td class="nump">$ 131,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent', window );">Non-current restricted cash</a></td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows</a></td>
<td class="nump">$ 96,070<span></span>
</td>
<td class="nump">$ 180,372<span></span>
</td>
<td class="nump">$ 178,454<span></span>
</td>
<td class="nump">$ 132,829<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708046229856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">$ 255,698<span></span>
</td>
<td class="nump">$ 285,845<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">44,911<span></span>
</td>
<td class="nump">119,919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">23,392<span></span>
</td>
<td class="nump">30,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">120,386<span></span>
</td>
<td class="nump">105,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">14,888<span></span>
</td>
<td class="nump">33,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">37,773<span></span>
</td>
<td class="nump">70,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">16,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">42,337<span></span>
</td>
<td class="nump">45,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">44,911<span></span>
</td>
<td class="nump">119,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">255,698<span></span>
</td>
<td class="nump">285,845<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total cash equivalents and marketable securities and free shares asset</a></td>
<td class="nump">300,609<span></span>
</td>
<td class="nump">405,764<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">44,911<span></span>
</td>
<td class="nump">119,919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">23,392<span></span>
</td>
<td class="nump">30,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">120,386<span></span>
</td>
<td class="nump">105,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">14,888<span></span>
</td>
<td class="nump">33,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">37,773<span></span>
</td>
<td class="nump">70,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">16,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">42,337<span></span>
</td>
<td class="nump">45,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">44,911<span></span>
</td>
<td class="nump">119,919<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total cash equivalents and marketable securities and free shares asset</a></td>
<td class="nump">44,911<span></span>
</td>
<td class="nump">119,919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">44,911<span></span>
</td>
<td class="nump">119,919<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 1 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">255,698<span></span>
</td>
<td class="nump">285,845<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total cash equivalents and marketable securities and free shares asset</a></td>
<td class="nump">255,698<span></span>
</td>
<td class="nump">285,845<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">23,392<span></span>
</td>
<td class="nump">30,614<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">120,386<span></span>
</td>
<td class="nump">105,757<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">14,888<span></span>
</td>
<td class="nump">33,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">37,773<span></span>
</td>
<td class="nump">70,701<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">16,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 2 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">42,337<span></span>
</td>
<td class="nump">45,091<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total cash equivalents and marketable securities and free shares asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Total cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair value on recurring basis | Level 3 | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Total marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708046533376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents, Amortized Cost</a></td>
<td class="nump">$ 94,570<span></span>
</td>
<td class="nump">$ 178,872<span></span>
</td>
<td class="nump">$ 176,954<span></span>
</td>
<td class="nump">$ 131,329<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale securities, Amortized Cost</a></td>
<td class="nump">257,092<span></span>
</td>
<td class="nump">286,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale securities, Gross Unrealized Gains</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale securities, Gross Unrealized (Losses)</a></td>
<td class="num">(1,412)<span></span>
</td>
<td class="num">(304)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, Estimated Fair Value</a></td>
<td class="nump">255,698<span></span>
</td>
<td class="nump">285,845<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost', window );">Total cash equivalents and available-for-sale securities, Amortized Cost</a></td>
<td class="nump">302,003<span></span>
</td>
<td class="nump">406,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax', window );">Total cash equivalents and available-for-sale securities, Gross Unrealized Gains</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax', window );">Total cash equivalents and available-for-sale securities, Gross Unrealized (Losses)</a></td>
<td class="num">(1,412)<span></span>
</td>
<td class="num">(304)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsAndAvailableForSaleSecurities', window );">Total cash equivalents and available-for-sale securities, Estimated Fair Value</a></td>
<td class="nump">300,609<span></span>
</td>
<td class="nump">405,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents, Amortized Cost</a></td>
<td class="nump">44,911<span></span>
</td>
<td class="nump">119,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax', window );">Cash equivalents, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax', window );">Cash equivalents, Gross Unrealized (Losses)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, Estimated Fair Value</a></td>
<td class="nump">44,911<span></span>
</td>
<td class="nump">119,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashEquivalentsMember', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash equivalents, Amortized Cost</a></td>
<td class="nump">44,911<span></span>
</td>
<td class="nump">119,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax', window );">Cash equivalents, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax', window );">Cash equivalents, Gross Unrealized (Losses)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents, Estimated Fair Value</a></td>
<td class="nump">44,911<span></span>
</td>
<td class="nump">119,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember', window );">U.S. government-sponsored entity debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale securities, Amortized Cost</a></td>
<td class="nump">23,832<span></span>
</td>
<td class="nump">30,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale securities, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale securities, Gross Unrealized (Losses)</a></td>
<td class="num">(440)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, Estimated Fair Value</a></td>
<td class="nump">23,392<span></span>
</td>
<td class="nump">30,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale securities, Amortized Cost</a></td>
<td class="nump">120,750<span></span>
</td>
<td class="nump">105,792<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale securities, Gross Unrealized Gains</a></td>
<td class="nump">11<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale securities, Gross Unrealized (Losses)</a></td>
<td class="num">(375)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, Estimated Fair Value</a></td>
<td class="nump">120,386<span></span>
</td>
<td class="nump">105,757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale securities, Amortized Cost</a></td>
<td class="nump">15,050<span></span>
</td>
<td class="nump">33,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale securities, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale securities, Gross Unrealized (Losses)</a></td>
<td class="num">(162)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, Estimated Fair Value</a></td>
<td class="nump">14,888<span></span>
</td>
<td class="nump">33,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale securities, Amortized Cost</a></td>
<td class="nump">38,039<span></span>
</td>
<td class="nump">70,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale securities, Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale securities, Gross Unrealized (Losses)</a></td>
<td class="num">(268)<span></span>
</td>
<td class="num">(107)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, Estimated Fair Value</a></td>
<td class="nump">37,773<span></span>
</td>
<td class="nump">70,701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember', window );">U.S. treasury bills</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale securities, Amortized Cost</a></td>
<td class="nump">16,943<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale securities, Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale securities, Gross Unrealized (Losses)</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, Estimated Fair Value</a></td>
<td class="nump">16,922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>ASSETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale securities, Amortized Cost</a></td>
<td class="nump">42,478<span></span>
</td>
<td class="nump">45,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale securities, Gross Unrealized Gains</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale securities, Gross Unrealized (Losses)</a></td>
<td class="num">(146)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale securities, Estimated Fair Value</a></td>
<td class="nump">$ 42,337<span></span>
</td>
<td class="nump">$ 45,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashEquivalentsAndAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and available for sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashEquivalentsAndAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and available for Sale Securities Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and available for sale securities, gross unrealized gain, before tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash equivalents and available for sale securities, gross unrealized loss, before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Equivalents Gross Unrealized Gain Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Equivalents, Gross Unrealized Loss, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708050674720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of cost and estimated fair value of short-term investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Maturing in one year or less</a></td>
<td class="nump">$ 218,998<span></span>
</td>
<td class="nump">$ 197,676<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Maturing after one year through five years</a></td>
<td class="nump">36,700<span></span>
</td>
<td class="nump">88,169<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents', window );">Total</a></td>
<td class="nump">$ 255,698<span></span>
</td>
<td class="nump">$ 285,845<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Including US Government-Sponsored Enterprises Classified as Cash and Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708054269424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealizedInvestmentGainsLosses', window );">Realized investment gains (losses)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded', window );">Allowance for credit loss related to marketable securities, not previously recorded</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings', window );">Other impairment charges related to marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss', window );">Allowance for credit loss related to marketable securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), for which no credit loss was previously recorded.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922900-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8A<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=SL6284422-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealizedInvestmentGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.3(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealizedInvestmentGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708052229136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIC AND DILUTED NET LOSS PER SHARE - Additional Information (Detail) - shares<br></strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options and RSUs outstanding (in shares)</a></td>
<td class="nump">18,524,016<span></span>
</td>
<td class="nump">15,838,002<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708046325984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 27, 2020</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostGross', window );">Contract asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc. | Collaboration And License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Proceeds from collaborators</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementTransactionPrice', window );">Collaborative arrangement transaction price</a></td>
<td class="nump">$ 95,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementLicenseFee', window );">License fee</a></td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts', window );">Collaborative arrangement estimated reimbursable service costs</a></td>
<td class="nump">20,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,900<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue', window );">Financial advisory fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeAgreementPercentOfInitialRecognition', window );">Percent of initial recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc. | Collaboration And License Agreement | Achievement Of Specified Preclinical Development Clinical Development And First Commercial Sale Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="nump">420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc. | Collaboration And License Agreement | Achievement Of Commercial Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Arrangement, Commission Fee, Portion Of Gross Proceeds, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeAgreementPercentOfInitialRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Agreement, Percent Of Initial Recognition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeAgreementPercentOfInitialRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement estimated reimbursable service costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementLicenseFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, License Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementLicenseFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Customer contract liability milestone payment eligible to receive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126905575&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from collaborators during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfCommercialMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfCommercialMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708046041472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">102 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Jun. 28, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 26,460<span></span>
</td>
<td class="nump">$ 28,563<span></span>
</td>
<td class="nump">$ 84,069<span></span>
</td>
<td class="nump">$ 82,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">9,610<span></span>
</td>
<td class="nump">11,514<span></span>
</td>
<td class="nump">29,433<span></span>
</td>
<td class="nump">28,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc. | Recognition of upfront fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">7,582<span></span>
</td>
<td class="nump">9,093<span></span>
</td>
<td class="nump">23,222<span></span>
</td>
<td class="nump">22,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember', window );">Novartis Institutes for BioMedical Research, Inc. | Research services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,028<span></span>
</td>
<td class="nump">2,421<span></span>
</td>
<td class="nump">6,211<span></span>
</td>
<td class="nump">6,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">9,413<span></span>
</td>
<td class="nump">10,967<span></span>
</td>
<td class="nump">30,658<span></span>
</td>
<td class="nump">32,184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc. | Recognition of upfront fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">7,306<span></span>
</td>
<td class="nump">7,306<span></span>
</td>
<td class="nump">21,918<span></span>
</td>
<td class="nump">21,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc. | Research services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,107<span></span>
</td>
<td class="nump">3,661<span></span>
</td>
<td class="nump">8,740<span></span>
</td>
<td class="nump">10,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">6,915<span></span>
</td>
<td class="nump">6,409<span></span>
</td>
<td class="nump">19,557<span></span>
</td>
<td class="nump">19,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Recognition of upfront fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">6,296<span></span>
</td>
<td class="nump">6,296<span></span>
</td>
<td class="nump">18,682<span></span>
</td>
<td class="nump">18,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Research services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">619<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">875<span></span>
</td>
<td class="nump">339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(759)<span></span>
</td>
<td class="nump">3,260<span></span>
</td>
<td class="nump">1,258<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi | Recognition of upfront fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,125)<span></span>
</td>
<td class="nump">677<span></span>
</td>
<td class="num">(692)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi | Research services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,125<span></span>
</td>
<td class="nump">2,126<span></span>
</td>
<td class="nump">2,417<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi | Milestone achievement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (759)<span></span>
</td>
<td class="nump">$ 457<span></span>
</td>
<td class="num">$ (467)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_NovartisInstitutesForBioMedicalResearchIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseAndServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgmo_ResearchServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgmo_ResearchServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_SanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_SanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgmo_MilestoneAchievementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgmo_MilestoneAchievementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708046634720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Detail)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2020 </div>
<div>USD ($) </div>
<div>product_target </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc. | Stock purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,420,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.2137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementStandstillRestrictionPeriod', window );">Standstill restriction period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage', window );">Standstill restriction, ownership threshold percentage ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementTransactionPrice', window );">Collaborative arrangement transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 204,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction', window );">Excess consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationAgreementEquityIssued', window );">Collaboration agreement, equity issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Recognized portion of equity issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc. | Collaboration And License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">204,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Proceeds from collaborators</a></td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="nump">125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable', window );">Maximum milestone payment receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets', window );">Number of additional product targets | product_target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationAgreementRemainingPeriod', window );">Remaining period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected', window );">Number of product targets selected | product_target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationArrangementResearchPeriod', window );">Research period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace', window );">Maximum number of product targets replaced | product_target</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue', window );">Financial advisory fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeAgreementPercentOfInitialRecognition', window );">Percent of initial recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Portion of contract asset recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSoldAmortization', window );">Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc. | Collaboration And License Agreement | Pre-approval milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable', window );">Maximum milestone payment receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 925,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember', window );">Biogen MA, Inc. | Collaboration And License Agreement | Sales-based milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable', window );">Maximum milestone payment receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationAgreementEquityIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreement, Equity Issued</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationAgreementEquityIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationAgreementNumberOfAdditionalProductTargets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreement, Number Of Additional Product Targets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationAgreementNumberOfAdditionalProductTargets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationAgreementRemainingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Agreement, Remaining Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationAgreementRemainingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Arrangement, Commission Fee, Portion Of Gross Proceeds, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationArrangementResearchPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration Arrangement, Research Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationArrangementResearchPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeAgreementPercentOfInitialRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Agreement, Percent Of Initial Recognition</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeAgreementPercentOfInitialRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Maximum Milestone Payment Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Maximum Number Of Product Targets To Replace</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementNumberOfProductTargetsSelected">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Number Of Product Targets Selected</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementNumberOfProductTargetsSelected</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Standstill Restriction, Ownership Threshold Percentage Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementStandstillRestrictionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Standstill Restriction Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementStandstillRestrictionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Excess Consideration Received on Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSoldAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSoldAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from collaborators during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_BiogenMAIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sgmo_StockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sgmo_StockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeAgreementMilestoneAxis=sgmo_PreApprovalMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeAgreementMilestoneAxis=sgmo_PreApprovalMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeAgreementMilestoneAxis=sgmo_SalesBasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeAgreementMilestoneAxis=sgmo_SalesBasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708046873392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Detail)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 30, 2018 </div>
<div>USD ($) </div>
<div>milestone </div>
<div>option</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,522<span></span>
</td>
<td class="nump">$ 6,013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Collaboration And License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_MilestonePaymentsReceived', window );">Milestone payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_InitialResearchTermOfAgreement', window );">Initial research term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_NumberOfOptionsToExtendInitialResearchTerm', window );">Number of options to extend initial research term | option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ExtendedResearchTermOfAgreement', window );">Extended research term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_SeparateUpfrontFee', window );">Separate upfront fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan', window );">Collaborative arrangement estimated reimbursable service costs for new research plan</a></td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementTransactionPrice', window );">Collaborative arrangement transaction price</a></td>
<td class="nump">189,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Revenues under agreement</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts', window );">Collaborative arrangement estimated reimbursable service costs</a></td>
<td class="nump">$ 39,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 37,800<span></span>
</td>
<td class="nump">$ 56,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Collaboration And License Agreement | Achievement of specified research, clinical development, regulatory and first commercial sale milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived', window );">Contingent development - and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember', window );">Kite Pharma, Inc. | Collaboration And License Agreement | Achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach specified levels</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived', window );">Contingent development - and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment', window );">Maximum amount of achieved milestones to receive payment | milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement estimated reimbursable service costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement Estimated Reimbursable Service Costs For New Research Plan</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Development And Sales Based Milestone Payments, Maximum Amount Of Achieved Milestones To Be Eligible For Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent development and sales based milestone payments to be received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Customer contract liability milestone payment eligible to receive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ExtendedResearchTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extended Research Term Of Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ExtendedResearchTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_InitialResearchTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Initial research term of agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_InitialResearchTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_MilestonePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone payments received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_MilestonePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_NumberOfOptionsToExtendInitialResearchTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Options To Extend Initial Research Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_NumberOfOptionsToExtendInitialResearchTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_SeparateUpfrontFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Separate upfront fee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_SeparateUpfrontFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23221-108380<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_KitePharmaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708045395744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Sanofi S.A. (Detail)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">102 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 06, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2014 </div>
<div>USD ($) </div>
<div>program</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>product </div>
<div>milestone </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jun. 28, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,460<span></span>
</td>
<td class="nump">$ 28,563<span></span>
</td>
<td class="nump">$ 84,069<span></span>
</td>
<td class="nump">$ 82,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,522<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense', window );">Decrease in research and development expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Increased net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,155<span></span>
</td>
<td class="nump">$ 47,688<span></span>
</td>
<td class="nump">$ 140,305<span></span>
</td>
<td class="nump">$ 140,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Increased earnings per share, diluted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.93)<span></span>
</td>
<td class="num">$ (0.98)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Increased earnings per share, basic (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.93)<span></span>
</td>
<td class="num">$ (0.98)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi S.A.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_NumberOfResearchProgram', window );">Number of research programs | program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Revenues under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (759)<span></span>
</td>
<td class="nump">$ 3,260<span></span>
</td>
<td class="nump">$ 1,258<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement', window );">Number of products approved | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod', window );">Post transition assistance period</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate', window );">Expenses reimbursable through December 31, 2023 (up to)</a></td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate', window );">Expenses reimbursable after December 31, 2023 (up to)</a></td>
<td class="nump">$ 5,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi S.A. | Collaboration And License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Revenues under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice', window );">Number of milestones included in transaction price | milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementTransactionPrice', window );">Collaborative arrangement transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts', window );">Collaborative arrangement estimated reimbursable service costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi S.A. | Collaboration And License Agreement | Milestone three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_MilestoneRevenueReceivable', window );">Milestone revenue receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_SanofiMember', window );">Sanofi S.A. | Collaboration agreement | Change In Collaboration Agreement Scope</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,500)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Increased net loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Increased earnings per share, diluted (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Increased earnings per share, basic (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration and license agreements number of products approved under agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement estimated reimbursable service costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_MilestoneRevenueReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone&#8203; revenue receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_MilestoneRevenueReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of clinical or regulatory milestones included in transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_NumberOfResearchProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of research program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_NumberOfResearchProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development Arrangement, Expenses Reimbursable, After Specified Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development Arrangement, Expenses Reimbursable, Through Specified Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development Arrangement, Post Transition Assistance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Termination And Transition Agreement, Increase (Decrease) In Research And Development Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23221-108380<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_SanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_SanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=sgmo_CollaborationAndLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeAgreementMilestoneAxis=sgmo_MilestoneThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeAgreementMilestoneAxis=sgmo_MilestoneThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInCollaborationAgreementScopeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingEstimateByTypeAxis=sgmo_ChangeInCollaborationAgreementScopeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708049392064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Detail)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">52 Months Ended</th>
<th class="th" colspan="1">65 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>milestone </div>
<div>product</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($) </div>
<div>product </div>
<div>milestone</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26,460,000<span></span>
</td>
<td class="nump">$ 28,563,000<span></span>
</td>
<td class="nump">$ 84,069,000<span></span>
</td>
<td class="nump">$ 82,715,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_AgreementTerminationTerm', window );">Agreement termination, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | S B Five Two Five And Other Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Revenues under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive', window );">Potential amount to be funded for achievement of specified commercialized and sales milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_MilestoneRevenueReceivable', window );">Milestone revenue receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | S B Five Two Five And Other Products | Achievement of specified clinical development intellectual property and regulatory milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">208,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | S B Five Two Five And Other Products | Achievement of first commercial sale milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">475,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | Other products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_MilestoneRevenueReceivable', window );">Milestone revenue receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerMember', window );">Pfizer Inc. | C9ORF72</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Revenues under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementTransactionPrice', window );">Collaborative arrangement transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerSB525Member', window );">Pfizer SB-525</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Revenues under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementTransactionPrice', window );">Collaborative arrangement transaction price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementResearchServiceFees', window );">Research service fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 79,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerSB525Member', window );">Pfizer SB-525 | S B Five Two Five And Other Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved', window );">Collaborative arrangement, number of milestones achieved | milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_MilestonePaymentsReceived', window );">Milestone payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement', window );">Number of products approved | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice', window );">Number of milestones included in transaction price | milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member', window );">Pfizer C9ORF72</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_AgreementTerminationTerm', window );">Agreement termination, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_MilestonePaymentsReceived', window );">Milestone payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement', window );">Number of products approved | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice', window );">Number of milestones included in transaction price | milestone</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member', window );">Pfizer C9ORF72 | C9ORF72</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned', window );">Revenues under agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member', window );">Pfizer C9ORF72 | C9ORF72 | Achievement Of Specified Preclinical Development Clinical Development And First Commercial Sale Milestones | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member', window );">Pfizer C9ORF72 | C9ORF72 | Achievement Of Commercial Milestones | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems', window );"><strong>Research and Development Arrangement, Contract to Perform for Others [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive', window );">Development and sales-based milestone payments to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate additional revenue recognition milestone method revenue eligible to receive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_AgreementTerminationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreement Termination, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_AgreementTerminationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaboration and license agreements number of products approved under agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementNumberOfMilestonesAchieved">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Number Of Milestones Achieved</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementNumberOfMilestonesAchieved</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementResearchServiceFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Research Service Fees</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementResearchServiceFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CollaborativeArrangementTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative arrangement transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CollaborativeArrangementTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Customer contract liability milestone payment eligible to receive.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_MilestonePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone payments received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_MilestonePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_MilestoneRevenueReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone&#8203; revenue receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_MilestoneRevenueReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of clinical or regulatory milestones included in transaction price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23221-108380<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6420387&amp;loc=d3e23199-108380<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_PfizerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_PfizerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgmo_SBFiveTwoFiveAndOtherProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgmo_SBFiveTwoFiveAndOtherProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfFirstCommercialSaleMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfFirstCommercialSaleMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgmo_OtherProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgmo_OtherProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=sgmo_CNineORFSevenTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=sgmo_CNineORFSevenTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_PfizerSB525Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_PfizerSB525Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_PfizerC9ORF72Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfCommercialMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=sgmo_AchievementOfCommercialMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708050713168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Detail) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 7,793<span></span>
</td>
<td class="nump">$ 7,873<span></span>
</td>
<td class="nump">$ 23,402<span></span>
</td>
<td class="nump">$ 24,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">4,395<span></span>
</td>
<td class="nump">4,935<span></span>
</td>
<td class="nump">13,656<span></span>
</td>
<td class="nump">14,645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 3,398<span></span>
</td>
<td class="nump">$ 2,938<span></span>
</td>
<td class="nump">$ 9,746<span></span>
</td>
<td class="nump">$ 10,235<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708045304496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Detail) - Jefferies LLC - At-The-Market Offering Agreement - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Aug. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_StockOfferingProgramMaximumValue', window );">Stock offering program, maximum value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock under public offering, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,483,104<span></span>
</td>
<td class="nump">202,705<span></span>
</td>
<td class="nump">14,711,770<span></span>
</td>
<td class="nump">2,007,932<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42.2<span></span>
</td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="nump">$ 66.4<span></span>
</td>
<td class="nump">$ 27.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sgmo_JefferiesLLCMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on transaction</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_StockOfferingProgramMaximumValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Offering Program, Maximum Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_StockOfferingProgramMaximumValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sgmo_JefferiesLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sgmo_JefferiesLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=sgmo_AtTheMarketOfferingAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=sgmo_AtTheMarketOfferingAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.2.2</span><table class="report" border="0" cellspacing="2" id="idm140708049168096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 30,000<span></span>
</td>
<td class="nump">$ 86,000<span></span>
</td>
<td class="nump">$ 170,000<span></span>
</td>
<td class="nump">$ 373,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_EmployeeRetentionCreditCARESAct', window );">Employee retention credit, CARES Act</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct', window );">Proceeds from employee retention credit, CARES Act</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_EmployeeRetentionCreditCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Retention Credit, CARES Act</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_EmployeeRetentionCreditCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sgmo_ProceedsFromEmployeeRetentionCreditCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Employee Retention Credit, CARES Act</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sgmo_ProceedsFromEmployeeRetentionCreditCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sgmo_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>sgmo-20220930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sgmo="http://www.sangamo.com/20220930"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="sgmo-20220930.xsd" xlink:type="simple"/>
    <context id="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5c49b51e78f84124bb9eb7003ea63dd7_I20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2022-10-31</instant>
        </period>
    </context>
    <context id="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i65c4b9f6e28c49ccb8e9f49894741665_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ieaf636eab7a446278c2c60b3497f65dd_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="ifdb651fdae9f4daba649e657742b10fb_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i0901c3888400484d82bc9d499ba27882_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4358e68463414d2f81e6d07be34f96f4_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i4f86a00ffb9a44c09b92cbd140f04b6a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i9f36b8087e874e84bb6cfbb657e30dd3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i477f878f2fc449a7b9b882f03d328aea_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia174d038fef54c1988b0d1f7bb55851a_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i10185405784946f6866fa6235275377e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic5629c83660045e689bee72501b7f3b5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id1842e89b1004e10ab03df6383c15efe_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie475194a8bc5487bb425f884b64c7cb4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="id44dcc12390c46679a8547aa1acebc45_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2a696035ebd0409f842a3d85f1f17177_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7eb5094c50c94679a226568ebb7c0cdc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic5f88f052bc74b0897f087b88dcf0e44_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id28e3d378e8e41c2b2f192f93c7e7a2d_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie86b8354fd9c48fa8f7effcc8fab0655_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i5b80b0627d224b51a736282e5de2e649_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ibe3dce0a01ae4da686148893e81e9cbf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i4ab6b60ff90948328c6518dfee567d60_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia4437087e8514ebf9125f5ef80b34f7d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifd6155b736044781a9509dd909a16744_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic1f86ea542ca45139f8b891e2b341360_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5b2b14725998443da0214724315022e3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i67e431fd603948ddb3a910386fcf7720_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2b20689a47fa4626b06dd28beb352cfc_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i888b3ba590bd4c97a8718de47daae199_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7b65f408605048399b735ab6734947a4_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia153a8e0f69e430e9b0dc937bd3916b8_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9241e8a504e3490192f71c9decdcd3cf_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="ib8bc460fcd2b4144afd1e6595036df06_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="iacd4ba876f2a4fb7b83c09ef9bd71e56_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i5bb367b30b03403c98021e1aba94eea9_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i53a9405cbbd74d8e87ce89d2e69fd569_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="idcd86bcf9af64a3a815fcc501ba0ad77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i920d94b246904434a9c24327eda62fc2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i12cb742f69d84eafb765fed1f2925d84_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib759e7d27c734ebc91eb8d8e7257be3b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i56f6f40bbe064e2eae76f5a1f8c67c65_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i451b037bb41149e78da8c2582ef147c9_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7d5c5e06d683406faa61d58c55c666a6_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i1053b2abcb2a42f6826b1ffc69e93fbd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="icdbe3cb5b46d4f3881583fc8ba6c0f17_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3d9943e3bd46453b9a5ad5d1f8b22844_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifb067ffcdfcd40edb211090a036dab65_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie9f15dab01ef4999822c32ed4f2574a1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sgmo:ChangeInCollaborationAgreementScopeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ChangeInAccountingEstimateByTypeAxis">sgmo:ChangeInCollaborationAgreementScopeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ia0f3233d7b70474da06a55adac0cca4d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib4943cb2b48343ef92ef1589edef40c7_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if38002de5fe848d088ca4840e3b302a0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia79b57d1d6da4b0d9ef31df01511d42d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9fef75604563438abe9538958474da7d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib8f43928847f42c1a83bf8800d5fa943_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i88ddbc38aa6445598de986913238d214_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ie4327ef899954f25af6c0c80522b2c7d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6fa286ca65b64056995eb4ab2664cdd0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3e54c4c6f853445c95d080879c43b2b2_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7ebc3bc839ea482380db614d89d89bb5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i45f1ab603cb94ccc868b785c550c0609_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="iacda68cbeb604746812d5bd97bf218a3_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="idf66e1bb8ddd4393b9d770b1885a7a64_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib124d69483284e9693d405b60f7383e0_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1634f7d6a7a14dd38290439da8287bbd_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">sgmo:RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id122cadbcd79415cb294942cf9401910_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iaa6d0f240a92487abfb8f0f38f3112e9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i1f8158142c524b369324fc1ebf0f9f1e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0a6fb7e7492a4f939428513d8fcff441_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i96d87151f3dd48979c96441aaec7b540_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iffdbeeb166274031b5cec94b4a93c065_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i681433de93e34299a5bb54fef49f27c4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibfbd33edee0941eebf5eb1beb36d33b5_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ie11a6708a3494e018d5eea96804cc1f8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i29f19ecdd60e4cf4881d032f9b06e15e_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icf1ed758ad3142609eaf08869c43df41_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="idbd920e533444e47a3756a9b4a8eb6b6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i32ad7e19c06a465f8f07b405b0f7cfd4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if27bae2120224abea6224708e6f3de8f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0ca8592334b04957a537a0d4cf813494_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="icc09550b59114bae9b748047cd9d24a8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4ab0f243dd424f92b69b063a217eae48_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i411394c5d10d486cbce2b24abae3a661_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i09186c27c86747a68746b52de10d7d1c_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="if5b732d846284342a16bea6ef1968757_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i769639b449a24295852cb05e72c00a17_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i9606a8a617b841e885ebefda50badef9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i122ce6ac71ea4602bfd1231782ca60d8_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic67eaaf5137b4b6f9b62df6016a69f07_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ifd4fdedfda294dfab406c29000abe2e6_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8fa8a902c3774cde978198ce09be1bb9_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i639b4eda38c648ffb15ee7b60a5bdfd4_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i6065eabb66dc4690a7523d48b52983fc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i0a4226459e39406dbf0ef1ecac2f7183_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i33868ebce0ac437282e6ca0c2cd516ea_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i51cf12c7232b41e7a436caf0336ac5c1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i7cb99b1da6c54c77bee0c45127be6f3f_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i21bb501c85b34076a54c9225ae07ee8e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i73036590c4ef457f87ba13c7f72633ea_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c608a75f06a443dae43f3295a547e25_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic9df22ac2f004b0fbb4e5f907ec70d9b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if90f6a0673d64365a8cac1c06453bb58_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9430e03891404dea839fb2cff64af738_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if003bbe1b3bd45aca76e20e836c5a3a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia43cd647cad04bb9a7cadc11f325af6a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibcef3b61008c46d0992163cd7bffe1cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2cf4147ceb5942299b88c10a4f9be27a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b800a8209c64902a695cd1dcd597172_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaaeaa77913ce413b93a7c9dab1d36cab_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0de8afe4f7c2493b8c43a2e0f29a7399_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9c91803551d641a8963ac07c42cfe596_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic47a895f418d48cf8f9d9eff69edeeda_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3be3d7d00461404e980d8a74a0ae2c25_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2c98918b8f5542dca9d804a934e84995_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ee5a63a339b4d8991f36eaf5ff1be1c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i983119dcdc834acda4676ea99a8c08da_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaa714eaea0f1411e85e65049e450b3eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i86315bd8be5a4ce4b190ddec3e753c05_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6016ec92d0c640e1aed56b72f34057e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i69ab4258b6f14b29bd7da873df0ba0f7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i764fb984c25d4da5b64a0b48e5199b99_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia28128c5fca64935bcf980ed70b30b2a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i386e3b89d03f479ca5825c2bebba2e54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie86bb74f566944b9839da6ff3a70d767_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i359bee546a724e5d8222c768c5722bef_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iab983723fa734404b015fc014b16e4f2_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic1f5af8c8327472da2ae3d160d57b379_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i48e0ebe4c00048caa8ca855361cd3dec_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ia9e93e6a67164aee80389e38c2ed7ddc_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ic708e40109d743859a0cbe3fd8575521_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ib9fe47fa2ac24546b0189e24f5f31056_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="ibeb29a716f8547e093a0767d93caf9a1_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8aa1ecbd5903489ea2ee1f51365efa36_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i09e4f486e25d4837bc2bd16e7e92edf4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ieb83f685b39f49fc8b06dfce81650e59_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id0d6f23a6e1e4fdd89526d7156771dde_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentSponsoredEnterprisesDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa0a0121a11a4f5a9c8f92c62eb8b617_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if51181fc5273431abe839125ae5e5dc9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6f81a5cb7fee4760866d108a18198b21_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6be12bead5e34d9d9730b4f9983fdc54_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id24858a277a44f918d47646294044411_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="ic3fcad2bda744a41b13d72cd6a61005d_D20200727-20200727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-27</startDate>
            <endDate>2020-07-27</endDate>
        </period>
    </context>
    <context id="id7052887b1af4eb59f472680a598c7ca_D20200727-20200727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfCommercialMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-27</startDate>
            <endDate>2020-07-27</endDate>
        </period>
    </context>
    <context id="i2ba866a4b6af4a9491a93eb6f0ff14eb_D20200727-20200727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-27</startDate>
            <endDate>2020-07-27</endDate>
        </period>
    </context>
    <context id="i2734364915f440429f325226570e6f66_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="iaae4a2b1c97a4a699c93a09a3af3d231_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3d5f1ae0ab8b4decbba471d9add02a71_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ic6ea8c76ac97403d9fe80699600d434e_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id1417415012944e48964b4778067acf9_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i916103514d9445a2b559cda726e4ef32_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i2096aeabf3b946a5875461aa88d4cb20_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic7556e9945944bb4963819871e859b10_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iaea4ef3b62d94312a30b3961e15b1c2d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2a807fb830ff454bb7a40d98e23ead88_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i813d7c4c38564599a7261dd61b7d10e1_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i41aa40e6f7734a11a5ad5d91444e8c71_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i640dece72c8d481a9e06ebab15977c75_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i901b43193e044942b699fb8fadfb9534_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9972fe6d5f2b42c89d347449caf70272_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iba431dc7b3114e9492531e7e49f27982_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i714565e5ccc14fd6ad101d485a5a8de6_I20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-31</instant>
        </period>
    </context>
    <context id="i449866dd2b4e4cbca1f5dbb0c02df99b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3ace65935fd74827a8e79d81a8c99883_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="iae8fae1af4ab4d9a8c4829058c9e5f83_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7f1b352df962492a825bd38db79c1fa8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:NovartisInstitutesForBioMedicalResearchIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="i68d24c5b8cee46749f97407c43bed757_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="ica4b8016d6044abd95e91f31762196db_D20200501-20200531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="iebf44488500c4b588b4bdf5563a4334a_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="ie47b011a38824aa1aaad584fadb9ebba_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sgmo:CollaborativeAgreementMilestoneAxis">sgmo:PreApprovalMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="i2cf72a2afc0847f7a0aa31702eac099e_I20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sgmo:CollaborativeAgreementMilestoneAxis">sgmo:SalesBasedMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-30</instant>
        </period>
    </context>
    <context id="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-30</endDate>
        </period>
    </context>
    <context id="if44d955f3cee4094a3a0cecf75e1cd02_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i70a681d5c2fc43359fac6166d3c7b02b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if0601be924aa4f1fad543351bdf06b1f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i58dad48ada774420bb627b6373806b63_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3567ee8e981a4805b1614fbb6249f324_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i12d66cce985941ffa95915f401661188_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifd568c62528c418d98ba3506620059b3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib95c66db249d457f8c5145b0b4180e59_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ia893d1f21e7e4bfc9e693b7773c6ebb3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i582600df1f494eeba31d6db660f24309_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i107234bf3c2c4164845bafb59e087b2b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i84f278d0f27941ff887205574efe505f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i640710eb43bb446395030cf119393d5e_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibbafd7f9191749e7a6078d50d26cff6d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ieeedce2ee3f2443aa731e0a0727b79bb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3e70aff9076046b0a8a267498a58548b_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i8ffaaa021478445aadfabd4cf2b1cd40_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i656cc305a9864393800b99c4084fc3be_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i26b2aa0ee0524b8e9864406fc3e47991_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="if93a6d1fdbb248ec8aa3ad0a3d16700d_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i33a718c16a224765bbf657e25d2f612a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:BiogenMAIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:StockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="i9ff2b470a6b840b1b600226ae0cb70ef_D20180401-20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="i65b35c689bc646deaec17d1a4a06e1ae_D20180401-20180430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-01</startDate>
            <endDate>2018-04-30</endDate>
        </period>
    </context>
    <context id="i93c77ad66a244121b7e7c0650a102466_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="ib2565b2e5ab3411d909ba058b98e784d_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i4f9193d162614c82aefef0bd29f76cb0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i08b40673b5374b688d69a9f30889e26b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i283bbba7da5c491abef1b46ddd866d80_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifb5cc7c162fc4f9f8aae9712c9c2186c_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idf1383bfc9fb4e4da9138b24f4483085_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i32258af563e84d3eaeffce96590ce4a3_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i4e36b699832646d09fb049651228fc3d_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icd52871c65e74074b943d036e228c407_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="idc52a7e61b9445fd932586d407d4b4b5_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3f401a18597344db8bea22b5b529e1fb_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6dd41724bd2c43c49a877cd10c22b362_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="if156dd60b13643d49e1714fc2aef31f3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ib5ee9fe84d52410e95ad3919dcf23692_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:KitePharmaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i965c38aa9a1b4725903d0bea5a63f9e5_D20140101-20140131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2014-01-31</endDate>
        </period>
    </context>
    <context id="ib5f997ce9152448ebb21b42facd1eb60_D20140101-20220628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2022-06-28</endDate>
        </period>
    </context>
    <context id="i710e17ccda8d423c80784fc598352f2f_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i06746c47a09e4d0ebce6f17c639cd75b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i3c1eafcb24464080b10cb25f38311835_D20220906-20220906">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-06</startDate>
            <endDate>2022-09-06</endDate>
        </period>
    </context>
    <context id="i5f1f8318a747463abe0b0a5f9f6fbc8a_D20140101-20220628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2014-01-01</startDate>
            <endDate>2022-06-28</endDate>
        </period>
    </context>
    <context id="id6da6fc44c004de5a49215fc13d59250_I20220628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sgmo:CollaborativeAgreementMilestoneAxis">sgmo:MilestoneThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-28</instant>
        </period>
    </context>
    <context id="i905f6dd1d97f41d5aefe0d9f9ce7d481_I20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="i933fae16aba14368bec01366d74236a7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">sgmo:CollaborationAndLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6c81a778afcc46f38bd393eb5ffba599_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i202d58a6a58d4af08b477d923ae048f3_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i66cdb12a800d4879bf0c3f1766fa88fd_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i892bdf3ab2944fb4b7a953ffd1c2f6d7_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseAndServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i17f9d36d461f448483df1b1e4e3a01f0_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i140d27fd2160489db7ee0eb0978a4d9a_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i724bc4b7322a4e759c114bb5082bfdac_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i364d22703c4f4fb590d565ce2c24609b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:ResearchServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ic6a265c8ac4e49de84028acd0fb40413_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:MilestoneAchievementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id79ab6aa736f4dcb9f4f3a8b1435949d_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:MilestoneAchievementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i09c51fb74c4c492ab74e416789db7c1c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:MilestoneAchievementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib5e292264aa1455f8199ac9bf6f10164_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:MilestoneAchievementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2a5d588119f04333847cb581fb37eb61_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icf6145619fea4fa78fa9c0bab78ebb20_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="id45979bc9fd7456cb09006afb528134e_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:SanofiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifda78d9bb9e34007aba808bc57d3ccc7_D20170501-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="ia67b43e22836459ca0c85db6bf587fa9_D20170501-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="ie097ba41160242b7b938ec9f67d75616_D20170501-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="ie76c5aed7b74477aa60d84886d741c43_D20170501-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfFirstCommercialSaleMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="ic34e88035a5f4bb08ff13aeb0beabca8_I20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="i9451d2ff95384408bb974670f4956acd_I20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:OtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-05-31</instant>
        </period>
    </context>
    <context id="iacfe2b36ef12408dba96a7eca579c6e3_D20170501-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i1a0335905c59449b887401672756abb9_D20171201-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:SBFiveTwoFiveAndOtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1a587603a6dc495fb68564a49c608c3b_D20170501-20170531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2017-05-31</endDate>
        </period>
    </context>
    <context id="ie6cc5e9855b44daa88a4b942b38da8a3_D20170501-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-05-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i7c3303f9b2c441e4a8661c7063d97b4f_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i35335210865a4d9fb1acf14e87a58341_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7f5fbe525ac74562ac7d8942cd031794_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i67383e30f21c4630a881224c8ec6917b_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerSB525Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ied5371b887eb4e1ba5e63238f1af294c_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i807e40274d2e4fa68fb97fd8f56732c0_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i49341b6dd59f4dcb8dc3e02283b1a9a0_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis">sgmo:AchievementOfCommercialMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i95d5384d7d794ed1b248fe403cff0f12_D20171201-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i309018fee1874efc81946dbe7c82f131_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i5c18ff8ca01c40e78481b76d8fe6dda0_D20171201-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="i92faa1298286405e93c727411f0747bf_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i7de837b09974499ab74e3907f4da3664_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia9394094054442f383751ceedfd5a981_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="icfffef1418344eb7a8831ffe392e5e22_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ifd20bbfeb147419cb5f8dc6db4ca9849_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i56dd64461cdc41a29f9de3b35af516dd_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:PfizerC9ORF72Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">sgmo:CNineORFSevenTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="id4198818716d4a5982ff62c84d98fc2b_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i398e9284c1254e7fa5e4faf15172c220_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i2ee803986f614d5eb89d119dfc27ff5c_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ifcb87a6bcfe548619d4c435b6326cad8_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="ibf9d9769367043dcbd6120a50e2504a5_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ida843af1fb12494eabfc5378c6f08828_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i7cffbe21ee8340aab6d270389c188838_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="ib4685841a6f74d2e879fd6085f56e095_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i6787fd385b854be098bb92baa474ae00_D20200801-20200831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-01</startDate>
            <endDate>2020-08-31</endDate>
        </period>
    </context>
    <context id="idcc3055e11a04301bd4380530c45310f_D20220701-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i99aed81b84ae4da8ac317dfc988149a4_D20220101-20220930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="i06ce069112274b73a381a623267ad36b_D20221001-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="ie3f90dae3d5d49c094e3925ff3e04933_D20210701-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <context id="i9b3959b3e8964e39a6463ae8b22b489b_D20210101-20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001001233</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sgmo:JefferiesLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">sgmo:AtTheMarketOfferingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-09-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="product_target">
        <measure>sgmo:product_target</measure>
    </unit>
    <unit id="milestone">
        <measure>sgmo:milestone</measure>
    </unit>
    <unit id="option">
        <measure>sgmo:option</measure>
    </unit>
    <unit id="program">
        <measure>sgmo:program</measure>
    </unit>
    <unit id="product">
        <measure>sgmo:product</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80L2ZyYWc6ZDg4NDYyYTQ5YTgzNDE5M2IwYzdmNjJjMWNkZjZmMDMvdGFibGU6ZTk1MmIyZGY5ODA3NGI0NmFhM2RmMjUxYmQ0ZTUzZWIvdGFibGVyYW5nZTplOTUyYjJkZjk4MDc0YjQ2YWEzZGYyNTFiZDRlNTNlYl8yLTEtMS0xLTQ5ODE2_a2ba43eb-c79d-4e10-9613-0aef880b1c2a">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80L2ZyYWc6ZDg4NDYyYTQ5YTgzNDE5M2IwYzdmNjJjMWNkZjZmMDMvdGFibGU6ZTk1MmIyZGY5ODA3NGI0NmFhM2RmMjUxYmQ0ZTUzZWIvdGFibGVyYW5nZTplOTUyYjJkZjk4MDc0YjQ2YWEzZGYyNTFiZDRlNTNlYl8zLTEtMS0xLTQ5ODE2_306b417c-cf7f-4aa4-9510-f90bf33501cf">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80L2ZyYWc6ZDg4NDYyYTQ5YTgzNDE5M2IwYzdmNjJjMWNkZjZmMDMvdGFibGU6ZTk1MmIyZGY5ODA3NGI0NmFhM2RmMjUxYmQ0ZTUzZWIvdGFibGVyYW5nZTplOTUyYjJkZjk4MDc0YjQ2YWEzZGYyNTFiZDRlNTNlYl80LTEtMS0xLTQ5ODE2_a133d534-4812-4710-9899-fbf2cf218aeb">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80L2ZyYWc6ZDg4NDYyYTQ5YTgzNDE5M2IwYzdmNjJjMWNkZjZmMDMvdGFibGU6ZTk1MmIyZGY5ODA3NGI0NmFhM2RmMjUxYmQ0ZTUzZWIvdGFibGVyYW5nZTplOTUyYjJkZjk4MDc0YjQ2YWEzZGYyNTFiZDRlNTNlYl81LTEtMS0xLTQ5ODE2_39c019a3-e5a1-4d5c-9c03-9008d58c5a76">0001001233</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80L2ZyYWc6ZDg4NDYyYTQ5YTgzNDE5M2IwYzdmNjJjMWNkZjZmMDMvdGFibGU6ZTk1MmIyZGY5ODA3NGI0NmFhM2RmMjUxYmQ0ZTUzZWIvdGFibGVyYW5nZTplOTUyYjJkZjk4MDc0YjQ2YWEzZGYyNTFiZDRlNTNlYl82LTEtMS0xLTQ5ODE2_82d98d79-9c5a-487f-bc39-d234d377d391">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80OS9mcmFnOjQ3NDVmODQwNTRlNzRjYzlhNzRkMGZlZDIxYTA5NTg5L3RleHRyZWdpb246NDc0NWY4NDA1NGU3NGNjOWE3NGQwZmVkMjFhMDk1ODlfMTA5_376aceb8-a05f-41d7-8aea-d3ba497d30a5"
      unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80OS9mcmFnOjQ3NDVmODQwNTRlNzRjYzlhNzRkMGZlZDIxYTA5NTg5L3RleHRyZWdpb246NDc0NWY4NDA1NGU3NGNjOWE3NGQwZmVkMjFhMDk1ODlfMTA5_66703c93-cab1-4b8a-a5eb-e71bc60ef0ba"
      unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xMzMyL2ZyYWc6MzQwMTBjOTg5MTA0NDg2OThlNjgyN2I2OTVkYzY1NWQvdGV4dHJlZ2lvbjozNDAxMGM5ODkxMDQ0ODY5OGU2ODI3YjY5NWRjNjU1ZF8xMDk5NTExNjI3OTk3_2cf88b52-4fac-4525-a48f-b581392da2d8"
      unitRef="usd">30000</us-gaap:IncomeTaxExpenseBenefit>
    <dei:DocumentType
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY2_05d24faa-b42b-4b28-9731-8a022ac7555d">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6MTFkNmYxYzg5YWMwNDcxZWE3YmVhMWYwN2IzNWU2YTAvdGFibGVyYW5nZToxMWQ2ZjFjODlhYzA0NzFlYTdiZWExZjA3YjM1ZTZhMF8wLTAtMS0xLTQ5ODE2_67794f31-69ae-4ff7-95b9-513e3e11308c">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMzE_d8927d1d-26df-4460-a1ce-ae6e981b46f7">2022-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NWM0YzNjMmY2ZTAxNGQwN2FiMzgwZjdjOGI0MDBhOTUvdGFibGVyYW5nZTo1YzRjM2MyZjZlMDE0ZDA3YWIzODBmN2M4YjQwMGE5NV8wLTAtMS0xLTQ5ODE2_4ea2faf0-bb83-4a90-b0a3-3485e43f6863">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjcw_2a7318c4-5791-4cb3-8507-41fc27cf15db">000-30171</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY3_4c76fbeb-10d5-456a-a2d5-43d06840297e">SANGAMO THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8wLTAtMS0xLTQ5ODE2_cea163d3-5b2f-4150-bbf9-505ae774315e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8wLTQtMS0xLTQ5ODE2_d82987e2-48fb-4307-a4fb-eea0debc8a87">68-0359556</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8zLTAtMS0xLTQ5ODE2L3RleHRyZWdpb246OTNiMDJjMzBjNzBlNGM5MDkxM2FiYzRjOWZlYzBmMzZfNA_884fdea8-cf85-4a5c-866b-b8ff77c6dd90">7000 Marina Blvd.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8zLTAtMS0xLTQ5ODE2L3RleHRyZWdpb246OTNiMDJjMzBjNzBlNGM5MDkxM2FiYzRjOWZlYzBmMzZfOA_f4cda879-df1b-45d2-a9b1-799b396dd0af">Brisbane</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8zLTAtMS0xLTQ5ODE2L3RleHRyZWdpb246OTNiMDJjMzBjNzBlNGM5MDkxM2FiYzRjOWZlYzBmMzZfMTI_a8c9be59-6fb7-4d2e-a9ed-8ae65b8fc870">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NGVhNDQ5NjJhNTQ3NDU4OTgwYjVkY2EwNzI3NWFmNWQvdGFibGVyYW5nZTo0ZWE0NDk2MmE1NDc0NTg5ODBiNWRjYTA3Mjc1YWY1ZF8zLTAtMS0xLTQ5ODE2L3RleHRyZWdpb246OTNiMDJjMzBjNzBlNGM5MDkxM2FiYzRjOWZlYzBmMzZfMTY_7ab9feb9-3a96-43cd-9f02-b2c019db1892">94005</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjYz_c5aebf2a-2f2c-404d-aaf9-48cb612b52f6">510</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY0_5ce47451-95ce-4da5-982a-08d4668fc04f">970-6000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NjMyMGU1ODkxYTE5NGZmYzllYTU1ZjI2MzEwYTk4NWQvdGFibGVyYW5nZTo2MzIwZTU4OTFhMTk0ZmZjOWVhNTVmMjYzMTBhOTg1ZF8xLTAtMS0xLTQ5ODE2_ab50e3c4-650f-48cd-afae-13e267857ff6">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NjMyMGU1ODkxYTE5NGZmYzllYTU1ZjI2MzEwYTk4NWQvdGFibGVyYW5nZTo2MzIwZTU4OTFhMTk0ZmZjOWVhNTVmMjYzMTBhOTg1ZF8xLTItMS0xLTQ5ODE2_3e087f24-25b8-48ed-9fd5-ee810e45d709">SGMO</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6NjMyMGU1ODkxYTE5NGZmYzllYTU1ZjI2MzEwYTk4NWQvdGFibGVyYW5nZTo2MzIwZTU4OTFhMTk0ZmZjOWVhNTVmMjYzMTBhOTg1ZF8xLTQtMS0xLTQ5ODE2_cc8c7cf3-bd6a-4dd3-9ca6-e0f9b8c8b80a">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY4_a7fe6aea-abbc-460f-936c-419cb4ff3982">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY5_553393cc-e699-46c1-bfd4-e1ce1812778a">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6N2RiMzg3YTRkYWIwNDFkMjgxNWIyOTM3MGUzYzBhNjUvdGFibGVyYW5nZTo3ZGIzODdhNGRhYjA0MWQyODE1YjI5MzcwZTNjMGE2NV8wLTAtMS0xLTQ5ODE2_3ec8c7d0-c748-41d6-857a-93276739c7b3">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6N2RiMzg3YTRkYWIwNDFkMjgxNWIyOTM3MGUzYzBhNjUvdGFibGVyYW5nZTo3ZGIzODdhNGRhYjA0MWQyODE1YjI5MzcwZTNjMGE2NV8xLTQtMS0xLTQ5ODE2_6ced6dec-98d2-4b88-a1c9-669a4ec509d0">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGFibGU6N2RiMzg3YTRkYWIwNDFkMjgxNWIyOTM3MGUzYzBhNjUvdGFibGVyYW5nZTo3ZGIzODdhNGRhYjA0MWQyODE1YjI5MzcwZTNjMGE2NV8yLTQtMS0xLTQ5ODE2_5fc49a16-9ece-44a1-9e33-e7afce27b707">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMjY1_e9b1f487-c92d-4310-8ee9-7515206f8905">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i5c49b51e78f84124bb9eb7003ea63dd7_I20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8xL2ZyYWc6YjcxYTg5ZTE0NTZhNGU4Y2E5Yjg5ODFlNzU0NzA2YjEvdGV4dHJlZ2lvbjpiNzFhODllMTQ1NmE0ZThjYTliODk4MWU3NTQ3MDZiMV8yMTc4_78bec4ac-d8a7-491a-8183-f3231df3bb28"
      unitRef="shares">163880007</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMy0xLTEtMS00OTgxNg_60ee500b-8c25-4fa8-aabc-faeb54eca986"
      unitRef="usd">94570000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMy0zLTEtMS00OTgxNg_2de840bd-acc9-47d2-8835-ec0c30c6ba94"
      unitRef="usd">178872000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNC0xLTEtMS00OTgxNg_8b54e9ab-6ff7-4a15-90d3-e2a32c59483a"
      unitRef="usd">218998000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNC0zLTEtMS00OTgxNg_519ba830-9b0c-41c8-9f29-95a3d8bdcfda"
      unitRef="usd">197676000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNS0xLTEtMS00OTgxNg_11bfd33f-d07c-4e7e-b1e4-f6cb723b42ad"
      unitRef="usd">524000</us-gaap:InterestReceivableCurrent>
    <us-gaap:InterestReceivableCurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNS0zLTEtMS00OTgxNg_eb86003c-2d6c-4507-a854-2b064c386a9d"
      unitRef="usd">349000</us-gaap:InterestReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNi0xLTEtMS00OTgxNg_c1578bbd-9528-4355-95c4-bf3ea7c5678c"
      unitRef="usd">4522000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNi0zLTEtMS00OTgxNg_8b1512bf-87a7-4fee-aecf-85f4750b5e20"
      unitRef="usd">6013000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNy0xLTEtMS00OTgxNg_6819d208-b97f-4f02-a204-e17d7fa4e32b"
      unitRef="usd">18007000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfNy0zLTEtMS00OTgxNg_8ee05108-a0c3-4feb-a662-179f4c6692c2"
      unitRef="usd">15859000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfOC0xLTEtMS00OTgxNg_e349d5dd-2ce2-4c79-a8c0-5d35ecc2cb9e"
      unitRef="usd">336621000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfOC0zLTEtMS00OTgxNg_b5d53dfd-0260-4365-b062-e7d43365ebbe"
      unitRef="usd">398769000</us-gaap:AssetsCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfOS0xLTEtMS00OTgxNg_89d85707-6e6b-4763-88b0-596a8df84ba7"
      unitRef="usd">36700000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfOS0zLTEtMS00OTgxNg_6b0ae8f3-b59d-45ad-97a3-dbc9600211ef"
      unitRef="usd">88169000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTAtMS0xLTEtNDk4MTY_cb753f5d-791d-4e0b-acdf-51656d7d3643"
      unitRef="usd">55986000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTAtMy0xLTEtNDk4MTY_494e2e30-517f-48a1-9293-972a05e87391"
      unitRef="usd">51523000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTEtMS0xLTEtNDk4MTY_ba0fbd18-fbf0-41a1-ab6d-b6a05e3c68f2"
      unitRef="usd">46439000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTEtMy0xLTEtNDk4MTY_7e816728-cdd3-4248-b9e1-4f5b1aa9fefb"
      unitRef="usd">53760000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTItMS0xLTEtNDk4MTY_f4606a1e-f09a-4036-b647-91028c8e7dab"
      unitRef="usd">34511000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTItMy0xLTEtNDk4MTY_96fd76d8-fea9-41f7-83c7-1eb96a183392"
      unitRef="usd">39702000</us-gaap:Goodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTMtMS0xLTEtNDk4MTY_045b0a1e-3af0-432d-9c20-2f0639196d7f"
      unitRef="usd">64956000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTMtMy0xLTEtNDk4MTY_b496ef48-57b3-4e34-99fb-6a99304e1b37"
      unitRef="usd">73181000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTQtMS0xLTEtNDk4MTY_ac42fe85-0c51-4500-b202-5c07c0da0800"
      unitRef="usd">17200000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTQtMy0xLTEtNDk4MTY_68d5aff3-e181-43ce-8128-93e6faf215a8"
      unitRef="usd">15319000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTUtMS0xLTEtNDk4MTY_3d64e3d6-e33e-4839-b733-2ec97b28373e"
      unitRef="usd">1500000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:RestrictedCashNoncurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTUtMy0xLTEtNDk4MTY_e90184f0-cedf-4d0d-b4b3-71021877fd6e"
      unitRef="usd">1500000</us-gaap:RestrictedCashNoncurrent>
    <us-gaap:Assets
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTYtMS0xLTEtNDk4MTY_996ed829-5b82-422d-a898-a1e32b8f8f2f"
      unitRef="usd">593913000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTYtMy0xLTEtNDk4MTY_8b93b945-09ce-4321-a302-1de18a0fec67"
      unitRef="usd">721923000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTktMS0xLTEtNDk4MTY_a885ce0b-29c7-4b8a-8f9b-bcb0f5521da6"
      unitRef="usd">17380000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMTktMy0xLTEtNDk4MTY_d2b1300d-f88c-4c20-a9a8-1eeca0a5d191"
      unitRef="usd">9759000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjAtMS0xLTEtNDk4MTY_ba678943-863f-48f5-baf6-5ebfac8b7b4f"
      unitRef="usd">19045000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjAtMy0xLTEtNDk4MTY_28bfa97e-bf2e-4d92-a59f-2d5050d0c88b"
      unitRef="usd">20840000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjEtMS0xLTEtNDk4MTY_dd3cf789-2f88-4a8f-be16-3b64a6f4d8e7"
      unitRef="usd">14046000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjEtMy0xLTEtNDk4MTY_834f417e-5a6d-4583-b4ee-b473f6901485"
      unitRef="usd">11577000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjItMS0xLTEtNDk4MTY_e44a8419-0363-4e50-935d-ab964f61eddb"
      unitRef="usd">71890000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjItMy0xLTEtNDk4MTY_86bf66eb-57c7-4d7a-ab4a-0c43b86a8dea"
      unitRef="usd">85711000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjMtMS0xLTEtNDk4MTY_451a9902-5be8-4434-b99d-55007af61bb0"
      unitRef="usd">122361000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjMtMy0xLTEtNDk4MTY_c8bb91f9-9d8a-494d-8f93-2a64714b1bca"
      unitRef="usd">127887000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjQtMS0xLTEtNDk4MTY_5b016cc1-ee94-457a-a2f9-ea9e741e0c47"
      unitRef="usd">115641000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjQtMy0xLTEtNDk4MTY_fb411656-f3f8-4d20-85cc-7383186aa8d7"
      unitRef="usd">166776000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjUtMS0xLTEtNDk4MTY_6208f11a-92d3-422c-a6e3-44b4fedd1791"
      unitRef="usd">39705000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjUtMy0xLTEtNDk4MTY_ea27b395-2928-4038-a141-6cbf8a0e5107"
      unitRef="usd">44055000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjYtMS0xLTEtNDk4MTY_b6bf5f9c-a2bc-4a32-af16-84332a42798c"
      unitRef="usd">5740000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjYtMy0xLTEtNDk4MTY_3374e803-6fe8-4985-bae7-e60175dc5739"
      unitRef="usd">6645000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjctMS0xLTEtNDk4MTY_a3a42341-9402-4f45-ba8d-1455ce05dd2a"
      unitRef="usd">1312000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjctMy0xLTEtNDk4MTY_090a3431-c199-49c4-9fed-b022257e353f"
      unitRef="usd">1217000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjgtMS0xLTEtNDk4MTY_7932a4e6-10a1-4a76-acf0-ff490df08599"
      unitRef="usd">284759000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjgtMy0xLTEtNDk4MTY_a8b72b11-c8e3-4817-8cf7-557a765b2d3a"
      unitRef="usd">346580000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjktMS0xLTEtNDk4MTY_66f7ca9f-53a2-41c0-b9b8-7fea7c19c1e4"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMjktMy0xLTEtNDk4MTY_5af7b6d9-de85-4f1b-9491-12797401fe6b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzEtMS0xLTEtNDk4MTY_323516d5-0131-4985-9212-9c7cf379c27b"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzEtMy0xLTEtNDk4MTY_8faf5772-3ad6-46da-ad38-6b9342f717e1"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockValue
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzItMS0xLTEtNDk4MTY_6461b048-3e54-46bb-9a4d-1762354873fd"
      unitRef="usd">1619000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzItMy0xLTEtNDk4MTY_11ca77fb-607d-4e4c-b149-78fdd6514174"
      unitRef="usd">1459000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzMtMS0xLTEtNDk4MTY_983634ec-cd14-4f03-9e77-6f0298da2b2b"
      unitRef="usd">1423105000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzMtMy0xLTEtNDk4MTY_42af8ebd-3ac8-422e-9e5f-a321e0cc6231"
      unitRef="usd">1334138000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzQtMS0xLTEtNDk4MTY_87e9a996-be41-4910-98c6-571fb72d8dde"
      unitRef="usd">-1096572000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzQtMy0xLTEtNDk4MTY_189153e5-16b9-43ce-a86b-9dcf8d85f824"
      unitRef="usd">-956267000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzUtMS0xLTEtNDk4MTY_806b545a-1c56-4caa-a1d6-1b2be3e859c2"
      unitRef="usd">-18998000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzUtMy0xLTEtNDk4MTY_5192a48f-46b6-494d-9a71-a5391c193b1e"
      unitRef="usd">-3987000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzYtMS0xLTEtNDk4MTY_92459500-c31f-47f3-a448-9b469ce4f19d"
      unitRef="usd">309154000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzYtMy0xLTEtNDk4MTY_ba320eaa-8d8a-46ae-b8dc-ff6840d73f5a"
      unitRef="usd">375343000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzktMS0xLTEtNDk4MTY_292ad0fe-ac3a-4484-a890-f05c4e0d3cb9"
      unitRef="usd">593913000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yMi9mcmFnOmViMjc1NTMxNWZmZjRlMTk5NThmMzM3ZDdlNDZhNzVjL3RhYmxlOmIzMzc5ZTliM2QxZjQwM2ZhNGFmMzQ0YTk1NzkxYjc5L3RhYmxlcmFuZ2U6YjMzNzllOWIzZDFmNDAzZmE0YWYzNDRhOTU3OTFiNzlfMzktMy0xLTEtNDk4MTY_fe6fdf45-dfad-4527-bdce-4853df8e1748"
      unitRef="usd">721923000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMi0xLTEtMS00OTgxNg_b685304a-510c-4f53-aef6-8f6455688c15"
      unitRef="usd">26460000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMi0zLTEtMS00OTgxNg_f692449b-35d4-4fcd-8ef4-911203ed2702"
      unitRef="usd">28563000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMi01LTEtMS00OTgxNg_a72ec2d7-334e-480b-989d-584cdc35de5d"
      unitRef="usd">84069000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMi03LTEtMS00OTgxNg_01c0dae8-7b14-4204-9d1b-0a5d83947566"
      unitRef="usd">82715000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNC0xLTEtMS00OTgxNg_1a10caf2-9063-42ef-b06d-a10d886adf05"
      unitRef="usd">65116000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNC0zLTEtMS00OTgxNg_a69c3dc3-0796-4d08-98e3-61cea9ef2b34"
      unitRef="usd">62498000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNC01LTEtMS00OTgxNg_56ccffe9-6d39-4730-94e2-d11111ac7a81"
      unitRef="usd">183719000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNC03LTEtMS00OTgxNg_a3d0ab0c-2f86-4006-a0f0-889e78cc5947"
      unitRef="usd">179018000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNS0xLTEtMS00OTgxNg_06f59103-6565-4339-8ff1-4f1be7542680"
      unitRef="usd">16238000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNS0zLTEtMS00OTgxNg_38aa6a6b-2ae5-4bf8-9861-2bbc286dc492"
      unitRef="usd">14501000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNS01LTEtMS00OTgxNg_ec7ce837-52c8-41dc-aeb3-479763c7d7cc"
      unitRef="usd">46239000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNS03LTEtMS00OTgxNg_6210e1f0-3335-40da-954c-203f2f373de2"
      unitRef="usd">47135000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNi0xLTEtMS00OTgxNg_b0667f92-51f8-48cc-9b12-2362965f20ec"
      unitRef="usd">81354000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNi0zLTEtMS00OTgxNg_df6352f7-e395-4713-b383-3f21b8e38596"
      unitRef="usd">76999000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNi01LTEtMS00OTgxNg_162f630d-5709-4712-8ae6-f1f655ea5ca6"
      unitRef="usd">229958000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNi03LTEtMS00OTgxNg_2f28109e-9ee4-4c9e-a67c-32269209997c"
      unitRef="usd">226153000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNy0xLTEtMS00OTgxNg_db684f45-de37-4046-84f5-2cfeb05a3b2c"
      unitRef="usd">-54894000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNy0zLTEtMS00OTgxNg_f94c7e39-094c-460d-9337-6e4f1d504e2a"
      unitRef="usd">-48436000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNy01LTEtMS00OTgxNg_efd765ff-9229-41ce-8c5d-d2c581819366"
      unitRef="usd">-145889000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfNy03LTEtMS00OTgxNg_79ff084b-7301-4668-bfe0-57889933beb0"
      unitRef="usd">-143438000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestAndOtherIncome
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOC0xLTEtMS00OTgxNg_ce7e9970-31f9-4bde-896f-bc39f9f4493f"
      unitRef="usd">1769000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOC0zLTEtMS00OTgxNg_d8b664ba-ec17-4b53-ad9e-cedae305df59"
      unitRef="usd">834000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOC01LTEtMS00OTgxNg_73be24de-d13d-4b7e-85b8-a735a9a25f06"
      unitRef="usd">5754000</us-gaap:InterestAndOtherIncome>
    <us-gaap:InterestAndOtherIncome
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOC03LTEtMS00OTgxNg_91c0095b-4c2a-41f3-9381-ca967da0fe52"
      unitRef="usd">3010000</us-gaap:InterestAndOtherIncome>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOS0xLTEtMS00OTgxNg_2a3c2c1c-0e7d-441a-b5a0-146d3a5e6782"
      unitRef="usd">-53125000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOS0zLTEtMS00OTgxNg_9268943d-eaaa-4b89-bc74-191aee4c9186"
      unitRef="usd">-47602000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOS01LTEtMS00OTgxNg_e6910011-58bb-4eee-895b-770d8e1cb959"
      unitRef="usd">-140135000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfOS03LTEtMS00OTgxNg_5f1d2ffe-ac4b-4c7d-ad06-67d0c9ee2096"
      unitRef="usd">-140428000</us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTAtMS0xLTEtNDk4MTY_448f0b44-727a-48da-a3a6-ef8f1d11a463"
      unitRef="usd">30000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTAtMy0xLTEtNDk4MTY_c0ae2e6e-952c-4d01-b5c2-e022463ab901"
      unitRef="usd">86000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTAtNS0xLTEtNDk4MTY_82fbbed1-897d-4ac6-82e2-2bdb2c2f5d8b"
      unitRef="usd">170000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTAtNy0xLTEtNDk4MTY_fed85073-c32b-478f-bdb5-68101b7c9817"
      unitRef="usd">373000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTEtMS0xLTEtNDk4MTY_e5abd17d-6803-4ce1-8bcd-b3763babe964"
      unitRef="usd">-53155000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTEtMy0xLTEtNDk4MTY_65362d4e-f17a-41e0-ad48-7c834c63a606"
      unitRef="usd">-47688000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTEtNS0xLTEtNDk4MTY_ecb11591-4682-4b95-a72b-29716e58ce33"
      unitRef="usd">-140305000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTEtNy0xLTEtNDk4MTY_f5662da8-9ef8-4b91-86a8-8e3c357f6684"
      unitRef="usd">-140801000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTItMS0xLTEtNDk4MTY_09e5dd3b-fdf1-4b84-9f06-62320ecaf308"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTItMy0xLTEtNDk4MTY_466c2f59-da47-43f5-8ee8-f32a50af09ea"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTItNS0xLTEtNDk4MTY_b90c8b31-899e-4c72-83e2-d54cc5a0bae3"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTItNy0xLTEtNDk4MTY_15e8ec7d-672b-4b53-9756-5ecc6c7e1a9d"
      unitRef="usd">-11000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtMS0xLTEtNDk4MTY_388f8d32-d536-4fac-9c8e-e95c0e07759a"
      unitRef="usd">-53155000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtMS0xLTEtNDk4MTY_53c780e0-ad99-4252-8fe5-ba842613a520"
      unitRef="usd">-53155000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtMy0xLTEtNDk4MTY_28ee90b9-f6c9-4519-99c6-56aa4b851fea"
      unitRef="usd">-47688000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtMy0xLTEtNDk4MTY_477e69e5-3a3a-4b30-a56e-fb41be1a3ed0"
      unitRef="usd">-47688000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtNS0xLTEtNDk4MTY_5d92e309-adea-40d1-adac-28ebee88a788"
      unitRef="usd">-140305000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtNS0xLTEtNDk4MTY_cd10c400-be2c-4f39-a8e1-8d97f440533d"
      unitRef="usd">-140305000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtNy0xLTEtNDk4MTY_74fde5cc-752b-4ff5-bb3d-bf42ee5bbc3f"
      unitRef="usd">-140790000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTMtNy0xLTEtNDk4MTY_781dac3d-4d2b-43b2-8f7d-d1d6632c35b1"
      unitRef="usd">-140790000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtMS0xLTEtNDk4MTY_9860e683-fc37-483c-a7fc-355dedd6a004"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtMS0xLTEtNDk4MTY_9bdd9809-f6c3-4449-97f6-31f5fe965b08"
      unitRef="usdPerShare">-0.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtMy0xLTEtNDk4MTY_20d44108-a163-4b05-879f-27ad5ef9d457"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtMy0xLTEtNDk4MTY_8bc50731-9cb4-4060-8bf9-bc1e8e43aec7"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtNS0xLTEtNDk4MTY_1001dcbf-ee5c-4f95-b8a4-cc82871b4c43"
      unitRef="usdPerShare">-0.93</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtNS0xLTEtNDk4MTY_4b9ad625-28a7-47df-88bb-a6636b6ccd8a"
      unitRef="usdPerShare">-0.93</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtNy0xLTEtNDk4MTY_49ca95d7-4401-40ed-85ae-1399d3bf64de"
      unitRef="usdPerShare">-0.98</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTQtNy0xLTEtNDk4MTY_5062eb4e-b0d6-42d4-8cd5-f677ae9b1b73"
      unitRef="usdPerShare">-0.98</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtMS0xLTEtNDk4MTY_2f002fa6-3a1c-4965-8d37-852eb63680be"
      unitRef="shares">158042000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtMS0xLTEtNDk4MTY_d524fa80-bd1c-47b3-9804-938152bdcd8c"
      unitRef="shares">158042000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtMy0xLTEtNDk4MTY_4a6c3415-8abe-4b2f-b932-08bbfa7ded32"
      unitRef="shares">145399000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtMy0xLTEtNDk4MTY_8c94de00-5c68-48f1-b699-636638520c8e"
      unitRef="shares">145399000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtNS0xLTEtNDk4MTY_6e74189b-60ea-430b-b9da-de4c7a496da6"
      unitRef="shares">150850000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtNS0xLTEtNDk4MTY_cb8f5579-a7fa-4e75-8206-27443f816d26"
      unitRef="shares">150850000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtNy0xLTEtNDk4MTY_58ee5354-bea1-4489-b84b-96b0ff503f40"
      unitRef="shares">144173000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yNS9mcmFnOjE0MTMxZDg4MmFjYjRmY2I4MWJjN2FkYzdiY2RjNWUzL3RhYmxlOjU4YTMwNzZiY2I4NTQ1ZjhhN2FiNWQ4ZjNkOTRlYjExL3RhYmxlcmFuZ2U6NThhMzA3NmJjYjg1NDVmOGE3YWI1ZDhmM2Q5NGViMTFfMTUtNy0xLTEtNDk4MTY_6b96018e-c1f5-47ee-91f9-5b1b2783e271"
      unitRef="shares">144173000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:ProfitLoss
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMi0xLTEtMS00OTgxNg_bd82140a-f73c-4a11-95ca-91c8f2248f28"
      unitRef="usd">-53155000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMi0zLTEtMS00OTgxNg_3d7e36f1-fe7b-4a26-8d2c-67f92e0b75cd"
      unitRef="usd">-47688000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMi01LTEtMS00OTgxNg_ecb11591-4682-4b95-a72b-29716e58ce33"
      unitRef="usd">-140305000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMi03LTEtMS00OTgxNg_67c485ba-061b-4f56-bfd8-6898d8ee904d"
      unitRef="usd">-140801000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMy0xLTEtMS00OTgxNg_6df23e86-bb62-4f7c-bf83-982b0a4f0098"
      unitRef="usd">-6028000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMy0zLTEtMS00OTgxNg_93221e0c-25f6-4207-8e05-16e25d8e7462"
      unitRef="usd">-2565000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMy01LTEtMS00OTgxNg_efaff20d-4140-42c7-878c-9afeb9f420e6"
      unitRef="usd">-14040000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfMy03LTEtMS00OTgxNg_b84f5856-2014-4326-a980-0108216c94fc"
      unitRef="usd">-6006000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNC0xLTEtMS00OTgxNg_69c110ab-a381-4e7f-81b5-2fda020a38c8"
      unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNC0zLTEtMS00OTgxNg_2e7272b0-eb01-4246-9b86-219dcce3751f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNC01LTEtMS00OTgxNg_7748b0d2-bab6-4cb3-ac82-e865ad5ae9f3"
      unitRef="usd">-130000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNC03LTEtMS00OTgxNg_4e082c6e-0e31-44f7-b11e-bf2f4252e937"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNS0xLTEtMS00OTgxNg_c4a28082-0c98-4957-8e1f-f7cfe2c1b196"
      unitRef="usd">135000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNS0zLTEtMS00OTgxNg_f5179a5d-0790-42df-a67f-05b30d55fffb"
      unitRef="usd">-45000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNS01LTEtMS00OTgxNg_3c55fa30-f347-4793-8680-62f4a4c0b09e"
      unitRef="usd">-1101000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNS03LTEtMS00OTgxNg_51ba145c-4748-4a4b-80e8-ef41c1195c08"
      unitRef="usd">-36000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNy0xLTEtMS00OTgxNg_2f752d69-5bcc-4b78-8ae2-603901cd1f93"
      unitRef="usd">-58993000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNy0zLTEtMS00OTgxNg_1c7d5f6a-8313-4e27-997a-2e5dd62e1397"
      unitRef="usd">-50298000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNy01LTEtMS00OTgxNg_bb0a2a9d-22b6-4fe6-a9b5-6734019f56cd"
      unitRef="usd">-155316000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfNy03LTEtMS00OTgxNg_458a1b80-0926-45af-9dab-562a06cdcd29"
      unitRef="usd">-146843000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOC0xLTEtMS00OTgxNg_36c49630-239a-407c-902b-a005e0556a6c"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOC0zLTEtMS00OTgxNg_37db10d7-3133-4e5c-989f-85c0fe216c16"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOC01LTEtMS00OTgxNg_eb0a2e32-2096-4ccc-ad47-501c0cbe1bae"
      unitRef="usd">0</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOC03LTEtMS00OTgxNg_4a821b72-27c4-4ed7-9ea9-617aa2d1fa61"
      unitRef="usd">-11000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOS0xLTEtMS00OTgxNg_a8798354-5ca9-4297-a2de-c64d2c41d19b"
      unitRef="usd">-58993000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOS0zLTEtMS00OTgxNg_11bcef60-c8c2-44d8-b675-934ead332bf7"
      unitRef="usd">-50298000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOS01LTEtMS00OTgxNg_5f9571d0-f638-42d1-be63-00ccb5e16f3b"
      unitRef="usd">-155316000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8yOC9mcmFnOjU2ZWJjZDYzYzQ0MDRkZDA5ODJmMDhlNTQ3M2RiNTEwL3RhYmxlOmU5YmM3YTI5MTA2YjRlZGQ4M2ZkODVhMTQxMDcwOGM3L3RhYmxlcmFuZ2U6ZTliYzdhMjkxMDZiNGVkZDgzZmQ4NWExNDEwNzA4YzdfOS03LTEtMS00OTgxNg_b76e5f48-43f8-4fa3-8566-1d5626af5e9d"
      unitRef="usd">-146832000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesIssued
      contextRef="i65c4b9f6e28c49ccb8e9f49894741665_I20220630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy0xLTEtMS00OTgxNg_f6e35846-06f6-46a3-a1bf-ad9f12596a58"
      unitRef="shares">153352502</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65c4b9f6e28c49ccb8e9f49894741665_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy0zLTEtMS00OTgxNg_2f4ef2d4-4a7a-44ab-9d04-b44b02680387"
      unitRef="usd">1534000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieaf636eab7a446278c2c60b3497f65dd_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy01LTEtMS00OTgxNg_fb2fccf7-59e9-48e7-b603-692174d7882a"
      unitRef="usd">1373324000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifdb651fdae9f4daba649e657742b10fb_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy03LTEtMS00OTgxNg_48194eb7-ab9f-471a-a338-e3be30473f7c"
      unitRef="usd">-1043417000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0901c3888400484d82bc9d499ba27882_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy05LTEtMS00OTgxNg_d83a2d9f-b503-4e93-97d9-5ba448c0677f"
      unitRef="usd">-13160000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4358e68463414d2f81e6d07be34f96f4_I20220630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMy0xMS0xLTEtNDk4MTY_64288048-abcd-4efc-bf7a-dd2e48e1321b"
      unitRef="usd">318281000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i4f86a00ffb9a44c09b92cbd140f04b6a_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNC0xLTEtMS00OTgxNg_823a4432-6942-4b97-bf25-33e9875ec0c0"
      unitRef="shares">8483104</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4f86a00ffb9a44c09b92cbd140f04b6a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNC0zLTEtMS00OTgxNg_851bb2d3-78af-473a-b152-d12a69a0a07f"
      unitRef="usd">85000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i9f36b8087e874e84bb6cfbb657e30dd3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNC01LTEtMS00OTgxNg_41ba3b2c-3d4e-4483-95f8-19e28d3d81f0"
      unitRef="usd">42089000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNC0xMS0xLTEtNDk4MTY_8975d95a-9604-4ebc-a3ac-02b5675b9350"
      unitRef="usd">42174000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i4f86a00ffb9a44c09b92cbd140f04b6a_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNS0xLTEtMS00OTgxNg_cb843e75-650e-4112-a105-4bf649d64a87"
      unitRef="shares">82617</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9f36b8087e874e84bb6cfbb657e30dd3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNS01LTEtMS00OTgxNg_a389fc5d-8825-42ff-b5a8-814e7866e5c6"
      unitRef="usd">-101000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNS0xMS0xLTEtNDk4MTY_51e3d54b-a046-4f60-ad7d-50bec7d9db5c"
      unitRef="usd">-101000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i9f36b8087e874e84bb6cfbb657e30dd3_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNy01LTEtMS00OTgxNg_4e876a1a-1e0e-4aca-8dcc-d18b510cb3b8"
      unitRef="usd">7793000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfNy0xMS0xLTEtNDk4MTY_59ed8a08-7a26-47a2-856a-eefd61128350"
      unitRef="usd">7793000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i477f878f2fc449a7b9b882f03d328aea_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfOS05LTEtMS00OTgxNg_3e42c811-02cd-4247-9c64-27b63e72fd46"
      unitRef="usd">6028000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfOS0xMS0xLTEtNDk4MTY_27a2f142-e705-4008-9a75-28ce223af521"
      unitRef="usd">6028000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i477f878f2fc449a7b9b882f03d328aea_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTAtOS0xLTEtNDk4MTY_f29ec8c3-6fce-4a04-b72e-98f4f798d5cc"
      unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTAtMTEtMS0xLTQ5ODE2_b9f67d24-f37f-4ce9-84d6-79006953d57e"
      unitRef="usd">-55000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i477f878f2fc449a7b9b882f03d328aea_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTEtOS0xLTEtNDk4MTY_21e83e90-6981-4383-ac38-98fc64c0cdeb"
      unitRef="usd">135000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTEtMTEtMS0xLTQ5ODE2_fa8aa81d-3c9f-48bf-8704-026b54c5067c"
      unitRef="usd">135000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="ia174d038fef54c1988b0d1f7bb55851a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTMtNy0xLTEtNDk4MTY_2e23e8c3-169b-471e-a662-eb40d55c6ad9"
      unitRef="usd">-53155000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTMtMTEtMS0xLTQ5ODE2_927ac77c-adef-4b56-b1a7-27054f3029ca"
      unitRef="usd">-53155000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="i10185405784946f6866fa6235275377e_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtMS0xLTEtNDk4MTY_27e36487-e090-4e4e-a395-15d220e14a80"
      unitRef="shares">161918223</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i10185405784946f6866fa6235275377e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtMy0xLTEtNDk4MTY_33e7ba1b-0772-48fa-b21a-8b57acef4917"
      unitRef="usd">1619000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5629c83660045e689bee72501b7f3b5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtNS0xLTEtNDk4MTY_c9ba2eb6-196e-47a9-859f-1a52c994b851"
      unitRef="usd">1423105000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id1842e89b1004e10ab03df6383c15efe_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtNy0xLTEtNDk4MTY_e96f422a-8f14-4b64-8076-a55688dd86a0"
      unitRef="usd">-1096572000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie475194a8bc5487bb425f884b64c7cb4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtOS0xLTEtNDk4MTY_e812d016-2248-459d-90c7-03c9f38f4ac1"
      unitRef="usd">-18998000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjI4NTE3MjQzOWVkZjQxMjFiNDExM2E3MGQ3ZTIwYjJmL3RhYmxlcmFuZ2U6Mjg1MTcyNDM5ZWRmNDEyMWI0MTEzYTcwZDdlMjBiMmZfMTQtMTEtMS0xLTQ5ODE2_7ff74b3b-2c69-4704-afc4-17e509370735"
      unitRef="usd">309154000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="id44dcc12390c46679a8547aa1acebc45_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy0xLTEtMS00OTgxNg_4fea933b-d20a-4d99-a259-734cf1bfb550"
      unitRef="shares">145921530</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id44dcc12390c46679a8547aa1acebc45_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy0zLTEtMS00OTgxNg_d31c03ca-c5c8-4890-8d43-a737110924f4"
      unitRef="usd">1459000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2a696035ebd0409f842a3d85f1f17177_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy01LTEtMS00OTgxNg_e147abfb-6c5a-4416-96fe-e7e3fb4e57ca"
      unitRef="usd">1334138000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7eb5094c50c94679a226568ebb7c0cdc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy03LTEtMS00OTgxNg_a2a0e701-c9e9-40fc-986c-a3ec25bc11f6"
      unitRef="usd">-956267000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5f88f052bc74b0897f087b88dcf0e44_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy05LTEtMS00OTgxNg_3e5c701d-6e35-44cd-8f8c-b4cd2040b28e"
      unitRef="usd">-3987000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMy0xMS0xLTEtNDk4MTY_e5a34187-9f3a-4ea3-b9c0-127fd3ab258c"
      unitRef="usd">375343000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNC0xLTEtMS00OTgxNg_3a45e174-c619-4521-9f81-30320e3a8bfb"
      unitRef="shares">14711770</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNC0zLTEtMS00OTgxNg_8a5c989f-a560-4b52-8ccf-ade42c722d7a"
      unitRef="usd">147000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="id28e3d378e8e41c2b2f192f93c7e7a2d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNC01LTEtMS00OTgxNg_c211a3b7-916a-4ce5-8748-b7fc47aa68a3"
      unitRef="usd">66301000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNC0xMS0xLTEtNDk4MTY_5398e364-35bf-4da4-980d-4c4bd68adcd2"
      unitRef="usd">66448000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNS0xLTEtMS00OTgxNg_9132e051-5bd1-48b2-87ab-5cc66b51ec79"
      unitRef="shares">925455</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNS0zLTEtMS00OTgxNg_84325d91-17b5-43a3-b977-f2183ccfa732"
      unitRef="usd">9000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="id28e3d378e8e41c2b2f192f93c7e7a2d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNS01LTEtMS00OTgxNg_d0f58623-bb94-498d-8792-0c783b818cf3"
      unitRef="usd">-1847000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNS0xMS0xLTEtNDk4MTY_08190b0c-cca9-450f-ab97-be60d61bf640"
      unitRef="usd">-1838000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNi0xLTEtMS00OTgxNg_3cd4c440-a6d5-4c58-bdcb-278bb3adf92b"
      unitRef="shares">359468</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i103f93a102e948d88feff79dfd30c06a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNi0zLTEtMS00OTgxNg_62e91de4-f600-4c1f-843b-b53c71dd296d"
      unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="id28e3d378e8e41c2b2f192f93c7e7a2d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNi01LTEtMS00OTgxNg_6ae63154-adeb-4415-82e8-fd64aa328499"
      unitRef="usd">1111000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNi0xMS0xLTEtNDk4MTY_899c89a4-cbe3-444d-8cf7-7213e060e39d"
      unitRef="usd">1115000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="id28e3d378e8e41c2b2f192f93c7e7a2d_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNy01LTEtMS00OTgxNg_def37cab-ed48-45be-932e-f02cdc6fd925"
      unitRef="usd">23402000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfNy0xMS0xLTEtNDk4MTY_a00ddde7-5a29-4ea2-9b54-9a86ab9e3ef7"
      unitRef="usd">23402000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ie86b8354fd9c48fa8f7effcc8fab0655_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfOS05LTEtMS00OTgxNg_195c774b-9282-45d3-b2c2-886909643e35"
      unitRef="usd">14040000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfOS0xMS0xLTEtNDk4MTY_749cb5fb-8e9b-4f4c-8f81-1f3acf9d560b"
      unitRef="usd">14040000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="ie86b8354fd9c48fa8f7effcc8fab0655_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTAtOS0xLTEtNDk4MTY_3c57056f-d2dd-484f-acbd-421c5e4bafa0"
      unitRef="usd">-130000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTAtMTEtMS0xLTQ5ODE2_addfe28e-0d7d-48f1-9599-16d078c7ebb5"
      unitRef="usd">-130000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ie86b8354fd9c48fa8f7effcc8fab0655_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTEtOS0xLTEtNDk4MTY_a6e1429b-0fd9-4abf-8f8f-e4096f94d0de"
      unitRef="usd">-1101000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTEtMTEtMS0xLTQ5ODE2_75518ab6-7f89-4aca-bf58-f664818764e6"
      unitRef="usd">-1101000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i5b80b0627d224b51a736282e5de2e649_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTMtNy0xLTEtNDk4MTY_181cb161-5db0-43ec-9d64-28419e978e04"
      unitRef="usd">-140305000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTMtMTEtMS0xLTQ5ODE2_8e5530b9-7357-4084-b360-ca2d057fbf81"
      unitRef="usd">-140305000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="i10185405784946f6866fa6235275377e_I20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtMS0xLTEtNDk4MTY_137c4f3a-1681-46a7-9255-6b6e6767e5e2"
      unitRef="shares">161918223</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i10185405784946f6866fa6235275377e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtMy0xLTEtNDk4MTY_8c2fe31d-6688-4c08-b6d5-430cd702fd49"
      unitRef="usd">1619000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic5629c83660045e689bee72501b7f3b5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtNS0xLTEtNDk4MTY_b9200c3e-0f56-43e8-b92a-96f57cadee4a"
      unitRef="usd">1423105000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id1842e89b1004e10ab03df6383c15efe_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtNy0xLTEtNDk4MTY_9abf8710-0c81-4708-b59c-2037a4c9e49b"
      unitRef="usd">-1096572000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie475194a8bc5487bb425f884b64c7cb4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtOS0xLTEtNDk4MTY_d4b43df5-d211-4538-aff5-219d3c4670a3"
      unitRef="usd">-18998000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOjgwZWY5NDY5MmQ1ZjRmMjRiNmZmOWYyMzU4NDhjOTJmL3RhYmxlcmFuZ2U6ODBlZjk0NjkyZDVmNGYyNGI2ZmY5ZjIzNTg0OGM5MmZfMTQtMTEtMS0xLTQ5ODE2_2cb91c92-0b99-4174-afe4-5c5a063f7614"
      unitRef="usd">309154000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="ibe3dce0a01ae4da686148893e81e9cbf_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy0xLTEtMS00OTgxNg_1d89af5b-d2e6-45e4-8caa-b5959a4f2469"
      unitRef="shares">145106901</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibe3dce0a01ae4da686148893e81e9cbf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy0zLTEtMS00OTgxNg_0527df1b-0e8a-4c1e-8635-57c10825c8a0"
      unitRef="usd">1451000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4ab6b60ff90948328c6518dfee567d60_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy01LTEtMS00OTgxNg_a788fe8a-37aa-468a-8ecd-426b692310cf"
      unitRef="usd">1313102000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia4437087e8514ebf9125f5ef80b34f7d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy03LTEtMS00OTgxNg_f4018d1e-d86f-433a-9902-86aa5ea4fd9f"
      unitRef="usd">-871083000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifd6155b736044781a9509dd909a16744_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy05LTEtMS00OTgxNg_b032abae-fca2-4784-8632-243764047ae6"
      unitRef="usd">1987000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic1f86ea542ca45139f8b891e2b341360_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy0xMS0xLTEtNDk4MTY_cc0148e9-520b-4f62-922f-101f19c25bed"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5b2b14725998443da0214724315022e3_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMy0xMy0xLTEtNDk4MTY_63420765-dc1a-43aa-8cca-9845e50e28b8"
      unitRef="usd">445457000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i67e431fd603948ddb3a910386fcf7720_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNC0xLTEtMS00OTgxNg_ba14817f-4c86-4a67-befb-c6e0346cd938"
      unitRef="shares">202705</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i67e431fd603948ddb3a910386fcf7720_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNC0zLTEtMS00OTgxNg_968c1454-cb81-4cbe-831e-27865c4379c5"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i2b20689a47fa4626b06dd28beb352cfc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNC01LTEtMS00OTgxNg_09dd84f5-f7e2-455a-b32a-7b7303a95402"
      unitRef="usd">2365000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNC0xMy0xLTEtNDk4MTY_cd3dd1e7-caf0-4eaf-a208-b22c62108278"
      unitRef="usd">2367000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i67e431fd603948ddb3a910386fcf7720_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNS0xLTEtMS00OTgxNg_dc2eadca-3439-4dc5-8bd6-5c294ed388a5"
      unitRef="shares">206970</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i67e431fd603948ddb3a910386fcf7720_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNS0zLTEtMS00OTgxNg_2cd8a46d-5792-40d9-9831-7a39cb061986"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i2b20689a47fa4626b06dd28beb352cfc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNS01LTEtMS00OTgxNg_3a105ff8-60f3-4fe8-9f7b-20d843b11b40"
      unitRef="usd">615000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNS0xMy0xLTEtNDk4MTY_46de59b7-cc35-496c-b279-14175f5a9544"
      unitRef="usd">617000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2b20689a47fa4626b06dd28beb352cfc_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNy01LTEtMS00OTgxNg_ebc107fd-2041-4b13-aa32-014ce46ccd80"
      unitRef="usd">7873000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfNy0xMy0xLTEtNDk4MTY_f854827f-3642-436a-bb33-28fc48f383eb"
      unitRef="usd">7873000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i888b3ba590bd4c97a8718de47daae199_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfOS05LTEtMS00OTgxNg_93308b41-5879-43c9-b5c3-b6209c3542b2"
      unitRef="usd">2565000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfOS0xMy0xLTEtNDk4MTY_550b77d7-0126-4dca-a855-2df50be9beca"
      unitRef="usd">2565000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i888b3ba590bd4c97a8718de47daae199_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTAtOS0xLTEtNDk4MTY_70322291-4817-48dc-bcff-2191c7cea130"
      unitRef="usd">-45000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTAtMTMtMS0xLTQ5ODE2_dd824bc3-8f9f-4542-b87c-8984ddd92b75"
      unitRef="usd">-45000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i7b65f408605048399b735ab6734947a4_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTItNy0xLTEtNDk4MTY_9aedc0af-3d86-470c-87ba-4d938c03135b"
      unitRef="usd">-47688000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ia153a8e0f69e430e9b0dc937bd3916b8_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTItMTEtMS0xLTQ5ODE2_cc40ff36-764f-4354-b4ab-8c0ed815dcec"
      unitRef="usd">0</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTItMTMtMS0xLTQ5ODE2_49abc30f-61f0-4a6b-90da-6f8630b40947"
      unitRef="usd">-47688000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9241e8a504e3490192f71c9decdcd3cf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtMS0xLTEtNDk4MTY_40a5f23f-9584-46c3-a9b7-6f237b1da975"
      unitRef="shares">145516576</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9241e8a504e3490192f71c9decdcd3cf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtMy0xLTEtNDk4MTY_13fe711b-2762-4bb9-a74e-88c138e91c3c"
      unitRef="usd">1455000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8bc460fcd2b4144afd1e6595036df06_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtNS0xLTEtNDk4MTY_f1b28b70-fdf5-4b40-853c-09f516403c2c"
      unitRef="usd">1323955000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iacd4ba876f2a4fb7b83c09ef9bd71e56_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtNy0xLTEtNDk4MTY_ef2b2553-2b26-478a-98bb-44e9cf4b6fcc"
      unitRef="usd">-918771000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bb367b30b03403c98021e1aba94eea9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtOS0xLTEtNDk4MTY_f6032607-653f-4637-aa12-0a55bb169a1f"
      unitRef="usd">-623000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53a9405cbbd74d8e87ce89d2e69fd569_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtMTEtMS0xLTQ5ODE2_3784c672-7942-403f-b921-196ef61932d0"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmU0NGYxOWU4N2RlZjQ3YWRiZmVjYThhNDU5MDk5NTgyL3RhYmxlcmFuZ2U6ZTQ0ZjE5ZTg3ZGVmNDdhZGJmZWNhOGE0NTkwOTk1ODJfMTMtMTMtMS0xLTQ5ODE2_cab8217a-6ba3-458b-85bf-e58bf2cc4570"
      unitRef="usd">406016000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesIssued
      contextRef="idcd86bcf9af64a3a815fcc501ba0ad77_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy0xLTEtMS00OTgxNg_db37c4de-f8f5-4396-bccc-222c498988be"
      unitRef="shares">142063203</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idcd86bcf9af64a3a815fcc501ba0ad77_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy0zLTEtMS00OTgxNg_cedf3a1e-959f-4689-a967-7b4a65ca25b0"
      unitRef="usd">1421000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i920d94b246904434a9c24327eda62fc2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy01LTEtMS00OTgxNg_cf82e385-c591-47b9-bbae-c70a166e1ba9"
      unitRef="usd">1269375000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i12cb742f69d84eafb765fed1f2925d84_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy03LTEtMS00OTgxNg_6deedc12-5e70-4073-930f-2dec47dbb3d3"
      unitRef="usd">-777981000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib759e7d27c734ebc91eb8d8e7257be3b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy05LTEtMS00OTgxNg_25eb6d23-4076-409a-aa88-e7a1aefb3e50"
      unitRef="usd">5419000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56f6f40bbe064e2eae76f5a1f8c67c65_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy0xMS0xLTEtNDk4MTY_21de3e4f-1123-4cca-a2d3-e010999d9825"
      unitRef="usd">-868000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMy0xMy0xLTEtNDk4MTY_fc479784-5f8f-4ba3-8677-9dd9e57ea062"
      unitRef="usd">497366000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNC0xLTEtMS00OTgxNg_73160e02-048c-441c-9e6c-fe95ed67d9ff"
      unitRef="shares">2007932</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNC0zLTEtMS00OTgxNg_8c38a57b-53db-425a-9b3d-3b25f8b94028"
      unitRef="usd">20000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNC01LTEtMS00OTgxNg_d826f859-1b50-41bc-8ff8-34c29615772e"
      unitRef="usd">27079000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNC0xMy0xLTEtNDk4MTY_48902739-e652-4558-b042-532ab1cc86d6"
      unitRef="usd">27099000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNS0xLTEtMS00OTgxNg_72aebb39-eccb-4e16-820d-a79963aa356f"
      unitRef="shares">1200871</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNS0zLTEtMS00OTgxNg_da95facf-1b20-41e2-a213-7d29f6c8fac0"
      unitRef="usd">12000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNS01LTEtMS00OTgxNg_02899b0d-52df-43d8-9503-3cef626e77d0"
      unitRef="usd">1582000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNS0xMy0xLTEtNDk4MTY_cd9905a8-ebd9-46e4-b78b-6910025bcaf8"
      unitRef="usd">1594000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNi0xLTEtMS00OTgxNg_3b6c85c7-418d-481a-8734-8368e19b288e"
      unitRef="shares">244570</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4b76d1f02edf4116ac5ab44d425baa1c_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNi0zLTEtMS00OTgxNg_85a650fd-145e-4a51-b78c-9b06d8a04708"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNi01LTEtMS00OTgxNg_7555b6a3-9c54-47c2-9342-43d2e1bca306"
      unitRef="usd">2052000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNi0xMy0xLTEtNDk4MTY_b03f41ab-b85a-4cde-b107-68f16bea826d"
      unitRef="usd">2054000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNy01LTEtMS00OTgxNg_20a8b2ae-baad-434d-9ac4-d7f5d8e11f44"
      unitRef="usd">24880000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfNy0xMy0xLTEtNDk4MTY_17e71420-3dbd-43ec-9048-105da16f509b"
      unitRef="usd">24880000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <sgmo:AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest
      contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfOC01LTEtMS00OTgxNg_ffa10de6-4de5-41c5-8a68-cb82ffb40f2d"
      unitRef="usd">-70000</sgmo:AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest>
    <sgmo:AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest
      contextRef="i451b037bb41149e78da8c2582ef147c9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfOC0xMS0xLTEtNDk4MTY_fe8d1841-2543-456f-a7c0-c241b91d8930"
      unitRef="usd">-64000</sgmo:AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest>
    <sgmo:AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfOC0xMy0xLTEtNDk4MTY_8995eef7-361f-42ec-aae4-343ff9e31305"
      unitRef="usd">-134000</sgmo:AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i7d5c5e06d683406faa61d58c55c666a6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfOS05LTEtMS00OTgxNg_8e3853fc-ba41-4866-b568-d9b8e00f72f7"
      unitRef="usd">6006000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfOS0xMy0xLTEtNDk4MTY_9f8cd814-f91e-4a5f-84e7-8742a7228e05"
      unitRef="usd">6006000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i7d5c5e06d683406faa61d58c55c666a6_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTEtOS0xLTEtNDk4MTY_7a6d9b57-c35c-43df-b8b2-cb67e8cbb141"
      unitRef="usd">-36000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTEtMTMtMS0xLTQ5ODE2_4b339e72-34aa-462b-83d2-b7b2cfb07998"
      unitRef="usd">-36000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i37838793d9244e2b86d0181baa4b3b73_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTItNS0xLTEtNDk4MTY_846166e4-ad98-4167-ab29-75194537b40d"
      unitRef="usd">943000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i451b037bb41149e78da8c2582ef147c9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTItMTEtMS0xLTQ5ODE2_239b19e8-b1f0-4a39-98b1-b64cf16a71b6"
      unitRef="usd">-943000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:ProfitLoss
      contextRef="i1053b2abcb2a42f6826b1ffc69e93fbd_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTMtNy0xLTEtNDk4MTY_9e40ff2b-3d4a-4334-a0d5-e428acf98b93"
      unitRef="usd">-140790000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i451b037bb41149e78da8c2582ef147c9_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTMtMTEtMS0xLTQ5ODE2_7b7e6736-1681-478e-ade5-55d4fc288e59"
      unitRef="usd">-11000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTMtMTMtMS0xLTQ5ODE2_fda1d91f-8f42-4feb-88d1-da84ababeb44"
      unitRef="usd">-140801000</us-gaap:ProfitLoss>
    <us-gaap:CommonStockSharesIssued
      contextRef="i9241e8a504e3490192f71c9decdcd3cf_I20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtMS0xLTEtNDk4MTY_de2abdcf-b3c9-4c76-8086-6e4511b7a430"
      unitRef="shares">145516576</us-gaap:CommonStockSharesIssued>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9241e8a504e3490192f71c9decdcd3cf_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtMy0xLTEtNDk4MTY_d612bbfd-9593-48b9-a272-65e9a8092d5d"
      unitRef="usd">1455000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib8bc460fcd2b4144afd1e6595036df06_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtNS0xLTEtNDk4MTY_26c6a061-0325-4e9f-b9bd-9e5a2cbcea4e"
      unitRef="usd">1323955000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iacd4ba876f2a4fb7b83c09ef9bd71e56_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtNy0xLTEtNDk4MTY_5e63d019-135f-419f-8d65-90261843bf20"
      unitRef="usd">-918771000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bb367b30b03403c98021e1aba94eea9_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtOS0xLTEtNDk4MTY_77be2394-2c28-4cca-914a-447acb0df680"
      unitRef="usd">-623000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53a9405cbbd74d8e87ce89d2e69fd569_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtMTEtMS0xLTQ5ODE2_c06fc792-c25b-4a5c-bccf-b29ce55f77b3"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zMS9mcmFnOjc3NTA1ZmFlZTlhYzRiZDhhMTg1NGRjNGI1ZGQ3YTFmL3RhYmxlOmQ1Yjc1NjNhZmM1NTQyNjZiMzk5NzRiOTZmOTUyYmE3L3RhYmxlcmFuZ2U6ZDViNzU2M2FmYzU1NDI2NmIzOTk3NGI5NmY5NTJiYTdfMTQtMTMtMS0xLTQ5ODE2_47b5f87e-d971-407e-9477-a58fc927cd86"
      unitRef="usd">406016000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMy0xLTEtMS00OTgxNg_c9c1ab4f-097a-48dd-b04e-2e325b18f002"
      unitRef="usd">-140305000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMy0zLTEtMS00OTgxNg_185eb723-6215-4354-8930-c2e9a98ead96"
      unitRef="usd">-140801000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNS0xLTEtMS00OTgxNg_052833ac-41a2-4f91-8245-1661414e3837"
      unitRef="usd">8765000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNS0zLTEtMS00OTgxNg_5364766c-97f2-434b-ba85-4784ab264436"
      unitRef="usd">6675000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNi0xLTEtMS00OTgxNg_86e82f7f-1703-4752-ad5f-d4d3323fb382"
      unitRef="usd">324000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNi0zLTEtMS00OTgxNg_2d4aa0c6-c628-4b2f-8f24-9a8ee563e878"
      unitRef="usd">-2394000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <sgmo:AmortizationAndOtherChangesInRightOfUseAssets
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNy0xLTEtMS00OTgxNg_ea4b74d3-989f-447d-a9d7-8b401e919884"
      unitRef="usd">-6357000</sgmo:AmortizationAndOtherChangesInRightOfUseAssets>
    <sgmo:AmortizationAndOtherChangesInRightOfUseAssets
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNy0zLTEtMS00OTgxNg_825111cc-456d-4c76-a2b0-f0ef10ac9136"
      unitRef="usd">-6104000</sgmo:AmortizationAndOtherChangesInRightOfUseAssets>
    <sgmo:GainLossOnFreeShares
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfOC0xLTEtMS00OTgxNg_eb89b8af-3222-480b-a64f-318fed7af291"
      unitRef="usd">0</sgmo:GainLossOnFreeShares>
    <sgmo:GainLossOnFreeShares
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfOC0zLTEtMS00OTgxNg_a32d691c-492f-4e6b-b0e8-1355dd8ba220"
      unitRef="usd">18000</sgmo:GainLossOnFreeShares>
    <us-gaap:ShareBasedCompensation
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfOS0xLTEtMS00OTgxNg_d30771c3-0746-4049-b47b-f344bf55f19d"
      unitRef="usd">23402000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfOS0zLTEtMS00OTgxNg_b112fb77-3926-46e9-91f8-8bafa7ba0627"
      unitRef="usd">24880000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTAtMS0xLTEtNDk4MTY_5fbebc66-3480-4cbe-82fb-4c088e0b96a3"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTAtMy0xLTEtNDk4MTY_2aa608b2-e68e-43c0-8661-8039609967a0"
      unitRef="usd">30000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTItMS0xLTEtNDk4MTY_729a5064-52fe-4270-be31-ecee7567e78f"
      unitRef="usd">175000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTItMy0xLTEtNDk4MTY_1b7b292b-3973-4880-8911-3f5e1fd463ca"
      unitRef="usd">-415000</us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTMtMS0xLTEtNDk4MTY_a939f277-060a-475d-8eb8-1084bba2543c"
      unitRef="usd">-1491000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTMtMy0xLTEtNDk4MTY_7d72b282-bbb9-4e4c-a24b-c3b605beee9c"
      unitRef="usd">2743000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTQtMS0xLTEtNDk4MTY_4a8c14d0-4f96-4629-a1c2-0acb3bdccf7d"
      unitRef="usd">5848000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTQtMy0xLTEtNDk4MTY_697ce68f-f630-4ed1-972c-3ef537b2437b"
      unitRef="usd">6467000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTUtMS0xLTEtNDk4MTY_88cee4fa-e902-4580-994a-b6b41c5c976f"
      unitRef="usd">9443000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTUtMy0xLTEtNDk4MTY_efc11a53-9072-4a0d-b9de-9f08feca8d74"
      unitRef="usd">-4699000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTctMS0xLTEtNDk4MTY_956a2bb9-5f75-42f2-ad50-e30169d929a2"
      unitRef="usd">-1225000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTctMy0xLTEtNDk4MTY_243e51a0-368d-4ef7-bb65-7ea7fe9f6be2"
      unitRef="usd">-1932000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTktMS0xLTEtNDk4MTY_b4335a38-924f-4179-8675-9905d01509e0"
      unitRef="usd">-64956000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMTktMy0xLTEtNDk4MTY_ae402276-0a4e-44b1-952d-6f677cc87ae4"
      unitRef="usd">-62292000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjAtMS0xLTEtNDk4MTY_12b89605-7726-49bf-aeb8-53e6a3cd3de3"
      unitRef="usd">-3298000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjAtMy0xLTEtNDk4MTY_0bfa10e2-0efe-4d66-ab72-f681aaad5622"
      unitRef="usd">-3227000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjEtMS0xLTEtNDk4MTY_6659e054-67c6-4cc0-9cce-0d4a05f1ed11"
      unitRef="usd">95000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjEtMy0xLTEtNDk4MTY_ef28770e-ff41-4bec-99d4-04f5f25e57cf"
      unitRef="usd">1204000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjItMS0xLTEtNDk4MTY_035a0915-10a6-47c5-b671-bd3c4adcbf69"
      unitRef="usd">-166578000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjItMy0xLTEtNDk4MTY_af3e6c5f-1c72-4606-a799-bd27978238f8"
      unitRef="usd">-180537000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjQtMS0xLTEtNDk4MTY_b284a18b-b8d7-4526-b387-fdffd6f8a9ba"
      unitRef="usd">225621000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjQtMy0xLTEtNDk4MTY_6eb70a08-12a6-4bd1-b936-1002d7b4cb3e"
      unitRef="usd">300387000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjUtMS0xLTEtNDk4MTY_7a01aa08-09e8-4993-af60-18f28a4abc5a"
      unitRef="usd">254990000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjUtMy0xLTEtNDk4MTY_93c4dfe5-06bf-41e5-84f6-cfbf64531762"
      unitRef="usd">509620000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleOfHeldToMaturitySecurities
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjYtMS0xLTEtNDk4MTY_17c586b6-d0e5-4d26-bc72-e5ec7a69757e"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfHeldToMaturitySecurities>
    <us-gaap:ProceedsFromSaleOfHeldToMaturitySecurities
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjYtMy0xLTEtNDk4MTY_bb9a4020-28c9-4108-af97-674c778e61ef"
      unitRef="usd">6870000</us-gaap:ProceedsFromSaleOfHeldToMaturitySecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjctMS0xLTEtNDk4MTY_ea562d78-1056-4f2f-abd4-56cb968c5d44"
      unitRef="usd">12697000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjctMy0xLTEtNDk4MTY_eb6ed747-5fcf-429d-ac11-7fcedf4a30d5"
      unitRef="usd">20420000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjgtMS0xLTEtNDk4MTY_772d8a33-a691-4c6b-8e23-71ba03eb9a9b"
      unitRef="usd">0</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
    <us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMjgtMy0xLTEtNDk4MTY_d5d217e6-c9a5-4020-899a-953ed0e154cd"
      unitRef="usd">119000</us-gaap:PaymentsToAcquireAdditionalInterestInSubsidiaries>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzAtMS0xLTEtNDk4MTY_2e83191d-8196-4599-a22b-f9fb57bfdcfb"
      unitRef="usd">16672000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzAtMy0xLTEtNDk4MTY_1b41264d-e795-4511-8a26-fa91f2f5ba5e"
      unitRef="usd">195564000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="icdbe3cb5b46d4f3881583fc8ba6c0f17_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzItMS0xLTEtNDk4MTY_9a910c42-933c-4e26-a154-4868d4033d69"
      unitRef="usd">65848000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i3d9943e3bd46453b9a5ad5d1f8b22844_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzItMy0xLTEtNDk4MTY_222a5cf0-e433-4cd9-a865-54e74bc54738"
      unitRef="usd">27099000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzQtMS0xLTEtNDk4MTY_f0969ba7-2fbb-48a6-8e37-1c5bce29b90e"
      unitRef="usd">1962000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzQtMy0xLTEtNDk4MTY_7f6894af-3117-45ab-acb8-1bac3dc1f842"
      unitRef="usd">2988000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzUtMS0xLTEtNDk4MTY_388c663f-cbc1-401d-9c13-60ad67b5999e"
      unitRef="usd">124000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzUtMy0xLTEtNDk4MTY_2cf2bfd7-1ac6-481b-8da5-00d5bf03ed9f"
      unitRef="usd">4582000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ifb067ffcdfcd40edb211090a036dab65_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzYtMS0xLTEtNDk4MTY_e122ddde-14b8-4b9d-a483-7333fcf95ea0"
      unitRef="usd">1115000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ie9f15dab01ef4999822c32ed4f2574a1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzYtMy0xLTEtNDk4MTY_273461e7-cb74-4508-bd6a-518cef38ec64"
      unitRef="usd">2053000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzctMS0xLTEtNDk4MTY_a06df171-b1fa-47b4-aa51-4c3e52ab27c1"
      unitRef="usd">65125000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzctMy0xLTEtNDk4MTY_5ced355e-f46c-4d62-b3ed-3407e5618838"
      unitRef="usd">30746000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzgtMS0xLTEtNDk4MTY_2e50ab29-1568-4e13-bf81-3b6b26ac23c3"
      unitRef="usd">479000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzgtMy0xLTEtNDk4MTY_f8fe1930-308d-468e-ad66-40b01b3af61b"
      unitRef="usd">-148000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzktMS0xLTEtNDk4MTY_32db9586-e953-4b7f-9fb3-1d3b016bfde0"
      unitRef="usd">-84302000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfMzktMy0xLTEtNDk4MTY_b7c6f277-04c1-41a1-bb38-9b3a7e9b9f3c"
      unitRef="usd">45625000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDAtMS0xLTEtNDk4MTY_274f08d0-14aa-474f-92ef-2a6b683bbd33"
      unitRef="usd">180372000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDAtMy0xLTEtNDk4MTY_f3e0139c-2b92-4397-8e20-34ba748fbf1d"
      unitRef="usd">132829000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDEtMS0xLTEtNDk4MTY_dda02f69-56b8-490d-ba4c-6e2603e0233a"
      unitRef="usd">96070000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDEtMy0xLTEtNDk4MTY_a9e26bbf-ba2e-4144-b6da-af49cd85051d"
      unitRef="usd">178454000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDMtMS0xLTEtNDk4MTY_1eb26a62-1644-4b00-9dea-962c826f8770"
      unitRef="usd">3927000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDMtMy0xLTEtNDk4MTY_a7fc6ece-7767-4590-a338-65bb7b7d2772"
      unitRef="usd">650000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDQtMS0xLTEtNDk4MTY_12e62324-809b-4520-83d5-26a534ac4314"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDQtMy0xLTEtNDk4MTY_db0cdf43-3803-40d6-ba22-e1f201eeb261"
      unitRef="usd">1349000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <sgmo:TenantAllowance
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDUtMS0xLTEtNTMxMjM_6f6e367d-2ab5-45f4-af35-567410f66510"
      unitRef="usd">1531000</sgmo:TenantAllowance>
    <sgmo:TenantAllowance
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDUtMy0xLTEtNTMxMzE_f5d3b81a-e5aa-4c60-83c6-edcd77fb4b0f"
      unitRef="usd">0</sgmo:TenantAllowance>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDUtMS0xLTEtNDk4MTY_cb61fbb5-e8b2-4849-bae4-0ee6b871694d"
      unitRef="usd">0</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF8zNC9mcmFnOmE3MTVkZTkyMzE0ZjRlY2U5NzQyOGM2ZGJjYzYwNTIzL3RhYmxlOmM3NzQxOTQ0ZmM1YTQ1MWVhZTdjMjdmODBmNDZjY2YxL3RhYmxlcmFuZ2U6Yzc3NDE5NDRmYzVhNDUxZWFlN2MyN2Y4MGY0NmNjZjFfNDUtMy0xLTEtNDk4MTY_5b0a97d6-2b5b-49ca-aa47-d211a7ade3a5"
      unitRef="usd">943000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDM_f5535700-d6a5-42b4-a3b8-8d7dcc55b51b">ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Organization and Description of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sangamo Therapeutics, Inc. (&#x201c;Sangamo&#x201d; or &#x201c;the Company&#x201d;) was incorporated in the State of Delaware in June 1995 and changed its name from Sangamo Biosciences, Inc. in January 2017. Sangamo is a clinical-stage genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients with serious diseases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of these financial statements for the periods presented have been included. Operating results for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The Condensed Consolidated Balance Sheet data at December&#160;31, 2021 was derived from the audited Consolidated Financial Statements included in Sangamo&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the &#x201c;2021 Annual Report&#x201d;) as filed with the SEC on February&#160;24,&#160;2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in the Condensed Consolidated Financial Statements. For consolidated entities where the Company owns or is exposed to less than 100% of the economics, the Company records net loss attributable to non-controlling interests on its Condensed Consolidated Statements of Operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements and related financial information should be read together with the audited Consolidated Financial Statements and footnotes for the year ended December&#160;31, 2021, included in the 2021 Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity and Management&#x2019;s Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sangamo is currently working on a number of long-term development projects that involve experimental technologies. The projects may require several years and substantial expenditures to complete and ultimately may be unsuccessful. The Company plans to finance operations with available cash resources, collaborations and strategic partnerships funds, research grants and from the issuance of equity or debt securities. Sangamo believes that its available cash, cash equivalents, and marketable securities as of September&#160;30, 2022, and expected future milestones and research services revenue from collaborations, strategic partnerships and research grants, will be adequate to fund its currently planned operations through at least the next 12&#160;months from the date these Condensed Consolidated Financial Statements are issued. Sangamo will require substantial additional financial resources to complete the development and commercialization of its product candidates. Additional capital may not be available on terms acceptable to the Company, if at all. If adequate funds are not available, or if the terms of potential funding sources are unfavorable, the Company&#x2019;s business and ability to develop its technology and therapeutic products would be harmed. Furthermore, any sales of additional equity securities may result in dilution to the Company&#x2019;s stockholders, and any debt financing may include covenants that restrict the Company&#x2019;s business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. On an ongoing basis, management evaluates its estimates including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, income taxes, fair value of assets and liabilities, including from acquisitions, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company recorded an adjustment to revenue related to a change in estimate in connection with the collaboration agreement with Sanofi S.A. (&#x201c;Sanofi&#x201d;) as a result of an increase in the project costs for its beta thalassemia program and the increase in project scope and the corresponding costs for its sickle cell disease program, both of which resulted in a decrease in the measure of proportional cumulative performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This adjustment decreased revenue by $2.5&#160;million, increased net loss by $2.5&#160;million and increased the Company's basic and diluted net loss per share by $0.02 for the three and nine months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its revenues pursuant to the provisions of Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&#160;606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC&#160;Topic&#160;606&#x201d;). The Company&#x2019;s contract revenues are derived from collaboration agreements including licensing arrangements and research activity grants. Research and licensing agreements typically include upfront signing or license fees, cost reimbursements for research services, minimum sublicense fees, milestone payments and royalties on future licensees&#x2019; product sales. The Company has agreements with both fixed and variable consideration. Non-refundable upfront fees and funding of research and development activities are considered fixed, while milestone payments are generally identified as variable consideration. Sangamo&#x2019;s research grants are typically multi-year agreements and provide for the reimbursement of qualified expenses for research and development as defined under the terms of the grant agreement. Revenues under research grant agreements are generally recognized when the related qualified research expenses are incurred. Deferred revenue primarily represents the portion of research or license payments received but not earned.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations based on estimated selling prices; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC Topic&#160;606. The Company&#x2019;s performance obligations include license rights, development services and services associated with regulatory submission and approval processes. Revenues from research services earned under collaboration agreements are generally recognized as revenue as the related services are provided. Revenues from non-refundable upfront fees are recognized over time either by measuring progress towards satisfaction of the relevant performance obligation, using the input method (i.e., cumulative actual costs incurred relative to total estimated costs) or on a straight-line basis when a performance obligation is expected to be satisfied evenly over a period of time (or when the entity has a stand-ready obligation). Significant management judgment is required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement, which may include total internal personnel costs and external costs to be incurred as well as, in certain cases, the estimated stand-ready obligation period. Changes in these estimates can have a material effect on revenue recognized. If the Company cannot reasonably estimate when its performance obligations either are completed or become inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. The Company includes the unconstrained amount of estimated variable consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint and, if necessary, adjusts its estimate of the overall transaction price. Revenue is then recognized over the remaining estimated period of performance using the cumulative catch-up method. The estimated period of performance and project costs, such as personnel and manufacturing cost, are reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s current assumptions regarding the timing of its deliverables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price of each performance obligation identified in the contract. The Company uses key assumptions to determine the stand-alone selling price, which may include forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical and regulatory success. Related costs and expenses under these arrangements have historically approximated the revenues recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from major collaboration agreements and research activity grants as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Novartis Institutes for BioMedical Research, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biogen MA, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Kite Pharma, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sanofi S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Funds received from the Company&#x2019;s collaboration partners are generally not refundable and are recorded as revenue as the Company fulfills its performance obligations, which are satisfied over time (i.e., stand ready obligations) or by using the input method (i.e., cumulative actual costs incurred relative to total estimated costs). Revenue is also recognized when the Company has incurred qualified research and development costs that are reimbursable from its collaboration partners and when there is reasonable assurance that such costs will be reimbursed. Any payments received from a collaboration partner in advance of the completion of the relevant performance obligation are recorded as deferred revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sangamo considers all highly liquid investments purchased with original maturities of three months or less at the purchase date to be cash equivalents. Cash and cash equivalents consist of cash, deposits in demand money market accounts and U.S. government-sponsored entity debt securities. Restricted cash consists of a letter of credit for $1.5&#160;million, representing a deposit for the lease of the corporate headquarters in Brisbane, California.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTEzOTc_e91aae53-64e3-4a46-b67f-c94a1bed4e49">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (&#x201c;U.S. GAAP&#x201d;) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of these financial statements for the periods presented have been included. Operating results for the three and nine months ended September&#160;30, 2022 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2022. The Condensed Consolidated Balance Sheet data at December&#160;31, 2021 was derived from the audited Consolidated Financial Statements included in Sangamo&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2021 (the &#x201c;2021 Annual Report&#x201d;) as filed with the SEC on February&#160;24,&#160;2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in the Condensed Consolidated Financial Statements. For consolidated entities where the Company owns or is exposed to less than 100% of the economics, the Company records net loss attributable to non-controlling interests on its Condensed Consolidated Statements of Operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements and related financial information should be read together with the audited Consolidated Financial Statements and footnotes for the year ended December&#160;31, 2021, included in the 2021 Annual Report.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTEzOTM_4d5f9822-30cf-4111-b5c4-bba7e76df3ea">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Condensed Consolidated Financial Statements and the accompanying notes. On an ongoing basis, management evaluates its estimates including critical accounting policies or estimates related to revenue recognition, clinical trial accruals, income taxes, fair value of assets and liabilities, including from acquisitions, and stock-based compensation. Estimates are based on historical experience and on various other market specific and other relevant assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for &lt;/span&gt;&lt;/div&gt;making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTg4NA_6baf3a80-5aab-4658-93c5-fcd8fdbd5599"
      unitRef="usd">-2500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTg4NA_ecc78aa8-ea54-4a9f-b48f-8188a8b7d2be"
      unitRef="usd">-2500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ProfitLoss
      contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTg5OA_21b165ad-87fb-4ef1-90e5-b32a85c454c6"
      unitRef="usd">-2500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTg5OA_714ed8e6-ea0f-44c1-adac-1ae8537e263a"
      unitRef="usd">-2500000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTkxMg_1424a8e3-07f8-4457-ac58-f5c4eae53b41"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTkxMg_d51b16ae-e60d-453f-a3ef-9ce3a6d0868a"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTkxMg_d82481a7-bb6b-4721-95f7-909bc1205fa3"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTA5OTUxMTYzOTkxMg_efdbf1e7-f205-4f9b-877e-4d7c63bb3645"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDg_cdb3f7dd-58a1-4487-8b12-c7f6fbe384db">&lt;div style="margin-top:9pt;padding-left:18pt;text-indent:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for its revenues pursuant to the provisions of Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&#160;606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC&#160;Topic&#160;606&#x201d;). The Company&#x2019;s contract revenues are derived from collaboration agreements including licensing arrangements and research activity grants. Research and licensing agreements typically include upfront signing or license fees, cost reimbursements for research services, minimum sublicense fees, milestone payments and royalties on future licensees&#x2019; product sales. The Company has agreements with both fixed and variable consideration. Non-refundable upfront fees and funding of research and development activities are considered fixed, while milestone payments are generally identified as variable consideration. Sangamo&#x2019;s research grants are typically multi-year agreements and provide for the reimbursement of qualified expenses for research and development as defined under the terms of the grant agreement. Revenues under research grant agreements are generally recognized when the related qualified research expenses are incurred. Deferred revenue primarily represents the portion of research or license payments received but not earned.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the appropriate amount of revenue to be recognized as the Company fulfills its obligations under its agreements, the Company performs the following steps: (i)&#160;identification of the promised goods or services in the contract; (ii)&#160;determination of whether the promised goods or services are performance obligations, including whether they are distinct in the context of the contract; (iii)&#160;measurement of the transaction price, including the constraint on variable consideration; (iv)&#160;allocation of the transaction price to the performance obligations based on estimated selling prices; and (v)&#160;recognition of revenue when (or as) the Company satisfies each performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in ASC Topic&#160;606. The Company&#x2019;s performance obligations include license rights, development services and services associated with regulatory submission and approval processes. Revenues from research services earned under collaboration agreements are generally recognized as revenue as the related services are provided. Revenues from non-refundable upfront fees are recognized over time either by measuring progress towards satisfaction of the relevant performance obligation, using the input method (i.e., cumulative actual costs incurred relative to total estimated costs) or on a straight-line basis when a performance obligation is expected to be satisfied evenly over a period of time (or when the entity has a stand-ready obligation). Significant management judgment is required to determine the level of effort required under an arrangement, and the period over which the Company expects to complete its performance obligations under the arrangement, which may include total internal personnel costs and external costs to be incurred as well as, in certain cases, the estimated stand-ready obligation period. Changes in these estimates can have a material effect on revenue recognized. If the Company cannot reasonably estimate when its performance obligations either are completed or become inconsequential, then revenue recognition is deferred until the Company can reasonably make such estimates. The Company includes the unconstrained amount of estimated variable consideration in the transaction price. The amount included in the transaction price is constrained to the amount for which it is probable that a significant reversal of cumulative revenue recognized will not occur. At the end of each subsequent reporting period, the Company re-evaluates the estimated variable consideration included in the transaction price and any related constraint and, if necessary, adjusts its estimate of the overall transaction price. Revenue is then recognized over the remaining estimated period of performance using the cumulative catch-up method. The estimated period of performance and project costs, such as personnel and manufacturing cost, are reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s current assumptions regarding the timing of its deliverables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the accounting for these arrangements, the Company must develop assumptions that require judgment to determine the stand-alone selling price of each performance obligation identified in the contract. The Company uses key assumptions to determine the stand-alone selling price, which may include forecasted revenues, development timelines, reimbursement rates for personnel costs, discount rates and probabilities of technical and regulatory success. Related costs and expenses under these arrangements have historically approximated the revenues recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from major collaboration agreements and research activity grants as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Novartis Institutes for BioMedical Research, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biogen MA, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Kite Pharma, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sanofi S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Funds received from the Company&#x2019;s collaboration partners are generally not refundable and are recorded as revenue as the Company fulfills its performance obligations, which are satisfied over time (i.e., stand ready obligations) or by using the input method (i.e., cumulative actual costs incurred relative to total estimated costs). Revenue is also recognized when the Company has incurred qualified research and development costs that are reimbursable from its collaboration partners and when there is reasonable assurance that such costs will be reimbursed. Any payments received from a collaboration partner in advance of the completion of the relevant performance obligation are recorded as deferred revenue.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTEzOTQ_4fb32d5c-af9d-4f8c-b01b-7c0cfb7944d6">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from major collaboration agreements and research activity grants as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Novartis Institutes for BioMedical Research, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Biogen MA, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Kite Pharma, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sanofi S.A.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia0f3233d7b70474da06a55adac0cca4d_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMi0xLTEtMS00OTgxNg_6f8cc16e-6be4-4048-8693-8821e4db1bf5"
      unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib4943cb2b48343ef92ef1589edef40c7_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMi0zLTEtMS00OTgxNg_7d62dfad-f510-42ee-9e50-6c732f473bde"
      unitRef="number">0.40</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if38002de5fe848d088ca4840e3b302a0_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMi01LTEtMS00OTgxNg_d61b392f-19df-4872-86ab-10635a8e415a"
      unitRef="number">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia79b57d1d6da4b0d9ef31df01511d42d_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMi03LTEtMS00OTgxNg_1ea71e7f-5a2f-4be7-89bc-b6935c13ace1"
      unitRef="number">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9fef75604563438abe9538958474da7d_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMy0xLTEtMS00OTgxNg_8e592838-8af3-4d7c-8c9f-03636e69e35d"
      unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib8f43928847f42c1a83bf8800d5fa943_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMy0zLTEtMS00OTgxNg_d252f61f-eae5-4a30-8ebe-a710e776bf7a"
      unitRef="number">0.38</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i88ddbc38aa6445598de986913238d214_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMy01LTEtMS00OTgxNg_110a97bc-a934-4831-845d-144d6a86d669"
      unitRef="number">0.36</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie4327ef899954f25af6c0c80522b2c7d_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfMy03LTEtMS00OTgxNg_81526d0e-e527-4bd1-9902-2ce33453c06e"
      unitRef="number">0.39</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6fa286ca65b64056995eb4ab2664cdd0_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNC0xLTEtMS00OTgxNg_599f29b7-8641-4ae9-9eec-1e77f55dbc54"
      unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3e54c4c6f853445c95d080879c43b2b2_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNC0zLTEtMS00OTgxNg_b83e3b05-ff63-4d4b-bed1-d7fe9b8176be"
      unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i7ebc3bc839ea482380db614d89d89bb5_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNC01LTEtMS00OTgxNg_71d520d7-95d3-474e-a145-fad4b3e38353"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i45f1ab603cb94ccc868b785c550c0609_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNC03LTEtMS00OTgxNg_dec45849-7a16-447f-8cea-f8e754ae740c"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iacda68cbeb604746812d5bd97bf218a3_D20220701-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNS0xLTEtMS00OTgxNg_08e96ff5-0743-45a4-a0e4-dafa88900a97"
      unitRef="number">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idf66e1bb8ddd4393b9d770b1885a7a64_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNS0zLTEtMS00OTgxNg_d9f0e4d5-5e5e-41d2-8bed-733a40dfae41"
      unitRef="number">-0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib124d69483284e9693d405b60f7383e0_D20220101-20220930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNS01LTEtMS00OTgxNg_3a55e54c-b57e-49f0-b004-5d6da22af9ce"
      unitRef="number">0.04</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1634f7d6a7a14dd38290439da8287bbd_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjFiN2ExMzRiNTZjNDQ2ZjdiMzg2OTkwNDQ5ODViNGEwL3RhYmxlcmFuZ2U6MWI3YTEzNGI1NmM0NDZmN2IzODY5OTA0NDk4NWI0YTBfNS03LTEtMS00OTgxNg_b2b7611c-3a43-4d0d-ab01-cee2ed678b62"
      unitRef="number">0.02</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDA_73162dc7-870f-4d97-b6e1-09ebdee4d370">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sangamo considers all highly liquid investments purchased with original maturities of three months or less at the purchase date to be cash equivalents. Cash and cash equivalents consist of cash, deposits in demand money market accounts and U.S. government-sponsored entity debt securities. Restricted cash consists of a letter of credit for $1.5&#160;million, representing a deposit for the lease of the corporate headquarters in Brisbane, California.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTEwMDE_6519d9a6-2d49-415d-9c34-a75dae893764"
      unitRef="usd">1500000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDI_1643d61d-94ef-47a7-b39c-fc46f5f8ae5f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDI_242f90ae-6efe-44e7-833c-e0c6c854d27c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of cash, cash equivalents, and restricted cash reported within the Condensed Consolidated Balance Sheets to the amounts reported within the accompanying Condensed Consolidated Statements of Cash Flows is as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176,954&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,329&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-9pt;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cff0fc;padding:0 1pt"/&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cff0fc;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMS0xLTEtMS00OTgxNg_244dc012-1c31-47ad-aa60-b92ff9d3eb8c"
      unitRef="usd">94570000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMS0zLTEtMS00OTgxNg_6e446b40-27cd-4130-b2fd-70b955d9dd0d"
      unitRef="usd">178872000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMS01LTEtMS00OTgxNg_083011bf-aeec-4cce-9eec-69af1fb50546"
      unitRef="usd">176954000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMS03LTEtMS00OTgxNg_39e1944f-ecda-4fd7-9e3d-7ac635b9e442"
      unitRef="usd">131329000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMi0xLTEtMS00OTgxNg_c20cf43a-3a07-4ced-8083-ea9d1a494000"
      unitRef="usd">1500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMi0zLTEtMS00OTgxNg_5d1a7b83-4f05-43fe-ac12-7f4ce47dc675"
      unitRef="usd">1500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMi01LTEtMS00OTgxNg_4289b1be-347f-40a4-a5b6-44df6948bed2"
      unitRef="usd">1500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashAndCashEquivalentsNoncurrent
      contextRef="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMi03LTEtMS00OTgxNg_e280865d-5fbf-4179-a25d-6678c9867613"
      unitRef="usd">1500000</us-gaap:RestrictedCashAndCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMy0xLTEtMS00OTgxNg_f57ca302-97d8-42b0-9718-74aaafeef9ae"
      unitRef="usd">96070000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMy0zLTEtMS00OTgxNg_5e033cef-bc97-46dc-b3bf-36cd6d9295b7"
      unitRef="usd">180372000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i134c4c83dfd6499d8dbb3b41d537f5aa_I20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMy01LTEtMS00OTgxNg_decf677e-9d5a-4b00-8b85-887348af04b3"
      unitRef="usd">178454000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib47e3ec2186f4a8f9abc0ea0c7c05858_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RhYmxlOjlmYjM4ZTE3ZDQzNjRiMjU4N2FjZGEyYWUyODk1OWFkL3RhYmxlcmFuZ2U6OWZiMzhlMTdkNDM2NGIyNTg3YWNkYTJhZTI4OTU5YWRfMy03LTEtMS00OTgxNg_284b2add-1e6f-46cb-9504-f530dbffb196"
      unitRef="usd">132829000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80MC9mcmFnOjU2Nzc5ZTBmMWI4NDQxYTE5Y2E2NjQ5MDhiZjE0ZTY1L3RleHRyZWdpb246NTY3NzllMGYxYjg0NDFhMTljYTY2NDkwOGJmMTRlNjVfMTE0MDc_84b787c5-ba51-4a8f-b2de-709a29bfa92c">&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;None.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RleHRyZWdpb246YWQ0MTRkMzUxODEzNDViNGE0MzU5ODFiNDNkYmE5ZWZfMjI1Ng_ca4f3424-22f9-4708-b8a5-12a5075f4df1">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents, marketable securities, and the free shares asset. Fair value is determined based on a three-tier hierarchy under the authoritative guidance for fair value measurements and disclosures that prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurements and unobservable (i.e., supported by little or no market activity).&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RleHRyZWdpb246YWQ0MTRkMzUxODEzNDViNGE0MzU5ODFiNDNkYmE5ZWZfMjI1Nw_a0662061-d572-4191-87e0-c41c8cca1240">FAIR VALUE MEASUREMENTS&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures certain financial assets and liabilities at fair value on a recurring basis, including cash equivalents, marketable securities, and the free shares asset. Fair value is determined based on a three-tier hierarchy under the authoritative guidance for fair value measurements and disclosures that prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2: Quoted prices in markets that are not active or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3: Prices or valuation techniques that require inputs that are both significant to the fair value measurements and unobservable (i.e., supported by little or no market activity).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value measurements of the Company&#x2019;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company generally classifies its marketable securities as Level&#160;2. Instruments are classified as Level&#160;2 when observable market prices for identical securities that are traded in less active markets are used. When observable market prices for identical securities are not available, such instruments are priced using benchmark curves, benchmarking of like securities, sector groupings, matrix pricing and valuation models. These valuation models are proprietary to the pricing providers or brokers and incorporate a number of inputs, including in approximate order of priority: benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. For certain security types, additional inputs may be used, or some of the standard inputs may not be applicable. Evaluators may prioritize inputs differently on any given day for any security based on market conditions, and not all inputs listed are available for use in the evaluation process for each security evaluation on any given day.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RleHRyZWdpb246YWQ0MTRkMzUxODEzNDViNGE0MzU5ODFiNDNkYmE5ZWZfMjI1OQ_8f9fa3ee-ad09-4de6-9b4c-6e8fc6ae7fae">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value measurements of the Company&#x2019;s cash equivalents and marketable securities are identified at the following levels within the fair value hierarchy (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="id122cadbcd79415cb294942cf9401910_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfNS0xLTEtMS00OTgxNg_f30a0060-25ca-4059-8509-2fc5bbab0d89"
      unitRef="usd">44911000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iaa6d0f240a92487abfb8f0f38f3112e9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfNS0zLTEtMS00OTgxNg_12d1fd85-8cfd-495b-9841-32049591f796"
      unitRef="usd">44911000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i1f8158142c524b369324fc1ebf0f9f1e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfNS01LTEtMS00OTgxNg_c65b39a6-bb46-4a45-b3cc-9a5e979e1bb7"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0a6fb7e7492a4f939428513d8fcff441_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfNS03LTEtMS00OTgxNg_be4fc840-2579-4ee2-83b6-86ee44941adb"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i96d87151f3dd48979c96441aaec7b540_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfOC0xLTEtMS00OTgxNg_b4f8c5c9-7d8b-4b38-adaa-4f599a0fadb3"
      unitRef="usd">44911000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iffdbeeb166274031b5cec94b4a93c065_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfOC0zLTEtMS00OTgxNg_b6bfd095-9bd5-463f-9992-e69f48b060d2"
      unitRef="usd">44911000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i681433de93e34299a5bb54fef49f27c4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfOC01LTEtMS00OTgxNg_58cbdfe4-4533-4e1e-8818-a9a77605b49d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ibfbd33edee0941eebf5eb1beb36d33b5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfOC03LTEtMS00OTgxNg_2e2fbb8a-9e63-4fc3-aaa8-0ba3afd92160"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie11a6708a3494e018d5eea96804cc1f8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTAtMS0xLTEtNDk4MTY_5b6148fb-0b99-4bea-abea-5dbea7ddcd30"
      unitRef="usd">23392000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i29f19ecdd60e4cf4881d032f9b06e15e_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTAtMy0xLTEtNDk4MTY_2f6473ad-46f9-4648-9988-b38832004e65"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf1ed758ad3142609eaf08869c43df41_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTAtNS0xLTEtNDk4MTY_09db6763-189c-4fc6-aab9-429ec87b25db"
      unitRef="usd">23392000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idbd920e533444e47a3756a9b4a8eb6b6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTAtNy0xLTEtNDk4MTY_6878e65d-5ba3-4641-9c0b-7761a898db64"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i32ad7e19c06a465f8f07b405b0f7cfd4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTEtMS0xLTEtNDk4MTY_4ce4f3f2-3b75-42af-b88f-75d8bce02e0c"
      unitRef="usd">120386000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if27bae2120224abea6224708e6f3de8f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTEtMy0xLTEtNDk4MTY_35058b95-3df2-4cfa-aebb-0c2f43048684"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ca8592334b04957a537a0d4cf813494_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTEtNS0xLTEtNDk4MTY_c409df31-4a21-484c-9ed2-a848867954f6"
      unitRef="usd">120386000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icc09550b59114bae9b748047cd9d24a8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTEtNy0xLTEtNDk4MTY_9de795c6-8d6c-41c0-adb3-c93487b1ac75"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4ab0f243dd424f92b69b063a217eae48_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTItMS0xLTEtNDk4MTY_72c96a63-805b-4da4-87d8-c66362bd1129"
      unitRef="usd">14888000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i411394c5d10d486cbce2b24abae3a661_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTItMy0xLTEtNDk4MTY_0e0165a0-cc89-426b-adca-c6830d5af917"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i09186c27c86747a68746b52de10d7d1c_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTItNS0xLTEtNDk4MTY_11524a98-d298-42f4-8d50-2d5420ff4a0a"
      unitRef="usd">14888000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if5b732d846284342a16bea6ef1968757_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTItNy0xLTEtNDk4MTY_70a3d740-83c0-488b-b37e-f2a1d982c9b2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i769639b449a24295852cb05e72c00a17_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTMtMS0xLTEtNDk4MTY_eb77dc6b-acd5-4bbe-afe2-94fac22d8aac"
      unitRef="usd">37773000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9606a8a617b841e885ebefda50badef9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTMtMy0xLTEtNDk4MTY_99a00e0c-3dbe-4678-8ba5-c611350a22ac"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i122ce6ac71ea4602bfd1231782ca60d8_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTMtNS0xLTEtNDk4MTY_587c28f5-b8dc-4c29-9251-f2663885abbb"
      unitRef="usd">37773000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic67eaaf5137b4b6f9b62df6016a69f07_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTMtNy0xLTEtNDk4MTY_531516a5-480e-485a-bd08-f04ce3c08e71"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifd4fdedfda294dfab406c29000abe2e6_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTQtMS0xLTEtNDk4MTY_51527ee6-c5d6-4942-837d-090142edc785"
      unitRef="usd">16922000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8fa8a902c3774cde978198ce09be1bb9_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTQtMy0xLTEtNDk4MTY_96538dfb-becf-4b34-ac45-ee7cac66128a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i639b4eda38c648ffb15ee7b60a5bdfd4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTQtNS0xLTEtNDk4MTY_3c701a89-c090-444e-a81a-8d59ef0afca2"
      unitRef="usd">16922000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6065eabb66dc4690a7523d48b52983fc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTQtNy0xLTEtNDk4MTY_3ed457ce-c838-4beb-943e-0e072bcf11fe"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0a4226459e39406dbf0ef1ecac2f7183_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTUtMS0xLTEtNDk4MTY_ee6057f1-7e8d-461d-ba8a-e0d3969e3b37"
      unitRef="usd">42337000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i33868ebce0ac437282e6ca0c2cd516ea_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTUtMy0xLTEtNDk4MTY_9207104f-5d9b-4a12-b421-55dbc05742cf"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i51cf12c7232b41e7a436caf0336ac5c1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTUtNS0xLTEtNDk4MTY_bb4989ed-fc8d-46ec-a132-d95cc8bd18f4"
      unitRef="usd">42337000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7cb99b1da6c54c77bee0c45127be6f3f_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTUtNy0xLTEtNDk4MTY_b4e47f54-f8d7-4a5f-8fe1-c05ab432e7ef"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i96d87151f3dd48979c96441aaec7b540_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTYtMS0xLTEtNDk4MTY_f780fcdf-9657-48fe-8401-ae7868b1aeb9"
      unitRef="usd">255698000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iffdbeeb166274031b5cec94b4a93c065_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTYtMy0xLTEtNDk4MTY_907fdb62-e2b8-4b7b-93a6-754bea5fc3df"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i681433de93e34299a5bb54fef49f27c4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTYtNS0xLTEtNDk4MTY_7ba8f37a-2d75-44fb-a930-1ce38d1478ef"
      unitRef="usd">255698000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibfbd33edee0941eebf5eb1beb36d33b5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTYtNy0xLTEtNDk4MTY_caa2f501-f5d2-4d15-b8c7-88fb721a4c13"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i96d87151f3dd48979c96441aaec7b540_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTctMS0xLTEtNDk4MTY_9c2b0fba-7820-4fa9-a17e-c2f19d661eea"
      unitRef="usd">300609000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iffdbeeb166274031b5cec94b4a93c065_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTctMy0xLTEtNDk4MTY_479c6d18-d8d7-497e-aa12-f60c1158a81f"
      unitRef="usd">44911000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i681433de93e34299a5bb54fef49f27c4_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTctNS0xLTEtNDk4MTY_e75004a0-5534-43c2-b372-935b2f392445"
      unitRef="usd">255698000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ibfbd33edee0941eebf5eb1beb36d33b5_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOmM1MzY2ZWI4MmJhNTRhOTQ4NjRhZTkwNzdlNGNiZGM5L3RhYmxlcmFuZ2U6YzUzNjZlYjgyYmE1NGE5NDg2NGFlOTA3N2U0Y2JkYzlfMTctNy0xLTEtNDk4MTY_515be143-b829-48f9-9b87-be584942f195"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i21bb501c85b34076a54c9225ae07ee8e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNS0xLTEtMS00OTgxNg_45ba50d5-5160-4358-a233-7eca883ca4f2"
      unitRef="usd">119919000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i73036590c4ef457f87ba13c7f72633ea_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNS0zLTEtMS00OTgxNg_a24d93fa-0047-48e4-ac4a-e1b067861ffa"
      unitRef="usd">119919000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i2c608a75f06a443dae43f3295a547e25_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNS01LTEtMS00OTgxNg_85e85cff-1137-48b8-9d20-861fbe979b86"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic9df22ac2f004b0fbb4e5f907ec70d9b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNS03LTEtMS00OTgxNg_602e4c0c-7b4a-4500-b7b1-10002c22cfaa"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if90f6a0673d64365a8cac1c06453bb58_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNi0xLTEtMS00OTgxNg_8f2661ac-e246-4df3-b580-5bd2c78e674f"
      unitRef="usd">119919000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9430e03891404dea839fb2cff64af738_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNi0zLTEtMS00OTgxNg_e825afa0-f51a-45dd-a95e-51c32c35f16f"
      unitRef="usd">119919000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if003bbe1b3bd45aca76e20e836c5a3a5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNi01LTEtMS00OTgxNg_de494d41-05ca-4ab1-9dbf-de2f73aebead"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ia43cd647cad04bb9a7cadc11f325af6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfNi03LTEtMS00OTgxNg_d0f866dc-7c37-4bbd-a761-07fa636de12a"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibcef3b61008c46d0992163cd7bffe1cd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOC0xLTEtMS00OTgxNg_16b4cdef-c546-4c09-bc5b-6792450707a0"
      unitRef="usd">30614000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2cf4147ceb5942299b88c10a4f9be27a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOC0zLTEtMS00OTgxNg_56b5b4b7-0344-4230-9ce8-78a688fef965"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7b800a8209c64902a695cd1dcd597172_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOC01LTEtMS00OTgxNg_09623621-d3ef-4705-acfe-fca94ae4b505"
      unitRef="usd">30614000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaaeaa77913ce413b93a7c9dab1d36cab_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOC03LTEtMS00OTgxNg_9117b481-bc0a-4592-8076-1b103d039d62"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0de8afe4f7c2493b8c43a2e0f29a7399_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOS0xLTEtMS00OTgxNg_99007efb-8199-4874-b750-03fb3f171764"
      unitRef="usd">105757000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9c91803551d641a8963ac07c42cfe596_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOS0zLTEtMS00OTgxNg_609f36cd-4a1b-48b5-8abf-30cc9689b9c2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic47a895f418d48cf8f9d9eff69edeeda_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOS01LTEtMS00OTgxNg_3f48d85f-a5e2-41b2-8b91-e7dff0c1efc6"
      unitRef="usd">105757000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3be3d7d00461404e980d8a74a0ae2c25_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfOS03LTEtMS00OTgxNg_3c185247-3270-457a-8a33-b7a64d9331d0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2c98918b8f5542dca9d804a934e84995_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTAtMS0xLTEtNDk4MTY_f9c41e68-653a-482a-9942-c6d73b74092f"
      unitRef="usd">33682000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4ee5a63a339b4d8991f36eaf5ff1be1c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTAtMy0xLTEtNDk4MTY_1c904858-f5d0-485b-9f9d-81ec1f8f0ee5"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i983119dcdc834acda4676ea99a8c08da_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTAtNS0xLTEtNDk4MTY_902888a4-6332-476d-92d4-6e2ad2a8aa44"
      unitRef="usd">33682000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaa714eaea0f1411e85e65049e450b3eb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTAtNy0xLTEtNDk4MTY_cdb82b96-a909-4eb1-8186-f24296079386"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i86315bd8be5a4ce4b190ddec3e753c05_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTEtMS0xLTEtNDk4MTY_8dae0e0b-ec27-4200-85b7-393ff477082b"
      unitRef="usd">70701000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6016ec92d0c640e1aed56b72f34057e9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTEtMy0xLTEtNDk4MTY_92815b6d-a534-4ffd-81b8-b22eeb75405a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i69ab4258b6f14b29bd7da873df0ba0f7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTEtNS0xLTEtNDk4MTY_c9a2446f-b009-4e9a-9201-d124f30c58d9"
      unitRef="usd">70701000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i764fb984c25d4da5b64a0b48e5199b99_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTEtNy0xLTEtNDk4MTY_16277d80-4757-4ec5-90fa-0434dba63e0d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia28128c5fca64935bcf980ed70b30b2a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTItMS0xLTEtNDk4MTY_a3b0ab90-6a76-4275-8b39-8dae8b3a1f76"
      unitRef="usd">45091000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i386e3b89d03f479ca5825c2bebba2e54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTItMy0xLTEtNDk4MTY_82e43911-1626-4872-95e6-c8635bb76ecc"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie86bb74f566944b9839da6ff3a70d767_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTItNS0xLTEtNDk4MTY_a6308e62-0c1f-4746-b612-099d0d38f7b4"
      unitRef="usd">45091000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i359bee546a724e5d8222c768c5722bef_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTItNy0xLTEtNDk4MTY_100267e1-4f7b-4fb0-a615-a8d1e847b6cf"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if90f6a0673d64365a8cac1c06453bb58_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTMtMS0xLTEtNDk4MTY_2df64ada-a5c0-4bb9-ae80-c8755b8fd20c"
      unitRef="usd">285845000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9430e03891404dea839fb2cff64af738_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTMtMy0xLTEtNDk4MTY_f0a69e8f-4798-4d8d-8fdf-47d772ac2e6e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if003bbe1b3bd45aca76e20e836c5a3a5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTMtNS0xLTEtNDk4MTY_45fe3819-4c76-44fb-8740-14ed86e52908"
      unitRef="usd">285845000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia43cd647cad04bb9a7cadc11f325af6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTMtNy0xLTEtNDk4MTY_0ee872b7-5a54-4696-a395-d57872ec6d19"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if90f6a0673d64365a8cac1c06453bb58_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTQtMS0xLTEtNDk4MTY_da4d7607-ec00-43d6-8554-fe3183403726"
      unitRef="usd">405764000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i9430e03891404dea839fb2cff64af738_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTQtMy0xLTEtNDk4MTY_604bea92-b3af-4d62-a0cb-eb4e6f656540"
      unitRef="usd">119919000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if003bbe1b3bd45aca76e20e836c5a3a5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTQtNS0xLTEtNDk4MTY_e2b2dbf1-de57-4c15-b895-094ce0793331"
      unitRef="usd">285845000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia43cd647cad04bb9a7cadc11f325af6a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80My9mcmFnOmFkNDE0ZDM1MTgxMzQ1YjRhNDM1OTgxYjQzZGJhOWVmL3RhYmxlOjZjNWRhOTQwMTBmMTQ5OTE5NzVkZTk2YjA4MmNmYjJhL3RhYmxlcmFuZ2U6NmM1ZGE5NDAxMGYxNDk5MTk3NWRlOTZiMDgyY2ZiMmFfMTQtNy0xLTEtNDk4MTY_4e1a4441-2878-41fe-9a5d-9333db0d4fa2"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjczMw_38a70890-a66f-4f25-881e-253b9479126d">CASH EQUIVALENTS AND MARKETABLE SECURITIES&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the Company&#x2019;s cash equivalents and marketable securities (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificate of deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificate of deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of marketable securities by contractual maturity were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no realized gains and losses on the sales of investments during the three and nine months ended September&#160;30, 2022. Realized gains and losses on the sales of investments were insignificant during the three and nine months ended September&#160;30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages credit risk associated with its investment portfolio through its investment policy, which limits purchases to high-quality issuers and also limits the amount of its portfolio that can be invested in a single issuer. The Company did not record an allowance for credit losses or other impairment charges related to its marketable securities for the three and nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had unrealized losses related to its marketable securities for the three and nine months ended September&#160;30, 2022 and 2021. The Company had no material unrealized losses, individually and in the aggregate, for marketable &lt;/span&gt;&lt;/div&gt;securities that are in a continuous unrealized loss position for greater than 12 months as of September&#160;30, 2022 and December&#160;31, 2021. Based on the scheduled maturities of its investments, the Company determined that it was more likely than not that it will hold these investments for a period of time sufficient for a recovery of its amortized cost basis. Total unrealized gains for securities with net gains in accumulated other comprehensive income were not material for the three and nine months ended September&#160;30, 2022. The unrealized losses were not attributed to credit risk and were associated with changes in market conditions. The Company periodically reviews its marketable securities for indications of credit losses. The Company considers factors such as the duration, the magnitude and the reason for the decline in value, the potential recovery period, creditworthiness of the issuers of the securities and its intent to sell. For marketable securities, it also considers whether (i)&#160;it is more likely than not that the Company will be required to sell the debt securities before recovery of their amortized cost basis, and (ii)&#160;the amortized cost basis cannot be recovered as a result of credit losses. No significant facts or circumstances have arisen to indicate that there has been any significant deterioration in the creditworthiness of the issuers of the securities held by the Company. Based on the Company&#x2019;s review of these securities, including the assessment of the duration and severity of the unrealized losses and the Company&#x2019;s ability and intent to hold the investments until maturity, the Company determined that no allowance for credit losses related to its marketable securities was required at either September&#160;30, 2022 or December&#160;31, 2021.</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:MarketableSecuritiesTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjczNQ_f4b3c27c-a097-46f8-b9b3-7e219924fe60">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below summarizes the Company&#x2019;s cash equivalents and marketable securities (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.349%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,911&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(375)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;120,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(162)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,888&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. treasury bills&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificate of deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;257,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;302,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,412)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,919&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. government-sponsored entity debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,757&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificate of deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;406,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;405,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:MarketableSecuritiesTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iab983723fa734404b015fc014b16e4f2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNC0xLTEtMS00OTgxNg_85c356b1-a749-446e-9b3b-9c25280f8014"
      unitRef="usd">44911000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax
      contextRef="iab983723fa734404b015fc014b16e4f2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNC0zLTEtMS00OTgxNg_dcb237c4-723d-4d28-aabe-08864a42c7d5"
      unitRef="usd">0</sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax>
    <sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax
      contextRef="iab983723fa734404b015fc014b16e4f2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNC01LTEtMS00OTgxNg_fc5af72f-7220-4bca-97e1-79ab8e82ac40"
      unitRef="usd">0</sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="iab983723fa734404b015fc014b16e4f2_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNC03LTEtMS00OTgxNg_d5069027-2275-4e3d-9562-945950584ffc"
      unitRef="usd">44911000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic1f5af8c8327472da2ae3d160d57b379_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNy0xLTEtMS00OTgxNg_0cf7cd25-f8b0-437c-be0c-1ad58f253d6a"
      unitRef="usd">44911000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax
      contextRef="ic1f5af8c8327472da2ae3d160d57b379_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNy0zLTEtMS00OTgxNg_d62cee8e-9975-426e-86dd-eb1d9f7481e0"
      unitRef="usd">0</sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax>
    <sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax
      contextRef="ic1f5af8c8327472da2ae3d160d57b379_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNy01LTEtMS00OTgxNg_06912c29-8b68-43ad-86b9-30a72e5fc4c2"
      unitRef="usd">0</sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ic1f5af8c8327472da2ae3d160d57b379_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfNy03LTEtMS00OTgxNg_98dd5b83-3876-4f97-81ea-31fae318b662"
      unitRef="usd">44911000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i48e0ebe4c00048caa8ca855361cd3dec_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfOS0xLTEtMS00OTgxNg_ead3041f-42e1-4d3d-a4a8-c72dad84eda9"
      unitRef="usd">23832000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i48e0ebe4c00048caa8ca855361cd3dec_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfOS0zLTEtMS00OTgxNg_3d4f39fd-cb93-4075-9f1b-2538026b75d4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i48e0ebe4c00048caa8ca855361cd3dec_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfOS01LTEtMS00OTgxNg_4bfc4f83-3a56-4106-af91-6bf75926677d"
      unitRef="usd">440000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i48e0ebe4c00048caa8ca855361cd3dec_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfOS03LTEtMS00OTgxNg_10b6d0e6-7fab-4510-9752-099a38ddf2fa"
      unitRef="usd">23392000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia9e93e6a67164aee80389e38c2ed7ddc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTAtMS0xLTEtNDk4MTY_5715af99-2bdc-4cd8-919a-0cb6ca082fb3"
      unitRef="usd">120750000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia9e93e6a67164aee80389e38c2ed7ddc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTAtMy0xLTEtNDk4MTY_8ed627bf-d114-413e-bcb7-2e99273e06b6"
      unitRef="usd">11000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia9e93e6a67164aee80389e38c2ed7ddc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTAtNS0xLTEtNDk4MTY_5acdb01d-be62-4d0c-b7c0-94a64373c74f"
      unitRef="usd">375000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia9e93e6a67164aee80389e38c2ed7ddc_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTAtNy0xLTEtNDk4MTY_82829bb8-0841-427a-8fc6-7a1edd5fb95c"
      unitRef="usd">120386000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ic708e40109d743859a0cbe3fd8575521_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTEtMS0xLTEtNDk4MTY_40fe830d-634e-4128-b512-09a13922fd0d"
      unitRef="usd">15050000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ic708e40109d743859a0cbe3fd8575521_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTEtMy0xLTEtNDk4MTY_a942e7b4-8ff9-4c20-9624-4d3bde6fe59e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ic708e40109d743859a0cbe3fd8575521_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTEtNS0xLTEtNDk4MTY_6d073665-826a-44a8-9814-7185d243c984"
      unitRef="usd">162000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic708e40109d743859a0cbe3fd8575521_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTEtNy0xLTEtNDk4MTY_2300cbc7-4e32-4386-91c7-d4537bc0ad3b"
      unitRef="usd">14888000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib9fe47fa2ac24546b0189e24f5f31056_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTItMS0xLTEtNDk4MTY_1b0655af-5db1-4e2c-a632-88fdc5b4f8af"
      unitRef="usd">38039000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib9fe47fa2ac24546b0189e24f5f31056_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTItMy0xLTEtNDk4MTY_ef8424df-20c7-41cb-9f80-3b7c69308e6d"
      unitRef="usd">2000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib9fe47fa2ac24546b0189e24f5f31056_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTItNS0xLTEtNDk4MTY_2bddb2cd-7f08-4b48-a8ef-056688e1d2ba"
      unitRef="usd">268000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib9fe47fa2ac24546b0189e24f5f31056_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTItNy0xLTEtNDk4MTY_0a785795-bb9e-4c12-9510-b3944f2f40a5"
      unitRef="usd">37773000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ibeb29a716f8547e093a0767d93caf9a1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTMtMS0xLTEtNDk4MTY_31a9a150-7e7b-4db2-a940-e97c94aa89dd"
      unitRef="usd">16943000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ibeb29a716f8547e093a0767d93caf9a1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTMtMy0xLTEtNDk4MTY_94717392-1e22-42da-a6c8-78ded0233028"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ibeb29a716f8547e093a0767d93caf9a1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTMtNS0xLTEtNDk4MTY_7249a6d2-9642-4cc8-b8d4-be5565f94396"
      unitRef="usd">21000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibeb29a716f8547e093a0767d93caf9a1_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTMtNy0xLTEtNDk4MTY_815a6683-489e-4bf5-864f-97fe145f56a9"
      unitRef="usd">16922000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8aa1ecbd5903489ea2ee1f51365efa36_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTQtMS0xLTEtNDk4MTY_8adb7719-dc58-403a-ac10-c1de2c267e00"
      unitRef="usd">42478000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8aa1ecbd5903489ea2ee1f51365efa36_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTQtMy0xLTEtNDk4MTY_27d5de20-6b55-471d-9f36-221ea289dc5f"
      unitRef="usd">5000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8aa1ecbd5903489ea2ee1f51365efa36_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTQtNS0xLTEtNDk4MTY_3d713022-7acf-4a92-8f95-f8abcaaa1b4a"
      unitRef="usd">146000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8aa1ecbd5903489ea2ee1f51365efa36_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTQtNy0xLTEtNDk4MTY_42af741e-43a4-43f1-af76-26b09efa897a"
      unitRef="usd">42337000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTUtMS0xLTEtNDk4MTY_d600f60a-e02e-4662-8cb6-ad36289bc1cc"
      unitRef="usd">257092000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTUtMy0xLTEtNDk4MTY_f741fbc8-9738-4d5d-a588-7cb74adf1563"
      unitRef="usd">18000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTUtNS0xLTEtNDk4MTY_c216e229-2abb-4f43-935a-bcc261971be2"
      unitRef="usd">1412000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTUtNy0xLTEtNDk4MTY_8e177d9c-d23c-46fe-aaa7-9197c8876915"
      unitRef="usd">255698000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTYtMS0xLTEtNDk4MTY_158f9cc6-2188-4ad1-9d63-ae5bada56732"
      unitRef="usd">302003000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTYtMy0xLTEtNDk4MTY_1efc9830-ce07-4e85-960e-fb2de8fc4f59"
      unitRef="usd">18000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTYtNS0xLTEtNDk4MTY_b8f08b11-e39f-41e3-9b9e-9d8c5c3f0070"
      unitRef="usd">1412000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax>
    <sgmo:CashEquivalentsAndAvailableForSaleSecurities
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMTYtNy0xLTEtNDk4MTY_9ef4dcd6-040d-4589-b72a-354fa7234a2c"
      unitRef="usd">300609000</sgmo:CashEquivalentsAndAvailableForSaleSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i09e4f486e25d4837bc2bd16e7e92edf4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjEtMS0xLTEtNDk4MTY_3eac10ef-5258-43e4-9614-5ce83ab25b3c"
      unitRef="usd">119919000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax
      contextRef="i09e4f486e25d4837bc2bd16e7e92edf4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjEtMy0xLTEtNDk4MTY_f7b3909b-4281-422d-89dd-1ded591946ab"
      unitRef="usd">0</sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax>
    <sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax
      contextRef="i09e4f486e25d4837bc2bd16e7e92edf4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjEtNS0xLTEtNDk4MTY_62d71d53-6edd-48e4-acb0-1462caef9b1e"
      unitRef="usd">0</sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i09e4f486e25d4837bc2bd16e7e92edf4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjEtNy0xLTEtNDk4MTY_62ed4ef9-dbc2-4b58-b45d-8146dcf5d7cf"
      unitRef="usd">119919000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ieb83f685b39f49fc8b06dfce81650e59_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjItMS0xLTEtNDk4MTY_966d8bd6-5a6c-40d4-a704-2c7e361136db"
      unitRef="usd">119919000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax
      contextRef="ieb83f685b39f49fc8b06dfce81650e59_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjItMy0xLTEtNDk4MTY_18c411ad-9b88-43ec-a188-5c0241d1b301"
      unitRef="usd">0</sgmo:CashEquivalentsGrossUnrealizedGainBeforeTax>
    <sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax
      contextRef="ieb83f685b39f49fc8b06dfce81650e59_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjItNS0xLTEtNDk4MTY_6c0d21ec-e044-4d09-bd2e-84f8fd88bd3e"
      unitRef="usd">0</sgmo:CashEquivalentsGrossUnrealizedLossBeforeTax>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="ieb83f685b39f49fc8b06dfce81650e59_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjItNy0xLTEtNDk4MTY_c5b54383-626b-477d-9c02-768bdc1e1b13"
      unitRef="usd">119919000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id0d6f23a6e1e4fdd89526d7156771dde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjQtMS0xLTEtNDk4MTY_5f66d13b-c2bf-4a91-ae50-b4f9b524a012"
      unitRef="usd">30700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id0d6f23a6e1e4fdd89526d7156771dde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjQtMy0xLTEtNDk4MTY_7a26f7d3-8275-4837-b8db-7e8f855e9467"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id0d6f23a6e1e4fdd89526d7156771dde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjQtNS0xLTEtNDk4MTY_12e640cc-e423-49fc-8d21-9c6c4db9d98b"
      unitRef="usd">87000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id0d6f23a6e1e4fdd89526d7156771dde_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjQtNy0xLTEtNDk4MTY_9d381176-3c3c-4551-9385-23c917ab67f5"
      unitRef="usd">30614000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ifa0a0121a11a4f5a9c8f92c62eb8b617_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjUtMS0xLTEtNDk4MTY_65b2f298-83b6-418a-8878-58a490224e72"
      unitRef="usd">105792000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ifa0a0121a11a4f5a9c8f92c62eb8b617_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjUtMy0xLTEtNDk4MTY_509b73c5-424f-4b42-8028-032fdf1aebcf"
      unitRef="usd">7000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ifa0a0121a11a4f5a9c8f92c62eb8b617_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjUtNS0xLTEtNDk4MTY_62a185f6-46eb-4696-9c3f-2500f27b3188"
      unitRef="usd">42000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa0a0121a11a4f5a9c8f92c62eb8b617_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjUtNy0xLTEtNDk4MTY_1082d71b-2c35-4c0c-ad35-433134de28d9"
      unitRef="usd">105757000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="if51181fc5273431abe839125ae5e5dc9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjYtMS0xLTEtNDk4MTY_c4cef532-0b0d-469a-b2e0-2796ec81c644"
      unitRef="usd">33723000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if51181fc5273431abe839125ae5e5dc9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjYtMy0xLTEtNDk4MTY_cbe9e2ad-fe04-47a1-bfb3-1886cffdee52"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if51181fc5273431abe839125ae5e5dc9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjYtNS0xLTEtNDk4MTY_430d6b2f-b3dc-4d29-b3d3-b92339be68e8"
      unitRef="usd">42000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if51181fc5273431abe839125ae5e5dc9_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjYtNy0xLTEtNDk4MTY_59002100-b040-47db-a1e1-7b241e146cd0"
      unitRef="usd">33682000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6f81a5cb7fee4760866d108a18198b21_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjctMS0xLTEtNDk4MTY_d1b86cc5-8941-4763-a394-86b95c3820cc"
      unitRef="usd">70807000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6f81a5cb7fee4760866d108a18198b21_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjctMy0xLTEtNDk4MTY_d22b582f-f921-4f15-9d04-a12a45f106f4"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6f81a5cb7fee4760866d108a18198b21_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjctNS0xLTEtNDk4MTY_22777088-05e4-4ea2-8f42-a95edc26c645"
      unitRef="usd">107000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6f81a5cb7fee4760866d108a18198b21_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjctNy0xLTEtNDk4MTY_27ddaacd-f31a-44f5-9a36-72b1110fac08"
      unitRef="usd">70701000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i6be12bead5e34d9d9730b4f9983fdc54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjgtMS0xLTEtNDk4MTY_0f5204ba-5519-4933-a3a2-3d8e26237ec9"
      unitRef="usd">45116000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i6be12bead5e34d9d9730b4f9983fdc54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjgtMy0xLTEtNDk4MTY_729b86a2-1f04-4b5e-a64d-08750028e3ef"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i6be12bead5e34d9d9730b4f9983fdc54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjgtNS0xLTEtNDk4MTY_35df8a8e-42f3-49d2-9e2c-7581c15481f2"
      unitRef="usd">26000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6be12bead5e34d9d9730b4f9983fdc54_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjgtNy0xLTEtNDk4MTY_ca131379-3ca2-41d9-a70b-e67aa88f5d4b"
      unitRef="usd">45091000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjktMS0xLTEtNDk4MTY_5d756754-eb98-4477-a216-377cbb1fbfa6"
      unitRef="usd">286138000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjktMy0xLTEtNDk4MTY_409b474b-a00d-459d-b81a-fe1f526f7d1d"
      unitRef="usd">11000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjktNS0xLTEtNDk4MTY_4c960a6b-4d7c-475b-90af-ebf5442b85f2"
      unitRef="usd">304000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMjktNy0xLTEtNDk4MTY_fbf0cf9d-69e3-4f5b-a43f-844d081df7e8"
      unitRef="usd">285845000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMzAtMS0xLTEtNDk4MTY_88b85a01-4908-49ec-9aa4-d606de9ffb6d"
      unitRef="usd">406057000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMzAtMy0xLTEtNDk4MTY_c0fe1bc0-ec6f-460f-82d7-fe1be322d142"
      unitRef="usd">11000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax>
    <sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMzAtNS0xLTEtNDk4MTY_d5403f1b-138a-4bbd-be09-ef20059944b4"
      unitRef="usd">304000</sgmo:CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax>
    <sgmo:CashEquivalentsAndAvailableForSaleSecurities
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOmVjNjM1MjJlMTg3ODRiYmE5MGU0MTFmNDYzZWQ1MjMxL3RhYmxlcmFuZ2U6ZWM2MzUyMmUxODc4NGJiYTkwZTQxMWY0NjNlZDUyMzFfMzAtNy0xLTEtNDk4MTY_9d0805cb-9487-4871-957f-2f1e4e56ddd2"
      unitRef="usd">405764000</sgmo:CashEquivalentsAndAvailableForSaleSecurities>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjczNg_4a7266d7-f871-4bde-9e5b-3aff37d0b351">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of marketable securities by contractual maturity were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.137%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.986%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing in one year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturing after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMS0xLTEtMS00OTgxNg_d87077eb-522c-480a-aebc-9b8463c61c60"
      unitRef="usd">218998000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMS0zLTEtMS00OTgxNg_09ac859d-d795-4460-aaba-da533b90ff8c"
      unitRef="usd">197676000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMi0xLTEtMS00OTgxNg_03cbfe41-f7eb-4491-9381-38d525f52b22"
      unitRef="usd">36700000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMi0zLTEtMS00OTgxNg_1126139f-bb6f-4f44-b129-05e97c1c3424"
      unitRef="usd">88169000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <sgmo:DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMy0xLTEtMS00OTgxNg_c38de49c-52ca-4e63-a6aa-b4bbed2c0778"
      unitRef="usd">255698000</sgmo:DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents>
    <sgmo:DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RhYmxlOjAwOTk0NzljOTQ2NDQ5ODhiZWY1ZmQ2YmMyNGZiNjEzL3RhYmxlcmFuZ2U6MDA5OTQ3OWM5NDY0NDk4OGJlZjVmZDZiYzI0ZmI2MTNfMy0zLTEtMS00OTgxNg_fb1a8be1-e436-4152-ac7d-0bc92fc527d1"
      unitRef="usd">285845000</sgmo:DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjY0_314b73ec-3cf7-4616-8f37-04366aa8c0cf"
      unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:RealizedInvestmentGainsLosses
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjY0_81292266-63dd-460f-96eb-9181d94b3ad7"
      unitRef="usd">0</us-gaap:RealizedInvestmentGainsLosses>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_0e26e49e-88ed-4aa4-8703-72e21ee326cd"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_555e3a1f-a7a3-4aad-b66a-d35bb1fefa97"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_608ed15a-4aef-420e-bcaa-cdf4e6321902"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_a66c8f9e-6d9e-4a5b-9040-e1944752581e"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_a792a554-4263-46fa-9ff3-c5cee84aa104"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_d95595c2-3c38-4b5a-a865-45abfbae80b1"
      unitRef="usd">0</us-gaap:OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_df2f6efa-cead-4794-a974-eaf650cdb70d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfNzA4_f7992cc6-7af6-4781-a522-c452aaf1b7f3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i53b0aa3b185a4cf3bd831669a1dfa206_I20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjYzMA_4ffc1c14-f252-45fe-9f7b-b6fd09074fc1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
      contextRef="i7c4dba8b39754fe49bf7ff57b434bccc_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF80Ni9mcmFnOmNkZDU5ZjgxZjViYjQ1NGFiNTNhYWUxZDI4NWI4OTZlL3RleHRyZWdpb246Y2RkNTlmODFmNWJiNDU0YWI1M2FhZTFkMjg1Yjg5NmVfMjYzMA_61a5edaa-7b21-46f4-ac6a-7bae41e91b33"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAllowanceForCreditLoss>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81Mi9mcmFnOmFjZWQ0NjMwYzcwNTQyOTlhYjIzYWJjZTZhMDBhOGI4L3RleHRyZWdpb246YWNlZDQ2MzBjNzA1NDI5OWFiMjNhYmNlNmEwMGE4YjhfMTE0MQ_64c13972-e616-421f-aa57-6e490e53ce69">BASIC AND DILUTED NET LOSS PER SHARE&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share attributable to Sangamo Therapeutics, Inc. stockholders has been computed by dividing net loss attributable to Sangamo Therapeutics, Inc. stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders is calculated by dividing net loss attributable to Sangamo Therapeutics, Inc. stockholders by the weighted-average number of shares of common stock outstanding during the period, without consideration of any potential dilutive securities, as their effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The total number of shares subject to stock options and restricted stock units (&#x201c;RSUs&#x201d;) outstanding and the employee stock purchase plan (&#x201c;ESPP&#x201d;) shares reserved for issuance, which are all anti-dilutive, were excluded from consideration in the calculation of diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders. Stock options and RSUs outstanding and ESPP shares reserved for issuance as of September&#160;30, 2022 and 2021 totaled 18,524,016 and 15,838,002, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81Mi9mcmFnOmFjZWQ0NjMwYzcwNTQyOTlhYjIzYWJjZTZhMDBhOGI4L3RleHRyZWdpb246YWNlZDQ2MzBjNzA1NDI5OWFiMjNhYmNlNmEwMGE4YjhfMTExNw_a65979e7-23f2-49ed-81ab-ba58581cc682"
      unitRef="shares">18524016</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81Mi9mcmFnOmFjZWQ0NjMwYzcwNTQyOTlhYjIzYWJjZTZhMDBhOGI4L3RleHRyZWdpb246YWNlZDQ2MzBjNzA1NDI5OWFiMjNhYmNlNmEwMGE4YjhfMTEyNA_40ba14a2-12e1-4256-8f05-6e98a9371e98"
      unitRef="shares">15838002</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNDg_3d4ce50b-9650-4a33-9eda-c04aed34fc25">MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Novartis Institutes for BioMedical Research, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 27, 2020, the Company entered into a collaboration and license agreement with Novartis Institutes for BioMedical Research, Inc. (&#x201c;Novartis&#x201d;) for the research, development and commercialization of gene regulation therapies to treat three neurodevelopmental disorders. Under the agreement, which was effective upon execution, the Company granted Novartis an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize certain of its zinc finger protein (&#x201c;ZFP&#x201d;) transcription factors (&#x201c;ZFP-TFs&#x201d;) targeted to three undisclosed genes that are associated with certain neurodevelopmental disorders, including autism spectrum disorder and intellectual disability. The Company is performing early research activities over the collaboration period for each gene target and manufacture the ZFP-TFs required for such research, costs of which are funded by Novartis. Novartis is responsible for additional research activities, studies enabling investigational new drug applications (&#x201c;INDs&#x201d;), clinical development, regulatory approvals, manufacturing of preclinical, clinical and approved products, and global commercialization. Subject to certain exceptions set forth in the agreement, the Company is prohibited from developing, manufacturing or commercializing any therapeutic product targeting any of the three genes that are the subject of the collaboration. Novartis also has the option to license certain of the Company&#x2019;s proprietary adeno-associated viruses (&#x201c;AAVs&#x201d;) for the sole purpose of developing, manufacturing and commercializing licensed products arising from the collaboration. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the agreement, Novartis paid the Company a $75.0&#160;million upfront license fee in August 2020. In addition to this fee and the cost reimbursements for early research activities, the Company is eligible to earn from Novartis up to $420.0&#160;million in development milestones and up to $300.0&#160;million in commercial milestones. The Company is also eligible to earn from Novartis tiered high single-digit to sub-teen double-digit royalties on potential net commercial sales of licensed products arising from the collaboration. These royalty payments will be subject to reduction due to patent expiration, loss of market exclusivity and payments made under certain licenses for third-party intellectual property. The agreement will continue, on a product-by-product and country-by-country basis, until the expiration of the applicable royalty term. Novartis has the right to terminate the agreement, in its entirety or on a target-by-target basis, for any reason after a specified notice period. Each party also has the right to terminate the agreement on account of the other party&#x2019;s bankruptcy or material, uncured breach.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All payments received under the agreement, when earned, are non-refundable and non-creditable. The transaction price of $95.1&#160;million includes the upfront license fee of $75.0&#160;million and estimated research costs of $20.1&#160;million to be provided over the estimated research period. All clinical or regulatory milestone amounts were considered fully constrained at inception of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the agreement. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at this time is uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will re-evaluate the transaction price, including the estimated variable consideration included in the transaction price and all constrained amounts, in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the agreement with Novartis in accordance with ASC Topic&#160;606 and concluded that Novartis is a customer. The Company has identified a single performance obligation within this arrangement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Novartis apart from the research services to be performed pursuant to the agreement. As a result, the Company recognizes revenue from the upfront payment based on proportional performance of the ongoing research services through the estimated research period. The estimation of progress towards the satisfaction of performance obligation and project cost is reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s current assumptions regarding the timing of its performance obligation. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of $2.0&#160;million and $1.9&#160;million, respectively, and deferred revenue of $17.7&#160;million and $40.9&#160;million, respectively, related to this agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Novartis agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of upfront license fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company paid $1.5&#160;million for financial advisory fees during the year ended December&#160;31, 2020, equal to 2% of $75.0&#160;million received for the upfront license fee related to the collaboration and license agreement with Novartis. The Company recognized $1.5&#160;million as a contract asset as such amount represents a cost of obtaining the agreement. This balance is amortized and included in general and administrative expenses on a systematic basis consistent with the transfer of the services to Novartis in accordance with ASC Topic&#160;340, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC Topic&#160;340&#x201d;). The Company amortized $0.2&#160;million and $0.5&#160;million during the three and nine months ended September&#160;30, 2022, respectively, and $0.2&#160;million and $0.5&#160;million during the three and nine months ended September&#160;30, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Biogen MA, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2020, the Company entered into a collaboration and license agreement with Biogen MA, Inc. (&#x201c;BIMA&#x201d;) and Biogen International GmbH (together with BIMA, &#x201c;Biogen&#x201d;) for the research, development and commercialization of gene regulation therapies for the treatment of neurological diseases. The companies plan to leverage the Company&#x2019;s proprietary ZFP technology delivered via AAV to modulate expression of key genes involved in neurological diseases. Concurrently with the execution of the collaboration agreement, the Company entered into a stock purchase agreement with BIMA, pursuant to which BIMA agreed to purchase 24,420,157 shares of the Company&#x2019;s common stock (the &#x201c;Biogen Shares&#x201d;), at a price per share of $9.2137, for an aggregate purchase price of approximately $225.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The collaboration agreement became effective in April 2020 following the termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and satisfaction of other customary closing conditions, including the payment of $225.0&#160;million for the purchase of the Biogen Shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the collaboration agreement, Biogen paid the Company an upfront license fee of $125.0&#160;million in May 2020. The Company is also eligible to receive research, development, regulatory and commercial milestone payments that could total up to approximately $2.4&#160;billion if Biogen selects all of the targets allowed under the agreement and all the specified milestones set forth in the agreement are achieved, which includes up to $925.0&#160;million in pre-approval milestone payments and up to $1.5&#160;billion in first commercial sale and other sales-based milestone payments. In addition, the Company is eligible to receive tiered high single-digit to sub-teen royalties on potential net commercial sales of licensed products arising from the collaboration. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the collaboration agreement, the Company granted to Biogen an exclusive, royalty bearing and worldwide license, under its relevant patents and know-how, to develop, manufacture and commercialize certain ZFP and/or AAV-based products directed to certain&#160;neurological disease gene targets selected by Biogen. Biogen has already selected four of these: ST-501 to treat tauopathies, ST-502 to treat synucleinopathies including Parkinson&#x2019;s disease, a third product candidate targeting DM1, a neuromuscular disease, and a fourth undisclosed neurological disease gene target. Biogen has exclusive rights to nominate up to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;seven additional targets over the remaining period of five years from the effective date of the collaboration agreement. For each gene target selected by Biogen, the Company performs early research activities, costs of which are shared by the companies, aimed at the development of the combination of proprietary central nervous system delivery vectors and ZFP-TFs (or potential other ZFP products) targeting therapeutically relevant genes. Biogen has assumed responsibility and costs for the IND-enabling studies, clinical development, related regulatory interactions, and global commercialization. The Company is responsible for manufacturing activities for the initial clinical trials for the first three products of the collaboration and plans to leverage its in-house manufacturing capacity, where appropriate, which is currently in development. Biogen is responsible for manufacturing activities beyond the first clinical trial for each of the first three products. The Company&#x2019;s research activities for any targets will be performed over the period not to exceed seven years from the effective date of the agreement (i.e., through April 2027). Subject to certain exceptions set forth in the collaboration agreement, the Company is prohibited from developing, manufacturing or commercializing any therapeutic product directed to the targets selected by Biogen.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The collaboration agreement continues on a product-by-product and country-by-country basis until the expiration of all applicable royalty terms. Biogen has the right to terminate the collaboration agreement, in its entirety or on a target-by-target basis, for any reason after a specified notice period, and also has the right to replace up to ten targets. Each party has the right to terminate this agreement on account of the other party&#x2019;s bankruptcy or material, uncured breach. In addition, the Company may terminate the collaboration agreement if Biogen challenges any patents licensed by the Company to Biogen.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the terms of the stock purchase agreement, Biogen has agreed not to, without the Company&#x2019;s prior written consent and subject to specified conditions and exceptions, directly or indirectly acquire shares of the Company&#x2019;s outstanding common stock, seek or propose a tender or exchange offer or merger between the parties, solicit proxies or consents with respect to any matter, or undertake other specified actions related to the potential acquisition of additional equity interests in the Company. Such standstill restrictions expire on the earlier of the three-year anniversary of the effectiveness of the collaboration agreement and the date that Biogen beneficially owns less than 5% of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the collaboration agreement with Biogen in accordance with ASC Topic&#160;606 and concluded that Biogen is a customer. The transaction price of $204.6&#160;million includes the upfront license fee of $125.0&#160;million and the excess consideration from the stock purchase of $79.6&#160;million, which represents the difference between the $225.0&#160;million received for the purchase of the Biogen Shares and the $145.4&#160;million estimated fair value of the equity issued. The equity issued to Biogen was valued using an option pricing model to reflect certain holding period restrictions. None of the target selection fees and clinical or regulatory milestones have been included in the transaction price, as all such amounts are fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that nomination of additional targets and achievement of the milestones at this time is uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will re-evaluate the transaction price as uncertain events are resolved or other changes in circumstances occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has identified a single performance obligation within the Biogen collaboration agreement, which is a stand-ready obligation consisting of a series of distinct days of research services, during which Biogen obtains access to the Company&#x2019;s license and research resources. Revenue from the upfront license fee relates to access to the license and Company&#x2019;s obligation to stand-ready to perform such research services corresponding to the targets selected by Biogen. As a result of this obligation to perform research services when and if requested throughout the duration of the contract, the upfront license fee and the excess consideration from the stock purchase will be recognized over time on a straight-line basis consistent with the resources expected to be dedicated to providing the research services through April 2027, the estimated period of the obligation. The estimated period of performance is reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s current assumptions regarding the timing of its deliverable. Revenue from the reimbursement by Biogen of shared costs of early research activities performed by Sangamo is recognized as the research services are performed. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of $1.7&#160;million and $2.8&#160;million, respectively, and deferred revenue of $132.1&#160;million and $154.0&#160;million, respectively, related to this agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Biogen agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of license and stand-ready fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company paid $7.0&#160;million for financial advisory fees during the year ended December&#160;31, 2020, equal to 2% of $225.0&#160;million received for the sale of shares and 2% of $125.0&#160;million received for the upfront fee. The fees incurred related to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;both the collaboration agreement with Biogen and the stock purchase agreement for the sale of shares. The Company believes that the allocation of fees on a relative fair value basis between the two agreements is reasonable. The Company recognized $4.1&#160;million, which represents 2% of the transaction price of $204.6&#160;million, as a contract asset. This balance is amortized and included in general and administrative expenses on a systematic basis consistent with the transfer of the services to Biogen in accordance with ASC Topic&#160;340. The Company amortized $0.1&#160;million and $0.4&#160;million during the three and nine months ended September&#160;30, 2022, respectively, and $0.1&#160;million and $0.4&#160;million during the three and nine months ended September&#160;30, 2021, respectively. The Company recognized $2.9&#160;million, which represented 2% of the $145.4&#160;million estimated fair value of the equity issued, as a share issuance cost and recorded this amount in equity as a reduction in net proceeds during the year ended December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Kite Pharma, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2018, the Company entered into a global collaboration and license agreement with Kite Pharma, Inc. (&#x201c;Kite&#x201d;), a Gilead Sciences, Inc. subsidiary, which became effective on April 5, 2018 (&#x201c;Effective Date&#x201d;), and was amended and restated in September 2019, for the research, development, and commercialization of potential engineered cell therapies for cancer. In this collaboration, Sangamo is working together with Kite on a research program under which the companies are designing zinc finger nucleases (&#x201c;ZFNs&#x201d;) and viral vectors to disrupt and insert certain genes in T-cells and natural killer cells (&#x201c;NK-cells&#x201d;) including the insertion of genes that encode chimeric antigen receptors (&#x201c;CARs&#x201d;), T-cell receptors (&#x201c;TCRs&#x201d;), and NK-cell receptors (&#x201c;NKRs&#x201d;) directed to mutually agreed targets. Kite is responsible for all clinical development, manufacturing and commercialization of any resulting products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the terms of this agreement, the Company granted Kite an exclusive, royalty-bearing, worldwide sublicensable license under the Company&#x2019;s relevant patents and know-how to develop, manufacture and commercialize, for the purpose of treating cancer, specific cell therapy products that may result from the research program and that are engineered &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ex&#160;vivo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; using selected ZFNs and viral vectors developed under the research program to express CARs, TCRs or NKRs directed to candidate targets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the research program term and subject to certain exceptions, the Company is prohibited from researching, developing, manufacturing and commercializing, for the purpose of treating cancer, any cell therapy product that, as a result of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ex vivo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; genome editing, expresses a CAR, TCR or NKR that is directed to a target expressed on or in a human cancer cell. After the research program term concludes and subject to certain exceptions, the Company will be prohibited from developing, manufacturing and commercializing, for the purpose of treating cancer, any cell therapy product that, as a result of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ex vivo&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; genome editing, expresses a CAR, TCR or NKR that is directed to a candidate target.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the Effective Date, the Company received a $150.0&#160;million upfront payment from Kite. In addition, Kite reimburses the Company&#x2019;s direct costs to conduct the joint research program. Sangamo is also eligible to receive contingent development- and sales-based milestone payments that could total up to $3.0&#160;billion if all of the specified milestones set forth in this agreement are achieved. Of this amount, approximately $1.3&#160;billion relates to the achievement of specified research, clinical development, regulatory and first commercial sale milestones, and approximately $1.8&#160;billion relates to the achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach specified levels. Each development- and sales-based milestone payment is payable (i)&#160;only once for each licensed product, regardless of the number of times that the associated milestone event is achieved by such licensed product, and (ii)&#160;only for the first 10 times that the associated milestone event is achieved regardless of the number of licensed products that may achieve such milestone event. In addition, the Company is entitled to receive escalating, tiered royalty payments with a percentage in the single digits based on future annual worldwide net sales of licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial research term in the agreement is six years from the Effective Date. Kite has an option to extend the research term for up to two additional one-year periods for a separate upfront fee of $10.0&#160;million per year. All contingent payments under the agreement, when earned, will be non-refundable and non-creditable. In connection with the amendment and restatement of the agreement in September 2019, the Company entered into a new research plan with Kite, with estimated reimbursable service cost of approximately $3.4&#160;million, which is included in the total transaction price. The Company concluded the total transaction price under this agreement is $189.3&#160;million and includes the upfront license fee of $150.0&#160;million and $39.3&#160;million estimated reimbursable service costs for identified research projects over the estimated performance period. Further, the Company concluded the estimated fees for the presumed exercise of the research term extension options and all milestone amounts are fully constrained. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at this time is uncertain and contingent upon future events which are uncertain at this time. The Company will re-evaluate the transaction price including the estimated variable consideration included in the transaction price and all constrained amounts in each reporting period and as uncertain events are resolved or other changes in circumstances occur. None of the development and sales-based milestone payments have been included in the transaction price.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the agreement with Kite in accordance with ASC Topic&#160;606 and concluded that Kite is a customer. Kite has the right to terminate this agreement in its entirety or on a per licensed product or per candidate target basis for any reason after a specified notice period. Each party has the right to terminate this agreement on account of the other party&#x2019;s bankruptcy or material, uncured breach.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has identified the primary performance obligations within the Kite agreement as: (1)&#160;a license to the technology along with the stand-ready obligation to perform research services, and (2)&#160;the ongoing research services. Revenue from the upfront license fee relates to access to the license and Company&#x2019;s obligation to stand-ready to perform such research services as additional targets are selected by Kite. As a result of this obligation to perform research services when and if requested throughout the duration of the contract, the fee for the license and the stand-ready obligation will be recognized over time on a straight-line basis through April 2024, the estimated period of the stand-ready obligation. Revenue from the reimbursable costs related to the integrated service deliverable is recognized as the research services are performed. Related costs and expenses under these arrangements have historically approximated the revenues recognized. The estimated period of performance and project cost is reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s current assumptions regarding the timing of its deliverables. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of $0.6&#160;million and $0.1&#160;million, respectively, and deferred revenue of $37.8&#160;million and $56.5&#160;million, respectively, related to this agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Kite agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of license and stand-ready fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sanofi S.A.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2014, the Company entered into an exclusive worldwide collaboration and license agreement (&#x201c;2014 Collaboration Agreement&#x201d;) to develop therapeutics for hemoglobinopathies, focused on beta thalassemia and sickle cell disease (&#x201c;SCD&#x201d;). The 2014 Collaboration Agreement was originally signed with BIMA, who subsequently assigned it to Bioverativ Inc., which was later acquired by Sanofi. Under the 2014 Collaboration Agreement, the Company was originally jointly conducting two research programs: a beta thalassemia program, which was discontinued in the third quarter of 2021, and the SCD program, which resulted in the development of SAR445136 (now known as BIVV003), a ZFN, gene-edited cell therapy product candidate for the treatment of SCD, which remains active. In December 2021, Sanofi notified the Company of its termination for convenience, effective June 28, 2022 (the &#x201c;Termination Date&#x201d;), of the 2014 Collaboration Agreement. A termination and transition agreement (the &#x201c;Termination and Transition Agreement&#x201d;) was executed by the parties on September 6, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the SCD program, the Company and Sanofi were jointly responsible for research and development activities prior to filing of an IND, but Sanofi was responsible for subsequent worldwide clinical development, manufacturing and commercialization of licensed products developed under the agreement. Subject to the terms of the agreement, the Company had granted Sanofi an exclusive, royalty-bearing license, with the right to grant sublicenses, to use certain ZFP and other technology controlled by the Company for the purpose of researching, developing, manufacturing and commercializing licensed products developed under the agreement. The Company had also granted Sanofi a non-exclusive worldwide, royalty-free fully paid license with the right to grant sublicenses, under the Company&#x2019;s interest in certain other intellectual property developed pursuant to the agreement. During the term of the agreement, the Company was not permitted to research, develop, manufacture or commercialize, outside of the agreement, certain gene therapy products that target genes relevant to the licensed products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the agreement, the Company received an upfront license fee of $20.0&#160;million and was eligible to receive additional payments upon the achievement of specified clinical development, regulatory and sales milestones, as well as royalty payments for each licensed product based on net sales of such product. Sanofi was also to reimburse Sangamo for agreed upon costs incurred in connection with research and development activities conducted by Sangamo. Through the Termination Date, a total of $13.5&#160;million has been received based upon achievement of clinical development milestones. No products have been approved and therefore no royalty fees have been or will be earned under the 2014 Collaboration Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In its termination notice to the Company, Sanofi indicated that its termination relates to Sanofi&#x2019;s change in strategic direction to focus on allogeneic universal genomic medicine approaches rather than autologous personalized cell therapies. As of the Termination Date, the 2014 Collaboration Agreement was terminated in its entirety and following the Termination Date, the Company will not be entitled to receive any further milestone payments or royalties from Sanofi. As of the Termination Date, Sanofi has no further obligations under the 2014 Collaboration Agreement to develop or to fund the development of any &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;collaboration research programs under the 2014 Collaboration Agreement. The licenses granted to Sanofi under the 2014 Collaboration Agreement have been terminated, and the license rights have reverted to the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the Termination and Transition Agreement, Sanofi granted to the Company exclusive, worldwide, fully paid, royalty-free, perpetual, irrevocable licenses, with the right to grant sublicenses through multiple tiers, to certain of its intellectual property, to develop, manufacture, use, sell and otherwise commercialize BIVV003, the product candidate in development under the SCD program. The Company has agreed to take on responsibilities for all clinical trials related to BIVV003, including completion of the ongoing clinical trial and the related long-term follow-up study. The Company also assumed all regulatory responsibilities related to BIVV003. Sanofi has agreed to provide post-transition assistance to the Company for up to 90 days after the Termination Date, and transferred or assigned to the Company all documentation, materials, contracts with third parties, and the right to use certain Sanofi-owned equipment related to BIVV003.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sanofi has also agreed to reimburse the Company for the costs of conducting the ongoing clinical trial of BIVV003 and the costs of the long-term follow-up study through December 31, 2023, up to $7.0&#160;million. In addition, should the Company elect not to continue the development of BIVV003 past December 31, 2023, Sanofi will become obligated to reimburse the Company for the costs of the long-term follow-up study incurred after 2023, up to $5.3&#160;million. Sanofi&#x2019;s reimbursement obligations will terminate upon certain triggering events, including the Company&#x2019;s entering into a contract with a third party for collaboration, partnership, sale, licensing, or divestiture of BIVV003, or if the FDA permits early closure of the clinical trial and/or the long-term follow-up study.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the 2014 Collaboration Agreement with Sanofi in accordance with ASC Topic 606 and concluded that Sanofi was a customer, under that arrangement. The Company identified the performance obligation within this arrangement as a license to the technology combined with ongoing research services activities. The Company concluded that the license was not distinct as it did not have value to Sanofi without the research services. As a result, the Company recognized revenue from the upfront payment and the milestones based on progress of performance of the ongoing research services. The estimation of progress towards the satisfaction of the performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s then-current assumptions regarding the timing of its deliverables. Related costs and expenses under these arrangements have historically approximated the revenues recognized. Sanofi&#x2019;s December 2021 notice of termination of the 2014 Collaboration Agreement represented a modification that reduced the expected scope of the Company&#x2019;s services and the estimated transaction price and shortened the remaining performance timeline. Consistent with this change, all services under the 2014 Collaboration Agreement were completed by June 28, 2022, and all amounts ultimately included in the transaction price were recognized by such date. The final transaction price of $96.3&#160;million includes the upfront license fee of $20.0&#160;million, two milestone payments in the aggregate amount of $13.5&#160;million and reimbursement of research costs of $62.8&#160;million. As of September&#160;30, 2022 and December&#160;31, 2021, the Company had a receivable of zero and $0.6&#160;million, respectively, related to the 2014 Collaboration Agreement. Deferred revenue related to the 2014 Collaboration Agreement was zero and $1.1&#160;million as of September&#160;30, 2022 and December&#160;31, 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company concluded that Sanofi is not a customer under the Termination and Transition Agreement as Sanofi is not entitled to receive and cannot use the results of the ongoing clinical trial or the long-term follow-up study. This relationship is also not a collaboration in the scope of ASC Topic&#160;808, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Collaborative Arrangements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Company concluded that the assets acquired from Sanofi do not represent a business, as substantially all of their value is concentrated in the acquired or re-acquired licenses to intellectual property. The Company has no obligation to repay Sanofi for its ongoing funding of the clinical trial or long-term follow-up study costs. Therefore, the Company will recognize Sanofi reimbursements as reductions of its research and development expense. During the three and nine months ended September&#160;30, 2022, the Company decreased its research and development expense by $0.9&#160;million, which is included within prepaid expenses and other current assets on the Company&#x2019;s Condensed Consolidated Balance Sheet as of September&#160;30, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the 2014 Collaboration Agreement were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Sanofi agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of upfront fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Milestone achievement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(467)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2021, the Company recorded an adjustment to revenue related to a change in estimate in connection with the collaboration agreement with Sanofi. This adjustment was a result of an increase in the project costs for its beta thalassemia program and the increase in project scope and the corresponding costs for its SCD program, both of which resulted in a decrease &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the measure of proportional cumulative performance. This adjustment decreased revenue by $2.5&#160;million, increased net loss by $2.5&#160;million and increased the Company's basic and diluted net loss per share by $0.02 for the three and nine months ended September 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Pfizer Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;Giroctocogene Fitelparvovec Global Collaboration and License Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2017, the Company entered into an exclusive global collaboration and license agreement with Pfizer Inc. (&#x201c;Pfizer&#x201d;), pursuant to which it established a collaboration for the research, development and commercialization of giroctocogene fitelparvovec, its gene therapy product candidate for hemophilia A, and closely related products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under this agreement, the Company is responsible for conducting the Phase 1/2 clinical trial and for certain manufacturing activities for giroctocogene fitelparvovec, while Pfizer is responsible for subsequent worldwide development, manufacturing, marketing and commercialization of giroctocogene fitelparvovec. Sangamo may also collaborate in the research and development of additional AAV-based gene therapy products for hemophilia A.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the terms of the agreement, the Company granted Pfizer an exclusive worldwide royalty-bearing license, with the right to grant sublicenses, to use certain technology controlled by the Company for the purpose of developing, manufacturing and commercializing giroctocogene fitelparvovec and related products. Pfizer granted the Company a non-exclusive, worldwide, royalty-free, fully paid license, with the right to grant sublicenses, to use certain manufacturing technology developed under the agreement and controlled by Pfizer to manufacture the Company&#x2019;s products that utilize the AAV delivery system. During a specified period, neither the Company nor Pfizer is permitted to clinically develop or commercialize, outside of the collaboration, certain AAV-based gene therapy products for hemophilia A.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, the agreement has a term that continues on a per product and per country basis until the later of (i) the expiration of patent claims that cover the product in a country, (ii) the expiration of regulatory exclusivity for a product in a country, and (iii) fifteen years after the first commercial sale of a product in a country. Pfizer has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec and related products will automatically terminate. Upon termination by the Company for cause or by Pfizer in any country or countries, Pfizer will automatically grant the Company an exclusive, royalty-bearing license under certain technology controlled by Pfizer to develop, manufacture and commercialize giroctocogene fitelparvovec in the terminated country or countries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon execution of the agreement, the Company received an upfront fee of $70.0&#160;million and is eligible to receive up to $208.5&#160;million in payments upon the achievement of specified clinical development, intellectual property and regulatory milestones and up to $266.5&#160;million in payments upon first commercial sale milestones for giroctocogene fitelparvovec and potentially other products. The total amount of potential clinical development, intellectual property, regulatory and first commercial sale milestone payments, assuming the achievement of all specified milestones in the agreement, is up to $475.0&#160;million, which includes up to $300.0&#160;million for giroctocogene fitelparvovec and up to $175.0&#160;million for other products that may be developed under the agreement, subject to reduction on account of payments made under certain licenses for third-party intellectual property. In addition, Pfizer agreed to pay the Company royalties for each potential licensed product developed under the agreement that are an escalating tiered, double-digit percentage of the annual net sales of such product and are subject to reduction due to patent expiration, entry of biosimilar products to the market and payment made under certain licenses for third-party intellectual property. To date, two milestones of $55.0&#160;million in aggregate have been achieved and paid, however no products have been approved and therefore no royalty fees have been earned under the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer is a customer. The total transaction price under this agreement was $134.0&#160;million, which represented the upfront fee and research services fees of $79.0&#160;million and fees related to two achieved milestones in an aggregate amount of $55.0&#160;million. Sangamo was responsible for internal and external research costs as part of the upfront fee and had the ability to request additional reimbursement from Pfizer if certain conditions were met. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will re-evaluate the transaction price, including its estimated variable consideration included in the transaction price and all constrained amounts, in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has identified the performance obligations within the agreement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Pfizer apart from the research services to be performed by the Company pursuant to the agreement. As a result, the Company recognized &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period during which the Company performed research services. The estimation of progress towards the satisfaction of its performance obligation and project cost was reviewed quarterly and adjusted, as needed, to reflect the Company&#x2019;s assumptions regarding the timing of its deliverables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2020, the Company satisfied the deliverables and research services responsibilities within the arrangement. As a result, the Company recognized the remaining deferred revenue from the upfront payment in December 2020 and no revenues have been recognized during the three and nine months ended September&#160;30, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;C9ORF72 Research Collaboration and License Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2017, the Company entered into a separate exclusive, global collaboration and license agreement with Pfizer for the development and commercialization of potential gene therapy products that use ZFP-TFs to treat amyotrophic lateral sclerosis and frontotemporal lobar degeneration linked to mutations of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; gene. Pursuant to this agreement, the Company agreed to work with Pfizer on a research program to identify, characterize and preclinically develop ZFP-TFs that bind to and specifically reduce expression of the mutant form of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; gene.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subject to the terms of this agreement, the Company granted Pfizer an exclusive, royalty-bearing, worldwide license under the Company&#x2019;s relevant patents and know-how to develop, manufacture and commercialize gene therapy products that use resulting ZFP-TFs that satisfy pre-agreed criteria. During a specified period, neither the Company nor Pfizer will be permitted to research, develop, manufacture or commercialize outside of the collaboration any ZFPs that specifically bind to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; gene.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless earlier terminated, the agreement has a term that continues on a per licensed product and per country basis until the later of (i) the expiration of patent claims that cover the licensed product in a country, (ii) the expiration of regulatory exclusivity for a licensed product in a country, and (iii) 15 years after the first commercial sale of a licensed product in a major market country. Pfizer also has the right to terminate the agreement without cause in its entirety or on a per product or per country basis. The agreement may also be terminated by either party based on an uncured material breach by the other party or the bankruptcy of the other party. The agreement will also terminate if the Company is unable to identify any lead candidates for development within a specified period of time or if Pfizer elects not to advance a lead candidate beyond a certain development milestone within a specified period of time. Upon termination for any reason, the license granted by the Company to Pfizer to develop, manufacture and commercialize licensed products under the agreement will automatically terminate. Upon termination by the Company for cause or by Pfizer without cause for any licensed product or licensed products in any country or countries, the Company will have the right to negotiate with Pfizer to obtain a non-exclusive, royalty-bearing license under certain technology controlled by Pfizer to develop, manufacture and commercialize the licensed product or licensed products in the terminated country or countries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following termination by the Company for Pfizer&#x2019;s material breach, Pfizer will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; gene for a period of time. Following termination by Pfizer for the Company&#x2019;s material breach, the Company will not be permitted to research, develop, manufacture or commercialize ZFPs that specifically bind to the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; gene for a period of time.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company received a $12.0&#160;million upfront payment from Pfizer and is eligible to receive up to $60.0&#160;million in development milestone payments from Pfizer contingent on the achievement of specified preclinical development, clinical development and first commercial sale milestones, and up to $90.0&#160;million in commercial milestone payments if annual worldwide net sales of the licensed products reach specified levels. In addition, Pfizer will pay the Company royalties based on an escalating tiered, mid- to high-single digit percentage of the annual worldwide net sales of the licensed products. These royalty payments are subject to reduction due to patent expiration, entry of biosimilar products to the market and payments made under certain licenses for third-party intellectual property. Each party will be responsible for the cost of its performance of the research program. Pfizer will be operationally and financially responsible for subsequent development, manufacturing and commercialization of the licensed products. To date, a milestone of $5.0&#160;million has been achieved and paid, however no products have been approved and therefore no royalty fees have been earned under the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;C9ORF72&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Pfizer agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assessed the agreement with Pfizer in accordance with ASC Topic 606 and concluded that Pfizer was a customer. The Company concluded the total transaction price under this agreement was $17.0&#160;million, which represented the upfront fees of $12.0&#160;million and fees related to achievement of one milestone in the amount of $5.0&#160;million. None of the constrained clinical or regulatory milestones were included in the transaction price. As part of its evaluation of the constraint, the Company considered numerous factors, including the fact that achievement of the milestones at the time was uncertain and contingent upon future periods when the uncertainty related to the variable consideration is resolved. The Company will evaluate the transaction price, including its estimated variable consideration included in the transaction price and all constrained amounts, in each reporting period and as uncertain events are resolved or other changes in circumstances occur.&lt;/span&gt;&lt;/div&gt;The Company had identified the performance obligations within this agreement as a license to the technology and ongoing research services. The Company concluded that the license is not discrete as it does not have stand-alone value to Pfizer apart from the services to be performed by the Company pursuant to the agreement. As a result, the Company recognized revenue from the upfront payment based on proportional performance of the ongoing research services through 2020, the period the Company performed research services.The Company satisfied the deliverables and research services responsibilities within the arrangement in September 2020, and as a result, earned a $5.0&#160;million milestone, which the Company recognized on a cumulative basis during the year ended December 31, 2020. In addition, the Company recognized the remaining deferred revenue from the upfront payment in September 2020 and no revenues have been recognized during the three and nine months ended September&#160;30, 2022 and 2021.</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:ProceedsFromCollaborators
      contextRef="id24858a277a44f918d47646294044411_D20200801-20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTgyNw_1d6ec99d-e5c8-4765-bf0f-058de65cc8ac"
      unitRef="usd">75000000</us-gaap:ProceedsFromCollaborators>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive
      contextRef="ic3fcad2bda744a41b13d72cd6a61005d_D20200727-20200727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjAwMQ_d456c2a3-5ac5-452e-9349-4d3a9e10c1ef"
      unitRef="usd">420000000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive
      contextRef="id7052887b1af4eb59f472680a598c7ca_D20200727-20200727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjA0MA_fa70fe52-a6d6-48ea-83bf-5719e5980ddb"
      unitRef="usd">300000000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:CollaborativeArrangementTransactionPrice
      contextRef="i2ba866a4b6af4a9491a93eb6f0ff14eb_D20200727-20200727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjk4NA_e3e8270c-427f-4f6e-9b3e-127aeebbfde5"
      unitRef="usd">95100000</sgmo:CollaborativeArrangementTransactionPrice>
    <sgmo:CollaborativeArrangementLicenseFee
      contextRef="i2ba866a4b6af4a9491a93eb6f0ff14eb_D20200727-20200727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzAyMw_aedb03b5-5086-45f2-b3bf-dbbd0920dbc3"
      unitRef="usd">75000000</sgmo:CollaborativeArrangementLicenseFee>
    <sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts
      contextRef="i2ba866a4b6af4a9491a93eb6f0ff14eb_D20200727-20200727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzA1OA_6f57535c-e135-4819-b8a2-e3c5ee28b368"
      unitRef="usd">20100000</sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i2734364915f440429f325226570e6f66_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDY3NA_4319b3c7-6c57-47fd-898e-bdd39e36cdbb"
      unitRef="usd">2000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iaae4a2b1c97a4a699c93a09a3af3d231_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDY4MQ_ef0a0339-89ec-4d74-bc8c-40c9c9541cef"
      unitRef="usd">1900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i2734364915f440429f325226570e6f66_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDcyMw_06157456-15ab-4097-99e1-ba66462b0e42"
      unitRef="usd">17700000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="iaae4a2b1c97a4a699c93a09a3af3d231_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDczMA_410c6ca3-794f-4864-89e1-6ac1372bcd2f"
      unitRef="usd">40900000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
      contextRef="i3d5f1ae0ab8b4decbba471d9add02a71_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNDc_b498effc-d215-497e-bb4f-4878ff66bdf8">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Novartis agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of upfront license fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6ea8c76ac97403d9fe80699600d434e_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfMy0xLTEtMS00OTgxNg_f37100b9-1e61-4108-a791-b6336d121f6a"
      unitRef="usd">7582000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1417415012944e48964b4778067acf9_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfMy0zLTEtMS00OTgxNg_5e7ffcd6-a2f4-4399-ac97-3dee43a0a6c7"
      unitRef="usd">9093000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i916103514d9445a2b559cda726e4ef32_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfMy01LTEtMS00OTgxNg_0dfe3d1b-3225-42dc-bcb1-dff68b4f031b"
      unitRef="usd">23222000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2096aeabf3b946a5875461aa88d4cb20_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfMy03LTEtMS00OTgxNg_6ce60adc-707c-4194-8d28-eebd47393466"
      unitRef="usd">22852000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic7556e9945944bb4963819871e859b10_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNC0xLTEtMS00OTgxNg_f8ea6688-72c7-4720-b4a4-450664b13ab0"
      unitRef="usd">2028000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaea4ef3b62d94312a30b3961e15b1c2d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNC0zLTEtMS00OTgxNg_0601be1f-814c-4c5f-993d-1f31c340e098"
      unitRef="usd">2421000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a807fb830ff454bb7a40d98e23ead88_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNC01LTEtMS00OTgxNg_ee71d76f-a7b7-4bba-894a-d4a63e0ba3c3"
      unitRef="usd">6211000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i813d7c4c38564599a7261dd61b7d10e1_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNC03LTEtMS00OTgxNg_288bb5e6-03e9-4d78-aa69-117e678d8529"
      unitRef="usd">6104000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41aa40e6f7734a11a5ad5d91444e8c71_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNS0xLTEtMS00OTgxNg_e9a4d6c2-d5be-4f02-90cb-e65729861bd3"
      unitRef="usd">9610000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i640dece72c8d481a9e06ebab15977c75_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNS0zLTEtMS00OTgxNg_83f8a591-e9fd-4047-8d57-852c346e055c"
      unitRef="usd">11514000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d5f1ae0ab8b4decbba471d9add02a71_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNS01LTEtMS00OTgxNg_86e3d74c-1522-4107-8b7b-f2587f067ccc"
      unitRef="usd">29433000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i901b43193e044942b699fb8fadfb9534_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOjkxMWJkYTE3ZjA5NTQ0MTBiNGY1NjIyZTBlZjRiOGY4L3RhYmxlcmFuZ2U6OTExYmRhMTdmMDk1NDQxMGI0ZjU2MjJlMGVmNGI4ZjhfNS03LTEtMS00OTgxNg_7c466db3-129d-4927-97de-2d7b586d5e8d"
      unitRef="usd">28956000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:CollaborationArrangementCommissionFeePortionOfGrossProceedsValue
      contextRef="i9972fe6d5f2b42c89d347449caf70272_D20210101-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDg2NQ_01404d89-8c3c-458e-828c-b1146bcb7cd7"
      unitRef="usd">1500000</sgmo:CollaborationArrangementCommissionFeePortionOfGrossProceedsValue>
    <sgmo:CollaborativeAgreementPercentOfInitialRecognition
      contextRef="iba431dc7b3114e9492531e7e49f27982_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDk0Ng_0200d5ea-c38d-462e-87f0-872c87a10746"
      unitRef="number">0.02</sgmo:CollaborativeAgreementPercentOfInitialRecognition>
    <us-gaap:ProceedsFromCollaborators
      contextRef="id24858a277a44f918d47646294044411_D20200801-20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNDk1Mg_36fa0908-2021-43ee-bb61-66c0eacf5959"
      unitRef="usd">75000000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:CapitalizedContractCostGross
      contextRef="i714565e5ccc14fd6ad101d485a5a8de6_I20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY2NzM2OQ_fd5b5b82-30bc-45e3-813a-0df24cbb9009"
      unitRef="usd">1500000</us-gaap:CapitalizedContractCostGross>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i449866dd2b4e4cbca1f5dbb0c02df99b_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNTQzNA_6d0be332-2fe1-4460-97cf-eaa210d87ec3"
      unitRef="usd">200000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i3ace65935fd74827a8e79d81a8c99883_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNTQ0MQ_9617ccc7-33e5-4d47-9a38-50c2bd509a58"
      unitRef="usd">500000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="iae8fae1af4ab4d9a8c4829058c9e5f83_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNTQ5Mw_d5481f95-5bf1-4cae-b059-73eb3223dbfa"
      unitRef="usd">200000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i7f1b352df962492a825bd38db79c1fa8_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNTUwMA_f5fc4624-a5ea-4455-a39a-459d5c1e72b1"
      unitRef="usd">500000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjE5MQ_d90d4b2b-ad80-423a-88a2-e7d4f166dff4"
      unitRef="shares">24420157</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i68d24c5b8cee46749f97407c43bed757_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjI3OA_94e87657-bef3-4716-b8c2-33a9a609b004"
      unitRef="usdPerShare">9.2137</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjMzMQ_14ac6751-47b3-4462-a616-2b9f07160882"
      unitRef="usd">225000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjU5OQ_979d5854-d3a3-49da-974a-40687419e3fa"
      unitRef="usd">225000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ProceedsFromCollaborators
      contextRef="ica4b8016d6044abd95e91f31762196db_D20200501-20200531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjcyNg_beff9825-caca-4ebb-8fd7-f374142091c2"
      unitRef="usd">125000000</us-gaap:ProceedsFromCollaborators>
    <sgmo:CollaborativeArrangementMaximumMilestonePaymentReceivable
      contextRef="iebf44488500c4b588b4bdf5563a4334a_I20200430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNjg4Nw_2fdfd4d8-ca64-4a64-8d95-3920877a60e7"
      unitRef="usd">2400000000</sgmo:CollaborativeArrangementMaximumMilestonePaymentReceivable>
    <sgmo:CollaborativeArrangementMaximumMilestonePaymentReceivable
      contextRef="ie47b011a38824aa1aaad584fadb9ebba_I20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNzA1MA_9693d792-d013-4582-ae73-2bf347a51890"
      unitRef="usd">925000000</sgmo:CollaborativeArrangementMaximumMilestonePaymentReceivable>
    <sgmo:CollaborativeArrangementMaximumMilestonePaymentReceivable
      contextRef="i2cf72a2afc0847f7a0aa31702eac099e_I20200430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfNzA5OA_efcb0786-10d4-4cf5-b129-8fa694a9366d"
      unitRef="usd">1500000000</sgmo:CollaborativeArrangementMaximumMilestonePaymentReceivable>
    <sgmo:CollaborationAgreementNumberOfAdditionalProductTargets
      contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY5OTAzMA_cd73cb5c-e872-4db3-b5e0-5d565b928c0b"
      unitRef="product_target">7</sgmo:CollaborationAgreementNumberOfAdditionalProductTargets>
    <sgmo:CollaborationAgreementRemainingPeriod
      contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfODIyNQ_43b2c951-d6ae-4f82-96e9-3b37630199cc">P5Y</sgmo:CollaborationAgreementRemainingPeriod>
    <sgmo:CollaborativeArrangementNumberOfProductTargetsSelected
      contextRef="iebf44488500c4b588b4bdf5563a4334a_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfODgxMA_313e7085-d1e5-4ca6-a852-a93a8fc9e887"
      unitRef="product_target">3</sgmo:CollaborativeArrangementNumberOfProductTargetsSelected>
    <sgmo:CollaborativeArrangementNumberOfProductTargetsSelected
      contextRef="iebf44488500c4b588b4bdf5563a4334a_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfOTA2MQ_1931e15f-ee1b-4075-a694-8caaff60e84c"
      unitRef="product_target">3</sgmo:CollaborativeArrangementNumberOfProductTargetsSelected>
    <sgmo:CollaborationArrangementResearchPeriod
      contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfOTE3Mg_41f1a42e-bd18-4086-aed3-3a827f32a5c6">P7Y</sgmo:CollaborationArrangementResearchPeriod>
    <sgmo:CollaborativeArrangementMaximumNumberOfProductTargetsToReplace
      contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfOTgwNA_06edcd19-5832-442a-9be8-2ac19d0abc8b"
      unitRef="product_target">10</sgmo:CollaborativeArrangementMaximumNumberOfProductTargetsToReplace>
    <sgmo:CollaborativeArrangementStandstillRestrictionPeriod
      contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNTM_3250c4ef-dfac-40b2-b8c8-e1b6e70dc644">P3Y</sgmo:CollaborativeArrangementStandstillRestrictionPeriod>
    <sgmo:CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage
      contextRef="i68d24c5b8cee46749f97407c43bed757_I20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA3Njg_f1f8438c-16f7-4bbf-8223-b65d14ceaed7"
      unitRef="number">0.05</sgmo:CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage>
    <sgmo:CollaborativeArrangementTransactionPrice
      contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5NjI_1247673c-9561-4cac-b5bf-09c4ea7f0d9c"
      unitRef="usd">204600000</sgmo:CollaborativeArrangementTransactionPrice>
    <us-gaap:ProceedsFromCollaborators
      contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTEwMDE_2b6d6e33-cc91-4ec4-a8dc-163fbc09c4e1"
      unitRef="usd">125000000</us-gaap:ProceedsFromCollaborators>
    <sgmo:SaleOfStockExcessConsiderationReceivedOnTransaction
      contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTEwNjA_a316392c-c771-4fc6-881d-6362d8509f45"
      unitRef="usd">79600000</sgmo:SaleOfStockExcessConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTExMDg_7fe77ca2-5069-4c6f-82d1-f72e3e4eb462"
      unitRef="usd">225000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <sgmo:CollaborationAgreementEquityIssued
      contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTExNjY_5b4b8f83-8889-4a8f-99e1-53f8b597b738"
      unitRef="usd">145400000</sgmo:CollaborationAgreementEquityIssued>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if44d955f3cee4094a3a0cecf75e1cd02_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTMxODI_679ccb3d-0410-48c6-809e-ac81a3022cad"
      unitRef="usd">1700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i70a681d5c2fc43359fac6166d3c7b02b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTMxODk_00219145-ddd1-4b49-a4e9-20c034cda9e3"
      unitRef="usd">2800000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="if44d955f3cee4094a3a0cecf75e1cd02_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTMyMzE_6e4bfdd7-b0bd-449b-b44a-f6d5e99800ea"
      unitRef="usd">132100000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i70a681d5c2fc43359fac6166d3c7b02b_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTMyMzg_34d3e3f2-e1bb-4793-95f4-db6b1391da22"
      unitRef="usd">154000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
      contextRef="if0601be924aa4f1fad543351bdf06b1f_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNDk_0dc6f46c-743a-4ece-ba2a-9d888e9be114">&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Biogen agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of license and stand-ready fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58dad48ada774420bb627b6373806b63_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfMy0xLTEtMS00OTgxNg_e0dcfe9c-8a70-4f55-b320-148a64e1b0c2"
      unitRef="usd">7306000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3567ee8e981a4805b1614fbb6249f324_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfMy0zLTEtMS00OTgxNg_6f9e9930-188a-47d0-9b8e-acd590ed0186"
      unitRef="usd">7306000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12d66cce985941ffa95915f401661188_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfMy01LTEtMS00OTgxNg_707908ba-5fba-467d-b4ac-ef2555837ed4"
      unitRef="usd">21918000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd568c62528c418d98ba3506620059b3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfMy03LTEtMS00OTgxNg_d99c7b23-161f-458a-a768-291c02c76843"
      unitRef="usd">21918000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib95c66db249d457f8c5145b0b4180e59_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNC0xLTEtMS00OTgxNg_28439830-2d16-4f85-8c62-c400408faec0"
      unitRef="usd">2107000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia893d1f21e7e4bfc9e693b7773c6ebb3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNC0zLTEtMS00OTgxNg_bda4047f-d430-4acf-a14b-9b4cf3771fbc"
      unitRef="usd">3661000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i582600df1f494eeba31d6db660f24309_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNC01LTEtMS00OTgxNg_b42746ba-3266-4e93-b2a9-24a3d4e928e7"
      unitRef="usd">8740000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i107234bf3c2c4164845bafb59e087b2b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNC03LTEtMS00OTgxNg_a197704e-ef59-46b0-a9a9-fb62bd578e10"
      unitRef="usd">10266000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i84f278d0f27941ff887205574efe505f_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNS0xLTEtMS00OTgxNg_71cfb14c-935f-423a-aa30-b8a516a800b8"
      unitRef="usd">9413000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i640710eb43bb446395030cf119393d5e_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNS0zLTEtMS00OTgxNg_3646d2a4-d09d-4967-a1db-1b12538ebe33"
      unitRef="usd">10967000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if0601be924aa4f1fad543351bdf06b1f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNS01LTEtMS00OTgxNg_7f04bb0b-1396-4f7b-9afb-e71e9a530047"
      unitRef="usd">30658000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbafd7f9191749e7a6078d50d26cff6d_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmYyZGFiMjA3NDE1NDQ3YjJhMzcyZGNmZDFhOTRjNjc4L3RhYmxlcmFuZ2U6ZjJkYWIyMDc0MTU0NDdiMmEzNzJkY2ZkMWE5NGM2NzhfNS03LTEtMS00OTgxNg_d4f22343-5cae-4269-b040-9b73d23b7afb"
      unitRef="usd">32184000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:CollaborationArrangementCommissionFeePortionOfGrossProceedsValue
      contextRef="ieeedce2ee3f2443aa731e0a0727b79bb_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTMzNzU_b3c45a90-9811-4675-a2a9-eabe9e7eab20"
      unitRef="usd">7000000</sgmo:CollaborationArrangementCommissionFeePortionOfGrossProceedsValue>
    <sgmo:CollaborativeAgreementPercentOfInitialRecognition
      contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM0NTY_f4c86d73-bbc8-4e75-853f-f19abccc01ca"
      unitRef="number">0.02</sgmo:CollaborativeAgreementPercentOfInitialRecognition>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM0NjI_7fe77ca2-5069-4c6f-82d1-f72e3e4eb462"
      unitRef="usd">225000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <sgmo:CollaborativeAgreementPercentOfInitialRecognition
      contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM1MDE_a6b26aae-a7fd-48e3-b7eb-88699e5199aa"
      unitRef="number">0.02</sgmo:CollaborativeAgreementPercentOfInitialRecognition>
    <us-gaap:ProceedsFromCollaborators
      contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM1MDc_2b6d6e33-cc91-4ec4-a8dc-163fbc09c4e1"
      unitRef="usd">125000000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i3e70aff9076046b0a8a267498a58548b_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM4MTY_3075de4b-0e59-4cd2-9650-f0cdd5e2122e"
      unitRef="usd">4100000</us-gaap:ContractWithCustomerAssetNet>
    <sgmo:CollaborativeAgreementPercentOfInitialRecognition
      contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM4Mzc_cdcf0d94-7e6a-445d-b6d8-5505a19e7aff"
      unitRef="number">0.02</sgmo:CollaborativeAgreementPercentOfInitialRecognition>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTM4Njg_55f63adb-d9c3-4f3b-b8b5-f5c93dc5fda3"
      unitRef="usd">204600000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i8ffaaa021478445aadfabd4cf2b1cd40_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQxMDQ_75869793-364c-4f5a-91ca-185c2633b95f"
      unitRef="usd">100000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i656cc305a9864393800b99c4084fc3be_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQxMTE_04a5fb53-abfb-4f92-bb9b-13277f65c075"
      unitRef="usd">400000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="i26b2aa0ee0524b8e9864406fc3e47991_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQxNjM_38aa6aca-62c1-4634-8f30-0049e8affeed"
      unitRef="usd">100000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:CostOfGoodsAndServicesSoldAmortization
      contextRef="if93a6d1fdbb248ec8aa3ad0a3d16700d_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQxNzA_8579aa3f-169c-4d7a-9a27-6dff24d90cde"
      unitRef="usd">400000</us-gaap:CostOfGoodsAndServicesSoldAmortization>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="i33a718c16a224765bbf657e25d2f612a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQyNDE_560e83c6-e4a0-47df-978a-e07ebc196166"
      unitRef="usd">2900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <sgmo:CollaborativeAgreementPercentOfInitialRecognition
      contextRef="iec4c90ea7012463594f1ff515a8b2ff5_D20200401-20200430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQyNjM_a91becd3-0a89-45b0-9f20-122bc04a697a"
      unitRef="number">0.02</sgmo:CollaborativeAgreementPercentOfInitialRecognition>
    <sgmo:CollaborationAgreementEquityIssued
      contextRef="if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTQyNzM_5b4b8f83-8889-4a8f-99e1-53f8b597b738"
      unitRef="usd">145400000</sgmo:CollaborationAgreementEquityIssued>
    <sgmo:MilestonePaymentsReceived
      contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTY2MzI_83459b4e-60dc-4ce1-9fbb-d19cfbdee8c8"
      unitRef="usd">150000000</sgmo:MilestonePaymentsReceived>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive
      contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTY4NzU_d60daa70-7729-444a-b84f-48ce3fcf66f1"
      unitRef="usd">3000000000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived
      contextRef="i9ff2b470a6b840b1b600226ae0cb70ef_D20180401-20180430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTY5ODU_9bf8fbec-5157-4eb1-a6bc-317854ed60d3"
      unitRef="usd">1300000000</sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived>
    <sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived
      contextRef="i65b35c689bc646deaec17d1a4a06e1ae_D20180401-20180430"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTcxMjc_9cc6df15-93c5-4f37-bf7f-3c1a2bfa5522"
      unitRef="usd">1800000000</sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived>
    <sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment
      contextRef="i65b35c689bc646deaec17d1a4a06e1ae_D20180401-20180430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTc1MDg_4c8e9f91-7817-4173-a9c1-2d6baa490ab1"
      unitRef="milestone">10</sgmo:ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment>
    <sgmo:InitialResearchTermOfAgreement
      contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTgwODE_427d1b6a-cafd-40ca-85d0-96d0a32a8c99">P6Y</sgmo:InitialResearchTermOfAgreement>
    <sgmo:NumberOfOptionsToExtendInitialResearchTerm
      contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTgxNjY_ac628a26-2dbc-4e6d-bcd3-17873cdec799"
      unitRef="option">2</sgmo:NumberOfOptionsToExtendInitialResearchTerm>
    <sgmo:ExtendedResearchTermOfAgreement
      contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNTA_a621c4e6-31d4-40a0-82e6-68595e0b003f">P1Y</sgmo:ExtendedResearchTermOfAgreement>
    <sgmo:SeparateUpfrontFee
      contextRef="ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTgyMjY_a573e600-b6c4-4e11-9ad9-efc29d068135"
      unitRef="usd">10000000</sgmo:SeparateUpfrontFee>
    <sgmo:CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan
      contextRef="i93c77ad66a244121b7e7c0650a102466_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTg1Mzk_dcfd5a40-db2e-41a9-922e-664b00e3a083"
      unitRef="usd">3400000</sgmo:CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan>
    <sgmo:CollaborativeArrangementTransactionPrice
      contextRef="i93c77ad66a244121b7e7c0650a102466_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTg2Njc_2b48d601-03e0-4039-bb87-1c422fb9e085"
      unitRef="usd">189300000</sgmo:CollaborativeArrangementTransactionPrice>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="i93c77ad66a244121b7e7c0650a102466_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTg3MTA_48f37156-77ce-459f-8e5c-bc9be4f52d7e"
      unitRef="usd">150000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts
      contextRef="i93c77ad66a244121b7e7c0650a102466_D20190901-20190930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTg3MTc_af228502-cf10-4344-a249-1890ac021166"
      unitRef="usd">39300000</sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib2565b2e5ab3411d909ba058b98e784d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjEyMTA_242382b0-c501-4ec6-9f0b-4c91a00e3c65"
      unitRef="usd">600000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4f9193d162614c82aefef0bd29f76cb0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjEyMTc_02e1871e-fea9-4c85-b37c-bdca1020dfeb"
      unitRef="usd">100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ib2565b2e5ab3411d909ba058b98e784d_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjEyNTk_5e2b0575-513e-4971-a39b-cdbe11c74c90"
      unitRef="usd">37800000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i4f9193d162614c82aefef0bd29f76cb0_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjEyNjY_20ac7057-72e2-4bc9-85e7-e7b57ceb66cc"
      unitRef="usd">56500000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
      contextRef="i08b40673b5374b688d69a9f30889e26b_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNDY_b5efebf6-8d2c-436d-a683-6818c102b8dc">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the agreement were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Kite agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of license and stand-ready fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i283bbba7da5c491abef1b46ddd866d80_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfMy0xLTEtMS00OTgxNg_272b0959-e131-4a25-beec-2ca5a26ebec9"
      unitRef="usd">6296000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb5cc7c162fc4f9f8aae9712c9c2186c_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfMy0zLTEtMS00OTgxNg_c5ed28e2-b42f-4bd7-9a73-b04f200fd24c"
      unitRef="usd">6296000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf1383bfc9fb4e4da9138b24f4483085_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfMy01LTEtMS00OTgxNg_982c5931-6af4-4dd6-9974-e140de6dcfec"
      unitRef="usd">18682000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32258af563e84d3eaeffce96590ce4a3_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfMy03LTEtMS00OTgxNg_b98f141c-6856-4166-9542-a9b6801fe248"
      unitRef="usd">18682000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e36b699832646d09fb049651228fc3d_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNC0xLTEtMS00OTgxNg_4f86401a-3469-4080-b91e-bf3e1460be04"
      unitRef="usd">619000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd52871c65e74074b943d036e228c407_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNC0zLTEtMS00OTgxNg_c9b7eed2-16a9-45a8-8d20-4a0d9e5466cb"
      unitRef="usd">113000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc52a7e61b9445fd932586d407d4b4b5_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNC01LTEtMS00OTgxNg_dc6801c2-3fb7-4439-aa09-cc09c3cefcd7"
      unitRef="usd">875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f401a18597344db8bea22b5b529e1fb_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNC03LTEtMS00OTgxNg_9baaf7bd-9a67-43f2-87a2-9ea5409d88cf"
      unitRef="usd">339000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6dd41724bd2c43c49a877cd10c22b362_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNS0xLTEtMS00OTgxNg_5528e514-9599-4020-9c4d-dfc0146fb156"
      unitRef="usd">6915000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if156dd60b13643d49e1714fc2aef31f3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNS0zLTEtMS00OTgxNg_9dfd8871-4152-4fea-a460-5a957b7b6b5e"
      unitRef="usd">6409000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08b40673b5374b688d69a9f30889e26b_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNS01LTEtMS00OTgxNg_b3e6b843-f3a7-40da-a3c5-6f48efc572a1"
      unitRef="usd">19557000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5ee9fe84d52410e95ad3919dcf23692_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM4ZWNlYTNlOTVkNTQ1YmJhYThhZTE2NGFkMWJiN2Y5L3RhYmxlcmFuZ2U6YzhlY2VhM2U5NWQ1NDViYmFhOGFlMTY0YWQxYmI3ZjlfNS03LTEtMS00OTgxNg_f25133e2-7a9a-483e-b89c-32ea3b977ba5"
      unitRef="usd">19021000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:NumberOfResearchProgram
      contextRef="i965c38aa9a1b4725903d0bea5a63f9e5_D20140101-20140131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjE4MDU_39bf789a-88f2-4c58-954d-93a516099def"
      unitRef="program">2</sgmo:NumberOfResearchProgram>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="i965c38aa9a1b4725903d0bea5a63f9e5_D20140101-20140131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjM0MzY_b7e7d63a-58d3-43c5-960e-8f20251e581a"
      unitRef="usd">20000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5f997ce9152448ebb21b42facd1eb60_D20140101-20220628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY5ODY0NA_854312f3-4830-4738-9bc9-fb036f65f243"
      unitRef="usd">13500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement
      contextRef="i710e17ccda8d423c80784fc598352f2f_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjQyODM_a8cb6b69-b2d9-4132-b8e9-84f5af102e76"
      unitRef="product">0</sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement>
    <sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice
      contextRef="i06746c47a09e4d0ebce6f17c639cd75b_D20220101-20220930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjQzMjg_ab7ec20b-7602-4111-ab1d-4de372a26d49"
      unitRef="milestone">0</sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice>
    <sgmo:ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod
      contextRef="i3c1eafcb24464080b10cb25f38311835_D20220906-20220906"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY5ODY1OQ_77582e72-98a5-49a5-b3cc-aedfe7445679">P90D</sgmo:ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod>
    <sgmo:ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate
      contextRef="i3c1eafcb24464080b10cb25f38311835_D20220906-20220906"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY5ODY2OQ_2ea6edf4-3afa-4ef0-b467-fe335c8a2751"
      unitRef="usd">7000000</sgmo:ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate>
    <sgmo:ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate
      contextRef="i3c1eafcb24464080b10cb25f38311835_D20220906-20220906"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTY5ODY4Mw_95cfd6fe-09f7-4b9f-889f-d739f7a015f6"
      unitRef="usd">5300000</sgmo:ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate>
    <sgmo:CollaborativeArrangementTransactionPrice
      contextRef="i5f1f8318a747463abe0b0a5f9f6fbc8a_D20140101-20220628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzc5MA_3a652e4d-0324-4de5-9a6d-7ebbecb814f6"
      unitRef="usd">96300000</sgmo:CollaborativeArrangementTransactionPrice>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="i5f1f8318a747463abe0b0a5f9f6fbc8a_D20140101-20220628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzgwNg_ac0c2eaf-8dff-4657-b663-b52e043725f5"
      unitRef="usd">20000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <sgmo:MilestoneRevenueReceivable
      contextRef="id6da6fc44c004de5a49215fc13d59250_I20220628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzgyMg_377a5fdb-03fc-438f-889c-3664c51eeacf"
      unitRef="usd">13500000</sgmo:MilestoneRevenueReceivable>
    <sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts
      contextRef="i5f1f8318a747463abe0b0a5f9f6fbc8a_D20140101-20220628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzgzOA_3736ff2b-c91b-4616-a338-1018a809119c"
      unitRef="usd">62800000</sgmo:CollaborativeArrangementEstimatedReimbursableServiceCosts>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i905f6dd1d97f41d5aefe0d9f9ce7d481_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzg2OQ_b4d99e54-fb3d-4f75-90d0-54bbb765419d"
      unitRef="usd">0</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i933fae16aba14368bec01366d74236a7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzg2Ng_01a01020-b7c0-4cc1-bfe7-7c4aef570d37"
      unitRef="usd">600000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i905f6dd1d97f41d5aefe0d9f9ce7d481_I20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzg3Nw_93a3fa67-768f-43f9-9a22-7ad2dfa5f4fd"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i933fae16aba14368bec01366d74236a7_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzNzg4NQ_bd112992-6cd4-4eb9-879c-65e30ef3fa6f"
      unitRef="usd">1100000</us-gaap:ContractWithCustomerLiability>
    <sgmo:TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzODE0Ng_986d8fe5-35d5-468a-b880-b3f25a0b6723"
      unitRef="usd">-900000</sgmo:TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense>
    <sgmo:TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjc0ODc3OTEzODE0Ng_f3296816-738a-49b8-9f50-242d457429d4"
      unitRef="usd">-900000</sgmo:TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense>
    <us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock
      contextRef="i710e17ccda8d423c80784fc598352f2f_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkzNDI_abd0a951-32ef-4063-b5d8-e903f6cd4ec6">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues recognized under the 2014 Collaboration Agreement were as follows (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue related to Sanofi agreement:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recognition of upfront fee&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,125)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(692)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Milestone achievement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(467)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c81a778afcc46f38bd393eb5ffba599_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfMy0xLTEtMS00OTgxNg_215ac026-bbbd-46fc-b609-8f65ec071227"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i202d58a6a58d4af08b477d923ae048f3_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfMy0zLTEtMS00OTgxNg_360b8c28-9fb2-425a-8929-93f50cd111ee"
      unitRef="usd">-1125000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66cdb12a800d4879bf0c3f1766fa88fd_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfMy01LTEtMS00OTgxNg_b776a239-7caa-483c-9fa6-d40952da8381"
      unitRef="usd">677000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i892bdf3ab2944fb4b7a953ffd1c2f6d7_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfMy03LTEtMS00OTgxNg_27dc6048-522c-45a8-92ab-a56075810795"
      unitRef="usd">-692000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17f9d36d461f448483df1b1e4e3a01f0_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNC0xLTEtMS00OTgxNg_18cc43d3-18f3-4a85-9ac7-eab097517671"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i140d27fd2160489db7ee0eb0978a4d9a_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNC0zLTEtMS00OTgxNg_f10fc074-b1c8-4df4-bd9f-ddfb792da62a"
      unitRef="usd">1125000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i724bc4b7322a4e759c114bb5082bfdac_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNC01LTEtMS00OTgxNg_a5e27dc3-8aad-4122-9d00-18547ae03130"
      unitRef="usd">2126000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i364d22703c4f4fb590d565ce2c24609b_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNC03LTEtMS00OTgxNg_31b79235-5abb-419b-85fd-520f07a085ee"
      unitRef="usd">2417000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6a265c8ac4e49de84028acd0fb40413_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNS0xLTEtMS00OTgxNg_334147e6-8976-441d-88bd-98ae85bb1484"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id79ab6aa736f4dcb9f4f3a8b1435949d_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNS0zLTEtMS00OTgxNg_1e25b857-4c4b-4ee6-a444-65705b9c9c10"
      unitRef="usd">-759000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09c51fb74c4c492ab74e416789db7c1c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNS01LTEtMS00OTgxNg_e523a8f8-b854-4c7e-89fc-4bf57012d051"
      unitRef="usd">457000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5e292264aa1455f8199ac9bf6f10164_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNS03LTEtMS00OTgxNg_b36ad258-9f7f-443c-bd89-da794969d75a"
      unitRef="usd">-467000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a5d588119f04333847cb581fb37eb61_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNi0xLTEtMS00OTgxNg_863dfadf-ac2a-43a4-af49-3f1407f77a88"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf6145619fea4fa78fa9c0bab78ebb20_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNi0zLTEtMS00OTgxNg_5b6f7010-9b12-4cc9-b260-9b937144910e"
      unitRef="usd">-759000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i710e17ccda8d423c80784fc598352f2f_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNi01LTEtMS00OTgxNg_a072d0a4-2176-463e-a2b0-126a75b86712"
      unitRef="usd">3260000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id45979bc9fd7456cb09006afb528134e_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RhYmxlOmM0MTJlZjhiNzhkODRlYmY5YjYwZmM2YTg1NzAyNTM5L3RhYmxlcmFuZ2U6YzQxMmVmOGI3OGQ4NGViZjliNjBmYzZhODU3MDI1MzlfNi03LTEtMS00OTgxNg_74957484-a78e-477d-95bb-653478ebf693"
      unitRef="usd">1258000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDM5MA_0cbda428-76ca-499b-8c8a-f8985d15ce7c"
      unitRef="usd">-2500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDM5MA_975a970b-1938-4c97-aa83-8b8469399bbe"
      unitRef="usd">-2500000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ProfitLoss
      contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQwNA_83bbbf8c-1948-45fb-ae3a-0dc3761ed039"
      unitRef="usd">-2500000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQwNA_a1411571-06d4-410f-a868-a45f59dd5a42"
      unitRef="usd">-2500000</us-gaap:ProfitLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQxOA_20bac8dd-38ec-4032-a981-ae0a97a91dbd"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQxOA_2356b970-ad71-4a97-abb3-ae275d5e1f50"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic55b190bc0d34686b2681d10937e9eb1_D20210701-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQxOA_4bbee16f-af35-4799-b259-a0551d9f2cc4"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i003343a2fdb34b08a9d96e9c0d3f0d9f_D20210101-20210930"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMTA5OTUxMTcwMDQxOA_aa2f89ab-4e0b-49e8-b47c-b53915a78679"
      unitRef="usdPerShare">0.02</us-gaap:EarningsPerShareDiluted>
    <sgmo:AgreementTerminationTerm
      contextRef="ifda78d9bb9e34007aba808bc57d3ccc7_D20170501-20170531"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjg3MDA_b56b6461-6099-45f8-898e-da813108b600">P15Y</sgmo:AgreementTerminationTerm>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="ia67b43e22836459ca0c85db6bf587fa9_D20170501-20170531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjk2MjE_52e398c8-ca2c-40d8-846f-3c582256b703"
      unitRef="usd">70000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive
      contextRef="ie097ba41160242b7b938ec9f67d75616_D20170501-20170531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjk2NTc_4a9052da-7312-4cc9-8914-3177e26c6807"
      unitRef="usd">208500000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive
      contextRef="ia67b43e22836459ca0c85db6bf587fa9_D20170501-20170531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMjk3ODY_e856cbf4-aa4c-4096-9ae0-d072dc244c28"
      unitRef="usd">266500000</sgmo:AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive
      contextRef="ie76c5aed7b74477aa60d84886d741c43_D20170501-20170531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzAxMTU_868782b4-eb68-4a7b-b611-879fc40aa847"
      unitRef="usd">475000000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:MilestoneRevenueReceivable
      contextRef="ic34e88035a5f4bb08ff13aeb0beabca8_I20170531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzAxNDA_c7036b63-1dfd-4bba-bfad-bbd7bcef27ff"
      unitRef="usd">300000000</sgmo:MilestoneRevenueReceivable>
    <sgmo:MilestoneRevenueReceivable
      contextRef="i9451d2ff95384408bb974670f4956acd_I20170531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzAxODU_86cdcd4c-e3dd-4952-b62f-6a36669638a7"
      unitRef="usd">175000000</sgmo:MilestoneRevenueReceivable>
    <sgmo:CollaborativeArrangementNumberOfMilestonesAchieved
      contextRef="iacfe2b36ef12408dba96a7eca579c6e3_D20170501-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzA3NjQ_e096051f-2808-46d0-8991-8c219dee4bd4"
      unitRef="milestone">2</sgmo:CollaborativeArrangementNumberOfMilestonesAchieved>
    <sgmo:MilestonePaymentsReceived
      contextRef="iacfe2b36ef12408dba96a7eca579c6e3_D20170501-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzA3ODE_3bf7214e-b5f8-415c-9bc4-0089b4ae54aa"
      unitRef="usd">55000000</sgmo:MilestonePaymentsReceived>
    <sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement
      contextRef="iacfe2b36ef12408dba96a7eca579c6e3_D20170501-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzA4MzQ_a3b61ebb-9fe1-4298-b59f-5f37986057c0"
      unitRef="product">0</sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement>
    <sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice
      contextRef="i1a0335905c59449b887401672756abb9_D20171201-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzA4Nzk_bef39069-4783-44c3-b782-c7cf008c8b2c"
      unitRef="milestone">0</sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice>
    <sgmo:CollaborativeArrangementTransactionPrice
      contextRef="i1a587603a6dc495fb68564a49c608c3b_D20170501-20170531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzExMDc_fe94f745-a94c-47a0-843c-d6a2ffa212a3"
      unitRef="usd">134000000</sgmo:CollaborativeArrangementTransactionPrice>
    <sgmo:CollaborativeArrangementResearchServiceFees
      contextRef="i1a587603a6dc495fb68564a49c608c3b_D20170501-20170531"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzExNzU_9a03477d-6027-44dd-a7a3-f54a3ce8e6af"
      unitRef="usd">79000000</sgmo:CollaborativeArrangementResearchServiceFees>
    <sgmo:CollaborativeArrangementNumberOfMilestonesAchieved
      contextRef="iacfe2b36ef12408dba96a7eca579c6e3_D20170501-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzExOTg_054b971b-a59a-47d5-87c3-560b56496ed6"
      unitRef="milestone">2</sgmo:CollaborativeArrangementNumberOfMilestonesAchieved>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="ie6cc5e9855b44daa88a4b942b38da8a3_D20170501-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzEyNDc_34830376-7c75-45e6-81d1-47c1c2b5d160"
      unitRef="usd">55000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c3303f9b2c441e4a8661c7063d97b4f_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzMwODU_08a861c2-0f7b-433b-bbeb-fef7300042e3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i35335210865a4d9fb1acf14e87a58341_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzMwODU_5fbe5e4f-3dff-4ea7-a09f-492e794c8164"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f5fbe525ac74562ac7d8942cd031794_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzMwODU_61298169-9434-4b8f-ac3d-e5de62296508"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67383e30f21c4630a881224c8ec6917b_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzMwODU_83a9d5a7-5e26-432e-9cde-caa80033dad9"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <sgmo:AgreementTerminationTerm
      contextRef="ied5371b887eb4e1ba5e63238f1af294c_D20171201-20171231"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzQ1ODc_b3cf7f65-a035-4d3e-9fbe-e12174d24427">P15Y</sgmo:AgreementTerminationTerm>
    <sgmo:MilestonePaymentsReceived
      contextRef="ied5371b887eb4e1ba5e63238f1af294c_D20171201-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzYyODE_e68381bc-1c6c-4408-a0d9-3c2eeef0c664"
      unitRef="usd">12000000</sgmo:MilestonePaymentsReceived>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive
      contextRef="i807e40274d2e4fa68fb97fd8f56732c0_D20171201-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzYzNDU_93949f01-480c-4447-8fb2-3f3b5d088e86"
      unitRef="usd">60000000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive
      contextRef="i49341b6dd59f4dcb8dc3e02283b1a9a0_D20171201-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzY1MzE_50e93196-c111-4462-b8fa-322a0a1c58d8"
      unitRef="usd">90000000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <sgmo:MilestonePaymentsReceived
      contextRef="i95d5384d7d794ed1b248fe403cff0f12_D20171201-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzcyODE_287fe07e-605a-4ab3-94db-9ac133a75702"
      unitRef="usd">5000000</sgmo:MilestonePaymentsReceived>
    <sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement
      contextRef="i95d5384d7d794ed1b248fe403cff0f12_D20171201-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzczMjA_1a4b7ec7-9d07-4d83-9f76-2fc547c881f9"
      unitRef="product">0</sgmo:CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement>
    <sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice
      contextRef="i95d5384d7d794ed1b248fe403cff0f12_D20171201-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzczNjU_355fe55b-73d9-4abd-9d1c-588f712eeb38"
      unitRef="milestone">0</sgmo:NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice>
    <sgmo:CollaborativeArrangementTransactionPrice
      contextRef="i309018fee1874efc81946dbe7c82f131_D20171201-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzc2MzE_b25a0564-0ee9-4861-afe1-e650b35ff239"
      unitRef="usd">17000000</sgmo:CollaborativeArrangementTransactionPrice>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="i5c18ff8ca01c40e78481b76d8fe6dda0_D20171201-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzc2NzM_d1df3f2f-ce0d-4d6a-bd82-c4f1a89a1739"
      unitRef="usd">12000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="i309018fee1874efc81946dbe7c82f131_D20171201-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzc3NDI_a9af79cd-edac-47d2-932e-42d350d425c7"
      unitRef="usd">5000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive
      contextRef="i92faa1298286405e93c727411f0747bf_D20200901-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkwNTE_a5167599-694b-4a4c-b1ea-820031de5906"
      unitRef="usd">5000000</sgmo:CustomerContractLiabilityMilestonePaymentEligibleToReceive>
    <us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
      contextRef="i7de837b09974499ab74e3907f4da3664_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkwNTE_e251a10d-96d3-4a27-ae56-ac2fbc25acea"
      unitRef="usd">5000000</us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9394094054442f383751ceedfd5a981_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkyNzE_420b903c-0778-4adf-acb5-ab20bd856d47"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfffef1418344eb7a8831ffe392e5e22_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkyNzE_be96ba25-01ad-4cfb-b8df-0ed992f70f38"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd20bbfeb147419cb5f8dc6db4ca9849_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkyNzE_d9443205-bee4-4e52-9d12-42796af30b91"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56dd64461cdc41a29f9de3b35af516dd_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81NS9mcmFnOjRmZGU5MzA2NTk3NDQ4YTJhNTQ4OWNlNDQzZmU4ZTBkL3RleHRyZWdpb246NGZkZTkzMDY1OTc0NDhhMmE1NDg5Y2U0NDNmZThlMGRfMzkyNzE_f4430324-5549-4915-a189-72f930bf427f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RleHRyZWdpb246ODhjNDUyOThhNjBhNDU1N2E3MDIyNjc1ZTQ5MGRiMWNfMTgy_c209746a-ea6b-4d73-96db-adf2844dbba4">STOCK-BASED COMPENSATION&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows total stock-based compensation expense included in the Condensed Consolidated Statements of Operations (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RleHRyZWdpb246ODhjNDUyOThhNjBhNDU1N2E3MDIyNjc1ZTQ5MGRiMWNfMTgz_ebd37058-8815-42c8-9d48-744bbef75b94">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows total stock-based compensation expense included in the Condensed Consolidated Statements of Operations (in thousands):&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="id4198818716d4a5982ff62c84d98fc2b_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMi0xLTEtMS00OTgxNg_cd66e1b9-7f4b-43a4-a63b-91a2177bed08"
      unitRef="usd">4395000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i398e9284c1254e7fa5e4faf15172c220_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMi0zLTEtMS00OTgxNg_6992048a-e349-4158-b8d4-9fc040d71026"
      unitRef="usd">4935000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2ee803986f614d5eb89d119dfc27ff5c_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMi01LTEtMS00OTgxNg_c99d68c9-a2c0-4165-b215-a0d612ac5fb7"
      unitRef="usd">13656000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifcb87a6bcfe548619d4c435b6326cad8_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMi03LTEtMS00OTgxNg_607e4d69-4966-4c85-bca3-b56136b1d47c"
      unitRef="usd">14645000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibf9d9769367043dcbd6120a50e2504a5_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMy0xLTEtMS00OTgxNg_964aea02-1ae3-4f87-8d06-4d97c229d8a2"
      unitRef="usd">3398000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ida843af1fb12494eabfc5378c6f08828_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMy0zLTEtMS00OTgxNg_f23bfdda-df97-4d91-b95b-ccaedabbc429"
      unitRef="usd">2938000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7cffbe21ee8340aab6d270389c188838_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMy01LTEtMS00OTgxNg_a997431e-d8ee-4cf7-aec7-008d323a9864"
      unitRef="usd">9746000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib4685841a6f74d2e879fd6085f56e095_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfMy03LTEtMS00OTgxNg_19fbe9df-fb7b-41eb-8cd2-d3b2963ea6f1"
      unitRef="usd">10235000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfNC0xLTEtMS00OTgxNg_70f949fe-5c19-4f7f-9418-f6c721ffd90d"
      unitRef="usd">7793000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfNC0zLTEtMS00OTgxNg_10760971-c83f-4dbe-a927-8f2249485c2b"
      unitRef="usd">7873000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfNC01LTEtMS00OTgxNg_551a6a4b-b887-4fcc-90b3-4c36897a9684"
      unitRef="usd">23402000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF81OC9mcmFnOjg4YzQ1Mjk4YTYwYTQ1NTdhNzAyMjY3NWU0OTBkYjFjL3RhYmxlOmU0M2YyYjhjMTkwYjQ2MTQ5ODMxM2E0NWZmZDM1MWEwL3RhYmxlcmFuZ2U6ZTQzZjJiOGMxOTBiNDYxNDk4MzEzYTQ1ZmZkMzUxYTBfNC03LTEtMS00OTgxNg_af5f99de-de01-415e-b2e2-6edc0e444333"
      unitRef="usd">24880000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfMTE0NA_b059efd3-45a6-494a-9d32-a6200c4efe8c">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-top:9pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;At-the-Market Offering Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the Company entered into an Open Market Sale Agreement&#x2120; with Jefferies LLC (&#x201c;Jefferies&#x201d;) with respect to an at-the-market offering program under which the Company may offer and sell, from time to time at its sole discretion, shares of the Company&#x2019;s common stock having an aggregate offering price of up to $150.0&#160;million through Jefferies as the Company&#x2019;s sales agent or principal. The Company is not obligated to sell any shares under the sales agreement. During the three and nine months ended September&#160;30, 2022, the Company sold 8,483,104 and 14,711,770 shares of its common stock for net proceeds of approximately $42.2&#160;million and $66.4&#160;million, respectively, of which approximately $0.6&#160;million was received in October 2022 and recorded within prepaid expenses and other current assets on the Company&#x2019;s Condensed Consolidated Balance Sheet as of September&#160;30, 2022. During the three and nine months ended September&#160;30, 2021, the Company sold 202,705 and 2,007,932 shares of its common stock for net proceeds of approximately $2.4&#160;million, and $27.1&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <sgmo:StockOfferingProgramMaximumValue
      contextRef="i6787fd385b854be098bb92baa474ae00_D20200801-20200831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfMzg4_745970a3-60dc-4f3f-975a-6febbbfe0540"
      unitRef="usd">150000000</sgmo:StockOfferingProgramMaximumValue>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="idcc3055e11a04301bd4380530c45310f_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfNTc1_e0ecb10f-1e8c-4f1b-aa54-d00da386d654"
      unitRef="shares">8483104</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i99aed81b84ae4da8ac317dfc988149a4_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfMjc0ODc3OTA3MTAxNQ_65b233b3-b49a-4d1d-8867-f28e486b40c1"
      unitRef="shares">14711770</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="idcc3055e11a04301bd4380530c45310f_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfNjM5_7735ab33-aa07-4ff4-becd-ee9b0c92b3c5"
      unitRef="usd">42200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i99aed81b84ae4da8ac317dfc988149a4_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfMjc0ODc3OTA3MTAxOQ_5417a4cc-aa82-459f-888c-445e19d92272"
      unitRef="usd">66400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i06ce069112274b73a381a623267ad36b_D20221001-20221031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfNjY2_80add8ff-8751-4708-a995-9ba09769a19a"
      unitRef="usd">600000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="ie3f90dae3d5d49c094e3925ff3e04933_D20210701-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfODY5_5eb311a4-68f9-4150-846a-aa7d7b69d6a1"
      unitRef="shares">202705</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i9b3959b3e8964e39a6463ae8b22b489b_D20210101-20210930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfODc2_b21f74de-8fb7-4f8c-9b24-03369b5c6fa2"
      unitRef="shares">2007932</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ie3f90dae3d5d49c094e3925ff3e04933_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfOTQw_de101ef3-15c1-43c9-9394-883e21343135"
      unitRef="usd">2400000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i9b3959b3e8964e39a6463ae8b22b489b_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82MS9mcmFnOmFhMTg0ZGJlZWYyMDQ3NDA5ZDIwNzc1MGVlMGI1MTNlL3RleHRyZWdpb246YWExODRkYmVlZjIwNDc0MDlkMjA3NzUwZWUwYjUxM2VfOTQ4_606f6a0a-7302-4f9f-8473-091425279209"
      unitRef="usd">27100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMTk2Mw_6518d5b3-bf64-4819-bb40-971890ce6fc5">INCOME TAXES&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s provision for income taxes for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items, if any, that arise during the period. Each quarter, the Company updates its estimate of the annual effective tax rate, and if the estimated annual effective tax rate changes, the Company makes a cumulative adjustment in such period. During the three and nine months ended September&#160;30, 2022, the Company recorded income tax expense of $0.1&#160;million and $0.2&#160;million, respectively. During the three and nine months ended September&#160;30, 2021, the Company recorded income tax expense of $0.1&#160;million and $0.4&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company continues to maintain a full valuation allowance on its U.S. federal and state net deferred tax assets and on the Sangamo France net deferred tax assets, as the Company believes it is not more likely than not that these benefits will be realized. The tax expense for the three and nine months ended September&#160;30, 2022 was primarily due to foreign income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Coronavirus Aid, Relief, and Economic Security Act, enacted on March 27, 2020, provided an Employee Retention Credit (&#x201c;ERC&#x201d;), which is a refundable payroll tax credit that encouraged businesses to keep employees on the payroll during the COVID-19 pandemic. Eligible employers could qualify for up to $5,000 of credit for each employee based on certain wages paid after March 12, 2020 and before January 1, 2021 and extended to September 30, 2021. Based on the Company&#x2019;s evaluation of this provision and the significant pandemic-related impacts on the operations, the Company recognized zero and $3.0&#160;million of ERC for the three and nine months ended September&#160;30, 2022, respectively, within interest and other income, net in Condensed Consolidated Statement of Operations upon filing for the refund in January and April 2022. No refund has been received during the three and nine months ended September&#160;30, 2022 and the amount has been recorded within prepaid expenses and other current assets on the Company&#x2019;s Condensed Consolidated Balance Sheet as of September&#160;30, 2022.&lt;/span&gt;&lt;/div&gt;On August 16, 2022, the Inflation Reduction Act of 2022 was signed into law, with tax provisions primarily focused on implementing a 15% minimum tax on global adjusted financial statement income and a 1% excise tax on share repurchases. The Inflation Reduction Act of 2022 will become effective beginning in 2023. Given its recent pronouncement, it is unclear at this time what, if any, impact the Inflation Reduction Act of 2022 will have on the Company's tax rate and financial results. Currently, the Company does not anticipate any material impact on its consolidated audited financial statements and will continue to evaluate its impact as further information becomes available.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMjc0ODc3OTA3MTYzMg_84c258fa-57d8-46dd-8787-e5674da36a7c"
      unitRef="usd">200000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib005ea27f73e4fc39f345a9958296961_D20210701-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMjc0ODc3OTA3MTQzNw_d843f762-f161-4521-8174-9b45381d1234"
      unitRef="usd">100000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ieef086fa53ae479c914db5632bc279fe_D20210101-20210930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfNTAy_445028db-6886-44e7-983d-9b6dec6ad605"
      unitRef="usd">400000</us-gaap:IncomeTaxExpenseBenefit>
    <sgmo:EmployeeRetentionCreditCARESAct
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMTU0Ng_b3b4f043-272d-4727-87c7-7c8e858c4dab"
      unitRef="usd">0</sgmo:EmployeeRetentionCreditCARESAct>
    <sgmo:EmployeeRetentionCreditCARESAct
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMTU1Mw_f63fed01-af68-401d-8b97-f653116facb8"
      unitRef="usd">3000000</sgmo:EmployeeRetentionCreditCARESAct>
    <sgmo:ProceedsFromEmployeeRetentionCreditCARESAct
      contextRef="i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMTc1NA_6c29f16b-3c24-4495-8ce4-44526c7c2b95"
      unitRef="usd">0</sgmo:ProceedsFromEmployeeRetentionCreditCARESAct>
    <sgmo:ProceedsFromEmployeeRetentionCreditCARESAct
      contextRef="if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjU1YzY4OGNhYWMyYjQ0Yzk4MjAwZDE0NGUzN2IyMTQ0L3NlYzo1NWM2ODhjYWFjMmI0NGM5ODIwMGQxNDRlMzdiMjE0NF82Ny9mcmFnOjBiYzkxNTVlYmNjOTQ3ZjU4YWVkYTcxZjgxN2JmN2VhL3RleHRyZWdpb246MGJjOTE1NWViY2M5NDdmNThhZWRhNzFmODE3YmY3ZWFfMTc1NA_9688e714-732c-446e-87e9-814099adf15a"
      unitRef="usd">0</sgmo:ProceedsFromEmployeeRetentionCreditCARESAct>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>56
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MBI09239F@L'C$8SB.!JQU&$P#DE(S"R#CF7@9/FE$$PNDI#)+&%R*B5=$\=
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M%G8 V5:DM+\DQ8 TZ?%?D(1O0X++#"2HS$2"R[J0;&M4VE^D3NJW<FL%"(
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MLH6HV@+R[S=EV?S^9B+Y=V7U86?CZO]02P,$%     @ 3H!C5:/$#/B2"
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M#;R3'D]X;UW^BD(F!GQ00&+KV1"N@86POB&6*G  ^5MZD+WP4/$+I2'6&H-
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MQJ*,&!XI*N"@WVE(N#)-8%_JU\!UHI;8ER,>[@<!Z]\8E-,VRZSK%J6.Q[O
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MF(> D10YS)#Y#F 6<^L=DC&&,N)I@   N85B,E#E$Q*==)Y4D,(-^Z./XSL
MN;(U.++C?;]/9)2XUVI+I4"9#9B0P*<10'##I@<O7X\"A].4J$ .J#R%@,M]
MF::,LLO4SJ>-('<1'TY<7CSFZ8:]]V"5CS5W&[X549++KV6=,TWTTTVN&F^V
MRB;,R'TN=X@6(FB51_$$(<J\=9*]D$,Q#.!'42A-H=L> -3:U(4G5U4 ?<B
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MCG;,MZUOE;7M_Z^DA2LD<5$A<)@F1]2*O?!E3;F1DV#.$Y0A28.:4?*"HH+
M2?R /-!\;,6I_ZR4$M=)W80F>R[R28B=][PV(L?S8IKMDS10NI/MPO33V/&"
MM).^&Z(PTLA)P^A'A!&Z,2Z*Q-:(A&'QJ!M#CT.[\2V94(!8K26X'VBQ@0P/
M2#I86J2 >Q6-;&#-%0>F82E+W#>?;G>/M[-'(KRV&/4*T 05!QO.%$@%)==$
MW/=29S(A,7N3Q(F3^,& +0UB##:F4+)=%;#$.Y/MP;K%5AEIZGCQ5I4'P_HZ
M>$AH0?QM$+7$BQLK[=:\PAMBE]82=V<,7];V'-"8<$U)$@^G,>0=*1I')IQ;
MNQH/**BZ*P6G*\6>C?T8;G[(H:6+\\6JML*JS0]S\(ZM OKS#<M:X^T6SS=<
M=,* $OH.BZLEKB8ZF];"%$#:?6 #N' ,%E_(H0Q/)I0BVSBP+D160"DJ&F]:
ME16, C42"KR-OOZ"LB)!":U;KKI<L%++K06%QBK9(B*E@S!V/#.#JZ+&P[OW
MC&1150PT9@6%W($^CC47F"&)0?),*O2%TTG"K,YP1: ,^QQLZX%Z0PH*!%H+
M92/#"!1E2_'2I@=#(5[[%Q!!?K]$[,2G=2I8#FT]R+7G^/_PP'5#-Q=%&^X3
M3@Z6(1?W(L?JEAN+(CIEL]5*\14:.I;2#ME]5\WQSJL!=_>5?1NA3DD/W0-B
MZ!V>7]/NU?$PO7N[X>&SHL56\B6:NL=)-$*AV_=0US"RL6^0A33XHK&?!3XA
MN:().+Z4TFP;Y&!XE)[_#5!+ P04    " !.@&-5UG10':H#  !5"0  &0
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M^NY![1;0_%;1E6\[;H/N2VKV#5!+ P04    " !.@&-5C2XK QXC  #1A@
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MA($J@7ZP*I%%BQ07+K,[ :*[BG2K#%R%I*B PMLML"0]=GM^_>ZUW7"8+_1
M,NYM6&B$,2]VV$<!DTV5SZ X*JP15*!I[_6$I.-6L&KXD51Q":WQ\2K-%_!&
M2PL,@YMJ\0OL-C*>X2,0.['EN2O8$2 -,)G,FA)>-ABBR-=R(9$KET6^,>N"
M&;<64-0FPN*\T]I' '/&9O::*<P;L'(<E 6D(13X@=)KT>_5F,[;>J!I'JPC
M12_E+*"P?*.F/8'WEH@[-[[XAM:Y+:2 F<$>)2++!YX\WLFB4L+M^7S^4UM+
M@P,@@FU5;$&X<91^2C6U$3[3TW0[#,N7"C\ALG<LO%,_6VIL(YG4]C(*'EV<
M#T?@$Z8IDJ;:0L>@2 U]ED!\(,^\6H$32?9P".;)2@^K,.@8W\,%\(S@U4+(
MS:(JE/9I6/Q[5$>+O40J5R2IT#V\G/%J[2JJ+7[P: J3<3.'6?IV$!Z#N.;(
M-C@OW>1LU&CB".ZU:.D_8J(#DX*%H+9:@_\>X ZE8I!  Q(VX-5!*03,,*\6
M]@,V<Z0Z04WF:+DD*9;2GY:*4D&Z[N&\ *N +336=!OM>"_N8?E@6ZT$P01A
MYA7'-TE%"V1#"MIA*POMS8)YHGE U/51E-9>@[T@"MON-R HVC8;Z=)35UHJ
M9)$,MD"U7=T H;!! VU^? <J16T&U,DJ,/OH:!D:#!:[@5$?+#]55A8[?*Q_
MQ6!+*G062ID2D=R:C-1K#8Y[:X@%7M[&TR)&@108G1'3"S2'0*2FJ,%JT7/
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M Q_6_81]N1I?NE^ZH$3CT45P%LYFX^ RO)B.@O$HG,QF'I9H.D;D$#R^FEW
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M-8TOP.?+/"_-'S@ WEE!TWOQ+U!+ P04    " !.@&-5,VELB^("  !8!@
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MARD([*^Y-WW\T_C9Z.@!O(=;O(</>?_7<OQW:_JX8IJYLE)V\_BG%Y/Q\Z-
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M MRGEX;B#]H@_:> =_\"4$L#!!0    ( $Z 8U4Z1M.6/00  *X,   9
M>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;.U7;9/:-A#^*SM.D[F;<0YC7HZ[
M<,P8[B5,"\=@KIVVTP_"+%B-+1%)'+E_WY5L$V@)33ZTGS+#R"MI7YZ5GM4L
MW:U4'W2*:.!3G@E]XZ7&K*]K-9VDF#-](=<H:&<I5<X,3=6JIM<*V<(9Y5DM
M#()V+6=<>+VN6YNH7E=N3,8%3A3H39XS]=+'3&YOO+I7+4SY*C5VH=;KKMD*
M8S1/ZXFB66WG9<%S%)I+ 0J7-UY4O^ZWK;Y3^)GC5N_)8#.92_G!3H:+&R^P
M@###Q%@/C#[/., LLXX(QL?2I[<+:0WWY<K[O<N=<IDSC0.9_<(7)KWQ.AXL
M<,DVF9G*[7LL\VE9?XG,M!MA6^H&'B0;;61>&A."G(OBRSZ5Y_ U!F%I$#K<
M12"'\I89UNLJN05EM<F;%5RJSIK <6$O)3:*=CG9F=[C]"$:#W^+9L/'L0_]
M*![&\'@/D^E=?#>>E<O1^!;BI]$HFOYJ-^/APWAX/QQ$XQE$@\'CTW@V'#_
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M>L&L1I]E3"0(L7U:-9'&*;/<%K\^ZHC1RY"OF7@I2NFHU]C0IZ!M=5SWEG7
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MD>Q%@2D'N;^C5%2&.J#N;N=_ E!+ P04    " !.@&-5CZVA2\L$  "-"P
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MC<6HIL9"U('&8E13XU85WJGQH-)XT*KQ+6*,BT;F@&O-5W4 409?XH@O.4,
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MQDB2/RX1#%&: 7C]G!"V?<D25#?1X_\ 4$L#!!0    ( $Z 8U5%/06I1 0
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M7O7,[7&0FX2\NDS0"+JL"X7?$:KY>E7Y>M7JJ^P(2\C1V#_?!UH![ZTXG;!
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M4S]Z#*#IX0JEX4K9>>O:O]&9'=^_\8#L/)SLNI; %_$DEA;31DZJ U)Y4_,
MS.B-ZQB$1PJ65-[4Y %8>GV.0O0147>.ND14C1DFHGI <1XIQ7EM/+.;H6(F
M:I32\84^XML0^S=>6X#3YE_S 3DL_\!@WMN$NMWKIO=&#MZ<\3(:@K$\8"QO
M7$J=1ZK447E3DP<LY_51ZGJ]@]KBFW8-:#0Z; T 77EOT^A@#5!LZ>#!& _R
M$&SE UOYXQ+Q?%(1C\J;FCQ /9]4Q//;ZESS;Q]JHD8)(.:_3;R#U6&XJ8.W
M:SR60Q"7#\3ECTO*\TFE/"IO:O(  GU2"/2[(1 U4:,$"/3?)N')"\%@4P=O
MU7@D!SFM*AU7'9>DYY/B)I4W-7F FSZII.>W);W6,L!,U"B!Z_RW:72P# RV
M=? VC<=Q"+7.!Y[TQZ76^:1$2>5-/4D.1!F0JG5!6X9K+@+41(T2T"T@4>GZ
M;^S@[1F??Q]"NPL &8-Q:7<!*4E2>5.3!R09D%YC$K25N=8"&(+N J"[ *<[
M V[JO[V#MVD\Y$-\MB\ L@S&=3U*0(J<5-[4Y %R!GVN2.F_7MI7H+36"V:B
M1BG=D(*S7;]%H+M^Z@/NV7BTAE % Z#'8%RWHP2D8$GE34T>@&7PFF,DVFZW
MCWNT9CEFHMY\ _ 6DL);V"8S[;D<G1UR+B<$C O[*'!#[.N$;25.WS6-'=8U
M8+"00K;CO3=V\.:,[QD:@K%"8*QP7&I=2*K647E3DP<\%_91Z_J\A<)NH0XU
M40,$G HIA#I.M)^#!V,\MD/ 5 @P%8Y+OPM)]3LJ;VKR@/%"4OTN;(MSNB,Z
M&C/DB$XH75-'H>-Q\WT=O%WC,1T"N4) KG!<6EY(JN51>5/O\P,<C$AQ,&IC
MGO:PCLX..:P3 0Y&%*H>-]WAP5LU'5,J;VJ.@"NC<6E[$2EW4GE3DP?<&9%J
M>Y'F4W>:8SL:,^383@2@%U$(=]QLIP=OTW@\AQ#N(B#-:%S"743*FE3>U.0!
M:T:DPEW45N5T!W@T9L@!G@C@+B(1\/KO^.#M&8_E$+)>!# 9C4O6BT@9D\J;
MFCSIWF/:BX_;PIWN* _>Z&NO1[3E*Y+?=C.,1%/]]WTZ&C6_2GF0NY1MZ3)E
M>UR7Q>SC(4O@(/<IVUQ*(.V-RK;FVAC-^1ZMW?$#/LR6KE2VWW9QS,O"</31
MTUZQ3.6ND0OIDF7;'=GT)^5/,G>-!$H7+=NO.9JB[WK[$$E3CL5M&D%*]RO;
MI*BW=X='VGN7EMG2C<CV:^[ H]@1VK>,=ZKW!_:8+=U4;%-(?4[OO:".]LP7
MT1#\Q6SI<F1[7"K?/AZR! [">G(YC(YZ& 9O(=;]B3W<IA&D7+>"0MYSB/:%
M.J(QKULQ"&C)E2O8N)0_AI?2,$_@$-H?DTMI=-32,/TKR+H_VH?;-"*5J PO
M#V&P4DP+X1!7N1BFS(5<YX*-2P%D>.$-\P0.H0$RN?1&1^T-XT71 PU1FT:D
M$AKB!26,%H5)T1SBJAC#E,60ZV*P<6F!#"_489[ 06A4+M714:O#>$ET?]@/
MMVG4LI*P#R]"8; D3$KLT-;1('/7R)+$G7QD$A]5E8U] H<IF2:19T?9#N.B
M:6WIKK4@4)M&I!+BX;4H3/^)T:,@#VTI#3)WC0Q):,E')OCAU3W,$S@(<4KU
M/5A'@0_CQ=!#]1ND:@>3RG8PO+2%"5L9[!715N<@<]?(DD2@?%SWT3"\8(AY
M @=!4ZEL"*.M&[)WYZ-K![-YB72:+X0H/L9%/#O=Q _B,LX>DG5N+<5]^8Q]
M4IV@RI*'Q>&;(MV4'9M8MVE1I*OZRX6([T16&92_OT_38O_-M/3_G&:/=1NS
M_P-02P,$%     @ 3H!C5?047@A+"0  65<  !D   !X;"]W;W)K<VAE971S
M+W-H965T,C4N>&ULO9QK<]I(%H;_2A<[M954#49]DR!K4T609B:UR50VV-G/
M,K1M501B)&%/]M=O"PA-7](@./A+8N#T2_?;4NL\])&N7XKR6_4D1(W^GN>+
MZJ;S5-?+=[U>-7T2\[2Z*I9B(3]Y*,IY6LN7Y6.O6I8BG:T;S?,>"8*P-T^S
M16=XO7[O<SF\+E9UGBW$YQ)5J_D\+;^_%WGQ<M/!G1]O?,D>G^KFC=[P>ID^
MBHFH[Y:?2_FJMU.997.QJ+)B@4KQ<-,9X7<)'S0-UA%?,_%2[?V-FJ'<%\6W
MYL6'V4TG:'HD<C&M&XE4_O<LQB+/&R79C[^VHIW==S8-]__^H?[;>O!R,/=I
M)<9%_M]L5C_==/H=-!,/Z2JOOQ0O?XCM@'BC-RWR:OTO>MG&!ATT755U,=\V
MECV89XO-_^G?6R/V&F#VDP9DVX <VX!N&]!C&[!M W9L [YML!YZ;S/VM7%Q
M6J?#Z[)X0643+=6:/];NKUM+O[)%<Z!,ZE)^FLEV]7 \FOR!DO_<??@Z^IC\
M>3M!HS]C]&GTY=_)[>C]QP1-DO'=EP^W'Y()ZJ+)YFA"Q0,:I]432OY:9<]I
M+A9UA=+%#(V>TRQ/[W/1E4=P=R(_01,Q7959G8D*O8E%+3]_*X7N)C%Z\\M;
M] O*%NCVJ5A5LGEUW:OEB)I^]:;;WK_?])[\I/<3L;Q"-/@5D8 01_.QOWDL
MIK(Y7C?'CN;Q\=_N:IX<_^V!WKPG9W$WE60WE62M1W^B-YI,DMN)R\1-.^9N
MURQ%[ZIE.A4W';G65*)\%IWA/_^!P^!?+DLAQ6)(L01(3#.?[LRG/O7A^GP0
MZGSX%8WF15EG_Q,S-"ZJVC4M&\5PK=@LZ,_# >.1/!2>]_VVHW#4[T=$#XM=
M8>& ,STL<8113,E@%Z:-GNU&S[RCUT_\JCGQJ]V)?XP5&WF^URTBG1@8@QP[
MPOHAIGW#"V]GVQY50&*:KWSG*S_'U]_+HJK0W4)F"/G:WM]E9N!<1KEE'#9,
M&SM"L.&KM[-M?042TWP-=[Z&H+Z^^2C?$-5;E[6AY5L7,VP>N8XH&A@G9^SM
M=%M_@<0T?Z.=O]$Y_B95G<D<3QK[6YJ5Z&N:KX3+VLBQ*O!P8!ZYCK ^[S-N
MN.OM<EMW@<0T=_L[=_M>=V^+.LW1U+CBK#.P]-R%N&]Y265V$E##<CN,!6'
M(\-R[SC:6@XDIED^V%D^N)#EQZ_1@\-KM"/$7*.]XVAK.9"89CD.%)H$KV6Z
M;P'?]N+0"NX*LY=P_Y#:^@^EID_ 'AOB"TW L2O\M@/Z>B-7DH%IOAW'Y'(3
M6O9[!]3:?B UW7[%<]A++,-/Q4)\E[!??A,U>EC]C)!!Z0Y4+0952Z#4].E0
MA(?IB7R-O6S8>@H@U6)0M01*39\"A9G8SYFG4#:VH9&Q@7G='#O",!X,\,!<
M84#A$DI-]U/A)?;SI>WG\>D*MH'1_.GB<$CL[V!K.R\!E5A1)?9CY1%V>A,1
M&Q(M1P^&Q/X^MG;T$AB)%4=B/TC:CAZ=6=A4Z#SM[3#W:0]*CU!JNJN*'[$?
M($U7G?Y!LML85"T&54N@U/3)4&2)!Z>F%9 L-P95BT'5$B@U?=]$@2;Q@^8I
M:06Q<="UOCC"G.N+OX>M=T(NP8U$<2/Q<^,Y:06Q2<^\"!X.B?T=;&WG)3B0
M[.WK^3GPS+1BJ^YU]&!([.]C:T<O@7)$H1QINUMW;%JQ%3YXVMMA[M,>E,Z@
MU'17%9T1/YW=74VNT&/Q+,K%7+K:K9;%HBI*Z:E\E=7?T4S<UWL_$SG]A<2K
M,:A:#*J60*GIDZ70C_!3JP4@D6P,JA:#JB50:OH4*%PD9^U"'I&#V#1(:)^:
MOUP[PF@0!=8*#PJ.4&JZMPH<R5D[D"WR$1L0K:NG@R%-;T'Q$4I-]U;A(_'C
M(^3N.;%W$KN,60X[HOKF9J._UZT]O@05$D6%Q+_A"+2#3NP=0T*I55?C"*-!
MB,W=%7^?6SM\">BC"OKH >@KYG-13K,T1\MT*<H#B8E?K>U5$50M!E5+H-3T
M>5'P2/&)B0F%A+HQJ%H,JI9 J>E3H("3^H'S[,2$VCR)21!QJ[;1$1?PR%R?
M8G]_6[M[D4+1O4I1/WR"I2;4!9FFPW:,>=WT=[>UN9=@4*H8E)Y5B=HJ-Z'V
MEF"71MQTV!'%K ,8%!VAU'2/%3K2LZI2C\U-J*/BE 2T'YH&.^+D(F$5F_E[
MW=KC2[ A56Q(#VPE%N6R**6+Q_QHXM=J?6&$5(M!U1(H-7U6%%72Z-3<!!+P
MQJ!J,:A: J6F3X&"3WH6?!Z1F]@LB7E@IR:.2E@:$6HN.J#0":6F>ZN@DYX%
MG2TR$YLG+7\=M:RFMZ"X":6FWR"C<)/Y<1,R,6&NBM70NEG&$64E)OY>M[Y7
MYA+HR!0Z,O^^(U!BPNS]1<SZ?;,8VQ%&:=BW' 8E0R@UW6%%ANP &<ICLN[>
MI]-OTD5_4N)7:GM%!%6+0=42*#5]3A1/LE/K4AEH72JH6@RJED"IZ5.P=_OC
M6=1YQ/V/-D32?D#-,GA'6!3T Y.$_+UM[>TE:),IVF2O= \DLSG2NF0Z4-/T
M%I0RH=1T;Q5ELM>[#Y(Y;G$DH771=-TN:1_ H- (I::;K*"1O<K-D,S>9:11
M%)EWYCG"HB *K,,8E FAU'2'%1,R/Q.N"T]J>916J_([NL_RW+T @):T@JK%
MH&H)E)H^'XHCV:DEK0RTI!54+0952Z#4].<&*-SD9^'FX8R$.PI7PP$SEQM_
M-]I. :A: J6F3X&B47X6C;9X>,/ADEA_5UI/ RBR0JGITZ"0E9^UF=DJQ^'V
M?F67F%MN_OZTG@M05(52T^="H2H_:^OSV%2(.S8^PP$QLWE_9UI/!"BP0JGI
M$Z& E?N!=2SD\O^03:795?,XKYE8%E7FOA" 5N2"JL6@:@F4FCXG>\_Z.;4B
MEX-6Y(*JQ:!J"92:/@6*A_F%*W*YC;>,L,AZUI(CC&-L['S'_MZV]O82&,P5
M!O-7JLCE-N&:-1F.$.M95J  #*6F>ZL F+]>12YWU-IB9A9EN**(=?R"0BV4
MFNZQ@EK^*A6YVV\)M16"TLCTUQ'&@X%U%(,R*Y3:QN'>WE-)FX?.?DK+1WE*
MHUP\2/G@*I('3[EYCNOF15TLUP\JO2_JNIBO_WP2Z4R438#\_*$HZA\OFF>?
M[IZF._P_4$L#!!0    ( $Z 8U5@FY3(T0(  ,H&   9    >&PO=V]R:W-H
M965T<R]S:&5E=#(V+GAM;*U574_;,!3]*U<9FI@$Y*--VK(V4FD[40T0:UKV
M,.W!36\:BR0NMM/"OY^=A%!H0#SL);&=<X[/N4YN^CO&[T6,*.$Q33(Q,&(I
M-^>F*<(84R+.V 8S]21B/"523?G:%!N.9%60TL1T+,LS4T(SP^\7:[?<[[-<
M)C3#6PXB3U/"GRXP8;N!81O/"S.ZCJ5>,/W^AJPQ0+G8W'(U,VN5%4TQ$Y1E
MP#$:&$/[?.1J? &XH[@3>V/029:,W>O)=#4P+&T($PRE5B#JML41)HD64C8>
M*DVCWE(3]\?/ZC^*["K+D@@<L>0W7<EX8'0-6&%$\D3.V.X2JSR%P9 EHKC"
MKL):!H2YD"RMR,I!2K/R3AZK.NP1[/8[!*<B.)\EM"I"JPA:.BMBC8DD?I^S
M'7"-5FIZ4-2F8*LT--.G&$BNGE+%D_YH&%S"Y-=B>C>\FMS, QC>C.%Z./LY
MF0\OKB803$:+V70^G01P"D%YU, B")F00+(5H)!451-7$!'*84N2'#5 Q(S+
M4XD\!9IM%4H=O11P/$9):"*^*;E%,(;CHV]PI! PCUDNE*#HFU+ETN[,L,IP
M469PWLD0X.8,6M8).);C--!'']/'&"JZ7=#MUW135;,NJ5.7U"GT6N_H35_B
MGL 8EV6=)@\YE4\08)AS*BD*^#-<"LG5>_RW*7*Y1[MY#_UMGXL-"7%@J(]7
M(-^BX7_]8GO6]Z8"_">Q5^5HU>5H?:3N7Q.I$F=K?<@L0WA"PH%Q2% TGG6I
MYA5JN@=M?<?N]GK=OKG=CW0(LWL=K^/5L%=FV[79]N?,DDB]NB]^9<Q9OHXA
M4CVG6&FT7FJ[>YY:7L>RWC@_1'6[MM=K-N[6QMT/C<^9)$F3)_>PG*[K'92S
M =9UNVWWC2MSK]/H+G]-^)IF0AUFI(C664?I\+)SEA/)-D7S63*I6EDQC-7/
M!KD&J.<18_)YHOM9_?OR_P%02P,$%     @ 3H!C58N2ITUS P  .0T  !D
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M+=TSM>;'MU#M9Z3Y0LYD\4N.E:UED' O%4\K,$:0)EGY3[]4.IP D*<9T*\
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MDY8EZF%2!XI7MA_77.GNMLM<SU\4)D&?;SA7Q\!\H)WHT1]02P,$%     @
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M0&DNE.9!:3Z4%D!I(8I6_XW5OJ]J&=__%@4+VHV%TFPHS8'27"C-@])\*"V
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MIP7-:4-IM.8;J%<'WT#44^6D*5*S8J*S!8MCWE+';,?";;V8H%88E*:7-.'
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M?*4A*/Q[8%,6AAH)[/A["]HIV]05]Z]WZ#_GG8?.+*ADTR3\@P=J?=$9=4C
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M ;068+R5P<@#C'J \49 +P_HG1K0SP/ZM8"^_D; ( \8G)IAF <,3_V51GG
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MPMUR)<;S<YY=D/,G=0SR;K<58WC9 S\W>M-J&#;N[*;J^K36,))F06DVE.9
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M57+J)^!TQLG75"[7W@8^JPI22SBW("IAKDJ8IQ+FJX1-%,$.#-(I#=+YGS>
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M0,<$]S.&/0-C#G5,2#G8L'+>*D@G/I49TPL2ABR$36]JP(*DEW<,60B;WM:
MF)T4@BR$#5L(QNRD$&0A;-A"X,*\4]XQ9"%\5 MUYB9D(6S80C"F/C==R$+N
M,;<YG;GI0A9R#5L(QM3+NPM9R#5L(1CS3,<$WZL9MA",>:YC0A9R#5L(6,@1
MR7,=$[*0:]A"_]KB'H3^7H>$'.0:=I"^USW U1TZ2#UNJQ[[\!Y_1=>LHJM(
MC5RK_CPK\KE S6'_OJ$_:#8 ZUU1C%5?7$UYMCI\%CA\TKC^!5!+ P04
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M\?QW4AWZ;]UX_+!\;D[8&7"V< V]_P502P,$%     @ 3H!C5:IG%&&8 0
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M4$L! A0#%     @ 3H!C551.PSJY!0  OAD  !@              ("!QQ0
M 'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( $Z 8U72?<L\
M 00  /<-   8              " @;8:  !X;"]W;W)K<VAE971S+W-H965T
M-"YX;6Q02P$"% ,4    " !.@&-5$K9X#FT-   F@@  &
M@('M'@  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%     @ 3H!C
M5:/$#/B2"   I2<  !@              ("!D"P  'AL+W=O<FMS:&5E=',O
M<VAE970V+GAM;%!+ 0(4 Q0    ( $Z 8U73M#S5DA,  &XW   8
M      " @5@U  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"% ,4
M" !.@&-5K>% = L'  "B$@  &               @($@20  >&PO=V]R:W-H
M965T<R]S:&5E=#@N>&UL4$L! A0#%     @ 3H!C5;<(.$G(!0  H X  !@
M             ("!85   'AL+W=O<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4
M Q0    ( $Z 8U76=% =J@,  %4)   9              " @5]6  !X;"]W
M;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ 3H!C58TN*P,>(P
MT88  !D              ("!0%H  'AL+W=O<FMS:&5E=',O<VAE970Q,2YX
M;6Q02P$"% ,4    " !.@&-5,VELB^("  !8!@  &0              @(&5
M?0  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    ( $Z 8U50
M,;K* @0  "T)   9              " @:Z   !X;"]W;W)K<VAE971S+W-H
M965T,3,N>&UL4$L! A0#%     @ 3H!C5=WF56UO!0  #0T  !D
M     ("!YX0  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $Z 8U7:IU)[J@0  *<1   9              "
M@4.I  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%     @ 3H!C
M5=1%+^+Q @  4@8  !D              ("!)*X  'AL+W=O<FMS:&5E=',O
M<VAE970R,"YX;6Q02P$"% ,4    " !.@&-5-"[A9S@%  "5'@  &0
M        @(%,L0  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0
M   ( $Z 8U5%/06I1 0  '<6   9              " @;NV  !X;"]W;W)K
M<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ 3H!C546:WFI6 P  O D
M !D              ("!-KL  'AL+W=O<FMS:&5E=',O<VAE970R,RYX;6Q0
M2P$"% ,4    " !.@&-5XL0W?;4+  !J@0  &0              @('#O@
M>&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( $Z 8U7T%%X(
M2PD  %E7   9              " @:_*  !X;"]W;W)K<VAE971S+W-H965T
M,C4N>&UL4$L! A0#%     @ 3H!C56";E,C1 @  R@8  !D
M ("!,=0  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4    " !.
M@&-5BY*G37,#   Y#0  &0              @($YUP  >&PO=V]R:W-H965T
M<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( $Z 8U5_Z-RNA0(  -T%   9
M          " @>/:  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL4$L! A0#
M%     @ 3H!C5?!&MQJL!P   4P  !D              ("!G]T  'AL+W=O
M<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " !.@&-5TK/VZC((  !K
M30  &0              @(&"Y0  >&PO=V]R:W-H965T<R]S:&5E=#,P+GAM
M;%!+ 0(4 Q0    ( $Z 8U4T78*I%0H  (9G   9              " @>OM
M  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @ 3H!C5>KR
M$9B4!@  +BH  !D              ("!-_@  'AL+W=O<FMS:&5E=',O<VAE
M970S,BYX;6Q02P$"% ,4    " !.@&-5#(X7BI8)  !77P  &0
M    @($"_P  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    (
M $Z 8U4KB8ID"PT  /FZ   9              " @<\( 0!X;"]W;W)K<VAE
M971S+W-H965T,S0N>&UL4$L! A0#%     @ 3H!C5>+Q9S*M P  $1$  !D
M             ("!$18! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX;6Q02P$"
M% ,4    " !.@&-5]"(/<S\$   7%0  &0              @('U&0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( $Z 8U6V3"+&Z0(
M $T*   9              " @6L> 0!X;"]W;W)K<VAE971S+W-H965T,S<N
M>&UL4$L! A0#%     @ 3H!C52(08.DG P  :!(   T              ( !
MBR$! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !.@&-5EXJ[',     3 @
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8;6Q02P4&     "T +0 R#   X2P!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.2.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>288</ContextCount>
  <ElementCount>221</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>53</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES</Role>
      <ShortName>CASH EQUIVALENTS AND MARKETABLE SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE</Role>
      <ShortName>BASIC AND DILUTED NET LOSS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>16</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - FAIR VALUE MEASUREMENTS - (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS - (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>17</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables</Role>
      <ShortName>CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES</ParentRole>
      <Position>18</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - STOCK-BASED COMPENSATION - (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION - (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration Agreements and Research Activity Grants (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration Agreements and Research Activity Grants (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail</Role>
      <ShortName>ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - FAIR VALUE MEASUREMENTS (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail</Role>
      <ShortName>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of cost and estimated fair value of short-term investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails</Role>
      <ShortName>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of cost and estimated fair value of short-term investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetails</Role>
      <ShortName>CASH EQUIVALENTS AND MARKETABLE SECURITIES - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREAdditionalInformationDetail</Role>
      <ShortName>BASIC AND DILUTED NET LOSS PER SHARE - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Sanofi S.A. (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Sanofi S.A. (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail</Role>
      <ShortName>MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail</Role>
      <ShortName>STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - STOCKHOLDERS' EQUITY (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="sgmo-20220930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.sangamo.com/role/INCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.sangamo.com/role/INCOMETAXES</ParentRole>
      <Position>37</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:IncomeTaxExpenseBenefit, us-gaap:RealizedInvestmentGainsLosses -  sgmo-20220930.htm 4</Log>
    <Log type="Warning">[dqc-0015-Negative-Values] Fact us-gaap:ConcentrationRiskPercentage1 has a value of -0.03 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:ConcentrationRiskPercentage1 fact are: Context: idf66e1bb8ddd4393b9d770b1885a7a64_D20210701-20210930, Unit: number, Rule Element Id: 521. sgmo-20220930.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="sgmo-20220930.htm">sgmo-20220930.htm</File>
    <File>sgmo-20220930.xsd</File>
    <File>sgmo-20220930_cal.xml</File>
    <File>sgmo-20220930_def.xml</File>
    <File>sgmo-20220930_lab.xml</File>
    <File>sgmo-20220930_pre.xml</File>
    <File>sgmo-20220930xex101_employ.htm</File>
    <File>sgmo-20220930xex311.htm</File>
    <File>sgmo-20220930xex312.htm</File>
    <File>sgmo-20220930xex321.htm</File>
    <File>sgmo-2022110322xex51opin.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>sgmo-20220930_g1.jpg</File>
    <File>sgmo-20220930_g2.jpg</File>
    <File>sgmo-20220930_g3.jpg</File>
    <File>sgmo-20220930_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="709">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>62
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "sgmo-20220930.htm": {
   "axisCustom": 1,
   "axisStandard": 15,
   "contextCount": 288,
   "dts": {
    "calculationLink": {
     "local": [
      "sgmo-20220930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "sgmo-20220930_def.xml"
     ]
    },
    "inline": {
     "local": [
      "sgmo-20220930.htm"
     ]
    },
    "labelLink": {
     "local": [
      "sgmo-20220930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sgmo-20220930_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "sgmo-20220930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 349,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 3,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 8
   },
   "keyCustom": 51,
   "keyStandard": 170,
   "memberCustom": 28,
   "memberStandard": 25,
   "nsprefix": "sgmo",
   "nsuri": "http://www.sangamo.com/20220930",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "role": "http://www.sangamo.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE",
     "role": "http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE",
     "shortName": "BASIC AND DILUTED NET LOSS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES",
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://www.sangamo.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - STOCKHOLDERS' EQUITY",
     "role": "http://www.sangamo.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - INCOME TAXES",
     "role": "http://www.sangamo.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Policies)",
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Tables)",
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - FAIR VALUE MEASUREMENTS - (Tables)",
     "role": "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS - (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)",
     "role": "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables",
     "shortName": "CASH EQUIVALENTS AND MARKETABLE SECURITIES - (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i3d5f1ae0ab8b4decbba471d9add02a71_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - (Tables)",
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i3d5f1ae0ab8b4decbba471d9add02a71_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - STOCK-BASED COMPENSATION - (Tables)",
     "role": "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION - (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail)",
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "ia0f3233d7b70474da06a55adac0cca4d_D20220701-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration Agreements and Research Activity Grants (Detail)",
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenues from Strategic Partnering Collaboration Agreements and Research Activity Grants (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "sgmo:ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "ia0f3233d7b70474da06a55adac0cca4d_D20220701-20220930",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Detail)",
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Reconciliation of Cash and Cash Equivalents (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalentsNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - FAIR VALUE MEASUREMENTS (Detail)",
     "role": "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail",
     "shortName": "FAIR VALUE MEASUREMENTS (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i96d87151f3dd48979c96441aaec7b540_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Detail)",
     "role": "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
     "shortName": "CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of Cash Equivalents and Available-for-Sale Securities (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:MarketableSecuritiesTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of cost and estimated fair value of short-term investments (Details)",
     "role": "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails",
     "shortName": "CASH EQUIVALENTS AND MARKETABLE SECURITIES - Summary of cost and estimated fair value of short-term investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RealizedInvestmentGainsLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES - Additional Information (Details)",
     "role": "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetails",
     "shortName": "CASH EQUIVALENTS AND MARKETABLE SECURITIES - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RealizedInvestmentGainsLosses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - BASIC AND DILUTED NET LOSS PER SHARE - Additional Information (Detail)",
     "role": "http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREAdditionalInformationDetail",
     "shortName": "BASIC AND DILUTED NET LOSS PER SHARE - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Detail)",
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Novartis Institutes for BioMedical Research, Inc. (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i714565e5ccc14fd6ad101d485a5a8de6_I20200831",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CapitalizedContractCostGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Detail)",
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Revenues Recognized under Agreement (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i41aa40e6f7734a11a5ad5d91444e8c71_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Detail)",
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Biogen MA, Inc. (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if5c7233362b14b3f8c28730e21b1dfe0_D20200401-20200430",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i53b0aa3b185a4cf3bd831669a1dfa206_I20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Detail)",
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Kite Pharma, Inc. (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "ib66c834fe5304c54a6528c55110a0e7e_D20180401-20180430",
      "decimals": "-5",
      "lang": "en-US",
      "name": "sgmo:MilestonePaymentsReceived",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Sanofi S.A. (Detail)",
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Sanofi S.A. (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "sgmo:TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "sgmo:TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Detail)",
     "role": "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
     "shortName": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES - Pfizer Inc. (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "ifda78d9bb9e34007aba808bc57d3ccc7_D20170501-20170531",
      "decimals": null,
      "lang": "en-US",
      "name": "sgmo:AgreementTerminationTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Detail)",
     "role": "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail",
     "shortName": "STOCK-BASED COMPENSATION - Stock-Based Compensation Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i6787fd385b854be098bb92baa474ae00_D20200801-20200831",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "sgmo:StockOfferingProgramMaximumValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - STOCKHOLDERS' EQUITY (Detail)",
     "role": "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail",
     "shortName": "STOCKHOLDERS' EQUITY (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i6787fd385b854be098bb92baa474ae00_D20200801-20200831",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "sgmo:StockOfferingProgramMaximumValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "ib005ea27f73e4fc39f345a9958296961_D20210701-20210930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - INCOME TAXES (Details)",
     "role": "http://www.sangamo.com/role/INCOMETAXESDetails",
     "shortName": "INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-5",
      "lang": "en-US",
      "name": "sgmo:EmployeeRetentionCreditCARESAct",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "role": "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "if55a7657a1994f36b1f94d2c9400151a_D20220701-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "idcd86bcf9af64a3a815fcc501ba0ad77_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "idcd86bcf9af64a3a815fcc501ba0ad77_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:FairValueMeasurementPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - CASH EQUIVALENTS AND MARKETABLE SECURITIES",
     "role": "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES",
     "shortName": "CASH EQUIVALENTS AND MARKETABLE SECURITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "sgmo-20220930.htm",
      "contextRef": "i1f8b0a077a184eeb814ccdfb8f8d0f5a_D20220101-20220930",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 53,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "verboseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "verboseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "verboseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.sangamo.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "sgmo_AchievementOfCommercialMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Achievement of Commercial Milestones.",
        "label": "Achievement Of Commercial Milestones [Member]",
        "terseLabel": "Achievement Of Commercial Milestones"
       }
      }
     },
     "localname": "AchievementOfCommercialMilestonesMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_AchievementOfFirstCommercialSaleMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Achievement of first commercial sale milestones.",
        "label": "Achievement Of First Commercial Sale Milestones [Member]",
        "terseLabel": "Achievement of first commercial sale milestones"
       }
      }
     },
     "localname": "AchievementOfFirstCommercialSaleMilestonesMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Achievement of specified clinical development intellectual property and regulatory milestones.",
        "label": "Achievement Of Specified Clinical Development Intellectual Property And Regulatory Milestones [Member]",
        "terseLabel": "Achievement of specified clinical development intellectual property and regulatory milestones"
       }
      }
     },
     "localname": "AchievementOfSpecifiedClinicalDevelopmentIntellectualPropertyAndRegulatoryMilestonesMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Achievement of specified preclinical development clinical development and first commercial sale milestones.",
        "label": "Achievement Of Specified Preclinical Development Clinical Development And First Commercial Sale Milestones [Member]",
        "terseLabel": "Achievement Of Specified Preclinical Development Clinical Development And First Commercial Sale Milestones"
       }
      }
     },
     "localname": "AchievementOfSpecifiedPreclinicalDevelopmentClinicalDevelopmentAndFirstCommercialSaleMilestonesMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Achievement of specified research, clinical development, regulatory and first commercial sale milestones.",
        "label": "Achievement Of Specified Research Clinical Development Regulatory And First Commercial Sale Milestones [Member]",
        "terseLabel": "Achievement of specified research, clinical development, regulatory and first commercial sale milestones"
       }
      }
     },
     "localname": "AchievementOfSpecifiedResearchClinicalDevelopmentRegulatoryAndFirstCommercialSaleMilestonesMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Achievement of specified sales based milestones if annual worldwide net sales of licensed products reach specified levels.",
        "label": "Achievement Of Specified Sales Based Milestones If Annual Worldwide Net Sales Of Licensed Products Reach Specified Levels [Member]",
        "terseLabel": "Achievement of specified sales-based milestones if annual worldwide net sales of licensed products reach specified levels"
       }
      }
     },
     "localname": "AchievementOfSpecifiedSalesBasedMilestonesIfAnnualWorldwideNetSalesOfLicensedProductsReachSpecifiedLevelsMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital Acquisition Of Noncontrolling Interest",
        "label": "Adjustments To Additional Paid In Capital Acquisition Of Noncontrolling Interest",
        "terseLabel": "Acquisition of additional shares of Sangamo France"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalAcquisitionOfNoncontrollingInterest",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate additional revenue recognition milestone method revenue eligible to receive.",
        "label": "Aggregate Additional Revenue Recognition Milestone Method Revenue Eligible To Receive",
        "terseLabel": "Potential amount to be funded for achievement of specified commercialized and sales milestones"
       }
      }
     },
     "localname": "AggregateAdditionalRevenueRecognitionMilestoneMethodRevenueEligibleToReceive",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_AgreementTerminationTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement Termination, Term",
        "label": "Agreement Termination, Term",
        "terseLabel": "Agreement termination, term"
       }
      }
     },
     "localname": "AgreementTerminationTerm",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "sgmo_AmortizationAndOtherChangesInRightOfUseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization And Other Changes In Right-of-Use Assets",
        "label": "Amortization And Other Changes In Right-of-Use Assets",
        "negatedLabel": "Amortization and other changes in operating lease right-of-use assets"
       }
      }
     },
     "localname": "AmortizationAndOtherChangesInRightOfUseAssets",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_AtTheMarketOfferingAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At the market offering agreement.",
        "label": "At The Market Offering Agreement [Member]",
        "terseLabel": "At-The-Market Offering Agreement"
       }
      }
     },
     "localname": "AtTheMarketOfferingAgreementMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_AtTheMarketOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "At The Market Offering",
        "label": "At The Market Offering [Member]",
        "terseLabel": "At the Market Offering"
       }
      }
     },
     "localname": "AtTheMarketOfferingMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_BiogenMAIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biogen MA, Inc.",
        "label": "Biogen MA, Inc. [Member]",
        "terseLabel": "Biogen MA, Inc."
       }
      }
     },
     "localname": "BiogenMAIncMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_CNineORFSevenTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "C nine ORF seven two.",
        "label": "C Nine O R F Seven Two [Member]",
        "terseLabel": "C9ORF72"
       }
      }
     },
     "localname": "CNineORFSevenTwoMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_CashEquivalentsAndAvailableForSaleSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": 3.0,
       "parentTag": "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalents and available for sale securities.",
        "label": "Cash Equivalents And Available For Sale Securities",
        "totalLabel": "Total cash equivalents and available-for-sale securities, Estimated Fair Value"
       }
      }
     },
     "localname": "CashEquivalentsAndAvailableForSaleSecurities",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalents and available for Sale Securities Amortized Cost",
        "label": "Cash Equivalents And Available For Sale Securities Amortized Cost",
        "totalLabel": "Total cash equivalents and available-for-sale securities, Amortized Cost"
       }
      }
     },
     "localname": "CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": 1.0,
       "parentTag": "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalents and available for sale securities, gross unrealized gain, before tax.",
        "label": "Cash Equivalents And Available For Sale Securities Gross Unrealized Gain Before Tax",
        "totalLabel": "Total cash equivalents and available-for-sale securities, Gross Unrealized Gains"
       }
      }
     },
     "localname": "CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": 2.0,
       "parentTag": "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash equivalents and available for sale securities, gross unrealized loss, before Tax",
        "label": "Cash Equivalents And Available For Sale Securities Gross Unrealized Loss Before Tax",
        "negatedTotalLabel": "Total cash equivalents and available-for-sale securities, Gross Unrealized (Losses)"
       }
      }
     },
     "localname": "CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CashEquivalentsGrossUnrealizedGainBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Equivalents Gross Unrealized Gain Before Tax",
        "label": "Cash Equivalents Gross Unrealized Gain Before Tax",
        "terseLabel": "Cash equivalents, Gross Unrealized Gains"
       }
      }
     },
     "localname": "CashEquivalentsGrossUnrealizedGainBeforeTax",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CashEquivalentsGrossUnrealizedLossBeforeTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Equivalents, Gross Unrealized Loss, Before Tax",
        "label": "Cash Equivalents, Gross Unrealized Loss, Before Tax",
        "negatedTerseLabel": "Cash equivalents, Gross Unrealized (Losses)"
       }
      }
     },
     "localname": "CashEquivalentsGrossUnrealizedLossBeforeTax",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_ChangeInCollaborationAgreementScopeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change In Collaboration Agreement Scope",
        "label": "Change In Collaboration Agreement Scope [Member]",
        "terseLabel": "Change In Collaboration Agreement Scope"
       }
      }
     },
     "localname": "ChangeInCollaborationAgreementScopeMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_CollaborationAgreementEquityIssued": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Agreement, Equity Issued",
        "label": "Collaboration Agreement, Equity Issued",
        "terseLabel": "Collaboration agreement, equity issued"
       }
      }
     },
     "localname": "CollaborationAgreementEquityIssued",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CollaborationAgreementNumberOfAdditionalProductTargets": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Agreement, Number Of Additional Product Targets",
        "label": "Collaboration Agreement, Number Of Additional Product Targets",
        "terseLabel": "Number of additional product targets"
       }
      }
     },
     "localname": "CollaborationAgreementNumberOfAdditionalProductTargets",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "sgmo_CollaborationAgreementRemainingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Agreement, Remaining Period",
        "label": "Collaboration Agreement, Remaining Period",
        "terseLabel": "Remaining period"
       }
      }
     },
     "localname": "CollaborationAgreementRemainingPeriod",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "sgmo_CollaborationAndLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration and license agreement.",
        "label": "Collaboration And License Agreement [Member]",
        "terseLabel": "Collaboration And License Agreement"
       }
      }
     },
     "localname": "CollaborationAndLicenseAgreementMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration and license agreements number of products approved under agreement.",
        "label": "Collaboration And License Agreements Number Of Products Approved Under Agreement",
        "terseLabel": "Number of products approved"
       }
      }
     },
     "localname": "CollaborationAndLicenseAgreementsNumberOfProductsApprovedUnderAgreement",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "integerItemType"
    },
    "sgmo_CollaborationArrangementCommissionFeePortionOfGrossProceedsValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Arrangement, Commission Fee, Portion Of Gross Proceeds, Value",
        "label": "Collaboration Arrangement, Commission Fee, Portion Of Gross Proceeds, Value",
        "terseLabel": "Financial advisory fees"
       }
      }
     },
     "localname": "CollaborationArrangementCommissionFeePortionOfGrossProceedsValue",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CollaborationArrangementResearchPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaboration Arrangement, Research Period",
        "label": "Collaboration Arrangement, Research Period",
        "terseLabel": "Research period"
       }
      }
     },
     "localname": "CollaborationArrangementResearchPeriod",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "sgmo_CollaborativeAgreementMilestoneAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Agreement Milestone",
        "label": "Collaborative Agreement Milestone [Axis]",
        "terseLabel": "Collaborative Agreement Milestone [Axis]"
       }
      }
     },
     "localname": "CollaborativeAgreementMilestoneAxis",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "stringItemType"
    },
    "sgmo_CollaborativeAgreementMilestoneDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Agreement Milestone",
        "label": "Collaborative Agreement Milestone [Domain]",
        "terseLabel": "Collaborative Agreement Milestone [Domain]"
       }
      }
     },
     "localname": "CollaborativeAgreementMilestoneDomain",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_CollaborativeAgreementPercentOfInitialRecognition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Agreement, Percent Of Initial Recognition",
        "label": "Collaborative Agreement, Percent Of Initial Recognition",
        "terseLabel": "Percent of initial recognition"
       }
      }
     },
     "localname": "CollaborativeAgreementPercentOfInitialRecognition",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "sgmo_CollaborativeArrangementEstimatedReimbursableServiceCosts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement estimated reimbursable service costs.",
        "label": "Collaborative Arrangement Estimated Reimbursable Service Costs",
        "terseLabel": "Collaborative arrangement estimated reimbursable service costs"
       }
      }
     },
     "localname": "CollaborativeArrangementEstimatedReimbursableServiceCosts",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement Estimated Reimbursable Service Costs For New Research Plan",
        "label": "Collaborative Arrangement Estimated Reimbursable Service Costs For New Research Plan",
        "terseLabel": "Collaborative arrangement estimated reimbursable service costs for new research plan"
       }
      }
     },
     "localname": "CollaborativeArrangementEstimatedReimbursableServiceCostsForNewResearchPlan",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CollaborativeArrangementLicenseFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, License Fee",
        "label": "Collaborative Arrangement, License Fee",
        "terseLabel": "License fee"
       }
      }
     },
     "localname": "CollaborativeArrangementLicenseFee",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CollaborativeArrangementMaximumMilestonePaymentReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Maximum Milestone Payment Receivable",
        "label": "Collaborative Arrangement, Maximum Milestone Payment Receivable",
        "terseLabel": "Maximum milestone payment receivable"
       }
      }
     },
     "localname": "CollaborativeArrangementMaximumMilestonePaymentReceivable",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CollaborativeArrangementMaximumNumberOfProductTargetsToReplace": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Maximum Number Of Product Targets To Replace",
        "label": "Collaborative Arrangement, Maximum Number Of Product Targets To Replace",
        "terseLabel": "Maximum number of product targets replaced"
       }
      }
     },
     "localname": "CollaborativeArrangementMaximumNumberOfProductTargetsToReplace",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "sgmo_CollaborativeArrangementNumberOfMilestonesAchieved": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Number Of Milestones Achieved",
        "label": "Collaborative Arrangement, Number Of Milestones Achieved",
        "terseLabel": "Collaborative arrangement, number of milestones achieved"
       }
      }
     },
     "localname": "CollaborativeArrangementNumberOfMilestonesAchieved",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "sgmo_CollaborativeArrangementNumberOfProductTargetsSelected": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Number Of Product Targets Selected",
        "label": "Collaborative Arrangement, Number Of Product Targets Selected",
        "terseLabel": "Number of product targets selected"
       }
      }
     },
     "localname": "CollaborativeArrangementNumberOfProductTargetsSelected",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "sgmo_CollaborativeArrangementResearchServiceFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Research Service Fees",
        "label": "Collaborative Arrangement, Research Service Fees",
        "terseLabel": "Research service fees"
       }
      }
     },
     "localname": "CollaborativeArrangementResearchServiceFees",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Standstill Restriction, Ownership Threshold Percentage Ownership Percentage",
        "label": "Collaborative Arrangement, Standstill Restriction, Ownership Threshold Percentage Ownership Percentage",
        "terseLabel": "Standstill restriction, ownership threshold percentage ownership percentage"
       }
      }
     },
     "localname": "CollaborativeArrangementStandstillRestrictionOwnershipThresholdPercentageOwnershipPercentage",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "sgmo_CollaborativeArrangementStandstillRestrictionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Standstill Restriction Period",
        "label": "Collaborative Arrangement, Standstill Restriction Period",
        "terseLabel": "Standstill restriction period"
       }
      }
     },
     "localname": "CollaborativeArrangementStandstillRestrictionPeriod",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "sgmo_CollaborativeArrangementTransactionPrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement transaction price.",
        "label": "Collaborative Arrangement Transaction Price",
        "terseLabel": "Collaborative arrangement transaction price"
       }
      }
     },
     "localname": "CollaborativeArrangementTransactionPrice",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Development And Sales Based Milestone Payments, Maximum Amount Of Achieved Milestones To Be Eligible For Payment",
        "label": "Contingent Development And Sales Based Milestone Payments, Maximum Amount Of Achieved Milestones To Receive Payment",
        "terseLabel": "Maximum amount of achieved milestones to receive payment"
       }
      }
     },
     "localname": "ContingentDevelopmentAndSalesBasedMilestonePaymentsMaximumAmountOfAchievedMilestonesToReceivePayment",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "sgmo_ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent development and sales based milestone payments to be received.",
        "label": "Contingent Development And Sales Based Milestone Payments To Be Received",
        "terseLabel": "Contingent development - and sales-based milestone payments to be received"
       }
      }
     },
     "localname": "ContingentDevelopmentAndSalesBasedMilestonePaymentsToBeReceived",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_CustomerContractLiabilityMilestonePaymentEligibleToReceive": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer contract liability milestone payment eligible to receive.",
        "label": "Customer Contract Liability Milestone Payment Eligible To Receive",
        "terseLabel": "Development and sales-based milestone payments to be received"
       }
      }
     },
     "localname": "CustomerContractLiabilityMilestonePaymentEligibleToReceive",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Including US Government-Sponsored Enterprises Classified as Cash and Cash Equivalents",
        "label": "Debt Securities, Available-for-sale, Including US Government-Sponsored Enterprises Classified as Cash and Cash Equivalents",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_EmployeeRetentionCreditCARESAct": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Retention Credit, CARES Act",
        "label": "Employee Retention Credit, CARES Act",
        "terseLabel": "Employee retention credit, CARES Act"
       }
      }
     },
     "localname": "EmployeeRetentionCreditCARESAct",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_ExtendedResearchTermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extended Research Term Of Agreement",
        "label": "Extended Research Term Of Agreement",
        "terseLabel": "Extended research term of agreement"
       }
      }
     },
     "localname": "ExtendedResearchTermOfAgreement",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "sgmo_GainLossOnFreeShares": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain (loss) on free shares.",
        "label": "Gain (Loss) On Free Shares",
        "negatedLabel": "Gain on free shares"
       }
      }
     },
     "localname": "GainLossOnFreeShares",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_InitialResearchTermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial research term of agreement.",
        "label": "Initial Research Term Of Agreement",
        "terseLabel": "Initial research term of agreement"
       }
      }
     },
     "localname": "InitialResearchTermOfAgreement",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "sgmo_JefferiesLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Jefferies LLC",
        "label": "Jefferies LLC [Member]",
        "terseLabel": "Jefferies LLC"
       }
      }
     },
     "localname": "JefferiesLLCMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_KitePharmaIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kite Pharma Inc.",
        "label": "Kite Pharma Inc [Member]",
        "terseLabel": "Kite Pharma, Inc."
       }
      }
     },
     "localname": "KitePharmaIncMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_MilestoneAchievementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Achievement",
        "label": "Milestone Achievement [Member]",
        "terseLabel": "Milestone achievement"
       }
      }
     },
     "localname": "MilestoneAchievementMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_MilestonePaymentsReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone payments received.",
        "label": "Milestone Payments Received",
        "terseLabel": "Milestone payments received"
       }
      }
     },
     "localname": "MilestonePaymentsReceived",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_MilestoneRevenueReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone\u200b revenue receivable.",
        "label": "Milestone Revenue Receivable",
        "terseLabel": "Milestone revenue receivable"
       }
      }
     },
     "localname": "MilestoneRevenueReceivable",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_MilestoneThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Milestone Three",
        "label": "Milestone Three [Member]",
        "terseLabel": "Milestone three"
       }
      }
     },
     "localname": "MilestoneThreeMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_NovartisInstitutesForBioMedicalResearchIncMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Novartis Institutes For BioMedical Research Inc.",
        "label": "Novartis Institutes For BioMedical Research Inc. [Member]",
        "terseLabel": "Novartis Institutes for BioMedical Research, Inc."
       }
      }
     },
     "localname": "NovartisInstitutesForBioMedicalResearchIncMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of clinical or regulatory milestones included in transaction price.",
        "label": "Number Of Clinical Or Regulatory Milestones Included In Transaction Price",
        "terseLabel": "Number of milestones included in transaction price"
       }
      }
     },
     "localname": "NumberOfClinicalOrRegulatoryMilestonesIncludedInTransactionPrice",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "integerItemType"
    },
    "sgmo_NumberOfOptionsToExtendInitialResearchTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Options To Extend Initial Research Term",
        "label": "Number Of Options To Extend Initial Research Term",
        "terseLabel": "Number of options to extend initial research term"
       }
      }
     },
     "localname": "NumberOfOptionsToExtendInitialResearchTerm",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "sgmo_NumberOfResearchProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of research program.",
        "label": "Number Of Research Program",
        "terseLabel": "Number of research programs"
       }
      }
     },
     "localname": "NumberOfResearchProgram",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "integerItemType"
    },
    "sgmo_OtherProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other products.",
        "label": "Other Products [Member]",
        "terseLabel": "Other products"
       }
      }
     },
     "localname": "OtherProductsMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_PfizerC9ORF72Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfizer C9ORF72",
        "label": "Pfizer C9ORF72 [Member]",
        "terseLabel": "Pfizer C9ORF72"
       }
      }
     },
     "localname": "PfizerC9ORF72Member",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_PfizerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfizer.",
        "label": "Pfizer [Member]",
        "terseLabel": "Pfizer Inc."
       }
      }
     },
     "localname": "PfizerMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_PfizerSB525Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pfizer SB-525 [Member]",
        "label": "Pfizer SB-525 [Member]",
        "terseLabel": "Pfizer SB-525"
       }
      }
     },
     "localname": "PfizerSB525Member",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_PreApprovalMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-approval Milestone",
        "label": "Pre-approval Milestone [Member]",
        "terseLabel": "Pre-approval milestone"
       }
      }
     },
     "localname": "PreApprovalMilestoneMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_ProceedsFromEmployeeRetentionCreditCARESAct": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from Employee Retention Credit, CARES Act",
        "label": "Proceeds from Employee Retention Credit, CARES Act",
        "terseLabel": "Proceeds from employee retention credit, CARES Act"
       }
      }
     },
     "localname": "ProceedsFromEmployeeRetentionCreditCARESAct",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Arrangement, Expenses Reimbursable, After Specified Date",
        "label": "Research and Development Arrangement, Expenses Reimbursable, After Specified Date",
        "terseLabel": "Expenses reimbursable after December 31, 2023 (up to)"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementExpensesReimbursableAfterSpecifiedDate",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Arrangement, Expenses Reimbursable, Through Specified Date",
        "label": "Research and Development Arrangement, Expenses Reimbursable, Through Specified Date",
        "terseLabel": "Expenses reimbursable through December 31, 2023 (up to)"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementExpensesReimbursableThroughSpecifiedDate",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research and Development Arrangement, Post Transition Assistance Period",
        "label": "Research and Development Arrangement, Post Transition Assistance Period",
        "terseLabel": "Post transition assistance period"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementPostTransitionAssistancePeriod",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "durationItemType"
    },
    "sgmo_ResearchServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research services.",
        "label": "Research Services [Member]",
        "terseLabel": "Research services"
       }
      }
     },
     "localname": "ResearchServicesMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Collaboration Agreements, Grants And Licensing Concentration Risk",
        "label": "Revenue From Collaboration Agreements, Grants And Licensing Concentration Risk [Member]",
        "terseLabel": "Customer concentration risk"
       }
      }
     },
     "localname": "RevenueFromCollaborationAgreementsGrantsAndLicensingConcentrationRiskMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_SBFiveTwoFiveAndOtherProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "S B Five Two Five And Other Products",
        "label": "S B Five Two Five And Other Products [Member]",
        "terseLabel": "S B Five Two Five And Other Products"
       }
      }
     },
     "localname": "SBFiveTwoFiveAndOtherProductsMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_SaleOfStockExcessConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of Stock, Excess Consideration Received on Transaction",
        "label": "Sale of Stock, Excess Consideration Received on Transaction",
        "terseLabel": "Excess consideration received on transaction"
       }
      }
     },
     "localname": "SaleOfStockExcessConsiderationReceivedOnTransaction",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_SalesBasedMilestoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales-based Milestone",
        "label": "Sales-based Milestone [Member]",
        "terseLabel": "Sales-based milestone"
       }
      }
     },
     "localname": "SalesBasedMilestoneMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_SanofiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sanofi.",
        "label": "Sanofi [Member]",
        "terseLabel": "Sanofi S.A.",
        "verboseLabel": "Sanofi"
       }
      }
     },
     "localname": "SanofiMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Revenue From Strategic Partnering Collaboration Agreements And Research Activity Grants As A Percentage Of Total Revenues",
        "label": "Schedule Of Revenue From Strategic Partnering Collaboration Agreements And Research Activity Grants As A Percentage Of Total Revenues [Table Text Block]",
        "terseLabel": "Schedule of Revenue from Strategic Partnering Collaboration Agreements and Research Activity Grants as a Percentage of Total Revenues"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromStrategicPartneringCollaborationAgreementsAndResearchActivityGrantsAsAPercentageOfTotalRevenuesTableTextBlock",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "sgmo_SeparateUpfrontFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Separate upfront fee.",
        "label": "Separate Upfront Fee",
        "terseLabel": "Separate upfront fee"
       }
      }
     },
     "localname": "SeparateUpfrontFee",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_StockOfferingProgramMaximumValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Offering Program, Maximum Value",
        "label": "Stock Offering Program, Maximum Value",
        "terseLabel": "Stock offering program, maximum value"
       }
      }
     },
     "localname": "StockOfferingProgramMaximumValue",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_StockPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Purchase Agreement",
        "label": "Stock Purchase Agreement [Member]",
        "terseLabel": "Stock purchase agreement"
       }
      }
     },
     "localname": "StockPurchaseAgreementMember",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "sgmo_TenantAllowance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tenant Allowance",
        "label": "Tenant Allowance",
        "terseLabel": "Tenant improvement allowance included in contra-lease liability"
       }
      }
     },
     "localname": "TenantAllowance",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "sgmo_TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Termination And Transition Agreement, Increase (Decrease) In Research And Development Expense",
        "label": "Termination And Transition Agreement, Increase (Decrease) In Research And Development Expense",
        "negatedTerseLabel": "Decrease in research and development expense"
       }
      }
     },
     "localname": "TerminationAndTransitionAgreementIncreaseDecreaseInResearchAndDevelopmentExpense",
     "nsuri": "http://www.sangamo.com/20220930",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r29",
      "r31",
      "r80",
      "r81",
      "r215",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r198",
      "r199",
      "r200",
      "r201",
      "r214",
      "r221",
      "r263",
      "r264",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r418",
      "r454",
      "r456",
      "r468",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r143",
      "r199",
      "r200",
      "r250",
      "r252",
      "r421",
      "r453",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r143",
      "r199",
      "r200",
      "r250",
      "r252",
      "r421",
      "r453",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r196",
      "r198",
      "r199",
      "r200",
      "r201",
      "r214",
      "r221",
      "r254",
      "r263",
      "r264",
      "r291",
      "r292",
      "r293",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r418",
      "r454",
      "r456",
      "r468",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r196",
      "r198",
      "r199",
      "r200",
      "r201",
      "r214",
      "r221",
      "r254",
      "r263",
      "r264",
      "r291",
      "r292",
      "r293",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r418",
      "r454",
      "r456",
      "r468",
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r30",
      "r31",
      "r80",
      "r81",
      "r215",
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r22",
      "r386"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r146",
      "r147"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedLabel": "Amortization of (discount) premium on marketable securities"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Employee Benefits, Current",
        "terseLabel": "Accrued compensation and employee benefits"
       }
      }
     },
     "localname": "AccruedEmployeeBenefitsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r17",
      "r36",
      "r38",
      "r39",
      "r442",
      "r461",
      "r462"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r35",
      "r39",
      "r45",
      "r46",
      "r47",
      "r83",
      "r84",
      "r85",
      "r343",
      "r383",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive (Loss) Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r83",
      "r84",
      "r85",
      "r301",
      "r302",
      "r303",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r266",
      "r305",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r235",
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "terseLabel": "Recognized portion of equity issued"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r296"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r108"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options and RSUs outstanding (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHAREAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r162",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r11",
      "r76",
      "r132",
      "r135",
      "r141",
      "r172",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r338",
      "r344",
      "r367",
      "r384",
      "r386",
      "r425",
      "r440"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r21",
      "r76",
      "r172",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r338",
      "r344",
      "r367",
      "r384",
      "r386"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r355"
     ],
     "calculation": {
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total cash equivalents and marketable securities and free shares asset"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": 2.0,
       "parentTag": "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedGainBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Available-for-sale securities, Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": 2.0,
       "parentTag": "sgmo_CashEquivalentsAndAvailableForSaleSecuritiesGrossUnrealizedLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Available-for-sale securities, Gross Unrealized (Losses)"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r153",
      "r179"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "totalLabel": "Available-for-sale securities, Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails": {
       "order": 2.0,
       "parentTag": "sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "verboseLabel": "Maturing after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails": {
       "order": 1.0,
       "parentTag": "sgmo_DebtSecuritiesAvailableForSaleIncludingUSGovernmentSponsoredEnterprisesClassifiedAsCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "verboseLabel": "Maturing in one year or less"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofcostandestimatedfairvalueofshortterminvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r149",
      "r154",
      "r179",
      "r427"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Total marketable securities",
        "verboseLabel": "Available-for-sale securities, Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "auth_ref": [
      "r151",
      "r179"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r8",
      "r151",
      "r179"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "terseLabel": "Marketable securities, non-current"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r70",
      "r71",
      "r72"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Property and equipment included in unpaid liabilities"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostGross": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Gross",
        "terseLabel": "Contract asset"
       }
      }
     },
     "localname": "CapitalizedContractCostGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r4",
      "r7",
      "r68"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash equivalents, Amortized Cost"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_CashAndCashEquivalentsAtCarryingValue",
       "weight": 1.0
      },
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Total cash equivalents",
        "verboseLabel": "Cash equivalents, Estimated Fair Value"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r69"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r62",
      "r68",
      "r73"
     ],
     "calculation": {
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents, and restricted cash, beginning of period",
        "totalLabel": "Cash, cash equivalents, and restricted cash as reported within the accompanying Condensed Consolidated Statements of Cash Flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r62",
      "r369"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease) increase in cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsMember": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Equivalents [Member]",
        "verboseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingEstimateByTypeAxis": {
     "auth_ref": [
      "r91",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of change in accounting estimate.",
        "label": "Change in Accounting Estimate by Type [Axis]",
        "terseLabel": "Change in Accounting Estimate by Type [Axis]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ChangeInAccountingEstimateLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Change in Accounting Estimate [Line Items]",
        "terseLabel": "Change in Accounting Estimate [Line Items]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ChangeInAccountingEstimateTypeDomain": {
     "auth_ref": [
      "r91",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the accounting estimate that was changed that had the effect of adjusting the carrying amount of an existing asset or liability, or that will alter the subsequent accounting for existing or future assets or liabilities.",
        "label": "Change in Accounting Estimate, Type [Domain]",
        "terseLabel": "Change in Accounting Estimate, Type [Domain]"
       }
      }
     },
     "localname": "ChangeInAccountingEstimateTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "auth_ref": [
      "r327",
      "r328",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "terseLabel": "MAJOR CUSTOMERS, PARTNERSHIPS AND STRATEGIC ALLIANCES"
       }
      }
     },
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CollaborativeArrangementMember": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity.",
        "label": "Collaborative Arrangement [Member]",
        "terseLabel": "Collaboration agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper securities",
        "verboseLabel": "Commercial paper securities"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r27",
      "r428",
      "r446"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r83",
      "r84",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r13",
      "r386"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r41",
      "r43",
      "r44",
      "r50",
      "r431",
      "r449"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss attributable to Sangamo Therapeutics, Inc."
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r41",
      "r43",
      "r49",
      "r334",
      "r335",
      "r348",
      "r430",
      "r448"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Comprehensive loss attributable to non-controlling interest"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r41",
      "r43",
      "r48",
      "r333",
      "r348",
      "r429",
      "r447"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r121",
      "r122",
      "r145",
      "r364",
      "r365",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r121",
      "r122",
      "r145",
      "r364",
      "r365",
      "r464",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r121",
      "r122",
      "r145",
      "r364",
      "r365",
      "r464",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r121",
      "r122",
      "r145",
      "r364",
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Percentage of revenues"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r123",
      "r364",
      "r366",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r121",
      "r122",
      "r145",
      "r364",
      "r365",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r238",
      "r240",
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Portion of contract asset recognized"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r238",
      "r239",
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "verboseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r238",
      "r239",
      "r251"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r238",
      "r239",
      "r251"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenues, non-current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r255",
      "r262",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSoldAmortization": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for allocation of cost of intangible asset over its useful life directly used in production of good and rendering of service.",
        "label": "Cost, Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSoldAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLoss": {
     "auth_ref": [
      "r155",
      "r179",
      "r182",
      "r184"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit loss related to marketable securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded": {
     "auth_ref": [
      "r183"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), for which no credit loss was previously recorded.",
        "label": "Debt Securities, Available-for-Sale, Allowance for Credit Loss, Not Previously Recorded",
        "terseLabel": "Allowance for credit loss related to marketable securities, not previously recorded"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAllowanceForCreditLossNotPreviouslyRecorded",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r312",
      "r313"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income tax"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r66",
      "r130"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r268",
      "r269",
      "r297",
      "r298",
      "r299",
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r51",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r96",
      "r99",
      "r105",
      "r106",
      "r107",
      "r111",
      "r112",
      "r353",
      "r354",
      "r432",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Earnings per share, basic (in dollars per share)",
        "verboseLabel": "Increased earnings per share, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r51",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r99",
      "r105",
      "r106",
      "r107",
      "r111",
      "r112",
      "r353",
      "r354",
      "r432",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Earnings per share, diluted (in dollars per share)",
        "verboseLabel": "Increased earnings per share, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "BASIC AND DILUTED NET LOSS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/BASICANDDILUTEDNETLOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r369"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r45",
      "r46",
      "r47",
      "r83",
      "r84",
      "r85",
      "r87",
      "r93",
      "r95",
      "r115",
      "r173",
      "r235",
      "r236",
      "r301",
      "r302",
      "r303",
      "r318",
      "r319",
      "r352",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r383",
      "r457",
      "r458",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r355",
      "r356",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": {
     "auth_ref": [
      "r355",
      "r356",
      "r357",
      "r361",
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.",
        "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]",
        "terseLabel": "Summary of Fair Value Measurements of Cash Equivalents and Marketable Securities"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r216",
      "r218",
      "r219",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r356",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r355",
      "r356",
      "r358",
      "r359",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r216",
      "r255",
      "r256",
      "r261",
      "r262",
      "r356",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r216",
      "r218",
      "r219",
      "r255",
      "r256",
      "r261",
      "r262",
      "r356",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r216",
      "r218",
      "r219",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r356",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value, Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r216",
      "r218",
      "r219",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r360",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair value on recurring basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r162",
      "r163",
      "r169",
      "r170",
      "r171",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r180",
      "r181",
      "r185",
      "r186",
      "r217",
      "r233",
      "r350",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Gain on disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r9",
      "r188",
      "r189",
      "r190",
      "r191",
      "r386",
      "r424"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r47",
      "r54"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of income (loss) including portion attributable to noncontrolling interest. Includes, but is not limited to, income (loss) from continuing operations, discontinued operations and equity method investments.",
        "label": "Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r195",
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r77",
      "r315",
      "r316",
      "r317",
      "r320",
      "r322",
      "r324",
      "r325",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r78",
      "r94",
      "r95",
      "r131",
      "r314",
      "r321",
      "r323",
      "r451"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.sangamo.com/role/INCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and other accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.",
        "label": "Increase (Decrease) in Accrued Interest Receivable, Net",
        "negatedTerseLabel": "Interest receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedInterestReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r65",
      "r419"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenues"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued compensation and employee benefits"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Net changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r65",
      "r380"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r192",
      "r193"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndOtherIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).",
        "label": "Interest and Other Income",
        "terseLabel": "Interest and other income, net"
       }
      }
     },
     "localname": "InterestAndOtherIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestReceivableCurrent": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of current interest earned but not received. Also called accrued interest or accrued interest receivable. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Interest Receivable, Current",
        "terseLabel": "Interest receivable"
       }
      }
     },
     "localname": "InterestReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Fair value of investments available-for-sale"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r168",
      "r422",
      "r437",
      "r465",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "CASH EQUIVALENTS AND MARKETABLE SECURITIES"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letter of credit established as a deposit"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r23",
      "r76",
      "r136",
      "r172",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r339",
      "r344",
      "r345",
      "r367",
      "r384",
      "r385"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r20",
      "r76",
      "r172",
      "r367",
      "r386",
      "r426",
      "r444"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r6",
      "r25",
      "r76",
      "r172",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r339",
      "r344",
      "r345",
      "r367",
      "r384",
      "r385",
      "r386"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicenseAndServiceMember": {
     "auth_ref": [
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use intangible asset and performance of related service. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "License and Service [Member]",
        "terseLabel": "Recognition of upfront fee"
       }
      }
     },
     "localname": "LicenseAndServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MarketableSecuritiesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.",
        "label": "Marketable Securities [Table Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "MarketableSecuritiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r236",
      "r336",
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Buy-out of non-controlling interest",
        "terseLabel": "Buy-out of non-controlling interest"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash provided by investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r62",
      "r64",
      "r67"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating Activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r40",
      "r42",
      "r47",
      "r94",
      "r95",
      "r341",
      "r347"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "verboseLabel": "Net loss attributable to non-controlling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r88",
      "r89",
      "r90",
      "r91",
      "r96",
      "r97",
      "r104",
      "r107",
      "r132",
      "r134",
      "r137",
      "r140",
      "r142"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss attributable to Sangamo Therapeutics, Inc. stockholders, basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r98",
      "r100",
      "r101",
      "r102",
      "r103",
      "r104",
      "r107"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net loss attributable to Sangamo Therapeutics, Inc. stockholders, diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental cash flow disclosures:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r83",
      "r84",
      "r85",
      "r236",
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non- Controlling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r132",
      "r134",
      "r137",
      "r140",
      "r142"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r379"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Long-term portion of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r3",
      "r82",
      "r127",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "terseLabel": "ORGANIZATION, BASIS OF PRESENTATION, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r32",
      "r37",
      "r368",
      "r375"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "negatedLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r34",
      "r36"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 4.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTerseLabel": "Net pension gains"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r33",
      "r36"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "terseLabel": "Unrealized gain (loss) on marketable securities, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other non-current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other-than-temporary impairment (OTTI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), recognized in earnings.",
        "label": "Other-than-temporary Impairment Loss, Debt Securities, Available-for-Sale, Recognized in Earnings",
        "terseLabel": "Other impairment charges related to marketable securities"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "negatedLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAdditionalInterestInSubsidiaries": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of noncontrolling interest during the period.",
        "label": "Payments to Acquire Additional Interest in Subsidiaries",
        "negatedTerseLabel": "Purchase of additional Sangamo France shares"
       }
      }
     },
     "localname": "PaymentsToAcquireAdditionalInterestInSubsidiaries",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r150"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r12",
      "r386"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromCollaborators": {
     "auth_ref": [
      "r63"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received from collaborators during the current period.",
        "label": "Proceeds from Collaborators",
        "terseLabel": "Proceeds from collaborators"
       }
      }
     },
     "localname": "ProceedsFromCollaborators",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from at-the market offering/ issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r59",
      "r300"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities": {
     "auth_ref": [
      "r56",
      "r150"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the maturity, prepayments and calls (requests for early payments) of debt securities designated as held-to-maturity.",
        "label": "Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities",
        "terseLabel": "Maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities": {
     "auth_ref": [
      "r56",
      "r150"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale of securities that had been designated as held-to-maturity. Excludes proceeds from maturities, prepayments and calls by the issuer.",
        "label": "Proceeds from Sale of Held-to-Maturity Securities",
        "terseLabel": "Sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfHeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r2",
      "r40",
      "r42",
      "r47",
      "r61",
      "r76",
      "r86",
      "r94",
      "r95",
      "r132",
      "r134",
      "r137",
      "r140",
      "r142",
      "r172",
      "r203",
      "r204",
      "r205",
      "r207",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r333",
      "r340",
      "r342",
      "r347",
      "r348",
      "r354",
      "r367",
      "r433"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Increased net loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCOMPREHENSIVELOSS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r194",
      "r386",
      "r438",
      "r445"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RealizedInvestmentGainsLosses": {
     "auth_ref": [
      "r452"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment.",
        "label": "Realized Investment Gains (Losses)",
        "terseLabel": "Realized investment gains (losses)"
       }
      }
     },
     "localname": "RealizedInvestmentGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis": {
     "auth_ref": [
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by form of arrangement related to research and development.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Axis]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned": {
     "auth_ref": [
      "r309",
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of compensation earned (contract income) under a research and development arrangement accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Compensation Earned",
        "terseLabel": "Revenues under agreement"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Research and Development Arrangement, Contract to Perform for Others [Line Items]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others [Line Items]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain": {
     "auth_ref": [
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others.",
        "label": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]",
        "terseLabel": "Research and Development Arrangement, Contract to Perform for Others, Type [Domain]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r308",
      "r420",
      "r470"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r68",
      "r73",
      "r466"
     ],
     "calculation": {
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents, Noncurrent",
        "terseLabel": "Non-current restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESReconciliationofCashandCashEquivalentsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashNoncurrent": {
     "auth_ref": [
      "r10",
      "r73",
      "r466"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash, Noncurrent",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r16",
      "r236",
      "r386",
      "r443",
      "r460",
      "r462"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r83",
      "r84",
      "r85",
      "r87",
      "r93",
      "r95",
      "r173",
      "r301",
      "r302",
      "r303",
      "r318",
      "r319",
      "r352",
      "r457",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r128",
      "r129",
      "r133",
      "r138",
      "r139",
      "r143",
      "r144",
      "r145",
      "r249",
      "r250",
      "r421"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "negatedTerseLabel": "Decreased revenue",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r121",
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue from contract with customer"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenuesfromStrategicPartneringCollaborationAgreementsandResearchActivityGrantsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r74",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r381",
      "r382"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Consideration received on transaction"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": {
     "auth_ref": [
      "r158",
      "r161",
      "r164",
      "r165",
      "r166",
      "r167",
      "r435",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.",
        "label": "Schedule of Available-for-Sale Securities [Table]",
        "terseLabel": "Schedule of Available-for-sale Securities [Table]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfChangeInAccountingEstimateTable": {
     "auth_ref": [
      "r91",
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A summarization of the nature of changes in accounting estimates, including changes that occur in interim periods. Changes in accounting estimate have the effect of adjusting the carrying amounts of existing assets or liabilities or altering the subsequent accounting for existing or future assets or liabilities. Changes in accounting estimates are a necessary consequence of assessments, in conjunction with the periodic presentation of financial statements, of the present status and expected future benefits and obligations associated with assets and liabilities. Changes in accounting estimates result from new or better information. Examples of items for which estimates are necessary are uncollectible receivables, inventory obsolescence, service lives and salvage values of depreciable assets, warranty obligations, and regulatory reviews.",
        "label": "Schedule of Change in Accounting Estimate [Table]",
        "terseLabel": "Schedule of Change in Accounting Estimate [Table]"
       }
      }
     },
     "localname": "ScheduleOfChangeInAccountingEstimateTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block]",
        "terseLabel": "Revenues Recognized under Agreement"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r295",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONStockBasedCompensationExpenseDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable": {
     "auth_ref": [
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A schedule reflecting the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements.",
        "label": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]",
        "terseLabel": "Schedule of Research and Development Arrangement, Contract to Perform for Others [Table]"
       }
      }
     },
     "localname": "ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESPfizerIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESRevenuesRecognizedunderAgreementDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESTables"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": {
     "auth_ref": [
      "r73",
      "r423",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage.",
        "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Restrictions on Cash and Cash Equivalents"
       }
      }
     },
     "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r265",
      "r267",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r28",
      "r45",
      "r46",
      "r47",
      "r83",
      "r84",
      "r85",
      "r87",
      "r93",
      "r95",
      "r115",
      "r173",
      "r235",
      "r236",
      "r301",
      "r302",
      "r303",
      "r318",
      "r319",
      "r352",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r376",
      "r383",
      "r457",
      "r458",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r83",
      "r84",
      "r85",
      "r115",
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r12",
      "r13",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock under employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r12",
      "r13",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock under public offering, net of issuance costs (in shares)",
        "verboseLabel": "Issuance of common stock in connection with at-the-market offering, net of offering expenses (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r12",
      "r13",
      "r235",
      "r236"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r12",
      "r13",
      "r235",
      "r236"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock under employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r12",
      "r13",
      "r235",
      "r236"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock in connection with at-the-market offering, net of offering expenses"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r12",
      "r13",
      "r236",
      "r286"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock upon exercise of stock options and in connection with restricted stock units, net of tax"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r13",
      "r18",
      "r19",
      "r76",
      "r148",
      "r172",
      "r367",
      "r386"
     ],
     "calculation": {
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r46",
      "r76",
      "r83",
      "r84",
      "r85",
      "r87",
      "r93",
      "r172",
      "r173",
      "r236",
      "r301",
      "r302",
      "r303",
      "r318",
      "r319",
      "r331",
      "r332",
      "r346",
      "r352",
      "r367",
      "r370",
      "r371",
      "r376",
      "r383",
      "r458",
      "r459"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r75",
      "r220",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r234",
      "r236",
      "r237",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r377",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r377",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r377",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.sangamo.com/role/STOCKHOLDERSEQUITYDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r162",
      "r163",
      "r169",
      "r170",
      "r171",
      "r217",
      "r233",
      "r350",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESBiogenMAIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESKitePharmaIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESNovartisInstitutesforBioMedicalResearchIncDetail",
      "http://www.sangamo.com/role/MAJORCUSTOMERSPARTNERSHIPSANDSTRATEGICALLIANCESSanofiSADetail",
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USGovernmentSponsoredEnterprisesDebtSecuritiesMember": {
     "auth_ref": [
      "r255",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debentures, bonds and other debt securities issued by US government sponsored entities (GSEs), for example, but not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB). Excludes debt issued by the Government National Mortgage Association (GNMA or Ginnie Mae).",
        "label": "US Government-sponsored Enterprises Debt Securities [Member]",
        "terseLabel": "U.S. government-sponsored entity debt securities"
       }
      }
     },
     "localname": "USGovernmentSponsoredEnterprisesDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r79",
      "r255",
      "r262",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. treasury bills"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CASHEQUIVALENTSANDMARKETABLESECURITIESSummaryofCashEquivalentsandAvailableforSaleSecuritiesDetail",
      "http://www.sangamo.com/role/FAIRVALUEMEASUREMENTSDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r116",
      "r117",
      "r118",
      "r119",
      "r124",
      "r125",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/ORGANIZATIONBASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r98",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Shares used in computing diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r96",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Shares used in computing basic net loss per share attributable to Sangamo Therapeutics, Inc. stockholders (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.sangamo.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "270",
   "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e777-108305"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=SL6284422-111562"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aaa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27340-111563"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(i)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905575&loc=SL49131252-203054"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "808",
   "URI": "https://asc.fasb.org/topic&trid=5833765"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613674-111683"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569655-111683"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4616395-111683"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62586-112803"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.3(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r471": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r472": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r473": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r474": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r475": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r476": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r477": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r478": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r479": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r480": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r481": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r482": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r483": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r484": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(2))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.18)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>63
<FILENAME>0001628280-22-028168-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-22-028168-xbrl.zip
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M=PF],YY+(5T27-411*T ,_0 <YA!'6[&R<Y[K\NL*603671,"Q%$M'6(4"O
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M8 :YKM:HP7UB0S6NOYUD+G-,5CM(DBMAF$?(S#E35CN7#/B5PO7]A%+-'6_
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MED1/9_@&0U9*.:<9BRIHYX(**6MM)"@I%53;DBPS=N[$IJ"R@7$.TCFA #@
M).U4AA1\.=9B<>'PN;S?79'R9$/L%='\U<.UL[,>D>!/^V4K0'3O'R)%S%:
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M#L3H& ])2<>T9%%IR5FN *.K431WTN@]8'(\.+(\JNP)C));BNO+@)WRH"K
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ML9169:XBV5S=7=U;;6R<GK6[E]@;RN"Z(6AL=U?_<:>8O .S>KNW_VQL;)E
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M!X]U_OXIN7ZCM91>QMA$XSTI>>3-D)-J(H_('1?6.JB5_$>5G-0*&FUZ$6Q
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M P&&*0<HTPXHH0EPQBH.TXKZL+$I91L]7%-IG@^ET<K(NVD#E[*TW7_'15D
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M\@C0P S26@4?3-0P2%OP)CDGGX/W8@J [*I8MF*1J:9^JME=4!X"Y9!KY$&
M2@,*"8]Z Q5 (8BEE5XX;=)YN39#=>5Q9+=$ U%;E_*04;L4U,XI"(H')[B+
M*K_7*JK\00!)K #(&Q71+ E1.&5BM 5LT@&SY^""V*]:ZZ8^V65K[7):0#^
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M 'SOAZ-!85-OZM0L)CLGEJU!7$QXZEF0&6@9#/1A08D@CD<+QG'@"?& 2J*
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M=(G7\:;IZ_XJ1L>OQ\/X['XP9:2SS$>U\]%B22E/HRI!D0*0\'1LG$&@"'-
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MU5E+-=3,JZ'O_7_'Q; 8^0,_^%I87^FM[[WM'_7*NY0J; YNUJ;)+E85B#M
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MRMH*HS8CL%YG\5,)PCWW+(>U3V*X3R+93_%=#J2M 3O^F&-'1Y"%Q&I@F96
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MMG,I+U->IKQ,#Y.<-3@!L^1LHN1<< U"B10TT )K=4IO@0'HJ"@#XSET')G
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M+!@1PO]U<,LV*'NY24VN>%FW/JEKQ)8V)ZM#LS]'\TE-B A+ ]$ <8D Y5H
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M;3<ZGVCBS*^:*8!7/]$F/NUXM/PGR\;WB("2P_G57,N F7_/!Y/!7.@S#\S
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M(H4B3F%*/3:2.X@DBEI+#3&"/)3F%L-E96H]'^G@).9!,@6081!09"R0(4A
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MV#.-K;%>4Y^PEV#24@5_"_X6_'UX%ZFVCAHM!0]8TV"$D<1"Y4-43($\^P8
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MD6-$!*9U\>IN,O;.EQ41A@4I/'!*($!A?*6H$$ S&:S"PCK)MW8HY"V(GD]
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M,8"@CAQ&6 8,%P@81RS5SIK 500YSEM,K,!_<FMEVB#GRDL&B(?SO!2 >"*
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M($)@PE!"C;7VKX.$D@@3]( H64!O5:!W]/J&TE:"QBW108"H3J>!--(I[ /
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MZ_Y?@3D2]PX-/$LQ^Y8GL]9RX)UU0@1##0PK,VN+*_*'%?'7\27HCW-=GB@
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M*@-TAX#19H BESPKEDE)&$; "4I,\HF@-463ULIG79PS4P&C L9- 88Q,?J
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M0TM)<O!"6<$A!Y8\ I3-+-TP-N7^WRF2[VD\JK!T.5AJ7\D-2GI1RL1[#XJ
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MK0I&;@QCF]"8/G7C\0'.V7_<8#]5"F-I%,;GQ2J0(I44#2D3R4O.!I& 6,6
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MRG^5_TJ@W*G\+Q H@4;.4.H3!2 0J24^\D0,9).C0=- +(] J?)?Y;\2%5U
M@985$*27((P@BBM/0&NT!]  (%HA  26F&?B'GD!CRK#Z>99&3VN%M[VL^PK
MG8EGK#V\]1X^JO)!38'A3R/LSW WE<_NC883M$1C#W_K3P]0I_GI#Q+H7,9^
M>,!60J1192Z<2BQ!CM%8R5743"JM68SIHE9"S2%\=\;"8ETAF96*3'@2N&]J
M%["2-882#]EZR<%1UJ2.6=64=B7G>:UA< _ENB8"OAEY;AG_VG&5=13$<"U)
M.78N-4D]T<ED(V6RH#0:_U64[XTH7R8)R%W+<JTK=!U9;M-YC"<%- 22@ M2
MF!EB(F?HS:L T=MHC5]9-XNU2&I9H0[*<0?$N.;<O14Q;F>RB,(PIA41H>3<
ME1(E6!A)N B6:>>5SK(QL16#KNCE1W7/[NEH=S>-0]\->GMN+XVORP4\_ +H
MV='B&#+'F(,LG0TF6QX43]YXQ73E KH/5(OUA)3T/'-KB!%>$6#&$6.T(=(X
ML)1S2+H4"*!R52^MGE!7XJ^K8-^F8%<RX&8$NF5Y2&J]%D$2X) )>.#$4&X(
M%3S'S%SR)63YVK4,JRAWD@RX:UFN9,!U9'GQ<I1C1F;4RRIY_&(5L4%DPB6E
MF6LOF#&E..GU2_=4.7X4*KF2 ;<BQNT076K*+4=/>!"HEP,-I5PG_B0$$Q 3
M-]'.;6S9&<7\J,(%GH[&>Z,QZK,:%W Q?)*,&9:#Y%J 8,XG(RSCTB699 P7
MCAZL7,#=X=1B29D (64I.*&^I-]5UA'/$R5<6Y6"84$!K*P+L:KYLBK*U$.(
MQRC7E0JX&7EN!P7[9!-WD>1$@8!VC/CL!4&O086<8TJ2U[B ^R3*EZ("[EB6
M*Q5P'5EN4P$@:%2>9^)%# 0BM^4G0;SE0EB?E$G7I0*J'#\FE5RI@%L1XS8[
M;RFN%J7$4Z"HDJ,GCB5&M.> WT&%2!L36YEKG[;5N("KIE G94PIUIB GX&3
MRH8Y&;S.*8%6U)3 <FH<(I8UGK/* W0?I,("#Q"91P<A2&(L, 2I4E566"!&
M>2N#,)R&L+*NZ:JAG:$KZ_G#/93KR@/<C#RWC([(N9<&?8=L.<IS9I+82 $M
M#^Y 9D95AB7P %64.\D#W+4L5Q[@.K+<Y@$XUUI38PB5"0@DQXG)P(FS,L7
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M&083/XWYR!66ZO?I^WB\-J8T@YZ!"E0\)(VCF<=0(X)T#KN5H;2Z7)H\.OM
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M:P.\J<WE<H_+N[V J.IL03\WS_:'6C+V-5CN[[@P.UKZ0EJZ :!N;#Y^YQN
M-XITW_R;AQQ:-?KA-F1T0X?BZQL0;T-BMVWTOAOD_1CDK7DLQ/^M;5[-LOU,
MWFU^B_9J&Z-:D]*Y=0?P-<M !W<></[KB^:W96_R[S&QVQPVR[TN;9%KJPI!
MN5/!ES17*J?4"2[\#;W:"%]M-!U1/!V)7/6LIH) L(@'3=#^6'_<SLG*[Z<C
M[.S-^<?ABW?O/Q[^^_?W;XZ?\K?O#B1<2P^/?ZV.?GO#CMX]OX)KAV_?O:I>
M_/9&M/? NV9OLS_S%\=//[XY?W5V>.S.#Y^\9_#\CX>_/:=OW_V9';[[?7CX
MV[_.CWY[+MYBI: K^O&?QT^GAZ\I?7%\^O'H]"3P HC"*,)\SHA@M"2Z4(R8
MG//<L8R%7#]X5.S)<K5@4/+2?@F7M&"X+;?<"N:7WK<L*G9H];=#*\<$*P23
ME&5*""]*E0LCB@(@J] VJ!LZB.W0ZJZAU:<EM)*^",&ZG.@L""*X4@0E$^'.
M>\$UU;DM'CQ2>["S.[3:H=7=1BO%<D:Y9,(!6$F=&2F5=;K -NP^\.R&8IP[
MM+IK:,66T(JZX+ECAO LDT1DSA)C#2,NA+PT(E#.,".*[V793KG:P=4=ARL
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MC2L+C]F,='_3P:G/K7+-M?6Y5%P&5X@R*W3I"^5*IDNK5%GRFUS3.UKXNK1
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M8NA?F4WLU='I"2A'0969)%9;8 YO#"F#*TC@P"2@5BMFL5/F%FP"(N%0)P_
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MI G/Y=X\@SE&Y+HU;P3>FNOZ[!9A[4/E\>SV?V8@"3SFKJ82Y^]FN!%1G(S
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M+656/WB4K6^JMFN=\C<@@G?/OV7KE%JGDM+UO%?*#B+N#74P[/&E<Y/E&O1
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M[*!66;I5:"^3N329E]IPP9A35!E-96E4Z8M2N&W+(!\D^=*<6,&1'/GIX[1
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M9K#*N)-6& VZ#"]ES_'%]$"D$GM-/<!O9T"V#6U.M3P;PXJ<7I&)5\%VP@#
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M1":N%-BSPE.@;WB4NX$,$]\'911[P9,7L;>U[I#'7.(09/^P."5?EXI>B;R
MM/"ONU"4]M(X$YS!"WSN9W&68I8JS:-8Q6'$HEM3%)D?3>%)0S5_%"(#\W5Z
MU6(YOA972%:[=O#'Y1LS] WMK*.=@V-YPD7J8<,E-PZ:(YA)RK@;L#C6?B2C
MQ(NQ6W:R(@T]3SQ81VRV  QGTEAG<_B:*)$Z-ZF-W<R%30J@'U 4H K@%ZRL
MTZCLC<IL[>)1L^,U_7)WRKPW66<-8Q#,IZ!\MML@BRV>ZO4 ;JET7X.QI>P%
M&UJ]+:T&ASOO3G2")VAR[@K!4<ZED9L*[;D*3[E)GW/I)T"K471W6EUM9/<H
M[8:8H7$@2_0""[*BK!W:!E;0.)XB"HTC1FB7D-?87'\7;ACT68%"GM</O9TH
M.(IU/1LU8=0%SH1!][BS-W%K8O6L#W2,[ZX-XDB&0JLXBSF/8R$B4%,\22(5
M<R9YL-$&WY7#/FU?[A^_/4FB)$[\C+LZBQ*7BSASLX@Q-XG37')/B(2#-N!Q
M>),I,6B2+&.L$]6?0S$RX#I)O" 48<ZSS$ORG 5"9QXX'ID4R<G>+0BEI8=.
M) ,58(7^AA#6$<+!SO:)!),QRJ+ 92I7+BR_<+-<*#?+@(.ESOTXSY^\"+R;
M;<K;",Z[$T?*0Z;\/$_#(.'<2[(LC7D4>SE/PTA(M2&.KT0<ASLH):22"E2P
M#A001QKZ("7\W(U$$$51&@6) "G!;I821!SSFM($3S%XE.GKX_P#S!TTJ9Y*
M4XH0O65P8Z1L56RCY4="+88HFKR#S;,4E7)-<&FEWMUR]L9M'JV-G]!H*( /
M;YKWRRE,TJ0;*8[5Z7O[ZC8"=$-&@]9$4'3$T4A\PF1#"TR@#^SY3U>!JIMB
M8 [/LHG3-DT@QF.<"-9YHFE V;!ZAN/I!;_QZ2O74\VTF1Y%N+M@]0!#A!7%
MW;*BK O84M'?1I-^,XE/8QV9K;B/G3@N'4R6#YRU$J,U8!9-?YEK/PLBG3,?
MQ(;*1!J)6$L1QJF,]+P9LHQXX<U;(5W^Y5SW(AL',RS/.<Q;^5)O&V-++0?+
M0;:TP?*?M>SJTW9P\.'/$PT&O1>RW/43#XR/2'G@BJ9@?$B?I4IKGBG^Y,7T
MHERNF^K9JW>->WT90:S3*-;\K*W5N0E@K=WYPYW=DR#+8Y]Q[6:8*^$LE&Z:
M2>YZ7I)F7.B0"_'D17BS/L&0=^...V?B7(,6T>/&UU%6#A4@,\_*"XT)NK6D
M8B79-Y(?Y7A[K&RI5YMIJQM!\MI*U>T)C KF064T[64W@C[^A *%[W_Z\T0$
MX+SH+'/37#.7^VD"!);F;I@'<9J K(FE]^3%>(4\:=58CX;LVC?'XRL-JZ[O
MKH&8\((@3+U0ABGG:98D,?=8%/LQ&*Y@QAH*8GY#0<&\"3M/00V!O+3Q@\/J
M31L<Z+3/GG'"U-[X&'14;4;ZN@)JVY#."M(Y^/3Q)--YD'I1ZO(X"5S.9>!F
MX!F[,I8Y2"699+Y<33HV/88YF#[Y:,ICK++N'EMVZKB?&;2G/U=DE/M92(F0
M&G@2VORR??023+A)(9W(BYIR'4.BQM3M:F2$(VVHIQ]"FW9D#*P*=-RN:[^P
MD, S[F(+,!$F<>0%(E(2O)H\BY(PXH*#9(<M#[([QJC66(?7\^#&-&@8<?=R
M?T>>Y#KE><Q#5Z08\XT%&(6(I:XB >Z_\)DO$%\GX+>-2%5Z@I62;7E;/V=J
M$@T+?<8-)]_1K/PVI-3D6(_,4%_!0#?4M(Z:#CZ]/4E!^1)&4^3Y,8AUI5P1
MB\#-P<(,I$YT)/(G+^+T5IE2HHL>&-#&&?U!*.7P^/3$"WF6QBQS19@*D#LJ
M=),8K( P\C+@Y#32*EKCC+;>QGP61?1]DRX)=*<D2B1EJ-,D##.@72&21, H
M.=!0HD0B;N^L;HHTOB5!71V (@MX$GA!'+FQC$.7A]AUCREP2[ [DY^%"L3+
M;7S<[C  FC>+)Q,P8%:-[6$(H!OS1ZO3#(@7W(?AM28^N*@!SX2UYTQ*S80#
M_ST#4NZ?(ZAT,<IF56U,+7C"J#7;\C:PAT<WZ(;:N0"/R1GIZ99S@%G)MH1Y
M7 .!%>-^20#,8W6ZGYY1-*9B4_RU: QN.=O=!*F6\5P,9VV%[=QK%XJI\/M"
MT;&D,59BEC-0__#LLJH']L5-_A2_MH'9^4PJA3U[)0JFEFX*)CCMV&S<+$Y3
MIPY/Q%M-'GI&57"FB!PF?*;-)-N[IE=]E8,_G8NJ(,BI9O 6D8F(HQR"(#*F
M<S-'*OFKM&M71:]>Q/YT:0TMNIU:^[Z;ML6$F8?#N3TW<I 6U\3(P3Q#-"5X
MJUD#<U=_V3!7@T1<Z7:"3IM&,'!\)&]E4<G9J)ZBWP'VFY2SZC&[6EC.6^"
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MO#T)PC#789BY<0!^*(@@!43$I!LF20Z;HW46)%^&!;0)2RV&I?KPFAN0I.M
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M@8\58I$&S:53\/ZYEZ9"Y2P43UX<+.NM945F!<$9F/Z9UN.N#$A]462TM;'
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M^Y'G1J)*%AKE*85KFL=8F4_WH<0EDAL6Y^:\&FCUHB4QFBY)ASP?%E2\0GR
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MXMN RG\&H;<5F!][%2!2U&<#^J^#L75P+[LL@BD],7CF(/@JTME;V-'OC/+
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M\L"-H)VG3MN9ELPD6&+3Y5N0C=UNQK7'P[K2AQ5G#I#>]%+E6<<(3?$PV6)
M/$V?5_0ZP6;K'$Q+S'V>6:"L96I_C#O<;5J?%V&]T1T"JP7-A>G\F3@3F%^]
M.?-63(\JUI_V:\P 0S?4DKL+>RY12I$W?%C/R(/%?KPFJ(U.@_5SE\^GF"WL
M9!E!V3?4L&!@;#FO04Q@!\I&\5E!8$+PO;HUBA T)V;_%RL-S1G7WHE8_-8$
M,KJSL8W7T<Z]IV=O0?=&=%$)A95HRB0WC/$Z)^>((VAQL]Z)'%J,_KCG1]A[
M@2Q/QQ1#(9N5V*$I-FH&C0V*34ZUE10FMSD<6J.FP'M%72(RRY41VG?H3_M
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M1]&NB?KO8Q_DK(@!4! +526=C:!)LP1SNFM2S#E3O44U67CU<+/ B6O*OR@
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M/38A694F)8=+?[]"I3W[Z-G(1'EV!WG?F1\_A3)M[/UV'VG!2'@@)&)":!B
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M<X&.Y7>H!YQRY9XOJSWS^GJN]!;[[-X.(V\&_QFGD^#/_Q]02P,$%     @
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MYFXQ81!N9KU@E]2TK!-?PA,7.:^ Y:%\4<?)URRY,2-S_.7=_P%02P,$%
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MIL_V+AKR">"\=] 'WQ_T)_W4])1UD)T.Q'I*B4PJ$7"*DF12<-0;T'!/6&5
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MOV[D;:.O\'G6>(=E+Z+,D7 G%&I?(2-CP%C81D:=-/AR[9.4BZ.KL"\Q+A>
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M>M518KTSXS?E9#!(AQEE@E*87)8RFDFYGV%ZK+UGM6::\TA<.4PBRYT,0'E
MCY]3F0P&H+IVS?=BR!8BUO>2;&]1:?6.7N#X[]WM<814'_?#),6KNS_N/G'K
MG;/:Q8?SYJH&;>]+F#J71S!)>SFG4(XZ,0<V41)%++>]!X$^I6 $,K-!T"!<
M]8*#]8ZP0O?(12D)S&F!/CK13!2^9$6L4H'P(((TS!NK6VCBNU21U(8/?G27
MXW-Z3;:A_IK-3>?AF^4Y[^+35G!@PA/E5=G0,9J@K>1$HQ>FF*16^-HG?1='
MUZ7BHI=/SU75WS8]W_:', QW\:&7EI5'S\V5,XY2&(6KK3+$*ZY=UBYRN:82
MTSGHNE2M]/+IN:KZJ]%S-L3#?'O8A\.5!-P#;66PI1_1M/-;SB7>U8)D8W2B
M^%\.M<UL"\/H4L75"R+\I@FU";\"\'4%Z/)X#+*)E.4WT$"T !278=;'-;F]
M3_H52VR8P>5TM_ADM!U0)^/T#L9_INGQG9OS8[T08LK>4 *V;"7;@"K*Y=*'
M&&VV(5OOJW<#6P38,YW^C03WJU+JP39;=8W5VWV]#VT[QGZ1' RN4UK[P^,+
MW_1C'\93F%QX(04G@2N*<S^4RXPY)92A!HS.G+/6B?44R$ZU\=@4R:IJLCW"
MW<ETX:ISD^P2U'.D/4X(A3&"U(X3:ZDAVCHN N=4R=HM.A9']TSW^_ND6!W=
MU2PE"2G%IK2PGJ51?TN#>#)Z!Y-B9"]O&=LH%(W,9Q(@BY*A!>*8]R0K9A">
M#UG7;IRZ.+HN>;KKHE8[JFN%6E>8$,NT:GDV)Z;W7P\&S2/ N<Q,1RL)3@D@
MDCF/]A9*QW3.K';&Q.IW6U6 W:6[03= QG4H>Q.Y+>5=5A1PVHBR1:6,)"YR
M08QG7 <)%$)M-V[9W-9JLW6_:2[P\]&BW+KZJ8?^-'<:_>P0O9K=*VM]LL2C
M$RX$#T*JVM733X+JTGY(2TQZ;*:MKJCJ3NK5$8&3T0E\*55)I[.&+>6.^OEG
MX4"%I,OU,6 UNM2:E2I*GDBT6F9E' NJNENQ)-:7$"-5I]LZ]-J*SW$S.69G
M\3X.X_3V(AQ-_W,IYYX/?-HZY6MF<3JC#L_+"PUZZ$YY;C4)JG1/T;Y</\HY
MB6 R QP8=;7[R+8ZH"[MAVS4>FZ"(&VVUSD\^G7[_?Y_3Z\+?[-]O']\^/;#
MT=[QWON3Z5/;[W>//[Y[MWWTS\.WQ_N_OM]_N[^SC:_M[!Q^?'^R__[7#X<'
M^SO[>\='*8Q0^H/9:?=1+AJ"X?W<]FZ:0']P=UR+->K9",X*+7\V+]]:/<57
MVM,P.H;@M"_=YLO9*W0T?%2,,,^8H4'14/URRXK;8<M):_N!>K;1<(W'EV@+
M?H?!1>JQI$(P./6%+$GIR'$)3"*69L."&\9ID+4=FH6 =<E77A_O'G1RKJ[#
M:L[+ PG< WG3"ZF7N5%2YTBLB.4B=*F(8X(1[G+0*3!JJW>T7QS==U,%M!+1
M6M)FFV[#V^W]H]^W#S[NO=O;/OYX-.M?M_SJ_MC'55B$%T9;::V<G=]Z"_WQ
MU$:4@\F#47,Q3KURTMUGQH@RZ(M*:BR!G!+Q7H@8'?=6US[7^TTP[:QQ\T8M
ML[%<,4D4I;ETV);$@@W$^2A]\7BUK)V;71A<E]:Z.KQ9;!U;54_U.C1<7Q]?
M$@1P>]-^-_G)K:0O#08C-J$)1R!$EF(=8*5G%E<N>RVC<K4+!A?%UJ5UK!T2
MM:*E5OO&;A__MO=?'_?1[A=KCX$61EG_N7>R_>8 PZ\=_/L3#*N.BU#'E[-X
MZM;LP-#JZXCSPQ$ON\ZU#ZI&E]KU2J[6FGN/H'=I>77PNJ1GFLD;:/KHL:7,
M<];HK*F2^V9*HL>&E'7.T9QC#C37=HR?B[&V:;WW?2%<G%U,<[6_CD=-<],Z
MO9R7>E.TEZ8=T:DQ&-$D8HM_*QWU.*,=ACE2\NAB<%"]4+L*\$X5P[5*SZ>,
M=?MZ;\T;6!1Z.=YW SV5"PT]3T0G1"T#,P@=71JG7&0>(W(OJK=OJ@&\4W[$
M2V#L\FI?O__*:1*6@R%<EBN,O:;$9L9)Y-2JH*4.U3N)U_1?U[6]LU'>55%>
MG0X^]_..M_RJ!V#O2*67E,U1YDRH*D=K#$X#ZY(C3#N5K.,@4G[*4UT-PMH&
M_N@")E.)<8PCGG)?0I% ?$H&PQ_%BS(S U5=#IWW2-9(KCN]CS:BUO5/Q4<7
M*"&- &\X<5*B%0G>$Y?P-R.YXT%J;6-LFY&=<SA>("&7U^KZ"=F+*@LG')^U
MX9$4&/%6)A*8B!"LP@7252==%SR*ET"L9VFG8]8L1.$MYY((PTNM.'?$1AN(
MX50&&8L]KN]G+&[-5A/+HR-GBB;*2N]BEU!I*BGBO,@D!YZ8-TY&1I<9^:JF
MNNV-BLWQY[$)5DU5'<MBB,R,-L*@ 2H-KBS#2)9)3X(U'/T?8"G5;GWWW60Q
M-L_4S7%A SX&]\($<*ZL7=-;,S.&QU(2)[1,23B?;=L^1IL;V$ZI!(D#R3J@
M$?$1RF6(@AA()@3JF:U^I]*+VL!NES#+;V@_1V_K3P@*L)93'+E'(<RJDZT5
MG-@4,@K$6T=K]V)[21O:ZR55*UK;N,-^-W,BN 3'A$+  $2"S02 <B)=#$9(
MD;Q[<@N[Q81858?][LAQUF>7?<3ULAQ8Q#63^/(0HG;90F(ZL0H.^RK9OF[,
MH6K\>8;#OKRJ-NZPWX5>2EZDD8$$8\H]SDP2[WPB5J!9 .9,[(S#_FRF=L[:
M5V?JYKA0M9GLTR7K4&ZRQZAEVN&J0 O$<0<$<)&T 2) J'U[VQ+'#EI<#2+W
M*6<<L8^^[" D2=!++!7;J#0>J9>^1OJF>WL_[?%D:7/_'%VTXDX]&G9G[T'J
MB*N/5"7LMJ6B0&?"G/.0-751+W8Q2N5$WSH/16R,*,NKHF6#.B_4U,9 5$P3
MX27#L&!:@#"+#;1#6\]4K%UR5#5%L,YNINTPJEV==:A6.8R:"0QCZ<IR5OR0
MC$/[7(8VRLWI:#R9I/%9_^;BNUG1;;.&>N4E@:V_9KF&!%>L6Y[:OWNNY3W'
M\^O)\8_'OXX^I_&P@#D^'PV;4;G%M?2=.Q_WF]3L#*!I^KF?XG8SG_T]Q[U.
M07KBA E$TDR)%X!4]RP#6M40[[?D^L9"MC;([:;A;CH/E185_>'A,/TSP?CN
M#G"$#-/2DMF2(ZU H25!3-#4.J&X9K5O\5@==6?2#MTD]_/R?M5ILJ8L\PWN
M[8R21-@GI^/1Q:?3M_W/TQ'<JW50QC-93GX501*,6\NIH  D6$II\LRJ^W[N
MVIB^T "ZX#-_AZ2O3YX%W:BKY\L_'IKTRP__!U!+ P04    " !.@&-5ZLPV
M$^5-  "2;@, %0   '-G;6\M,C R,C Y,S!?9&5F+GAM;.V]67=;27(N^NY?
M4;?NZPU7SD,OM\^B)*J:MB3*(LL^OB]8D9.$TR0@ V!5J7_]B00)D2()<@/(
M#5"$>I X0'M_&?%E9D1F#/_RO_X\/_OI]SR9#L>CO_[,_YG]_%,>Q7$:CC[^
M]>??3E^#^_E__>L__=.__#\ __O%AS<_O1K'B_,\FOWT<I)QEM-/?PQGGW[Z
MKY2G?_^I3,;G/_W7>/+WX>\(\*_S?_1R_/G+9/CQT^PGP82X_=O)7WQP*C!C
M@"690!EAP$OZ"@W3!:WQR,S_]_$O10C%(K.@#?>@G#+@!"(8:;V0RF7.XORA
M9\/1W_]2_P@XS3_1X$;3^;=__?G3;/;Y+[_\\L<??_SSGV%R]L_CR<=?!&/R
ME\6G?[[Z^)]W/O^'G'^:>^]_F?_VZT>GP_L^2(_EO_SOMV].XJ=\CC <36<X
MBM<OH->GV==_>!.-_N7RE_31Z? OT_F_?S...)NKY]$A_+3T$_4[6'P,ZH^
M"Y#\G_^<II__]9]^^NE2<CB)D_%9_I#+3U=?_O;AZ"[2X6CV2QJ>_W+UF5_P
M[(P0SY\P^_(Y__7GZ?#\\UE>_.S3))>EZ!=#KJ!TA?/_UJ?]LC&F3P1D$B]"
M!OII'E6"-\1XW],WQ_SU69!RP8NS64/$=Y_=%._X'(<M!7SGT0W0SA\$Y_D\
MY$E+J-\\]P;.!<C;".LCISCZB.?C?X[C\U_FZ%X>OWMU^.[D\!5]<7+\YNC5
MP>GAJY-3^O/MX;O3D^/7)Z?'+__];\=O7AU^.#G\C]^.3O_[\3%,/YZ/H:Z\
MS$LV![O.:VX,B;@S' WK<O2&OKUZ5\7?\^#RG[,\2CG]_-,P_?7G83).&ZF%
M1R>55@R5]SDE3=N%5$J+P3HOK*-<C/-L'+]Y_UE=A,=?67.&(9_-?SJXF,)'
MQ,^#DQGMAW5K),'D(_IR.LB,,U<, Z4MAPH14%@)*EOI!4O"LWB7<],%APM.
MPYQU5Z_XI2KREWPVFRY^,E?M7*W+45QJ;_UQ'8TB;?73_"I?_GTT.IF-X]\_
MC<\2F0V'_W,QG'WY,#X[>SV>_(&3-% >HTY9@'6*=G1-F[E77-,&+Q(:I5$:
MVWC0*T+\5B+7C#Z8+&1SM6*LN:14.Z@I-V;C[:GDDA8TOI]_&D_H<7_]F6W*
MH)?C\_/Q)<233SC)TZ/I]"*G ;V=>1X91&D=*,9(!(&^5<P*)9 EY*DQ4Y9
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MO8<<="I1DNF6NW5,[/"R/;5E>]%%OY4B[N!;%,SN@/!^2W8]UNSDY*L7=:W
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M9!M(Z>7X_'.FP=2Q'.)D5 MV2Z]<R0IDI"&H1!/ )Z&!)16#=L:7U#I!M.D
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M=EU]9/SQ4F=?A_ VSSZ-T]4'[@XDD/F-#!.4$FD@A9PU[S('HWAB@2F,H5L
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M>Y@]80H_4HWCV3!X!:6W-@BO,ATJUN-R\CG'81GFM @5O3&HH]$LGYWE.+O
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MQ I&7^SMADWKQ4\M7KBG!SSK"[UE-OL"Q!4!N\!H&6EY_>KMW]:N*?S;ZMM
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MG7%EW(_.>K@>7P)MT8NK [B>(C@>!+:;R(QF:NQ&CPUTL'6B)).<M5Q!IJ]
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M&AF>4*Y',([&K,]G@5(TD#Z,U$;]GP;1IUYZNQ)0,[&DI\83CS9PD@#0\YV
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M9Q7<HU]I%H]>Q2+P1TN&FW3(;#2G[6MYDF!,1L]@STS!&"N "C%/!.-Y .M
M$\1HRF^66Q3ICKZH#4T<<^SW+UE"FVTL _J!AX$QL6WI[>A#3"LW8VZ$?8:]
M)W:%33_AD):2&"^@A',CVFXAU,O-9B7C45'&9[*BJN TW^6/D7,G#+.95KI(
ME(>#K:D&5H(+.4$L&4BBPK<L XV0OD+$Q6"E'<N?0\<5BPI.R& ^LYBEG\Q,
MP^G["U]LI+LV&%,(:1/H8\8XI;98)1LO?!@]X 7J@Q-S'UWM.5IH_,.WD9L
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M/BVL4F (_I+P51$^13U-M^XA&/K$VFONC<<FP[/[\=/P"U_R,RD&";:)D>0
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M_^LKPB4IBW9T)$W?:"XN9V"SJ73H&82$K&%(V>GUII,8^0\F]Y2/B8Z";L4
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MB$_ID4GK,I>Y=^M>JXYG47H%7BW!_6D>W/Z!FDY!>21+Z[1X/NV6G>W(])T
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M.1N?2]ANS<83_4\4KSLZ>+IEG?[@<,VQVCA#I&/NB7GR:GU>BLZ);,6@S(;
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MJ!=X!^%474?,BBP76I,F/6132K/N"Q_4-@:?E:C->)RR/^449G%"8F>M8'G
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MI'H:A>VPQX$N.:H&#8T$&R["><Z3_7I#<B>6['/AV$9]LOV'9D+\>?Q8"IS
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M,G+(Z A!)D^.%6W[%4$./(*)68;I-5;R'$$]02IF*EH]VR.ML=V5N7-R5;S
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MY#L-R.#XX*:2WK@0 0(K=BSH3X,;&#QT30#E2"(DIP]<?PC@]K6PR@<>AKV
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M^RFS)[%XO1.KJ8&&E\Z0\OX ]T$U'(OP9OZ\O0;R*YRX-KXB/5HKQY<FU*Z
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M>X]=);<-!-,[!7N7XV'OZ@OU13OZJ:?HG)UE-"\S5K2$AE@!B(S6A@^W<VW
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M^(OE2YB(2]&7MOYJ*WK"UXCG!]06J I'RT)FQ#V:U1<=_(:6GXM<GO^%Q%B
M]<##W!>![&EO(B.S,BK@=>7?OO)'L+80N>G#N-!F 68=D\X$'"W<02WO-[_*
M1K,,%I1FH'9;O>KOC.DI7CI-G::+&06P*%3N?.G+$51(\PQU'KW@,B$3'5=W
MDZIT*)0TK!66H=_.>LP/L*$4K672M0VA=W=S4U0\8)-E>49,^IP<<TO=)4/
MR4:>].B.$W3D($S")8.]^*/.!9'Y:,4A[,6S!X05F82$7K#E_6=/(1P@QU@
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MM:YY@$YZ@BI_8L^M"Z3Z1)QC"Y(Q1G:6E)8%3:%LIMHH7]2];[A5.7L)=C;
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M-:W]46;7UT1MKC",NHQ+2ER5/04T63F&Z9+<K]G8B$WX']Y\AVSS404..>+
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MY2O$/.,HTH$H7<ZGUMI&L9[A:(_-JZFFE2>#*3)$"@_23R>06D/\+<8)U@"
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MR9T;E:;<\U8MHOFG+_*8N9=<CY>"HS*43N]([R30FR/($H5-4(8*7?#QD3;
M8MOL<RHLVI>K%&_CG+&M\,I0YD5;]( /Y(IJ\GZ5KO7[&)!F_H'9]].:YF-
MSS%;6$$N['2LM8WQ\5?$FP)F)B]>H_UN=[MF\E99$0B:R>YT!9L0$7T#EE>B
M:\/9!J-)\;:Z1)72H.: 01OM*JST@\*D^QT3HAG#NQ4BR!CI/BD;=$S:_2CS
MW@J9B!/IAH%U5>74NKR1Q#V?@.^C5D9?T@PR,3S$H7<8DH6P:@'%>AEK@)^/
M-<0E  RM.S7@@1Q5&K8,\J9E6#;MV7#41OV.W$J#I1/M(<+N?AM+LB0'KR5^
MZ<RJ;2?HL\K5<-W &X,)[63N#QT40B$\D+_,4?"#SB'; ;.EO&O/>JSE[ZG
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M3?[:N^J)*P!,DR[[M>O2,4'I&/VCGGL7'%/GBZ;VQ('$U25)]]+*EV^0:V1
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M9*ES_#:^)K>J.MWGLK'FO400^"LC>1;^.7@QM:@5#QHJJV6'<P8\&WE$,2;
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M]'?.]G]4CEN%&CV>*ORF?\@V)4GDF:C+C9D=.V1[<,AFI%@G+1#YJ^Z)0NS
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ME>#UNM75"UC7'@#3J>^:Z$&A2>(%H]ZL[Y\0#->JAVD7NH*DOF@*+G>:EII
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MUHRO/8R+_%2&0)J!!"N5GDGT1G#XOLS+:!WI >D@]>V!TTC]EY0%@P&EHBG
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M%O>*F*8W)?_0(%Y61.38KRLJG>==,H;+^%R3_+C(H\.@5=X<Q6,;C43?K^V
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M'?383A\;I^E&LT6-#QEW8,74[TGDPFAKKW=*''=ZC'VR 0UW6^GBF^+B[L9
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MSCUT#?LY^[QY6EB:=O?TH:4'/7@WLJ,SC'\E!2?T3CP*YBS8MRC/^/UL^Z[
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M2B$W:G4F=3(;6!63G;VDW@$OX*OP[BV/AJ\^'-AOH-+N.W>%U5/R>R61((G
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MP*@:R+-$*TX[)4WK@\9\GV-IHR@/5RXJ.R!A8'Y5VQ9&L-5Y(<: +O?1%1M
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M!I![D?Y% <:TW./BVPFZ57>]E0;Y<#O$TDK0Z\)!F])"&*9[P9I!6 $HB95
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M!\,E$Q)%-NZL,NT]]DXM.BJTB(&8BED6ITVPYI@7*%_DI4.9:LT[%/4MMR[
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M<P UOL)D2Z'X!*8<$-E"QVNR1*1R;98/BQ:-+10&53I.3B?MF4\AU@IA;K/
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M4$">>K0O%)M^J7@$,HF:CL%^O)#?5K8,Q#*;T4LQHE0>CT"% T#%GG+@:)?
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MG(4*FJC50MC=S$KYTU<7'BIH98_YI)V0E[.F(I@7QHU]E9COSK4W_G3V'-O
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M%/";>)<K.I#,1RE,51:"ES#I%L6/8"UB2^- ]@SJ^]M7*8;5O&XN.I[+H;"
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MV2'M7#RIZJ*'K)&:>;17S0K?XY\\\DTD\'L"]03GX"BA2'K\Z%BHQ%,+G=$
MXQ/<46:8;3TW:@1P+'$%(I9@!.D,4^*N1H> 7.]U.'DY^">\(Y =3P+7\BP
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MDTL^'E5WB5]+ A 8),F7ZG9'VOMPUP^;I>9L<,PYEP0!^^UC-ICO&-CR<;-
M?E9_8;G+KDM"1\$0=5H>/CAX$/98W[(7*]=Y;:-F -ZT6JSC)525LU>:X">O
M-/IP(#1K/"YD3TU7-X &*2]>5DA>T&#MV/3[F%IWD/; ]#L65V#"XPSY*3*
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M\AE#9*#R7K9H<X"9K&?0U.G %(_;SC'WW'[&[&?-0!IR]OVA]<I=]\*IR4;
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M:BGU2%-Z;7-EH&'ANC(ZPU7"R+<*'RRNL;]ZR4:NU6_5 DS"V8A!*Y\SO9>
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MDZ7AAQ:283Y:B<#RJ_R5=*VQ7K),'W9/LCK@:8;AVDZ[_\QD0G3M/ OHD0B
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M2QQM]4G0(ZV"TL1*I%&KM[6/E)W)=>I.5K6]78+T(-SZ%#*U'\-*5E9164/
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M@OQD)L(3YE..L3\\8[A_X^\#N80J3LU+?^LFS!F07FO>DQ%?=*&VGHH1=3+
M*5[C-"\*&W3Q'VU1T9&C#J6M7E4QX(WE+GH,<T8Z4>@;1RN.3QO%49)=(ZA1
M;T\F@65%@: IT^T)7USB$/HPEIK:XRO?W^"3:HAC##:+7Y)T?EW165LZ!T3%
M285&,AM:3!)76#?,\%%_"=;GSB-\Y)LS9N<+,]O=9?4UTYO*^8G],)._O0J0
M,)$\IH3KKB:VB6CO]*2H7;SEU4,UE?FM9LND))U^S]D[LB9;7JL<,#%:]M<C
M/^^+R3RIH_WVJX_U+8614D+.1IX^C56I:ZD1J,9A,-!;A-P2A#<B\<5OCI2J
M<^0DLR^C5Q\-NR0=7:S>EI"S<&KF .:-LH3SO2V]V'\5J).OFI7GNO;#'PZ>
M!D@92U&>;V;1;KQ2LW]'RM1 5- 9_<6 TJQ[CHGET05;3J0,(D[*-3#W@I6F
M>)K^,P@)!,$Q\;T^2#B,<CX1W?=+T@7C7G_Y(>V=A +R!92A@E7[6D84D=(>
M0S)Z_6+AC3R9X]/)8(-6+  9O"?687W^-&"_OY37.3:UEO"@ILR^5'<=)OE8
M 8]PZ_/7_3%!D5CEFJ"@V[JN<GVL39P(.5"(MK1;<KD..BD\?D,1;9K_02<M
M4#D_MV^<'X$\X^YY8HE]J10>7POJU)E^J!BW8V6P8BD"L_-SBM'W8Q)X7+7?
M0W^&4I)/:JI^0:5\>0K,,=J4NMFMJ* :._S=0@18,4U4DO:"<=RU;$$9/ML%
M3&C5GC%XD:W_=EP9-]5/ZD.>I_$4MM4OW$M5[G,G&8/O P$B>.^/&U1M?KIA
MNC*?8Q:T5?>0KR'"@CX)U4VOY]EXOIF\.EN.<,6.%5CUSF"S ]X4!RH^M1
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MP#H1U*]^JE,7S5)PAU,\3 '%8_JZT>WKZ'@$2^7S&#)V=>&.\$ZG8;3P S4
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MW<V?(08@M@,6?XFCAIIXV9MR:.W!;\DAN?<3JA3OH*OB:8 N6X;H]8D?F-$
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M-7)E2%AP-5Z^?BQOC:=[\*,1S\V"#1'1X_4"GN/2+)L(Q,D7V=G5]9<G^4<
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MY/K\ZXN:X9.O^F];)Q]_:O7^:/+<7T3N<(N+P2XL;G]E3\NGV*U[(=5PSY9
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M))>N6HV?56M)^WL,MT@@_^@5F7$G-<C8B &=.(G*D& **^98/]]\L,YF=D*
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M%U.MW#>=452'1[6RJNCVJ%\_Q*@GJ40:JF5U%K\432C:D\@*Q'1J::P=$0R
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ME*6G3\/K"MA@L9@IDUC"7D!LL22.=_@VHH#N*%!">XV1E\%M$?IX]U=>?""
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M]F[[O% G3S?CL4 2*8KM8;\<FV6?.3$Q20[\=I=ZP0CP?5_,OW!*=6U&.=I
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M0BO&@6 YT!-= K/"8+!(>+)[KX6%15\&NUFKC*?:[XXJ53%&3Z9*M2UOS>@
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M/6V"V5$U#@][:U]3P(YTM2*K1[?60:]OJ6C6&.=4+KR_C'7RKA7\**.D?3U
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MHY8%\TEV>Y+U.^*XU(M4HF(B<$233"49YQ%J!Q6KE]F^K@P4&"4M6W4CJML
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M%C'6ZWJKHQ-7G)^(7?W32#E+2L:N^J>==@&!1\Y?3LOIW+8+&'IDG-QNGBY
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MJ^(:8IGOH7>1_IBZG7: /=X?SR00S>H2&I"O@DY7=D"[GA.9&;ITH!%LC>T
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M@I17F(8!'IWWNF9@$J<(<L>^&UXQV/</[PRW[YHE;*O(45MB+"%;/@5X_#@
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MF9L:/5!)"* :5@P_!3#..LZ";EF4EU5R]&MO5(+8E"K0VY#QL?S-30I;R9M
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M4$90<-\GC5 0*-O,V!WA0=;NMCR">Z!*&C']@CIMF:HX-\X(+B;#F.A5 -7
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M6#@%Z""V(_1,\TI<]-YJHK"DW$ 4\34[EY4QYP*]&-/M&IF*A7C]GC!CB-D
M'2RMRBR03CGJZUC\M9$V2XM[(B_*B&;<.$"C[_DUJYWM,IEN*V2Y%3YL+\R!
MTU7I+VG@9((U='E/RL!8[1(P 1V)_$A.IH660X. Q"&G/=I*"Z>EHQN4F-\^
MT5C,IXU8,F0IVXH"A0Z*7K.=R8(_XE=;>]"&(TZE2;Z6CVNK&IL?WU&UZ1+Z
M*&(AU)E&44U:GN;DMW&E=^8@V  ?5M)TZ;-"2J/K@9WU1%5."UR*<EB_K^QA
M3:)3CGXB&QO6P-9B( .IR<4W7$O']^K@F[AJ3J/F[=PB*J8DT"ZMNA=#,\P
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MHPF]O1]:V!5&,-=U=KSJM%2N:]5DT7S);WZ-)F@<*4F?+&ULG&X06<;'QZ]
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MQ:2;,*-QOC?U3497PWG#;!K!8&@]<9SC.$/VK_U%@UD2:"#=$+J@' %=!<H
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M9_7]9P[7?S?=<G8MEZPDWT.< N(OH&" 4P (MG1\%[NFP+-H7'<*R$R8H:8
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MO!-79*OHFYLE^:6_EE-=B.=3":A(ND(U6<'JE6"I@YP^(M=[TD\W?JS 2M@
M7E1'LS_YN^^*^*MP1,?_"PK8'VC.Q5>S##>CYY]0AFD[?>:N%@/QZ]ST>DVE
M/&?R$&:1Q7&P8T4Z-!I4Q]22&5(D'IAV^X0*@X/8YT"*5SA4<XI3[_<N^=].
M4(YU>(7@-_\0G76HY:QG&58CC(&,#HOE9FS)@/+W1J?5A_ARVB].5[XO$+,
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M^R(A 4V5T*[4LLL1Y6!E^[+AIYPG$YXB#_4J@_'+4ZT7-<7%3*!X9%YK16!
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M=#/'GA.?YDOT_2Z X)'SX>8093X,R;R0/1O=#5>SPLEK/FH56,^'?1X%V[:
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MIP[S^A9N"0XW5P5) M_ ?BJF09$[.KZ-GPN\]:Q?*<O+P#>_WLV=MV]_+FX
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MY;NWU#,L]!Q"O$5&H)=>";"=K%[TP"^&X(*VQ_)/K:_]KJ&SURT?:>(C!P>
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M4P"!P:NMJB&?62(W^\E\HC[@3+R"APHYF,SN(4@8U5.[I0E@#;D/+28V#CZ
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MY217 0.YDR3L)5USP=S)\ZYE:*BBW,; +3S4%]/>MD7#= Y27)W"2CB5E4Q
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M'Q0^8MN]HA)_X5KYI!XV4= ;A.W$T@#XXCS6QH:GF#Z<C#';#L<T^0P"X9H
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M^@0'0O?-,YH&I#(IJ;JI3MJZ^.> QV4P%Z4W:M88@*RU;W7=[@!?>ZDJ\Q#
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MPI6<H8^+P5E\TFQ;PD+ZN< JHXWJ9-Y2!^OE)ZS)<?ZB4XF6LMKS1G[@2XB
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MZYG]>R'R7F?',LZ-I['E@E8]L[9]>2/W^(^?#757/@@+!7B<N-HWT,O:E+)
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M$'IERL19E+SJ(EY ##@3%ZM$1G$3$4AD^WX?E50.W%Y1""%'[:Q5*:BTQ,F
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MF7(>?Q\$A$9VM:EJX$.<XV:UGVOIBKB],:8B(F2#J(W-+!%)EK]]'2ZMLHJ
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M^:0YQ,3<WQ!DMD4C')0.N<9&U^K"/""G'YS5"QE@:_IR(AO?E6"YN6WW#(L
M)E5[FB^O5MC\6F4U8U]5VX+] >?^O&@=2;[?MCJ)_1!I$">DS<Y5R925AM[R
M%3_H+PSBX6CL-9AYIN?M ZQA'!D&_F2F(XGCECG$&0$,<8G_CT_-_%U9.F)E
M=<02PT1XK>CSLYB)'=-:RAAPC8)?M!VN+DQKRAV/8/C5HG;]MOTN8V46) J^
M5B[P$2WZ6=,+,U(]S)^F$D/Y2KM*UV*O.[-%DU0-E,V\NT[,O]Y-RED+%42;
MO?GK1IF53OP]I@LW&!:,F;R9_VRLQ>S]ZW!E?/QF-%&#UF$8P;.38K2!26@E
M[5U:;WBC^R QNRG;2MW3^+&OM$I.A<Z)P8:5TR35:Y<*.W,3@&K/T"6DB4BD
MNM>'S!]G$T9): "Q8Y5/*')*X)&#L3@<\G3!BU3!4N@N!#Z_)^&/00SJQCNV
MQ.>K[X:8S<UXKW+V1SPDY:_IJC/BC-!H?<;TI&ZO+7@^X\@I,*+7Y\83;]?,
M!' 6YEE:]]J(3*+LKZ5,]@U4_J$B9@GH+/?0PZO]T/^46Y5AN7T[U:%[6QV%
M[]\%WDZP#OFO"%[J6IE]ODB)N%>J[T#2%K.;78H&9BII=W'$*BD3XCGJJMQE
MN?)1V4PW&Q*=<,T:Q#LQ<RX6Z['!?WK,-5?9*P&V8^5-2-.//GA&"VE0X2U=
M$+BDL"HC?/F=29)&8WLK)"S&!5/DS3R5]-H2@E!8VGRF5Q$9-F4STGD+;V:(
MLWH2P=GRT[[V"_U#'-L^LWK;+[PE(KEK0?49[<1X2XS[>\\>^]@OY3/B9K:\
M\NM\@0@L6OMRURQ*H-*P0F\0:U!.:OS[.W?/SS]P[7'=(\SAY?PZ,49V+J$/
M=QHBD0J4X*[2-\!('6] ZY-(#[7@1R6!82M\#HQ/_2'IU>+P[-LZ5TI&:#A0
MO'6OOY-B6K-JAFUF .\KIW9#Q[PH^L$<PEF>1)AWA$R!NF:3@F28#*4WMO4%
MDO( W%I[R:^FN=T(N;>H%!-VPK>_*Q"'Y$>W;(N$FWJ:1[XE?'GZ*[BA\TLR
MWW>%TR_F%K;;R1$M+:R+CWW:AC=MZY>3I;?K#Z$;!!K?[V/,W@^>OX^]#?#=
M+H9V0'06IC]?Q=$^O%_Y*UK>'.PBN$\4E8W)D@%=GZ^L.VYCHG9U37H^#:R1
MS_3=)59\Q#9KXELBI"7L($DOI0KYG_K]^&MBX5GDTI?VQQX_[[7/UP<D*\Y;
M/U'D9O=^;KW$<43ZQ@Y=<)CD2[3?2\M&;#HT.GW.ITK/-Y%VDRR,"I3$#'>
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MIEA?G^D-_PLG,WR:RNJ[.[AS=Y2)@G^,-X<-0<T\U3 V7M 4[@-(KI>Q*NB
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M:XV9A8S<MTA<<_:1D)N^7#089AEA:%]=%<"%0.T;]'S*\3B+89/O[<A"QVV
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M])N5&]<PR1\,$/'UCZ'KU*JT2=^!YM\TR1TY+V!L.%;T15_4&F1S&]P+&+^
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MCJ7;M-6^[X\%"V7MU%+$:]P(KG=S>!YXNPN1I>5MVTS!E\,\#A XTO'U[S)
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M$U[! 6'ME[9^5]@#)TBA)R !BQY1:-UD\2LK W_D&);$W^]\9#SO-IY9R0A
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M5;U]#)/RS.7\8?RP=5H\L_4*S 5]I8Z5)F-WOKX1D\C7E5G5\(+DZ\M#A:P
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M^L$U]I7M>C'Q45D0=QYH@(1\45=^I'(CU55\6Y$8J;0<(I@=,?K<"Y5 SO$
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M&LMZ]!=RNBI$QBE*ATN;9Y;J%1>JY+H_E'G.)RR,BD0G)K]^3P$J6GWT:'G
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MNP5@^R4-/&#G=*2-0S!U:]Z.<.\MV4T6*493?3*[IH9<JECFJ"7Z>>7XNH4
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MIXGG+:,?SEK [<#+H.7 M$UB)\O8U3(TL=DG.DV&Y+1-<PRKWHZYD7T[62G
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M <;@TJSQ(JL< ;)YYKAF 5LDQ3_W/PC7:@=3:$P\Z9A]+^R" 'D;V?Y4L51
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M@%G7Q[/3[)PXC'D=KN3]=W2R[B(Z?OS@/&#6I1Q&9UR]'6 FK)&OBHYSGP&
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MD[1K(C/@#/I<6V_B,;CB20/?Y;>T H+?5?^2C<9.SA:B\<Y 3&C8Z6HR?2R
MW>C%?Z?.*$[,Y:?\+KI7NM5A![ ^-Q208:RKV:-[^0VJ):[+IK%?3(5H+)$M
M&]:WE_DE6I^S.K #:\O&]DA\/%.3Q8?**=.<36;OTG_Z[]<3%;-'OB6I9Y#%
MO:<(%JN754OT^8$.;/JVX98_M.[,,2Y@H3];[>F\5B=BB:=PX< _(+O=],H?
M?I>LC-(3Q3?;&P:9<HA[V;#$1I+*X(ME+/A[!B[WAJ/4L(/F 6EZ1-:D5LFT
MA1,P,]W0:5 E6:A$3M?)7HL31G$Q4P^<;>F) U\/BJCE'J+^?;<5WQ2?W$X<
MJDRUN1R7QC"=@11L.^]=HCM5D+XX(91O=9)POZ1K8C.S>[J>A#EGRSJR='\0
MS'H4WF,XNNC0M6U93V;=@UE)K<[6*Z]TV1"0[/D9U8D]46K6FCD0/(F_Y9F
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MWL!G;@1+=342TZF9XJ ?2<-6U;7$PHPPB/$7A^UI.W3U1KSEAH8;7(D*G!_
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MN&LUCZLQ]7Z?#+Q1U.6,YH,K%.T&2NG#AU^WN"O-,'J*,;8Q.&#\W";(9'#
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M<+;1P\SH*,?.$F17EK.0*]JI"N?A;"[JPE%E!*P8'[YLJFQ@MKLZ2Q:P0S6
MRY##R1*V.#4Q5V!7R+E,3)[0CZU3=\5X@#6F[UOI>A62.U9FI$Q.O;XIEIC
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M:0CRC0@8 YN: \+^F7%9,X:'H0!E\[/YFU/OBP2K?M[U7D\S6Z-/!>@\#^V
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M_8SQVB$2@9;2I>]GV>/K^=<S]>Y<81A7P,[9 U6KB%2<]2R]LY5(U4X=/W"
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M-5O&^$,*RT036J:3:$G^;N=<U].KK\TAKX=M*,Q?][JZC=&-,+,^*<15A?'
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M"/FX(WQ<_81^F^^Q^9#4*D^?#QVPJ-S83CL*03&_^^U;C!J<#BY 5G850:*
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MUI)#0'.M3>;QJ0A@F=$V=4:C0-<DG6XO]<+0+[AWQCDX\_3#Q-%<,*K X=P
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ML1A_NKA]@-D4_!"\=@O+49J4N)3H0:\^/W7<W$YP2JM3CZ2=ES&GF;Z&G7N
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MOSG_[MO;6T,^_]?;J9T";B0;!][Q_)X4GL^7>NTCS\JR=35#Z^7$D4_]"ZU
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M& 6C8!2,@E$P/ #__YL 4$L#!!0    ( $Z 8U6(U9@3)KX% .PI"  4
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M$#6>NFOV#?&Z]'?F1J+#0ILDR8,F/]]E]);OKIMLR%MU3WG,)P8:W$] ^.5
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MB*?F0P;F#\;TJ =Y:U1"OR:LPT)[Z! Z%=@,M6<_=&7#M-C 7H2.WH/[K@5
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MD5.G"3%'>H*#?DT'L\7' @F=!4@$$&E$7X\@T2.#J,A<A-YB$20.V(XEB 5
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M=S[/?]YWK=^S?JL^:ZUY?US--=0-L,H8-4M#:RA01-S&Y3@$--=5 8H[FFL
M[>U=P.I.-C_%B^YJ!E!'95$Q+*\NSHU7Q0&"@VNB',01%GJ_'#N[PY'"S@[V
M2%>$GJZS$L)!5U!81]W0'&)K*XJ'Z]N(V.*%H# 7#55-=P&<,]C1_7A. ]E:
M.HF)ZNBAA)Q$<.[:AC (QOEX3_S+%9*PBK*KG@S"W$E4W%83"K.'J<FJ*3GB
MH-J\!BA;%P<W882ZL(:[CA <Z A1<0(Z'U-Q,\"IR DB$$!Y<64''1=A,4-U
M%QL'$.;G"!9OK^2NXZRIR>N@",:ZN"+=W,WUU)4L@7*:NE"LM3D(K&<.A^'<
MP/)(M+6#($[8P5I80$9935!60,$5#E(3UD.)V0F*Z\.=D3H__VS5S16%D\.A
MX3]=L*)T+"VU!5Q=$2I:4'5E=4-].SM#,4>@GHB=-4390D 'KZ8MJX)UMK0R
M5Y.!R(OIJXIJRD/$!91M(&(RQSO5GR\7X$BTH)V.G;.@"\@& A9RU1&&*4-!
MAMCC=9&@(FPC["JCHV.K**OZA^LG6!LH ,?INZ,=>&V5+7[YT,#<$ D%V=I9
M.3D<;^^$Y.QL1)W=,&XX&45S.T4G5;BPL#[.6D[>&2BO!-1W$S)4MG;[TS7Z
MY]WHO_UIH \2MP,:B%J9"YEK:_#:N)B[N^OK6LI"71':[@24I:(M%*I$. YO
MX$I0N(.+(%1+#V*NY^RJ ')R$D3JX?$_7R$Y"NMJNSF+FN.4\$"(,LP1J"DC
MKFNKKXI!B]JC% DP!/YX:RH.=4/R"@@ZZ#D#'=U$-<UEM:#Z C^=]:N:*X)D
M,:I6#K9PC(W:S\<L('6XUD_?44)U!,%V%H+6!$U5I+"2@8LY7D]#54G1'2-K
MHZ*M+'N\1[=Q=M4S%\,[:IMCS<T=U!UL[?7M''0T$6XHN*J,IJ+RSXL41$Q7
M#FRCBL#8&"IKP#5<");'L:VZD@%$3!RNSZLJ[PQ"VAMJJX&@ NX6(B@L+TA,
MX'CI$E35U5-1A@DY*6NZHL7A. &LH;7.SV<.BG;*D&,\, SU\^<=,E#5XWZ&
M=U.!:1XGL]%%(GB/9VQ=91V@H:V-'$0&XB0C[R8K+V-MZ:JK8_'OR(!8&2)5
M!/%Z8!U>K).(LJJ0.DKM>(8U5X3#'17M<1B$I8JC/%#,P-'Z3X.PW[6RCIT[
M7%99W1[I!K'1T\;(H*T)& LQ91Q,55')T%K#7@D")%C)HG10>H) 5Z0NK[.;
M.1JI"577QN#%4,+F*LB?-SZ"" =[" [A:*=@A=>1%S^>TK6%W Q!6MKB*DAE
M32=;<8RRJZ.FK ;,48Q7!:-^'.,(NSL;"BE@+?1ML5!E)4$;&%)-#8QWL!/Y
M^0I)V%U77$7'2@^C#=&QT=!S ,KH.0BYH6U<\6!> TTWA)V"/5K>$JHM(P,Q
ME <)86#"6 %W574'9Y"%JQ"2X$P0LM*SM5&%"BJX_7(@B1+&BPACL' A:SU'
M&82-GLOQDG$<6;LK.AP':@@=C*@>'"$@HJ7IC'(7M4"+"AB:&QH(.=E:Z<NK
M*RABY)T<+*%*#O;:[IJ_"$2(8!R<A845M($.5CKJ&*R[B+6EC(T"$*VO::5J
MKH!0D5-Q=K' X 2%A R &L>]5=#-4/D/A&/^1.SE/Y (0@F(R_#"T;P./WWT
MY^+HX@@\WA6KH] J#B"T@3#HYQ**JXMKB*IC100(,K)HN)V( %Q3"Z0J:J>(
M51'D5<+J*B&16#E5 :R^TG$_!>I@=?7M]%R$G$41SKPN.G86#LXV>+R[/9H7
MCD#]/!]J* %U;5P5-) HN+H+2, :QZNA(2JF+& O+*HFH(U1$E5U &O9H[5$
M@ XZ#C@P3L11W!&(LU2!65CC!, 8J;^*H/VL</8[83>!GY7=_DX'3N#W0G _
MJ\K]H7+<G=_H(?ZJH*>#M_ACX;T[ O].ZM]@(A&_ZK;]I>0"-@XHRSL"?WWZ
MMTF=K9VQJ']2S,[5%BN!-;>SE&)WY4.BT.9XK#.[M.!Q7"TF8B8H"#1S.GYG
M;FMO9NYD96:),W>PLD;@'9#FSB@SK/T_4V]_4+P[?U%YE-!&V2&M?U+!E,.:
M.SE)_U*(O]3T[]_^+K>\/0+_DY8D5%[Z^ $_TAHI 11&(H!"PJ)\*) (BD]$
M$(W@ Z-!*#YS07$+$0LA813"'/PK_&^R_PX::N?D;&Z'0/T";?U/0O\F^^^@
M-7#6EM9VQZ'B7]WC\<?X*%%Q81 ::,$G:"YFSB=B+B+$9R&,L. 3!HDCA=%H
M,$)(7/17_#_ ^'WMH'#6+BBD L[>]A^4+;SS%P%-">N_%OXO!3,'(84M0.8(
M/I2@D#"?L)B(.1\8*2K*)X@61@N#D0A1M#CBCL#O\OX1-/+W+29J 42!Q!%@
M/G%AE- Q;: H'Q@H),J'/E[XA(018%&0"/)7=.0?T?TKNOU_JF;_%../7.'^
MI./^X=N_FT/^MFU^WW!*UD[',X+;'PQF'93C?XTRY5\$3B7,$3^54=K)_+@H
M/Q7]-\_^/)/U[T>&J(6X(!HD*'3<-Y!B?")"XF)\8#$Q()\%2!B!0%L(BZ!^
MKM^_R_[G/@A6*+N_D?<4EQ &2P!!O\I[_B;5GX,XV:.=">8XE(SE<3/^0_JG
M?Y3OS_$15L?3(PHI+?!KQE\?_&-+S/^,IOO')K7_3-/]G3+KOT+3_?ST;P?C
MKR/[]X/WEU']J[[O?^^P5D,['>>RPR@<QPC2$%L+%%+6[7A&0AW/2 C43VS_
M)L&?8^!^S?-/%8#UW^9'M#46I6GN;"4M '-"X9P$S 6%Q81$@ +R]@0[K+TY
MTDE S1J!L_^IP711YK9.?'^)<5AO ;GY'>PL?YU'_PWEW_7UFU5!\#]:*?X^
M[V_ZM.!_M(;]DE'@[VKHOZ#3_$'?N.-PG%H39X_$(U"X7X: IKP"*];: F>.
M<V,%BO(+BMT1^)M4I+_U]!N)\9_URP5^$3"7)CUV^ZMZ^I_4SG^QG3@Y<7+B
MY,3)B9,3)R=._D<Y(?WK_U\YWK1*L1/8[TH?K0,H_A)Q )!O?_HO+D>C@">
M4_^XG?ZKD?R;_?KN+Z]/_?;-/VA';P%4%\XJ7&@E.44%.$UUBH3JU%']*5;
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M!D:]Z9,MI5K>X-4>*W/,L"!W#]V2_63&(BY0*J80Z5^^'%R:;&,UP2:JLI:
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M LS3HC;3E;ESYC;1AYG6CY.$7DQ![VCIM#?EA3AA50-CV9/M<WP,;-@\K@R
M!O)U6Z)I)M231Q1C)3\H0R"?Z\+/S<Q/9)DD"_"-\8<GR&$52G\LSY'R^7BF
M,H"OZA,BQ"%X_Z<%5Z%43$5>/L'T.C=#U6X":X='W0)BW(W3 I[/1TBRX@=3
M1I<VJ:X7W3Q$V.[F<55,@9HF@,N<Y4I<6PE^-Y++: UH608Y#7DIA>;Y^26M
M3;DPH2CV248R"6O#MB@<A*)#M!7%1(?1N13<P@->+^8;E7JRK:1AK*YP6WE
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M G#IF^]I6ZY7W?#Y ![>MZ&JA\)Y*G2H0M@2;WU<.Y!J7E-'%AEG8&-938\
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MCP#-F(CK'*H+X'N/-[05H_K3\>5 5SUNSN[@(OY#T]E^'FY"-NUX"%VOH>\
M(T,[AIJ1-+%43-=F@"FQHLOR2HN+!W/6Z6^?*)2EW'9XQM4D=HU*=H(=1NHU
MQ.,MG\1/F/+)J95&%WU04NQ;$SK#RQ%EE^N,'BA1XWC,FHF3%'UNQ,FO_N 3
M16&_1+L:3XYAQML4]&<\SW<0FI9D-D."2A#8D9(:#GPFWXS@[$@F2_R4WN@4
M6AGD#2")NFM2-1Z9F9D+L9LEL[+D5:1V^[*2=&TV387*LJA,73G3Z84D1#!.
ML\FZ;(GNPI@X=^@XC74T92)W9-@K/&)@]$I".7[MN@VF<IXNGJXI6Z^ IHW)
M< D<FIAK:!'?(:LL8D*=!*+R8/HB/%.8N",I%3KU]C2IIV6(+MRUJX<D_'/!
M+,.5E1:ZCXGXP;! Z1N6.A0%VL&Q;RIE3O/H!8KZ# !U^$,L+B_M/F"-J,F&
MKSYDN][G-U-2 J]<H.3EB+N=J#8PFK,%89X.[@RG@S]BN%^#U6&O\EV5A$ $
M2M_3<R^<55-8IAD&%@=QGOW\EBG54]-[DAE^:+*;N>E\@20G[+]K6_!_PMB.
MPZN<O2/ P'%,YPD4^U9]>'=-R:S1;/$N5O76$[7_#<0+[LMJVR5+M/M30]X*
M1>RV8F\[UJ5PM'H?Y-8/+<SEV:W^":Q_Z%?@9VT/D:9AWV.6RYO6U-N")1V?
MP(KOZ?,1;HH?.#J,4/A6HBQG$.S#K9D.[^[NC0W!Q#.ZXNOC54CK\Z.*GW26
M$+ YOO?2=T*7:5?(MD0MDT".@]417%HZ\9<+#<NC]@,&B[9R+]UQ-'E>,<A(
M(35S-GFIH_GQBU;:0&W!FD(::9WU)RT!YYMFR[4ZJSR]S3^);Y_*N#U@JR5P
MI\=\@#A=EE@)*^5["N?K44].VT&M=TO9MH:!*CE='2:I8^23$Z39[2C4]Z!5
M_H\(1P"]V)3(D A#BB7)"A3&)=]@\Z(5_:B";'[R+,9].=D$TEIJHF$4[SQ>
MU4NF6!?ELF,G0_/19F\_FS4<+BM570Z ;0Q EK3:7_!M4T<LAWYP1]>_7DEZ
M[)2Q/F=_[2F%<H?53!,;=_TS4SBZA?9*J[JL:+7YZ\'NUT)Q)M2-NP>#EXQ1
MM\,KC1_YW)W67^GOLK$8TYYI+,[@+<JCZB!&#'9R6YE$K'C=GE#-"'(_-( 5
MZ-G$U.*^^^KQJC2]_W!-[#5^-+^+VUS^;9L4Q;X4GN53@4G^S;9-WB!&479?
MQ2S;P+PNE\&5KW3C#.?4HNO5"JF9S;PK+89RY+07:%TJQ KJ0M0V0X"W(4*3
MM0QQ](&G;.P-&>7M:B'.<4.&&_>638*K12E?D M(1U/J]EIN[.J%?1%]?&#U
M0R(;;LY]ES/(D2D:<C!>E0'E'Y9#G.$.?LAMEIQ:]66_$K;\DMWZFH5K/%G$
MR'JR1VV/*%UEF>FV*NV3;E(IV;Q:F\L%.?3!C.79:V/$N*#41= $:#4U>HQ0
M')/[MDE2SQ7_8CMIURM]\(>M(;3;>A,30R&FKYD[<A"P[V8=W1U:@LV9&VG@
M<G*W7&Q*?E(<=S$;>BGMT4A]B; ?:<HGBOA#<,7=@BIGAU'H%T83\,[$7?U!
MV.?XH51C$8+[D"A])Y:^+;5>**65;6T['O)NE!5%LR'*(5.H%L&N>5XT_^_B
M1PJ?&G05<E B[_/3N<;M>0114O2*C:3E8F ?D2>'7F]D.T8HZ,:5EVT*ZV;3
MV39/XCVI;B*I8?!%Z8VT'@-T"^?]6^<;:CVVT[:QJ )CUU%CN^B8C\211%66
MX"H,W1ZS4E#O(&<(P>'C0=FK[0OGVO/)RC2JHZNSQ1L&.=714&FAA6;& OD5
M_ KCMLHL2Z(8J?BRB7>^]>[R^+L&2_T5_\4.B*-/:(S5FGZMS,9:VMZ6<C2W
MTAP,.W=UH7]KO%2G3(980 U1/?5Q9#L?D_!!PPBDL)CUO@U6UEC]/&7MFO3U
M',G3FRP+)J97IHP4#%R']*Z$-]JR3E6IMW?'$R-+]2K9L3N^)+$_#I:^]$_V
M?Y@'Q88;BZ!>"TAPXSF2EQ,:(U6,4-UY52^TS=\420Q&B&3M4-ZY&FV[AA&J
MUIJ^-)R[=[KJF:>O2M"K\R\GI3 24]LMJ9D?R(TRV2GU:^LLSWMD._3J8)_C
M!=J+<'QKTKTUHSMT#>JE"HWJD-E6ZZM*3F5<Z'N-F,<SK,Z*2PP-(3*?JS,G
M65P76LEK%YS6^;P-'$9<L!OPF)#,)NDPW'X-,:=W0\E A99@()L?)*>87YQ(
M5!A_0AHH6V87QC0CD:&[Y]&=D/]C=+[#R-2EI7,S$+49&KH[_E@W]F6O$;ND
M>TW)Z&V\V!7!SI6D[VD"3XL^XX!KLU?;A3=,U^.?O$N0U"03<F9=KAY(R-(#
M<V3NP9HJ]?FOZ)>2I_M0BW10<Q%+,LJ&NG,:AXAEXKQSAVXY>9L*GJF*E]L:
MTN\*(@LYQX?#96ZJ9S^L?$4R9>"]JEBW9;\_0K+LD&BVIE$ES?20)%Z/.-S[
M-2G1:;F%^<'L>?+*NVE6FH:\>-GF29?&P&'W_6!_0L/#X- @!*YT8#I'NVLV
MR1)L$ZFHDM0J+Y%]?^GRPBUFOGLT=[8C/4UJ^JO*;V]HL;P4*2<$YF73]3+Y
M=\,@$=;NX>7O7G57FU1FWZ#>,!Z:FT<,1PIKD4?M]%O3S;EVB&&J'>+OR>.O
M#]BOM#3Q4/,#31=+J]$= 4$@[6M?FM4EL-%[MYL$^1*B&MW];V]?\,!'\/DL
M$GI;EE=S=ID+]=Q3VHCX*)+1K<9%6!]CSDN!L/E!G0K/3*UNI[*A\<>E_ E$
ML+)+[RSN]2Q:J8K\2L!:D&H]^37H$P\%GM9I:2&&* K))]*ZNO[A  E7A<8F
M.47!9\_NM_)P<D?J#U54#&0!0X)#+'QL#03OMQ"M1=$M"<B >"BG=K@0_5G^
MX_T(@,(HR3/GT'H_[&LLD@W4.Y. <=P-%4OXD3<3;&3Z)=!];/L@X(E4>+OV
M*"R/6*W@;58Q)%I%19X6$V%5U*'4QA<O!NZV]X614'U1='7O></<*YCH.5W
MX-:1!;IY)NC-AVLEBLI#U@UC[5T2&Y5NV6V@:O\!1ML7UDNM\NWKT(-R#KN
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M8"\!$,7<C<G017#TFA(5)UFBEF@:34IY826)UU"^CS&+)E.6\D;>.1<5__J
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MNK;093DT3(;,>@CN.E8GD X5,\*F]KOKB\=JA)VH)-P@!IW'.\Z/2Y!TLT?
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MU4UQ+N^?5WLR2&K@P*\':=1MIKN#@/=K$ 4JD#R8W^9,<=1]8 H4:"I^;>T
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M9BCU&^GXPWWOM!>^&T'M*;-@QVG@C+ZR5$ HH8$[A6F=/!]?@O8OX;T5#:K
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ME?-VK<&!Q;< 4$[]E5K@=;=KWD&.LH76R4_CM(%'6T&C6HX8W6MS\9KSGZB
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M-9KJ[#:*+L"3IG_-KO"CBB4%ETOH(4WO8Y<#496NH8M/N;L]OJSJ9NT&&^\
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MK91,-P&B.(;I:B ,/E*:/#BDZN$88LP@D?)'Z=[C3!FMXEZL@^^V);DM:[2
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M&I[2B6(B@D&U<1Q]8T /N6VIK-MEH_V^1C,+;\;AROE;W]/D9[PREN_.D2/
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M%J,-3X=#CXA,JI>E5X#OE5> U$FZIF12$%/W63>IGTV'SV%,48!NP([^%6#
M/LI$Y?8_O17<4KT@=:8P)H.2.>8-6 %V5; ':BKL7NY^-378?7*1_^>*VDKR
MCZ\ [^8K2H]C_$=^#J\/7]YG.HER0?6^'=<\#VARGISP56BU/;4YL+D"W(HY
M[ZK'+GV&/KN4F16UWY!FG:OQ$SJMO@)\Z+ZT,(+NZ0,I YBV&8 '.63;..FT
M"X,K0)O%%4"@'.C%2Q<N$W,43?>70G\I])="_UB%4JE7\ A.?C&--A[UZ;7^
MG[:3#"YS&L+&+=L_F[[A4S =/5BFWY^E!(+S=8N59I%(V<-!;5_$F6,7>9=
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MTV]%C,5A\3 B:K\"LSIF1_N8EW(D.L3)II=N5'673B#[@7A$Q&N"O*P<&BG
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M@UXO-%=B(!560CEXDUVCA!;8?-VS_.[G!2T@%_'7:73:E)[Q+88>W7['+A.
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M\R^)%.CEM1IMW DI8OV:ZZC&+YQZE6U*D%,MEA]X_4\H?Y+DS@2C6<OMYN;
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MP#ZQ.EJO]].@C;25&XH_<D%'D.BWIYQ,S'K2WJ4QK<R0BCRNG3@&+:[18Z%
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M]3[V]O F2 *CH/U,JKK5$N_CDS/T[D&3U9>J&:PJR*?;3?F4E8S%'H1V0KX
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MKC$1X[WH%+R^\&YQFS)W=/50TR<DS2B7@X320\0TN!Y3 2#U07 [;<:YF_U
M<2C47MX#/4&W9 F]<&JQOW$L?<2<,3#$[W*(ZA!T/?AS]D#'5#_X[;>2HJO.
ML#06*\9-QQ-/IHM^;/L*%Q)==[M.K("79-3TZN.(9'4QC^C45$EWJ+7$^MPO
MI7O@+B!@V^M_3C"X[,GV,NZ>U5V=RA[>#([9?T'!(8.D[_M3C>=.I@*>WV0+
MIRZ)F)8;V35>&_U/K5S#!P[LS$3]5"I,LOP7E?_71-Z*FMB1#JG;_64O+J6
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MQ'I&N=D94$G3^ W:Z:9\*+21'" -Z_[XHVI#V;\$:(: .;+I40'[W7-!X6G
MYQFI,R'/^Z>70'6K=]KG7XL:%0#-2=L ^H*#KND<4D5%6^(8GZE'D5D56F7O
M C-IF&H<COS-#,;<)C"T5U](%$\,Y*>A)1#K25A>ZC%X?CW T8C!6-QTOBH<
M]KXU<!IY+-P3X2.UYMOWA=NWZ-N/M*2M@";MSA?L;&RK%(,BMUD#9-]D]N*\
M'I@5'REU6Y,K==8YLNN\FC=L:+7K%7'R#J:9%'?*OXXX(TG<U5JH[*@HK^Y/
M*G4L5:U<A>=C!)25C1"2MC/6^5RD)8"LI-8^L6[M.,>EF$)X)S[?DLM1J-=S
MM#^(E".Z))^U)FSG1G)D4@=&C1V>EI$@HK/LL4"U.]VLOMVX!2V>2M4AV=WH
MXV?BQ%O7RO))8U%%4"=_#O=1I0XL:-*F>MQL9@'X ,BT1BX(V -:+T4R*N9N
M",CMEB7Z]W<Y%JPRW=709TW_B:@24>?=/"TO".,V'#'.B$IU_LF1FP(]KW[&
M'N>1N,! )S;$#01(2G9'AF?RV/2A"0&*M_!0!AN WV/[]AV>J*&\\ 6H*+0&
MS!_M 60LBAE%(# 3,Y'C_.&JY8LV+84QD6?A*P-]%@W';/=9!>_,APT&?BK=
MZ:IGBRZ2HW;]S1/S"TL<#J9&OR"JV?9KZF_X-I39S+X0^])W;C].<:&MYA"L
M3=+6BKI398=)83UHJW&$:NRM/I/8,HQ@MTIB+Z6@T$=QEABM:_!D>)H9XWP7
MYHR%F'Y4-HSJ X!-#%D"NJH\)IFW F;:;V%PZB&J[]>K#2E]S5 II9UK^#X#
MT"B$#9>D=XZ7Y7>:KT#L.V*9ZA[^WC[$:'78D/#Y&'7ALB97F[+KJ"!7Y[_M
M/=BWT?=],)M??[B*<V,CH\..QX:^O'"87,]6IZLD:G=1B$$VCE,S[RO2>UXI
M0F!'J7\:/L$XM5;<;=.PN$4<ZS-!!E;)FUC0*/'\: M,!J)YJJ7S8<GPQEX$
M8HPU-WO(U0\'\K3]DC= G^<[U$2[0?>@.[DJT#/#KMUQ<$H.4[H+MI!(LPT%
MF@X7 .Z <!\ZI=PRI7T3XDN_YYLKWXV$8DX(+99EN(1</#W3OM6@$SB)H'#&
M9)L]6JTWW/C.TW&;E9>!S03EXC[J6(VI)M?(BVR?SUG.%^K5OX\5@F52Y@L(
M6].V#UC?$!":[/?(7-I\>17!"JJ_\>5$9X?-U-6[+8_C^.Z[E/2 >@@$@JP>
MZH27-'X> ^*IPBZ)9 X=WG5HM[*W]GJY-.1-Y="YOO_@-$>AEL:>MO=LT]C5
MWU#T?< I),J%..7^>SNYII=1]",ZD47XM%D1%BLA S;\N-R^DU;D6!T0B&%G
M645AQ9:83R;6S;'50RS5YYH9C!_[(O PHX!,>H.:P!20I8.T2JO>4&M1C]9G
M[DQV9:IUD?6/'^1?8I=L*R;2HN=,WUIE:-;2FSVX^>),)^!JV$]01-#\<[4*
M//:!R5C):^"#NNZB-/5[7T 0*3*= _*42;.YL;-&S?2/>Z.E (<&G_(<Z)IB
M!"XO<148E=CW,LT=_Y97MW5/IP7 A&/\*8/JQ@#5<Z%N6H@TOO)V"2<FBR'K
M#,&;#]"C)O3?R6R21@V:$W=R62'4:AF<RFF54SZ>I\S3R*0:X)9H64X_WG4X
M D]6,&W9XUE6"9L[INI9JEC-\Y"9P'AWHO3A<NYOB8VU5]<_ZLJ6^M,"ZP/
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M('%E2F,\=>WYAT\/P!8()#\C_W<O XN=!(.O[J3DVA%U9L9[EA/#AQ$.:7<
M&&G%#L ML7>UK>]L>S3\]*]'Z5;$C$LX$&C*#:QIA[+V7E\2N;20SS@+ =8
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MYWHU,:^EHYX?(%!-]7'@ :N*I 2HU%H0X5IM4821&G[,@ 0&]=A5K3OQ-_/
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MFO'M8E[46'>Y3/:'>UAW!6Q>3"; =5H3]V8I5ZS9\3GSLFZ6J2CI^H<$ E4
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MDGD.@MF4SDUSJBV^^EV-6W99G.T*M\(,?W-S_M*H7WDX;]]/*>584ZAUA:G
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MBM=W6IY=4[SX^O8:,$2K=5E%">SXMK&?9G+X=!8Y\'NK%+4TN\#1($%BQ7V
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M_4>943G,TUJQ!/%\_H0IYOF[VDG#87X!E<#Z=\N%$]]^# H!DXI?M/+#OZ>
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MAZITBS_M,5%J\P5-+6:E)[SM+Y!Z<B),3MA1'?<[;OB;DHP!%RUV?8,-;"=
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M+@0,SC-^Z+!=55'C#Q@W"7.[$>^ZWWAB(K1R>TQ2J;++!ZT?K0NN?7]NOL*
M)4EW=Z1GLU.M43USUWO=0S\<SX;QM5?"=F64VJ'!XB#=B]V$'1V[[N<D(N1\
M7U@C!LB5VU6$_$OD*WR?]K2KL@]8:C8K_)9%(_'@1P0538=%]4-5U^08IC>G
MN=F9-'F%2"B2Q><-MC-=H#,:7'V XX65.#ME'X8.O@4 &#B^)!6_75"W8]MW
MFU"Q]#-[">%\CN6Q^92IBY+/8E4@DV@B4TX1?9O?,<4GLWS+TO_-K>]>=%]
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MO"C4T-25V3'=[K_L^/>)Q#XW4#CXNZ5'BU"TM[*+.)F6Z5^_'L=8)31._]4
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M(LLNT 9Z:>\H#/:1Y_(?3I9R[]75?W*@^TU764?/\IQ6/Z2(_QIPJ'ZRIW&
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M%5Y=EA4+,^J-,K8I;W5*&?-%-%X+%.7$@I.P]H(2WN:C4W3Y8'3X%G1.%-)
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M^!N5+X-X9)'VWTY>W+*(?#MM6I6A,V%);3]I&38P\:@JG\XMW+^I6GNI,):
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M8[/?5Y[<E3E)U-QSIAHSI5BUU "U6RAC?&/F;ZW-"/MTU?(8B<Q<Y*9_.T=
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MW\8;6IB+\$P<%EEW,!4/PJ24;+%*6:\!H(#WS)7< T5_"@^ZY2_VDL84_38
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M=%P_6[U]9_[&_MF'RD=>:=IGR>_+0_)M./(1&_FOU>W9?[ET.%4H\8WYXFN
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M O:WI?HU@+_Z>!C5%*N@\0U\Z_3FHV. VZ9G0E<:550+/$3[I^T\,R8]UHW
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MR]%6=H(-O 763:L/))"6:E/&,D@<*:4DI=(O4 YS[(FY<:73=BY S8X4ATZ
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M#"N!$5<,<\MA]IE\#_>NG?J#;5EN[TV$:Z>GPOK4T:6?2WWZN&#XGXAI:O]
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MGZ'A'5))7K&/"V)#0R$^>) $^NS:.'UYP9AD"LU0<M&O13M%_0D33,^8J"8
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M)?3OL;T'98\E?RQ?ON'P[4@LO9_Q_E\TYUV!+]1GM\'9)_]YZB7J3+OAQ#4
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MR&IUG@>RF9"5S[Z<ELC S8ILB/-]0&['\IC>2%5/52>LQWVSWGO"6FB5ZQJ
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M.;#^56/C5O'5WI+.\>6%ROGF"6\%B75CNWZ]<  ^$>&:]>W3U-_0?O_"T'Z
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M.C)&]&580HOO Q&#.9,^?LYF_5&V4ZURX;1=9FFZ_.3=L%DG0<MK@"/?C-?
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M?.*'^!S]U-?B>:I]BQ+M*"7%:BD/[&,Y1K:GZ4\+';C)Y(P=1#Z=LJ@W5P9
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M6$AP;- 3\E<JI" 62F"(D1'"H@ZNF[#5HBIW+E%-'"Y9Q/'7Y(5 68ENL(E
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M\>\5/9RQQH<-G880E!]0TXYK*QDU9B'@[UCA,_5D&XP95VF\3A<,*+\:5T)
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MI]>8<@;%:YX+++)4KKJ>K3?1P'BQF;YN%?CSL2-N8]C-7W(K4^JW\(2_$]T
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M!(^MG=@J?2AB"ECLN%W:$5R M1 MH37XE(2*:OS,Y:ML8^"5,[@Y"TY$^UV
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M"T; DOG-(W'O0MPM5U+P9:_VDTI>+\&9FIC,]3%DVM]@3(9F+K"C!2Y$M.Y
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MGQ<+#JHC<E<%'/WN:K>&VXPWF!FW9&IZ<J$KHN]'!VR6V3NMR/?J["DOC81
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M;30&1X92[<^LVWP?<CJ41DC*=?GNB(L$9+R9DU';"^P>ZX<7$2RL5 X;T#[
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M+D&4DT"LLTI?<BJSS(=Z6X&\=BI[ &FM)\-%F2*8@]'OZBQ(SB33:S [P[M
M$!@&:8+JI3S<L0NS*%W&D+TB8,K=E P7U*6RF<5H*.JSE(A?E.%V/$FBN96Z
MDVUB-I=)LP<HM!"Q'^"JZ^D8).@%55&SZ92+0+IX1/GV3PF4 F1>]P,;/X,-
M,6%L>_)Q%K, *.DR6VKE9[\L]:RA:L>"ZS&TF1EQ^V*/T%MI;M'Y"BZ@N_W5
MV0'!995 <1K8=SNLM.DRB>;G9+5#+XJ<Q,'3,>LD ;:LI9X]],G/GM\)!H/K
M:XQ9'?#'1HL0!)1#0U6O Z-TR#/2)/I>\.$ZK/$#8N,"Q6-Z0J"<@$F%CM%Q
MO7M&95$\J1#9K"'QU-R/$R61_>%M;W@4 AG41TB$P,M.FL2O](WZ=0)*PQ>6
MA^ GFUS]%XG->V8X; Z5(YX-$274#WKK%&6W/>\"T?+EJH^UYWJGI1N#<#(^
MT4JO")VN2#]>=U-D]@\-\JAU7643#W>XHA%;GEC47"A(7T-2 +#K$5+C=\+E
M3V):QTEX]*8?'QOHEA@SR0Y1>3?<RE$]SFXRC\UN9OO*CHFA#9Y"!ZQP*,AF
MSXL%7=U<2&&<M=<Q6YC<;7E8:AO?YDVAN#B0IBN@4V&^\O3#&Y,B!8VEBQP]
M%W?QGU70_\!L(Z/Y9D+QB*RH1+&)QE;;E1R#7(VQE(XI<(M4('$A4;3#W'Y+
M-D*Y-T501Z#\X%$.5?3)@:[CLL<P"J4,?.8L($.5*B#=-SGX1%?+TPCL-] 8
M-N:.PQ6.M2U9B,[+^YWAO8"F3;=J7GOF*AVFQ-:#!FA<DV-*I\R<S=BMT!LD
MZ8'QJ*D:) P5^!N&FS](#;;5?44;AM9,#?4(\8@#4<Y9E3U_/#BIIFD@)#UO
MO10N]+[4]0 :O?.LN4B<.!U=-% TZI</%QUFS14M]DX2WBN[X\+=VI542BL_
MF.?.]"Z39\2A%H!^(\]E D;8<=T?&89WX8A(4IF#_;)";<?TMJ&7$>,K %ZU
M!KOX(U^$!&X*^ASP!O'F80HA<R@D23F_E(6?:% GL'XT>T2]OP,N.PMX7F P
MPE*(:_ZL.9-PYW!7Q;O"GQ>N5BK?4J$=:I"%<901:4+;ZD*&\^'AHN=0"):J
M_KB2M"&!J&O1KY'T(:.B7$2<O[>G?FT <_C)YODW0?L#BW=#8PTN]'7-6N.4
M40L4<]6"3?I3^&E!V^8_I9G0V)>O['CTZ,?5P+:8[[A\"W+1RVTVVAAUA;XZ
MN!O:9/ 5P7N_C.S).8[W>RC>HT]\>\LV!75*B=Y4NN4%12 Z2-ND6:? -]\C
M,X4='4_:=)1J)_.U\PU=0A=^>[]S^=P3,<NFXQ2],SQBBS.\UE#O>*YDP!9J
MXUV@[C?66KF3Y43/E@\M<3^Y$?]YC"B@YD##<<K7K,T6IS,\>O.GA6YO#L99
MMJR=>BE[%NB^<;#,P45Q 5K!D?S \PT19M5P>#E=NWZ&!T:I;8%^ZU&J.C+R
MWU^MV4I^N_YM]1'Q])T]/ZO691-;O'\M_?EB75_SZG89)@X%3Q 7=H24N7:S
MQN@(G^#]/WX(8RJ4-)B;S7+WH1IE+7[WLU&@2-]E Z0J=!@C:&$#]+<(NV-"
M3&24I[TD,&< >Z>84P+?>CI,0,2J+N6?KAY!/D(WIMRZ=@6:FV%8@K6"ZBU2
M#^B!ID#FL;O:U?!@ *B]-%^#S6)\?W?0.'OD;0,C/]"FM%G@0X@KFO@5Y;R$
M("[Q>HAMF@8])([ <8$.>/K2X7*CE/)^92//>\U9)=X;2,PL*S+^('+(KY(Q
MWK[)I/=;Z0WI3FH*T@YY60E>J2#W!Z-;10?JFT5'-XJK&%P5V5@XH;TM"@P%
MLJC/@0;\V;E1:BA$KE$I+AJR6^6<H%):!FMF@JMQ#R;<4JJ@%$W/,4^<DX(2
MZ2U HH>,<JT^3ZNH(_;JDP1;=473WCO8N[BPW(OD[#;JU+3@<HSR%,^[-WKI
M<HX&>G<Q5J@/4%8DH9NOURQK5%7& DQZXRA*O?L&]C@IL]%TDUKM6X&ZP[ST
M(#^];6[\7"W6H )1V0^E'E$CNI=5#'4*6LTD@_I,W<JRTD<,ML]7&,,9=/JQ
M%;0#&7X+;'KF>2#0,XD62Q$M1NT$9 J[?0M^J<JEG((E\MXC[II*GF?JZE7W
MOW^/Z>:O7KYGY98+6B!*-KO52S@0D25DKVE3H$-<.]".GS9RTA7G9\%\R1_!
M(0I2#S]ANHA6(VH-J^B9@R6.()'SD&C(K*(_G/.M:X-38(DSN%T%W9__=A'I
M[<J6"S(T-VQC(%]I[3=?@R+,8RJA))P2,M</4^UN_X8O]_A+PH6XQ>+0$TPB
M5K.UX";_Y\A2V0 V!:8[)HJ,DTR)[\?X1D7\73\YR64^RW-X'._,I)2)0R0-
M]YMOFFJB^#DLT*@V(EZH05J84-B:+3.4 R/OQE)-DXUKLGML%I%3,U!)<?=8
MOF)].  +)2*!S"-3F;Y/(>(V>^7ASJ6YZ(H$++%&Y8AR#\JFO4&'P=X([%C\
M .YM"U#WN,EB6 ;=<#16LS5C'1U+H]T,TWT0E%I@&1"0F1%Z84RB[05)<(%_
M!! K78HVL=,)MK5FXP^"@33\=4+0MIE @/*G$K>Y$:7T#YY4[),9Z6%E>I&K
M=B1K>J2YR0>T?M7XP78(Q4 X6VJS";G+-9/IS(.!8Y\,\,.RFYYY<78O\SY9
MQ,9IM=O,=Q,Q45"Q,E%=$]6*U)ISZ7]E"*%A:36BN)K]T'(TG<=DO7R>Z*JX
MCY(WL!:RM #G[PI6*ZCZ+I8]?A;=&J-K#AY 9BH3OU\]Y5<KCFTD'V.T[OC^
M*6%'Q0[Z7..@1J*6;S",A7:BVV!A9)S17#NYMF]<U0\H8SA6W"[JB7IF%68*
MO-J8:U>H<[)$BWMN-<X=.=U =A[;'QCI"KIV&M#D9EH"+3_<"ONL<YQRJ7[9
MVNH]LT^N][(ZI_Y=[FR_$:$>J $[B"<UE8TSVR-K^)9>#(U2^FL308K!2ET3
MRIIVY!Q0)R $H]:I$X %(R&9JULS>2J<PF]SZ$Q7+, Q6-?A#J%Z;-']$N,J
M[2 $QB+4T3L K!MT*OW)V(.3L227CR9?NIT77A7=FFVO%*FQYMK5O;YBLNMT
M1U$]"<L[@$;BQL1B=A2!1:NFP7!Z"-(?@?1#^E4 UQ(4JD_2A]WYK0.B>S54
M9;?=45F!FOFN;)Q+()T=VV&_7 ,,B1J)!CVQ_SGWI)GJ#_>DP_.7>_++/?D+
M_7)/_G'WY.9E4SVHO=W46SH'ZB#)V[IV,Y&"(GTNND,A3]'^OV6LN-'*2H='
M"9%&5WHV9W)1C[5%:W.;XLQ(1OEXX&+OY)JML:4,38Y>SE5R@?T\BH#'B82"
M0[<U07:S5OCB[2W-1Q9HZA W-=)^<Q+1+.-$*C,G_:)R3M[I^D&*X1LP0$I>
MFG9KTL<\N'AX42,4%# @#.+0%*<9+>.WVP@\IIE349)RS?J:H.Y!E6$ZZ!?O
MN=)/U,Z/ '.5#I+'4Y6BWD-R_!X>9.>2U)*,L*C=*+98IUDJFHHC:Q8='RER
MGN]_(6IVW#@,#ZFB1K-/Q2%JP@+IV2K<,N"84!D&+(@VCL:$8-!BU\O0,?!%
MGW,"BU(_HZ^AX=<,O\\%%G"__G6UUH5F%)A!#3)7/>*1S[.$:%1F!@H];5/.
M<>\;M!1$,,@.*T@-Q.OSL F\3D8O\.'L9U>#J4P>RI&ZCA493,>%;=@;-V97
MVE?)T'V#W74<0Q!*JI5L0V\6:S!Q@H!.L_$=.@-[YC"0\Z,B06'+.0<47%@T
M=:)J+&ZH$A%>,$Z+?8*QCPR'3[\>H5QP(L"T)@JFL)./#&!*A=L'G9@G-U\6
M**^7VT"K0KFI20?<Z69]R+3:5CV4/'LZFF4^Y=5+*(L4170\ET^B#Z3A\ :$
M#Y(&1<B@-Y1/$M*00\8=Z<]9!FT&$;ZKC!E-LTTL38_-3&3G0MQ  TCV/'C-
M!A"39XO1GA\#HEMG=6K23*!HJI&0@LNAU[+JN7%F Q##+#25 1O/8!I#,.E*
M<J.=SJ >'(G1S@E/WU+K?C!K2&^HMN%RO2P_+45PW9]SE)9'5[HK;#V;!DBR
MKI!NL-O([6?98D+1);'8O>IF:"#;A F1 F['L%$.,M 0CU'UMF! ),(:]!%#
M/71O=)Y-E,EZ#'ZF^93/K1<RJN;J!-YTU7Z1 ]U[U!<16B#_M#+AM>+X4/M*
MB=*+!X_'D'#ZS1&CPA,@Q7VD%;?R-\<T4^MXDY<)HBH"%6;19G U43\#@*TP
MY?KEB(HIG>R &"*=;-3GA,PAFKAF^$@@0AQ(Z8ME)%(7'AO]QL:OG6^%WS1F
M3<\FK&:%Y":AF11),$N6Z!>9@/(A,:Z>B3.N(X'^A>!%REN, /P,U?<Z_+[!
M+NA9 WKS[(;&3_?6LA@-2=4N?ABR1@8:XH2#7G(9V'#HI3ER3YLQ1@FU:X"$
M0\(Z&"88F)(8 )K:^;LH.-122NH!XI3D=9\57)$5%A!S41LI4(/&H-%AM6P.
M4=H#8]*S=HFE6E$@9P5&R$O'M;UPL>(I+@9GMUS^%MDDDY85OHR;L#(LPCRR
M_9:[N C^,V*8JH"P:+##";:H2[\<E*BE_LY;U( U@MX1F;URJ^$1G=R;ET=*
M;PQX.ZM9EX?#95":$@#-"AKJL"-# UP_P 'E@8Q3:PWNZFOR'X"51[?-Q.J*
M495DI;JVL#T+-C0=X(=RV!Z!PCAM<[5@:6@R>@P(>S"CHVBETA5Y5!<KX+?K
MOT6<\GE5!SK#Z)X #&6XE!XB<ZN,M-EBK,-R_8U+[70EHX2U@1/8ANW=D-P4
M.K$L6/8$-=*NF_1*<S&("0I2SZZ@$;S%C4JB#ESB\*_ON_F"NP7M5ID[[.J;
MU>?<*Q(>1<)3>BM'+#L@D; ].<% [QJ5TWG0 X>U/T /:!)^P3S_@GG^OTU_
M.ICG6P2MM4],/8569M>K?<;B0Y_W&7,08802+.>'[HWI:T5BQ)\>]XGTV^^,
M&Q.RKKT:%;NT8,8CIR&L5LR$9>61 G)[9MUH&N]OYTNHX3("FB=<TAE9WCND
M::8)]DUS3.]N'$8*Q-[@PY\7L*TP?.UX2FE+^Q3=GDJHG8=DBQ#B)D@T*9*@
M#OT1B?OS1:4NQUMSJ6PW#45U-'2YV]:9;8YW4AGYFDEY#Y:(<J(P\:55)"2Q
M[[P8;F;O0F7+E P? S76VQ_L9:Y5Q74$S=HGY38ZC@>8)A39WP$_F6>KZ15'
M@2M'_?R68"" 8@7G]I>-$1I?R]/:&TFED"@ P7-#N#1NQJYGK;@2!&Y@HT^=
M;<]98A7R4,4T EC20Y ?MEOT<DI$G.MUBDUF";\4Z$57(FZPHYGC"LAG#*3B
M23F%LKU70^(J(GB<Y3H$<0;^:6FQI0]BFJD(M)B4O[(@1^S#"0KLG5[X?ZZX
MR[,\D@OM@(\!I+^FEFY-N"66&M5,?FF2J]*&B_\&619X$#Z1$U6D'V58'<V1
MX\"AT([UB&;7M7G$':Q@4_94'K/\/-#](Z)=0&2H3IY=E-5!X-M: ;^@KF:7
MF#N?")<Q?X1?$&-.5^!5;LXYZCW'?/F3ZY\!2*>U?BG%\9+MO!;KA1<*/&LK
M)/RLQ-H;GY H?Z9JY X<DN.@[T$4$/!D=$X<MNM&;/DE_4:5/]'P7%R7U90:
M"M/#[D+DMX,AW9+)!;F!" YGC*[Y;%(;S[4=7H&:[9WJRO>'WG@1.1(QPL9@
MU*1*JKO@\!S:O(H_!KM1K=9NQ,>>5_J,2<ZNA"^WC^+RW19@,W(W7-'JMM*J
M#"-4;(B+G]["G+(M8HI44)1%B5-SM";7$J11,<D'92>]X)\_GQ& R+37U"D6
M ;>'#===#N>/0^P&&G#K.T&._7S(9QDF&NL\2-B:9@W382W<6VI%!-&&I^)'
M3"%#,V2?1\,$"6CYK.,B0$SX&IFVLYG-O$&3"&+:-O)PZ>QY82(U-00 T!X0
MD/BP6A[.@-L?1[<&#%$B P*BV=@,@4"=[.SJAU9OY2?&G]:K#,B CS,-1?+'
M3H(;C^7U=I2GJNK*("JA#1,?BG2]O-R\.,[PUAF.BI<^&(T)SI_A??]*43E0
M;#IR/\-+S%/8JYLM)%<)*-;I7PAIZG6_ &M-FN//M1PP;74"QHD'V\:F]IN^
MR^##1#MT(CZG^66\S(G*WN.B+ &)E=&W$?$%:&3K=7;3!AJ7@D.RS'5EY(<7
M8Y&ALKA0M[$PE P]U'PT.R GN@EC^\!L:*BTP,(\1X ["AO:,!]&B<XKL+<(
MKND;18&*5L@#9N&S&")BMCCS7-+]0^"6ST#!#,;1V#Q8ARNUZ(NV-N6'N[L&
M3#Y<.IGCI#T>(M:KBF-725EQIUC!(=:[VIP)U E"75?J7E@7O+?FRV^F'9B!
M1.:*M>](@=R3^F#MU9SP([U[MN455G3DIS8(_*E]*MKC:_@^K)/F1#I^K7GF
ML^OJ'=2SK>M78!"YA?-7#'H%_[AB8'C[GQ!L_@E;D8SJ?,)*\E\35M[\2ECY
ME;#R@_Y\"2ML5U9R/5<XKQV>X2UWKZ^TO[\\8:]^TG,B[ 4DH-MBYKC ,HGW
M9T1GA4#UM@&#QW5?*KV,MD_GC7.&JYC6!!X?C:@CXL1Z.+#FRV/%.9E1.%.(
MV<AE,1TVR\<C-7,)-((^AFF[1>R,<\QM!I2=\]C5778U *8<(75/CGZ9R9\+
MT_.57R<?C &-"J!MM8/LB+3S=88 E7#.K$\YYKM<))DY!9"(O.<\RZ-M0CK!
MYMH+_%2?8'V5E07F6.I@I?F4/'A^D =;Q<NFL<X:3.;DG!,7Q=#*6DEM311G
MO,CK&F3\^&]YQ=E[Z6:<I-IIU"+OM!%'0M.58?">-*F0-,MESX)[.T>M(^VW
M[ @RDE,N-&#SM=(5<ID&5S@ "FI6J&!I?ET8J,LV5:1QK4]C:B1O;("I&(<R
M)('*^*<-OY,NZQ5=E=U@XPR(N3O($6*.L.5' <##Y3._[8ZQ]%.E<RS(#U)5
M1K6LRZNN%T776"9M217R=^8-=;5[E'SXNC0XG@M[D)YWFWZ\Q.@M3UA.L=E]
MZ7QUF0I*8VS?M!M#-?/:L'J'YNN.NSQ*VGKV"KFRT8TGEM)I8>#FRD&>;R#$
M_56$,G%I5;'G^I@F":GX+>0^)M"AF+Z]6 ![XJ@I_+T_;I:8Q4%ZB EA<I)X
M6X^5J9YP6O_-\$/Y5S2Z Z0!&#IM\Z.@I->#A22%(B$=3?X$[%>TH]"[/O[K
M-IMJ*+V\J:7"*3N,4K(;JMA\M^JP_</W34H^ &E2ZUBQ)=MH#JL,- ;:A56+
M]R6BI!3]0C0-JRR4F[Q $.\14&G4]KOF=J<BH337BBT]8%D%&*/["0;IM\VM
MR@"GV3:>X5UT=LJMK+?3C]X5#RWM:,$M'2!BZJ:653D?Z&H9#N!$+QK;0/8-
MY[#2#T3F+MQ03U9A_(1MEY'*F>*A /1L5&F6@$:JAA(E*$4\2W<%A$C6-1DT
M-"D%L,6<2QSKSJC2$7"CC@VZBNOMABA\4W@%Z1II98_AA*DAYP9D%R C8YVX
MM?7]U:*.NU@EVTDF$5'M':L9XYJ0LF=ZTXON7U#J,"N'T]&HE321@3:Q2U1
M0C+AJ$9 %+.A8]_5+I5(36;>Q%D]QZ*,G:HZ5)Z[I?_65+XK>GPH8'&#7;=]
MQ$(/R.%&)=].,*>J)L/.'$(-"DL/WBUB8*H,M1JM[- (4VU/\ORLL6,YERQK
MD$ N$/#(5F<2]\F_.4G@>4QQ2/?$G;DNWM M$YI7E^PG$HXE3R3G>,EHOLV-
M@YE,SO"X#CBNRDVG%WNF)/&7;O#?=>S,8CPHV6IKZF)+#*!/KQ$$?I1HI]I#
MR,24M*-TC$%O2SJC65N+A4D_]S??"F\G>XQ>'#1W[$TQCB*QUN&F H'BMBHD
M+]Q=:"W#"I$@9Z>D6%9G4;B:-SG#)4!%-U)-=77[N)N:)ZF&GTLS&O5(*RBK
M\=.3[8?"9H%U*K0\4ML?AJJM!]S@!26[?"VJ\PDO42_-TU]+W".2)T$V3-WC
MJ,+P&^I>HU!R2#T:VK,6M8\38D@WM!:1'N:]%FJ^DCZ"8V=IF+AL]C9/?L5_
M])0(59D=CXU@8T A2G/#M/-$3S_54<<8/-[?LU%[KN(OH\:.9HRC\'"K^U0S
M&#_7G^Y"H@7+JPRR%::U<E+66A<><OV\PQ4S<V'%DG\D6 LIQ\T@]]DF>VN$
MY@;IPU56^;!IKX/$:>&Q=P%S[8N[:@XL;Q4R89D?""US2[EA=RQG+H=2UT;Y
MBY4RK-6&X2I+/"H0TD,&CX"(?IV<EZ,"E!:$::[.QU62N=HD6;Y;+<:HWN'X
M)J/1@( 5!+"UH#H'SID1W$S->S[V\>O<XP?].O?X)]*%X#(JFBP69"FU9VA2
M+EC@:-A[!8%X6040B4=*Z8!>H.]/*#<7@_A''P-V%2),KNCD+!3:O9_TX<&W
M,VIT-><$0Z.[J BY:O. (8T><9Q=FL8UR[N0/7'3*H5X]ZE9W:H8WNLYW(&Z
M]'V4NZ$%)KJIEG-DM$GY5];"F^B((DC$C(77C.KLN&R?WM-@)4@(GY9MJKB,
MD'5QUI0I@A(3:-T]WA(V[DJ\L;A* ?O Q2*X4_L\5H=C5G?Y.0(JI%4<*%N
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MZ3;?%?7U_D)>1/H:FPU6IL?2FZ$JISFBC_]4_(O^QV4EV/7]X_*IP$LU?A]
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M)@E&$-F11),7>F5\!\T?]>./^O&?LG[\B_P!3P0'XR,\.?(\-?AKWRZ,-$X
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M/(QV'#U\N'UD$8W13+9$DZKQ!O1O;O<,R<LC$]Q$#&2UPV-W(D=33L:*I9;
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M)A2_3+@BUF69YC^H206.%I30M_*&6(:!.O/-C7C*O^<./O9W[%-R_"#POXO
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M:XR,YWWHJ(XKF?,GU:_U>=;263M4M4+6X*Y;'75BBR8%M"A"V#2[N$  'OG
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M27=0UW@K8>MM\J1<##/+P-/F>4:5P=)8(E(XNH1,@UW84;INES&_3?@SX"F
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M<DT(%/@%2^*+Y[A["N/GQ=):&]F_M,E++=MC+=YD<&3Q;BO^Z:"@L-965/4
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MHBZ%YS);8N/%'+):)<Y;X0-?P^3!0*'A%P/,]$;BE7:T\76J+=MLB7555_L
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MUF]AJ>XQ]=H2)>XA<ELJPTX7/@4"WM'!2.ITGD:?PG*KES67GOCXI)QWD7$
M[:'^73M[*]6SQOU$?>DNPZY @"-+_1.O5_%/XS<VDM(+&WWF&5B5]N1>@#(
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MBNHSQ& ?O+1VJD]3YO$!?Z^SD#VW"2>*GTP/64>9EK\AZ@GR:F?M0)J5RNT
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M,>S)(PAE^UH>U!,LLGD;?6X#R@>J:GV8!IRU5;Z(-=W?H9*>LU#$8&S<+7.
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M]"*R%G'S\Z$8%]<DJSU:.6;*32<6DR@:D8<FIWB?&A;[95+WM.7M$>JZU"(
MWF_J9CI.%YLSO^M3'VY19^+KY?<\C%SMA$G4&=ZXEFT7TDZR4[[Y9LHNV374
M5.36UV"EYWJ@H2E;+9G !5[20VP:0"4[$%I;V1H<[PI\Q\2[IGF"W%X7]^>#
MT?/M)DJP5U=GQBLDW 2+6!\'.ATKUZ);A(\;:H+%]7P0QH]A>.Q/E?>C#4]"
M>9K,4]_&),W6'YBC7D$?N[C:,+F,: ">5#*8R%5)V24(:LQ^(H2[@JQV%HW-
M]C*0%OJJ#?/EA&.PO<.K#A[MR+8!FI(OD4&3L7B"]76; 2A+;H! N\$VNBQT
MR:;11-Y;?"?PWA Z5T%.0(T1,MUU^3;F-O(,Y18']@MF]ZRD!>W \XC/77K0
MXARG2XV?/'^"Z >,&-<U-[?Y%33X_Z&R[:CP0Y0 N%]\/HE=Q<'T!K1LUFJ[
M.A9&G*5D+EPB)8\EH.86X)DYT&8EK\W3]K3A8-Z4VAID@L:&G3S_Q'R&3&6\
ME]MJ,]I(MJUD!F,MO!%LUJU'2QU>N::OV&T;VT)YYUH8 *B,*EU7K19IUW--
M^ &7<3,U^"GTHQ95*>X[E!3>YE'S'MZ;EE^AOAEQ)LTT^FR]PYU-_O4O_PTB
ML,/BTD73'M. K!;5#9;QB<]GA\?/:IP^/%;*K6RPO-?+1=GQ*M)F][ I[BP=
M?$;L<B[#L3?C4;B6)%]SBE?D?#<O0<H^8MM8("L]P*$I9 9>SUDT72Y:7AFJ
M6A_O8N/4A;>M!X[-7IDI(#-0O/K\'1L&R1JC<PZ.NO>^G4^JE(S7&:,\%N*C
M/>^.7HMY/]FMFXH[;9JJ$[2#'(^O>2?V:W'6E@IRZIF[6H[(@=)976<"<KSF
M!=K"Y9-MC&:Y4Y+?WCQ!W34#/BA*\>Z]/]@4R:X;^3#^/WC\H]9V>JKFV"(>
M&CNE_7<]MW>1(?C=/WUQFL^6EN.R-X2,#_/'\QEE?-"9@JSB!D8D(8BRT^\;
MM,)] G"WT7R -H]'Y?.P63MN2'VQ^)Q!P=DSG\[ <A;NBQ#3#=K6:U($&I P
M\2G7S@W 1C0QGU_"ONZ*OP,L*6?6U^K_Y]VDHTR<FQBT(HIT]RG0+Y':RG8W
M-X+#*KRY;T\XAZ]HLM1'.HINLG.V=1EH<I=O5[M&I%M2\0FNNJ!C$;9.J<KV
M,EJ[M13(PPDI.G\1T]"3Y"Y\+L-LA=BCBK4;M\8&2A3OATB2QUV!V&<N9;AN
M4%G![4MWZXV3WS?,OP !]!F6( XRA[,%[DK?V'%ZK&ELJ=WNA2(8?KUD^N:(
MM2J9</PT+4&CG+>\ E7KDB6"@^[4$EZBZD7%WTZ<+A(95(B* O=-"Y.-5SR>
MQ+[#8GH:Z@MHS99C&S+>$MIXPXJ1.Y*IM;-+A.\>0;U>&A$$J<.MJVZ;:9<2
M.BHV[7E"XU&\TH]MSP[/1[-D:_U\)L8O<>+%.K:GHR5<&=O%3*ZC?N$V],L1
M_H-^#C'?6U'>)Y>90J&IE$\]LPO^1\XZ;T\0*>SC(I^NEY<Y*6_:AJ119Y5)
M,OTT14S5J.?V^X5QR /+14\-Q]9]_[OR+V_U->?CUPJ7W58?>M$Y@)(TZF#R
M7JV\WFP"9F;B]Q8Y(0QBJ#.FW:8-5X1[Y8#MNG8Y'1_FDG[9.*GL]O^[Q_4W
M6B@E-_A9@= $%^2RU:N]&;&Z0"Z\;;(/VJ<Y%IE@35U=U;[']6I!#F94VGGY
MBBPFT]J2Y6A>;^)80_=C @(F)"3&Q:,LJG<,P=^F:(3K!%Y9)JJ9/*_=X5Q%
M_TCYEEU5.6/DQ"]MF]J6LG2_"S%BMY-O2X3/H.%C"K6KH_D,6=&^[<#NY8 ]
MD0%,+T?M4WQ(Q7=&$<D.7*B[Y[!K<O+0YXUSTWY=?FM5(W%#DOWN!_E0 64\
M#H98I"<KPP2_BG!H4++%DGERU768=IX@\M+%,D2D/ ,:H^JI2,DM;ITE*82$
M)V2'F5O"8VI%\'5GQ'L[.14W8;O=8IQ9>I8OSOQ.Q[G9,ZM9\3XB<-+) %.?
MCX0&BYH@T3;"8BVG+LWOU"SBP[F+#,2FY$[T<LQ(.4M,)]WB,OLY]<SO#V\\
M?#Q1K$L9*R?)FZFQ*A@B1)7"V$B$ J)_:S'"]E0F.F+JVT;K4_)KN_&LYDN&
MD 2A)7)N?;U!OM3I/D$\'&#[.O$!6-8UW>^H^D_/9J(8GGZ-)C"#=<IJH$ND
M;-F2B(V3$9<Y6*(]_J'1VKY@L;%T)#"(^.%3W-=0T!;5@-VW% D6>^"U@LN1
MFH0W_LS)^B(>OMF)YZ?](9[QNBR^S:@RO#*E-$-8 -9JU_R!/[%Z*JLRME5(
M:)D+41?<5K<ZECFUQVH3S;FW:,?CD?*39\+W"9B62%=//NWZ1BXJA=.(O\I]
MXU549CJ<0^=6D@,;,!@:F=U85@'MU+Y/G>[O:@'W,7U5<ZLXV:\+L7Q'UC3#
M)&:,T3XTT]58:E#FK$E,-Q%KQ>^SOM4\9O$-_HORON46K@@'J7\NCRNH#VT2
M8MZ2,H#<-*I)(=J(A]V+NIXXYP5JF5XIMA<*O*R(YZAD$?A:^;V,002]S>==
MU0\= "L='U93M5;?KG0T4G0 Q,ONXGUF5M:1@ZLG9'&(J.O)?UQ2A&I&@G_M
MMJUJ203:T$#=5)&.T8X%R<?)<%=#A,^">D]72+=Z%LC+MR35AA2I/UJ43N(G
MBS/M0RLEJ8.K?LG>3#M$HP%X2JZN)^P7543@-6J.988R_>(H+-(3?@98>DEY
MO24W8("T;H.TM?EWZNMVJ$L).#<T4W'W41*8F!@]/KID!6L)U%#^0DF:]1.Q
ME]2,BQV)D;!TSR<QMRXALYLG5\PE0GG9X GE[O+.K)->TR_"#C^82; +&;!\
MM0]ZO2I\VNQXLX3=^,]X<]-7!<?#(-1^?M4XSK8B"GZSTTN$\>7/+Z$'/A7L
MY4DL';E4>6DHR@3,KP\A 7FCHOF2'5M;&BS20]?0.8NRP&N^W.44G:HY0L1#
MWTQI_%VWY.5C:/BNI$]'XW!M.2^+3[SA./]^*8-,-GJ/R"9^/XHH?*KL_);6
M&S!:EX]S!TX-SDM\U89'-VV!/-?)61G?EALN4 O!_X.Z]_QJ0NN[17UTVT!1
MNO1-C73I!,1";PE20F]2)?2$WMRB]":A0P!I(846($!H;@1"!RD!0JA20Q.1
MHB!X]O,^[SGWGOOACCO&^73_@?5AK3'FG+^RYHSZ$CA9%K*]9ZKC'A7CBW?V
M'9>_S5[?U#"36.ZY06>K<&, 5F!6JGJ[X%8-Y7'Q#]/1J!\.N$+MF>8J@NV.
MK)5O%=KRH8WUABJ6R$F%4=WON;(TLAN!_*=52EJ\30HU@D]*YJP]O#T>?JJV
M+>U^(;B9O[M>S<K.R RM-9K(7Q\OY818&W[ LT65AEI- +OAFSSCXB #-+)'
MWXW(Y\O3SA%J\;YM4I98"\' (=G^5MT9L@!1=OL&YW";CI*)BVK&[Y9#W04G
MQ[X@1(0FBRN?IW4W26AGK!!%*W_K3/"0<C$SI?NS-90?3A6)"#+("X'D"'?L
M>1E$?KO'VA'%U3E';IC<-ZS8>#H=?>[LW]V;PO_[RD2-LN>CFK?GKR/@Y"]+
M#T9G%A$+@VY<*N+EOZ\(.IVZS&OEP$A'A]1AQ874?XEL/9M5A#]1G+7Y?P%[
M"64?26?SQ\G3%459N^\HZ33MM0SQ8P/?RF!1#9"J'<$D\/>56\&GDICLB[')
MV'M^7@\UQFD(,;SS-=>>E7E;00EA4))Y.1+_6 ^9SF@WP%*GJ8WA3B)U]&]Z
MS]JC-_6XQ5(PK7F11CKLMV<L4SV=$2X6)HNV"=0C?Y1&.:J<N,,34_4J1TU:
MSK*(S$R.S[&^!.?%8LA3.-14BM-<MX(;XI8V(>7Y'<6A)VL)%![F/P,F5=SX
MP]KF3CJLSXVWB-ZJ!MQ],CP\B;V&V1SW_8'W2Z8 Y:Y+^8_+I]MKR1%C;=^4
MG#U!NE2SGH'/Z/K#:4VNLJ=X8=L1=3OQ KCEZ$QV5A)%NLSN0S9$;$\.X7)1
MFL@LA\%Q_2%./YL&;9W'T?PMB?&L\N BESR$.'=*@T!81! *)AL*K#K#!P3C
MU ];KQ7G^'C3./<ZV]B;T50"EV=9<W+]4P]&OJQ9NUI5X_G((+!COPZGN@!4
M12MC,R59DU7/ BC44JACW9J5(IAN*E!15 _POH6HKX]1&! 8X)0RLXD,M)_(
M3A\/=[L9Z>%MT(:E\1#"?3P3[?OB7>II0#CWX*9=6ITPV[&+G]EW?M:XB_U5
M'@Q,:P((,]GD($G*RCBGC]?20TR?!Z?0A+S3E;GC6_57 W67+)Z@'K]]0[O7
M76&2%9_<W&L5&DA\3W+Q..H_<UYS4*ZJ6<?4DX?T-9N,_?E3M[5XK(Q=61+Z
M6WT,"@J%/ R8ID>ZW6%(3]^GF$P"N7\;$Y;)S79JT),-#R/2 Z I'N:3*MWV
M4!55C4>5GIP@IQC+5Q&90\+736/=;W(LB;U_]VE_=#S=L#Z/= =+E/E^"D_W
M#,_Z:M%&%:.6M^(3N!A33M#9O+_\@?^%KKQ!2Y!W'6;5+$GBZA]K;#T; FVN
M70MZ9%&7_6!&AJGZ;@9+[YYM74B)'(7D?[KT]Q,"I$8'0"?ZK3\52@AAI9-Z
MM6\W=I"$JC0#,XR!E'U;T.U_P4N/<1HNW[Y+/S[F?6VW*_QGA@"N!=0N&6PV
MHE_JMBXS&2R4K5_[<VW4X-?[\F-C,T"C^5Q',F:[9&8USX/F5NG@DXI7!;)/
MF<)"+[J2;MYL]0S86;O1D>S3'1SP^TKKN$_;7:IB$F!A/6@$Q;L*>]S^%L[A
M<>.^#4:Y?YH",\R1X'UH<BJPV<*;HJ!N!!'R^0%D-%;E8&ZTP%1:AUE6^'[2
M1N,H@QT-?T*:%,(Q1O8+]&&51/MPO6_NR2S5?6SV7_*3,](;QU>_'H"YJ[08
MDCQFSTG;[_1&GVSG6M_I/VG9UP:&X,QS&. 60FEAE3YCQNQZ ]Q9EDFV2V^=
M&</-S[#Y=V@[VI'/ F_NQ#V[H(?]8?HI"O;5KQ/+*O.Z0&FA$HUBFVZUF+:%
MU[QB$(UH6^V)!(:!(-""FX'54L%>.+&N1X_I=73@)/8:\$JC%8+_L'2(3T0J
MW+E +<.]8.W3U^H-E6.<[[TE%BJO>*!41[/7VOG$IU_ Z+5CSY2S.>8\"_VF
M3VL%\M5 BN*9LR4*0G1N;;.R-TOL:N0!IS'EXQLM&%.X3V\U]<B5LXRYVFZ*
MBWH7.EE!'+5T6](C)8@_AI"WQ3035$J'2!C:VA>P0/H%U_$_^KTMM78>W!K@
MRV.'?;7[]7/UB83WF<@;@1/SZ;!O9BD170:Q'RA2IM!,G9=R+UFI@(S?5^A"
MQY;HC^'HN9/C;%RAFX'D<1;]=7I/V[Y "T$;'QNOE=W2[&@:K4:ESTSI+M84
M[7,YI6H DJP6?@#!95I"_XCX;H<DE)9^$?"&T,Y,;5OE-?1Q>IEL F-31N(J
M.LH^$:NMPAZ80.;<!,,9P;W5YK?28H?L86X6"ML$*6C]J+@RS$US7?#FM+.W
M6WA3F$U#17]]7$O;;$$7 6RM)U#+P^YF/T3ZXX.+PP>WM,$&$9,X/<@_QW=E
M2/G/C_V^ I ]P$D9A$?W7."969M^*442<.X=,NZ:>M7>?8MA,%7][XA*\7]-
M0:F^^;T&OKLT$UV%)J6L3U* [<8^DQ3J:46#H]2Z7I#LUC^76\HF[D;2(&9Q
M, 1NT42I0O3>LH"K83B:'TS:,^9JDUB<SHM_@'$-LGK4\62.G8--_21B@.AV
M\&CB>]JM^A3^,KXA%1!>-YA.*16*Z^V?3T0G:EL.""*9;P#I,X)4@:0G6V<)
MT-D("%[RX<B$<\K"\]!)YW7WAX'2#\M^5%QK.BDO-Y^9QT/,+5)P'JW*>U\G
M A*=H/W=EIX02\7FC=2%O-OQ 85B95=7&89["M=?5V7G%W(P4R*MYQ/^SO:S
M;@6"/VJQ@M0[W9Y\ <*JLZO;%460M![]H.PUZ<>ML.]4O8.V@H(Z).XSLMKR
M@%,U6$];,8&H87M :Q>"ZVRK0JP"S?T=7W.23&1VD_'&0C@=K\*UBP-*"$S+
MR!1,6_8>X/B$- ]3$W"!F9E,-='%.:3\HN_SR"/:C%MX?I5ZY5WC_FJ_Q.9I
M0O9>V[_ U2-]GBK"Z:(] F*-6,GG/<"O@7=WJEW6'$6F9\8/Z>JMFF'BC0G(
MM9]Z<NSO%(93;W0)O3HA6,2$0D)8V8$FT)L#JI6I$&=DPM_(>.1#3.[GA:'P
M;:O/WUT\(A-:B.[NFQ8,0:!)%L]F)&),N46C_V%&0O#=<7_?PDXK7/:UF?2(
ML_N[5?<LV^4]W_$2^&\M =Z3)F8((\Y,P'1) V55\R 88]%_.=LMUC_#.5&[
MJ<WXS&9!=\E%)9]O!>_L&H,2P=:M7AAVG_76-3&TLD^KMJR!0+UV5SQL4U@&
MGKRJ]L9-6N?D/]K78FCZ^21"<?\>^93@P) _W_*1Z#&#@DN8[*<YBP<U"Z/T
M"Z\Y_UJ-6H>^OG(PN'JCZU'?UZ2Y$T.#[ ?G8FP*)[505'+[>C-+BAT8 6AR
M3H_T<3;?4-QAJ%HP5H%/+6=Z2*)_C/4ENLLI_H)Q#,5G<XGLW#9J;Z[ZF-)%
M]EJWQ&RR;!TS!F#S--/X '/NUU_@(-J!*GJ0R+;Y:B,]23 LL4-<[ LT7%N!
MNS-_MKVO,)HJ<R&D@CYF0NDCTU4R$/-A'8>KIO56UYI3 NLPQ]2:48\;O=B=
M8*PW!.D9&.N5?Y/$9GQ#-[-\-TO^$J>R+@0V\ND3M)BP8<[]D:8O1K3N'-^S
M *"R:U5>*7&1.R<1"KSWYI0(90R%ML3G1!^ER@QIQ+ZORTZ@C@A*BP?N_FLU
M=0?Z\LD!=O-ZU\'Y5X.YDSMAR@5[:-W).3PZ'_:=]:"%W+@C<.Y.M)C>%'C[
M?S*G'4IP-%1(>I&(GVOGI86^B!,#MQ1,%!H+X97A=F M878MVIAEIU(@%"BY
M/L3P9%:^*FBH["/U,V/6B&YRU0G>U34%'OXNP9HYY06B?V@(,A&P@/D<-J#>
M\B*O^UTXSQ1>*.H!GBCHC#!@&^7EE9YA6DUCUN.L5\/Q8'QOWN3;,5+[WR@&
M]M\4P_?_3XIYPYTXW8Z<;4_=D?*F:\=M\Q@@"J"3_=! >.<]QWK/_D6=74C9
MTDJ9HGA;5K49X)85AWFOE2PC2S]-<PJ$2<YQ2AA7?*A01+'.#@LV):NL565-
MC.%.T,?MR)R<*:FX\27O;]?<#XKMY%:. [,_5D]R5MS%*[PEWH %#T:1C"7"
MPTX=]3YDN"MZJ#I5PX[+*1-Z0,50$690L[^J2)/*M.' C&T3]D":J1)0D=LY
M_N3FW_GO\,PQRN.AH0-@QMON/R!FXR"M[!<) ND,6"P6ALK70]GF;C^$NU_G
MOV7K#AR%)SL_N *QB;F8P:99=HR,#&B$1Y*B6-.;/JZ>V F5K+A)H'$R/ ;Y
M\8:CL(6^(#\KW)OI/J\&K04M5LT!JO"<W>;O*RZE7K</ZET='*9!PD7W3@8W
MS:0LR_J+FFM:;[/M- CVO&MA]HY?1Z:\*;.R$7*:,Z:3>S5P-Z9PAH=+9GD^
MQ5[%;O)AK]6CA)!?&?I JS\,Z-8'M5[4F'N9DKHG?.J2[B(YO)<;QKL&]7O8
M>&LP"NU B97F\>Y^"R/8;F>;B>V_WK[LGXL\%(\YA&"'?08^JIL3HJF4$P2P
M=&)4ROCV:-EK9Y9&CD3(0K^.ML2>_#E3S7GT#H]G!D=<A=%REL+)FF&3S4#O
M5K\-[Z_G'A_IDM -8FM-H_9/M4VH=@JHD"[I3Z ;Q??X/H:6E&#=8ZHKU-Z9
MM/09$C(B.D8*+PHB3F]8]'K7+ *SQ"R_0@J59?=@0=@/);O'>F+@O>!/-K-K
M#>_;)ZH,P LZ713*>G/V9-@?L&?_G2_U5!LF6JE79!I8-RG+8!(3YPS*63J[
M(?(,0WA5C3)_B;4NZF#.,BP+OI'EV\G/11PPL0"H/]C<HY\'%_DBM&8$WOP*
MFNW\B&XUX(8= RM30B0(:KX0>;X3'=1P:J1]>>V^98MI5*63THM@9I[>+]-:
M97SUW0I48OY^)W5=8(L9X6%2?,,0D; )%+E'@3T1-HD4#OY5W'@4I -Q*/-]
MG=GT^TH9/O,G]6WZN^WQ@<Z$,->;VOG)<%#R8D1T C0:VJA03W1\_[*I3)C.
M=#E%/\/[NKQVGNGU 4Y0>24THLK$?4=@V]\(<)7J%&9KCWWUY(E]F\2=+_7D
MHQ\76A.@)8>G"S*#OZ^<)UX>MOH]Z^X,&1T+J^AF_%EPSG-XO^O379V=&Z!O
M<AH&_AF9UF+%'XH_.\]#6T<2/V)L1]7)=U:F.64R_)7Z/#7K:S)LZ-R!]L_G
MBH-_7\EVWP\"F#UET$,B\$/"Q)"H'V_ PWHOH3TGY4$NR\L7"<Z=Q0K@8-.C
MZF@EM/UPZ9[=U*;KR,<:HYT3UOXM%&>O/OEYHY#@$;3UW*:GR(Y>0R_GQA,.
M"91-J\X-/Q\2DS[%I'$_G2V/5; A[8D]9$TJ<P3M!<T22T4L2E" S)FX39&=
MB"%"6'=$8<)RS&5%=3 -K?*S6UR!G.7_BS-0,Z2WK,'%*>@D'W()D"HL=:DK
M@O-ER<QM$EX4K[?VU(EP]J*U+/?L[P6THZU=]6:8PTRQ0MD !D],?WGI5@=P
MAYVT7ZTCW$Y\V4>]D95*"0@^#[LJ2\0P9A5-2U3A:WS]TL75_;%,5ARAT%9P
M 4'EGM5#"SIF9;\TY]9LH;1N-B4A+YB>$Z6[N_?LBZW_%P]!<QV",T%R>7GU
MPJ/1+N+WE8 ^\=]7]L7/!VE=!@P_5U75MK/P?'D?\4O\ID5BB*?J,.>_PG&8
M:K"#F[_)"FI[+V0!"C%M)^>OE &%QJN5ZY\5\3_XV7+A^KBMTOR!;1"WJP7-
M0'1I;<^FO1WDE:['(T:156T=_8CKZ8@>N;>\GJK?V,0*M1LNQI *,TK6;,M=
MUEP"IB22;L=[Q-X5%G M76A^GYR9_-ZGH(E)9FSN88-%%2_!,K&T7D<6*N+U
M@#@JEYS:B$8W2=^FI!N;3"T_#;E:VNY+;8O[$#6Z-!^PT.XUW^899W/OU=">
MFGC+4;5?$X3JIO7.+O)&K4E!5DJTN?$ZC)<'F1Q.B?4M6\3+)@3O!(M*> Y7
MN0F0AKCR*>,29@XZE3U63N$'FZVB#];?V$'%PM2DY&Q#[8;MBJ>*,;^O&,X9
M GA.@GG%\D]AYE*<(R#\U9,.@F06)B4'7-#I55EWL7!K(ZOUR!YIT<[HM$YY
MM*&V'_Y3@XNHB+LC45&>-;@&SVJ21-Y.]P)3]#V6(!;,QM@I'>OL@QHS0KCF
MTEGWZ]8Q^*6*1]I$BN.S[JB@);U(+:D'Q<,+M$JL;[,1'_K>C8^FHW)1,1@!
M-:-1EU.?8[-TT/=7%]V1FDIW7HC_7VN!K-';[(AOUVKXC#IM42A^#'=\HE02
MA8GA]KM25H1XS'%Y9OGDKE@ZDR^'#85U)F0_C\1TDD-W C;)C6F=C.*,U@VQ
MG<=LGPV5-TY=7NT$_KYBO9NT'4;[\*/C22,Y'/.5/ZP.SN4D8B5ITV9#;;&K
M*%_@SV.6F:%$ISF>]=(E)LJKR^JKE#&;A;V9R\6^W-F,C$GT6=#JG.IO3.^^
M%MGF!3N+2C+*'-8GNA4NCB\,ACE@7K)*_TSRGKK@!')--LU_FU2C84-A8RF
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MB(-+_\GG&>BP070TRLK*M?Z:6P" *?RNCI3!^ U1=N 8TEXU"MSV;9(M43"
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M-8646_%Y=3%O"UY%AY\?G"U=>^BI'UV '=&J0ZDWIQQ?ANL+6'+1O8[M+!J
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M@P^5)1Q-KL5>5)J19 7$/[-O!;0R\J0K^:23&VX!F%SXZ]Y31KV'<A47-?Q
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MKX?,,\>N3:3KEG$(N9#4BW2?W!_ELEDJ"7>M+=IA' PU"-\)BVDGO;:3L((
M/C5Y;52?K4"RZVQL$S#MEPT:UD-SZ+!",.D ?Z!2?;FF"$%Z+Q(*]FG@/+'0
MM%4AH&+F/99^^#\23'$\L:Z^_TPP79&\)G<26$\[:LEM%BF=A+_$S>[EM?D!
M=HRUWU:[-#JC.ZUQ:C%&LJZ\?G$8YU%Q,6KB^O@/']);J(2MKHV;J_#5EKFY
M&IFSCO;^'_/U])A$!'NG@6* ;=YM@:.2V4.'A;+&H/)>!.\N'.:D;LS46<NL
M@&)5AL) $EN#*=EF\=YQYF?*8$.^HE[M^,6([KE!W(MFW^*DH.I3RGI36NHR
M/V\LQ_?CJ8:/,.;,.8CHGJY3G3.)FXZT:K(:MCDML50RFWU'U4856U 1HRI*
M<FO0UHK>1@AVSWN7"0]M5"^U-]R6U:;E4B"UN+V9<FEX;'(4&+RZI?%KRW"Y
M&.?E*5@\H#4QN0F>HB:1NSY['8_0W_RHG^%BD.'42_>]_4^%.E,%??U7?7F!
M<8:N/Z0&\UIRL3)/L5[3W\(F*^ )SJ9K^D'P23'SM=HR ]O@BUZ)[8SVC"DY
MF<::&R)O"C[DX>1V$'*!#T)X(^:MLO$I9AQVHA:G2;S9#Z?C6.AM\ WF Q(F
M:OO3!OV2'KF8!1:?!5 ,&VC*?BJ$;]</_*5#+J)#+44O^FDR& PB*S;VF#XY
MK5I\38J!M?Y@0WX$<@LR4Q5_C_AJ:)D#Q&G_@1> ]9=-*NW18]H3LXTB>]4H
MEMP,K4I\=I7K!(O*6+L,K_HRYM8TH8%OBE$V:VR.;&PE^7GU:=&9KT?U 4"Y
M#N"T&K9'0AM/2\AY;ENP5HA%I"N-_TN!P.U,)JAINI8$'_P]:OYQ$9?/VMH-
M$8ND4>?.V[I?4T&:%@M\\(12%QSOK70-GV_GB-YMMP;'T/8'+8.A_?=2D/;.
M? GIEU.\3\*%U&P6UPG#G4N) >DIQ54JB(-2>H?CGJ?QA^VW7G+4]JT".9;-
MKY-1%FSG?Z#/U<?&DLRF_$WT&]UXF\V49;33GTH2XSB2P',RS.E/OE@['WS\
M\<@ >*MQ0F2I#JSFE<K5&V3+(%5LPL!:[NU9'*\IIZ1?194$RT*I8=K<=@#Y
M;,L\W$1$Q#=$)_!M2OEO4<<[)-T7<Z'XGOYC"IK2%%^'7<Z*F:V2:_5Q6>%(
M)+;58<MWQ2&(>;LU&X!Z(Z9\"XD"$J/482N*2NDTO:P(I1ST.C]ZHE^KG/%-
M'* DR2XAEE8TQ(Y)TWOR-*3M<V6V?A(**08[(C9HT'#YQ8U!F+.;H1+B/V6/
MZ_YH('T=.G= P=;/"<WFJ+&\T#9/VV0&?>YDGE"1(N^!<U=T;:Y:ME/7+<=#
M>6<0$Y9WE5:.4:5V311TQCT%CCQ%J1_8<XW4[R8N44WV"J6#E'V>N/J,LEQ*
M\@S  L2%<+V:.()-C]7CK7^PC%M_0-H@S&#ITB[OTVZF(G9G=W$+0:#L=,PT
M<\IB G*WC[I?QBLPAH76IIA&R&0<^A7R,W;]1:R:G_['1HA+W!MR)^G!W:TN
M,TF49^#;,K,<*]^Z"HM>9X[6 '_"X$71%8FGY[]+O?\G45I=]>'Z\PW1CN;U
MKLW)AQNBM!NBPDN;WOBWJ3=$Q9?ZP\%2%P6>5B<>(W\]!WQ#Z^SOG;EL9;YY
M^4?NDIQ"\7S],;(F=9Y1[WT5C&=](_:SJP(!7(B:^SX#W@R8"6LN$#=.&-<;
M=1@H,+2'%9030T:&@);3B->6+]("54ZLG)Q-\ V3?-/-M78V7!W&F L3OI-^
MLWV'=._)WX++$;=MJ4>-$.Y,QR>0\<'-%]G3Y66!5)1<'R'7FZC",FKR/8['
M\-4^ID=Y\MXXFM@HL;&VP5/$VHEFEXQYS].I(#OGP CQ\_X;HG)8ZL72\<$Y
M%]8ZJ/10_S+J>KIV/,! #B^GDDFQ\9;F>5/>]YWA[H!X4>6K^9)-#7#+[+,'
M4[ZBS)H2K_)T?YXR4A>%Y,=!+@$!/)DV]LF$4\13$YYU8T[7F&]QF:,K@NE/
MBO:;.9; O9L'U- 3YP!5L7*_#,(BS:C,]'WQC3H_:>5 N^Y7_G(-U12B @-E
M2P7(H >:_1/+L6O@OLS9?1_@]!P\DZ[%)IEMQ4U1&)<<PK%HI0(=B="J3!X?
M[H6 C\<BY.CB"A"(-R4%_=Q*R6I1!@8&4B!M]C$!+1\JJ;JPC^$"(O -*:Q0
M/ E="#>KW:KTW$G=2\VYXL9+8Y2U;*5"F?^O:T$GNMNK.?'P$HO,'-R42:^'
M*\_\J&_KU=!J;I!EUQ'QXZ/8W/. -END?77U#9%XW!XH;TK >@C"-=D4]=WM
M*[8AH=!V'#-FH/'N1"EH+D'_RAP G=EZ'>ZLS]3JJITB56Y>E.0T9VQO]W()
M/'0W)=<^S*$_"WIA;G]80)5+J]3JE)KL']L:B)8MA(VW]/MZD#@Q$6YG>^%:
M<EC;A&T_MS+CIV+H:1W 'B-&<N$<:UL'RE"$O>:NOW2I*V1(,W[.4RWY ).?
MY=KS)65?L%#*J:/$4&W+<;4!$.C4D1O?-6)@( K2LT]C52M21" 0\/*2%*=,
M3NE81ER[F@(MW9 7?.4I]F[\ES1R82@3Y *7Q[$[.AM2:?(BUY %+!O\EK8^
M_OTA$ L$"?0/$;8K5QO%J?:<9"Q#-Z Z<M4VYQ'WS[MT@EOG:Z>$IZ9NB+*5
MS\J'MS.MUDJ65>-;]1>"$$(5[!GC]) ]YTJ5LSLIB?J^]^K/Q!XDGK$&*-,
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M/I64LQP1D>/Y9:VTE$3FPV3(W/!TV'ZNW*=_?A6]+'?+V%4B3LDLH&$D13A
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M.BRU?-$Y .9HMC4C8*6U71(:E>ME_$31K,%TE.-,,\%4R<@ AL=S6P)KLQA
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M6;-@RS]7>I08#5=14>-M=<)#:B"%^F)A&:2LRN<V(UY(J)1BF%UH4;,):%_
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M*[42VJZI(@SU*W/$&TH[X,H="9M\,;D?(Q3&,QX&Z24Q339.6!OIA!TP(^9
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MW P^CKU#'R&?CN[T_':K_L)>^APW401WS8I+@LQ-W7T:!L0'W[M'&M=,F)<
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M7!5LIU]/Q3I4?UG)J7_\#9"Y'[LF[8K/B:T#>FYD3!=*(*GV^@8*.W[B_*N
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MIUCG8)YZN^SH9J,MRG$IH661>^./, L"8=1,LB<BA"[P^3Y0^8SRC>Q_^T$
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M]&SVYV%(QJ[]L-H+M.H"OW?+5E@0[>\+D3Q78Q9:CY8HX*.=%V>T'UGS$\3
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MD5 *K+Z#O]6K8A!+N9D)RDCHC!J"Z&@GAE4&2<ZK>%31(Y^"-U#%PB'KU+*
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M_FI">]L^_7KLG=Y!J1*:] Y'>D<@"1T$0@N$3D"*#:0GF$#HH'02$I"2T%%
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M')F;KEC;F9K7T4I-%?J"$Z%&Q[$#R#NY$Z+."]BUU[A<<6_'6HL[_1<K91Y
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M(7?#3U4'0[^P$<O7*DJ,'^I1G'"NLL;\LRL>(*MJ6#O)?LSN>_/LB7 HBFT
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M_;)5/ZY(>C247\?[67>D(?8RY &I:"0;IAI&WEG0P=<5*@647O%=DF.SYMU
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M50N'TS4K-:[5%8  05.'Y'=U@PZY(HZ%1Y^Q,KQ>B?KA Z\&7^/1AE)J42D
M;XE2>_ "JZ,D &@S,UW'(ZB7):UO"I-]@;=Q_&@3>76JNYBXGF>OA $=2 5"
M9DOGVYYW/S^_6KY<LBMO]DX[8.+G#)HD6F-K#D(;@ZY5W IAI8[)CM\"MY;8
MR@MQQ$TV/>AG,53*$^V 106=PCU%*POG_EYALZQP!1#77 W\U,YM'()?!-.Q
MMP2A]V"\M@R',R=+1PEV@Q#C^J-^^M'4=]B<Y,'0VE3IUW.J[K'NT5.;40E<
MSEH(KGJ"0SI<#/B8Q9=_&BIDE8+-D'/PV:@N+VELK+04WF.FE;J,S 5&BWEU
MS_G_#.=4S1UFY74\JD-]EPNQ3BML#;XPD1MB+<OX,'7%2O=8:QYTRY>S(-TD
MOZHZG$GRH1NJKY&"8=['T=]^<KY1,KOM4E;HK- KTG)?L=#&C^Z^?2AJUVUE
MY>_#L^$# L!H2J(WT)>27L:40KY;K_"-J_1_]^!+R7F]6)Y@&!VNQR@!9'XX
M,"!;]*VZJ\=-@C[\XJ\M^DB.#@SXF0'=5[M##%G?\5I!F0SS?6#Q=&NP^5H&
M$<#Z8FH-Q@ G>FRASR5R-O8FS(:(0@:C9SB(:Z/MKO!&':I>!/AZCT.@^&Z.
MG]WQP(D5>\FQ $>QY=YT-PK?6&GW.W<F0$C/UD\#W;&3DWE<:/$2'/PFUBS6
MO\)62(3QP0KP?N81Y7:LE)^O\+?!^Z4Y%9$@W?SK&#-QIY.'GL8$.Y2<XSN9
M*M(-4KW:MRP>9I!356Y]T*EOX-.CSKK4G!RIABG^Q28VX7[.[;89W[&U\J^]
M$0R\";NSE;A:=>M^+'GZA'_[VV!6TFJ55,)Y*]:C+CL24! T#$*7:K$YHL).
MCWCKU)E^J/ZY<!$YE*?I9R9%L7W^0^CM 9)MJMDXC'SFBDG>I84BS!^\=_W;
MDHIM#'^ZEFL Y'AFHY8*7"W:X0COS=%I[;Y#PW7I'E^*UH63'_U:3YY4*V9[
MT$JB]W44\6:MJ;@SZTIXP-1*1I])-B1K@T<2Z8=5IO>=;;N9AQ^2[76H1R<0
M# 1T;=#XEJUB)__#+ZDO"H5LFAGU1;>/9\4\&HX-1X3HQMZ7D[?37.@H>@_T
MM ]ZB!$P;H[_JBDW+R9QO2\_XOZZS<(^GD_%GUR<LYSV)MS04]^ZHCJA<=//
MHV*^Y3:-KR[-:47EK/%[FQ3*\7O57.%'E^X*"1B*N'BI9IAV2!#9#@T.?&FX
MA,&APBG<UL3>) 2X,05^K9FV<BV*;%7&'2@HH]B6[R&ZS6(DJ,<OGV6\6=@1
MBA:0 (2'9O0@'1!1JKBUO$4=%M?;2L4.JU!=[V+8X8#%MR[M>L_3^Z'2:BO9
M6U,2LNW8Y.DQ@=7S^&WIL/QGU9?"C"T"^MRX%\HA9/$A%XJ,4ZL8K"!#1')K
M%6I;Y\C(8K0^2V(%'/:L&D8#.[R0H9.G=<!"<[\EEWV'J-*:G>RP%ED?1"[8
MY2)1%FJ!>H ]_,][.^/"%4/F55Q'=J!,EJ]$@8+5('^$!N278]U/MM!)^"P.
MT48G1GM+BN#M^*""K7\N0#\?F9F^E\@TE]@&.!*;F&D&?T.3YR,"_-JQC9E?
MD&7 U=#*4;_\>&1*RBZ3.9<LK>X+X.&7^"&K?8N9 !V1N;:\F%5;[9N&YIBC
M\I1V#8V9S!6#_A2)!P.]^D26N+BBGN.#SC\7IF6G*3]DT-H+VOIO7#/<#^@+
MV*.,(>M3B[VWOS3,)QWR(Z)Z__GNU_10D9 L4+/%,9]AE43J*U:^SA.1WO@M
M!0][96?;ZR!M/ ?1[_C-XS9I*CK?'1^4:[+$"K3<F=32D%-/P4)+9,K=?PH\
M0*#=0USU@'H@T]#5#>VK^'F=LBWC(I8]9U^;VDDE-/M\_.NCH1%3%>/K@M;M
M\[-;HIG6LNP5,<0 D+[%J,U&JR!H6MR<ML$I<2.T"&VP!O),II.FUB5GZCQ0
M24EGMC+EGF_P\)D?4VK,[9/4-E)-QW1XXC[A_NRXOU_,;361G9ZYC8X5!ZUW
M,;U7I4=RS;!)NCSB[W/)VM \;U78+<2^U.R$4WNR;V0,JB]K8!4:0D@P=C_)
MS!=%6]70!@R-% -.XHZDF>&#VV*^3/ :FMK?6_?7JC-9Q:>>),C>T?50&0M&
M]<0)?B_X%5+YG].7K/V']M]83<>G*GN@(),EANM$.FW\AE_0S%V_MN/-ZXL=
M*XP&L=C-Q=AOV>&[L;5ANWJ,-LT:=8X1^[& FBU<=,"=+H]N;HJ?C* ,\;P.
MMOA(3>A+1=E)<V7,+4D:5<UBLGS#5D!?X0'0 FFU(QAU'*Z4D@*9E).3K91?
M62DMI0N.QD=?B1F9N9U;#QFM8PF8*#78Q"A,F94+0J1O.'EP]EU>)H*"?F$B
MHXL.335OV"<-)7?-1PS$FG=P&.0?EAVN&O0AL<-DR%-!!RD.N/>=WYV_@P/X
MJ<E/_$O%I\F(< #AHZ0LMUGF,+=I<\2MB.?K6K)..2;5L*:,>4_&U5);#KWP
MK)"S@L(&K=-AM3@$I@;@1ZA N&<;KPKR)+1=K954C+1+XL&47+WWTX+PI-YB
MF:Z$SB!\(NDW3 )JS(R.>P. 8T7..=4VW8N $3P1K-X2RA8,UGM;NJ.7=62V
MWA-NDM]N'^N:?SG=:ZE/R>SWFR7@0E=/ ^_NCT@,+28JUK^G%!?.JIX>F!U,
M7^V3K0\8]U8=GV?%,F&32I1II87>Y>X8 'DX ?>1+N$86.EG9CA16BEVY7C<
MO$@%%MO3!_/X %>L'K\:#SZ[Y5@IS_Q[8H]0ZIBTUYL1E7QWX=X3AD/EK+3Z
M]?M.+S+J52D@H"%P778+82H'O[>D:VHI(N%R)-@"&Z9:PQK%KJOD]U(WAPT%
MPJ0[R>P2PCI!\AD@HU(B"O7&?%GN<JK]Y"ZO>()]S+RBV;^O;J'>8 8\1.?H
M_J"5PB $"=(3Z[\D*U5'Y*[.0>P"PVW6E5XOTGF>; >@"G)6]06S'["._15J
MS0>["*I]:&3[H**@,U$D&F';'%+*_]L8++8K-_;GPAA1&98Y3A<V?C3Y6-CG
MV.Q_"J[7&L"6O/]7P=7R06EK6V@@-,#9GB#-QWD"PN(BML\MBB$T);%\2\7S
M\*MN^=X<XO!"R3U.@*QH8G5#2$3-A_9\P;5+YFD2<7!UC;*25VFV2G! "8":
M(2-&TC)T?'+"A'S%@!*RU@:'&4_>605("_\_UB42,@]\-@>[.GY.>2-Y7(-^
MY-OM\"&@/[N6V#I[V#='/G]LC-[VF5E6_P%9*-$]CF=5!V./;B*[C3@$5G=2
M#LD@)K)J6E2I]4AAO-"7R:E!$TI'4HUCR!$PIR.V^[?R#R4>K_E?A?V$V!JE
ML,[.PC2O+>S=.8CWG)Q/8SOOQ6&-D";_P?E7I1Y<TK/Q5CHL8CM'Y3LZ8?LC
M5=0"W+#QZ.N'5LXWK02\F:RU$C</KV2DK&I-+S%,XY09V6)U3+XD0CO.U:=M
MX4>U27^>)\NC9T^*DN1O.->#I@Y!3TZ&DZ^# Z([S1.^P9M2?N-39LSJA20'
MX</J,9[9=[<!R)CKW)USN&T8(U@<H*&V29V^B"*+OU-55M"^IZ@8,@HBZ>X.
M<7")U09/P!,:IHU5? P)OG #]'PIE1!WDTE"$(>^UA2RKNJM(NH,.9\4)BOL
MEFWM=.)2LB3PX^\F11^;6M,ZZT3Z2BJ L):&*+@XXBC]-_:Y\F_/C1>MNZ>\
M]-7LZ%KZ@][?MMXMY]7)R*V,T:C OWYA//]/FV+Y$&3H9%'(6@VFF]<K!?R-
MA]V0$0!D^>']B)L<-:BAJ\.-M.,6L]RL[K(XX[]PH@:"5'<'G'EU%4P#<"Q"
M(B3E,B08TT3^ZIG./&6_<='P[(O0@E"4'Y:@6KKUK2.^/\S7>MQ_2 NP1;&.
M^;$F7A8?CY^*I%H+_C::7SZ9D7W-LY<<4K[E"T0D0^Q#UAPEG5(#Q0-PVZE&
M-1@AHWJ(*<P,.ZL<'=46<DPNBK>G;34#"Q16JO_'HKAYI\Y]\!8G=2PH PS+
M,,KY??%M3I_6^J7(?ZHZ&0LM+I8B8LV!>-CBW^/SLKUWSPY_[[>E67U^'OF[
M/^I-C/JZ_\[Q4+0%:;%U//MC<KC,).)>S/L3NJ;B(>N9ZT_E4^.M8CS?A>:E
MXKR#R2E'=35T_-G3W:N.X6,#S6;@DO4-ACCEV*"GM,= $YWE?S@49$5N[=&S
M23<:K._.L0I8F\^VUP<LRPW.% R#M_T;=,1-;Z=HX2CSIF,D\@Z.VWFRHO:O
M\M;=<)&)UC'%#DN0$*&6) ILKC]N%_:8'254..LV_7NW^E S_;F4>$MNY;_-
M,:_V_(Z.Q=Z<9=MF<TWL%:KOG!Z>=7%_PV.M86!'165)6PR%YNEV_0Q%[Y'O
M5HE^FE#X_6!>5=N!&K&ZGAMZC]+/<O#MHC^=]:\FM5<W_#]#\=<=3:35^+:1
MFP4-2% &G-I]LSK.MFJ+48:HEYADTSLB>0[V!Z UM>W"G9 (SOJ26E*3J(N$
M C-W0)'FDZ./5D6/?GH$4)HE*G>BNC>MPNL6?\QT-3P5A;,WI]0]S29[%>]@
MJ=/UM#)?I:L?FL.S;P<U>/LHAU58"SX3#F@P&O+^U(OZERDZO/27&6O"A] F
MLES$%JT*"Z.'5 KX/4@]T:U67-\\S/GUYT(-B:!SYT0_BRSEZ;D%-W@X^&E8
MK?*;<U?H2TF\W^M"?*H!7.W,\,IC]T*VMFR?8C.SG)8-EKD1\3'WV>U8D)[*
M2-]@"K'6U#$B;E+?1OATK-72FM(<4:H$BG">JFZ*##"D**[<O/V\C>7F?1/G
M5!##MP6P5=W7X!^^(B]FC 0)IQ>@6!X<Y\CX!XS? ACB=Z&XZ@ ZE:@Z9M?H
M;\1]H&?HTE#G_I/GSX4!%\G@(?52+SI!WU?3FXG%]BNYR>OO<B[SES[KVD^!
M!]%TO.:H^,5'>S]I-[T0YI.35Y^,\XIGK(%N8^X6]"/MU?8!+3![R1T U4W4
MSMV$0U!1TH@<J;)#FA3[-1I%AVG:=7S]Z3HP3/"LSO FK["Y;W;+%!_B:];C
M;;TPU9E@XS#NNA+JQAP/44D=6.\/EW/M8!'QT\+ =B\WF.>JP^\MA_Y.#E]@
M;=)OB0:C$R?$'O]X8%'0ZO#\E=Y,A"KAE7-DY]Z[C-<O&V9%E(P+)1>H8%*M
M<'P<:72;V@US,)"8^R)T2[C%^L^% BZ0N^V@LGV(*HB)0ZS,]#V2'T>&"N(J
M7"TSOTAG,;'==IU9J3(H6W9 L"U+Q$8G-LB2^W_/6KVO#;;FGOOV(2DLHTDJ
MFN!^Z-&D9_!>_XY>CMO@-2<F7CA:@FV\&/$S1K$C7^YTA@G+A*]%O?WG<F%J
M2-11\9HDCX#QIH#]W4"GDV+_L@]5QING4["_0C]JI7Z7<7)PF51,4>R7DUFM
MQYM?&J%^IMDOT7ODS97WVKX-L72:%)\(03)N&7Q*C3H"6K -M4:FI_Q:Z>7=
M)$O/[X(B601]5K36P"?532_P@?C:&"X4WK[J21[@4_K#O;SQCG?;;?YU$NH/
M\-/;@[3-S(3Z^VO/H$XA@9-6!MMC"G_/M^9:BHWW*_Y82J&E6E':,EU8OQY%
M7YT.%>YEFCZ2"#@V*;C9LP.WS/;]<X'L3?AS@7GQ17#^M],B(U?+HV\QKI)B
MY6?Z6J1OU4^4Q?"HN[4GSVD ;SM;A7--"C?VN$F<8$*R,]9)*$Q&:  SWD'+
M3+8A;8V #*$,\8'!?L%7DXZD;N\3GH(1Z0.MA>,P;'?N,[S6P,Q'UC;M1H/R
M:9?+@^.^'SKK C#+C:Z7G/W%\X@7"SL %(""2WSF&S<F1Z*Y&JI11[&5G)<E
M?\MY]),"Y?S/A?O5H:@P;OP@FVG\."U?X4/_")'#"N0!=(P-H-JP(%DKVZN2
M!0'VE3(^:0%M-FW\XU,K9;#4P*6]@I,.G]_6!_AWL&1OL&%K[1,5] LYFYQ^
M$ZB^QUI$_+@?6O7)VJ!I ;PY.['4N@3BW=@DBA%TO[%6\<:5L3-<_+_8>\^O
M)O?N#]-'Q:Y(5Q \= A-0'KQB/0J);10I 0DA1(ZB!Z17J4%0U,Z22! @(2$
M)IU0I00(H5?I-:#8YCQ3ULSOS;R8M6;-F_D7[G7OO3_7]?W>^[XIX-^K=4 8
M_PQ?W&(\'3?/26\KKIJ<<>QHLBYK@#]'&-:A;YB4VPUH/Q*07)TU%!N?68"F
MSO2A$$H]G"8]EAJX H.Q0B)PBDKQN>-PFFT?MVCOZ:0[JSN3F"$"O5;^]=BE
MS?2$?^V244ZU=52EUM%I2^6=0S!26DQX0FH]VP!I;6ZZ3FG]G%-@7"(*T?H0
MTR/[4V6P?P+B>JNI T./4 NMY#>7R+X3L7=9SV[3;L3K,,)99HYCL'I$C__/
MA2:1[/_N0NC= RV(=6JZ_[D0T++U<(0:]X7;.CSA1VJ(K4*R8B?A=A]6D:!U
M^.*=FY(2CWXD];R@H[_M1G.1*>7*J%=X+B,?7&ANOF>*<KAO\2F&S16O(0)[
MB47L$A SS9W74Q2BQP "K0SDD6W>NDPY5<)>?C(QN63+5JR?X\F+B4HH#<I!
MB-=YJJR^P>I)N-P.TL$#;LT("@=6$3*  FRDM?E;K[CN#ZL]R,.*L(5N0]/>
MP#TK?*$6ZD[;<@J6IX3STK*-L],DS,YY:T:=-Z^G\RR7=<*3BNWKN2T(U>_N
M+_\=RO;<F#T=\?(UYT:)3-\<D?YO3V'E[Y8XPHT,]00_5.MB:I6M!Z/GW)/Y
MTK!I?,W7O1VO.#RXX_Y_'Q35OEI6*"@4E_IPEL-FVARGRQ9"]_9IJ!D3B!-P
M(QPA[R,/7[!@94GA;=P/2A[7SR<=SXAH9?-&9M_K57^Z;T@L A2YK_S(5';9
M<1VM!;+8R'#-B1-^_AY3=1*-?#"5E3"AVBIG*A__X/W[E+343\#[;:FO1TP=
M\NK"*"LO,V<?!XUV@,T5V&1-40/ON)2'9=.T"@PXBQ[;2&73>TA?JBUY6 MT
MM(V\U1+3]"D,A]^?U-XP.MM^1S?^%%Y>4/%I- /J?] ;RM^;FGAFJF&?,-R
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M=K=![S^\)"HL1J&7W[U]/UM8D(]^^Q&8_8G_+O5Y3UI\WPF:G$ T9^V(N?\
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M3=6B<XYF:7NM2:B7*8:1TSYT#%+M?G DNO=6@QU ?@E(XC*K=AE@JWW(]O%
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M= Y;UXIE3''($534OA,,=?"O>/ .7(_0ZUO'0@00F*2L;/X<9<YL&_V%#B:
MEQ:MG&U]91*N';R)G\E-K'#*HKE3-QT?0<E4O)69:L.(*XC EB7K(+26S>(E
MYP>3=V5KRUOMTKM*:1*A^%;D5AKC:6""^]*B]E,S9IOH&CH<N;:X!'1VH"]I
MXRY<N/"?"O63Y4CUQ>4@VO+666E@H6*D53/G7C(,N=(N93R=Q1M%,YYB5K'O
M*C)SL.J?7MU?IXES4@Z\*;X.D^6YV,%T&ARYNKBDHQ6MK>'*]0R.I&7'OC6/
M</G<*B;8_EL4XBU=&&8#SK I#6C';5M3S-6WIC3BO:=-K;I],Y ..B64[IJA
M.-/?_ADL#QZ*[.0*=Q1YU\H-@)&TC-BW+$SJ&DZ<G7 "*/M=-##"WR>:E73Q
M0>K7I]HM^VI*0LK)E%_M[2;5P;[?=TG#I28_<L8IUX,-U LB;CZT)VVK:01,
MBBJK[H,$Y4*.&V6M#/"V[7'A2;;O<KEUY'D$V9YLR52 2CMS-CEMG;[.-RN^
MQH25C06<;T;\IQWJ1)FQ:$Z85X^?!2$$%%F_^]*LKXJW&S0D!&2<^B0"+73]
MZ$T7S1ZA+=]G9&8@:)C>IZ0TP#!B.=G$?D) @7NRMIF3 XUFS>]G^.<+-@*-
M52:4BG7>Y#8=)5/(S(+5>2ZS#9"="%/[$9-JM,OC677#H[*4",[ZB/YH)>OZ
MD@YXIS!?R?<.0%V']H WY0XX=-Q&DJ72%**1T/RFHE0UA[TB31B:E2Y@E\%X
M?G*8SWTR4,!DWRA:&_1[<>;1I$8R?Z-@4$/I3T.BH34ER%K%T*)H8C /[W,U
M*Y>L5F9F^MTF-#MMV.']'IOJ0]7CL4( ]V11D9TG:WGQQ+/TY[U49/XPHJB*
M<%AT%*8\,;$2<)G@Q,@LJ%CUM) VW+<W>5TJR%0B;G%;^ 5COB9?Z^%,F!02
M@N*ODZ(XQ3\SNK?O8: :+1#/=8U#VYP2!UG0+W9\+98S!5AS4AA!=N'G*<^^
M4OVEC21F)XSCNU!X>P)M6BAL=WPMJ[<LURG_=:"CGJ)7Z=>PS%S_SUT%TI[L
MP5DT]LJ8HF^F5,T5@=.V%%J*\(%[NHUP9\:]EE970MFNC5T=HY\ ^I@]+:R:
MPY !$AD52%IN!DUNX^*W3ZE7O^6C&\G1FXY($Z>L\2M-52!A[6.LPZEPDXN*
M)4>'J9T?9X8H9Z<BO]KW86-MWU>Y>%CV X#(-ILDP0Z.4@YAN;OQ/POGAP-U
M156]>WE]<<4R,9W\+=?^HN8]XN,7!B_5+XXBQ4 \GJCJ M>V>/>D9?;X?+Y?
M\(R[WW?$'%;N7_O?#9W@SO]AZ Y#N+HOASSIVC7IGI QW,%#3G ?%.8@-(!H
MOOU&K13]>O\''"MB(*X>I4RX7WM]81CA*OAN=2[#O?%_N*BC@O_AHJJ:(S;S
M'-DFW-*;_UP8WE*H^!E3-HT1GOCM[7?%/A3&Z>CIJO9S_I7:AZ&H(7_<HQ36
MT_Q4GP64$CQE;09M;5\%EO^W/0>&P)>6ENNR54Q5'1TMMWQ H9+XX3MWU$+E
M[Y7GMG TR "45!WR)T"I;H=LZ;^*/-)HYWEEYI4[N4$J*5[@S.C4G I3A0:A
M+C01N.,^$>2H).U+XK#1H#]8Q+V2I&I4?*N3*8S0RM>Y)))AWRLA/%P0-4#3
MS+X6INV9R#/;_(GNT+UJ R#B%;SLPQ0E9G\VZ\"['BSKZ3ZMWQ&J*OOAAB])
MN9%>Q=.::Y=H8\ QS)/? :?Z'!75.?*ADZ""A-E_ SYS_8D]2F$D_*,P$OP+
MR#".]]S, \E8M?A/U- K!H^K-\TPE\>FIY2=6<O"*V7"Z'*ZTZ26XGD=X^Q7
MS7O*D39UR&DCLALY6,O/$"O.B=R_<4#O3VSW%/'/&:-;9]DTL@Y(KEHM$;-E
M=\(* [[IH94>0F:D'/&X' V0MPVA"6H1@("QJMK?* ZOR&$)80.A50"F]'DK
MT,VL?; \45H-=0 [U;2P8MAQ&A&KX'F*?D7K#KTS9.\&5KVPW11BY+RP\68>
MS3&K]R2(BW7_IZTPVM;C+$5UIO$WJ+8P7JC>0M'QY9\+CIP3D-]"*WV_K(7"
M%T(]8^-<'+))9ZY!X:\L8-D>!I6+@80@.*!5[4NEXD&#Q7QW#-/FC\^-KUG\
MQ)J?USH)GK5$#%(9)ZO-#?]I,06T,[]Y/IV!,QB?LY>Y[="+2H_U)K"'%'E;
M:OJZ#R2MDM"6S^N&<-IDDO+NXEJ?95FY84@@@)@APY&GCM)O: LC-8AD0Q^7
M<X:B6Y4;JKR/H*T-6R\YCX)"P"A5140]NWJS1_LG5<EG 6:9N:XN][O3C6HL
M*ZK=]@:\1=8@0J,->Z9/M&0@'8(U/?/ &#U9;$=!M.E<"?Y HKS\X7G(UMG,
MF:$>I6_0;DXN<SH7,%G,%0S=J;ML8Q #YGWDT9U[3TRKV:&VMFI,, CL:+E!
M;K3KC"Z<^.]1\9BOZ$4_?KF<'%4/Q]3H$&"(51E'V/64F-4%R9#>?M,\G&H%
MPF.@MK3J:"K?L8EP<<JZ@=%7_ZZWJJA^]YG+\&>U3'M+5AD$3-NH]WX[2,VX
MU.!B^C<,7IOBFFW)*HP$".<W:01(ZL<_J$YXV3"&H4, ]!F=#>'@=_FF(>V=
MM_.M5DJ/2V/Z-BMBUK+?Q4-]ZI\TVHN463F."O +RR!R;9R>*QKG Z,R9H6S
MP7Z2N8+2@0B4+]B8?\)B0,W:NC]][J3)&E H5X"[QY>FRI%PQN<T5Y'HD6ZW
MINJ 3]]"@[;\-FK')*:VH1W?LX[#TN/5P@BH@G&GZ=#.@U%Y(L1V<_C7_IN7
MPZ\JL[WFFBR#C&X#=DKL0<VO%(_H[9XX$WLC*"ON[**O'<7S=FOM/CGJI'7E
MS/R>:L>/ZT.QSO"PJS#'-Z0*7=?YA2M?AF^=/9)#:SS5/>7N$4I>,""HI/F.
M3L&*;6X?U:7L]N3@#,$@@@17-/N:I0&'H?"V^>9G=(?>Z7M&&&-59 P#FW<Z
M*O;V=\CY-<\[]I5^16-50XKU4Q.8IF=_?UJ&1\ZZ_4ID<ER@K5(P-V5IG-]!
M"/M*+!(OU)57::W5T^MSHYRY(NKEP63QZ''+F-WGQ/8M=(N&[KF[^7F*ZDJX
MVN^NK)+Q /"1QY![98=-O,"VF[6DV%3NX(3]".?K^_;/8F]O=YFHL']Y+R=D
M^PO#VWH-\:44&RBUC8;FY:B$&G!8)6-(H3"HC9DH_[V47_;]/_.:;B01-4@<
M4CUB\4(%75^]KM4[JJ8\%=6QK7A<7^6KP8]-XD_*N%ELHM^MZ/O*C3>E!QPA
M5H$L@4]NG BWX$5'];&![D%8I4+8+MN7A<3SX>KNT!3!K>D)!4*M7P6<'-D<
M97\U70,A37?.C@Z6<]4(T%DO'=X#>^X!?=N"7AWJL .-\_]+EM5V#2/]/_K(
M-U-*X^^4HNX'6AI4.#Y1]2QNE^:'[P%*2=094;KUKT1O_PA+I_0/^CK5Y.5B
M7#_E1J'W9&6KH7"+CI*=2LGXP+M*UR#6GD>P231FFXT )3AJ4^#--["YF<4F
M1M2E *6J!B </\RN/=(7ALN.T!@8=TL]G;OGV @?R;5>K(&_F_%_UM/4*6@Z
M+L9QZV\D,Y?$2+"$A;GO2BOB(']<&F^ZZK1!?[CF:&:?)M04U$/K].'&N0]'
ME)1MU58&5]MOAT@N:P^3DMZ(CZUE9@,-%RQ3-5+2G-I 3ER#U;D3F09T:OW@
M:<YIY_##F/C\)HM>T^#]\!^Z_FON3::[,[EX)P,;L,#8W,H2$3E_4\,_80QD
MFQ7<R!8Y;*0,9\21M["?S\=:+)1%^W:#Z]9G]Z5UCH)U>OHVP8)J/V094G?G
M60WWR7])2JU_B6#ZCP%ZHJCF5(FE/\OF)NX@95S6-'YMS$K&*EU4='&F>V#S
M0-2#*F!M6>Z08EV]]."$TI<G,:TM92K%-#O!%^;WE,_73PUV&!@^1OZ2^Q3@
M=#-8EV#DMX@L@QFF=,#*H+%Y5:[FHC@ &(8(/H9E)KI_4W)OE(9:#E'7#6"$
M 82O;U&A5A%?[<U"P@!LH/-S16O-HC,[R^*?"VP-2ES/6R3P%.P8^<54(-:]
MHB 06M!%A(D"7!L-!J0%QMR7ISVZ1-^H4.)2F#."3-*7S)5L46#\ (S2^3DN
M\G^&@0^D_Z?ZL./_U(> _XL^+ AHV3Q(-2G0G FP!X$=^\--9VMV@Q5+Q5:G
MNB#UN[KQYI("=X6)CGCW'*5B$8*-_'Q_K"\L6.Y%X\X4%KUM(93M/4U7AJ\
M!U'][)ESUL(IC&U''Z8\?=24+,?.OS7W^++#&C)Q<(Z"^W[QQXM9V!=Z0@:H
M.TQ3\:/' ,<]"W?QVNRR#.:YIXTP,BK3TR5IH%--DP,>R<):+K.I!YA>5W"K
M>^N_01BF1CWNR(F'NB.,(&O&M$KBE-*[\FK=?)7V_&CY5DDZ8(DBK6^,#^=-
M;G@-CBOZFX"$SF<,2P 9(K#]G"%;GGM]JJ_/+7060G.EQE0-*E9N]J)Q$<\"
M7\9-U_$+Y$1G[DT"L*7_-7Z_?YY_S>^:#YUU@E.(P;Q/FTM8DG1!X&VB,=!T
MTO;E>LWA?3+5@ZZ6],%)6CA=:A0QI#\U-W0YKCB:53]^R<Q90<U;."55[KRC
M+)([UAD$$@E8.1EB3F9X^_MD1GE2O N;H^?/YYO^TO.M5]=2K>;3(-N:"S1X
MR?K2U)Q4U;<4GOBI#@G0'XJO3HMZT=T:WC?F3_QD-X%FIS)8KFU&SX.$LX9=
M_5YCT*Y#2N6!;0\9$3(F$.ZZ&T[$J8/-=BK6K\=1^UY=QW8S C^<CUG:B<K,
M?%>:KQZTI./0%$1.E/2O*$S.=9O?Y*L.FUF3AKD)NLK&N]VEO(L?O'#AFLBZ
MWM^O)1!O/ ?WX>'^T^J>LZ=JE^B!,=VX"2\IF[S&OA8+\]UNJH6!M<R*Y%YI
MZ@) ADV".QW+JV.E/X#.\O-]QY(C IF-.Q6PRU9T7=#DO34RJ0!,!1)%7OVY
M4 ']Q45M+QN>@Q):78_-PA$SJI4X>1[K3*BHD>L2DN.I97N?\?".1CG8Y\I!
MG]N=_Z6]^PYJ>GL;1>_>MBW8Z%)5.H0BG=#<TGL))$!"43JAAQY MRC2.P$"
M :23A"(E@82V06KH)710.H2F:%!!].SW]YYWSMP[<^:\=^[<^]Y[QL__WYGO
ML]:SUCQKS5JS6!+#V<DQ71$ZF8,!Z19S^>FX--T9V#P]K6Q)$K<1= S<P=CQ
MD?/;IYO+")95BJWK'8U_+<1]7*GOCP6-X"?\N49J*&+(LB1>WX[)>C9V(Y00
MP\*# /JKW2;S"D2&Y_FV_ZA,2B\#M+<B$(,-MQ]RKRY+P E/$ZIUR#/'L$Q#
M9NZ!6A6:%)@&<$M=85-LOO','YYGEHLK7AC0'5#0X$A\8[UY>]"^>^Z^?19>
M(2C^C1,WI]B;H)02]V36NIA_.R28EBEAC$[DB?>RJH/^J#%& E1+'@5?VI#0
MXRS2Y]VK80^[M,R)X/U6M,TXTMRN9[ZD?MB./5LU#&]$#2W+&F^K)]D]S3I'
M]"W[_FM;LU-'A&# B_O7\<#$8WQ92M6*W?77'P3,[&[UMT?5^!#R7>%A!./]
M6".UF-ZL3P SW3K/BCI):>\T0BORX_8SH<+OEB+=X2+?VG1?U7^<EM2:_(22
M&!DUR(O/L"R78]^S\!D;>>N)(M:9J'.VMRC@PPQ:$#4-2F8T]=#:JD5P&<PF
ML<!MK%:T7KZJ/1&J/S3(S/OI6.>)7L"6_5L]2:HJN $7?A![!6S JSDZG(/!
M87M1/F^V3FTV*@U#-W4)3!RI_+:>[\/"I]YZ?ZR+YXZ(C1#),?MRTDJ>J+:2
MA F>67SE %8\/F3+YPUYRSKR-KDX7+V!K#5$#+[3I54O\23-EE\TB,-$L:T2
MZ]*H&"*[E^YC1UQT?W+S@:6&J/W%HG!<MK"11',#L1!?X6A:-5J "2 ';!Z.
M&B$;V@Y430=S,>FS![L2K+H31J63& @;'N_55G;PW :4$&P%7GW38<^#UB^7
M4O5#@0&6XH;QP182J\W)UIE 2@9*K,2FIAW^3VG%+"+EI%&G48?1\7.!^47R
M;_V\<*]%B^EI1 X[6;@3A(0P2EB!)RG6[S?$SP0@H\UUKT.!1Y#)%.$'LU>
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M9L-GA/MQRI"Z0C%H\.(FTQ_8#8^>^;2MH8ZN ^O/.7K@#UA7T>L]!O/E!!F
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M<(]U/>N5A'CQ9@Q=K$>6=2+GSN,%/&$VQ*4] ]P\M/VN.?!(/9]/, X(%GE
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MG<P]Z@GR+,7'QCRO#[B_(I%MW9NU 6I!N+=R% $!N+W.=U ,I)@<@H![=[5
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MRP3B57N_/31Z/&5+,L_43YK<B^%!6[\9G[XU)73Q>QZ9F%ONSV]:K^<$M7O
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MY#G,3J%M(?_KMH0A]T#E.J*!DF5NM5[6D);FJR"@=J'MNH%(JY0Y+B!T^"/
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M2T]/0YB-G*H[0L_3#66C;*^JJN)VG-[ 553ACJZ"JKH&BI8&!'<EL+.S(-+
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M(A[AA%.R=8$JB!TOZ7I #V.PKIZ8.E)-Q]E>#*/F[J0CIZWO),JKCM$ZSG%
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M7-OZBV92;:1RO#A)20WRW#'Z>CO]EIMG\[D"<T4Z?0: UTG:V5=:5NY,?+N
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M_._TFHC..-\?3TAQ5/]P.81"+\P8EMLL XE@M2Z]1"G^QIDC$&E]&K;_[#O
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MBLD8S!/7DM66+:3S8HAWQ#BC5JQ=-[IP/(VNYY5*YB/O2@IOZD-V]>##Y"8
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M0,KG,H:#?>.JLJ<J-Q(#"X8HN!^1R5LR$%G;%U: AT.'JT*:JO@^ES.B"C'
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M0%]$^L1H H3Q/HE8D7&=K21693:RQI9%CY% ='5Y"]O(>)A+X>3?*> X;^H
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M!C$KK'<CKYS*>H<RAE._A4HW^ZDUP'-S%S)4Q9*VR8M$GVL)R6O%EAA/Y:O
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MD6U'0\U"@]&"\?Z&X,%/-7@)HFXO0Z2F@\TM?UQ@GCIO2J=4DRH_/%L'TWH
MHJ VO&Z/K;+PX]C*FV"=\*/TJXZ (,>):_F5\M*6KF22DS+QI;R:FS&RBKQU
M?&+'PAV:9L\>"D/Q4.V5?+5V"Q&K;XV@*><ZMX5": *;J-,F1,:VN;D/#9(F
MYW_O '] M;]%$]8,E'_JH30&%HN;QUOS3!SWJ)P[M3ZL,#,'E*79/&H-MT6=
M->2O)M_.8]>9WE.EHE .C(\@6V1'\6?2TQX9EB)<K%8@PK@=2^( 1:[)[@N[
M3%J2::356 CYUG2W]%R.KZ;N.::&J[/,^6>96V^JZE,+3\E2+%A]ES"J=M?#
MAAKU71,S22YU7@(@A2LLT9-IE*OE],<SHC<!O! ]WE*P90W:-RSTJ4%^=!2S
MKR%;-&82Q$099LR_LS">K<$^')6D*>%F7IO=.^OB>W_.86HL_K+\%):@EX#*
M$>'P*1EG91P>W_EMC\QW"K^"<BR.FA0%. 4+![TZ#]#(VBY7;WJ:O*Y)\>N0
MZOQ]IYUE):M]7CV 77$LO*U/G4.-(<.O+FK:9*]_R'+1TOFZ;:VA).?#*])D
MB%MU1 ?&9NK)X]Q^L?=C(IVEG?T4)B?YOJ;CW=6P#PN%6G#A>>P4L(<'3,!E
MQ;MSDZ8^*VG(#"W,=,J\<:EZF^<L;CZM_ZF1P]+ VZ/%@:YU\HIA5<+=3W,.
MZE$+*-$:;M5]>]TYZ6?1-[ES@BE(-&-S7:FS_+"HS'804:V.JTA6+G(>($_,
M88_ZF6R458<,;LE[7@0I?::,TINCG#XANP ]2Y56;?@"@8$@E,BFP0=F#B9"
MMR)K%.%%JM,;D\D?^@RK^_N:+&EXU^/K'A Y!E&$V*R;:,DDFZ!TG>.DXED]
M;4%CXPJH,:-R+YK+&\?0[C$0<"!^RB#2A<374'+'J:#LT8N!OTS\WBO/*,F9
M/=5*0@$1.J8+!F:]^BD.C,NCJ(43=F''+$FQX/[7[WLSMQK8Q<R3NC6QV.CY
MT_>*+7 P>DYZQQF?;*;L8][OFT($(M??=>?]IR/SD@A#2D, KR#;E,@0:HRY
M+%F$'/1\WB]XMO2!Q1E<N9I64Q9F3BS_;EH5HLJKWWXJPJ_0T^P$R;6RQ[;7
MLNNRW^'H#FGXS=[A["4]&,I963K#W;*[ ?QYJ4%[A^/&<7:6,I]R[7"'@V=V
MNRW[5U&_WOYHYI-%!MT@/@?MLUSU[ZO?BMSA?*ZXP_&0/D6LB#$Y@)7!!ALU
M9Q_EWY@AQG6'7SOD2_Q2Z2TA@&[N^],7)'FIGX44T]VT*TB&[.YR03-6'UCM
M.^0(J"XD+M[V.6G)5LD(?#1O5 \! ?N/HDENC,E.OFF^2F$I]X]!T]+MH%##
M'LDBY9!< <#<8FSZU^Y:2IJV;P-FX'#0LDALYS!YF=.%=5%<7.W15MK4(C2.
M#QJ'<$(6)R-$69:.!K[B5! ]%.?J<Q*84LY\78:5[$U:>%)?0ILK!5[\[3D]
M3EWY&NT<!7#]0YG<FP>8V<?2_I5'0$\PNZ>&6TFY7L85&EN( 0+EV<A<44YQ
MR.0"6&=$ICRUMO8KCS&-XTHQYIG:(IK<$W4B KL$GAZI-G[=EI./7/Y+3F4D
MLE3F2&>X+-:P8>2Q>W9)5[K--Q;F<4*[KAL0%)+TML[3H"EOGI;[+&"'6E1(
M58=HL%_;I6&NS>*H;/G'#T&8MMB0JHXMVK##'NKX8WE9ED-_,7.^8\.,7QR&
MJN]LXJ-O22X"VP:\&C9\OYKJ<),.SE0[*B?MI#9I:I#QX+(,_A"A-=,IZ]B[
M;6[]>Y[=@G:/7..YW&E_\N$O6RW<-?+J\6%A>@KU8C14X"GD),IDEN[U3N:$
MQZ14=,:\&^*5%_6.Z(S$U?KL9QXYURNK(MS@]&3-1$*Y48>,Y#1F->[E=,H]
MAY%\WTIG<N5&YW!=).8GEU,R_E 2@)D/+3.LJ";P^3FRDAM6%D[)70!W!V\S
M5=$;GA/W#>E++A,1>.^5:Q.V!QCYFI^&=&G]+E_118J&M!MM$#> )!H!^.Y'
M9;:E1M+N\Z7+F2^V[-S'F2+=)YB!Q=M,H8:O2_9WG,(M3GSA^HEE8,U7L_7,
MVJ[J?&  !Z4^,\0MH<MP+"TZ&UPQX= PF\1H5O*V<_I%*D7-<X1!1_M+%VJJ
M 63YJ&(2CXVFB@;5AF#4_.FFQ#"6:MUO'KD.JM'XI-2=*T+,*Z\@F?>+IGF@
MA<J)7OU- 1"^E[HBV+IUIB+XN8)N[EE>TK0E,=R#MM:^,WE&V6494A),XIC,
MZK<2P2YGM8[.+S;@4$;K;=X_H42U@R?'67_QT(0'!4LB3@V4/.9,3XIN225M
M(U[Q/?<>D@LZ["H4'4QJV1O#&.6ZTYN4Z$UXN7J*^:G$LJ6@ITU)"%?VUHQE
M'6<%/5[&XWE'%"^(3,B(;V4<0)8U8.U-KXV-V?+2S5:<@LO.M'#[,NB,_?T?
MP7^U*GK<_M!#!92(W[0YW6.D%9-<P=A5&3I?\D-VG%/>I3J/.CS<]D^/8=XS
M7^W3&TC+_40(YEC(0)RM9W"7^:QU(!D#5>F=X,E#QWD/O9.D^)5I';<+2NYP
M5% 'VK1![Z2BR]'2VRPEG#1Y'X1;N,>22-_$E:I4)>9<O7V*9F,%(AP#$BC2
M6ZDH?,/5;/F2#^PLV971&#(9_H+J05_ORA*X#1CZ4YY#8SM%T-^:N**.#=Z,
M"P@*1D-P<![2N7-.:VSZZKG9@\"F[5$ZTX7[6XGTBQ!F/H;?O8--<PSX=(/M
M3NEG RP+V>ANJ1H"2]O==.8[G.<>22[JI##8.:?EKU/F4923J8S()A??[3_-
MN'=E_NDXX0_^9UXK^*])U/8S^Z362&<P856XK@)* K?ODARPKT&3H)'KPC+^
MN3 XB6= CI\??LP:'<@)K/4AF0VN72O#^.9_OB+[I.'\5T_\Z^G5+'C.[VQ3
M4LO9[70TC\DGSM-+$:G9R^7BVAE+M?63PWZ#*'>%_/QW&KU?*\NA2R\=.>(3
M-_CEGV5QLD$+P,1@N'Z4,-6UTA/;\+)P/J!'$V>&>L;@PGL+WR]+XL?]&K\>
M&'E/BM3&O/\X-UWK1V0V4@J49/'\[<TK;:V^WIZ5%D^+3Y0I;+(#HN/N@EEC
M/K&7)-*Q:87;I?-=)J%(/_*":@(>FC[(M <V\)D(&94O@W5XM14!7T(6J48D
MSUQEM5^-T] 6UI&"Y3?>#DQ&3]NTC.0?>*$WV3%0"4A&Y(8_BRIE6=K[J/3"
MSTJ#8%&5?%5FRP9,19$GX[NK0[4K7YB%AY1NWZ.55[N3/:2\P_9&S:8S55XD
MO$W)]6X[I@87GROL9DOBXEFK-BW??1"8Q4Q\?3:U96D)ZE2?\C()P[HX;A'F
MF0I\TFANHZM_A^[SX=?5)A=2P)(S@0SJD[R])<-[>JW-#4U(>'^&"]!PX!&!
MO-&:,6017_^FO:3_@CUMN)R]MEX3X+YTLXL*ZAX41GE%+>*G7:[L"(.F0';J
MCKO62K)*$,E[>U&[[FK/Z,1"'<2L8^P]!HR?ES0IP(?M^B-#\9X(-+-YK&_J
M'F-^1%=B:R2VV=MSW?S>3>Z[]RLXI/K16W01ZT3;<>&+4?P*;XB)?[\ES(Y4
MH\1C^IUA2__U">'?LO"O2SE5L659@/EZ 9Z4'$=YL<UY(@\B9X_T1SCXSH>^
MCI/O&G$:G8X8F9B+PGV6RO82(!?M:I(=#]=8321X'-'ZK8E/O'/=#Z=O-!NH
MC^M63:=GI?P,'13J2[Y'P3S5M0S2I@H]7]'K1R;5JCDX\-3MLEG.3[";:.6?
M6$W9KS[THYN$4#[-A?<^5+S,2[NL0/B83<- NM1E].I3_B&CEY<Y#.NK"$H"
M^^/!N,'9M0<B:PS%53W](N%1*J&&EID@#>/4"TQ5QA_\NSB;U.U95==6/Q<F
MU2MR7^=/78?5\O6V^"V8ZHR-5=\$O2Z%:CJT7MC<ZDS"I<.K:WS21-/-:_(H
M(Z5>R_ DJB&&$V%?*K]1K&TU3_L5Q0#!M(,^/64?'9#[>N]*#&+RO33-FRDM
M6C_;Q-MC5/2A]"(?"HREB[BB4HH5-%K=1UD'&A#DK1;8^Y;?_\8?+OXWF-*2
M 5&),-P,OB70,GI_&]8'WX49+;$FS*2']L3\?*!T:UN3O09\D<.Q1+^;,L[3
M=59[178<V2Y.]_V!?OEKQF6;SJI!DUJ\Y][-OF@L XU2EW/]3T(=VZIA%;HO
M&@<;11O;V@76#/2O^HR1#4A&<7[!N=.7PHESVM75KJ+)"<3E$?!P2P/,NH,1
M/&VJF9@T[OG.))BM,FF2J*2LX^4%,A]L?#8N=X:&HH<LD!7<B(V@4#/MUM2*
M9[(VTAP;;RIN7LXNG1>RW(Z++23*?KVB_',(T'Z'@WUQAZ,D^\]B!FF(UMUR
MA=WA5 ^>65X2H8)^^0O<Q!,=V[3MT+]%5"<YJ3G#)R\/=";($SQ>E>D;C#D
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M'R>738H40&76\N"2N:K0J6VW=&?.I#_^HHKIH7<0L,EO%BT#L>0)N=Z5%*.
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MJ!?@UP,UEN8SUF=MJ ECDQ<?PI5V5-)V!V/'*2B@1/"RY&082)(7M<7TN"Y
MQM2K?9.M3<5Y_E2_Z..)D#W60K(?<A/QKKC8^I4OAAA4BTW8E6,,JJ'^SNC[
MS/SB7D'K^5?%@T&1UQMVIFW61\UB(I>DE<X']QOZW8**HQ<JMYQXE);(_4S
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M.J-NB>P+_&!:<?'!/.6HW4.V%S#KD7:YX"L2Z"M"="!6WD/#R)P]4^%;Q'W
M]QG+X1]<W/VB/VGG)/6VW" F/Q!U#9_)8POV4;O"/1[IMFA1OY7TS?_HBJ>R
MY>/\V/6_L??6 7%UR;YH?TF( \&#)VCP((U+@KMWX^X-C;O&",&U(7B"TTT#
M3>,:@KLVWA#<-;B^S)EWSWSGW7=GYLR<<]YY]W[U[ZZUUZ^J5JVJM?9>M;+
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M5"(]2+RX<SC:/D^CO&O=&$?#ZQVT/V@H="ZH=\T@I"[><59X/8"Q:U?K'[K
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M5<516#%K-KQI43/J#F$8<'Z:FA=&2=JH+QEN;UOB>W''=;C'R#,E>&#:='G
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M15!T6(_^!-XZUB241V8\.RHTYG:=+TOF)'FM%<\@_JKH;OR/_"*W(>!UZU
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M\ZH]6_G)B-XAK@[IRN9BGR02<)BW2=Z=$-+@?NCVY-'_:^KUL;'4R+3 B+U
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M)#.1+I/LU71?.8R6OFHG/#^B;FHBH'QJRB@N .C8.>\"KHQBEX%8%RL09AT
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M1!PW0MFR V )S%5,/QV=K<,*%WI =OTK5]BLNTH-.K[D"[J<;+I\\\MY!FX
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M'!?*<.B!3]%-2US*_K^%L<]7LG\$LB/(_R_C]#\!_A/@/P'^KP28;:,EG9"
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M2^[X_!1<62 ;F]JW\=!LF?BL-LYL/;I:-:"H,%DC"]XF+0QX(U#$Y$'9AQ2
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M8VJ(F^]YV!ZY\2]LY(KR>)!B6H98T>R572T3HAW.UU9S_$@HG*A(-@W=#/-
M)40D%R_M]?O9,N$!-@<F7GJY3R*U.9E[HN?MMS]WS0F1I=:5\&LKD#M:E#+J
M5169EZO2X=>6&VNIN#)6YN"595 :5TCCJGNGYO"*VZ=C1145%N+5;^D47M5O
M@[M7(/#8N!3*V)IO1=NAX:R4.<51\+-X@J=VQ]_FM30KT'LRA')W!ZM#=G"L
MD+ 8=K2OZ2%Y?BY/'VI^^(N"W^A-=6SWKO7\@IS[PBG3O.:(0VT-=#05UPTH
M"^GP6!2E_^:&!H/BQ"/*.0.9U-8NFDB\HW-]WX=7*EZ&RK>8^/W@OBN<WIG_
M :.:YQ47=,?7'K=JG[Z,J;#LY%$OR1'Y/HV2,T6]@.!'<^ 6WRJ;5;%%T ];
ML5#+XE=DNM!\LF@@ %*AQU5]+0JPQLJ7F"CEH ##K=97UM<&=4HYK0MEXH%3
M%%I]/7T#:3-(5)83.?5I0*R"#9J8Q,]IYVH5!>V'NL78];9P799V%8Z/*4.Y
MRZ8Y)(EH-:YC)KK?\P6D/+TRYI1[+S(BPRWM<4W"8RJT*+3A[Q3PX;E;'=C.
M7:6K+9]FLMA0[2]+-VH<W]#S*CZ5FC%+M'7DU?OB7+?OUH-06)=;VM@5]IZN
M;]55R=,Q X=F#+:DIQNUL4'5G/9F5;GJA1C=U_:5Z>*0G^5+(4@/[: "%?K1
MG>)3]V:O&/;1@ZC#WOBG89K5'_+^V-MYFW8;2S+;%YZ6RC=LM^>0L>Z0,$T?
M!='NSM%.X,+4Y$W[\I#[JL8S8+\U@XS<^Y+_L9[R[:U0:".<&>*9[A7KL485
MI9WX5V/_#>$^/(6W%#,_.[D'P#,;RQF^8'N-R6Y';@V<?!B[!T2S&[X0^5=.
MG*):H%/0.R];2&#+1I,C>G9LD6NT0NPR*?'G"YPNX0$WR(<I'I(W\=:?.PH3
M]XUIF5/)M"J?B3:<#1/R/%%DH(CYCIY^VL"+ZFDDE_NF+ZOUNE"UGO@[MW4>
MMW]C=J[)T[9*5NL6C6WN9K,G=.)$<O*5$AFW\%0FY?X>R,HP:511]),(0 9&
M*G%97^]=IB#=PK0DBX%>30&^8WCW/@6*MW_<14O/XV%>BP9?>\@F?;_FP7J[
M&WNE9WZ^0%F'\RK FFIGAUD?PW3()"'"MVS:*-?,;-.4C"?B6T! L&FU?TEU
MKA\,"]S-SQ?JA*<'>J4V+A7XQ[Y:/H #:INRPB6RY$,D[[EZ;7H-2C_*BX43
MGZ9&O_Y'_NP\QSQL;>/'.$^HD%$GTC]6E^J,G5ZJ$[>-)-?E-1?N=5BT?VG
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M*2]4R^\!R7:WEXIWA:I_ZH5L!A/AL'M F%'FKL,]()?'K^!1P,C@+:=J6<5
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M8/N4BU.R6$PRQKYHLB[VP'46MG#*9*/U-+]BOMHN&1HGO1TC>2 94=C,.[?
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MCY:U?'Y)ME[QW.P^..558-U3;! F^>\V7R!)ZZV2%G!SL9LY,'M(_8-\T-$
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M]>*Q,]'WA_! IBE<74\5C!AR/F5<0O XZ>8RHU HZ\D]Z-?DXVW;@G^K10W
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M7\B:6@UV'$I3>B-+F%EG)^WI-E=#UN#^8JL7!U G3H ,SL=0_!S50U:#F_Z
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M9-B6>XNQT_YI'SDXH5)^WK! [H>:ZL#X-IN>EO#3@N U!W+],+D.@:O ;IF
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MMML 6>E<Y+Q4PM:4D)(8.F&;NBD"'WC[O$P<6OB[XRR*NP06:E<7)O<6XLK
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M;>]+4H)G^K#R 3RC%Z]>D^_:8,:G7LR!3-*C]8]3=)TQ_-^&>41S^CNF79=
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M]WKE?D!3,3?/$;>$]<^$$;3GCQ=#NX27M5 'Z.Q)=$;":6/9Y>; L$N#0H.
MB-2QN';H6]=)1B1DB^OW#R,N:!0F+;O_Z9)6@^.2/7M_I;X,%"H=.C$>>5_2
MU5AF5*$^)=5;+RAAGND6AZCT#^&$,?T44X/T[A;Z+D_LJF83]SQ(.',-WP>!
M3>F.<!P[:' 0^_+"-E0*^@V: HAD2AML^2A5$0#*EM16 6^N3 P>TN&,)HJ
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M[IL3"D&='0#?=QHU'K/#[_G-SO XQ_P=6+.NX79Q!H#/--VUT$4!07D@72_
M@>&,PY\2@%Z%[M>(&N&;;VQ5W1]K>B".6?$&FUJM\#O:67"@G.FY9AL&WX4"
M]+B#+(U2FHH#T@L7ZM.>6J@VW^'Q+NL 2&#2W\"T'>[3%>]':PG/SE"HIY.:
MDT#6J 3( ' (*CG7T;P]I#>8J/K%+0E*>=/42[UPX\@E?7\H4;N[3TA.KWH2
M/3!1S%!<X>O0SE!3IZO6&.CY>']+I(C*C?;.*RK5/H9E$)XQF-&":[1ZQXAU
MVBZ+S%'Z)MI6$NV.8UEJ+[>E(&JTBA,FMQ!#UFC[1,WIF*0$C'K#&N"C@V*(
MJM# GN$.9FRYC8#5T7%LP[XP[PGK"K,QOVC8BK1B>U[" YQ\KM\2J+9\X\NI
M9\[#@RC-$E(UG*UIAB60Q[GB$=,T7M_E;+[ 6^G"P\Z;E?L$ QSPQ1ARCW'^
M"XR(\3][36__Z[TFU&FEPK7;H+E9MLKI75P=ZV64<M1MA> LUQ]J_(5T AZ3
M.RO@&A'N,6N-;4'-.([^6&[;\D+3/M]<-^4&#//5E+M%C/I'84_J9/RK54I+
M^:)V8E$)_EBP']H)U-B-;#%FA1'IQ^V,KGUZJ#DD,WH*WLO7G)&(QJ5[:9/*
MW.Y6%?*1U$O#>!A@P'/<0RY:V,#/*WXGK:R#V<[\5(NT=TQS?UX)'X5^X2@$
MA.I :!1W:1\NL=B)66@]Y7F #8/T3GF^@ ]!D2YM(M0$2D!Y>6SQI?$WFFL?
M=W-4 S"B27MDN:!)!PK^Y2R13$SWB"DIJI5S"!#@?.M^ML*"*X@/G/FJPY66
MT\9E6."?#[1(X0B1_)+W\XH_6V_%/"V#R: UT_C?3Y34>M9-3K#IW4[2) ('
M@>;:4Q) L!^C,=B&7K+(R9F?ET5=_5&8L"C@N!+L[.P)7-#6[E6Q3<AZ]+P/
MQP@]V.X!I$DC]$L5W\E2V[HI=-^2@NB)/%/?7/>SNLV*]<LM3_ T%@4";6-B
MLH 6W/Q $3VBHNZGX-JQ%-"^7=_UNC)1ZX<6(]R[MQ^/.N*?ZME/3@6\D_9_
ML;B:7&GI(F%3+2\25Q:C(L0IFBNE\CO,4TB'$W7!0.3^<:,U5P\L-Z!5VW _
M9@@6%"]A[.2R%968'T(/],NND6CLEEVVKL174$JPYB5^&B;&.6?C89&)Q,7>
MR>PLTN%Y'F>;54HKV%/:)G!@0 +=U1(/,U2Y>S<F^+N1H8&!##C:'%"BRB.R
M+EAI=B>K@3AE,F[C;>H]TY27'BC=2Y'E$AF*_GT6E6#%GABP/D.Q=6)9%TVW
MKK<)0:V8I33:\11&[,T:R$=I3E%.*KQQELQ3I B=;[N"2YSC_D"7(N['-+EY
M8U &&C<^_6QC%-I"5<#S@61N3)H^RZPHG/[K-$CW^]-BE9'/7I27:F4TV=&"
M" _W  ,M+7INA4FTH].N$\0":0; BYI9 "RSC;"-+SLF%2N!\D)- G>Y]+RK
MART.AQ*;:;W-_-U' @->H&[7V;DLV2UPL^'C'6AL75R-.% (3T:SZE(%X2:]
MWJ#OIB$I$WM>D*7G='-5UO83<4['DI5]1MPH +<"%[11O9G"/HE$@VUH+J;O
MS\M FPP#&,ID/U\*Q]8^9GA;,[@M6O4L?LC+RUPS>:]3?8.BVBYA'#-"QE9Z
M6AI(<U;P1O3=R9)*<S:&UE_',TI2/##5Y$OT]&R0RW9!G0P+B4V#%Y*?K^7@
M9 .0FJL8M5UU]A5)1^%9\DI@L"F%A-$9C$ZE?/W8B<IFK6" TD,^XI!K8ECY
M9*V:ELYT@$ILD;*+('ZR9G&3.<@>T9BGYM2>_8!!.3'+XVV0);A0JG_"[ZL/
M5_7S[H/PZOGM\D?96<@9@_RH/A-XRY"+@6TO1KM8'<<Y77."U=!4$9AQ.3+A
MZGH:F"?14/#5:MEB[9K!=SN+&T5-)5OYAKME^7_;$6#/L?;J(6W=+XO,?=AQ
MY ][GY]7,CG"SG0B&)?VPAD^<<:W6=P]U_7Z2G^[R^3I+]JW4,B?5TI)^]VH
MTP77MXL>,2'7?UZY^N/8L,CQT]=?$QXR-GD.W"I.X8Q$J@,=KX<V<P)F>TI-
MYQ\^M&8BS_3=9"4"0RM_C35OE%]:C5QX_KS2].['CZ@'P3$A8SUGU[[N+[F4
M1]%S_!+"7K<(J#ZO49 X9[W\'*"]_C P>FF6>7*2X<RB=XOZ1ES*V+_ 6/S?
M 1)Y"-/5R%7W._-@;.94D4BI8!Y6(J-.H\')Q@-I36/7@2YA8T(L<WW43FRU
MM2S#$1_X;5^;=^*#J7-\?:>>#==+YE0E^SY>F7G)NYS&YM+GF6>L-O:[3L]0
MY66D<T 6?^ [H!Z>51,8G+V*$O5@]G;FA%_T".C4&"1K1QE)R,4]XW&R'-,!
MB@(=O@A%O^OVG!@KCF/7)G +5%;D4N8SFNM7P[5R7L(W@P9W(Q<"YNKR;.OS
M(,1:]AR/OJT]7X,,0\GN78)D';P,9<,I"<R:/^V)UX\K13<Y_- W,49',[[&
M^_!-$L%FX]/"8P92H(<ZBO-^)B0[#D0'#ZOSWYY/:,44<(7MK[][M]!J^)K9
M[-4K(\>]8SWK!0$'Y_DS*EZFDO],B_WVPQ#*_P\&AWJO*?NZ0K7)O:A_DLO=
MP]0FJ0V[PWXG$G_=?/,0]?.*GMFP,VG+] .WX%.6=UQG23V.N>_$H*;WNV2[
M/\(<<SBRNB.&):\<2WL57RH&AK<2JP*J5!J U?M35.;50( R6^JY),6[;ECE
M2:@+C2WF3_L5_M)5>Z'\5?[=9* +S0FU[<IOC7_=_>H'EWR@<<>$7RUS76'H
M37*DF.3?QLCZF*26]'CY%>#BK\BLZT(I\;G)! A*Y?5\XP#46EJ_\@[37,(4
M4_F AZ"?K/^:661\#CS::M;*OEDF4/5Q*:+_ ?.=# W#1;-$M=>X7Z;)W2B7
MGU<*.7]>V5@XK+M%6I1O(ZIL?/L/0AO4B(EX>N+:)<=WLU'UU]-),INOJ!:=
MGTC]O-+,<-)$WE]K^]3@6U2$OT?ZI3^I))96D]S0[]^VO >F?X/UM$E,?C?Q
MOKD,/8)>%LK>O7![$X$H%1/CT3GO^G6V7LUCSSO3A3(?+A->B;MUIG]X)3'Z
MTN3AS?&O 6-R)Y&4D=U\N7/=XH\= (_WOS2;%\MI$^60.E?_5M%"BR;\\)R(
MN-O>K5\U=WIAMY-T6+9AJXY_E-2S^<N[>$6ZMGRA5RKC529'VIGL$?2??&7K
M7OWVP^OGNK27M+[(C>-_.?5QVS6T[F_O&(FVL>)OS>?])3C0^90V;=[AS7<:
MHW J-[AZS.?_5/[-TMO*Z9)JR6C9?.%BO*K+O:'/=U1KX*#J=>E^*<!5F.'Q
M .OA4V_1QDG5D[)Q-@>WFMB]2WQ(E<Q<Z]:D5$N:5,7N6]CLXVS]IC<HV_56
MYY;,?]+QUY90 E31G2=);M5:A,>NK3"$UJF0]($Z]D2()QN]P;+ER.K8(GA"
M'P'0I765\9.!QV0Z;DF:*/<I20;N6RKKW()8\$LEC@FJY7"T]:ID:0N\03&1
M3)41?Q[AL:"B[)5A6#JR#""TB<KN<5[@QM36A8<%$]N?O<C S9>"TA2V[P/%
MFF=NT=J.V#@[LCSVL(WVFD&B.,8[D*]_AP^E.-T8]OU*$A7V?2E,F\WZ4@V5
M3PW+HDLFZ+#TZ!Z;J3M#H,B6?E1, @B 0CGW![\XZGV MCVHA]M$,PYEF+@K
MC]>AXXO3HT.>8 -<UO:IQUXTN58QP_R$K=ZD.$8B:![^4?%),=.LHO*I<X/0
M0.YWH/JBZ348Q'S@<P"53H*CV?T 0T>%!\KJ$LK6J/)$S=X3%![(2 >N(9DM
MF2[\0#;/GN5^+3L)HT2X)V7DY-UQVV8(^GGE8/;A)2'GDNO[\1.J$*<F@D'.
ML^V\V]7%!&4^693=-@..#TDL_A8:8JT@G$)9.LYL+*I0UW6JTU0-[&_DHDG5
M?7E_YJ,M20\(9<?EM4T/%;07=A_HZZ9EVJEA49I*MH@9^ "]&D)1';3R=PB;
M@!<'6$=+SK%*>?F23RZL]OKO_&ALZJE7W4I.Z>6U;4ST#T!XBM)Q#[D92WT:
M3@>C/)J=FZ)1@K!(0):DV\<()+*DW*6:H_"C;!&ME^A?9EW =T2@."Z8/=UZ
M2L:8O8<; ,!O3/U]+8&]VZ9D7_/>\#]>RO%*WTN%5*C&S!R9C]$_2BP8&%T'
M^L2;C9=/$^6^WKL56*0A\1DA)!UJN%ZWD?&@QX.1^:_%-Q"Q6W6>9IE\3T'T
MB26D0V'K(\W^ <8A+87RI!K2;B;6\4!!7UXEJ^/_'E[)DW7JP"2#,D6OU?=G
MM>6[SZ0FA4T"8VB-/"M%1?U>JS9QU[C9][-X"G!=XWBX8&':(O-"L%U_.W6$
M-6@2,WF+!X,O\JY.V*KE>.LA>Y7P0 CYSOR<ZL(R'T5 [^(Q87EP4;_EE^ZP
M^/ D/X.#\<?P3='QYQDTF*Z!]/G5JC_64&/ QK=- 8Z@0MO*0O[ +=00^835
MO(775,#0R42J)\%:MY?CSFFDTBBCK:]96(V8NLRD<DW3YCSJXUO(R_OR8H,]
M4LYI/'"$B@:D L3#E_T5J>"%'TZ(::G%F'D@FV57+>Y).:X\-GI29R]KXZ5G
MR4'F"P*&H*JJ%'^$&IKK!C[[M#-XUAS_.&RF3TIY8#JJCRN*H=V0_N5KF'J(
M @=BGZ[Z9-LI<*'+AUCO&?.MJ#H3(3O6 H:YRF"<O$5A4P")>B_M#!&;(7\O
M#0MO63PY_%Z#A%O/'_X:M2^_IOA^J(O8MAW'/JJ!?SH69NA&UX&_5(FPUIIW
MU"KYSV?FLQ/<;"6YH$W.ABNQF;- WD"-WNB6+I^(9*6.XA\)$'9YK[NOM5=T
M5F.'_(H=_YY=\>7E4(I+/8/)5!7HE(?Q65*^TE>M/[U4WINRQVT)T">\==AY
MP*:_<ZC.O;X."*!</=BH*9%+Q70("#OGE0 =R?P?FZ3[-VT9^7O,T'0RU!&Z
ML 1<,_\@.3R-;'L[$+[3NCV/<_3'),0#_1[P3,/0 (*6G1,?O+_*+WW+!2J[
MA0(\OYRDP')X<DQ'R8[V6L8'*NOX;0ECII#?,VH$BL;7[K]-JK>QF5JUZ^IC
M:GH(J(M\RW^[/"5Z-&^3P:E)P*^@ B0G3C7]Z-9N.F,UW4"2!+[)[<;]1'\(
M5,Y&V+M1?F)72_8B.]XI/P;CGTZ4%"TNLE88Z<#FLTY.E3:Z/8+/Y"#7.3+M
MW@X,+%]C&4)\5$HS*98.;>>RNM;3)#$\=#]+^JVJ\RCTY4#! Y5@.PO1JL^#
M(%;E><CPX8&[[]P.L2[S#FT;+=OMAA 7,PN[YG2>-/M-(..@@9JS\ 77'S^L
M+F9TM+ KQ2MYQ&0X/!E:V_/U[KQ(T%W.EN#/6_+^N^-1=Y P02?V=5E]\+K"
ML(:);M=]G^[I%YY_AWT)GM8Q,21U'!V=)#>WL[I^3&2\UYXZ*'OJ9O!9)ZV*
MY>Q0?ONNW<& TH,7_-MG:12$#N\8$7/'([,7O\9]7.DH;^!BLTHR[1&4]GE3
M:BRUSD['])5H8%-[(1$_L7^7@1)>&LNCG;,4[">.._7( ;5&3 QK-@:)EB<V
M\5A7><+IGL&5/0>'KX([@ZUZE;<;Y;"9<X^Y)X]$(Q+CWUL(E(*4U,E=^OE,
MAA4"C$R8B-;)F3>,"MUC=YV^*RHU)"K4(&[XE#%Z(DB&-V2BA:MS^MKMDG:&
MAS^]F/AV\Q/00')B\$16-_Q5X SKND-H3\?MS*G9\!JD]2I(B[]Z5@=Z%WTS
M?P[SV;A2ALR^0Y)C\J$*:LZ6B._>13<XSRV5_[P"]1/ZG,655VG['-TH"7-B
M^=ATBT_O@1M7'>XE3:";GPQ%99/);71G5U_W!Y2 4 ?J!;-!ZDUC"0)TGXIM
M.%U^^1FX[GG\ZKR>J/4-;?IMH(06O/>)3$DZ)WW\P6KTF]#("9Z_FZGG-PFA
M>U%O)/F] (::-\9*-.HH3'>3_?>XVKN]=BJX>.=XN/U<^!Z9%"CLT7S/:E &
MH&&Z,*OG4=OWJQ*&/,<!N+^_7KWII>98L_Y<=D&KGF@.2WG%].F$HG8?1W1'
M5LO[&M:OPH%;%JELD9>02YPSTFFVMQ$Q =0R3AXJSE U76_IEP9$ N)J@9(Y
M5U,RMT4)8[R[:VM!D0U2..J$PAR.LB*-+%*:D+1^J&9&;H(F23L1BF=D$/'"
M 5F/@$^?RFKI[N)Y2)1C5<0T>OH 5[/LNPZ='N\K794!HRNL'ESX%]VZG2)Y
MRC0F434MB "X"$#=5R['M#//]!#*8O:R*HRM(DRB8S^O&"R5:#>;]SLPNOF0
MHXNL>\GE>96Z4Q(;J'2"3$T7E*^&C>00;TNJ-ZVPY5M,8L+B?[![E XF2[^1
MM=9CIN0O39@J^[GE?Z%X,N\O9NN6NPD%FU"5GS_K5U%0>O2I_ !4WP@]Z<;-
M!4Z!:1@#-!=VUR2,Q.8L4)B)1*"N99J(]HPS*&;5&U0/-(;/L(H'8L_RS.1]
M^^+J;X=Z2:"V0HAE+U\L7]\6_3)7F1!$[5EOS(I6E4/HJJ/U2W;3K46UTC[6
M=+0?%%R3]<W]W-D7#[6W!P+V@KP(AF^] U&Z_=/+KN)Q./<)ZY]7@K3,S(6!
M!#D\GB^IJ6E.0#0-S!@;8>C&J3#><3G4V9]$W0@#>NO\N16D*U0:E%@+SHGC
M,'^T;L>/&WGF];8^P;Y#XF5@12[N:WP!3H>>Z/F.IK>1-('5:!Y3AJCLRR[_
M1M$YN0@X-,48@%YA3 P)DEK.^%Y4.2S13 O@D+ 32K2\P)H3;!7#%397NVFH
M^O9,?1%H(A^ E5QZEKK.%33 3[<?*%D)73+F\*BZ[]Q-HR8IO2U?\QCP#/Z#
M_OCP.DDJ#;['9AJP:J:Q*%UZ^*!Y%TO6YW$Z(8"8+("#L'Z C 4OT_1$?ACP
MS$L$1G$)GY0$JCO9>6X6_'%&*CJM\4[;WR^V([X\B%B4;CHL\^3HB HC\QK<
MOUCJ=U/NHS99KJ]EZ5;YT"  ]JUAH=SW<(: N/F=U7'RT"\,,0FL<UVM!=G[
M28TG34(2 S_*Z3\=UDSTNI::3]WNL9SXF@:H-&N:87;9_&V@0PQK)NGQ(*YG
MLPJQ6.5O'4C>MB"JJ2C=0Y(O5R<@L@+"/-/AR4Z94\3PH0FLG@MB_@8):9EN
M74^A)U!.Q%*^>I9Z2P0G:<;/V.18(ML3SUQ%BD6 :%X:8I2]N7JG3BZP^)-X
M7CZ7&ZT9@*IAF/:CVTV 3H-BM)#!,>>4:$S0)6)^N ."_>.[\&]H"T<:#?,:
M314^.&;1/VA4G)L?Z!T8"T(;TYG5%/Q+ 6O)7LM5H?^Z@!7@MBW\\TKI=]WO
M0,I"^,;5.EOG3QM%9VVLWT!>)T[ZW]Z-+2?:1E9N*;DLE*?'E>@M9-<E9X^.
M(E(UY*X[ED7\/^R]9U!;R[8NREK.8(S)F&!LHLD&3#;@0(XFB"0$-B""$$DB
MQV6"R<(BFFR3D9"($AE,1D2302*89##1Y(R?UZEZ9WM7G5=U[MNW[MNWWM7O
M5O<87X\>8_;LGM^'(@?H.XA4O(+U^ S?/"Q E5. 68L,P*B:,P,8?$PZ<=O/
MI?&B>"JJCBBH"-YACN!+TDMRALX*+I4SFJ FZ>DCT$DT2O@.S<UY>2E0KU'+
M2Y\U-D;.$D&S=<U5-J>HK-@@V5RI[KF%%!=+1':ULH9R0Q"S9^:W2J9>RMN?
M+/&<+QYM\JR5SJK%!<]*",G*#LTCIHB;.5%8_A(_&O0X(%=(.:R[%,X)-X]8
M=XI7G:U83.J)@2.K4R9=$S36![*9*87S&\K_4M%\W5\-BJ.L<J]M8- /;'E
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M30! FFZ"E));0I0O)X)*6Q:20VQVKFO2"7BN"98B6:>8(XI)2J-^&3$>X[+
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M _3J2CK!3QR]&$X#'9L4UHD;>5TBIQ\U7P[T&C],2P6:B[!9&_<8HLKUMVU
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MHY=)8E(]G]Z[7B%?QV%[*SCSBAC8UZ2SNU2-N'5#[ P)H#XRT*\+>7BK[5+
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MT54&BKO^)-/IKDXN=KRW0CEAFC>*7I6CQS<1DB Z *_N@LQ@ B^?<+0'J%E
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MP</Z+U9J--#,_ANM$.]V/<U^5(DM=M!DP'LTVK-DFBD^;I#3OE4DJ]$_A+7
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MW(.F?ZP(0=?)X/>5<%_/T)A_J>?>YO$^#-\^+^HWVG(4'K=UF6+[0\U4+Q;
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M-]@,C(GWU9J"DEYJO2;KM28W!!+^LYRT+15:0MX2)#8  NX"%)B,8'4D)*)
M?7Z+AEUZO*/=C,;Z9!$+$U.-U(1_&)-/RAO7HLO8!LL TX%<BB(+[;H'5:CS
MXR2Z, 7KCYZ-IOGVH]O:0W8%3D#?/1>2*$*L@QC_(W!@[9;9Y9V($OD0A*A9
M1R#\0&#N=IJ^:<MQ\8;V-)5#X='&=([Q.F%V\ZE]7_B.1I?+PE&@8,"D?IZ*
MKE6.=D4WQ^/>:: A-DS!LG[AT&-<DV.A79Y:^"V,>,;Z9J*T=A\D5I5'(GEP
M5]9NMKK:3Z3&FWDOPD6A:=Q9.9W+I!2R$BNG!O=ERN5!B=&NYN5!EG68Y&4]
M_WL5Y"6K/1KTJ?$>H]5;6B-"7N).F5S;1CRK("GQ#KR8_M"*,?GBIP6,2]63
MJM<$ !,G+[W8&189!JXG=SDX+9F@8V_O:*P;;HZZR,JX7.BZZJ>?1S:TU.E7
M.7Q*)_@A":4?Q<"J <#X7+?'Y'?2-I5O@REBWJ%9<: !935&)@6!8 &2$+EP
MNK%AGLX_S-_!VBO*@0M,7&])E$Y?FM#> C_W]IZXFA[??<3,'._4DR:Y+TM3
MJQ;"Y^ZX5E7SC+B,8"30_,?H]QJ)S4IDH-9^D8&CUQ.E.F:_UI+^[\(9-XL(
M!\-00O!L,Q;KQ:=8'W[-A/R+U@D!J[8>3IF39T1.$A_E(-<$>H+PP5B$[JZ;
MGCHYAY!IS01\U)#%T].+;'<"Z6"L:NQ(-@4+?A@5H/[9KSJ9/UQOHT<@*H-9
M[U2[DN,]YN\D):G!5"WS!5SN[5V<] PS;<;M;FR;SD'!QLM;V^GSC"P?QNO_
M"7@O>"OOR!DRCX:K[B<9_[6,,3M++X5\'GBGZ)N2UKA)5O2[V['B N[]L.V4
MI#D=UZP64S_X&BL+.(T8.)=6Z=KG;(B54^OM-628+.BU2::>87GY*++4@$YH
M_YDG;^;S+&I!C@R=^&,KC2<\N_-^0E]T6:>NXI+U%A&(\M+B$"!%FI";T=0(
MOK>'?@U!_P-0&P<B<6[2KJCJK[TG7L1W9JA?*MLY"08V*SN+/C@*)/EH4&OP
M7#0@VRXV(BP\VBJ!>REWB4I8_<XZDPQ+I!S' Q-*JF^K<ROBH>=3*FF1 ^&M
M)9S+_DC7!4"<WQQL37*G*&;0+0-5DK$"_&<S*>I=G/N0O<+P[$CC [Q9@U/5
MVD@KS,A";U."A859H:RP=*S.)EG)*S48CI;P"O;+WRO3;A5P!8F)!<*FDI-0
M[?8<*%D;L' "''8*9=1GUG9L/@(X.M9$7L:"(7W6J*G&6YL[4DH_$-]CVY(7
MDV3?(9U4E\S$]Z4=(;.??I8=3_D9WR1+?O):NG(4KVG%"LK*!)@NI&'02@U*
MZS5L)(R/.)@DIR$5L:<4O;MAWK4@X=X&>[8V?WNAZO%AE@AZN%_4!BTBSV@9
M8>S#[HK4'C3N+7:P!<12KT,\9$=,!A?OTU<N!;%H[5J7-+GN]]B+B,3O%*6B
M*]I7S!KCP$QHJ=?D2TFNS2#SSK(TVUXV]9=U_+U-);5:.^E?<4UYG?RTBF^.
MY[90)0_,FYF8P):*S.2#"!):.- R;P0:D" $Y&,J*:)O(:_:N-B*>:4P0FLP
MJ5_VQ>N*QB2Y82X3'%J5I)K^-+*QO<ZO<_02Q&/F[&+HN3W)+#)E^ .1(EXK
M4.>:%K.QC #JUS#/JDW)>PY:XB#5WIU J1,.Q%W4<QT/JW@N*P=AJISNH\A.
M5ZY4$#."E+5342Z%9#VM)2QUC5*;(L3:8K+^5X1:5<UWMPF)]YT[JEA;8UW@
M\D2IB'-&=0N]*ZBU3Z)DQ+3!Z;K3ZW?A?BX#$_7H_?WT$H@+K;E34!ZN(F =
M\4HA+:N*HB'>XGTT>)YZ.AYVICW!E&NPVI%!_.SUX:2.IIE2DSXO?8O[PA9R
MX,/G/G%WZ.1;:*3,YY#>2&C&&A6:/W8>\1X0OX_NSG/4+HA'DI (,K&&AZW<
M3/4RUR]??BIX=DTP99X(^,.9SV.=/NA'^CDZ;KW;GZ5C_8'5/^/<%R),I]<$
M.6=TY8D%KI3*FY+[ZF$5"C@F!^-TXS'/$!O>\9Z[>Z7;B&$1;_ON0KT[GPYW
MTUB.6")7A(?TE8I:*;0*SS/8*;W8M/-'.7PG\DPFSU=S]+]J;0QO@S'4ZFPW
MV$JT2_Y4>*8W4N'1.T.J\'CX[3X^'##LB"&+5_K2JF0"HONXT'WT%R;_+O[T
M5_LO+O[T>]=$_][O_M^]W_V_MQ @_;S1MG%H;LO8<6!+2C\A-NQ-=#5P]04F
M?1>\:FD2/\9^QYII=NQN1)(.J%[9ZK.ZS!HKOUOTVLW% JCEETO]ASGHO>F]
M:/6T?JE"=D5F"*!QDC4R&:FM"XN,S)";JMU2+!6F'M$G4O@QN^2Y-3-":$32
M/"38C3V/S:I0?R7@Q4XJ6<9WX'I/V+3>@:0^H6F#MSV)]^3C5:0O4N.V,>&M
MV;;%4Y"Y;"4.&+EP2HJ!%"&&$)0AU*N:#XU@D<5E2GB32-24XHFH^#NG04_<
M&]9C\;<>1J:L#84 0@L-^3$'N"EEYO?8^6P^6E$?/JFK!CE2P]%"CA=R*G(D
M3MGV@@-PA3T:+B\<\IN(ASP+E5&/4(!,[H V9VX/4P&*34X.3 ($4J="C$W6
M>'4E7/A@ UMQ6)\NZN.?&9,9)4OODX%V>-NJ%U%>0@=\S_(K]_>J8A<@),WC
MJX9NC<J4"&> W9:HA/5CM(#:I9X1JE!>? ?KY$R$=701+K]9!FM%%?;1O:*
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M<5-\*L#F\LL58> N-M^D:X9Q@_=[,_1M=F^SH9:\W:K3L]^ L5D/+FM$W7Y
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MP/7B0<&'4KEQ%IEUTQKCD;FLT^PP2/,4OI#QHX4WCQG+9T+TOG##X[142T=
MA">TS&,EW=B%=CP1Z'*,& 37H']%1E&/IV:#(7I##AS@+:[O^49),9&?^Y//
MFZV1L A+@945>;WY1AQM.!2:X3\>)QHS[JR]]]/-0>:0P?#@KIH1ZM;9,82S
M (3:3"?WI6^7)K=QYFQV%- Z4GT-SGK0V1)JD580O]W++OY<3&IE3N^GYVZ
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MZ-\B?A!::T MV/HXY@, ZE5_N61PR*EY;U#-:8W]0A3M=LP?[2<[3.K5X--
MB%:M\FMKX]HS\9DZ O1H&M[\GFKI_Q)NE<+B(+Z4T95G:AT)-Q:]][&%;LNI
MW?_";K9L5DHZ&,_6+Q#):0M<P&@#Q_+WZQ5[B%!WF]+0PDHSJSBP-KXF>&97
MQFAMQVHW17](+!CWERFSG_U_MU"2]\'9=8G-IN:O5A_N+ ]_! R:<DW3!R.'
M9GKF><NSW&Z?N-J]AMGR)FW'_:O;#Q=U+Y_]PY2J]/A.X*BGVP.SJ,&V+E<S
MUIXK$OU7/K*)?AYP/1& #C)5DJ&[Y"8:OHFK9[#$4"G1ZY5U+W]RZN&XE<@4
M7EBG;>J.^7\,:P^/Z?.M>(G$PJ([*-0W^?Z8>0N71!UCB&8.2_Z&-M&:#<QE
MU\I$8=R>F.OS^9(0+:=C? ;X3O0P'S8__F$TZ%_XLQ#_+QKSTGDM R7L&I_P
M\DL5U3SZH0Z^N^I]:P>J*6U",3RC3;AI$3X&'FS]ZJ $DG!F293#[]?G:2XL
M@?HV'$E!^%?<8:M1)^^9V%7A<+GOUP2]UP0R"^C4V''9WYWP_AE72ZSFIWIZ
MH06 A#+A0,E4/9-JK0,4)]'0^K5.UQ4#H!/1ZN'(L) ;E+^?7:D+$D4K<-'U
MO)_@NQK]ZX*_NYNJKXPC4]"9]8>?"84\2;^-+B;E%W^))RC^*SC\_YVS]!]'
M-$EH&4PQDA$R3U+:FT.MN /YV@DE-VTO4)HNF'.Y]>"7QU&VT1:B_ K$^=RM
MV/\JD49LT)4EZW;*S3SSBW]D;#S)MS0<)74:NR;HXP;_2%(.50",_<:;/^HR
MI7*8'?T;Q]^.]O!6^PTQ^#,*#V6CRYSO3H@H*GL1@VBK_.,LURG%=LCX/**M
M"O&\;M%'IBB@^A<HX)J@:@^1R'X2F,NG"D^0_\7_@;]68E-_&Q[UG5_D93PW
M_6]+X/^X)+"QS5/'1I 4"OOGW3L+GJLHT*QW\"@3$8D@<3?@=N_/TT?=):0E
MO=,US10L1GB9BG[[DD]%L<Y7#%(9="9DVI&U=VB]XR1<>(3RT<$%>A8NF?O;
MW_QX,.'WC(!\>*WHF6>8%OQ'D5K@T_[G<^DTSS0GK@F\7G!,OB]_W:G"%+PB
MQM[-'4J'EFE@>Q(X2YZ@YV"0']W:/2U2J#LV&-N FN:-D:C72*8Y?$\7J\IP
M39#GK7N@_K)2H81<!:'MU,.E]X//S01KY&&$!!>XWYMZWR19BCZI0:K6F<YT
MP]N_7!-<8A%UAC34RXIML?*J1IW=Q[FY SR?C**5@6,^Z)\26U)<&[V>\>/#
M'1'0<:J3QK+">S[&C\8R%NQ+Y-]/JWZ4SLP,2.2N3+W0 ;$J,\63C:I](O65
MZ,<V[>([/><AG[>$!8U94:SUM99.2M %9ZP\*3=8-\2U:7.#_D1<==NS^WL#
M857UA="[KI*O1<[$.*6CWC,K<Y3?;)+^>P&AXABPMI0UWZ=&OV6RB<EQHR&G
M<5[4YA/G+6.*.PCNJ!Z'WCA_ ?+1S-:Q76)=FQ^1(MJ>TV]G[\KOJE#! @J=
M]F>QSER>U53"6(C90^/7'Q8Y>]8+LX0<W?)X>\>[40@3C"(RKO9$H08;.5-
M*P+V5 5S@H^#;G=P;+H\ +A[/(KI+H_%&33&RAD;E4%6D3T>0$K&.V;E^(2X
MXL<KE"3EQ:\!/H* 69W*A)'*\)IHI-'F<,4(.6FG0NG&+09U11U'+<V9A3H-
M?Q'N^2".%\!8__/[%]T535]Q]L** 1+BFY&SXQ-O^+MHEH )65FYAE909?H8
MH)4F+-3.,$";#\X+-RFA,8J/R@VQ>5JUW25\DUP)>CSZ2'G0SR1\VCHBVDK?
M"!:^AGI*=6**=,J?C.=VA1Z)G8BI3F>:GSN/5^N&US4MP7=._9J6N;P5E/NE
M&J*K]$O-> UG7ZC[OXP/+4 ;Z1G>'@@QJDE096_S!J0.%"G22M-/:P1?C*!K
M@J>A)T&16J9MAI*ECDF5KU^*GU(?J?8GP]0DX7Y/MN/>K^-ZN\A/X+JA2Z;/
M4.(?K3$)>$DZ=619;!<7!X[%U6%9#P=*?>@ --J&.\:@^KK51,3.A(<B:&VF
M&H*++35F9A.$(*8FG)P2;@Y8SZHTML1[F \L0)]'ENKF#UTCK7M#K3#^*4\'
M;S&O7]3[G(PT.0I:DF-+R4=YY/V/\XPUP\8**V'ZDD"2K-4TE%AO>$(/-:\\
M"]OA\83DNZGZ@1RYEG!F'4Z[;:0U- 49$C[>NS/M7$?*@ZX?O,&V!78E?D>=
M&.DO/E+Q68+XE=B W72ZKNTVOO$*;7=TD:CDF3S[D?G5L42MSYNTT"C7Q#NL
MJD2)0*65I'9KC'OD0[5H[73D!B/*#]1\]1U@^7*67B1 639L6,NB5),F+76T
M/BWF$_(815407Y8&](0/*"_9H(1ESI[F%,\B&XJ_O>"9<^P 5#FKVJ]!85!H
MB>LF*)4J87"MKL[*C[H8;>A##G(KDQP"FS;0WEM!GTTWZ,?[:ZSXWVD"=_,*
M\JA[\#N/QYK7?34#>WDWJOP/]MX[JLFMVQO%KBBZ 1&D;JE2E1*JP%8(O0@D
M]"*$(B$!"5W:MM )O4B7#@FA)W102B!4@806BO0.*B5TKIXSSCF^=YP[OGOO
M-[X[OG/NN_Z>3[+F;SUSSM]<:SUSXA6=(S;LC F>VND V79)%CMSN:U;@Y68
M4:V7SK&^R5/3A(V 7I=XMT3I-(H3%EX, XU%&$]TJZ_:DIK"2PC<S@@U)*C%
MR\B'-S$./V_G7.:R7\C<Z8I\1^XJ9L%^$&@M2THT+]=F[6L<Y903M S%@'5&
MR/M",#?6]SFA4<X_M*0O 3'F-I+0^$VK6KD;S'4L=@FG;QDO"P8/!QM1WZ/3
MERX53\^S["U^M]#RS=-SN6;\9SZAMJB=13939&WS8[.F.G+$EK;O!\QXH[=7
M";=^<_:O9WXYX?\M@L#_;+3"A)1 @!B#XG2P_@7T_G*@ _FR6W+5_HT25LQ<
MD;WFC21G?67,3B3*>;+PK>W,M_U]2&6>,Q@W9.&N"S$+A7CZ]DDQ[Q0(M K$
M*_^^N7D[B$T>RT9G]2Y=+R&0XW'NZ!&?A:R[N[.4I".;![JD/SL>VOUI*A=A
M.WY\6>O]@\!X)OR5ALP%1&%12)+9,!+=Z <W) <@LI#^WWVT.WZ;N=\O)=W9
M_FN!_)].5$^N)(\;[E;,P96=HV_!M!\0^H1-ZE$60<3J^I>)IO\+ILOP 84!
M&@QE?.+D77V<H'-GKRR)2!LLD_;[[3=)W_>19NH[<J&#9=39$VH(WZ<5[LK)
MKT@&."\L-%0$-(D%7],FBFDX,.F)QSYSV$@8ZQ>-_3Y.:Q2S2F[7]/*/*CRG
M4L$<2A0J_R3/_PY14--/X)2Z+?X;(*]J90@'J_V].D](\<;1K2K:&:/9ZJ.$
M<8>7-2 ;4"@O8;RKO\&V62PUI=,F+(UI8+QS'"\F([IEQ/FH".[?B2=.E]XN
MAM>O2H].\SS4$LS\O10 U0577:,6"^+FI.AXI4')0KJ<4ORH)']&1ES?[206
M/E1UY0)_FI*6*E9/2V#AL#N8%]0O'FD[_EDS4B^V.\+&_D]5#4, ^7,N^)SJ
M'1#?$DF*K_I-V]E?P"!?_S?P.^@[)=9:90:EZ6"="U5+"X'&Y&MN(55N\2:B
M:=V#U$D&$I,)86GS3*"I6EWNSRVSFQN==FJ3I;@A1W==J-0=_ 9ES7G?!G>Q
M6.2OW\%?V>S R/SEC]>1:7)CDW!X)*&2X_Z5,"6RPFLWZ73TH_M#J%0%]UON
M[I !Z^OZ,;7'3'C1\3?.91[H,24"IAJ9-<QJ%K*38<1\?'RHM?V;,H>_]%Z7
M_6^ >P&?%7.OO$&ZJ^BKE_5/8ZNUKXRH;>D;6EB>8<)WE=)N%["W>+VU+68L
M_Z#H&KV(%TU?QI5 4630+GTNBUY#[6N^:_T&WM)JV@PW;O^&.WMFW#.T6U&!
MGP.W_L!%I?FKHN)QF>!L[4BF%/Z(S-YS*A'QR*]^0M\Y^G9.;AZ39"&_X26\
M_7-R['_]U\J]_M.)QAO7U12NZ*6++O;&2Q_&R47/WS[Q(ZY-EI;&<26EHD;J
MK^I5H:DWS7G!!GA$ZGM9A\ZQ?ZF1MFZY"-(Q[_(2GOKI6FY?K@M\,NA:-B^*
M2%_O^+S6]?O[?<]KSY6?H2=Y/7[^DD._?.FII1_]IT*';-_H6[N+,\?;U7&N
MT_13WOQRF<=3%+:4+5^Y7,^AV&ZRT(-13<G<YA<U9Z<G6E4U_Z%1:\9/Y9^Q
MKOW7!S].5+8;.@%V*UCF*K Q[N'Z<V#PVKNBI5%XW%_-M,T>OF!?G+Y;-!-F
MXNT27JZZ;W)96M27)M*!]<.R8.S=2=^_(0:^WAKYN',JC&O9'/@*/=!MZ&^J
M3T$+456N=;G5YI!B_K3X#0W>Q4DS>V?!+P,YG-R\F<!N=?X_PP]BM=.A0:(L
M'[\68])YLT/].*[,^SRRF <,N6C:<9.+:OS5#ATZN4>X,EA,R]L/YOU*HU31
M@RZYQD5%>'GF+5(W"4LO'Z72045CEK"(JQ8AO"61+O/NL[W5\,A[TM#]CI[P
M;"368DB8K4L^1O/:MUVN6\VWYX6O5ZK_4;A%Y(^8= C:Q;5W0P6:=C9RX-H*
M75\Q1>W?^:$L=Z,*;)H?TIHCW:9W<4>J\#)2;BI1U1(A8.R;,5X_MTL$W>B[
M).R"->>]>4&[\.G7_-B,A/X;\<DM*8#&^SGW33A9%]7MY.8("<5I]_LU]_H;
M2'*WIS<W>=OTANL<ES!X00?BL %PJH]7$S%68YJ$9= K]2B%<AF20 >I#@'Q
M+[7'BPTUE*>KQO;N,BM^*.R7YCK)Y*?X?O-YN,H]4=Y3?3-Q:#MCV+TB4B1)
M/?$Q;*&%>1TA A229/3>G)@X:KQV]V-1*RXG#.-7/53'L>52N3ZVZ_2(UY#L
MQ#)585H*!.O68*0$_;/<)QA6I!DT34=V;J'#)G>X4S>%W ZU\?8?Q%ZHV+;>
M4!(*OCGS:A8F!+P>T/JB Q^0BP%7O;EYFDC^@*MAZ_@VJ9!B0-VZ#+L!]F>H
MZK-9-\9SZ;>'Z?=T42R!3B50 ;/43JYFJBL=\I:G7@8UKSKM"3I5<:\V;^N:
MCQ5X>FI*R!K#,E%#/3$%<!I1=A+P,3I^68 IQ4"Z7S3>X8J(J(JJ@'#8AS=L
M_,:C+E>11F<TC,QGXH8Z __Q7K<%_3)!P/_')BB_&=! ;Q0EI"4@\MP&F&A>
MW! 7GVA&+9QNI[4X6=4Y(&:^S/&BSJ#NT0G3ISD4"E?<1\N<Q'=AO[-MY1^O
M,5Q0VK84[9NL[RS45+G1U%]C22%(26(-SJERP[R<K(;YG1:F MT[3[#&C$FP
M[/W@XV?"^YHGP1=[FV@>F<:=#DD5DOND^"_Q7#";V\K-(=.],:GKH<>M)JQ\
M8.M@%)JZ I;CGX/AXIQD.6LYP]G\A"<I LDRESSKK%FR[0X(+9 Z-8WQVJ5Y
M?2MY0.JDY\O1M'5W=/0H]DG [/ZK=TJB$=K &*O[ D726N%\Z0_U':C<IO:X
MMUD8LB0//3"02<7^_(KO%MBY22):>-/:4_@1_,M' #G(C+(A]6UGI&SD;8%?
M83RE,HMM1)3\[L+0O]41-4P.F[@4L'.M1&%OV8K7?6F8=)2%),B/-AK^/9'0
MP,!%;L6Y2AD6CWUD,AXKE^C5_R-<:RRC:.:VV0,I63*_"(Q3+R%5;38'_D0'
MZ%M9WU&#'EM[$!XLPX?Q4,: ( A)8M7&O"4JR92I2N 7PBS^9@K/*#,#=^ZT
M^&5<%"DZ.\OLF%I+PC;K-!.:?M"I"6M^_-=Y?6$OY.!:IYSZ*)U4A+"U63]9
M#!E3GY9^%]@(V=?O5) +/FF^6)KKGY7V4Y$G$&'7,HCS,(N(;(A6]-@($]&Z
M<'L#]0WN/!Q+0V!.\RZ.T+]ED!&/?"IM;\=Y4\0]W+!H_@J>CL_M:75"29&'
M&2=28#I)9H6HBK+M*JTD:87%&H6)L\6A8;CF&GM'G$ 50WO!V(1,TLN''&"Y
MHH\I/9SUQH[F>V]E6*NT4/LJHP(]G*C]K9K3+J?NRU@<^SF5H$JA^O1ZWSWK
M"QXQ):U-N,\5KC-B#0]]69(TM%0DK 0Y&K090I6\?#;QOHC;^?E^F\5^KAA-
M?7R3:?B"5M>ZL/(:/SX>)EES9_P(&?>Q0Y1)TK!2.>[UPS5[.^YM>+(50,XR
MIFM_+$EF Y$?9K.@=&"YEX2;T.O-WG=NSMTP_C"ZD!@5T43\"A_LY:%_ZID7
M9]O]J?5IE=$";%'Y6P4U^'%J\",7ZZK(D^+<O!(;59.[B(I[1%5LJ;+Y2A2P
MPD>C01!W[%B.C9N3HXV8^R#Y0$+P;MP7DJXZ=ZQ@ZB)RNS!.2A;@9KH(233S
MP9@)*\O7ULI^7A9P7T-2W\@PC0!CAM9%EQ">#!/IK':(&V'3]2;K;56A(=!^
M^8J,QE<YW0MAR0(";DQ3!?UNJ<^?7I%PI!&_S\K_:20'0#>)MN$)2T2D9'R<
MD,^>Z#74\H(ZK;L^<;:%JNL9/<'2-S$1(;0_>I>[%B#,(Y*CPB-8YB1.3O9
MV1"#U.W5QQ-MEBRV7I7YJY<D4-/.IRNU>.HLI$_D_G%3\D^"''U]H_-%_IR$
MI>C\ZP^-+EFN-:?8I+W>>I<[+L/VBMG\49 ;%4GD.78Y@SG#,NJ#TBH]%Y&2
M+IN5U:\7[-CC WD(=_HQ5=L T,O3N8! EX[QF2>G-\[6SZG&<8&; )>_<[@G
MW94&_^4CM8LRK[/<I^9'02+RH^Y2W-,;AG?#=<9*MXSM/!+C1,ID?=T9+->5
M;>-'?Y#(XAZS.S<J\L3<-=[<MNL.*R]XK'1W04$&IOE\HA^PPBS%4'TU<]ZS
MTM0'WS3$O%^%X8^8X&;1&".5$N?_"(]X,ADO20NW4K^/1BR"#6!O;@=,?@WJ
M'+NTFO;W?]_65B]N@]6$Z?&;,[QOZ/7L98=&5L6$W]F)IS#E#TQF71:E&7/N
M'ZA(][S=A&VX$+QM9"](@4?VR2LP1.D3@$+EDR.=K)O&DP?;V(UFHIF93ZFF
MMYY.;@V9A/>Z7V%<<+#OF9E4QC:>RN_*]&=Q<[FFL*"A8:=(\7<"&H'K-/>U
M<+B8#<[2II]!Y"B>WI%/X-0]2?5B/'6<F)(./(Z]>$YU3I6C$-]"1+[;KZTY
MF_/Q[3BSW]&H&4H&][FR!%E^-C1M,_";$QB^F/B69U(C'EP,; 0PD2^;L"UZ
M.M\*[P!VVRJH^4'J^JU^KI+[U7G/0/:<SMP)MCQ47' I\_O@[&HZ@][RKG$Z
M_GD-%<'9N$V"<12T+GPI-XZL*:1[3K7/L"H5-HME<L))V3R *],I5P)WT'8V
M:B2[@\G:=[&5DN1>1,[8 K#"^SJ7U+, ]G2\S/X=GEZ( Z\HTINT)!H)VU_
M][OCW-*798YEV(,+UE&I2;P/Z#@#IXQ.%R(BCD<I']'0C>9++JVD<ZH\*?KW
MDQ>&GMR:D!3&%O'M8Z(Z[3\2G HW<,"XXD=7$[CS@ROL7JVB-9INIW^K; \T
M@"D3]5K#&.A1EI1XEJLB,3,S2O(IJ_25$@WW<;4D#Q%&]=!*;'1V,-.B"238
MF[;4_4QLRK0R>PVC NA>L)FN8&"TWAJE$+=K/#XLC)T-;$1U]YD N(HG)T)&
MFT([U5G#BV)!K35ERD2@D8!QJ::PF0'G=]]068Y0WS28B[R218K&(NY+7%3
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M-E]59EA)D\MQK(L,BB(19Z+,-IQ$H)/D3NL)JYG1(7HG41@? UY2T"9C1]X
M]2"H19:;3JLHE,!K,RHS8 Q^!/38J%_T6._"L?LF39B9N"GDFV/@17R#<=5A
M^4*FQ]9?>#,,)84OPA%_IA7NF5T,(WPDMST>O"04OIDNJ:?2]=#V1\X-UA3Y
MWH#-TY!)0W%P^(8]:?-NM??[&S1V#+;>?KO@6$X4-O&/?"'H>DTFTHV]$UL6
M6[1>*5]:1=Z>J6M!SG]1 D9O*+17OG8$Q(#^VC"4#67'F:[D?:=PFD'@JH ^
ML!-8?\>T^- [(@?K<%,05^2O?H5/4"XPT4FF?%^DM5P!"V.91-/)<O$9\E<F
M 5+*B0.31<JI6%CP/41E"B\(M-0'WSW;@H?/-/.IFN%\C:H?SQ[ 1,+#PZ.$
M%#*CXJ30+I),C>"MS5)1AB%UKBT\?KH>G_-J[,Y,10N</#B@^S=,H4,=;,2I
MD).3/59=U;]$MNDZITIG3GDDH\<\@AN5@6&["Z9?O\P\3J0]IUKQV<C.5UP8
MKFU9UQE9;3NGFD2^.:<ZI=W-.,N#<6 [6BATT".M22LR^AAKU)<J^>U^N)@C
M0^F]3H^9<9->O^+$1*.:JJ;YJJJJ,X[%<ZIW/EOO<FZWNVL6E+;M/Z+O<'U8
M4=/!C3:M7JO B,F7J.W]T9HDP^NQ/EI+UR-&YGVM&/"-;=%])Z]#%#[_8HS]
MCDB?^N7'4C0:>>KZV,IF8!H>)7!O!"-.FRS"$^6Q/BZ4G%UW@^ZW>/7/J_K_
MO*K_/[BJK^H%GG*1J9&^UKRW""=J\J.OY<Q<])!NP \Z^AK4 WKGHZE-WMWG
ML]V:4"G2][K.@=5*OK^!1\"<D)O;N@X4P89))9\T QH[E4O!4$#%D)@440XO
M8)UGCZG2O.QD&U_1WR3XTV_J[\0R-Q3F=LBM4=K>#>.+HKV0W[[9YA1;<IN/
MASL$TIS.;J%!YU0*9B?X/PK/'/TY6KX>0\X(P>=46YV%68-KT^ZF%A2^CHK=
MKFE#ZMW=&RZFT]S#KX9BKR1&5IBS$%3LU<,W*AZPUSU<%'N48N=\$/L]W1;%
M>/^<ZF]&2KY[ *AJR;_BG,JV+9!BTWEWG'E#\U916YQ[$/3/.'E;9X2"W(;A
MC,U4US[9!]U>%/Z,FT^W;O,*R>RO[X87/U.===J.C B&1(JYN>E"V.6LS.&'
M?%NV63;E@_->-R71Z?GJ5Z_J7B7(::=_6,;OM+ZV=NZY-ZG#,\29%,+FW&$-
MQN2G7FM32^R/W1D:SLU%"EI<K#RUU4"M)<FNVYJABD;JF:U9:G/&1.*,V;MG
M'_F%KMVP<X]K,E_N6C-=[T?DZM$1;8R14$[;63#8A'3&<MPV95A\YE=S&"GA
M<#)TI!CX>;_S-)[FG&HJK.J4';,,S)]!*)6!PC<'D(CZJJ@=.8$W1LE3Q4L:
M9&=D3'6C'7#D($7CADG8!I>1RQ,U@I2MM]U-9M+.* V$]6.<P,-B^B>)DS7J
M??$S6X2Y8XMR8X4O^5?I>8LA1<%1,M!EDM#T(W5$O7&2)II9!LI3&(:6@!XR
M]VS;FJ]R8 %I<@RW6X=('>H*PDD%OE9;=Y,'P]$>-5M-+M,D[( ;IR\SR6BL
M%AV9IACDOOH0HZ1#!ILZYF4\CK9Z:;6>W*4F:-Y6XG6C*;WB@8;O ^J>UH2M
MQS[W2B!C"5-U8HXOUFB0U2R?.G!N#E;1YU1 R3CLH,HR05MS!X2%.R$PL:4"
M^.YU85#4#9[8J1[3913 U1<[+;+@:1(+PUW37W.0-QTE$?_:Y_[QB*PI ##'
M3^!X*TK"):RP\%(>*?_=D(7,'MZ&QG5X;!Y767VWHZ\PT"<L+;Y^8]A$XO[B
M+J0C50\,EARRBW:9+,FDB8R_^FB"XOT\)N6G9V5\)9P,%KF#T^L:-:XI^K90
MCQNKB5\&(TSP20(+7ZLGR?@IPR^;&K,?]GO!@VW5'[2?]>E4SKB+ 5;(WYM,
M.Q  RGTRIX@RB "5J1?N4KB'>!<*$ SDH0#;] 9<_"?GRCK[Y$L!$LC\^78^
M>-1@FV0,<FE]\# ^QC'T;6/G23:,%R4M C)H^9I'-LM=_5P/W]F4M^_?P-[^
M\I3M*IN\AS;<0EX(!-JM7B'YQ75UC]M!!>IHB\HGT% ,$@@BLFC_#6_>YG<5
MGM\$ ^^2/^,A$;<^%N:.F".'ZG#F(YPRV\X8;JW2BKX*\_73DLB7.K''N<_7
MZK&/<7"],&63))W>>?&1*M2/@8?Z]2DF8(-\(6!YQ#MO6?O/?5'?PD3)F?V#
MQ5;'@T<*RA257CX8^TB='NN$ED*G<=.098?I.F/0(P#:@9IS0:I_BV*MT Y#
M\EX<?8:%VQU..37X+&SF>]0@<AZ])"T!BMOM%6=;&N5)T*SEGL /;='_: !1
MV_]F (K!9]\H8%1@EO 9Y-H_"H7LOJ[)N)?L3X!F!A_ID+)KT\I1]PZI3Q(2
MDCF%DY09,0VQWNV1EDX6ZO?B--#\#+>_EG;/L9E_J%5K_WS+_.MXO]O;'N%V
MEQW($1 6I$.&:4OR:0;IS^D_;TH<_,R*%GHUW+\,* >!*B"&('PHFE/VASQ#
M:&CXMH*LL5Z/4J/IPWQ#=/*5((297::X<?K+E+ 4EI+(W^/J[X-V@"15L%^P
MEM8N5\B(>S=PSS:]R0%!8A%N-'6C2RV#/@4$3#2YVC'G%K"/5XK+2+G^T"J?
M;;;L:'X5!@8JT=I^6E;1^>.H2_XF#MP7POBQCO6U1'K*=%VCJTW>3IQ?X-@-
M2745+1%)[9=+6=Y!P?':\0$_@!APT2%O1S^]B._X</??@3>3JO<^OO[RZ!I:
MRD(U>;_IU1HX;#(?ZU'B12>]%;Z1),93/LXDF;]ZZ@-S,^_6X*CGXC>1T)V:
MK5>QT/GZU7(X.T2%^9':;07C%[9">F3!N(:,7NX1RO@@A@%^)?HEK9]&?_W'
MG+V[MK%Y(#>A32UIA+Y<8L"J@R;MW1.&W+_X6/\1C_^['>IH+JRY_E!H"1Q-
M4.QA<IV4I.\W]G^?,1\J=8Q7M!-RFZ]UZ?DJL"8U?ECW#T2B6Y[W3#..(\/,
M81I:-'C<?G(V$U'5['-$?SIZ3E4%.Z>:@,Y<4%:O70G)^?KK@?__U<E=[-F.
M6SH](9D'[-3=;TH[.:=2_1[LU?7R=J)5E?-DH+W3R:7NMS?^# #_P[IEWD:V
MK(P<G5.5/>38N6E,;.@]/N4HCQ^VWO3:2M[QA9_)!'O+#D&OELK[_?84==OK
M'HX57;I 9MQ/V#("!(%XS:AP!2ND'XV4OZB!J''*U]__Q!VQ2OAQ:XYOZ9KI
MF7;EO=*M9)2/4].C$C^75?[C/2DM5]G?NU(]%\>$C+@0HK^,;IVB@+W^K>QQ
M6S?7DF^<H!<3+QM&V<_])DM3_+6LQRU$42-3_@1.5&7T$B3*>GY7*/L^D[T>
MH/U@Z)5I)NBW!;GLM!=X5%.G>H V..C)OPW;^C)!CCXB?CYCUKW /Q!JGOGA
M'U;/O<7HT8)J=7.B5&"X-ONOFLP7K^SF'7W*/6)_E$"*W^6/_;VAC8##NN Y
M5<&)Q@F8/.._<K':W/;+2N[A3TX/==ZW*6^M$/Y]O:A6D>WG5'$#S"V/F5WF
MUFJ%V7Z1>B_XD^\=S?&H;]OB!P<>'W\3SS,JX?NQ$W+R:7VF6_-;&:/;2N;?
MNW9'M8%#!EXQ,98"<4R_"<N#&4\E"P, 1LW'$APWM92Z^ X8*2@/EGLA,2]^
MTP\UN79(N\.R@NG2#==\=?2K'[SKU,S(U2N['8S=$)F*B"K2;^)45,*J:_V!
M9*O3247*[J\&:OU)BET<R8'TPLH/8S9^DP,XI0;R^B>>4WUU63P%*?5G655:
MC@0"SE+:D)N#N>LU5TZJ%AB4K]_IJUN_3F7TR/6<ZGOGD^<GG\;.^&0$Y!7&
M L^I$O?'SJD<_SSE>Q-S3O6R!29T;25%03TTZ:X'#"U: 22RCSMM;,;#V;J>
MD::T.J4J-,NC^2-/-\P%2M6Y3W,YXV5,0'$R]'CQ*0>V=WW2KV"6N;?2F-_&
MY1\ Y"8(#C!=8XCO<;"Z ,"X4W::5(H0K(U5AQX=,:'&0P@2VF6)J"65,JC:
M?DV]FS':IVL:H S2$<-F/%LYFIQR]@8"N@YJ&ZZ&-:VKF:X)P\<[P_FP;=WP
M@L1:?K%&A,IMSK$-S<N7EN$C&_9U')2;!3E0 8.C[,'<EY+YLI?@>U?7"U+3
MO(T]!86ZUUSX-7RXVC*>5$Q!FRH5PIF[<GW]26B:E<E10/B88U.C^%7+.+*X
M 4[(MN$16+EKD.=X!!N%4AM;-US#8NG^HF!]@:ICNR C3L*,(8WUQZ6#"\VC
M$X\9'BZE'IOI]*P5 [ARF1I+8,$8.<")OS:!'O@2*W0O72+*Y.HXOSGVE7N4
M ;W,I["FVY(UWD0V;DF$?%PQ)@FFR1#^Y)F$[_3X2OKV7B<1 -97#LXR$;?B
M%*A4 6R"$)QI98%,O-W$K5P&3QD&.:Z\'-]5<XR3H>Q[W5<PS5C32DT$P G6
M."H(9KBC-*0#754<3@L?DIIO, R\*_-PI%O!Q.'VW>)GYAO?ZD^U4+/@1#&^
M;%6\G9"7!4&?\,K\;NUG5^1JVM._9YOX<*W)#K1AP2=SG75,H2/YRM7EFL9)
MG)RFB=&9^YK@$=3/@5GZNN8JT#3PU< &M8C^;@1X)(!:2Y&(?"<P@8.RL*4G
MF<0,'5]M+_FAF&'FDI!,T2QNBTKP,(M7<^B+E8CT:(G%6.^(EQ=RIN2U^*;$
M?%2IY/)<C:\^"!B15ZX:6Y=O&*49CS3SF&+_9C$(FV=.^S;#8">>#TF:7RTW
MTD3EAJL*F-$+LB_Z3M8!Q$ 5JUMJ3N&-EA$PKVRK&B9THI=7>8Q6)()GJ2>4
MZQ%1OBB"7'\5RTS4JB'?3)O*0KPAQ7OSO!QB5'CVK=E%X[M2@N$124IUJTSM
M,4Y&.=,B5@XED3B-&^=.5U4QS55/7A![;YTPWYVSV2C/'>D&V8_/QGU2O-'Y
M37@"/J4@WRP?FY-9R-!ZHF/,93B$F<#I]R^"_!*V+31R#6U-$BMZY@9> T1>
M99S"Q9W*>U6=/)W-I5Y\[PZ=S2D9K53E[$UJ7<U5!CK9N3@GY0HA6?>=3$G@
M](KE6;Z_+CJ\]CBG>N89W9\PLY#XI^_ <6G 1]'H3:35RB3WCD/!HQ'XG2_/
M3TJK9UQ7']#_[D/_?5R\<W3:L2?EV_KZ?9F&0]J-FC_7S(/S)A[18/V"M+%X
M(PWQ[,U[DDPK!VC'$W9BE$L<&#L2 4T+B:)7XFW5X$[MH *A35Z/R9L=Z+FZ
MH(^B7=D9(6JB6ZX\'.584F&8&>$S2UGP-GNB/:GCI1-NP-XW<T=779Q_?*ST
M1CJ$RI@E/*!&54/[=!,D.94\T:A:^V33>9&F2<N4\*PW9((I#+\A;(EI?!\%
M"O>TGNQUOT^=X_"Y6Y]2A;H2OEO#Z7Z'6_#&E/1A T!ENYBU.$U26+<<VG"1
MYY+@%.2ZG*]A8@(POC(]^,&@&3=8/*9=])7-,M,EL?\S!%PN:(<NR^/#V5G*
M=OQ'((EC9GBLH4E_I(8P.B[5_$S]2K'[OPHR7R+.+_@'_ K*@4F/YVMA?.GE
MQS?D.O]PH40&=!LO=[Z:2?X$)KI4[2!^__TK":^U3Y*Y%65Q XTDO5Q*V.%I
M"Z.#W\XNWW'9.97]^#E5-:GY8FB\Z^ =X+^$HCM!=N=4V>SG5"LS.]77B+/2
M+74**P?_\IO_3;N& GJ29WCZC@]1M:?+"'%?J<.SZ/E;VS%?V 1:[*=JSWI'
M#ZXE7J;[ZP3U^_PN/&%C"1S$[)U363Y77+I74>R50CE2M.8K:)O8GGJTM$\^
M<;OUS2./2&/^^N"WQ_ZYQ_?//;[_P1Z?<HWY,1+U9J@SP7!"^ZTIQB%LEV?3
M=I>%E+O(=!#(B66%S%SQGFPWX:".]D;Q;?3+Y1%%W?;%8]/'FT+&3N?GGV_8
M3\]6>S<31F9&A\#MX\6+1/SJW(C*KF&#D81>-]F :VR4%Z14"#\CP7D[8$C+
M81C20X>E6F(" P8^B0I_N1>O>C>9G:0J>:(O'U6!P/8#NPJ?Z([2)W)(LY4M
MI@]4JI#.%MC^4#S&C6V?BJ5M71\]7:U7/:>RV$\^K0]LX"CE$U!X)6?5(Y-E
M&T+Y<^7-SS0>UQFXFC#S2K%)2NV<:KUYZ)RJ1I=B7ZT]YG5WFU> -=^GWCD<
M!K5S[8,*6#M$)U=\[" "<FB4)TQI!(RTTNR0&()8K)ZDF%)Z4U.X0^5F$YT4
MRQ4NG&6(PZN'4A"QF:+/9D^IGQ.UPJ-@0RKAL6@RUY^Q##;@ELM.\*(D*_&\
M_3V+O]922\SNI3G'CBA%R.)TF=\*ZMWC%2;YDVQZF,<%]3<&-*7U_$ZGF@G-
M/WAS"3Y-/>5&8PD[?Z%9Q!I[(U*6ND>BBN?H(RN8U:(Y<PF)T4%FO"GQ1M2"
MY/$97;*A0MAQ<G:N9]^+6G9ZI8:43=-T=H&'9D#]91-_6Z2035ZR68FJRJ('
ML8)@8[(O$D\>].!"N3Y1::Z"D>-NZ6L4&Z*N+E8P+V)'*D>%H'$ %A=$8=6"
M_-OOW1H+8"]WF&#&H,!ZIQC :]A-A\?2R*H)R,TAS.QXJU9 78WSK>VK+(=7
M.'I>M_WV!Q%QG^H%M^Y K(NUIS?PM%58K+:3;=KM@JB4;14!-)VVF5XE +5L
M' VLW"F= E>W$8:4_&H3S<7AAO*A$% YNK3-0B*^XI%QE*$EV-W9C!YGDX,)
M>_W#]O&3I8:)M!L)-%X>""-W9V9A<*NS(,@)V3TN>.&6[?,>Y3#V_@"2M1VK
M?M5GO7Z3CV.GZ_?YM<P=V#*L(+(/G MM*L:_;W#<:5UU$C":R@*&Z'_IDQ5,
M[!Y?>Z!M&UJZF40"@K%Z>H;$K6.#H0&7_>1KT3=B21IC\9,G]CAH[9P9;4U.
ML+(34U%2CID/K1 0J%SAY7C[.0+*7H!\EMN,TU:1%*G/<"Z?X.SDG98L[TAP
MYGKP/"(<NIGF;MSZ,0[XM-Y'+4B;,Z9.1$Y.1#0@R()!-(1D2/SIFVRSD&"A
M: _E6OB3(:$?EH@^SB9<]UYL-P4]!8O"[6# !BAK?WZI<ZH0=5V.W9:7R3??
M#!9D)^XH=X2%AZ'L2)62:+IY9QR>)XE7\];39]4PV=MQ"5]H&]B_%M16J8[?
MGWI!G_QZ2&"ZJ2LB;NS(^@TKRN@V[[>O'3()LBAKL9BF:=^W"PXL@P:OP-)(
M]L'YAD=O1S<Q=UVYC1.J*PX6G$.$=()A94&<YN4X*4Y@W!H9BL%:J0O_D-F3
M^* B'_9E8U$K&O&E\_DYU3W#YG8WVV@NGN8P6]3^<8$9P6;L0S;2RTD@JKK,
MK.X&UH69K-D'- :(U&1FQ+F9YW7_Q<@_.BD*7=.;OV5_@Y52\ &(]I-2D@$J
M+-(SI7Q^X4_KI?0.#@@8*F ,JD??A96@W1X?&0L(<J6X:++!07!U:(I@B3O2
M/XPKEF$D(Y=EU:@19N90_$V-#_UF=_0>G["=\J!!O41]YY!!DX?[  2N(H-:
MM'GD9#-6L!%0FUYT^&DS4&C)/TXA$'$[E..4#/,Z2]&F7+,XVYWB.J<J/=8\
MFU*<BO[-ZR@=Q[C_=4ZU18:T[':[U'),I^4%[LTX!I(+CRN_36/8"2V;(C<V
M(Z[B:XV=AV&'3KXA3H*V\6X"AXT&_G+9T]GL\2&J>L\DU"??KMW],.#V#@4[
MIQ)! /"C6U6>QSGM*56^99\?]UZBRKQ*).@J7>*?\U>:/L@23V'F,E15O:5E
M)&"*089](DI-KTL>PVN053L07Y_P49N#1G#TFWBPQF$>3#B*GX7>? ^LPK48
MVS5]V6VR$6KL[6%@1_6?C@O1GLYY)+G2DK7H.D!2$QE4B-^:'MZ'B]3XH>44
M??5$5DD!)!9!NJ]3JP:,U2O+\H2JZ(7^OQBV%@-1R"&I.&!,8IZ37,M=9^=A
M48)<9UKX(&FXB=-!T$!^A()+?BWN/9?%L]VE7!VB9Y.\(:2T+$ E6-S0])P]
M9]*RJJSZR,N-KJ:"9U8+]45^Z3-L#K_C'/7D_H[GXR0FQ[HUWT)'1:C^HL?&
MXV+656[<=:UE;K5;DC-HJY+O0P#[+R>M([Y<MNLO&2\_=9A$$U$;$T[5]U-X
MZ6X\7KQ:YO=Y\<U:QBEKHM>]<1O>BCB#IG14.OJ"L_.[TU>$$?O<EIU'G6TO
MG999M(MB:^Y)'D=,J<QIXZ((^Z4:."]P/;'W0HKTR!V_!Q$Y3:VVKZ)?;<(H
MWG_2'_P#=M?):^,_&)O/O+W]CQ=6:#U4*;O[(ML@+.:'Q[[V=DS<4ZC%OPI>
M_7M/^I##JF6]FV,Q4GJ+Y<:RD$*KSO=VEM-YCLHDF>^34HO?&#Q8-DXF_X%@
M_#^]R$4K>[#WM-D];1;?LB#22"*Q8<7]%H+$U>1*)Y=XK;F8?MH=;G),4$?2
MXZI!O?[3AC[;=X@"ERT?]:'@ ?+=CWX@K! WUYO)B-3%F5O2G[MOLB%$LN6;
M=S,N.?:09MGD_&DO/'#]V_'QD@!@_L1Z/@E&=(OC]7"=^E"[.3!^:17WBTK]
MDYS_MG[_J\CYP$+]"N"I@XBA>H/]ZL.&D)M%RL^?7E9/9#"Q Q$,U+GC1;0@
M+-*?7:,FW[2J<X5+:0K&5@ 8?A7VI*4C@<%=H6&)8 0G\VZ+L/?"M--C:CB4
M$I*HE9\8IV+B[<=:N.US3K48=ITD.-7Y,[4F>!NYC>_[^BITS?K7]3GR'M98
MLP7VE>+Y&^WN]>AQ&V-P RVY]UAD/))<R=;E6M,2,2_'CZ]I9XF^?JN3TF1?
MKV,J!ZNC1MUFD5;N!+K?TQH3O6V^4"#BFNY0CI#4HF\SN"G@F#G.OP"5*87F
MIBZA3*.<XH@@4'=XA$T!Z DO8>+HG$I/J2IS+(G.R":/6YVN#P_)7]29/4*F
M-PA<=KS!P;USI<TSG(6OVUNKZ0->._)#[4 'R.7&**X0YNEB4V02N@G0,-#K
M$5 9-8\#&J'-UT7:.QOJH!B<<3HU#F46U&*Q]>AX.7##LG5'RV]$7.;+.955
M0_XY543@K)/BU(#Q0(*IK$:LPYAKLBX-&F1DWVV]72VI0GULQQ5Y;,'T.:]1
MV2V%;T!\_&WLQ:S+>-]\L6<0WM9C6$UHW].FOAG2"P9?;76KDL\KZ2/=IUH;
M9MM;7!!;9)3O5'LDL"JH>V2B\ >Q,764)1B^:,/ (H_H)T7CND:W8MJ#8N-#
M-W7OQT=LW[$UE85'"BEYR>^B[<2]O'G5#)@*FMCB(V<KTD;'_6O* NC_FJ@W
M-XE=IV,NBN,CL.NZ1W7*ESJ#S!YQE9B-.N>@?-TE^RRFQWP*[W,)[0\S&O)4
MVLW;(P>NW!ITH(EUXN#>':!>O>_@^$3==DC@*J_>\SK"]W0*U^8";OM^5C3L
M6QBN6SOD395Z1)M*(ET=!AC.BTY%0F9>_U!;<#,?R65@* 4V1L00VF+)5)=R
MDW5T8QQH%1_+COZ QV"]W)L,>BQ6_2'S@>JZ,\7UD+ OOQG6Q=@F2V]LT[ZB
MWNUGYJL)5LY.!@IAIYBX[YD9;+,*HR\W'>_NG*D*6MN<LO\X#2\^IW)7:QIU
MFV*LKL.[L4GNY%-4X:-P"\/6S9$O!U&DYVO8;][!?( ^=U$B<*MZ5[]U_4L/
MR[$ZF]UZ:4774F%!!ONW[C7D%VOZ9ST0*^8*./25(;&0.>=;-HMB,2/?Z:]Z
MFI:'8[(AE-.5V-.?@7FCT>&<REE*L7<L^5?!7H<I9DC3KM3SD32=FISJ:-:\
M/IL*0U8RZT;#I>X>U&5S ]4/MJMW,?S]&!V($ $6WXSS^SJ0T-J^+43D[RJN
MZETM&WP+3TUVLIE84TR91<'E-@LQ<!WL9B.Y6B1?8YS+, ?5V^WU+-D\@E/0
M/*Q ZIU5TX?]MUD02N#[<ZJ2@8O=1ZN#:%T6O5$P\WH/LSS:;B%N9^0'UP./
MHD524\N=@?YKZL\+?&)-4 /0AKV_]Q)*P2$DK[K(^-;[K]$V&+"&G+ 5(%H@
M2NT=7EJ0R(("@;>&9<(FO8R&#!#':^VH<N3X/*S]N\!#.L?<[Z83#C@>CYY-
MC?J7 *0J"C#10&'H537QQZW#C)RD>NI95<(M5KV3'E3NQ4-'<BY#A9QGS>Y)
MSVZFDBV1?AIQ@%*5)M;P8N&B;[GQ(K3J;?[.J2LB*?>>NCL?;8(,@?I?5U%Q
M[W$?PGFS:2(3QOI_>H.:2R:*A:/*79D5!"QTG!D5'A$TKU94'*NG]VI=3P\A
M\.B"(/F]S1VH?&P.5I\(<F-@8$3*070/&^AQ!]J%,>/):_0J44*2]J!4-U7/
MU[WA=TJBY_-YY0J1@O&58K5(:WKJ13O09WI=/H&7BZ#^2I]^PI27>E_7=B%+
MEH,4!"E'CW<LOE=@^%,EG<B@2E6Z.EM4WEL>LQ\5M*%[L5VH):QI)]HC@"+9
MFNM!YJW=*)?46"V$_2':KUD:V^>VZ4]J<HV$I.-,H%-V2^A8K0O>\ZI&PL#B
M_$,>;\P0ZR!J+WT&_M.3">@1$TJ)9A+<Z6F%)3;$9X0@Z_G''E:<JB@1$B?K
M^.?*E')+=-6I>+TD7&=$?T/ETL]("1>&0QQ?1+17W!,SF3PUXX(K)\ *S;8K
M2CSKYTFFD8AI>'TN?40>KF]C9W_G;C)-VNW@NYE0-G.O^2!:UF-G_.@$?J*2
M4P=%Q.J3@,J4>/VT@,^?U/MA3A,J3PQUJBMK8]K[[+7VZO)$7JX3.M*?\O.:
M=%X?6=:I7-SN?05.S0/V9IIEU<C_*,L367GI5=!'(,T=89;52E3TZI.PM#T\
MBDBQ3?UA[]3I(!>>Q/M66XH!P,AMZ<R9.4!#?);/L2+-^$@R%]CT5*M^H2 6
M_/.M#5I;SE\:6P*P8NK7;UUC+#J4S]]^(A;K56TK>63>&_O6FE[+"U%D8J91
M79U[W;8$R[L!IPO_9/2 ,?-!HF<V%SD_02[1[>TB*+[FXRIMO= SMCQ480<?
M7+)+$HAG$[[*<^GEB"!E#"W/[2C1O'1</KQN%]=N/+;@!A\Y0&R6=LPW\)F>
M!/A!:0KC)#6UN<A<>E7< 9LZR9,5'70$:%TQLV>2C$A=KW/'L/LH]^&-7C-<
MXXBKV'*!JPQ]&[R@?)1Z_;HZ,@VBOB,!':KDS7*Z)O^!M<KL&@R<OIA;M'=<
MPBC R$6+]1>@W*R0DWN[Z4F"3//]#:>1*VR;7A,"#H%:B38ES2+=JB @<UZD
MH<++7*?!KA(CS@F8AFQ&+MGB6T_0URIM]IX-HL9$=91F!=%0*YP8K,G P@FT
MV2]M<OVN^,8\W&5@#4@XI_I5W7JTV?/VNU_5K;D#?Q6WOG].148N[TCR; ?N
MIE!4"-\&0B8C2G8NA1NJ]WE]?8X]4U^I(W@U2PZ:'W";ZWQ!*\9X?-T4ZF>K
M_>:)[ ^8Y>[//I:C-E^6QB..%8=]<\Y&($0YX:ICW7FF?3X3&AX)*RF;WA$0
M2&W,.NHDX18R><'7[+4J%HD;E<$ 0:MIG:VNURD^T6H'&Y!7IB3+\<8;V@)E
M][_<U1 G_-X2!QE0=DYE2'EX3L4 #;SOGMV7,<%BYGI.9?I!L4W]*X_,]YOQ
MP_]V\OJD?7$ZV>1UJR3!!3V:9^<6"2Q/SPH/\^5)S^*?O\7<XCGEE=+]@1!8
MES #WU=,\ ,KSXI*!RN^L1;OU PW'#( :U-PFA*N=8>P368*9X.(#HF1GS+]
MQ)%UD/C^74&OL2BLH;/,4B3>/G)"4JU'QGVU&\\I3)92#I;I=WN1)R*>OLST
MZ<C6(9/YI96!_GZG+@MXP#>1>01;[)2^+!PZ\JMD.IB65MC@4(6 [U.M2@J)
M@0@S<DY)N?[0*_WBSWZ(ZO@\B.B;!S,X+];G#3CJ*#$5=([C5=N0PA;"'N*"
M#^VBH#*F49"Q!5]V4G>44RIJ%&#P1@]\]S1WU;S>"IW\@VO"2B.MI8,W^MX/
MBN6;BT?Z_B_T3N\P=D,)1W>[?M^T8Q#?2SRG&@[@"1#8W&[>O6 J(O;27>]D
M!ND'D/(5-;8V3OKZ.T%UQ\\%$AR05A]HI+Y[F-^+^G7X+8?+])Z;42=Y>Z6<
M^,G^?O2O+SA"?^C3=O;"8WN1Y\ HHFY7]Z_78J?FBJO\#5UJCQC4;_TFS(Z*
M.$LS:&%&S_BGW@DJ>+! _R]?(",CE+I^W^4D.7OXA1XB=PT7^#IX:OU=W#,,
M:K>VUR]=/+*)6!1-'^L87_O]')OJ7NZ>@^)FV=D6Q_'1KYY+RYH<"W=Z6L*2
M<NZJ>?XF]\?B*&4M9C%KA8OR85@)XIRV?NG.B2*A !!P>(9Q?40X U_H,]:F
MN_8/=#W@$3AM[7A24<O_W7>^SHJ[4NO+<,7!P0/H6]M=GQT1]*KZDRNB=D_S
M^[Y1_>?CPA5YA]?3X'I9$VD/1I<ONA2A:_QP%@')SQ!(%?W'+# 8"SE5GNZT
MT_ASXF@K?_5P' X3>1]P+XQ_A]W&CH HUOI+=.9AT\NHF$;S,7KFOJTUW+:@
MMNL,=I_^^U",/](P/)8SHF QW&NTDI0J=-1;F?2X+L<VCTYKN=5'T9\S3XMF
MZ:NJD676E Z3=N=W)P^\Z>:72 8/*-%(S819IR\B1#8%6A).) MZKAD++K6^
M%RC+(<:^B#+D=!( TDQ_XFA+2@MYV\1\,-4EXB@[Q#P#?ISB:M37K:CJI 'D
MW6F15 #[W\2LWTGZ._(]3YQWO[V%M52<P$,U/)_WRE*KLEDUM:;FT4\N8P1!
M\UQJ%Q&L) ;<RXXIT&PF(](X/OGQ&W#'-0 RIMFKD@.NQ/W1;9,_Z37)=,#G
MEO['1_/M/$6C:44/[T&Z!G%#8-=Z4U89>\?GK3X.2+RCL'Q90?Y$Z1*OAIAC
MKB>_V<,D+3&/T#H8P#YG^66])LZY4E7K@O"?_[$,_[NEY1\MZVM(=A_/LHZJ
M*!Z+SR^ZU//[ZYW*!(0R*_[@%;K ]\LF_YDW_P;P_[N\F9:&% ]RZLN_D!?3
M0AH;CPO^T(AF2ENT+# ,5[ SYLHM#(Y*\U(QQAC@?4O7J^J.V3+J-G=R*>]=
M6EZ;);9*6I9Y2E=]0T4^*ZA+I!YS+!B1Y-6OEP 5!]O"2;X;AKE&.#/P\U2+
MVR\=G2I8?;#"1EPO\D 5_2YDW3[0 ZL]U?GH)JUK![T#LT^7^"C;J]:GSFFG
M(3?/J5SY''J9C)I:3A9:/*TQ/[US="29 IH 0+H72ELTNN*?W!M]FAK(81,)
MCB>R%TY7<%>G:[WCNZ_45 O;K%Q!Q>[L4Q=<SQ8GBQ]_?OW\A?$D4X%@%#!B
M=E#&90@T.%AY/Q4#JAC(?YOI.8;V0;-B0 B>];Y&TMJQ78/?)=B^9ZZ#( =8
M]\HS3L'9E)7=^@6$+:(N"CH.^;!?ATI7*PK_8+@W%%^0SQ)->>AT-:+0$$HR
MI7FKX0)5\!' 'ETHD: OC-Y"6["I)VD-T0;!'.JTNAFB='3F&ZU9*=D>55,R
MK\TAQW9*JL&09BDCD] V5I#PQ[8AF0RA/B=^_6Y@"M,>0CE*'=!%JC$)Q,E:
M\M<V]5FG\1AH&@4-*SV]PAWE;X QF5<1!0\+K:U3TFR:>YQ-DRP:)E+YOJAJ
M&>)J:$IV6#S_QK?B^=PG'@ F)XOS_D TV3$OJF_$7\VDWJM@!:J:6BEL0Q=2
M!@+![@TELT)WX\B%6>I36\X1O@DLPO5]N7%OD:^D[5&%</F[F[;;1<4J=19Z
MVN(3AP]@T(K<K5R]:)6<)O#$<4X0FPI?@V-&I*2J?D>81K>#X/2,&ZE]&5 T
MRFD.*_6/<' OT_0UH[/?2&>> Q#"]9).KY5MZA7)<!$A&[']?$PYWR42@5*.
M$O&>JY<G8QFIZ:E?U"I0NT'N;_3[6E/O;JU:-LI92!W?9CR;4RLQL,9ILA9J
M:$'?4G<;-K%&9HX;1RF#5+ELC3AE:,&T,%P':%Z?[:AY5>>6*TO8CY#1=/,A
M4=\VUYX'&(#H_$L]3>U.6=_I$:QI#IFV$K5(O!+(JX[*ZW1_G[MDW^GL>S/%
MY4MGP!2?UV(3;@AN.#S N_WXM<.(C>&0=87HAK+AYTOY=EQL[#@SUD6GU$TM
M ^,EE*4:>>BF0XU=.<LUOCYI]KM]!>V6"<0:Q_EFDJ>)'90+CI/>5$'9P<J0
MNCV*@Y7 VZFF6:9.KS=?3I:CC5=]UXB)37-]G,X4MX^''<F&NC)M[3:#$1'A
M:4(02-;UO%GC]V*HHEDP(\\M/DKH'&;U?KAZ]8<@):\+<FL/5R$%A6]^Z%?4
M0 K;Q]#41 U*/2#EN_P/ *;HM20_ (8,(.X&ED8C)%ADWE8JKN8Q/)ZCJS02
M4 4 HT8,"(GW(4R[8:4@940[N1\J8Y[)?21[D#D;LW:IEYT;)!W_L38MIXS?
M0;]\?,-3&.T^O3"W]&"LQM#RBEOL>\%Q)UIU)F!X\!_^P0>?,VC!R;K6Q-WT
MSN^W1-ZYF:5-,UA.;&<YNG9[*D7(72O\6-CZT@7P(V>8H#.V%%LANBY65UF*
M&:JCNU8I*4LZ\!PN)98>U(2]J[HPOIG96@@UR+>*U#42G]CG\HBT')&2->,"
MUH<>XZQ490@X"Z$#85V/[ 49EBX+?T:^VCH]&Z\:2]6Z_<'4N_67/Y-<RZ"T
ML*[-2]4V:@XR ?H<]7H2F7EO=B9F+FFYYZTV-36E3S<9MF^%O+0M&.^EYGW>
MIQCQI?=H8@6N41]2;^K(3.;!W86I=6'"!ISTV).\^MHW!%.JW.#-1)7%"61V
M"G1A,Y,4=<VT^CM/%+ ^TFPE IHCC['\&N]"XHA2V'O,,2^N&'39[>ST5$@1
M,QQ8/ANXQ?OC\!TUI>:<*CUYJW,MNI/C]8<[WU.R6M^<'A\9!YH5G%-9MYY3
M3:K^N[,SC0[_(LH0(.5(O7&3>][:&HO15Q!^RPM:%;>=$+[\Q3DV20^,2%7&
MBT:MC _87VM.>S.AY0+SXJ\D@ZOC,8:*H5\3L ST@L8=<8XV3M-[,#B$Q:<;
M[8%T,GA3%!;S@\-WL))M9?Z[2I+*I&$V?1"".SPL$5$&1I3=SPJ>!OQ>P.6O
M$(DS Q;!<ZI/,UW412?DW:-3C&358=FN).OKML'<-<TK)U6+>RJ8Z]XN+ZA*
MEI\?#YWJR3BB9!$KMP_ERB3ZV_O;%K8&(&-Y;'8;%YVA0YM<'/$-3U5!*SZ'
M#[<FEWE\%;G3GE&88*B"/8=<R0'502XWZ0'UTP43W>JQK?MSQC27?FC*V1L2
M55:9< *2!6HOTIZ 7LG:-596A-VLJ0N7\R?[/ZT[3<"9<]TN^1ZID5]GPHR/
MH!\L_8J[I\X=V):I@D_B8EVL[+FG#3$1C[*)8JE\06K@?<G()_H<2N+\<XHN
M18EUJ=61[^W\SXPE<Z J=M%.>0>L<X0*L<Q41:?732Z"P81X 53I,_L.E@?(
M\O8D%7P.I[VR)JT$K>9(!&BE*;N5Q;2AQ;83JC\(T_-B<W0+Z-BM2!P7GB^P
MR1'@;U7FK9Y<D[I.D$(R/"V^*VZSKRAS2T6EGY?CJ7S%]&V"RSXR[4*09F3I
M TT>@(<@>]=&ME$'=Z*@4'BL<O60*BO2+YSX^IP*#>A:>U^CO!O]"0=AF4I?
MKR:5?-0P20-(]#MEP9\!-FV-F,(I>1BW"0Q4>*89):"<]P>\&=7T=#_K9LJ7
M?<NW'J5[EF-ECT<8HZR:1AHT.\@TS%WQKT\FT8 ?@]!.G&>HEX/VW":#I^H8
MF,"$4S>@OW[$49%QYPBP$7R:56TF6 UKWV^[6NSO+]*':[@SJF1TL?YE+L)2
M?>^5!M$=%EM1HC&6H2<X%M7"*'IZY.+$.M7VJL2)VH/]BM5-QX*.I,Q"(VXZ
M3A4*YUC%=&)X$474/!J[2L^\J(FSFKT:-]_A\DXV5W>-T+V_-4B?>J2-1LL5
M+6T]P(5[,5;V;^L69%O$&DBV5R^D+6UQ3GWMY]+0O6#&).?&R YR.7;Q2@G?
M?8OW)#NMKKVBF1V>TZLK!ZS%?1$6A\"Y.!-QEJ0.5EW;[V,$DI]U$DX9G')<
M-8Z)S9U"7AUX@6@+VVBLC@+&FH9W9R#J'-S&<.,^6[X6+,<O-TAR@@PTHM/F
M#E_+-)KTL#*!A=61Y@IK+JP_*@II'LC!ZAI<JAZ%ROZ-41IZL(G8O^J:00[I
M+MW^'-.3!8U!I&A/-QCT[T[M[]4_<_]$9N5 ^+I$]RE\KC<<")L,STQ$*ZEA
M4GV@^851C.H0XQ%5?\H3Z^\R^J=1@/[A#<MU"N/?HR[7',KQJM6A'5%Q.XLI
M^@7NABI=)H(+*HN(NE$S7]!HCO!D\.3N^%Q#,]]WYWP0SJO3]^W9ZM+8M$'T
MW6\I)MH97@)B=)O<'!QLAQ.)..]G4GR$JB 0-&?LV Z9OAJ00)X)\?.=PN ?
M.]VOD'9B";'6 XATLET1+D'VVMA"==9WQFT$S;A,/K7+G2WM,VN_&WO]FOK8
MHAK@;(H:+362+7!BW76K!4,T*\AXC-&K.NU#VJZ) H/!EF'[S)-5I^WNL3>U
M]4_\ S>D]CNOGO)HN6NO^IO .;Z SZFX$RJOGX(R17]CNU>1>P]'2W$UUZ6V
MFNVX_P_RWBNLJ>W[]V9ONX*(%)&ZI4IH4D(54.E=2FBA2$(12.A-ZE:4$IKT
M#M(A$"!  H0F+720DE "07H'Z2CM^/N?YSS'W]U[\5Z][[I85VO,9ZPUG_%=
MGS'+F.0GA.2_ZPE\O&I/EV^V4/DA>U@V_HGHR<L:A>V;0Q]W3PW=K">O[/_8
M'G;>I"7K"&H#+5D_*3//40+&X]:Y1CJ@]!O1& 9#;Y"F'KV@Q,[\]T"=XZJW
MG(:J. =874COBCD6O$Y'N&1B: V4.4FHMOIX_?H517K%9FL9XQ7%SS[=P^*2
MN9$MQ2QJK,\,F]WFF!A,4*^Z4)'DZ5VGV-Z37+[@5_?LK4VQ.T'7R8/[^\Z,
M0(96PXXK=)[[C"PV:\OM%E7D^/GR2&Z\Q0@;F#%]\U6%DD?<>(P1=@89/2&Q
MGV>KU$3R%=2A98[:(H]J?C)4?=^OSO!LS?QSB^9.=+5)'6A0Q:PDDE#SR6QI
MV_@E_V6E3B_NA3C&A<U(D[_>"LN_ZF0<OF_V-YH']VX(.BV;]/+.X] M?U>=
M[1;(V)!(?-&KA!L2[XPN#V='%8VY#,%RM6*CF(VH.*-XH+_!^PG@CA&I/;P"
M5!/:U1-'S,D;$HDV"-C$UA_9D,P/FX.DX3&/ #Y\0;QR:^3[(]^P ]%*FG1=
M%V+B1>.S$S$&;M4'U8RX&C>5$X0;JI)9KNK)<X21$TKC)4XTU3.RF,I40W^@
M#/BH#PF8FO"8?5.2\O=+E[ BE>X=%XB$@8N( #]M1;LW-@+@D,;4P?(-[;".
M9)I*XQRAZ>M+SLLWWZQPS/N1EP+^MTNBF+ZT6X*6K40#M_5WI6%"\XY[,ZXW
MS\-E<E6.Z11DL@IH,#O#3HZ_TCINO;[LQ8": EL&V[^2^D 4OQ?3D?ZRV4^M
M@B&B<,(&%J^6F]ELP&BJXE;<YC&3L5T3BXXKDE ]274^@QW7W)L\Y[=SZ^P2
M@:FDQ] ')(:/)R/M7K(NJ]/KU9&3D1Q+M7/U1X(JP]^]ZH_,.FMK#1,,Y6B&
M,*:4SG$]6<54T>#;"0NW- 8SQA/T)9=UELG528 C<M#0!-B ?RU-B1."K-FG
MQ\Q]KJ1YQ]:6)[87RU3P0<WW52H\B> *+8LCUZV.D7S L61!HVVT.2]#IQOB
MZ1?/W6(S;Z5NPU=]H2KIO31#AJ%JY&5<>,J6)DR?=TME763[S)J_2;"N"V"J
M:BQ>JJE[;R0Z(DYM;5LIP!V-4L5L.YF-^\T:MRA[)/YBTHTZ\XC->IFP/E4M
MD0MS-9X&;Q)3FC1J@HYX:;:^KY87*$6GN(7%K0L02T5[V^5.>QA>R=Y4900T
M[#1:/-)JCNST>T[P#&]W;=+(M__Q:V64,&KY'O-:;3WWDR!XDS8#KOT\ CKB
MY9Z?1&.&$O/_BXVP<^!_?V9%UF1C2Z@B;>Q;+W\FDIC/E=P)4G;GP/*E'I_(
M].R*,,486MB0_?CUUIM)@QI68@4";F>O=R:\\(1[E;MBV\<$A\W'UTOA1YE-
M3Q(_122XS*K^@XO7*!JD=TN4W3%4;W^\"[XQ^G>D7P;?A^V*W6>E(@*W:#PR
MS*\H6//>G_*GEL3[GNOW3;%$:P[I,L"&_9EBU8Y<H!-6< N&OC=GIIAQ$K$X
M[4S]]8D0XV9" _?O."N&\Z<2('+92P1/))$#NXPMB#+OYL/++?*7G IW\-WI
M@DI?ZSN%:LT@=Q>Y##+'S>[?AZC_HCV!"KG<M:O&2%P7,EOFX"<Q[J6G K)Z
MM<<GBF[NIMACQV"08F2"M81$;F)%)73>4RH+6JY+W[$5C)/F\H29LJR@P0+Z
M0"-)_HSI,CZ)]IHW6&./@X:1;6?9AP)KF]-],!EIMB73.+#3(WTBMA\$0YAD
MAI=92WI=)GO0^SYUG.'IJQ +?Q\%I68<3YH2ZF3LEM NLSG(H>[VA!0DRVKG
M5,..5Q7L.8#%NZ!9=^Z<D:C@\V7>7_IFUHVL/#1A+S^]YJ+,*XJ(PY.&>O!
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M.<^AC\PCUK(V'8Z';T^I__BE];)&'1QA))%]>\%1>F,5P-&L-P2/ZWY7-X-
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M+RK*P-LCOP1HY9IP.<4-1YM-SCD!1;! 0\RV'X8&VUD)+FE(R$U.F<89?'B
M/K.3@?RM<H)&D3A*C7)@C7<<9SG\)#"/[Q/&/>+C.H-XYEXTIFH#[QHL\XGF
M2.&U)V44=J^3FF-)0Y\/QK=@58:C\Y,60"IE)2'5;CE#X6QUE@DLL=6P-[_(
M(PXD_*($41(&6>NJ\=T9=,9*N:VHTQ% \>/*=.&H -=F-"8<98YJ69$W5.ZW
M"6^R[ZH7%Y;S2U;4&\SLV:LK!L1-\$>X:@E2OUNVC7ULA+8"MW!_'_Y,1)='
M59_B=;PK,^J=<_W#?'M:VG@L8YKIBZ>OGPBNN[QDU]9.[G60"*),&$@67!'T
MF(FV4U+G"-!'N[PJ 4-HBHXD!]D>SVXY=Y?9940G0.)M8X"]T/BL4L<?9983
MZ%Z;CUK[NAX,(_ZK,0-+5E(^5Q3,T@;=K,4^E7N*L>(.[])G!6?E;U3?W:B#
M/YG&(\'J$F:3'/H/J<QKVN'NIKRFKB.><5Q]LW;M%;0UI,8I[<F=*PJ[XS*/
M,[V0T<%:J4%S-UW#Z;3,TG#@:,/ZPN:K9!RCC4U=@7)A&$C<)6[Z$0P;S8_6
M+L5C6QWV8,S.57[K^>UK__@O?H) .$:1(DRXN<?@A^I,*R8DGOAS%R?];\_5
MZ[<&0_"L=WQGT/9ATT8H XW,IFH0TFUS)>@557Z82Y8*5SI7N ]_2-+HP(]7
MODQEC]F6FKOMGB?-R=^IS@ V9^5_E6"RR;%YNX<H*66),2XJC&]@PO<@RSBA
M:"@,6X%&J0N"B0DN;]PHG1@F,_EIIWD$?)<.'[38&.)PW2+TYB@E3<3.NBG$
M'&0TF<R,R0\N&I3[.3HQEX2^)CBRN'E%8=V*E9+\#83]?E9&8-5#^N!>;H$/
M"B#>J#=_0!1JINFGU#;UKPK>_60Z9<N,UFK\Q+E.SO)XT>K:P5'_^_/GK3RI
ME=_/?V,'Q74C+_F-!SKL>D^ V&([S4H!'X=>\[%Q(\$:@6-FT1T/RJ1],VZ.
M$OO;V 1#5)YI#FMU_+NV9XI?0IJ*G\EP'SIZGWF'YCMZ]VZ^;&CZBR%  [5#
MP%J O<K462)M"9YO*TN21 W:G)+ 7)_S:RW/?&HSFML7VJH83H?("T&KZM?T
M?U7_FE$GC\\KN<]&1)Y,B7+P,W/G^!3&WN*J!^7:J%<5!+;,910YM'3->JAZ
M1-Q@&BR?,E >Z^</*4MS!Z'_61MB7=JP'LB80!1Y<'@VBLP*^[W0WUWT1<O:
MY>T%SGQ_)LCPB)X4OA;76UY*F$S'E#0PB<HRN]_^ DV/==K&S3AO%<VV]#6+
M^&QZESV, _"SPS?92NJLFY,OD0=)0Q@7M9\L")11/$T5WP-9T3#O"8:"^QN5
M50 )#>4X9.!JB_1[3(?<^]07V0]"DB^F1W;'A607'&GK%& &T+K'T6#)V 59
MOEI#9KV0AL>1UI@JT(ME+'Y0E]\NPF@#0^2<)/0LF?=%)I),L(\UHZV]I.3<
M+7/+BN,?T_(8:71!QP  6Z>43_1B>4G?%ANSBV8%TH;VXL7"W5E&1P11!J)^
MCGN5VX_+<5$.M@D6&^O]Y<2':^4L_BE%>J0B40&F4^;5>VF2FQ(R*L/%&0.1
M>6&:O>LG:&,L>HOG1Y8JG6\6MZU\<[7,[9$2='YAH;HET2)&VCI=VT8KFE6G
MU^R0XV9/:R X.L8"$68_5YLAE- \[O%2"&46+VU>1W@LBD9NFJ^HX6?\,TOY
M4U$&5E+#;Y9O/9/Y/B[\/**H_5OYN7ONH$S5"-_N(L^BUR<@2@9O]DE>H_OA
MAEO^V<,)[8KX45_WQ?;P^?ZB*4Z#)Z&#QT9'5;.C.[I?J)R'=_IP :IWIJ-4
M>#J,]7LY @,UD6_VTI-?<D(\GFB8RPU^6 0ZXA4%U^.5DRV+T5[^+DUL">*G
M11,&W9K@D-%FFP^\P.VB3T\20+0%D&96CD'#2.Y52U7IK6J@+=[L<N@8?>O!
M+Q+LN>93/\^ I*2M)9R:;;.?/!]BF)M'=!W",F!@S_8A3._5ZN-VV^'S:]T"
M/)3@!ZC8FVWQ#OQE!3:4""#8+B!6I9MUW+"EPB\/6 9'ENC\FGI:6CIK98G&
M9F?%Q W[<<=A4""/;<MEFA(D,E/I']?0 ^5JL#0W82[!VV\'50+O)7CQLN9L
M\=U\387\=3_IG[<E!]4#H0]DL%0AP#LQZXT!3Y=]*,T?/\R,\1=3D+RH.5/\
M](8D^*W&BR[)I$7RPU@19[1H=$P:@;'9 !BK:HYYR"15V',RB1<U&=F84'9X
M?&*/L/;"G ZK46&RF5@4'B0YN)[\!HH"PV>X35BS;;7.L8\@9LB##:6LFB",
M]&%#DKT8)@9EJQS]>;+7O<QX%733;<7;> =_*$K'^-HALM1^2G09-H"JE[4]
M?\!\E+J=9=\0)[?D)YW/F(*&MEM^$Q 4YBAM71HQ(F>"G?5WX>!<](KTVC(6
M(0K&@.GB?!E&WH!UP^KHIC9P?C-R?:7E$=O^>KWM!+2_,7>IDP4T?AQ#&2]3
MFL;C4VQUR/OV?%W[4EW_5M,5!6YUXQKCY23A,KI=5\(/<F'W[>(&==^F]@E;
M/(W4'\C*(5M:(/"\8"?O>:86+&(TO"Z)LQ5"F(KGRWYATZ4U]-" BZ\F9F:1
M-2N_AYT<B,D U4@==]?9[3U7I(:-^X:B^9 \(:;>&IIU1[JVFW59WD=82["4
M8786Y?KZQK.F8$N\?!\"+ QDZ#>5PYI%VF)Y/@B=ZR']4RN#1?%GC.^L?Q')
ML4<)[%<4XX KBC%:JY4M!?*3X^@M:CK'[!7^N0%T"YZ:B#T,+D^]HKC,-;Y,
M#9@-.^N4'VD.Z2-C;C9->I;![[:9VT71$^LD06E&MU,K!XH?*3"M"/Y<*.9X
M1M3A_FF&D_1S_? 1Q'G,V+#]M>^-_S9Y:'C1,'6;[=O"/FADO%OLL9SY0?NJ
MTJ$_6$"T9VTY&B00X.*(V<;0"^AWTTUM<3[J<'R&K#=+Q#QKX2V3&UR;P)AM
M5MK&0,M!Z$%#0_.2MX4*A<8Z@7R%W"7'@JRH+6"R:Z5Q'3P03[ZI<Q$:06\O
M7#P'.X%SL(Z>TU NX?7_V:-ZK94Z=%L+*CTTB__UYC";--@4QMXA$4)7U)4C
M^S"#NH/A[=JN8+2-P!>G CAHN2>Z5".-K0S2X,[42CUCN7KL8K?4P?^L3[HD
M@SG9#%D++48+&JMM)*D(2/"R:-*:17S]:'1H/G9W6_O:N+]VU6?/U5@?9HL4
MD[7^LV.V!T?T*/K ]X:U4[DS['=\[H^42Y<]5PAAE5\>\O=WA1TO.'DND,G2
M5<Q>C:Q%H;]QSMGA[4(E_MD:P";FSD.^DA7$G05H14-E&N9'!;JB^:%)"4J3
MZM%(A]T$ZY0V>FHR>Q66I+1OH*>S,KUDRI'-9P-9ZHM#B1$WBN%INFV_$CU.
M'-W.U#T7F_;\C3;E/$J/Q<6[&E-?-]XLYHFZ8'L8Y*[<.*VLG. )'Q"J--/A
M#ZD'XTP7"H=8.#K+2HH K05%"]X&SFXM<;YL,]OWA2,64F'1^5/J7\IM/ GQ
M7<P@ +<_,<YA\G3;":JD%M>'5G^] BS3/')JAOG8_!@<AOBR4C%0OS3I[H\4
M]<V,?]7=W%/5.:X.%LTG3@@95WI/Q@T9N-3G@T-7%5YK3PV$_:")D;KH&NMU
MZXB*HGXX7I6LF>!>%IU0\]K1SD'"+VCA)0QHOK2;YL3S+6V('GJ,\PF4?8?-
M"%W;J_'/-K>G\SZ62&..7@3>+\\BB"=6UG2N,0/ZUCF4ZV>=&)<<6^X0NVQ5
M+$*J$@U)P^0AWB9U2+2W[C5CZU,G9^Y>'LT 2.'#?M99P0D V%MM#!?)->.;
M;W@B8GEI&WW\[$,K"KYV16$J<D5Q\:KR0H2[Q;GC8H']+?GKGDKI#J3YO)]Y
MZ\V%DXOJK][8*XH-^N#UL,')X";%;>9)MJ<$N0'CUC1H8!3[?S7R[&<C]4EX
M8+[_M2ZFX@;$R8& "SKD"-7,OLFC<$51 KJB*&*7M+[<HZYU>5.3G:_.!=1!
MO[P^IDSGM2W(I:?V29LK7J>.26E,6Q1ZG<.&1R0*RH@7B?)^$Y3G\_(Y 5PT
MY9>>@M.(D/"A\B O&TL/>;$ 5J7['1N&0/]S@0WW0EST:)W="K3"4S%6?5RB
M#R;##/Y0J[O*?NW!PE+! _>;SPM:[^[YR$>L4:M8E85=<$N^NW-CH?1)M-2R
M"T^FP]M] A]:QQ:K-<Y44S[^W'UG@=]KG.@W-1A]XJY5L&>T\<SX3OX5189N
MPV[9ZIWO!489<SX<KNFR >")%&N^A)M?YP-(!G(R?00C_OP/=,; L5;N&*,R
M5JA_8O5Y,I"FLF?&K,E,0B4\SWS'W3>U>F!A,(*/130V]D>.4X4$8W+:#REL
M>2IG8NHSM9R945ZOF1/3;0F/S L($DN8EU59\PYAF,Z:G9_<D15JI<^Q"CPQ
MZ9\ V$4WE\.='N)%2N-*X<D5()#$=0\)]2)P?CSQYB/#VNS0BOQW)"%YHM[H
M:7O2AI\IAR/ 9[5]>\1TTQ#4EMR'+)@JTM+B2Z(;>MTEJ2!(/%&))#5O+!B>
M[L,8=DK!X?"$EM/E?BI1$T0=D9C74(+%':3W$/18*KS0:77J1(DLLX)E++E)
MO!G,96?>G[7($$0Y^J0&6SYV')U7J!SOG [T_(#@@6#@'TZV4F[LN+WO+2E)
M\]6YJ#+1F9AG%%L@F;],#143V(DSQ\_"X!YFZ46H:%5@A:HT/:=M2A*-@!)G
M[4E@*YSH3YU@F5W$=V!X%MFSEF7TH837$$(H"+EN9K3R)&;Q*[D?YWP@I=F*
M=?6JRA;UR  P]HYB^A!G@7^+RK*38/:V(G*_B5ZM.+<RM\*#LV-$CV^2V!P^
MR1UAX34J7;'M@M[8I#%?-@;40.ONCS98_B-N69';$E\"@Z^RFF!,+#NDO=N-
M(K6/F\L'#@HRO[BWO*DPIS=,D*!KB\D C@[YZ\:0G4%@IDP G*IN^MSG[;/M
M["G6K'@SUI+IVU]*TD:D!^+CDQ=MTWJ6#/T92(/*JF:E=%'F%8H^WS2;_D$P
MZH%<$>J%<\;R( N=8RW:%H&BH#Y$3DTM?GA_52XOMS7?KD*BVQ$UKH0Q(H ?
M]H-\";X3TA<O5OY_.ROD&FBGDP1F+RV^6R8J<R>L[ARQ<%3A8N/T2R\S;_*,
MH_#-1PU)Z+<G0PT:$8+[:AUXA8A=1%%&F$B:?7:'#$?$7X8Q.98854&9MVL]
M.G3[3N&?YNZY';T'HAXDDY9V6;WQ=:B)AR[LMRI<T/%FV"N*B(]OM\"G][@(
ML8B@$ X.1!]_8A7TKX<6FC)I^X_*J)\<50K\!)?S F8@^5-/@+;Z*>40NR9-
MY/C@TT_9)Z\KM^[43E6AX8TVLJKW9QK<EW%]MG2N2F!Q6+S#>QEYS"W0_;L>
M![%-S,0 ,9(6=JL3U-)?LYI7EA1)R0<\O)[T2@(-+C-EU.Y4+'OD\MEO#_*0
M^SK!(@]&G=07 7)*^CK(JG !3[]%*26FL6 ,D,IIY'DGV#E-:?0^#UC\L-"D
M:!J"$7=S #)J8S("RH%C>M. S]]0$.XJXOV^LC"!1$_/;R #"2U*^HVFUY(I
M"C*#[IQ(AE'$%04A,924  &C!/-F'M9$$WH&^HQRO99!]FE6;6#%UUL&B*)X
M)T -(U$[SGC;@@?ZUZCO?_KFINQTAH?)VPTE?-^,Y'0%)O?K@] DC+F=Z<L.
MK Q^APG#GX(L#A.E3MK2;K2IR@\#K%Y7"Y-W-=^'LG-6_$[+&V*$_3GAJTA.
M ^E0W]A!JK^&F+C+;-V(HY=3NB56*\#.S*A$NBR']IK/>Y]K5+Q' 0XWX\EC
M/<J3S ($K\]*?6_P0FH&1>[)!=_4=99L2J%)@GP=S[VHC)6P&(8.QT\/J_Y?
M+@++Y])OZ;2^P_95L:F53_!-'8G.]*YE0^D_(9N@:$-WI9C-9BF+QK<]-A:
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M94%ZCK:7,3;WND/IFAO.I/'R/7T ) >2N\S^KY)_HJN'>K*/\=UR-.:;,$?
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M5T]Y3Y^VS=:,S-JKS[3>MP3WN TQ/IS*O'WXMN1]G^?($.]V+R]OX]T[#$?
M,&F#U2G&5?'J9H].R;G\ L*06 =-:LJ:^6*NGG@B"NN\QO(USA.N7M)TBB/<
M#BAN\KDA0'JEEZ>4Y)Z&%Y-6O$'UIWV>FN:NE=.VA>I+K2\HO+8Z>+<^J7ES
M*DG#8$V5@L'5I %^?"P)U8G)!G(I^_3L68M[,B2/:7-A.;^0_^C?"S7C^C&(
MIIJ;#5OJX,%,)/F%XLU&XSVF_>"ZYQYO(%,231SENX (47N$B%V"TD<7J.W+
M#!].LV=-M3U/2;OV!%QO"2(E<XB477/U]84GX14O5@<\E;*^# *YF<\>65[-
M#H069@_@>'2-7LD1)L#<-B]S3K4ND)<)I[]E?_GI>=_M[)BW1YY6?W?.[))O
M[6I.2TWP"F =E>43@%=:-'M4!+4YS@C_N46_</"LKN?B9]3G>'0((.,UO\LI
MCD^0!F^Y]^(M..H_NBG5E?JH%E?$;].#EV+ZI>OU_!\/J/4@3,I$:',89H%=
M,G:'^5'I-C,?CTBII*V5;<#4JX+VGKJC'3!=S(E\,61G/OHD<63YI>0T?-48
ME!.E-;$+S/VJT00X%H]Q=[5^ZVI^76HYN;AS\SEMK$IY@!42E'88F&U5LXE2
MI3X8^O0'F4/T2CI=NLAC7+_7GF!Z3Y%Z0E;1$*U!W]0E2O)B7>A-/970+ 56
M@CC^671Q-]((<4)XM8O"29$:PB<65W8,@+S1FDEL00T683:-20,[.P,)N_EY
MEDO6F2\6QXH)V4,]R 6&K)+JAF3SN%,Z^N ! *7"=1L%$;WS#RX/UOO;AV?L
MU7UWN'W0VDTM,Y5O\Y>%Y\^'(=F)?UYDNUM$9))'G'&EM*RVT/ ;8"^MH^.-
M)AWPVP#<#K_Q%[=^%2-[LYKP,'1S@ML,Y>^<8^L@,AY8M6A?69%:AKTH'^?;
M[&J6K.X\,V]"?A%UO[IO'H233='8S"^E0_*6@2^VY0),^),G;@G:?N];KN;T
M+;.7$(Y7DQQ>H(Q9]0P^^,O4RY:VRSU1Y3B_[/KP7;.AX2W!PWO==CK_23W5
M/!E5?OVH(3;S_,].(L91]XHVUE7#S"*87RT5JLT]R2O21"C'\+D5I+M9V]\;
M=C.UE[B\@]WA-LU4)83SIOZMH\+P/-]II2*/*YF.X;\.T6P+MM I=T=S*V9\
M!N8BORY()19J];=7?4R&]\@Y?G,V_[/9(P3*0N6V0,TY (M)M D3N[*B$I]W
M&QW39&'/$)4T2@9$ET27 WK@,9T;3-D#'&!,\6]MR,>D=SO #B\A)NS*P+M"
MJO0 G:[M'9L=, PE4H'6H8^QK=!Z($')Y3>T P<R"@N.] DK]6.PQ$-9*74(
MI#*>B)S\U?1T<Z"=72L]P\C+0^&XAQ%JYN>KQJ_94TA#$+,>@\V(8J<G:6Z%
M%YLK3N6ER;W6,$!/5E.;O:%1ELWQ-9Z.H@8-W$[UXX&- UMPLZ)(5]K4BHKL
MBPMO9-(P# *:!:A-S6"M'87,3T#U4OCM$A/LLOTS="9QDXWUTXBLT1-*JH:[
M,7E+LB]/0-7W45')0UI%IG_TVOV X._M09L)Y3_6"43KX-Z9I&D1$8%SXE0X
M9^+=*A3JQ['*O]OW*#(L#HM>>/^(F]@[BC:)\HIW *U\+HYKWN0" %0V4G:C
M/(>561. UL;@Y+XX4&UH$\RBR9.YXD@J38JL<<(PEI9<<Y_<-25B%4!3CYGY
M] )#I="H!D/-I0FIIF'VF>C3!=4D7C6Z/C.CA,86U2.BB\',B&X0;*!U\U-F
M)^Y+A;O1WIQ?="2B+[(?0+L=*#\]8&%;3VU-1S,R9;V@:='"4#:C02::4E<2
M[\C&<S*^:_(BN??+N6W""[(>*,0Y SD0K19)EN ZJKWU8_F68--P&6L#740R
M@D=OR-MZY$E_F1,/:YV)!%DWU56#_:R-YC'H)CTVL\\&MA"4HOHM 8KAJ01R
M7%ZB2"CVVW APQFFATKN;3^7:7 ;+QC!W+ZQ4IZ[KR-@VOSAJ1M\10L@!=WW
M8J&=UYJU!-ZK'E2V%D=[Z(_@9]$V;BP%078*_:,JC1K@I"@GV,5HI[^%ESOV
MG6C;U) \L)A:?](EH4[:5B)IM,)^\"FJ-_%>%*Q*3$GF=W*&/LUO>IS^1%E)
M'MD?"E(*0:()2+E)4$[)O%+>Z:0;=QG(3NGY!NG^ [PIDZT5#AJ-?WS9P(FB
M#G@*$(&GJ!J=ZU2!=2@")R6]93_OF58DU&UM WAE(/OJ,>\SY] B5,E86OZG
MIYJ#@_/X_ S=3P6VF74^UV6A?==N5ZN;-E;;>Q0V,+5XWSZ9-L6#,+-<CC<3
M!=.XG83H#(S*@6I!\X9.)")9!U >B,EW8U?GZ4UF:/.\XBXV&"J8MEO8-?BR
M.%VI\IB*V)&"7?0"MQPU:.,4ETSQC-BJF_>USCX@\/*TSE-0#TW;=2/[8MQ*
M@J*_/^4BSB;*Y[KCA=*5U=(X*'#F8%ME*F\L&H-?UH(KLC0*O?W\T6F9>D@?
M<H)YZ4Y3]%CV;94013=K1UKN#S.B /-L\7*0T3J[/SDSGZV6@VO+X.<.,8F1
M=>(Y14B%V9XS22E>O>:(-RX=.:Z&&M55B<2@KB+C$Z13;2)LZZ/>E&B\W;?/
M*HR^,#9S0-\(M5C*.):UR0X-H\7;)7PW2J:,7ZE$M^H!B>>E%"$%[NR0MW/9
MZ;WNN-PJX8B#F=7N3"O^Q.IFWPNRZVD2D(=3-H4.U84F\-N+*)9?XR-)C"LN
MZ1AH-.3FP)CDF=O,2]6W]3-K):C=Z1.)76>';2H;7RZ-!%14WCPA@@[D_Y_H
MR?)^L .'?YXK@'XIX/K<R%2GR6U*^$',;?..?=USIA7<#I]0UBW!\<N'4\ O
MQ=TRJ3YZJJ=-OX#!;S^O[/(_&^.-S#\?P1)-V_%'+D<\;/FF%W('#@^['1=0
MKO.>GFSU<XMX ,4K\^-ZI><-B?9U$NZQUUGV=X)WU+@@G5S\I/4^QJ2#5/MW
M],U3_4U*D^6._M;2O=#ZW[1T-Z1C$+'N*;]_LIU$4VU?C[8N=IKCR?0J-\$V
MMG(UI'+#K5A#'K)JI*V+NNBFT@RYQ[ZU0BX,>.8^RVRMG6VB/_((FU8T)]U,
M(;I02\-R%#+8[\<H'M6WG/^IU  =*-XF^J]X./]3>EQBO6*:%F[<03(VJP]B
MYYW*BS;S,0CV1411!;\0_-,J:I-ZDR]DD^G^\_ZLI,XAH=AUFJ=ZOU]U*Q^J
M!-!I]^ZK##0]%]W5"[VPC0M**!5YX+;79-M]\0S3AQ<MHI LT")\+>F=R'6D
M>E$H:]+>VO4'@&E@H&G?;E\SL\A34#?M1ZO>\R%@QI5\_.,B3S/PR$<Q.<+*
MI\PN\ J;8VAY0R!NM_GTM"+7"O-[".0U4TF_9PH+2QQ/D_!1?==K(E[U494U
MS 18=ZJNW$QY24[82XR7?Y*&.DAB]@6]L[.)UU(V9H_OC2.;8[5(2IQ3HK"5
M5$UZCLBL^P??WN7D)-7Z7:EPT[=]WG=;O_F_,HP;KSL<5:5\&@M$-80/H06-
M6ZT*F_KJ.S40J:RAFP]&$-9^<CO9#(PL&",OWF;O220Z39/.=&.3,_L9U+ ,
MPSVJI#*=T!<Q)JFD[OL1+OB]*97_QQ3\/&0>2R9'(Q>$.PMJUSUQ%&&=JNH7
M[6\4Z,@\26H+BXHVWGL\=^<,/2OEID=63WB&'DCNDJKQ,'HJD)!?6)98&Y<]
MNHJ:&$A9T:( ]$1B>+.=\[&*<8V;9").S\.&5<-V1*E6TPJM$ Y+GOT7)2,\
MQK9*QJQ1OK!.6O1H7_\A:T9#A62- I/EI.<4^_D<NK;@8NM;'%>U=\>JZ9=Z
M,V_>#+2!QO>:"YZR !!<4J/8*U'9,3-;?M6Z*$6CU&4\$S),:\O'KRI#7@"D
MK<1T+O6#C4K2?70HR*$=?<Z:J.N%Z1@O62S$^SDF[?Z"[F*LX<1K>:2H%[K<
M/0O&2N$YHLK,8EH>==3)&CD%FCG+4T*=2_6NOR\,V%U[Y*-3@L#K27Z7XA>Z
MI&6Q2'E .:!7-3Z*1GC&X*W5[-"@_5HGDPK=?<;'YOO<9V8'3=UN3BTU:?O'
M0>'H^G+/39U49[-%<+8CUFP0U2]^KLH_ LQ''6?,,]BU%@E\9]9].V98=L.]
MG(H&""==E!O&CN+\NRH7)GE3^6:!DUBUX*@SOI:#_!7O\Z'!6X(E5X;@"TMH
M<"OHEN!'[L8C@>MN29E;@K,?R)PIXEN"J\BY( VWQ2F&\PG#V7UT1^9<>+!!
ME%'QEG?%I-UQ)O,EI8,PJ%I;FS%F?-!",7^@EM.$O7Y+:%^<BUVO0;MJZ7RY
MJI$M>2_*  Z,@X P?,A-QPD@[RX$Z&:",4Z8A66ZF3']L4!RL8UU5(]MI>RQ
M)*XH+>LTZO"G(OF4S&)28I3 3<%%<5  0M7!,(Y6]?JV4XN#I/U05>$5@'ML
M5M>X!]<]O-V8'=\,O!=19-8S94M>*>;_7,@P%73CUN?L1-VEV !0'/61_S@8
M$_N'S2P[AN?EK#NE$]< "V/("SA[G 5=/L"@' \P*8'OE$0B0/Q4]Z*C(8%;
MQ_ZS34KK8+&%D?YWKA"@G8N&&BV/;BYY.&Q< 4UBXS+>L?&M2%-]-84=(]8&
M+V6N0#.1+YLBR^ODG/%97;.2NO%W@)X%-2*J8;8W5RA!^'#]W-/XWB1X53PY
M3(T:!GM,YA,ZKF^7']+TML+_4,6F#SRC8>6WXQ<@FUUF*ID>&1\$[.>J=(MQ
M3&$VB4X!@OC,[WQR+%K&>'LWT7MY^V;J& (9OV,JGP34/'N(9"5NS8MSA*?'
MT Z@^IG;SLUQF;3M4N0&%<IUU;9C;;J"5&E^(5I6BF$:8&<51O+G[+L-]S4O
M3RL:Q)1;&CSR5-@6#/4+^#T@WLJB O'566^!CBBNG4Y=#M*Z<Z,AW&4+!7GA
M?"_7BO;5V#$?L_'V*+3ZK#/OAYG%U1_"/R%/[[CAORE1^K^>>%4&H*8S;I1C
M+R?" K>R?GQOLG1R&LF4DF8I=C+4?=ZJI]C@P<1@F_P&M\.I'KLN<:/Q>'(0
MW1L_LF+QPCX@XOVF_BF_TERM@C[V0LBB^Y;@[5%1GG)N\C^4ES@>%,A45 (K
M]IF-RCX^X? 641#2U=105DSOU;%^UU;D9#CTIJ]3G8OJ?J^_?\XV0TO_^U)L
M2G3UJ%&NP]^&E@S/O5S#VI_.'.4%5_SM&'7:PB^W,7'&D*YM?O)/AJS_802V
MW-:?V3I5(WVL:H;Z4YNAL,4S?>2Y'4OAXVF$_#:$U?Z>U6I 'L MO<HTL[I^
MSQUWE?Z4R"6RU#!J)O?$Y6R4#%'@GK'%P[65=UEVO:,H');(_ _SGAA>2YKO
M: 8SC%6&0UCY]=?X,US; 9]V,_NE60P=4[7*OL"9%^OW(U%<11 OZJ(NH=A;
M@A<A#1Y3?#@K4&0SD#^@^'-#HS^Y95420#U GE'NV_/F7V_MMPD^*<'L[O\7
M+/WOZ25F49G7J?16E)F6)7Z 6?+2KG^U#U51DG*Z3H1^[YJ3G',ZV(5'?ZKT
M,V-Y,M=;/9M5UQ4T)/1>Z$PC.K.E?<0G<&%5Z,GK@+Z8QC)5/:Y@Q%7*[W_<
M[Q+YZY<'X/1 VU#3Z/MVZ+!YW:M,T8"69?7_14CGGA4:NJUZ:BA\?'4W*I%^
M;8A0=UEBR#66I [#Z&"5JZQ_3I6=;R7H6/0$T?J]D/]#[);O+S?V1'2YFG,#
M@\Q:&97Y-T0=3#.DR?)+A*)B2%?Z9]-C?>N9/3.1)&GCU@1RZ@U1&DC6S?()
M!XM1'Z_KN9@5*O0.T_J4TJN067T.79=0EYE\A+\E>/!NM^%1F&7M_*3.HL\<
M#X6/Z;";ZN-#C%%.%-ULY/D*.&U%F9F+!>:6QT_(0.7KDVU'534='D2APRO[
MG!YBH/H,"E7BZJ?E0N_HNQMTZJ,I!+D^#QF.Y>R<+<X$/Q1=:%MZ<U/LK7@-
MP U?"\9<__8XV#BS^Z;*.GAWPF)3N5@&M]]><_/$L26\_42JGG^K8BAX,\EB
MX\&VD,\MP>1CY^MZQ/6+X_4&F7.OW#9B[$%MT"^+$5S;.3-=M,;=$F !P86,
M66?V+21CYZ\P-U2DXWL;+? &B5N"(IW@3TQE@\NW!$8"+:=;E<?YOUS;XD7V
M'-6)H;W<<1__\9V3],;@[?MB-W. FR0_][F<*RGMQ?OX<U,YO8:\&_C.^DVZ
MXLU?0=5B\==ONVX)\/"6T7@M_^J%#PY7?^"#B3YL>7M83)C]S/C&7K1\)9VT
M.[PE**->N/0TO-#9'/;R/]B5"Z-S7G2YUMJ+N4!4YU[84EW\=C$P+W<22G=+
MX 2_)5"3D=@;#F(H/@AUO.)C*IT;"09XN=\2:.3=$OPI]U]E-7[RK:^[XTPN
MZA#>:B\_;8Z8?N",(T73G,J2*9)ZK)Z^AWWZ])%08X<3(T.7:LAZD_=L*>X4
M]S(>/XG+SL$%YGT@Q07(QI"T+RCT,C#PD.EU;5(:9U0:*'2)F)=;TU;H-Y:#
M=0RZ"A-2W:AOA.(AA8IV<D ]H-&LDI+(";FL??Y3:OI8995U"5JH>S)MC!5W
M%L8$;A3ZB\.+)/^D J[;_P]LOW]/[T\J$ZB_ XF42<T=[OL<E;+"4Z=WBF*V
M1>"BPOG7<!B\8)$SM@G=[D,;<^XJ^,%]P7^-,&A^O:[;\TF]M@?)O+:&WP[3
MTVD-B[MM2U^L2J)M.BA+$<P3DE1(JT,_AQ&=TCNPL[UR.)ZWWVYL;EC=[,/&
M%+$9R>3B>6% 6G5^ EN^FC?+TVS&*=:,S46DH0D>Z^S"B['!/ F.%:,+;-TG
MY2BQF!2/83J2V22[!D^W.$?=$NRN]=T29$!7;PD0ESJ[+X(7E \CEIUK9197
M3H@NNDE_,!Y'WJ!W++ =MP2G/UU<A*'_EL#P-'_FS2U!<]HE^$1AF1$WZ=UD
M<TJ5"&#W[BN;  QF?)R,N>,4*N\0/:"?4-F?:%G^3= Q&J.1?O0Z4>+R/F=,
MUK),JG6+.Y7*7-Q,HQ1H\S3&^Z1Z<0*F+TI8T%%4E&SE)T,C#/XS=7J;1Q]-
M%4=!0::A)7,Y=,89_Q9MQ%/+-S76#;BS9/S\D%*MPQ^ S0^&\DZQU5%V:FR4
MO.K42V@\7#YQIW6'-C:DIHS"-M882];!VY+.\4GU>R_M!M.GJI9'C?&7YJT:
M% W.3B\'F]]H$_?,U@T)2)V&GMGL,!X>YFXV'WKYV^$PHU+&.DOB*2_Z3$I1
M$L/I904%BLW' /\3VNYY+_0H;[3R8_[B.;L^RUN"D=V4RNZYZAUUF$\GQ9VB
M"-F[$-!6:3)?D1+6V!/#UF%%ESV&]7"U#[N!G;+A%OXXLV<^4Q]KP67*JE5J
MV,UN\K,V+M>F>>UC"F)C\E6TZJ7J'E&!;3NB5U1^J/Z>^"A.9-3ZS/DX90'O
M4I[1ZNH8CKN>>:N3_Z+J?+7#O*2D(PJE<KKHBB2#B;!$4$_'AD>O-#'7'\Z?
MJ8ZUN%ZB/9WX+2(<[3C0M8G[^OK-7)0ST:M^Z'*3LSIG&<"1S)"AR@IH>ES]
M<104 I+Z\.;>#S#Z+49XJ'E"$EG1LG1"RT=2MF9>+@,&A^Z:O8= +N:'!,*C
M#B==J3L&LIO:#D$?^[V3=9XK ^SW/BVD$(U,>/.C_%^ADL[W^&/.UR2,?K@2
MH07T*B_BZ%_,W//*DZ*1CF(6T?6J7UUKZG)<:-3S2(LX'G,^+*-[M]I>\LZ3
M.E#*.@]#U9>[3=Z#,+9#3M:+SF&F)_B-RE\#L;F<^Q0YJGM:KPZD+(U.WO^0
M>: 9-2^2C:W<TBU5'-1]GEK1:B&R?(ZGR.K.M'RV:TMFLQ,IVH[ESMIZD3ZJ
MV3PP'3\76%.;L^W",+._>RD6)V2S!;)I6_]<T5$Z<0A02U17->A^@Z3DZ)G,
M+XCKNP:R@$VF1/832W8?[-_!<6DB.TZQ7E^MI_V1M9\=;0#/:@3S+8@H1;7O
M)" A_B;PDFXV_) ?',YM,CC\;4'D/+^M0N3K\6-IRE.,1(6_(Z\MFE<O3]FJ
M'83LY><6OBZS\XH94.IFA:]")AC/W2E0CU9?,VADK8TVW!)<CS.PBQTV\;SV
M.;E41 KK3("60[+9.U;&]=IIE<D9. ;+)F5T*(YDMW7,S\S )G$@[VM<T*%9
MUQ[>VL%+-_/>3,:'UX&C:LBO6&-6J*%,SP*CY^2J$AI3'@<R@6/@N]V_;G-:
MZQOE)F:Y<G^JW4.YZ\;]A>\ZLRTGP2"90M++C9N7LXYG#QJE<SX'&RW>$K#,
MPY@FFV).SW-OYN76\NN"MV[&_=68SD:N+&OQ>Z0^OC+R-\CV?U@O>%#9[99@
MXKKD-$ENOW#J^/[>Q&DV:<%.S]R6:^3T"2,V6TU4=\1<7DM&P@\B_)Y&Y9.Q
M"&',6KAKV"3[8PB%_#I#'>/G'6BO(82OSS*3++)9 OF8CJ3H<XK*/FB!C96G
MV'^Y,<ZS6U+$G5^DHKX4Q+S" N6L\? WCAK?U:0SHV#DD$YV19XY(Y-)C3.F
MY@".:^@-*!+ JX@$"*:[_Q+&I8B[[73;_]DX]G]4+Z$V$""QVF7VJG<2P!V^
M^UHMTPC %NFW(AT.%]Z95\,E*(LG5A;^T8-85"IN'17H*Y42R$JM$W#/%9$T
M/B;8I!JU\-/9I_*L23/%"PYP$8IX*GIX'($7$[R;1)S5G>;24Z3>.^HOL79M
M2EKL 5TO>79C\#,9&\AN0*]N%#%/8C6 VQI,>4G9[Q@WB0WGT5@!WQ(\TV+P
MKT?ZWG.\HF1ANLJ5=+@E:*\BO38@K1,-ONKQ>QDD$Q.\^=U+4WO=68>1%V).
M>V07!:@=DD8!/0:W[I/E'?<+L9JJJK1).$VPF=5#-1O<&/26:20&0U)OZ.-@
M=;<$<^ZC_9X-HU_$XM UXCS^0B%6-2?)6O%/(U3I'C]E63%0B@+/QBDB2Y-]
M2+ 8!ND+Z=V]?BLZJFIT6N;AK&Z*VCO:"TZCSA0#A!'4;P7$50$PC7Q;D3SW
M9^W(IWK/34FECFHC$Q-.'J_+'[4E&0%7K0WXP6[4SLZ(S6:^!M)C<4 _1(+3
MI4(@G'0V4WQ("(?S4P_:XTN4.EE@EV@F#BUH8ZHZSW0P>YPXU?T,Z_""LY3#
M\+7G*!NNM!!)1K\N0F82X_ND:LY;DZ%KK]K&Y1JW:Z;UQV!9?D <##8J<SA?
M6I*0QZKJ"!;LEO:"PUD  /I2J])=JXM:5^[L (\5\U)TI_GQ6'^@Z'999KYE
MJ,'LG-'VH+D5\^^38>$ Q J=[-N5'\9>'[0Y0'"%/A!_Z-OI#7SC]70V.P;H
M*\Z.W]N"D#,4?3FDI<6E=AE$];(*%506*XV+/%620=:5G+9@P*E&/>4*YA/8
M)M$SMNMGY;C!6B>V",WH4<"KIZR,@M%3RJYL@"B T5I9'+#",;)T1N*4-\-[
MM!A!$KYD_I?<LQ_Z6[U_)HUC_(TW#=YM95WG/0UJ@"![3>8$ (UWP75=@H]W
MA/@-5 % VX84IZ>]^IPQ"2278W*?M([/4IO5LENFO2T/QZ?TOO3-@'HM[B+U
M]>3[O)J@$+=N5NV0%RCTIG4&/'5FQ?7#QH_14"M19V^/<TJ^9+W1UZSQ13GI
ML;#X:/MZ !AVI'0J@VHZS4,;="IX3HF\.4\R=]T<4CMQJW0W/HO5YR7]=$(_
MA"WH5S5D3<UN497YT-A:A)A.4T*E0;R)=A^)*7 AWO8(6DT1KL0P/5RVW)GZ
M\_I"[',$1VUY3$3H,[RT/5TT"J6L7_#,HP=7RC;1*KP;-RI!]^J.:5Q,0PH
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M&FJBFHK1L\.3KLS6- &%84^5;@F>E);8RG=-<1M%IA@G+"#5'TMF9!]OLF1
M_>!X)Z#@*6EBH6>@WGO9*F$J!O&F5!<3L<1&G]1ZR+7QL^O^K:;?0;(-J)T1
MAW.ZV48=**TFN AJ?62=K*2YLPZ)ZILP/["!FL1* ?F,:;?)W ^\_+I[IF<"
M5)EC]IT=X>FU_@QN8Z^?V@YWLS P\3->L!O'2*B4*CGE%RRSFGPZE562V7H
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M%27^( :>=_53W0A5QD'[].S2[1R,4 KQP98H,^%4T1_I[R0N.1-MB6C$E^H
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M5HJF2NJTX]"LKK-JAXXPUY;K$]1O)K+4TF.HLMT68H++Z1G9@W+23R)@IK%
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M$RQ 1=XOH9JK:3X0PNP2NN%-1YJO6;*P#9Y]E_P29(81'9B.-.U7=.WS8'
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MU,AG,EG&\_D@-D5/2;>X+R?*U3_:!QXXHODPE+X58_<LW65LG2)$>H&+,@5
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M47GC[!LX/_X:BW".A6IW>A??<)&\N?20N**J"4DBR!.1.B:D-37)U_ZQ;M\
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MQ6)\E^&1=+7J_XK S_@N.>5_+MB'RT7NDLBD1(5X<?W=7?O!B,Y983G=X"5
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M^^!%AJ_^M6;])Q'*]7@JN_3R@*$P?S500M9A&RW+*#]?HC!_VH'<&HE6IEN
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MWE5O67!T)8-#G-<9!408P4XB =<.W2&,$O+YZJZ1&JJ4'XZP95&[99 .*^+
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MX)&6E$;C5B@6;2*^%]?28F4"JJ*#M(3+.?5/NW%LSVI9BJ3'&$@#Y/@<!()
M']WO^6V8,C2$E]Y1_!S4;,]4)<KI^2WCY$7SQ3(\D+@Y! 4\45YE\_J&\0V!
M,[5&N^<.<KU6_DA'1ICH?J;G^2R8'\H.K*ML^-[*P*4/OM,IKBV^]HHF<J35
M=!;$@XN"FAIR1.HNRS:WVM68FET?L4!)-#L<6L8H>:GJZY(MKS)>WJ/7V<!C
MZW&8=B^<4L=VM^_582TH"O]JDN,L,9G9_&S3I]=N-!V[PJQ*!VF&9;$FI(XB
MKN4(CDSX4M=5&/-J'Y]1I#RZU3!O^VW\@,=BV=;"<[E<P1].]EUUJPK#_CJR
MU._1ZYC:J8<74I][07GA?)?/7T_A2R?9QKDOWJ+X5J;9(O'#)YYR1K3"V6;$
M0N%[*4Y2U!4,!E^[%0,V%4>(L?<&JN'AA;&(O CRJI+7>87 PX96KW1(;&::
MZ^VJ"8 1MYCIB$49 ( G@ *E>BS&%[)%21UDG&5Q!K_M6LJWC'$JC?=L&0UQ
MK"V\,UF?Z83Y6K'<UDC>/%"*">#5=AN+*NNQOQ_ +#7#&OO:$GU]@'/TT(=7
M$?&V/*W%G9]CU#Z) 6EO<$PS$8"2@G+@=XO+.J))-"4YOQ]J,/XC2.?&R*[#
MD3XJHO7=<4R"XL[<MA1%Q5E:9PB@(.B>T)9-HE/!8"++^*TY1)I<3SU0?4%#
M,M!V,\IG;%G>%OI!]GS)=R:SXF.1(T $V#=&ZQB"*@DFAS1@!P8J)39DXO?O
M5P'.Z)F0T EPYVGQA;/E_BM^=B[$'N\+3M'OA8JUIP?J^!CZ6]Y@BQ$K7-_T
M&)5(P57&&WX;7EW9:7 E![EL6@(2'TYG0QT2M/%K  =B1YPW4O/)%(_'K\K:
M%-:5ET]C<8\;['L(=A.$5TUOVO56P@QE&_C?) N$Q4M9Q=EF#/NP%=)$%NID
M[O8=ZYBUFIR4,#5:NOR="1/I%8-_EZ9ZG#ZV6(1#61O#+7&\%# \H14MNCEA
MP.7!38)&#Z6UT/U0QD/=4 ,'^]N .X;#'9'G_7+ ;)@#^J%B?$>ZML@_!3PU
M_*=V;3U^_P\$D6803F_ET\C <RM9:EH[WI/JGETRAWEW 8IM;N4*WME5Z+%4
MN>%+_(+[H>=KYL/UXBW+'XE):])4'.219AI])71\'3Z<W2AQ=)&UU)5O C<7
M>Z6C.$@40&%!^>)BG#71E(FW5?(:CV39/G:385[W*V#BD]-%"98TJF8U5C3'
MNLC1G=0?C,%KD]M33_?'D%KX&BC9>?XF[?L$-5=<ZS51;"C[,P^&:UI)KFS%
M2IPN&_#B3D"+ZGBMX7,(P<S,]O[R'@M8>O3^PONUM)OA:Q?YPJK5\HM1SH+[
MX-U4!DM$X92W%I%,8F<W=9?OIEDZW!B2[V8=2S=A1Z;=U#P0EU T4R'X$N*M
M"#:."2-BUK,@+:V@M>HH%"XW?WF"[\-N!)W?&!D+7TT;4:@4GB]HLQD9'G?/
M?.EJ/1)O9GD_D];MH#Q=E ^8M\^8UB[54U!MN^-R(>Y5]N"-"XE;^JOF 8=W
M,,,#R%DI^V1?64POZIZI#:" VZK3U-1<U#JF5Q-$UC*WGQ[57I)W.YU'H*?,
MMQ+U"Q.TPI*Z8B(Y(Y&/)73DT"J6 M:X**>'X7T+&L;NW-:*ZE-%4",QN5UE
MYSIG-\BX\A,'15MC1-CTUK"-=Q,7Y:7E[-'C5^=GC[SXRSR_V'.>=TIX/#8&
MRW<_[(>3VUU%=C+\)%&6G'TF#M5<.1UCXH@:(%;.M->-0&'!Q"*(O22T)_TX
M; R!3S"J'141WB]*$+@9!B8-T&=1A<5N\58+\E_!_5IN\6N^P]VVII6]@A:E
MD,7U\%KM#P?>3MZ23I.4.HJ"G+KT>GW^C,_6<_WY6DQ"5^@.&<8R<L%(BE/F
M_,8YN4 ]RKPTLR+R<1Y'_!EDEO&(0UH__3PD/\KE1M3YYJ)<B!N"&[/$KCA(
MT_^A)9G-NB, >66B:<T7FQ3TRBW4@'[#_?) #%@S05R6 $+JUAHX3J.5BN/I
MG=QS()B IOHCI0-OS\'IQIUC_6I7RU+*D-R*C!5Y>NB0I>F+-TCA4G[V2N;E
MWIYG_3=G9M^XW)R).$X,3SQ3Y2B8.-_7-2'S:#((2%;1,ZE8(08A.NK10>P?
M>J]I=SJ"QY!$7*R;C6]'-,@;'(LJ3@P;697O!B,34/.->@J]AO%<JM)X0NR(
M $H+9HT94:I,)02*6<>Y$?+M#-H>7E3P+,];3YQOV3WG.Z6TLR"L,-< ';W,
MD$JI,/=E]ZN4@I<V@P2F;7X?<_A$\/O.Q'XDK31@L8=H2^Q#4SHF3H7GQ'1'
MKTF,@U9[+-)';?FU=#MA.%AI4I\VQ9:@(P>.KG-,V!ZN>8_!?:K_Y>+)LK3Z
M7'KGNV2IQ_KUI$T5Z]=CS%8+I!+M8MN(W?%::DV AR=.CKL^_.6Q\#9XI$3B
MS4P(EJ!!LU)P19P[+?H(SC*>&'O<GOI+>N^"JWDNOZI_.7TFW(60'07 51>U
MJQ/)-U2PH8:A.<_7MH/EUY>ETO66U$5.:KYZ5\?6)4BL+L@&6*Q(_M#G7Z?Q
M) 7!P5:CDVN?E^L6!C]:@-P+FD1%<HHSY<#?F2"Q(V[)N&(WL'NV/!7DEH>X
MB8B(O%!WAYR/'7]</\%Y36DE4+UXH'#4%.=VKJVNI!7DUK=<447S=89LN+Y-
MJW!Z%3.GF].CJ!'4E*\RM4Z13I;J)>YH/V=M)@>FIG&E6FYJP?=M!)+6==3
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MAB&%RFF"L;'CQQ"QZG[=>XJ4U5VK1.,5%3YTA5F702]J+.70;5%7%B8/-G<
M6\&Q]7&!"EX)P=%I5]L9+G;KP1O-?A>VJ](21*\4IFI3QEB( A:QOL6MP67
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M<TG1"/,)(+5M\XZ]R1OEZ)P&M^,CYKBJV$*;9PKU RNJ[6Y_1OM6E;1H&LO
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M#.KZ=]XPL>B%CM-#-&K-N]H?9\"$C:OM>KF+,K-Z%N" OM7[$[8X+*Q(GV[
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MI:'P->U:GN*(XFNTGT% RP?3'>FT[<GV+K=I2>&NC\IJ3"5K(V"SE#]!1_X
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M_Y3"I7>"=[8/F@VT.;,2+0-(#G[FW]XE7<A3''YB=+?(@ZT0]OK3)--C8)'
MIAEE_!O5C$;C'D^PM7L2@-GZ^9\]2=6_VM[;?VQO>'3E_XM:_=_ ?D2]- 4E
M(I0G\#9PU77:B9^VF#=JX;J: .QPW5-<_S#@/'1^]+?&I"*R'-/]Y9*RRX[+
M<>JF),Z__WQ/'N)JZ OC66Z![ MQTLNV>_\468DZ.QKT_E<7>+*[&:8ZW;3'
MD:D37S],/S<U4QQ;Y86_7PZOA_$[++WPSG2M/WZEYW%F6TA\NC Z;W:.,LFO
MO(]/#70J\ZP?G-/6QV*-X";V/X>MAK;9/L3I7S2HL_%3,TLI_WUZ^W_\ECSJ
M>Z62/A\59?CRC%<U4)+9_FM B<$;YV(LG&ZAO9-S6^SM%P<<9)\MGMK:<0\C
M@\'JP^Y/IP$%] 5_L;S52V$W^+YH4Q%:D9:$E@V-$$YC3M$>\J\0G'ZHGN&'
M$MG*$Y -9+E.V[/J%_-(%M=6T,!NUUXEX.9YV.# UF_MR:)I"DRKG-6?&*\"
M.-!C.% _]T^,_]G!%M+LD&Y7F=I4]OWUI<"H_5\T>+'L'\ULJ?[W]D(..=TV
MUU:]K6&?3=MVVS\?&'T['3#I)J]@M-%RU/5-G0+^+,)2<,-^S,K0;7[C='3?
MH;9FIGY@>$;=>F[^Q[$7GPT[N.: 0,^;7#]'AV^V2Y6<%T$2Y;\@<-Q3-:P6
MNJH6J#ER.JY;9B,]!^41_\RTP,40:NMK.FJT:%^OY[QB31E\EGSN\E)O'/9]
M?;?'::M_5;T8&J9<]Q\[\_![F<'\HBKNR[]KZHS@/QK8A?\W'QJT*BP;K*,4
MBC](Y]^=])^D#:XK?I+D 3"JLI4S0&,%-R-D_&\;6:<4R7T,#3AW56W$F[4/
M]@*O;$*O>GS<C#GH/I2X@&DN45$.B/D9BTW_LY6&>K;RSV>*ZRVZ.R):8G]$
MX>9""HUOR+CS007A-15\>Q(*5^N&+OR1J^W_1Z(1=M]FH.S9D\[N[X;GG<(O
M/%N(C8L9-8,0 Y4H\@:JZ5.TX%/PB]W> X("&49.UD#P"S-%'(M>M\)ZG]'5
M[429%E]RITU^)AIAK4-5TBK-EVV-!OM4WCCJ7!1U<ISP^[9^J =(;X0^X*^7
MD6--QG.\MXO*$XW(3<#R%D<S"I3P.=%I@.!3ZD&KA%0ZCVQH<CT:K@(=@@X1
M:(0O0+2^]8//WV/="A)5ZJ.2)"['B"999<WHE22YI9\$N+VL=;_R_(9WO,.U
M+KGXQX_ACB ]&/W-QXUPZ4O3@C&@.32GE*'M%<V'1^,_CJU=$JX,RAP0I)JF
MO&+;P'8>.IO</-\Q!B$]:P9%#A7?=JWG3=J.2B&;L^4?[9S"ICU^5B1/N/E!
MAM/HOK] )$C&#>3IXO4EBO[VD<D]",NCY0[ 870<@A!@%!3C"7'VRUJ0=])$
M_U*W;:"+B?V=U# M_LUF@52N9BS%I!=EM8=DXF/32K0T(7U1LD&UM %L0]S8
M#O\#>XWQ2I_^X?O(U72$) ESZ<Y27^; @+58D *C<#GG^IM,<(HESF%IA0T*
M\66%3H,O.3E0>.^=L[^(GM"/1^J2C$_ )X/,<+!V@:\/N<(XO+K'C>M0@D$4
M*:QYUO*\CPZZ SH4XU9Y%G-I]8M$2>S=E14^W:+[HDEZ/BB,>)9>B=65F)+[
M,Y6FER-_:O ?-3Z-MGXY*8: <[23#FLTO)R3T?LC7!V=VYH_8[/FA]]?;A^=
MSLQI8T$E]"_2ESU%]YVXO :,E/29X#%7JW6S4W$X-]EK;OK+V#&Q2W^XKCF?
M47T + C?F;\R?M.NQ\Q^)=EY/^ 2'FU]\N05'B/:QF*$N)JTEA9E$ FTC,73
M9"!0X]^G:I'^^5PE&%Z1&/BX24O_2*^))'.#1R"-.@PCQ4:7(1TA6H9XNRF/
M3J;JF@'?U)<]GP)I+X+!6S9AS/T3)E):,>2WK*S@3(>[(BOBV02CS%B5((%5
M8+5OBMX<M[*7S4""D:"8O1QP 0O!:H;(4LD-^RP,NRD.PZ:Z^YB7(9DE,FD-
MM$B;&C.#<_W\A6'=]>F+F/2,#<+/@^L3C$&*03JJ"US97;:Q!W5:9*:2F3?R
M1&Y< I\$[ #L)8X<WK'GM'N[RV<VKD8+"Q9!15*6AR>[O(#]5\RZWKN@;#F2
M.E$X'AX%H(R6L=:M=L7Q'5IP0'VR'!J519@ E/Y>4!P;U_>B>I*5[KDUV>%^
ME(]RSZUW\AB/1S#],2O#X3GWD@)ES@Q>1T&*JG>SDD_(W,Z$M/W$;C/L*?I!
MU#S3T> 4_\,+=X&TF9B$!-HJ!1_CAHFVS\B3EH?84Q7&QP'FV#2=G@T%FV#"
M9*^;ORP,2%16^9M$VP)]=B2^RI>5)0T+7YS]#48$&BF\2E7HO"!Y^5O7U4=Q
M5S*[+D4$2*17-C?7#]C.%12@T6KXN!_'TO\AC/0>62,T7H7@"?F?_UF9H)3^
MXN7&_G&Q@^S_XW'&?\W!2[1M&/VM_^=<'5(/[#Y3/H3D?]53IAA_7]SI>0EU
MZ*+V80PV42*VY6%\=F-;]925OW\83K3V#+XF,#7&I>'!;(]6.(X$8\S#"!7U
M#^<T(5]U 4J_KOC\1M=YX2<)SA/Q=GH#MEGO%3M<+N+5R_;'B/PQHH3)?;SD
M'I-6 :29_EG29I"<T;79!?;-^8;[#83K_0:H^!FFJ#\)\WZ_WR\W-Q*O3+/]
MXY]L*?@7,>PJ?LJ1R?[OH^[_< Y[_Z'%_1M?91\=PGQ UPT4XK>'+4DQU_T6
MD_PAPZ[,8DEW7KELWIDUJ625KA#L1LTD>RB\VY$ZG<2BD!=^'+-.;XZ/XO^F
M951O#V1]?WWUB02G@-4R]FB^9-2A+G [[(E6/<BYQNQKR3.+.V!1[F(NZ$SP
MF$V2W@!D5R'RD9'Q;H.SO&1)5D^FTIC1_4UWWV-O_),BO3;M1=,R8>/S.DJ]
M?Z_42\$J@#(0*N\X] '<?7_4 2P=77(SPO ]$B=E<Q*5U20= AOWA4=U&O[T
M8_8%$I*L0@9X7:-.:;$Y3%BL=)?AN)@2E]JXU@#%\G[]3%@#Q!7>4/%LMIZ:
MR*LS4MA7C4$)+0N4.P *M-\$/7QMUYC-G%:E &>G8K.)2'D7JH/6 MN\2S(9
MM[Z$D"]8KG58:/S$*C>.<<U8MT0,4APCE$%:QNJ3.[H)T*$.9'$]C[S%<4ER
M=6J:S[*3U1TO0ER=5\,+J!,#\MD$F@8US%@GE TF7^L:\G%?K15!%HB8\(U3
M\&YTJ \QAT"&]I5HCB'TVPO]OY?-8'@IETA93QQ':*EVJ4^K:U_*2JE^'[[J
M'HD"C:I]11R87!0MX!))>>LWZ5"8?"6VQ/W=874'WJ[S]GJ\_&NKE+W++3<E
MW75$')&4/CH$HD6!]9N8SEXQ/>#H<'DCI^INF<E'5:SN5N#L(=#]/'6H M%X
M AU6C(^-<_F]]&S2YY ^Z\A!8\U-8T.V;E:HX">GK+),)N&\WP!4+T]B-Y9^
MZA;EO!3W?LSS<T72%A3&A^%IQZWSK^.2TL5NN--"?B^<+!<2X'HZJIK$,0'3
MT@J>"RE"0$G( &.$%-*QFN (RG9%^5<(Y MW(+@E@3(VNB,]'?7\#@;X5;69
M?BZ653UZG5^PGTP():T,Q8[=#9Y)7.,PJ:F.+KNSBLG:?&Z$W;"/(+64/;#T
M')Y]J$]YF8/]*S7PZ04AAES]#MLL5P3OSG\-G<<T/.WLK9]C>U[/E%#,PR.P
M!*.0?=00?"(F)H0E+79J/XZ3MUVEAM4YI5;>MN9E:/&6) @H** 0L+A!)*4"
M!^V+74+6@R%()R@$>M?_[3I_(VCBC&+B;^740?LQX_>(>EDJAX"4V&M:7W*&
MGB!V1IQAD5XK<:Z]9QPWQ76MC:^]"JZVUN)3XJ,E3^J\V&.7$3Y&1SO*YGKS
MU5$]43GT!.[I'2IG])*MCR<'79YLS"'M?8'629%.*F).+I8:RF#1#@*,9C%X
M",'\0)(>F[>^=4K)1UE&J_:ZMT@Z&!S9R-=+\]MTDD,_4RKWF!JZV(^.24E]
M0MX.<A^)VU@^,9+\,C*6*2?%CW]VU:-R+\NUT8I 19SN]@VKX==X4%/CWKY]
M53\E(3=)I1RBF;1 *!2EDFE*")Z>-&E\FHJ4% CEYGTAA9S,]8;%Q6C)T\TZ
MH$+M&0! KR 6G00 %$(]E3A_CMZEPPNMTLHO+@3<A1V,^">UV9A7)\4DBQ)-
M!_YFH:JUM?0(G2TWWCPW]KD(=<:7%SBK7#'J.WM'3W-"2TQO6'#RJZSKQPD[
M\Z* ,JB):2=EP#<D72Z<WHLL0?&8F)A +_*#:S):^NU)7;=C9&  2=AXTP1U
M9DR(OI5% Q"\IJ*7?G9OHV<K%?^#O?>,:KKKTH>Q*XI*52FB5 E-NH" 2N\"
M*4 H$JJ!T$,OMR*]@_2FH2<$#)C00>E%0""AA2)->N_]?]_/S'\>[O6N6>^L
MF7?>-1_F?,BGLW.=L\_OG+U/V?O2.U792BW1'(122@"76.1?)3E98-_64BOK
M!A0;CAB+NY&:4WZX+&#X&@]<V-G6*CIZHMY?]?C5SJ51E*<9,HP-_DXP\>1]
M,J8C^YC7ONKM1%&L85@XDIZ1J-"63H6W4P?9R8OAO;^UNE5E A@'^O4F8RJ-
MAGBF24W10" $S9L^ZP::1(9Z#K 9YH4O;<[LC;RD=.$RAV(4 8&KSC"+?CY<
M0-+5[^%C]R176NU%WHWP/H\S#7#WRG^-VASRH\_89+$[9PF",Y/^.@S2V/D?
M>;[P'S9$+9]W+J,,#-9YTXH'1Y(DZ1@W[L1%,42[]A6 2^+D-<;H==+BQ4M0
MOPHD'SO+SXK$[/.4C:8]6&Y;ACZ<.4V<]*3=BA3W]S,;$!^+T@QO'M@\M46O
MTS"7AYG?;9:\!6,.^A[B/,<II&&T^[%97%I8[]ZSE1:GX_<>ZS-ZW<6W"AN,
M'+QMNIR6;B[<EG+0O%2S(ULS=[MX< 59O$#TEK)<-G2^-0R8@JEVT_[Q/KV<
MG:ZE;><XXGG L_S>U50UP/L6^]FJ0 [7!IS:V,\I9+()O[J.^ ]MX?9;.#;^
ML$K:*A<#.)YQ$&\TR(:GYX=_?N(4P1;LFZQY6_#]@-Y+/'&=0Z^1-X%?827!
M&URYRY[0;9[:*J:S&(9U ?^0_,(K98NRUNH&;V2:>]J>]'37V;_,+A84[3+C
MRDF_78Z""72]]DT18Q5V$&[_('JEZOL'(]6R"&]NSD>I*E_9-"&.1I$<^XE;
MX@T!3%&)<$1B(TN1^:PZ"_N*;5\G0S/(A1W/6&QK^)==B;UEC)"]5^4;W.1X
MP_81>N38(+7P <W(4#9N&8I0<&8W/."#X*-<TD,B%> 53;6<>Q.,!]P-,GM]
MZHE,7-S:M&8]&)_IU9XOV(<=#Z5^S!(Y!A[?Y!38^:#W-EDZU_,&%Y;!H*1<
MTX)5A/<#<4U15MYA/=WVRHB7YJ\W=ZMRS:R*45PC:"RNJQ;&ALY.GH6CV4;!
M^ $ U$K";:C[4K1=AM6*6Y1;7\[:@)[:$G7!#KAJI1BHX&)"=!8#"69GDML(
MT,S]GI]AO!^@52D=J]Z;]9%WCSWZ76*/E/(RX%UO1,:BA?1</^X8U)1*,&(M
M SSZGBNF-3]0*)1=U"Z[U2<@O0&^7^3@%8>0?<!UJ?0C?7$+P! GNP6UL-FN
M6A*0[$0DHB07&"6J3&[>:KE0N;^KSA!NL]M)\\G^AMIV0M+#)4L7ABUJ!UQ(
M*"(*C+. N/,TOF4P"B'3RY;(& Y5^GO+:RQ2->+0J8G13E^_/F8H6E(CTS2^
ME'-GGEQ@^FQ1]<P&\S&U:":R]V,2    AL=/U[[9IF>J'3O$Q_)KL6O>G/5F
MK"5&08U"".Y\>&H0#<F67Z'\<8G0#[4TS[1V95F+W$9 OH50[<*H K&*!"1T
M]@$ *,!0M&\8P5)88,N:_Z=TH=# U,KNN[8'*C*ZJ2OM^,<6,T)Z+<VOU+A@
M65[1*,.W^3)58M==9^Y*6ZMP_A+6=$;)3+@9&4S:1WL=W?MS,29&()5/]&(%
M%Y>!WO0K_C:$,:@.>,L8-FSF&TXP[EJ9K981%2L53B4.BH%_$P8JXS@<K.V3
M'#C#0I%=>/ZO'?:^EIGFM<Z3T]TBZSSD<EOT;'^^E.U;@=G.!*(PYD\'J'IT
ML:BJ(XM+LBL]N:7;)7TW_.HJU)J1:&OK!(1SAH2*@MG\DX4%)@:(,AUSK]]T
MS$)!X!M84'?]TN5LI..B2_E.]*4J?]67\%.IKF=S)338OC35VKAP6))M<2)N
M4>;^[)2A62F$$%A8;C/]5H6ZTJ*VLL,#UO^@/>)]"B3;_HP"]G1Q!=T\S+<3
MJ<%]%Z:(7%&,6RY#V29.390#R?:CJQD9?$/0#O*Q]IVA90:5M_,FR]947C^B
M(CMB38(R(*]3FRI"RJ0Z!Y>K1CL15H=F&VYE'=V&0 P30/7#PPC2%Q?R6LQ6
MG_WS!Q_ 'TGZUH)VO/BG>FCP5O>H2.CKA21NA;@'D/L]WDPEB(WV=9:L."\N
M#$YU=(AG) 5DE4BTS&SF]^<G/^NZ5GV2F3\BDQN66=ME1:W5"@16@IM4'N-Z
MRF,[L%9:-P<V:"8:3&QU)7U)T3'>NT><Q4^\A5NSW8S9\P%I"5<7%KN4<;_"
M6>D_HW+)* UA,XX1 B3\">S-!^.M\F:XT7/GGP&F*^)=(+O=;[V3HI&IAEP@
MI6-YO;UA<R1&*I\15=6DT:5DLF(X;6F72>I#R&[R.J6VOJ3R^>C<&F1[NG4+
MB^/I;?\6%EF#R>CV'1_NXA?Y5A%E*=NW11)P7>5'\'3J0]TXN%G?]BV5CGS"
M,Z?>=L'"Q$41;E4-=?$I#Q)W[^DL?G[XGE*X_:E>1H>#9@85@;5W$'8KS?)Q
M0?0%%SY[PLF@6I://FEQ%D=MKLQ6"6))0?<I+JLAI,RB\\D\"[DCXNVV>,/J
MKD"_[;ALQH&18E40.E(!/.?\;/2,XMS=+W'M3X.8T?D_<L?U'S?'"G(FC(CW
MO+G< -.Z88;V7>S)-?>A%'%\SK#T6DU,_WQ\?:8L55J->R!=0^XJG2 YGJ4V
M=Z7%36"!=,_COI_"&47)@6C+EPE>YC1"4X(1.FOQKW<1<T^Y/"__[5U$K2F&
M'I26_@M,=F?R*07]U$Y*&IB+#G:@P( 2N%)^JJ5,!26$^$W?+% ,TYB^]EWZ
M8^>0R?CH;QZ'7AUQ0B91\8RB\Z\$N2WSVR3C<#00I'W<IWU!0[__G$+>AO_9
MT=^[_[]N;-=X-[3-LL,Z7GFIM?W" /(L9N/?Q)=1:TQS*G-$6C67>"O?7Q:$
M^0Z>&LTX@? N](QAH3!L/IGUSJ=_]\W'A<ARAN_NA3O@QN&()[LGR;NAKS.^
M?AW<9KC\L7*465ZY:.<)Y:@G4?OVK(56(JU&\FIT^MR*BHO;W=%D\IH2 &58
MP_LM^%K5-/U\&#KT6SI ?C5EYX.7QX184J2WX9YDZTGLW>_:S%]G"9\]2[45
MM415[63"BK4'X+<?KT3^V"@-E=##A=><Y!E]M3'_E5SKQZ0[J-^D+!&JHU=J
MH!RJ)YE8:U\=27\/]['O81 U6*:S1^ 3\_B Z(,QXR:6BL7V2XH?8B(<J._9
MEK?;J51SN*9=[3HR^*V%IV+E*@J[%56F,B?.1V@(;G>*=0H!"&<^>UA0)A%<
M:#W\J;RQUU2'4YZFC>4[J7RYSS '=NO;?P<K29+)0U?8+(0769VQ)7L8WI(I
M*1&$%"<C'=J+@)^LDW-2'$DG7D)&#"]_7,I7YS#2>+Y^/R#/?/8:;X%&;H;W
M5VC;-T=&8@-*U=8IP5G,[)U@):8ERN2R,V<MRL3/#<6?USD<.8!@Z/U9+"3<
M^/)=-GV[C'RQ6'L35HL>CLVH+BX+:@7D?E N#B47E2&%8Z/>H]E<'E4)Z CU
MR:K8H69+P\H=$YU-\5+60G>B2XWF'K0H?5?$4^N]\[U=.BN&1N%!&,N"6I,J
M"],7XR8TKC.SIJ]OJ@_)RKWN6*V\O%&F'O437RWF;JA'Y_(A"LBYK&R_8+U9
M85_)T&1A[KX9]&)LC^IH0-@'Z9M'YKMF\4G5R=,N91[=EIR4XYN2%M<T53-K
MBVA'5-X>*_6F^NK]]O677U_(E^BI-VOMFSH]NW$(J/ H3'+7LMI*CV9S(OK!
M5-:CW=L?NCL_(XY_&KW"RWX;B.NR7!3A[8"P<3\4MRES=[A-.KXTS,F>2=!O
M-KX62<\3'OU%<-?__L'1]6!ZHKHV5EF@6 'HI3\+!\RHZ[2%_$9; (%"U>KO
M_96%"M<=[@=A=+&:%FI1YEA;HX)$P! 6!*Z\!Y"D&]A(?:KPRZF$M+'(W<[O
MTVB9:S@HI58KR1(*[Y39LOY"7-Y],JLF+^8Z7JB?-V8]>?TXJ#VFJ8$Z#\1G
MIF%>RR*2I6\.'1TZ9L#:)&R!-$BXSDN&NWB/OJW,EJINZ;"E>]R4 *Z1;^Z\
MY?=W:" YCKHO=D>:"KR3][AILN^W,Y,]2K(1&C648;BU'P)4FWKOO2]$5<\@
MKQAF'[386Z#%G\QUY;]-LFE1DU#=&L$F/F^U.N[MJ%8H'BG\8"K2T>[QZH89
M\*ANK*Q:Y_V*)MO F[ZE^R0%;Q!]":SDHB0F@1]G9X2%,C1#Z1:@VJ7/=EL'
M<F]+W\:N*8(EZ9G;J9^!HC3"+0OA_%&(0D\:(@'$XWLYU^H-<O;J01?B)OJ@
MK'RG RIMZ+C:R<0VY:9T8QFZ$$0] .U\VY3^0M^Y6VC@GOW 11TV0%<W-:@!
M082PT.1[];;RD5R3+8V.1+3%T6H$M+$R&PJ #QL?)J#U,>S@9D1!6$%04\[H
M3%SC%18K?F5M?,)K6QC*&5!I6%"LX!JR9+A$C5"(7+ UAE4RHI7W;GAY3APX
MM/.N!GX=UOWYT^M5)0Z;'C*<J')KV'Q[AJM,I&!XN:-)(OT/:Q[.<&$%RZ#]
M>$0$9_!M-9>\80UKPHKX8)_=Z4T&WDO/[0WS6SH\1I8P(CDX*&S,&67<B2!U
MP@QL8Q;2N'%BU>K1F@% E8^.?<J\BY8N#AQ4841D010<,+%B5Y<B*$52*OQ$
M<_VK_<DF]1H5V_=K43J6CZQ:+:R[:/5G[-9_$*70HB(?U?1FV>\/:U>MNJ3/
ML603<$9%BE[Z.PIX?D+SM+K'<K=K>;;ACNV?'CJXN;13+]1NJESH)RLIXK#"
MVB^.++VI9QB24+?V/&7C2?7!C<\5=X1,-PZ\V\*I(V7M_Q'U<O&3254YR?+3
M:=9AV1YR]O5%ARH>7YT32;\01KE-+KX+W+\H_C?[S?GRWYO]1AM';YJ9P8&*
M<8S;XOG>7)F>J@L06PY]/&DP*UR=]%%$%,SG ]4#&#V9-)EDLQA:C8P:I=35
MI%,C)G3!*]L&1@H2*SVH^2=!4PH=P*@'><I\?"Z]D1"I)E 5<=)Y^%MH"R9F
M?ZI0XQ^M.J*E/UC<&.*6NR%X-:<(*MGV]3>[2<M#-0;E:Z(^U1=K%2\]#_<!
M=GTTXA[C*+Z9.3.\W);+W*L1AI,L5JHT) #XH[3HH,_HG_4'4L8UBE(24Z)@
ME04S-6&)> _FQ'74!L!"CTUAGF5-#CLKP<'PD>QB&'2W6UT,#T/6MJA#FQ[$
M_DAKZ# Q:.37?V,51LL)H:SB]A87"7"SOMBG :4,PU?8X457FHPM8_DB5!G&
M;]['>"*F<#?GO]C!X-=@,7W ^EN6Y7EVVOIIUE2E[/:<Z6Z%,T^^,@W\Q#?^
MW,D D'&"#/1&CR]HH :Y^ F5S:G"+FPK][V6+TG>\!0S;"TS0%*&<;=3J\SU
MF*G934VABQ.#,DB@TE8J7NG\VK86<9*"NM&L@CI(1[B$$L5 =$4F!ZK;S+,E
M>I6CQRP0+N-+U"![?$$QE)H>W/1+4>]'I=UL?-*M<0GC;$(X>K@?PO,D(+'[
M]>MV@;$&RH]AJ"I /*<D5<3]O!:G=+>P+A<CH@N('IV(RK_XV?YW912XDIXY
M'(9:1_W6*RQ79\4$?/!7PNH< +Z]1%1O==+N+]=N9@;;;_TPXIZZNQ?BT+9H
M[7SN^[H-/_'W(YP:G+Z7<_,5Y8I:J"M9/Z-H/,Z#77/(6N*E.<Z:^7)W2EP(
M\^V?,I><#I$G;]+I#\TWHJ=+8Z1^_QN5C5MD\%;_M4/=^,86I,-=OFV+<TAL
MT<6L)-"/.TV+UBW-%.YC0YX'P3[LQW1!E>,3I 'N=8WUWO1VA9%'C\Y/F7M3
M.P9U);6-VZU#<C0^WM3R?G5N_2<LK$$%7-K*6<*+=1_CO^DQ !F-)LZ[FNJ"
MT)N'+R>UI^Q7C_:P"A]'66.G_&_>\7Y,+Z5\8$^[KK?72\] <ROR;U#(3Y/!
M;5NA9Q1*&;0;QN"[-]\^GRK97SZE;\WQYOU=Q[1!Z7^YT3*([OR<OB;;8]"Y
MQ/KA4,R6M0,;QUDW4]/EWFJY9O[8ZHSB^-"ZB6UMEK="XD+.BW/:&[:M7[@8
MOC^M?[3;! 5[<M1?7=U11[/R!T\:3#P>NNLYY65_#H+1B:BW>#0'^3D=GT7C
M[C2T*]<]*KC Z'"K$;/2FN+1VHOTNRC_\8_,X/1S(T1!8>1 $CRC*%\[POB/
M/U>6.:/PYS@%'1M]9&'R3ZSG.!4ULE-^]?J/?];_#^7T!-,JO/L;BFGXWP+D
M%:G^+4 ^1>;?#9#_=\O5.N/]^&:9%*OF00NGI.BTBS.0*VY0Q(2&;;AQVNT0
M5Q)[NK8V>*)C\CN]0M#WHS5D .V#E966*TI=(C1+#V?L+4"OTCX'+GDNPZL3
MJ#7F:&GI+]UO8;@M+,OPD!_-E\T&,Q"/BHBR&$W6O!JA+Z+)@&7\E/E4ERN%
M\M4T2W++M2L@$-Y#RR8D%.;(^L)']@^*"TR^4-E7>Q,]=^[4^V1<%"@X/<UL
M'EM,Q-=IU;77;M*H\*M_^I>6?[BCG[2(&:N/,H1,FQ2(^\T='^7M\]301JK7
MG5%@T/6! 8U/T?=>GEX!299U)L5+F]#U'\I'[>Q* [8NHB@KS1Q**^,Z-7V5
M$^SC;J;, !MW!5FK;>/F[J0T%0T^:P>W34")(Y6[UM9]4M>,FI8>XG"CE"TH
M*'NO1P*U3D$]O$39B;K5A<RBB4]3*YW2J/_P$\<92S",=L;&MA2V1 %=TK/L
M!G@]VH&+T&^R7V5>65DX:-L0T5I1^465KN74V>54)K+PJU7?"S?N\,,BHMU\
M;05+3;^(TSB7QEOSBFE916RFO4KBGD^CQZ<1AN^3U88MD^AB94:P9L[X;E!'
M)$@3IA2>0/T@0=K:<!JVLMKBH(?(19I/AO&Q<>Y1<J2$_,;3XEUB[P$70,*
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M=B>ZP9<1'ST+;J>9<#:QJIXNW</%E/F?^HI,4;MO)HPR_='WZ)SREO'_S-_
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MGH6Q2I?F.485I$3V2U3F*WP*BX$9XR-M^'1%KX>4N4[^.*6 OZB@L9@84/5
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MMK]J8O.^NXC[1.7S<I/W2G&$2O=;Y/!I]/5Y2(5UO:#XA*"NV!(6PV%-KN0
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M?"HH>][C( MV2]#MT(ZA>*R 06$N;$8N76]&#D71"2D(A.1MN#L[]GRSUWL
MS<U1QYF<V#1"@LNO?WN4/^A"93O-.45U4X#94W0YUD8@:/I=E6Q&DE HG[U&
MH;JML; I)@_/#K(2'"1_#<"'#PU]@V5$B+D4!'4XP\$0W,B8C)8]HDH[/2MW
M3H0Z&DW_TC;AL<M*"_[YO* >BX&^)40RJPVM@^-TPMASJ-.8I.;.R/,6@+@S
M=BCGB)-FJOV*<S:V BMQP8E&<@Q6 8-=""X:%J\R6=WH-YW^2;>71>X_K70T
M@S8Y1DJL;&7W&%2T3QO,:.9:UR-QO(%61VRYS1LW$$A EG%;(1"# GLP6Z K
MR-%($$I6!A8"BZ6#6@N6$XV ^K]]C[>ZYTTA%VYET:1BTK<'TP6B!4 H%%DK
M % Y6(G1>"+O)$HJ+BX[>O)0.+0YR'EL1$];,X6VNZ*S%Y7<3W--3*#; 9XH
M4\V@]W"-7)GKKOEZ9%=50_=T-_VK".>2(/+ZC#99C1;X"*V0J\?3L';_KP/E
M1,.?1S!6?04++$!EM(%V#6TPA,-&;D!)S!R>GN3_VLY@V K;TQPX>3>L>1<.
M$J&[$NC\2)V*I3QB P'DU/(:ID5 #(P9/U66'MJ<FSU(]=9F5 2MWN2RT"T1
ME2;WH^"9]$ 9+VH]EMCJ%.]6&(PTUO8."I(<160J(?KJ&K'F.S_O#MW FY]"
MNEH::B"T2E 7+]1=84DQ_66E2TWT".A8L%=A-18P,N/0IU-D7,%3 V_E2BDG
MA"81#=7,+/LQA%GM/NCBL"ANX0P/$U !)SGUR@UAD4'AT >A6J%AT)'8W62I
M\;<E5>-A=&R.LWL+!:U!/3LSU[#3[T<B.FANBF)@11ZYH'135ISF_&)CDS#S
ML1FE=@GV_E3S9KKZQM@P'-F1&/Y\/DTP6YSC/FXQF0/&0:_TIK^/=[L;"XG?
M P@8'H%0H(R8^<"8GLJ V SK-.=GRB:7\,W<O,6.O%C8517/"$P5L# B5-:>
M3ZP W$Z-O#?'E8L=!X(I]J*6-WER4L/P7E".&&S,<^V2_FAK*>BIWM9N@5XC
MY>&:3N\7%BX>MTR Q8#B=0S-E)PMF\?8XS>C@G%>C,^F9[2&<WQ7O-G]K/NV
M1!7-F\P0D9%O>LIU.0R,>0\\S#[#C] X8V3^]V)$F)4J:=":GC -K=:^_A-U
MK#$G+/"N*JPP4CP%#B5EJC&+S1@[I7E^M'-MYEEU[\SN_#09YPT2,&I(/?#C
MLP@XYQ9I05Y?_J(6JS4X/5)&]5=,P.M.L5;SUW2 ;*+=S]R\Z%WY2RI)PXM6
M#-K;?27#=#!TVPZH+:_=#4@><><;#EJFA *K $.9K.N9ED/1NLZLC'Q/M'KM
M<A$=B"88Z.G"4- @L)9#I:?N&1][7 []3<\Y5L!U5S6:O<LR8M71V8)B2S%M
MRE[A,X*$AF,-@-4S@CLR$WLDT0W.L"ZXD)LPI(CPL+7=7)3_PI0N?3Z!LXNA
M_A*+R#_75)]J3I*_3I?C^NP[+;,>NN40?UITE)P*J;H5?*(#XS*M>'?=5"DD
M>;;WM63;BL?-5M;A5T%Y4;^C=KC&B.#BH1+&K-_S2Q[7BZJ)?_G31F /WNJ5
MH_E(O^-Y_\M7US/?5RD]ZBI2_63_/70"+:+-Y]5@OM+P6NMS[QF!LESW"<H
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MG5H&_DDT\&H(OM/IIFK%>^.8JD]-2X^K]6+38?&I9I'WC67 %/9LCK,E&(A
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M!>;"9Y@)',+EK)AKI92)@@#0 %Z)V$]!(0K9Q7J,H<Y:4NWCF(A]U?LG)UC
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ML_]_=#FI:4&P@NCNIH>0]!U!"MVT$SU*#(1/%-,R 5I3Q70U&M>4G]F2-+6
MMJAZJIAVA:.$>LJF"#;EB3#Y^:OZU*[X=Z2RD!DS 6ZVVTR*4*A9#H)@CS>1
MIS0;$]J((OD8*.^H!NK-[[\VQGYWM(J%>3T,6^&2%JLMR><0WZL.N8:!\I5
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M*=H>N6#H.Y# &]\PV)>R_.^QX(WT%\4JPHN^(O+YWQ.?L6]*YZPOL4XY.#_
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MU<SW!F/OZW^YN*\HOY4"##,&LN2 <Q;2E^\L:^KP9-!#LFFL"?,$J^QV_L,
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MT?;CQ[%XVRT/6(MYC^0V#PLV4+,,7/GZU$5<<>Y4)RQ@B8TY;:I(<U,C=$+
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MR9YKC D'>;#T.3#R+?QB'X[]37I+<CSZT?=B/OOS("F7+[[#SJ%(4_.>QPI
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M<I&Q($':*JR8/HOE;849_T=<;*2^%LEU+,:4&V[[.?P]%L0'>*3T'3A-*-(
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M4;W'F#T!VQ&]\/L2!?^;WP(&JD4>L=TE_[L-Q8A\,F"\C%22A?ONG++\4[]
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ME3'TER4LXXVKFGU6B))O:OVBQ*L6._.!MAA'C2D$V+E<B*/WBS916AK]7/=
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M/=!F(]I?9-;SQL)N1O(D>1!AJ#+ZMV>!;J1WU4XVY<6OF<B]LE+!08W9<)S
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M$^TJ6=)K>9L$#3'SL.#9*@;+.F<$C /OR6HG;!EVT8E;IN8B26QR9M3CFT3
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M\G[ 5JUH#2J?D16!W;QS-EDO?J(#1I5H!*02//.SYS_.4ZAA-VZHSN/G&Y(
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M=M??9LD_1746_% B&2186 C[3@:-:JS51O]@X1F))2?^9PZ8>,!85;E/5JJ
MWJ^YV,X7@C_*8$.'\C)5W8;N_BH#),$":^EA^HE;>7$ ,Z:VF.C 3#TR6>7H
M1QN,74T*37/N5(WN'4<+B<M*K!Y23QE167-0R2.6\JU]WXNC";!83FMXTI8+
M74,_6RF-U]O#G_Z*CQ[4MFY0;'@9& N/4'K:K%9#/UL7<ZW^P_Z,0Y&=<5$:
ML: !N-[,Q@%CSKI.88!>'R)2M,FJ $22-L,/:ZW:-+A.;@Z2*G-_Z_J7U#'#
M)9%1.9@E>?JX%95?7ES#P6(F':O#$87,>-5W!;TR%R6%&=&ETV\:?!D\4F)#
M)779FW8(-7JV%,=-R7#-)%_?V7^,9+VW#O[(F4^S)7I)ME=HQG#F?"MUGDE8
MR*[<T0_+1\\$NK7U^GA+6LY.#?YH?N1VE+LFQ;V&2:\>'3?HDBXN:J()F-OJ
M), SY_J]).&./I&LH!U,.LH>?5KFN#VLF_XT'@<VIDG0D5P[40XA$'?UZJ-3
MLBV$PBE"A6@>0X2QAB,FP4S'@<4-U;Q"'MR.?JF+;1I1/P<3@D,ZTV4HYO.)
MBQ:HK3)3'9.A".I]TG@T%8BGGB:.)\8\1(]X+.-CA"X *1IQ>TY<\'N</&N(
MB*QIU= E>!IOPFVY9/Y,F@)Y@U/3+7)HW%$&T9BHS/E19TEX<MWYV91QUQQT
M6K.,M< ]EC._2#",  -6TPWU>B\*R#VWJ6+7NZ5=DHZ(W</3_=BL"%#D4IR\
ME<>\:LD(2N+M"]C2'0WW6B43M3E2BXAB:)"_?4I/%@<LLL0:\#O24)< JUGP
M%[1CC\W[MQY/*'X;KU<5E:L0]1EM&SD$3/AZ)OR\?.S8GF>0<\ \R;31D-_E
MWQ^K.P!H*BQJ?3#6#%29^<;LSO2W*:M&KKQ2L*O<W 5]\K#YV1;7;5 _;XH5
MQH5\0-<4:.!RTWK])BA2S")LB<=R7TOUISUY1H,L:WYEV6?(B0ZN[(*R,"S%
M?(CWZ52H(F9.VJ'Q8L;@"UK;KOUU:A\!(P'DIAVQ"5)?[H;U=F;%?%2-PB[D
M+(ANISAQH0K<G1)"&*9NY73K CU13DE0TS4CL\,O/'46V:5VLG&_[[#>[RXH
MCBE85\NZ)\2^77:K"D3R&A'';Q\;]Z3Y,V,TB[]4<@>NY&[2XQ:FVP 1R,:"
MGTX6GUMS_M8R/^6 '>U7K!7.:>O/#?<FDF*%BR49?_AFN44]]\O($(VIH_4N
M3[!E*FIC:-H0+:MP4BHG4!DG(F897L>TUR^_:,P>;9/'R&7UD&O[Q;U;Q%]8
M.L./$5IU'.NI5&ZR;#\S ;?D+.K)R4>?4B<A02DTBB:2@ZG6PK#7ZF7MA<C<
MG .IY1+7)7SE(SM; (6^&SEK:^(AC.\/=S9E4YP4Z_WBW3QJJ\G;NUEE%Z6Z
M%PI.U.:39DS_L!#;B*B3\9$&0,>@UAKRJ<#=ZZ2!_8T]-ZA92[Z)"0=6@.7$
MYV[WS;0(I9<G35<-WWL__*]LD7;(N^&&YZZS<TD9,M--P?JF9KZ'#3H+N@B:
M!54G#HVM/$U$</*;WY9XW#^S0J@<M%T&.Q+#*T!E&4!)QW4MWE25:LTB98AH
M6HIE<TCS5IBRV2]YO>?%?O=@5^KLE9(^T+_&3$DF2:QUZ*<I GJC;^U%,@,<
M&B\1%C2O^HH*W+17I7\4F7Q!;=P?6*\IW>Y:^7.P#7C+H)/R3PQX((-)-PV+
M?&YR'V\=O/#MTMF23/O14HK_^"H(PR';/_*>@R);XV.@X1RY4ZG@0R7CPD04
MQVOH\*%[SZB[EX&=($F?3YF?,YV@38#H%RO4M%&U%+NX*^S V9O4T:;H:UBS
M'J5/M'I&<JO:1G["D'T]=%8AM_"QLWZI?@SH>%]<('RC*YT+K3[$$0"-;">+
M1BU=$8F'U_V!\$#UW'D$'W53@&]@,D(IK!S,SB0M=7HQV.JI MSS8@X;4,I9
M5CSKYC"?'9$NY<6WECB%N0_OUDS^L!MWT^2(;WQ@M$FND;JT//ZUP,=P%$]4
M])&HB-7YVM?/9'E@U@Z@OBZ.IGT+%4FI5ISBF;U5BQ#^>7U<<(]9:^2]RS=/
M6VFI,L>V:V(:O)EVZL3";_;>VSU4?U(O\-I)\$KEM3OX/^N]"$D[S]IJ%HD.
MY];=UK20W$^<'SACCEO(K5P8/V-CBO"H$1M:^_\8,%FEEGIDO+=)F@'(N=MT
M(,3WPS 6T\@KNL[6$0];@-#9+D\9WN/#6$8L3K-?54/VX4QJXJ;!I$,V":\?
MP(&UD>B;;O ]$)R/TRQ-Q/0AH,7B@NKVG$V>ZH8\W*-QK1<;?(J%HC.4,M:.
MV$/IS0I]Y:J:>D5IG26/IIG4E9Y/V(KT]$%%KPMZLBM!GN6-!^ISLL[ABI[.
M93"$,8^>R+E>N2!GN88Y;,J0!?:$9H*SZ9[//FJFK\PM/JT*!%G4"OX\]ZPT
MM^12U)G>%LK,\P%NE20]&& M\7;$OP3MW*=KSRPW,# CB$\EX=50-[P@#Z3F
M0N\S-1E;M9U]BGXS=<6 (0RS>&(A?4/5S9YG"H,@$-J>#+&1*/0#L7#D@6Y_
MMV;A&5@B&5!SL4.DT^N3R\QRW(/@$G'&V]/.//?[S;,,#%E^U9QNF^3E_I (
M/ZQWLVIE; M8)X*]38^LPUNE1U0]W?/TG69M;.W 1M.0L7V6PY(-N./>3EUB
M.I_P2JT?-&59VBJAR76/A\K\ U#R8Z-+]7B3^7GU@/.GRX&I</H9%.U/!P6D
MV4V8VP2(_YAKNTFCOHB-IT(HE:8;>3X@K7\L?SQ?*R.N_WZ#(_]9@ .34,%/
M%UZ;G49%YQ,)Q!8=YU3[;,2>7&@HF<)^'=(IY?9;H[R\=LZ>VK 7%,Y=;([/
MW]QF#.*3N.K"S ='#KPKO1:7.>;0Z7=$!%>N.8.F]+Z'!WW3DD2Y<>ZT?,HD
MFHH/+]/'&)[5D!*6DAV$W[<^\@CX^OO.7[7%^8D/,)L1M2TQD*#4QU\SJD>/
M7G27%QAXYIE-0$4@O<N6^1D-4A^:1VQZH,,8DL"4ELJO4300"YU7^?M]TO36
MJ6->M7[:CA@ZX2_?155R?HF8)O'JH<O;H;L2=,*ZN4#MLQ5WP3"WDD1#Q+*?
M7$')]YQ7&R<2O+A<H;!3*'I4;V"*IQ[6E>_OEC:3WEL)2F)-;+-\77\]Q5',
MW*_L(OMIDNO9^Y$LB?26-6]!5UZH$XSL/Y?8U")[.%)I4\/!7-1#PC9BM<D7
MUNP;E?#:G559!4Q[H>&!LFJ3A^^-MX&F.3CDWN('8<OF+?2,U")GSGRKDI5,
M85+WCK8PQFI01_XEG9D$V2>X![!JLE_'LT;:T\:0C7"9>#XM ;)P8('QB9&\
MJ?G<F_/ZWV0G(-U%60#U50X/NFQ*3PO?#8]?9'_C9W*7E6@4K[U]-;6&E(H2
M-CY!2^BZYDM^;I$@/(GSTUWQ@="T?DG8<1>D\MEN4FPHDM5ZC"GY/#DI:"_J
M?D4.#,I_#'AIEU\+=^H7" OQSBT)L"LYSMUGR6NQ04(UK=<@"YU\_M04#GD9
MC(H)0O<Y+.(S'Z7A):!/#X]&G1_(Q%H#]:POT7BQXH,M">"X!PH^=9PA&,96
MCX3=X!5,7F5WD05=UCH=# 7S7E$4S95L0A/%>,0 Q?QAIB:5RTW X,IE@0 /
MAP 7TKP'9EVWX?#?=W9H*Q.U4Q%<AELIM>-6[5DQY***=0><7]MF;AYE3-9-
MKUJX$V@,EI2%1;X=("KHS)R.6[@G,\<L)E+6WQRQV&2D6\N,#!0=4R;)E,D\
M?/5IAZA(EKPC]Q\IAN%57S,U.DLT1Q<[Q@Q]3NS8A#[^6=@.B_QQ9?0^I7C[
M,_X:7YF;"ZBQ^K&C1;0FU3&BNW8J;BK D#6%W+H%>Q9N]XJ;@E[^^'/+[<!M
ME[,6I!$=C[GW]&HO1^;LH2#@BE%_#VWU97[42]Q#2N+%+90GM:HYUG7'Z3ML
M9M'.2"7:6C\DKM-:N6V?Y6,;<:K,&RQZEV#E2:71  8$4W?AM/N%*K:;:#BC
MU=*W%>%4:K37_?-]BBH#(_:TM:;*&&K+^)QQ<EY6L_M*7A",/7H;*&R+;/X2
ML+L*-DQ UO<MU0S8RA@DI)@4L_-@9+B%!![M23KQ;Y,.$LQ>OQD8M0KB5JOP
MXULEMW*<ZPO7%#^G$Z^VV2Z=TF]Z3:AIAVD5,VVU8NP=323"HMZ=]B%D5"5N
M5C?$,HJ.\[XYMA,B>&'UJ@C.2X&]QEN$10@=_CNAZ<G^^.1.EU"X:.R1ARQ'
M_10-5XN+<R*8%#I>;?Q>U#"SSK3'!/EJF4G]*Y#YW8'IU]R]%EM5_GU&(27#
M,B&S)EM ]=^W%OK?"S8RY]G@ ON7 1EBDZ,%87GE-C')BY;7IG8BU2J/*/"!
M27&]H?)8G" GZJQS,$>C>M/C&[=7<7P.9XEZ/KXS"<Z[Q2 R5HU"1DAELW;V
M-(VU(U%.^L&+R[Y(IULYBK(E\/V5LFGP8^?GQ8N7#@L\KX(F)FW'S*E-=GQ\
M*=AJI_X6\MTQ5E+,2E<P-Y!P:%;Q+ZCG&)E3,W;P;GN*3G#_6GF7SN8@V:Q(
M$,UWUP?UN-EEAFIOX^V,C?21Q](.^Z6ZVGTEOTG80LPV09E.;IRGZE*P2=6B
M7"X.+RO9-\B];-@G^NTRQV^\,"W*_N*[IYZU Q7+"H^&(<&)C4=_V_*B^5C*
MU*8/H!WV5,/\2DRI^2__</,QE\#@)T$;&&X*>NI7XJWJUKA5GFK.P_0)"+/L
MD4N.PI34V]P:?@F%$2[X7,TB*3M/GT;?L_+!D"]A1<,K;*4%SE&KCS4BU+/(
M]9X%DX!6:W6$EK6OMSY'"DP/W1^,W]=<G>.-[_G)D(83&&.FWU-R.1!=D+ZV
M+W/8Y-@;JQ%;-]0G#"#0?%\!:^1R%A)%'@J680D(B$Q]JQ>^YV)H 9WH:D*H
M\&_,<\(<,+%/LL<KWGYDR0F>9LA=N%$UT9'!8DW625@L7]7'.* #SZ%^O881
M[FMYLL$V7X-H1N,[^;0;(J\/BZ^E/WH!&;_,TOEKL=@(W%W1"W=QL:VM IN\
MY(9^7]H+A!R!<U2(!(?J9(E_#;G^L&&W4-35MI9[:;PR#6]S\=K@7<,LTL!3
MC-6YBP2#LQ[I9@&C\8-_7T27'*=B4A/7N!P)(7S>_FD_UD.%1=4A!TQ78I[Y
MB4[G6/%/)<&H"?4U!^PY U^97?-/)CEBI$C Z5CFM?:)!RYX#ABL\5.R[ /"
MF5![.[SQ(&VB?][PU=V<(WV37J(_G#4V_-V9?4Q \T*VXI$QQ$AM5I3??FI2
M&K,L"CR/\" ]]O<NF[P6;6M.L]30[!#-WR(2"OW<.RD7R9Q)=9A +F6R4"-M
M)^U.MWK:BCDV.PW20"8^)U%2@)W7FGZ6LL&G<'C;(A6X+'IJS($/">RQ[#EF
M*S]B4<%!C]3^=$D4/V?:=^A1(=T[.GF]&7,<5*H8-N]#K[OAFBC2O)#7"*/S
MTY2W=I$>R*%E8DD37_J2^+2,J$(4G[_4?/>D-+?PR!PZI4Z,#_RA@",-69H'
M]0*'T>8=!H&?]\;;\0@: X^4)J>/[9 \&J92314]$$0;9$(SX3QH/$R7!<7]
MW9F>WWBH'6>^:=3^M)%0G7R9[+ KZ&#?-J)7GN-7F.$4(9RF*3T4"NH9* &%
M#8&T<[W6]NR\"ZR.WJ!;Q +G>>'(*&*F-PV)Z_HY/'$/[Z7!X!-@42]?]8JV
M7\5WSLI%ON_^-GUB10Y-C+'JH(@X4)- EOV>[AV!F_V_H*WGO]&VZ5]H.[R8
M![-4S/DI%-K[[Z#>2?I1C19Z]NNN7]U%W3E]1KT09V</\'UR^/EP7NB?= *W
MR<B :5$?R$[#4^2 8Q1.1ANF<!LA"<_04F9)2_#T[.<S3V%+9]&>@B_N%J:0
M-!:=;9/VUEU^*V>\=.+EV\U^ )WGB3RQ\'F[\7#XI9QOAIWDY=]']_CG_<J7
MG;0]FN<+[@=5P_D3=I'V,XGTIJ_=5S^CVZ-VQ,V,;&R.5C+?IOE/[!34LAZ8
M-&=T-LZV<9L:DR9+F7[;B8ON,O&"RO]\NNQ()TX:"&>6MH +3X_Z+';PCV;I
MDU<D]>VU=. -5;^665/23K:GVM*BCE6F0SH^MSF)5#S?=HRG=+P(*OJJEUF'
MD!Q@Y:E[(Q4X 8-W&QIH5BM-V\K4P[&K?SMXI%<L*>:D1;G&BO,&6&U;UQR4
M0?O*Y_8:32Y)94U?U6AN6E"%%]0>;@F783V5!@A,**:RP,L(^ ?S"Y/]K.+F
M:->9MW_N_9I8)$2@!A93J)5O!]!T@P4TEK'EX'5O<T&;CW\+3J )E9+F+FN4
M?O/\2"H5^K6AGG_Z%X]F71V!DM/$/*:^HM.BKYOKP@>"&ZBT7A0V? G5@_J,
M/\WS)QKZOPCP^&(8O4$A:B^Q-M@3X"EK_9J155+![FY*4&.*.Z%Y)U>X(+R'
M!GR/1"[.OF'^XSMHV1)KK4N.88JRPLR4@IEC[!GZ4I$G+/%#(1)B,"0]I7YX
M24'[OXBPZ_\=81O^&\+"QF9G!_.G"DUD(DC-:\^MTUYC;07\2UTX6"S0B';&
MK-@F8?/KH&0><WI=-@VZJJ22)S[9P4OE.8^C&9X&_\<.TQIY^MYS\FZKV7JV
M):QIO4)BV&G/YK_(CS9W*\Z(H'A500>>>MC?)H/8I,#8^&UO/5[P^]R!FEK?
M0D!Z2S,XFYS7IJ;[*NW>+#M1=XV,OND*Z?/!&>*"F#YX,57>!A4U&)%8CCQX
MX.X4Q)U\JR4H'P:/" ^ #6U[LZU?6_1ZGO:CU!<+%%6MB%TO*T[DND,6,TSU
M)-7RS!H.':L87 >NEG,.^_Q6J^R^I-MEU?!17S3>]#F'0%VMJ4_+;)-P9GS3
M[S<N$GDJA>5I(AU$$2D""P5,SR@48W[6QAI9]W-)AU<*NJ#Y#^.UZ$;LH-IO
M4"5CU6V;;3-D4:49O8X:330A$BU&)&C[KY^RQ :/F;UVURXHXO^+YE#V;\T!
M^'^*Y@!BH_[6D@*GV2^;3ITD, >TZ3+=#HBLVE944IG4@$U#^1@&1MYS7M#E
MS6R4@)S5%]" -_M?2F7\YY-WN$24E>II??#<]<:H?I>%POBR\L3\&J<LB(;?
M*?ART)"<H8)DXE>O+(6M7;-GS#MY(5;* >+Y+Z+[&&YSN8A0C9 WJ5U9;.@:
MRFYYO?HFYH@8V7<_:FW:%88!Z#+^V8.B@VB)M&E(W9L1OU8[3_UQ[FDTE"I$
M!I<\\0^G/8>#[=]%1,^+(2>=P_K.^QJ/=JK@IVO0&MIC5]?*/^I$LXSJ6_L6
M8LOI2(R=4XU8%RAEE#6*)>F5FK1_+5<3BLT$Y[LEJ+/H !:_*E7,60N29FP:
M'H&:TT=_WS&/YCX:Z7?!['UE5ISP0/U4*[<I!DD08J79#/<O*<R/E0,S0@2A
M3[TSN:IKW(>S=.Y+FB'297VVJGV<[!P??\$$(8.2FHHMM/==%G+L;>Y?J!"I
ML:Q@=PO[S2PYP/2MW".GH/':R]1/;2_Y]%<:+(KQ0QFDG&NUF<.)N\(Y+;H!
M,.UK@>J":KA+E45V*\\+A2 _8L:XEL]9\%_P59X"ZX.R14T]S[V1@13-<==*
M\PU'!TYT.:&\J_*>D,/')/ST_KBN;$!O<4G.@%30-)'*-.=PQ+1K_U*B*+\W
M$";X5-<B[\75I*EE"GX*K$S9E"ZJ.,%<D0;THE58;[V?#TY5(L=C&[S!VZ F
M<5!";I8(+,=?5P!-0S6"9);(39\Y-1Y/7BV:T2 LJX!%H)"$618PT[B)=H:@
MAZ,>E5RH,B"O1'=_X(*_N7QFVIILGUJ@46%A+U7L&XW]:3;,LMAU-TR*C#\[
M;..MSDL]L$<>8_,(%0CDQ+1ER&;HQM2)$,LT5TRY_+)C?!\0DL$SZ*CG/D@R
M=%>/M!C>*M#I#-VZ..U6Z)4$8M?_8\MUD8:J2:K5^,W4RO>USRH/JFH/OTO]
M#W;>,ZC)?=T;9B][0:1WD-!#DQ*JH-([!A)**"()+1!Z+[H$Z4TZ@0!*)Q!Z
M@-"4%B T*0E=I4N)2%6QO:Q]UCI[[W?>=Y[SG#-GGN?#^7_*9#*33')=OWK?
M"5BTFYL/Q8TJ]T-QDR\=WF^(;F:(B879<)W>AGXP:,HC,+^3=["X,8F82+6M
M>5_:ORXN^=(-"Q37:N@S0+6D)%18D0WG/\OG%I -*-BY[OX!LL0>(QN% 2C#
MGGS#'"R]6\R>:;:N=94<B9AOZ8EW9B/%](C"6^Y^VMQ-E,%5N>9IUHNK_?[E
M[Y!(:[GQ,TY8J#5F<)0QNM]?L!X/ZN)I0,>C29E+U0X-1PK1@'+=>!:U+8[N
ML&QAD[:]\/PYV8(=YLHULN&<8NI0<4HUN"+%^EKQJGE-@23!+@7ZBR;9=$1D
M\??USHE+.R.+ B_DF/]VU#UCJH77L)6V_SF;X,C-]E&UW%SS37U%^;RIPN@3
MD8Q68%"WCV)U97!=RU.96NCC_DFX5TXFQU9^#X&Q J-6%ODUY V75UJPX>HO
M&LDM5,G-?.R@T?ZAO:Z&XP2"VZSY'+NK?@0=DXL#5A<BT*C"42\[GY=NJ?]T
M'R.ZB([2S\Z_ULH*]#?;-;HT A-LF\OK0;-6=/#4I/5B;DT(K$K=_+)9Y#.+
M0^#'RBHTYM)%S?B@[6V)^G9?/I7H;J?*#-H*%-9&O-\.5#UL;%?S7G+F!@LU
M.^OUU=ARV<*%37BP+ /$)*,[X3ZUG":9(=;1;QOHA *-O]<-FH,.C5SU<+6B
M[':YC<KB3;]HV/Q@X%@'R;^E?SU'#V]1\ L37F1LI#8F+UZOXDL+DZXG9K61
M]S+ZNES>]_,*),#=C8^O^/]\\\[@[N/0\M?$B4-[J^\+%J-&HG-2CWV+-R6C
M0"H4FS_:1Z3WRK^UC^,9'%DSUNE L1;Q1-J$^WMQ_W_MH]@C%QS6UR**K2N7
MR=N"OQ*V]MZBZ#ACC.,_U^^8_7._4_'?U^\\.W\46W-O41GK7U\Y[\"_RYPG
M/['T2?ZRJ%.E:@(Z*GLM>NB1,"M@U">?U;!0UF8+B*Y/RXD>DY$!Q>.*GPZE
M@AD[-;@U8[?;HFL@%E)A9;=F0:K]VP>^ESC=K*4;=CWRPI(;,C.Q.1&;02OQ
MOVB$ ]IAV[6%7\RM;5VO+XEW!A]&F>XG"PI:*5N+%55E!..MXNY[4P3-S&+N
M5G<$9Y1MO+I>\$T"9B%UT=-6L3%K@:QB8;='ZVNR "N;8O>?R9XUGSJVEE..
M41%5W&17#J8"2O2&%:H72XH#C2P 'C!E/4US/F;#-4GV73\/<U5Q'_8RU080
M3S\>:__1YZ" T/-3S$-2:U:?/-FDW-,EVJ-DT;DR_AACRZ8,\BH5"KOU86@.
MP;D\D28ZMA1G\5#Q(X.\MVD!<X%3'\8MNY)H5H&^%359R^#_);;R.$RQ_:[Z
M:M1"3BC\*LGC(W)AK5GVZY8ZUR%ZIG*8I!1ANT+*-WS4OS+ )V@/U6Q/5$8>
M)T.(AG&A>2/Z"+_*<VJ?.:P^G"Y>*."\VBR8_XLF+!5UI/J8D26$Q!'I##NF
M8_WL'U(J58^_Q-.<E/8D^$VQ[I93\GMW$0A3;*.EF4MZ%/O,RH*Y0!&FB^0D
M)F[\GKC+EX3QZ7E+Z=S'SGX6TIHZ";ET'9SBRPX0K$:N&_$Z%X7>,/)_M14<
MN'QQ].GO^*#/$G5^TS\ YY)O@/!8H4=7XK:'8UW:1K[F6YB56/"+T4$-A[M0
MM]H1#*AW_"/KA@J 0L"+*I0ZL#0VN?GXE</Z+YHK)-BICAD6,(]=D)Q]]?Z;
M#'LO^?.$2J2&W_[3I,74],PYU9C&CWGZ^>!ZO#>OK/F+V:+M^MLX;J(RT -N
MH,IG%RR?IL]43I(I44I(+%3LOZ.MK6>*':F(C>U\V,AG1INT/P702X5"P;+"
M<QEY]?8/_\V 7S ,=QY3L]S@W%=X?G31M+Q!ZJ[;JMS^LDRE@-.5>C@%_7)F
ML!B:ZOW^0-'3"8$5ZI[PTY,\\MB\. 0=>60*>!BWR,Y='#-]>[9)OT70D[;%
M[U-(:=(7U,"7CV+[< WODSM)G\)M<57XK_CY0#4Z?D]P;7-V7$D[)E!UA$JZ
M_^U=_<*)Q<\S;A(A&@%&Q4KL0+]H+EF2[C-H7',8R7^L1C =$_0[?5*K:A_*
M@AYQ.SH:Y\:IG,OR:[59=G\],(VZ_6GL.+ZNW]9&UJA/L&W*-L5K66"D*DIL
M0W<I?[--1QIDM OB/5,H:]JU+WLI+7K1T6CK.#&U"6R-<3FKK=G].YUA/RN3
M+7Y&O JV593^$I@E.[$'&5Q1T_Y%H]&E?O<TZ+AU:WE@C-&[Q0!%6X6,GE5>
MA6E1J-[N>+M>-))HU9B-K8Y@2,W\++VG:RK^L$5/(_WN)X3-])OI(942N.EV
MC9]$9=56\=/4SN%@1DDM(=Y85>.@P+$$5$W* '>4M%N3Z4X%;!,N)#)S-37M
MJ9W>Y10Z9&<RCVIC3_$M*M,TP)D4M=<_[CNW@+$<-5!5 4^6QE;E,W5&U%R-
M$7.PAC*\O:!.^/:?Q_F\?\)YHMI_%.?5LFU4;&@/BQ_R[3%;K&=4+>YT>.(I
M:Z1XZC#_.8<UEK3LF,<0;H&$C*L'JBM(^_B;\:QMN]+>&.=SZ[^)N>62E[4"
M2XIO^BA'C1E?T*[](0#:,S\ZI(1K*8ONTUG-&U):ZG=";)]MY,Z]O1I(Y]),
MYNKHB;NCQYAJQ9&9*=3G*CZN2KF1XM-F*59&G1:TF.[*[=PSK+9P-/S9Y9 G
MBH;>(TKJ\/M(PE_[)6X+-N*U1P,G6RKX\J=;/M8^UC?.;I_GSAA\"V<K6;KZ
MD>!_&\&H;GNZSV;4#X,#*_(C%+=:/AY\P'V7S724M7O'63;,L0X9'9XSYD]B
M-IO]1<-8.01 :(T/S=K)C&HP.>HV;>N,2Y[;-ZZQE(3HF,K_[);3%O[0$>YM
M_/MLB][J7:N B=IA9A5>/CKCJ-0G##Y.QII4\-V(PLN/>H8R&6TGIZ8-=Q[A
M<:O^S<(U,"C$3#W+")[?MR#QT/+-SYSO]]\M_KXVW%7109F9.$W3PZ.0V3<5
M5R:9J\6XS6I+TK. OCL6U^?:VSY'UA6$:5]1UFK_/.[(.U0=Z5,Q?K&U*E=Q
M95^7Y<!Z047Y1W[$?-H5@6SBID&5,W)QZ"3 *.(X^F>5ZOB7K3(U.;??"CC7
M4=M2):4V)H-+9!/#=QX%=V_QT(;3*8[N2^BQ'*N9"3<&EI7V*Z3K[')N\;4Z
M/+7YQ[T?M735^:4"DIA;%7O(,;O&%N]T+S(U;DR[HH@!S*Q">E:JC^U><'P0
MTCT9J ,=T/)*;4!T,+80!GYZW\EB!<C[)X5F-X]KR9R:YXR8JDQO ;SJ*:?7
MTJ?JEAXG<3G?96D+^J ?5A*(GU'9!;87_41/]1@W(N9^;'A'ZFS!=\OY_F9X
M4B;JL*DT=J-7]=57:?4V6Y1!_DE%L_#+G6PF::1K+OEC-O!4#1\5J-0RM?4]
MVVY)!P<H?IAMXK.)>$, V<>@HAHO""2)R4[E#0F7R)38-\W'F[O3W2Z*4DYB
M;,B^(%K7XE6F7U VHCIF1XW%375ONTBG3P%7)!P"Z2 !R;P6>@$O(V3[V4YI
M_:57>"_XG7RN\%'_K&*:W^G>>DW0NTF+90EEM&APE<#/5=.8NV883WM#)^>C
ME]9ULTU>9[;=;_QW8TU''YQ4ZR$!SIK*/_^[JP#N$()'^).!Y/8.^J504_"T
M9.>,3?B,_#6;*A'"E7+#XBM-7\6GA_F8F9:F(Z<^?]8<\$IS4IBC[NX2M8X9
MN85X^=DS2>M'N5;F@[/U;&M/?)),C/H*G[AXEA:^4IUZ#W?Y6B>AAJK:*,O8
MS7ZB-'&8K9ZG,I3_#O>5;S(OL_T5V%@,/L-)]^Q[?D[52"T[__7E!4V04'>"
MGP6]#Q4]6.]%T8H8K,BMS%94#MZE#CCYZHLL,</Y'^L()!V]J1)/RDHZD!4S
M5PC1UYS1319 &J..'A C%\'!OA<<YD.#IZ]_DTEG/#*(U'-/>Q58W:KF_<SI
M%D9QJ [][4' TPQW L2CH02T[CX>T6XYQJ1Y9";MK'4-* +R? ]]>-\WIZJ\
M5BI@3U]-A[#E.SZ7?%QIJ_=^T>UM&E D2IL#&'S8V[TLJJ#']3/1H^%J3I3R
M&&UN]1@+<K,5]2[#F51VT5QKU6_IW8(P[Q>SFIBKKN]TI.(AGWF1'0_?VS5D
M4=A\9<P9*;E? =ZK6SPF"6)O2,MWGP36'3_H6_E%$^39>,R4_QCE?;2(77'Z
M1;.Z$(B:U:/2HE0OV#X^9!\6DI]F$.A46MV%U[VEH4QQC&I]*^@-+,IKW#VY
M=EE@>N3,_#SI00#Y9]0_M)*5OVL%G]H>ATYBY"9$/D56F,X8JU#?R@Z/F^9T
MU#V0/&GV]>\7%A"$ S M+RQP#/N3Q^_<;TP(7I^1'H>;(9?;2T.7ZVPR;9G2
MAVK+ZD<"[)B.#5&"[EXZ*\?R^-VAUUTO#YM*#P*K'UH:.9)4_1_@-3XM1'XJ
MU?]MU2E>SE6B10AH9' ?W0;D%72U;[!>7U#M%6=WA'6KEP5J>2QW,USAR( 8
M,&:"#J0N"7]1W@Y+&K:%I8-8P;R\4E]"!E%EGS]$MC4[RS;7ROD[@_.:H[O<
MG7="36$G.>$J#B4S+#&)4:,PX%X2U2XH:+(^$6BY1\O.2CN:X64HG&X_#:]-
MJA.@B^.:7E\^$A?3N\^_:34'Q \/=7^8UQ2&O;UZT)MH8_GB76"+*7?C"$?B
MJUM _&6J:UBIH07@UJ[G,86,=@UQ/]7P<C\/34M,_#V81[-NB)]=%$0;E1"Q
M%F_W9EI#G#2[XL8=L  .-A/^C05Z=*AU55G/YN1M0[^QUG!/:5W076+G*I';
MU[G<\['-6T(< M-:Y1#7^<XMN<H'U KE6UE-@"+(U)7O6[T 58>JKB_.SZ3"
M?!R6 2<(8N^T 5>-CG:?@]7KPO<:LB9,J2!K?O*.Y]5?-%%&4TQ7W_\';L3[
M6Z*\1^KDM\I(%]Q0!3YZ/L$)SE[B,?J"+)7(D?.5:.PT0@7+X-Y(-]@X*XEZ
M+V!NN*?I'M23R&O6-^B2E1@&\%R82M<?H+*<J7F81)"J2N5Q6=DS'Y^*#5X8
M&'BDVW*555@:8J>&8V::,,L@Y2D.Q6%6A<9_VD26A%)FL-@#W,O4!KGZ).UR
M@"6B_O6&O6UZO\=M#U?3<8\;BBZV.$73YZ7H.>4G=F\=]2%3/9JB"!3SG$Z.
M*,. ;V+@$_M7\*\7M$?%&(A*@YCX"K.PVYVH4(XJ4FP9M-)T:_JR]C%6T!BO
M7R,KG3CYRC0BH48=)/W)%#.Z\G*^T?YILBDK^Y#9@(=TRO?(",*8M0T6Z^L&
MFZZOB,7$I-9]&!7VF,W,?^4V-=\PWNQJ=#.EC'KM1E>ED;M^^L4:A)V\HU6[
MGJ92P^LFCX^/YBO+R"1-0'*6O'0D,"PO38\?5NV6R=8ABISM>MH/3QK3J0+;
M8:XYP KB,ICU0.E@YG1 !5:C!*O_'"N$1;(**B-OS@X9:V0K$<]D#SM1YQPZ
MWM\X<@+&5S),RUN*E\^%.WA-+#TMJ)R1^Q$PZ;]PGJ(569EU?-G%#[$HHT5Z
MIKGS?L,0RWEA[+;[R6%8FM[G ;'J,6P7NCMU@$=WGK* IE?E9YU3%.M128KV
M6?!<'F?&F;??Z4C\D36*6'U;@JF;=2Y=POZ$>?@@C8NV]6%VX,,H%J_U'JQX
MVX#T&)Q3:7 CDQ$OB=_3-(;N8E@*\H>#1QRPOV@NJ%Q:3GE/=Q[PL"$S?EF'
M@5]@E;OY>7)JRNICC--/U6^@V/4\B@FGF9G7Q(+.E4S-:<-^96?)ZS:KBL3[
M2""SN!6O<X/=H#[2CY3:\,XA/U(11:M4T1(>C#/PV^[T;L$FEBZ,-U93KZHZ
M_**Q<[TS6KQ!*S3?,[^R7FP]C(>+K#,MIHJ+:]H U?,N//@R*J^ZC]L XH-9
M>HIGAQAV8Y.-(4VOG_0._'Y7NH;G\<B\]4BJ!1$9OO]S+E10BJ7L<W,H9)>]
M!>J2Q%MD::#E2@O"^BTBOC4)",/QYNT5;D1&D_DBIU&[8=F*WCZ%U( Y0D,N
M4MP,\VS,('&5U]XL+$VW>7#=YP!;6P9!> ^DR>,K"*F,DW>ALOI;G=[.[4OX
MC5**GTK!:)K<V&"+F8@_LK/0?CC_Z!FZU./PD[>A(\I'.RT[8%7L%;2'8#N)
M#;2=C!E[K+3GPV^#Q1E?LXBLX.3DP&[@Z8=[*C"J9D(WA&4'96:F17:J*4,I
M)1 V=VN!.ZB _L>.L&@W_\+:7A'LFT]FYAGL# &F/(*.R0&C%K::-Z5'TY@(
M8SIB8^:+4.O*_C[OMFG_-<V.CC#G/%2Q7)YJ*5\'>HMJ.>,_?%O INP]JA:K
MBQ(5Z5NUTA#FYJMCB)6H7SV_O&HM!P2JR 2Y+\G5)[^/DE3;$2!4=;1U4'"Y
M=+FM>SN298VJ<1X%C-_>^=7DS:<=55T<GVX;AX^[N9J-[52V4V_@O+)?C &W
M1;<;Y2K%KD,2YINP*?9H<>?KQA%ST-Q+0^TEZ4./07L.0&DH?9"[M<1VC/8
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M B[<P/D^T<,HCW 5.!4=## +K+0  ^F-(,/1VEKN^0W:']O-A+R[&U1C*P:
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M6?@9J;2FTZ;\E8(>'\E2W^>U?9UX<K'XNH.!N+]/WWI1VJ=$<8%$5,Q@LY7
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M=W"BJFN$'K.9,,_:0- Q5FG/T1J8MIV62385HW='"F*;K6<ED-MY!ARJIC/
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MQ%$]US3WT$_,I,O9'[<!4F4U2<8HEG,+%TIA<%[><#?U4PTV^J@GTQ;PYOE
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MC$3ZS<?8!E(RRG@K#,YD7#<YK)_?@"EX=!Q8OP&'S.8T6#YA+.DUGS^;)_I
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M--^7JB"4D76NP'<Z&=B6;YD%#A+$-ZA*A9TGNLB8<<?+5SW(!)S?''@5J#[
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MRM#33.TERP5-F3/0YK8Y\%;%Q_#N6U6B9T_*DD8):$JF>W(E@+AE?V&S;]#
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MRG,<;/^K_ST[\$XW:7/H9]V(42$J>LI6M2FKS\-A>FX$4@TV^L>2(!I:L;_
M8A,@)>N>$?,<BO5E&M)G$'?@U4#E"M"LLK:.)W$FQI<WZ.*EQ$ZSJ*X6UV6E
M2Y/$0I?F+<PY3RVW[Q]NR=_P7 Y.M=@RP8-57M77W*W6K)]#:+NQ*<M!2BPM
MH7GR3^JPP4GIQUV]1K,@F)QD..//\B'@OG-^L1/[,I'A8,3O3;RNQU0Z(*4Y
M<BPF]?^ C</_&QN+?0%Z8,4]S8AB+4!!FKRKZ.?-8I%&E=AFM"V"7CZOUHL$
MBW2XGFW8ZZ[79\7G7%12$&408,7K7<#9JBB=7L!Z..B?F.@_QWF&] 5BTJ%
M*;H0TWO#?''#_W/Q%'74V?G/CJ"L0D3=62S[IS@X>-<GK>DP&N!DMF!46<1D
M/8[ D^^N%PL_?6OY9@[25-N6AHR-?N*<^E&*$GYO-><R?.H]J!M2CYTSDMTV
M6%7OHWMILZ&MF=W&F="/ A=AX3FZO]0.(\5.3[?GX]>8RC#?]5.SI\QF;+61
MUX9U,Y8OC(;:^WGRL)VHL;]W+9[7-YM\@^]#[^T10-Z?*@:%+74)G@[\7E[,
MDWKWJK4X-BO@2$ *.)2$56KU^TWA=9)16<D38)E2"_!=M@IH1F9Y3L^D,C6
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MSBKU-2K&"T9Q=<3I6B%A6[;Z25?[!T<Z;?_D ;VE,I[0Y7U99L^N3,0/"01
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MWUQGAFQ5ZA<@=AM,IRT+XTH4<IQA<**<UP+Q%";(-3IL6<80WE>O1&_<<B<
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MJ(EC_ESI,]MI,]!T_AZ0EMZSE*[_HF5*M<GH#]B2&4_,(&_@8#72AE%[M3A
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M;\Z; ED  ;FNZ9SIFUAZL3M4$S@IG;D=[>#L_=I&PB*\Z354WC7KM2J':^T
MANTZNMQ9[OKZ%K*AM!YHYJK -)?/U?=TY(*2PK -+SJ1"O7*6R;BT-BXM(#V
M@WR#+6#;G$I]%?%:_%'^$X(BDQ[OYB7$=L.1".%==_K*L'A/_@-7M^7T+\Z2
M6:K%3WI/A;((X$:B/2-:<&7#77E3:) AYO4. PQ"\LN.['QZ.C,1 BD9;NLO
MR.VG#_'W;D&<\X](9$_27AR%1[??3@R3E5Y:^G;&LHJ0N.)?B*IFG3Y5B]XA
MN*GQ!%'$;EM6=L9Q]5M=FR:TTQ)3?T'T!SH$6C 3MYV>3<&X7#BV55"=;13-
MHD+0?YVLV]?&O,Y0*I0:F#3? S5)FM&]2BN>8ROOXO19YREH;^>E<<A&NA 1
M2V),41%._0'LJJV=$I*--2_WTB*Z/AFL=/&AKE&-5" ?L"J&&>$/['?HZ1P7
M%G X#^$Q[@D(L%&_%>:J^Z@<"D1R3O?),K#,D.L##&J_W:C3=(#>HH6=#NG(
MRW1"87:;:,WG"U\):[18QUR=1"5XL1&FY'CL:MZ"Y<4B@L040-(K6%LHRBFR
M(5$:YYEQQQWTMCS90HI>C,^L)&B7K0&$'O<>^QKN-5OW_DIO)0'YR/.WE]CX
M5$URVGS0;.8 VB7I7%A"+D'7:+3.$\0FFO;%;8>[ &HA'9#..3VP.EV&P"D0
M8$8\MXR8LT0%);"3X(]$,W$,GJ2_W<FN/FA6%--D(3(VF%-ULE7"U6*E^.WQ
MYY6>B&KXCF6'SM5RIV//2J?C7^<-%9#696)- DF:Y0% 4O#9&+_=>>OECR?C
M&S^Y^ 8[A*>>2=]CX9RN_?JPE&W*Y#C8.M_=X!9H>'+Q@JO$UWAOSLK87-=<
M^OHW;3.O3%5B$@SH4P)^;26MVB=%>>>35<%A]K*WM=ZT0TBGN7=KL,N5)'/'
M? 3X;G;)<Y.OWU)[NY*D=@-NQJL:PK\P3Y Z/.UU#-G;<!3;2BNLUJ6" =MH
M<I>Y 6YYG4<MM@\H2W">;K9'IPQ5.69X31^T]X)] VV,G<XT7IAQ(!"IUMI]
M=;[XYO$;<\7#B:+Q+ #I=4;S)<.+PV,&9-D1)&N9M"JRL*OW%LS;B"4=)VC=
M?O%-[]=+"7+9?P1MR8@KK\L\]5]7-/R\AVJSUK7E",=5O<K0\C*4I X#UF$8
M@:NYCRE#SLZ<_;[^@&HY(3\)OA"U1$<]L1B[('[&3 W$,)$57<Y$W$<E!ZKF
MVP6$+BLFEWLK]0.\*X,[&A\1YA;N!5*K6+PLLHO<E3^NZ4XKWM>2PV8KC^Y?
M349;*'ZU7O$-!->5-_1,V2'S4H;AUN;NM&A9X[KP7-Y8\0%4UC-9 ]N/O;*&
M2I3JS%Y%U8#T-:[M/G]@2S.2PR2*(FMI'"0#>TB5NE$=$HN9KZG@]RQX@R<M
MZ0\]#U#4L>Y_ MT=QH_CRH-,D[#V>"G)3(/G":+.;!Q<A@:9Y!'9F:0DR%+Z
M@U0X:6[=,<LEC>+3+U0]5%EQ8A/B&<S0*'\9T!STG*?\D?R$I,+5J8UB&XTM
M#<[6C =X_=]6$KV0W+ITB#)UV<.E[KF86>O.5>]%?/IJP\;&UYD,7;I.E$68
M0F[-X"O\&\M1PEIIT5(%UT-4T$7KQ '1#=4.684%AQNPCCWB?%AKQK8T+_20
MR0_]X/GKB1"S_-.D[:LV4 78R=<[NM:58<ILDO*)2;!R_<9+P#V72?#N,Z))
MWWU;X3=([,=)_Q-S(X)5'FX0* V%A%>:]\"+?K=^2;X-092#;22'2A?@!,A>
M/^IA%GJ<]Z]QFW2CWXIOL]3/XN%CBCS?S)FSY-QJ77,GW<OF=.01'\F&"NSB
MEY%+(GW(HCK).ZSU90T*P[](\<'@$80U]Q<KKLHUB1121+L^*HY4K'"4X*_C
M@%J="@_!PJ\"XBA*B RS="E!)R%KEG1NB4N!9WHGPS.-O@9K?!6/5Z15HS+=
MX&D6S DL@-F%0P,I0+&3&6 9PO=!P&/8><#N0ANOOOR$ZCOC[?[',93R?"^^
M;$AG2[RXN022VX2[>A*7M@)8ZY+#^!N]6^,\LSVZ_L^'J_7*P*%C[=+[Q1;F
MIH+86 =QN#SQR@;J+6%3 1H,9@2=T),?_$<D\/Y8*G M:0TT$I#D_/NSH2[H
MCEE HI.MK5='U,#\C;!I*>9%,:AU\,(4W2O1E7MY.C ?W2,5LS4KYI.^UOED
MP%EX:]3O2>7G,B\_$$%[#6ISU2>/0V73EA;L FT:H-<DUWJDXDQ"4/.*^2)/
MZQ4K381JS./UOV[6$#^Y6Y79EX[;?55B5V4I39?-<!G"@T 0;&9N'U"YQ'83
M5HF+SZH51& QPS[Q*UHP&Q9,V/6(O\]E\GJBWRQ!]1%WM+6WA52/VEMI9[.O
M&M_D_GTNHMO^ AJ9>#Y8LFV7W(7Z$!T224>IJNI(09O]YH.&CJ3RC"3D=3?1
MJQ^&X3:O3O.5(C[/ RPG=@Q'<0KB;LS08J;&8*E'L58PYHHP0 "Y:0CLN#?4
M/+MT)<2*TMF_GYJ<HG/,!-L0K#K<U[GS@9=^"+LY<%/NBV*EQR:;DZ]@OT,.
M//]SPC27*/+F>!)F>]=HJ72)[D_Y"E-5IVFE.+F?74\!H!.=ELW2 0#KW,?[
M^4*^\&3091OIA9G98]@4<]5+D6@7.XG 4,UJ6]8^K092V#W216B9HESZHM&<
ML_(=Z_X.;R= K:!U!&JZA[@1C\4['GBTW7#8YO[J%=S8/D$2,5D<RH"HL0]?
M\ZU5>9Q06C7AHW#NZ)$"$B,RX/T1MZ8L/EBT//+;,)*]O[AX?YD):9^=4UE%
MR3P8OWU=T%(-@PD?!P)E2W*O<'%=NM?HR-^5)X;8VYQ*,<H/3N96,J#>*XX5
M9Q% .+MS]B'^'UVI$?"%&[M6*7/>JL5_>$TI-':, <9XK^,+]3TS>17]GPVE
M;\_=K7F/*VX 9(N F)(XR_L"L,'H!2F37;\C_/2]T&&E3CF&F LAI$;LX>_>
M$W-L3;3R3Y+$1,F=J2*"Y4?AW*&WHV^':(>E25ISPNV($><5)Q'GN?(V]WOW
MBB6*7QMI_KHC,J/;Q&1?<!G:2)/-:2UN4#"H))W$M&ES#G,"Y7YE3%XGC[GF
MKXR!>']JD=#TBA\F:D1%2#1*O+@Z2;M(NN#-Z>\Z_/Q)X8UYE^];6]ML[.(F
MS30"N;"W4<]0-,$N@)?QO082>.=&S@=A(V@DKU)<+P8;&;V[=>2Y7B1V^N[G
M\Q-PV$];]4>?I83>&F*S/B]P1SVNDAGB62\VF^61SO[S0:YQ>=-M+?D *:2)
M:+@9X-E@4L5\<$YL__Z2D$A"OS#F2@ AQ -[&=]7KG0M2WD]VW*UN=F>3>O3
MHS$B0R3XP[4[KE6CW;,2Z9]7AJ _@TV2YB3S(^X%(CZIFRN$2-J7Q)C)HIHF
M95'%:WP=+0,]. GS?A&T:YH)Q<M\\K[K^9#XG>.L\61:Q@,$DF+\AQ:C)N:\
MCE5->_MYOF #FWQ/!4*UU_%SL$K$S&TWRX[NJY*YLG/+*WUPD"BMN/,(CV9X
M'RBC?2R#T$EM-4L-@Y'\:J(:![3R+Z1NOP)B]>E920#OA-?KI16;-UX<2*8O
M&P*$;F.&_4[6)Q,":LE)S[$^VW@[(=IY*T6E>7G;@O21\FYR!$&7D_$NJ&6V
M9R8XKVY*:W@8TILR(A7:#ID9]AQM1XM\K@U5V;1BU'C5JPJ2'LVMS.A=1W7]
M9=_3Y\&<WW[!6/\;*=HA/H@@D\= R^531MY.<7%NJ#_HKW._Z3TTMWEY\ONC
MLS9U['%6X?B9PEG-@L2)Y4QF3="26)-]X<^VH^C^*RU1OFH51XL5,:$/([Y$
M7=7I#%$[**"'L*'U%,))9+K]1[#M3!(SFV3 ID**ET];=V7NUZRJ,X&YW[[O
M?_EZE#N^@+ING @]9?S$'5U_DS2!6E)K"-8?/7A2;['],R0\@P% UAVA:XKO
MY)  M*PV4:KO&Z?:X:\<YA1-HRZ#/L*JBC6_-8CJR]WJ6QROK/$(&RMKF+0F
M;HN>4Q>V16>C:+)00$J/"!)1O+#[\LA&FF)7&3XAGRC5\)2]UC:^N ,I\= I
MT_G*-<X/#_@ZA.)NWVZ D)PHO+C7D/G*7Q</Y_;VR"7VXK8K4+@UZ>]S67%B
M."4.,&(Z*^IE66E0E$ @^\X#M+5#J.?/]E(- T^7PZ>#91]&.4WOI>O()P R
M3/M<3''D:]BJN2/.E?[]M=]O?UM.;?/*IX$UI2G.&;N^7JUHM/:4PT.<,^;O
M<Z]J%RR,KE6K#G)]/L99?_J7#Z?&>[F-G$]QZU/'F#G'^._./YD/+_[+NU.4
MU8JCU'-7O4Y-19E!E,HS"T2( YX.ER@_&:=90V"^F]J"MI2>.JS+L]6J$WJ7
M?2 N#>%QS_ONMFU%QO&E'2,S#@Z3,2BU)UUQMG?%& :QDO!T"O^%3\(1,I5Q
M^?1YKQ/G[?D8'9KU:8:GT0=%<,/Y9$BTC?'N -#0N@:8[.BUQYE=MS&0HWB5
M0NW0.W]OG7KYXX9SJ[KLD<[48YHL[EB.J$5$5+A\HI[HD#FGCJ@D4?#6[5=2
MU[KY6[__-..M_7GAZ7ZKO_WB@N6H3H?IX*U]I1.^?>9_<S6^KC-XYW-(Y?U=
M(?>2#^+WBP<Z9(W&%TX>ZL@Y"K4>2U=-[.WC"BXWGT*<H JG()&,K9VQ)QLS
MLK>C>_7FG9NJ<F;Z/58'EC.$?2QD! '8.\(!*VG#< 1.K!S%'3->4.<U1I]E
M:R"&X"!EF$_>AU>FVZ3"37C=1:AC$X]'"OLZ(!?[W0/3R_L]/JV2\<YI)F%&
MADC;?VRDEB4P3S>FQ"[1LRT^#^S8K8NV7PGX,Z>O-RKWYUU":VI;PR1#Y4G"
MB&_%90EQ!ZSFDUXM^4')D6;C;F"^[>OY:J>J#!]NJ:N4@ 597R,>;Z)R*S96
MBH;&K'.K=<JXV5^3J@\](05DL93LJ($;/>%;!3Y$A;[N*0]^L$CM)*K7:08"
MUDTZ@HC6E%\T^<'MGCCR<(63^HUZYT<1XA\DOTD Z[A!J2ZS1VK-LY4U(XDO
M^P/^>PS-ZS\9FO__8&A&X8Q(\XB.'Y"J"(^Q"^$W)-QAD2+W++[SG"2LO_YT
M<C'2C/?Q3Y6S_;:DR)Z(^K.X\+@AU8&9S\=4E!'I ZQ()NKVA@.WO,9^-'6&
MYJ!G3#S3/BL.]_#*!G=\+S[(UC.Z*T$^-BJ?U(/PA+-+V1755QVP+B<7&OAJ
MU5E^G5UUTO\R8\8WZA2FQ(A,76&3*$G7[Y^#MT4_8WM*NPJ]K</'\JO.A(;"
M6+8SL8#YO&;$\^0FJ.3-X-;)P0C5N'KSE1PC#8@\9:203WL0W!+8]36B,C=Q
MOO3UX#R'\O;VVSJH>4T*A'5 L"2=7E,9-I],#'I:6)LW0SH"7S*GZ=;S\ _7
M$]@VP!$IK'V(?*3!3*FS$+I^+^F(!1!BM76F<5B-HO<)XO9%*OK5DB"C4*T5
MFXODV=8W_E.#WI/Y@M%-N K+[02W*:6KAPN=(5>6N$S(;EY 8$"?9<Z(JEZ,
M:G7PW^?N@E*=I@^@]M ZA:UP>Z?B"L'9J++@POI''T"UV=,'\GY$=*X?2?\1
MZ60_^.20<S.W2CH#4S+PR4VT/$28&IKFC_;>CW#I^-K,]RS@V,^R&>9-&LI:
MW4C<Z@B>;$_PR5II?/AXWWHSW3:(\16A4 -Y(T\:JW^'T82\]:JIT&XS[,7P
M?L1S:P.(JJ+?$TQ' J)=H8-S:P]=(@--9:50M@E4=!S[( N]#X1K1Z.CQ D&
M>YW$<$V+Z>\72I\H.F/B9TAM>;,'ROB)N*OWM,Q\8_0.]EDVJH.@XOZ/FBD-
M_V)ZZJ6F>+\2VYI?J<5NF3;%-JSSS\C);=&@TM$GFB*MLF'U>8-$^Y!G8S6S
M>CW!R2O_DN=85<9X+'+FXTI*?/U(WX :\"==-4DXMXWPH7X61!+GSZHG0)?!
MIOEE"8G.<Y/V,"W@*<=0Z8Q\>G(P_9&*!CYDZ$Z]?P;)V$I5-Y$8/#9^R>22
ME.VKUT9Y+V3C$3Q<?<BD%%XNCA=5[S#*-\3J%,W)DX?]''P54:6;^HE@W6B\
MT5NBAIE7<I:)2):@M)BD\9+S+>CGYL??Q#%]".APT;(T"J20$C[O!&C+$.\=
M];K]E7:KG7R=RV;-XO*.(J<*1C-GSIQHO;6_]YX--^SW,B\=\<ZQ,#LXXW*.
MKK+E(+)*W#-,9X0%W.:V?J]AD[=4P,![Z7SQQ,AD^ZK:+1!'G9D^.D2*WH'&
M_Q#>PHPU_7UNCQ[^84_J>$<NDDO^Q_L.A_WW?3)K+S9^-::Z"C%'B5LWUK8R
M9&&?[Y6OAH@K@ 3'10457LLE\4U\%]M4<ALFRV&#"S0S6[;/3.+^806 W!CH
MKVHMD$S\;TP:>(MXDW9FES>*7_?^)U6J5JIQ_\GWY=W>1.#/I2E-J1<AID$L
M-%GE?N0=6.2CP3ILU=*%K+T"5]OEIS%%,\K^YKE3[_.C[:D+][?6!+6\\O)Y
M;G]=N!G$*N[_S]3)V9FO@/RV5Q)8XB=AF_PK:UQ-/3!3MX8MW(A2<@\8.6[^
MX[N2OD+<%GG:#Y$/-GS,XS458S6*<53E;+OOZ%[.'LO,5?^@QA?H+*:,-?(V
M[VT&PA]+[S%HOWAS:3L:3?6Z9/P-K]0_L1ZJ%S;*%-8_(X7P<;SU(%UJ9:N0
M=<FV)J_D2B"C76]B9U?8Y@\H6N*(*=H=FZ!P*MH1E<4(7[N<Q5.X%&+Q@T=R
MTT7]19%8Z-25/_]BL#R(':OG)M%UT#02M'#F]?U75BRIB&"_R;_(*D7Z;?>U
MI2> $-<VS/WT&(KAM+?[N31]@KF07:1RM4W@A3QAN)HM([$?;E4Z\-^88?Z>
MF+<JE0H&KPP@O/+^472,#"KJ>8W^_.V&W;]9?LOX_\NDSC7^.\]/YN],/I^S
MAPAWX84Y6+=7V_SF <TV]A\CY5 H_3=^:HY&I.Y3SP&I6@6N;2*BUR,E)^6H
MCQ_<UJ2Z+[P[G&UH&OQR11$^U26WL; J2Z4U @1Q_@+:ST.Y=/LZMG1$R&PF
M'*UF</+,R,A-QC?-(72!<2XOK,FZAA>VK!!,M";L\Y@,3TN:7^G0\4N.??X\
M-KF9G):5DY6&R ^NL2DOWN%X_.M,.#MSE1@;J[H[X?GC4XU$1K Q<#0ZQ*RC
M!L4&2SEU&6HO3P\G1-WE>W/P[LT/2, W6Z<%TP]/"O,R[Z>*AC0ZZ#&)'0:&
M2+\:IR^4-9ZF>GGY&/ZQL_?ZI9="HXP"FE<3DUZP3& #MV/*3<7SJ!795X[!
MXE^Q(:[;9[;!4SW3QZ6Z/3 ;CF=2JUG?7)*272UP"E)&;(U8F\[$NL.SL5K%
M9B_5854G&#\O1;YQS/L]:>-KV>4\_0+%B<<W7(0L0*:VL2-7"<CG6/*9P4='
M[)2L=SA 1EI3?DIA/0R-QN;J/SU\'%#7&G;X>K)#MUIEU=G-D\<FO'5[I"@X
MM-S4) \SDDDVXQQ0T=.=MLFT_2W".5XCHC2Q K+XZ Y125M'02^X/,;3Q#M-
M5;'X4#FSFVY?3O Q+:NO=>HUJN5R71 [O/#IAO+=^+5'/K/SQ9Z6[0_RZ<A8
M*92KAM)CG.@>5ZMDGTFF%=[LY3IN^[5=7]%W,__7U\UXV!3D)S=WDJ$&/ZP-
MJA7N0\7(9#9DP&=%+Q=O:]&L*0Z^UW6K-I.'=!)>?W8[(];IYV8H8#CL>6JI
M_6T@6\9WG1@/2B=">YNGNC6W[W*>FZ*_[;B7G5!:,G7%%(^E*]AO)6L1=4EG
MZI&BZD%_G]N22'\S^;'M>VMC[I2?2]/WOM0B>LB3N:?WD!,)<Q^U#]YP!%-M
M_LP;LYY50GS*KA=/U."?TWLW!2SQB3&I:@G/+)<P;HLF 7JD;7@N49!S2_*B
M%7F%PW KOXM0>^9BS.O*V.)Y2$UCG&#%#=A-QJ(6P51ZK6FM5>6P:X%Q&K&9
M#WX#0< 6AM)>M.D0OQPGC!VS=;;5V0^/V>JNM'&!AGV<$X2%/@^U^+8&S'\I
M'6&Q(IB/*B38_#F]!-7C<C."0H"'!K\7-BE'EZ:Q.4>2P]A\*),?I<C]OC8!
M<3DT-LG9WWU,%7MD;WHT#6FAL+=[?UN\ '[G4A.86\IEA4\\=I-!6 RE;8.0
M<T?+;YR9A(%O-X7!\)_8JV[%>>(,;R,=L9F>\!1-W0#20VM==\QN($I*>4=?
MO+1V\_KJ"X8U*%LNY>]SE^F:XQH4<VO=$<:QCVX%G/RXH&JIM7_Z.[=^[3'/
MU'>IYNI(C),VBL@HZFX8(6=NC'H!@_*V,.)SK#&*CZX*;.O]M.I!M0[.#K8<
M;;YM([0FJ*09/<'VWDN;O3?=YQN\*FHVHH=EO@8'E-1T^)KE65:B%];B>XS#
MS/HN,]:**?PZG\UY5+L?L(R]F^^JM?[P0*:SX,:%/0W4[> ;EW<I.07]T<=V
M8\B4D3GF\%S?#ZV;N5LV\EB%,2&"1'Z40I7O<ZY(MX?X+*'U.]51HL'W.KO;
MRR*?GWA8.G5"SE3"2_/\G<:L2@\^+A:TKCD]KZ1)8"67(HBQH^[9J7_5:H#E
MQJ%$>[VA8?T63QX.?IK@,E6RM=0@IM^S,>F:_@L+F!IW%FY@UQ#2&J0]WK<F
M%9_6/*YYN!OYKDK)[_)W![\)'HCM]FR^W;7.)P56AS$+C4\))*P[SFWA0:P]
MO$I,BCL);XZ0HIF0,=T]AH%#3A\KI!')J2FOD\,ES/?]R[!..@WZ(:T*.B*T
MCS:A\4F'MF=_JD:MQT5]RUKZTM';7M;9I:8@^>5?U>C*_$Q[YE(A)B,Y9B[_
M5!]NE?"<33>^()]XKPD$@HX\/8()65J[.Q6H"V2>VKH*\G"-3G,>]4J,TQ6H
MV'B<RQU)DYIT4,T_4&?.H EZX,Q5"5+^7AFF7=F1E)40/JL-!&<\=]3BJW\Z
M#,YK@[>&=<47N\LR)1TM@7C9V-A[%T'%Q655;R-_^W)B=DHC=Y@J]&;@+C0Z
MSL&;5*HC)_X,C<Q;<XS'3TT?(R,**!% MX ESM5Y^I7"D>U'1T?NOY#JL%,R
M,ET8#JA)[#H3?]$]1Z\F((I%JMZ=R7KYN)(/CC83@M3*27U-#']O<\/&F0)7
M%/Z#DU6+)8Y+=*<4WM!0S:BN,E74URRZJ'BM<"@R*4ES*<++><RZO<HQQR4I
M3<HYC3) *MRQM@9<E#V87,9&2#ZP@152!B%J/GQ<O!0RL'CGP\/08BEK!8T'
M+OTFFIDQ?:I(+/,]--[)'XLQN4W[*"O:L%S!>PS%9DKG?Y@U\S'0?$F%]&Q*
M58$[]7I%-8\;Q86[:U0!ZPE7*V;7 "];^IZ^7?U<YF1]1&;!L#%?SQ)G'YB;
MDA$L+EREU1.W;QWJ2^^BRB=<:NFBM*O"0;BQ*_:10:1V@TUY_&0>I-/M4[]3
M8+HVT#L7XRXFCDS/4.[38?4J@!/9?L6R;&263JZIYZW\%1VB5B"U:#\Z6=;B
M!SS!2//SP'RI^].I;.LW#"A[R->'NSF0M_5& 4^,>K,CCY5E4%]\=UM'W=T]
M5G!9VZ?_4M1ZW1+X FS_I:@AW78+>,H@W)$4\J%VF607-5.#Y-M;^7@0\'IR
M5\1(23$WOEH=E'5JZRB]"5*:/C/9JQ\X6\1U:,'4.W673I?R%G#%7.<O/KU(
M8^)SJC;LL=S\RF06>4OU=^$1)VZ3](Z.];E ;/@(ESJ\PGVV,FW(X.]S76F]
M)B;>MF@$& PQ _";N?@,FU0(7'-E,%3M-UH7:< _ZKP3RWQ3+P<E/L\9R#(?
M%6%_2\TL[T/8BC.2W'_?M#RN20+#EB'&J2C.K X3%HRW>C*'X^;/$GL?7WI(
M7G /[@$HW=.]>.:U#VU-_Y8\1L6G_!7_@#8!44IFPK+9KET (7_DO@41_H,J
MV3XC>(U_96,# 0OS'FF\@%QJ:*BUUM;6ED<*" G=76'W%IJ6T]JQ5PO?HTSX
MCI5HK^>"61_W"KI(_P+9G",ZK&!8O;*1/LG5_G<S[.&%CQ E9J[VU=V;LZH>
M#34%"DB*(3 Z=N0F*-VN[05;*QO4'&RZ7"%0'\TZ/2*7,F;3BU/;/J.A+MS@
M*C_N0[EL848.2]<^^N2AGI/RFN; 6?6N!;-?#P=Y_\@ Y7!]X\KK;$J+SW^1
MG6(U%%&M58W*G/)>N< *#H2*#SC_NB,B5!^@KF6+S@HOE^. FFM78=@_/&[V
M>,=5<E$;$9TL9_$./N"K^9GB@[6XX.$3P$6JE-F-"7;U?V:=]XK^MB::^3JY
MSH"EZ[2Z2*V@H+BX%Z!X0IR2FR9YBI>.21"$_J/"1B]^Y5E.H*:6Q'[YUM"8
M6A?YLW!836[Y[W.A474.NK4/\7$#=A=*0Z\TIL_SO#/>8!/Y'ATIKX_2=!W_
M?"E#_(#^7#<V180 %Q[5=WT,"L@\)4S<G#ZS=7&I5UY.?RVM,++-\HPM=+)O
M$='/!]SDI1]M=E=B=:T5VUP(C$7G+2+HFPT88<=+1A<1J++Y,1E^,<PIMCK4
M/L)*XJ0_SDTF."]6)M!VJ;F9BQ,#AD\OUQLT_,<,-?;Z*Z,]OH7]69/6!O<4
MHS#QC_'Y076O=#<5FK/_TB10$I$^HD1:\M,ONA7&^8(&@QPM&N ,454LMF58
M1WBVR6*!%F#C4QAWRQ#/7&^2'=0>;.57TE\ZH)[7M, ^;?B51"R*FO05RO,)
M?!"!#]EVVG'LY--2F-8[]9H?G]-7&(WPUI-4!*[_K+_O'9G6;_ZC '<TQZ4<
MGCMBW>>ZG4%<'.RB#47,NPY(76FEI_N5-S]]S?#J/GXZ)U1-@@%/FHS#8?*L
M1Q25ZLFJZ1!BE@#3!W^C=W<X1V=&?ML;&-DF&.$ %R&\12BDW2343(;YTOW_
M_;]>7&6<C!7=Y=,X>/<J H+XP_5^D7A(G8/A=7N9Y>$CSW7Q+\H)[^4J8I<^
M17$&;\]6-?':'E7PRQ/ZFY539UE,MC@:%Q2(\-$'C:)7!#)SFLS-3<Q$$Y#I
MI08?6TXY[[CUP*WDIFF0RA4M2J[Q2\?)VIA4A-0*'+ R$MM^:/6YHLM7V)\G
M8I_%R)PD_'1@ZBRQW39$M=YUS2EMKQ:YB=-Z$P-6T:I4V7VIJ ,6"RIJ>MRK
MKD[Q!YA:3!H^GO[@2FM.3(.666D8,\F5.4D=-*9B;LX7YD7]\-VXH\.,^.&"
MD'R,^[%VIJHFBEF/4HR*__N<88_)@>RZZKM.9("S^XZ1EH4T'1*H?D2$MT 7
M94P/+>,K.7V"\#Y2PCP-T>]@V!$WHXW=2ZIE6$6@EFZ+)I=X$HIZ0EE?U=:J
M3&[SNP0XNF:@GG(U'K9?C*^U>C=0D.&F$J5E$^X>A&TYF"[WOB9UG&Q#>BWB
M7]EMS5\B>E8EV6^EOZT;UM_KE!3H#<,TJ@QERM'R2!KBP=0F.Q=_A%(W*QQ&
MA(I#E[4P>'?[45N\04HIP=H<5VT$,<L0Z6P6QRW4<\A^/G7(5?%*R)A0-/-X
M"J*^'=E%/G[I*N2.\FNKX=QX3^_@D1%G<LBJ-U5X:JHOU\U/U$U'[-H0BBT%
MDM'3WLPNS+F2=-7G<Y09TQ0Q50=51YL@G\5&E2.6"<6*EW:H$WN_!>DM=8"^
MQX+-.Z_-K$8S.TUY5X)\1314C[.K(3!,N9R\S*X7XPG<\^9O%$5!8K@J?B&*
MYO-)H4&VB-*!57MP<TPDOS2PJ259^&4U8&H>VO@,Z';J*W1X4M<^T!N;T!0*
M]LW8*;MW[0%C]IG8518N\_R'PO/E/82FKDPQQ[O;HPQ]X=S+R*K<"O<1?V@T
MV_-^X?6W9 Y\+YW3X(CH.=^=:U;5/W5 ,5TS%@U7AD>.=%>-6C+]+ML6 8Y.
M3W5P#]!'AEB^?/T@LTB2Q:5F;!;Q8[[4T?5EFHH!\"!6:X//H-16*II_O! P
MU3 ;%$Q8$+/*KH)S8&Z_;X 0[\V[8GV:Q<Q[Y?>R01W6DFJ>64',_ IA<8;[
M8Z-??C3=_Q*B#,W5B&*V2/80'FW'3_N>.+^L.@JQ4I3]IQ'L&>P>_7WN!_B/
MRNZ:@:2CHA\BJ;'WJ=P)(V=F7?[O$AA%:2Q<'HTG8,/QP,HXLKI)O;?G4-;M
MZ'.O;VW[NZ6SQPVW2U(^]FDDF-LTD@VZB0\D'@PG*[,A#I6I"BS"-UMABUH4
MVB=QY-@N[N'M;]RU=TG90AMS\3/8A(6C\K67Q#% WD87.[UP!K8E,VD-GR%Z
M(J]:25MX5AB5F;V34Z)P D$PV?W7>MB:TKSB34'S4D.C"\UQ[\$?-2^ +9C4
MUJ@I5K;MNEA^=,75+X40;(%)T\7^#;;^SM>\RI6^W/9=KU":Z_ [GE/K,-*Q
M'RO=B"O[+U"%-\^GE!\^]''FS?2.7[A =9!]N&TT0G:2 C(;UYUU-S.J,:^]
MD+4\GM"?N61BP8.S,3L/XL4JSF2-%-=>=9'RF604I"CH0!(=))1W54@NP2NJ
M]L!))7;RGRFO;LUY:8O&E+:(SZ5AMY_6_1P?X-C>7X )HR,B7[?)LC8=;XQS
MA7+CX4'7>^W 5'">-(>@Y?_%RGM_-8&]_[Y^9L8*HO0.(U5"D]X$1B#T%D(2
M(!3I$$(G='"4WJ6%#M(A(8$$$B 41WI'2NA%>@=!0!31,]_SO7>M>W\Y]ZZS
MSOX+]EK[>=9KO_?:KZ?#KE&/8^GN+F?/0VJ/$:0]1$2X43YV?=.(CM%W>*&<
MS)3%)Y>!K+IOM6[9^^<(=AWJ6V&-4<I$/7/G;\D:VCEF%-)/E\!(L9?G.2;V
M.$+':%==Z3U,XEX(B B0L4OH1:_P]\Y5\A=6Z_!_%BAI+QJ5AV1C&WS'!#&I
MAIHMH/: -$'+=T%W]63-I/OTN)R^B=RS+FAN9.N?XR(XD_CLG'_J==\S8#'?
M\OZF,W4!5B_O=/VI[.[='L8D%;FO5O8];HFW-1-37'LDG_;K%K=DWZ];(^TG
MQVV=<2P_W8.(OVZ)T)G\.!YW_&F0QCHC<]"Z)WRUUV>RLOQBZ+\_?2C.AH2K
M0K_VQUV4*NY580BA'AD-3)/]QQVUKVQS(BCKD1]W9"XP*0\%/ A]^+8"7_-4
M63\C1LE7;A_:LGT,@WKIE.RE.[RUL,=NZ#*4^482D(/?6>LK$,X<FO".T,P<
M&O!Y,;IQ9EB!K>FD7*2M1_.>J,&JKHKQSE&%N6.O !OILV=4$*G)>84;X_C5
M<PJH&7C)-B\YQ]:*<2VB%T35%,879[#KNK^LAE@4.-0#ZJLP7@/O8$^%)QJK
M\-G[CSJ44/SO78[U#VZXD;4M?12, 0]EX42]H?J2"!JODQEM:V69(*&9^J,!
M8I^C*K/2/R3N,4V!A+D3*1A]M[GT^9"!5G]+5Z>#+%G"],!%QB+.?+!X,>S.
M)R1>8499\R+S4Y+:4PO/S_GUV>"L993?;*;_V [(6/X+(=>#D\D@[VYK=QYF
M[Z$2MT2O0I7/7F&Y& ;BG\QG9NJ$KRO-M'&^M*KIT&K"7V4D4E3U<?T8OFH(
M\F+\Q:SCV\PPDQ)EFC>7V_"%#WW*6X'UQ,N5^HUP!GG/9I*+DSEQCAM-U[EU
M'L;>" -D;_^\&R<\)!5B^>5'.E@HS^#+HQ1VX_UH2@9>"^8C/%>]I &,,'!?
M#G'0(H':12]#M^//,E[WZ[H=N1.5[3^+8NR8OTG52;R=2I\I<*GJ'(2X.'+^
M>5A?K/+J2=-E\KEJT=V0OW;7,ITVN.6'8\?@;$E,>TL:WR 0DIG&5;9,M3U-
M2 $#GW*&4AY \D'9I?G;$PL#)Z2HY!UEKZ,#6N0V<6'F_O>^@<+XOS*RDX0Z
MYLPHD2SCPAR)KBHAF/,MXX'620EI!V6WME>-A4^-E^#V.(2)**,HHS!$7,)7
M6,E]/70S%",)0E[09@_SPJ9B0SW>J*S:P[;ED\E74Q3PRZ,M^::MCB VLH7<
M$53_1(I7T(0_',:I,6= UV8^E&\1NDJ3M1U0.YC)FZR8=5+C 1V%%R8XYYWY
M%&YWOW16*40?<%#A_^)*\C_1RD;GN(U5D*UX[9"7\V)SX-[\9<+BG::8$*DF
MUX)J ZQ'DR7,(R8Q9+DU-_.M6[I1AOUUCM1>=?24J*$3AML+E>T'-L"\YICA
M@W_H=C=.307DHJ:PA1>#W1_LBR+LE,*@>9NOS.CNY4]((F:>OUKT3YA@RO5=
M+I;7+B?BO_=U\U&)SGI8S65V#6U*8+Y>%9I+]GA(8TOS\G-/.B\3A,5B1\@.
M2!_::RAG/>A<39Z1FY?%H$;]/JFS>'3X!Z4)*Y6.%J3,C&I7KY[BY;0S7A,&
MH(Z(CQB2P!+2,LOMR)+C)O!.YQHFV)/'96C(0.SHH/HN_,'7[]F,XG\@W_RA
MY5>)J02X@1^G?YD&8$%(+55HWX3;.7#?MUOXAT/[$GHC1PZW=\ =55Z]O60L
M-,ARB5"5!NU100ZUBFZ02["(VUT)<$]4D)&-[' EIZ)%[-7\\\CT[]-&2'>$
M1/:%=(D=;SRDCP#8KX SRPIC$9SJ!P^L\8$%WB9X;IYY47Q G(A"2=-BXA;'
MX4AB4QA-8$.MC-M%GX]+7").:DY2<!:YFZ1@TR4.&53?7'5)Y9@ITY-##_1M
MFKP(8V$F""N-)=(@4XZ'.A.%,3J_;EEUYBTI[.W5M8R^5SPQD%%Y ">_!Y(0
M;:-502]AY$,.9NQMBH9?H/PL_]-OOPL<8Z(#7O-+3R1DYDOZ)0+L^6GR.6KW
MK:^VK',\2=*6EZ$QI @!IA&G="'XC$6KY\;&/FKD_<'S#_] 985-]JG&#3.9
MT'KE^<<HC"/+P_4\\Y=\[OD=T7+VA7!#Y@H/BWO;>TU&%(LNMW2QQ^\=V;B>
M54(R@! 2=*3UK':<14MW7;LR'KTYFOYPXR)*B:9YC_(EF4M_BMQO]5VG@%,;
M9F=U0FNCG!PP5OH[_U\Q0=9F[@558P[K8AG73_(JVB82@WSK9A'^P<H'5;A.
M3DZNG9'S9BAZOKK!VL&L ^<D!F<!$F"9PDYG7TN@Y3&#I]\U""^(A[FJW^AA
MGW-MUJ0\?!H5FBUFH@-@C5GA3V.<8ZRT@;19NW(G$O-D<!-^K"SB\X^"1),Z
MTD!^6[#8^GX)=\P++(5JXUSXO$/S-*!OJV]HRQOXTSS3:T1_X81#!>[':5I\
M)+_E?K\@PKDX7:ZL_HGJTT_;OH+J+%T#;M19F+!-EUBZ#8K9QMDDVUPLMC5'
M6FZ(VB@/WA(8SW_]]:RU9K-934.1PG9>M+:JU$)H_"K,)YKC(4CA#;,B60-\
M<FI#Z[3,:>4I5#(ZX^'\BS7,F*N,,"HHJFARC).=3\#Z27)6GRHUPNG\"S^?
MN?9R<U1VV&TRK\YM+< W$&2V;FW3>+"16[U,O$.&,F8=B@3+WT9?]^$633-:
MS.W%'X$R7YFC'>LJ RN>;ZP3M)7E 4/S12[Z[/NC\#^SVIRM)(B*2IQK#^0
M"Q@FC!^?/K6QWA4/J=(Q@XF+0J#"@K6#&:OPK%^W.B3?7ZVE5KU/"$^_V3BW
MN(9](TM@PZA,)865^RJ=FI9\BG"SG1V;U$ W\?+0#BCI#YKYHN5@K%FE/UM$
M]%G\%^LICV=I:'B7A=1GX3 @ZO/Y*!<%2.9ZM_CTZ8$$ Z81I\;+E:P%PVLU
M)R["ID4$'M;V"*3LUXPQ-Z8.,U+5[T)2_SS@22E8C'U>NR:;/1.]K[WJ+G:D
M=X,QZZ,Z@HQ,0X\:W450.5G^]X/JYXK[#?K;; +WRPM?YHH8^ZWIR!PX9K ?
M6A<7=::?$5E,![FF+ZML:?PM]TYS7K,QJOV78_^7[9L;Q9;!:9H+[(VC/8ZX
MDJ!ZYZIHG=1Z _OP(^*\>^-17/ #U\\_K]<=>2Z6 X/PFS<EIV<J+$\@XG*C
MD"+2?\UH<#K(18E!%"YJ.G!HYW'OEPVSE[ZA3M>IBZ]H,E?ZV58+]QN;7V1^
MPV=*[_&YE@:VU+F/D99NILVS;)JK$!1> *H7V!Y%$N MM2@_&P;-_ D*O;&V
MAXU-)B;I8L20+X=*V.4CQX#;?VY%T'H'!6"H=D",I?V1-FR@[^O35*USKKA/
MVS".BWK)"">VL>='9\98O/?%T]O(^)E*W_O2:\K>C-O>!%S!4+!HHRQP9-2&
MZ"6M8:\I+QWS9$I-OS3R@VAIMUP=\4RRZN!19L_@J1'X.MM$CUP\CGEOB+.;
M/(ZK^[;U#S;FWY1H>X&?J7VA#RM9YK7D*R85Z@.US>A%C;)'%BO-TU/YW2VJ
M4XOZ!K65S*N TA6EL T=\^_-XJH:_/FUN5N6ND/:E4!IK'5BH?,;!3O5TJ:O
M1BQ+GXM>#BF;C?8;132*4!4LK'&KA[AFPZBW9>"1M B;D]<\5">OS/:LH:?+
MB09BR)W[!?S<W,J=V-ZIUUS_WCFL,4X5M=IF5UV?L2"0$D3Z"2@U+0)TE?,/
M->1V4RLO=%-[9-/X*TGA>0P^P7P6>H_<=#E4;Q]9-@4=Q1KDF@WZM1DIHP#%
M['F=NA_2AVK3LA\8]GH*4%DM&4A\"!_Q=K4WDK^Q(0 M[B=JYGY#6^M:G\XA
MBK#H,^O-_91W\NJF>-6+>VN]FCZ3EP]_7^ U,+TV?J^/:VX+KB+ZC+3_9U3E
MY2I3T(87^6V0=?;)S_LK%F3/E;!_FTEOJ#A#>THY'X4@!8LU"V49/Z_F2&Q9
M-EO(I1_87"./D%',P> GK\3A1 0\$VY*'GV@19S&99K6V^Q/*IX$J^2*RH(M
M@S<4C02A_$%.R,-*2XD#(:!#;MZUX,!!/8*PWQ^D2^9.2?682_/VJW6W2*VU
M;EWDU@QYW%U1\KL=CN]#2'GCEL1,HN68J"'G7YTB8B1+O< _Y#D^NGD\SBNQ
MP 29$6_VGS#D;DD;GS6])>:K<]6L79M?*\XFZ25@\RZDKXK4[RY*UDX;/S]X
MV^!*VY*$#5;O7[#C1:F@3!["]?1H;J>?/>57"*7H5:WVB5;\NA5\9"(-IE%X
MHEM,ZR#KDO@P<SSTKRCNY^/%P/0?HC.&??KW+$T8M,;^.,#[*;9"AKVB \1_
MW2)@N!KK3LO ;QM,UA8.<V:+V2S(V;6P'9Q&:ZQ8QRDZH5F^ 1!C'RA2Y:#;
MVG7O;;RKX)"E8?.S[GAEV0# C1US:B,.P=)H%$<&(@=&$3X+BS"CQ. C[I$2
M6.=H*\K9 PBYPG)2D+#OA73583:?CA(37NHX&!HUIE9? _U"^O>_(*:[,L=,
M^6%QX5/W\ X[G9GJ3GX9M'IL6+[.=;[%Q<7,-,'J@9UNJ);N1'ZO=5%E7C!Q
MSJ2FGYWQJA6YO!%$NZ( 7-1QP\Q/P43H X_A>$V!MJ![ +  450 F;4I+PUF
M5>KSG;M5H=VP'!_ N \:*0*ZI6:C^B.PN#J%(PA;_B.N=;U $%H4_QK(**!%
MW+DW(BX.#-QI!3)T6(PQ@P3@N7/C:NJ%(A;GU_OB27N23O](FQ1@BOLC]@81
MH>[[I>_5\";<GH%/(_]"<2]U7+JZ^%EMN=1/UTD[ XB2V($%UN+YRRQF$",F
M,RRR[XE5H+W7DLL?<X//-!_W-?=L:4&G=-)3##NKHL^'"R6$ <JU-XNSPMC*
M"/Y;9^ K1<](6S\>C;8N'H3_%P\<,OU5F\O5+&^C(&J+9:P8G% <1*?OO/[V
MVW#T%A_7%G#F17"<!)$PX8>)Z/<UD^1Q$@=F*,Z[&,Q844#Z?E=).ZCT0?ZC
MX<!%1HWJEU]_XHH^W%$)JYDI*&]NZW+GN.RI@\ME\SN1+BFG!B[KU,:#IS*D
MWO2I26T;+JK]NM48_^ILE[?C [,2U<'D2+;R,-WB [G$/(@B:Q2NVWZ8)LA;
ME-,+Q\HG^<#GXDM^/WBMN'FGQ&8EU*UCRKY#=CJ[<<S[_G>4<E<=#9P:F\9?
MMTNM^7:1"+R>LKA<M'JAH?17='@Z'497+)4+8&\Y12EYE*K-9V>-KF<FU]>
M=#E!\8-<B<V,X@G]S@G[&6WCD8RG!U'<W$IM.,4#<) %SG+R[S:C?"OGFPSW
M']VC<3A'!J.>0\)LII6\M+*40/Z?*%ISW^4";@R@=MS5Z'DV,X$"(8&%+0V&
M<OFJ2]/3!>-;0W<=BFGG@C_87:!0$TI)ROMW_[+P"!MJ](6*=ILXO?45'U)M
MLF"C) 7/U-LID90*@+]+?V"08H"H?2?KOD'4V*+N ]8]:J[7 99'X.@U8X(0
M6_Z_;,>(=\[KBFRKZE2S7R6H!&VH&X]%[B[>+S+GW8\$'UFH["^\V>]=[J-O
M)P:ZMZ84.)03/"5AP3OTB)Y&$,3IV72>U+/2$>G'XE#*(5%[<P-AB7#:MW+<
M\90HM6$RD_.SV"+W#E,;B"XGG?.!K[#C@I&MNJ*2R,;/VC%/'')]O/:F1_J3
M4+$GV[8%AR_'MPK_=*79;!'Q(U8=^YA=.K*U+"3WX)M;]5BITD0EN]B5H =]
MQ>E<JD+*$J>NN=;/9MM+M[BVIQ=@XC5#\S9U0(8+29OX&;F'-OY$A-62H<B<
M6%TRMLIS3PGRZ('%!,[J:916;A9N!/,5DCVEJ=S[,'YZ<PUB$&$VF1K+_DFO
MBF1-/OW,)UY<NO^=86#A:G'Z7\JI..(9T45R>!J"A)R 2[;(CSMPRZ/08HJW
M=*99D'AYE;A<4AM2?XMP+S.[/'W,=R[O+M<+!BNW?8A8Z%R^V:KI5ARV#).1
MQS(W235Y@;SPR^]O"@T[_?WZK_S,^.!I04GN2\'?N@-:/(BK\NX&XLXP[:/K
MTTT#A/@4J]OD]KR-R\D]V8P79)7QT*Y@K7Y#:AY88718[@0%)"XR*@MY*#XP
MJ8K:$?H0M)0M;D[R!^PT-8]S*0Y7**;76>Z-J4Y&\!X$?PL)F<D>9Q>?Z?PB
MJOP)7VD3YAU40C0163/(N7-,NSN8^>V>V<8AK1AQ4.9D@-SV\8)V&J1#(Z&%
MEIFX,-2;EN_N>_#KUJ,@T/]=<DYU2Y#$SU/S EP&:LC_5<$%# +&EG56Z?U"
M=QYD)_P9^/X$D:=OYL]3/I7\0ZNH[;2DVE4]P#-Z#//H0EWDLH[[PO,%RN%X
MX]Z*I8KL4M\H 31'SL&V^\>3'"QK,$0VA&%NKNDV^QP+UB;0DM_/ER1&DD:)
M/Y,AYYCB$T4X6L7\%AVV]N<LVE[YO_)T5XOB:,XPG?+V;Z^W#OHXW3+\P= .
M:0$_(3QF'L3]C4H%,Z'_X(O_#KS]P/@3L55W3N)^ZH@C7[53[IN>]V$Z@/F!
M0FUC_;C^.(':K[T(P79L_Z5O?L<_D:_;_UJVUJ+"^S,RPF3<O"2T/JXI<'5@
M5.SU-/@MA89>9N,%"\UHASH%73F 0^5Y"N [&2H)AOC(-6FG6@:2-K^LOYBO
M13)B_D/!X;H(>.VCW@,]<<Q70?)BB>2\>TH'M 7]61Y?_A$Y1DQY4L?EGX H
MSWQ\S.3-S3\(=>/^,&G$E$S(T&%7T]=@%3HZ[).ZO"MFZ:F;,_\JPZ>+H3=;
M"?X3='YC/KY[DO?K5FH^_(2GE]:.DE;36?KU[K'3?C4FS*C\UZU^@]/W7R15
MKO$GI;WO\VT.WP]I9OZZI=(X]^M6QD;O1?+WXU"]G\J^F5^;3?W*SNY34D^,
M_R]?:NW&S5C9'5-GF[]9=UN6<%V/L)NM7/5J*6E2&KE!E&OJ<1SZ8O';2Q#^
M%*Y,K>'5A6=>6]:,W*>:J1:&]? )P'6^8$T11'%]0CM^'J0Z >VU+7,3\^RU
M+7HNOR9V01SM$U?9'?(Z?=SU8/+K)-U4Z[4[,]NIWAWQ<,Z7RT>>[$%QB-R;
MQ8 )T^6.6'F#RSL2B+P=+3T;A#"?<$6L&8>%"!4J-(<=PNYA"HA/F8<$$<>T
M'C_?<0<HK55?XLKF;691*I'G"^2:?8\*_LKCD8-%KTQK1Q,SRRZOS(04?QD?
MY+>N.2]*JU$LV* =4\I5.L=KNH]44R#06]?$%^:Q2EH<C%1[&C_AY\&D "&#
M_=G2J)%*JDE,?EMY\>3:KUM2P7HBJ-EQ/:+3D[J >1IK7'9%[,M\G5&N%($J
M%EO3CY>4;Q4.VX[++3[421KAZ"&TRO&CKM2@&<+G<8?-M6OE?N4!=HU+$Q.$
M\Z?FPW.CB8NW(5*$3Z^@=)QFF]X@\V,-@T$#+Q;*D.+DUVNJ?64JR>+OV8O@
MZ.4&V>]G:0*K8FZ98AE^]6"'UV/FU]L/-6D3L)%!EA[!XI^,S3I%1"<W'Y(/
M6I!KMB;PY,1B'7?CV[J[]1Z*(5/E6&CAYI'61^FFA^^1TS-?1ZH.'T^"#NI(
MITR!%RG)(D5-0&=0"#PVS28K+@0B.Y).^QJ_GE$J0':W#S#H0E?#A:LJ*PA3
M^X=O1 JD?0!E%V??=5UYZ@JBWK*N9"U+D/N.'4-F?\2X$G 51.62M/R*0Z%+
MS^#D"X<[5Z>-6>5"]DAHH!S:O\='XT\DYC.V_ U3S^&:]L B3(:?X$A0 DNR
MUIC7A>/+8\ZL,A:GK0LC:RGMA(L(1=>J%OZ.2^9(1[=A[Q252GFZ%;"',7S6
M-\DYRI;JA/]"?V9^IM#KVR0>W7! ,JRMC,-];C5VU2_,D]K53##^'DM"4EL'
MT)8EPO=MD?)WP*V#7@0<A+S"*?V93;-B57]%]8)Y?:&P:MNF+<BKJ,2MJ,%#
M%Y;)J1U"":"0VX#9@2T6U46+>0E*=Q*8YH5X6_UY\H.-I)OZ]$MG=BQA@K*4
M&GJ<@V [EWS6[NYZ;9R-<NNX=>%S%O99ZI<<DGNQSL6?GQ)P#)<XQ_Z;9L4B
M>KTX[OD-)X0*X*0.*2T.%S+/;U*=R!+PJ':OR'>W[S8^K) P5_>FU:,_!8*<
M4_V<ST&L=>;=D!&T59BGHTVF?K7UK,3OIRYMLPK!9_[Y7/,MR\AI1,2O6QP;
MYNY/.;EB7.1Q#[!F1GV]>=JIU/3ZV9<>QQS5L1/;R+H*XM@*Q0?54/^J%B3]
M47O@3RT=@!7&K"I&ZCZOJ@:&Q-*C245ZLJ1IV59S2;_J$QT=]%+RMUHI)LPI
M*T=Z]JPCT[U=RJ<$>8H@+(#,V!@[9VGTWWY;SW45 JA3AA108TR\=TIF_QXO
M3FNF#UVV9P<6N3B]BK'V8,!C@ 2P1BBYM/%G0^70CCOY_/O:Q%$&94?7+S/D
MVJ@%#\*/#&!U&IH]'F3*IUF[WG$+QDQQOSFS"1R+;T0M\5&M,W\:7;JMX1 "
MF9;(9"^M<U:"/9S!OW#W'7E@Y1"[6Q9:\>H"NU?4'5F</YR\^"7UO%&FH;+-
MXQP.Q;8ON ;>#O/Z4&K5 *\0%G;T])-.>RMMO%^CH\L@(\Z6IU3V]6E9%<.S
MUE),<>5X*F0P<!$L6.): X=-OC#LTV-P[G!.0J^HJ55;#_]L'.&Z[:@1\!-G
M?O#070[Q!9=^UZI*ZN6*2+;V;T)YV#E-*'MOTP<K;=+?J5X%6HN5R4()#!]H
M+J5>=S^ 6 I X!#D< F@\-1)*U4 89'@93C_>$7=0N9M6V1!O>*''IP*$E5?
M$4)H<D9=X#_W3M7T&^X_EI:]!T/U"N51D-L2?(.21/9\@PZVZB".T<!JA2@\
M!;&X1B",A8\;H-P]\\-N]PF*+LQH]!*<X,PATH$FDB$7"$7K$MX*429.B<&H
MU73F5_=C5AA9FFEDPE I;CK ,"6=KGBH!:3"R730.,KV[*C 647_<%]X]=%@
M2\7W8>L$;/.;,8G:TSESCC8<9,:R>WA:G=70RQJ)AY[;;>G)'_;@\*?EI.8G
MI/O'4U[0MWG-,Y9[C%: ,\;)5#I7!O I4BPVQ0;E]^\A#C+/@B SYM\@&@,>
M>?[\UCBXC+.:F>&W&MY7HOFI!OZ;_$FE:7HKW%\*DCC5_?SX6@.)\-*O)"RD
MJ_I^: ZF!_A7MP<.[N[^YW(6#T?=MK]T$"Q8:5ELC9#!!^QB&S1T7(;-F)A(
M2PMJ>2X&*\$:X/;G/N8:]=G,-J%C/%J'!5)3W_D6IU3JMOJK>F5>6GJW(Y9)
M]T5CM!D^7K K7.BY* _!$)IC:J),CN4.=;B\&:?2XCHJ\;X!&5)VP!^5WOFX
MW R'*=6OYA/ P94O0[>LG%""?I,DB(.?56&>^$6KR?7D];\L9MOWN,H9Y%U1
M!Z:17A4X[#=W@/2^#=F6MVW*9?#'D"0B47,[+F\6%+!4#]._.O*69Q-) )A4
MW)S)TS2Y4?G&>]^<VP6C>'\+:H+9/3*<&*Z VP\])+Y)):X!L,I3:Z<#/<#0
M38-@'"E"(^.OA4(-W15,\AI<\9"@"OZ,LEBG(^S.=[0X#A4SZMFX&5=X7F:,
M39<L5(IY0N68J'?QB_(9.98A.L]R0F\2#@/:PTBS7ABEOOMOLG8DF/S5R$I/
MBGL']Q;W>$6?.-.FC_Y//LD5E[ 'T[^6^73KEBGKN_?&$M*HWVX0OVY9S'D@
MF\M,7G0*!^.\7D$^O^*->';5O;;R6]X/]<ZKW/Z.()NB@U9UUQ_AJ;WQ$ ,C
M?XBKIR?YS')>>9O;@-GH!B'IX9SGOS@G)G=3:)NGMD%>[=K\2NA3V%&N._KH
M]-.C8H2BF[=K@Q?E\,<%J:.8!5D]]_+Q<4-%OB#O/X_T[NY"G_X@3J/BF6S?
MP]@@7YK*RB8!29QLTM5]1B6-Z2'Q2G::G,O+ !)L H&V" -EGTEU#/&GJ]Y]
M<J64W=?A,;QJ>4<F324\$W-0<*/_'SB?7*VUAF&+<4'/MX)##Y>SX@>'H_3^
M,C!D0?+;7-/1Y%+=@/&,&KL&_5V?40^Q]J0]2O?FJ70XV/SG%GC2L[IQOWY*
M%';>5GJ@%N(#6'LU!>OP(&%,S;)WONK,Z%;C7!G205G1^E/._O)[$ ''^ 6H
MR$:U+Q&4"A%)-ZQ]"KF:H*KAADU,X[<Q+DI0,^GT6I A9I:OFEVX TY^_37H
M1=O/7:@BX8'GD7KWS;L*/?U2&K:PGVL?Y1O[F1(QE$I1?H.@]I?]2H2EFTQ7
M=2<K4",LGE\)[^<&E#BPJ^M&&_M;42#WG/<&/S(:?G&-#?7/1'=<-]:"KV4F
M6>-F/*C[V-W@<4;YR@T[N<\*9L!A:KA4-DCA0="K4XCY7/_"QF_?J^G#&2D"
M"(!@40!0S-UG;N<UL74HD;R]#M&(5/8*")Q1E;^4_S!W;C-,(,L<1>EYZH4]
M0J34]VK)N*V@LO:<$K.4;;Y-9WA(=>FQ;7\PTX/XSA>6-+7L8V8A<AS;91;D
M/( 5BUF'[2Q@ >W\G!70ZODQ->;]I9PF&E4LJ^_'<O^'BDW&]R_=-"R3),"/
MBQK8L]Z<3ND)^>V9VZ9U$KVR(WJLBB\8Z&DW6PU$<K*>K=.E<#]X#^MUK#NP
MBKM?U;W(1W9R(2EZ>F*K>I\'IFZ;8%==EBA$4AGF!R1E65[TQO@NN /_.;!7
MJX&?("0TWP^^*6M]OG$10D+8Z^T\I<=V=[I'PZ3\5_5*B$IZ=P22(>EVOO2>
M1T>#_1E3F_YK6#X!MU$'O/'D2+LE4GC:,3GA?Z48W+O]OWT2O_.#XSOO+S/(
M,3.,4?AR%ZSEE3XA\7YEN-:6;-,BM7L!A=,W(EM!7M]J/8]RFAZ*U HZ;HO.
M*'X_U/+S1>4(M *.6OE 0ZF"H[E>GU]/R]_+\!"]K!K\.=-51KB(GZ/6%#77
M.8GLSFOCT_&0HP@_ I?UO#)G;IAHR%E][2-6I8/1X8B^U2-!-954I@*FL9)W
M/4UNA;4'-,8S\K&M!!UU/#D7D8Q4IO,9+8S4I_3:N$8LA.@5"- B9>M39;6&
M0_SJ+0-R<VVX3@*HAADZ@$U*'B,^_S[MGD#'KUMZJ!<%I:<%+[Z86/AP1D(/
ML0;3K7+8.D@/J1?3_%<$(KDHY%ER2FK':F8CS.@^VTW((]K +F=Y? -Q3Z#3
M$RLQJ!<*TR8]M"/9<I%#?[Y& 4.524BC=)'"0CICVA*'4"'!!575J]<W[XST
M>IXC&')2KQE>VU.LY>:]"V0KT41L>>#-U9D@B64OJ<G='XEO#(KFT/MSD7NG
MP_XYGV,5(KFV8'LK_RNE;-XSH8A1KO#NW:D77S)?MAWKHS%6K=G^"Q8%K]PB
MBY^+[*TV-XUUQ:)J@GWYAD D]!W 8%BS);?QLJ"5(G*F[.>@J!_Y.4G?HJ 9
ME!%QH7U$->GDO:]@!,YAY\J6F28='56?,T:I_R<S0]E-I(BSS4*5>6VR4D<I
M#;37%\EGO'PU/M580I'O<H7<_5Z2=0VE^TY^1R$$^49[BQ7E>SFZS-4<P@VH
M*TH]5@2Q:8@EK9R0H>%3?]H1&@B^32R]57$!;96GC,ZU7#2H@0&94JS12IX$
MOPNDF,S0\%&.Z_=6U_?6%<PY9,NKI/Y:&J;NJ"#C*I?G+ZE'JR,="G,?2H85
M_QIC'?0QVW(V6OI4^6\T;2"Q)RQ[^Z4%89RJ_-[3M!\S.T9H.BG_/Q1(L_]6
M(&.0_S\42 U67>,$:^"6S@.Y$\$0M@T')(T05>V#JS5>&[[I3AWUOFTT'P20
M?JI5?:^4=WAX8!AF,PAHK"0.\W"8)X[?-0(NV4%G1VD/F*!\\F.BGB1Z@P>
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M^:8?[)JN/B\9&IMZKK1GU/\SW"TL]?,6<Y3CRDM4YUC#'K<_AM_SC$K!N1<
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M)JN%#".?K8,[2W%P.2\_0;3K8)=_P</76<=^\#H/B&=S[$C[G<=["I/-:1'
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MQQXXE8N2S$W=D,*\&4*EM^J6.S[R3BE)YHN:UJB%D9_E9+OZJ+YC03VDS96
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M4=?R>UK_#8D/0Q6-K2@"M^_8^JOPS*4B,WN#C?+/%2F%NPD)U4%*Z2469LN
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M#$3G%5 WP$(NN((T,QM$:EN.4'[ "&S,KF 0%9+Y9QDJO=_5(Y-#/9URJS7
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MHGV/(,EV9W$ OMAOE *STUL7=6",33S1QZ%09/5YWDS+$=V!9_OB]G0GIW*
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MT(4!LE=1F#O],=G6;SKSVQG7('52CL*(U[5SLJ0,=P\.OIN+?%CQO_M$__^
M2^*SC3I6!]<<1K=VVRR]??)IO* Y\PZLGLNM V.+\C'KQJ*(C/)^G6%\FE(U
M6U.'J+ZPR9I 3)Y9"NK6CQFA93_-.*=42I]/."*9T(LKAZH/PI%#[^-<=H<:
MLNH Y]6A,K:9K*D&([S.BF.#T0?:&9+2:<D"836!60VB<O29>,;+\G6MM:Y]
MEQ]'W-NXS3P;R64B-F"WPS&APQ'W72$"$VKD6H%O3E^]F)76#-_,Z832;RC4
M?K]JC:'Q2 :KP5RK:;_/ 77$W8U_GT/[<0DQ715GMG!)1#+)FR<VN21\M,/S
MWEVH+7&,%8P ;88D0)D4*J>+0:7IX,RTM])3#=+@H5Q'\>(P-J_ 0Q@M'#E]
MII+%,>+IRQ.T.["&IM\ZPQ5.9)&X.]V]?CTJ?YTG],"CU2C?RN?+N#E==-ZT
MQOG^K:%916 C@ :>63H:\K?AUE>PG*R)C!",:W:,W@U;L1'P+X,& TO0)HM#
MOQX>+*?_U#4=WWY#S_[A%$G%=+^>6L$?O'(IF(N*MRTU*BP(-HJD%W?_\.6Z
MU_HAJ/+/%YRK] :A16OW.AWQ2K,KBZ^S>M8]C\#$DNYC&##[P%3)'/5P.R;6
M(R,I[J413VR[O9A_'2K+^&F'UYZ7ZFH2)W:2LSZ_A"2T(UOW"O#C0-7*X+,4
MT/)KK[.U,R?8P.NG@H3U:PNI0NJ#YA+T!LC47(')*7&%O%H3-5J3S'#X95+[
MR%"XC2U3>K%N9_6CM?>[^RC4!%.8V6ZQ^IG?>>1!EKV9D"QX\J./=4R"D*MC
M6#P,$6TCU>$8I#<TT*[=ZK/>^BQ(VMX9"_RB&Q.>>3];3G+'8Y,VC9:O, X3
ME0^Q5+26QXUD<KR4SK[/%?MRJ[1F)2CHH8;5QCMX'%=$4T&]4\TJE[*LWUQV
MPIG'_@'U>ZG?<58#H"G3Z=:[W=%GOI'.>L/V@LE%YVU7/J(<K#1AG5: Q7_[
M$7<A)F#_^[DO'ALA/=ZQ< -2R4&F9E:+DDQ),^;!TT^&5T*W70]^;>@?=H;M
M3W2.A3U:H?!W3OHZ.ZPJ_AJEN!^%XFR1(B^2<:YUC1-[6,[.IF*K5-1R171D
M<\FSRKZ[F)\4PJ#SI-F*&(18<RR\D+ ZG9=2]))+A>N1]M-<<>ZCN-K(2F@8
MKH:B16F(E?76*##62*LS,P?U\5UJ>$9J. ]8U:J<R:K029&;]9MS)GA([RK/
M;0&;.&S-^0>RKW=%'?R=D*ONZ^ET._61AK"@MX^:8Z&$O*I8!C/55U()_ZV]
M^WIK E'3 #X[*HIBH8L4I4-H([WKT#LD$$((@D"H@6 "(31107K1T")UE)Z$
MA D0D.9(";T,);30.X& ,H ",\Z><[-[<Z[W[#[K[S_XGN_F^V[>=R@:AG&;
M)^3'TG4\)PS-VE]ACA UIB,O%8\\EVL!I];=!J\BQMJ-L3=YQ0%N<8TF'0A;
M]/A3&I).]3YN).9CD:T#D)!C" \UFWL<A>KUJC=/+LV)S-T''^1;:S$8M[I4
M-2T*CITKP<.!ZS8)"=?U)QY2,B'WN><Y2[H'FBTM5Z>=VP<?+M<:;)S:]?"P
M^T<*PSM9,+=XQWRYXC2?7V@6K.% 5G>YM9F+*D4S2+A'57FN,BFA_B$E.B?7
MX91>/AF$,0FX85%A[9B=$45?UZ@-UD_3A'K!!/$INEL)TW\JL/[^X8.Z:73!
M!BN22FA[/L/WADU_N%8CY7W28M!F&W=?S]8*IW9CJMM*%P2ZM<_DME%RPOU,
M/!W$'!X(Z>'Z)\;,9<J<TNXHI>X;4F*;Z;\Z]]]Q0N1*.=&$Z7WY+3W\&WCG
M&P^#1E[K6VR&-S19LH(//#;96A[!#[B7!CH9[%!UI<CWBB&>OE["'VP5;K2V
M50A=EY;\\=-@;W7H1EV"0PK?[-9UD6!RS UK;Q<&:%$!K+N#E[<+[+]KTC_3
M:)$EH504+G&,ES'R_VK9D0E"'?@.[\=:'5]=$'F71P.ZT6U9_5W670'$X0]&
M9A*FC"S"#ZQ9<:ZQV^&H055_9RKW15VDD\L.KP[ A%I2*G0;1^=U26[3?^97
M6G%LH#]F ,^#&("UM<GG.K<H33]%\O-72IP4,QTP)^L<NQN:;45F[B3"V^5:
M[CMF(]U?;O?-7JV#ONS>S\C/C4N(61F-Z=QW;1O4KUI.N76J&JGM!9F9GJ!1
M 3YN>2<V\,-R?XJ/=;&J"@=,.T*-1V?*]!I63E=YUQ"J,XN/^@^>B7D,<]K6
M'I2%[DRBP;7:DXQETDV_Z0@2FO+2I\<;+_1WEQ,1N4(7LYW:^U/BK[D*4R&*
MFA(G \EM 3YMHB!6R]&DO :QF 0&:@LPM:.*S")W2&5^VMZ=<UOJX2I*D>(M
MF"[*)5#X0(N:Y[QT%892^3R-P;] V=1SZ=#/QB&NYB*OWK>(6+VWH"C31=47
MK+\M5P66L-?].*5!F0*X%BGD#7W(!^5IQ%TL'HTN))E2(1+P)MGR0!4Q=7LG
MP^H"DLAJ+DOEZ:JC09(L K?V+662:\\?\35J(ZI#UB/#[E,1_W@I5,9>VA/R
ML"IV',7*B,:GBIPZ<@VZ6LK+WUT]*W]:!&@S3+3K,)-CL6;7K@&H DQN;0,1
M JOP0J]8./IN6-@L*]AY8:)D+/1RW-Q!CF[+&G5;01X6*NE?SEIXL=K8G13-
MD:YSCUT3=&R^/C"V72\.>64Y)__6IW4\;*,J)1>H^"P2YUJ=-D#()N00^$WJ
M0 -9*JT]F:9.ZZ:#4S\=V-@]^..W0E=\FO[\_%-K;(.HKK*73KEA4JF2GB@O
MMFQ'.'LA1+TK>+3IO7%92-U>_IT+N>7K\+)-T6KS5$6?H;I3VQL8D./'+Q_[
M"B@C;58$I$V^8M/K%4M14V,AA]-'6%54J5(^>J-QQ%$>=1.[OWCO&+XT?WF]
M<766^0"*%L6='-QDMX8?>+?J9@;GROBZ L7]E.KL\+[]%G ?SRE3->Y+O@KR
M*RW2:HL3GPNT-\N"36Q-HM&ZW?5C_5755=I265=[':TVG/44P,Y+QLJ9Q+M^
M*<)EF#\&24F2X0O6P4%O8GF?C"OH>M4:URX$.\SU!K$OO2YYCM)ZX)C^QL>I
MU4=>VJ\B^7C0S^KMV!6>PML]P/NQ-GT[VW/T0,12'E.U-*K(LMQ8*I>?$NWV
M07DH#X:#$'I[6CB#ML!9778K=^^3C^7[H^@4$AUI!%70=.$41/$R=KG$RILL
M.T>,K'\"MVXW1^3+$+2#5OBOU%V3<7P]<Q^%\[-+WIF9]C&-BO)WGP0T%N\C
M3<WTQD%7=;U0?_]0_.?<9!MT<W.-!6M_NS,6RCTL?F3 '3"S7=A^UV*^9#>R
M4ACYM+U35/@I'M[WNPA95E+Z[D]L(WV@M[(/?L#?@V%I?V'I@D1@J^YG0$6S
M*KQNT?CNOU@'K#EILIWRQU;FGVN+PZS+=6<1J.B,PS_NL,3,S9Q.PAHGF.=&
M5)5D!?0!6Y?"X>[.H2K1S[=7(;%;RE0$6DK<(XZXU62XR&/"V#AJ>5VK,DS1
M9'5%WAY<4QT6@O-*R%>5F"/U?O3[]H_SI&ESE/I'=DJ8[78LVCI@@3^$V::Q
MU'0G(0NO%8/A%1:ZR6TU>\6MS%-QQ!G$1B:%Y/I8^!7_Q2F"8S9" \,(C FS
M[DP_+>=,M"1.@*D#&K%W(%B"):<L7-E>-"(9;*VT#HL$ZVZVA77-,:UQ>G'/
MOP1CT.N)-9M<FLL085(BK/2Z_X#MU(\WUK=',5,-9->-L@#N*?FS+JYR=JM<
MG)5),Q#-HY[29#E  \STS32)!W9A);,3_AD5Y59E\67@"#*T7G+B7/OCQK(U
M&E/G*Q7]NK7J26=4YSS?^$],B+?)3F$2/U)  5F9T3(SLPLS>-&.>),)&YGQ
M9Y=GU0P-::% :;K((DU@V+#8DK2F7K]>H?^:UTJ=135^;,=K%L^.^(MG$RKV
M)@=52B&[-%8T&S+3?A=)6-!+Y)T26*[$)<ZUWI&UF=<F/:'",.K!4SV]KK-[
MUW?=NM&+X5WFP5*YOKZ>K:DYT(FPE;JT2O^34WGJHN5\649:8K]$J8=Y19JO
M!VWMR*3.X+[<FNDC5VJP-?IID^!;;V6;OW_X/+2@'YN$#^DW1&>B8@/QLU6G
MEX6>Z=+W!,<C1:+JXX1ESJ?.\^?1/B,4YS%V YGWYJ_EIX(.'T9,D;"&F$F(
MD _/VUE%I2I<+*OP5LG'H%F2L0Y0JO"C.?Y2#[<,)_HL4?-%%FN&#(%B'"6P
MT*AF799K7?%(;9:2]U@?,T1BPWU+UE$%>JT8J)"Y,YD:;&;4KX%Z!B9.DUZ1
M3\PYL%XTO?ADO]N;_8;;6P[[OE4"@7YV.?T9V11"?=%64\/C^:8BB@F5/X)K
M%[0+)#8293E925W;_^X/Z/^BBS+'&ZLWQ2,)W4HH4@3#2*:[_2':JC@V[R5H
MVKIJA6RE!F6?S;]L:L22K@>*/[N$IU'MY62:YXM(\&X;NO@A[$]#_^5\#\ ,
M([#JS@9-[;_[N([<I?J]ME@E901SCN9+M/"1%YL'G,&,P%'E]R.+[E<!OT5U
M\%2Q#; Z[#QX0!V:0^7)< >GCLP+7A<VLSE8<4V,;Q@^YB$2X)>1'L9;6J,R
MW)E6= ZVEUR<2^;G"?=;=AH^\=.X763/2IK$AF\'?"A3)^OTE&B@QO_^@9?&
M67E<D:B\\J#QX/4UD3&%WZ*OA\UDS- 5YW?5'X%]7(4:HG,=30LH@FHY"KL$
M>6^THT*Q0M8@)$5=MAPXR6!8,(AF=3+D1AD8Q"J_K"A&8./8,9_VK?RI;H4<
MFDFE2U.:YL_L?12GE)MI@+'A G7_LH F>R]A'PCNTQC93<O52-[$7H#1A7VC
MR6>MOL,2=Q'(JUQXU%A:Q0TJ+0D?77-J1"A2@1'?1HV?'[5 8,<AZV<Q\8Z%
MCBVU:5&MOI\G/ .N.B<Q+L6]'^UZI/)3W4\97RXPVQXE+M? BU&RE4"^L>+P
M[)K;Y8.:E=:_*1R: ^E8A\SHL3XB*5L"!<T>-^R9FPU![%-3&28F@[D1[,$=
M7%%7_((KY\3BP<1]/%]$KUO9=,$L?+"/BVTU07@T]N9</W'H97J5LU#[IZ_!
M\?!? N=$=5IU@4K<<()5HS!?XI/B\4G@UP&PPB)E<[8C:ZBM*%P\8/6X1+$!
M?SO#3B\BXA#]V;6\X+ ^63]AUN Z25^[PB%%HZ]O1//3:MR!1\2T=::X4DO!
M,_,''TSRF$J>GA8/&H8)=3* KUF?_*#&MW\V52U]NE"C9C9W7#RX#REJW%B&
M!?5W]3P:OEC;-<Y1U3(?",U.4&Q2N<PMY:8U?3)LWVT(8 WN03U57"<RSO0\
M%L2MS@P=J (#2"II.@CEDYT<]@U@4B,CZ6Q]C?;(=Q<K.N>GH^KH.X65W(QF
MSI-R'<= +([FU_<S]W'5:0P322Q1]E;DM;Y%]Z/".5?T2VN,8'I;%B9VH=Z7
M-KY[6NF4,UN$JN-QH>9%<ZFWOVI)GAXG8I-S[NIT%"XWV[> %<586?ZKB;X&
M0:%,KR<;,-%9I<#E/.A*-,\4]:26PX36'N^!7Y,%NHM@.#9J)2,&>Q8>#*9B
M58H[A^^W+#8F>+LQ&PH3S7!@5V;NGJIBE0")?QX?C1X7;YVWH&9FC("1]:%2
M $1 524<U#P4JHU3,CW7B;2*(E8#/!1M$'/?-&#\!L@J\5_.3#XQ<T1 ,T7'
M=>C ]H?IN>L":X3@VT+M4+F.X,C'3S7G=OU;W]D^5]L(UHAB>_6&#B%\#]E0
MBI<6V_IJ61PQ$%-/5Y.TR U"@%4_?88BXRKX>(UV!)RLW=;=BD3"9ZO2T\6X
M/L=3EFS_XI4W&=>]^ZKPCNP3EXK]K+-O![_*I[HVY/Y)M\HBYP]U*;T"DJ"2
M01C=-KV]Q@ E=1"W5,HB3"7)LA8#5+X+EMX167>NR"M5=EH9:FNS<'7L2@;U
MAFO2@(/!J01<A%J5#-HL C]^B1WZLJAF?)[4KD$+*<':VKAC&8<4T* &>6XJ
M:C,V+R)AJ3Z5GFE4'!+1P$RXD75%18H-!XU&2"!*Y@(GH;-2\G#4NLG1T2=!
MAS&HW==-&#P;4%OQ#EW0"YDN^36S>(*L;6!<]9G(,*N=&B15Q_1AT>G>6N#I
MZX59/!=9#S_0WGD-M:-;\H6;W"9W!*^/V;P?3: 8O=< A]_Y\K4K=WL#!FY$
M_554P8>4%M9_5$T/E$[>C>#=6S?TT(K21_J+98M@5@3Y2-T+YYHO^N4,6NO6
M1Q]7.? 48^5_G@=.G1N;JN3Y7VDH7?,-'J,.S?$/O$)W2&5ZR:%K8I[&T=)<
M=C;9+F2J]M?QD1MOJ]_AY)CV5]VC#!G+=M)-24079N1NE5Z\Y;ZHU<#'_<H_
M_%G#\90"U[+S&,.&338(3Q9_[#._Q?'IO0_\TX;AT)K!7,3MO@44^VG>3'4+
M5U'&;\)OTKR(@  C<I"V >-ML<'^7VI"*/-TS(!!)#G/INWYR"19-W=!Z%5]
M7U"?Q0#&LW#I9N*,IN4)^=U$87T%SYB 50[)DVKAQ[F15_JJ!T1P/\9JCG#E
M^:RO4;G,TZ8BZL;=O#2TV2MK_8/TP"QZN[;]>RS$-+"7\TY].N7 6<1QC?_^
MD$C-D!<NHU$S"T'80S,T]NY3I#RYS.MS+I59G?(S?!84$IY00.<H/Y&]S&:_
ME<QS_.^P:.GUUX96%ZN6L]8<QZSU+L?O3-=&Y0P$YOT)W2J)'SL;3<N]H:B^
MEJ-F19\R[*(AQ2:FWVDPY>5I"$&E%"=739C'/;961,?JB+FOQ$L+NB9(%H '
M+4U-- \"/GSA,%D;2NM$502#ZAT=ILKE!MMT(&FZGS'7[1@%LI3+=F<YH[SO
M*ZQ^%_EEC0DEJ;98(SWV'# DY^KXAO[?\,!KEY#N?_]@"5T=VJ@0B/%-42M!
MFJ?*+S* U-3)W%^D+UGM5D)4W=7M+NVJ5 /AF*/AR<Z,&.=U\&K3F+T34Y1S
MPC$ M55U61MCP\A-W-Z\>_^X2:*F52Q6@VGQQEIF>>Y.YYA'[>2*SQ;5_;%+
M^=;F#6]+0SL=:3$+;9=UY-)["2<X$4X#MO/L*3K/3IHJ]%I])<"]R#N+F4W$
M?Q;T6K1?:(QHGQA\%:42"4ZSF@M#L]WF$)>**5"48*$A>U;K-N@<"\*7U!JH
M$8\32D\_^2$\]4F+HUG5CCD-I'^9)?2AH)9;Z%O=(U7"A=*OQ_T%[ [&M>P[
MV9ANR%%W<<Q@%:*^L5X+I:3%*9K'H3 DUG;8,@6^#. W$<[7@(4_/KS40?FU
M20<>9I7731YP7<TPR:@KG55XE/U@]@25A1VO2DIYDO9R+MNAKQ>7UXU_-=([
M?Q4K'V'4JLE:*-MY/PTH-^E;HPMPJL=;?.UEOKMM'+XE,Q(: #'\@#70*[G(
MDO5[V5(63]^9H^^_AQ#;,R]XGN)JV87>R3%$1HY<W?!BHX?PE\S?*CKSCV*@
M/FR\DK<_95IB6%9YYZ43RF/(4B(/$M:B-+9_3KMA]+B'KBV2GO\*B\XT]?C9
MJIXV^F(O)(SL9$=\1VZ7.+HQN_K%7ME@NWW#64DA8&R0%AI0(Q#>[-/M'G3>
M!)_WM&8O6+E'M1V-D*8$TK8ZBLDO#VNC#:W>V8$8-;BLR1:+J2FEDBQQJ_^*
M'#L+;#-+9AN*_7&0J,]<%*'O,.VG"@\\#DD?-[!)(@=YU2U\]=%=TB+ZPR7M
M7D5O:CI^^6!G96$AL6+^UV?% 0-DF>D3N*!TETQ5"4<'B#BM]J(?+X[\"GA<
M'7;4EXGXZMJLFL5+EW>O4#L[B)PY#7!:2Q"&VQ9#VL*FPYJ;3^52 W>FW!N,
M>!&SDOK>EGN $^<AM_S)P''[)Y";]7$Y;_P9>@%9N2*3"6[D<Q]WPW>A5QD*
M;O62P*7 %#KCWEJ6_AT685*,78YP>[DZS1\FVN2ZM.MX4A+.VLVY$>)((YY#
MN.J%^*^)^A>VZMR_X66I[OLYU38%,-L4 =+A>M]1NUI=7HG(TVKO(\P#X/</
M)Z:<F@D*MZ<EOO@W1QM^\([5+?Y$PCL;@E%IU<\NENT(VI[WIOY9_"/,>1&^
M]C9_GE [BARP5,TMR"=WR<4G_Q6OWW&F8-E#<?*0J0=_(D;N-967\"4<,03*
MD8.!*&6[3D&-)S;UJI4E=!S!)ZTG/QJ Z'FS\L5)%,_02GEJ=)ID-LG8)K(1
M3QP4PPP>(6IUC'_^?2Y@(>-:K?>F*JM7ZFQ+.FH&!C)U%!/?B%>ZOG1CQ9F<
M'G?%*>8HH_RI^M5&8NE<&R(0-DGE?5TAPA]"\K'9GC0QM>9-483I-A(_NP:[
M'_[C&$<^0D<$#T5M7,D2"66(!-,<0IB7-5M@QATP^#T=NXX<.X!]C1+EL.36
MEF^7X+7ZC"<S[S%%^48KTM&IP&%A_[L_UK:0R":#'7.?/Z'D72VDP^_UCQGT
MUU ALC>#Z5T]B;\>:J46VZG[@8,9(T@NUG7SYI53H4J$;J=MSU#SST8FB)J>
M:0U]OKC#7^U#)H7YTE["&W8O5\MUJ7+*+<P11/7ET^$TKX(\*[.)284",J:9
M-RD)%YKCDTC1[75RI%',-8=('1T#^1D?-AM47$B7( D %, #! Y1RLL('=S<
M6R?N,G@;5G6KE@2"MA[3I954"+=BH77-B%N9LEQ@V)<ZI:Q<D^V'#19UB%J%
MV.G:PE?QKVMU(0!S0DOF.;(Q5EF,J[S_FL3_0%GQ_R\*"RWJF6M;SUS^<IWV
M8F7@82O8'W<#W,6#! LTLGC=]LF3.Q&$.+(M_LVK $YDX.)3_YR\3FCX_!!K
M_W/1BE;W_J$-+N?(&@/TPP7U-0-U0J,V-2V6@&YX'.C*^#P!!\E^(!#7*7D'
M_OS?/>EWWWWWW7?????==]]]][_0@[]G_Q-02P,$%     @ 3H!C54B.'1,T
MN@4 $@@( !0   !S9VUO+3(P,C(P.3,P7V<T+FIP9Y2\1]+L2I8FED7.:M1+
M>)9E1B,-G0FMDI79A@AH%=!J!AW0&@%@(=P)1QQP&QR2"VCC$HJX-UZ)S,I*
M=N-9X,8/P#^X.'[.]_GQ>/_T?_W3__V;_R3S$O^;O_L?_NXW_]O]WV_^Z;_^
MYC\;[V$=EO<P_H+^'OH-]9"T__&__N;'\9]^//&;O_O-W_WSO__T_^3_^WM=
MQS^ 8+_\/LZ&)/]].G3@$8\@_'L(_,T__I=CC-,F7W])\K+J__C;__?_^#]_
M^TN5_?&W/JY!VOC,WY5XS;E]Z4YZ-2F=_?:__.GO__'XP]&-7;[&OQQ=VR]_
M./[XVY_@?[B__[@,_O:7GX^LS1]_R_RX\4N@&;\\ASG_A?P]\KL4@J!?2/KW
M<$+@,4G_YU\0"$% B !A]'<P^0>,^ .,_?+K\=L__?U]_L<Y*_Y@L?RO[[O_
M^N-O?VW8Y_/Y_0?]_3"7($S3- @A((+\[G[B=\O9K_'QNW[YAR_(/^.P^9+.
MU;A60__+C[_C9-C6/_[VMW__R[\Y?FU8-_[+B_YJ#_X'A02I*_]VP1*LNO*O
M%J_:=EO6.5Z'^:]#_)L'_L,Z9.F_E!VWN?W9/5D*YFW>Y?VZW.7@_ZCNFO:W
M:]YU?[7DLEIY\;=++LXYYJ"5+\,VI_G]^#_\=2!N7_][@+C];M)_ *45RW\+
ME!;W59$OJ[3FW5]%&K/_H&WWC1L'!?_%Q'Y8V=V+?WC.^8\1<H:A_=-W#DC_
M.FZ_(,3O\5_^9RU.J_['7/Y?_A'\RS)_#2YG[\^??LR6W\'P[R#$0: _P/ ?
M(.1W$/8'"/HW(-\G_P)#&[*J./\< W6@+P8:?8O_FX?^LO@]L[-XC?];*O%G
MS_X%CO/>NJ2/JW;YTY_U],_)R;3KGU_]YQMM]7.RCO&\Y#_&[(^__>?Q_^V_
M*_#KFW[,PC]\JFQ]_PG!B9\5^S>7_E:A=UZ5[_5/,(K\:ZE?K_VM8L4P=_'Z
M)]G@A'\M]^O%OU6NZN(R_Q-(UR#&,*;=1+)5,@^FY)BV?/H,PX*DR2RN\-XS
M@;YB@?Y(K+9I#(.93:LS ,3\/![,_?R/+QSS/_W#P?ROC/FC\'V8S ,$,(9M
M^"9!Y)81G&^! DP8Z;Y9FMR#<;E'Z?*/LA$>9B@_/Z7P*$N590;E^1F4GX#L
M@]%8YO/C8[(,9G ,]6(?FL,_3(<[/HEP+*EX4,6_?#Z<^/BD.LM X?V&4'B[
M%F\-/^_]!/RSA_\[/R!U-]0LF??=7.;#6=\F,Y+%F)IU-XUC8NE'(T7F1^M,
MCOG7P^29CR3<W2(^F>9NWGVOE-B_?.[7/F2>=VOO?DFEISFH]^WG_0*6*<WG
M?>WND1NHU^[!TJR[_WG)D@[3XP0.X:HTY%QM%-Z/PS_,RGC\!'17\:T=444]
MK;/<N=:\+*>9E#-$C:?NFGU#O"[]G;F1Z+#0)DGRH,G/=QF]Y;OK)AOR5MU3
M'O.)@0;W$Q!^.5 4^'P;^_"1!2WM1\A[C+MU27Q\#U$+SOH,RX.1+$08*- 7
M]PYCL9(ZI<).O1Z 9X/;7COF81?]!)R27D;R'E?J4?&[D:C&:=J6.2;VP;K[
M]VZ^Q#[,VUS,D'O>!I'\Z+,WQSZ>G*VY'.]:^ELJHZ.,N/,GX)"('UX3+<S6
MG[PG5^G.73)KL>4[MMW3KT)2?3Y0P]9SF2N/S&T^Y<\FRW7$"U769+R+4M/K
M^ISE^!,0 HSK+=O-JCDN;EAM%OK>F 0\G >PU49=-L3^."<"O"7(_U_S?P("
M;"O[?HM743=N:1\113.]FC&.^TGIIHDXUWD"=C"^#8W]81'<#Q-C*89VL8GD
M@_#?GGX"_L6UOWDZDHO.?98(Y)%KFFA/-NVRS(T\P&W .=O^"6AJM=5-@A<S
MNDO?MFCZPH>(<'^C@W5P(I2P;<<^ZO?4C1*?B4V+IX[63X^]'.KY<#TW2?B:
M>(?H.'T'!:=2V:H5$QNI7;>@^8KRP\][^T+6-3OU,1\"B*Y53B(GC[2]LG0_
ME:\7;Z>&]1AX/5'C\SFB(?5? ?\3D#N9Q\+E!3+2> RWJP_C(;Z^[H!W;+I:
M[MZ*/CM?R'JIJ75F;MS0D_T.39Y;X%2<NA?5?#K&E1E)'/P$'.W+A]^\(>L&
MF[0AUF6M[P'JBWD9B(?.%1RF@1!O:ZN<5&/Z,!Q? D![JK>_W['D9KFEBW$O
MUSLL4S\!->=:QTIAQ+3OICM(&A#JS8FC5B_W"ESGLDZ5"&O&A ;[FG*+9-A"
M:!IRO$K[WXW;3\"?W]P&$H-QM>'BXL/SJ:D#3(JQQ2M4M;3](X6;R:$"):4?
M=ONB4\_9_ZHA_"O@O]A%<.W#.BH2'>?NF"*IBD#V:SHM7JU\&04>30B, "[R
MI44"Q_-)W=U@!4\@DD![DX2?@&7BK[:VCQ8H[)^%8R;>:394F7H<[W#+U(O+
MI*ZV%E[#AP:KR-A,4BW&89V?ZV7(2J$"R[*\J])G6_\GX!VHW'<NX,'VZC3*
M;)R(*/.DIM]=&H;I<ON'3P\;1J47Y3@"'F&SUSNR4?XS]F(;0[;/<%M>S&Q#
M*]UW4*H!@-A 63K.JL,%F/HI)%"Y;=U*D;")0IRB(^FP..&X\ (O>DQ9X^-
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MR,T+^@GHF8.LO)@-_?0I/#LL$+;T8)Q1;9O,D#PKHYOC!QZOF;"U,.OH84'
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M-SF%EV0<;7R;3"8(#$E\"*^ FHZB,FVPL?+O /W43G]+U"2T2;LVN1 %FZM
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MA@LOY>,4T(KBC85@9FZ0W)?!KNID@1^&+-P5ZOF1#8F\)76BZG N8'B)K,)
MR\P&%MI)SDW\V8'J0Q7=A[H'U$<6/X"PB3.* J.4?6?*?DO6WMP-U?Z<S^L-
MVIK7/J,';85V\-RU'0XO70BBO?+V"1L]L#(D7,,,7T)OY_! !_!U2)13(C7(
M?IL,4Z]IGVF\J,\,M\O:)T#;._)T@'-,-8@Z3B=SCWJ"/$OQL3'/ZP/NKTAD
M6_=F;8!:$.ZM'$5  &ZO\QT4 RDFAR#@WETM4"?@'(ESN+11B"!WU;UXOZZ+
M1I;P]R/['&(9 $8>W86EU\6(=],58+H=%KA->/(U[*LX^9&F(W2;!=]\0GW,
MDSFB\:THC;Y1D;H1._:J0XS<>@Z61%XDH?AB,1;R6-@94 "\>ZER=>OGY:OU
M8I&H+/NT)UA"WF6W">;RW-4W(\LL/%+:CU^OI"T#^=H1CGB+)Q#I2YGT7N0C
MO8B*GH$::1.']KQ7]NU#_^;E37Z"V33-UB5-E+YYRAPHMY*/_)>'$(Z*F&D#
M*!9X1J5%7H5!5R_J*EH0'UX=T=]T)8PC/8N3[\8)NEQI-74DOEVCL$N7X_TL
M.:M1/-X)TC",*TG:B*7'-T<T.^TEZ,_AJ.X^U$?F(+*; MS!_XZ8<PZNWU3F
M;9O%HKY#'/<MOW9M74Z.&KK.C*"5\-&7C+YCMJB<L:J*L-A*98VR74^W^).B
M3%0O*?A*=C8FT)3XKGTI_63W;7R6><LI=_ RZQ&BJ<?U&<CB WWJ\J9TX.<I
M]9A2-+?-JL75C]V:NR3IJ1VR&9"<H.M>O)KFN^M>EY+)MR E'=KY\. 'SF5:
MV\*<+3-L[XCL.!Z:[="2"L^:?*'AU( =8,IX# N+UG[$,C.<RCQURFZ^L@(K
MIYC=]Q^)MX[:KX#>)P^</%@L' FY)WB='**]1ER%T,>)64!'5Z+(,225\]GF
MI6<4#8UKX ,[I=]1CB@<EQSY9F51P= <'-P>6+</GVW\L%UFPTU2I_-3K0Z6
MR!/\1E',9U&IM\1>FLP2BWZSZ(H(ED\H?7?JOL56K "XCH%@U\-]IUYW ,B2
M!G!S:3MTF0ZTFGA?P%*9%CR8]TSTS@"O>#2@//#9*Z"$%RPV\]X'_'H;U" ;
M #:HS;@>VYA%N4*O#;"/8X5DD5R&5R0+Z^$W+W3B6;N',(FHF#EI"X3JN%5O
M=)("1/(5RQOXG2DT100\3I !O[C!93WFB3EMF&^?PJ-$W@#L[0L8T11S'0Q>
M?#SJ'D#JS NJX"G!S@N5=?'57M56,H'OM@03:0B4>\>/YT(Z"&FI9][T7*5O
MIDM"I/"^.+9KWT8+!H^I[\X/L#0.ZLWWR,4^5 O6<51>Y<7NT"K?K6[U4@QD
ME*?&DRU>I7D3(MB/\X('GZ]7*.T=HZ^S/H8)Z4KK<QV#*M=&O(!;M)I%/>:F
MJ'NDW$ *E3M^E_LZL)B;I=/.GC*%?6%7XZ,)*B^,YI0"0TM$?=.LZ QC6QVX
M_8A41WWV87!K9SB%<[(.*B9PTWSE"/;K#[,[>"D;D?=B(CV6DLSW'B7E?MK6
MIP)0UR!A?LRZ],/:W*>(15Y88Q6N]@EI 1=R,A!@PB>Z3WEO#-]! =N80:9@
M0$#HE*#+6[V.^KS6/7F'$$5>_HI(#U/03?1X>0(VP]&VU\U^XM-I&DXLTY-U
M\VNN!QB4_G*;'+A]!?>FT-P+=RV;'XDCH$_S?#JM$?LT\J','FZC$,+9L/_Q
MZQ1)>7)Z"%ASK!$Q3:=@P([3'0/Y^;L?VX$K6M.$JA:?B ?YTC2ZEM8199,M
MB=^@SHGCN46V$+1!'HG"CUR3I#+:_?'FUHU*%4;U"M09_?BK^I6WN$\M3\2&
MA,8WUQ#G^KKD=YZ(SV/B;%,]!M'CG^]M$! !'A6UIO;9SM. C>O7<AYZ,DJJ
M8U?G9[GT;Y(K7N#F>C#!S06[S[S[<PS-<88+-TO:U0K+\7LD=SX-VEF/B71)
MR5/BFJ;5^)F5R-O1KE[^GJ%QK6/HJU,8:LJ]MO31P"(YG[!EK9'6(6>:*G@+
M6% [3557(U&&R*KBA5JT=U!4L/;N@:8OG_-#@[@HXZU#*:U?M[IYSY/1F!<
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MJ-!)+&C#^FTRM22SMK@SVD#%+9EO =5T(6Q,VC-_82%&V902VX SBE7M$/5
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MVDJJ/R]2"B*Z<A!K=:2-M9&JEKZ6LXOE<6ZKJ6RH("*J;\"C+N\$1MD9037
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M0B(Q%B A],_M^W?5_]B'BQ4:_VN&3P%1,1!$3 #\"\/GKTK]L1%'.XR3"X*
MEK$\#N,_1('Z>_7^V#[2ZGB&1*.D@+]4_.7!/[;*_,\(W3\VK_T70O?WY*S_
M&T+W\]._'8R_C.S?#MX_C^I?*'[_O<-: ^-X7 MOHWB<)D@IV%J@4;)NQS,2
M^GA&0J)_>MN_*?#'-@B_U/FG -S\R_R(P>+0V@@G*RF@GB.:X A$\(-$!(4$
M@/)V+GB<'0+E"-3 (@EV/P5,%XVP=>3]4YIS\[8 %Y\]WO*7>?0O5OY#7[]:
M%?C_LY7B[^O^JD_S_V=KV)\K O^NA?X%G>9W^H:$_7%I;8(=BHA$$_X\!+3E
M%6_BL!8$!,'MIH P'[^(!/!O2I'_VM.O6,9_IC '_IG#7(K\V.TO!.I_T#K_
M8CEQ<N+DQ,F)DQ,G)TY.G/R/<D+^UW_!<KQIE61Q89&6.EH'4/XIXP"@7OWT
MCUR.)@ ^ ))_7$[]54[_17[1_4E-\FO-/RA'KP!7R,XJDG6>)KD".'6%Y/05
MDJ,W),P $L"I/QL'_"SGR4G)*,Z=/7/ZU$_/2,Z<_HOF6,Z</DM*1G+J_#GR
MRP# N9]*D)V_0'F.] R [MC.F;/G2$C)SE^AHKY*&TT')Z?1BQH:CA%UA=QZ
M%SFH7V'I4EEUC4& )2*C?-XYDU/$;\3 D+6,*$P?*R/(Y@-V$],!L?NWCR*4
ML[&R0AQ9GQSDN*"8\ '?!2N5N"L DM,DI\^=N7CI'#DI*8"$!D!R[.\*U=E;
M.F'4YT@%$"^@7V0>%O>7L)9>=:(1)G-X/<,B:$$ P83*P$21\^$#CA&ZSANR
M3>]\]&CIZ$4?R3UN9HLL3T4.1@WI7V.71W-DPC^F/<FP9$"E*\Q'+RARWB8_
M&@=<.'W</%=.7P%( QI? 4[D1$[D1$[D1$[D1$[D1$[D1/Y;A"4POZ'QR;B$
M^),7H\QJ)7[EFX^?1L71\6NI,7,_IL <I@VFZ]_[\@G"8]FNV)OOO(SR;=(D
ME]MEK%YW%'S2V?&9DUQ@TC]7KM!:ZHSU%YZ)$7GPNQWGKVI+\%COZSKO 2WF
M7'UQ\9+A,1%<6XU:+Z7A=CX-46Y^&_/,7RY(9$EAK':53C0GFO^:YJY6/N)5
MDOE K4]\[;/[Z-%O:X>;LYWNFO'12E:X%E[ML]FC1([/M=)ZB??E)4T[0?1Q
M(T'\\:WV!!IJ;I.LQ,1,UD['!4PHRDTP17S[VYEPIX5/I2T_=+^(^T^&C=5*
M1Q;LTGY^:S2!GGR;M\[1K_<F7[]S@LM05E:Q+D=5#,D U[SH$Z[3N7A+7" B
M05KW;Z#A8Y;7OL0,%/'_D$AK(/&+7.SNN=Z^B99R6=HE/=&<:$XT)YH3S8GF
M1'.B.=&<:$XT)YH3S8GF1'.B.=&<:$XT)YH3S8GF_RK-^;PAHW5J;>M#NYP\
MOH4;PSM$\I3"E<_Y6H%<]]S.JQ0IZ:<F]7:$U4*5NT41]'%30)^(IJZYMM<4
M$V/^EPCURSLS>GH#6DB=($7.4RP<CZ=#LN[]\056VPAO>6[Y8(M@[4MG3$.J
M@;#$BGM#W>-JDY6HIX'S<1.^/48CV+ (@KK9.*=)C7L MLQ"89)9P=^$&B+@
MD-R#G PH4-#59*1^/"16O6J="M&A<>4UNZ&]MR"@#&-:X"*3G6N#E#Z*S. 3
M5T<R2L9RJ04Y+T(.'PZNWHOOXZIJ<:KA+<B9#'Z[V^,_97?.029_;<U3TDFF
M52#HJ]B052U%SIOH56%I*Q2_7=ZW4ZG-/,9N/001R4"$!L?3WJH1L&G\8%G?
MJ3AM (!L8CEETW[D"" A1?7#*;Y,-?WKT%?*-=U PPV5+V,3M]@><=W^CR[R
M3A4GEW^FJF;M3DYR=S%R\-":J-3;K.T^)'HGY+UC!!,Y&36"!R3\"Z1?5FM,
M5&"C)?/72B YP8]14SOCKJNKO8X//LRP-V?0OFQ<,HM/9!A,T"_@4AIC6 R*
M#W_AFM63&0_=R1-BUY2,+!,*M\HMD7=M&5?44+^ZT'HQ=*S]U-U7_]IKR?]7
MY.J]>8Z0A>#3N>_5#QM[>3/4ZE8/Y[LD[V:X)Q7VW<D ZD)O&W_3+WV2?_>C
M D=!7+G;[+7):[4$WD2>J?R9B4J>_$S@EX[3V?,HLNSA8D(1>6YJBK208T4)
MYR WS^1V>R*9?[8Q,'E2-GIAU]<AE=XNV.]YZOS:98+S4H'[8R5-/J==5^?I
MUT4X7CB1H=2?XC1GM0A!B4TY]+*,$EGMW0"P49^6H Q'L5&(L9@GG^"6#OF@
M4EY=@1IA[)WZ&X:=&Y^>O&J0L#>WQ@=S4ML-,=K(#O;7R>)B)H3G19=G>:EY
MZ!4W:)4[<BSUAL-AG7D?NFE\+"F=4-%WOZ[[FZ3;/.'UE"\_SQ0-"3&^4RSH
MY#!NO)S-]3'+D+6\R-K8-B\F+: )*::^EO2BSIVX@<2LPZFT=MG6*!5\NM]T
MYHK&%+<-\0E;>QJ-<*]!9RPW]3LC3U]CG\R)N#T/5]1=$ B-P%Q$7F-6&^]S
MM#/E78G(GM[G,MB7',@JLB!0L;%2W3TE?)#U/1%\!.B[Y-.8Q%% E2,%]CI=
MJ\<R?!]Z7]BY7>5F@.I_&+RO^N;?KWP^G#BT)>FT3S)?UZH1%?]OZC>_E;.F
MATC-],FMCS_JDF<K2;8Y)L"YQC+JGZ?>=7\5/5T@-[L>Z1M5WFQX#8[KI!MU
ME2S\$(7,B='24W'=Y7O;;<&',DG- X LY3WWNH(CE@^LIC;(#VRBF5X1B_9A
M[!J]1X#Q:,Z2!.B.[ESF_H,7KTR=/9/>3"[WA(7X()DF>Z?8M,[A DUJ,"'\
M,P#6PJR!B&'0?+EH8MR<DJ':XB61U14T;G"=:]G_&T@#KL.33FD5X-MJKKMJ
MA+[.U<56.ZY)ED@SN83<71%S6B1W?EC;4/@9%J+E2,L:8W)W4:MXX/[K#^?Z
MU0Q6*;IQ.!0\M-_RY71.B(;H,$DI_5G;[=J0JC"+G0G%?&VO?F?5O331+^6:
M9W8VQ0TF*O4?3C'X/JPH8*#=*"U_,AX(G7**'#::RLW7#]CZZAJXXR!<\O92
M,!!^?S7D[1<LV:+IN,%GRO&"2;Y8&G/OY:4=Z4"+34VM8<_%="><H]*E.;8;
ME7.LPG?H2^77F>M<U]JTKTZ46PW58,0"F%IND9G$CK4*)#X PX<<E!(D8A9(
M>=PHBFL>.ZI%?N>?A7W3C!JD\DAS6"<5JM_P+I66+G:YI@%S&!=GH&*W;BC&
M1];T!T+<ZY!=;%C_3PO*^^UT)?^_=:?_BNA3%P 'GO0#%V]H?9]QNEWS]ONP
M]\,5+FS1_I1TL^88!9_11Y1E[JZRZ--*FAQL['G_V%I&^:#:FN]!08[1N,SQ
MYTIWNDO]LWAH"-04[!'7))"UP$.<T7AV0$ U=& Y.S?@:1B.V[CW1["DC-X[
M:,*IUX/<L[T&%^4#@Q,$GKN(\X8J%8RG8;-YP6S#O.GZ'ZO*HI.(5Z>:V(">
M_JZH2#';]RPY'6&N6869C416Y:$Q7C4ZO^SD:DSVBYQJ-[3AE6J<,>QQ;D.Q
MA"2OVQ.9A39*XGK_"R@K^"FW)1PZ3DRD\L\Q?V%TN]A^3NBB(Q<-B--8OY:=
M:5>2G4SO&6J#+72*/@Y2L&-?<WXHQ-BV"^^A%LRVEGS& ]HER(UY.<VSRAS>
MHUH&7QJQ/!@? IV_Q6S>J-#TRF N9[,W(8E#_YRV<"955+6+0" C>5CMPHHP
MG'U5VY?/\2%SKO\<G#TG 6+:GCND6!"8(O!"^DM,;^B6T:3T9E&SW;J/RHC,
M)N_W+&?E@_C0:)>YRI=6G[4IQ0@#*9GEVT/?LC%=$^6KA"S_?)!FPNQG^F5U
M#2ZN]AY"$ZT'Z&JP'86X'TV<TGEIE0M WUY=N?-\<JG("/#2_),^79S54-5J
M16U\]6 H[&J/!4\&G'UWKF::@)&UJ5,9G8[GO!_TXEOKS6D[,$1EQ+S7]/SH
M=;95.PWJ!D7MPUF*GH6LVS4_")\T7VUP(MVMDC8%_3[3FQV751C9BI%U)GTJ
MSOA._G-8I+1KTY9;3B=?8V(-]4N)O]JE2^C1U"%^GW^;]/"C9NMVO_@<^M(T
M?]VT-2&P:)'/9_42E;-(YM/WK+>]-IXL;,$B3;TA3ISW7".*ZX4T]Z_)[04!
M1>(34U?VNUZ(GWZ3%+R4ZM+>>:,.X58W.$]W O9?!):T/3D3Q_;1-,FV67A&
M<"]DB1KV:2GRL%"G55PSDDLK9&ZLU2O3^],91]L]24<_\)[GP"?-USO?_Q8+
M+.%_=1N=@#T!>P+V!.P)V!.P)V#_E6"#"DMW>"8T(^KE3*7'MZBZGWW$+.@-
M6@RI(N536%1]?'6MTZ)U?CK/B%E&=<1FM1U>8^*N%#&99Y@S*326E >#AD+R
MIE#NU^V#YS1[HXN4"HX 5%Z7*,=+H<]D4CSFIP]5S&;F$F$Q7:ZR<X+5Z[WX
M1<X.M5$3)#U+.36W$4VA7CE3=G+JM9%\%]@Y9D[7WLS6A(D2^-1^28RGUBP^
M5+98_DU#4]U7,5<H1B-/&<S.L#)NF'RSKOE-Q)K ,*Z%E69B8:KNI_19\^<&
ML;F4-S2P&&:B^)81%F$2W="MMQ_<%YAF.U-KD3C,8[<*CHT)L5PE&@V]?"=0
M2-GT9=-H P@2':IFO)+6(2B@)Y';S-E'EIW(A1UKG_]@+$1[Y5?!6/BIW8E_
MBM%KXT;#MGA&D-]W*C59FYYFRV("=9)CX3;-J1A2_=PT2Y>B],M6[_#J+=&4
MX+)IRDT^AV#;"V6])O-K84P9(0/T;V;T*E":U9W@]FJ3W.14*KT![ZR+H5GF
M9YPL&2PJ9)[;%NMMFE32WLL=7*(E)*2N1K@E/?H0<6FTO2[!Y@H;X8V 4VKC
M$BNK\;UT]5AN-$M%=_9Q4[;/R^]<#BOZ:YQ#[([[7];_E*[V?]6X. %[ O8$
M[ G8$[ G8$_ GH#]?Q;LZ\\V&P/]#BU8,,(1X_DD"I+!W-:J>,>I+Q$M)#C,
M7JKORBW:AKGXR,5P[:"Z?3DWH%J0N9^&FGL\:X*)Z<$?7G2<H2:*S82RN5WI
MHXS^EJ:UTF1,+&(6,?6:JL:Y5?8_!VD4*>*9%6P=;\5Z@*,9G)N/ *_R@%'<
M.AKFP B1=?$@IJ7(/7*5CP')&$F<8X(%RJ2:AL+3A*I+AV(TNKBPG)"IGIVY
M2:0<D*B>9H!R Y]\]Q>Y(;PCNW;>#3_C%#3.: $NVANYK8.C7J/O:&]JK@MK
MXLE7![LV*?O/1VQ?M:J)8W/'W@K>[9WHUBT=G&73;1,*&SM=6$_['N[O?QC&
MN<)H5X^5;#M?*+41J@.ND9%.GX0P7WR9VYZ]6RW8;^ 6(^#@,*&Z(6[BP47[
M==3PG>JP25KX;6=L!>SVAU*C6!1>1:>/&(<?6^4T\=EY,V?QI@!IVUY8.696
MS,<L7 4Y_6XQ$.QYFA'!V_3&[:G-<%LE6]_HKC[S0Y0LI*[4OT*Q(T;VNJ#@
MK4A'B7Q<81Y&7D=S;K&#@CSWA37&D.:.YAE-%EM>,9AL6.IX'7<=YL!_[@$@
MN"'G",!YT7NK>0:XJ)(GGZL5;/Y@?4BY/.5JRL6D$BIEEO 'I[NFUK?7L%JE
M.&8_;%'_I[(J" ]OS8Q--/*T4?[(B_'L77UK@K6&<_]&6-C:%<' .R4^ZCY\
MCHD/N"]VAII\>W00_1ZH,ZOI,\F4:T>V-LL.[%U(+?.J2=:IIFVBS,6O7JYD
MG/.Q6%>615ONC)9^\!5\FIEC;_:5U/^M62W=)7Q$OP/3TX_Z&_U7!L[A'N<I
M,+S7GW[VS*;@$<)%L"?*?TA8CX7A!L=Z)/+ZSEA@$*K ,7%/]-38I/%\$9-;
M7O9,91;M[KP:P>9\>10JR3=_"7\$H.8?HUV_#N?5IE+F+WY7<,&X5D%AEMT(
MY!6NQO8B_/55]=;3%L>=E"1-4K[F(=8L[CXZ9=[L\-$8K:F'>:D>MUK3LJOJ
MVJ-/NV:S[*LH'0.E\;4R_SL5*B;T*TE8-@^?KN1%4A$$@31T*7!P);3>0/0;
M<LZ;B2?!+$<MU]:#,B'!9S)JN=QZ<GS** ^*!U[52!);\W[D</DC^1& *96'
MDP4YMZ#MI^[+X?",S0  4#(-S(-KJJ;P(;]R6LR'5 ;.JR=VZR$*"TUY(.W&
M3DNQG!3*;AZR#845P0UJ0(XIVB]X#%6,8=,;Y>#-3/N[9P)^/<(NB-=5GLL8
M*/-F$.'H'S&*+F47N&$64HR;*+?V._/#LY^I4_@Q&F@=$1!*Y/\H?&OBD;"&
MW!TGAOQ,BG".^S&1,V*UDW%41=;Y9CS/8LCU0LZ]AY:TEL45&EEO7=DEG_LN
MOAU0>\U I2J&<I8=:7;S/C/[6SWY2 Z'\ 11)N;0*L<PP6L*%Z <LK&+D)Y'
MSWSX!)'TK<+VT,B,-KQC2DX0@!49RGS/W8[0%A[MQ;+Q+E(OJ;B1^TY!N.".
MZI"TI6M#+;EX*^[.9YY:*<609MU)8Z6J^\FJKD\K1PDQSKG,.VR#D+OAS\Z1
MS7ES5AV^D81#:B$"%4OQEO"16I\Y7A<5V6)\[5# B_AF6:6;2B!AFZN^5,(,
MK:T5+C<_M?1>D=]ONW>J4KC1)"+=TWDZPYJELNO;'!=3TJE5[LSX=% V=Q@E
M@>8CKDC<*\ZK&:VJ3E\E=$U_72/D4VP?GO_,>WNY7#I2]PB]>=Q]^6E[<4K%
MDK&\A*13,I$9<I8#,-?[+(]V52\F):(?TF>8.C^/3$ EOJDRR62AC!)P'#UW
M!'C WW $F#-[^K&B)'ZR+GA"R%8@;V5!Y1I/\JL4- GU3*]R\6ASV_Q K"/X
M7N1G4A[1!96J^U_F.RZKR'G>/8LK]*KZK%Q3WPC.%O4R7G4U@>A=$M7M$8 A
MM3M5$M^P=@N.>NC[>7U!=QW#[;Y.^]HQY-.3GV#W?1')/0*<JHEL[2IX$[Q#
MZEXZ',O.B1N&A94*>688W,O-$>D./) L]]&M\V'@B]&@86=5/;B=ERM?Q]G
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M(>II0!EETE"@'A^8,2OJ79[(\N$+(VMP-^/@/=849LT? 8Y&:!KCY;%LJ2/
M#JU,'EGEF!)$@[3@"&!M\;#ND+7FWHI4Q'V%)[,*M)V9;TH[##.=:2?&US]
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MA3I3>07Y7? #A@)H>+BD?.1#@+@)PBHTP(.NJEY@0WGM::P;S&H!ZJG6L\!
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MTZC;O@FO)KX(&T-<OJ\_]!R#09'FA=W<.:#ZK88*4+\_90,(MU+EBFRG0,2
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M4U Y\ .1>39<G6P$6+:)B@=]+,NF1O81G8[K(($4!:P,R.#/:O:L%L7VHC(
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M7X3O 1B#[E*"?;___V<_MYI&-M)4>.5++YQM*FS>6)_ZZP_0EH9*M'>U\FV
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MD-0XJE2+,[39-8BE<&S^Q<,I)K[^NKQ0_9JC'R]PW'IL"[;A/H#%G;MLR'7
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M,7\#'-'7_GF)V [N@>AKU+IVTSZXZ+/.TV51L<99=49^J>T>@>VPM<=8N!!
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MI-$H% KFG$=9+97TUI//N4[MG'!P:MCS#*))+ C7U-@0DM+4-7@4!X5UQ+"
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MU VXO^H&:L6;R7M 1+&M;YCMKZFQEV;F0@]/-^GIN=NONF&+B>Q.+N6R]!Y
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MNYZ_424OW+F1DG,ZK2E[994PS4-7:#FS%8D=40%4MIR?Z7\1+S?[25I1D^/
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MG" JXF"D+$R[JQTRK1 &"=7<SU[!G\S6+_5JFZ:R'UKFL9E0?:JH_R93*3F
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ME<K> YYS(\(O,O9NN/3 -W03]P!]\7L T_YZX#:3FF^S(FS9A_:Z\24(_QZ
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M.+(J))MYZTF;.-GK]WC4DS["F+9#H2FZ7<$X@$&[QJ+T@(_*AG79ZNP>'RK
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MG#5=ZWK^4'N9M"'#HG)]0:T+B@&,];VV*>N=/4K<+V;&^:?U2??^?ZK]_P_
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MW?O\17]MA#.]T$3[IE[1C@];;:.7@G$:LIZ-B>+^O<_@D9A 10%F ?J.<+;
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M6UCL'A1(3>'J#"<ZW_EEY)8>1S<DUN*C&M42.?!SPG@Y,YG4>UAI3*)S5KS
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M+2J*EM*&)+$JZJSQ?.Z<\GI<(PP?CRU,75Z#AXYO?FX2M_HXZ+1M.^K]CDY
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MD6LY'Q#?B:&OC*S*"KHS(9/2=FRA#JSOQ76PQ#JF<3#D[[072SV-D;##OMR
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M[5T75 A1'J>9V/Q\8BKQ.Z$^^:IU5&U9CL*1EH69\= (X-P0"G>4FJZI'CU
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ML6-03POH<TA,U/+D[6,4G&UN%X[YT>-N)X/K<S]4;E*MK:.W9^*/ Q;% ('
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MG3(9VD9S.;L[IAZTIC_1>8]M/6DI-F:S#ID<<@)Q@(]B6HXXK007:[O.UE[
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M8[\H6LV\_-NB3^!%KN>Z5W:3QP>T1 2?"8=7FFO3N#]I#%\3]BF6JQ9.PR8
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M3;:\V:JS, 7M-97M#8+.F!E#S^2Y9CLE*A!WF,ZQ;U\4:'P]$.*@X[PGAWW
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M48I ^="@BJK;UPQYGX<%L?*XNR8MP-7JT%:+( ?5<P>%[5#%:[S!!(&<AB=
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M#(2JVC2A]H8?J^&RH,I;G6)&MNVE'5GG.B L,>U,]"3![)<TZZC/[T.)RW"
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MYAEZOQPFK*Y\WN$S2#">/1J42J[$P/8IE>FY(MPY,)@Q-%10+S=!WJZ./G2
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M0.93[>!+->M!-/[]M+AQ^:_P$1/.U5/Z.P7EG^\5)&+1^Z6^TH\5E06RVE6
MD9S9=F@?.BG,0.9])Y +>:$?<U.>I8&&B@OI N [$3 65Z2OX_5ED<D#)#2W
MOJ9&A>W4AG)\C9B]*IN(F$K3*-47QI8D+#2)-MT\>R!9CFN4,ZB4%1>6YJ&M
MDG@'3/F &Y>C24DT=#Z4=S#0C5 6H*7M66SN.'G.UD%D9E@VFBS_.50O-Y8J
M,+2"\OQI]NX:0L7[*&@8C+Z.*6I2E^69LEH(4\L]ZJNDHAK4.$";C/%/>R&Y
M\_I]V(DMTX20P([W(3O9J[47 &S+:>5?%X"U,*<+P!)L>^P"L(F\ $R<CUP
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M%N.5A#Z6NX]ID=V&W7IX70.NM94Y5ZQ*#0\G$T128?5YG=9EE\JF>;?KCL!
M]<CIF(KAKV,]7?-!,<CSJ7>;-@652N.;3>L^J'*?11!]YFGCUZ :(HOS_$O7
MH4B/QTVEZ<D)R= A7VK_1EE^F36,VK!:5=]3[-:I;89B<]>W2)J(]WE^5PRN
M*THQ% UN;6_OE4W6T.*8;1JE+Q\."]-4^],X63Q9<4HJ\?$Q"5T[Y?QD*B&*
M>:M8ZMV/5?(V*Z'J)&XI_-0@HC^U-8,&M,QUR]0RP4;'S*PZS47#*BRU>B+[
MAK>^[#SW:+Y:+3S!I-VI_-'80BT+BU>"R2[?9@FTGTVV;6=:45]RF&RX<%#3
M<'JXNB%%99Y5N=D0,EHT]"N87$DAP)CO3@^KSH$O7+:E><KJ?7)!1W> S%S@
MAY\6:[QI?H2D*'K=QAO\%*]NH5%-BG0J2*<HB<<RQW,6@)544'EFB!(YY6QI
MG&6R?*RL9I.S=H&=-D@66_&MOU!#HXX[W^Y1-W^+60>^E54"L<0O>I>(Y\=$
M5+:[.JSR=?<Q=VIK-O36"-D.:_F6WRMGEC5?H?,A1;HZ%950JU>X,5KI!(!*
MSU!+8D(W(@T^I\HS5ZF#W97Q8+&@F8*!V:U52+-0 6'B+.8CM-W^\X%]4E@5
M34E9JV-1F[.-,7HI6")1.^BY>3F$I-PB,!Y161GKT^KY(O4\MO'2F[EJDW.)
M-17PW'?#QZI7N7VT#"N:F&)BJK"9)J<1,<K.* NH.?IYOU+BP!#D<XN6<Y"%
MB\)+3OV6HZ2]Q0O Q)["CP[:"T"4N-7_8T(6-LY9SA.2D=4BS!J+I\#82L:\
M!H5U$'W]<V*6.;?O??*J=5<:^[,'YZYH&\ZG8[Y<)=7AD7';U?>R@X=%W+@6
MM6WE$DC0B_SS@U5^AEC88,*P0>>M/M5*<+E*5^>OO+F>W,4H1%B,"R4PG,2C
M8%%MHHG7XF_&.J>88XS0N5FJFLR)94I>8),%, Q)*T5+I54J7UWUVQ[-=>"+
MEA;-$,$+0$5<7[8VQ>"4Y-0Y^_G,JC@3:W/(AU+-8X7!9_?;;*'TOS6Z4N8M
M=PR6"C[%UK_0$&G]5IN]Q,-YS.,W_B6F0?>#N?A>^988*R@L/OW@=[-\G8\R
M-UN-5Z;9_S3CM,:BXQ@>DF9B11B96@S/('HL%XH>%%B%O!U^N>?0^]N]KD:<
MF<SDOW!;&JUJ/L95M)Z0O@.;9>EA]]-K+RT/GSZQG.9\GS(2ZOT1\*\C%-1K
M@8T@!>8&O^^JP:L_JF&RNOH>G<Z6N+.8-B6EW:>@+K*JP[<)C&^R[;BO\CN.
MM7&T/UYWH "+/@3K/TT5%;L:+&?87Y*QLJ8_D]GE9>S#69\X!/- 6KAN-PP;
MP(KN<!%L%VX*]24*E^0.IFGF'DT</.Q>G-,L?IF@$"BJD5,!J*W[I_[\J['5
M1Q;G+9=M,=)V-J\CLFRCPF('G8!,/7HHG8AZ/<YWQ&9E[XAO$75/4^1%0Y\5
M@60#Q;.F#5ZO;7D&%&J9JHB[L#/UE09><RR<2J?3'G+L0WM'O<H/M>^BDGBJ
M+#9?4<#G;@X]>"@ER_XKP?<=!;SFV>+7F0W9"\#QF:%=$^%4V:$UKO1[^^WV
MO'[6R!U!W>;!.V5B+Q?N_?X\]!%,Q2]Z_OH=*@CK/\?6T._.$4[E[H'"0I<>
MGD=FHMC?!L\'ST)GX/@S'H/6FZH=O[6Y4KL7?-YXX#97HMN\-MX)Z3Y&W68X
M5XS35R"S:M;./2-8%>G3,3+8'OY>_UO4Z. \7Y)W#FU]MM(;%4:UCQ&)5B7F
M1!^.'DKB6AJEBKXZ\*6 X*?_5(3MDD(F:PC:HONT[N7YI:?69XNGQ^E[.J0X
MCPO S:W&*<R)??I*C]:SCO#29[\U,@PQ&ULX:;_=R3J\Q4V554NQWQ02)5X+
M[!T27S.7[,C?LKNGTI^6]/M+N&Y&R1 4)Y7]W6E0(7ZMXJM0_G=$2Z?#5ID<
M)\$*N#USIVA+"V1BJOE[2?"_?>'^$R2JO\9*R4TO.XUG[:0?"0 SCT!_+NIR
M0W:U+P"#[H"6;_]T];_:!"!/FWP!N!)X ?BYI('\Z9G!:WR2L!E+^1'PM\+^
MK;#_[12VW*&T?(0Z40YT=+N\MI:*UQKV?[#WWD%M=4N^*)]S AN3\T<VV>0,
MMLG9!"$R)H,0.6?;V 213,Y@,I)((@A$M,D9$R00(N><3#+Q?3[GWCE,S;M5
MMV[-FWOFU>D_I"K5ZMV_W7NIU^K>O;JI"'IZ'8+@G)YLO;*2^_EJC_ST'>U5
M/T([)BBE/YLO+Z<E/A\GF&(H? 3HCQ4GU@EY06QT"99"FB[0&5_C]74FGE+B
M!2+I#'GVGY9=XRTO*E_@XTD;/BU-/@T=#SK8+PB\]YZ7Y?PHX:S6U5#%@4!Z
M>V!9/A-#%9(H65[^I=_=L_"C#RNP$J$KII]N%P:!*XET)(,0$, 7'4B\M ZJ
M\Q4IU1&%H0A'8-'NDX\=MO53W.#@/"9_8?TV+=<FH")3L\I,@GZE!B'?ITY7
M<Q(M&Y'.)R8_>/[=>?+_]-92P!?65=_>WI3 ==).%[?R\0*@W?(!A^\TJ5&^
M*6'V.Z6P1<[T %=QC=<@0#,?TAE!G_WM]_"GGZVN\;[37N--MV!^4!<]1%\M
MG><%_^Z0?>?I4=PUGH^[\#G!-=Y5"X#"R3.(4']O<5-B7V;?]F>HN;\*T6ZU
M+$?D5Y\'-P'<7;@'HZO\>O,G-K.JEI+2SQ=UR*"GBO@Y_Y9Q1N<]ZZUW@A-L
M44K8:]7<O\'S!]<E75#99?HI3'NW'LF+.0B$!7?^3B>+:4W>C;=M\02NCWT.
MD:>07+@AY@F@J06*WW,*FPCRY5N8_Q1@K[)(>+QF(7D4,+#MM/.WU"MK_'1I
MIC]O@M-853#=&'<-XOXSZ+T.>9!/D%3A)5&#Q510J]_.B7T@MO",+YZ<-V>3
M_ 8/@ Y3\TOJ+SUTN9_WR-J4M@4XF2[T;P^X'D:>)>/O0\6QBH15A07O;[#\
M@0D.H6,<9+V8=-=8JB\1>&PGL5"^CSW?C%$\!@[X"[>SG8_B)Y%J7=S@H4:?
M75UR751=M4H+!0@(*[C/>IT&G0?E]]MZ_KHZ0/"L7>/)O0\EC(TTN<'T'/7C
M9%UG_N2@=_G7BY:G'V>"4E)BUE)G+?B$UJ7VG8=&6AJ[W2<IE9TF;FJ!.E\,
M$O!GQL:OQ0.W ZP7U3KBRLXLR$;;*XG6S:$K*Z5K,C'@2D;]_G V]PTN4L8C
MB\#87RWINH/G&YBVI[NU_9C3+>.2$,>I^]D:^P_]O*,_6FCAC^+]$],_W5_R
M4;GO#/7[66J7=40!=Z/O=+J;S%2A:$LIR!4SS5_);= \P ;PRQ5E%3BH8914
M3 U.]#/UXL7KF"Q)U!E(<.VYJZJ:2=S_EH4C7VYFO;+>9(_Q'=@^(/<:S[]N
MWT)]PF'<OOJB!C9MEQU?U"4:EX' LAJWI&:D?'%U>]&0K,)>632HZF8CNHVG
M^'MI^=?IX__UZ>/BJYKRGA,(7;1XT8PRHZ0CU:;O-1ZIC:-]<K[-6)U3E-),
M[ZNH3$'.FY((JJE?_J)UD5X9S0UB1IM]-51:)0F*'IHU\E6H;+:?;Z;7F$D!
M5U0FS]W@62D?/UEW6LX^)OQ5M9Y3+UYXWM)VC8>[9+&0J1TZ20P/4CCCO",2
M&6E^<[.2.!C:HESTM"4)R-,C=^I/^O.BO3U(=O"<(K96Z20B)##Q<D6F\,>(
M=N"WF_"6Z<>TU^^L H?HXK.3^NIFU6)^JCP^%TMOK/B9[BAQV"DU!M\]H'26
MBOSE?(,+00>G.HP9N)A$>LWJ(LF# IJM:[O,MRWY/><DSH+"5'#M[D247QQ3
M\/XIZ ^\0,0J,6JSG_;AYJ75**H4*>/>>A#XV;M&;N3DKINRFA*H>\"N[FMA
M^@(65/_6S*3ZS:Q5L'/>729EJX9.$GH"2Y?(/Q2S?QAORIZ)+BE<XQT2R00=
MCN$)#*53"V[&C,)- <?)?#8G,VGYTUSKP^PCRC]U8_V#!&VU:-7]."EUCZ+/
MZK$7%(TZ;S:X]_I[>YK]L"0Z$,YPXMM<^PT%NR5J?5%LLDL:=',^/!ZC.-[@
M=0/!2H4T@[./U1>6_NV1SP]>8(2D_]P06HDDC848?D]R_DX\G?.1.T3GM>R8
M"!U'_*5@@-D.-4A_>[-;K)P+5%\(,^(!U0)^ >_6/H,KG+#P57G:-HDWE(\F
MGN%4R:Z&6?9AO-L-+K.ZK![1/[C<-FP'L+M&WLO'?0VND[BF4B35<7'9@)UX
MR?),H-.KM,)16PX:B_;$>G.Y]&.J,O;6#R,F@@+#._!01^B8/@H21B;][[1]
MQ^%(XY>(_35>%MW#(#$U V8M?]#%?4^87,EI_BEX^TO<:^*$OX\DU$=O+HTK
M7GACFO>0>MU4M6<'IL1>_F$_I?>UK_%XO(5W,UDOA4DY$OCUYU[<%$%Z?K.P
M0^T_"CN8_K\5=KC[JLG#*;?O]<5?!LUF9;/WZYU9=ZTSQC/7BQ\"03.J>K<T
MOOUW;*!&XN2T(>,:R(ZDFXFLJS.C,Q@Y;0^H)Q\*,'7S,SRO@@3<<TT-MA[J
M^7=;-:)?P^-G-5/9?6%T<R3WZ&9,AZ MLCL3)W1[6>=-D[-(N^;(_,XGMKXW
M4P5)%(Y* S4:WUZX3$L=:%)L.L\:CI]6B;L9-3%*%;3Y@]2/M>Z UZ'O;LKQ
M^#H?VOTS_!I/*)/H%S<<_]:DA@C\PC/P;'%$,O&G*?[^H\##-JO/"2TW>/X5
M@?U/IUSI<B*MQL:Q:0D>EW71P9K2+779L5(X<:]9KE=ZJ;U6OWU[,LOS7GG7
MZKNWAA(J+1(FV(AWE,&6V!>DM&OXO9DD/3N)1L+VA:4O7=W$B&+JO6+./WX=
M:+/<$C#.A*T]2^@Y!']I9U=?[ -[W<EO]_M,M,-$(<'>+I:ZF_J-ZF?_Y35>
MEPF_2XS+=AE@@OU+FA1IJ)V-6PRRSB:DUO.YX"]9X+@F+W=4HH,01QL?['N&
MBN6XQY^Y3=L"0QFK> 0!5_EPR?>!GJ[3%X[&OTH<VO.Q4Y WT#G1B:>UI$V&
M!E;?*[*TVBK'+;8S5RE$U>*L3/JIR(64[ZO\C]W!']''A5,82K%8WLI:_&-X
MJ:WS'?H"!R!%TEOG[6A$0TBI\O(&=+X_>-F/R!'+^6*^%_7].?U0!IED2E?W
M9J0<D-L"/M.-\]D(&QLTRV+\*?/*+20<A#7RJ&Y!:F^0_8IR865DOLMJX%RR
M)&').9Q9#4E[G5];<4#H>:]/T-B2D"^%-R*.>#VC "KP7!M%P:ZWK*+L/$0C
M QCF*I6KF,R1+?F7K?S?L)4OEQ=^:F!JE/H&CKM(M(LQ$W!&86F!M<C%"4&5
M*IJBM]=X2( 'FE=;CGC/(UEO68TO4X88!=74OLM$ (7ZZ=]^CG8M#0L?_I;!
MCB)BL\<&)$URU72M>QI:KFWPXN>4)C*&/# HCU/@ME0-PQ24^4T5=_)2GZ!*
M0#"%K \;]VV7A0ZB2M=I)8WS1>:^^]T):/LB%-@M9-?-%Q[8*/_.W,@K*>+K
MBGZ#98+3O$HO24,K+$_^LE/9*;E-* ML0ZA8L:%/]E#.5<S&4D63M(\H.*0_
M"5YB""AVN#IN(JS@:G>L!]OXX$Q#9)KM]#686?Y0FYY!-.OAN)MU)X]1"#$%
M(34=]SXF]DX=-1\2%%VZQ 7:B*N,5P#G1"=D>8UGMFG0S&#5:!0?PB1L_C.)
M0H8_<=\<+_N(R&@;"!BYQJM^3?)(+CJR-&<2Q)4=+AA> O="19%V5(DG==3/
MB), O E=L?M9D5GA?G[K7)&]*187B0B!5'8743-W1,WFSKLBR(4)D=AY$6\E
M(I8?I\)(,BRD!AW%X378:(&FB_4ROB5;;:;)?^.DR#97_=&!TK7@] [O3Z)\
MV1YB@6">\;O&\Y9I/J$9]V-U<HM WP6&_&@S]-RI9Y'J<Z@\U\08FAM:(?_Z
M2/F&Z\"23.#/+3;<VXAY;$1$4?IU? IMWTA0:!#@6':1UF1==MFWBW+ [52B
M+QJ273>;[I9M4:G8Z3TKT^$(>[:321UJO#@>D=WT,BSL7;)]N&BX,$6K[9]9
M_/$VHKR56L2K/ 9G9T9\B>C$:/E7[;U-@B9Q#.YH7T7%Z>;MXRX_<0NEBH;'
MBF<#.26^>0:0* OR,:1286Q B7,GSN@$!9;M3D(9H,.3:2RL+O#5/M"UTKZ2
M6#P#03-VY!2WJY[>9HQDGA>5$PNNM\./LZEE&HBONK_%XW7D5^*OO+VX<ZKM
MO%'0)@7D2@I4KKK&:Z6ZQGLZWQ-ZJN(I7^YSSDA[C(9>X_U8*W%/1B.G:T!8
M/:B3VLM-0//DKF*\& _K$4'7XL\9E;%5:FD,KP<55ZO5]TFSQC$. W<W+(>$
M3KYYA 5^X7Q\C Z$>=8U=B"21I @MCNGN3F=/ ?>1D;VH;?:MDO4U4H6Q(XB
MX2^(B'^#31A1@TYY[AT+^\4Z:M 56!JZ2-&K*3S6/,E)1<?QB=F9)Q+A9/BZ
MT?9E>;$D!L="\JAP\N$ )1^U^T9?#TQ!^YA0H_FRWKJ*,OD^&?U9B<D:17T?
MUEC$\?I6.8MM#_G4Z:W>+REA,1Q9<P6MQ?/NQ-+=_/:\*0L19*4%X2EW1A@U
M-7LK!4D A(-]YH5R5QP.@TFY9;OCOF2.K,2=+@X]6Z03"^CF.')NZK-PAK34
MR-:-PA A)68F,G., JN[!6"&["UBQJW&E5,+T=#4(Z6!.\)L+WK1N!_B.Z*K
M3B2KXSRK.6U[Z\U41_9L#(5P6L7MBAW<G](3J,2.1:V( <U/J5'JD)!>JZ$?
M"Q/MAW6?64A>8:0J<X[KCY!\3"?JW=#DD(T]/T W"M]L"KF(] )[62#3%V:X
MC!WNM8$QM BM^DQS<&)*_UK60^4(3M>:8<'!B%9R#%*%G4&WNUT!YKAW1J2G
M]%_AR-Y>[>UK_\ZGI>RH)48K2L0@E]W;Y$#;PUBG$_6#(3H3!KG#MUFL140A
MQ&>13M[EZ!9)4.['Z/"+A+)_ \F2R/S#[.BT0,6VHIL%6N+*GN_".R*I65SF
MFJ<'69:O(>DSMY0%&(4%AL90*E2[7YX7;NDA'!NZRDVXXZVC*(44^T3=UWL[
M&;APM;*IHH/^<_G<_!FKY-^6!^T-REQS!9^C 7.R+T9'QP!C?'&Q,4DP8$VD
M!669W\RRK+W!F!Q0M+<X"L0 @^4R&'AO" UA&D3A)V?C9L-((O):$2N6@RB'
M]TC!:&\P';/M9?N=3Q\YI](?IB,$^;1744-C9ZG$;' V#LJR_"11 S0"$&T?
M2\8W#:@XDRR>"*B9\%DHP!G1$7_?*+(Z3354DF3,M]9P[!RB!ATO:X#'='I3
M7;,!AIF25!:@1YCZ$>&B"@@V=02=&:$^L8.<GM'C>>=@)%ZBRO,@XL(KN(%!
M]!4\<)3U>_/7G9IG3.NJY3:?X$Z,7"J].'"3)PY<RXS4M[N;+ERMM75^7"GV
M:!Q<#5!2/6O_",BWDDDM<1"'$=8G]:_XN8>;Q'%(5@KU%X3]N\!#>_K_##Q@
M_A5X^/]=X.$OHDP<Y"99V_G::#-Q 5RBYD=)!E5,,'Y4EBD>+BU,MHX$/N7P
M2K.,Q[CB+W*10)\G6F^\^-C-KIIY=P10W\?D+#KN.*1+5^IUR^M.QVQ1Z=EW
MY&9QZ@B@M+:+:VD\"I=3ZF!%W O>KH%.?Y!-M&/-.E1EGWQD[G-7/#?[_C5>
MF>S[@R,GH KF^<9MGU+QE<S<78/R"F?="6QCUS);K5'_'76=UN<^90#Z79SY
MGDV!XSCYZ_H>.:0[F#42I<:YK/5'X%6",;O[?:5HD45%NQH3'!<&18J,&JY;
MQ7X='*WA5IO,S .J4]0">I^1*&_*)3C@$T!@#!TD)&\WN+?[:M7QXO\^4>X/
MI*9$E,LJ#PTT.U$\OD]Y9FZBA-V+5SRMZX0U!?X:09V%U]H.WRYV"_JAM<J8
M( = B*B3:#Y'S[V)CT(Q=C872636'/A![S/9IR5_2O-=NT)T-K]HK.HK$*[H
M;R^!U,#:-*'STQV-%A@G2I'4)#7HTS_WW3H%/.41T=K,)P N3B42#B<==C\;
MZXUR!@]?JU!#$B,XE_8PVV0S^B_9R6B3(L5:85*A^R2[DTDTCK1#&Q11XG?\
M6^6[UF/(L!@.]72FV)@G&[?^($TI4XI%Q;\=R*AU7&3+@%BBV'K!V )P:9"G
M@JG1\@;9FQ6ONPZ#C!8=#- EI_'ZLHH" T_F%>"$F <WP9LNZY0]"C9I"S/S
M],S1DZRNMJHO"3XSSS18=AU^ +0]/8G_,FXT:6B_V-(390^WV"B@^%3.UVN\
M@L6BT--/UWC[&HW2#:\9O\%\&J%8QE,'8?%8OWLQ'G@;"JW3?84U1QR&CD[D
M6RO+&H1@D<B?7C7SY^;L4Q'C0@]7 ZDDY2)B_G*L915*:OUVFXY,%E&J15+*
M1N-%!9DQ0%$D<Y?[:%JCI6]:,5,499=!+6[$Q-6%R'2U"Q@P%G@PT;3^S,.I
M7WU<(;M,XG1CMSYFQI"LB1X>:%86(VWDLX^>]:!K1/+XRNA>M!G3!M;]7(0W
M;TC[@$T.0TI_A=1+7+K\XT+XAC_QW7W.%H>BR\Z++Y<1?B.4M2N4:S^/N@<V
MX AHTI6DMH5]E51WDXP;,)L]!C%2*IX$U1)B=(//TO&"8QL2C>)I!O'C;>JW
MM[8ZW6):IONHIQP!)D_O_':&9/8U_8S73H(9@3S'O?%7Z1'/;O$KS;VZ^8<D
M12QDS8X[7X"'AUV%Z.X'T95LJ-'D;*DN3*^W\G)UYP8</>C0U$8)B8LK6Y!)
M'UK:1P]W'G7!28A8/_WN+::Y!N<@&FXP&_Y+PM_+=/A[>$TK[')%S,1:H5MX
MLVN&5S=CI,0:=O).DCIV%4&S*?9Y0^.T_S;J"[KEY?^F'E%Y-*]%QK\[YONJ
M/U4XR(ELVOFLC7WF9]Y"^)BW\L5.^O3<)J;7C8*9&587&CA?+XB;RM5WS"U\
MM:)7U./JWI,AZ+2>T]K?Q\=M D74DU_8+9JD8"AO:_:(?<!0^L;_46[K/*2%
M&FR,A.N2,U(0]/2W-Y#%Q=D+6W]0MLI@SX79T!0*N?[U<$1_P[4J_S^ZIT\[
MI5X& [UM^8#2GG,F^6>U"=/IWY8H3O+J O3Y1+8"A\MT=O9B6S9.]+ILT%MG
MP5R.P[ )]NW5W[GXR0O]QPVVGBR[6[]?.3#@62YVO[OY)+G-_C&K*,OA@1;'
M:O^)T[$KF\;X1/.\S_PD7]"I7_ _[ZG^1SBN7PTIW#/!'(L)3Z>_+JS:&A.=
ML/!XQHTZ):A>]NQI)]?3([+Z%RFZ+AEMBOG>MF:?_&XJ]WF7BGL/,?NW(P;
M&9A_2'#3P:*Q2^!ZQ%19 H;VF_ZQ')&18%^?9V?S!'V4]!_Z,0[S3Y0MN.XS
M4P^0T9PWF"LI1!,QP LA\IU4-A %[6BYX#%[X] VCQ$^B;+8'94!D+-[8G&$
MH\J@3HWFLZ/1'\)NIX6]9U(6X@?8<N;7C5-NIFJA0'-NE%+H6^V!XJQ"!>.
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M#^EK5F_P+N<8\+'97555(G&2\ YCR2>Q9I5"[./"DZ@>$ ,.73E6PX4 SR/
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MRP% N>*3,'9]D*B8?I3?%/+D.-W%\'O^C'IWFXQFM&:'!#BZ-*[G=KKFX_F
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MY:BFTDMLAU2PJ)RC<DZ+T;I?FI%E #!Z"FO] 5;F4"QL(DW3EA_#D,ZIR+1
M(=J10O(&(?!1^65;9'++XL/CE :2B$*6.O_P3QS/FX?L_8*C^UP-;>[NVCL1
MR!QLHO2]U @.*K#"LR3N."1&O#5=<55(M50GRA2NVU_!E*QK6>1FHS<\60"<
M0$=6_KS&R]:L:=-:/G/>6DV/%<)&*X^33OY8U1%)8 _H9,E@[ZP\$[T7L!<J
M9!#WS7)HPF1YV+E0//O+U:@#/\.>USP_5T"2B<ID@]L2J" #>(TWTNNXV/0\
M@,C>)6'22-I_@MJO%KA)F@34JB4!Z^*@(*F".-%C#DUF@SNN5LC['*13+:/"
M(2<SDO91Y9:S=Z*!MJZT+OG3"Q4?^_.IVMIYU8.^,UAE=!:7B*<"![==5<08
M^6DJ98T%>MTL"[<R*T7PU<F4).H2LRATEH"U#!/AONV&? :P579L/#M]]*50
M$^.QAM^YS?MW.*A^>@6.3OG4%F84$S6J?/3Q B$DJY1.1*&BWIUD"8YVHSVR
MU^QQS-!D-QI>=PO )CH OY9(P!9)9KIK"HMHU'0!]K*/QYF5TL$BG$^XZGV%
M -4&7-CN9;TBSEF27(Y<F.AN?D=(&O[7B8W4G-Q"#\>GC+N"% XKY?>5J)<,
M.14,T'(($A*^=)H:P]=KZ/71RA06\=IT0X4*P[W6M;BD,N7V<+8B"P>_LLV5
M_(^*F>P]@F)",-$<?4N(O&(RM>^D==:RDS1*!>XUSG+$,2B]9DRY3W673'<B
M>K-3*?53-E^*7'JG*Y<YR[C)&Q/>N+@86H6N6GX665!$X-8&&^3PD!PS:O%R
MP;OQL4K(*->*_*X[',0%@82A ,\/X 9)# RLC[*EJ],[INAR=1<0TV..,K:,
MD]N;VZKV&L;AHWG^M.2 F,]#%HON/P01'4P#A2&4D/#G=ID2\<;VY U.@Y)=
M@VIV5>ZJ&J2"A$(D[*T7,Y)-S Z7GYDM'[-C;XV7C$0]<+4_&U[02&Q*DG:9
MS!FX^M*TR*3[JQIP+J<$5.VGQ'<03\:5HCT- _H2)=O ?7[)S!'E61$-=8?&
M.(>PR1*9P/,W=5*CFJU9MSJ@5F+Y]D29\\3#DIKV&UHZJ+EPO\E</SG,3,SZ
M$?."7$O\67V>,'2&H<UK75RT[&QBAZ8VABD6W<;,//?VB[LJ,B;.NU&&C!.C
MU^XTKQK/4,A@PQ=^,ME/X&\>%:?)E1(EOMN5U.?-I0+\H-NN ^@!,:-(QX+7
MC-?O5^&B<24RCW&GT]Q;0FFAWQ#$]C0,G>$!])G#-4Y*5%0"^_V=##VPU)VH
M,C_-Z%&4NM41_X1 J,$;LH_"!B%+26$=!MH>TIQ+QG?S0FU)A=1[GF0T6?.E
M4YXPN\VFPQ<Y,*5CG1J?T/3B'R=,8[8] &+SP_.5"B8KT_JZ8^:&L49)->01
MH^IKQ:D)$Y-T\KMOU&(G/9VDB6;**,)V9K+R6G._YXVIF!PC)KNAA7H@RY+8
M).12U &8KQLM#U]T*^>,<E:(J%O@H;$7@_X\CL-T\2PYDF%%KC9YR\J(VFWC
MVRT(<O'']3^I6KK)L[%#G7.7[6==M;R\5;.!5=[27_8*-44U1V'P+.AW'XRA
MS7,&!L/1RAE&M2;VVM4K>J\NX]KJBAZ-]WSDZR\8XQ>IE&XUZ54RB XH,<<I
MV;A1PC"<M83&GN<57<^.$D_,'?[:N?9'?=>M?,N3+B1W53E2DYY 59<N537B
M(:@ZR-;[@XA+OQ&26*N<%SJH"9 P4\WY')YUO#:-;KF=!X65P+K@*:<P:T T
M2Q,)#;5:=Q8:K /D!L@-@"Q=X@+HD;-60M)FGBK#75X>8WK(WG=?NL(M! 7<
M*@W *I0P6?]2I7DW+*=.+'L;U>1R0PD:Q?,M2=8HE$R8K8:HF8'MNRB46Y6C
MFCA%6EA\,K2T"6)PDOK3.*8FHX(C,M66__2/A82 8&\AU[V!RR_;JO[B%:!K
MO#^,\)W'N7G*:ENO\2#0P*-+J]2F4IRW9$UR)>VG$:=1S_5&D4OZU"9E6V&F
MJ8?T:A$USPOB"@CROL4_ D-PS]W'"[3?5>E;B:G-!4ZM$PY;I4]L"U<Q+BWI
MI,196!97?4D"\.66Y&%JS+_NR,FJQ),PTY;)<,0MBGYW=?R.\QYP8X=2'C4>
M?M $BN$2??.=6GL+DZHLA3!E$.*BW&1;!G\7ALE8WA^B_5$DKC!>6)3<.M9.
MX#95%NR&+W!7\]+>-'Z76)K:2Z,Q0=YW2AAS=,4Y.#7.HS@$=9ZEC&]*^$ E
M!M*[Z3_0V(J8'4@L! T4R5ZIP-I>(>,'V:_Q:+*;ZPYCK/S'V_S?9#>]Q)I9
M\7R[L3 .F);OCLSV26\Q_K09E7'W4CL)"KW&JSU3[0QURM[E>'X5<ZCWP(6"
MO&/N!A-'YM/ 1'6Z(,XRT[B(O5.NU5_A85?AF<?\C([QNV1/+CG.^T/5<O(+
M+]_?@/='KTQQT<C#P?(L:59IKF27YG2ZE22RX[^U&Q2:\EF/#( "9Y<$Y@(H
M#F[*,I?6%5ZG2_]5 ]YM+@6_O#KW'W"*[ICLMM[^YO.7N_ LN39LC47PS^F;
M>8/_=XD#L/G@J&PF@+8D@["S$',6_VX,16@[530E@N45%A4]W;#."<J]H"^K
M,X#[%2(@E2J=X)/+/BA3 153E3O_7">//]NWT69-WU6)YV-^M\P3NS+)ZD15
MGM[9_0;$VJJT;3RBWE@O1M&(%)OWD;Q#]78R3\7?<3ZFY6])9^VUXM-3 [R*
M<TRZ0MR_(P:=K,K?@!JZQ]";ODQTH\GW>O326NL:CX+R^U;"\%%'+LG/4X[8
MO#]38<N+=\-:5:/B]+6J-2O9R][R#6E>J;G0Y=02"B?SU>Q2'E[:F#D\EN-+
MI-#!N/<Z0OU:A&56//DU*69M-I]%TO17PX _,I)=ZSO<]\F1,<ZS-$?J_1_>
M &FK0TW$!?J/C\N,-\&'4W=0E -HCBG#G-[U1XO)CG'Z^=0=&V_R>(-B]-85
M:U]]<@$S?G[@_C-R6>;$^M8NS3W?>9VS%A"5OU4O_#Y<5+^ ,$0(^Q4X(VY2
M9%NN>N)@C@Q!J>M[:7/9.Q50P88/[1-GZD(\9A3S"D9=I[4__-UQ_SO]TY7(
M?$!Z%"Z6YA2=*,&,F7J_B%;1G"H#9FF,".176Z]\0.G9<VU4G=6ZS68I*O#G
MFWI,P83N% K"B>, 0+@0AQ60[0MO?UHX 0F7RD.&]=5N^R(N$?[V*S6P[?_#
MWEM'M=5U^\*I4*- <8<"!8H7=VB+>X$$"U)< R5HT;84M^(.+4Z"0X)#<2M!
M@VMQ=[?;ON^YW\MSQO>-\=UQ[KGC.>=V_9?L-;/F^LV]Y_K-[+7F[*IEVW>W
M"'4H9^OGB57K1Y.LGGLZ)==&"<T_'*MYUBWK2%')^49I\#B8(+X-.V__W"9,
MJ1WP)U7NGU2Y_PU3Y=[^*%8[:'[/;O#6W!NMGB?@1+8X1V!X[$JEH_)S9C2&
M9J/[@+6@7&*;8@+J,3338YZT46GT[@]'JQ7M04;='<R0\WO';4I874HY]0<:
M99-@3,NM-0P51WY/CG++/A<0K84-QV-6WO$"?61T"<D+-;8R&>P(B28*BG76
MPI>$+H=QKL+IU2\=C#^+Y,W>X=-A:"V>GD!:N;45L#VU8/,N=<0HT^UJGF*)
MD)=-E*_2KC-;DVX/>6624;,@'(FDE10*C'ZH=SBX$:QU(O$]SU'^2-0WZ3U*
M&^=)=5O[>^WI#.U!KCK)!&;FNC!I56"Q1UQYRJXB<=F]7@LBP56,+">0=\;,
M+=Y:3[Q2*X:F.:( A+Y5.,W\]*L)LV/EC$)]/H<: FN_94O.>=^PB:=E Y6T
M\6!L+G7GN#4 $^\ F2]^8SB8VGQ71CFWS!/$Y+3$D!@>9OJTYK,1PD?/W':&
MD+D\R6>>68ZH@*[(<#1OQF$B+J3K6UE4W-K'@:%_X7^+W%/]2IGL&K#LWV2
MBM((!*:1-=R:@D58BS&)D0N;//LB1?_/GG<UG-Q.>0?$J7B+:MEBN>YM7M7&
MM5+.T(KT7@"O =W36.?+<M< I=:@Q<?#KH]NVABC_L1G3[?/( CFLB-L6' N
M=WAI'O([L8'F"OP*[$Q]_#NIP6B_"??)/S1ZPZ$'7BGM\Q:_U#ZMWLN]Q3]%
M4!]PE=S @T5]'$7TS_0>+Z\!VAS'<1+>Q=O7@/5#U=AC\UW"-&RQLEX"<:)P
M 6?&EA*Q<\G7E5WW_Y+Y'Z#_U.K;.?-?;L!8<N&SKE&#[F#SG8,/XV0X\<UG
M#,ZY7J^.0X]]PSW+P <)*H_IJ<ENB.#-]!^?;8\U!&6)G<.-*>T8UW)%C$^Q
M164OF+Q.^8*/?Y\KU3(QC)I^>D.H%3QQ]F4R+:C _SB#G9U$9KB\GI/:UH][
M1G-R>OAJXV?:J^3LMV-E>W])7W?WRM'IJL"%<>_G_1.,5_['<?MK=OW"2-'V
M"\;Z;>>*S42[#"9.'S*JDAN3_,-*_Z?4?SU6^G2]*$TN2ZALIR-Q+9 )5W=!
M.;%48&R<R/8]"-S8K41&\P,4!];2CV)@U:7Z'L+UK'GZR/MVE$FG\=%7J8YW
M3/CM5/"K8F*I1^(7I!,GO72";]+K7'!>PZ%1$IO6-?(*FH4:6A&).<;KUG4T
M6;!X%TAR*D^@?$\+@SJSAC8S?:/LW?>'M\J=P NM*-^AXSP52N1!=@KJ>^8Z
M;([#[<CNC9744Z.4!@1R*-IM(0.O4W.-*-N>RY>GD$R8;B1(0%5366]A] 6>
MSSKV8<%\G-:F79,><?.E9Q755+H=ER:Y#6]781>7MN_:+BZN/,PJL?N!MO:\
M'BNVR715$TIGH8 [F9?.04!H+::8JCUTNNP:(%RM:3\NDT--(^"B5V57S]).
M+F<-M^VJ45$S=0H1?=50@M!!]HSL\G9F\B6#7E-CZ4@(!:06/MW"N)? C'IG
M(Z+U>'TM;E?]BT?F\M7EVDA=9+%X85L&HL^XE'[,2)2RJ.-RGB5F>^N;<'2$
MQ1E7GF9,S(\(G6R-32H%3BF1^4I5KEO]'_YEFS^>\H^G_.,I_Q;M-H%0Y6'[
M_+9,7@H^9NW!T>Z8O%T;\2KSQ*5&6Z1K!_)L%2V5.?^>6./<TZ2[,WZ$SY_V
M.>[K&)&C7*B+2>.'>!WZ\;+2W(.I4/D8B+!2 YIEQ"IZ@O<!7"ZH!T:3O/$8
M#E+G'%0M_ZQ^$$L3G#Q/+\8=LG!K[0/@_L=QLB*=K7&L--#6(TH%LW7W3*.^
MX2[>I7M\W9K%TD5C4;Q1?K&VJU&1$:]C)'LB72R97R<G,'6IOWT4L+?_UO'6
MX?O3E!P1X.J(4>E>L/$(<.P+]"Q1:JLO&HT++1O@B6>21QL[VC)&''2N2V32
M1[R5W[\G3\KGSZ02ME'YG<AMQN/Q'#_3QI/A:=E=[K#S ;3!MF1 &4140KIZ
ME(Q7HK*3CIM;^,&1W ]V:(([DCDW@U<XV47.O(SR@XV36-*;$42 O-)M.#AC
MD(45+Z@0:+EC[Y38ZL6)/;U+^?#6(W0T4/VN>_[Q@Z^1EG$5:V]OK=Z _&_W
MLO])Q8A!5LNQ1OW3OI-MO4E[,JE-S B"RY^(;*OXH[UAN0)WO4U/-[<U>T4;
M4(Q.I2.R5VF88M$AVM?,R*5V49'$QQ>,-^AUPM].7/MR;IG,M8K>VMK-^VMY
M#SY(I+(T4 ,C):&5[V&F4)G2-TWOY^4Z'#\FZ@GO".IVSHLF"#:88"OE ?[_
MAN12C*PBA4LCG"[8'2.Z#WKP=:VF9%[4F;F[VA I4=,;%G\M[:3^KAY3J/OD
M53""!#X+F9 0<9B=ZHZ3_S8S("4X, ^6"-?LEBO3J<R==1I1/)"JW6+1V0@V
M&@U @[E@6;F!X3NAC6><9X);ZQ@3U HXS//"3N4\FWD^=[^ZCY8?;$D"ZTN
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M!+ 9MPI#-G/(>1PTR%*-M"/)4)E1VCP0Q[9 ,<D(MIVDS G1.*GQNUJ5FXU
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M=D/F;L6!YU7-D=W//)7ZM=%V<.<9#(?D2B)<3?R10;U2^N6808X:$2F)R7'
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MSLU$-P%$D+P;%*YT\X'_6[V"JW6,G3'8L>_+2:C-&A[*%0TN@Y%?J?(7:Q"
M-#CP.$8MA"!.EBT)_%+[9SVT8@O6MT/E\Z 5QM%=BPT>70'S4PU-#>7N \WO
MF,?TL/X'>^\9U>2V+0RS[0T0D2)U2]70I#<!"[T*)*&$HJ&G4$*5NFWT(B"A
MPY8:$@(&2.B@@+0(*) 0$GJ5+B!%$?CV/O?>]WB^\9TQ[C?>=[QCWWO/_)FL
M-==<\UG/G&L^LUUZ%>.4W0Z5W/!GH(3SRBD,5S-8+9C,)>;)N'9$7G_&0><Y
MEZEYG0-&'_&V+3/MG"!(@763J !(.D-T@0&#+YI--(1V3]RNI>9$S&<O:QY^
M"LUJNNNA?OJ"'NCCH^P1]M&4F\#97!V!:OMX,)2MZ5652BI<-1.8GM!&Z[34
M@M8UKGFN!/A>'/VV&?J+:-'[&U"_OF319"_8X/>""11MA<T3)XU5Z[_:;1,@
M$\(PCUN3TKQ8$\?LR19M3./G:><U;Z#4Q:;SI&?%ECT6:8EE!''=S%#9^,1N
M8^9OO" DORG1[R,<9=4PCY4 =JJ9PD*@QJMJEY3F7B^?8O>>STZ#^V>,?LUN
M(A>KSVXIZ\2@+27J_=(:N2?\$9"+49*FNFMGA-FSJK#V" ^^N(L+4XZ(>1C6
M9AUI98U6Q/F^W3.*ZFNZ;2X&:W5]4Y_U]07G=K$?@10TW8NIM4[4]F]9[G#!
MP7/R[T,W1W!N,FHE/O!4R+-8+GN?W[\.B"F$)G!F%;=#&GX;HCODUP(L!P=&
M'G$%!D8%<-UZ><2O,%]PQGRP.TW$8.(R+#;LQF;"Y.INV\C##/]02RA%P;)P
M$J7M-Z0I3KQ"@5H/H\:A@#D=(IB"PANNLCZ&F#3=5A?L^#+Z\%T9?(FJY!@#
M.74I,Q%$$('8X9%+'&5I%AU&;)@LO95+/O+)'!,H%#NZ6JW%)9W?J_J[*=Z"
M+A9VJD:AXT! "_[YK'G1PPD;CX784EFSE/MGO#^)? @HZ3')<<Y4'EJ/$GRW
M,!JLD9\84"'++N8[0Z 6@@OTA!@NE.[="AT']KG:T>J@.5Y[2$W54/TMU?R3
MUZ3P#8NB"D@@@?^Q1C5?IFV.P&N')^GQ8H8552O(X0/3%:P29B0TS^'",SSV
MI4(PD#?A[N^K%^Z!X&SXZ:GK9'D7BB_[P,>X./>4\_Q#Q90VC_1K2B&W-%EJ
M R"LT50C1YM[2;@L/8WU$5-&/XH^3Z@JM*" 0 0V*3FI,[N!3UY\;(_\.'.A
M]X8PPH?XJ-2?*LN&1R[>6Y2*CHZ!86DY(G/N#OJF_@5+/@.&^;* KSV'Y':L
MQ'@I7MD)L,U3\"+=_WXK [:!%C$4?70>0#>RN?U()6C8MNKQN<,3_/EAQKVX
MN$T['BD&LI_#O+HR.<-3&* C I@/UPY%H%QZYZJT?64 6 UL;3F$7?HA;94Q
M/+XN;T)DZ_AA>?&%:ZP?3)XAB=*(6T,IFD-]G1NB1W3G=)!EL&$O&WAV^!2M
M!@FJG.'*:UR%V#%+E[%,GNE-6BQ'F<P4/I"-M=Q[);?T"86M[_)."9+MHUDL
M"C_$P6]^65:%+X_%%T<J:ZQDXHVLDN7$35 \0W?O@V)&[D>9*SI:W4Y(2##-
MSL%$9UD!OJ;>A)JZ;TXBMR1</_<GAI[%9D,MZJ[=DV@FNWH>*34^R)@[77E>
MG1["LO0HS3S>2:Y#OQ?SON"LN55'Z+).H7/:1I#8K:,^)^YP5AU0$Q*7:FD9
M2W:6(MA]?9(IE)!@!$)J-^&2:\T304;&DT1K,=%$JT_KK4Y.(X,//S+4/YF7
M^QMM]4DF0MBDL3C;3+M$*R*&9 T]RN<3FJL\$]S]I=$!I>>@4MS;3]N0H]A$
MILA2+^2V257@FW[?7(.16:;'?+=OV?CU+A'BLSLS09I'L6&;FLL!(TC-BT3>
M^@[<+8\4:UJG<+*Y[2Z@E\S6!^&0(D/G=0@($,$H_#T"K5'%^ZD-0Z!QWA3X
MQI&HHR?[^64/C-@'TJD:)LJIDHHQZ-<?BV#7&WX6V?\SG(Y4%EO?^_%\'%2?
MQCAT2'AK,;&FKU/&L8,N*5E^Q62NPE=6OIJ0MF ,O[6=TN_8$%FNK]9Y;E(4
M('55-=[NZB]\^>5AGY1_A,);KRM;[3DSX?7PZI3LTJC;:F$>:_<[\DPHRKI=
M%;["CH@8; T__-%]]4<&T8.A+\H-_@P\,JOLNC%:OM:FV&(IU.DHYF<WE7G3
M%/JDRJ&BTJ8EDT]ER:K83T;TFXLI11U5[3\NYUM3%ESQ(2V"KZVO9HW]HRG'
M8]LBDXX;-N>B>B3MV-[%6^1S*UWP''MX_OVATWI,Z^RL_;?S#:V-OY[9]E[$
M5%YH^*V&QAH4V(K-?L]OO5 S\C"EF1<6'0@&S[R:(3KIOR&-K S\X/$C9EY2
MLE'HCXUT)GA[+LD[,7G^_A_,"G= -0*]J^^-*^].I0D#UNPKG[6W%33<[)N0
MVC#WR=H1>#-NMR@C[I:CK.P;?[4#,2J:*S56ZUGU''=))D\[(4>B.[/7\D.W
ML(W@VQQ<QE!XTNW]T7&=H'%";< PYN.2Q4[%W3'_YY>D6[T>ZBJDJ01+5]=J
MWY0F)@8_'DZ(4:R\6# _J.HZBBK(C*;P[5GW!=,#+ V3"2!SV[AT#6P>X5YD
M\8ZY9)*VCA[ >8<M#&5]2N[A7[ )%,>)'4I+G-39[6,F2GYV)> W]K!/1I^3
MELC;=SX=,SV6?7A>B^F_8N-D9H^%B.YMM*!2[MHWZ9HX:M^W]W=GWP12T?S8
M;<<KFQ<2OVZG[$\.];W]F3;IP^7BT/S'CONSQ8=SY8IQ$5J0CT'5![Y(#;ZC
MXHXFF.:N[=1#2Z<[?Y_QE[JTGEU9DAW.=_">8Z3?107_82+!O?=2ODRTKRZ7
M^X*K+!1'$5UJ+S22G]]/9YL@WTI_$3B%TA=9JZYB.],/N3F9E2;:L';TGHH4
M? :E\969U0!-2>( K'#*L#\%J$,P[X&#S"TELN8(U%(D SG/0MX',]=<;BAU
ME1@-  L)X<#OD7,PK&TB;!PE5# 'SR*1WK]L=JL/<Y3.K]7:+YU%XI)#\1.W
M\([=L&9SWZC\V IXG/H<2YR5 9F^(U:5" LXIX^99!UK)JJX9HG95QFJ 0#Y
M<Q+>X^M(I/)+ N;SYUNU )$J@FU%<ED;6LX&A*QB8)*%&%"LTK 9Z??WRA($
M?T>ZY!G#52,N**#](GT.8>9PNFD?JEW%D)$H 8_"S>VAY5QC:I';8N_J C47
ML5L2OLL7SWQMT6QU$*J9&&J!6Y]% :;Z'F7FJ15J74E=($;+%?-UK(=L+=7<
M*9;MR_L\VJMP<+WZY?0P#?'5CW)YL".9X!JKRA?3AH/321*Y\%R7&-@7[E@<
MDE2"L,!QE%9@B_.J7%*TGWH(P2I/6G2JD@IYG2!(;()VK^LZ8$=NGFCUBL^K
MQK/%>^O=>A9^HUE+@S1*4Z9NU+YMI#XXN- H'(94MC0DWRHNN!Z,"W3QY0,G
MQN_P9?()59B-\8PF(4P'!IY0WT4^\CL?HYGBVH%_RJDJ:CV6C'/TE\:O2/J7
M^:/H:%M[4J 7"9WM?@,@BW"\8B>MUFTOIU802(0B$FS8/K2LK-7%P3WQ<SU0
MQJ.UX$Y?XJ3TMYB&G*6C^XC#M Z#:R:.LN4W+<#,N<SE-D9OEWI-@GMD3Y=5
MS+] 0I*E^E1S<D,[B#;^=M(M<M"ZWEC=<2I9V8T4D%F7P'=Y[8(2,.TS#0W2
M,]Y3Y)>0D4B9_Y!.86-C+X8:3D32U#U(!7B:B[_V@=RB]N="*T-:<M]3I?J^
M2",,I35"J@,$ ATIXE;58E8=4CF/;OBH<3WS4[4=$'H(Z4CU:;2],GYE+4<
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M&3/6P$7^[T%PZR&*N^TD!)A>P" IWKM6GTCM\1I)-M1%M(V(9G)=K*Z8N97
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MJ;?2;J)^$R0A \GA/7C=.QY!*Z>RD5K.(>J/W#N5GB>^=B[Q4(E#JU>]:<N
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MZMWVC,??NDNY[<G$RYT2WGJK2F:B(G' EA"83_#AM%,K+2PKN/9L#)4*5)8
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M[T[2Z< [@1=XF-":74,X8VY]U74GSWPN_0 X+.E&?8;X<JJF;';HCI;;$++
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ME?O^+^T +M8\GN*KI>><$_G\L\7_IH6BK PKDKNCAC\*.%]1^-PM+!W<U_6
M>293-V.X%%@A8P>_39T/-R,&!^BF"M;90:'4U>5?FBN[LF#OKF<[]5:':B>R
M0^"^!(=?=T>_E6$0Z74"U26$LYK>U@QW,$A+/=%[C4,B#>:0%;90"^!P$(I)
MAT"]"%!O6C;UN_;\Z? 2SY%<&'SM3TO?S7P\XJ0R5Y''>\M<=*9@"X-;#7^*
MU>CR$FADP?7CQ9"H'I^CH4(?G9ZP'Q>?UDOP>_,*R#I-NA[XXGPS.LU<#D^W
M"SF7?EPROB.("-$_1W2O_.O^LOKT_G;[_.'#VCM^$[YQ<>%+\9-0;OYE\2V[
MGK[:JE:G$0IYV^'S4J#*$ [ROI^T<CB[[;B-<:5<+CPU?^%K^B,CHJ-U2TI<
MRTBT]ZFD\K7>5(YS5"3T>U"?B,/:1$@W;F6PX<YF:>?@P9I>GK_-V+54E:T;
MGFYA?E!5O'[ G[C\[2=SK!JKBB>T'IZ+X06U=%YOR-/M]5T&O).9?;(?260(
MQ#O56LA. .7Q0PMX_R!:_.QJ-I\P?(+C$:3L1.Z%M$37Q1CFV2)LNP=M90^7
M7>K==R62/K)MJ4:_MO9BY3R]OG^Z?HIZ.2^H7+#//$Y%_?+[]_N^>;&XCD^U
MPZYG@+TC6(=G\4%0S[L?V9UI@V631 AG-%.]TQ[H&E]J_>5\YYQW^9Z=1)__
M<J&U-,+@(?OJP2QFTJ<?^E67=B7(@"2XQ'PA1F@/;1JJ,$GUHM"!_?DY"C-;
M,'3^7:MOHOP9()K:YY'+R?%X^M;DOBKEE:7U16G7 -_JD.J7Z"C;+[\3_7Q-
M"OCYFO3O+G]S<C!(P6#\D?CN?@^M@8_4X74>F9FJ=1A.6/E$^;GO4UON99^!
M\"KU#]24^N9_D"RUBH?F"145_2'2(KP:<DF:?[.'3:7%>/W#KH1KBN&T^(,[
M9O['X5'BK;^V_G^?#N12A"U=S3.=H:V6XIJ3K):/91)HHAIV4K/^+C;'57@/
M16R-8(/AG/:7WRDN?IV MW3<>7\&X(\^ P"%CY^OXPXK96=K-S+X;_6.=@=M
MWCT#>))[7LAEFCS7^=62'8DY]XX[B<K8XUAMZ563XYF/6\,BJPKX:/>"0+>W
MLA[N;5ZVRPM3YT='ZK.G6J-257!LWW>Z#:%HJDU%+(EJG92C4L)\56?T^6@]
MV>T>L11^_)WB@KJO]M <KNE."W7_)B-!2BG>7K5O,$\I7T<?SXJN0'/&IO%]
MF>Z$F/.]7-/&)_,*%TS=,>^5B%SY_)4]8R>HML5T,U^,'F/ ]VWR;O:F(K^F
MEL)YK\518Q6W6[K=@[M^C-G].D[=[STY_=V'/HWB^C2ZB&MOK$T_(;E()2/#
MY7:.2'Y1<C)3[=UD!VOL7-JQ^"WW4T/#[XZE=TCK: :NJ4%"_G3G0;^9.4OM
M\_/#<WB_PK+KYYB[&-[6TV$\9IO5<ICY]B19:4+3O:N4Q@-*:P'>/\03I)7Q
M.F]6:(:C0X]D%TZM=40V<W5N2]1,\NC,%KH4D5?:T7A+-#*NSPC?"'TJH CX
M$Q=Z6[AO6X/!\;<#A<,^BUY@U*S&E A2E=VTB;G!U.I-Y/6,CW]IB#! \.QZ
M+V^FB-<<!V[?-0EM<A\%89V2CY*^G+Z?,.X[R:%URWDHS%_5__P\?^&4W<(C
M04'9'0LTK4?>U2#KR13-U+".498EGTW1IGJO)S2]>(>T3-[O?S2^0#X.$4XP
M\XD6M<_;OO0>R5[ND#7A>L527JK9/(["VK]S BVA6CT9W_JTN'+2>4R5;_?3
M7NY<-)@Y5X@U^AG+,Z[;:8%WI]LL-*U[2,OQ%.:SJ9T*F)"=QFDD[ZJ1U1IF
MZH8VG6E01.]7DH,2QEFMX>''2I@'"8KW,77R%=8&55+9S7;2*N&C1@ZF+P'_
MHU> :?.)U]Z,YJ-:>P9QHDUYZ,F5W-M5F1JA"8Z&O,_7_3=+N=\DQ\<BVR!,
MK280CTR?F^4/2[S,^^P#>5I$W.":1HU9SGZNN:5[O'A1IB[.F_)8/FHU7@O8
MYT+= 9GTQ.@"QZ0!1X1":<* 3C>V\D[Y^*CJ#&>X.39-</R=6'N[)J.4>O+2
MD% /1(1^>!"Y,CA<NE'>'DN^_M$QL22N5=_=85/7LKW*B5=4A<-UG2E4(5<:
M&1(8%/*BG/T].*':X9X0$;EL"Y=%)!XY\C$W0Z0QG1''K9#GQGIQ.5Z5K.\&
M(6)Z])\/:/;+P6#P"VC2HI #'#X"SXW6 ,:Y6IK3!UO9"U,\'&E-#!R0I20+
M" B(JLZ#:L?0T3$&#"@&Q-"1L(X(+V9M2B;+9IB/X@*1-HZ.KRU4R0TX[70(
MU@@KQ$!^&\3/3_C?%O]B8/$9V<RS5!,:J%5R:7'GIHR@W;S3C3=J3#2?\D;%
ME@R)P8+*#YA(B^_*YT'39>DGJEBLAV06A72<>Z0C$,9S,FGS:H*&1"(W*D2Y
M(V,I&J!-6%064:1,.T)S.&8896 58@D:2FAZ.K8X[I@$BZ%SHTYLP;^ZIS>%
MVID/OWIP.A14E3F#8]/$AH7#RPSEW_JCWEB%!HXRV=L_;(20/%$M)0#.W)07
M!S*NYI!EQI591E(3$\9*AZQ#ZJR5."X@B2T-7FFP#V<[EXZL@F#P7,LB(>UP
MRZ1=F7*J,-2 IO,!28LMK1$K?Y21613^")48IX)RDT*8!5TYB*!4*QKAT;Q0
M&*;!I;DP#,L!OTKN<@'<4MZE7&95'NF!']<ML)ODGP' FL;SP"JK_D2"]&M6
M M[E'QC6.JOSY0OY);F+T:S?P&W2Z;/*42%R*4*C3:H-3(P\>835>K4Y'ZT2
M18H+/#0*82OQZ6#IMT$+:7Q48PC/I(7T9 N]JL&T"5?DL'?WQD@L@9>G"I*@
M>4UH Z):!Z3+V)0I[_8HQ- T(PL@J*9:YV[ULAYK/%RNWO*<<($U0L72G*"@
MY**8)&?"1FMSS3C"XFI$=M1<",+B10:]YB04\XL4)$?S66B49!5#+Y&"G^L5
M#A%N<7*M@/PZM9F[K%E-L=>-0C6T%\5MK\G2E4/0#N7'_-\U*Z:?U+!$4-N6
M)AL/)E/GER7 H"R3QE=8-RT_1 ]BDT$6CAHR!@3$L[&OOW@[6CKQ=+OG357H
M]$;>$#6=<RIM7M\']K!),#)?[2'7M]TEENM*H;\,SVWR#>U#.H1\IB'VQO)/
M[JX'9"D&CL#3$1[^NN)15QNPB5<;31/=U-!(AG#M?*^@ @=A(?K]ITV%L*!5
M;1R8.SV"LIBG*7 06A;3-ANG)TI9DIWFT0)\$FID-LBGP^: BXY@=\C5@J87
MDM(AP>C#65U%6Y7N#[C:./X ;. V86KGFJ[.+(-7HGHX_:6,,-G;I23-5N,=
M-J>OW6NV*QC$[0Q=!^V![S%RTX5)I:%/3Q"C[7K)KS3:R.11\$R0@[ -&51'
MJ)QT0(OP;1;)%VBXX;ZS1LD>G@K[[-,5>77U]F'NC.TTH)T(T ,1Z$:E>.<\
MXDV+Y^'1Q.NFU-%XD9]78?_#K\*@ULTMYFTKB'>TZ8L6Z- :["?A41U-FU[E
M+'@$*;$FVU.!_L(\M)+K;0+OR#E,G0;0?4WHJ]V3^"LB13-B?#&Y[!VF>.\T
M)B% 64/QSIA%UF+]/4\VSY02O<PN<;MMCO&.^#?J<4WY$>:AGK)#Q?F] A[!
MX<I#%[%MAN$!;4$I/%38HLGJV.K[02P?_+O:[!D,Q_SX,T2]6-,Q[('^>8$^
M[E3%ILJ7EU;(H9\XF07V:B3C=-GF]%8DK74$M8J#GQ98DPN1$D:J/7M3/&GN
M\#E\<2+9G"4&1/B!7C#88=V40[D+"VJ/DX,S4G-=3[?@=HM<$6,O?G*T:"6N
M157@!ZY:&NQPRL[3U-51B#]@9#2<FM7O5&I[]"X@Q"H7PZ(E&SH["\5\5(15
MEA8DPX(AH1%,W%#8IR#56>KR5CH@(K#>#AX04W AV'>&]A</A_Y)\@\%/BW>
MNDE#9FKY*'%'IT\T8DJNRDE%]CB#9@V7[N*4R#- <#Z9*%:<9!_RP7LJ1$@H
M3U_<>2K$6,.@+IY7:@7NLUBNQ#W7W'TK9$XN$]HG#98NFJW0WWN*=.""2LDR
MEH[V[[?*QX;RA5<(<CK/G@X3L*D:YR1?^_W#+2+M^*]N_9JX=+]]?8GUEX72
M?W<UH@!!R7>'_@O>+V^\2BSW@CN%+V9))R[D1P.E^ZK\'GS@-@,Z3HM2S3<[
M8C"C2=#3B 0!DN 3Q&^NH;'T<(6.!()^DYCQ]M4A"IOS^G9-53D&"\39)(TQ
M/VY<X[Z5WCRNG@!#,+4QJCY#0LBXB!17/\P).>($N[F2\(A'2PS6_^4<A[JR
M266-@S#V# ![L'YWTH#"DM;)3G^UY>2SN'*3>/M ]^OFA)9Q*M**K3. U94@
M=L4E4?,\[]XZSP):[!?-M/^\_JVDMU,.S)TFYHCX^J'9T"IIJ@=2C:YK1T,^
MFFYK\L,<M[_2%64OYM=)9=V>(B*.(;Y]) ^1I"\3?8))OL\GLEKXF;W(;;^E
MK3M/L^"L<D5RZA_8F3BOT@4F.R2]X_ U)6_F^2'LI*C:WT?^G0'/QZVLPGW9
M*QM5OJ,7#(/5A._\L?K3E?$71K-&>0D,O7VW#:(?*FP0\S";"==KB1RAY-YR
M^P4]C^>_E=(]T3U1%U-J&GGS+\=5$L%/TM;Q&S$XDA^(#,;_!I$!>?";!KR"
MHUAP+/_I./Z9U9_:Z-\O A._+_=4_BRMW@W%^))1@ES*:GHFVVI$P]UVAHGD
MZ\WV./JOBK\?LPG\]9BMUX']Y>\SOV!: (Z1$1>)HWH+>;S#?X,V-#A+FJ9<
M&FZJUNT-&*_#+V]5HRWG<,2$YV)>O2[=7%BG#3L#5+P?YI0UEAKQ6/5]_L/L
M=S\#_#Y"/HLF_J/_>_7[A]=;FO*P(9O<?-L'(E/?@,%NF*I^)=YYS61I(O'/
M)41O'MRL471,PJPU<^TY1GA@OO_1_HJ,EZ.&XPHT5HE3=\U..JD [:Z]G<^L
M&:H1(N3PKYQ:I.Q5Q52C+G<T3:>O^0=8)=7P9;"E.S_S2,PAT0+VV5 LLA8]
M-XQ@BYY%:8J/K6\,*Q3O;DUKBD"L80B=]S*!%BATL69.G2&'3-J<AK&!Q1 %
MN#+Y7; YT*B9JX6!DOZ7V!4&AW%9/861++@Q4HT5S8TL)QP5BFDON%<1K.38
MD6^+KZD&52DH*\S$V'IH4/-=NAKP1/H7--2MKHSN:['\+RTL<:@8N;*%IPSJ
M!"UNP6'25Y^Z3#."#::PKZ%I&+TA0\X<ETKJ'$U:$#=BWC$FB[@B3!<^^-U!
M*=>=U^"\26>DES :Z-+B6:;#H@/#C*C#PA*(%&"#C QMWMKQ!-U24H7<7+!!
MYHOPIBO12;SO].6P).);,SL;^0YYBU6,RKNCPZ:B;7KD*M<U2JJ7[UP0PA6[
MS)9SVLA./EDFK\@2IW1N*VY%%/L/I+>U0P-'"?<;L2HFGUSB08/?]+374'NW
M>U:IJF(<T91&Z73.G=TB6LN#=F0:%9OFC2DQW8\-^=>[[2=XA ^7BS%[(M/A
M9P 5,]2&=6'IBT\0+7?3>+V52?6.TR !F)[ PJ%>%4N?@@TJY;)M'3IM[@P@
MIX<N&:D%3[553'K5^*5P5?T2/?L8STY)-RD//T% <-"<'!.8.A+WOLC!C<-3
M).]NNXMO'YO(%K),F9K-0,3:MJ1G@]C!-R-T3CR\=PLTW,U\>Y+;^5IIUT8O
M]QD@K6 >N,L36)!1LYN^C+G5H>!=X.7 I(?G6M<MD)99[&EU(S:X01:#=Q<C
MY&7Y5$MFY>.>@"I;$3ACC*];P^A+$YT6:XO59R_WTLH7'#W]+6^?KVNATI V
MCRD8X:.0+L/L*P'E%,$1>M'>N;I&XV-KHCIR:DQ<84+W,127:T'T,2O"*_IH
M/C5V>+Q^3C2B-073B0*[10]H6Z;H.;HYU"=2>'LWA7)T>/:5+</(>)_< U[-
MI6S&JR-YFZ!Z54BQJ:1(J87[,=W',)%&78>'W)*E-X#P,\"U$DIJDO:-2@)O
M!>3PNOR7H\!H6]8DY"/$@,,\! F&H-L7@>5N($*ZM<$Q!93(>#U&?ERFNR]3
MRNEKFIY,(0N3PLI :Y@#'6-@1*A,H2 QI";YO($94O[;_0^9QF\7^N2V0<6Z
M XMA37U>%Z"MR?-\N3:#9JVNZO%BH0YQ:0-F[S-YD3'.7=:=Z0&9+W*B8?N<
M%"5@T5*Z-@+>(#68_JB/&$F7%8):>; B+!K9RP6FB2BDV:^DUPZ30@V5@XC5
MV(,MYI[,%Q=;ZP\/J5I!67-IWW71\4&U])<PE-[%8PAPT2I9T)S%')* $!AO
MF4MR< 8(2GE6@3YVR>_LLL]]NPO1OJ4@J4ZGWRGU.7/UPVC]"&>V,G5@XL?Z
M)A':L2P<(YV"=#$TRI3\2^D:/O$<%1YKX3MDV2 CL(>[&D1LP(RR<M=XBS!P
MK _3(&6?G:4=8?^D*W$).OER^EFF*)XA:P0Y<:A7"IJML%LQ; K"]^;0 [Z]
MQ55Q*?I-1%38<V=7O$?+$:N#78J?[.5UR+EN5N3,S3?[9-M<99QL!\[\>I'1
M11-F$>@W SE%TWJJHGUX!\67IJJ'PG'/GUL2#7?\N78VL(IVFCZ3PB_VBA%]
M]CW=,=/ER4^X/3"]41SF3V>O"CT#*[XO[QE8;^T1\9=6U/_UTF5QF0Q6QD%I
MNJ[J6L)"]RNJZ+DBW&#7W:&K\.Y854[K0"I:(32!BX]0%1Q(I/3$\F:YLN3[
MCJE&(;RPSED)#7**:R4!M2-_!1T*-@9+%)/9J!_^"@MX3FQ:5JHG%J:/9Y6@
M&V&WQMW. *B+32193C2_MV #_1/JA5#.NT[H34B8II#)_#7KZ!WBB3%^+;ZO
M:F6SD$3%D_H<LN74LF?Q')X\>SPALUB9)9MS6(9W?L<RW/Y76(9@#[IRFWZX
MZ]VD2KM@R+*NC1#8]6;$9;5F9_!N67L0S/!]7%MHB+?N:;=LG:W(#\?2ZH^.
MI>'OYO6KC$&66L@_7U;_J2S5]_#!C(=G@&[P5Q!?A$Z<5SR8.%)(_;L1.ZX!
MS4JS(!1ZT"_T78R"W?9)IJ67O+"_0S5Z_P6J,;>VU7SJ7T$U-M#D=2R 3F1,
MAGRV<HEXFL<34DC<IIG:C"6UD37RR@>%K<IKPQR>7*.C*77GW>8K(/YE[&G=
M#RC':^?,&CRY0J6^/[6E^K/Z9_7/ZI_5/ZO_'B-HCT+,Y(1*T'"]>/"0*_#M
M"$?4!P?#$TG2FVF.44P<OJ;4M<_L'"TX+QS]\K\YR+QPEUKK*)KP307V&F2Y
M6:K&D=Z;6K@F<JAPW9'[]!:/<O'5F(;X=U)!\>WLQF!631,@M"(VIONZZL/Q
MRK%L_K!8_=7-MDMN&H-K"P\@8 N*$!.M\2\IM<]WQ1Y4^+;;28;U&6%4?;@<
M>#R52S&C,VX;6PSI<GLC>68)CQF_I34G,$H5*7?.+ZAKX&>F5H-YXB]E8IJL
MY=45UAVDQ@(Q*TF]:NRB^I-L^3H:A0.KD54/HNZ\-H>C-_G:*IP'2R_9P3!0
MO0;-E<$X-]P5ASK\$_K[1T ;?*W*LC;-(1@M _A*'XCQ1M)44S>WD#0$L0!/
M?S\-HHK5#4"H06IEPP&^7X;N2,PG*GC=(*YBRIZG/53 /#S@$V@KWE;[;"8+
MRB>UV]0QZ_(V'=)5GE6ZVJJO9;="3T(!"42CS3NENK?5M!N5I6>T\?.:3NFS
M#)/AZ!'JG>HRFYS^9UD/BG1;LU)<G\(6JU5GR\#N<%FXWU69H$$N$IP;@5"K
MXK6$==.EE>"Y4-^)K9NXXAP>2+>%&8TE,C4=SAG)=P;PK,<5P]#%"0GG&GZK
M65OALUK(>K50J74DG'9(;[!?Q5DI'*HCE//1/7_0)PQ6\W3H9//61G?Z?\3M
MYI3'5]YV;]>7%8'K/CDZ?FX%G$OL8-<[5TC)EF6R^W G:BB0B](S]25J]>M6
M44(;#H:D8LEE7[HH@QUC+2W8P4<5/XXJPY]"D)6D\K" X/FGN"8YJ0?(K*0_
MZ-0 3^9&Y="VF/ !Y/1)L++7X205G_;&A&C>$V&7>6=@Y^VT;BJ.QE4VN'^/
M>8C5HE#/6BCQ:+80?P>A%/APK;HHQ7]C*T3/OQX,8O]VW4-_"^_;CE[>"37(
M*Z( -R&N^EU>6&&4H]HOY[Z2CB?+()(&OHH.64K(JALP6)[NO]TW!>6:\O'>
MX1OIZ463ME&< :JGO3$#%I@NI4M=+L6[SM+;,K6;;@8NSA3?N3T&A>L>Q:OD
M[U9^[;'<DQ\C;'+?RDV ;]#<Y.#J"U5I25&%N[1SM,%O)E^"O\*+-!7K5GRR
M6%Q*1L6:5 7,?CA8"J2CBX+V>NJM'M)$Z8D8M(+,>U)%9CBB[-9GVQOILVTT
M5*/)C$GLIEV8M8S5^3T5H:9"W;ZF](G=R@EOH<36Z@K>3Y2J_C!\M;_GM[TN
MMK*EA1A<\^"-'CEFN$%=K]^]]+Y0D:Y]KK4F=YI>D)5DZ064\2V>W]QX=8]S
M2@^&W-(E*/>*7NZQVU&/J.JQULC@.G[CN)3*P:_I*!:XW>?^ +U+JGQ.W'S:
MWW\$'/,_7D/_*=SF6EJE(B5]-B_?5>(%R=JNE41(TQ'S1LJ)9/02*O&VA=P-
M?!_7S!4")6OFPKQ:HKFS)\T9+#W"NZ-&>;12W)RY&?;HH)SDG 4/*':%S^J_
M+-S>>:]D]<AN!_%^UF.#P):'K!UT66,G^;%*+4/P *D2GR>F4W^5K-F3)\D%
M:_1\'0?,ZN[%X&QQ.7BO=EVE7/J'M -JO]%N0CFISPW:8OR[8M@Z_S<4\^"I
MD:6U4W^ 5X[3X&MYJ_E2ROU@_PU*],<(O8JE5<HG 7E!;9^!@<#(MW5!AHOD
M'/8ALV)I>\4VKMB@U\!C[*^/I14-K9H9(\1?@/K. !7NCR?(G4OFKUT[. VG
MY,M'S()G]1G-4E#42J5/AR'FV=S\UQ0G*J1[I_BKY?%,E'0+%=<[8LB>^;?8
M*%O-DC>/K#.M?1/+;HJE0*2@@!VAI@Y>UA;T(!!;->&X1=H\=EQ2 :7A2?FX
M2!/XG)=HEQ#$$.;K$B9;#FX/0HW'AQ82W^NQ1#.99L;J;,@X;*8(,X>3GA V
MW@0KO$@T(8%TY?&]72EU#^/345YC+;%_GF6"ZHKABD]M'_QJ-7N3VZ"F1$N]
M8XQJ_EG9K$TI]+45MAT-)8K6#$'>75FS*BKLU.F7::H*#82CZ*-56QB# JK(
M;V=7=JU#*Y50O&Z,UC3DQ+Q'HP9$JOQ2Y9<C&8>$3=.T$5(ZVJ@TN!&X)%"_
MH%I*X.K._%ZMP5/5W:8'I;</U:H?[!DWZ*@S/<B/$1W >KQ_7YR(;P/!/+=\
M$0MT\@\+<PE-_RJ"A*C=@%YCD=O'50T?B]S"+*U@V!7S&V'WM;3H>S5'M_0=
MH19<\ 'L2CRXPY!.)XJ#?\)F=":NIE]!ZB#'T(8X8("?M+&%;Z.<?;!"EG4L
MS-51&@L;0(*M.B)U#A\W*XFL7E;;+6 YB*WF(T'.?^"H#OFX@: LGI]L3.8T
M)/;FR-%X4DUN6B:PY:*M= B=)PSV:3=D5!?)I 0.+(?XOIIU"UL& NW8/V;"
M$@%.'0P\C0%5_,Q;T7G8UM"JT2Z(&"E]1&N6_,CM2[<FE=B9>JW0QKR43UOO
M"2W/.Y2.C6S.I$^N@_6<EUKXUM3;T1:?9MNT^\8O'W"V!8EBOPUY>L)4@*M!
MJXTK"7V_]'4ZY_G0+4QIBPKX,U)#@U_#,HW??P =IPNB&><?]:995;XATKG'
M-QRSA\H*@@.U<K RKXXZMAF#Z4:&@$9(^.*XI0U2-\1ZD16A_@3X^*V-HQ'K
M,E.N7[:U/=F>*YV.*D-AEW0'-"*O9G'"4[O >S"=35J5M>*%4_F UUY?4B9F
M]%K4EK:,J8Q4A*:F!AZ]+D^8W%/FXBO#(N1RUVZ(R.I%C-I>/ -\AM8[P!42
M@:2,THRG.S;\BW<QBLK^_I%OT2"TR*@P&NE=Q)0OPFW)IC,QRA@4+PCFFMC<
M]_1?#R,,F"$N>VW.F&Z+M$@#,B,U+!F1UFCM6.]\'9!#9D#8@2[WJGD[_IVM
M$QI^2SV=YMSF*OE>,2OA1)N(SWG]RD96^/'53L'I7ZP]/E!T)I0;QH_&LCWZ
MA!<VEH1IY@E*E*L4O6.^9=R<:XH(*IK5&DNEU X84%?@E-K7AI5[ESY++ZH<
M'L&+K%.[\#'[8T(@@R.NQ$&L/5\=C%KKM Z Q7CJY_"(L55,.O#$>FWUBKK5
M+J7<5X7KW!Y]5(2R?I''":[LM(>/N+[02P^^PL.'LBH,Z3R%H%Z;DH$B3_;2
MVK/TIQ:!;ULHG2NI*$U1D%RR#'BC,>R=!M0X.LQP(H&??<Y*"5Q(!8\18E.7
MGFHU%INPM:0>L2Y,KV,U^]::DSTX<I 64<38RA#!4=XO=@]M03>"1A*KT2$R
M1/<R%FW:YFF94/X19<^<JO4+F[IEMH&!LH66"2&=C.V3A-2?:=1U6M>TVA2,
M7Y4<%_7ND:PFRUBG?^7)'/S+GRM"P+*H1)/DQE5F)7;%J"%0?_5ZQ-("%X37
M.P))AK;0WE.$SQ<2L+?%DMEJ6+%BW]'"ZBT^98:EWLG/"1.0:N';M'B:)QW=
MOD\?TTPW,F"A#4<9MVT(YK!-9B\J65=V2247F[>)6XL6V3L&9=,%Y' JH1_=
M*?(_&07-;W#G:I!'OUCC,0YR8.N6+N;C>LU0]+93UX-O9+PD&Y,IK4MZ6P8-
M-O'*5YZ^M]A:BA8DAL]-2S%9S2&&JU_GC)2H*WJ2:*BJ.L;?TCBE,^I$93;J
MDY135-W,2''"1,RIUZK0<$OM?L)4V0UZ6A248'E;GBTDOD"\L,SP$^<ED">&
M-\P2L54B^8STKI$K.:<=D^^[B3C%"])G&-F)TUN3OVY![O59KQ%'36_Z\38,
M,CHW8JM[$16P!'04D!YAC<J-T,X3/P,\GPQ3*"3S\BR#?<IN3(=%#T<JAM34
M3)97#R7,#V2X$VM!\RI"'(1H%+-5EDX9K,*4G%E2OO)U.9M\G'6S0&W.3WW*
MC1QHP=T04VY,O/<DKM*DHU!49Y2+F"<S<;%*Y$-#9G];_[-W_#RC9%MP+](K
MX92#C(:J'8;BH\LT2&<SG,-(:%&C+FP45J[:P+HF&H>G+!'>\9+!)DV[U1JB
ME:OES)('T8IL<D;!C30FU)$D?>#CW^VZ\)??MTBCY#_[9OWO< ,VK"H-6$1W
M76DR7D4'[=[L=CGI8KXE^:2Y"3Y-I]HKI*8EP_Y>..?#&4"#C-\QQ'0E9*?,
M%#BSAX4?8Y++\U,BK"WM=/E7Z'R;Y";:GX4F\?T!S1X?D20P.+(\>?<@;QE]
M]<-\1XK TB(^E6#N8[;*MX.#?,XD6L8?GAL3@\%X463-W0[?_89N3QD_:_KD
MD[2"]EJQ'X?QKXTUFS A G1>]:F99P"G!J-S[D P^[ZIZLG?X1#\8]V+_PMN
MUP0YJNWMWU=KEFN1WZ&J9^(KC>NY&AYB-OZ:Z0076N%</SZ=KM[WF..H(DNH
M,G*V0J@XZ41WD=YQ7Q%>6=N =O/\\>Y+TJLUL"I/CI#.M^&$Y.+]JS)<Y^[W
M ?*^4L/#RSXY5-)AT<_;E<70]5.R; P4'_<2_6+!DT0L&A9S01\+Y3\]LGK>
MU/W("BI1_.J;3G?;Y[C05*9? W+E RH;&PC<^'XDDV7U^GU>H<S?=<RV^9\F
MNW_P+\$F_DE)NW!Q2%"+V^HUO]6A;YL)@H)/FG]=&VE;P9%S'U-T@RCPOM\-
MPBL/;H409?[J-%#._QZPYK1>HU32U"LHF@.>G.,]_E=9()Z? 2"1^"1U ZKF
M;W:E=$>I[!M,./T=MM89$EXXK0M/Y2#\-PFTJ(!/8%;/QY/+ZHHQ./J[MD@P
M/Q\\%?4K'.27-(ZQ:F)V%4!L:4"M[;E#AAR!\62EWC_3:O*3VT]N/[G]Y/:3
MVT]N_YVYW0$1XMVYV$_PS1[TN?/F)S3KPQAV: (QV#$$ED7)(T=DEQ;?LEX\
MAET\C:B'YX-%Z'X\;+J3(2CT'U_*W+[5=E)M_K7BCLEZA7A&U:9G-#\@;&4D
M2E>R745GH[_OGN(#PW1-F?J6#@7RUZZ14H[WBUWRP984?JO1C-RI]@D17 P1
M9(OTVC]0*M7B5ZDLL$C=.>7+TZJQ8]JC8WL#8\48W9FY;#D;X^V>2-=K-PTC
MS"+3;4)M-0>X;#!"P2[UL:H2-"[DJN JBLR0<)WZ?JPXSTVZ)^32@YK[;?'*
M!ZHI+'&M4>^ [#7PB2=-MU;(N0<4;H='NW$#M588T>Q\_9,).%Q<SGKZIOB-
M#1HB2GV:(.TZE_I]QJIYPT$=?Y/0"[,^:>B;I(UK@R-N&FZL,XL8*<^JS"32
MF]H6S\-N\3GP*UA/%3-?-=:_MZDD&C4Q*+.T5NP_5B74*WCCP:\@)G\RJ),2
M'R3SK4.1;I^4BG?J]I)J"AMBKS47Q*LPA$B8ED<5*VQ%"A(S1PUYXBT+:1LY
M=@@=U>0 A18E6%)[Q6.4_(S>"@5143$4[GX>J"1\LCLU31([&OU.O3HU]P -
M9Q%HCQH"]:1H6/,=97C>"'C'24?SM*E<*[A149*Z8I7!:K8DJUL<=LGGEW]D
M8B=\Z:J@P\>V!BTTW3AL(HW?U!E 7?6@1"]=A;>P)S]7U$+_8!8O.,+R',DM
M28]<6C9QR>,1C6/8ZM8?GP';"K-629ZL&:]=S4L\'ZGR,]4<X&>JN;^_A-;D
MG &8\7QW&J8Y%^5RI> JH08O-]!/D:E$J7C)1?>>TD6^_+7A1:1/24_O?G:-
MVQ%NF[GU<8( \:*U+*;/=<7QTI&D>ZP"-L-[)N/CTLB.TLOS':QX]K4L34W3
M=N6J>Z]\IF I]7$W]!'AM,K^A*O:(;VQ==U32F#.*Q[[RX_&U^J+S@!3X;X;
MDZMF^&IO5LX #MZ]=3^0-BY>.VKSK:J@/'GG>P8P@(>45DH$Y!W8[Z6X?3HH
M<6\H%&<,W!^A(VY^)OKF?.\7MRZ![V#^@*%+%>Q.O.TW41LFEKR_SB]VI>X4
MEKEE5BF38@Y-U8.X#51O-5.2T@V>HR#QWX.(:WJ].RPI. 0-S5ZSG>P:D: ^
M S@_^*P?-N&DX?8.-]PQC*?%?Q[7Y4^7^OU<^9F9^<]:_G;(UBL6)^:IZ9LJ
M7EM[^W,J[U_SVK!VCX079VP.+%S;]=_AB%W_\:3@<2]R(1%PN=IN-NV:F!!"
M)F2$5SM40-ORUD4:8G#U1B55J#SW2'_%LYI6C1?/60=QB4MON5-$^M>:(H*3
M*,D?&]N_-BK;,=M/+DKD4U^AR&%(*0^&QM\"K31U+@IU&G*X3%0E\THR6=4L
MN[18+%,&@)J(Q6EVD9'*\X9B/$B$Y02B<S56(P/^W,9FMW5^4F7HF8+#U8 Z
M8>_,F4(D(OYIG#*Z8'[^O=2&NG]GD37F:;UB/-P4S%1D-9P_3S0 N@B3BF[C
M&.5"X<20"(\7]PK>R,14"&1B" 39BX%"[*UPM ,=G YCH6,Z,OYRQ#K8D93B
M;<TMNF$,U/E@K$K NA7A' ^B&82G 3-AP2;^3=)RW6W-]4]D:N/BXWRZ@71T
M+(F!-X2TA*[=*'E!25&79BGB=;*##(A\F"'Y$.Y?IQ"R*/CE*(?!2-&IJ)R2
M$@0&0QJE%.'PW @"0B#\&RTUE8,2O6%@OE.^ [UV !P.1]'1,8'!N@&!T>K1
M70V]+5&BMC.7]]G*:5\,"H/;;P[:*WQ%K4(O[_/-5ZV-L>GZ:TD2.#1S1_N%
M)S'X;6DZ+&CQ=XV]:#!I9_9+G?J\/OL\KKN7!U 7+Z8 V3L<;AHH6@6KHJ?5
M'5 KPHV&\,PP!P[%T,"-6MHOJ!<XN;":E(@VAWF1B81#@FX+]M I:0OA[2*T
M!YWPCG:.X4'*3:<I@U@B]L(:;,KI1WO9X 2(#$FEZ_C000L)-\+^\P$_%(CV
MR#7W6#;)(&3%IA"^-4H@RWIO(75];B4NIWTDN4@I-3>['L;"5-!B >HVXD),
MFHU:.R9#\[.DBYH+RAT0 XJ%_!(O-,S-5NR39%!4 J8Y5(-MH@'YV(VB9JZ
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M-V#>$R*8="$(MI_&8>Q)L4"7K3S$&!SAD IZ7(E7W0CKJXFZG6P>S2[M4"0
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MT\/KRA:9*W$^.+<&C\XWGX[3OM25E?KX7QJ_:I!UN2 D4PH345T%M;^TA(E
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MU(WBNRWVU/5&&(=P>INM6\SUR-N95ETY<2:NW##)SG G HFF!\B@ V*<*$A
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M,.QI%; B!K^(@C_+E@9)A]I3FVE?Q1N,R-"QX_J"(.O(Q ]ZW.\TIF1"KDH
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M>"Z)(4QX(=0"=M[TZN_>OI"7%QIME/5$1N0^RKLHYO(GOSQ[&[O+1I.9 H_
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MPBDA*2E/LWG$+&QN"-*WC+_D3SG[I)UB\_"H\BC <']KR-CT-5$1<39!$@6
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M^5Q#6S)6\!)-X^K\"03FUM;'#0(\+H 8A#4B8)!$*#+4YM6DMZI@Y#AUN''
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M>!T:!L;AG;[\19!95=:4U-!LC0Q[E[DK^XTGK!&N!WI@\2DHJ% 0Q-@, JD
M.?K!@CKY,6TMJ=^JJFY\SLK7+U&R(4M/^IH6 ^_/IWTF 9SOVA*F=$MHNGEE
M90?,@>)@Y4)27 H_5(W-)N+KXD#NF)DB]01/"'9"D+)1.N<- (>($*BH8\R\
M5Z2*C:^K+H1&Q6> QTDT0JK5781BB[$)2X;6_4?A'03[:!BOZD(N"@[:C"9C
M,Q7&S-Q<(MH@BWACDB\F^-FYTB4<X^J*FLK"!O&+<#>S-F6Z<98GEV276[T=
M^]IIR( >*6I/,IYJ$7/6O'YEV MN2'7XQ/R>RG$5[Q3]8*=4FT_GZ-.CPPJ\
M(0_C;NEX:M;3R0!I*A,+->;.KD*#,,(#^-!D']0&#V5LL\(-CB$G^LB7_);%
M()HH(VA$ [VF;IO XY-@Y>7)*--F>V< B1P]B*]"8BT%X\:I2Q03AZ3R3G*P
MSG9 8,-;AZGO%('&2=B-4Q_(0/%!0#_BLCZRQ/^-N:G>Q0UP%\X6ORYVW^=L
M(G6$]/PV814K<##V2N*F'7<$08X_^69\3(!!28BT8)DQWMF!XT*YA]3!5I$L
M@'QCV\9<O45-&.VR/6'*9@%X$*ZZ7!^4>/!L.U7@4+NM#@A>LF<ZE$.6P<+!
MW;YR-,4&D[O,QVO*:5CL<&QY-%M7.;VL>D^'WA++Q*2%VN4</1&',6YZ?EW]
MC5LQ%0F,HD':[^836!'Y)4T"!IK B7 UR!HA4\87K2#",V1Z Z0GP"ED,HED
MO/9N8*Y&J9RV0S/08A 3:MI:.,PG=3ID4$$29/.UYW08#:IB,(X&&N4X0N-
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MI;&_E7%]=+=CO,/C1 KQL[\G^\L,6@9;7H*.H<IY'C-88Y&$G31U*4VHQO_
M3,W,O<]'%6;B]3!4F--"VG17[ X<T$P*C&CZ)^[=D?N[2,"<YW]E-?; 1HN
M'<*XN1. CU5=UF"3TR=APG.J-;Z<;Z=#(F+E.^Z1@:JHO6(50^970:E5[514
MN/6FG_AU\D>Q=QC](&IC70B 4UZ;VMA*AL$V$4N"L#@FB,%J,"TA;S25'\ S
M'5>\=@QX]RQ<2'R*+G ?%<Y_GJ*4_.]3E.=_35'^:W79L)J\:3Q,H5Q\0E?J
M,5J2/IXHDEC]::MG-3G@90=#),I')6NF-D90MMS;UU'EF1@ QH=&@CM^(#+F
M<IHF$9H\!P_5"MHXK?4"EE/V*-+G*VM)>B1@+8DBJU.OY&$GJGI2X:PY-U=\
MS]V"6,/D @?"IUW@%5$Z_TS;>_\8&YC]_R=[_0_J.=_(-7_6=)-VF/_MSD_=
M'N_3Y=/FMW57O^W1;)#3POMW6;LKS%4GG<XVD,0I;XL?SS$JPW%3T[*GD/W<
MH/)T+E'7:8KUMS\$ZNK/:3XZY]VI(Q65$DP/V[6]?*"UUP@97LUWI)"OBU+F
M]2>F;UBT\F&,GQUJ) ;FS'1[=I-WL"3X/B=\RM'^G\@9(O!O(F#E_4MK_PFM
MD1+O>="7VE-<.",#!#C'SU+3)R21KJ[&/8J)G^M^D\KBPRAU&0'N#8I7#13T
M]_-(1-9:BQDV=P8(V$D%>1S]@+1IR#F<AI;<MI5%$2D4VFL+D[$RE=^;X3^R
MQ74NS9-F5SEK2:KJ23C]5%#F+L1*?K6L2G#PS'!BQ,?MQCY=VK^K-!G^46EV
M_I7P_J_@T3(OIY-=QKBU*[H-K8Z'26=4B,PQE3CN1!'[),?&N1;_UM[3.CQ+
M&6&A^M).M1](@^A] EI1I$+;_-GM-8YX);SO\.N(?FLDPT6WZ;R+1,9R^F)0
M00:]M2?I='@H%F\PN(JQ)B5U'R \&^A=K)1FT$U(I7)^B),Z>YXO:<,EO1S;
MW1#5]>"?Q'0;_V]J>F#XOZR<_B?X2Z=*L_'&_*<<R8!7O\C>#1XOKM 1[(Z,
M3#"[O)1I)!;- 6>CE3(JF[3!0G3]H9)JOG,OE][>4]QAI="<==/V2._.Q(&#
M:-\M#2YQS"-5$N=*\K-<(C/<*,&-8I<I4'G.]<AG*JIK:2M!72X"X_B-I3O&
MJ'UZT-3%4"IL[W8.J,?R_\CSU]&M?R?L\/\:POH+WE_P_H+W%[R_X/T%[R]X
M?\'["][_"^!1_>@SSW>?8S2)J:N:B9W,KSCM?3PWY*3>7&)"5#='S"),'B)I
M#4 ,;\HOLFGFJ3%HN74$]:;]3^Q;M=X^MII*91%)QW&N[C-51IDA@Z9 ]3$A
M(Z3^__D^(?GIY:!PC+JEE@IJ]9;^CD@ZNT_"/!17#+N79GJYVC6QP>*U)+YW
MW\[Y]WI^BMSY\8SB7V2[D?@'GIR:F3.H"4LC[&*%H=Y,#C?;R?@D5W1\-M5G
M[/E: =;%>.;Q)P')5,MI:\/?SG6*U/2JGBX8Q(98$.9>N5M_JK7;EG3FLF)Z
M*NCU_HY!&:<7?22MZJ@$*[4%@IS ._?\)''U)-=Q&.W\@RV:H7%/>&!S >[>
M8E>%<#(M?Y/&C#9[&K'/P++RC&@QN-36TA<D]K;:*BZ%K2\2^+G/5Y-G"E@V
M)VC3<J6T\K4MY:O\F/D?_]W%RO_0?XO_BO_[T<M4IO55XC9J[Q+LV GOJ,*:
M.RF5.<3N]4&;:P[OG]+B[\;X EEY&==CFNQ69'N8)!5%5!%/,UB6@@H#5083
M%255>@=Z$BY,2@U%<\;BRLZH"E>\]^X$QCE/68CU#^";$L-)3^[T8(M91;_W
M^>;XU%6\P4XKJMHD0HPA^46?P.X_,#B]UQ -*[,Y8T70M](8GU;+3@06WCLZ
MT9G.LZ)IR$KN*< 9D>K=OQ%@\OV6:W?+S"ES[N%RY590-,G4?8CM@+K9+7T+
MGWOG/@/W84JFTZ[C6)*-I939'F>N'SDPC)9&3PL(,2$ 1%"^7/LO "G)/,EF
M98&&[BA>*X;__J= _D/_I_PK_A-Q3WIEQ#10-O$;=;#)DAL3]DPTX*;.WL8<
MZC)'XLXH;<G.(T+MD\S4,!24EZ.5P&].4\OI>*]05)WY \M(A-]R<A[%S:(D
M4]X4\<GWAN?@2M/5*J@GGZ#@F KB9<Z#"5D!&LFER0;[%^A@O6]7;[Y=:<U/
M]K7WZ6^)]D^;OJ&=]TOGCTV;MD$SGJZ1O9^I,S9KT;NO= \9&^W>S)/*S3ST
M6TUWG=)IN_!"W3E$0D$\3!7PAIT91R^WSW9(S=+DIU2Y-(^IW[D>\H[^Y(RV
M?FS#1V>,T6>WP^7(/R<6&@R-FQ\7E<=A5,*57/2,QQO(*3G DE$\7O?C@Q.5
M!(&>J3;)R8*6;%,$WG&Y+:9"SSR$8[=%7NN'Y1V]&[^-[N[LY*E!J,!-_%[1
M1A]*G35;5V+Y6PI8;LCH%J:R(1\6J#)=/VWB8O"1JD^P.K;7!Y;%6D (O6L%
MWK_(WM.0=A_Y="W)"8HZ23["Z[9[]'U\S-H2'SUI*GC+K+I6#:0*F7LM;\+P
M:;!_V@0Y;98347@/HX]SUY>ZS,0]D"\(,S(M5U16SB$GG$> /QN45J2"<OU0
M],:\]#>:1*K$\=J+?'L<.TSTX"_;_3#GH-<G)HZ&U TLX?J<5OSY]*58OOAQ
MY/*GG D#5:NG/1ZS?@B_5L35V"BG@CIO;KR"J;AX:HF3O3BZTB1 CZO& DWR
M]Y\LMEH5OE2>X)ROQY[7N.2F7/TQ*7D=BSKO\4QNG;TW3UN W+.UO%U[T)Y_
MK[;$J(='I355/EOB%UD5:3I^4D-4S,9FR-"N1DY"C3>F?[8JLG_VM&HU7[95
M?06>L5J95KD70B]=/R3O8B_H^9 C.SDR)=\A4;6VCN:'C3&]IQ'^EJH%F]?'
M6'18/U]J! VD&0<(\O[:?I].@IK$+<#@$>6PEL"1-'O2F!8V!-NZM\/XC>WB
M=M^<X;C?[WOVS7>A4$U[H)0\"<O [0E<-PQHUO,-()_S2L3V.&O:FW5FZH]"
M2&'%J6>M?$CU5+OOLR)QU#;!I:3^.)A0<>LR<*\[-Z692Z&R>44C+A.ZBOKA
M9.X?X&B+,7"N#!3SE.6IOPYCI.W.2V2B?6>M TN!]AA>+WRC*YBI^.Y8!9.*
M-,-JS(V\A6FSE/0]B.[\4%;E=I=^[5:W'42!( =8LQSB6$-SZX0=3RU=JP=D
MZV9[K1(;>2\1,*BE8.5^_W@]_OJS4"]B2/3HVP AS:QA'RK$'8PO9VU/;SOC
MCE/57-#C\ZN<(OD#-PKL-9:;F_-N)W"T!$X:=]FK&H)6V0)*RBGP]^\D6%:O
MC_?[E5LT*)+$$@2R.?'*+LQ(2':ST\(SKAQ:4F7,OB=S)D[+;$E\V"-9 />U
MY/)T77OXQ86:[<!'*;6?CGQSDA)]F(LVR#0<6-*UD]3M)RQUBX9/VJX#EI=^
M,'W??S(I5^Z#15>%2&K1=81NK6/C"R8)[9]?<X-VA1"I3S8=IV\4"*[_ !>/
MK>C9 M]L4D*V#8S:9//86 4^7&M[G_$TL0P\XP'2KD[Z'/2Y07?>L1K#JHM!
MYF6:$Q,; *^A2(C7M@(_4W/7>=W+G_2<[JV!#SCRS22T 3G/[(J"!4&N=!*E
M[065IC+)%*9<L/U]E4E 8&F<;7L'%QO/R]B?C#Z" OP!?H.5O-1JV99+,?2\
M+LIB75"HB5<U!63:E\7;[R>O58SY@4Z5]LUT?_5I!OZSR*!);]>U=CNSX^8,
M8Y$MMP*;NC!"@P05>87WV!M??)PM=G^E[E6YCR P'6W1NX$T!]@%3!XC18]V
M$=M0@1BPS 2-9NJ'L:UR7<I]-J1Z.\/9]G 9"3YMV+;4[E=+!Q]00+=UMM)Y
MH-U)/1F<$(RSNM][(':>P^*!^%%N%>):W<>-[+2/>D,*WKS=_(LL99P)],S-
MJ2%C .C#_Y)C$B64D5%><N]B*/&1WIO?"PQC"W;0-179+YOT?!!GY1[::I=1
M,H.64#S('CO?,:0(YLGM;9,IV\%GX:4X$I3[7\%_'S#@V5(5QXDF%+$76<\6
M'$2$W_V0C!<KSQ653)BK]YV3+\V*R>C6B>J(0RR)]\>6EF(%[O/0S:*^*$[J
M)B(YOS_J7%1\(*E/LKDJ:9X!W$X[2HA]X5!</K0Y98VSS?N0SC<=?R0E1/[V
MV0_667\Z]6\4WX+ Z>KJ"\"@*O/&S(J&Z 0A2@"ZE6'0A30Y,<S$]WW1;+FX
MLAF8;(R'I;C.-:OQ-V^5*B2_IHF!T1K;ZN-4LE0_-@G&0Y>>]DIYLE$-7!P^
MGF!>FN.VD2,P&XPS264U](^W0&LOA\ *>GF?'2J?0(H]?8INC_79O;[=7I#$
M( _X,B7X,&PK;:ZQ23FJ?]4R$\?D?Q[BVN222AU3U?3 0-G#/?#:>F!SQ*A/
MGS,X:G(6M]B[NY 6?Q:TK]JBR[$K<KX\Z1-AVC\B]DYUTD^I&JDP)3@G%/DN
M8B2WB[ZQ%](GT,7J>_S8>5RY$C7@8\>%G[2W+H1L7O:W1@WY%&YD4DZ81DGV
MJ4]>/,*K__;%=8">/5]4P;5)W4/99)'!V3Q3+2'F+55B]^2]H@''W$F.6#V%
MT";W;&GNB,>1/S8-B(J*-?[JL.66 %#^<S.>);^K9P>LB69&!R/#W%=R&Y>R
MI0=[/=]H@ET.0)3E8G7S?$%2]J=WIP7N[.4^V(Z;/YKSDSF_SIGPEV*2_3.Q
MDQ?I7-M2C&),5/HWVV%2VK:]BE*\# R,SY8QI"SE%HCLSW!CVBV$19IKSTS%
M4?@"Y^-PFZ:=/E?9TI:6!PF9K""V@P+NPS@I#U56V$=T"17Z%QG'5 YPBW8C
MAB6&MNPBIH^BK3..>?HK.X]IS;>938]E_^T=8ZDZ\1"MR<E[XGW*_((+D>&>
M0S=_OS#63]$8B'7KLO2]>@2-Z>F:U%\!],74F'OZ2HHL_;QE(=]UX)F<FIP\
MKE/+Q_4"^50X+08>YSLO#](#O6YVG5+IDW,H&+*H#B1: 6)QS+C2S&JK-?%A
M$# V-LYJ/UU87Q\C_O Q_IDR^#RI#]C23QJS];N)WGQL/QZ]OZ@$M*_F*Q#T
M 01)W&:28:<_>Z ?+MY-!P+ .,UI5E_$FGV'1'%K\EJYD5?)GY"#U::LO"N_
M*_R\M9D7]X$Y&WG$E#"3EWQLUQL?-0TK6IXW)(;&%Z*+8>'I3TYG4G&W=!P,
M*WD-C,XT?OPB\W=;X% I>\NQCWP0,2IYWYRZ4??='Z]Y[6,XW6X@X]<=1@"!
ME2(+>2(B]$Q^PS%^^J-!Q:UNL=+5HKV:3H<"\[3BTZ)U^MJ4L2J])T%@^% Q
MK?29[[#$#(A;O37O%M6+PLDO&]8^M6*1V,#3U<5%]B'CTIP:%1*[W\V*D_*-
MP%:;AI:/;Y]U$,K.*AB40 [UX3AN5UUH1^&=_DQ\=&4NGZ?8ZP(*'.Q1_E#8
MDPQ<'<*:I8 VMLQ>(]N)S:3UEHJ['QK=>K'<?DB\M$]R.^HS?UFV&GN8^;/O
M%UFUJ0WH3/ DZN/E[,QU,XIQT<XMM[ZCA 9R#UELWND(J&&ZCZ')?4QM<>9G
M^(YNQ&(^O52^I'P_TZQ7K$GL?&+_A&_CLJ@(*A.M1"#$_5GY^39**C[*IEET
M'7&N^:PDRL@HV. 5WNB[XT73"(IE1A5E!A4;&BUK@C+?I#5]F&C:5<( /5-F
M5VO0:Q4)\A3? G%SH@SS(SJJ\R?)[]D+&XX^]1DT'#S!)0>S+T38G(Z-V#"@
M<(A2RU]D=UM6P7W76EO537G+S64-;15-%?BIE><!>O"3;RYV02#?@/M8X@]G
MD]T<+V-25N7&;;^)R7MAPX85^XG[Y>#U7>*]IF';V-AMEE?FM)2^TSA*SZ%.
M-;9F1W1FO]%CZR7/FO72XPWJJ5,50A#=1)5&5%O/%LWQ$B&(=K?540R#G6<K
M@L?"6S<!9LRG[78[E>[*RBXRUDWZ<T89; W>\BT?G)\30Y>X%16I<5J.@UV
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M%&7@%^D_KHN4BU0]/I+TWVM#]S2\?_?^'EW^Y0!3H5-]<C(Q!.";BX^/]34
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M]XH%!9\%.J(F<-1L^P(J5;<U1'B@ZC!Q,#)J)_96^!N))8)7PK64(TS=]3S
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M:0+0O%]CN@WF6$P,DA=?]S5/C5T$T>Y:YTN-176C\C-IA=AS@H$Y6JD4F#S
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M03QB<.69^?SCPA79(6K,'/S"IXK'UM?TT\YB?&\97Z#.JCO!NK=#!10&^ :
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MZ10='%*2>$ 'F>QS':T=3^-]50[?KBD;\TFX.V<I6&>OSZCVVXB*P<0M!7/
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MTP8J&1G^Z>B5>Y_ K2R]9DVW.LQEIGSXA'PET\RQ,NR+*0 &DXXE4\F"$[>
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MY:913JYWA]DY:K4*!;@6+7Q*:I*3O\GH'^KT@%3C41/OP_&S1'0[LS6Z#^J
M]78^42#Y <^0354Z&J*9.Y24)FDZA-X,P\),QVQC>; ?=_[#X4]FV-EY'@Z:
MNS3L"$/GOG@U:F/^-'LQPCA!?!3Y87ZH'KGU=5M^STS>W3L[NK'25;K"SI 2
M43%7['BT_98N*'^:'NK>&>@6PK/"?AC^^0C=/R8[L<9?*;B7<V=>GI^\Z,C6
MG_.8_P"$?7$6BHW97Y\-C9]KF4[ JCW9%/N85. ,2,WXD7M:5N5]W(*7FSXG
M"G(5E-D:8LN=6EU]+Q3O6-J^Y] Z>_'EQZ:SDDU#\[N<HN>2(%;HORXE2-6F
M0E+(4<3:C!R;+KU-F2LISW-0CO$D,MT>=C"[RVBBN%E<G!O(=#SD*GBPZ*%I
MTC9% (UE0ZT8Z=^/2/@Z"OVYUA(TBU'PN?@<NK9\V5]1OP-F0W-2"IHC72J_
M8;U_QHU\@>D#S-F&\CLZ5S43E*X_(Q-ODRKC&\%"[;1*O&X!/0+>#HHDSQ_K
MB4;L2> 14IN$J/?"1;3Q=V-M;L%&2T3Z--Q/MW?"<Q]W>C.H)!Q!D(H7V;;8
M663%R&*,3_4<)3!',X=*V$*[UTZP+&"B_)=N(CI"%EJ:9L 1$"AX]UDH>U2$
M\BVU!YT;ZE#?J2*&PEMA2GLM!)/@ ^[CBQ_ KY%Z_TMS4G=1+N/>#G10IK#E
M94'27\WT]LQW@T+\YSM-P;^NTQ'=XHZYCG2_G;O^9A)=(IC\N>;P4GF'*Q:^
MM$6.$=1F;QCYY;B0#^]RZ4V%I@F6_A:JM/ED/\3A T\*HI'LTD=>K)@GV?C<
M\#45S0;$9DY9R"C$U>S6^]?U6W=<\7U_(B2QYQS'F]L_)F0QIE)4 U;X*FN2
M9M)VEEBK;).0#^I\NNLZH+.ZCB?\9XI)(_LU_/C/M21_FR!?XH)D^,-]Q")\
M* RMF@UA=YBI2PG^3C<@]2Y=4$WC+GU/GY[_1N158S+_$!"Y$;4;*VN9.EU_
M1H1>=#"A#<DQBB9U(-6SI.:*B6Q,4-(_C\9E?Y^11*8U_/AF5#:7Z::I>=#/
M6/C,7[3G>=6[U?1*M$I\<!WFMRF=Y[U\.T%;Z.V6IYP_0FN2)%>1?H9K#%Y.
M3Y"63@,:?^KW0\SNL';5R"N7!,:3^8[L/(]8][<NK1MGI(:/3L28<"=CI^+R
M_0^8D%:J4, C)HNI0*.O*HIKEIO<_N%+?;N?*^=*\^[!>( 0UZUM4>]T5!*[
MT7ZFFSLB_VU<#F)D%N*&A^[FO],@-#S48PH^K7.GX#D$[R]XI- ^SFVR0K%\
M-H.&92 )XBD3_6G9*>KLPKO=#Z:&+LO^T_"A*R3J)FF;K1 3H)F@+[[T9'92
M>;"_<U9P+N=?$10=%3Q1^)3CQ<^>C^'JK==YUU3E S[;X&D/W^;)KJ$M=/]<
M*U<@^^*P)'=;B_Q-L7]&9_V6^:D=LG.>:,@?R)O'3=N'1MC>=2JWEO+ZMK>(
MS%_0X9 \\<_H%_5"3H5SFE:#->S!-GDA?!I0!N=>]7 3-:)B#5 _<C4X+QV?
MBVYO<*]ISK<($I['S*1UFY,_9/1Y#X@;Y_ZY]JUI+I#M'KUXS><V=Z2\<Y)!
M1DA=@/:'&"D 3ZB!^0;P2>3<AGVE-H^5^:>N*0!;Y05B5L';I[JR<^ +K?NE
MQL_.9G5% Q,(+<DS>9=OPW$@F.0Z>54!S")@>E0&1!]Q5RB$AJ+FZ056'Z[=
M^UF1A2JX[2G.&O<I+>I=IC;02+'%ILI$[<\U;>T1HMD4]^E? 1](G.-+9W^N
MC>JU'Y_,W0FA=H?PE97PY:#R',;9WZO')<T)]3U.!+UH5>SSED+4N4<21A*8
M;D&LP)T/]-)N;IXH;'8GI0[NWZT84:R[*!@WKY%KRGYZ#6=@RS'EL3B%="="
MBC>&W8N&89N6'O:\[Z]BU<A;/JT>((<WP[#70SV?ZFIL_-9"_BYVAZFK7JE[
M12S__6.AU\^Z8 V13B">*)1A:5/'38T&]E9:P_2SG<K#;%J4)/ O?<L(P4[Q
M!^G&"C_C_7%OQ=U1+YLA&QMC=6@C' %MBJZHT=UWXG@Y-LHE)EB@!06LLFMA
MD2Q%WG(?\['FU=G+RDQ]ZV"#;QORO4^]C4H]T8W0LHK>V$\]PX$%$(HH\4U]
ML-GB\4I]'G9,>ZDA+?A2Y[!*$"N9UT'CA+UM3@(PQYP\D.)"PD*,TH)+"\.$
M G[?#I6&#"%1X+970-.%AA!<+8=K6VG%U*1?;E7B<5R_H"6NELW1Q";KO1%>
MV:6CK4C!U^N3)?RXC*=Z(L74!<U8T6"B \VA\FBW<,^,2T"QLXG1IT2_RX6#
M\ZK? YX4U8VT JR8K_/!YOF RYRMS7H(AU(\OXJ"J82!GV.\V3_IM Q9_]MT
M$Z]E!:82>"H\_LJO,K]8:NB2U<=&6Y?!XQX)HVBSHF%L"1_*P)>[L*:U+[7:
M":>]Q1)%.B]1H?<:/?Q+XXKD0-S'P>66SFV)U@W+H@P_*(Q2M*JCF.C![;%1
MDL5T/$1/NQ9W$.- $F3*-A8Q02""3S[58B&U<T5?,*(/C9]_[%-\=^1G)"\N
M=&F<5_\LRYYZP;]/9X^%%AS<P?0(PTK*!IJLW"'0*N0SI?VY1JC/GP@1*Y9I
MF)=NO6DY)U\Y:S1MP,F&S \\OVG2-^[>W=SM*'N5]<0F\N3NQ"<WZS/-D*O,
M>\B7)6A3,ZS9>T6SVMF&?"O#Y(^:Z/M9_F:X-SOXB!_&AS&$J9K_HCB8P-[N
MKZF@;G7I[Z!4!7A7F*=)+?*TK@T/_&3V>$S7+>"MF?PXW&<F5P_.G^:;"2DF
MS0_Z@)Y@[YM?."=.!8EL*LWJZ]==R?C*WCX;13=]XOD%GENX-.^;Q5%6)2])
M/G.(Z+&"\GI5!W(P'GKWSS5/]?B",\(DT:F9Q*9JX@-^!>9[M=*_0+#. =5Y
M 2% #L7'I^8;NJW,-?JVS$$^ P5.Y'-(67]^)"13+:)YT'#321S<9B(Q.<](
M<T/E-^]$P,*RI<,K+EHG:',XCX^L"OOK,A _8-B<KH?W8:N@.5F$*&;>\DH*
MU/0+"'.O1^4$EUG[_S]'6<R.?;QS5A:LEF0S67F?K&P]=KF25<&Y17J%/]<8
M)>FSJ_#SOGV+BM<3L<[LN<*4??M%LJ^""4O#ZE-N<6FW9EW)?ZIZ+P'R&#NN
MDD0^L:=Q<A:+D6SH]%.=9R_7^?LZIAG=7#N^G)1G59D0_;1W__78J8EA5>!:
M"3%J"@W;[/B/#YMO3QC/AXE=BP_/UQ4Z,$BHJN1;4-/+CN!/64KOMP-8S_(F
MJ2)NGMQKG9C0]A[PT@G4A3D'YUE<A\[:J+\JSIOQC97:RN427:O5W_/[65K"
M>B*KT!KB'2H.&KY82.A<7$!K&N"ZK5BD,FDEX@KS=K.KI\D'3"MKFM0-U3>E
M(I]D3CWJT[Y)G9 X^>/JIA)LGNFGC![+/8>B[^9C)IZ=VDLRKKIG4B'6M#>I
MC9E)\^@"'81T,HG?7LSP!8=2<,L%=@HLLV,DQ.A-\<4V<,1PC2H?-IF_&O/Q
MLM&8R]FAFA&6RFX%8:9H=^V/2B71<1UA#"L]X3YO7"F. _WL4'&&,9],;CMF
M-SWK96NWL_A62;&7YI:>O;#&--5MYKIMM=]L!@#"$P%K+[%*3KV'SXG@IR0K
M66_;.4) G_%'[./9G[ZG 7$:'7W%/;?[_,]'VBCZIY),FOKTW 8&UZU/\C5(
M;!P5C#^-@.Q96-8<QC!U&R"]]@R.[8&O\4#JGA6SCH"@X ^5Y$J6SP]>0UX,
MZK^=$\V3F&J8]BJNR! ,;4QGF;GH9Z.GL+K]%CS@]5A3/AE\Q^Q?Y^05'1E(
MZ3Y[)52QZM7/9GRYBU)3<P2#B=74R.\F7UI(F6"S#37]-$\NI7RE\.=*K.<%
M7GE'(MI,%X7(H8/E6>,UO9_.OV\$#\(??S3[/T2AX&%EVO@#93M<D:;")F+V
MU_'T^%Y*HAG $/I]7H2]K._+^_B-7MTC_2:5FGH9]\)Y^;*:;&^'AR#'G;W]
M:)Y/B:S'WH),60'WC:Q^6="M5-- F+4K.@P;RP8P!LJM =6-EVC'<M_-[R)1
MO^3-.82Y7)82&>T\LK E46D^A0YN507XZ"&];\0-0N4VE0#\89FKIDQ:?E(
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MW,)4;JQ)ROVO0XWO_S/4R+?V;XQZGWQBV7FLB;^+ MEZ[T(),ZB@6NDFA6@
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M)%.)C=\0HOGYGQ^9&DT'_%*]->,GSB1ERLGG&%/DH^SRYV[*1>O@C)JH=/A
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M<N)NQN#IN<'6Z)N@:@6C=#'F%^L_<1: ^],\E,OA[_'-2<$+2 WC-6N[;NH
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MZVJ=O-C='!)HDVC]Z9)=]_;YUMM0=R/9"TJ"Y@Z'K5R[@]]@OH"VG8Q$<-Q
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MXF0$P'V:EH'!P2BMA]3!R>>I.IFP>\:3Q_[IPW,)J-!?1 6>-$O!,NSP\.?
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M*'D>*E$_XR?[VX'TO0"T<@]_X&#[3S&<))Q4HVFG:?"9:8#'AJW#K%Q\>G)
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MN W;'91ZRU'';Q!B4I,0")8HU*#O*VP+U1&8_',6.BT@ ,"9>\3\ \YR_W?
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M>GN%]/6H]YE),S]-@_RTTO_<,%'3_(2N,4Z[!;-L[ICJ?=-[5K;!;.WP<TB
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MA*=SB/\E&< =P^R(.\K_5O?1JFPHP#VQ!=S?Y#-4A2> 9BB\)8VJ#7D9S^3
M-"*[^]LCI04F" 2_*DNTGGV&8!)$?3#O3E2\J_QNAF5\#3(0JJ5#3VWOZ:>Z
M>U0(]KAN.!%_6+);3)*[%^(>2,QGZK@M_B.B?!E]ZZ]SIAD:?8ZOY@$EXC'6
M+!4A4NZ,G84T 6H96L8K#2*9ULTX+\H4:+0MMMEWB9E#(_@PN25B*;7<EZAU
M)U[[?V5'Y/\<-*^#]Y9!F9&7OZCVQL=F,OZD[MXI^Z+Q9?/RG?,OJL[LNAN%
M?_WK3_DW_C]!/C+ROIW$17JGYDJ$[!+>',W4R=WY]ET9O!,Y1.]](5AI<=-?
ML7>AVEK"M.'>(U&P:$)>(=\Q?'K0^\P[[[<,/_^Z=RY6?MK3*#2658,\M]7"
M;%@RM<H(%8PG.=Y#NQ>_+#$V@V;PR(HR .U[DMU76J_:AJ\O_=^.^M_X-_Z-
M_UNXJ]%\^5M1D^+CY(#DP^E@AZX<V Z,=>X;?V[-1)THDWJ\-L\=;+<C5RIZ
M$'EUR[+20;<D.@W_3:GA_,(>H?79PZ=Z-+[+KF0C6271QP+NI[:?;?<EQNOV
M=\2GTY^.OBU]+XU[T.%ZOZA2NR(*HZ9"2U2$E/C[]W^45)^/BB>B:FTG_*T"
M.H#6X_O?_,(W:9?I= 75?J37:&I)'!$+0JKMNOTWWL/.;PI(C%H\B$\8>HN>
MJ=]U8V:6SYQ:I*NPNSUVXIG4C$6-:\]>4I>LR/$F?#5M_:$CAQ,TLI#YDH_D
MKQ&N']WQK/C8K/CJ2>2T/IY!6C(YMEXR\UYD%JX8!&PT34(T*B<XIJ)&&%1,
M:EQ59*K@D3\]'NA_KM48'83)P1[Y^K^K&]/(-.>X[7R(8GF?DQDOU3S+HB\I
M1E%AN/P>5"AKQ"62ZF0 ++?UOP 1']N#AS/K:Q#>@,K0>G6<YE9S((FQQG$C
M0\]^RHSY#AKX-KX4K0&,0Z.B>V*+G<00QF\WB5*)ZPJ#WDC=RE=UM]_,=JB8
M[]$T=@S.S?IZ6&G;K.9JS-Q+\/BKE)2CA/121QY:S8HTT"-%%U1\B\!J,1:W
MH,]MR@9]\FS\W;C.VONA_O8$/Y_9_LXS-;B?Q5V&]8)0#D<B +0LU?J._/2#
M!O##>^]A[)^1"DV4)V"%-21=1BLS-4#ZK>:.<+IN*'\]XKD_)_N'JI4S+M:'
M:4NU-A6K3-\5!QTN\!39>CYC,VDR2!487PJH B()Q:[E15ZV@CDC>>D;"CZ)
MZ_)$[SQ[(^&'![^MXL3&R>T1U4>?<3AN3A@X6]YQXJS/=MY&2,91?\.2OC0$
MYD\K$F6O$_#[HB $^8C<DV$X*^2=M\W&C1I2AM<S6^5(YEN>2X@K&W'FF_1=
MNGE@,!>B#DHU[RA,W!@]Z'[K-+9];M6ZDPQ%VM@RG][8QC!((C6"APFLM'S1
MB.(@6:5JNQ:J+>4$OYW* T+F+>54OBV@L$_Q7,CJ],'_*_M_BSPKY/\ZW^[.
MT*RL,*SW$.=A*,*2GH=U4ZY7[39]5,+9Y<FQIF["@541YN'JH69UD5,<X5<C
MM)?R^T1RLHUI#(BXN,UM57  F2@B8%&R0@UDM++<BXGPU]_W9F.Y)!0\=AT!
M,HWE#_^@K8'3)8*;JY;E;G55FEEF+Q[?!-XWH64*+1Z4-1%PI,D,":E^=?BA
M<M8AV-K.$KL& N>6QR7X';DJ2:(?Y=K9EY3;47345!R$F7E)M^LGO6O>ACWX
MD99.:'1R+Y Q,B&B6C6_2C ]2GR>)4^4RJ.+CT^P_91!;P2>7E%Q7OE72<(V
M']/U)3SN):-PQX58U91WVM%,2@1RKH.AJ)9-3\4USK+=@>%D4>+^$FC><:LW
MGC\N&<$H+^N=&&:TB,0#*)S0D?Y_DL23!@4LB%B9[T,=_O:(ZA=5LO6#5Z/$
MS*_NP$ 9 _S[$UB=\2>49[K3IH#]?[G@P3WC$\_O&0>_4Y=?JH>#_?6BR?,P
MV)$Y(<#J68.@D@D*,^-=9>'7W-L55(T!?.@7WJ(>-^%U "2?(=/%6'1H-M5.
MW -,A^!_4\F!12U(PQ%2AQYJ4.L< ,%]+0Q"%?/_^I_$3\*H* 0::-;K31WE
M]:Z1U.?-TH*H[3&4RYM5-B+0R^Q-XIPJ ,Y@LC"I#]2+3!]%C<UHR8 5$,:L
M[(->PGQ/CG3&[$BL<2$WF2M?8_S&;17DIQK"3>%!GUP' ',/WH\>">J/=*D$
M.S'?&\8^$P <ZO[L]<AN:!7;]-G^1?62-B]B:AI@7ATLT&/]03O>SX)!W>)3
M6H,'F+9XD\D29R9P;X$7M2,6$05EGH!D&_$AH4^RXWF+[D4R#?Q=DTXMU^),
MOTOY>)$J74*XDZTEWUO7#JKD%A3DAD\".1@XA(IK-_DV-Q^B(]EFA\F"@HTQ
MM()J2,TW"F,1ZPI<Q4!L7 9D%4HO:AG[1I;$]=?'^57V%D4E_SWET:4&S T1
MM[VD-+W9V!ER!D\S8"+7I$CJL6:9?6R/SQ_0DP*37J!]?E=/A])3!9ZO@VVX
M;9!^&RE50V"@K:91LO@L):DF"#3H,>#\MM3UJ=H.ML(WSOY$VZ2HQG_SVK%S
M8G)RX-+39]^C;CKV"(C@TUB/)I\Y0#2K2AM*'S7^77WC8O$F?-O-PPM[\3'W
M4 )8L@+Z8+BRW._OZOLMPC.T=)T?VU8_PRF'#!:P/%"0+F%-*EHZ/WI?:;E!
MCT*4R#MDDPY8V"Z'7'24-/$RDLZ<M)66Z?D3]7DT2?$PW"G')MP7!!%J=\[>
MK_4QHF08,?VB:M].MW1<,(FC42_9T(^?"]#,-. M<^78AAN*G<<.[VPGK6\\
M'/[3Q)T!,9HC$7[(RP)5BT?I %4YY27J$_.9JG7&W9!M).;KCG'[?LFN'9)
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MQFTR4,Y+#7OLXU]J2$QI;H,H',\+<E2,:S17ZKT$H.4Y<=_>@)BY4BN<K0)
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MN?K?_Z/\?U_\K]P6KA?DB,X3.16:>Q16//V)'8)<&*S?E\]?TAQ=RKGQ&@?
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MS8J-A9FL_Z):<\]!R$9N4*].A^*( _LFQA$T#3C7 'Q 41EUI?3GU;^W<9/
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M>0R5&4G!)-IZ$TS$=H"XC"VV)%V\AF;)!NA9XG1(6X)VU^LJHM-*DJT]:V+
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MABEHH%T@0;6U=:ODK'^7*LTA;R$XQL9Z*SZ/*K,=D*4Y8YT9!.=]\5!M@_(
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MZDAVQF./)!@'9D%1JCWK*H_N6W>R,M=!AV-U_XYOR>AWRXLS*0K=&VWGC(5
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M7<#Z6?'/M7;TY^B8I/!W[N@.S1$*C0;UU);+V-24_*_$2609;2B1^,9#?S^
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M58 &3<$)T;&;SEQS!I&H%]QL\@EC'?J.-@^S>_/NUPXH=1QK'J8TK[.,E"3
M"96>QP D<]0:V^>R5V7$NI@1AY2?B>ZI[,8!F]5H]QZ<X^(D2VJHY@Z_ Q?:
MZ7$UTXFV*5)WZ=F@=T!!E[+X[2AZ'_\V![VLGO*JXA0FD^O/JQ>&127"1.O$
MIRI&%[;6E6OTT!=X,QQ:.7/#*3PI,#^PPIDY;L24,8MW33(G*]:V&+NHG].Q
M*^"C-9:"5@F*?":HDIOR=$5*2\ISEV2/$N,3ANWDMVZNVVK$R5BA.\<:9FK>
M5N8PI:>(0\:#MRV/ SH\.G?4?>XD6PDWI6A2KR1VH[PI\:$L%IWEP[('<F$.
M=1#9M_2<@)Q)*4-&4\<DQ N9A!1?=N;681F*[$YJWS\0_%F:E#T=[T9>1Z>G
M0<1K$]!09R%G]#)_#.#D9V\T%:5XLRTL82[;D0 I8FLA5-58>:Z:(Y]./ZI,
MO3=,"H$P3PG9%#N+S<CZ30OH )@=5K$>RMXSJ1S^7@;!LVFDVX9$D1\Y_>XL
M??FV7S\&[A2IF,M=?];LZ"W_[A:I?\"-<?D!#QXK7PY(<*!7V>@I 8>&#8 W
M3RY?@;?G5L&*I!= %OG>DYZC'#*PEMCH YB1]I0SV,A-(!M> \!?QW]]P38F
MFU01ILP"F$Z=5D'[G:VWNM:.)Z:-L;Z;%5%TJ:V#UC]BNB@M_@S?A<P(@YN"
M]Q.#2X]&=/ \ KS]&5*T&4K\^Y;9MS[$OV,\D;I9Y-1P$",)^D Q,S+O4!_3
MA48Q0Z7VIWN@ONB%XI 5A&CWE_+8KVX^EEW.X;<13-FAA>O7=>8A(5?%]_L:
M\@T\3XA*@?BOXQM,E)RDK0F9+L8^=0@C&EJ<A+(EQUT!ZI'=8UX!>N^V]43)
M M]]CR,Y@,&OF1447C$8'QX,RC+JQL4#B_;V'"'J(D$B#6>_]UIA%D$0<M"#
MMMR5YO%A*F)+[($)?J2T!+ -/^J*RS,5O2$SFD$'\$EV7IXB*4Y.41#9-M\G
M!J03LM)XD^GSIY"R:\O?(36R=;_L^:OLGTDZAV1A#<0,LW]I;J:I=14\GY[U
M*ZCU==!7W6??56F?^KV$JO=E8U!& 8-'KMX4=$9WF! RWJ3[V_H+HME$(CE)
MIN 0!.1F(>;:(XZ%V"O95LF$5UM"!DJ-MUV2^3*090QT.7P9OR+.8C8 <Y1%
MOC#I8E+;[0 @*?&U4U01BTZPK=OM6*:03RTU#:,[AHSZ]M^&NJ7,)24?)[!\
MG11<U\K!(092.8'9&]U>BCV-; C>/6] @*YD?RR8\("90F**$808<]^SL[Q)
MLW8\.AAPT+S87%O66Y^N8I<>B@BX^)G\W"$URLLQ.IK(GNWN(7]M<KIVXEQ,
MCE(<L('[TO;\M&'4,$<OFR__U5@UH8723SO-]#DF/44+RC_@)RV0)G_"^I1F
MV@#JK_E+/IU6_D)G/>)D-0,]R2]KN])V2\\?ZVZ7"_(0EGFX4N1;!'Y>F2V;
M9FFQE:U?G7(AV>.\E\9QWR^C/;ED[ZK_^"N5.E"91T5G84*-2D8X=V+S_ TB
M[V$EX141-BRNTY(3(_'R3%SN>IZ2<4SM\;"Y"%.V$KDVR8G5P@>&V(K!=A8-
MJUF[D=L#N0?9>#O:U(,DB50P]$@K-5!]7:Q,"Q[@+;&'MVY^,IG+E4&;E#IW
M[_>533:)%#<OF>J ?FC".IAU7GAL3A@S/<\$S)!GL>?B>S@'NQK&KLX<, %^
MEZ\5]\;S5O;8U^&O79X$-VHLM@;J":,?WI1U1Q,MG0U>T78BH('47PO1Y$\'
M&/B!6JQ\?Q@>M;$\8:5::%=FI N9FMQ.858HLKCK6@%@ 2]R]_>2W'R)I,IE
MJ8:OA#P7-DEQ@DZ,\;8!^R%B#S"=,_.;X(8TU+\F.NC+7.%4D:96GH\(AL^<
M4-)M"_95GFSO#TR;+54[/?!@+)EM$390^F1G_T+ES7CEK,+.-!*RW1QT(T^B
MX"3V3AXF+UMJ5;%&0&D6]+W_&)HAX]<;-TJJGF/<]?5G&82BRGBNUO\_4@"_
M_Y\5P,G_7P'\_X8"^(R2$;*"DL .JBTJ,#^IM TL:"?NNM$.>AJ!;$FXM9V
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MV.=!_6KYL7M,^]"V)0CWAX8T*333?KK]AX9X6OKQ\)9[]00U:?6RV"I_CTN
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M\'4J^>2,MDU79>DVS4A:MT  #@2=1[R\VZ9(XP).M@W^_=]69?N_I3Q,=O]
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M'7V23&P9[9<2_.[F8AG^]P&KH%:#W10+Y@"/# 5QLI8*@*Y,MX:\./"=E'#
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M(EN(76;J!)&N\%=>7"8_%SW*_3"DU!Y1PB,2V!@S:6<@V5,>9!PZR'9[BIJ
M5(5\NWEUJHGMV93M7-40M+,VX@<[>\2@X*GCD1=2*L(QM1EE#6FM-JI*.0&M
M3".4(>W=#RME9*B1'$#-5MC?X1&J;O$MEI8(EJX9JE5 ['J=R[RHR>_/NB\$
MB? ?YQ<>510(%Q (%KR:$>R+%!8R:X]T EA6FCQ,Z@K/."4"=68SB*B4E#Q%
MD.E)XWWY+5]7&KD0.U=V??W=L?=/]=]%?N^,NO7^R5[47VI].VM$UTMR3Y5]
M/B4*O(HQ9R8DH(S6JMI1'RG^M."7D:R>_YH6Q#5$.=?-T+ J[G^XOXPF UW(
M\EA"<-'M^(\P9[,[:/_SK#N-_=9F4FMRRL'E%$=&Z@)W,P(]@R8G3#87$-',
M]!O<==_4?9\XP\@K3<*Z-8K!@JPS*5T6XSYOBMD%D$*015-M0VU3EKR-VYJE
ML$2-\-3Q)D>_X&(3>>>%4+C27:^"=4DW8C/6>:=#20^@P') %O1.+6?,W!P?
MG5C)M.A_)4<"1!]4Q#0/=$80E2-3UIHB#BFX46^$^L'N9(3X^HXTK2V,6<TY
MV^G.:CK.B\)L)=JKL+RT3P90?0VHN[%IA7=J"KYOWV($@VQN.[&14J:$II(H
MM\0B]MX[1TA^3H1>YW77,21$E3=^_AJ"N]!6CW4=P/?*OZ)[W46T,&!0$X!)
M ;>++R,JX35@-IZ4OQ\T^YIT/\F0W]J<OMBH_[K_]MBW^]7S+]NN!P_VQCSR
M7HCV)U?,ON[[?!G*D#ZP.7Y8=>Y1+*-_T(B;/K.PM+Z^,;#8P.BAHE%*@D2I
MZ\*.&@U BJ>NF7928OMUPG,JA?VX; WZN2GCOJ](HE:N[B64$M2,F2XZL""Q
M+[3R(/V#3K+A.1(&WW +45"HNXMJR:@ P=O7=/W4*5L/BFXB=AP=<AYX]C%[
MBOSJ[54Q)(D<7L>+C+EXW)EW&=I14A4_;.M&/WY() ?EK?Y.3=E)WT6?J5WV
M-:'-2L;;F$$/<Z-/1@:'-TQG@IH?](":_CYP44JL<E>AN[B>?J24G4_:;8V>
M,/6<U33<JPIH <LT8$QN%$^%Y(7*;K-O3%OY$PRMS-4>1\Y40_EPDBUZ_-GF
M-#>.*C 6+!)\'6*H/[,0492V\ 8*HAF;R@Z!>AW,+R?A,K**DG,1C2KZA?YV
ME3[R,'U%)X^*I=-",!*=5(/+7<6;GIE\X1^.88N 0^R%&LI573N.R'!POO.A
M%;B80+9DPNA>'^.;"]\3*G+$P:2*:0SCGK6;8BZ2P@3J9HB+%T^(F$J9^BY>
MFWP1RE\ZNYGG4I45@=5G0U8FR[VG^FCG4@5.MS<U^>?,V@( G_Q+V<4/M'_9
MRWZH-6US'4+G.V8%Q+R/\O46F_96F.Y["GVZIZ.>:EF6^A6^W,@[);9O^3,9
M;#@#C_H\CU''X!=L5](YVH=FY(%YXIZM/BD9]2ZU EES2H_])W6Q#XH?8 -)
MQRU38YM7-?NLM:W2>("YML$2A6R#%-1"*_-? D]5"OM/]8DKB:H%4AZ3="MX
M'G'F;%;U*6DC'P<.5/F$'2RG]=S1F-]6JQ)I,F*"KYY_LA:#HD%A?A ]V^!E
M@Q]&H/0?(]!J+]ZGM;]9)0H%G[\=W_]&3@Q?7C=G+\$9?'-:;)K GQ1;@^1A
MO><2$G?-XI*S0IU=+1_H.,>$+I:HKD)E-%M9J+)</52$+W=QS'*I K[H7/.K
M*CF5)ZFG/[48X9:R. <!T6X[K:QG6A O2LHBW1-<UUX1X(!J./8;QH8\*WN,
M6N]8Z-T+F_<3%7$2;NFSN_\U(L,KC-.9CA0!Q^8]SZ=FV4BG$/KR'IFGUP&_
M4^KT\&N&0",/MAB.T50+1EZ@B7^$GBJRDC)_67^R8OZ:0?;O24SK/)WLARW?
M,KPDEXU#XHEUTM<F:*E1*2DXV(F<* ]."/TF3.-XS>>DAILS_HO?Y\M[&Z;;
M]^0"[)%3=.1GLJWXT[,CXEUR&EF;2A7@M,F>FZKI*O EO4OX12;4-3_M(KPL
M8@ET2P.>ZO>D-X\2S(.1)!);:^] <UJUR70E_VFAVN2QI:?']K*V/\PO-N=A
MOS=*_CF5AO@4U>LQIJ=;W7L?76R=V"\$O]KD9(1^-XU%RG=Y,# F_1T97>?,
M@$;"F]2[$BE*502,K*MXWO;8"]B9I?AX8F">;\E0@%7(#MMJ<,YW0X9P[O#G
M]LXOT/(=^YYFN]^MALA25%JF->><1!@95A/8$&-=:59N&-X91O^+O06X4[1X
M::ZQ<@C=/7^XY_@HBW8:?4X5<-X*JAW&92D](Q-K?'. (A.1H_JQ&@Z0["WA
M/*\!YOFMZK.?0VKX^S/%A!HSWE!&J/- C<-)[YD,RCFU"O<ISEB]7Y>+YNE[
MGRVB[LTW-S=!8'[.,RZ&2TCGD<.Z#^2CMI$WEZD:8_Y!RI.K!<M;@NMBUCV,
MAB@)E7/R[*.C8^ 7#\&DB=-<0SOG%V*7@@DY4(43OBS;?XWGA4?WA=:<ZH\Y
MV;,;8A35\/A^$)DW?5JB27ZWH3K6(G6/AW1 #EHK.'6_4O["28\ZQV:OO?<4
M_.)36W.WV:8=\N5R@AUN 6)5;:$VNFEQ_L04/7="%(KO188J_>J:%ZB]Z$UP
MJ;QJP5Z-:CF1B5!0+SOG46O:__M5\W*?0E,Y&2%A;L61(#_3!:YJT(\+78^X
M RL4%PT*%&I4+N?85PZ0UFNNV"8;_GT@:%J$_RJ)V&[_X>X(95JSN8X7%O/U
M7L I6(='9_6BF.!$K]?5&,P&VT"JU;4:?&@$Y]NC&<[]<79&#>N*.QX*XDDY
M[H=+@EO*SIR[()OW:*FS0K?$PAM&_^;D@&#T<=N:/"\O-JE-[57Q435JI0S0
ML8O8H@V),U-#ET:?MT2GX8MK5!_R@"!NGRU&V_''6"("^Z^S;+__F.2._M=9
M#7ITUE@[K4G"> 0/C)X)@CUT=*-S I![)5]H\5#(0'9#6*!;N5]VZD.P/,-)
M_?5Q0G:^*#-!ZT_?; LLVGFZ,/@TVD#]R3]]0H9<V<S__0M*_QL &O%_6-T6
M8HE[%E+]R1<U@$^ T^:C;/Y!"BLX"-7;/]!:F)Q6;V:D?1@;](O>3D#M603O
M\M6*)(=L@ZZ3OA^UBQJL?9W+Y2H\LQ_R N<)$!21#GH#T96J(8VJ-"B2GFYA
M6#=SX;5EK(5C'TXD&;Y-%&LT7U'*+>ZO4HOBMH=MX4L.EHCDHD.[(GXK2\.\
M9"90Y1B6/1X@6Y_\FK^.W?]#40T+_-"Y89__GI@G4PY&B/?E0SENWSLEG"H=
M?P/P=JQ9)I=/2QP_>&)$40 S/#Z(3MSF$A7.1T:(F2XW]?^X:ZK7;_ "U3J$
MQ-KDN$T Q5E4?.%I5WVC_X-K* !C7:E\DLKC/V\[V>A<G%?T6GRC(I#W8(&#
MT--M]9Y?@ \_[W4%E!3^RFCZLSB^<8(/&"7SVVAWS:#DFP?:<85V, 5M-;#
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M]0?@I9LM]05@ Q3S83RV1'*M]8!\L "LR]__KQ^/2_"-EU5>K/[A+_XOWE\
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M&B8>% E.Y%HH89"0+(;RORCQ4$:BB)C,=#:'8<I]E[?"7V_:<H"JXQGJB^3
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M2;RP:ZTA<1NQO](1+TUW*D;\1O#S2X]UI6DVA=ZV>!9$BD0B* &$B0S C"<
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M2QJG^(/LT$+%8Y+W:J;BCT=+6Y4+!O4INVRZN#S*Q;,VTF8.\^,80Z)87@A
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M;*Y<, IDH:RF[-4HN8"P;X><[O4S/7\LY9VZ6:XFSW0EEV/$4)XF60JDA!S
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MN^!SN4RP]Z-Y"0)H*_M+F!D")A'<[_;'_B3E<IRR1!0\A2#.6 )@BK$ASTL
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M$=X=6]X=J;=-;+216]O3+MK!>0 6+*_5?N:>LUV=(3G,@74?XO+ZO[V:!I/
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M"S2TY_'U+J_M'5O1R<RT1[CYQ7\8(A\MQBX3;E-%^#:FD/$<<@0(5@F A>2
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M C!>)6(EG.C6<5)/SDW YMQ].XPHOF$>+C,4UY;0:J5TH@*<"0&$-N@J:^.
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M>H58JRE1MK2]J;R 7R!E^]CB:QI?IG>X))^KE+EM05#N=>%_L>SXFGM-)96
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M[QS^[>#H^*R;XM*G;]E)C>EWF*M4:GJO@?H2M8OF!T^N7MQ!V&;F%.' /'6
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MGTP3WZ&J6[:6OQ\?O47WK&3DSO^QL:5\^)1J5O(5XFI%KXL<QRVB6#8J62'
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M_.35AC?MG/-:':/=2QVC^Z]3[(:AEBH<=Z"RIIH&Z:B-B)2#CHNND<6U"(1
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MTBBX^#4KB7H3DTCH9*@RID>7*CEJ0"B9J4"+;VGM(1"OD-/OJ4:_X-I$(RV
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M<)>:ZQV@=]G$KVGOV8SER708TB!$W&6$U!!367J&X2;C0AD<E+,S1@BNOUO
MM]8;^\V)]0R^+K32*M2N$]CO4AIP8JR3S@(G'%<.4H#N>8S@J&*.<$6E%EN!
M[.Y=_7I_;<)K0TVT"JR#FT90IVEXX2^GL^(M+X?VI=*+8S:0S-DB+7 L:Q#9
ME_F,C(+A'GUI([,-JX70&Y/0;^NW-F%85V\-!!Q[(90ZFMG202C<?$CS_<MI
M4=% 2!DMB1:"C^C.HMDN[BR!S)+73J8LJM]X?HV>?F< ]!YV5%-5 ["[D57I
MOW7CSMZZL8.HO2@=MH $4AP&F< 2)2!SC*B<*+,YJD]U?8V@?AOX]PZ\>LKJ
MOVO4PQ*%^S*\N!C.9O@ANA@GI2M6*<A?])N]"?>7\_ET0K?6*P4NV 3"F03.
MH4AE$M9GKS"XRNONRQM1TF]'_V:VY^ZUV)8/>5-+@U(-BXS_X7@X'Y;ZU,5%
M_L+QP$9',W<18WN/2](3BIL!C< =PWU":.D>-V]8R7=<X=4K@=+^]*#L0$\M
M;-KNRW"^; UT(\CB\RZ6UR!&+X1 XIGA)=S/!!P1*#NN(XO2!:]KYZ=?HV>U
M%#7YZ9!875<MX X)1RL^F<2[T?9I=C89Q>O^E0N]#EA4W KAT?,HTRO#HFP1
MQ14XL0D%YJRK':VL1MEJ6/QYSTLZT-_/<3/]%-4QODRSNR8\EV,$P^W>L;/[
MZ"L2TL,M]$U$U-3=<T&T9<(+8(KK<@*>P).L@1(CA70FZ" K6Z6?[>ZYR<(1
MYAEX6@ZM$KKMWG,.+)"DO!?&Q]IMUO_?W?--,=SAW?-U<-#BW?.4)55,,L@D
MH[OOH@7G!8&<C,V&&F+\2LV%_F^^>[X6!KYW]WP=A?PP=\]M#D$:3T&'L$AM
M1'#22W""$91/LCJMU"WX)[U[OI;.-[I[OHX"^LXMK7WIV7KML^0,0B8"!#4:
M;&0<J)=,AR@#5>I[SNE/>_=\+<UO=?=\'37TC3'DXU,:O]^[HUX+(VTIDY.R
M!)-<:C#!8LQ7>CH:+@V:^)5 ].31_92%[0@EVPFR;QC\=3A/)Y_=],+=IU^K
M<GR$CJ4OIY:Z=%SV"4*BF9+L^)/.]B\ X9F']U.DM2,H;"O,OL%PYL:3/+QI
MI)&EDRDHT(SAEHQ,@\G>@0Q2!?Q.2+)::=7]I_931+4C]6\LOGX/8%$X)]-)
MO SSX^EU&G#ADWE*K5/. V5EVJQ#B?@R88 +A^0S*N+CV_@;N:S/O?NGZ3NR
M:6"TM4)Z#HRNZ;^?6;Y>79P&QS5WP$M;:$%%!IMHP!U22JE84DFN-,%L-50]
M): _CW5[G3X%R)8";N 8Z:8;Q2T?-^THO$Z*!XIT<U'LIP"KT)*JK$G2*1,?
M:W=F>(&4WA&SK9(G]27>MZ=R8YAOQ'+C;#D9LZ<6:286A$%S:\J)598Q9)==
M8FZU$HOGG]]?'%,7";5$V#<*;F_6W+ML>P/FZ%UR&'2%6.80,&/!JR0@9J,T
MAF3<IM4N0[W\COY"F0[04$F4#6PH50[6J:!,.Q- &5K&6 0&CF @H#%V4T:$
MS"RKO/OL[(;RC] 6:!._N3< - 'ZQ8'\\N[KT[K@Y3B"X?C37AD6-TOQW'T;
MB.0(45I"%N7&CD%!&TH$:"NL0P&[K.OW %J;S)_@5O-:6'H"YFX5^W.4[-S+
MP>ZL.N?I.WLHQ/D.XTW5W.24N4HZ0AE(61H81K#,*P@N\92RDHSPRO;F9ZNY
M291*S[@OX[PBNG<40S2:+!ABK:=9.4EK#T+Z?S4WFV*XPYJ;=7#08LV-X#P3
M%C5PJ@B&%+@C>J<84*4";DXQ<UZC&N*GKKE9"P/?J[E91R$_3,V-_S_M75MS
M&\>.?M__@JJ^7UZV2G:47>\Z43;RV<L3"WVSN4<6?40IB??7+YHB)5FFI.&P
MR1E-4N629<MF-X"ON]$-X$/,W@7N("@CZ1*A24.H,D2'/'C!!>>=#IR)YMSL
M9/->.3>[&&#HMZ3OP_C9,LE,BK3->PY*8P'RGB58\J^+0)>S[Q8 [9</,7#6
MS$ZV>SX?8A=%CN NO9W:O9AHG6,:T$1:+=8%NL0E!3PFR^A.I[-IW?-^VBT9
M^IQ?[4PT ISM3 "/5@>=+3CM:C*1#>"<B$!JS.@]3R*WKN6;0$N&G4"Q;TN&
M'2PT]'EW?KV(?__E\6&PV;&Q!J4U ^:TJ:2D"9R5BC;_D'DR3/BL.QU]SXWR
MRMHO[&+;Q2$4/31B.O:12)@\XXR3>EPEL^,24"/Y$=P5DQQ/2AZ]B<?!SL.C
MH>@ RA\1GAY4YM\'(E<-=1@RK[RL74[2+5>^T]Y##CJ5*,F%R'WXMK8.-IG@
M6:^7@4-89.0(V]QT>%'%APPH'.W!BK;?X&0!9B7MP@$%EF[<_YV&&^CN=Q#S
M[H"='KH>&CV_7.63+U^N%K\]8&U?;[.LE*RM05I7JT*/FF$AC .,P9-3Z4A-
MW4HEGAYCO#CI8\I%>[T.#8_:-F+YAGRZ]%@*+9*S/" Y=;20E,D)O-0<M)$Z
M<8=<FFY9:$\.,5 BVA' T4:K([C=-\D<R#&$$%F$;'1E+D<#B$%!TEIX[X)0
MC]O2O)XTI-?0*&&?-ZJC V $H*^K]ZRL;KP_W]152W_X1$9;OELN;W)Z=_G@
M2C1CUD=-MU] &WW-\6(0C/(@?- E.SH+3.O\HUWF-X'$HYW0\SA:?2A3C@NF
M*U9TTN!*MEFMV I>%2#%6)+#1Z"#BB[2/B+&9&IEY^$@^<U<)M!*H1'\^IMH
M7%"K62=S,MO*B.O6#^GLFW7D#2\Z9 O!2@%*A@(HF06#:+4DK\GKUF1I.TUP
M BT6&H&RL3%'@-2G^^<$R:U@B60HG#QOBQR"CIF<>9="]E)QUAJ5^S4Y&G<7
MAGT0V,9(0U^=G^+Q_PG_F'^^^?RX8<X]M?I,H>.12PZH>*8U)6AU&6G .LZ3
M$-IAZO;PTGL*$^B_T > 1[3;B-!)1MV\<&R<X).45C3!>+&NPOJ 5Q_S]7(F
M,DJ1"P)/+J_ZZ8#W3( N4202N+#'?'B=XEY=QY] &X86N#R4Q<8)RE]S?6V;
M7WXDI<X7::8]IQ4E ZAD28/)2W"9&_) (L]6*442[X'!1\--H %#8\CM8X\1
M(>R;S7VSC+Y=/.?Y(L?KG&:FH'!,!$"G$92)!5RH7B[=_+5%)TK>KP/7\^-/
MH-]"\^.XH<5&!,IO6DIL%+]>9T4DQ9A()(@KU0-&<#$[8%%E*U3"TFO?>VJ\
M"?13:+3Q-;'(B$"VS:W=OIQJ]\XO%QC)M^7HHJ+;?= DH(JE=HY0&I(W)G I
MG"H[.WX]YC&%W@J'NIFT-.%8T7I^C9=I>3V_J,24UU?SVZ:?MZLQVBQ,#<(J
M&31M^;YVE4@>D@@8M)!:JHZM@7<?? I]%IKCLI6Q7A48SWZ_I%$_S;]\((PM
M/RTNTKH-#W[,=S^[_ZN99%PEG054UA)0R#GX3'_$$M!H@F;Q^W40;C'+;O">
M7J!F7.8?ZSKXKO]RR%)&60P(+M,M-ZQG 6MW%26\0>Z$W0O3O;IB\^G%; YG
MEJ&Q]B *=?I'S,MEAUA4MIQIS3,(\K]!<:WH]B<1(I*8*13C53?8]1B\&P*G
M%[,YBK&&!N/V=[#3?]S,K[_>9HK,BC,QIYI(S"K]3:AI(EP%0(]1.5&,ROL\
M2CX<JQO4IA^=:6&*$82DG^VM+%'9:$/=LBL5AQ,2/"8&@46E2;1D=.M<G;W;
M8//I!6":VVH$N'N^M;+7 H-(#J)FKE[22([:]*&(E+GSW#O6NO'5_GVP^?3B
M,.VM-8%&V"J%S%D.D*KZE)<< DD",A=1!,NH_,XO/8=KA,VG'YDYO!E'Y )V
M[+#L6'8A) 6U10(H@QI0% TF*F-T#A@?]X0]:B=L/OW0S0$,-=)SNQ)C7I,K
M,E.E\%(+[(M,O);:._"1%=#<!HF:_.!HCW!L;^;3+;][>N&:YK8:!>XZM5*.
MHCCA"P<M@Z5-W43PCBO((6JI3-0BC[@5MIA>B.: ]AL!*D_2_]*Z6E%3?%@\
M2(+#>7IWN>Y$OWJ86E?TT%>\C+DJ8SFCVQE*ZS+$(#VH6HZ+*I'4T5GEG3#%
MJL98W6>^W1 \O2C,T6T]#;[H;QJU'8TQ>MNH W!&ORC\J%BC<W#:,.V@,(>@
M"MW?O34!C)+,9$%?7">JV#\Q:[0W#IVR" )3 *6C!^<M@YK7@C$FITOS0MN_
M6*-[8OB K-&[X&",K-%9&*.XDH"%OBC/&6!@) 3-7A@1,PN='E[_S*S1.V'@
MQ4[M.QCDU;!&%Z\*VA!!VZHA92L'3:1E:VGUT@\3$YT\WXFR1N]D\UZLT;L8
M8.BWSVT=?X,FC]D7!4:6&NPB24)MQ.5JYR)RY87DAVV?/#!S]$[V>ZE]\B[*
M',&=>SL'+?-1TVJA&Q4S9DTC8Z,%'T3T&FV6S3LM39L[NL\IULY$(\#9KKRC
M*+WTR1?PJG:CCBF!=\H#$[9H;C$HU1J!$^".W@D4>W)'[V*AH4^]KF2T11D6
M8P$6:H,)Q@2@BO5!RZDH0XY,[DS>NB\3\&CXI'>R=Q\FX!V4/X(-;8\CX<W7
MNGI7"U:;6$IF*U72N9 QTW=>D_\A(Q<^B:A;OUHWF?ADJ(?W.9B/#X'7C?LJ
M\L;E1C1,< ^DXPBJ2 07C(4BHD/DAI9_ZUS()A-_M1Q[?0'7#O(]K3^TZ_"@
MO?19.?^2X[S,<]KHX2W]GWG$BP?*^#5_O+FHG_B5E/3C_&JY2J+*5ZNG5KS(
M=Z0S=Q3[1D4C @>F:RD'EQ*"$P9$$D59[E%WK!H[^%1?+?K[8F\Q6B",<UEL
M(4->OBLGEY<W>/%?BZN+]/L\U33KU;\[*VM/,&W:P_^:,7ZZ^[#W594;W1@F
M-;.($'5-R/9!TJ9E-!2,#(-$P6RW)AU'GOBK9<4\W)(9!TA>MROU( DC<Y22
M(Q2E!2A;21L9*V X628Y%E)I'6[^BW%[^ M$/P ,?6H\)MQ;;NH)9TEE99-/
MD$B9H(RUX(U6P(,T*:M<I.K&D_CD$*_6>>EIZD5SO0^-GDW6[495=S4SC\4[
MO9A_G-/BK'PI*SEG3"@N#'E5+)&$RA4$7R,^3'L1@O4FRXZ4-[WG\&H]@0;X
M.Y+E!@<HB3<G?5Y>/]3QY3:/9[,0/RS>Y+O%*$*.19B5Q^] ">/I E#K7@T7
MND3F6.I:9K+71*; FMT;JD>TX2O$ZYJ?ZN1S#:6?E;6'_\"3OUNYZ_\Q"TJH
MS"TI1-4.?X4Q\-(EL%PR974)0G2MIC_\;*? UGU$Y!\6#4,OC[OZLENK?,A7
MGTG&3=AJQJ632A8+0JK:*CP9\+7/@Y,IB,*X%"9U O;SXTR!O[LO)!M:8&@P
M;1C]SKZL@JH?%J>KI/4M$LZLLJ:@2E"LJBE$EH./J7(]!XO(HPB^6QBZ^YA3
M(./N"[(#669HP)VNBR*>6CQ!ZRPC21"P2%!!&'"%14"E=2@Y,1^Z\2"_,- 4
M2+?[0JNE#8;&TWDFC>-U_ML7TO+E]8\YSSPZF[$N NXXT)P]..L,T-;K##>(
MH73L&_G=9T^!)KLO:O;4]-! >8K#[G1Y/?],8M%JF'\.-U?+^GZZKEU=U?61
M#G_.O]_Q,E_@Y<RYQ),D3U$RZVF!Y%Q;JTI 8W*LFZXI^_' ]IC4%,BT^]\1
MAK'M6#']'2^CD2FYH!QHAH5<TA# !?)+BXZ\V,Q=3D/098Z<EJ$U'/<RR^N.
M#+Y=?/Z22?@J^RE>7=;^"=(K5[("&4EDE6BU^20TL*1BT,[XDLRWF!PR1/B]
M ),@Y.X!\>'1,-9M]\7C9A8JYZBS"GC.=+AHH6C!JP(B>BM\\8;+;ODBO:<P
M"9[MH_L).QEN!#OULRR23J#0)3%(M-9 F43.C689. O*&X7)<]EXX]V?\7-Z
M<9WFMAH![I[GD#0BEII] I+7H"F:",%:!)N2<JQ8Y7E[XJ:]&3^G%U=I;ZV&
MC)^#$MJ<X^6BS,]/CL9E\VC  6ALGA-Y5 PVP2H5T">(N38!U+E H$LY1!ME
M)$"2&4+CW6-J##;DQ1B!D1R8K&HJ=V3@2&@P# -C1D618V,5_L5@TQ?#!V2P
MV04'8V2PH7/),$_GG5'5&V<Y@U-:@N5*)*N$\J63(_%G9K#9"0,O,=CL8I!7
MPV##K/.9ZT!+5!902JYZ+T;@@MDB'>>R=+HG393!9B>;]V*PV<4 0[\)W;I1
MFY(I9:,/G*YI3BF:N$L02N6$9)&N<"BC5-U2)1Y^ZFO@K-G)8HL6ZAO!I7<[
MZ47T5@6'!HKP)$0I 3 (#:O:"RD\&OX76<VA#ZQV)AH!SG:EQG#99-0R PI&
M"D-T$$(6H&H?5E%$L.8OLIK]0+$G6<TN%AKZ@.O*ER(4U\4@Q!(-*(<>O"77
M0+*LLZ*5:LS.S48G0U:SD[W[D-7LH/P1;&A/=IN^E89E5ONK24B6W$J5> +'
M2'G1>^5,MJD4T7C_>GY&PQZEQP#; 2PSHGWK0;>6NUJ 6^Z1DH)(08).R*J"
M)/B0/&C,PGL4.L4^8=FM@TV&HZC7 \(A+#)RA*VO1MGYY!W=BG2.52*C:@?F
MN%J=WA=53- M,#;H6\%!S+L#=GKH>FCTW,V]MO/.&\J(PIG*+D)0D>[1]4@/
M.6MPB8YW5F)*CWLCOE1W_N#3QXN-/N;;6E#>5Y=C<(H^U0WXW>4Z+6!^^7&3
MG?* +"MI.G-Y4L"YJDFJI8#G!2&Y% 5F7Q(V=XTZS&LR]!G[O#4T-^"H0?F
MD">2CZET,'3[L+7&N+@:W*JN(?/&2L.X+T<#Y5C(\=JCH3/<>IIFZ -Q(]#V
M/MSG<?%EL[,KGDDQ(D#,G*XAQM<CPBI0)*[5-DGQ.)'M*9>JZY!CQ5)?4R\.
MKO<1;%Y-\JP,D@M2+[H:666DX;;&.#+=@'/@+&%1SC?>W(Y&:'6P,NV1G,A'
M!\#06^BF=OBNL.EJ\?$*/\]B5#(5[4 [+T A*=$'<JQ3C+2@#;/A<?[/"R7<
MCP:8 )G53F;>5J^]C\Y?]V:YI:K#>4Q)!/)D2B7U5=F"ESZ#D"&&A)CSF&@
M>];XC+M8H@^@AP?#*%;";_GR)O](9MF6*'WZ1[RX2>2#U6[+]"M]P#]FR((K
M7B1(2D3RAVC%.ZL8F*28C0%MMNUKVG:>Y@2(M/9#]6$-._3I_U*P<+DYJC;<
MM2=?OEPM?LOI;Y=D^7L:B)BET8@"K&2T7HNNO+62$01)TR79('0W)J%&$YH
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MF0AM!*!/(I0=L1[F(5RT(J;96S/Q/RVW/TF@['<U\-6^4Q!JRZ. -BR/ ]H
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M9Q$<[>PA(]K'Q2A-#G].,6*<OIP3DH@%%MF?!EO<.GSOICT%PMCY@%3MB,)
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M8-RVU^PPV\?"YUR:VX>G^"W8,#H%6["'27QRDUT?8*UEOF=[OY%#<Y;S*:*
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MS.?S]KS?UF;:F=QT:*A!1VEMH2V<:)R=TAO\"UR<_>/TNU:+7>JDRJ%P+#'
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MO>G//&='0Y^%N&J;$DX9UE ;%]C1PIS9GD1G5:5B%T.7.+@X? U@L0"P988
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M6%>=C+J,&;-/:.%E],Y[7"YYF8G'AG(5 0.A8:BV?MF"N<Q"P3*(7:C.+73
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M+3(P,C(P.3,P7V1E9BYX;6Q02P$"% ,4    " !.@&-5ON=0V&J0!0#FW@<
M%               @ 'SFP( <V=M;RTR,#(R,#DS,%]G,2YJ<&=02P$"% ,4
M    " !.@&-5B-68$R:^!0#L*0@ %               @ &/+ @ <V=M;RTR
M,#(R,#DS,%]G,BYJ<&=02P$"% ,4    " !.@&-5<Q;M HSM!@#K6PD %
M            @ 'GZ@T <V=M;RTR,#(R,#DS,%]G,RYJ<&=02P$"% ,4
M" !.@&-52(X=$S2Z!0 2" @ %               @ &EV!0 <V=M;RTR,#(R
M,#DS,%]G-"YJ<&=02P$"% ,4    " !.@&-5<^DDE]RI   8\@8 %0
M        @ $+DQH <V=M;RTR,#(R,#DS,%]L86(N>&UL4$L! A0#%     @
M3H!C5>>P:X%D;0  N>D$ !4              ( !&CT; '-G;6\M,C R,C Y
M,S!?<')E+GAM;%!+ 0(4 Q0    ( $Z 8U7784S;'QD  !>$   >
M      "  ;&J&P!S9VUO+3(P,C(P.3,P>&5X,3 Q7V5M<&QO>2YH=&U02P$"
M% ,4    " !.@&-5/H1I"AH(   4)P  %P              @ $,Q!L <V=M
M;RTR,#(R,#DS,'AE>#,Q,2YH=&U02P$"% ,4    " !.@&-5A^GU2B,(  "'
M)P  %P              @ %;S!L <V=M;RTR,#(R,#DS,'AE>#,Q,BYH=&U0
M2P$"% ,4    " !.@&-5O1A+MUD&  "N&P  %P              @ &SU!L
M<V=M;RTR,#(R,#DS,'AE>#,R,2YH=&U02P$"% ,4    " !.@&-5$+1:OU4(
M  #J%   '               @ %!VQL <V=M;RTR,#(R,3$P,S(R>&5X-3%O
=<&EN+FAT;5!+!08     #P / /<#  #0XQL    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
